LGND-USA,PGNX-USA,ILMN-USA,SPPI-USA,ENDP-USA,ARWR-USA,BDSI-USA,TECH-USA,REGN-USA,SIGA-USA,OPK-USA,IONS-USA,BMRN-USA,ALXN-USA,NBIX-USA,SGEN-USA,IMMU-USA,BIIB-USA,IMGN-USA,BCRX-USA,GILD-USA,ARNA-USA,MYL-USA,CGEN-USA,AKRX-USA,AMGN-USA,MYGN-USA,LXRX-USA,MGTX-USA,INSM-USA,AUPH-USA,INO-USA,NKTR-USA,RIGL-USA,GERN-USA,AERI-USA,AMRN-USA,INCY-USA,UTHR-USA,SRPT-USA,ALKS-USA,CERS-USA,AMAG-USA,ARQL-USA,LMNX-USA,SGMO-USA,EXEL-USA,SNY-USA,VRTX-USA,ALLO-USA,ASND-USA,BLUE-USA,ACAD-USA,AFMD-USA,PTGX-USA,PRQR-USA,TXMD-USA,ZGNX-USA,ALLK-USA,OMER-USA,RVNC-USA,XON-USA,IRWD-USA,ADVM-USA,RARE-USA,AGLE-USA,NSTG-USA,PDLI-USA,SYRS-USA,RDUS-USA,ASMB-USA,ANIP-USA,ENTA-USA,ALNY-USA,WVE-USA,AKCA-USA,MRTX-USA,PCRX-USA,RTRX-USA,PACB-USA,EDIT-USA,CHMA-USA,MGNX-USA,BPMC-USA,AKBA-USA,EIGR-USA,MNTA-USA,PRTA-USA,ZLAB-USA,SAGE-USA,CTMX-USA,GMAB-USA,VNDA-USA,MEDP-USA,CBAY-USA,INVA-USA,CCXI-USA,HALO-USA,CBPO-USA,MNKD-USA,URGN-USA,CYTK-USA,ESPR-USA,AMRS-USA,PTCT-USA,ACHN-USA,SYNH-USA,FOLD-USA,EGRX-USA,DCPH-USA,ADMA-USA,GWPH-USA,EPZM-USA,JAZZ-USA,MYOK-USA,GRFS-USA,GLPG-USA,PTLA-USA,VCYT-USA,DRNA-USA,CLLS-USA,CARA-USA,FLXN-USA,QURE-USA,AGIO-USA,IOVA-USA,ANAB-USA,XLRN-USA,FATE-USA,HZNP-USA,CSTL-USA,ICPT-USA,KPTI-USA,GLYC-USA,XNCR-USA,ITCI-USA,TBPH-USA,NVCR-USA,ARDX-USA,AMPH-USA,ATRA-USA,RCKT-USA,DERM-USA,FOMX-USA,PRAH-USA,SUPN-USA,FGEN-USA,PBYI-USA,CHRS-USA,CRBP-USA,BOLD-USA,COLL-USA,XBIT-USA,MCRB-USA,AIMT-USA,GBT-USA,RGNX-USA,KURA-USA,APLS-USA,AXSM-USA,VYGR-USA,BGNE-USA,RARX-USA,RETA-USA,HCM-USA,NTLA-USA,ACIU-USA,CRSP-USA,GTHX-USA,ARGX-USA,RUBY-USA,ATNX-USA,PETQ-USA,RYTM-USA,OPTN-USA,TORC-USA,DNLI-USA,QTRX-USA,SLDB-USA,EOLS-USA,FIXX-USA,EYPT-USA,SRRK-USA,UBX-USA,AXNX-USA,TCDA-USA,EIDX-USA,AVRO-USA,MGTA-USA,XERS-USA,AUTL-USA,FTSV-USA,TBIO-USA,MRNA-USA,PRNB-USA,ARVN-USA,YMAB-USA,KOD-USA,GRTS-USA,GH-USA,OSMT-USA,NGM-USA,TWST-USA,ORTX-USA,GOSS-USA,ALEC-USA,DTIL-USA,TPTX-USA,PRVL-USA,AKRO-USA,BCEL-USA,PSNL-USA,STOK-USA,BBIO-USA,ADPT-USA,KRTX-USA
" 7/30/2019 LGND-US  PRN  Lemelson Capital Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Calls on US Attorney to Investigate","12/11/2019 74318710 PRN  SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation Regarding the November 12, 2019 Registration Statement of Progenics Pharmaceuticals, Inc.", 1/10/2020 002WRP-E    PRN  ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Tests,10/19/2017 84763A10 PRN  Latest Developments and Advancements in Healthcare Industry Pushing Companies to New Levels in the Market, 4/16/2020 G3040110 PRN  Endo to Announce First Quarter 2020 Financial Results," 1/16/2020 04280A10 PRN  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Arrowhead Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors",12/11/2019 09060J10 PRN  Emmy® and Tony Award® Winning Actress Kristin Chenoweth Introduces 'This Is Pain' Campaign to Improve the Lives of Those Living with Chronic Pain, 4/16/2020 09073M10    PRN  Bio-Techne Introduces RePlex Capabilities For Simple Western Assays On Jess™, 4/16/2020 75886F10    PRN  FDA Accepts for Priority Review Biologics License Application for REGN-EB3 to Treat Ebola, 1/22/2020 001M2B-E PRN  Researchers Say Flu Vaccines May Shrink Tumors and Aid in Treating Cancer, 4/06/2020 000CV5-E PRN  OPKO Health's BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with Suspected Coronavirus Disease 2019 (COVID-19), 7:05a     46222210 PRN  Ionis Pharmaceuticals to hold first quarter 2020 financial results webcast," 4/21/2020 09061G10   PRN  BioMarin Appoints Global Pharmaceutical Veteran C. Greg Guyer, Ph.D., to Chief Technical Officer, Executive Vice President of Global Manufacturing and Technical Operations, Effective May 4",11/27/2019 0017F0-E PRN  It's Been a Particularly Exciting Year for Biotech Stocks Across the Board, 4/15/2020 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2020 Financial Results, 2/19/2020 81257810 PRN  Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for PADCEV™ (enfortumab vedotin-ejfv) in Combination with Pembrolizumab in First-Line Advanced Bladder Cancer," 1/30/2019 45290710 PRN  IMMUNOMEDICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Immunomedics, Inc. To Contact The Firm"," 3/10/2020 000D1R-E  PRN  Genentech's Ocrevus Offers Stiff Competition to the New High-Efficacy Oral Therapies, Novartis' Mayzent and EMD Serono's Mavenclad, While Biogen's Vumerity Begins to Chip Away at the Company's Own Tecfidera","11/09/2017 000M1T-E PRN  Technical Reports on Biotech Equities -- ImmunoGen, Incyte, Infinity Pharma, and Insmed", 1/28/2020 000CVC-E PRN  Global Glioblastoma Multiforme Drugs Market Projected Could Reach $1.4 Billion By 2025," 3/09/2020 37555810   PRN  Thinking about trading options or stock in Caterpillar, Costco, Deere & Company, Gilead Sciences, or Tesla?", 4/10/2020 04004760   PRN  Arena Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference on April 14, 4/15/2020 000TBT-E  PRN  Mylan Board Appoints Robert J. Coury As Executive Chairman of Mylan N.V., 8:22a     M2572210 PRN  Compugen Expands Intellectual Property Portfolio for COM701 With New European Composition of Matter Patent, 4/01/2020 00972810 PRN  Akorn Provides Update on Sale Process, 4/14/2020 000C35-E PRN  Iceland Provides a Picture of the Early Spread of COVID-19 in a Population with a Cohesive Public Health Response,"11/23/2019 62855J10 PRN  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. and Encourages Investors to Contact the Firm",12/09/2019 002SM4-E PRN  Cancer Drug Revenues Expected to be Largest Share in Pharma Market, 1/31/2019 MGTX-US PRN  Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases," 4/20/2020 45766930 PRN  Insmed to Host First Quarter 2020 Financial Results Conference Call on Thursday, April 30, 2020", 9/26/2017 XTLB-IL  PRN  XTL Biopharmaceuticals Reports First Half 2017 Financial Results & Provides Clinical and Operational Update," 4/16/2020 062S3Y-E PRN  IVI, INOVIO, and KNIH to Partner with CEPI in Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine in South Korea", 2/28/2020 64026810 PRN  Nektar Therapeutics to Webcast Presentation at the Cowen and Company 40th Annual Health Care Conference, 2/27/2020 76655960 PRN  Rigel Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update, 2/20/2020 37416310 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Geron Corporation of Class Action Lawsuit and Upcoming Deadline - GERN," 7/26/2017 00771V10 PRN  Drug Makers Stock Performance Review -- Alliqua BioMedical, Aerie Pharma, Shire, and Heron Therapeutics",12/13/2019 02311120 PRN  Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk, 3/16/2020 45337C10 PRN  Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata," 6:00a     91307C10 PRN  United Therapeutics Corporation to Report First Quarter 2020 Financial Results Before the Market Opens on Wednesday, April 29, 2020"," 9/26/2019 80360710 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT", 7:00a     G0176710 PRN  Alkermes Announces Publication of Preclinical Data for ALKS 4230 in the Journal for ImmunoTherapy of Cancer, 6/20/2019 000LS4-E PRN  Food Safety Garners Increased Attention With Mounting Contamination Cases," 1/24/2020 00163U10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG"," 6/26/2017 04269E10 PRN  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating ArQule, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors"," 8:30a     55027E10 PRN  Luminex Corporation First Quarter Earnings Release Rescheduled for May 4, 2020", 6/21/2019 SGMO-US  PRN  Sangamo Announces Upcoming Presentation Of Investigational SB-525 Hemophilia A Gene Therapy Data At ISTH 2019, 6/25/2018 30161Q10 PRN  Copart Set to Join S&P 500; Exelixis to Join S&P MidCap 400; Clarifications to S&P U.S. Indices Methodology, 4/02/2020 005M9Z-E  PRN  Plug and Play Partners with Sanofi as Anchor Partner for Innovation Platform," 7/12/2019 000YJB-E  PRN  BNBuilders Implements Flawless Interior Design for Vertex Pharmaceuticals Building, Earning Calibre Design Award", 3/24/2020 005QS2-E PRN  MaxCyte and Allogene Therapeutics Sign Clinical and Commercial License Agreement to Enable the Advancement of Allogeneic CAR T (AlloCAR T™) Therapies, 5/23/2017 04351P10 PRN  Ascendis Pharma A/S Reports First Quarter 2017 Financial Results,"12/05/2018 09609G10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE",10/22/2019 0032YX-E PRN  Clinical Trials for Acute Myeloid Leukemia (AML) Drug Therapy Advancing With Encouraging Results," 2/03/2015 N0104510 PRN  Recent Developments at Pharma Companies: Special Research on Aerie Pharmaceuticals, AEterna Zentaris, Affimed, Agenus, and Agile Therapeutics", 4/15/2020 74366E10 PRN  Protagonist Therapeutics Reports Granting of Inducement Award, 9/18/2015 N7154210 PRN  Quarterly Results and Corporate Updates - Report on ProQR Therapeutics," 1/07/2020 00G5KL-E PRN  TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products"," 6/01/2019 98978L20    PRN  LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors Who Suffered Large Investment Losses to Contact the Firm"," 3/28/2020 01671P10 PRN  LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm",11/08/2018 68214310 PRN  Omeros Announces Proposed $210 Million Offering of Convertible Senior Notes Due 2023, 2/28/2018 76133010 PRN  Mylan to Bring a Biosimilar of BOTOX to the Market Through a Collaboration and License agreement with Revance Therapeutics, 4/20/2020 008349-E PRN  Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors, 5/31/2018 00FJ8Z-E PRN  Sarissa Capital Issues Statement On Ironwood Pharmaceuticals," 3/02/2020 00773U10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM", 3/31/2020 90400D10 PRN  REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder,#N/A, 3/28/2019 63009R10 PRN  Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling, 3/11/2020 69329Y10 PRN  PDL BioPharma Reports 2019 Fourth Quarter and Full Year Financial Results and Announces Plan to Dissolve the Company by Year-End 2020,"11/14/2017 87184Q10 PRN  Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team"," 4/27/2018 006RGD-E PRN  Biotech Stocks' Research Reports Released on Pieris Pharma, Portola Pharma, Protalix BioTherapeutics, and Radius Health", 1/09/2017 04539610 PRN  Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs, 4/14/2020 00182C10 PRN  ANI Announces Upcoming Departure of CEO," 4/21/2017 29251M10 PRN  Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic Regimen of Glecaprevir/Pibrentasvir (G/P) Achieved High SVR(12) Rates in Challenging to Treat Genotype 3 Chronic Hepatitis C", 1/22/2020 001M2B-E PRN  Researchers Say Flu Vaccines May Shrink Tumors and Aid in Treating Cancer, 2/12/2019 0015MG-E PRN  Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer, 1/22/2020 00972L10 PRN  Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx, 2/25/2020 60468T10 PRN  Mirati Therapeutics Reports Year-End 2019 Financial Results And Recent Corporate Updates, 9/24/2019 69512710 PRN  Pacira BioSciences Set to Join S&P SmallCap 600,"10/06/2016 76129910 PRN  Technical Roundup on Drug Makers Stocks -- Tonix Pharma, Retrophin, Heron Therapeutics, and GW Pharma", 3/05/2019 00674X-E PRN  Loop Genomics Expands Kit and Service Offerings with first tech that combines transcript counting with phasing for mRNA using long-reads on Illumina sequencers, 8/06/2018 0DFYQH-E PRN  Allergan and Editas Medicine Announce Exercise of Options to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101," 7/01/2016 16706W10 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Chiasma, Inc. of Class Action Lawsuit and Upcoming Deadline - CHMA","11/12/2019 55609910 PRN  DEADLINE ALERT - MacroGenics, Inc. (MGNX) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: November 12, 2019", 4/01/2020 09627Y10 PRN  Blueprint Medicines Announces the Achievement of Key Portfolio Milestones," 4/07/2020 00972D10 PRN  Akebia Therapeutics Appoints Myles Wolf, M.D., M.M.Sc., Chief of Nephrology and Professor at Duke University School of Medicine, to Board of Directors", 4/01/2020 28249U10 PRN  Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic," 1/03/2018 60877T10 PRN  Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA® (aflibercept)", 7/06/2018 G7280010 PRN  PRTA LOSS ALERT NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Prothena Corporation plc - PRTA, 4/08/2020 98887Q10 PRN  Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody),"12/10/2019 78667J10 PRN  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sage Therapeutics, Inc. (SAGE) Investors With 100K+ Losses to Contact Its Attorneys, Securities Fraud Investigation Opened", 1/07/2020 063S78-E PRN  CytomX Therapeutics Deploys Genedata Bioprocess, 3/26/2020 37230320 PRN  Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewing," 4/15/2020 92165910 PRN  Vanda Pharmaceuticals Announces Initiation of ""CALYPSO"" to Study the Role of Genetic Variation in COVID-19 Infections in Collaboration With University of Washington Medicine",12/21/2018 58506Q10 PRN  Medpace Holdings Set to Join S&P SmallCap 600," 3/03/2020 23257D10 PRN  CBAY Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Investigation of CymaBay Therapeutics, Inc. and Encourages Investors to Contact the Firm"," 3/30/2020 45781M10   PRN  Armata Pharmaceuticals Announces Closing of Second Tranche of $25 Million Securities Purchase Agreement with Innoviva, Inc.",11/27/2019 0017F0-E PRN  It's Been a Particularly Exciting Year for Biotech Stocks Across the Board, 4/03/2020 40637H10 PRN  Halozyme Announces Change Of Location Of Annual Stockholders' Meeting, 3/12/2020 G2151510 PRN  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019, 2/20/2019 0FL5G3-E PRN  People With Diabetes Using One Drop & Afrezza Significantly Lower A1c In 3 Months,#N/A," 2/26/2020 23282W60 PRN  Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis", 5/07/2019 002VD4-E PRN  Biotech Stocks: Why Expensive U.S. Drug Trials are Pushing Pharma Research Overseas, 4/20/2020 03236M20 PRN  Amyris Receives Approval to Sell its Fermented Sugarcane Reb M in Brazil and Canada, 4/17/2020 69366J20 PRN  PTC Therapeutics Announces New Leadership Appointments, 1/28/2020 000CVC-E PRN  Global Glioblastoma Multiforme Drugs Market Projected Could Reach $1.4 Billion By 2025, 1/09/2020 06CGGL-E PRN  Indegene's SaaS Platform For Life Sciences Adds Syneos Health as Strategic Collaborator and Minority Investor, 8/09/2019 ELOX-US  PRN  The Hennessy Group Announces Rare Disease Leadership Placements at Amicus Therapeutics and Eloxx Pharmaceuticals," 2/03/2017 26979610 PRN  How These Generic Drugs Stocks are Faring? -- Neurocrine Biosciences, Evoke Pharma, SCYNEXIS, and Eagle Pharma",10/29/2019 0011X6-E PRN  Clinical Trials in Gene Sequencing Reveal Novel Mutations Aiding in New Treatments for Acute Myeloid Leukemia," 3/27/2017 00089910 PRN  Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of ADMA Biologics, Inc. - ADMA",10/10/2019 05J212-E PRN  The Psilocybin Mushroom Story Could be the Next Big Investment Boom,12/09/2019 002SM4-E PRN  Cancer Drug Revenues Expected to be Largest Share in Pharma Market," 4/21/2020 G5087110 PRN  Jazz Pharmaceuticals to Report 2020 First Quarter Financial Results on May 5, 2020"," 4/18/2018 0011X6-E PRN  Free Research Reports on These Biotech Stocks -- Moleculin Biotech, MyoKardia, Nektar Therapeutics, and Novavax", 4/20/2020 39843840 PRN  People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers, 4/16/2020 36315X10 PRN  Galapagos and Ryvu Announce Research Collaboration," 4/07/2020 73701010 PRN  Portola Pharmaceuticals Announces the Establishment of a Permanent J-code for Andexxa by the Centers for Medicare & Medicaid Services, Effective July 1, 2020"," 9/19/2017 92337F10 PRN  Awareness Campaign Takes Lung Cancer Risk Head-On, Asking North Carolinians To Screen Together", 2/12/2019 0015MG-E PRN  Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer,10/02/2018 15117K10 PRN  Personalized Immunotherapy Could be the Future for Advanced Breast Cancer Treatment, 8/21/2019 CARA-US  PRN  Enteris BioPharma and Cara Therapeutics Enter into Licensing Agreement for Peptelligence® to Advance Development of Oral KORSUVA™, 6/13/2018 009T7W-E PRN  Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)," 6/17/2019 N9006410 PRN  Thinking about buying stock in Aurora Cannabis, Array Biopharma, Beyond Meat, Dare Bioscience, or Uniqure?"," 4/10/2018 AGIO-US  PRN  Lessons Learned from Implementing an Enterprise Clinical Data Hub, New Webinar Presented by eClinical Solutions LLC, Hosted by Xtalks", 5/31/2019 09N40F-E PRN  Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business," 3/31/2020 03272410 PRN  ANAB Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against AnaptysBio, Inc. (NASDAQ: ANAB); Lead Plaintiff Deadline is May 26, 2020", 2/20/2020 00434H10 PRN  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Acceleron Pharma Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors, 1/29/2020 001SM5-E PRN  Several Drugmakers are Racing to Create and Test a Vaccine for China's Deadly Coronavirus,11/08/2018 G4618810 PRN  Clinical Study Advancements for New Cancer Drug Candidates Boosting Optimism in Oncology Therapy Industry, 4/18/2019 00BJ80-E PRN  American Cancer Society's Newly Formed Philanthropic Impact Fund Makes First Investment,11/20/2018 0G0TRY-E PRN  TARGET PharmaSolutions® to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead Sciences, 9:08a     0844XQ-E PRN  Precision For Medicine Partners With Karyopharm Therapeutics To Initiate New Global Clinical Trial To Treat Patients With COVID-19,"11/02/2017 38000Q10 PRN  Biotech Stocks on Investors' Radar -- Curis, Egalet, Esperion Therapeutics, and GlycoMimetics", 6/24/2019 98401F10 PRN  MarketAxess Holdings Set to Join S&P 500; Axon Enterprise to Join S&P MidCap 400; Others to Join S&P SmallCap 600," 7/28/2017 46116X10 PRN  How These Biotech Stocks are Performing? -- Inovio Pharma, Intra Cellular Therapies, OncoMed Pharma, and Ophthotech", 4/20/2020 G8807B10 PRN  Theravance Biopharma Announces Peer-Reviewed Publication Highlighting TD-1473 Program in the Journal of Crohn's and Colitis," 2/27/2018 004SP8-E PRN  Medical Equipment Stocks' Research Reports Released on Nevro, NovoCure, NuVasive, and Nxstage Medical", 3/16/2020 03969710 PRN  Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors," 1/19/2017 03209R10 PRN  Lifshitz & Miller Law Firm Announces Investigation of Ally Financial Inc., Amphastar Pharmaceuticals, Inc., Lannett Company, Inc., Live Ventures Incorporated, MiMedx Group, Inc., Seattle Genetics, Inc., Teligent, Inc., TerraVia Holdings, Inc., and Zimmer Biomet Holdings, Inc."," 6/16/2015 04651310 PRN  Critical Alerts For Juno Therapeutics Inc, Cigna, Atara Biotherapeutics, TASER International and Halliburton Released By InvestorsObserver",11/26/2018 RGNX-US  PRN  REGENXBIO and Rocket Pharmaceuticals Announce New License Agreement for the Treatment of Danon Disease Using NAV AAV9 Vector, 2/20/2020 24983L10 PRN  Lilly Completes Acquisition of Dermira," 3/09/2020 M4613510 PRN  Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications", 1/07/2020 69354M10 PRN  Perspecta and PRA Health Sciences complete successful modernization of Million Veteran Program for U.S. Department of Veterans Affairs," 6/01/2018 06C8FT-E PRN  Faruqi & Faruqi, LLP is Investigating Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of its Shareholders", 1/30/2020 31572Q80 PRN  Astellas Submits Supplemental New Drug Application for Approval of Evrenzo® (roxadustat) for the Treatment of Anemia Associated with Chronic Kidney Disease in Non-Dialysis Dependent Patients in Japan, 3/04/2019 00189W-E PRN  U.S. Medical Device Market Reaches $156 Billion Mark," 2/05/2018 CHRS-US  PRN  AbSci Appoints Alan Herman, PhD to Scientific Advisory Board"," 3/22/2019 21833P10 PRN  Lifshitz & Miller LLP Announces Investigation of Corbus Pharmaceutical Holdings, Inc., Domino's Pizza, Inc., Eventbrite, Inc., Healthcare Services Group, Inc., Maxar Technologies, Inc., and Micron Technology, Inc.", 1/15/2020 062SS6-E PRN  Astellas Completes Acquisition of Audentes Therapeutics, 1/31/2020 19459J10 PRN  Biohaven Appoints Michael Heffernan To Board Of Directors,12/30/2019 000NB6-E PRN  Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc., 6/17/2019 81750R10 PRN  Microbiome Therapeutics Innovation Group Statement on FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms, 6/07/2017 AIMT-US  PRN  CoreRx and Aimmune Therapeutics Joint Expansion to Create Pharmaceutical Jobs and Increase the Base of Scientific Capabilities in the Tampa Bay Area," 9/13/2018 37890U10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Global Blood Therapeutics, Inc. - GBT", 6:30a     75901B10 PRN  REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD,10/05/2017 50127T10 PRN  Searching for Innovative Cancer Therapies in Biotech,11/13/2018 APLS-US     PRN  Enable Injections Enters into Strategic Partnerships with UCB and Apellis Pharmaceuticals,"12/19/2019 05464T10 PRN  Thinking about trading options or stock in Apple, Axsome Therapeutics, Deere & Co, Johnson & Johnson, or Eli Lilly?", 2/22/2019 92915B10 PRN  AbbVie and Voyager Therapeutics Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson's Disease and Other Synucleinopathies, 1/17/2020 0FTRYX-E PRN  111 Unveils New Video on the Impact of the Internet and other New Technologies on the Medical Industry, 4/02/2020 00CFZL-E PRN  UCB Completes the Acquisition of Ra Pharmaceuticals - to Deliver Differentiated Therapies to Patients, 3/03/2020 0085JM-E PRN  CNS Pharmaceuticals Announces Brain Cancer Patient from Berubicin Phase 1 Trial Remains Cancer Free, 3/26/2020 44842L10 PRN  Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewing, 1/28/2020 0DZX54-E PRN  Scientific Advisory Board Members Join Versatope Therapeutics Team,12/19/2018 H0026310 PRN  WuXi Biologics and AC Immune to Establish an Exclusive Strategic Partnership,11/04/2019 0DP3CK-E PRN  ViaCyte to Present at ISSCR International Symposium: Stem Cell Biology to New Therapies, 1/14/2020 3621LQ10 PRN  Quantum Leap Healthcare Collaborative and G1 Therapeutics Announce the Selection of Trilaciclib in the I-SPY 2 TRIAL for Breast Cancer, 2/04/2019 04016X10 PRN  argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE® Technology,11/04/2019 78116T10 PRN  Entrada Therapeutics Appoints Nathan Dowden as Chief Operating Officer,"12/13/2019 04685N10  PRN  Faruqi & Faruqi, LLP is Investigating Athenex, Inc. (ATNX) on Behalf of its Shareholders", 7/08/2019 71639T10 PRN  Perrigo Completes Divestiture of Animal Health Business for $185 Million, 1/09/2018 76243J10 PRN  WuXi NextCODE Artificial Intelligence Used to Advance Precision Therapy for Rare Genetic Disorders of Obesity, 9/26/2019 68404V10 PRN  Currax™ Pharmaceuticals LLC Announces First Acquisition: Acquires North American Rights to ONZETRA® Xsail®,#N/A,"11/15/2018 DNLI-US  PRN  Flagship Pioneering Names Ryan Watts, CEO of Denali Therapeutics, as Recipient of the 2018 Pioneering Leader Award"," 4/12/2019 009FRV-E PRN  Slone Partners, Where People Are Our Science®, Places Amol Chaubal As Chief Financial Officer At Quanterix"," 2/20/2019 83422E10 PRN  Lifshitz & Miller LLP Announces Investigation of Bristow Group Inc., Helius Medical Technologies, Inc., Nordstrom Inc., PriceSmart, Inc., Ryanair Holdings plc, Solid Biosciences Inc., and Vanda Pharmaceuticals Inc.", 5/21/2019 EOLS-US  PRN  ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt,10/01/2018 43808310 PRN  Homology Medicines to Present at Upcoming Conferences," 7/08/2019 30233G10 PRN  EyePoint Pharmaceuticals, Inc. - U.S. Commercialization of DEXYCU® (dexamethasone intraocular suspension) 9%",#N/A, 1/08/2019 91381U10 PRN  Ascentage Pharma Announces New License with Unity Biotechnology,#N/A,#N/A," 4/05/2019 28249H10 PRN  RM LAW Announces an Investigation of Eidos Therapeutics, Inc."," 3/25/2020 05455M10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVROBIO, Inc. - AVRO",#N/A,11/20/2019 007TNF-E PRN  Xeris Pharmaceuticals Empowers Their Medical Affairs Team with rMark Bio's Cue, 4/01/2019 05280R10 PRN  Arix Bioscience plc - Autolus Presents Initial AUTO1 Data at AACR," 3/17/2020 34983P10 PRN  FORTY SEVEN ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FTSV and Encourages Investors to Contact the Firm"," 3/27/2020 89374L10 PRN  Thinking about buying stock in Aytu Bioscience, GameStop, Translate Bio, Tilray, or T2 Biosystems?", 4/15/2020 0DMYDK-E PRN  Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response, 1/27/2020 74257L10 PRN  Sahm Adrangi's Kerrisdale Capital Issues Negative Report on Principia Biopharma Inc. and Announces Conference Call Schedule," 6/04/2019 0FV562-E PRN  Bayer and Arvinas, Inc. to develop novel Proteolysis-Targeting Chimera candidates for humans and plants", 7/03/2018 0DWMRJ-E PRN  MabVax Therapeutics Grants Exclusive Sublicense to Y-mAbs Therapeutics for Patented Neuroblastoma Vaccine, 4/02/2020 50015M10 PRN  Kodiak Sciences Appoints Charles Bancroft to Board of Directors," 2/03/2020 00FWPP-E PRN  Applied BioMath, LLC Announces Collaboration with Gritstone Oncology, Inc.",12/12/2019 00FYYJ-E PRN  COTA and Guardant Health Collaborate Using Real-World Data to Reveal Insights into Metastatic Colon Cancer and Prevalence of Biomarker Testing, 9/04/2019 G6S41R10 PRN  Osmotica Pharmaceuticals plc Announces Results of Extraordinary General Meeting," 1/15/2020 001M2B-E PRN  New Medical Device That is Proving Effective Against the Worlds Toughest Viruses, Including: Ebola, Hep C, HIV, West Nile and Smallpox Wins FDA Designation ""Breakthrough Device""", 1/23/2020 90184D10 PRN  Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus,#N/A," 4/06/2020 38341P10 PRN  GOSS INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies Gossamer Bio, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm", 3/10/2014 005Y9C-E PRN  Alector Teams Up with Johnson & Johnson Innovation to Explore Novel Alzheimer's Target,12/10/2019 0084LG-E PRN  Biotech Industry Focusing on Growing Demand for Lyophilized Injectable Drugs,#N/A,#N/A, 3/31/2020 00973Y10 PRN  All AKR-001 Dose Groups Met Week 12 Efficacy Endpoints in NASH Phase 2a BALANCED Study," 1/10/2020 00DHGL-E PRN  Serimmune and Atreca, Inc. Establish Research Collaboration Agreement in Oncology"," 4/21/2020 00DD8T-E PRN  Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities", 2/26/2019 XENE-US PRN  Behind the Seizure™ Program Expansion Helps Speed the Diagnosis of Genetic Epilepsy in Younger Children Experiencing Unprovoked Seizures, 3/04/2020 000D1R-E PRN  Advances in Treatments are Leading to a Decline in Deaths from Cancer, 4/07/2020 00650F10 PRN  Amgen And Adaptive Biotechnologies To Participate In Webinar On COVID-19 Strategic Collaboration,11/19/2019 00115K-E PRN  Why Oncology Drugs are Projected to Generate the Largest Pharma Revenues
 7/08/2019 53220K50 PRN  Ligand and SQ Innovation Enter into Exclusive Worldwide Captisol® License and Supply Agreements for High-Concentration Furosemide Formulation,"10/08/2019 74318710 PRN  Lifshitz & Miller LLP Announces Investigation of Arotech Corporation, Dova Pharmaceuticals, Inc., Highlands Bankshares, Inc., Progenics Pharmaceuticals, Inc., Proteon Therapeutics, Inc., Roan Resources, Inc., SemGroup Corporation and The Stars Group Inc.",12/03/2019 45232710    PRN  ArcherDX Announces Partnership with Illumina to Develop In-Vitro Diagnostic Tests," 2/02/2017 84763A10 PRN  Research Reports Coverage on Biotech Stocks -- Anavex Life Sciences, Omeros, Spectrum Pharma, and Lexicon Pharma", 2/26/2020 G3040110 PRN  Endo Reports Fourth-Quarter And Full-Year 2019 Financial Results,"12/13/2019 04280A10 PRN  Live Nation Entertainment, Zebra Technologies, STERIS Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600"," 3/22/2019 09060J10 PRN  Lifshitz & Miller LLP Announces Investigation of Alta Mesa Resources, Inc., American Renal Associates LLC,  Belden, Inc., BioDelivery Sciences, Inc., Blue Valley Bank Corp., Bridgepoint Education, Inc., and Care.com, Inc.", 4/15/2020 09073M10    PRN  Bio-Techne's Exosome Diagnostics Launches ExoDx Prostate At-Home Collection Kit, 4/08/2020 75886F10    PRN  Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)," 1/15/2020 001M2B-E PRN  New Medical Device That is Proving Effective Against the Worlds Toughest Viruses, Including: Ebola, Hep C, HIV, West Nile and Smallpox Wins FDA Designation ""Breakthrough Device""", 3/24/2020 000CV5-E PRN  OPKO Health's BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19), 4/20/2020 000VJ8-E PRN  Ionis and partner announce enrollment completion of global Phase 3 GENERATION HD1 study for Huntington's disease," 4/14/2020 09061G10   PRN  BioMarin to Host First Quarter 2020 Financial Results Conference Call and Webcast on Thursday, April 30 at 4:30pm ET","10/18/2019 01535110 PRN  SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc.", 4/03/2020 64125C10 PRN  Neurocrine Biosciences Provides COVID-19 Business Update, 2/10/2020 81257810 PRN  Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV™ (enfortumab vedotin-ejfv) in Combination with Immune Therapy Pembrolizumab as Investigational First-Line Treatment for Advanced Bladder Cancer," 1/25/2019 45290710 PRN  IMMUNOMEDICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU", 1/08/2020 00167Y-E  PRN  Behind the Seizure® Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsy,10/05/2017 45253H10 PRN  Searching for Innovative Cancer Therapies in Biotech," 1/23/2020 000CVC-E PRN  World Health Organization Accelerating Diagnostics, Vaccines, Therapeutics For Novel Coronavirus"," 3/03/2020 37555810   PRN  SHAREHOLDER ALERT: WeissLaw LLP Investigates Forty Seven, Inc.", 4/01/2020 04004760   PRN  Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR), 4/08/2020 N5946510  PRN  Mylan Updates Its Efforts Regarding COVID-19, 4/20/2020 M2572210 PRN  Compugen Announces Publication of BAY 1905254 Preclinical Data in Cancer Immunology Research, 2/12/2020 00972810 PRN  Akorn Announces New Extension of Standstill with Lenders and Agrees to Pursue a Sale of its Business, 4/14/2020 000C35-E PRN  Iceland Provides a Picture of the Early Spread of COVID-19 in a Population With a Cohesive Public Health Response,"11/18/2019 62855J10 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - MYGN"," 2/26/2019 52887230 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lexicon Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - LXRX",, 4/03/2020 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)," 9/26/2017 05156V10 PRN  Breakfast Technical Briefing on Biotech Stocks -- Amicus Therapeutics, Argos Therapeutics, Array BioPharma, and Aurinia Pharma", 4/15/2020 45773H20 PRN  INOVIO to Host its Annual Meeting of Stockholders in Virtual Format and at a New Time, 2/27/2020 64026810 PRN  Nektar Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results, 2/20/2020 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results, 1/31/2020 37416310 PRN  GERON CORPORATION INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action has been filed in the United States District Court for the Northern District of California on behalf of investors in Geron Corporation,"11/12/2015 00771V10 PRN  Covered Call Alerts For Skyworks Solutions, Alcoa, ADT, Box and Aerie Pharmaceuticals Released By InvestorsObserver",11/19/2019 00115K-E PRN  Why Oncology Drugs are Projected to Generate the Largest Pharma Revenues, 1/30/2020 45337C10 PRN  Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis, 4/09/2020 002G54-E PRN  Celularity Expands Strategic Collaboration with United Therapeutics Corporation to COVID-19 Infection and Acute Respiratory Distress Syndrome, 4/15/2019 07YK6X-E PRN  Paragon announces its second GMP manufacturing facility and the expansion of its strategic collaboration in manufacturing design and operation with gene therapy leader Sarepta Therapeutics, 3/04/2020 G0176710 PRN  Journal of Clinical Psychiatry Publishes Data from Alkermes' Phase 3 ENLIGHTEN-1 Efficacy Study of ALKS 3831 in Patients With Schizophrenia,10/30/2018 15708510 PRN  Data Projects the Global Medical Device Technologies Market to Grow $674 Billion by 2022, 8/29/2019 0FR2FY-E PRN  BioPlus Specialty Pharmacy in Semi-Exclusive Relationship to Dispense Vyleesi™ (Bremelanotide Injection), 9/12/2016 ARQL-US  PRN  West Elects New Director and Announces Increase to Quarterly Dividend, 4/06/2020 55027E10 PRN  Luminex Corporation Pre-Release of 1st Quarter Revenue," 5/15/2019 80067710 PRN  Sangamo Therapeutics Announces Presentations At Upcoming Scientific, Medical And Investor Conferences",10/23/2017 30161Q10 PRN  Biotech Companies Attempting to Save Lives, 3/20/2020 005M9Z-E  PRN  Arcadia Consumer Healthcare Acquires Iconic Over-the-Counter Anti-Diarrheal Medicine Kaopectate®," 1/24/2019 000YJB-E  PRN  Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors",, 5/11/2017 04351P10 PRN  Ascendis Pharma A/S Announces First Quarter 2017 Financial Results Conference Call on May 23,10/26/2018 05N2D8-E PRN  Bluebird Botanicals to Speak at Foodscape 2018 About the Future of Cannabis and Food," 6/25/2019 ACAD-US  PRN  New National Event Series ""Parkinson's IQ + You"" Launches to Educate and Empower Parkinson's Disease Patients and Care Partners",, 3/10/2020 74366E10 PRN  Protagonist Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results, 7/16/2015 N7154210 PRN  Quarterly Performance Review - Report on ProQR Therapeutics," 5/02/2019 88338N10 PRN  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TherapeuticsMD, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors"," 5/14/2019 98978L20    PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zogenix, Inc. of Class Action Lawsuit and Upcoming Deadline- ZGNX"," 3/11/2020 01671P10 PRN  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Allakos (ALLK) Investors with Who Have Suffered Losses to Contact Its Attorneys: Securities Fraud Class Action Filed", 5/22/2018 68214310 PRN  Recent Developments in the Stem Cell Market," 3/18/2014 008ZWN-E PRN  Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on Cell Therapeutics, Intrexon, Chimerix, Receptos, and Revance Therapeutics", 3/02/2020 008349-E PRN  Precigen Reports Fourth Quarter and Year End 2019 Financial Results, 5/01/2018 005VD0-E PRN  Allergan and Ironwood Launch Interactive Digital Destination During Irritable Bowel Syndrome (IBS) Awareness Month Designed to Encourage Sufferers to Get Educated and Take Action," 2/26/2020 00773U10 PRN  ADVM INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Adverum Biotechnologies, Inc.", 1/13/2020 00D326-E PRN  Growing Demand for Novel Drug Delivery Technologies that Allow Medication to Cross the Blood Brain Barrier,,"12/05/2017 A-US     PRN  Purigen Biosystems Appoints Life Science Industry Veteran Barney Saunders, PhD, As Chief Executive Officer", 3/09/2020 69329Y10 PRN  PDL BioPharma Announces Appointment of Edward A. Imbrogno as Vice President and Chief Financial Officer,12/15/2016 87184Q10 PRN  Flagship Ventures Evolves Name To Flagship Pioneering,"12/22/2017 005W0W-E PRN  Pre-Market Technical Scan on Biotech Equities -- Amicus Therapeutics, Radius Health, Sage Therapeutics, and Pulmatrix"," 6/16/2014 04539610 PRN  Ventrus BioSciences Analyst Report by BrokerBank Securities, Inc.", 4/13/2020 00182C10 PRN  ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL, 3/14/2017 29251M10 PRN  AbbVie Granted Priority Review in Japan for its Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of All Major Genotypes of Chronic Hepatitis C," 4/08/2019 02043Q10 PRN  Regeneron and Alnylam Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and Central Nervous System (CNS) Diseases",,10/08/2019 00DWZM-E PRN  Biotech Brief: U.S. Medical Technology Market Projected To Exceed $200 Billion By 2023," 2/19/2020 60468T10 PRN  Mirati Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","11/29/2017 69512710 PRN  Cancer Treatment Centers of America® Teams with Pacira Pharmaceuticals, Inc. on Innovative Collaboration to Educate Physicians and Patients about Responsible Opioid Use"," 1/09/2015 76129910 PRN  Ryan & Maniskas, LLP Announces Investigation of Retrophin, Inc.","12/06/2018 69404D10 PRN  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Pacific Biosciences of California, Inc. - PACB","11/14/2017 28106W10 PRN  Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team"," 6/27/2016 16706W10 PRN  Why Investors Have These Biotech Stocks on Their Radar? - Cerus, Juno Therapeutics, Chiasma, and Sage Therapeutics","10/08/2019 55609910 PRN  Lifshitz & Miller LLP Announces Investigation of Church & Dwight Co., Fibrocell Science, Inc., MacroGenics, Inc., MINDBODY, Inc., PaySign, Inc., Zebra Technologies Corporation and Zynerbia Pharmaceuticals"," 3/16/2020 09627Y10 PRN  Blueprint Medicines Announces Part 1 Results from PIONEER Trial Showing Broad Activity of Avapritinib Across Measures of Mast Cell Burden, Clinical Outcomes and Quality of Life in Indolent Systemic Mastocytosis", 4/02/2020 00972D10 PRN  Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 3/23/2020 28249U10 PRN  Eiger BioPharmaceuticals Completes Submission of New Drug Application to FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies,"10/04/2017 60877T10 PRN  Generic Drugs Stock Performance Review -- Momenta Pharma, Medicines Co., Diplomat Pharmacy, and Zoetis"," 6/05/2018 G7280010 PRN  Lifshitz & Miller LLP Announces Investigation of ACETO Corporation, Esperion Therapeutics, Inc., Flex Ltd., Kulicke and Soffa Industries, Inc., Macquarie Infrastructure Corporation, Mercury Systems, Inc., Ormat Technologies, Inc., and Prothena Corporation PLC", 1/17/2019 0DW6T1-E PRN  Qiming Venture Partners Announces 2019 Promotion," 5/23/2019 78667J10 PRN  Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Healthcare and BioTech Space - ACER, ACOR, ALNX, BIIB, DOVA and SAGE",11/08/2018 23284F10 PRN  Clinical Study Advancements for New Cancer Drug Candidates Boosting Optimism in Oncology Therapy Industry, 3/26/2018 37230320 PRN  Genmab A/S webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference," 4/15/2020 92165910 PRN  Vanda Pharmaceuticals, Northwell Health Conduct ODYSSEY Trial In Patients With Severe COVID-19 Pneumonia",10/06/2017 58506Q10 PRN  Hillman Announces Key Management Change, 3/02/2020 003MH3-E PRN  CymaBay: JFL Supports Engine Capital's Proposals, 1/28/2020 05XCS7-E   PRN  Armata Pharmaceuticals and Innoviva Announce $25 Million Strategic Investment to Support Advancement of Armata's Bacteriophage Development Programs," 6/28/2016 16383L10 PRN  What Investors are Making of These Biotech Stocks? - ChemoCentryx, Alder Biopharma, Neothetics, and OvaScience", 2/26/2020 40637H10 PRN  Halozyme Therapeutics To Present At The Cowen 40th Annual Health Care Conference, 3/03/2020 G2151510 PRN  China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial Results,10/16/2018 56400P70 PRN  United Therapeutics And MannKind Announce Closing Of License And Collaboration Agreement,,11/18/2019 23282W60 PRN  New Results From COSMIC-HF Presented At AHA 2019 Show Treatment Of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral Or Improved Measures Of Diastolic Function," 4/24/2019 29664W10 PRN  Moore Kuehn Encourages Esperion Therapeutics, Inc. Investors to Contact Law Firm for Possible Claims Against Officers and Directors", 4/13/2020 03236M20 PRN  Amyris Experiences Very Strong Sales Start with Pipette Hand Sanitizer for the Whole Family, 4/16/2020 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss First Quarter 2020 Financial Results,"11/04/2019 00448Q20 PRN  Lifshitz & Miller LLP Announces Investigation of Achillion Pharmaceuticals, Inc., Anixter International Inc., Central European Media Enterprises Ltd., Digital Realty Trust, Inc., Fitbit, Inc., MutualFirst Financial, Inc., and Ra Pharmaceuticals Inc.", 7/30/2019 87166B10 PRN  Acerus And Aytu Bioscience To Co-Promote NATESTO® In The United States,"12/22/2017 005W0W-E PRN  Pre-Market Technical Scan on Biotech Equities -- Amicus Therapeutics, Radius Health, Sage Therapeutics, and Pulmatrix","10/20/2016 00180J-E PRN  Research Reports Coverage on Generic Drugs Stocks -- Akorn, Eagle Pharma, Tetraphase Pharma, and Fibrocell Science",," 5/18/2015 00089910 PRN  Earnings Update: Complementary Research on Tantech Holdings, Sypris Solutions, Swisher Hygiene, XTL Biopharmaceuticals, ADMA Biologics", 8/21/2019 001BNC-E PRN  Cannabis Sales Continue to Grow Due to the Plant's Protean Nature,11/05/2019 29428V10 PRN  Royalty Pharma Announces Agreement to Purchase Future Royalties on Tazemetostat from Eisai for $330 Million and a $100 Million Initial Investment in Epizyme, 3/31/2020 G5087110 PRN  Jazz Pharmaceuticals Provides COVID-19 Business Update,"10/26/2017 62857M10 PRN  Stock Performance Review on Biotech Industry -- MyoKardia, Nabriva Therapeutics, Puma Biotechnology, and PDL BioPharma"," 4/06/2020 39843840 PRN  Grifols 2019 Annual Report on Form 20-F Filed With the SEC on April 6, 2020",10/24/2018 36315X10 PRN  AbbVie to Assume Full Development and Commercial Control of Cystic Fibrosis Research Program, 4/01/2020 73701010 PRN  Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 6/27/2017 92337F10 PRN  Veracyte Announces Publication of Study Supporting the Development of Envisia™ Genomic Classifier for IPF in Annals of the American Thoracic Society,10/29/2018 25303110 PRN  Lilly and Dicerna Announce RNAi Licensing and Research Collaboration, 5/01/2018 05G05Z-E PRN  Harvard's Wyss Institute partners with Cellectis to recode the human genome," 7/11/2019 CARA-US  PRN  Enteris BioPharma's ""Feasibility-to-Licensing"" Partner, Cara Therapeutics, Initiates Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA™ for Pruritus in Patients with Atopic Dermatitis"," 5/03/2018 006Z1J-E PRN  Technical Perspectives on Generic Drugs Stocks -- Allergan, Catalyst Pharma, Flexion Therapeutics, and Supernus Pharma", 6/28/2016 003MJS-E PRN  Protein Sciences Announces Exclusive License to uniQure of Cell Line and Technology for Production of Human Gene Therapies, 8/03/2017 00847X10 PRN  Recent FDA Decisions and Clinical Trial Developments Influencing Current Biotech Run," 3/06/2018 46226010 PRN  Johnson Fistel, LLP Announces Investigations of RH, WageWorks, Inc., BRF S.A., and Iovance Biotherapeutics, Inc.; Investors Encouraged to Contact Firm"," 3/31/2020 03272410 PRN  ANAB SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm", 5/01/2017 00434H10 PRN  Leading Protein Scientist Dr. Asya Grinberg Joins Dragonfly Therapeutics as Head of Biologics," 5/11/2015 31189P10 PRN  What Influences Business Growth: Complementary Research on Synageva BioPharma, Array BioPharma, Sarepta Therapeutics, Fate Therapeutics and Dyax", 6/07/2018 00FRH9-E PRN  Egalet Appoints Industry Veteran John Varian to Board of Directors, 5/31/2014 00BJ80-E PRN  Castle Biosciences' Esophageal Cancer Test Accurately Predicts Pre-Surgical Treatment Response,"11/11/2017 45845P10 PRN  November 27, 2017 LEAD PLAINTIFF DEADLINE ALERT: Monteverde & Associates PC Encourages Investors Who Suffered Significant Losses in Intercept Pharmaceuticals, Inc. To Contact The Firm - ICPT", 3/03/2020 006MTQ-E PRN  Research Studies Progressing Towards New FDA Approved Treatments for Glioblastoma,10/29/2015 HALO-US  PRN  Halozyme Announces First Clinical Dosing Of Pfizer's Rivipansel Using Enhanze™ Technology, 2/25/2019 98401F10 PRN  Xencor Reports Fourth Quarter and Full Year 2018 Financial Results," 6/28/2017 46116X10 PRN  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Intra-Cellular Therapies, Inc. - ITCI", 4/09/2020 G8807B10 PRN  Theravance Biopharma Responds to COVID-19 Pandemic by Advancing TD-0903 to Treat Hospitalized Patients with Acute Lung Injury," 1/18/2018 004SP8-E PRN  Quotidian Technical Highlights on Selected Medical Equipment Stocks -- Accuray, K2M Group, NuVasive, and NovoCure", 3/06/2020 03969710 PRN  Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights, 9/19/2016 03209R10 PRN  Cirrus Logic Set to Join the S&P MidCap 400; Amphastar Pharmaceuticals to Join S&P SmallCap 600," 2/13/2015 04651310 PRN  What's New in the Pharma Sector: New Research on Amgen, Applied Genetic Technologies, Aptose, ARIAD, and Atara Biotherapeutics", 2/24/2017 77313F10 PRN  URGENT: Monteverde & Associates PC Invites Inotek Pharmaceuticals Corporation Shareholders with Losses To Contact The Firm Immediately - ITEK," 1/29/2020 24983L10 PRN  Lifshitz & Miller LLP Announces Investigation of AquaVenture Holdings Limited, CenterState Bank Corporation, Dermira, Inc., The Habit Restaurants, Inc., Hexcel Corporation, LogMeIn, Inc., Telaria, Inc, and TiVo Corporation", 2/18/2020 M4613510 PRN  Foamix Announces Integrated Efficacy Results from the FMX103 1.5% Topical Minocycline Foam Phase 3 Program for Rosacea, 5/25/2018 69354M10 PRN  ABIOMED Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600," 5/03/2018 006Z1J-E PRN  Technical Perspectives on Generic Drugs Stocks -- Allergan, Catalyst Pharma, Flexion Therapeutics, and Supernus Pharma","11/05/2019 31572Q80 PRN  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages FibroGen (FGEN) Investors to Contact Its Attorneys Now, Firm Investigating Possible Securities Fraud","12/04/2018 0C4KPC-E PRN  uBiome Announces First Stage of Companion Diagnostic Development in Collaboration with Puma Biotechnology, Inc.","11/28/2017 19249H10 PRN  Stock Review for Biotech's Investors -- Spark Therapeutics, Agenus, Coherus Biosciences, and Acorda Therapeutics"," 3/21/2019 21833P10 PRN  CORBUS INVESTOR ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc.; Investors with Over $100K in Losses are Encouraged to Contact the Firm - CRBP","12/06/2019 05070R10 PRN  SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Audentes Therapeutics, Inc. - BOLD",11/20/2017 19459J10 PRN  Therapeutic Advancements in Breakthrough Therapies for Treating Chronic Pain Take aim at Reducing Opioid use,"11/16/2017 98400H10 PRN  Lifshitz & Miller LLP Announces Investigation of CBBC Bancorp, Clifton Bancorp Inc., Dynegy, Inc., GenMark Diagnostics, Inc., Impax Laboratories, Inc., RPM International Inc. and XBiotech Inc.", 3/18/2019 0CT325-E PRN  Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space," 2/16/2017 AKBA-US  PRN  Longitude Capital Promotes Josh Richardson, M.D., To Managing Director", 7/08/2016 37890U10 PRN  Global Blood Therapeutics Announces Publication of Preclinical GBT440 Results in British Journal of Haematology that Support Sickle Cell Disease (SCD) Program, 3/31/2020 75901B10 PRN  REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder,, 6/29/2017 00CLR1-E    PRN  Positive Data from APL-2 Studies Show Rapid and Durable Improvements in LDH and Hemoglobin Levels in PNH,12/04/2019 00FKGV-E PRN  Biotechs Move Forward Developing Latest Targeted Therapies for Acute Myeloid Leukemia, 2/20/2018 92915B10 PRN  AbbVie and Voyager Therapeutics Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer's Disease and Other Tau-Related Neurodegenerative Diseases, 1/03/2020 07725L10 PRN  Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing,"12/03/2019 74933V10 PRN  Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina Trust BancShares (CART), and Highlands Bankshares (HLND) Investors to Contact Firm", 2/04/2020 0085JM-E PRN  CNS Pharmaceuticals Announces Completion of GMP Manufacturing,"11/06/2019 44842L10 PRN  International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 13th and 14th, 2019", 9/27/2018 ARIA-US  PRN  Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture,12/12/2018 H0026310 PRN  Lilly and AC Immune Announce License and Collaboration Agreement,10/21/2019 0DP3CK-E PRN  CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics, 3/27/2014 0CRRZ8-E PRN  G1 Therapeutics to Share New Research Findings at AACR Annual Meeting 2014, 4/21/2016 04016X10 PRN  AbbVie and argenx to Collaborate on ARGX-115 Against Novel Immuno-Oncology Target, 1/04/2017 0FYJ7K-E PRN  Rubius Therapeutics Announces Appointment of Top Leadership, 5/07/2019 002VD4-E  PRN  Biotech Stocks: Why Expensive U.S. Drug Trials are Pushing Pharma Research Overseas," 5/13/2019 71639T10 PRN  Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., Community Health Systems, Equity Bancshares, Inc., Ford Motor Company, Interface, Inc., Monotype Imaging Holdings, Inc., PetIQ, Inc., and Pinduoduo, Inc.","11/14/2017 76243J10 PRN  Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team",12/11/2018 001LBG-E PRN  Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA® Xsail®,," 8/25/2016 0FK32T-E PRN  Denali Therapeutics Announces First Clinical Trial Application, Key Collaborations And $130M Series B",11/15/2012 009FRV-E PRN  bioMerieux and Quanterix Sign Strategic Partnership in Ultrasensitive and Multiplex Immunoassays," 5/25/2018 83422E10 PRN  SOLID BIOSCIENCES LEAD PLAINTIFF ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Solid Biosciences Inc. To Contact The Firm", 5/15/2019 30052C10 PRN  ALPHAEON Corporation sells 4 million shares in Evolus Inc., 8/30/2018 43808310 PRN  Homology Medicines to Participate in Gene Editing Panel at Citi's Biotech Conference,12/29/2015 30233G10 PRN  Pharma Industry Poised for Fast Start in 2016 as U.S. Food & Drug Administration Receives Requests for Newest Orphan Drug Designations & Rare Disease Treatments,," 3/27/2018 0G390C-E PRN  UNITY Biotechnology, Inc. Appoints Pharmaceutical Industry Executive Paul L. Berns to Board of Directors",,, 6/22/2018 28249H10 PRN  Eidos Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares,,," 6/20/2013 007TNF-E PRN  JDRF Announces Two Partnerships to Develop Stable, Pumpable Glucagon to Support Advanced Generation Artificial Pancreas Systems", 3/29/2019 05280R10 PRN  Arix Bioscience plc - Autolus Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019," 3/04/2020 34983P10 PRN  Moore Kuehn Encourages FTSV, MINI, POPE, WAAS, and TLRA Investors to Contact Law Firm",," 4/01/2020 60770K10 PRN  Thinking about buying stock in Advanced Micro Devices, Aytu Bioscience, Inseego, Moderna, or SuperCom?", 3/29/2016 00FYYJ-E PRN  Guardant Health Announces Collaboration With Principia Biopharma To Use Guardant360® for Monitoring Patient Response and Tumor Evolution in FGFR Inhibitor Trials,,," 3/24/2020 50015M10 PRN  ""Kodiak"" and ""Kodiak Sciences"" Trademarks Registered to Kodiak Sciences Inc. for Its Exclusive Use","12/19/2018 39868T10 PRN  TCR2 Therapeutics Announces Oncology Industry Leader and Expert Andrew Allen, M.D., Ph.D. Joins its Board of Directors","11/23/2018 00FYYJ-E PRN  Precision Oncology Company Guardant Health AMEA announces launch of its Asia, Middle East and Africa regional headquarters in Singapore", 7/02/2019 G6S41R10 PRN  Shareholder Rights Law Firm Johnson Fistel Launches Investigations," 3/20/2019 009Z8P-E PRN  NGM Bio Appoints Hsiao D. Lieu, M.D. as SVP, Chief Medical Officer and Alex DePaoli, M.D. to New Role of SVP, Chief Translational Officer", 7/11/2017 00FLML-E PRN  Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers,,,,11/14/2018 MXCT-GB  PRN  Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement,,, 3/30/2020 00973Y10 PRN  Akero Therapeutics to Announce Results for Week 12 Efficacy Endpoints from NASH Phase 2a BALANCED Study of AKR-001,,,,10/22/2019 10806X10 PRN  BridgeBio Pharma Gene Therapy Subsidiaries Present Data Demonstrating Potential in Two Rare Disease Indications at the European Society of Gene and Cell Therapy Conference, 4/02/2020 00650F10 PRN  Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19, 8/05/2015 09ZBXZ-E PRN  Karuna Receives Wellcome Trust Award to Advance Innovative Clinical Stage Product Candidate for the Treatment of Schizophrenia
 2/05/2019 0JD3SD-E PRN  Dianomi Therapeutics Receives Investment from Ligand Pharmaceuticals Based on Technology Developed at the University of Wisconsin-Madison,"10/04/2019 74318710 PRN  SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.",11/08/2019 0HK2JT-E    PRN  Lexent Bio Enters Partnership with Illumina to Develop an In Vitro Diagnostic Kit,"12/29/2016 84763A10 PRN  Research Reports Initiation on Biotech Stocks -- Incyte, Anavex Life Sciences, Portola Pharma, and Spectrum Pharma", 2/19/2020 G3040110 PRN  Endo Names Blaise Coleman President and Chief Executive Officer, 5/20/2019 04280A10 PRN  Kontoor Brands and Arrowhead Pharmaceuticals Set to Join S&P SmallCap 600," 2/20/2018 000CVC-E PRN  Technical Perspectives on Biotech Stocks -- BioCryst Pharma, BioDelivery Sciences, BioLine Rx, and BioTime"," 4/08/2020 09073M10    PRN  Bio-Techne To Host Conference Call On April 30, 2020 To Announce Third Quarter 2020 Financial Results", 4/06/2020 75886F10    PRN  Regeneron Finalizes Praluent® (alirocumab) Restructuring and Updates Accounting Presentation,11/16/2016 001M2B-E PRN  PharmAthene Receives Final Payment from SIGA of $83.9 Million, 3/23/2020 68375N10 PRN  OPKO Health's BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19)," 4/08/2020 46222210 PRN  Ionis establishes $25,000 scholarship to help ALS patients in greater San Diego area participate in physical and mental wellness programs", 4/06/2020 09061G10   PRN  BioMarin Plans Regulatory Submissions for Marketing Authorization of Vosoritide to Treat Children with Achondroplasia in 3Q 2020 in both US and Europe," 5/23/2019 01535110 PRN  Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Healthcare and BioTech Space - ACER, ACOR, ALNX, BIIB, DOVA and SAGE", 2/25/2020 64125C10 PRN  Neurocrine Biosciences to Present at Cowen 40th Annual Health Care Conference, 1/15/2020 000VJ8-E PRN  'Guided-Missile' Cancer Drugs are the Biotech Sector's First Major Story of the 2020s," 1/25/2019 45290710 PRN  IMMU CLASS ACTION: Rosen Law Firm Announces Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU",11/12/2019 09062X10  PRN  Alkermes Announces Receipt of $150 Million Milestone Payment from Biogen Related to FDA Approval of VUMERITY™,"10/05/2017 45253H10 PRN  Stocks Under Scanner in the Biotech Space -- ImmunoGen, Incyte, Infinity Pharma, and Insmed",11/20/2019 000BKB-E PRN  Why the Global Pain Management Drug Market is Adopting More Non-Opioid Options," 3/02/2020 37555810   PRN  (FTSV) Alert: Johnson Fistel Investigates Proposed Sale of Forty Seven, Inc.; Are Shareholders Getting a Fair Deal?", 3/30/2020 04004760   PRN  Arena Pharmaceuticals Names James C. Mullen as an Independent Senior Advisor," 3/27/2020 N5946510  PRN  Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept", 4/14/2020 M2572210 PRN  Compugen to Present Data Update on COM701 Phase 1 Clinical Trial at the 2020 AACR Virtual Annual Meeting, 2/10/2020 00972810 PRN  Akorn Continues Negotiations with Lenders, 4/07/2020 03116210 PRN  Amgen And Adaptive Biotechnologies To Participate In Webinar On COVID-19 Strategic Collaboration,10/01/2019 62855J10 PRN  MYGN CLASS ACTION DEADLINE: Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Myriad Genetics," 2/08/2019 52887230 PRN  RM LAW Announces Class Action Lawsuit Against Lexicon Pharmaceuticals, Inc.",, 4/02/2020 45766930 PRN  Insmed Appoints Carol A. Schafer to its Board of Directors, 6/15/2017 XTLB-IL  PRN  XTL Biopharmaceuticals Reports First Quarter 2017 Financial Results & Provides Clinical and Operational Update, 4/06/2020 062S3Y-E PRN  VGXI Supports Rapid Timeline to Clinical Testing for Coronavirus Vaccine," 2/18/2020 64026810 PRN  Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2019 on Thursday, February 27, 2020, After Close of U.S.-Based Financial Markets", 1/13/2020 76655960 PRN  Rigel Pharmaceuticals Provides Business Update," 1/25/2020 37416310 PRN  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Geron Corporation (GERN) Who Have Suffered Significant Losses to Contact its Attorneys: Securities Fraud Case Filed","11/03/2015 00771V10 PRN  Covered Call Alerts For Netflix, First Solar, Johnson & Johnson, Baidu and Aerie Pharmaceuticals Released By InvestorsObserver", 4/09/2019 02311120 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amarin Corporation plc of Class Action Lawsuit and Upcoming Deadline - AMRN, 1/27/2020 45337C10 PRN  Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in Patients with Moderate to Severe Atopic Dermatitis Not Controlled with Cyclosporine, 2/26/2020 91307C10 PRN  United Therapeutics Corporation Reports Fourth Quarter and Full Year 2019 Financial Results," 9/07/2018 80360710 PRN  Parent Project Muscular Dystrophy and Sarepta Therapeutics Partner to Launch Duchenne Outcomes Research Interchange, a Patient-Data Warehouse Serving the Entire Duchenne Community", 2/24/2020 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at the Cowen and Company 40th Annual Health Care Conference," 6/02/2017 15708510 PRN  Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Cara Therapeutics, Cerus, and Concert Pharma", 8/06/2018 AMAG-US  PRN  California Cryobank And Cord Blood Registry Combine To Create A Leading Life Sciences Platform," 7/02/2014 04269E10 PRN  Market Expansion, Merger Agreements, Management Transitions, and Market Activity - Analyst Notes on Intuitive Surgical, Auxilium, Horizon Pharma, Tesaro and ArQule", 4/06/2020 55027E10 PRN  Luminex Receives FDA Emergency Use Authorization for ARIES® SARS-CoV-2 Assay to Detect Virus Responsible for COVID-19 Disease, 5/10/2019 80067710 PRN  Sangamo Therapeutics Announces Participation In The Bank Of America Merrill Lynch 2019 Health Care Conference,"10/19/2017 30161Q10 PRN  Breakfast Technical Briefing on Biotech Stocks -- Coherus Biosciences, Exelixis, Geron, and Grifols", 3/16/2020 80105N10  PRN  Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19," 7/11/2018 062212-E  PRN  DUSA Pharmaceuticals, Inc. Files Lawsuit Against Biofrontera Inc. for Patent Infringement, Trade Secret Misappropriation, and Tortious Interference",, 4/28/2017 04351P10 PRN  Ascendis Pharma A/S Announces Upcoming Investor Presentations," 8/06/2018 09609G10 PRN  Regeneron and bluebird bio Announce Collaboration to Discover, Develop and Commercialize New Cell Therapies for Cancer", 9/01/2018 00422510 PRN  ACAD NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against ACADIA Pharmaceuticals Inc.; Important Sept. 17 Deadline - ACAD,, 3/02/2020 74366E10 PRN  Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results,,10/09/2018 0C472F-E PRN  Variant Pharmaceuticals Enhances Its Board of Directors with Three New Members," 5/02/2019 98978L20    PRN  ZGNX CLASS ACTION ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Zogenix, Inc. - ZGNX"," 1/17/2020 01671P10 PRN  ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against Allakos Inc. - ALLK"," 5/08/2018 003KPN-E PRN  Stock Performance Review on Biotech Industry -- Neptune Technologies & Bioressources, NewLink Genetics, OHR Pharma, and Omeros","10/16/2012 BHC-CA   PRN  The Zacks Analyst Blog Highlights: Medicis Pharmaceutical, Valeant Pharmaceuticals International, First Potomac Realty Trust, Ameriprise Financial and First Industrial Realty Trust", 2/24/2020 008349-E PRN  Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd,"10/27/2017 46333X10 PRN  Daily Technical Summary Reports on Generic Drugs Stocks -- Ironwood Pharma, Mylan, Neurocrine Biosciences, and Versartis", 2/15/2020 00773U10 PRN  Adverum (ADVM) Alert: Johnson Fistel Launches Investigation into Adverum Biotechnologies; Investors Encouraged to Contact Firm,10/22/2018 RGNX-US  PRN  REGENXBIO Announces Exclusive Worldwide License with Ultragenyx for the Treatment of CDKL5 Deficiency Disorder Using NAV Vectors,, 3/14/2016 63009R10 PRN  Providence Health & Services and Institute for Systems Biology affiliate to catalyze scientific wellness," 3/04/2020 69329Y10 PRN  PDL BioPharma to Announce 2019 Fourth Quarter and Full Year Financial Results on March 11, 2020", 1/22/2016 0DWB1Z-E PRN  WuXi Healthcare Ventures Joins Financing Rounds for Twist Bioscience and Syros Pharmaceuticals," 5/11/2017 75046920 PRN  Research Reports Coverage on Healthcare Stocks -- Radius Health, bluebird bio, Universal Health Services, and LifePoint Health"," 5/19/2014 04539610 PRN  Technical Summary on Pharma Stocks -- Research on Pacira Pharma, Ventrus Biosciences, Teva Pharma, and Novo Nordisk", 4/02/2020 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Omega-3-Acid Ethyl Esters Capsules USP, 2/27/2017 29251M10 PRN  AbbVie Receives CHMP Positive Opinion for Eight-Week Treatment Option with VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) for Patients with Genotype 1b Chronic Hepatitis C,"11/15/2018 02043Q10 PRN  Rosen Law Firm Reminds Alnylam Pharmaceuticals, Inc. Investors of Important November 26 Deadline in Class Action - ALNY",, 8/02/2018 00972L10 PRN  Akcea Therapeutics and PTC Therapeutics Collaborate to Commercialize Two Rare Disease Drugs in Latin America, 2/15/2020 60468T10 PRN  Mirati Therapeutics Announces Initial Data In Renal Cell Carcinoma From Ongoing Investigator Sponsored Clinical Trial Of Sitravatinib In Combination With Nivolumab At The 2020 ASCO Genitourinary Cancers Syposium," 1/25/2017 000NB6-E PRN  DePuy Synthes Announces Exclusive Co-Promotional Agreement with Pacira Pharmaceuticals, Inc."," 1/08/2015 76129910 PRN  Updated: Harwood Feffer LLP Announces Investigation of Retrophin, Inc.", 6/27/2018 00674X-E PRN  Researchers Of Newly Discovered European Cavefish Awarded Genome Sequencing Grant From Pacific Biosciences And GENEWIZ,"11/13/2017 002WRP-E PRN  Biotech Stocks on Investors' Radar -- Endocyte, Editas Medicine, Halozyme Therapeutics, and Illumina"," 6/23/2016 16706W10 PRN  SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces an Investigation of Chiasma, Inc. - CHMA","10/05/2019 55609910 PRN  ROSEN, A LEADING LAW FIRM, Reminds MacroGenics, Inc. Investors of Important Deadline in Securities Class Action - MGNX"," 3/09/2020 09627Y10 PRN  Blueprint Medicines to Report Updated Data from the Phase 2 PIONEER Trial of Avapritinib in Indolent Systemic Mastocytosis on Monday, March 16, 2020", 3/23/2020 00972D10 PRN  Akebia Therapeutics to Present Research at NKF 2020 Spring Clinical Meetings Live Virtual Conference, 3/13/2020 28249U10 PRN  Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update," 9/12/2017 005L7T-E PRN  Palatin Technologies Announces Appointment of Anthony M. Manning, Ph.D. to Board of Directors", 5/17/2018 G7280010 PRN  Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Prothena Corporation plc And Certain Of Its Current And Former Senior Executives,11/07/2017 98887Q10 PRN  China's Healthcare Market is Expected to Grow as Government Changes Regulations,"12/22/2017 005W0W-E PRN  Pre-Market Technical Scan on Biotech Equities -- Amicus Therapeutics, Radius Health, Sage Therapeutics, and Pulmatrix",10/03/2017 23284F10 PRN  Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology," 3/21/2018 37230320 PRN  International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on March 22, 2018", 4/08/2020 92165910 PRN  Vanda Pharmaceuticals Inc. And The University of Illinois at Chicago Announce Partnership To Identify Novel Antivirals Against COVID-19,," 2/28/2020 23257D10 PRN  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics (CBAY) Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating Possible Securities Fraud", 2/13/2018 00FJ8Z-E   PRN  Sarissa Capital Reconstitutes Innoviva Board Of Directors, 5/12/2016 16383L10 PRN  3 Stocks to Buy That Are Breaking Out in a Big Way, 2/25/2020 40637H10 PRN  Halozyme Announces FDA Has Accepted Biologics License Application For Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Enhanze® Technology, 2/24/2020 05PVT2-E PRN  Centurium Capital and Certain Other Investors File a Transaction Statement on Schedule 13E-3 with the U. S. Securities and Exchange Commission, 9/04/2018 005SV0-E PRN  United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products,," 3/20/2019 23282W60 PRN  Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis"," 6/05/2018 29664W10 PRN  Lifshitz & Miller LLP Announces Investigation of ACETO Corporation, Esperion Therapeutics, Inc., Flex Ltd., Kulicke and Soffa Industries, Inc., Macquarie Infrastructure Corporation, Mercury Systems, Inc., Ormat Technologies, Inc., and Prothena Corporation PLC", 3/31/2020 03236M20 PRN  Amyris Scales Up in Response to High Need for Its Hand Sanitizer and Wipe Products, 4/07/2020 000VJ8-E PRN  PTC Announces Regulatory Update on Risdiplam for Spinal Muscular Atrophy (SMA),"10/18/2019 00448Q20 PRN  SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc."," 4/10/2019 87166B10 PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Syneos Health, Inc. To Contact The Firm"," 9/26/2017 03152W10 PRN  Breakfast Technical Briefing on Biotech Stocks -- Amicus Therapeutics, Argos Therapeutics, Array BioPharma, and Aurinia Pharma"," 8/22/2016 26979610 PRN  Chemical Financial Set to Join S&P MidCap 400; Supervalu, Shoe Carnival and Eagle Pharmaceuticals to Join S&P SmallCap 600",,, 6/25/2019 00G39N-E PRN  Continued Legalization Efforts Aid the Cannabis Market's Global Expansion, 9/14/2017 29428V10 PRN  Biotech Sector Looking to Outperform in 2017, 3/25/2020 G5087110 PRN  Jazz Pharmaceuticals Announces FDA Acceptance of New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy," 8/09/2017 62857M10 PRN  Latest R&D Success, FDA Approvals and Significant Advances in Clinical Trials Boosting Biotech Sector", 3/25/2020 39843840 PRN  Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19," 5/14/2015 05MQCD-E PRN  Bryan, Garnier & Co Announces the Successful $275m IPO for Galapagos NV, the Largest Nasdaq IPO of European Biotech", 3/18/2020 73701010 PRN  Portola Pharmaceuticals Announces Proactive Steps Supporting Public Health Efforts to Combat Coronavirus (COVID-19)," 6/26/2017 92337F10 PRN  Veracyte Named a San Francisco Bay Area ""Top Workplace"" For Fourth Consecutive Year",10/03/2016 25303110 PRN  Biotechs with Key Corporate Developments," 9/05/2017 15117K10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Cellectis S.A. (CLLS)"," 6/27/2019 CARA-US  PRN  Enteris BioPharma's ""Feasibility-to-Licensing"" Partner, Cara Therapeutics, Initiates Second Pruritus Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA™"," 1/11/2018 TMO-US   PRN  Thermo Fisher Scientific Designs Flexible Manufacturing Site for Flexion Therapeutics, Inc."," 5/11/2015 N9006410 PRN  How it All Plays Out: Complementary Research on TrovaGene, Advaxis, NewLink Genetics, uniQure and Spark Therapeutics"," 3/08/2017 00847X10 PRN  How These Biotech Stocks are Faring? -- bluebird bio, Opexa Therapeutics, Agios Pharma, and PTC Therapeutics"," 3/02/2018 46226010 PRN  IOVANCE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL:  Kahn Swick & Foti, LLC Investigates the Officers and Directors of Iovance Biotherapeutics, Inc. - IOVA"," 3/27/2020 03272410 PRN  ANAB ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against AnaptysBio, Inc. - ANAB",10/03/2016 0068K6-E PRN  Dr. Matthew L. Sherman Joins Pulmatrix's Board of Directors," 4/23/2015 31189P10 PRN  Earnings Report Update: Free Research on Fate Therapeutics, La Jolla,FONAR, TASER, and Allied Motion", 5/03/2018 HZNP-US  PRN  AGC Biologics Enters into Commercial Manufacturing Agreement with Horizon Pharma plc, 5/14/2014 00BJ80-E PRN  Castle Biosciences' Melanoma Gene Expression Profile Test to be Subject of Presentation at American Society of Clinical Oncology Annual Meeting,"10/28/2017 45845P10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ICPT"," 9/18/2019 48576U10 PRN  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Karyopharm Therapeutics, Inc. (NASDAQ: KPTI) and Encourages Karyopharm Investors to Contact the Firm"," 8/26/2014 BMR-US   PRN  BioMed Realty Signs New Lease With GlycoMimetics At Its Newly Redeveloped Center For Life Science | Shady Grove Campus In Rockville, Maryland", 2/20/2019 98401F10 PRN  Xencor Announces Partial Clinical Hold on Phase 1 Study of XmAb14045," 6/02/2017 46116X10 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intra-Cellular Therapies, Inc. of Class Action Lawsuit and Upcoming Deadline - ITCI", 3/02/2020 G8807B10 PRN  Theravance Biopharma Announces Closing of Private Placement of $400 Million Non-Recourse Notes,"12/14/2017 G6674U10 PRN  Stock Review for Medical Equipment's Investors -- Prestige Brands, Senseonics, NovoCure, and Varian Medical Systems", 2/26/2020 03969710 PRN  Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference," 5/14/2015 03209R10 PRN  Business Highlights from the Healthcare Space: Complementary Research on Amphastar Pharma, Can-Fite BioPharma, Nanosphere, Immune Pharmaceuticals and Actinium Pharma",," 2/13/2017 77313F10 PRN  ITEK INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Inotek Pharmaceuticals Corporation and a Lead Plaintiff Deadline of March 7, 2017"," 1/15/2020 24983L10 PRN  Moore Kuehn, PLLC Encourages PRMW, DERM, CBB, and HABT Investors to Contact Firm", 2/06/2020 M4613510 PRN  Foamix Announces Publication of Phase 3 Studies Evaluating FMX103 for the Treatment of Papulopustular Rosacea in Journal of the American Academy of Dermatology," 5/02/2018 001CGF-E PRN  This Morning's Technical Outlook on Medical Research Stocks -- HTG Molecular Diagnostics, PRA Health Sciences, Quest Diagnostics, and TrovaGene"," 9/05/2017 86845910 PRN  Technical Snapshots for These Generic Drugs Stocks -- Catalyst Pharma, Flexion Therapeutics, Supernus Pharma, and Lannett", 9/20/2019 31572Q80 PRN  Evrenzo® (roxadustat) Tablets Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients, 6/18/2018 082SHP-E PRN  Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PDX Studies,"10/19/2017 19249H10 PRN  Breakfast Technical Briefing on Biotech Stocks -- Coherus Biosciences, Exelixis, Geron, and Grifols"," 3/13/2019 21833P10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corbus Pharmaceuticals Holdings, Inc.  - CRBP",12/04/2019 00FKGV-E PRN  Biotechs Move Forward Developing Latest Targeted Therapies for Acute Myeloid Leukemia," 5/15/2017 19459J10 PRN  How These Generic Drugs Stocks are Faring? -- Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharmacy"," 6/13/2017 98400H10 PRN  Pharma and Biotech Companies Significantly Investing in R&D, Focus on Rising Demand for Advanced Medicines", 8/14/2018 81750R10 PRN  The Microbiome Therapeutics Innovation Group Announces Coalition Formation and Leadership Team,"11/06/2015 00900T10 PRN  Covered Call Alerts For Tesla Motors, Ralph Lauren, Opko Health, BP and Aimmune Therapeutics Released By InvestorsObserver", 6/29/2016 37890U10 PRN  Global Blood Therapeutics Announces Initiation of Phase 2a Study of GBT440 in Adolescents with Sickle Cell Disease, 3/09/2020 75901B10 PRN  REGENXBIO to Present at the Barclays Global Healthcare Conference,, 5/09/2017 00CLR1-E    PRN  Apellis Receives EMA Orphan Drug Designation for APL-2 in PNH,,, 1/02/2020 000C35-E PRN  Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China,"11/04/2019 74933V10 PRN  Lifshitz & Miller LLP Announces Investigation of Achillion Pharmaceuticals, Inc., Anixter International Inc., Central European Media Enterprises Ltd., Digital Realty Trust, Inc., Fitbit, Inc., MutualFirst Financial, Inc., and Ra Pharmaceuticals Inc.", 1/14/2020 0085JM-E PRN  CNS Pharmaceuticals Announces Contract with International GMP Manufacturer for Production of Berubicin, 9/30/2019 HCM-GB   PRN  CKHH Aims to Deconsolidate Chi-Med and to Hold as a Strategic Investment for the Long Term, 5/22/2018 45826J10 PRN  Recent Developments in the Stem Cell Market, 9/12/2017 H0026310 PRN  Alzheimer's Disease: Cannabis Formulation Shows Promise, 2/26/2019 0DP3CK-E PRN  Open Dialogue and Transparency Drive Progress in Modern Agriculture and Consumer Acceptance, 1/08/2014 0CRRZ8-E PRN  G1 Therapeutics to Present at Biotech Showcase 2014, 6/10/2014 07N3G8-E PRN  arGEN-X and The Leukemia & Lymphoma Society Partner on the Development of ARGX-110 for the Treatment of Waldenström's Macroglobulinemia,, 3/04/2019 04685N10  PRN  Almirall and Athenex Announce Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual Meeting, 5/08/2019 71639T10 PRN  Perrigo To Divest Animal Health Business For $185 Million In Cash As Part Of Consumer Self-Care Transformation, 8/01/2017 00FMDK-E PRN  Rhythm Expands Executive Leadership Team," 6/12/2014 00CN92-E PRN  OptiNose Expands Senior Management Team with Three Key Appointments in Core Business Areas of Operations, Regulatory Affairs and Commercialization",, 9/08/2015 0FK32T-E PRN  Denali Therapeutics Appoints Steve E. Krognes as Chief Financial Officer,"10/11/2012 009FRV-E PRN  Quanterix's Ultrasensitive Simoa™ Technology Demonstrates Equivalence with NAT and 3,000x Improvement in Sensitivity over Conventional Immunoassays for HIV Detection", 5/02/2018 83422E10 PRN  WeissLaw LLP: Solid Biosciences Inc. is the Subject of a Legal Investigation,"12/03/2018 EOLS-US  PRN  ALPHAEON repays outstanding principal amount under its secured convertible notes due December 23, 2018", 8/13/2018 43808310 PRN  Homology Medicines Reports Second Quarter 2018 Financial Results,"12/22/2014 30233G10 PRN  Earnings Review: Free Research Reports on PMFG Inc., pSivida, Quantum Technologies, Raven Industries and RBC Bearings",," 3/19/2018 0G390C-E PRN  UNITY Biotechnology, Inc. Completes $55 Million Series C Financing",,, 6/19/2018 28249H10 PRN  Eidos Therapeutics Announces Pricing of Initial Public Offering,,,," 2/25/2019 05280R10 PRN  Autolus Therapeutics Reports Financial and Operational Results for the Transition Period from October 1 to December 31, 2018"," 3/03/2020 34983P10 PRN  SHAREHOLDER ALERT: WeissLaw LLP Investigates Forty Seven, Inc.",, 3/03/2020 001715-E PRN  Aggressive Infectious Diseases Prompt the Development of Powerful New Blood Tests,"10/29/2012 00D1VN-E PRN  Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team",,, 3/16/2020 50015M10 PRN  Kodiak Sciences Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights, 3/01/2017 0FTYWS-E PRN  Gritstone Oncology to Present at Cowen and Company's 37th Annual Health Care Conference,10/19/2018 40131M10 PRN  Guardant Health Presents Data on Immunotherapy-related Biomarkers MSI and TMB in blood of advanced cancer patients at European Society of Medical Oncology Annual Meeting," 4/02/2019 G6S41R10 PRN  Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., iRhythm Technologies, Inc., Orion Group Holdings, Inc., Osmotica Pharmaceuticals plc, Quantenna Communications, Inc., WABCO Holdings, Inc. and Zafgen, Inc.","11/12/2018 009Z8P-E PRN  NGM Bio Announces Preliminary Results from Phase 1b Study of NGM313 in Obese, Insulin Resistant Subjects with Nonalcoholic Fatty Liver Disease (NAFLD)"," 7/11/2017 00FLML-E PRN  Quintara Biosciences Partners with Twist Bioscience to Launch New Gene Fragment and Cloning Services, qBlocks and qGenes",,,," 2/22/2018 0084LG-E PRN  Cargill, Precision BioSciences team up to develop next generation of low saturate, high oleic canola oil",,, 3/16/2020 00973Y10 PRN  Akero Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results,,,,10/17/2019 0JVC6M-E PRN  QED and Parent Company BridgeBio Announce Preclinical Data Supporting Tolerability and Activity of Low-dose Infigratinib in Treating Achondroplasia, 3/20/2020 00650F10 PRN  Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access,
 1/16/2019 53220K50 PRN  Wolf Popper LLP Announces Investigation on Behalf of Investors in Ligand Pharmaceuticals Incorporated,"10/03/2019 74318710 PRN  Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Progenics Pharmaceuticals, Inc. has obtained a Fair Price in its sale to Lantheus Holdings, Inc.",10/29/2019 002WRP-E    PRN  Illumina Celebrates Grand Opening of Its Solutions Center in the University of Maryland BioPark,"10/28/2016 84763A10 PRN  Research Reports Initiation on Biotech Stocks -- Spectrum Pharma, Pain Therapeutics, CoLucid Pharma, and CEL-SCI", 2/19/2020 G3040110 PRN  Endo Appoints Mark G. Barberio to Board of Directors,"11/08/2017 001B9Z-E PRN  Biotech Stocks on Investors' Radar -- Aralez Pharma, Arena Pharma, Arrowhead Pharma, and AveXis",11/27/2017 09060J10 PRN  BioDelivery Sciences Announces Ohio Workers Compensation Adding BELBUCA and BUNAVAIL to Formulary, 4/01/2020 09073M10    PRN  Dr. Roeland Nusse: Gairdner Award Recipient and Bio-Techne Board of Directors Member, 4/03/2020 75886F10    PRN  Dupixent® (dupilumab) Phase 3 Data at Revolutionizing Atopic Dermatitis Conference Show Significant Improvement in Severe Atopic Dermatitis for Children Aged 6 to 11 Years, 9/16/2016 001M2B-E PRN  PharmAthene Announces Receipt of Payments from SIGA, 3/20/2020 000CV5-E PRN  OPKO Health's BioReference Laboratories and State of New Jersey Provide Testing for Coronavirus Disease 2019 (COVID-19), 4/07/2020 46222210 PRN  Ionis Pharmaceuticals to present at upcoming investor conferences," 3/09/2020 09061G10   PRN  BioMarin's Brinda Balakrishnan, M.D., Ph.D., Honored with 2020 ""40 Under 40"" Award from the San Francisco Business Times"," 9/07/2018 00FWPP-E PRN  Applied BioMath, LLC Announces Webinar on using Systems Pharmacology for First-in-Human Dose Predictions", 2/04/2020 64125C10 PRN  Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2019 Financial Results,"12/18/2019 81257810 PRN  FDA Grants Accelerated Approval to Astellas' and Seattle Genetics' PADCEV™ (enfortumab vedotin-ejfv) for People with Locally Advanced or Metastatic Urothelial Cancer, the Most Common Type of Bladder Cancer"," 1/12/2019 45290710 PRN  Johnson Fistel, LLP Notifies Investors of Class Actions Against Sogou Inc., Immunomedics, Inc., and Ternium S.A.; Investors Encouraged to Contact Firm",10/30/2019 09062X10  PRN  Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple Sclerosis," 8/29/2017 45253H10 PRN  Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products"," 6/20/2018 BCRX-US  PRN  Great Point Partners, LLC Remains Opposed To The BioCryst Pharmaceutical Proposed Merger With Idera Pharmaceuticals, Inc.", 2/06/2020 000L1R-E   PRN  Sierra Oncology Completes Conversion of Preferred to Common Stock and Issues Stock to Gilead, 3/18/2020 04004760   PRN  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 3/26/2020 N5946510  PRN  Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn, 4/06/2020 M2572210 PRN  Compugen Announces First Patient Dosed in COM902 Phase 1 Trial for Patients With Advanced Malignancies,"10/07/2019 000BNP-E PRN  Notice of Proposed Class Action Settlement Involving All Persons or Entities Who Purchased or Otherwise Acquired Akorn, Inc. Common Stock", 4/02/2020 03116210 PRN  Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19, 9/30/2019 62855J10 PRN  MYGN Loss Alert: Hagens Berman Notifies Investors in Myriad Genetics (MYGN) of Securities Fraud Lawsuit," 1/30/2019 52887230 PRN  LEXICON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lexicon Pharmaceuticals, Inc. To Contact The Firm",, 3/16/2020 45766930 PRN  Insmed Provides Business Update, 9/26/2016 05156V10 PRN  TechStockInsider.com: The Week Many Have Been Waiting For, 4/06/2020 45773H20 PRN  INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today," 2/03/2020 64026810 PRN  Nektar Therapeutics Announces Publication of Two Manuscripts on Lead Immuno-oncology Candidate, Bempegaldesleukin (Bempeg) in Nature Communications", 1/09/2020 76655960 PRN  Rigel to Present at the 38th Annual J.P. Morgan Healthcare Conference," 1/25/2020 37416310 PRN  GERN LOSS NOTICE: ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Geron Corporation - GERN","11/02/2015 00771V10 PRN  Covered Call Alerts For Netflix, First Solar, Johnson & Johnson, Baidu and Aerie Pharmaceuticals Released By InvestorsObserver", 3/19/2019 001H9D-E PRN  Clinical Trials for Leukemia Exhibiting Encouraging Advancements,"10/23/2019 000M2Q-E PRN  Fourth-IR, Incyte, and Xylem Receive ""Tell Awards"" for FDI in Switzerland", 2/25/2020 91307C10 PRN  United Therapeutics Corporation To Present At The 40th Annual Cowen And Company Healthcare Conference, 5/07/2018 80360710 PRN  Sarepta and Invitae Expand Partnership to Advance Clinical Research in Duchenne Muscular Dystrophy, 2/19/2020 G0176710 PRN  Alkermes to Present at the 9th Annual SVB Leerink Global Healthcare Conference," 8/04/2016 008BK4-E PRN  Research Report Initiation on These Biotech Stocks -- Tesaro, Cerus, Five Prime Therapeutics, and Intercept Pharma", 6/15/2018 AMAG-US  PRN  California Cryobank And Cord Blood Registry To Be Combined By GI Partners To Create A Leading Life Sciences Platform," 5/22/2014 NOV-US   PRN  Washington Prime Group, NOW, Civeo Set to Join S&P MidCap 400; UTi Worldwide, General Cable, Matthews International to Join S&P SmallCap 600"," 3/31/2020 55027E10 PRN  Luminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test", 5/08/2019 80067710 PRN  Sangamo Therapeutics Reports First Quarter 2019 Financial Results, 2/27/2017 30161Q10 PRN  New Cancer Therapeutics Drive the Cancer Biological Therapy Market, 3/02/2020 80105N10  PRN  FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma, 6/25/2018 000YJB-E  PRN  BNBuilders Completes Construction on Vertex Pharmaceuticals Research Center in San Diego,, 4/03/2017 04351P10 PRN  Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017,12/20/2017 05N2D8-E PRN  MilliporeSigma Signs Commercial Supply Agreement with bluebird bio for Viral Vector Manufacturing, 8/29/2018 00422510 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD,, 2/19/2020 74366E10 PRN  Protagonist Therapeutics to Present at the SVB Leerink 9th Annual Global Healthcare Conference in New York,," 5/30/2018 88338N10 PRN  TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY™ (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom of VVA, due to Menopause"," 4/22/2019 98978L20    PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm", 1/06/2020 01671P10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK," 2/21/2018 005P05-E PRN  FourWorld Capital Spotlights 90% Sales Collapse of Omeros Sole Product OMIDRIA in Past Two Months, Reflecting Company's Weakening State",,, 4/13/2017 46333X10 PRN  Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5), 2/11/2020 00135R-E PRN  Biotech Brief: Global Diabetes Drug Market Could Reach $78 Billion By End Of 2026, 6/07/2018 0GGR0D-E PRN  PANTHERx® Specialty Pharmacy Selected by Ultragenyx to Distribute Crysvita,," 2/17/2015 63009R10 PRN  Be on Top of the Latest Happenings: Special Research on La Jolla, Lpath, Macrocure, Momenta, and NanoString", 2/28/2020 06C5B2-E PRN  PDL BioPharma Enters into Cooperation Agreement with Engine Capital,," 1/27/2017 75046920 PRN  Research Reports Coverage on Biotech Stocks -- Idera Pharma, Ocular Therapeutix, Radius Health, and Grifols"," 7/02/2013 04539610 PRN  VENTRUS BIOSCIENCES ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Ventrus Biosciences, Inc. of Class Action Lawsuit and the Deadline of July 8, 2013 to Seek a Lead Plaintiff Position"," 3/26/2020 00182C10 PRN  ANI Announces Launch of Polyethylene Glycol 3350, 17g/Packet", 2/02/2017 29251M10 PRN  U.S. FDA Grants Priority Review to AbbVie for its Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6),10/29/2018 02043Q10 PRN  Invitae expands work with Alnylam Pharmaceuticals to provide access to genetic testing for primary hyperoxaluria,, 7/05/2018 00972L10 PRN  New England Journal of Medicine Publishes Results from Pivotal Study of TEGSEDI™ (inotersen) for the Treatment of Hereditary ATTR Amyloidosis, 1/14/2020 60468T10 PRN  Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares," 8/24/2016 69512710 PRN  Research Report Initiation on Generic Drugs Makers Stocks -- Ironwood Pharma, The Medicines, Carbylan Therapeutics, and Pacira Pharma","12/12/2014 76129910 PRN  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Retrophin, Inc. and Lead Plaintiff Deadline of December 19, 2014", 4/24/2018 00674X-E PRN  GENEWIZ And Pacific Biosciences Announce Winner Of The 2017 Structural Variant SMRT® Grant Program, 3/14/2017 28106W10 PRN  Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases," 5/09/2016 16706W10 PRN  Lifshitz & Miller Law Firm Announces Investigation of Amaya, Inc., Chiasma, Inc., Intrexon Corporation, Natus Medical Inc., NRG Yield, Inc., Sunrun Inc., TransEnterix and Vivint Solar, Inc."," 9/19/2019 55609910 PRN  MGNX NOTICE: ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against MacroGenics, Inc.", 2/24/2020 09627Y10 PRN  Blueprint Medicines to Present Updated Data from Phase 2 PIONEER Trial of Avapritinib in Patients with Indolent Systemic Mastocytosis at 2020 AAAAI Annual Meeting," 3/12/2019 00972D10 PRN  Thinking about buying stock in Aurora Cannabis Inc., Akebia Therapeutics, Bio-Path Holdings, Globus Maritime Ltd., or Stitch Fix Inc.?", 1/07/2020 28249U10 PRN  Eiger BioPharmaceuticals Appoints Industry Veteran Eldon Mayer as Executive Vice President and Chief Commercial Officer," 5/15/2017 60877T10 PRN  How These Generic Drugs Stocks are Faring? -- Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharmacy"," 5/17/2018 G7280010 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Encourages Investors Who Suffered Losses Exceeding $2,000,000 Investing In Prothena Corporation plc (PRTA) To Contact The Firm", 6/28/2017 0DW6T1-E PRN  Zai Lab Secures Series C Financing, 4/03/2017 78667J10 PRN  Pershing Gold to Present at 2017 European Gold Forum, 9/21/2017 23284F10 PRN  UNITY Biotechnology Appoints Additional Biotech Industry Veterans to Executive Team," 3/21/2018 37230320 PRN  Genmab A/S to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on March 22, 2018"," 4/02/2020 92165910 PRN  Vanda Pharmaceuticals Announces the Initiation of ODYSSEY, an FDA Approved Clinical Study of Tradipitant in Hospitalized Patients with Severe COVID-19 Pneumonia",, 5/18/2018 003MH3-E PRN  HistoIndex and CymaBay Therapeutics Team up to Advance NASH Drug Development,"10/02/2017 45781M10   PRN  Breakfast Technical Briefing on Application Software Stocks -- FireEye, Fortinet, Innoviva, and Intuit", 4/12/2012 16383L10 PRN  ChemoCentryx to Present at the 19th Annual Future Leaders in the Biotech Industry Conference, 2/24/2020 40637H10 PRN  Halozyme Reports Fourth Quarter and Full Year 2019 Results,11/13/2019 G2151510 PRN  China Biologic Reports Financial Results for the Third Quarter of 2019," 5/04/2018 005SV0-E PRN  Free Research Reports on These Biotech Stocks -- MannKind, Marinus Pharma, Mirati Therapeutics, and OncoSec Medical",," 2/21/2019 23282W60 PRN  Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure"," 5/31/2018 002VD4-E PRN  WeissLaw LLP: Esperion Therapeutics, Inc. is the Subject of a Legal Investigation", 3/26/2020 03236M20 PRN  Amyris Launches Leading Hand Sanitizer and Receives Initial Positive Result for Vaccine Adjuvant, 3/16/2020 69366J20 PRN  PTC Therapeutics Announces Management Change," 3/29/2017 00448Q20 PRN  Biotech Stocks Under Scanner -- Celsion, Achillion Pharma, Tenax Therapeutics, and Cerulean Pharma"," 3/11/2019 87166B10 PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Syneos Health, Inc. To Contact The Firm","11/29/2016 03152W10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amicus Therapeutics, Inc. (FOLD)"," 8/10/2016 26979610 PRN  InvestorsObserver releases covered-call reports for Netflix, Nevro Corporation, Eagle Pharmaceuticals, Mylan and Weibo",,, 6/11/2019 00820H-E PRN  Dramatically Improved Delivery Systems Promise More Effective Cannabis Treatments, 2/06/2017 EPZM-US  PRN  Strata Oncology Announces Collaboration with Epizyme to Support Tazemetostat Clinical Development, 2/26/2020 G5087110 PRN  Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences,"10/17/2016 CALA-US  PRN  Sofinnova Announces the Addition of Industry Veteran Sunil Agarwal, MD to its Partnership"," 2/13/2020 00394S-E PRN  Grifols PharmacyKeeper ranked No. 1 in KLAS rating, extends category leadership",10/27/2014 36315X10 PRN  Calchan and Galapagos Collaborate on Osteoarthritis Pain Research, 3/16/2020 73701010 PRN  Portola Pharmaceuticals Announces Results Demonstrating Andexxa® was Associated with Lowest Rate of Mortality in Patients with Multiple Types of Factor Xa Inhibitor-Related Bleeds, 6/01/2017 92337F10 PRN  Veracyte to Present at William Blair 2017 Growth Stock Conference," 6/10/2015 25303110 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dicerna Pharmaceuticals, Inc. - DRNA", 9/05/2017 15117K10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS, 9/26/2018 14075510 PRN  CBD Supplements Primed to Explode Ahead of Biopharma as Farm Bill Legalizes Hemp,10/09/2017 33938J10 PRN  Flexion Therapeutics to Hold Conference Call at 8:00 a.m. ET to Discuss Recent FDA Approval of ZILRETTA™ (triamcinolone acetonide extended-release injectable suspension), 1/14/2015 N9006410 PRN  Treeway Announces License and Collaboration Agreement with uniQure to Develop a Gene Therapy for Amyotrophic Lateral Sclerosis (ALS),"12/16/2016 00847X10 PRN  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Agios Pharmaceuticals, Inc. and Certain Officers and Directors -- AGIO"," 1/12/2018 46226010 PRN  IOVANCE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL:  Kahn Swick & Foti, LLC Investigates the Officers and Directors of Iovance Biotherapeutics, Inc. - IOVA"," 3/27/2020 03272410 PRN  ANAB Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AnaptysBio, Inc. and Encourages Investors to Contact the Firm"," 1/15/2014 00434H10 PRN  Additional Analyses Results, Stock Price Updates, Products & Services Deployment, and Proposed Public Offerings - Research Report on CytRx, Intrexon, Allscripts, Acceleron, and NewLink"," 2/16/2015 31189P10 PRN  Recent Developments at Pharma Companies: Special Research on Discovery Labs, Enzon, Fate Therapeutics, Genetic Technologies, and Genocea Biosciences"," 8/14/2017 G4618810 PRN  Breakfast Technical Briefing on Generic Drugs Stocks -- Horizon Pharma, Mylan, Neurocrine Biosciences, and Rigel Pharma", 5/06/2014 00BJ80-E PRN  Castle Biosciences' Esophageal Cancer Test Identifies Patients Who Are Resistant to Standard Pre-Surgical Chemoradiation Therapy,10/13/2017 45845P10 PRN  Intercept (ICPT) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH, 8/24/2019 48576U10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI,12/11/2013 062RZ9-E PRN  Study examines new class of anticoagulants for VTE prevention and treatment," 2/19/2019 98401F10 PRN  Xencor to Host Fourth Quarter and Full Year 2018 Financial Results Webcast and Conference Call on February 25, 2019"," 5/22/2017 46116X10 PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Intra-Cellular Therapies, Inc. To Contact The Firm"," 2/24/2020 G8807B10 PRN  Theravance Biopharma, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update","10/06/2017 G6674U10 PRN  Today's Research Report Coverage on Medical Equipment Stocks -- Varian Medical Systems, Senseonics, Xtant Medical, and NovoCure", 2/19/2020 03969710 PRN  Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference, 7/18/2012 AMPR-US  PRN  Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On Market After Removal Due To Environmental Treaty,," 2/02/2017 77313F10 PRN  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Inotek Pharmaceuticals Corporation To Contact The Firm Before Lead Plaintiff Deadline"," 1/10/2020 24983L10 PRN  SHAREHOLDER ALERT: WeissLaw LLP Investigates Dermira, Inc."," 1/14/2020 M4613510 PRN  Foamix Announces AMZEEQ™ (minocycline) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S."," 8/22/2017 69354M10 PRN  Technical Reports on Medical Research Equities -- OpGen, TearLab, TrovaGene, and PRA Health Sciences"," 9/19/2016 86845910 PRN  Learn how to target a 20% return on Netflix, or get option-trade ideas on Supernus Pharmaceuticals, Avis, Intel and UnitedHealth or any stock you choose"," 8/09/2017 31572Q80 PRN  Latest R&D Success, FDA Approvals and Significant Advances in Clinical Trials Boosting Biotech Sector"," 1/26/2018 74587V10 PRN  What's Happening With These Biotech Stocks? -- Novavax, Opko Health, Otonomy, and Puma Biotech"," 4/27/2017 19249H10 PRN  Research Reports Coverage on Biotech Stocks -- Ultragenyx Pharma, Chimerix, Coherus Biosciences, and Omeros", 2/06/2018 21833P10 PRN  Cannabis Legalization Continues to Influence Consumer Spending,"12/03/2019 05070R10 PRN  SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc."," 2/16/2017 AKBA-US  PRN  Longitude Capital Promotes Josh Richardson, M.D., To Managing Director"," 5/16/2017 98400H10 PRN  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc. -- XBIT"," 3/26/2018 09JZQL-E PRN  Intec Pharma Appoints Roger J. Pomerantz, M.D. to Board of Directors",, 6/24/2016 37890U10 PRN  Global Blood Therapeutics Announces Closing of Public Offering of Common Stock, 2/26/2020 75901B10 PRN  REGENXBIO Reports Fourth Quarter and Full-Year 2019 Financial Results and Operational Highlights,,12/20/2016 06CR5C-E    PRN  Apellis Announces FDA Fast Track Designation for APL-2 in PNH,,,"10/08/2019 07725L10 PRN  Lifshitz & Miller LLP Announces Investigation of Aflac Inc., BeiGene, Ltd., Meredith Corporation, New Relic, Inc., Ollie's Bargain Outlet Holdings, Inc., SmileDirectClub, Inc., and Sonim Technologies, Inc.",10/11/2019 74933V10 PRN  STOCKHOLDER ALERT: Monteverde & Associates PC is Investigating the Following Merger, 1/06/2012 0085JM-E PRN  Reata Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference,11/07/2017 44842L10 PRN  China's Healthcare Market is Expected to Grow as Government Changes Regulations,, 6/15/2017 H0026310 PRN  Pharmaceutical Leaders Pave the Way to New Alzheimer's Treatments, 7/09/2018 0DP3CK-E PRN  Abingworth Raises $315m for ABV VII 12th Life Sciences Fund, 1/07/2014 0CRRZ8-E PRN  Dr. Seth Rudnick Joins G1 Therapeutics as Executive Chairman, 6/04/2014 07N3G8-E PRN  ArGEN-X Enters Long-term Strategic Alliance With Shire Pharmaceuticals in Therapeutic Antibodies,, 7/18/2018 300147-CN PRN  PolyU - Axis Therapeutics Joint Center for Immunotherapy Launched to Develop Innovative Cancer Treatments," 5/01/2019 71639T10 PRN  PETQ INVESTIGATION ALERT: Hagens Berman Alerts PetIQ (PETQ) Investors Concerning the Firm's Investigation of Possible Disclosure Violations, Encourages Investors Who Suffered Losses to Contact the Firm", 6/27/2017 00FMDK-E PRN  Rhythm and Camurus Announce Positive Initial Data for Extended-Release Delivery of Setmelanotide for the Treatment of Rare Genetic Disorders of Obesity, 6/10/2014 00CN92-E PRN  OptiNose Announces Positive Results of COMPASS: A Head-to-Head Comparison of a New Migraine Treatment Using Bi-Directional™ Breath Powered™ Technology (AVP-825) versus Oral Sumatriptan,," 7/22/2015 0FK32T-E PRN  Denali Therapeutics Appoints Carole Ho, M.D., as Chief Medical Officer and Head of Development", 7/20/2012 009FRV-E PRN  Quanterix Appoints Paul Chapman as President and Chief Executive Officer, 4/28/2018 83422E10 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Solid Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline - SLDB, 2/17/2018 30052C10 PRN  Evolus Announces Presentation of Phase III European - Canadian Comparative Data, 7/16/2018 43808310 PRN  Homology Medicines Announces Peer-Reviewed Publication Demonstrating Efficient and Precise In Vivo Gene Editing Capabilities of Nuclease-Free Technology Platform,"12/24/2013 30233G10 PRN  Drug Availability, Clinical Trial Partnerships, Labeling Discussions, Stock Updates, and Credit Facilities - Research Report on Forest Laboratories, Oxygen Biotherapeutics, Alimera, pSivida and AcelRx",," 2/07/2018 0G390C-E PRN  UNITY Biotechnology Adds Accomplished R&D Leader David L. Lacey, M.D., to Board of Directors",,, 4/05/2018 0J0BD9-E PRN  Eidos Therapeutics completes $64M Series B financing,,,," 2/21/2019 05280R10 PRN  Autolus Therapeutics to Announce Financial Results for the Transition Period from October 1, 2018 to December 31, 2018 and Host Conference Call on February 25, 2019"," 3/02/2020 34983P10 PRN  (FTSV) Alert: Johnson Fistel Investigates Proposed Sale of Forty Seven, Inc.; Are Shareholders Getting a Fair Deal?",, 1/29/2020 001SM5-E PRN  Several Drugmakers are Racing to Create and Test a Vaccine for China's Deadly Coronavirus,,,, 2/27/2020 50015M10 PRN  Kodiak Sciences to Present at Upcoming Conferences, 4/13/2016 0FTYWS-E PRN  Gritstone Oncology Appoints Dr. Karin Jooss as Chief Scientific Officer,10/16/2018 40131M10 PRN  Lung Cancer Study Published in JAMA Oncology Shows Guardant360 Outperforms Tissue Biopsy Alone in Identification of Targetable Mutations,,11/09/2018 009Z8P-E PRN  NGM Bio Announces New Histology Data from Phase 2 Trial of NGM282 in Patients with NASH," 6/15/2017 00FLML-E PRN  Twist Bioscience and the BioBricks Foundation Announce First-of-its-Kind Partnership to Provide 10,000 Public-Benefit Genes to the Synthetic Biology Community",,,, 3/10/2014 008STR-E PRN  Precision BioSciences and Agrivida Announce Collaborative Trait Development Agreement and Successful Genetic Modification,,, 1/13/2020 00973Y10 PRN  Akero Therapeutics Expands Phase 2a Trial in NASH to Include Cohort of Cirrhotic Patients,,,,, 6/04/2015 0DMSKV-E PRN  Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium Study Shows Adaptive Biotechnologies' clonoSEQ® Minimal Residual Disease (MRD) Test Superior to Flow Cytometry in Predicting Post-Transplant Relapse and Survival in Acute Lymphoblastic Leukemia,
" 1/16/2019 53220K50 PRN  Rev. Fr. Emmanuel Lemelson Renews Call for Investigation in Alleged Accounting and Securities Fraud, SEC Failures, at Ligand Pharmaceuticals","10/02/2019 74318710 PRN  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) on Behalf of Progenics Shareholders and Encourages Progenics Investors to Contact the Firm", 9/03/2019 ILMN-US     PRN  Ilumina Announces a Bespoke Concierge Diagnostic Medical Imaging Service for Insurance Companies and Law Firms to Ensure Medical Evidence is Present When Validating Claims,"10/10/2016 84763A10 PRN  Johnson & Weaver, LLP Initiates Investigations of Puma Biotechnology, Inc., Virtus Investment Partners, Inc., AAC Holdings, Inc. and Spectrum Pharmaceuticals, Inc.; Encourages Long-Term Investors to Contact the Firm Regarding Their Legal Rights", 1/27/2020 G3040110 PRN  Endo Begins Shipment of Authorized Generic Version of Carafate® (sucralfate) Oral Suspension in the United States," 8/16/2017 04280A10 PRN  Biotech Stock Performance Review -- Aralez Pharma, Arena Pharma, Arrowhead Pharma, and Aviragen Therapeutics",11/16/2017 09060J10 PRN  BioDelivery Sciences to Present at the 29th Annual Piper Jaffray Conference, 3/30/2020 09073M10    PRN  Extracellular Vesicles From Plasma Have Higher Tumor RNA Fraction Than Platelets, 3/30/2020 75886F10    PRN  Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High Cholesterol, 7/08/2016 001M2B-E PRN  PharmAthene Receives $20 Million Payment from SIGA to Extend Payment Deadline, 3/17/2020 000CV5-E PRN  OPKO Health's BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19), 2/27/2020 46222210 PRN  Ionis Pharmaceuticals to present at upcoming investor conferences, 2/26/2020 09061G10   PRN  BioMarin Announces Fourth Quarter and Record Full-year 2019 Financial Results," 7/24/2018 01535110 PRN  Free Technical Research Reports on Biotech Stocks -- Alkermes, Alnylam Pharma, Altimmune, and Alexion Pharma", 2/03/2020 64125C10 PRN  Neurocrine Biosciences Announces Appointment of Shalini Sharp to Board of Directors,12/02/2019 81257810 PRN  Seattle Genetics and Astellas Announce Clinical Trial Collaboration with Merck to Evaluate Enfortumab Vedotin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Metastatic Urothelial Cancer," 1/11/2019 45290710 PRN  RM LAW Announces Class Action Lawsuit Against Immunomedics, Inc.", 9/13/2019 00167Y-E  PRN  Eisai And Biogen To Discontinue Phase III Clinical Studies Of BACE Inhibitor Elenbecestat In Early Alzheimer's Disease," 9/07/2016 45253H10 PRN  Research Reports Coverage on Biotech Stocks -- Biogen, ImmunoGen, Jazz Pharma, and Cempra", 4/02/2018 09058V10 PRN  RA Capital Management Opposes BioCryst Pharmaceuticals' Proposed Merger with Idera Pharmaceuticals," 2/03/2020 000L1R-E   PRN  Thinking about buying stock in Canopy Growth Corp, Gilead Sciences, Microsoft, Shopify, or Snap?", 2/26/2020 04004760   PRN  Arena Announces Management and Program Updates and Reports Fourth Quarter and Full-Year 2019 Financial Results, 3/25/2020 N5946510  PRN  Mylan Announces Additional Efforts to Support Response to the COVID-19 Pandemic by Voluntarily Waiving its Marketing Exclusivity in the U.S. for Lopinavir/Ritonavir to Help Ensure Wider Availability to Meet Potential COVID-19 Patient Needs, 3/17/2020 M2572210 PRN  Compugen Announces Closing of $75 Million Public Offering of Ordinary Shares," 4/09/2019 00972810 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline - AKRX", 3/31/2020 03116210 PRN  Amgen Establishes Wholly-Owned Affiliate In Japan," 9/30/2019 62855J10 PRN  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - MYGN"," 1/22/2019 52887230 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lexicon Pharmaceuticals, Inc. - LXRX",, 3/05/2020 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),11/11/2012 05156V10 PRN  3SBio Inc. Announces Unaudited Third Quarter 2012 Results, 3/30/2020 45773H20 PRN  INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia, 1/24/2020 64026810 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics  - NKTR,12/17/2019 76655960 PRN  Rigel Announces Chief Commercial Officer Transition," 1/23/2020 37416310 PRN  Johnson Fistel, LLP Announces That It Has Filed a Class Action Against Geron Corporation"," 9/24/2015 CPST-US  PRN  Technical Insights on the Healthcare Sector -- Aerie Pharmaceuticals, Dyax, Cempra, B/E Aerospace and Capstone Turbine", 3/18/2019 02311120 PRN  Vascepa® (icosapent ethyl) Showed 30% Reduction in Total Cardiovascular Events Including Recurrent Events in REDUCE-IT™,10/08/2019 45337C10 PRN  Lilly to Unveil New Data for the Treatments of Complex Dermatological Conditions at the 28th Annual European Academy of Dermatology and Venereology (EADV) Congress, 2/24/2020 002G54-E PRN  United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin®, 1/17/2018 80360710 PRN  First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene Therapy," 2/13/2020 G0176710 PRN  Alkermes Plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2019 and Provides Financial Expectations for 2020"," 6/27/2016 15708510 PRN  Why Investors Have These Biotech Stocks on Their Radar? - Cerus, Juno Therapeutics, Chiasma, and Sage Therapeutics", 6/04/2018 06V94H-E PRN  Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA,"10/03/2012 ANRZQ-US PRN  Insider Hot Stocks: Sprint Nextel, ArQule, Illumina, Alpha Natural Resources, Coca-Cola, and Host Hotels and Resorts", 3/27/2020 55027E10 PRN  Luminex Receives FDA Emergency Use Authorization for NxTAG® CoV Extended Panel to Detect the SARS-CoV-2 Virus that Causes COVID-19 Disease, 5/01/2019 80067710 PRN  Sangamo Therapeutics Announces First Quarter 2019 Conference Call And Webcast," 1/12/2017 30161Q10 PRN  Investors: Covered-Call Reports for BB&T Corporation, Exelixis, Merck & Company Incorporated, Parsley Energy Inc and Workday", 2/28/2020 80105N10  PRN  Sanofi US reaches settlement agreement to resolve allegations related to patient assistance," 8/07/2017 92532F10  PRN  Breakfast Technical Briefing on Biotech Stocks -- Sarepta Therapeutics, Trevena, Tesaro, and Vertex Pharma",, 3/31/2017 04351P10 PRN  Ascendis Pharma A/S Announces Updated Time for April 3 Conference Call to Review ENDO 2017 Data," 8/25/2017 09609G10 PRN  Technical Snapshots for these Biotech Stocks -- Gilead Sciences, Biogen, bluebird bio, and BioMarin Pharma"," 8/17/2018 00422510 PRN  ACADIA PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD",, 2/07/2020 74366E10 PRN  Protagonist Therapeutics to Present Preclinical Results on PN-943 at the 15th Congress of European Crohn's and Colitis Organization (ECCO),, 1/05/2018 TXMD-US  PRN  International Academy of Compounding Pharmacists Announcement," 4/16/2019 98978L20    PRN  ZGNX CLASS ACTION ALERT: Hagens Berman Alerts Zogenix (ZGNX) Investors to Securities Class Action, Encourages Investors to Contact the Firm","12/19/2019 01671P10 PRN  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Significant Losses to Contact Its Attorneys; Firm Investigating Possible Securities Fraud", 2/14/2018 005P05-E PRN  FourWorld Capital Issues Eye-Opening Research Report on Drugmaker Omeros; Concludes Company Faces Perilous Future Following Loss of Medicare Support for Propping up Price of its Sole Commercial Product,,, 1/26/2017 46333X10 PRN  U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS® (linaclotide) for Adults with Chronic Idiopathic Constipation, 6/13/2016 00773U10 PRN  Adverum Biotechnologies Appoints Leone Patterson as Chief Financial Officer," 4/11/2018 000M0R-E PRN  Technical Perspectives on Biotech Stocks -- Syndax Pharma, Teligent, Ultragenyx Pharma, and Vascular Biogenics",," 9/05/2013 63009R10 PRN  New Workflow to Provide Scientists with Tools That Enable Single Cell Analysis for Oncology, Immunology and Stem Cell Research", 2/25/2020 69329Y10 PRN  PDL BioPharma to Participate in the Cowen and Company 40th Annual Health Care Conference,," 9/12/2016 75046920 PRN  Research Reports Coverage on Biotech Stocks -- Northwest Biotherapeutics, Radius Health, Spectrum Pharma, and Kite Pharma"," 5/18/2013 04539610 PRN  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Ventrus Biosciences, Inc. To Contact The Firm", 3/24/2020 00182C10 PRN  ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL," 1/24/2017 29251M10 PRN  European Medicines Agency Grants Accelerated Assessment, Validates Marketing Authorization Application for AbbVie's Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)","10/24/2018 02043Q10 PRN  ALNY NOTICE ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Alnylam Pharmaceuticals, Inc., Important Deadline in Class Action - ALNY",," 5/10/2018 0F98BD-E PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akcea Therapeutics, Inc. - AKCA", 1/09/2020 60468T10 PRN  Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock," 7/21/2015 69512710 PRN  Technical Roundup on Drugs - Generic Equities -- Allergan, Akorn, Ironwood Pharma, Pacira Pharma, and Catalent","11/18/2014 76129910 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Retrophin, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 19, 2014 -- RTRX",11/15/2017 69404D10 PRN  PacBio And GENEWIZ Announce Winner Of The 2017 AACR SMRT Grant,12/15/2016 28106W10 PRN  Flagship Ventures Evolves Name To Flagship Pioneering," 4/18/2016 16706W10 PRN  CHIASMA (CHMA) ALERT:  Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Chiasma, Inc.; Encourages Investors to Contact the Firm for Information Concerning Their Legal Rights", 9/18/2019 55609910 PRN  Hagens Berman Notifies Investors That Lost Money in MacroGenics (MGNX), 2/19/2020 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences, 2/27/2019 001R0F-E PRN  Biotechnology Companies Ramp up Funding as Deadly Diseases Come Into the Spotlight, 1/06/2020 28249U10 PRN  Eiger Updates on 2019 Progress and 2020 Milestones Expected," 3/24/2017 60877T10 PRN  Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander Consumer USA Holdings Inc. and The Interpublic Group of Companies, Inc."," 5/16/2018 G7280010 PRN  PROTHENA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Prothena Corporation plc To Contact The Firm", 1/08/2016 0DW6T1-E PRN  Zai Lab Secures Over $100M Series B Financing from Leading Healthcare Investors," 3/24/2017 78667J10 PRN  Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma", 4/21/2016 23284F10 PRN  AbbVie and CytomX Announce Strategic Collaboration for Probody Drug Conjugates, 1/05/2017 000D1R-E PRN  Janssen Enters Immunotherapy Clinical Collaboration with Bristol-Myers Squibb to Evaluate daratumumab (DARZALEX®) in Combination with nivolumab (OPDIVO®), 2/27/2020 92165910 PRN  Vanda Pharmaceuticals Announces Participation at March 2020 Investor Conferences,, 4/12/2018 23257D10 PRN  Companies that Stand to Benefit from the Biotech Market Bottoming, 9/18/2017 45781M10   PRN  Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US, 3/30/2012 16383L10 PRN  ChemoCentryx Announces 2011 Fourth Quarter and Full Year Financial Results, 2/24/2020 40637H10 PRN  Halozyme Announces CFO Transition,11/04/2019 G2151510 PRN  China Biologic Products to Report Third Quarter 2019 Financial Results,"10/11/2017 56400P70 PRN  Stock reports released for BlackRock Incorporated, Delta Airlines, MannKind, Snap Inc. and Tesla Motors?",," 4/17/2017 23282W60 PRN  Gigamon, CBL & Associates Properties and Cytokinetics Set to Join S&P SmallCap 600"," 5/08/2018 29664W10 PRN  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline - July 6, 2018", 3/16/2020 03236M20 PRN  Amyris Provides Business Update, 3/11/2020 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 2/17/2017 00448Q20 PRN  Biotech Stocks Under Scanner -- Celldex Therapeutics, Achillion Pharma, Vertex Pharma, and Concordia"," 3/08/2019 87166B10 PRN  SYNEOS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Syneos Health, Inc. - SYNH","10/21/2016 03152W10 PRN  How These Biotech Stocks are Faring? -- Raptor Pharma, Amicus Therapeutics, Neuralstem, and Macrocure"," 7/29/2016 26979610 PRN  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 - EGRX",,, 5/28/2019 05J212-E PRN  Public Figures Take a Prominent Stance in the Emerging CBD & Cannabis Space, 7/09/2015 EPZM-US  PRN  HemoShear Therapeutics Names Robert Gould to Board of Directors, 2/25/2020 G5087110 PRN  Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2019 Financial Results,,"12/12/2019 00394S-E PRN  Grifols launches XEMBIFY® (immune globulin subcutaneous human-klhw) 20%, a new Primary Immunodeficiency treatment", 9/24/2013 36315X10 PRN  AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies," 3/15/2020 73701010 PRN  PORTOLA 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Portola Pharmaceuticals, Inc. - PTLA", 5/25/2017 VCYT-US  PRN  Invitae Broadens Management Team to Scale Expanding Business and Meet Rising Demand," 4/23/2015 25303110 PRN  What's New in the Pharma Sector: Free Research on Asterias, Dicerna,OncoMed, Heron, and Providence Service Corporation"," 6/09/2015 SANW-US  PRN  S&W Seed Company and Calyxt, Inc. Announce Alfalfa Seed Collaboration"," 7/19/2018 CARA-US  PRN  Enteris BioPharma's ""Feasibility-to-Licensing"" Partner, Cara Therapeutics, Doses First Patient in Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA™"," 9/05/2017 33938J10 PRN  Technical Snapshots for These Generic Drugs Stocks -- Catalyst Pharma, Flexion Therapeutics, Supernus Pharma, and Lannett",11/20/2014 0CDXXJ-E PRN  uniQure NV - Product Pipeline Review - 2014,12/15/2016 00847X10 PRN  Flagship Ventures Evolves Name To Flagship Pioneering,12/13/2017 46226010 PRN  BioLife Solutions Executes Supply Agreement with Iovance Biotherapeutics," 3/26/2020 03272410 PRN  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed"," 1/06/2014 00434H10 PRN  Clinical Findings Presentations, Stock Price Movements, and Addition to Indexes - Research Report on Acceleron, AcelRx, Antares, Chelsea Therapeutics, and Clovis","12/22/2014 31189P10 PRN  Equities Reward Long-Term Investors: Analyst Notes on Weatherford, ExxonMobil, Ally, UBIC Inc. and Fate Therapeutics", 6/27/2017 ARLZ-US  PRN  Aralez Announces District Court Decision to Uphold VIMOVO (Naproxen/Esomeprazole Magnesium) Patents, 4/29/2014 00BJ80-E PRN  Castle Biosciences' Mesothelioma Molecular Test Accurately Stratifies Survival Risk Under Surgical and Non-Surgical Treatment Plans,"10/09/2017 45845P10 PRN  EQUITY ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses Exceeding $100,000 to Contact the Firm"," 8/02/2019 48576U10 PRN  ROSEN, A HIGHLY RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Karyopharm Therapeutics Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - KPTI",, 2/07/2019 98401F10 PRN  Xencor to Present at Upcoming Investor Conferences," 5/22/2017 46116X10 PRN  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Intra-Cellular Therapies, Inc. and Encourages Investors with Losses to Contact the Firm", 2/18/2020 G8807B10 PRN  Theravance Biopharma Announces Presentations at Upcoming Investor Conferences," 2/23/2017 G6674U10 PRN  Research Reports Initiation on Medical Equipment Stocks -- Lantheus, Cynosure, Natus Medical, and NovoCure",12/04/2019 03969710 PRN  Ardelyx Announces Pricing of Upsized Public Offering of Common Stock," 6/06/2012 05QZSX-E PRN  Avrio Biopharmaceuticals Appoints Laura Jones, Ph.D., J.D., M.S., M.B.A., as Vice President of Quality and Regulatory Affairs",," 1/20/2017 77313F10 PRN  Johnson & Weaver, LLP Initiates Investigations of Rent-A-Center, Inc., KalVista Pharmaceuticals, Inc., NovoCure Limited and Inotek Pharmaceuticals Corp.", 1/10/2020 24983L10 PRN  Lilly Announces Agreement to Acquire Dermira, 1/09/2020 M4613510 PRN  Foamix Announces AMZEEQ™ (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of Moderate to Severe Acne, 7/06/2017 PRAH-US  PRN  Trovagene Engages Leading CRO in AML to Conduct Phase 1b/2 Trial of PCM-075," 6/28/2016 NBIX-US  PRN  Drugs - Generic Stocks Technical Snapshot - Sophiris Bio, Neurocrine Biosciences, Lannett, and Supernus Pharma"," 9/16/2015 31572Q80 PRN  Biotechnology Stocks Technical Data -- Anacor Pharma, CytRx, Cerus, CorMedix, and FibroGen","11/22/2017 0H44P1-E PRN  New Early- Breast Cancer Drug to be Made Available in Australia, New Zealand and South East Asia Following License Deal"," 5/02/2016 BMRN-US  PRN  AbSci Appoints V. Bryan Lawlis, Ph.D. to Board of Directors", 1/29/2018 21833P10 PRN  Data Predicts Legal Cannabis and CBD Markets are Expected to Grow, 8/26/2019 05070R10 PRN  Audentes Therapeutics to Participate in Upcoming Investor Conferences, 5/11/2016 00772J-E PRN  BioDelivery Sciences and Collegium Pharmaceutical Announce the Signing of a Licensing Agreement for ONSOLIS® in the U.S.," 5/03/2017 98400H10 PRN  Lifshitz & Miller LLP Announces Investigation of Bingo Nation Inc., BofI Holding, Inc., Corbus Pharmaceuticals Holdings, Inc., Lion Biotechnologies, Inc., NewLink Genetics Corporation, Power Solutions International, Inc., Walter Investment Management Corp. and XBIOTECH INC.","11/14/2017 81750R10 PRN  Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team",, 6/20/2016 37890U10 PRN  Global Blood Therapeutics Announces Pricing of Public Offering of Common Stock, 2/19/2020 75901B10 PRN  REGENXBIO To Host Conference Call on February 26 to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Operational Highlights,, 8/08/2016 00CLR1-E    PRN  Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer,,," 9/12/2019 07725L10 PRN  SHAREHOLDER ALERT: Hagens Berman Notifies Investors in BeiGene, Ltd. (BGNE) of Securities Fraud Investigation",10/10/2019 74933V10 PRN  Ra Pharma (RARX) Alert: Johnson Fistel Investigates Proposed Sale of Ra Pharmaceuticals; Is $48 a Fair Price?,11/29/2011 0085JM-E PRN  New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System,10/27/2017 44842L10 PRN  Developments in China's Healthcare Industry,,,"11/29/2016 0DP3CK-E PRN  Bayer/CRISPR Therapeutics Joint Venture, Casebia Therapeutics, Named 'Most Valuable Pharma Deal of the Year' by BioPharma Dive",11/01/2013 0CRRZ8-E PRN  G1 Therapeutics to Present at Southeast BIO Investor & Partnering Forum," 5/29/2014 07N3G8-E PRN  arGEN-X to Present Results of Phase 1 Study of ARGX-110, a Novel Anti-CD70 Antibody, in Patients With Advanced Cancer at ASCO",," 5/24/2017 00695P-E  PRN  Athenex and Its Partner, Guangzhou Xiangxue Pharmaceutical, Announced Chinese FDA IND Approval to Begin Clinical Trials of KX-02 Tablet for Glioblastoma"," 4/30/2019 71639T10 PRN  PETIQ INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In PetIQ Inc. To Contact The Firm", 5/17/2017 00FMDK-E PRN  Rhythm Expands Phase 2 Clinical Trials of Setmelanotide to the Treatment of Bardet-Biedl Syndrome Obesity, 3/27/2014 00CN92-E PRN  OptiNose Announces FDA Acceptance of New Drug Application for AVP-825 for the Acute Treatment of Migraine,,, 2/09/2012 009FRV-E PRN  Quanterix to Collaborate With the Forsyth Institute and Beth Israel Deaconess Medical Center to Develop Tuberculosis Test," 4/27/2018 83422E10 PRN  SOLID BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Solid Biosciences Inc. - SLDB", 2/16/2018 30052C10 PRN  Evolus Announces Presentation of Phase III Comparative Data of PrabotulinumtoxinA and OnabotulinumtoxinA, 7/05/2018 43808310 PRN  Homology Medicines to Present at the National PKU Alliance Conference,"10/23/2013 30233G10 PRN  Healthcare Sector Announced Clinical Data Presentation, Upcoming Financial Release Schedules and Updates on New Drug Applications - Research Report on Alexion, Pacira, pSivida, Momenta and Impax",, 8/17/2017 0G390C-E PRN  UNITY Biotechnology Announces Extension of Series B Financing Bringing Total Round to $151 Million,,,,,,, 2/19/2019 05280R10 PRN  Arix Bioscience plc: Autolus Announces Updated Results From CARPALL Trial,12/10/2019 0084LG-E PRN  Biotech Industry Focusing on Growing Demand for Lyophilized Injectable Drugs,,,,,," 2/08/2020 50015M10 PRN  Kodiak Sciences Announces Additional Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the Angiogenesis, Exudation, and Degeneration 2020 Meeting", 1/07/2016 0FTYWS-E PRN  Gritstone Oncology to Present at the 34th Annual J.P. Morgan Healthcare Conference," 9/05/2018 00FYYJ-E PRN  SLLIP Study Meets Primary Endpoint, Finds the Guardant360 Assay Performs Similar to Standard-of-Care Tissue Testing in Advanced NSCLC, Investigators to Report at WCLC",,"11/06/2018 009Z8P-E PRN  NGM Bio Announces Multiple Presentations at AASLD's The Liver Meeting®, Including New NASH Histology Data from the Phase 2 Trial of NGM282 and Topline Phase 1b Data for NGM313", 6/14/2017 00FLML-E PRN  Twist Bioscience Raises Additional $27 Million,,,,,,, 1/08/2020 00973Y10 PRN  Akero Therapeutics To Present At The 2020 J.P. Morgan Healthcare Conference,,,,, 5/29/2015 0DMSKV-E PRN  Adaptive Biotechnologies and Collaborators to Present Eight Studies at the 2015 American Society of Clinical Oncology Annual Meeting Demonstrating the Relevance of Monitoring Immune Receptors as a New Class of Biomarkers,
 1/16/2019 53220K50 PRN  Former California Deputy Attorney General and Special Prosecutor with Johnson Fistel Launches Investigation into Ligand Pharmaceuticals; Investors Suffering Losses Encouraged to Contact Firm,"10/02/2019 74318710 PRN  ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Progenics Pharmaceuticals, Inc."," 5/07/2019 45232710    PRN  Population Health Study Goes Statewide As University Medical Center of Southern Nevada Serves As Host Site For Enrollment Of 25,000 More Nevadans"," 9/12/2016 84763A10 PRN  Research Reports Coverage on Biotech Stocks -- Northwest Biotherapeutics, Radius Health, Spectrum Pharma, and Kite Pharma", 1/24/2020 G3040110 PRN  Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results,"10/14/2016 04280A10 PRN  Biotech Stocks on Investors' Radar -- BioMarin Pharma, Keryx Biopharma, Puma Biotech, and Arrowhead Pharma",11/09/2017 09060J10 PRN  BioDelivery Sciences Reports Third Quarter 2017 Financial Results and Provides Corporate Update, 3/25/2020 09073M10    PRN  Bio-Techne's Ella On The Front Lines In Fight Against COVID-19, 3/30/2020 75886F10    PRN  First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19,12/15/2015 ALT-US   PRN  PharmAthene Reports that SIGA has Filed its Reorganization Plan to Exit from Bankruptcy, 3/13/2020 000CV5-E PRN  OPKO's BioReference Laboratories Offers Testing for Coronavirus Disease 2019 (COVID-19), 2/26/2020 46222210 PRN  Ionis provides fourth quarter and full year 2019 financial results," 2/20/2020 09061G10   PRN  BioMarin's Biologics License Application for Valoctocogene Roxaparvovec Accepted for Priority Review by FDA with Review Action Date of August 21, 2020", 6/11/2018 0GZPD4-E PRN  BridgeBio Pharma Enters into Agreement to Acquire Late Stage Therapy for Ultra-Rare Disorder from Alexion; Launches Origin Biosciences to Develop and Commercialize Therapy, 1/20/2020 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2019 Financial Results,10/22/2019 0032YX-E PRN  Clinical Trials for Acute Myeloid Leukemia (AML) Drug Therapy Advancing With Encouraging Results," 1/04/2019 45290710 PRN  IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU", 7/30/2019 09062X10  PRN  Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis," 6/30/2016 45253H10 PRN  Why Investors Love These Biotech's Stocks? - ImmunoGen, Immunomedics, Vanda Pharma, and Arrowhead Pharma", 3/09/2018 BCRX-US  PRN  MGT Capital Names Robert S. Lowrey Chief Financial Officer, 1/22/2020 000L1R-E   PRN  Sierra Oncology Announces Reverse Stock Split, 2/21/2020 04004760   PRN  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 3/19/2020 N5946510  PRN  Mylan Ramps Up U.S. Manufacturing of Hydroxychloroquine Sulfate Tablets to Meet Potential COVID-19 Patient Needs, 3/17/2020 00356F-E PRN  Medicxi Bolsters and Expands Team with Senior Industry Leaders," 3/19/2019 00972810 PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm", 3/28/2020 03116210 PRN  Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol," 9/17/2019 62855J10 PRN  Lifshitz & Miller LLP Announces Investigation of 360 Finance, Inc., Canada Goose Holdings, Inc., Merit Medical Systems, Inc., Myriad Genetics, Inc., TenCent Music Entertainment Group, Two River Bancorp, UP Fintech Holding Limited, and X Financial","11/27/2017 52887230 PRN  Quotidian Technical Highlights on Selected Biotech Stocks -- Advaxis, Grifols, Juno Therapeutics, and Lexicon Pharma",, 3/04/2020 45766930 PRN  Insmed Announces Publication Discussing the Clinical Management of Common Respiratory Events Associated with ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in the Journal Open Forum Infectious Disease, 5/09/2011 05156V10 PRN  Inmarsat plc Interim Management Statement," 3/28/2020 45773H20 PRN  LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm", 1/14/2020 64026810 PRN  Nektar Issues Statement Regarding FDA Advisory Committee Vote for Oxycodegol,11/15/2019 76655960 PRN  Rigel Receives Positive CHMP Opinion for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe,10/01/2019 0017CF-E PRN  Biotechs Endeavour to Increase Access to Cancer Treatments, 9/21/2015 00771V10 PRN  Successful Results in Clinical Trials Playing Important Role in Advanced Development of Therapeutic Drug Treatments for Various Diseases and Conditions," 3/15/2019 02311120 PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Amarin Corporation To Contact The Firm"," 8/23/2019 45337C10 PRN  Lilly Announces Top-Line Phase 3 Results for Oral JAK Inhibitor Baricitinib, in Combination with Topical Corticosteroids in Adult Patients with Moderate to Severe Atopic Dermatitis", 2/24/2020 91307C10 PRN  United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints," 8/07/2017 80360710 PRN  Breakfast Technical Briefing on Biotech Stocks -- Sarepta Therapeutics, Trevena, Tesaro, and Vertex Pharma", 2/06/2020 G0176710 PRN  Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results," 3/10/2016 15708510 PRN  Covered Call Alerts For Kinder Morgan, Himax Technologies Inc, US Steel, Yahoo! and CERUS Corporation Released By InvestorsObserver", 3/26/2018 00163U10 PRN  Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women, 2/23/2012 06R7QB-E PRN  Caxton Advantage Venture Partners Announces Formation of Valence Life Sciences, 3/13/2020 55027E10 PRN  Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts, 4/15/2019 80067710 PRN  Sangamo Therapeutics Announces Presentations At 2019 Annual Meeting Of The American Society Of Gene & Cell Therapy,"12/05/2016 30161Q10 PRN  Covered Call reports for Exelixis, Alibaba, Procter & Gamble, Whiting Petroleum and GW Pharmaceuticals include trade ideas that offer returns of 20% or more!", 2/18/2020 80105N10  PRN  Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine, 5/18/2017 000YJB-E  PRN  Maxor Selected as Limited Distribution Provider of Orkambi® and Kalydeco®,, 3/23/2017 04351P10 PRN  Ascendis Pharma A/S Announces Conference Call and Webcast to Review Data at ENDO 2017 on April 3," 5/11/2017 09609G10 PRN  Research Reports Coverage on Healthcare Stocks -- Radius Health, bluebird bio, Universal Health Services, and LifePoint Health"," 8/17/2018 00422510 PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In ACADIA Pharmaceuticals, Inc. To Contact The Firm",," 1/07/2020 07F0YZ-E PRN  Protagonist Therapeutics Achieves Milestone in Janssen Biotech, Inc., Collaboration",,"11/13/2017 000Z35-E PRN  Technical Snapshots for These Drug Makers Stocks -- AstraZeneca, Impax Laboratories, TherapeuticsMD, and GlaxoSmithKline"," 4/15/2019 98978L20    PRN  Hagens Berman Alerts Zogenix (ZGNX) Investors of the Firm's Investigation of Possible Securities Law Violations, Encourages Investors to Contact the Firm", 9/08/2016 0CX82G-E PRN  Allakos Initiates Phase 2 Trial of AK001 in Patients with Nasal Polyposis,10/26/2017 68214310 PRN  Omeros Reports Additional and Consistently Positive Data for OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy,,,"12/20/2016 46333X10 PRN  How These Generic Drugs Stocks are Faring? -- Ironwood Pharma, Medicines, Lannett, and SCYNEXIS"," 8/28/2015 ADVM-US  PRN  AVALANCHE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Avalanche Biotechnologies, Inc. -- AAVL", 2/23/2018 4151-JP  PRN  Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorisation in Europe for the Treatment of X-Linked Hypophosphatemia in Children,,,12/19/2019 69329Y10 PRN  PDL BioPharma Announces Upcoming Changes to its Board of Directors,," 8/15/2016 75046920 PRN  Learn how to target a 20% return on Valeant Pharmaceuticals, or get option-trade ideas on Acacia Communications, Radius Health, General Electric and Exelixis or any stock you choose"," 5/17/2013 04539610 PRN  Ventrus Biosciences, Inc. Sued by Investor", 3/02/2020 00182C10 PRN  ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules, 9/23/2016 29251M10 PRN  AbbVie Presents Data on Eight-Week Treatment of VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) in Patients with Genotype 1b Chronic Hepatitis C," 9/27/2018 02043Q10 PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alnylam Pharmaceuticals, Inc. To Contact The Firm",," 5/10/2018 00972L10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akcea Therapeutics, Inc. (AKCA)", 1/08/2020 60468T10 PRN  Mirati Therapeutics Announces Proposed Public Offering of Common Stock, 7/14/2015 PCRX-US  PRN  Aratana Therapeutics Announces Positive Pivotal Results for AT-003,"11/14/2014 76129910 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Retrophin, Inc. and Certain Officers - RTRX",10/09/2017 69404D10 PRN  PacBio and Bluebee Launch De Novo Genome Assembly Pipeline on the Bluebee Analysis Platform, 7/13/2016 28106W10 PRN  Dr. Michael Rosenblatt Joins Flagship Ventures as Chief Medical Officer,10/30/2015 16706W10 PRN  Chiasma Supports Acromegaly Awareness with Launch of New Online Resource for Patients and Caregivers," 9/17/2019 55609910 PRN  Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against MacroGenics, Inc. (MGNX)", 2/13/2020 09627Y10 PRN  Blueprint Medicines Reports Fourth Quarter and Full Year 2019 Financial Results, 6/29/2018 00972D10 PRN  WeissLaw LLP Investigates Keryx Biopharmaceuticals Inc.,"12/17/2019 0G4L3T-E PRN  First-Ever Treatment for Rare, Rapid-Aging Disease Progeria Submitted in New Drug Application to the FDA"," 3/07/2017 60877T10 PRN  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving the Board of Momenta Pharmaceuticals, Inc. -- MNTA"," 4/24/2018 G7280010 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Prothena Corporation plc (PRTA)",,"10/07/2016 78667J10 PRN  Biotech Stocks Technical Reports -- Tesaro, CTI BioPharma, Sage Therapeutics, and Lexicon Pharma",11/08/2015 23284F10 PRN  CytomX Highlights Data from Multiple Probody Pipeline Programs at Investor Event During AACR-NCI-EORTC Conference, 5/19/2015 07N3P3-E PRN  BioNTech Signs Co-Development and Commercialization Agreement in Immuno-Oncology, 2/25/2020 92165910 PRN  Vanda Reports results from the EPIONE study of Tradipitant in the treatment of Pruritus in Atopic Dermatitis,,"10/03/2017 23257D10 PRN  Technical Insights on Biotech Stocks -- Cymabay Therapeutics, Cytori Therapeutics, CytRx, and Sorrento Therapeutics"," 6/09/2017 45781M10   PRN  Technical Snapshots for These Application Software Stocks -- Cadence Design Systems, Shopify, Sphere 3D, and Innoviva", 2/13/2012 16383L10 PRN  ChemoCentryx Completes Initial Public Offering, 2/10/2020 40637H10 PRN  Halozyme To Host Fourth Quarter And Full Year 2019 Financial Results Webcast And Conference Call,10/17/2019 G2151510 PRN  China Biologic Special Committee Retains Financial Advisor and Legal Counsel,"10/06/2017 56400P70 PRN  Biotech Sector is Fertile Ground for Continued Rally, New Drug Developments and Latest Collaborations",,11/30/2016 23282W60 PRN  The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function In Patients With Chronic Heart Failure," 5/02/2018 29664W10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Esperion Therapeutics, Inc. - ESPR", 3/12/2020 03236M20 PRN  Amyris Reports Another Strong Quarter of Recurring Revenue Growth, 3/02/2020 69366J20 PRN  PTC Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update," 8/23/2016 00448Q20 PRN  Research Report Coverage on Biotech Stocks -- Halozyme Therapeutics, Achillion Pharma, Aegerion Pharma and Chimerix"," 3/08/2019 87166B10 PRN  Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Syneos Health, Inc. - SYNH"," 7/26/2016 03152W10 PRN  Biotechnology Stocks Under Investors' Scanner -- Mast Therapeutics, ZIOPHARM Oncology, Amicus Therapeutics, and Repros Therapeutics"," 6/17/2016 26979610 PRN  Lifshitz & Miller Law Firm Announces Investigation of CBL & Associates Properties, Inc., Eagle Pharmaceuticals, Inc., HCP, Inc., Immunomedics, Inc., Infinity Pharmaceuticals Inc., Neovasc, Inc., and Unilife Corporation",,, 5/10/2019 05J212-E PRN  Analysts Earmark Numerous Strong Cannabis Market Drivers," 7/01/2015 29428V10 PRN  Critical Alerts For Skyworks Solutions, Chevron, Tableau Software, Epizyme and TASER International Released By InvestorsObserver", 2/17/2020 G5087110 PRN  PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer,,12/06/2019 39843840 PRN  Grifols presents its latest Alzheimer's clinical trial data, 5/17/2013 36315X10 PRN  AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease," 3/14/2020 73701010 PRN  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Portola Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm", 5/23/2017 92337F10 PRN  Veracyte Announces Clinical Validation Data Demonstrating Envisia™ Genomic Classifier's Performance in Improving Idiopathic Pulmonary Fibrosis Diagnosis Presented at ATS 2017,"11/18/2014 25303110 PRN  Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA", 5/27/2014 ALCLS-FR PRN  Cellectis will be Present at the ASCO Annual Meeting, 6/13/2018 14075510 PRN  International Cannabis Legalization to Spur Global Medical and Recreational Sales, 1/08/2014 009T7W-E PRN  Flexion Therapeutics Files Registration Statement for Proposed Initial Public Offering, 6/18/2014 0CDXXJ-E PRN  uniQure and Medison Sign Glybera Distribution Agreement for Israel,"12/05/2016 00847X10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of Agios Pharmaceuticals, Inc. - AGIO","11/16/2017 005K0V-E PRN  Stock Performance Review on Biotech Industry -- Ardelyx, Bellicum Pharma, Iovance Biotherapeutics, and Inotek Pharma", 3/26/2020 03272410 PRN  AnaptysBio (ANAB) Class Action Alert: Johnson Fistel Encourages Investors to Contact Firm,"12/25/2013 00434H10 PRN  Upcoming Presentations, Milestone Payments, Quarterly Financial Results, and New Appointments - Research Report on Medivation, Acceleron, Aerie, Arrowhead, and Oxford Immunotec",12/04/2012 070JFC-E PRN  Fate Therapeutics Strengthens Leadership Position In The Development Of Wnt-based Protein Therapeutics," 5/30/2017 G4618810 PRN  Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Neurocrine Biosciences", 3/22/2014 00BJ80-E PRN  Castle Biosciences' Non-Invasive Gene Expression Profile Test Shown to Identify Sentinel Lymph Node Negative Melanoma Patients at High Risk of Metastasis,"10/04/2017 45845P10 PRN  INTERCEPT DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Intercept Pharmaceuticals, Inc. To Contact The Firm"," 7/26/2019 48576U10 PRN  KARYOPHARM SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Karyopharm Therapeutics Inc. - KPTI",, 2/05/2019 98401F10 PRN  Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech," 5/18/2017 46116X10 PRN  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Intra-Cellular Therapies, Inc. and Encourages Investors with Losses to Contact the Firm"," 2/13/2020 G8807B10 PRN  Theravance Biopharma to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020"," 1/20/2017 G6674U10 PRN  Johnson & Weaver, LLP Initiates Investigations of Rent-A-Center, Inc., KalVista Pharmaceuticals, Inc., NovoCure Limited and Inotek Pharmaceuticals Corp.",12/04/2019 03969710 PRN  Ardelyx Announces Proposed Public Offering of Common Stock, 9/19/2011 000YQ7-E PRN  Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R),," 1/18/2017 77313F10 PRN  Lifshitz & Miller Law Firm Announces Investigation of DaVita Inc., First NBC Bank Holdings Company, Fresenius Medical Care AG & Co. KGAA, Inotek Pharmaceuticals Corporation, Natural Health Trends Corp., NeoPhotonics Corporation, NewLink Genetics Corporation and PayPal Holdings, Inc.",12/10/2019 0084LG-E PRN  Biotech Industry Focusing on Growing Demand for Lyophilized Injectable Drugs,"12/11/2019 M4613510 PRN  Lifshitz & Miller LLP Announces Investigation of Carolina Financial Corporation, Craft Brew Alliance, Inc., Foamix Pharmaceuticals Ltd., Grubhub Inc., Lipocine Inc., Pattern Energy Group, Inc., TD Ameritrade Holding Corporation, and William Lyon Homes", 5/11/2017 69354M10 PRN  DelMar Formalizes Collaboration with PRA Health Sciences for Phase 3 Trial of VAL-083 in Recurrent Glioblastoma Multiforme (GBM)," 2/09/2016 86845910 PRN  Covered Call Alerts For Starbucks, GW Pharmaceuticals, Supernus Pharmaceuticals, CSX and SunEdison Released By InvestorsObserver",,"10/26/2017 74587V10 PRN  Stock Performance Review on Biotech Industry -- MyoKardia, Nabriva Therapeutics, Puma Biotechnology, and PDL BioPharma","12/29/2014 19249H10 PRN  The Right to Invest is 'NOW' as Traders Look to Upside: Complementary Reports on Coherus, Barrick Gold, Atossa, Intersect ENT, and Walgreens", 1/23/2018 21833P10 PRN  Diversity Spells Success in the Cannabis Market, 8/06/2019 05070R10 PRN  Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update," 5/31/2013 00772J-E PRN  Collegium Pharmaceutical's CEO to Present at the Jefferies 2013 Global Health Care Conference in New York on June 4, 2013"," 4/21/2017 98400H10 PRN  XBIOTECH NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In XBiotech, Inc. To Contact The Firm",11/01/2017 81750R10 PRN  Sigilon Therapeutics Appoints Eric Shaff to Board of Directors,, 6/20/2016 37890U10 PRN  Global Blood Therapeutics Announces Initiation of Phase 2a Study of GBT440 in Idiopathic Pulmonary Fibrosis, 1/29/2020 75901B10 PRN  REGENXBIO Announces Presentations at the 16th Annual WORLDSymposium™ 2020,," 6/23/2016 00CLR1-E    PRN  Apellis Announces Positive Results from Phase 1 Clinical Trials of APL-2, a C3 Complement Inhibitor",,,11/08/2018 07725L10 PRN  Mirati Therapeutics Announces First Patient Dosed In Phase 1b Clinical Trial Of Sitravatinib In Combination With Anti-PD1 Antibody Tislelizumab In Patients With Advanced Solid Tumors,10/10/2019 74933V10 PRN  UCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare Diseases,10/14/2011 0085JM-E PRN  Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors, 2/28/2017 AZN-GB   PRN  Edison Issues ADR Update on Hutchison China MediTech (HCM),,," 8/19/2016 0DP3CK-E PRN  Bayer and CRISPR Therapeutics joint venture, named Casebia Therapeutics, establishes operations in Cambridge, MA",10/16/2013 0CRRZ8-E PRN  G1 Therapeutics Raises $12.5M Series A Financing Led by MedImmune Ventures, 5/28/2014 07N3G8-E PRN  arGEN-X Announces Collaboration with Bayer to Discover and Develop Therapeutic Antibody Candidates,," 3/28/2017 00695P-E  PRN  Athenex Announces the US FDA Allowance of the Investigational New Drug Application of Oratopo, A Combination of HM30181A and Oral Topotecan For the Treatment of Advanced Cancer"," 4/30/2019 71639T10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetIQ, Inc. - PETQ", 5/11/2017 00FMDK-E PRN  Rhythm Receives Expanded FDA Breakthrough Therapy Designation for Setmelanotide for Rare Genetic Disorders of Obesity,10/31/2013 00CN92-E PRN  First Patient Enrolled in Phase III Studies Using OptiNose's Novel Breath Powered™ Device to Deliver Fluticasone Intranasally for Treatment of Nasal Polyps,,, 1/05/2012 009FRV-E PRN  Quanterix Announces Strategic Investment From IQT, 4/03/2018 0G9J11-E PRN  RM LAW Announces Class Action Lawsuit Against Solid Biosciences Inc.," 2/12/2018 30052C10 PRN  Evolus, Inc. Announces Closing of Initial Public Offering of Common Stock", 6/25/2018 43808310 PRN  Homology Medicines Added to the Russell 3000® and Russell 2000® Indexes,"10/04/2013 30233G10 PRN  Events, Appointments, Approvals, Recommendations, and Agreements - Research Report on Elan, Alkermes, Hospira, pSivida, and Kindred",, 4/24/2017 0G390C-E PRN  Nature Medicine Study Describes a Novel Senolytic Molecule that Slows the Progression of Osteoarthritis,,,,,,, 2/19/2019 05280R10 PRN  Autolus Therapeutics Announces Updated Results from Ongoing CARPALL Trial of Pediatric Acute Lymphoblastic Leukemia Presented at the EHA 1st European CAR T Cell Meeting in Paris," 6/03/2018 07YR31-E PRN  Forty Seven, Inc. Announces Proof-of-Concept Data from Two Clinical Trials of 5F9 In Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphoma",,,,,," 2/05/2020 50015M10 PRN  Kodiak Sciences Announces Upcoming Presentation of Additional KSI-301 Phase 1b Clinical Study Data at Angiogenesis, Exudation, and Degeneration 2020 Meeting",, 7/19/2018 00FYYJ-E PRN  New Nature Medicine Study Demonstrates Ability of The Guardant360 Assay to Predict Patient Response to Immunotherapy in Advanced Gastric Cancer Patients,,"10/01/2018 009Z8P-E PRN  NGM Bio Appoints David J. Woodhouse, Ph.D. as Chief Executive Officer and Aetna Wun Trombley, Ph.D. as President and Chief Operating Officer", 5/01/2017 00FLML-E PRN  Twist Bioscience Appoints Chief Ethics and Compliance Officer,,,,,,,12/16/2019 00973Y10 PRN  Akero Therapeutics Completes Enrollment in Phase 2a Study in NASH,,,,," 5/11/2015 0DMSKV-E PRN  Adaptive Biotechnologies' immunoSEQ® Assay Provides Groundbreaking Insight into T-Cell Fate, Significantly Advancing Understanding of Adaptive Immunity",
10/30/2018 53220K50 PRN  Keysight Technologies Set to Join S&P 500; Ligand Pharmaceuticals to Join S&P MidCap 400; Marcus & Millichap and Arcosa to Join S&P SmallCap 600, 8/12/2019 74318710 PRN  Velan Highlights Progenics Pharmaceuticals' Continued Mismanagement Following Q2 2019 Earnings Results,12/12/2018 QCOM-US     PRN  Tech Coast Angels-San Diego Concludes a Remarkable Year," 7/11/2016 84763A10 PRN  Biotechnology Stocks Under the Scanner -- PTC Therapeutics, Inovio Pharma, VIVUS, and Spectrum Pharma", 1/10/2020 00FV7G-E PRN  Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million,10/03/2016 04280A10 PRN  Biotechs with Key Corporate Developments,"11/03/2017 09060J10 PRN  Stull, Stull & Brody Announces Investigation Relating to Potential Securities Law Violations by BioDelivery Sciences International, Inc. (NASDAQ:BDSI)", 3/18/2020 09073M10    PRN  Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With General Services Administration, 3/17/2020 75886F10    PRN  Regeneron Announces Important Advances in Novel COVID-19 Antibody Program, 6/12/2012 82691710 PRN  SIGA Technologies Files Notice of Appeal in PharmAthene Litigation, 3/12/2020 06SR5N-E PRN  Non-Opioid Pain Relief Progress Showing Impressive Growth Rate Opportunities, 2/19/2020 46222210 PRN  Ionis Pharmaceuticals to hold 2019 financial results webcast, 2/12/2020 09061G10   PRN  BioMarin to Participate in Two Upcoming Investor Conferences,"10/06/2017 01535110 PRN  ALEXION INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alexion Pharmaceuticals, Inc. - (ALXN)", 1/12/2020 64125C10 PRN  Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2019 Net Product Sales Results and 2020 Program Milestones,10/03/2019 0032YX-E PRN  Patients Demand Personalized Treatments for Cancer as Death Rates Soar,"12/21/2018 45290710 PRN  IMMUNOMEDICS LOSSES ALERT: BERNSTEIN LIEBHARD LLP ANNOUNCES INVESTIGATION OF IMMUNOMEDICS, INC. - IMMU", 7/08/2019 00167Y-E  PRN  Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen," 8/12/2015 45253H10 PRN  Critical Alerts For Linn Energy, Google Inc., Gilead Sciences, Skechers and ImmunoGen Released By InvestorsObserver"," 2/20/2018 000CVC-E PRN  Technical Perspectives on Biotech Stocks -- BioCryst Pharma, BioDelivery Sciences, BioLine Rx, and BioTime", 1/13/2020 000L1R-E   PRN  Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences, 2/20/2020 04004760   PRN  Arena Pharmaceuticals to Present at the Upcoming Investor Conferences, 3/10/2020 N5946510  PRN  Mylan Wins District Court Decision Against Sanofi's Lantus® SoloSTAR® Patent, 3/12/2020 M2572210 PRN  Compugen Announces Pricing of $75 Million Public Offering of Ordinary Shares," 1/09/2019 00972810 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akorn, Inc. - AKRX", 3/23/2020 03116210 PRN  Amgen And The Amgen Foundation Commit Up To $12.5 Million To Support COVID-19 Relief Efforts," 8/22/2019 62855J10 PRN  Bragar Eagel & Squire, P.C. is Investigating Myriad Genetics, Inc. (NASDAQ: MYGN) on Behalf of Stockholders and Encourages Myriad Investors to Contact the Firm",11/08/2017 52887230 PRN  Lexicon Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides A Business Update,, 2/26/2020 45766930 PRN  Insmed to Present at the Cowen and Company 40th Annual Health Care Conference, 4/11/2011 05156V10 PRN  Inmarsat Makes New North American Team Appointments, 3/26/2020 45773H20 PRN  INOVIO Reports Positive Interim Phase 2 VGX-3100 Results In Patients with HPV-associated Anal Dysplasia," 1/13/2020 64026810 PRN  Thinking about buying stock in Bilibili, Microsoft, Nio, Nektar Therapeutics, or NVIDIA?",11/13/2019 76655960 PRN  Rigel to Present at Jefferies 2019 London Healthcare Conference, 4/17/2019 0012QB-E PRN  Healthcare Companies Search for New Ways to Oppose the Spread of Cancer," 9/18/2015 00771V10 PRN  Critical Alerts For Mobileye NV, Aerie Pharmaceuticals, JetBlue, American Airlines and Skyworks Solutions Released By InvestorsObserver", 2/25/2019 02311120 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amarin Corporation plc - AMRN, 3/12/2019 000M2Q-E PRN  iOnctura Bolsters Management Team With Senior Appointments," 2/19/2020 91307C10 PRN  United Therapeutics Corporation to Report Fourth Quarter and Full Year 2019 Financial Results Before the Market Opens on Wednesday, February 26, 2020"," 4/18/2017 80360710 PRN  Scott+Scott, Attorneys at Law, LLP Reminds Investors of its Investigation of Sarepta Therapeutics, Inc. (SRPT)", 1/28/2020 G0176710 PRN  Alkermes Announces U.S. Food and Drug Administration Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar I Disorder," 2/24/2016 15708510 PRN  Covered Call Alerts For Seadrill, Valeant Pharmaceuticals, CERUS Corporation, Amazon.com and Microsoft Released By InvestorsObserver", 2/03/2017 00163U10 PRN  Palatin Technologies Announces Closing of License Agreement with AMAG Pharmaceuticals for North American Rights to Rekynda™,, 3/04/2020 55027E10 PRN  Luminex Provides Updates on Critical Efforts Related to Novel Coronavirus, 4/08/2019 80067710 PRN  Sangamo Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares,"11/22/2016 30161Q10 PRN  InvestorsObserver releases covered-call reports for Exelixis, Valeant Pharmaceuticals, Cheniere Energy, General Electric and The Kroger Co", 2/06/2020 80105N10  PRN  Sanofi delivers strong 2019 business EPS growth of 6.8% at CER," 5/15/2017 92532F10  PRN  How These Biotech Stocks are Faring? -- Seattle Genetics, Sangamo Therapeutics, Vertex Pharma, and VIVUS",, 3/22/2017 04351P10 PRN  Ascendis Pharma A/S Reports Full Year 2016 Financial Results," 3/08/2017 09609G10 PRN  How These Biotech Stocks are Faring? -- bluebird bio, Opexa Therapeutics, Agios Pharma, and PTC Therapeutics"," 7/27/2018 00422510 PRN  ACADIA PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. - ACAD",, 1/06/2020 74366E10 PRN  Protagonist Therapeutics Initiates Phase 2 Study of Novel Hepcidin Mimetic PTG-300 in the Treatment of Patients with Hereditary Hemochromatosis,,11/07/2017 88338N10 PRN  Clinical Studies Elevating Biotech Drug Development to New Levels for Unmet Medical Needs," 4/13/2019 98978L20    PRN  Former California Deputy Attorney General and Special Counsel with Johnson Fistel Launches Investigation into Zogenix, Inc. (ZGNX)", 1/19/2016 0CX82G-E PRN  Allakos Successfully Completes Dosing in Phase 1 Clinical Trial of AK001 and Announces Expansion of its Executive Team," 6/14/2017 68214310 PRN  Covered Call reports for Akamai Technologies, Cheesecake Factory, NVIDIA, Omeros and Tesla Motors include trade ideas that offer returns of up to 55%",,,"10/17/2016 005VD0-E PRN  American College of Gastroenterology (ACG) Launches ""Picture My IBS"" Campaign to Improve Patient-Physician Communication about Irritable Bowel Syndrome (IBS)"," 7/30/2015 00773U10 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Avalanche Biotechnologies, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 8, 2015 - AAVL"," 1/18/2018 000VC1-E PRN  Technical Perspectives on Biotech Stocks -- Ultragenyx Pharma, Regeneron Pharma, Seattle Genetics, and Sangamo Therapeutics",,,12/16/2019 69329Y10 PRN  PDL BioPharma Board of Directors Increases Share and Note Repurchase Authorization to $275 Million,," 7/05/2016 75046920 PRN  Why Investors Love These Biotech's Stocks? - XOMA Corp., Navidea Biopharma, Radius Health, and Cara Therapeutics"," 5/15/2013 04539610 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventrus Biosciences, Inc. - VTUS"," 2/27/2020 00182C10 PRN  ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020", 7/25/2016 29251M10 PRN  CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) for Patients with Genotype 4 Chronic Hepatitis C with Compensated Cirrhosis (Child-Pugh A)," 9/20/2018 02043Q10 PRN  ALNYLAM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Alnylam Pharmaceuticals, Inc. To Contact The Firm",, 3/26/2018 IONS-US  PRN  Ionis and Akcea Present New Data from ATTR Amyloidosis Program at 16th International Symposium on Amyloidosis, 1/06/2020 60468T10 PRN  Mirati Therapeutics Announces Executive Management Changes," 4/21/2015 69512710 PRN  Factors Moving Markets: Complementary Research on Fairchild, CNH Industrial, Synta Pharmaceuticals, Jumei International, Pacira Pharmaceuticals","11/05/2014 0CH215-E PRN  Lifshitz & Miller Law Firm Announces Investigation of AmREIT, Inc., Digital River, Inc., Greater Sacramento Bancorp., Hampden Bancorp, Inc., Integrity Bancshares, Inc., Retrophin, Inc. and Sapient Corp."," 9/25/2017 69404D10 PRN  Technical Reports on Biotech Equities -- Opko Health, Otonomy, Pacific Biosciences of California, and Portola Pharma", 6/29/2016 28106W10 PRN  Flagship Ventures Names Daniel McIntyre Partner, 8/31/2015 16706W10 PRN  Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights, 2/07/2019 05LJZC-E PRN  Paramount Developments Crucial for Advancing Clinical Trials Targeting Cancer Treatments," 2/06/2020 09627Y10 PRN  Blueprint Medicines to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 13, 2020","10/20/2017 00972D10 PRN  Biotech Stock Performance Review -- Agenus, Akebia Therapeutics, Acorda Therapeutics, and Advaxis",12/16/2019 28249U10 PRN  Eiger Initiates Rolling Submission of New Drug Application (NDA) with FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies," 3/02/2017 60877T10 PRN  How These Generic Drugs Stocks are Faring? -- Diplomat Pharmacy, Momenta Pharma, Agile Therapeutics, and Sophiris Bio"," 4/24/2018 G7280010 PRN  Prothena Shareholder Alert - PRTA Stock Drops Almost 70% - Kehoe Law Firm, P.C. Investigating",," 8/10/2016 78667J10 PRN  How These Biotech Stocks are Faring? -- bluebird bio, Sage Therapeutics, Ultragenyx Pharma, and Alder Biopharma",11/05/2015 CTMX-US  PRN  CytomX and MD Anderson Cancer Center Enter Into Strategic Collaboration for Probody-Enabled CAR-NK Cell Therapies, 4/17/2014 GMAB-DK  PRN  GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate, 2/25/2020 92165910 PRN  Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results,," 8/08/2017 23257D10 PRN  Breakfast Technical Briefing on Biotech Stocks -- CytRx, Aeterna Zentaris, Capricor Therapeutics, and Cymabay Therapeutics"," 4/28/2017 45781M10   PRN  How These Application Software Stocks are Faring? -- Zendesk, LogMeIn, Innoviva, and Rubicon Project", 2/08/2012 005XF5-E PRN  ChemoCentryx Announces Pricing of Initial Public Offering, 1/14/2020 40637H10 PRN  Halozyme Provides 2020 Business Update And Financial Guidance," 9/24/2019 G2151510 PRN  China Biologic Forms Special Committee to Review ""Going Private"" Proposal", 8/07/2017 56400P70 PRN  MannKind and One Drop Partner to Launch the A-One Clinical Trial,, 5/01/2016 CYTK-US  PRN  The ALS Association and Cytokinetics Ring in May as ALS Awareness Month at NASDAQ," 5/02/2018 29664W10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Esperion Therapeutics, Inc. (ESPR)"," 3/10/2020 03236M20 PRN  Amyris to Participate in Fireside Chat at 32nd Annual Roth Conference on March 16, 2020", 2/25/2020 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conferences," 6/08/2016 GRF-ES   PRN  Biotechnology Equities Technical Notes -- Grifols, Achillion Pharma, Jazz Pharma, and Puma Biotechnology"," 3/07/2019 87166B10 PRN  SYNH LAWSUIT NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Syneos Health, Inc. - SYNH"," 3/03/2016 03152W10 PRN  Covered Call Alerts For Bank of America, Twitter, Inovio Pharmaceuticals, Marathon Oil Corporation and Amicus Therapeutics Released By InvestorsObserver"," 6/10/2016 26979610 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Eagle Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - EGRX",,, 1/31/2019 36197T10 PRN  Hemp's FDA Declassification Opens Door to Massive CBD Market Growth," 3/13/2015 29428V10 PRN  Critical Alerts For Alcoa, Epizyme, Palo Alto Networks, Wells Fargo and CA Released By InvestorsObserver"," 2/11/2020 G5087110 PRN  Jazz Pharmaceuticals to Report 2019 Fourth Quarter and Full Year Financial Results on February 25, 2020",,12/05/2019 39843840 PRN  Grifols Streamlines Hospital Pharmacy Operations With New KIRO Fill® Technology and PharmacyKeeper Enhancements, 3/20/2013 GLPG-BE  PRN  DART Therapeutics Develops Drug Candidate for Duchenne Muscular Dystrophy, 3/05/2020 73701010 PRN  New Data Demonstrates Andexxa® Can Provide a Net Cost Reduction for the Treatment of Intracranial Hemorrhage Associated with Oral Factor Xa Inhibitors, 5/18/2017 92337F10 PRN  Veracyte Announces Anthem Coverage for the Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis," 7/03/2014 25303110 PRN  Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array", 1/16/2012 063J3K-E PRN  Medicago and Cellectis Enter into Research Agreement to Improve Therapeutic Proteins Using Nuclease Technology," 3/01/2018 CARA-US  PRN  Enteris BioPharma's ""Feasibility-to-Licensing"" Partner, Cara Therapeutics, Doses First Patient in Phase 1 Trial of Oral KORSUVA™",10/30/2013 009T7W-E PRN  Flexion Therapeutics Presents Robust Phase 2b Data for FX006 at 2013 American College of Rheumatology Annual Scientific Meeting, 5/21/2013 0CDXXJ-E PRN  uniQure and Consortium to Receive EUR 2.5 Million Eurostars Grant to Develop RNAi Gene Therapy for Huntington's Disease,11/21/2016 05Q0XH-E PRN  Flagship Ventures Honors CEO of Agios Pharmaceuticals with Entrepreneur of the Year Award," 6/12/2017 46226010 PRN  LBIO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Lion Biotechnologies, Inc. and a Lead Plaintiff Deadline of June 13, 2017"," 3/25/2020 03272410 PRN  Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against AnaptysBio, Inc.",10/22/2013 00434H10 PRN  Flagship VentureLabs™ Launches Pronutria to Prevent and Treat Diseases with Novel Protein Nutrients,11/27/2012 070JFC-E PRN  Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the Treatment of Hematologic Malignancies," 4/27/2017 G4618810 PRN  Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Rigel Pharma", 2/04/2014 00BJ80-E PRN  Castle Biosciences Launches Educational Effort Aimed at Stage I & II Melanoma Patients,"10/04/2017 45845P10 PRN  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm"," 7/26/2019 48576U10 PRN  Lifshitz & Miller LLP Announces Investigation of Choice Bancorp, Inc., Eagle Bancorp, Inc., EQT Corporation, Highpower International, Inc., Karyopharm Therapeutics Inc., MicroStrategy Incorporated Investors, Pintec Technology Holdings Limited Investors, and Speedway Motorsports, Inc.",," 1/07/2019 98401F10 PRN  Xencor Regains ex-U.S. Commercial Rights to XmAb®13676, CD20 x CD3 Bispecific Antibody"," 5/16/2017 46116X10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Intra-Cellular Therapies, Inc. (ITCI) and Lead Plaintiff Deadline: July 11, 2017", 2/11/2020 G8807B10 PRN  Theravance Biopharma Announces Pricing of Public Offering of Ordinary Shares,12/02/2014 079TK4-E PRN  Novocure Announces FDA Approval of an IDE Supplement Allowing All Control Patients in its Phase III Trial in Newly Diagnosed GBM to Cross Over to Receive Tumor Treating Fields,12/03/2019 03969710 PRN  Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialysis, 7/26/2011 05Q3TD-E PRN  Statement on Availability of Primatene® Mist CFC,, 9/21/2015 77313F10 PRN  Successful Results in Clinical Trials Playing Important Role in Advanced Development of Therapeutic Drug Treatments for Various Diseases and Conditions," 6/29/2018 24983L10 PRN  Thinking about buying stock in Acadia Pharmaceuticals, Camber Energy, Dermira, Nike or Constellation Brands?",11/18/2019 M4613510 PRN  Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for FCD105 Minocycline 3% and Adapalene 0.3% Combination Foam, 4/25/2016 69354M10 PRN  CytRx and PRA Health Sciences Receive Gold Awards for Excellence in Clinical Research as the Strategic Partnership Team of the Year," 9/29/2015 86845910 PRN  Drugs - Generic Equities at a Glance -- Mylan, Zoetis, Ironwood Pharma, Akorn, and Supernus Pharma",,"10/03/2017 74587V10 PRN  Lifshitz & Miller LLP Announces Investigation of Equifax Inc., Intercept Pharmaceuticals, Inc., Inventure Foods, Inc., Puma Biotechnology, Inc., Tintri, Inc., Twenty-First Century Fox, Inc. and Ubiquiti Networks, Inc.", 9/24/2014 000BG2-E PRN  Coherus BioSciences Appoints Mary Szela to Board of Directors, 1/10/2018 21833P10 PRN  Cannabis Market Sales on the Rise According to Data, 8/01/2019 05070R10 PRN  Audentes Therapeutics to Participate in Upcoming Investor Conferences," 5/17/2013 00772J-E PRN  Collegium Pharmaceutical's CEO to Present at the UBS Global Health Care Conference in New York on May 20, 2013", 4/21/2017 98400H10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of   XBiotech Inc. - XBIT,12/15/2016 81750R10 PRN  Flagship Ventures Evolves Name To Flagship Pioneering,, 6/20/2016 37890U10 PRN  Global Blood Therapeutics Announces Proposed Public Offering of Common Stock, 1/09/2020 75901B10 PRN  REGENXBIO Reports Continued Progress Across Programs in Year-End 2019 Corporate Update,, 2/12/2016 APLS.XX1-US PRN  Apellis Completes $47 Million Series D Financing,,,10/11/2018 07725L10 PRN  MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies,, 6/16/2011 00282410 PRN  Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes,11/21/2016 DB-DE    PRN  Chi-Med webcast presentation now available for on-demand viewing: Deutsche Bank ADR Virtual Investor Conference,,, 8/01/2016 0DP3CK-E PRN  CRISPR and Transformative Laboratory Technology to Be Highlighted at the 68th AACC Annual Scientific Meeting,, 4/07/2014 07N3G8-E PRN  arGEN-X Uses its Simple Antibody™ Platform to Identify Four 'Hotspots' on MET as Targets for its Therapeutic Antibody Program,, 3/01/2017 00695P-E  PRN  Athenex Inc. announces the promotion of Jeffrey M. Yordon to the position of Chief Operating Officer,, 5/04/2017 00FMDK-E PRN  Rhythm Starts Phase 3 Clinical Trial of Setmelanotide for Rare Genetic Disorder of Obesity, 6/28/2013 00CN92-E PRN  OptiNose to Present Data Highlighting New Migraine Treatment at International Headache Congress,,,12/22/2011 009FRV-E PRN  Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology," 3/30/2018 83422E10 PRN  SOLID BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Solid Biosciences Inc. - SLDB"," 2/07/2018 00FCVN-E PRN  Evolus, Inc. Announces Pricing of Initial Public Offering of Common Stock", 5/18/2018 43808310 PRN  Homology Medicines Presents Data from PKU Gene Therapy Program Demonstrating Long-Term Durability of Treatment in IND-Enabling Studies,,,10/27/2016 007LL2-E PRN  UNITY Biotechnology Announces $116 Million Series B Financing,,,,,,," 1/14/2019 05280R10 PRN  Autolus Therapeutics Enters Lease with Alexandria Real Estate Equities, Inc. for Future Commercial-Scale Manufacturing Site and U.S. Headquarters"," 5/17/2018 07YR31-E PRN  Forty Seven, Inc. to Present Preliminary Data from its Ongoing Phase 1 Clinical Trial of 5F9 in Acute Myeloid Leukemia at the 23rd Congress of the European Hematology Association (EHA)",,,,,, 1/08/2020 50015M10 PRN  Kodiak Sciences to Present at 38th Annual J.P. Morgan Healthcare Conference,, 7/12/2018 00FYYJ-E PRN  Guardant Health Appoints Leena Das-Young to Lead Efforts to Develop Liquid Biopsy Products for Early-Stage Cancer Applications,, 4/14/2018 009Z8P-E PRN  NGM Bio Announces Results From Phase 2 Study Of NGM282 In NASH Patients Demonstrating Clinically Significant Improvements In Liver Histology After 12 Weeks, 4/10/2017 00FLML-E PRN  Twist Bioscience CEO Named Distinguished Alumnus of the University of Houston College of Natural Sciences and Mathematics,,,,,,,11/27/2019 0017F0-E PRN  It's Been a Particularly Exciting Year for Biotech Stocks Across the Board,,,,, 5/08/2015 0DMSKV-E PRN  Adaptive Biotechnologies and Collaborators to Present 5 Studies Demonstrating Utility of Immunosequencing to Determine T-cell Function in Chronic and Infectious Diseases at the 2015 American Association of Immunologists Annual Meeting,
 9/12/2018 53220K50 PRN  Fr. Emmanuel Lemelson Responds to SEC Charges, 7/22/2019 74318710 PRN  Velan Announces Progenics Pharmaceuticals Stockholders Support its Campaign for Change at Progenics' 2019 Annual Meeting, 9/05/2018 0G7STL-E    PRN  Inscripta Announces Strategic Acquisition of Solana Biosciences," 2/19/2016 84763A10 PRN  Labaton Sucharow LLP Announces Summary Notice Of Pendency Of Class Action, Proposed Settlement, And Motion For Attorneys' Fees And Expenses In In Re: Spectrum Pharmaceuticals, Inc., Securities Litigation", 1/06/2020 000ZKT-E PRN  Lannett Launches Venlafaxine ER Tablets And Lidocaine Topical Solution 4%, 9/29/2016 04280A10 PRN  Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations,10/30/2017 09060J10 PRN  BioDelivery Sciences to Host Conference Call and Webcast Reporting Third Quarter 2017 Financial Results on November 9, 2/27/2020 09073M10    PRN  Bio-Techne To Present At The Barclays Global Healthcare Conference, 3/16/2020 75886F10    PRN  Regeneron and Sanofi Begin Global Kevzara® (sarilumab) Clinical Trial Program in Patients with Severe COVID-19,12/19/2011 001M2B-E PRN  Delaware Chancery Court Denies SIGA Technologies' Motion for Reargument, 3/05/2020 000CV5-E PRN  OPKO Health's BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test, 2/11/2020 46222210 PRN  Ionis treatment for Alexander disease granted orphan drug status from EMA, 2/03/2020 09061G10   PRN  BioMarin Announces CFO Succession," 5/23/2017 01535110 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexion Pharmaceuticals, Inc. (ALXN)", 1/10/2020 64125C10 PRN  Neurocrine Biosciences and Idorsia Amend Option Agreement to License Novel Treatment for Rare Pediatric Epilepsy, 9/28/2019 81257810 PRN  Seattle Genetics and Astellas Announce Results from Phase 1 Trial of Investigational Agent Enfortumab Vedotin in Combination with Immune Therapy Pembrolizumab as First-Line Treatment for Advanced Bladder Cancer,12/20/2018 45290710 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. - IMMU, 7/01/2019 00167Y-E  PRN  Biogen Announces New Data Further Establishing SPINRAZA® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients," 7/29/2015 45253H10 PRN  Critical Alerts For Apple, TASER International, Stratasys, Chevron and ImmunoGen Released By InvestorsObserver"," 2/16/2018 09058V10 PRN  Great Point Partners, LLC Opposes The BioCryst Pharmaceutical Proposed Merger With Idera Pharmaceuticals, Inc.", 9/10/2019 000BG2-E   PRN  Advances in Biotechnology May Offer Cancer Patients Renewed Hope, 2/19/2020 04004760   PRN  Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2019 Financial Results and Provide Corporate Update on February 26, 3/09/2020 N5946510  PRN  U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review, 3/11/2020 M2572210 PRN  Compugen Announces Commencement of Public Offering of Ordinary Shares,10/23/2018 00972810 PRN  Resideo Technologies Set to Join S&P MidCap 400; Akorn to Join S&P SmallCap 600, 3/04/2020 03116210 PRN  Amgen Announces 2020 Second Quarter Dividend," 8/19/2019 62855J10 PRN  Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations, Investors With Losses Should Contact Firm","11/03/2017 52887230 PRN  Lexicon Pharmaceuticals To Host Third Quarter 2017 Financial Results Conference Call And Webcast On November 8, 2017",, 2/25/2020 45766930 PRN  Insmed Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update, 3/31/2011 05156V10 PRN  Inmarsat to Acquire Ship Equip International AS," 3/24/2020 45773H20 PRN  RM LAW Announces Class Action Lawsuit Against Inovio Pharmaceuticals, Inc."," 1/07/2020 64026810 PRN  Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA",11/07/2019 76655960 PRN  Rigel Announces Upcoming Data Presentations at the 61st ASH Annual Meeting & Exposition, 4/11/2019 00115K-E PRN  Why International Regulations on Clinical Trials can Actually Reduce Costs and Shorten Time to Market," 7/28/2015 GSK-GB   PRN  Drug Manufacturers - Major Stocks on the Move -- GlaxoSmithKline, Sanofi, Aerie Pharma, TherapeuticsMD, and Aoxing Pharma",11/13/2018 02311120 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amarin Corporation - AMRN, 2/04/2019 45337C10 PRN  Lilly Announces Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis, 2/04/2020 91307C10 PRN  United Therapeutics Defeats Preliminary Injunction Motion In Litigation With Sandoz And RareGen," 1/27/2017 80360710 PRN  Option Trade Reports for Comcast, Southwest Airlines Co., Sarepta Therapeutics, Toronto-Dominion Bank and Weight Watchers from InvestorsObserver", 1/08/2020 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at the 38th Annual J.P. Morgan Healthcare Conference," 2/10/2016 15708510 PRN  Covered Call Alerts For Bank of America, CERUS Corporation, Seadrill, Johnson & Johnson and Facebook Released By InvestorsObserver", 1/10/2017 00163U10 PRN  Palatin Technologies to Hold Call Following Closing of Licensing Agreement for North American Rights to Rekynda™,, 2/24/2020 55027E10 PRN  Luminex Corporation Submits VERIGENE® II Respiratory Flex Assay for FDA Clearance, 4/04/2019 80067710 PRN  Sangamo Therapeutics Announces Pricing of Public Offering of Common Stock,11/17/2016 30161Q10 PRN  Biotech Stocks Press Forward with Drug-Development Advancements," 1/30/2020 80105N10  PRN  Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency"," 2/17/2017 92532F10  PRN  Biotech Stocks Under Scanner -- Celldex Therapeutics, Achillion Pharma, Vertex Pharma, and Concordia",, 3/10/2017 04351P10 PRN  Ascendis Pharma A/S Announces Year-End 2016 Financial Results Conference Call on March 22,"12/02/2016 09609G10 PRN  Fitbit, bluebird bio Inc., Johnson & Johnson, Skechers, and Diamond Offshore Drilling and more offer option-trading opportunities that offer returns of more than 20%"," 6/29/2018 00422510 PRN  Thinking about buying stock in Acadia Pharmaceuticals, Camber Energy, Dermira, Nike or Constellation Brands?",,12/03/2019 74366E10 PRN  Protagonist Therapeutics Announces Preliminary Phase 2 Results with Hepcidin Mimetic PTG-300 in the Treatment of Transfusion Dependent Beta-Thalassemia,,10/23/2017 88338N10 PRN  Biotech Companies Attempting to Save Lives," 4/09/2019 98978L20    PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zogenix, Inc. - ZGNX", 9/30/2014 066K5C-E PRN  Allakos Inc. Raises Additional $10 Million to Expand its Portfolio and Fund Development of an Additional Antibody for Allergic and Inflammatory Diseases," 4/27/2017 68214310 PRN  Research Reports Coverage on Biotech Stocks -- Ultragenyx Pharma, Chimerix, Coherus Biosciences, and Omeros",,," 8/24/2016 46333X10 PRN  Research Report Initiation on Generic Drugs Makers Stocks -- Ironwood Pharma, The Medicines, Carbylan Therapeutics, and Pacira Pharma"," 7/24/2015 00773U10 PRN  Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc.",12/15/2017 4151-JP  PRN  Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children,,,12/13/2019 69329Y10 PRN  PDL BioPharma to Exchange Approximately 80% of Convertible Notes Due 2021 and 2024,," 5/14/2015 75046920 PRN  How Healthy are Healthcare Companies: Complementary Research on Idera Pharma, Athersys Inc., Nevro Corp., Radius Health and OvaScience Inc."," 5/10/2013 04539610 PRN  Bronstein, Gewirtz & Grossman, LLC Announces That A Class Action Has Been Filed Against Ventrus Biosciences, Inc.", 2/20/2020 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-to-Date 2019 Financial Results," 4/16/2016 29251M10 PRN  AbbVie Presents New Phase 2 Data for Investigational, Once-Daily, Ribavirin-Free, Pan-Genotypic Regimen of ABT-493 and ABT-530 for Hepatitis C Genotypes 1-6"," 9/13/2018 02043Q10 PRN  Alnylam Investigation: Bernstein Liebhard LLP Announces Investigation Of Alnylam Pharmaceuticals, Inc. - ALNY",, 3/15/2018 00972L10 PRN  Ionis and Akcea Partner to Commercialize Inotersen for hATTR, 1/02/2020 60468T10 PRN  Mirati Therapeutics To Present At The 38th Annual J.P. Morgan Healthcare Conference,12/16/2014 69512710 PRN  Aratana Therapeutics Initiates Pivotal Study for AT-003,10/27/2014 TSCO-GB  PRN  Law Offices of Marc S. Henzel Announces Securities Class Action Periods,"12/15/2016 RHHBY-CH PRN  Roche announces termination of 2013 Development, Commercialization and License Agreement with Pacific Biosciences","12/01/2014 0DFYQH-E PRN  Broad Institute, Harvard, And MIT License CRISPR-Cas9 Technology To Editas Medicine For Therapeutic Applications"," 8/24/2015 16706W10 PRN  Chiasma Appoints William H. Ludlam, M.D., Ph.D., as Vice President of Medical Affairs", 4/22/2015 GNVC-US  PRN  Michael Richman Appointed To GenVec Board Of Directors, 2/06/2020 09627Y10 PRN  Blueprint Medicines Announces PDUFA Date Extension for New Drug Application of Avapritinib for the Treatment of Adults with Fourth-Line Gastrointestinal Stromal Tumor," 2/16/2017 AKBA-US  PRN  Longitude Capital Promotes Josh Richardson, M.D., To Managing Director",11/15/2019 28249U10 PRN  Eiger to Present at Jefferies 2019 London Healthcare Conference,"11/02/2016 MNTA-US  PRN  Momenta and Mylan Initiate Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIA® (abatacept)", 4/23/2018 G7280010 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prothena Corporation plc - PRTA,," 6/27/2016 78667J10 PRN  Why Investors Have These Biotech Stocks on Their Radar? - Cerus, Juno Therapeutics, Chiasma, and Sage Therapeutics",11/03/2015 CTMX-US  PRN  CytomX Appoints Matthew Young to Board of Directors, 4/03/2014 GMAB-DK  PRN  Ventana signs companion diagnostic agreement with international biotech for antibody drug conjugate program, 2/19/2020 92165910 PRN  Vanda Pharmaceuticals Appoints Stephen Ray Mitchell to Board of Directors,,12/08/2011 003MH3-E PRN  Metabolex Announces Positive Results From its Clinical Study of Arhalofenate in Combination With Febuxostat, 4/26/2017 45781M10   PRN  Sarissa Asks Innoviva Directors To Explain Continued Director Over-Compensation Despite Promises To Cut Costs," 1/05/2012 005XF5-E PRN  GSK Exercises Option to License ChemoCentryx's CCR1 Inhibitor, CCX354, for the Treatment of Rheumatoid Arthritis", 1/03/2020 40637H10 PRN  Halozyme Therapeutics To Present At The 38th Annual J.P. Morgan Healthcare Conference," 9/18/2019 G2151510 PRN  China Biologic Announces Receipt of Preliminary Non-Binding ""Going Private"" Proposal"," 5/10/2017 56400P70 PRN  Biotech Stocks Under Scanner -- Bioverativ, Zosano Pharma, MannKind, and Ocera Therapeutics",, 3/31/2016 CYTK-US  PRN  The ALS Association Awards Origent Data Sciences a Grant to Enable a Research Partnership with Cytokinetics,"11/02/2017 29664W10 PRN  Biotech Stocks on Investors' Radar -- Curis, Egalet, Esperion Therapeutics, and GlycoMimetics", 3/09/2020 001MF1-E PRN  Amyris Expands Distribution of PURECANE Baking Sweetener on Amazon ‒ Strong Early Sales, 2/18/2020 69366J20 PRN  PTC Therapeutics Launches Sixth Annual STRIVE Awards Program for Advocacy Organizations in Duchenne Muscular Dystrophy,"12/31/2015 00448Q20 PRN  Covered Call Alerts For SunEdison, Achillion Pharmaceuticals, Ferrari N.V., Valeant Pharmaceuticals and Alleghany Technologies Released By InvestorsObserver"," 3/07/2019 87166B10 PRN  SYNH CLASS ACTION ALERT: Hagens Berman Alerts Syneos Health (NASDAQ:  SYNH) Investors to April 30, 2019 Securities Class Action Lead Plaintiff Deadline","10/30/2015 03152W10 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amicus Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2015 - FOLD"," 6/06/2016 26979610 PRN  Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Eagle Pharmaceuticals Inc.",,, 1/15/2019 36197T10 PRN  Companies Explore Market Potential for Ready-to-Drink CBD Beverages," 9/29/2014 05PLGR-E PRN  Atlas Venture Names Jason Rhodes, Veteran Investor and President and CFO of Epizyme, As Partner on Life Sciences Investing Team", 1/22/2020 G5087110 PRN  Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy,,12/02/2019 39843840 PRN  Grifols to present latest Alzheimer's clinical trial results," 2/29/2012 GLPG-BE  PRN  Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases", 3/02/2020 73701010 PRN  Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)," 5/11/2017 92337F10 PRN  Data Demonstrating Cost-Effectiveness of Veracyte's Percepta® Bronchial Genomic Classifier Published in ""Journal of Thoracic Oncology""",, 9/07/2011 063J3K-E PRN  Cellectis Announces a Ten-Fold Increase in Nuclease Production Capacity in 2011, 2/20/2018 14075510 PRN  The Medical and Legal Cannabis Market Projected to Have Positive Future Estimates,10/02/2013 009T7W-E PRN  Flexion Therapeutics to Present Phase 2b Data for FX006 at 2013 American College of Rheumatology Annual Scientific Meeting, 2/20/2013 0CDXXJ-E PRN  uniQure Named to MIT Technology Review's 2013 50 Disruptive Companies List Recognizing World's Most Innovative Companies,"11/15/2016 00847X10 PRN  Learn how to target a 20% return on Sears Holdings, or get option-trade ideas on Intrexon, Agios Pharmaceuticals, Mattel Inc. and Myriad Genetics or any stock you choose"," 6/08/2017 46226010 PRN  5-DAY DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm", 1/11/2017 008H33-E PRN  AnaptysBio Announces The Appointment Of Dominic Piscitelli As Chief Financial Officer, 7/14/2010 0068K6-E PRN  Parent Project Muscular Dystrophy Announces Grants For Clinical Study Sites,10/15/2012 000C46-E PRN  Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer," 2/07/2017 G4618810 PRN  How These Generic Drugs Stocks are Faring? -- Mylan, Allergan, Horizon Pharma, and Catalent", 1/16/2014 00BJ80-E PRN  Castle Biosciences Announces Data Demonstrating Ability to Identify Esophageal Cancer Patients Resistant to Standard Pre-Surgical Treatment of Chemotherapy and Radiation,"10/03/2017 45845P10 PRN  Lifshitz & Miller LLP Announces Investigation of Equifax Inc., Intercept Pharmaceuticals, Inc., Inventure Foods, Inc., Puma Biotechnology, Inc., Tintri, Inc., Twenty-First Century Fox, Inc. and Ubiquiti Networks, Inc.", 7/24/2019 48576U10 PRN  KPTI INVESTOR ALERT: Hagens Berman Alerts Investors in Karyopharm Therapeutics (KPTI) Public Offerings to Possible Disclosure Violations,,12/03/2018 98401F10 PRN  Xencor Presents Initial Data from Phase 1 Study of XmAb®14045 in Acute Myeloid Leukemia at the 2018 ASH Annual Meeting," 5/11/2017 46116X10 PRN  EQUITY ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Intra-Cellular Therapies, Inc. - ITCI", 2/10/2020 G8807B10 PRN  Theravance Biopharma Announces Proposed Public Offering of Ordinary Shares,12/01/2014 079TK4-E PRN  Interim Analysis of Novocure's Phase III Trial in Newly Diagnosed Glioblastoma to be Presented at Japan Society For Neuro-Oncology 2014,12/02/2019 03969710 PRN  Ardelyx to Host Conference Call on December 3 to Review Results from the Pivotal Phase 3 PHREEDOM Study,,, 7/31/2015 77313F10 PRN  Changes in Senior Management - Report on Inotek Pharmaceuticals, 7/03/2014 0C5GYQ-E PRN  UCB and Dermira enter into strategic collaboration in dermatology to broaden patient access to Cimzia® (certolizumab pegol),11/15/2019 M4613510 PRN  URGENT NEWS: Monteverde & Associates PC Announces an Investigation of FOAMIX PHARMACEUTICALS LTD - FOMX," 5/12/2015 69354M10 PRN  Latest Business News: Complementary Research on Fluidigm, PRA Health Sciences, Huntington Ingalls, A.M. Castle and Global Power"," 8/05/2015 SHS-US   PRN  Drugs - Generic Equities Coverage -- Oculus Innovative Sciences, Medicines, Supernus Pharma, Sophiris Bio, and Rigel Pharma",," 8/04/2017 74587V10 PRN  PUMA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL:  Kahn Swick & Foti, LLC Investigates the Officers and Directors of Puma Biotechnology, Inc. - PBYI", 8/14/2014 0CT6N9-E PRN  Coherus Announces CHS-1420 (Investigational Adalimumab Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study,12/20/2017 21833P10 PRN  The Value of Medical Cannabis Products Are Expected to Rise," 7/30/2019 05070R10 PRN  Audentes Therapeutics to Release Second Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, August 6, 2019"," 5/08/2013 00772J-E PRN  Collegium Announces Poster Presentation for Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid at American Pain Society's 32nd Annual Scientific Meeting"," 7/26/2016 98400H10 PRN  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding Possible Violations of Federal Securities Laws by Certain Officers and Directors of XBiotech, Inc. - XBIT","10/13/2016 81750R10 PRN  Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Seres Therapeutics, Inc.",, 6/10/2016 37890U10 PRN  Global Blood Therapeutics Announces New Clinical Data that Continue to Support Safety and Efficacy Profile of GBT440 as a Potentially Disease-Modifying Therapy for Sickle Cell Disease,12/18/2019 75901B10 PRN  REGENXBIO Announces Interim Data from Phase I/II Trial of RGX-121 for the Treatment of Mucopolysaccharidosis Type II (MPS II),, 7/15/2015 00CLR1-E    PRN  Apellis Pharmaceuticals Announces Formation of Scientific Advisory Board,,, 8/09/2018 07725L10 PRN  BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China,,11/20/2010 000BG2-E PRN  Reata and Abbott Announce Positive Phase 2b Study Results for Bardoxolone Methyl,"11/10/2016 DB-DE    PRN  Chi-Med to Present at the Deutsche Bank ADR Virtual Investor Conference on Wednesday, November 16, 2016",,, 7/19/2016 0DCWQL-E PRN  Precision NanoSystems Launches Innovative Product to Support mRNA and CRISPR/Cas9 Therapeutic Development,," 1/13/2014 07N3G8-E PRN  arGEN-X Starts Phase Ib Expansion Cohorts With ARGX-110, a Novel Anti-CD70 Antibody, in Cancer Patients",,11/18/2016 000P56-E  PRN  Athenex and Lilly Enter Clinical Collaboration Agreement,," 4/11/2017 00FMDK-E PRN  Rhythm Appoints Head of Sanofi Genzyme, Dr. David Meeker, as Chairman of Board of Directors","11/14/2012 00CN92-E PRN  Fast Relief of Migraine Pain Achieved with New OptiNose Migraine Treatment, Phase III Clinical Data Show",,,12/01/2011 009FRV-E PRN  Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin," 3/28/2018 83422E10 PRN  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Solid Biosciences Inc. (SLDB) and Lead Plaintiff Deadline: May 28, 2018"," 1/09/2018 00FCVN-E PRN  Evolus, Inc. Files Registration Statement for Proposed Initial Public Offering", 5/14/2018 43808310 PRN  Homology Medicines Reports First Quarter 2018 Financial Results,,, 4/24/2016 0FQ709-E PRN  Ascentage Pharma and UNITY Biotechnology Announce Collaboration for the Development of Senolytic Healthspan Therapies,,,,,,,12/20/2018 05280R10 PRN  Autolus Therapeutics to Join NASDAQ Biotechnology Index," 5/16/2018 07YR31-E PRN  Forty Seven, Inc. to Present Clinical Data on 5F9, its First-in-Class CD47 Antibody, at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting",,,,,,"12/19/2019 50015M10 PRN  Kodiak Sciences Appoints Taiyin Yang, Ph.D., to Board of Directors",, 7/12/2018 00FYYJ-E PRN  Guardant Health Announces Medicare Coverage for the Guardant360 Assay in Non-Small Cell Lung Cancer,, 4/13/2018 009Z8P-E PRN  NGM Bio Announces Late-Breaking Plenary Presentation At International Liver Conference 2018 Of Detailed Results From Phase 2 Study Of NGM282 In Patients With Primary Sclerosing Cholangitis, 4/04/2017 00FLML-E PRN  Twist Bioscience to Present at SynBioBeta London 2017,,,,,,,11/13/2019 00973Y10 PRN  Akero Therapeutics to Present at the Jefferies 2019 London Healthcare Conference,,,,, 5/06/2015 0DMSKV-E PRN  Adaptive Biotechnologies Enhances Leading Position in Growing Immunosequencing Market with Completion of $195 Million Investment,
" 7/13/2018 LGND-US  PRN  Rev. Fr. Emmanuel Lemelson Calls on Congress, Office of Inspector General to Investigate SEC Failures", 7/17/2019 74318710 PRN  Court Upholds The Validity And Determined Actavis' Infringement Of Patent Protecting RELISTOR® Tablets," 4/13/2018 45232710    PRN  ILLUMINA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Illumina, Inc. - ILMN",12/10/2015 SPPI-US  PRN  Marqibo® Made Available to Acute Lymphoblastic Leukemia Patients Through Global myTomorrows Platform,12/17/2019 G3040110 PRN  Endo to Participate at J.P. Morgan Healthcare Conference," 6/30/2016 04280A10 PRN  Why Investors Love These Biotech's Stocks? - ImmunoGen, Immunomedics, Vanda Pharma, and Arrowhead Pharma",10/12/2017 TEVA-IL  PRN  BioDelivery Sciences Announces Patent Litigation Settlement Agreement with Teva, 2/24/2020 09073M10    PRN  Bio-Techne To Present At The Cowen 40th Annual Health Care Conference, 3/16/2020 75886F10    PRN  Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19,11/09/2011 001M2B-E PRN  PharmAthene Reports Third Quarter 2011 Financial and Operating Results, 4/11/2019 00115K-E PRN  Why International Regulations on Clinical Trials can Actually Reduce Costs and Shorten Time to Market, 1/22/2020 46222210 PRN  Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx," 1/29/2020 09061G10   PRN  BioMarin to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast on Wednesday, February 26 at 4:30pm ET"," 5/23/2017 01535110 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alexion Pharmaceuticals, Inc. - ALXN"," 1/06/2020 64125C10 PRN  Neurocrine Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference  Live Audio Webcast will be on January 13, 2020", 9/16/2019 81257810 PRN  Seattle Genetics and Astellas Announce U.S. FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer,"12/13/2017 45290710 PRN  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Immunomedics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors"," 5/23/2019 09062X10  PRN  Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Healthcare and BioTech Space - ACER, ACOR, ALNX, BIIB, DOVA and SAGE"," 7/20/2015 45253H10 PRN  Encouraging Clinical Findings for Mirvetuximab Soravtansine (IMGN853) - Report on ImmunoGen, Inc."," 1/22/2018 09058V10 PRN  SHAREHOLDER ALERT: Monteverde & Associates PC Launches An Investigation of the Board of Directors and Officers of BioCryst Pharmaceuticals, Inc. - BCRX", 9/09/2019 002XC4-E   PRN  DURECT Earns $10 Million Milestone Payment for Further Development of a Long-Acting Injectable HIV Investigational Product Utilizing DURECT's SABER® Technology, 2/11/2020 04004760   PRN  Arena Pharmaceuticals' Presence at the European Crohn's and Colitis Organisation (ECCO) Congress Further Highlights Commitment to the GI Community, 2/27/2020 N5946510  PRN  Mylan Reports Fourth Quarter and Full Year 2019 Results and Provides 2020 Guidance, 3/09/2020 M2572210 PRN  Compugen Announces Updated Clinical Data from Ongoing COM701 Phase 1 Study," 5/29/2018 FRE-DE   PRN  Moore Kuehn, PLLC Announces an Investigation Involving Possible Breaches of Fiduciary Duties by Officers and Directors of Akorn, Inc.", 2/27/2020 03116210 PRN  Amgen To Present At The Cowen 40th Annual Healthcare Conference," 8/16/2019 62855J10 PRN  Investor Alert: Kaplan Fox Investigates Myriad Genetics, Inc.",11/02/2017 52887230 PRN  Lexicon Pharmaceuticals To Present At Upcoming Investor Conferences,, 2/19/2020 45766930 PRN  Insmed to Present at the 9th Annual SVB Leerink Global Healthcare Conference, 3/23/2011 05156V10 PRN  Media Advisory: Inmarsat Welcomes Chancellor's Budget for the Space Industry," 3/24/2020 062S3Y-E PRN  Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant","12/17/2019 64026810 PRN  Nektar Therapeutics Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.",11/05/2019 76655960 PRN  Rigel Announces Third Quarter 2019 Financial Results, 9/27/2018 37416310 PRN  Geron Corp. (GERN) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws," 6/17/2015 00771V10 PRN  Critical Alerts For Disney, Aerie Pharmaceuticals, AT&T, Orexigen Therapeutics and World Wrestling Entertainment Released By InvestorsObserver","11/11/2018 02311120 PRN  Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stroke Demonstrated in REDUCE-IT™ Supports 25% Overall Reduction in Five-Point Major Adverse Cardiovascular Event Primary Composite Endpoint",12/16/2018 45337C10 PRN  Innovent and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China, 2/03/2020 91307C10 PRN  United Therapeutics Announces Study of Unituxin® (dinutuximab) for Small Cell Lung Cancer Did Not Meet Primary Endpoint," 1/11/2017 80360710 PRN  Investors: Covered-Call Reports for Boston Scientific Corporation, eBay, MGM Resorts, Sarepta Therapeutics and Williams Companies",11/26/2019 G0176710 PRN  Alkermes to Present at the Evercore ISI 2nd Annual HealthCONx Conference, 2/10/2016 15708510 PRN  Various Development Advancements for Targeted Treatment Therapies for Rare Diseases & Disorders Lead to Newest Orphan Drug Designations by the U.S. FDA," 1/10/2017 00163U10 PRN  Stock Reports for AMAG Pharmaceuticals, Inc., Acuity Brands, Five Below Inc., Medtronic and Morgan Stanley include trade ideas that offer returns of 22% or more!",, 2/18/2020 55027E10 PRN  Luminex Corporation Declares First Quarter Cash Dividend, 4/03/2019 80067710 PRN  Sangamo Therapeutics Announces Proposed Public Offering of Common Stock,"11/10/2016 30161Q10 PRN  Google, Weight Watchers, Exelixis, Palo Alto Networks, and Skechers and more offer option-trading opportunities that offer returns of more than 20%"," 1/23/2020 005M9Z-E  PRN  Sanofi Completes Acquisition of Synthorx, Inc."," 1/11/2017 000YJB-E  PRN  Merck KGaA, Darmstadt, Germany, Licenses Four Oncology Research and Development Programs from Vertex and Becomes a Leader in DNA Damage and Repair",, 2/28/2017 04351P10 PRN  Ascendis Pharma A/S Announces Multiple Poster Presentations at ENDO 2017," 9/16/2016 09609G10 PRN  InvestorsObserver releases covered-call reports for Alder Biopharmaceuticals, bluebird bio Inc., Expedia, Amgen and Computer Sciences Corporation", 4/10/2018 ACAD-US  PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acadia Pharmaceuticals Inc. - ACAD,,11/13/2019 74366E10 PRN  Protagonist Therapeutics to Present at Two Upcoming Healthcare Investor Conferences,, 8/15/2017 88338N10 PRN  Tracking Trends in Biotechnology,10/03/2017 98978L20    PRN  Biotech Sector Notches Impressive Year-to-date Returns With Positive Outlook for Development of New Drugs and Therapies,," 2/02/2017 68214310 PRN  Research Reports Coverage on Biotech Stocks -- Anavex Life Sciences, Omeros, Spectrum Pharma, and Lexicon Pharma",,," 8/09/2016 IRWD-US  PRN  Partnering strategy and thought leadership in biotech startups, serial entrepreneurship, and digital medicine are themes of BioPharm America™ 2016"," 7/22/2015 00773U10 PRN  Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Against Avalanche Biotechnologies, Inc. -- AAVL","10/13/2017 0FW89Q-E PRN  WEISSLAW LLP: Dimension Therapeutics, Inc. Acquisition May Not Be in the Best Interests of DMTX Shareholders",,,12/10/2019 69329Y10 PRN  SevenSaoi Capital Supportive of PDL BioPharma Announcement,,"12/22/2014 75046920 PRN  Pharma Deals Watch: Coverage Initiated on AstraZeneca, Advaxis, Radius Health, Cubist and AbbVie"," 5/10/2013 04539610 PRN  Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Ventrus Biosciences, Inc.", 2/12/2020 00182C10 PRN  ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL, 4/15/2016 29251M10 PRN  AbbVie Announces Real-World Data with VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) and EXVIERA® (dasabuvir tablets) from Large German Hepatitis C-Registry," 9/12/2018 02043Q10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY",,"10/02/2017 00972L10 PRN  Today's Research Report Coverage on Biotech Stocks -- Marinus Pharma, NewLink Genetics, Akcea Therapeutics, and Amgen",11/09/2019 60468T10 PRN  Mirati Therapeutics Presents Data From Ongoing Clinical Trials Of Sitravatinib In Combination With Nivolumab At The SITC 34th Annual Meeting,"12/01/2014 69512710 PRN  PCRX DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Pacira Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 2, 2014 -- PCRX","10/22/2014 76129910 PRN  Harwood Feffer LLP Announces Investigation of Retrophin, Inc.", 9/22/2016 69404D10 PRN  Dovetail Genomics Adds PacBio SMRT Sequencing and Assembly to Its Services Menu,, 8/17/2015 16706W10 PRN  Chiasma Announces FDA Acceptance For Filing of New Drug Application for Octreotide Capsules in Acromegaly,"12/23/2014 55609910 PRN  Equities Lead Investor Sentiments: Coverage Initiated on AMETEK, FedEx, MacroGenics, Walgreens and Apple", 1/22/2020 09627Y10 PRN  Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock," 9/28/2015 00972D10 PRN  Market Update on the Healthcare Sector - Amedica, Accuray, Acadia Healthcare, ANI Pharmaceuticals, and Akebia Therapeutics",11/12/2019 28249U10 PRN  Eiger Announces Peginterferon Lambda - Lonafarnib Combination Interim Results in Hepatitis Delta Virus (HDV) Infection from Phase 2 LIFT Study During Late-Breaker Oral Presentation at AASLD 2019," 9/15/2016 60877T10 PRN  How These Generic Drugs Stocks are Faring? -- Evoke Pharma, Mallinckrodt, Catalyst Pharma, and Momenta Pharma","12/14/2017 PRTA-US  PRN  Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors",, 6/01/2016 SAGE-US  PRN  Socius Expands Southern U.S. Presence with New Atlanta Office,10/26/2015 0DZ2BK-E PRN  /C O R R E C T I O N -- CytomX Therapeutics/,"10/17/2013 37230320 PRN  OTCM ADR Index Up 11.12% in Q3 2013, 12.75% Year-to-Date"," 2/18/2020 92165910 PRN  Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020",,11/29/2011 003MH3-E PRN  Metabolex Gout Program Recognized in Windhover's Top 10 Most Interesting Projects to Watch, 4/21/2017 45781M10   PRN  Overwhelming Majority Of Non-GSK Shareholders Support Sarissa Capital And Not Innoviva Board And Management,"12/08/2011 005XF5-E PRN  ChemoCentryx Initiates a Phase II Clinical Trial For CCX140, A Novel Inhibitor of the Chemokine Receptor CCR2 for the Treatment of Diabetic Nephropathy",12/12/2019 40637H10 PRN  Data From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Halozyme's ENHANZE® Drug Delivery Technology To Be Presented At San Antonio Breast Cancer Symposium, 8/05/2019 G2151510 PRN  China Biologic Reports Financial Results for the Second Quarter of 2019," 2/03/2017 56400P70 PRN  Biotech Stocks Under Scanner -- Mast Therapeutics, MannKind, Celgene, and Opko Health",,11/08/2015 23282W60 PRN  Amgen And Cytokinetics Announce Late-Breaking Presentation Of COSMIC-HF Trial At AHA Scientific Sessions 2015," 8/09/2017 29664W10 PRN  Latest R&D Success, FDA Approvals and Significant Advances in Clinical Trials Boosting Biotech Sector", 3/06/2020 03236M20 PRN  Amyris Discovers Major Breakthrough in CBD Delivery, 2/17/2020 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results,"11/09/2015 00448Q20 PRN  Covered Call Alerts For Mobileye NV, Monster Beverage, TrueCar, Seadrill and Achillion Pharmaceuticals Released By InvestorsObserver"," 3/06/2019 87166B10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syneos Health, Inc. - SYNH","10/16/2015 03152W10 PRN  Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Amicus Therapeutics, Inc.", 3/30/2016 26979610 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eagle Pharmaceuticals Inc.  - EGRX,,,11/01/2018 36197T10 PRN  The Burgeoning Reputation of Marijuana is Driving Global Market Growth," 7/03/2014 29428V10 PRN  Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array", 1/22/2020 G5087110 PRN  PharmaMar and Jazz Pharmaceuticals Announce the U.S. License Agreement for Lurbinectedin is Effective with the Expiration of the HSR Waiting Period,,"11/07/2019 39843840 PRN  Grifols introduces AlphaID™, a free cheek swab to screen for Alpha-1, the most common genetic form of COPD",, 2/26/2020 73701010 PRN  Portola Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update, 5/10/2017 92337F10 PRN  Veracyte Announces Six Studies Highlighting Value of Company's Genomic Classifiers in Lung Cancer and Idiopathic Pulmonary Fibrosis To Be Presented at ATS 2017,, 9/06/2011 063J3K-E PRN  Cellectis to Present at Two Upcoming International Investor Conferences, 1/29/2018 14075510 PRN  Global Cannabis Sales Projected to Grow, 6/26/2013 009T7W-E PRN  Flexion's FX006 Demonstrates Superior Pain Relief Compared to Standard-of-Care in Phase 2b Osteoarthritis Trial, 1/22/2013 0CDXXJ-E PRN  uniQure Appoints Philip Astley-Sparke President US," 9/08/2016 00847X10 PRN  InvestorsObserver releases covered-call reports for Valeant Pharmaceuticals, Agios Pharmaceuticals, Apache Corporation, FireEye and Coca-Cola Enterprises"," 5/26/2017 46226010 PRN  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Lion Biotechnologies, Inc. - LBIO",12/13/2016 06CR5C-E PRN  AnaptysBio Announces Clearance of U.S. IND and U.K. CTA for ANB020,, 6/11/2012 070JFC-E PRN  Fate Therapeutics And BD Biosciences Launch BD™ SMC4 To Improve Cellular Reprogramming And IPS Cell Culture Applications, 1/17/2017 G4618810 PRN  Global Genes® and Horizon Pharma plc Partner to Offer Nephropathic Cystinosis Scholarships, 9/30/2013 00BJ80-E PRN  Castle Biosciences Launches Tissue Repository for Eye Cancer Patients,"10/03/2017 45845P10 PRN  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm"," 7/23/2019 48576U10 PRN  Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Karyopharm Therapeutics Inc. And Certain Of Its Senior Executives, Its Board Of Directors, And Underwriters Of Its April 2017 And May 2018 Stock Offerings",,11/20/2018 98401F10 PRN  Xencor to Present at 30th Annual Piper Jaffray Healthcare Conference," 5/02/2017 46116X10 PRN  Investor Alert: Kaplan Fox Announces Investigation Of Intra-Cellular Therapies, Inc.", 1/07/2020 G8807B10 PRN  Theravance Biopharma Announces Presentation at the 38th Annual J.P. Morgan Healthcare Conference,11/15/2014 079TK4-E PRN  Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success,11/26/2019 03969710 PRN  Ardelyx to Present at the Piper Jaffray 31st Annual Healthcare Conference,,," 3/03/2015 77313F10 PRN  Early Briefing on Biotech Industry Stocks -- ARIAD Pharma, Array BioPharma, Rexahn Pharma, Inotek Pharma, and Neurocrine Biosciences",,11/12/2019 M4613510 PRN  SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.,"11/18/2014 69354M10 PRN  PRA Health Sciences, Inc. Announces Successful Closing of its Initial Public Offering", 6/04/2015 MANH-US  PRN  Manhattan Associates Set to Join the S&P MidCap 400; Supernus Pharmaceuticals to be Added to the S&P SmallCap 600,," 5/23/2017 74587V10 PRN  Options trade reports for BlackBerry, The Blackstone Group, MOMO Inc., Oracle Corporation and Puma Biotechnology include trade ideas that offer returns of 21% or more!", 7/16/2014 0CT6N9-E PRN  Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy),12/18/2017 21833P10 PRN  Research Predicts Further Growth for the Medical Cannabis Market, 7/19/2019 05070R10 PRN  Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 4/30/2013 00772J-E PRN  Collegium Announces Results of Chronic Pain Patient Survey - Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid"," 1/25/2016 98400H10 PRN  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving XBiotech Inc. and a Lead Plaintiff Deadline of February 1, 2016 -- XBIT","10/11/2016 81750R10 PRN  MCRB LOSS NOTICE: Rosen Law Firm Reminds Seres Therapeutics, Inc. Investors of Important Deadline in Lawsuit - MCRB",," 6/02/2016 37890U10 PRN  Global Blood Therapeutics to Host Investor Event on Friday, June 10 to Review GBT440 Data in Sickle Cell Disease Being Presented at the European Hematology Association's 21st Congress",11/26/2019 75901B10 PRN  REGENXBIO to Present at the Evercore ISI 2nd Annual HealthCONx Conference,, 2/10/2015 00CLR1-E    PRN  Apellis Pharmaceuticals Enters Clinical Testing Phase in its Age-Related Macular Degeneration Program,,," 4/30/2018 00850Q-E PRN  Technical Perspectives on Biotech Stocks -- Axovant Sciences, Aytu BioScience, BeiGene, and Bellicum Pharma",,11/11/2010 0085JM-E PRN  Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease, 6/13/2016 44842L10 PRN  Hutchison China MediTech webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference,,,"12/21/2015 BAYN-DE  PRN  Bayer and CRISPR Therapeutics AG join Forces to Discover, Develop and Commercialize Potential Cures for Serious Genetic Diseases",, 1/13/2014 07N3G8-E PRN  arGEN-X Receives Two Preclinical Milestone Payments Under Collaboration With Shire,,10/25/2016 00695P-E  PRN  Athenex and Beijing Sciecure Pharmaceutical announce binding agreement to launch and market five injectable pharmaceutical products in North America,, 2/16/2017 00FMDK-E PRN  Rhythm Announces Completion of $41 Million Mezzanine Financing,11/08/2012 00CN92-E PRN  OptiNose Receives Grant to Fund Nose-to-Brain Research in Autism Spectrum Disorders,,,11/02/2011 009FRV-E PRN  Quanterix Fifth-Generation PSA Test Enables More Sensitive Measurements Following Surgery, 3/22/2018 0DGVHF-E PRN  Scott+Scott Attorneys at Law LLP Announces Investigation into Solid Biosciences Inc. (SLDB),10/26/2017 00FCVN-E PRN  Evolus Announces Health Canada Acceptance for Review of the New Drug Submission for PrabotulinumtoxinA, 5/10/2018 43808310 PRN  Homology Medicines to Present at Bank of America Merrill Lynch Healthcare Conference,,,,,,,,,,12/03/2018 05280R10 PRN  Arix Bioscience plc: Autolus Announces Update on AUTO4 and AUTO5 Programmes," 5/03/2018 07YR31-E PRN  Forty Seven, Inc. Granted Fast Track Designation for 5F9 for the Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma",,,,,,12/06/2019 50015M10 PRN  Kodiak Sciences Announces Closing of $317.4 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,, 5/23/2018 00FYYJ-E PRN  Guardant Health to Present 29 Abstracts at ASCO Advancing the Science of Liquid Biopsy Across Multiple Indications and Applications,, 3/12/2018 009Z8P-E PRN  NGM Bio Announces Publication In The Lancet Of Phase 2 Study Of NGM282 In NASH Patients And Upcoming Presentations Of NGM282 NASH Histology Data And NGM282 PSC Data At The International Liver Congress 2018, 3/27/2017 00FLML-E PRN  Twist Bioscience Raises $33 Million,,,,,,,11/12/2019 00973Y10 PRN  Akero Therapeutics Reports Recent Highlights and Third Quarter 2019 Financial Results,,,,, 4/28/2015 0DMSKV-E PRN  Adaptive Biotechnologies and Researchers from MD Anderson Cancer Center Demonstrate Ability to Detect Hodgkin's Lymphoma in Blood,
" 1/18/2017 53220K50 PRN  Lemelson Capital Management Announces 2016 Performance Results for The Amvona Fund, LP"," 7/08/2019 74318710 PRN  Velan Reminds Stockholders to Follow ISS' Recommendation by Voting ""Against"" Progenics Pharmaceuticals Directors Peter Crowley and Michael Kishbauch"," 2/28/2018 45232710    PRN  Mérieux Développement and Paladin Capital Group Co-lead $55.5 Million Series C Financing Into Inscripta, a Leading Company in the Field of Gene Editing, in Preparation for Platform Expansion and Commercial Launch","12/09/2015 84763A10 PRN  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Spectrum Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of January 4, 2016 - SPPI",12/10/2019 G3040110 PRN  Endo Launches Generic Version of Afinitor® (everolimus) Tablets in the United States,"12/18/2015 04280A10 PRN  Covered Call Alerts For Micron, Inovio Pharmaceuticals, Arrowhead Research, CyberArk Software and Exact Sciences Released By InvestorsObserver",10/06/2017 09060J10 PRN  BioDelivery Sciences Participates in U.S. Department of Health and Human Services Round Table Discussion on Pain Management and Opioid Dependence, 2/17/2020 09073M10    PRN  Bio-Techne To Present At The SVB Leerink 9th Annual Global Healthcare Conference," 3/09/2020 75886F10    PRN  Thinking about trading options or stock in Dollar General, Eli Lilly, 3M, Regeneron Pharmaceuticals, or Slack Technologies?",10/13/2011 001M2B-E PRN  PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument," 2/05/2019 68375N10 PRN  Johnson Fistel, LLP Announces Investigations of AbbVie Inc., Macquarie Infrastructure Corporation, OPKO Health, Inc. and Uxin Limited; Investors Encouraged to Contact Firm", 1/09/2020 46222210 PRN  Ionis appoints Onaiza Cadoret-Manier as chief corporate development and commercial officer," 1/13/2020 09061G10   PRN  BioMarin, Pioneer in Phenylketonuria, to Begin Clinical Trial with BMN 307 Gene Therapy"," 3/14/2017 MBBYF-US PRN  Options Traders Alert: Covered Call reports for Alexion Pharmaceuticals, Alibaba, Intel, Mobileye NV and Micron",12/02/2019 64125C10 PRN  Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy, 7/16/2019 81257810 PRN  Astellas and Seattle Genetics Announce Submission of Biologics License Application to FDA for Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer," 7/27/2017 45290710 PRN  Technical Reports on Biotech Equities -- Opko Health, Array BioPharma, Immunomedics, and TG Therapeutics", 5/10/2019 09062X10  PRN  Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401 for Upcoming Clinical Studies on Prevention of Alzheimer's Disease," 7/14/2015 45253H10 PRN  Critical Alerts For Alibaba, Facebook, ImmunoGen, Dominos Pizza and Invensense Released By InvestorsObserver","10/18/2017 09058V10 PRN  Breakfast Technical Briefing on Biotech Stocks -- BioCryst Pharma, Celgene, Juno Therapeutics, and Lexicon Pharma", 5/30/2019 000L1R-E   PRN  Taiwan National Health Insurance Adminstration of the Ministry of Health and Welfare Approves Epclusa(R) (sofosbuvir/velpatasvir) for Reimbursement, 1/16/2020 04004760   PRN  FDA Grants Fast Track Designation to Arena Pharmaceuticals' APD418 for Development in Decompensated Heart Failure Patients, 2/27/2020 N5946510  PRN  Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer, 2/20/2020 M2572210 PRN  Compugen Reports Fourth Quarter and Full Year 2019 Results," 4/11/2018 00972810 PRN  AKORN ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Akorn, Inc. - AKRX"," 2/26/2020 03116210 PRN  Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis"," 5/28/2018 001D3K-E PRN  MYGN CASE NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN","10/18/2017 52887230 PRN  Breakfast Technical Briefing on Biotech Stocks -- BioCryst Pharma, Celgene, Juno Therapeutics, and Lexicon Pharma",," 2/10/2020 45766930 PRN  Insmed to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call on Tuesday, February 25, 2020", 3/16/2011 05156V10 PRN  Inmarsat Introduces Data Capability for IsatPhone Pro," 3/23/2020 45773H20 PRN  INOVIO PHARMACEUTICALS, INC. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Inovio Pharmaceuticals, Inc.","12/09/2019 64026810 PRN  Nektar Therapeutics Announces Presentation of New Preclinical Data for its IL-15 Agonist, NKTR-255, at the American Society of Hematology (ASH) 2019 Annual Meeting",10/29/2019 0011X6-E PRN  Clinical Trials in Gene Sequencing Reveal Novel Mutations Aiding in New Treatments for Acute Myeloid Leukemia, 9/13/2018 37416310 PRN  Positive Clinical Trial and R&D Developments Creating Big Opportunities and Big Returns for Biotech Industry," 6/01/2015 00771V10 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Aerie Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of June 29, 2015 - AERI"," 4/25/2018 001H9D-E PRN  Quotidian Technical Highlights on Selected Drug Makers Stocks -- Amarin, Apricus Biosciences, Depomed, and DURECT",12/13/2018 45337C10 PRN  FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE), 1/06/2020 91307C10 PRN  United Therapeutics Corporation To Present At The 38th Annual J.P. Morgan Healthcare Conference,"12/06/2016 80360710 PRN  How These Biotech Stocks are Faring? -- Celgene, Sarepta Therapeutics, MannKind and Amgen",11/25/2019 G0176710 PRN  Alkermes Completes Acquisition of Rodin Therapeutics,12/29/2015 15708510 PRN  Pharma Industry Poised for Fast Start in 2016 as U.S. Food & Drug Administration Receives Requests for Newest Orphan Drug Designations & Rare Disease Treatments," 5/19/2016 00163U10 PRN  Why Investors Still See Value in Alkermes, AMAG Pharmaceuticals, IDEXX Laboratories and Atossa Genetics?",, 2/13/2020 55027E10 PRN  Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020, 4/02/2019 SGMO-US  PRN  Sangamo and Pfizer Announce Phase 1/2 Interim Data For Investigational Hemophilia A Gene Therapy,"11/01/2016 30161Q10 PRN  InvestorsObserver releases covered-call reports for First Majestic Silver, Alder Biopharmaceuticals, Exelixis, NXP Semiconductors and Intrexon",12/16/2019 000VJ8-E  PRN  Sana Clinic Joins Startup Creasphere as the First Hospital Partner of the Munich Digital Health Platform," 6/23/2016 92532F10  PRN  How These Biotech's Stocks are Performing? - Intrexon, Vertex Pharma, Arena Pharma, and Regeneron Pharma",," 2/16/2017 04351P10 PRN  Ascendis Pharma A/S Announces Publication of Comprehensive Results from Randomized, Active-Controlled Phase 2 Trial of Once-Weekly TransCon Growth Hormone in Pediatric Patients"," 9/09/2016 09609G10 PRN  InvestorsObserver releases covered-call reports for Micron, bluebird bio Inc., Walgreens Boots Alliance, The Blackstone Group and Priceline"," 4/09/2018 ACAD-US  PRN  ACADIA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In ACADIA Pharmaceuticals Inc. To Contact The Firm",,11/06/2019 74366E10 PRN  Protagonist Therapeutics Reports Third Quarter 2019 Financial Results,," 6/16/2017 88338N10 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in TherapeuticsMD, Inc. of Class Action Lawsuit and Upcoming Deadline - TXMD","10/05/2015 00FZX7-E    PRN  Tokalas appoints James B. Breitmeyer, M.D., Ph.D., President & CEO",,"10/18/2016 68214310 PRN  Biotech Review DVAX Vaccine Faces Crucial PDUFA Date, CLDX Seeks Fast-Track Orphan Drug Status",,, 6/09/2016 06CR5C-E PRN  Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review," 6/19/2015 00773U10 PRN  Lifshitz & Miller Law Firm Announces Investigation of 3D Systems Corporation, Avalanche Biotechnologies, Inc., FXCM Inc., KYTHERA Biopharmaceuticals, Inc., root9B Technologies Inc., and Ryland Group Inc.", 4/27/2017 ARRY-US  PRN  Shalini Sharp Joins Array BioPharma Board of Directors,,,12/09/2019 69329Y10 PRN  PDL BioPharma Announces Completion of Strategic Review Process,, 7/01/2014 RDUS-US  PRN  Oxford Finance and Solar Capital Close $30 Million Senior Debt Facility with Radius Health,, 1/24/2020 00182C10 PRN  ANI Announces Launch of Tolterodine Extended-Release Capsules," 4/15/2016 29251M10 PRN  AbbVie's Investigational, Pan-Genotypic Regimen of ABT-493 and ABT-530 Shows High SVR Rates in Genotype 1 Hepatitis C Patients Who Failed Previous Therapy with Direct-Acting Antivirals", 8/13/2018 0895TM-E PRN  Orsini Healthcare Specialty Pharmacy Selected by Alnylam Pharmaceuticals to Distribute ONPATTRO™ (patisiran),, 7/27/2017 00972L10 PRN  Akcea and Ionis Announce Submission of Marketing Authorization Application for Volanesorsen to the European Medicines Agency,11/04/2019 60468T10 PRN  Mirati Therapeutics Reports Third Quarter 2019 Financial Results,"11/04/2014 69512710 PRN  Quarterly Financial Results and Product Approval - Research Reports on Pacira, PAREXEL, WellPoint, Illumina and St. Jude Medical","10/21/2014 76129910 PRN  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Retrophin, Inc. (RTRX) To Contact The Firm"," 6/10/2016 69404D10 PRN  Coverage of Biotechnology Equities - Pacific Biosciences of California, Peregrine Pharma, Dynavax Technologies and Anavex Life Sciences",, 8/10/2015 007MPF-E PRN  Chiasma Expands Management Team with Announcement of Anand Varadan as Chief Commercial Officer, 6/17/2014 063HNX-E PRN  CMC Biologics and MacroGenics Enter into Process Validation and Clinical Manufacturing Agreement for Commercialization of Next-Generation Oncology Product Candidate, 1/21/2020 09627Y10 PRN  Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock," 9/02/2015 00972D10 PRN  AKBA SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Securities Laws by Akebia Thereapeutics, Inc.",11/07/2019 28249U10 PRN  Eiger BioPharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update," 6/30/2016 60877T10 PRN  Healthcare Sector Equities Under Review - Nanosphere, SciClone Pharma, ConforMIS, and Momenta Pharma"," 3/20/2015 G7280010 PRN  Critical Alerts For Twitter, Ctrip.com, Prothena, Amicus Therapeutics and Ryder Released By InvestorsObserver",, 4/12/2016 SAGE-US  PRN  Experienced Business Development Consultant Roman Cortez Joins Socius,10/14/2015 23284F10 PRN  CytomX Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares, 8/30/2012 0CPNB1-E PRN  Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab, 1/31/2020 92165910 PRN  Vanda Pharmaceuticals Comments on Court Ruling,,"11/01/2011 003MH3-E PRN  Metabolex to Present Data on Arhalofenate, a Potential Novel Treatment for Gout, at the 2011 ACR/ARHP Annual Scientific Meeting", 4/19/2017 45781M10   PRN  Innoviva Reneges On Accepted Deal With Sarissa Capital,11/10/2011 005XF5-E PRN  ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology,"11/13/2019 40637H10 PRN  Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $400 Million of Convertible Senior Notes due 2024", 7/26/2019 G2151510 PRN  China Biologic Products to Report Second Quarter 2019 Financial Results,"12/06/2016 56400P70 PRN  How These Biotech Stocks are Faring? -- Celgene, Sarepta Therapeutics, MannKind and Amgen",,"10/30/2015 23282W60 PRN  Covered Call Alerts For Alcoa, Cytokinetics, Under Armour, Expedia and Rockwell Medical Released By InvestorsObserver", 2/07/2017 29664W10 PRN  Trump's Intentions to Streamline Drug-Approval Process Fueling Biotech Optimism," 3/05/2020 03236M20 PRN  Amyris to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Thursday, March 12", 2/06/2020 69366J20 PRN  SUNFISH Pivotal Results for Risdiplam (RG7916) Demonstrate Medically Meaningful Benefit in Broadest Age Group of Patients Studied with Type 2 and 3 Spinal Muscular Atrophy," 9/29/2015 00448Q20 PRN  Covered Call Alerts For Ambarella, Regeneron Pharmaceuticals, ACADIA Pharmaceuticals, Achillion Pharmaceuticals and JC Penney Released By InvestorsObserver"," 3/01/2019 87166B10 PRN  SYNEOS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Syneos Health, Inc. To Contact The Firm","10/09/2015 03152W10 PRN  Harwood Feffer LLP Announces Investigation of Amicus Therapeutics, Inc."," 3/30/2016 26979610 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Eagle Pharmaceuticals Inc. (EGRX)",,,"10/30/2018 36197T10 PRN  Cannabis Ignores Wider Stock Market, Follows its own Path"," 6/10/2014 29428V10 PRN  Epizyme to Give Oral Presentation on Pre-Clinical Models and Early Clinical Observations of EZH2 Inhibitor EPZ-6438 at ASH Meeting on Lymphoma Biology August 10-13, 2014", 1/20/2020 G5087110 PRN  Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea,, 7/16/2019 39843840 PRN  Grifols presents additional encouraging Alzheimer's trial results at AAIC,, 2/24/2020 73701010 PRN  Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences, 5/08/2017 92337F10 PRN  Data Presented at AACE 2017 Annual Meeting Demonstrate Long-Term Clinical Utility Of Veracyte's Afirma® Gene Expression Classifier in Thyroid Cancer Diagnosis,, 8/24/2011 063J3K-E PRN  Cellectis bioresearch Grants Recombinetics an Exclusive License Agreement for the Use of Targeted Nucleases in Large Livestock,12/20/2017 14075510 PRN  Canada's Cannabis Boom Hits New Heights, 4/18/2013 009T7W-E PRN  Data Presented at OARSI's 2013 World Congress on Osteoarthritis Show Flexion's FX006 Has Prolonged Therapeutic Concentration in Knee Joint,12/11/2012 0CDXXJ-E PRN  uniQure Initiates Phase I in Acute Intermittent Porphyria, 7/13/2016 00847X10 PRN  Dr. Michael Rosenblatt Joins Flagship Ventures as Chief Medical Officer," 5/08/2017 46226010 PRN  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Lion Biotechnologies, Inc. To Contact The Firm",10/03/2016 008H33-E PRN  AnaptysBio Reports ANB020 Top-Line Phase 1 Clinical Trial Results,,12/14/2011 070JFC-E PRN  Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO,12/07/2016 HZNP-IE  PRN  Sobi and Horizon Pharma enter five-year distribution agreement for Ravicti® and Ammonaps® outside the United States, 8/02/2013 00BJ80-E PRN  Gene Test Identifies Non-Metastatic Melanoma Patients at High Risk of Recurrence," 9/27/2017 45845P10 PRN  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Intercept Pharmaceuticals, Inc. & Lead Plaintiff Deadline: November 27, 2017", 3/14/2019 48576U10 PRN  Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application,,"11/08/2018 98401F10 PRN  Xencor Appoints Ellen G. Feigal, M.D., to Board of Directors"," 5/01/2017 46116X10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intra-Cellular Therapies, Inc. - ITCI","12/23/2019 000TBT-E PRN  Theravance Biopharma and Pfizer Inc. Enter Global License Agreement for Skin-Targeted, Locally-Acting Pan-Janus Kinase (JAK) Inhibitor Program",11/11/2014 079TK4-E PRN  Novocure Announces the Presentation of New Data at the 19th Annual Society of Neuro-Oncology Meeting,11/25/2019 03969710 PRN  Ardelyx and Kyowa Kirin Expand Partnership with Two Additional Agreements,,,,,11/04/2019 M4613510 PRN  Foamix Announces Publication of AMZEEQ™ (minocycline) Topical Foam Long Term Safety Data for Treatment Up to 1 Year in Journal of Clinical and Aesthetic Dermatology,"11/12/2014 001THX-E PRN  PRA Health Sciences, Inc. Announces Pricing of its Initial Public Offering"," 1/08/2014 86845910 PRN  Upcoming Conferences, Share Price Updates, and Leadership Changes - Research Report on Lilly, Allergan, Waters, Novavax, and Supernus Pharmaceuticals",," 5/19/2017 74587V10 PRN  Harwood Feffer LLP Announces Investigation of Puma Biotechnology, Inc."," 7/09/2014 0CT6N9-E PRN  Coherus BioSciences Appoints Dr. V. Bryan Lawlis, Jr. to Board of Directors",12/11/2017 21833P10 PRN  Legal Cannabis Sales Grow Globally, 6/07/2019 05070R10 PRN  Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 4/22/2013 00772J-E PRN  Significant Unmet Medical Need for Treatment of Patients with Chronic Pain with Dysphagia (CPD),"11/24/2015 98400H10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of XBiotech, Inc.","10/03/2016 81750R10 PRN  Johnson & Weaver, LLP Initiates Investigations of Cognizant Technology Solutions Corporation, BofI Holding, Inc., Seres Therapeutics, Inc., SeaWorld Entertainment, Inc., and ProNAi Therapeutics, Inc.; Encourages Long-Term Investors to Contact the Firm Regarding Their Legal Rights",, 5/19/2016 07G766-E PRN  Global Blood Therapeutics Announces Presentation of New GBT440 Data in Sickle Cell Disease at the European Hematology Association's 21st Congress,11/05/2019 75901B10 PRN  REGENXBIO Reports Third Quarter 2019 Financial and Operating Results and Recent Operational Highlights,,12/02/2014 00CLR1-E    PRN  Apellis Pharmaceuticals Raises $33M to Fund its Complement Immunotherapy Programs,,,11/07/2017 07725L10 PRN  China's Healthcare Market is Expected to Grow as Government Changes Regulations,,, 6/06/2016 44842L10 PRN  International companies to host live webcasts at Deutsche Bank's June 9th and 10th Depositary Receipts Virtual Investor Conference,,,,,"12/17/2013 07N3G8-E PRN  ARGX-110, a Novel Anti-CD70 Antibody, Meets Translational Development Goals in Dose Escalation Part of Phase Ib Cancer Study",,"10/18/2016 0DZ97S-E  PRN  Athenex announces Xiangxue Pharmaceuticals Company Limited, its KX-02 development partner in China, has achieved a regulatory milestone in that territory",,11/04/2016 00FMDK-E PRN  Rhythm Presents Positive Initial Data for Setmelanotide in LepR Deficiency Obesity,10/18/2012 00CN92-E PRN  Study Shows OptiNose Bi-Directional™ Nasal Technology Reaches Target Areas of the Nasal Cavity Much More Effectively Than Traditional Nasal Spray,,,10/13/2011 009FRV-E PRN  Quanterix PSA Test Found to be a Reliable Predictor of Prostate Cancer Recurrence Following Surgery," 3/15/2018 83422E10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Solid Biosciences Inc. (SLDB)",10/09/2017 00FCVN-E PRN  Evolus Announces Presentations of Phase II and Phase III Data of PrabotulinumtoxinA, 4/30/2018 43808310 PRN  Homology Medicines Announces Upcoming Presentations on its Genetic Medicines Platform at the American Society of Gene & Cell Therapy Meeting,,,,,,,,,,12/03/2018 05280R10 PRN  Arix Bioscience plc: Autolus Presents Initial AUTO3 Clinical Data at ASH, 4/30/2018 07YR31-E PRN  Forty Seven Inc. Appoints Ian T. Clark to Board of Directors,,,,,,12/03/2019 50015M10 PRN  Kodiak Sciences Announces Pricing of $276.0 Million Public Offering of Common Stock,, 4/26/2018 00FYYJ-E PRN  Guardant Health Publishes Extensive Validation of Guardant360® Assay Comprising Largest-Published Blood-Tissue Comparison,, 4/22/2017 009Z8P-E PRN  NGM Bio Announces NGM282 Dramatically Reduced Liver Fat and Other Biomarkers Associated With Nonalcoholic Steatohepatitis (NASH) in Phase 2 Trial, 1/10/2017 00FLML-E PRN  Twist Bioscience Supplying 3.2kB Genes to Ginkgo Bioworks,,,,,,,11/04/2019 00973Y10 PRN  InSphero Wins Sino-European Innovation Award for Breakthrough NASH Discovery and Safety Testing Platform,,,,, 4/22/2015 0DMSKV-E PRN  Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Detects Relapse with Higher Specificity than PET/CT in Diffuse Large B-Cell Lymphoma Patients,
12/21/2016 0645PB-E PRN  Lantern Foundation Founder Urges Senate Committee to Commence Investigation into Ligand Pharmaceuticals," 7/01/2019 74318710 PRN  Velan Urges Stockholders To Follow ISS' Recommendation By Voting ""Against"" Progenics Pharmaceuticals Directors Peter Crowley And Michael Kishbauch",12/18/2017 45232710    PRN  First Genomic Platform Powered by the Blockchain Raises $2 Million in Funding; Backed by Illumina Veterans,"11/10/2015 84763A10 PRN  Lifshitz & Miller Law Firm Announces Investigation of Applied DNA Sciences Inc., Barrett Business Services Inc., First Niagara Financial Group, Fidelity & Guaranty Life, SORL Auto Parts, Inc., Spectrum Pharmaceuticals, and 6D Global Technologies, Inc.",11/22/2019 G3040110 PRN  Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference,"12/08/2015 04280A10 PRN  Covered Call Alerts For Micron, NRG Energy Inc., Arrowhead Research, Ferrari N.V. and 3D Systems Released By InvestorsObserver","10/04/2017 09060J10 PRN  Biotech Stocks on Investors' Radar -- Athersys, AVEO Pharma, BioDelivery Sciences, and BioLine Rx", 2/05/2020 09073M10    PRN  Bio-Techne Announces Availability Of Next Generation ELISA Kits, 3/03/2020 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentations, 9/22/2011 001M2B-E PRN  PharmAthene Awarded 50% Profit Split on Worldwide Sales of Smallpox Antiviral Therapy by Delaware Chancery Court,"12/27/2018 68375N10 PRN  OPKO Health and OPKO's CEO and Chairman, Dr. Phillip Frost, Announce Proposed Resolution of SEC Action"," 1/07/2020 46222210 PRN  /C O R R E C T I O N -- Ionis Pharmaceuticals, Inc./"," 1/08/2020 09061G10   PRN  BioMarin to Participate in Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top on January 9, 2020 in New York"," 1/12/2017 01535110 PRN  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - ALXN",11/26/2019 64125C10 PRN  Neurocrine Biosciences to Present at Evercore ISI 2nd Annual HealthCONx Conference, 6/24/2019 81257810 PRN  Natasha A. Hernday Elected to PDL BioPharma's Board of Directors," 3/15/2017 45290710 PRN  Immunomedics Announces Publication of Results in Journal of Clinical Oncology, Demonstrating Treatment With Sacituzumab Govitecan (IMMU-132) Produces Early and Durable Responses in Patients With Metastatic Triple-Negative Breast Cancer", 3/22/2019 00167Y-E  PRN  Eisai to Present Latest Research about Alzheimer's Disease/Dementia Pipeline at The 14th International Conference on Alzheimer's & Parkinson's Diseases," 6/24/2015 45253H10 PRN  Critical Alerts For Tesla Motors, ImmunoGen, Celgene, Sarepta Therapeutics and Lululemon Released By InvestorsObserver", 9/26/2017 09058V10 PRN  Few Biotech Stocks Keep Momentum Going With Key Developments and FDA Approvals, 4/30/2019 000L1R-E   PRN  Taiwan National Health Insurance Administration of the Ministry of Health and Welfare Approves Vemlidy(R)  (tenofovir alafenamide) for Reimbursement," 1/13/2020 04004760   PRN  Arena Pharmaceuticals Appoints Joan Schmidt as Executive Vice President, General Counsel and Secretary", 2/27/2020 N5946510  PRN  Mylan and Pfizer Finalize Appointments to Viatris Board of Directors, 2/20/2020 000D1R-E PRN  Compugen Announces Phase 1/2 Triple Combination Study to Evaluate COM701 in Combination With Bristol-Myers Squibb's Opdivo® (Nivolumab) and TIGIT Inhibitor," 4/11/2018 00972810 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline - AKRX", 2/04/2020 000C35-E PRN  Frost & Sullivan Releases Osteoporosis Drug Market Data," 5/19/2018 62855J10 PRN  MYGN ALERT: Rosen Law Firm Reminds Myriad Genetics, Inc. Investors of Important Deadline in Class Action - MYGN", 9/27/2017 52887230 PRN  Lexicon Pharmaceuticals Initiates Patient Dosing In A Phase 1 Study Of LX9211,, 2/05/2020 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), 3/07/2011 05156V10 PRN  Inmarsat plc Reports Preliminary Full Year Results 2010," 3/18/2020 45773H20 PRN  Kessler Topaz Meltzer & Check, LLP:  Securities Fraud Class Action Filed Against Inovio Pharmaceuticals, Inc. - INO",12/03/2019 64026810 PRN  Nektar Appoints John Northcott as Chief Commercial Officer,10/29/2019 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Third Quarter 2019 Financial Results," 3/28/2018 37416310 PRN  GERON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Geron Corporation To Contact The Firm"," 5/05/2015 00771V10 PRN  Critical Alerts For Celgene, Sturm Ruger, Aerie Pharmaceuticals, 3D Systems and Zynga Released By InvestorsObserver","10/04/2017 02311120 PRN  Breakfast Technical Briefing on Drug Makers Stocks -- Amarin, Endo, Ionis Pharma, and Teva Pharma",10/21/2018 45337C10 PRN  ACR 2018: Lilly Shares Updated Safety Analysis of OLUMIANT® (baricitinib) in Patients with Moderately-to-Severely Active Rheumatoid Arthritis,10/30/2019 91307C10 PRN  United Therapeutics Corporation Reports Third Quarter 2019 Financial Results,"10/06/2016 80360710 PRN  Research Reports on Biotech Equities -- Celgene, Sarepta Therapeutics, Threshold Pharma, and MannKind",11/19/2019 G0176710 PRN  Alkermes Submits New Drug Application to U.S. Food and Drug Administration for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder," 9/16/2015 15708510 PRN  Biotechnology Stocks Technical Data -- Anacor Pharma, CytRx, Cerus, CorMedix, and FibroGen"," 2/23/2016 000PLZ-E PRN  Snyder's-Lance Set to Join the S&P MidCap 400; Trex, AMAG Pharmaceuticals to Join S&P SmallCap 600",, 2/10/2020 55027E10 PRN  Luminex Corporation Reports Fourth Quarter and Full-Year 2019 Results," 4/02/2019 SGMO-US  PRN  Sangamo Announces Agreement Securing Access To Large-Scale, Commercial-Grade Manufacturing Capacity At Brammer Bio","10/18/2016 30161Q10 PRN  Biotech Review DVAX Vaccine Faces Crucial PDUFA Date, CLDX Seeks Fast-Track Orphan Drug Status","12/12/2019 80105N10  PRN  SHAREHOLDER ALERT: WeissLaw LLP Investigates Synthorx, Inc."," 6/15/2016 92532F10  PRN  Chipotle Mexican Grill trade offers a 45% return in 31 days, or find similar option trades on NXP Semiconductors, CVS Caremark, Vertex Pharmaceuticals, and Perrigo Co.",, 2/07/2017 04351P10 PRN  Ascendis Pharma A/S Announces Presentation at the LEERINK Partners 6th Annual Global Healthcare Conference on February 15th," 9/07/2016 09609G10 PRN  Oncorus®, Inc. Appoints Biotech Industry Veteran Cyrus D. Mozayeni, M.D., as President and Chief Business Officer","12/15/2017 0033SF-E PRN  Stock Review for Biotech's Investors -- Bioverativ, ACADIA Pharma, Inovio Pharma, and Biogen",,11/06/2019 74366E10 PRN  Protagonist Therapeutics Announces First Patient Dosed in a Phase 2 Study of Oral IL-23 Receptor Antagonist PTG-200 (JNJ-67864238) in the Treatment of Crohn's Disease,," 5/10/2017 88338N10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TherapeuticsMD, Inc. - TXMD"," 7/21/2015 98978L20    PRN  Leadership Appointments Bodes Well with Strategic Focus - Report on Zogenix, Inc.",, 8/11/2016 68214310 PRN  Omeros Announces Pricing of Public Offering of Common Stock,,,10/27/2015 IRWD-US  PRN  Allergan Acquires Rights To Ironwood's CONSTELLA® (Linaclotide) From Almirall In More Than 40 Countries," 6/16/2015 00773U10 PRN  Harwood Feffer LLP Announces Investigation of Avalanche Biotechnologies, Inc."," 4/27/2017 90400D10 PRN  Research Reports Coverage on Biotech Stocks -- Ultragenyx Pharma, Chimerix, Coherus Biosciences, and Omeros",,,12/03/2019 69329Y10 PRN  PDL BioPharma Congratulates Evofem Biosciences on Achieving Major Regulatory and Clinical Milestones with its Lead Product Candidate Amphora®,,11/23/2011 00441H-E PRN  Radius Closes $27.65 Million Second Tranche of Previously Announced Financing,, 1/16/2020 00182C10 PRN  ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP, 4/14/2016 29251M10 PRN  AbbVie Announces High SVR Rates with VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) Regardless of the Presence of Resistance-Associated Variants Prior to Treatment in Genotype 1 Chronic Hepatitis C Patients," 7/24/2018 02043Q10 PRN  Free Technical Research Reports on Biotech Stocks -- Alkermes, Alnylam Pharma, Altimmune, and Alexion Pharma",, 7/19/2017 00972L10 PRN  Akcea Therapeutics Announces Closing of Initial Public Offering,10/28/2019 60468T10 PRN  Mirati Therapeutics Presents First Clinical Data Of Phase 1/2 Trial Of MRTX849 At The 2019 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics,"10/31/2014 69512710 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Pacira Pharmaceuticals, Inc. and Certain Officers - PCRX","10/14/2014 76129910 PRN  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Retrophin, Inc.",10/08/2015 JUNO-US  PRN  Multi-Billion Dollar Tissue Engineered Skin Substitutes Market Expected Robust Growth with Latest Biotech Advancements for Treating & Restoring Damaged Tissues,," 7/21/2015 CHMA-US  PRN  Chiasma, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares", 5/06/2014 063HNX-E PRN  CMC Biologics and MacroGenics Enter into a Process Development and Manufacturing Agreement for Oncology Product Candidate," 1/17/2020 0BP4MZ-E PRN  PANTHERx® Rare Pharmacy Selected by Blueprint Medicines Corporation to Distribute AYVAKIT™ (avapritinib) for Genomically Defined Patient Population with Rare Cancer, GIST"," 2/03/2015 00972D10 PRN  Latest Updates in Healthcare: Special Research on Agios, Akebia, Akers, Akorn, and Albany",10/21/2019 28249U10 PRN  Eiger Announces Peginterferon Lambda Combination Therapy for Treatment of Chronic Hepatitis Delta Virus (HDV) Infection to be Featured in a Late-Breaking Oral Presentation at AASLD 2019, 1/08/2016 MYL-GB   PRN  Mylan Announces Worldwide Collaboration with Momenta to Jointly Develop and Commercialize Six Biosimilar Products," 6/30/2014 G7280010 PRN  New Laws, Pricing of Offering, Recognitions, Donations, and Upcoming Conference Calls - Analyst Notes on Hospira, Prothena, Quintiles, Sirona and Covance",," 3/23/2016 78667J10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Sage Therapeutics, Inc. - SAGE",10/07/2015 CTMX-US  PRN  CytomX Announces Pricing of Initial Public Offering,"12/07/2010 000D1R-E PRN  Data from Phase 2 Study of Alder Biopharmaceuticals' Anti-IL-6 Antibody Therapeutic, ALD518, Demonstrate Reversal of Anemia in Patients with Advanced Non-Small Cell Lung Cancer", 1/13/2020 006GP9-E PRN  Vanda Pharmaceuticals Wins Key U.S. Supreme Court Patent Ruling on Fanapt®,,"10/20/2011 003MH3-E PRN  Metabolex Appoints Raymond Urbanski M.D., Ph.D. to Position of Chief Medical Officer", 4/17/2017 45781M10   PRN  Sarissa Capital States: Innoviva Already Appears To Renege On Cost Cuts; Innoviva Thinks Its Bad Corporate Governance Is Not A Problem,"11/08/2011 005XF5-E PRN  ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis","11/12/2019 40637H10 PRN  Halozyme Therapeutics, Inc. Announces Proposed Offering of $400 Million of Convertible Senior Notes due 2024", 5/10/2019 G2151510 PRN  China Biologic Reports Financial Results for the First Quarter of 2019,"10/06/2016 56400P70 PRN  Research Reports on Biotech Equities -- Celgene, Sarepta Therapeutics, Threshold Pharma, and MannKind",,"10/27/2015 23282W60 PRN  Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A  Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure"," 3/08/2016 29664W10 PRN  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 14, 2016 - ESPR", 3/03/2020 03236M20 PRN  Amyris Introduces New PURECANE™ Baking Sweetener Direct to Consumers on Purecane.com to Outperform Low-Calorie Competitors, 2/03/2020 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 9/17/2015 00448Q20 PRN  Equities Coverage on the Healthcare Sector -- Achillion Pharma, Perrigo, ACADIA Pharma, Kindred Healthcare, and Insulet"," 2/27/2019 87166B10 PRN  Syneos (SYNH) Investigation: Bernstein Liebhard LLP Announces First Investigation Of Syneos Health, Inc. - SYNH"," 9/23/2015 BMRN-US  PRN  Scanning Stocks from the Healthcare Sector - Amicus Therapeutics, Arena Pharmaceuticals, Cerner Corporation, Amarin Corporation and BioMarin Pharmaceutical","12/28/2015 065S4Q-E PRN  Teikoku Pharma USA, Inc. Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula",,,10/22/2018 36197T10 PRN  Canada Leads International Cannabis Boom - and It's not About Smoking," 5/28/2014 29428V10 PRN  Epizyme, Inc. to Present at Upcoming Conferences in June", 1/06/2020 G5087110 PRN  Jazz Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference,," 7/04/2019 00394S-E PRN  Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies",," 2/12/2020 73701010 PRN  Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020", 5/04/2017 92337F10 PRN  Veracyte Announces Pivotal Clinical Validation Data for Next-Generation Afirma® Test To Help More Patients Avoid Unnecessary Surgery in Thyroid Cancer Diagnosis,, 7/20/2011 ALCLS-FR PRN  Cellectis Bioresearch and Lonza Achieve Significant Milestone on CHO-K1SV GS Knock-Out,12/19/2017 14075510 PRN  Biotech Market Banking on Big Cannabis Returns, 1/04/2013 009T7W-E PRN  Flexion Therapeutics to Present at 31st Annual J.P. Morgan Healthcare Conference,12/06/2012 0CDXXJ-E PRN  uniQure Appoints Hans Christian Rohde Chief Commercial Officer, 6/29/2016 00847X10 PRN  Flagship Ventures Names Daniel McIntyre Partner," 5/03/2017 46226010 PRN  Lifshitz & Miller LLP Announces Investigation of Bingo Nation Inc., BofI Holding, Inc., Corbus Pharmaceuticals Holdings, Inc., Lion Biotechnologies, Inc., NewLink Genetics Corporation, Power Solutions International, Inc., Walter Investment Management Corp. and XBIOTECH INC.", 9/26/2016 008H33-E PRN  AnaptysBio Announces Checkpoint Receptor Agonist Antibody Portfolio,,12/13/2011 070JFC-E PRN  Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference,"11/14/2016 G4618810 PRN  InvestorsObserver releases covered-call reports for Micron, Smith & Wesson, Horizon Pharma, JC Penney and Procter & Gamble", 7/29/2013 00BJ80-E PRN  New Website Dedicated to Patients with Thymic Cancer," 9/12/2017 0F98BD-E PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intercept Pharmaceuticals, Inc. - ICPT", 4/06/2016 48576U10 PRN  Karyopharm Taps TransPerfect as eTMF and Functional TMF Provider,,11/05/2018 98401F10 PRN  Xencor Reports Third Quarter 2018 Financial Results," 5/01/2017 46116X10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Intra-Cellular Therapies, Inc. (ITCI)","12/03/2019 G8807B10 PRN  Theravance Biopharma Announces Dosing of First Patient in Phase 2 Allergen Challenge Study of TD-8236, an Investigational, Lung-Selective, Inhaled Pan-Janus Kinase (JAK) Inhibitor for Inflammatory Lung Diseases",10/29/2014 079TK4-E PRN  Novocure™ Announces Publication of a NovoTTF™ Therapy Supplement in Seminars in Oncology Including Analyses of its U.S. Commercial Patient Registry Dataset (PRiDe),11/06/2019 03969710 PRN  Ardelyx Announces Presentation at Kidney Week 2019,,,,,10/18/2019 M4613510 PRN  Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers," 9/08/2014 001THX-E PRN  PRA Health Sciences, Inc. Files Registration Statement for Initial Public Offering","12/30/2013 86845910 PRN  Healthcare Companies Report Board Changes, FDA Approvals, and Conference Call Schedules - Research Report on Quest Diagnostics, Supernus Pharma, Puma Biotechnology, Pacira, and ResMed",," 5/18/2017 74587V10 PRN  PUMA BIOTECHNOLOGY LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Puma Biotechnology, Inc. To Contact The Firm", 6/23/2014 0CT6N9-E PRN  Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Rheumatoid Arthritis,11/20/2017 21833P10 PRN  Legal Cannabis Medical Market Shows Strong Growth, 5/29/2019 05070R10 PRN  Audentes Therapeutics Announces Changes to Senior Management Team," 4/17/2013 00772J-E PRN  Collegium Pharmaceutical Announces Successful Completion of Clinical Study Evaluating the Impact of Tampering on Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Opioid Product"," 4/23/2015 98400H10 PRN  Health Care Stock Check: Complementary Research on Aduro BioTech, XBiotech, Eagle Pharma, Steadymed and Flex Pharma"," 9/29/2016 81750R10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Shareholders of Seres Therapeutics, Inc. - MCRB",, 5/18/2016 00G7QL-E PRN  Global Blood Therapeutics to Present at the UBS 2016 Global Healthcare Conference,10/29/2019 75901B10 PRN  REGENXBIO To Host Conference Call on November 5 to Discuss Third Quarter 2019 Financial Results and Recent Operational Highlights,,11/20/2014 00CLR1-E    PRN  Apellis Pharmaceuticals to acquire Potentia Pharmaceuticals.,,,10/27/2017 07725L10 PRN  Developments in China's Healthcare Industry,,," 6/06/2016 DB-DE    PRN  Hutchison China MediTech to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on June 10, 2016",,,,,11/04/2013 07N3G8-E PRN  arGEN-X raises EUR 5 Million from PMV in Extension of EUR 32.5 Million Series B,, 9/26/2016 06CR5C-E  PRN  Athenex Inc. and SunGen Pharma enter into U.S. joint venture agreement for a portfolio of 7 approved pharmaceutical products,,"10/27/2016 00FMDK-E PRN  Allergan to Acquire GI Disease Subsidiary of Rhythm Holding Company, LLC, Expanding Innovative Gastroenterology Pipeline","10/02/2012 00CN92-E PRN  Popular Migraine Medicine Quickly Absorbed When Delivered With Novel Breath Powered OptiNose Bi-Directional™ Nasal Technology, New Comparative Data Demonstrates",,, 9/19/2011 009FRV-E PRN  Dr. Martin Madaus Joins Quanterix as CEO, 3/15/2018 0F98BD-E PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Solid Biosciences Inc. - SLDB, 7/20/2017 00FCVN-E PRN  Evolus Announces European Medicines Agency Acceptance for Review of the Marketing Authorization Application for DWP-450 Neuromodulator, 4/23/2018 43808310 PRN  Homology Medicines to Participate in the World Orphan Drug Congress,,,,,,,,,,12/02/2018 05280R10 PRN  Autolus Therapeutics Presents Initial AUTO3 Clinical Data from Phase 1/2 Clinical Trials in B cell Malignancies at the 60th ASH Annual Meeting," 4/03/2018 07YR31-E PRN  Forty Seven, Inc. Appoints Ann D. Rhoads as Chief Financial Officer",,,,,,12/02/2019 50015M10 PRN  Kodiak Sciences Announces Proposed Offering of Common Stock,, 4/13/2018 00FYYJ-E PRN  Guardant Health to Present Validation Data for the GuardantOMNI™ assay,, 4/05/2017 009Z8P-E PRN  NGM Bio To Present Phase 2 Data Of NGM282 In NASH At International Liver Congress 2017, 1/03/2017 00FLML-E PRN  Twist Bioscience to Present at the 35th Annual J.P. Morgan Healthcare Conference,,,,,,,10/03/2019 0JNJRY-E PRN  Akero Therapeutics and InSphero partner to evaluate AKR-001 using InSphero's 3D InSight™ Human Liver Disease platform,,,,, 4/15/2015 0DMSKV-E PRN  Adaptive Biotechnologies and Collaborators to Present 4 Studies Demonstrating Clinical Relevance of Immunosequencing in the Treatment of Solid Tumors at the 2015 American Association for Cancer Research Annual Meeting,
11/15/2016 53220K50 PRN  Ligand Pharmaceuticals Inc. Investigated For Securities Fraud By Block & Leviton After Announcing Restatement Of Financial Results," 6/28/2019 74318710 PRN  ISS Supports Velan's Call for Change by Recommending Stockholders Vote ""Against"" Progenics Pharmaceuticals Directors Peter Crowley and Michael Kishbauch","11/13/2017 002WRP-E    PRN  Biotech Stocks on Investors' Radar -- Endocyte, Editas Medicine, Halozyme Therapeutics, and Illumina"," 9/22/2015 84763A10 PRN  Expert Briefing on Biotechnology Stocks -- Baxalta, Opko Health, Spectrum Pharma, Arrowhead Research, and Oncothyreon",11/19/2019 G3040110 PRN  Endo Announces FDA's Acceptance of Original Biologics License Application (BLA) for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite,"11/24/2015 04280A10 PRN  Covered Call Alerts For Skyworks Solutions, SunEdison, Invensense, Etsy Inc. and Arrowhead Research Released By InvestorsObserver", 9/19/2017 09060J10 PRN  BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2017 Healthcare Conference, 2/04/2020 09073M10    PRN  Bio-Techne Releases Second Quarter Fiscal 2020 Results, 2/12/2020 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentations, 8/29/2011 001M2B-E PRN  NYSE Amex Required Update,"11/07/2018 68375N10 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in OPKO Health, Inc. of Class Action Lawsuit and Upcoming Deadline - OPK", 1/06/2020 46222210 PRN  Ionis Pharmaceuticals to present at 38th annual J.P. Morgan Healthcare Conference, 1/08/2020 00167Y-E   PRN  Behind the Seizure® Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsy," 1/06/2017 01535110 PRN  Alexion Pharmaceuticals, Gartner, L Brands Inc., Weight Watchers, Zayo Group Holdings Inc. and more offer option-trading opportunities that offer returns of more than 17%",11/12/2019 64125C10 PRN  Neurocrine Biosciences Publishes Long-Term INGREZZA® (valbenazine) Data in the Journal of Clinical Psychopharmacology Demonstrating Once-Daily 40 mg and 80 mg Capsules Reduced Involuntary Movements in Adults with Tardive Dyskinesia, 6/03/2019 81257810 PRN  Astellas and Seattle Genetics Announce Antibody-Drug Conjugate Enfortumab Vedotin Produced Tumor Response Rate of 44 Percent in Patients with Most Common Type of Advanced Urothelial (Bladder) Cancer, 3/03/2017 IMMU-US  PRN  Immunomedics Board Institutes Measures As Stockholder Fiduciaries To Preserve Their Best Business Judgment To Protect The Rights Of All Stockholders, 3/22/2019 00167Y-E  PRN  Initiation Of Phase III Clinical Trial Of BAN2401 In Early Alzheimer's Disease," 6/02/2015 45253H10 PRN  Critical Alerts For Alibaba, ImmunoGen, SINA, eBay and Ocwen Financial Released By InvestorsObserver"," 5/16/2017 09058V10 PRN  Biotech Stocks Under Scanner -- BioCryst Pharma, Biogen, Celldex Therapeutics, and Concordia", 4/29/2019 000L1R-E   PRN  Taiwan National Health Insurance Administration of the Ministry of Health and Welfare Approves Vemlidy(R)  (tenofovir alafenamide) for Reimbursement, 1/08/2020 04004760   PRN  Arena Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 16," 2/18/2020 N5946510  PRN  Mylan to Release 2019 Fourth Quarter, Full Year Results and 2020 Guidance on Feb. 27, 2020"," 2/10/2020 M2572210 PRN  Compugen to Release Fourth Quarter and Full Year 2019 Results on Thursday, February 20, 2020"," 4/03/2018 0CJTL1-E PRN  AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Akorn, Inc. To Contact The Firm", 1/30/2020 03116210 PRN  Amgen Reports Fourth Quarter And Full Year 2019 Financial Results," 5/18/2018 62855J10 PRN  MYRIAD GENETICS SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN", 9/19/2017 52887230 PRN  European Commission Approves XERMELO® (Telotristat Ethyl) For The Treatment Of Carcinoid Syndrome Diarrhea In Combination With Somatostatin Analog Therapy,, 2/03/2020 45766930 PRN  Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchiectasis, 2/25/2011 05156V10 PRN  Inmarsat Appoints Frank Coles as Senior Director - Maritime Services for Global Xpress(TM)," 3/17/2020 45773H20 PRN  Thinking about buying stock in Chewy, General Electric, GrubHub, Inovio Pharmaceuticals, or Rite Aid?",11/13/2019 64026810 PRN  Nektar to Webcast Presentation at Jefferies 2019 London Healthcare Conference,10/23/2019 76655960 PRN  Rigel Pharmaceuticals Provides Business Update Prior to Investor & Analyst Call," 3/28/2018 37416310 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Geron Corporation (GERN)"," 5/01/2015 00771V10 PRN  Robbins Arroyo LLP: Aerie Pharmaceuticals, Inc. (AERI) Misled Shareholders According to a Recently Filed Class Action"," 5/04/2017 02311120 PRN  Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin", 9/21/2018 002PYJ-E PRN  Agenus Closes $15 Million Partial Royalty Monetization With XOMA,"10/23/2019 91307C10 PRN  United Therapeutics Corporation to Report Third Quarter 2019 Financial Results Before the Market Opens on Wednesday, October 30, 2019", 9/20/2016 001H2N-E PRN  Advancing Preclinical Autoimmune Studies & Accelerated FDA Approvals Producing Rewards in Biotech Sector,11/18/2019 0D6ZDW-E PRN  Alkermes to Acquire Rodin Therapeutics," 3/04/2015 15708510 PRN  Stock Updates on Health Care Equipment and Supplies Industry -- Stryker, Cerus, DENTSPLY Intl., Edwards Lifesciences, and Align Technology"," 1/27/2016 00163U10 PRN  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud by AMAG Pharmaceuticals, Inc. and Certain Officers and Directors -- AMAG",," 1/23/2020 55027E10 PRN  Luminex Corporation To Release Fourth Quarter and Full-Year 2019 Results After Market Close On February 10, 2020", 4/02/2019 SGMO-US  PRN  Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data,"10/07/2016 30161Q10 PRN  InvestorsObserver releases covered-call reports for Exelixis, NXP Semiconductors, Qualcomm, Generac Holdings and US Steel",12/10/2019 000VC1-E  PRN  Regeneron and Sanofi Announce Intent to Restructure Antibody Collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)," 5/31/2016 92532F10  PRN  InvestorsObserver releases covered-call reports for GoPro, Verizon Communications, Vertex Pharmaceuticals, NVIDIA and Celgene",, 1/03/2017 04351P10 PRN  Ascendis Pharma A/S Announces Presentation at 35th Annual J.P. Morgan Healthcare Conference on January 9," 8/10/2016 09609G10 PRN  How These Biotech Stocks are Faring? -- bluebird bio, Sage Therapeutics, Ultragenyx Pharma, and Alder Biopharma",10/18/2017 00422510 PRN  Positive Developments From Clinical Studies and FDA Approvals Pushing Biotech Stocks to New Highs,,10/31/2019 74366E10 PRN  Protagonist Therapeutics Secures Debt Facility for up to $50 Million,," 5/09/2017 88338N10 PRN  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In TherapeuticsMD, Inc. To Contact The Firm", 7/13/2015 98978L20    PRN  Biotech Briefing: FDA Events & Recent Clinical Trials Fuel Therapeutic Advancements That Continue to Drive the Pharma & Biotech Sectors,, 8/10/2016 005P05-E PRN  Omeros Announces Public Offering of Common Stock,,," 9/29/2015 46333X10 PRN  Drugs - Generic Equities at a Glance -- Mylan, Zoetis, Ironwood Pharma, Akorn, and Supernus Pharma"," 5/11/2015 00773U10 PRN  Pulse of the Healthcare Sector: Complementary Research on Sorrento, Aoxing, Neuralstem, ICU Medical and Avalanche Biotechnologies","10/28/2016 90400D10 PRN  Covered Call reports for CenturyLink, Francesca's Holdings Company, Myriad Genetics, Stamps.Com Inc. and Ultragenyx Pharmaceuticals include trade ideas that offer returns of 19% or more!",,,11/14/2019 06C5B2-E PRN  PDL BioPharma Reaffirms Commitment To Shareholder Value Creation,," 5/24/2011 006TCJ-E PRN  Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis",, 1/14/2020 00182C10 PRN  ANI Announces Launch of Paliperidone Extended-Release Tablets, 2/26/2016 080RQG-E PRN  AbbVie Receives CHMP Positive Opinion for VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) Without Ribavirin for the Treatment of Chronic Hepatitis C in Genotype 1b Patients with Compensated Cirrhosis (Child-Pugh A) in Europe, 3/21/2018 02043Q10 PRN  Regeneron and Alnylam Pharmaceuticals Announce Collaboration to Discover New Treatments for Nonalcoholic Steatohepatitis (NASH),, 7/13/2017 00972L10 PRN  Akcea Therapeutics Announces Pricing of Initial Public Offering,10/23/2019 60468T10 PRN  Mirati Therapeutics Announces Presentation Of Interim Phase 2 Sitravatinib Data In Urothelial Carcinoma And Oral Cavity Squamous Cell Carcinoma At The SITC 34th Annual Meeting,"10/07/2014 69512710 PRN  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Pacira Pharmaceuticals, Inc. (PCRX) To Contact The Firm"," 9/17/2014 76129910 PRN  Harwood Feffer LLP Announces Investigation of Retrophin, Inc.","12/19/2014 69404D10 PRN  How it All Plays Out -- New Research on Pacific Biosciences, Park-Ohio, Perceptron, PGT and Planar Systems",," 7/15/2015 16706W10 PRN  Chiasma, Inc. Prices Initial Public Offering of Common Stock", 4/11/2014 55609910 PRN  PolyTherics and MacroGenics Extend Collaboration to Produce Novel Antibody Drug Conjugates, 1/13/2020 09627Y10 PRN  Blueprint Medicines Announces 2020 Corporate Goals,, 9/27/2019 28249U10 PRN  Eiger to Present at Cantor 2019 Global Healthcare Conference," 7/22/2015 06T43N-E PRN  Generic Pharmaceutical Association Selects Chester ""Chip"" Davis, Jr. as President and CEO"," 3/05/2014 0CXBJZ-E PRN  Quarterly and Annual Financial Results Release, Executive Appointments, Upcoming Conferences, and Promotion Announcements - Analyst Notes on NuVasive, IPC, Portola, ICU Medical, and Prothena",," 3/23/2016 78667J10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sage Therapeutics, Inc. (SAGE)", 8/28/2015 0DZ2BK-E PRN  CytomX Files Registration Statement for Proposed Initial Public Offering, 7/01/2010 05FT2R-E PRN  GlaxoSmithKline and Genmab Announce Amendment to Ofatumumab Agreement,"12/12/2019 92165910 PRN  Mihael H. Polymeropoulos, MD, President and CEO of Vanda Pharmaceuticals Inc., to Receive The Physicians Committee for Responsible Medicine Trailblazer Award",, 5/19/2011 003MH3-E PRN  Metabolex Initiates Phase 2 Trial of Arhalofenate, 4/17/2017 45781M10   PRN  Sarissa Urges Shareholders To See Through Innoviva's Last Minute Flip-Flop On Cost Cuts; Notes Conspicuous Absence Of Promises To Fix Bad Corporate Governance,"10/17/2011 005XF5-E PRN  ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis",11/12/2019 40637H10 PRN  Halozyme Reports Third Quarter 2019 Results, 4/30/2019 G2151510 PRN  China Biologic Products to Report First Quarter 2019 Financial Results," 8/24/2016 56400P70 PRN  Research Report on Biotech Equities -- Celgene, Sarepta Therapeutics, MannKind, and Opko Health",, 7/14/2015 06NCG8-E PRN  Cytokinetics And The ALS Association Announce Awarding Of Grant For Phase 3 Clinical Trial And Biomarker Research Collaboration," 2/22/2016 29664W10 PRN  SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Esperion Therapeutics, Inc. - ESPR"," 2/26/2020 03236M20 PRN  Amyris to Present at Cowen 40th Annual Health Care Conference on March 3, 2020", 2/03/2020 69366J20 PRN  PTC Therapeutics to Host A Conference Call to Review Part 2 of the SUNFISH Clinical Trial Data at the SMA Europe Conference," 9/09/2015 00448Q20 PRN  Critical Alerts For Fitbit, Palo Alto Networks, Regeneron Pharmaceuticals, Isis Pharmaceuticals and Achillion Pharmaceuticals Released By InvestorsObserver", 1/27/2019 87166B10 PRN  BioDuro partners with Advent International, 9/09/2015 0070KW-E PRN  Significant Shareholder Update - BrokerBank Securities,"10/15/2015 065S4Q-E PRN  Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula",,,10/09/2018 36197T10 PRN  Public Acceptance Fuels Growth of CBD and Support Industries, 5/13/2014 29428V10 PRN  Epizyme Announces First Quarter 2014 Financial Results and Provides Corporate Update,12/30/2019 G5087110 PRN  Jazz Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 2/3 Study Evaluating JZP-458 for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma,, 7/03/2019 39843840 PRN  Grifols Selected to Build Its First Intravenous Solutions Manufacturing Line in Africa,," 2/06/2020 73701010 PRN  Wolf Haldenstein Reminds Investors In Portola Pharmaceuticals, Inc. That A Securities Class Action Has Been Filed", 5/03/2017 92337F10 PRN  Veracyte Announces First Quarter 2017 Financial Results,," 7/11/2011 063J3K-E PRN  Dr. Andrew Scharenberg, M.D., to Serve as Chief Scientific Officer for Cellectis therapeutics",12/18/2017 14075510 PRN  Research Predicts Further Growth for the Medical Cannabis Market,12/17/2012 009T7W-E PRN  Flexion's FX006 Achieves Prolonged Therapeutic Concentrations in Joints of Osteoarthritis Patients, 7/20/2012 0CDXXJ-E PRN  First Gene Therapy in Western World Receives Positive Opinion in Europe from CHMP," 6/02/2016 00847X10 PRN  What Investors Think of These Biotech Stocks? - Genocea Biosciences, BioDelivery Sciences Intl., INSYS Therapeutics, and Agios Pharma"," 4/28/2017 46226010 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lion Biotechnologies, Inc. of Class Action Lawsuit and Upcoming Deadline - LBIO", 7/06/2016 008H33-E PRN  AnaptysBio Initiates Multiple Ascending Dose Cohorts In ANB020 Phase 1 Clinical Trial,,12/09/2011 070JFC-E PRN  Fate Therapeutics Secures Foundational Patent for iPS Cell Reprogramming, 9/01/2016 G4618810 PRN  Nuvo Pharmaceuticals™ Inc. Appoints New Chief Financial Officer, 6/19/2013 00BJ80-E PRN  Castle Biosciences Announces Availability of Esophageal Cancer Test Designed to Identify Patients Who are Resistant to Pre-Operative Chemoradiation Therapy,"12/06/2016 45845P10 PRN  Amazon.com trade offers a 6.05% return in 74 days, or find similar option trades on Intercept Pharmaceuticals, Energous Corporation, Opko Health, and 3D Systems"," 6/27/2014 48576U10 PRN  Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics",,11/01/2018 98401F10 PRN  Xencor to Present Initial Data from Phase 1 Study of XmAb®14045 Bispecific Antibody in Acute Myeloid Leukemia at the 2018 ASH Annual Meeting,"10/21/2016 46116X10 PRN  Covered Call reports for Gilead Sciences, American Express, Petrobras, Merrimack Pharmaceuticals and Intra-Cellular Therapies include trade ideas that offer returns of 20% or more!",11/26/2019 G8807B10 PRN  Theravance Biopharma to Present at Two Upcoming Investor Conferences, 9/25/2014 079TK4-E PRN  Novocure™ Announces Recurrent Glioblastoma Patient Registry Dataset (PRiDe) to be Presented at ESMO and EANO 2014,11/06/2019 03969710 PRN  Ardelyx Reports Third Quarter 2019 Financial Results and Recent Highlights,,,,,10/17/2019 M4613510 PRN  Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea, 8/26/2014 001THX-E PRN  PRA Health Sciences Expands in Pennsylvania,"11/19/2013 86845910 PRN  Healthcare Sector Announced Reforms, Financial Results, Public Offerings, Top Rankings and Positive Data - Research Report on Kindred, Zogenix, Sangamo, PhotoMedex and Supernus Pharmaceuticals",," 5/12/2017 74587V10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI"," 6/09/2014 0CT6N9-E PRN  Coherus BioSciences Appoints Vince R. Anicetti as Senior Vice President, Global Quality",10/19/2017 21833P10 PRN  Legal Cannabis Sales Projected to Increase as the Illicit Market Weakens, 5/08/2019 05070R10 PRN  Audentes Therapeutics to Participate in the Bank of America Merrill Lynch 2019 Health Care Conference, 4/03/2013 00772J-E PRN  Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development, 4/01/2015 00GL6Z-E PRN  XBiotech Announces Publication of Positive Clinical Results for Xilonix™ in Non-Small Cell Lung Cancer, 7/13/2016 81750R10 PRN  Dr. Michael Rosenblatt Joins Flagship Ventures as Chief Medical Officer,, 5/12/2016 37890U10 PRN  Global Blood Therapeutics Reports Recent Business Progress and Provides First Quarter 2016 Financial Results,10/17/2019 75901B10 PRN  REGENXBIO Announces Presentations at the European Society of Gene & Cell Therapy 27th Annual Congress,,,,,,,, 5/27/2016 0085DK-E PRN  Edison Issues Re-initiation on Hutchison China MediTech,,,,,11/04/2013 0B8NFJ-E PRN  arGEN-X and de Duve Institute/UCL to Collaborate on Novel Immunomodulation Therapy in Cancer,," 9/15/2016 06V74D-E  PRN  Dr. Daniel Von Hoff, MD, F.A.C.P. Joins Athenex's Clinical Scientific Advisory Board",," 7/27/2016 00FMDK-E PRN  Rhythm Announces ""The Genetic Obesity Project"" to Expand Understanding of Rare Genetic Disorders of Obesity",,,, 8/19/2011 009FRV-E PRN  Quanterix Digital ELISA Measures Low Abundance Biomarkers of Inflammation in Crohn's Disease,, 7/19/2017 00FCVN-E PRN  Evolus Announces FDA Acceptance for Review of the Biologics License Application for DWP-450 Neuromodulator, 4/03/2018 43808310 PRN  Homology Medicines Announces Closing of Initial Public Offering,,,,,,,,,,12/01/2018 05280R10 PRN  Autolus Therapeutics Announces Update on its Novel CAR T Cell Program for Peripheral T Cell Lymphoma (PTCL), 2/20/2018 07YR31-E PRN  Forty Seven Inc. Appoints Kristine M. Ball to Board of Directors,,,,,,12/02/2019 50015M10 PRN  Kodiak Sciences to Present at the Evercore ISI HealthCONx Conference,, 3/19/2018 00FYYJ-E PRN  Guardant Health Applauds Medicare For Final Decision Benefiting Advanced Cancer Patients,," 6/08/2016 009Z8P-E PRN  NGM Bio Initiates Phase 1 Clinical Trial of NGM313, a Proprietary Antibody with the Potential to Treat Type 2 Diabetes, Obesity and NASH",10/11/2016 00FLML-E PRN  Twist Bioscience and Distributed Bio Partner to Offer Antibody Design and Optimization Services,,,,,,, 9/04/2019 00973Y10 PRN  Akero Therapeutics To Present At The Morgan Stanley 17th Annual Global Healthcare Conference,,,,, 4/01/2015 0DMSKV-E PRN  Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA,
11/15/2016 53220K50 PRN  Harwood Feffer LLP Announces Investigation of Ligand Pharmaceuticals Incorporated, 6/28/2019 74318710 PRN  Velan Clarifies Interactions with Progenics Pharmaceuticals' Board of Directors, 8/09/2017 45232710    PRN  Azumio Introduces DNA-Based Insights into its Fitness Platform," 4/27/2015 84763A10 PRN  Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation",11/04/2019 G3040110 PRN  Endo Implements CEO Succession Plan,"11/10/2015 04280A10 PRN  Covered Call Alerts For Micron, Arrowhead Research, General Electric, TASER International and CSX Released By InvestorsObserver", 9/12/2017 09060J10 PRN  BioDelivery Sciences Announces Granting of Market Authorization Transfer by Health Canada for BELBUCA® and Associated Milestone Payment, 2/04/2020 09073M10    PRN  Bio-Techne Declares Dividend, 2/08/2020 75886F10    PRN  EYLEA® (aflibercept) Injection Reduced Risk of Developing Vision-Threatening Events by 75% After Two Years in Patients with Diabetic Retinopathy, 6/27/2011 001M2B-E PRN  Chimerix and BARDA Reach Agreement Ending GAO Review of Smallpox Antiviral Contract," 9/22/2018 68375N10 PRN  OPK LOSS NOTICE ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against OPKO Health, Inc.; Important Deadline - OPK",12/19/2019 46222210 PRN  Ionis licenses investigational Alzheimer's therapy, 1/06/2020 09061G10   PRN  BioMarin to Present at 38th Annual J.P. Morgan Healthcare Conference in San Francisco," 1/04/2017 01535110 PRN  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Alexion Pharmaceuticals, Inc. To Contact The Firm Before Lead Plaintiff Deadline",11/05/2019 64125C10 PRN  Neurocrine Biosciences to Present at Upcoming Healthcare Conferences, 3/28/2019 81257810 PRN  Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer, 3/02/2017 45290710 PRN  Immunomedics Outlines Revised Settlement Offer Rejected By venBio; Announces Actions That Are In The Best Interests Of All Stockholders, 2/25/2019 09062X10  PRN  Alkermes and Biogen Announce U.S. Food and Drug Administration Acceptance of Diroximel Fumarate New Drug Application for Multiple Sclerosis," 4/28/2015 45253H10 PRN  Technical Coverage of Biotech Equities -- Celldex Therapeutics, ImmunoGen, Hemispherx Biopharma, Intrexon, and PTC Therapeutics","10/12/2016 09058V10 PRN  Biotech Stocks on Investors' Radar -- Alexion Pharma, PDL BioPharma, BioCryst Pharma, and Cara Therapeutics"," 3/15/2019 MRK-US     PRN  Fish & Richardson Named 2019 ""Intellectual Property Firm of the Year"" in the U.S. by Benchmark Litigation; Wins ""National Impact Case""", 1/06/2020 04004760   PRN  Arena Pharmaceuticals Highlights Strategic Plan Driving Near and Long-term Growth with Eight Ph 2 and Ph 3 Data Readouts in 2020-21 and One New IND Per Year for the Next 5 Years," 1/08/2020 00GDWJ-E  PRN  Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceutical Ingredient Manufactured by Solara Active Pharma Sciences Limited", 2/07/2020 M2572210 PRN  Compugen Presents Update on COM701 Phase 1 Trial at ASCO-SITC Clinical Immuno-oncology Symposium," 3/27/2018 00972810 PRN  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: May 7, 2018", 1/27/2020 03116210 PRN  Amgen Announces Webcast Of 2019 Fourth Quarter And Full Year Financial Results," 5/16/2018 001D3K-E PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - MYGN", 9/18/2017 52887230 PRN  Lexicon Pharmaceuticals To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference,, 1/30/2020 45766930 PRN  Insmed Appoints Sara Bonstein as Chief Financial Officer, 1/28/2011 05156V10 PRN  Inmarsat Receives Phase 2 Notice From LightSquared," 3/15/2020 45773H20 PRN  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed",11/12/2019 0011X6-E PRN  Biotechs Seek Advancements in the Immuno-Oncology Field for Childhood Brain Tumors,10/18/2019 76655960 PRN  Rigel Receives Positive Trend Vote from CHMP for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe, 3/27/2018 37416310 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN," 5/01/2015 0070KW-E PRN  All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc."," 3/27/2017 02311120 PRN  Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin", 7/19/2018 45337C10 PRN  Study Published in The Lancet Shows Benefit of Baricitinib 4 mg for the Treatment of Systemic Lupus Erythematosus (SLE),10/21/2019 91307C10 PRN  United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study," 8/24/2016 80360710 PRN  Research Report on Biotech Equities -- Celgene, Sarepta Therapeutics, MannKind, and Opko Health",11/12/2019 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at Upcoming Healthcare Conferences," 1/22/2015 15708510 PRN  Health Care Supplies Stocks Technical Review - Cerus, Unilife, DENTSPLY Intl., Alere, and Align Technology"," 9/23/2015 00163U10 PRN  Stocks Update from Health Care Sector -- Halozyme Therapeutics, Celldex Therapeutics, Galena Biopharma, AMAG Pharmaceuticals and EXACT Sciences",, 1/12/2020 55027E10 PRN  Luminex Corporation Announces 2019 Highlights and 2020 Guidance; Company to Present at 38th Annual J.P. Morgan Healthcare Conference," 4/01/2019 80067710 PRN  Sangamo Therapeutics To Host April 2, 2019 Conference Call To Provide Clinical Update"," 9/22/2016 30161Q10 PRN  Covered Call reports for FireEye, Barrick Gold Corporation, General Electric, Facebook and Exelixis include trade ideas that offer returns of 20% or more!",12/09/2019 80105N10  PRN  Sanofi awarded $226 million by US government to expand pandemic influenza preparedness, 5/25/2016 000YJB-E  PRN  Spero Therapeutics Acquires Novel Gyrase Inhibitors from Vertex Pharmaceuticals,,11/30/2016 04351P10 PRN  Ascendis Pharma A/S Reports Third Quarter 2016 Financial Results," 6/27/2016 09609G10 PRN  Biotechnology Equities at a Glance -- MannKind, bluebird bio, OncoGenex Pharma, and Hevat Biologics","12/21/2016 00422510 PRN  Investors: Get options trading reports for ACADIA Pharmaceuticals, Advanced Micro Devices, Allegheny Technologies, Host Hotels and Resorts and Microsoft include trade ideas that offer returns of 21% or more!",,10/30/2019 74366E10 PRN  Protagonist Therapeutics Initiates Phase 2 Study of Novel Hepcidin Mimetic PTG-300 in the Treatment of Patients with Polycythemia Vera,," 5/03/2017 88338N10 PRN  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Encourages Investors with Losses to Contact the Firm"," 5/12/2015 98978L20    PRN  Market Updates on Pharma Stocks - Zogenix, Valeant Pharma Intl., Sanofi, Novartis, and Ampio Pharma",, 7/28/2016 68214310 PRN  Omeros Corporation Confirms OMS721 Phase 3 Development Plan with European Medicines Agency,,," 7/21/2015 46333X10 PRN  Technical Roundup on Drugs - Generic Equities -- Allergan, Akorn, Ironwood Pharma, Pacira Pharma, and Catalent"," 2/10/2015 00773U10 PRN  Valuable Updates on Pharmaceutical Companies: New Research on Avalanche Biotechnologies, BioCryst, Biogen, Biota Pharmaceuticals, and Bio-Techne","10/17/2016 CALA-US  PRN  Sofinnova Announces the Addition of Industry Veteran Sunil Agarwal, MD to its Partnership",,,11/14/2019 06C5B2-E PRN  Engine Capital Releases Presentation To Board Of PDL BioPharma,, 5/24/2011 0BHPTF-E PRN  Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study,," 1/09/2020 002QRN-E PRN  ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd."," 1/11/2016 29251M10 PRN  AbbVie Initiates Enrollment of Six Global Phase 3 Clinical Studies for Once-Daily, Pan-Genotypic Hepatitis C Regimen", 1/30/2018 0DLB6Z-E PRN  Alnylam Awards Albireo Energy Building Automation Integration Scope of New Cutting-Edge Manufacturing Facility,, 6/20/2017 0017CR-E PRN  Akcea Therapeutics Launches Proposed Initial Public Offering,"10/17/2019 60468T10 PRN  Mirati Therapeutics To Present Pre-Clinical And Initial Clinical Data For MRTX849, A KRAS G12C Inhibitor, At The 2019 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics"," 9/30/2014 69512710 PRN  Positive Study Results, Acquisitions, Drug Approval, Regulatory Updates, and Collaborations - Research Reports on Gilead, Pfizer, AbbVie, Pacira and Thermo Fisher"," 9/17/2014 76129910 PRN  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Retrophin, Inc.","10/27/2014 69404D10 PRN  Technical Coverage on Life Sciences Tools and Services Equities - Agilent Technologies, Thermo Fisher Scientific, Pacific Biosciences of California, Sequenom, and Covance",, 6/15/2015 007MPF-E PRN  Chiasma Submits New Drug Application to U.S. FDA for Octreotide Capsules in Acromegaly,"12/25/2013 55609910 PRN  Additional Shares Purchased, Extended Collaboration, Credit Facility, Publication of Data, and Interim Results - Research Report on Karyopharm, Agios, Lannett, MacroGenics, and ZIOPHARM", 1/09/2020 09627Y10 PRN  Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor,, 8/29/2019 28249U10 PRN  Eiger BioPharmaceuticals to Participate in September Conferences," 4/21/2015 60877T10 PRN  A Look at the Health of the HealthCare Sector: Complementary Research on Horizon Pharma, Enzon Pharmaceuticals, Momenta Pharmaceuticals, Athersys, and Pernix Therapeutics",,," 6/10/2015 78667J10 PRN  Critical Alerts For Bank of America, Lululemon, Sage Therapeutics, GoPro and Salesforce.com Released By InvestorsObserver"," 8/27/2015 0DZ2BK-E PRN  Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer",,11/18/2019 92165910 PRN  Vanda Pharmaceuticals Announces Participation at November 2019 Investor Conferences,, 6/25/2010 003MH3-E PRN  Metabolex and Sanofi-Aventis Enter Into An Agreement for Novel Type 2 Diabetes Treatment," 4/13/2017 45781M10   PRN  Sarissa Capital Urges Shareholders Of Innoviva, Inc.: Follow The Recommendations Of ISS, Glass Lewis And Egan-Jones; Vote On The Gold Card For Sarissa Nominees", 9/15/2011 005XF5-E PRN  ChemoCentryx Reports CCX140-B Meets Primary Endpoint and Demonstrates Clinical Efficacy in Phase II Study in Type 2 Diabetes,11/04/2019 40637H10 PRN  Halozyme Announces HALO-301 Phase 3 Study Fails To Meet Primary Endpoint, 3/06/2019 G2151510 PRN  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018, 8/11/2016 005SV0-E PRN  Asembia to Provide HUB and Patient Support Services for MannKind Corporation Related to Afrezza® (insulin human) Inhalation Powder,, 6/04/2015 06NCG8-E PRN  Cytokinetics And The ALS Association Announce Partnership To Advance The Fight Against ALS," 2/19/2016 29664W10 PRN  INVESTOR ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Lawsuit Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of March 14, 2016 - ESPR", 2/25/2020 03236M20 PRN  Amyris Expands Distribution of PURECANE™ Packets on Amazon, 2/03/2020 69366J20 PRN  PTC Therapeutics Announces First Publication of Real-World Data Showing Translarnaä (ataluren) Significantly Preserves Ability to Walk for Longer in Children with Duchenne Muscular Dystrophy," 8/26/2015 00448Q20 PRN  Critical Alerts For PayPal Holdings Inc., Skechers, Intel, Achillion Pharmaceuticals and SouFun Released By InvestorsObserver", 4/11/2018 SYNH-US  PRN  Capri EGM Provides Build-to-Suit Financing and Announces Acquisition of Global Headquarters for Syneos Health," 6/12/2015 03152W10 PRN  Critical Alerts For JetBlue, Tableau Software, Tekmira Pharmaceuticals, Canadian Solar and Amicus Therapeutics Released By InvestorsObserver"," 4/23/2015 26979610 PRN  Health Care Stock Check: Complementary Research on Aduro BioTech, XBiotech, Eagle Pharma, Steadymed and Flex Pharma",,,"10/04/2018 36197T10 PRN  Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector"," 5/07/2014 29428V10 PRN  Epizyme, Inc. to Report First Quarter Financial Results and Provide Corporate Update on May 13, 2014",12/19/2019 G5087110 PRN  PharmaMar and Jazz Pharmaceuticals Sign Exclusive License Agreement for Lurbinectedin in the U.S.,, 6/19/2019 39843840 PRN  Grifols to launch plasma-protein-based bleeding-control solutions,," 2/03/2020 73701010 PRN  Portola Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President and Chief Medical Officer", 4/26/2017 92337F10 PRN  Veracyte Announces Multiple Studies Demonstrating Powerful Results from Afirma® Classifiers To Be Presented at the AACE 2017 Annual Meeting,," 7/05/2011 063J3K-E PRN  TALEN® Access by Cellectis Bioresearch Receives ""Most Innovative New Service 2011"" Award at Life Science Awards",11/28/2017 14075510 PRN  Medical Cannabis Data Shows Strong Sales and Growth,12/04/2012 06BJYL-E PRN  Flexion Therapeutics Secures $20 Million in Series B Financing, 6/21/2012 0CDXXJ-E PRN  uniQure Collaborates with UCSF on GDNF Gene Therapy in Parkinson's Disease,"10/28/2015 00847X10 PRN  Covered Call Alerts For Corning Inc., Seadrill, Arrowhead Research, Intrexon and Agios Pharmaceuticals Released By InvestorsObserver"," 4/26/2017 46226010 PRN  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm", 4/18/2016 008H33-E PRN  AnaptysBio Appoints Dr. Matthew Moyle As Chief Scientific Officer,,11/16/2011 070JFC-E PRN  Fate Therapeutics Strengthens Its iPSC Platform," 8/04/2016 00G0R2-E PRN  Rheumatology Nurses Society Announces ""Heroes of Caring"" Initiative Celebrating Nurses Caring For Patients With Rheumatologic Diseases", 6/05/2013 00BJ80-E PRN  New Website Dedicated to Sufferers of Melanoma," 8/04/2016 008BK4-E PRN  Research Report Initiation on These Biotech Stocks -- Tesaro, Cerus, Five Prime Therapeutics, and Intercept Pharma"," 6/26/2014 48576U10 PRN  Completed Acquisitions, Index Inclusions, and Conditional Drug Approvals - Analyst Notes on Universal Health Services, Brookdale, Envision Healthcare, Karyopharm and NW Bio",,"10/29/2018 98401F10 PRN  Xencor to Host Third Quarter 2018 Financial Results Webcast and Conference Call on November 5, 2018","10/20/2016 46116X10 PRN  Biotech Stocks Technical Reports -- Navidea Biopharma, ZIOPHARM Oncology, Intra-Cellular Therapies, and Cempra",11/06/2019 G8807B10 PRN  Theravance Biopharma to Present at the 2019 Credit Suisse Healthcare Conference, 8/21/2014 079TK4-E PRN  Novocure Announces the Submission of a Pre-Marketing Approval Application in Japan for the NovoTTF™-100A System to Treat Recurrent Glioblastoma,10/10/2019 03969710 PRN  Ardelyx to Host Analyst Day in New York,,,,,"10/10/2019 M4613510 PRN  Foamix to Present Data on its Topical Product Candidates for Acne, Rosacea at 39th Annual Fall Clinical Dermatology Conference", 3/28/2013 06F04Q-E PRN  Marken Hosts Industry Panel Event In Mexico City,"11/11/2013 86845910 PRN  Upcoming Earnings Schedules, Conferences and Quarterly Financial Results - Research Report on Supernus, Ironwood, Neurocrine Biosciences, PhotoMedex, and Kythera",," 5/11/2017 74587V10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Puma Biotechnology, Inc. (PBYI) and Lead Plaintiff Deadline: July 7, 2017", 5/19/2014 0CT6N9-E PRN  Coherus BioSciences Secures $55 million Series C Financing,10/10/2017 21833P10 PRN  Data Shows Positive Projections for the Legal Cannabis Industry, 5/07/2019 05070R10 PRN  Audentes Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update," 2/28/2013 00772J-E PRN  Collegium Pharmaceutical's CEO to Present at the Cowen & Company 33rd Annual Health Care Conference in Boston on March 6, 2013", 3/12/2015 00GL6Z-E PRN  XBiotech Launches Website and Call Center to Inform Cancer Patients about New Xilonix™ Therapy and Phase III Clinical Study, 6/29/2016 81750R10 PRN  Flagship Ventures Names Daniel McIntyre Partner,, 4/04/2016 37890U10 PRN  Global Blood Therapeutics Announces Appointment of Jeffrey Farrow as CFO,10/11/2019 75901B10 PRN  REGENXBIO Announces Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting,,,,,,,,12/18/2015 HCM-HK   PRN  Initiation of Sulfatinib Phase III Registration Study in Neuroendocrine Tumor Patients,,,,, 9/19/2013 07N3G8-E PRN  arGEN-X Reaches Milestone in Simple Antibody™ Research and Product Development Collaboration With Shire,," 9/06/2016 00695P-E  PRN  Athenex, Inc. and Gland Pharma enter into U.S. supply and marketing collaboration for a portfolio of more than 20 specialty injectable pharmaceutical products",, 4/04/2016 00FMDK-E PRN  Motus Presents Clinical Proof-of-Concept Results for Relamorelin in the Treatment of Anorexia,,,, 8/16/2011 009FRV-E PRN  Quanterix and STRATEC Announce Strategic Partnership,,"10/03/2013 00F58S-E PRN  Strathspey Crown Acquires Evolus, Inc.", 3/27/2018 43808310 PRN  Homology Medicines Announces Pricing of Initial Public Offering,,,,,,,,,,11/23/2018 05280R10 PRN  Autolus Therapeutics Submits Fiscal Year 2018 Form 20-F, 2/06/2018 07YR31-E PRN  Forty Seven Inc. to Present at the 2018 BIO CEO & Investor Conference,,,,,,12/02/2019 004ZNB-E PRN  Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors,, 3/12/2018 00FYYJ-E PRN  Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of GI Cancer Trial,,11/09/2015 009Z8P-E PRN  NGM Bio to Present Data Highlighting the Therapeutic Potential of NGM282 in Cholestatic Liver Diseases at AASLD's The Liver Meeting® 2015,10/05/2016 00FLML-E PRN  Twist Bioscience to Present at the InPho Venture Summit,,,,,,, 8/12/2019 00973Y10 PRN  Akero Therapeutics Reports Recent Highlights and Second Quarter 2019 Financial Results,,,,, 3/17/2015 0DMSKV-E PRN  Adaptive Biotechnologies Invited to Present at Upcoming Conferences,
"11/14/2016 53220K50 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ligand Pharmaceuticals, Inc. - LGND", 6/25/2019 74318710 PRN  Velan Releases Presentation Reiterating the Facts and Setting The Record Straight for Progenics Pharmaceuticals' Stockholders, 8/01/2017 45232710    PRN  Kindara Unveils Plan To Revolutionize Women's Health Industry With Kindara DNA," 4/22/2015 84763A10 PRN  Small Cap Company with the Pipeline of a Sector Leader; Spectrum Pharmaceuticals Analyst Report Issued by BrokerBank Securities, Inc.",11/04/2019 G3040110 PRN  Endo Reports Third-Quarter 2019 Financial Results,"10/28/2015 04280A10 PRN  Covered Call Alerts For Corning Inc., Seadrill, Arrowhead Research, Intrexon and Agios Pharmaceuticals Released By InvestorsObserver", 9/07/2017 09060J10 PRN  BioDelivery Sciences Presents Data on BELBUCA® (buprenorphine) Buccal Film at the PAINWeek 2017 Conference," 1/09/2020 09073M10    PRN  Bio-Techne To Host Conference Call On February 4, 2020 To Announce Second Quarter 2020 Financial Results", 2/06/2020 75886F10    PRN  Regeneron Reports Fourth Quarter and Full Year 2019 Financial and Operating Results, 5/02/2011 001M2B-E PRN  PharmAthene Completes Closing Arguments and Provides Update on Litigation With SIGA Technologies," 9/21/2018 68375N10 PRN  OPKO HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against OPKO Health, Inc. - OPK","12/18/2019 46222210 PRN  Ionis appoints C. Frank Bennett, Ph.D., to chief scientific officer and promotes Eric E. Swayze, Ph.D., to senior vice president of research", 1/02/2020 09061G10   PRN  BioMarin Announces New England Journal of Medicine Publishes 3 Years of Follow-up Data in Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A, 1/04/2017 0F24XM-E PRN  Vtesse Announces Appointment of Jason Meyenburg as Chief Commercial Officer,11/04/2019 64125C10 PRN  Neurocrine Biosciences Reports Third Quarter 2019 Financial Results, 3/04/2019 000KYG-E PRN  Biotechnology Companies see Rising Demand for new Therapies, 2/10/2017 45290710 PRN  Immunomedics Announces Postponement of 2016 Annual Meeting, 1/04/2019 09062X10  PRN  Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets," 3/24/2015 45253H10 PRN  Critical Alerts For Kinder Morgan, ImmunoGen, ITT Education Released By InvestorsObserver"," 8/29/2016 09058V10 PRN  Research Reports Initiation on Biotech Stocks -- Hemispherx Biopharma, Vascular Biogenics, BioCryst Pharma, and Alnylam Pharma", 3/13/2019 AGEN-US    PRN  Agenus Milestone Triggers $7.5M Payment from Gilead, 1/02/2020 002XMH-E   PRN  Arena Pharmaceuticals and Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory Targets, 1/06/2020 N5946510  PRN  Mylan to Present at the 38th Annual J.P. Morgan Healthcare Conference, 2/04/2020 M2572210 PRN  Compugen Announces New U.S. Patent for Methods of Screening for Anti-PVRIG Antibodies," 3/09/2018 00972810 PRN  Block & Leviton LLP Announces The Filing Of A Class Action Against Akorn, Inc. (AKRX)"," 1/22/2020 03116210 PRN  Free ""LabXchange"" Science Education Accelerator Launched By Amgen Foundation And Harvard's Faculty Of Arts And Sciences"," 5/03/2018 001D3K-E PRN  Investor Alert: Kaplan Fox Announces Investigation Of Myriad Genetics, Inc.", 9/13/2017 52887230 PRN  New England Journal Of Medicine Publishes Data From Phase 3 inTandem3 Study Of Sotagliflozin In Patients With Type 1 Diabetes,, 1/09/2020 45766930 PRN  Insmed to Present at the 38th Annual J.P. Morgan Healthcare Conference,," 3/14/2020 45773H20 PRN  Kaskela Law LLC Announces Shareholder Class Action Lawsuit Filed Against Inovio Pharmaceuticals, Inc. (INO) and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm","11/10/2019 64026810 PRN  Nektar Therapeutics Presents Data from First-in-Human Phase 1a Study on Novel T Regulatory Cell Stimulator, NKTR-358 at 2019 Annual Meeting of the American College of Rheumatology","10/16/2019 76655960 PRN  Rigel to Host Investor and Analyst Call on October 23, 2019","11/01/2017 0017CF-E PRN  ASH 2017: Janssen to Present 40 Abstracts, Including 8 Oral Presentations, with New Data on DARZALEX® (daratumumab), IMBRUVICA® (ibrutinib) and Other Compounds from Robust Portfolio"," 4/29/2015 00771V10 PRN  Tracking the Pulse of the Healthcare Sector: Complementary Research on Enzon, Aerie Pharmaceuticals, Catalyst Pharma, iBiO Inc. and Perrigo Company",10/20/2016 02311120 PRN  Biotech Stocks Worth A Glance Testing Sector Trends," 6/05/2018 45337C10 PRN  Lifshitz & Miller LLP Announces Investigation of ARMO BioSciences, Inc., Financial Engines, Inc., Globalstar, Inc., Gridsum Holding Inc., InnerWorkings, Inc., Incyte Corporation, PPG Industries, Inc., and Spectrum Brands Holdings, Inc.","10/10/2019 0CW87Q-E PRN  Respira Therapeutics Regains North America Rights from United Therapeutics to Phase 2 Inhaled Drug-Device Product, RT234, for Pulmonary Hypertension Indications"," 3/15/2016 80360710 PRN  Covered Call Alerts For Netflix, GW Pharmaceuticals, Sarepta Therapeutics, General Electric and Whole Foods Market Released By InvestorsObserver",11/12/2019 G0176710 PRN  Alkermes Announces Receipt of $150 Million Milestone Payment from Biogen Related to FDA Approval of VUMERITY™,"12/17/2014 OVV-CA   PRN  Stocks in the News: Analyst Coverage on Encana, Unisys, Salix, Cerus and Eli Lilly"," 7/27/2015 AMAG-US  PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals Inc.",,12/06/2019 55027E10 PRN  Luminex Corporation Declares Fourth Quarter Cash Dividend, 3/29/2019 80067710 PRN  Sangamo Therapeutics Presents New Preclinical Data Demonstrating Significant Reduction In Tau Expression With Gene Regulation Technology," 8/30/2016 30161Q10 PRN  Kinder Morgan trade offers a 6% return in 108 days, or find similar option trades on Amazon.com, Alleghany Technologies, Boeing, and Exelixis",11/21/2019 80105N10  PRN  Pivotal data from Phase 3 study of sutimlimab in cold agglutinin disease to be presented at ASH 2019 late-breaking session, 5/24/2016 000YJB-E  PRN  Lithuanians Triumph in Western Union Tender,,11/16/2016 04351P10 PRN  Ascendis Pharma A/S to Report Third Quarter 2016 Financial Results and Host Conference Call on November 30," 2/02/2016 09609G10 PRN  Covered Call Alerts For Netflix, Google, Celldex Therapeutics, The Kroger Co and bluebird bio Inc. Released By InvestorsObserver","12/05/2016 00422510 PRN  InvestorsObserver releases covered-call reports for Freeport-McMoRan, Pandora, The Home Depot Inc., US Steel and ACADIA Pharmaceuticals",,10/01/2019 74366E10 PRN  Protagonist Therapeutics Announces Acceptance of Abstracts at the UEG Week 2019 Meeting and the ACG 2019 Annual Scientific Meeting,," 5/02/2017 88338N10 PRN  IMPORTANT EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Encourages Investors with Losses to Contact the Firm", 4/08/2015 98978L20    PRN  Post-Earnings Report - Zogenix,," 3/09/2016 68214310 PRN  Covered Call Alerts For Facebook, Nike, Omeros, Smith & Wesson and Frontier Communications Corp Released By InvestorsObserver",,, 7/09/2015 46333X10 PRN  New Studies & Research Evaluating Stem Cell Therapy Treatments for Bone Marrow Diseases & Conditions Look to Identify Next-Generation Therapies For New Pre-Clinical and Phase I/II Clinical Trials, 8/01/2014 00773U10 PRN  Health & Wellness Industry Gets Excited by Recent Federal Medical Marijuana Legalization Efforts - Company Initiates Cannabis Drug Development Plan," 8/10/2016 90400D10 PRN  How These Biotech Stocks are Faring? -- bluebird bio, Sage Therapeutics, Ultragenyx Pharma, and Alder Biopharma",,,11/06/2019 69329Y10 PRN  PDL BioPharma Reports 2019 Third Quarter Financial Results,, 6/19/2010 006TCJ-E PRN  Radius Presents Positive Phase 2a Study Results Establishing Clinical Proof of Concept for RAD1901 in Reducing Menopausal Hot Flashes,,"12/18/2019 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50  mg/mL"," 7/24/2015 LITE-US  PRN  Signet Jewelers Set to Join the S&P 500; PAREXEL International, Catalent to Join the S&P MidCap 400; Others to Join S&P SmallCap 600", 1/29/2018 0015MG-E PRN  STORM Therapeutics Appoints Distinguished Professor and Nobel Prize Winner Professor Thomas Cech as Scientific Advisor,,12/19/2016 0017CR-E PRN  Akcea and Ionis Announce Positive Results from Compass Phase 3 Study of Volanesorsen," 8/15/2019 60468T10 PRN  Mirati Therapeutics Appoints Jenny Gizzi As Vice President, Human Resources"," 9/29/2014 69512710 PRN  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Securities Claims Against Pacira Pharmaceuticals, Inc."," 9/17/2014 76129910 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Retrophin, Inc. - RTRX"," 8/27/2014 69404D10 PRN  Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma",, 5/18/2015 007MPF-E PRN  Chiasma Strengthens Management Team with Announcement of Chief Financial Officer,10/10/2013 05LJZC-E PRN  MacroGenics Announces Pricing of Initial Public Offering, 1/08/2020 09627Y10 PRN  Blueprint Medicines Announces Top-line Data for Pralsetinib and Initiates Rolling NDA Submission to FDA for the Treatment of Patients with RET Fusion-Positive Non-Small Cell Lung Cancer,, 8/20/2019 28249U10 PRN  Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection," 3/04/2015 60877T10 PRN  Stocks Coverage on the Biotech Industry - Achillion Pharma, CTI BioPharma, MiMedx, Momenta Pharma, and Anthera Pharma",,,, 6/16/2015 0DZ2BK-E PRN  CytomX Raises $70 Million in Series D Financing,,11/06/2019 92165910 PRN  Vanda Pharmaceuticals Reports Third Quarter 2019 Financial Results,, 6/22/2010 003MH3-E PRN  Metabolex Enters Into Type 2 Diabetes Development and License Agreement, 4/12/2017 45781M10   PRN  Sarissa Capital Files Presentation In Proxy Contest With Innoviva," 6/27/2011 005XF5-E PRN  ChemoCentryx Reports CCX140, a Novel Oral CCR2 Antagonist, Demonstrates Clinical Activity on Glycemic Indices in a Phase II Study in Type 2 Diabetes",11/04/2019 40637H10 PRN  Halozyme Announces Actions To Focus Strategy On ENHANZE® Drug Delivery Technology, 2/25/2019 G2151510 PRN  China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results," 6/27/2016 56400P70 PRN  Biotechnology Equities at a Glance -- MannKind, bluebird bio, OncoGenex Pharma, and Hevat Biologics",," 1/02/2015 23282W60 PRN  Happy New 'Investing' Year: Complementary Reports on Daily Journal, Trina Solar, Cytokinetics, BrainStorm, and Resolute"," 1/12/2016 29664W10 PRN  Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Esperion Therapeutics, Inc.", 2/19/2020 03236M20 PRN  Amyris Provides Clean Beauty Business Update, 1/23/2020 69366J20 PRN  Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy, 6/30/2015 00448Q20 PRN  Clinical Studies of Disease-Modifying Therapies & Drug Delivery Candidates Lead to New Drug Therapies & Patents for Treating Patients with Parkinson's Disease & Other Neurodegenerative Disorders," 3/20/2018 87166B10 PRN  Lifshitz & Miller LLP Announces Investigation of BioScrip, Inc., Civitas Solutions, Inc., Iridex Corp., OHR Pharmaceutical, Inc., Overstock.com, Inc., Syneos Health, Inc., Ubiquiti Networks, Inc. and WageWorks, Inc."," 4/17/2015 03152W10 PRN  Technical Coverage on Biotech Stocks -- Agenus, Raptor Pharma, KaloBios Pharma, Amicus Therapeutics, and Sarepta Therapeutics", 4/15/2015 26979610 PRN  High Potency Recovery Supplements Combined with Increased Global Distribution Channels & New Branding Partnerships Fuels Growth Potential in the Pharmaceutical & Nutritional Supplement Industries,,,10/01/2018 36197T10 PRN  The Most Exciting Story In The $140 Billion Cannabis Boom, 5/07/2014 29428V10 PRN  Epizyme Initiates Pediatric MLL-r Proof-of-Concept Study for EPZ-5676,11/15/2019 G5087110 PRN  Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea,, 4/30/2019 39843840 PRN  Grifols Announces PharmacyKeeper Bidirectional Integration with Epic,," 1/27/2020 73701010 PRN  PORTOLA PHARMACEUTICALS, INC. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a  securities  class  action  lawsuit  has  been  filed  in  the  United States District Court for the Northern  District of California against Portola Pharmaceuticals, Inc."," 4/19/2017 92337F10 PRN  Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Wednesday, May 3, 2017",, 6/29/2011 063J3K-E PRN  Cellectis and Pregenen Sign Collaboration Agreement for the Development of Meganucleases,11/20/2017 14075510 PRN  Therapeutic Advancements in Breakthrough Therapies for Treating Chronic Pain Take aim at Reducing Opioid use, 6/19/2012 009T7W-E PRN  Flexion Therapeutics Names Arthur Fratamico Chief Business Officer, 6/18/2012 003MJS-E PRN  uniQure Extends Collaboration with Protein Sciences Corporation on Use of its expresSF+® Cell Line for Gene Therapy," 7/31/2015 00847X10 PRN  Biotechnology Stocks on our Scanner -- Agenus, RXi Pharma, Nektar Therapeutics, Genetic Technologies, and Agios Pharma"," 4/25/2017 46226010 PRN  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Encourages Investors with Losses to Contact the Firm", 3/10/2016 008H33-E PRN  AnaptysBio Announces First-In-Human Dosing Of Anti-IL-33 Antibody,, 2/21/2011 070JFC-E PRN  Fate Therapeutics Announces Encouraging Clinical Results and Change in Management," 5/06/2016 G4618810 PRN  UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Shareholders of Horizon Pharma plc of Class Action Lawsuit and a Lead Plaintiff Deadline of May 9, 2016 - HZNP", 6/03/2013 00BJ80-E PRN  Castle Biosciences Announces Availability of DecisionDx-Melanoma Test to Identify Stage I & II Melanoma Patients at High Risk of Metastasis," 6/28/2016 008BK4-E PRN  Technical Analysis on Biotechnology Equities -- Seattle Genetics, CTI BioPharma, Five Prime Therapeutics, and Intercept Pharma","12/25/2013 48576U10 PRN  Additional Shares Purchased, Extended Collaboration, Credit Facility, Publication of Data, and Interim Results - Research Report on Karyopharm, Agios, Lannett, MacroGenics, and ZIOPHARM",,10/05/2018 98401F10 PRN  Xencor Announces Topline Results from Phase 2 Study of XmAb®5871 in Systemic Lupus Erythematosus and Selection of Late-Breaking Abstract for Presentation at the 2018 ACR Annual Meeting,"10/04/2016 46116X10 PRN  Learn how to target a 20% return on Tesla Motors, or get option-trade ideas on Intra-Cellular Therapies, Inovio Pharmaceuticals, Universal Display Corporation and Southwestern Energy Company or any stock you choose","11/05/2019 G8807B10 PRN  Theravance Biopharma, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update", 7/15/2014 079TK4-E PRN  Novocure Announces Commercial Launch of NovoTTF™ Therapy in Europe and Israel, 9/17/2019 03969710 PRN  Ardelyx to Present at the Ladenburg Thalmann 2019 Healthcare Conference,,,,, 8/05/2019 M4613510 PRN  Foamix Submits New Drug Application to U.S. FDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea, 3/04/2013 001THX-E PRN  PRA Acquires ClinStar,,," 5/05/2017 74587V10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Puma Biotechnology, Inc. (PBYI)"," 5/12/2014 0CT6N9-E PRN  Coherus Biosciences Appoints Lisa M. Bell, Ph.D., Senior Vice President, Global Regulatory Affairs",10/05/2017 21833P10 PRN  Data Projects That the Global Legal Cannabis Market is Expected to Grow," 5/01/2019 05070R10 PRN  Audentes Therapeutics Presents New Positive Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 for X-linked Myotubular Myopathy, at 22nd Annual Meeting of the American Society of Gene and Cell Therapy"," 2/12/2013 00772J-E PRN  Collegium Pharmaceutical Inc. Announces Notice of Allowance for U.S. Patent Covering Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid Product", 3/04/2015 00GL6Z-E PRN  XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology," 8/03/2015 81750R10 PRN  Pre-Market Scans on Biotechnology Stocks -- Sunesis Pharma, Biogen, Array BioPharma, Seres Therapeutics, and Athersys",, 3/29/2016 GBT-US   PRN  Global Blood Therapeutics Reports Recent Business Progress and Provides Fourth Quarter and Year-End 2015 Financial Results, 9/30/2019 75901B10 PRN  REGENXBIO to Present at The Chardan 3rd Annual Genetic Medicines Conference,,,,,,,,12/09/2015 HCM-HK   PRN  US$105 Million Shanghai Land Compensation Agreement,,,,, 9/17/2013 07N3G8-E PRN  arGEN-X Initiates Phase IbStudy of ARGX-111 in Cancer,, 7/08/2016 00695P-E  PRN  Athenex Announces the Addition of James Hussey to Lead its Commercial Business Activities,, 4/04/2016 00FMDK-E PRN  Motus Completes Enrollment of Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis,,,, 7/21/2011 009FRV-E PRN  Quanterix Digital Immunoassay for Prostate Specific Antigen Improves Analytical Performance,,"10/03/2013 00FCVN-E PRN  Strathspey Crown Acquires Evolus, Inc.", 3/15/2018 0FZZYY-E PRN  Homology Medicines Appoints Mary Thistle to Board of Directors,,,,,,,,,,11/02/2018 05280R10 PRN  Autolus Therapeutics to Present New Data at the ASH Annual Meeting, 1/11/2018 07YR31-E PRN  Forty Seven Inc. to Collaborate on a Novel Immuno-Oncology Combination for Leukemia and Bladder Cancer,,,,,,11/12/2019 50015M10 PRN  Kodiak Sciences Announces Third Quarter 2019 Financial Results and Recent Business Highlights,, 3/12/2018 00FYYJ-E PRN  Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of Lung Cancer Trial,, 7/18/2013 009Z8P-E PRN  NGM Biopharmaceuticals Secures $50 Million in Series C Financing to Advance its Portfolio of Novel Therapies for Diabetes and Obesity, 9/06/2016 00FLML-E PRN  Twist Bioscience Bolsters Executive Leadership Team,,,,,,, 7/02/2019 00973Y10 PRN  Akero Therapeutics Announces Dosing of First Patient in Phase 2a Study of AKR-001 to Treat NASH (BALANCED),,,,," 3/03/2015 0DMSKV-E PRN  Adaptive Biotechnologies adds Chad Cohen, Zillow Group CFO, to Board of Directors",
 5/16/2016 53220K50 PRN  Intec Pharma to Nominate Dr. John W. Kozarich as Chairman of the Board of Directors, 6/20/2019 74318710 PRN  Velan Releases Detailed Presentation on Progenics Pharmaceuticals," 5/09/2017 ILMN-US     PRN  Muse bio appoints genomics industry expert, John Stuelpnagel, as Chairman of the Board of Directors"," 3/23/2015 84763A10 PRN  Technical Pulse on Biotech Stocks -- Geron, Lexicon Pharma, XOMA Corp., Spectrum Pharma, and BioLine RX",10/28/2019 ENDP-US  PRN  Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation,"10/09/2015 04280A10 PRN  Covered Call Alerts For Chesapeake Energy, Joy Global, Intra-Cellular Therapies, CyberArk Software and Arrowhead Research Released By InvestorsObserver", 8/24/2017 09060J10 PRN  BioDelivery Sciences to Present at the Rodman & Renshaw 19th Annual Global Investment Conference, 1/07/2020 000XKX-E    PRN  Bio-Techne Rebrands Atlanta Biologicals Serum And Media As Part Of The R&D Systems Product Portfolio, 2/04/2020 75886F10    PRN  Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus, 1/24/2011 001M2B-E PRN  PharmAthene Provides Update on Litigation With SIGA Technologies," 9/18/2018 68375N10 PRN  Scott+Scott Attorneys at Law LLP Alerts Investors to the Filing of Securities Class Action Against OPKO Health, Inc. (OPK)",12/16/2019 46222210 PRN  Positive results reaffirm plans to advance ATL1102 for DMD to Phase IIb trial,12/23/2019 09061G10   PRN  BioMarin Submits Biologics License Application to U.S. Food and Drug Administration for Valoctocogene Roxaparvovec to Treat Hemophilia A," 1/03/2017 01535110 PRN  ALEXION SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - (ALXN)",10/14/2019 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2019 Financial Results, 7/09/2018 81257810 PRN  Seattle Genetics and Astellas Announce Progress in Enfortumab Vedotin Urothelial Cancer Clinical Development Program," 2/10/2017 45290710 PRN  Immunomedics Enters into Exclusive Global Licensing Agreement with Seattle Genetics for Sacituzumab Govitecan (IMMU-132) with Potential Payments of up to Approximately $2 Billion, Plus Royalties",12/17/2018 09062X10  PRN  Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis," 2/12/2015 45253H10 PRN  Technical Roundup on Biotech Equities - Gilead Sciences, MannKind, ImmunoGen, Dyax, and Pharmacyclics"," 6/30/2016 09058V10 PRN  Technical Coverage of Biotechnology Stocks - Agenus, BioCryst Pharma, Cempra, and Hemispherx Biopharma", 1/24/2019 37555810   PRN  Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead,11/26/2019 04004760   PRN  Arena Pharmaceuticals to Participate in Upcoming Investor Conferences,12/18/2019 000TBT-E  PRN  Pfizer and Mylan Announce Two Future Viatris Board Members, 1/29/2020 M2572210 PRN  Compugen Further Expands Intellectual Property Portfolio With New European Patent for Anti-PVRIG Antibodies," 3/01/2018 00972810 PRN  AKORN INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Akorn, Inc. To Contact The Firm", 1/13/2020 03116210 PRN  Amgen Announces Global Diagnostic Collaborations To Expand Molecular Testing For Patients With Non-Small Cell Lung Cancer," 4/27/2018 62855J10 PRN  MYRIAD GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN", 9/08/2017 52887230 PRN  Lexicon Pharmaceuticals Reports Positive Pooled Continuous Glucose Monitoring Data From Pivotal Phase 3 inTandem1 And inTandem2 Studies Of Sotagliflozin,, 1/03/2020 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),," 3/13/2020 45773H20 PRN  INO Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against Inovio Pharmaceuticals, Inc. (NASDAQ: INO); Lead Plaintiff Deadline is May 12, 2020",11/09/2019 64026810 PRN  Nektar Therapeutics Presents New Clinical and Preclinical Data from its Immuno-Oncology Pipeline at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting,10/02/2019 76655960 PRN  Rigel Secures Credit Facility for Up to $60 Million,"10/19/2017 37416310 PRN  Breakfast Technical Briefing on Biotech Stocks -- Coherus Biosciences, Exelixis, Geron, and Grifols"," 4/27/2015 00771V10 PRN  Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc."," 9/23/2015 BMRN-US  PRN  Scanning Stocks from the Healthcare Sector - Amicus Therapeutics, Arena Pharmaceuticals, Cerner Corporation, Amarin Corporation and BioMarin Pharmaceutical", 6/01/2018 45337C10 PRN  FDA Approves OLUMIANT® (baricitinib) 2-mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis, 9/12/2019 UTHR-US  PRN  Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application," 3/01/2016 80360710 PRN  Covered Call Alerts For Sarepta Therapeutics, TASER International, Groupon, Terraform Power and Consol Energy Released By InvestorsObserver",11/08/2019 G0176710 PRN  Alkermes Announces New Data From ALKS 4230 Clinical Development Program at Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting,"12/11/2014 15708510 PRN  Health Care Equipment and Supplies Equities Scrutiny - Abbott Laboratories, Zimmer Holdings, Varian Medical Systems, Edwards Lifesciences, and Cerus", 5/06/2015 00163U10 PRN  Pharma Companies Beginning to Mix Diversification by Expanding into the Multi-Billion Dollar Nutritional & Nutraceutical Supplements Market as Projected Growth Opportunities Continue to Rise,,"11/25/2019 55027E10 PRN  Luminex Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019"," 3/12/2019 SGMO-US  PRN  Sangamo Therapeutics Appoints Jason Fontenot, Ph.D., As Senior Vice President, Cell Therapy"," 8/19/2016 30161Q10 PRN  Research Report on Biotech Equities -- Gilead Sciences, Exelixis, Ariad Pharma, and Novavax",11/20/2019 0GXDW0-E  PRN  Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence," 4/29/2016 92532F10  PRN  Vertex Pharmaceuticals Incorporated, FMC Technologies Inc., Juniper Networks, Herbalife, and Seagate Technology and more offer option-trading opportunities that offer returns of more than 20%",,11/02/2016 04351P10 PRN  Ascendis Pharma A/S Announces Participation in Two Upcoming Investor Conferences,"11/10/2015 09609G10 PRN  Covered Call Alerts For PayPal Holdings Inc., Norfolk Southern, Etsy Inc., Peabody Energy and bluebird bio Inc. Released By InvestorsObserver","11/07/2016 00422510 PRN  InvestorsObserver releases covered-call reports for ACADIA Pharmaceuticals, Valero Energy, Kite Pharma, Inovio Pharmaceuticals and Fitbit",," 9/25/2019 74366E10 PRN  Protagonist Therapeutics to Present at the Cantor Global Healthcare Conference on Wednesday, October 2",," 4/28/2017 88338N10 PRN  Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, Inc., Incyte Corporation, MOCON, Inc., Ocwen Financial Corporation and ThereapeuticsMD, Inc."," 3/10/2015 98978L20    PRN  Technical Snapshot on Pharma Stocks -- Pfizer, Zogenix, Sanofi, Nektar Therapeutics, and IGI Laboratories",,11/09/2015 68214310 PRN  Omeros Corporation Reports Third Quarter 2015 Financial Results,,," 5/12/2015 46333X10 PRN  Technical Scrutiny on Biotech Stocks -- ARIAD Pharma, Array BioPharma, Enzon Pharma, Ironwood Pharma, and Regulus Therapeutics"," 7/01/2014 0D98KG-E PRN  Avalanche Biotechnologies Announces Appointment of Samuel B. Barone, M.D., as Chief Medical Officer"," 6/29/2016 06X5BP-E PRN  Pre-Market Review on Biotechnology Equities -- Northwest Biotherapeutics, Titan Pharma, Ultragenyx Pharma, and Athersys",,,"10/30/2019 69329Y10 PRN  PDL BioPharma to Announce Third Quarter 2019 Financial Results on November 6, 2019",,,,11/26/2019 00182C10 PRN  ANI Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference," 4/25/2015 29251M10 PRN  AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA® in Chronic Hepatitis C Patients with Renal Impairment at The International Liver Congress™ 2015"," 9/07/2017 02043Q10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alnylam Pharmaceuticals, Inc. (ALNY)",,11/15/2016 0017CR-E PRN  Ionis Pharmaceuticals Reports Positive Clinical Data from IONIS-ANGPTL3-L Rx, 8/05/2019 60468T10 PRN  Mirati Therapeutics Reports Second Quarter 2019 Financial Results, 9/26/2014 69512710 PRN  PACIRA SHAREHOLDER ALERT: National Securities Law Firm Investigates Claims on Behalf of Shareholders, 8/05/2014 00G37M-E PRN  Perlstein Lab Raises $2 Million For Orphan Drug Discovery,"10/04/2013 69404D10 PRN  Positive Results, Close of Public Offerings, Grants, Data Presentations and Partnerships - Research Report on Lexicon, Sangamo Biosciences, Immunomedics, NewLink Genetics, and Pacific Biosciences",, 5/11/2015 007MPF-E PRN  Chiasma Announces New Data for Investigational Octreotide Capsules to be Presented at ECE 2015, 9/19/2013 05LJZC-E PRN  MacroGenics' Board of Directors Elects Paulo F. Costa as Chairman, 1/06/2020 09627Y10 PRN  CStone Pharmaceuticals and Blueprint Medicines Initiate Phase 1b/2 Clinical Trial of Fisogatinib in Combination with CS1001 for Patients with Hepatocellular Carcinoma,, 8/08/2019 28249U10 PRN  Eiger BioPharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update," 2/17/2015 60877T10 PRN  Be on Top of the Latest Happenings: Special Research on La Jolla, Lpath, Macrocure, Momenta, and NanoString",,,, 5/28/2015 0DZ2BK-E PRN  CytomX to Present at the Jefferies 2015 Global Healthcare Conference,,"10/30/2019 92165910 PRN  Vanda Pharmaceuticals to Announce Third Quarter 2019 Financial Results on November 6, 2019",,, 4/12/2017 45781M10   PRN  Egan-Jones Supports All Three Sarissa Capital Nominees For Innoviva Board, 6/27/2011 005XF5-E PRN  ChemoCentryx Reports Novel CCR2 Antagonist Significantly Improves Kidney Function and Hyperglycemia in Models of Type 2 Diabetes,10/21/2019 40637H10 PRN  Halozyme To Host Third Quarter 2019 Financial Results Webcast And Conference Call, 1/07/2019 G2151510 PRN  China Biologic Reiterates Full Year 2018 Financial Forecast," 3/04/2016 56400P70 PRN  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of MannKind Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 15, 2016 - MNKD",,"11/25/2014 23282W60 PRN  Critical Alerts For Outerwall, Cytokinetics, Union Pacific, Accenture and Monsanto Released By InvestorsObserver","10/01/2015 29664W10 PRN  Critical Alerts For Twitter, Esperion Therapeutics, Western Digital, NVIDIA and VeriFone Systems Released By InvestorsObserver", 2/14/2020 03236M20 PRN  Biossance Expands The Clean Academy ‒ The Ultimate Clean Beauty Resource, 1/13/2020 69366J20 PRN  PTC Therapeutics Provides Corporate Update and Highlights Pipeline Progress at 2020 J.P. Morgan Healthcare Conference," 6/18/2015 00448Q20 PRN  Critical Alerts For Alibaba, Stratasys, Windstream, Achillion Pharmaceuticals and Qihoo 360 Technology Released By InvestorsObserver","12/13/2017 87166B10 PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In INC Research Holdings, Inc. To Contact The Firm"," 3/20/2015 03152W10 PRN  Critical Alerts For Twitter, Ctrip.com, Prothena, Amicus Therapeutics and Ryder Released By InvestorsObserver",,,, 9/26/2018 36197T10 PRN  CBD Supplements Primed to Explode Ahead of Biopharma as Farm Bill Legalizes Hemp," 5/01/2014 29428V10 PRN  Epizyme, Inc. to Present at Upcoming Conferences in May",11/14/2019 G5087110 PRN  Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences,," 4/29/2019 39843840 PRN  Grifols Announces the Opening of its new Plasma Donor Center in Hinesville, Georgia",, 1/24/2020 73701010 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA, 4/03/2017 92337F10 PRN  Multiple Studies Presented at ENDO 2017 Support Use of Veracyte's Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis,, 6/06/2011 0BJV4J-E PRN  Cellectis and VitamFero Collaborate to Develop Vaccines against Parasitic Infection,11/07/2017 14075510 PRN  Clinical Studies Elevating Biotech Drug Development to New Levels for Unmet Medical Needs," 5/30/2012 009T7W-E PRN  Flexion's Lead Osteoarthritis Drug Candidate Demonstrates Significant, Prolonged Improvement in Pain and Function in Phase 2 Trial", 4/05/2012 AMT-NL   PRN  Amsterdam Molecular Therapeutics Announces Completion of Disposal of its Operations to uniQure B.V. and its Dissolution Becoming Effective," 3/02/2015 00847X10 PRN  Critical Alerts For Advanced Micro Devices, DigitalGlobe, Infoblox, Peabody Energy and Agios Pharmaceuticals Released By InvestorsObserver"," 4/25/2017 46226010 PRN  Investor Alert: Kaplan Fox Announces Investigation Of Lion Biotechnologies, Inc.",11/19/2015 008H33-E PRN  AnaptysBio Announces Appointment Of James A. Schoeneck To Board Of Directors,, 2/21/2011 070JFC-E PRN  Fate Therapeutics Announces Emerging Data From Proof-of-Concept FT1050 Clinical Trial and Receives Orphan Drug Designation, 3/31/2016 G4618810 PRN  Law Offices of Marc S. Henzel Commences Investigation of Companies for Violations of the Federal Securities Laws, 2/14/2013 00BJ80-E PRN  Website Dedicated To Sufferers Of Most Common Form Of Eye Cancer," 5/25/2016 45845P10 PRN  Why These Biotech Stocks Have Been on Investors' Radar? - Juno Therapeutics, Immunomedics, Ultragenyx Pharma, and Intercept Pharma","11/20/2013 48576U10 PRN  New Supply Agreements and Analytical Tools, Expansions, Conference Presentations and Financial Results - Research Report on WuXi PharmaTech, Sirona, ICON, Opexa Therapeutic and Karyopharm Therapeutics",, 9/25/2018 98401F10 PRN  Xencor to Participate in Upcoming Investor Conferences," 9/29/2016 46116X10 PRN  Intra-Cellular Therapies (ITCI) Alert:  Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Intra-Cellular Therapies, Inc.; Investors Encouraged to Contact Firm",10/29/2019 G8807B10 PRN  Theravance Biopharma to Report Third Quarter 2019 Financial Results on November 5, 6/13/2014 079TK4-E PRN  Novocure Announces the Presentation of Subgroup Survival Data for Recurrent Glioblastoma Patients Treated with NovoTTF™ Therapy," 9/12/2019 03969710 PRN  Ardelyx Receives FDA Approval for IBSRELA® (Tenapanor), an NHE3 Sodium Transport Inhibitor, for the Treatment of Irritable Bowel Syndrome with Constipation",,,,, 8/03/2017 M4613510 PRN  Foamix Announces Dosing of First Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101, 6/20/2012 001THX-E PRN  PRA Experts to Present at DIA Annual Conference,,," 5/05/2017 74587V10 PRN  PUMA BIOTECHNOLOGY INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Puma Biotechnology, Inc. To Contact The Firm"," 4/28/2014 0CT6N9-E PRN  Coherus Biosciences Appoints Michael A. Fleming as Senior Vice President, Commercial Strategy", 9/11/2017 21833P10 PRN  Little-Known Biotech Breakthrough Could Save Millions Of Lives," 4/30/2019 05070R10 PRN  Audentes Therapeutics to Release First Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, May 7, 2019", 1/17/2013 00772J-E PRN  Collegium Pharmaceutical Announces Relocation to Massachusetts, 2/24/2015 00GL6Z-E PRN  XBiotech Plans to Conduct Initial Public Offering of its Common Stock," 1/21/2015 0CT325-E PRN  Seres Health Announces Addition of Mark Wilcox, M.D. to Scientific Advisory Board",,, 9/04/2019 75901B10 PRN  REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314,,,,,,,,12/08/2015 HCM-HK   PRN  Initiation of Fruquintinib Phase III Registration Trial in Non-small Cell Lung Cancer,,,,, 9/12/2013 07N3G8-E PRN  arGEN-X Identifies Potent Antibody Antagonists against Complex Chronic Pain Target Nav1.7,, 4/26/2016 00695P-E  PRN  Athenex Announces Jeffrey Yordon to Lead Newly Formed Specialty Products Division,, 1/07/2016 00FMDK-E PRN  Rhythm Receives Orphan Drug Designation for Setmelanotide for the Treatment of Prader-Willi Syndrome,,,, 7/20/2011 009FRV-E PRN  Quanterix and Sony DADC to Develop and Manufacture Smart Consumables for Life Science and In Vitro Diagnostic Applications,,, 3/01/2018 0FZZYY-E PRN  Homology Medicines Announces Peer-Reviewed Publication Indicating Low Prevalence of Pre-existing Neutralizing Antibodies to its Human-Derived AAVHSC Vectors,,,,,,,,,,11/01/2018 05280R10 PRN  Autolus Therapeutics to Present New Data on Its Advanced Programmed T Cell Therapies at the 60th ASH Annual Meeting," 1/11/2018 07YR31-E PRN  Forty Seven Inc. to Collaborate with Merck KGaA, Darmstadt, Germany, on a Novel Immuno-Oncology Combination for Ovarian Cancer",,,,,,"11/08/2019 50015M10 PRN  Kodiak Sciences to Report Third Quarter 2019 Results and Host Business Highlights Webcast on November 12, 2019",, 2/15/2018 00FYYJ-E PRN  The Guardant360® Assay Receives Expedited Access Pathway Designation for Breakthrough Devices from FDA,," 6/17/2013 009Z8P-E PRN  NGM Biopharmaceuticals and MedImmune, AstraZeneca's Biologics Arm, Announce Agreement to Discover and Develop Therapies for Diabetes and Obesity", 6/08/2016 00FLML-E PRN  Twist Bioscience Continues to Support Growth of Ginkgo Bioworks with Agreement to Deliver Industry-Leading Volume of Synthetic DNA,,,,,,, 6/24/2019 00973Y10 PRN  Akero Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares,,,,, 1/12/2015 0DMSKV-E PRN  Adaptive Biotechnologies CEO To Present And Join Distinguished Panel At 33rd Annual J.P. Morgan Healthcare Conference,
10/02/2014 53220K50 PRN  Lemelson Capital Management Fund Tops BarclayHedge Performance List, 6/20/2019 74318710 PRN  Velan Calls on Progenics Pharmaceuticals' Board to Back Up Recent Claims," 1/30/2017 45232710    PRN  ILMN INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Illumina, Inc. and a Lead Plaintiff Deadline of February 14, 2017"," 2/25/2015 84763A10 PRN  Market Updates on Biotech Stocks - Hemispherx Biopharma, Nanosphere, Isis Pharma, Keryx Biopharma, and Spectrum Pharma",10/25/2019 G3040110 PRN  Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 Fall Meeting of the Sexual Medicine Society of North America (SMSNA)," 9/25/2015 04280A10 PRN  Covered Call Alerts For Chesapeake Energy Corporation, Exact Sciences Corporation, NXP Semiconductors, Ulta Salon and Arrowhead Research Released By InvestorsObserver", 8/23/2017 09060J10 PRN  BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman, 1/02/2020 09073M10    PRN  Bio-Techne To Present At The 38th Annual J.P. Morgan Healthcare Conference, 1/28/2020 75886F10    PRN  FDA Accepts for Priority Review Dupixent® (dupilumab) for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis,11/07/2010 001M2B-E PRN  Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent," 9/17/2018 68375N10 PRN  Kaplan Fox Files Class Action to Recover Losses for Investors Who Purchased OPKO Health, Inc. Common Stock",12/12/2019 46222210 PRN  Ionis Pharmaceuticals announces private placement of $507.5 million principal amount of 0.125% convertible senior notes due 2024,12/23/2019 09061G10   PRN  European Medicines Agency Validates BioMarin's Marketing Authorization Application for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A,"12/30/2016 01535110 PRN  Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Alexion Pharmaceuticals, Inc. and Certain of Its Senior Executives",10/04/2019 64125C10 PRN  Neurocrine Biosciences Presents New Data Analyses Demonstrating Long-Term Effects of INGREZZA® (valbenazine) 40 mg Once-Daily in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress, 6/03/2018 81257810 PRN  Astellas and Seattle Genetics Present at ASCO 2018 on Enfortumab Vedotin in Patients with Locally Advanced or Metastatic Urothelial Cancer Previously Treated with Checkpoint Inhibitor Therapy," 9/08/2016 SQNM-US  PRN  How These Biotech Stocks are Faring? -- Immunomedics, Sequenom, INSYS Therapeutics, and Regulus Therapeutics", 9/20/2018 00167Y-E  PRN  BlackChain Announces Consolidation and Name Change," 2/02/2015 45253H10 PRN  Critical Alerts For Isis Pharmaceuticals, ImmunoGen, Pixelworks, ManpowerGroup and SouFun Released By InvestorsObserver"," 9/11/2015 09058V10 PRN  Updates on Biotechnology Industry Stocks - BioCryst Pharma, Incyte, bluebird bio, Cempra, and BioLineRx", 1/17/2019 000L1R-E   PRN  PhRMA Welcomes Genentech and Gilead Sciences to Association,11/18/2019 04004760   PRN  California Life Sciences Association Honors Arena Pharmaceuticals at the Pantheon 2019 DiNA™ Awards for the Deal of the Year,"12/02/2019 N5946510  PRN  Mylan and Biocon Launch Trastuzumab Biosimilar, Ogivri™ (trastuzumab-dkst), in the U.S.", 1/09/2020 M2572210 PRN  Compugen Highlights Recent Accomplishments and Previews Upcoming Milestones," 2/27/2018 000BNP-E PRN  Investor Alert: Kaplan Fox Announces Investigation Of Akorn, Inc.", 1/09/2020 03116210 PRN  Amgen To Present At The 38th Annual J.P. Morgan Healthcare Conference," 4/27/2018 62855J10 PRN  RM LAW Announces Class Action Lawsuit Against Myriad Genetics, Inc.", 9/07/2017 52887230 PRN  Lexicon Pharmaceuticals Announces Four Data Presentations At The European Society Of Medical Oncology 2017 Congress,,12/03/2019 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 3/12/2020 45773H20 PRN  INOVIO Pharmaceuticals Reports 2019 Fourth Quarter and Year-End Financial Results,11/06/2019 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Third Quarter of 2019, 9/23/2019 RIGL-US  PRN  Rigel's fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune Thrombocytopenia," 5/30/2017 GERN-US  PRN  Sofinnova Announces the Addition of Industry Leader Alan Colowick, MD, MPH to its Partnership"," 2/03/2015 00771V10 PRN  Recent Developments at Pharma Companies: Special Research on Aerie Pharmaceuticals, AEterna Zentaris, Affimed, Agenus, and Agile Therapeutics"," 7/30/2015 02311120 PRN  Market Updates on Drug Manufacturers - Other Equities -- Isis Pharma, Endo Intl., Amarin, United Therapeutics, and POZEN"," 4/23/2018 45337C10 PRN  FDA Advisory Committee Recommends the Approval of Baricitinib 2mg, but not 4mg, for the Treatment of Moderately-to-Severely Active Rheumatoid Arthritis", 9/11/2019 91307C10 PRN  United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review," 2/17/2016 80360710 PRN  Covered Call Alerts For Apple, Fitbit, Ambarella, Sarepta Therapeutics and ADT Released By InvestorsObserver",11/04/2019 G0176710 PRN  Alkermes to Present Data From ALKS 4230 Clinical Development Program at the Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting,"11/05/2014 15708510 PRN  Technical Updates on Health Care Supplies Sector Stocks - Align Technology, DENTSPLY Intl., Baxano Surgical, Cerus, and Alere"," 2/12/2015 00163U10 PRN  A Look at the Latest Happenings in Health Care Sector: New Research on Alliqua, Almost Family, Alnylam Pharmaceuticals, Alphatec Holdings, and AMAG Pharmaceuticals",,11/04/2019 55027E10 PRN  Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA, 3/08/2019 80067710 PRN  Sangamo Therapeutics Announces Publication Of Data Demonstrating New Zinc Finger Nuclease Architectures Enabling High-Precision Genome Editing," 8/15/2016 30161Q10 PRN  Learn how to target a 20% return on Valeant Pharmaceuticals, or get option-trade ideas on Acacia Communications, Radius Health, General Electric and Exelixis or any stock you choose",11/06/2019 80105N10  PRN  New data to be presented at ASH 2019 highlight Sanofi's commitment to treat challenging blood cancers and rare blood disorders, 4/18/2016 92532F10  PRN  Enterome In-licenses Novel Compounds From Vertex Pharmaceuticals to Treat Microbiome-related Inflammatory Bowel Diseases,,10/19/2016 04351P10 PRN  Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs,"10/20/2015 09609G10 PRN  Covered Call Alerts For Netflix, General Motors, Qualcomm, Five Below Inc. and bluebird bio Inc. Released By InvestorsObserver","10/28/2016 00422510 PRN  Learn how to target a 16% return on Apple, or get option-trade ideas on ACADIA Pharmaceuticals, Yamana Gold Inc., Level 3 Communications and Western Digital or any stock you choose",, 9/04/2019 74366E10 PRN  Protagonist Therapeutics Reports Granting of Inducement Awards,," 4/26/2017 88338N10 PRN  RM LAW Announces Class Action Lawsuit Against TherapeuticsMD, Inc."," 2/02/2015 98978L20    PRN  Pharma Equities Under the Scanner - Pfizer, Sanofi, Eli Lilly, AstraZeneca, and Zogenix",,"11/02/2015 68214310 PRN  Omeros Corporation to Announce Third Quarter 2015 Financial Results on November 9, 2015",,," 2/17/2015 46333X10 PRN  Technical Briefing on Biotech Stocks -- Exelixis, Exact Sciences, Idera Pharma, Seattle Genetics, and Ironwood Pharma", 5/20/2014 0D98KG-E PRN  Avalanche Biotechnologies Announces Appointment of Industry Veteran Linda C. Bain as Chief Financial Officer," 5/25/2016 90400D10 PRN  Why These Biotech Stocks Have Been on Investors' Radar? - Juno Therapeutics, Immunomedics, Ultragenyx Pharma, and Intercept Pharma",,,10/24/2019 69329Y10 PRN  PDL BioPharma Responds to Letter from Engine Capital,,,,11/06/2019 00182C10 PRN  ANI Pharmaceuticals Reports Third Quarter Results, 4/15/2015 29251M10 PRN  AbbVie's Investigational Chronic Hepatitis C Treatment Granted Priority Review in Japan," 9/07/2017 05SJ7P-E PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY",, 9/22/2016 0017CR-E PRN  Akcea Announces Publication in The Lancet of Clinical Results with Lp(a)-Lowering Drugs Designed to Treat Cardiovascular Disease, 7/09/2019 60468T10 PRN  Mirati Announces Clinical Collaboration to Evaluate MRTX849 in Combination with SHP2 Inhibitor TNO155," 9/25/2014 69512710 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pacira Pharmaceuticals, Inc. - PCRX"," 9/30/2013 0D0JWQ-E PRN  Transcept Pharmaceuticals Statement on Request by Retrophin, Inc. to Acquire Up To 15 Percent of the Outstanding Common Stock of Transcept"," 9/30/2013 69404D10 PRN  Conference Calls, New Appointments, Agreements, Pricing of Offerings and New Clinical Trials - Research Report on Abbott, Cubist, Pacific Biosciences, Synageva, and Oncothyreon",, 3/16/2015 007MPF-E PRN  Chiasma Announces Mark Leuchtenberger as Chief Executive Officer, 8/20/2013 05LJZC-E PRN  MacroGenics to Receive $10 Million Milestone Payment from Servier for Dosing the First Patient in a Phase 1 Dose Expansion Trial of MGA271,12/08/2019 09627Y10 PRN  Blueprint Medicines Announces Initial Data from Phase 2 PIONEER Trial of Avapritinib in Patients with Indolent Systemic Mastocytosis Showing Activity at All Dose Levels Tested,, 8/05/2019 28249U10 PRN  Eiger BioPharmaceuticals to Participate in Investor Conferences in August,"10/17/2014 60877T10 PRN  Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners",,,, 5/27/2015 0DZ2BK-E PRN  CytomX Expands Executive Leadership Team,,10/28/2019 92165910 PRN  Vanda Pharmaceuticals Appoints Anne Sempowski Ward to Board of Directors,,, 4/11/2017 45781M10   PRN  Sarissa Capital Is Concerned That Innoviva Will Waste Shareholder Money On Imprudent Acquisitions," 1/26/2011 005XF5-E PRN  ChemoCentryx Initiates Phase I Clinical Trial of CCX832, the First Small Molecule Inhibitor of ChemR23", 9/23/2019 40637H10 PRN  Halozyme To Participate In 2019 Cantor Global Healthcare Conference,12/14/2018 G2151510 PRN  China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman," 2/24/2016 56400P70 PRN  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving MannKind Corp. and a Lead Plaintiff Deadline of March 15, 2016",," 7/07/2014 23282W60 PRN  Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec"," 9/24/2015 AGEN-US  PRN  Health Care Stocks Technical Review -- Agenus, Esperion Therapeutics, BioScrip, Affymetrix and Alnylam Pharmaceuticals"," 2/13/2020 03236M20 PRN  Amyris, Inc. Appoints Han Kieftenbeld As Chief Financial Officer", 1/08/2020 00167Y-E PRN  Behind the Seizure® Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsy," 6/03/2015 00448Q20 PRN  Critical Alerts For Facebook, Mens Wearhouse, First Solar, Achillion Pharmaceuticals and Universal Display Corporation Released By InvestorsObserver","12/05/2017 87166B10 PRN  Shareholder Class Action Filed Against INC Research Holdings, Inc. - INCR"," 3/12/2015 03152W10 PRN  Scanning Biotech Equities -- Agenus, Amicus Therapeutics, Peregrine Pharma, Vanda Pharma, and Acorda Therapeutics",,,, 9/24/2018 36197T10 PRN  Data Projects the U.S. Medical Cannabis Market to Reach USD 12.5 Billion by 2025, 4/30/2014 29428V10 PRN  Epizyme Nominates Dr. Andrew R. Allen For Election to Board of Directors,11/07/2019 G5087110 PRN  Jazz Pharmaceuticals to Highlight Growing Hematology Oncology Pipeline at ASH 2019 Annual Meeting,," 4/18/2019 00394S-E PRN  Grifols US donor centers exceed 250,000 pounds of food collected",," 1/21/2020 73701010 PRN  ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc. - PTLA", 3/23/2017 92337F10 PRN  Veracyte Announces that Multiple Studies Supporting Clinical Utility of Its Afirma® Gene Expression Classifier To Be Presented at ENDO 2017,, 5/18/2011 063J3K-E PRN  Cellectis bioresearch Appoints Wako as Exclusive Distributor of its Genome Customization Solutions in Japan,"10/31/2017 14075510 PRN  Enteris BioPharma's ""Feasibility-to-Licensing"" Partner, Cara Therapeutics, Doses First Patient in Phase 1 Study of Peptelligence™-Engineered Oral CR845 in Non-Hemodialysis Chronic Kidney Disease Patients",, 3/30/2012 AMT-NL   PRN  Amsterdam Molecular Therapeutics Announces Results of Extraordinary General Meeting," 2/03/2015 00847X10 PRN  Latest Updates in Healthcare: Special Research on Agios, Akebia, Akers, Akorn, and Albany"," 4/21/2017 46226010 PRN  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Encourages Investors with Losses to Contact the Firm", 9/09/2015 008H33-E PRN  AnaptysBio Files Registration Statement For Proposed Initial Public Offering,,10/14/2010 070JFC-E PRN  Fate Therapeutics Announces Collaboration With BD to Develop and Commercialize Induced Pluripotent Stem Cell Technology," 2/29/2016 G4618810 PRN  Covered Call Alerts For Fitbit, Relypsa, General Electric, Horizon Pharma and Rockwell Medical Released By InvestorsObserver", 1/04/2013 BMR-US   PRN  BioMed Realty Trust Appoints Former Amylin President And Chief Executive Officer To Its Board Of Directors,12/10/2015 OPY-US   PRN  Oppenheimer's 26th Annual Healthcare Conference Provides Investors With Access To More Than 140 Public And Private Healthcare Companies,11/12/2012 0844XQ-E PRN  Karyopharm Therapeutics Announces Oral Presentation at the American College of Rheumatology (ACR) on the use of Selective Inhibitors of Nuclear Export (SINE) CRM1 Antagonists in preclinical models of Systemic Lupus Erythematosus (SLE),, 8/06/2018 98401F10 PRN  Xencor Reports Second Quarter 2018 Financial Results,"10/09/2015 46116X10 PRN  Covered Call Alerts For Chesapeake Energy, Joy Global, Intra-Cellular Therapies, CyberArk Software and Arrowhead Research Released By InvestorsObserver",10/21/2019 G8807B10 PRN  Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting, 4/03/2014 079TK4-E PRN  Novocure to Present New Pre-Clinical Data on NovoTTF™ Therapy at the American Association for Cancer Research Annual Meeting 2014, 9/03/2019 03969710 PRN  Ardelyx Announces Positive Results from the Pivotal Phase 3 AMPLIFY Study Evaluating Tenapanor in Dialysis Patients Who Have Uncontrolled Hyperphosphatemia Despite Phosphate Binder Treatment,,,,, 6/29/2017 M4613510 PRN  Foamix Pharmaceuticals Appoints David Domzalski as Chief Executive Officer, 5/21/2012 001THX-E PRN  PRA Expands Operations in Europe,,," 5/05/2017 74587V10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Puma Biotechnology, Inc. - PBYI", 1/07/2014 0CT6N9-E PRN  Coherus Biosciences Invited to Present at 2014 J.P. Morgan Annual Healthcare Conference, 9/07/2017 21833P10 PRN  Legal and Medical Cannabis Market Investments on the Rise, 4/26/2019 05070R10 PRN  Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),11/27/2012 00772J-E PRN  Collegium Pharmaceutical to Present at Piper Jaffray's 24th Annual Healthcare Conference,," 1/15/2015 0CT325-E PRN  Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer",,, 8/28/2019 75901B10 PRN  REGENXBIO to Present at Upcoming Investor Conferences,,,,,,,,11/06/2015 HCM-HK   PRN  Chi-Med Initiates Sulfatinib U.S. Clinical Trials,,,,, 8/06/2013 07N3G8-E PRN  arGEN-X Grants Licenses to its NHance™ Antibody Half-Life Extension Technology,," 4/04/2016 00695P-E  PRN  Athenex Announces the Addition of David Cutler, MD, FRCP(C) to its Global Clinical Development Team",,11/06/2015 00FMDK-E PRN  Rhythm Presents Positive Data from Phase 1b Study of Setmelanotide for the Treatment of Genetic Obesity,,,, 4/12/2011 009FRV-E PRN  Quanterix Discovers Link Between Heart Attack-Induced Hypoxia and Suspected Alzheimer's Disease Pathway,,, 1/17/2018 0FZZYY-E PRN  Homology Medicines Appoints Matthew R. Patterson to Board of Directors,,,,,,,,,,10/30/2018 05280R10 PRN  Autolus Therapeutics to Present at the Jefferies 2018 London Healthcare Conference, 1/04/2018 07YR31-E PRN  Forty Seven Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference,,,,,,"10/11/2019 50015M10 PRN  Kodiak Sciences Announces Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the American Academy of Ophthalmology Annual Meeting Retina Subspecialty Day",,11/16/2017 MRK-US   PRN  Guardant Health Expands Support for the Development of the GuardantOMNI™ Assay Through New Agreement with Bristol-Myers Squibb,, 1/03/2013 009Z8P-E PRN  NGM Enters Agreement With Janssen to Discover and Develop Novel Therapeutics for Diabetes, 6/01/2016 00FLML-E PRN  Twist Bioscience And Desktop Genetics To Offer Integrated Design Services And DNA Synthesis For Gene Editing Research,,,,,,, 6/19/2019 00973Y10 PRN  Akero Therapeutics Announces Pricing of Initial Public Offering,,,,," 1/07/2015 0DMSKV-E PRN  Adaptive Biotechnologies Announces Acquisition Of Sequenta, Inc.",
 9/05/2014 53220K50 PRN  Lemelson Capital Management Marks Flagship Fund's Second Anniversary, 6/17/2019 74318710 PRN  Velan sets the Record Straight on Progenics Pharmaceuticals' Latest Misleading Statements," 1/28/2017 45232710    PRN  Johnson & Weaver, LLP Announces Investigations of The Southern Company, Illumina, Inc., PixarBio Corporation and Midcoast Energy Partners, L.P."," 1/07/2015 84763A10 PRN  Technical Scrutiny on Biotech Stocks - Galena Biopharma, Synta Pharma, Merrimack Pharma, Vertex Pharma, and Spectrum Pharma",10/24/2019 G3040110 PRN  Endo Presents Data on the Use of a Standing MRI for the Evaluation of Cellulite at the American Society for Dermatologic Surgery (ASDS) Annual Meeting," 9/22/2015 04280A10 PRN  Expert Briefing on Biotechnology Stocks -- Baxalta, Opko Health, Spectrum Pharma, Arrowhead Research, and Oncothyreon", 8/17/2017 09060J10 PRN  BioDelivery Sciences to Present Three Posters on BELBUCA® and BUNAVAIL® at PAINWeek 2017,12/17/2019 09073M10    PRN  Bio-Techne's Exosome Diagnostics Lab Receives Accreditation From College of American Pathologists (CAP), 1/22/2020 75886F10    PRN  Forty of the Nation's Brightest Young Scientists Named Finalists in Regeneron Science Talent Search 2020,," 9/17/2018 68375N10 PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In OPKO Health, Inc. To Contact The Firm",12/02/2019 46222210 PRN  Ionis Pharmaceuticals to hold technology webcast,12/16/2019 09061G10   PRN  BioMarin Announces Positive Final Results from Placebo-Controlled Phase 3 Data in Children with Achondroplasia Treated with Vosoritide,"12/23/2016 01535110 PRN  ALEXION (ALXN) ALERT: Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Alexion Pharmaceuticals, Inc.; Encourages all Investors to Contact the Firm for Information",10/01/2019 64125C10 PRN  Neurocrine Biosciences to Present Data Analyses Demonstrating the Long-Term Effectiveness of INGREZZA® (valbenazine) in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress, 3/26/2018 81257810 PRN  Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer," 7/08/2016 45290710 PRN  IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics Inc. - IMMU", 7/25/2018 00167Y-E  PRN  Eisai And Biogen Announce Detailed Results Of Phase II Clinical Study Of BAN2401 In Early Alzheimer's Disease At Alzheimer's Association International Conference (AAIC) 2018," 2/02/2015 45253H10 PRN  Quarterly Results Review & Outlook: Complementary Reports on Costco, Chevron, ImmunoGen, MasterCard, and Intercept"," 4/23/2015 09058V10 PRN  The Health of Healthcare Companies: Complementary Research on Landmark Bancorp, Genetic Technologies, Novogen, CorMedix, and BioCryst", 1/10/2019 064FG9-E   PRN  Fish & Richardson Obtains Denial of Cert at U.S. Supreme Court for Gilead Sciences in Long-Running Patent Battle with Merck Over Hepatitis C Drugs,11/07/2019 04004760   PRN  Arena Reports Third Quarter Financial Results with Continued Progress on Clinical Programs,11/25/2019 N5946510  PRN  Mylan to Present at the Evercore ISI HealthCONx Conference," 1/08/2020 M2572210 PRN  Compugen Announces Appointment of Dr. Oliver Froescheis as Senior Vice President, Corporate and Business Development"," 2/27/2018 00972810 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc. (AKRX)", 1/07/2020 03116210 PRN  Amgen To Present At The Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference," 4/25/2018 001D3K-E PRN  Scott+Scott Attorneys at Law LLP Alerts Investors to the Filing of Securities Class Action Against Myriad Genetics, Inc. (MYGN)", 9/07/2017 52887230 PRN  Lexicon Pharmaceuticals To Present At The Bank Of America Merrill Lynch 2017 Global Healthcare Conference,,11/26/2019 45766930 PRN  Insmed to Present at Two December Conferences,, 3/12/2020 45773H20 PRN  INOVIO Receives New $5 Million Grant to Accelerate Scale Up of Smart Delivery Device for Its COVID-19 Vaccine,11/01/2019 64026810 PRN  Nektar Therapeutics to Host Webcast Conference Call with Melanoma Specialist for Analysts & Investors During 2019 Society for Immunotherapy of Cancer 34th Annual Meeting, 8/28/2019 76655960 PRN  Rigel's CEO to Participate in Panel Discussion at Citi's 14th Annual Biotech Conference," 5/01/2017 37416310 PRN  Faruqi & Faruqi, LLP Announces a Proposed Class Action Settlement Involving All Persons who Purchased or Acquired Geron Common Stock between December 10, 2012 and March 11, 2014"," 7/14/2014 00771V10 PRN  Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals"," 4/21/2015 02311120 PRN  Stock Updates on Biotech -- Celgene, Amgen, PDL BioPharma, Amarin, and Pharmacyclics"," 4/20/2018 45337C10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Incyte Corporation (INCY)", 8/06/2019 91307C10 PRN  United Therapeutics Corporation To Present At 2019 Wedbush PacGrow Healthcare Conference," 2/04/2016 80360710 PRN  Covered Call Alerts For Apple, Sarepta Therapeutics, Freeport-McMoRan, PayPal Holdings Inc. and Vuzix Corporation Released By InvestorsObserver",10/30/2019 G0176710 PRN  Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple Sclerosis,," 1/12/2015 00163U10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.",,"10/25/2019 55027E10 PRN  Luminex Corporation To Release Third Quarter 2019 Results After Market Close On November 4, 2019", 3/06/2019 80067710 PRN  Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences," 8/05/2016 30161Q10 PRN  Covered Call reports for Valeant Pharmaceuticals, Merrimack Pharmaceuticals, Exelixis, Under Armour and Harman International Industries include trade ideas that offer returns of 20% or more!",11/04/2019 80105N10  PRN  FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older," 4/15/2016 92532F10  PRN  Covered Call Alerts For NVIDIA, 3D Systems, GoPro, First Solar and Vertex Pharmaceuticals Released By InvestorsObserver",,10/18/2016 04351P10 PRN  Ascendis Pharma A/S Announces Proposed Public Offering of ADSs," 9/29/2015 09609G10 PRN  Alexandria Real Estate Equities, Inc. Announces 10-Year 253,000 RSF Full-Building Build-to-Suit Lease at 60 Binney Street for bluebird bio for Its New Office/Laboratory Headquarters in the Heart of Kendall Square in Cambridge, MA","10/14/2016 00422510 PRN  Covered Call reports for ACADIA Pharmaceuticals, Spark Therapeutics, Valero Energy, Lululemon and CSX include trade ideas that offer returns of 20% or more!",, 9/03/2019 74366E10 PRN  Protagonist Therapeutics to Present at the H.C. Wainwright & Co. 2019 Annual Healthcare Conference,," 4/25/2017 88338N10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against TherapeuticsMD, Inc. (TXMD) & Lead Plaintiff Deadline: June 19, 2017"," 1/05/2015 0070KW-E    PRN  Zogenix 2015 Expectations and Developments Drive Price Upward: Analyst Report Issued by BrokerBank Securities, Inc.",,10/15/2015 68214310 PRN  Omeros Announces OMIDRIAssure™ to Expand Patient Access to Omidria®,,,"12/31/2014 46333X10 PRN  Technical Report on Biotech Stocks -- MannKind, Amgen, Celldex Therapeutics, Juno Therapeutics, and Ironwood Pharma", 5/05/2014 0D98KG-E PRN  Regeneron and Avalanche Biotechnologies Announce Collaboration to Develop Next-Generation Gene Therapy Products in Ophthalmology, 3/23/2016 0DRMTT-E PRN  Ultragenyx Funds Saint Louis University Researcher's Quest To Treat His Daughter's Disease,,,10/23/2019 69329Y10 PRN  Engine Capital Issues Open Letter to Board of PDL BioPharma,,,,"10/31/2019 00182C10 PRN  ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias", 4/08/2015 29251M10 PRN  AbbVie to Present New Data from Hepatitis C Clinical Development Program at The International Liver Congress™ 2015," 6/07/2017 PRTK-US  PRN  Stocks Under Scanner in the Biotech Space -- Paratek Pharma, Verastem, Alnylam Pharma, and Albany Molecular Research",," 6/29/2016 0017CR-E PRN  Akcea Therapeutics Announces Launch of IN-FOCUS, a Research Study to Assess Impact of Familial Chylomicronemia Syndrome", 7/01/2019 60468T10 PRN  Mirati Therapeutics Announces The Appointment Of Dr. Julie Cherrington To The Board Of Directors, 9/09/2014 69512710 PRN  Aratana Therapeutics Reports Positive Effectiveness Data from Pilot Field Study of Bupivacaine Extended-Release Injectable Suspension (AT-003)," 9/25/2013 0D0JWQ-E PRN  Transcept Pharmaceuticals Statement on Unsolicited Acquisition Proposal from Retrophin, Inc."," 9/26/2013 69404D10 PRN  Biotechs Leading the Healthcare Sector - Alliqua, Pacific Biosciences, Oncothyreon, Keryx, Organovo",, 3/05/2015 007MPF-E PRN  Chiasma Announces New Data for Investigational Octreotide Capsules," 8/12/2013 05LJZC-E PRN  MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development",11/14/2019 09627Y10 PRN  Blueprint Medicines to Present at Jefferies 2019 London Healthcare Conference,, 6/17/2019 28249U10 PRN  Eiger Announces Breakthrough Therapy Designation Granted by FDA for Avexitide for Treatment of Post-Bariatric Hypoglycemia (PBH), 9/08/2014 008H33-E PRN  Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibody Program from AnaptysBio,,,, 5/05/2015 0DZ2BK-E PRN  CytomX to Present Probody Overview at the Credit Suisse Antibody Day,,10/23/2019 92165910 PRN  Vanda Announces New Study Results Showing a High Degree of Inbreeding in Beagle Dogs,,, 4/10/2017 45781M10   PRN  Sarissa Capital Compelled To Clarify Egregious Misstatements Made By Innoviva," 1/12/2011 005XF5-E PRN  GlaxoSmithKline and ChemoCentryx announce initiation of Phase III study of GSK'786, formerly Traficet-EN™, for the treatment of Crohn's disease", 9/13/2019 40637H10 PRN  Positive Results Announced From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Halozyme's Enhanze® Drug Delivery Technology,11/01/2018 G2151510 PRN  China Biologic Reports Financial Results for the Third Quarter of 2018," 2/23/2016 56400P70 PRN  Lifshitz & Miller Law Firm Announces Investigation of Cigna Corporation, CTI Biopharma Corp., G. Willi-Food International Ltd., MannKind Corporation, Navient Corporation, Primero Mining Corp., and Skullcandy, Inc.",," 5/27/2014 23282W60 PRN  Pre-market Equity Watch on Top Gainers -- Research on Cytokinetics, ZIOPHARM Oncology, Microvision, and Nimble Storage"," 9/23/2015 29664W10 PRN  Critical Alerts For Micron, Halliburton, Esperion Therapeutics, Alibaba and Lumber Liquidators Released By InvestorsObserver", 2/03/2020 03236M20 PRN  Amyris Announces Execution of Definitive Agreements for up to an Anticipated $70 Million Debt Reduction Via Exercise of Existing Warrants and $42 Million in New Financing, 1/06/2020 69366J20 PRN  PTC Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference," 5/19/2015 0D4NSD-E PRN  Janssen Enters into a Worldwide Collaboration with Achillion Pharmaceuticals, Inc. to Combat Hepatitis C Virus","12/05/2017 87166B10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against INC Research Holdings, Inc. (INCR) & Lead Plaintiff Deadline: February 2, 2018"," 2/04/2015 03152W10 PRN  Biotech Stocks Scanner - ARIAD Pharma, Celgene, CytRx, Amicus Therapeutics, and United Therapeutics",,,, 9/13/2018 36197T10 PRN  Cannabidiol (CBD) Infusion into Healthcare Products Industry Growing Faster Than Expected, 4/24/2014 29428V10 PRN  Epizyme Announces Notice of Allowance for U.S. Patent Application Covering Methods of Treatment for Cancers with EZH2 Inhibitors,11/05/2019 G5087110 PRN  Jazz Pharmaceuticals Announces Third Quarter 2019 Financial Results,, 4/15/2019 39843840 PRN  Grifols donations of blood clotting factor helping people with hemophilia globally,, 1/09/2020 73701010 PRN  Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 Million," 3/01/2017 92337F10 PRN  Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook",, 4/11/2011 ALCLS-FR PRN  Cellectis Strengthens Management Team to Support Stem Cell Activities,10/19/2017 14075510 PRN  Legal Cannabis Sales Projected to Increase as the Illicit Market Weakens,, 3/28/2012 AMT-NL   PRN  Amsterdam Molecular Therapeutics Publishes Positive Data from Glybera® 14 Week Study,"12/16/2014 00847X10 PRN  Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Halliburton, Agios Pharmaceuticals and Urban Outfitters Released By InvestorsObserver"," 4/20/2017 46226010 PRN  Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Lion Biotechnologies, Inc. (LBIO) Securities Case", 7/15/2015 008H33-E PRN  AnaptysBio Secures $40 Million Series D Financing,, 6/28/2010 004SRV-E PRN  Fate Therapeutics Receives Red Herring's North America 100 Award for Advancing Stem Cell Technology and New Medicines, 2/08/2016 NRI-CA   PRN  Nuvo Research® and Horizon Pharma plc Extend Term of Manufacturing Agreement,," 7/17/2015 45845P10 PRN  Critical Alerts For Netflix, Baidu, Schlumberger, Aceto and Intercept Pharmaceuticals Released By InvestorsObserver","10/31/2012 0844XQ-E PRN  Karyopharm Therapeutics Recognizes the Contributions of Co-Founder Ronald DePinho, MD",, 8/01/2018 98401F10 PRN  Xencor to Present at Upcoming Investor Conferences," 9/17/2015 46116X10 PRN  Covered calls for Ambarella, Intracellular Therapies, AbbVie, Chevron and Amazon.com Released By InvestorsObserver", 9/25/2019 G8807B10 PRN  Theravance Biopharma to Present at the 2019 Cantor Global Healthcare Conference, 2/18/2014 079TK4-E PRN  Novocure Announces First Commercial License of the NovoTAL™ (Transducer Array Layout) System, 9/02/2019 03969710 PRN  Ardelyx to Host Conference Call on September 3 to Review Results from the Pivotal Phase 3 AMPLIFY Study,,,,, 6/15/2017 M4613510 PRN  Foamix Pharmaceuticals to Present at the 2017 BIO International Convention, 5/14/2012 0096QR-E PRN  BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy,,,"11/11/2016 74587V10 PRN  Puma Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI",10/28/2013 0CT6N9-E PRN  Coherus Announces CHS-0214 (Proposed Etanercept Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study, 8/25/2017 21833P10 PRN  Data on Legal Cannabis Products Show Strong Sales, 4/23/2019 05070R10 PRN  Audentes Therapeutics Announces Launch of New State-of-the-Art Internal cGMP Plasmid Manufacturing Facility,"10/19/2012 00772J-E PRN  Collegium Announces Poster Presentation for Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid at 2012 American Association of Pharmaceutical Scientists Annual Meeting",, 1/06/2015 0CT325-E PRN  Seres Health Announces $65 Million Investment from Nestle Health Science,,, 8/27/2019 75901B10 PRN  REGENXBIO to Present Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting in October,,,,,,,,10/30/2015 44842L10 PRN  Completion of Phase I Clinical Trial of Novel Syk Inhibitor HMPL-523 for Autoimmune Diseases in Healthy Volunteers,,,,, 4/24/2013 07N3G8-E PRN  arGEN-X advances ARGX-113 into preclinical development for autoimmune disorders,," 2/25/2016 00695P-E  PRN  Antony Leung, Group CEO of Nan Fung Group and former Financial Secretary of Hong Kong Special Administrative Region, to join the Athenex Board of Directors",, 8/13/2015 00FMDK-E PRN  Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing,,,, 2/23/2011 009FRV-E PRN  Quanterix Announces Publication of Novel Method Expanding Single Molecule Detection Capability,,,11/13/2017 0FZZYY-E PRN  Homology Medicines and Novartis Enter Collaboration to Develop New Treatments Using Homology's Proprietary Gene Editing Technology,,,,,,,,,,"10/17/2018 05280R10 PRN  Adam Hacker, PhD Joins Autolus as Senior Vice President for Regulatory Affairs and Quality",12/06/2017 07YR31-E PRN  Forty Seven Inc. Receives $5 Million Grant from The California Institute for Regenerative Medicine (CIRM) to Support Ongoing Clinical Trial in Acute Myeloid Leukemia,,,,,,10/11/2019 50015M10 PRN  Kodiak Sciences to Host R&D Day on October 14 in San Francisco to Highlight Recent Clinical Progress and Development Planning for KSI-301,,11/15/2017 00FYYJ-E PRN  New Research Reveals Molecular Heterogeneity of Metastatic Gastroesophageal Cancer,, 3/28/2012 009Z8P-E PRN  NGM and Daiichi Sankyo Collaborate to Discover and Develop Innovative Therapeutics for Diabetes, 4/27/2016 00FLML-E PRN  Twist Bioscience Announces Microsoft Purchase Of Its Synthetic DNA For Digital Data Storage Research,,,,,,, 5/29/2019 0JNJRY-E PRN  Akero Therapeutics Initiates Phase 2a Clinical Trial of Investigational Therapy AKR-001 for the Treatment of NASH,,,,,12/02/2014 0DMSKV-E PRN  Adaptive Biotechnologies and Collaborators Present 13 Studies Demonstrating Clinical Relevance of Immunosequencing at 56th Annual Meeting of the American Society for Hematology,
 8/25/2014 53220K50 PRN  Lemelson Capital Comments on Large Institutional Selling in Shares of Ligand Pharmaceuticals Amidst Company's Insolvency and Mounting Going Concern Risk, 6/11/2019 74318710 PRN  Velan Capital Sends Letter to Stockholders Calling Out Progenics Pharmaceuticals' Board for Unnecessarily Diluting Stockholders to Support Outsized And Undeserved Compensation," 1/20/2017 45232710    PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN","10/21/2014 84763A10 PRN  Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum Pharma, Sangamo BioSciences, and Cubist Pharma",10/07/2019 0DPG4L-E PRN  Nevakar Enters into $17.5 Million Product Financing Agreement with H.I.G. Capital Partners for Continued Development of Injectable Products," 9/10/2015 04280A10 PRN  Critical Alerts For Netflix, MannKind, Arrowhead Research, Google Inc. and CyberArk Software Released By InvestorsObserver", 8/09/2017 09060J10 PRN  BioDelivery Sciences Reports Second Quarter 2017 Financial Results and Provides Corporate Update,11/25/2019 09073M10    PRN  Bio-Techne To Present At The Evercore ISI 2nd Annual HealthCONx Conference, 1/22/2020 000VC1-E    PRN  Forty of the Nation's Brightest Young Scientists Named Finalists in Regeneron Science Talent Search 2020,, 9/14/2018 68375N10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OPKO Health - OPK,11/12/2019 46222210 PRN  Ionis Pharmaceuticals to present at upcoming investor conferences,11/21/2019 09061G10   PRN  BioMarin Submits Marketing Authorization Application to European Medicines Agency for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A,"12/13/2016 01535110 PRN  Covered Call reports for Alexion Pharmaceuticals, Cornerstone OnDemand, Inc., Northrop Grumman Corporation, Opko Health and Lockheed Martin Corporation include trade ideas that offer returns of 23% or more!", 9/30/2019 64125C10 PRN  Neurocrine Biosciences Appoints David W. Boyer as Chief Corporate Affairs Officer, 2/14/2018 SGEN-US  PRN  PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates," 7/01/2016 45290710 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline - IMMU", 7/25/2018 00167Y-E  PRN  Eisai And Biogen Present Detailed Results From Phase II Clinical Study Of Elenbecestat In MCI And Mild To Moderate Alzheimer's Disease At Alzheimer's Association International Conference (AAIC) 2018,"12/30/2014 45253H10 PRN  Biotech Stocks Technical Data -- Gilead Sciences, ImmunoGen, Exelixis, Cubist Pharma, and Vanda Pharma"," 2/10/2015 09058V10 PRN  Valuable Updates on Pharmaceutical Companies: New Research on Avalanche Biotechnologies, BioCryst, Biogen, Biota Pharmaceuticals, and Bio-Techne",12/20/2018 37555810   PRN  Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies,11/06/2019 04004760   PRN  Arena Pharmaceuticals Presented New Data Highlighting the Human Mass Balance and Metabolism Profile of Etrasimod at AAPS,11/12/2019 000TBT-E  PRN  Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination,12/20/2019 M2572210 PRN  Compugen Added to the NASDAQ Biotechnology Index," 2/26/2018 00972810 PRN  Block & Leviton LLP Investigates Akorn, Inc. (AKRX) Following Investigation By Acquirer, Fresenius", 1/02/2020 000C35-E PRN  Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China," 4/23/2018 001D3K-E PRN  Myriad Genetics Shareholder Alert: Bernstein Liebhard LLP Announces That A Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. - MYGN", 9/05/2017 52887230 PRN  Lexicon Pharmaceuticals to Present New Clinical Data at the European Association for the Study of Diabetes 53rd Annual Meeting,,11/14/2019 45766930 PRN  Insmed Appoints Dr. Clarissa Desjardins to its Board of Directors and Names Roger Adsett Chief Operating Officer,," 3/11/2020 45773H20 PRN  HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Inovio Pharmaceuticals (INO) Investors Who Have Suffered Significant Losses to Contact its Attorneys: Firm Investigating Possible Securities Fraud","10/30/2019 64026810 PRN  Nektar to Announce Financial Results for the Third Quarter 2019 on Wednesday, November 6, 2019, After Close of U.S.-Based Financial Markets", 8/06/2019 76655960 PRN  Rigel Announces Second Quarter 2019 Financial Results and Provides Business Update,"11/03/2016 GERN-US  PRN  ASH 2016: Janssen to Present 43 Abstracts with Data on Ibrutinib, Daratumumab and Other Compounds Showing Treatment Advances in Malignant and Non-Malignant Hematologic Conditions"," 6/30/2014 00771V10 PRN  Leadership Appointments, Acquisitions, Orphan Drug Designations, Strategic Collaborations, and Technical Updates - Analyst Notes on Aerie, Medical Action, INSYS, Novadaq and Foundation Medicine"," 3/18/2015 02311120 PRN  Biotech Stocks Technical Study -- Orexigen Therapeutics, Celgene, PDL BioPharma, Amarin, and Synergy Pharma", 4/19/2018 45337C10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporation - INCY, 7/31/2019 91307C10 PRN  United Therapeutics Corporation Reports Second Quarter 2019 Financial Results," 1/25/2016 80360710 PRN  Covered Call Alerts For Sarepta Therapeutics, Anavex Life Sciences Corp, Constellation Brands, Caterpillar Inc. and Skyworks Solutions Released By InvestorsObserver",10/23/2019 G0176710 PRN  Alkermes Plc Reports Third Quarter 2019 Financial Results and Implementation of Restructuring,," 1/09/2015 00163U10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG",,10/01/2019 55027E10 PRN  Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay, 2/28/2019 80067710 PRN  Sangamo Therapeutics Reports Fourth Quarter And Full Year 2018 Financial Results," 7/29/2016 30161Q10 PRN  Learn how to target a 12% return on Exelixis, or get option-trade ideas on FireEye, Baidu, Marathon Petroleum Corporation and First Solar or any stock you choose",11/04/2019 80105N10  PRN  Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes, 3/10/2016 000YJB-E  PRN  Hovione and Vertex Partner in Continuous Manufacturing,, 9/22/2016 04351P10 PRN  Ascendis Pharma A/S Announces Webcast of R&D Update," 9/24/2015 09609G10 PRN  Market Pulse of Healthcare Sector - Concert Pharmaceuticals, Clovis Oncology, bluebird bio, ACADIA Pharmaceuticals and DENTSPLY International"," 9/28/2016 00422510 PRN  InvestorsObserver releases covered-call reports for MetLife Incorporated, NIKE, Bitauto Holdings, United Parcel Service and ACADIA Pharmaceuticals",, 8/07/2019 74366E10 PRN  Protagonist Therapeutics Reports Second Quarter 2019 Financial Results,," 2/03/2017 88338N10 PRN  How These Drug Makers Stocks are Faring? -- Provectus Biopharma, TherapeuticsMD, Novartis, and Tonix Pharma","12/15/2014 98978L20    PRN  Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis",," 9/30/2015 68214310 PRN  Biotechnology Equity Picks -- Arena Pharma, Biogen, Omeros, Illumina, and Merrimack Pharma",,,"10/30/2014 46333X10 PRN  Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma", 4/22/2014 0D98KG-E PRN  Avalanche Biotechnologies Secures $55 Million in Oversubscribed Series B Financing,10/29/2015 90400D10 PRN  Ultragenyx Pharmaceutical and Arcturus Therapeutics Announce a Research Collaboration and License Agreement to Develop RNA Therapeutics for Rare Diseases,,, 9/26/2019 69329Y10 PRN  PDL BioPharma to Participate in the 2019 Cantor Fitzgerald Global Healthcare Conference,,,,10/30/2019 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2019 Financial Results," 2/23/2015 29251M10 PRN  Results from AbbVie's Study of VIEKIRA PAK™ (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) Published Online in JAMA; Sub-analyses to be Presented at the Annual Conference on Retroviruses and Opportunistic Infections (CROI)", 4/03/2017 05SJ7P-E PRN  Invitae announces new partnership with Alnylam Pharmaceuticals to provide TTR gene testing for patients suspected of having hereditary ATTR amyloidosis,, 6/27/2016 0017CR-E PRN  Akcea Announces Publication of Positive Volanesorsen Clinical Data Showing Reduced Triglycerides and Improved Insulin Sensitivity in Patients with High Triglycerides and Type 2 Diabetes, 6/27/2019 60468T10 PRN  Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares," 7/01/2014 69512710 PRN  Dividends, Mergers, and Study Results - Analyst Notes on Pfizer, Gilead, Pacira, QLT and Agenus",,"12/05/2011 69404D10 PRN  The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.",, 2/27/2015 007MPF-E PRN  Chiasma Announces Completion of $70 Million Series E Financing, 6/03/2013 05LJZC-E PRN  MacroGenics Presents Phase 1 Data at ASCO Showing Signs of Clinical Benefit for Margetuximab in HER2 Expressing Tumors,11/06/2019 09627Y10 PRN  Blueprint Medicines to Present Initial Data from Phase 2 PIONEER Trial of Avapritinib in Patients with Indolent Systemic Mastocytosis at 61st ASH Annual Meeting and Exposition,," 6/10/2019 28249U10 PRN  Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs"," 8/12/2014 60877T10 PRN  Technical Roundup on Biotech Stocks -- Medivation, Ironwood Pharma, Momenta Pharma, Galectin Therapeutics, and PDL BioPharma",,,, 4/13/2015 0DZ2BK-E PRN  CytomX to Present Overview of Precision Cancer Immunotherapies at the Jefferies Immuno-Oncology Summit,,10/16/2019 92165910 PRN  Vanda Applauds White House Issuance of Executive Orders Requiring Federal Agencies to be Transparent in Policymaking and Enforcement,,, 4/10/2017 45781M10   PRN  ISS Supports All Three Sarissa Capital Nominees For Innoviva Board, 1/06/2011 005XF5-E PRN  ChemoCentryx to Present at the 29th Annual J.P. Morgan Healthcare Conference, 8/26/2019 40637H10 PRN  Halozyme To Participate In 2019 Wells Fargo Healthcare Conference,10/24/2018 G2151510 PRN  China Biologic Products to Report Third Quarter 2018 Financial Results, 2/12/2016 56400P70 PRN  Harwood Feffer LLP Announces Investigation of MannKind Corporation,," 1/15/2014 23282W60 PRN  Stock Price Movements, Completion of Acquisitions, and Clinical Trial Initiations - Research Report on Endocyte, PharMerica, Synta, AtriCure, and Cytokinetics"," 8/10/2015 29664W10 PRN  Critical Alerts For Invensense, King Digital, Etsy Inc., Monster Beverage and Esperion Therapeutics Released By InvestorsObserver", 1/23/2020 03236M20 PRN  Clean Beauty Leader Biossance Lands in the UK,12/13/2019 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 5/19/2015 00448Q20 PRN  Critical Alerts For Invensense, Rite Aid, Achillion Pharmaceuticals, CSX and Qihoo 360 Technology Released By InvestorsObserver","11/28/2017 87166B10 PRN  Johnson Fistel, Announces Investigations of INC Research Holdings, Inc., Acorda Therapeutics, Inc., and Shopify Inc.; Investors Encouraged to Contact Firm","12/04/2014 03152W10 PRN  Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma",,,, 9/06/2018 36197T10 PRN  Global Cannabis Market Set to Expand as Investment Traffic Increases," 4/22/2014 07CMVM-E PRN  Epizyme Achieves Lead Candidate Milestone for Third Target in GSK Collaboration, Receives $4 Million in Milestone and License Payments","10/22/2019 G5087110 PRN  Jazz Pharmaceuticals to Report 2019 Third Quarter Financial Results on November 5, 2019",," 4/05/2019 39843840 PRN  Grifols 2018 Annual Report on Form 20-F Filed With the SEC on April 5, 2019",,"12/23/2019 73701010 PRN  Portola Pharmaceuticals to Webcast Corporate Update on January 14, 2020", 2/28/2017 92337F10 PRN  Veracyte Announces Executive Promotions,, 4/05/2011 063J3K-E PRN  Cellectis and Caisse des Depots Sign Agreement on a Project for the Industrial Development of iPS Cells,10/12/2017 14075510 PRN  Legal Cannabis Expected to Benefit From New Technologies,,,"11/03/2014 00847X10 PRN  Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver"," 4/19/2017 46226010 PRN  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Lion Biotechnologies, Inc. (LBIO) & Lead Plaintiff Deadline - June 13, 2017", 7/13/2015 008H33-E PRN  AnaptysBio Appoints Robert E. Hoffman As Chief Financial Officer,, 5/11/2010 070JFC-E PRN  Fate Therapeutics Expands Scientific Advisory Board to Advance iPSC Technology and Stem Cell Modulator Pipeline," 2/05/2016 G4618810 PRN  Covered Call Alerts For First Solar, Alibaba, Rite Aid, Buffalo Wild Wings and Horizon Pharma Released By InvestorsObserver",," 6/22/2015 45845P10 PRN  Critical Alerts For Seadrill, Intrexon, bluebird bio Inc., El Pollo Loco and Intercept Pharmaceuticals Released By InvestorsObserver",10/31/2012 0844XQ-E PRN  Karyopharm Therapeutics Announces Multiple Publications on Selective Inhibitors of Nuclear Export (SINE) CRM1 Antagonists in Cancer,," 7/30/2018 98401F10 PRN  Xencor to Host Second Quarter 2018 Financial Results Webcast and Conference Call on August 6, 2018", 8/25/2014 46116X10 PRN  Standard & Poor's Raises Alexandria's Credit Outlook to Positive," 9/09/2019 G8807B10 PRN  Theravance Biopharma Reports Positive Results from Phase 1 Clinical Trial of TD-8236, an Investigational, Lung-Selective, Inhaled Pan-Janus Kinase (JAK) Inhibitor for Inflammatory Lung Diseases", 1/24/2014 079TK4-E PRN  Novocure Enrolls First Patient in Pilot Clinical Trial of NovoTTF™ Therapy Plus Gemcitabine for First-line Treatment of Advanced Pancreatic Adenocarcinoma, 8/09/2019 03969710 PRN  Ardelyx Reports Second Quarter 2019 Financial Results and Recent Business Highlights,,,,, 6/12/2017 M4613510 PRN  Foamix Announces Dosing of First Patient in Phase 3 Rosacea Clinical Trials for FMX103 Minocycline Foam 1.5%, 3/05/2012 001THX-E PRN  PRA Recruitment Expert to Speak at Partnerships Session on Experimental Operations,,,"10/14/2016 74587V10 PRN  Biotech Stocks on Investors' Radar -- BioMarin Pharma, Keryx Biopharma, Puma Biotech, and Arrowhead Pharma",, 7/27/2017 21833P10 PRN  Sector Market Growth in Legalization of Cannabis," 4/15/2019 05070R10 PRN  Audentes Therapeutics Announces Upcoming Presentations at 22nd Annual Meeting of the American Society of Gene and Cell Therapy Including New Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy", 9/18/2012 00B0RT-E PRN  Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors,,12/02/2014 0CT325-E PRN  Seres Health Closes $48 Million Series C Financing,,, 8/07/2019 75901B10 PRN  REGENXBIO Reports Second Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD,,,,,,,,10/30/2015 44842L10 PRN  Sulfatinib Clinical Results and Fruquintinib-Savolitinib Combination Preclinical Results to be Presented at the 2015 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference,,,,, 3/25/2013 07N3G8-E PRN  arGEN-X Announces Preclinical Development of ARGX-112 for Dermatology,," 2/09/2016 00695P-E  PRN  Athenex Announces the Addition of Simon Pedder, PhD and Raymond Yeung, MSc, MBA to its Global Leadership Team",, 6/04/2015 00FMDK-E PRN  Rhythm Initiates Two Phase 2 Clinical Trials of Setmelanotide (RM-493) in Rare Genetic Disorders of Obesity Caused by MC4 Pathway Deficiencies,,,, 2/22/2011 009FRV-E PRN  Quanterix Announces New Technology Evaluation Agreement,,,10/03/2017 0FZZYY-E PRN  Homology Medicines to Present at the Cell & Gene Meeting on the Mesa,,,,,,,,,, 8/30/2018 05280R10 PRN  Autolus to Present at Upcoming Investor Conferences,10/17/2017 07YR31-E PRN  Forty Seven Inc. Completes $75 Million Series B Financing,,,,,,10/10/2019 50015M10 PRN  Kodiak Sciences Treats First Patients in DAZZLE Pivotal Study of KSI-301 in Wet Age-Related Macular Degeneration,,11/06/2017 00FYYJ-E PRN  Guardant Health Database Reveals Potential of Targeted Therapy Combinations to Treat Advanced Lung Cancer,,10/05/2010 009Z8P-E PRN  NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director, 4/06/2016 00FLML-E PRN  Twist Bioscience Acquires Genome Compiler To Add Gene Design Capabilities,,,,,,, 5/01/2019 0JNJRY-E PRN  Akero Therapeutics Appoints Life Sciences Investment Banking Veteran Bill White as Chief Financial Officer and Head of Corporate Development,,,,,11/26/2014 0DMSKV-E PRN  Study Published in Nature Suggests immunoSEQ™ Assay May Be Used to Predict Response to anti-PD-1 Therapy for Melanoma,
" 8/15/2014 53220K50 PRN  Avion Pharmaceuticals, LLC, signs Captisol® License Agreement with Ligand Pharmaceuticals to develop four new products", 6/04/2019 74318710 PRN  Velan Responds to Progenics Pharmaceuticals' Misleading Statements, 1/09/2017 45232710    PRN  IBM and Illumina Partner to Standardize Genomic Data Interpretation, 9/18/2014 ENMD-US  PRN  Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs,10/02/2019 G3040110 PRN  Endo to Announce Third-Quarter 2019 Financial Results," 8/26/2015 04280A10 PRN  Critical Alerts For GoPro, Palo Alto Networks, eBay, Arrowhead Research and Illumina Released By InvestorsObserver", 7/31/2017 09060J10 PRN  BioDelivery Sciences Publishes Shareholder Letter with Mid-Year Corporate Update,11/07/2019 09073M10    PRN  Bio-Techne To Present At The 2019 Stifel Healthcare Conference," 1/10/2020 75886F10    PRN  Regeneron to Report Fourth Quarter and Full Year 2019 Financial and Operating Results and Host Conference Call and Webcast on February 6, 2020",," 9/12/2018 68375N10 PRN  OPKO Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against OPKO Health, Inc. - OPK",11/06/2019 46222210 PRN  Ionis provides third quarter financial results and improved 2019 guidance,"11/14/2019 09061G10   PRN  Poised for Significant Growth and Profitability, BioMarin Shares Company Highlights During R&D Day on November 14th in New York","11/25/2016 01535110 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alexion Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ALXN"," 9/17/2019 64125C10 PRN  Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) for Tardive Dyskinesia; Opicapone and VY-AADC for Parkinson's Disease, at the 2019 International Congress of Parkinson's Disease and Movement Disorders®"," 1/31/2018 0032YX-E PRN  Cascadian (CASC) Alert: Johnson Fistel Investigates Proposed Sale of Cascadian Therapeutics, Inc.; Is $10.00 a Fair Price for Shareholders?"," 6/30/2016 45290710 PRN  Why Investors Love These Biotech's Stocks? - ImmunoGen, Immunomedics, Vanda Pharma, and Arrowhead Pharma", 7/05/2018 09062X10  PRN  Eisai And Biogen Announce Positive Topline Results Of The Final Analysis For BAN2401 At 18 Months,"11/19/2014 45253H10 PRN  Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics","12/23/2014 09058V10 PRN  Stocks Cheering This Festive Season: Featured Research on Bristol-Myers, Rite Aid, Boeing, TASER and BioCryst",11/20/2018 0G0TRY-E   PRN  TARGET PharmaSolutions® to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead Sciences,11/05/2019 04004760   PRN  Arena Pharmaceuticals to Present at Upcoming Investor Conferences,11/05/2019 N5946510  PRN  Mylan Reports Third Quarter 2019 Results and Updates 2019 Guidance,11/11/2019 00356F-E PRN  Compugen Reports Third Quarter 2019 Results, 2/09/2018 0D9WRY-E PRN  AKRX Investor Alert: Kyros Law is Filing Compensation Claims on Behalf of Akorn Pharmaceuticals (NASDAQ: AKRX) Investors,"12/19/2019 03116210 PRN  Amgen And Allergan Submit Biologics License Application For ABP 798, Biosimilar Candidate To Rituxan® (rituximab), To U.S. Food And Drug Administration"," 4/23/2018 62855J10 PRN  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Myriad Genetics, Inc. (MYGN) & Lead Plaintiff Deadline - June 19, 2018", 8/15/2017 52887230 PRN  Lexicon Pharmaceuticals Reports Additional Positive Data From Pivotal Phase 3 inTandem2 Study Of Sotagliflozin,,11/05/2019 45766930 PRN  Insmed to Present at Two November Conferences,," 3/09/2020 45773H20 PRN  Thinking about buying stock in Avista, Canopy Growth Corp, FuelCell Energy, Inovio Pharmaceuticals, or LYFT?",10/29/2019 0011X6-E PRN  Clinical Trials in Gene Sequencing Reveal Novel Mutations Aiding in New Treatments for Acute Myeloid Leukemia, 7/30/2019 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Second Quarter 2019 Financial Results, 9/13/2016 GERN-US  PRN  AiVita CEO Comments on Recent Milestone Achievements in Asterias' SCiStar Trial for Spinal Cord Injury,"12/25/2013 00771V10 PRN  Upcoming Presentations, Milestone Payments, Quarterly Financial Results, and New Appointments - Research Report on Medivation, Acceleron, Aerie, Arrowhead, and Oxford Immunotec", 3/16/2015 02311120 PRN  Billion Dollar Omega-3 Fish Oil Market Forecasted to Continue to Grow - Company Receives FDA Approval for High Potency Omega-3 Recovery Supplements,11/05/2017 45337C10 PRN  ACR/ARHP 2017: New Analysis Shows Rheumatoid Arthritis Patients Treated with Baricitinib Reported Greater Improvements in Pain Compared to Adalimumab or Placebo," 7/24/2019 91307C10 PRN  United Therapeutics Corporation To Report Second Quarter 2019 Financial Results Before The Market Opens On Wednesday, July 31, 2019"," 1/22/2016 80360710 PRN  Lifshitz & Miller Law Firm Announces Investigation of GoPro Inc., Iconix Brand Group, Inland Real Estate Corporation, Nobilis Health Corp., Sarepta Therapeutics, Inc., Synutra International Inc., and Wilshire Bancorp Inc.",10/21/2019 G0176710 PRN  Alkermes Announces Clinical Collaboration With Fred Hutchinson Cancer Research Center for Novel Immuno-Oncology Drug Candidate ALKS 4230,,11/12/2014 AMAG-US  PRN  AMAG Pharmaceuticals Completes Acquisition of Lumara Health's Maternal Health Business,," 9/26/2019 55027E10 PRN  Luminex Corporation to Present at the Cantor Global Healthcare Conference on October 2, 2019", 2/21/2019 80067710 PRN  Sangamo Therapeutics Announces Fourth Quarter and Full Year 2018 Conference Call and Webcast," 7/22/2016 30161Q10 PRN  Exelixis trade offers a 16.41% return in 183 days, or find similar option trades on Consolidated Edison, NextEra Energy, Gilead Sciences, and Barrick Gold Corporation",10/31/2019 80105N10  PRN  Sanofi Q3 well on track,10/08/2015 JUNO-US   PRN  Multi-Billion Dollar Tissue Engineered Skin Substitutes Market Expected Robust Growth with Latest Biotech Advancements for Treating & Restoring Damaged Tissues,, 9/12/2016 04351P10 PRN  Ascendis Pharma A/S Announces Participation in 2016 Morgan Stanley Global Healthcare Conference on September 14," 9/11/2015 09609G10 PRN  Updates on Biotechnology Industry Stocks - BioCryst Pharma, Incyte, bluebird bio, Cempra, and BioLineRx"," 9/09/2016 00422510 PRN  Bank of America, Tesaro Inc., Juno Therapeutics Inc, ACADIA Pharmaceuticals, and Canadian Solar and more offer option-trading opportunities that offer returns of more than 20%",, 8/01/2019 74366E10 PRN  Oral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates Sustained Dose-Related Target Engagement Activity in a Multiple Ascending Dose Phase 1 Study,," 6/30/2016 88338N10 PRN  Momentum Indicators for Drug Manufacturers - Major Equities -- Sanofi, TherapeuticsMD, Immune Pharma, and Heron Therapeutics","11/04/2014 98978L20    PRN  Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix",, 9/03/2015 OMER-US  PRN  Omeros Files Infringement Suits Against Par,,," 9/16/2014 46333X10 PRN  Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma",, 1/13/2015 05WZCC-E PRN  TB Alliance Announces Two New Members to its Board of Directors: Dr. Mario Raviglione of WHO and Shalini Sharp of Ultragenyx,,, 9/12/2019 69329Y10 PRN  PDL BioPharma Announces Private Exchange of Approximately $86.1 Million of Convertible Notes Due 2024,,,,"10/29/2019 00182C10 PRN  ANI Pharmaceuticals announces the launch of ANI Global Source, its contract development and manufacturing business", 1/30/2015 29251M10 PRN  AbbVie Announces Top-line Results from Phase 3 Study of All-Oral Treatment for Hepatitis C in Japan,"10/28/2016 02043Q10 PRN  Lifshitz & Miller Law Firm Announces Investigation of Alnylam Pharmaceuticals, Inc., Chesapeake Energy Corporation, Cognizant Technology Solutions Corporation, Fenix Parts, Inc., Genworth Financial, Inc., Illumina Inc., ProNAi Therapeutics, Inc., and Supreme Industries Inc.",, 5/16/2016 0017CR-E PRN  Akcea Therapeutics Announces Completion of Enrollment in Phase 3 COMPASS Trial of Volanesorsen, 6/25/2019 60468T10 PRN  Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock," 5/19/2014 69512710 PRN  Technical Summary on Pharma Stocks -- Research on Pacira Pharma, Ventrus Biosciences, Teva Pharma, and Novo Nordisk",,11/02/2011 003V5M-E PRN  Gen-Probe Reports Financial Results for the Third Quarter of 2011,," 2/24/2015 007MPF-E PRN  Chiasma Appoints David Stack as Chairman of the Board; John A. Scarlett, M.D. Joins Board of Directors", 9/20/2012 05LJZC-E PRN  MacroGenics and Servier Enter Broad Strategic Alliance to Develop and Commercialize Three Anti-Cancer DART™ Products,"11/05/2019 09627Y10 PRN  Blueprint Medicines Outlines Precision Therapy Research Vision, Provides Update on Discovery and Clinical-Stage Portfolio at R&D Day and Reports Third Quarter 2019 Financial Results",," 6/05/2019 28249U10 PRN  Eiger Appoints Jeysen Yogaratnam, MB.BCh, BAO, MRCSEd, PhD, MBA, Vice President of Global HDV Clinical Development","12/31/2013 60877T10 PRN  Commercialization Agreements, Acquisition Updates, Conference Calls Schedules, Stock Price Updates and Clinical Study Data - Research Report on Biogen Idec, Covidien, Vertex, Endo, and Momenta Pharma",,,," 3/19/2015 0DZ2BK-E PRN  CytomX Appoints Immuno-Oncology Leader Rachel Humphrey, M.D., to Board of Directors",, 9/11/2019 92165910 PRN  Vanda Pharmaceuticals Applauds the EPA's Landmark Commitment to Eliminate Animal Testing and Urges the Food and Drug Administration to End Unnecessary and Scientifically Flawed Animal Toxicity Studies,,, 4/06/2017 45781M10   PRN  Glass Lewis Supports Sarissa Capital's Nominees For Innoviva Board,"11/10/2010 005XF5-E PRN  ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR)", 8/06/2019 40637H10 PRN  Halozyme Reports Second Quarter 2019 Results, 8/28/2018 G2151510 PRN  China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman, 1/20/2016 56400P70 PRN  Harwood Feffer LLP Announces Investigation of MannKind Corporation,, 9/03/2013 23282W60 PRN  Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil," 7/15/2015 29664W10 PRN  Critical Alerts For FireEye, Ariad Pharmaceuticals, ACADIA Pharmaceuticals, Esperion Therapeutics and Humana Released By InvestorsObserver", 1/13/2020 03236M20 PRN  Amyris Provides Update - Achieves Record Fourth-Quarter 2019 Product Shipments; Clean Beauty Produces Breakout Performance,11/29/2019 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 5/19/2015 00448Q20 PRN  Preclinical Studies Data Used to Pinpoint Potential Disease-Modifying Therapies & Drug Delivery Candidates for Patients with Rare Diseases,"11/16/2017 87166B10 PRN  Lifshitz & Miller LLP Announces Investigation of Acorda Therapeutics, Inc., Alkermes plc, ASB Financial Corp., CalAtlantic Group, Capella Education Company, INC Research Holdings, Inc. and YuMe, Inc.","10/22/2014 03152W10 PRN  Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma",,,, 8/16/2018 36197T10 PRN  Cannabis Retail Sales Continue to Grow as Legalization Spreads, 4/08/2014 29428V10 PRN  Epizyme Granted Patent Covering Diagnosis and Treatment of Cancers Associated with EZH2 Mutation,10/10/2019 G5087110 PRN  Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of CAR-T Associated Neurotoxicity,," 3/23/2019 39843840 PRN  Grifols Announces the Opening of its new Plasma Donor Center in Russellville, AR",,12/17/2019 73701010 PRN  Portola Pharmaceuticals to Support New American Heart Association Initiative to Address Hemorrhagic Stroke, 2/27/2017 92337F10 PRN  Veracyte Announces Publication of Data Demonstrating Potential for Non-Invasive Nasal Test to Improve Lung Cancer Diagnosis,, 4/04/2011 063J3K-E PRN  Cellectis Receives Payment for License to Homologous Recombination Patents,10/05/2017 14075510 PRN  Data Projects That the Global Legal Cannabis Market is Expected to Grow,,,"10/01/2014 00847X10 PRN  Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter"," 4/14/2017 46226010 PRN  Harwood Feffer LLP Announces Investigation of Lion Biotechnologies, Inc.", 6/30/2015 008H33-E PRN  AnaptysBio Announces Appointment of Hollings Renton and John Schmid to Board of Directors,," 5/10/2010 070JFC-E PRN  Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery","11/25/2015 G4618810 PRN  Covered Call Alerts For Freeport-McMoRan, Chevron, Johnson & Johnson, Nabors Industries and Horizon Pharma Released By InvestorsObserver",," 6/08/2015 45845P10 PRN  Critical Alerts For Tesla Motors, Chesapeake Energy, Intercept Pharmaceuticals, Linn Energy and Groupon Released By InvestorsObserver", 8/01/2012 0844XQ-E PRN  Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML),, 7/12/2018 98401F10 PRN  Xencor Doses First Patient in Phase 1 Study of XmAb20717 Dual Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors," 3/18/2014 46116X10 PRN  Intra-Cellular Therapies to Announce 2013 Fourth Quarter And Full Year Financial Results and to Host Conference Call on Tuesday, March 25, at 4:30 pm Eastern Time", 8/28/2019 G8807B10 PRN  Theravance Biopharma to Present at Two Upcoming Investor Conferences," 1/06/2014 079TK4-E PRN  Data Published in Pancreatology Demonstrates Activity of NovoTTF™ Therapy in Preclinical Models of Pancreatic Cancer, Alone and in Combination with Chemotherapy", 5/30/2019 03969710 PRN  Ardelyx to Present at the Jefferies 2019 Global Healthcare Conference,,,,, 6/01/2017 M4613510 PRN  Foamix Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference, 2/23/2012 001THX-E PRN  PRA Opens Office in Singapore,,,"10/11/2016 74587V10 PRN  Puma Biotechnology, Inc. Shareholder Alert: Schubert Firm Investigates Company's Top Executives",, 7/20/2017 21833P10 PRN  The Next Gold Rush is Green, 4/08/2019 05070R10 PRN  Audentes Therapeutics Announces Expansion of AAV Technology Platform and Pipeline with New Development Programs for Duchenne Muscular Dystrophy and Myotonic Dystrophy,,,11/17/2014 0CT325-E PRN  Seres Health Appoints Biotechnology Finance Leader Eric Shaff as Chief Financial Officer,,, 7/31/2019 75901B10 PRN  REGENXBIO Announces New License Agreement with Pfizer for the Treatment of Friedreich's Ataxia Using NAV® AAV9 Vector,,,,,,,,10/23/2015 HCM-HK   PRN  Proof-of-concept Study of Fruquintinib in Non-small Cell Lung Cancer Triggers Milestone Payment,,,,, 1/07/2013 07N3G8-E PRN  arGEN-X Initiates Phase Ib Study of ARGX-110 in Cancer,," 1/25/2016 00695P-E  PRN  Athenex Announces US FDA Allowance of the Investigation New Drug Application of Oradoxel, the Proprietary Oral Form of Docetaxel",, 4/08/2015 091B1B-E PRN  Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis,,,,12/01/2010 009FRV-E PRN  Dr. Martin Madaus Joins Quanterix Board of Directors,,, 8/01/2017 0FZZYY-E PRN  Homology Medicines Announces $83.5 Million Series B Financing to Advance Lead Development Candidate and AMEnDR™ In Vivo Gene Editing Technology,,,,,,,,,, 6/08/2018 ARIX-GB  PRN  Arix Bioscience plc: Update on Autolus Proposed Initial Public Offering in the United States," 3/20/2017 07YR31-E PRN  Forty Seven Inc. Announces Mark McCamish, M.D., Ph.D., to Join as CEO on May 1st",,,,,,"10/07/2019 50015M10 PRN  Kodiak Sciences Announces Upcoming Presentation of Durability Data from Clinical Development Program of KSI-301 in Wet AMD, DME, and RVO at American Academy of Ophthalmology 2019 Annual Meeting",,10/02/2017 00FYYJ-E PRN  Study Demonstrates Potential for the Guardant360 Assay® to Predict Which Patients Will Benefit from Immunotherapy,,, 3/03/2016 00FLML-E PRN  Twist Bioscience To Present At The Cowen And Company 36th Annual Health Care Conference,,,,,,, 4/23/2019 0JNJRY-E PRN  Akero Therapeutics Appoints Industry Veteran Jane Pritchett Henderson to Board of Directors,,,,,11/24/2014 0DMSKV-E PRN  Adaptive Biotechnologies Launches the immunoSEQ™ Kit to Enable Researchers to Sequence the Adaptive Immune System in their Own Labs,
" 8/14/2014 53220K50 PRN  Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy", 5/22/2019 74318710 PRN  Velan Files Definitive Proxy Materials in Connection with Progenics Pharmaceuticals 2019 Annual Meeting of Stockholders, 1/09/2017 45232710    PRN  Philips and Illumina join forces to offer integrated genomics solutions for oncology," 8/25/2014 84763A10 PRN  Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma", 9/30/2019 074HTM-E PRN  Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy," 6/17/2015 04280A10 PRN  Critical Alerts For 3D Systems, Arrowhead Research, Consolidated Edison, Whole Foods Market and Chevron Released By InvestorsObserver"," 7/28/2017 09060J10 PRN  /C O R R E C T I O N -- BioDelivery Sciences International, Inc./","11/06/2019 09073M10    PRN  Bio-Techne Licenses aTAG Technology from C4 Therapeutics, Inc.", 1/09/2020 75886F10    PRN  Regeneron Announces Encouraging Garetosmab Phase 2 Results in Patients with Ultra-Rare Debilitating Bone Disease,," 9/11/2018 68375N10 PRN  Investor Alert: Kaplan Fox Investigates OPKO Health, Inc.",10/28/2019 46222210 PRN  Bench to bedside strategies demonstrate Ionis' foremost expertise in RNA-targeted therapeutics at DIA/FDA Oligonucleotide Conference,11/14/2019 09061G10   PRN  BioMarin Announces Cumulative Additional Height Gain of 9.0 cm over 54 months versus Natural History in Children with Achondroplasia Treated with Vosoritide in Phase 2 Study,"11/10/2016 01535110 PRN  Harwood Feffer LLP Announces Investigation of Alexion Pharmaceuticals, Inc.", 9/11/2019 64125C10 PRN  Neurocrine Biosciences Announces Appointment of Leslie V. Norwalk to Board of Directors," 1/18/2018 000VC1-E PRN  Technical Perspectives on Biotech Stocks -- Ultragenyx Pharma, Regeneron Pharma, Seattle Genetics, and Sangamo Therapeutics"," 6/17/2016 45290710 PRN  Lifshitz & Miller Law Firm Announces Investigation of CBL & Associates Properties, Inc., Eagle Pharmaceuticals, Inc., HCP, Inc., Immunomedics, Inc., Infinity Pharmaceuticals Inc., Neovasc, Inc., and Unilife Corporation", 6/06/2018 00167Y-E  PRN  Alkermes Receives $50 Million Payment From Biogen Following Review of Preliminary Gastrointestinal Tolerability Data From the Ongoing BIIB098 Clinical Development Program,"10/21/2014 45253H10 PRN  Critical Alerts For BlackBerry, Sears Holdings, ImmunoGen, NPS Pharmaceuticals and Medivation Released By InvestorsObserver",11/24/2014 000CVC-E PRN  The Ebola Report: 2014 Epidemic And R&D Drug Prospects,10/03/2018 0GBZHG-E   PRN  Vineti Appoints Christophe Suchet as Chief Product Officer,10/31/2019 04004760   PRN  Arena Pharmaceuticals to Release Third Quarter 2019 Financial Results and Provide Corporate Update on November 7,"10/25/2019 N5946510  PRN  Mylan Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Alprazolam Tablets, USP C-IV 0.5 mg, Due to the Potential of Foreign Substance",11/06/2019 M2572210 PRN  Compugen Expands Patent Portfolio for COM902 with New Composition of Matter and Use Patent in Europe," 1/18/2018 0F98BD-E PRN  Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of Akorn, Inc.",12/12/2019 03116210 PRN  European Commission Approves EVENITY® (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture," 3/19/2018 62855J10 PRN  MYRIAD GENETICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Myriad Genetics, Inc. To Contact The Firm", 8/03/2017 52887230 PRN  Lexicon Pharmaceuticals To Present At 2017 Wedbush PacGrow Healthcare Conference,,11/04/2019 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 3/03/2020 45773H20 PRN  Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800,"10/16/2019 64026810 PRN  Nektar Therapeutics Announces Initiation of First-in-Human Phase 1 Clinical Study of NKTR-255, an IL-15 Agonist, in Adults with Relapsed or Refractory Non-Hodgkin Lymphoma or Multiple Myeloma", 6/13/2019 76655960 PRN  Rigel to Present Two Posters Highlighting Fostamatinib at the 24ᵗʰ Congress of the European Hematology Association (EHA)," 7/27/2015 GERN-US  PRN  Pre-market Equity Watch on Biotechnology -- Geron, Alexion Pharma, Cytori Therapeutics, TG Therapeutics, and Rexahn Pharma", 3/07/2011 085BQN-E PRN  Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio," 2/12/2015 02311120 PRN  What One Ought to Know in the Healthcare Sector: New Research on Amarin, Amedica, Amedisys, American CareSource, and AS&E","10/05/2017 45337C10 PRN  Stocks Under Scanner in the Biotech Space -- ImmunoGen, Incyte, Infinity Pharma, and Insmed", 6/05/2019 91307C10 PRN  United Therapeutics Corporation to Present at Goldman Sachs 40th Annual Global Healthcare Conference," 1/12/2016 80360710 PRN  Covered Call Alerts For PayPal Holdings Inc., Tesla Motors, Sarepta Therapeutics, Alcoa and Kohls Released By InvestorsObserver",10/16/2019 G0176710 PRN  Alkermes to Host Conference Call to Discuss Third Quarter 2019 Financial Results,,"10/31/2014 06V94H-E PRN  Claims Administrator Angeion Group Announces Settlement in Silverstrand Investments v. AMAG Pharmaceuticals, Inc. Litigation",, 9/03/2019 55027E10 PRN  Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference, 2/20/2019 80067710 PRN  Sangamo Announces FDA Acceptance of IND Application for ST-920 Gene Therapy Candidate for Fabry Disease," 7/14/2016 30161Q10 PRN  Learn how to target a 20% return on Gilead Sciences, or get option-trade ideas on Aetna, Exelixis, Priceline and Abbott Laboratories or any stock you choose",10/18/2019 80105N10  PRN  Sanofi to conduct precautionary voluntary recall of Zantac OTC in U.S. and Canada," 9/18/2015 92532F10  PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Vertex Pharmaceuticals Incorporated -- VRTX",, 9/09/2016 04351P10 PRN  Ascendis Pharma A/S Announces Multiple TransCon Growth Hormone Presentations at the European Society of Paediatric Endocrinology Annual Meeting," 7/06/2015 09609G10 PRN  Critical Alerts For Seadrill, Health Net Inc., American Airlines, Horizon Pharma and bluebird bio Inc. Released By InvestorsObserver"," 8/22/2016 00422510 PRN  Learn how to target a 20% return on GoPro, or get option-trade ideas on Deere, Foot Locker, The Gap and ACADIA Pharmaceuticals or any stock you choose",, 7/16/2019 74366E10 PRN  Protagonist Therapeutics Reports Granting of Inducement Award,," 7/28/2015 GSK-GB   PRN  Drug Manufacturers - Major Stocks on the Move -- GlaxoSmithKline, Sanofi, Aerie Pharma, TherapeuticsMD, and Aoxing Pharma"," 9/29/2014 98978L20    PRN  Pharma Equities Technical Momentum - Provectus Biopharma, Shire, Impax Labs, Zogenix, and TherapeuticsMD",," 8/19/2015 68214310 PRN  Critical Alerts For Chesapeake Energy, Omeros, Second Sight Medical Products Inc., Denbury Resources and Whiting Petroleum Released By InvestorsObserver",,," 8/12/2014 46333X10 PRN  Technical Roundup on Biotech Stocks -- Medivation, Ironwood Pharma, Momenta Pharma, Galectin Therapeutics, and PDL BioPharma",," 5/01/2012 00D326-E PRN  Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease",,, 9/11/2019 69329Y10 PRN  PDL BioPharma Announces Favorable Decision in Wellstat Diagnostics Litigation,,,,10/03/2019 00182C10 PRN  ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study, 1/16/2015 29251M10 PRN  European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) for the Treatment of Chronic Hepatitis C," 8/29/2016 02043Q10 PRN  Research Reports Initiation on Biotech Stocks -- Hemispherx Biopharma, Vascular Biogenics, BioCryst Pharma, and Alnylam Pharma",, 3/31/2016 0017CR-E PRN  Akcea Therapeutics Supports World Lipodystrophy Day, 6/24/2019 60468T10 PRN  Mirati Therapeutics Announces Proposed Public Offering of Common Stock, 4/07/2014 69512710 PRN  CorMedix Inc. Welcomes Additional Board Members,," 3/01/2011 69404D10 PRN  Zacks Sell List Highlights: Thoratec Corporation, The Advisory Board Company, Pacific Biosciences of California and HEALTHSOUTH",," 2/09/2015 007MPF-E PRN  Newly Published Phase III Study Results Show Positive Outcomes for Octreotide Capsules in People with Acromegaly, a Serious Hormonal Disorder"," 9/05/2012 0CGPGK-E PRN  ImaginAb and MacroGenics Collaborate to Develop In Vivo Imaging Agents for Autoimmune Diseases, Cancer","10/29/2019 09627Y10 PRN  Blueprint Medicines to Host R&D Day and Announce Third Quarter 2019 Financial Results on November 5, 2019",, 5/30/2019 28249U10 PRN  Eiger BioPharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference,"12/19/2013 60877T10 PRN  Strategic Acquisitions, Commercial Collaborations, and New Appointments - Research Report on Solta Medical, Opko Health, NuPathe, AcelRx Pharmaceuticals, and Momenta Pharmaceuticals",,,," 1/05/2015 0DZ2BK-E PRN  CytomX Expands Leadership Team with Addition of Michael Kavanaugh, M.D., as Chief Scientific Officer and Head of Research and Early Development",, 8/21/2019 92165910 PRN  Vanda Pharmaceuticals Announces the Appointments of a Chief Corporate Affairs and Communications Officer and a Chief Marketing Officer,,," 4/05/2017 45781M10   PRN  Lifshitz & Miller LLP Announces Investigation of BRF S.A., Innoviva, Inc., Panera Bread Company, PRA Group, Inc., Proteon Therapeutics, Inc., tronc, Inc. and Vuzix Corporation",11/09/2010 005XF5-E PRN  ChemoCentryx Reports Favorable Phase I Results for CCX354 in Patients With Rheumatoid Arthritis at the Annual American College of Rheumatology Meeting (ACR), 7/25/2019 40637H10 PRN  Halozyme To Participate In 39th Annual Canaccord Genuity Growth Conference, 8/24/2018 008V29-E PRN  China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement,"10/26/2015 56400P70 PRN  Critical Alerts For MannKind, Amazon.com, Synaptics Incorporated, athenahealth and Opko Health Released By InvestorsObserver",, 8/27/2013 CYTK-US  PRN  Amgen to Highlight New Data at Upcoming ESC Congress 2013," 7/02/2015 29664W10 PRN  Critical Alerts For FireEye, Petrobras, Impac Mortgage Holdings Inc, Esperion Therapeutics and Palo Alto Networks Released By InvestorsObserver",12/27/2019 03236M20 PRN  Amyris Announces Successful Shipment of First Fermentation Derived Cannabinoid to LAVVAN and Provides Business Updates,11/25/2019 69366J20 PRN  PTC Therapeutics Announces FDA Grants Priority Review to Risdiplam for the Treatment of Spinal Muscular Atrophy," 5/14/2015 00448Q20 PRN  Biotech Stocks Technical Analysis - Achillion Pharma, CTI BioPharma, StemCells, Progenics Pharma, and Bluebird Bio","11/10/2017 87166B10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of INC Research Holdings, Inc. (INCR)"," 9/12/2014 03152W10 PRN  Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics",,,, 8/15/2018 36197T10 PRN  Big Businesses Look for Healthier Alternatives to Smoking for Drug Delivery," 2/28/2014 29428V10 PRN  Epizyme, Inc. to Present at 34th Annual Cowen and Company Health Care Conference on March 3, 2014", 9/30/2019 G5087110 PRN  Jazz Pharmaceuticals Survey Highlights Prevalence of Misinformation and Misperception About Narcolepsy Among Americans,, 2/21/2019 39843840 PRN  Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year,,12/09/2019 73701010 PRN  Portola Pharmaceuticals Presents New Interim Data at the 61st ASH Meeting on its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated Patients with Relapsed/Refractory Follicular Lymphoma, 2/21/2017 92337F10 PRN  Veracyte Announces Ten New Blues Plan Coverage Policies for Its Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis,, 3/31/2011 063J3K-E PRN  Cellectis Publishes 2010 Financial Results,10/02/2017 14075510 PRN  Sales of Legal Cannabis Products are Expected to Grow,,," 9/29/2014 00847X10 PRN  Critical Alerts For Invensense, Agios Pharmaceuticals, SPDR Gold Trust, Nu Skin Enterprises and Nike Released By InvestorsObserver", 4/13/2017 46226010 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lion Biotechnologies Inc. - LBIO, 4/16/2015 008H33-E PRN  AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease,,,11/19/2015 G4618810 PRN  Depomed Comments on Horizon Withdrawal of Offer to Acquire Company,," 5/04/2015 45845P10 PRN  Critical Alerts For Rite Aid, Applied Materials Inc., MobileIron, Teradyne Inc. and Intercept Pharmaceuticals Released By InvestorsObserver"," 7/25/2012 0844XQ-E PRN  Karyopharm Therapeutics Initiates Two Phase 1 Trials with Oral KPT-330, the First Selective Inhibitor of Nuclear Export (SINE), in Patients with Advanced Cancers",, 5/31/2018 98401F10 PRN  Xencor to Present at Upcoming Investor Conferences," 3/10/2014 46116X10 PRN  Intra-Cellular Therapies Announces the Appointment of Juan Sanchez, M.D., as Vice President of Corporate Communications and Investor Relations"," 7/31/2019 G8807B10 PRN  Theravance Biopharma, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update",12/10/2013 079TK4-E PRN  Centers for Medicare and Medicaid Services (CMS) Has Established Permanent Billing Codes for the NovoTTF-100A System™, 5/07/2019 03969710 PRN  Ardelyx Reports First Quarter 2019 Financial Results and Recent Business Highlights,,,,, 5/09/2017 M4613510 PRN  Foamix Reports First Quarter 2017 Financial Results and Provides Business Update," 1/11/2012 006LB5-E PRN  Premier Research Names Susan Stansfield, PhD Executive VP, Clinical Development",,,"10/10/2016 74587V10 PRN  Johnson & Weaver, LLP Initiates Investigations of Puma Biotechnology, Inc., Virtus Investment Partners, Inc., AAC Holdings, Inc. and Spectrum Pharmaceuticals, Inc.; Encourages Long-Term Investors to Contact the Firm Regarding Their Legal Rights",, 7/18/2017 21833P10 PRN  Where the Smart Money is Looking This Summer, 4/05/2019 05070R10 PRN  Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,10/06/2014 0CT325-E PRN  Seres Health Appoints Two New Board Members,,, 7/30/2019 75901B10 PRN  REGENXBIO To Host Conference Call on August 7 to Discuss Second Quarter 2019 Financial Results and Recent Operational Highlights,,,,,,,,10/16/2015 HCM-HK   PRN  Hutchison China MediTech Limited Files Registration Statement for Potential Nasdaq Stock Market Listing,,,,, 1/07/2013 07N3G8-E PRN  arGEN-X Expands its Therapeutic Antibody Alliance With Shire,,12/15/2015 00695P-E  PRN  Athenex Announces Progress in Registration Studies of Oral Oncology Drug and China Approvals of Symptom Therapeutic Products,, 4/08/2015 091B1B-E PRN  Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis,,,,"11/02/2010 009FRV-E PRN  Quanterix Awarded $733,437 in Qualifying Therapeutic Discovery Project (QTDP) Grants",,," 5/31/2017 0FZZYY-E PRN  Homology Medicines Strengthens Manufacturing and Product Development Expertise with Appointment of Tim Kelly as Senior Vice President, Technical Operations",,,,,,,,,,, 2/24/2016 07YR31-E PRN  Forty Seven Inc. Completes $75M Series A Financing and Licenses Technology from Stanford University to Advance Next Generation Immuno-Oncology Programs,,,,,, 9/15/2019 50015M10 PRN  Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting,," 9/26/2017 00FYYJ-E PRN  Guardant Health Receives Investigational Device Exemption Approval from the FDA to Support Merck KGaA, Darmstadt, Germany Tepotinib Study",,, 1/22/2016 0DWB1Z-E PRN  WuXi Healthcare Ventures Joins Financing Rounds for Twist Bioscience and Syros Pharmaceuticals,,,,,,, 1/04/2019 0JNJRY-E PRN  Akero Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,,,,, 9/29/2014 0DMSKV-E PRN  Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board,
" 8/04/2014 53220K50 PRN  Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Updates LGND Research Report with New Material Information", 5/13/2019 74318710 PRN  Velan Implores for Improved Transparency and Real Change at Progenics Pharmaceuticals Following Q1 2019 Earnings Call, 1/04/2017 LH-US       PRN  Leading Genetic Testing Companies Join Forces to Launch the Coalition for Access to Prenatal Screening," 7/21/2014 84763A10 PRN  Biotech Stocks Scanner -- Regeneron Pharma, BioCryst Pharma, Spectrum Pharma, Exact Sciences, and Vical Inc.", 9/06/2019 G3040110 PRN  Endo Announces Submission of Biologics License Application to FDA for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite," 4/29/2015 04280A10 PRN  Critical Alerts For Arrowhead Research, Canadian Solar, 1-800 FLOWERS.COM, Maxwell Technologies and Visa Released By InvestorsObserver", 7/12/2017 09060J10 PRN  BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada) For The Licensing And Distribution Rights Of BELBUCA® In Canada,11/05/2019 09073M10    PRN  Bio-Techne To Present At The Stephens Nashville Investment Conference," 1/08/2020 75886F10    PRN  Publication Highlights Regeneron's Costimulatory Bispecific Antibodies, an Emerging Class of Cancer Immunotherapy",," 9/11/2018 68375N10 PRN  Hagens Berman Alerts Investors in OPKO Health (OPK) to the Firm's Investigation of Possible Disclosure Violations Related to Alleged ""Pump-and-Dump"" Scheme","10/23/2019 46222210 PRN  Ionis Chairman and CEO Stanley T. Crooke, M.D., Ph.D. to receive Massry Prize for contributions to biomedical sciences","11/12/2019 09061G10   PRN  BioMarin to Participate in Jefferies London Healthcare Conference on November 21, 2019","10/12/2016 01535110 PRN  Biotech Stocks on Investors' Radar -- Alexion Pharma, PDL BioPharma, BioCryst Pharma, and Cara Therapeutics", 8/28/2019 64125C10 PRN  Neurocrine Biosciences to Present at Upcoming Healthcare Conferences,11/08/2017 81257810 PRN  Astellas and Seattle Genetics Initiate Phase 1b Trial of Enfortumab Vedotin in Combination with Immune Checkpoint Inhibitor Therapies in Locally Advanced or Metastatic Urothelial Cancer," 6/10/2016 45290710 PRN  Block & Leviton LLP Files Class Action Lawsuit Against Immunomedics, Inc., Alleging Violations Of The Federal Securities Laws", 6/05/2018 09062X10  PRN  Ionis Closes Strategic Collaboration with Biogen to Develop Drugs for a Broad Range of Neurological Diseases,"10/15/2014 45253H10 PRN  Technical Scrutiny on Health Care Sector Stocks - ImmunoGen, Arrowhead Research, Chimerix, Tekmira Pharma, and Celgene","10/27/2014 09058V10 PRN  Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon","10/03/2018 37555810   PRN  Hong Kong Department of Health Approves Biktarvy(R) (bictegravir, emtricitabine, tenofovir alafenamide)",10/28/2019 04004760   PRN  Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis,"10/24/2019 N5946510  PRN  Mylan to Release Third Quarter 2019 Financial Results on Nov. 5, 2019",11/05/2019 M2572210 PRN  Compugen Presents Preclinical Data for COM902 Anti-TIGIT Program at SITC 2019," 1/04/2018 0F98BD-E PRN  Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of Akorn, Inc.",12/11/2019 03116210 PRN  Amgen Announces 10% Increase In 2020 First Quarter Dividend," 3/15/2018 62855J10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Myriad Genetics, Inc. (MYGN)", 8/01/2017 52887230 PRN  Lexicon Pharmaceuticals Reports Second Quarter 2017 Financial Results And Provides A Business Update,,10/30/2019 45766930 PRN  Insmed Reports Third Quarter 2019 Financial Results and Provides Business Update,," 3/02/2020 45773H20 PRN  Inovio Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020",10/07/2019 64026810 PRN  Nektar Therapeutics Announces Initiation of Two Clinical Studies of Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Psoriasis and Atopic Dermatitis, 5/31/2019 76655960 PRN  Rigel to Present at Jefferies 2019 Healthcare Conference, 4/29/2015 37416310 PRN  Harwood Feffer LLP Announces Investigation of Geron Corporation,," 2/05/2015 02311120 PRN  Coverage of Biotech Equities -- Amarin, Cytori Therapeutics, Medivation, Sangamo BioSciences, and Immunomedics", 9/14/2017 45337C10 PRN  Baricitinib Meets Primary Endpoint in Phase 2 Study of Patients with Moderate-to-Severe Atopic Dermatitis, 5/28/2019 91307C10 PRN  United Therapeutics Corporation To Present at Jefferies 2019 Healthcare Conference,"12/30/2015 80360710 PRN  Covered Call Alerts For Frontier Communications Corp, Whiting Petroleum, BP, Sarepta Therapeutics and Alibaba Released By InvestorsObserver",10/07/2019 G0176710 PRN  Alkermes Presents New Health Economics and Outcomes Research on Patients With Schizophrenia and Bipolar I Disorder at 2019 Psych Congress,, 9/29/2014 0D8QKN-E PRN  Lumara Health™ to be Acquired in Two Separate Transactions for up to $1.107 Billion,, 7/31/2019 55027E10 PRN  Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend, 2/07/2019 80067710 PRN  Sangamo Announces Interim Results Of Phase 1/2 CHAMPIONS Study Showing Preliminary Evidence Of In Vivo Genome Editing In Patients With MPS II Treated With SB-913," 7/05/2016 30161Q10 PRN  InvestorsObserver releases covered-call reports for 3D Systems, Exelixis, Caterpillar Inc., Barrick Gold Corporation and Priceline","10/15/2019 80105N10  PRN  Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing"," 8/14/2015 92532F10  PRN  Critical Alerts For Ambarella, Wayfair Inc., Vertex Pharmaceuticals, Perrigo Co. and CyberArk Software Released By InvestorsObserver",, 8/31/2016 04351P10 PRN  Ascendis Pharma A/S Reports Second Quarter 2016 Financial Results and Provides Business Update," 6/22/2015 09609G10 PRN  Critical Alerts For Seadrill, Intrexon, bluebird bio Inc., El Pollo Loco and Intercept Pharmaceuticals Released By InvestorsObserver"," 8/12/2016 00422510 PRN  Covered Call reports for Micron, Macy's Incorporated, International Business Machines, ACADIA Pharmaceuticals and Suncor Energy include trade ideas that offer returns of 20% or more!",, 6/18/2019 74366E10 PRN  Protagonist Therapeutics Reports Granting of Inducement Award,," 5/08/2015 88338N10 PRN  Morning Analysis on Pharma Equities -- Teva Pharma Industries, Hospira, Depomed, TherapeuticsMD, and Pernix Therapeutics Holdings"," 8/21/2014 98978L20    PRN  Pharma Stocks Review -- Eli Lilly, Zogenix, GlaxoSmithKline, Novo Nordisk, and Valeant Pharma Intl.",, 8/18/2015 68214310 PRN  Omeros Announces Additional Positive Data in OMS721 Phase 2 Clinical Trial,,," 7/14/2014 46333X10 PRN  Scheduled Conference Calls and Managements Changes - Analyst Notes on Spectranetics, Charles River, Chemed, WuXi PharmaTech and Ironwood Pharmaceuticals",, 4/23/2012 00D326-E PRN  Ultragenyx Relocates Company Headquarters to Support Operational Expansion,,, 8/07/2019 69329Y10 PRN  PDL BioPharma Reports 2019 Second Quarter Financial Results,,,,"10/02/2019 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg","12/22/2014 29251M10 PRN  Rewards Outweigh Risk for Long-Term Equity Players: Featured Research on Pier 1 Imports, CarMax, Transocean, Enanta and Aratana","11/10/2015 02043Q10 PRN  Covered Call Alerts For Skechers, Isis Pharmaceuticals, Alnylam Pharmaceuticals, ConocoPhillips and Apache Corporation Released By InvestorsObserver",, 3/04/2016 0017CR-E PRN  Akcea Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference, 5/30/2019 60468T10 PRN  Mirati Therapeutics To Present At Jefferies 2019 Global Healthcare Conference," 1/10/2014 69512710 PRN  Healthcare Companies Report Stock Price Movement, Conference Call Schedules, Study Results, and Presentations - Research Report on Merck, Keryx Biopharma, Pacira, Ligand Pharma, and Dyax",, 6/17/2010 003V5M-E PRN  Gen-Probe Makes $50 Million Strategic Investment in Third Generation Sequencing Company Pacific Biosciences,, 7/23/2012 07Y4QW-E PRN  Chiasma Closes $38.5 Million Equity Financing, 5/23/2012 07Z03J-E PRN  New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments,10/28/2019 09627Y10 PRN  Blueprint Medicines Announces FDA Intent to Split Avapritinib New Drug Application into Separate Submissions for PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST,, 5/17/2019 28249U10 PRN  Eiger BioPharmaceuticals Announces Transition of Chief Operating Officer and Executive Medical Officer,12/17/2013 008H33-E PRN  AnaptysBio Announces Antibody Development Agreement With Momenta,,,,,, 8/19/2019 92165910 PRN  Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag Disorder,,, 4/04/2017 45781M10   PRN  Sarissa Capital Believes That Innoviva's Recent Statements Reinforce That Innoviva Is Being Run for the Benefit of Management and Not Shareholders,10/27/2010 005XF5-E PRN  ChemoCentryx Reports One-Year Results from PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Treating Patients with Crohn's Disease at the United European Gastroenterology Federation (UEGW) Meeting, 7/23/2019 40637H10 PRN  Halozyme To Host Second Quarter 2019 Financial Results Webcast And Conference Call, 8/21/2018 G2151510 PRN  China Biologic Announces Receipt of Competing Non-Binding Acquisition Proposal,"10/12/2015 56400P70 PRN  Critical Alerts For Linn Energy, Autodesk, Palo Alto Networks, Exelixis and MannKind Released By InvestorsObserver",,," 6/18/2015 29664W10 PRN  Critical Alerts For Esperion Therapeutics, Ambarella, Horizon Pharma, Universal Display Corporation and Vale Released By InvestorsObserver",12/17/2019 03236M20 PRN  WWD Beauty Inc Names Biossance Brand Digital Innovator Of The Year,11/19/2019 69366J20 PRN  PTC Therapeutics to Present at the Evercore ISI 2nd Annual HealthCONx Conference," 5/08/2015 00448Q20 PRN  Critical Alerts For Yelp, SunEdison, Adobe Systems, Achillion Pharmaceuticals and El Pollo Loco Released By InvestorsObserver","11/09/2017 87166B10 PRN  INC Research (INCR) Alert: Johnson Fistel Investigates INC Research Holdings, Inc.; Investors Suffering Losses Encouraged to Contact Firm"," 8/25/2014 03152W10 PRN  Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo",,,," 7/26/2018 36197T10 PRN  Free Technical Briefing on Drug Makers Stocks -- GW Pharma, AbbVie, AstraZeneca, and Bristol-Myers Squibb", 2/27/2014 29428V10 PRN  Epizyme Announces 2013 Operating and Financial Results and Provides 2014 Guidance, 9/25/2019 G5087110 PRN  Jazz Pharmaceuticals Presents Positive JZP-258 Phase 3 Study Data at World Sleep 2019,, 2/07/2019 00394S-E PRN  Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System,,12/08/2019 73701010 PRN  Portola Pharmaceuticals Presents New Interim Data from Ongoing Phase 2a Study of its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated T-Cell Malignancies," 2/15/2017 92337F10 PRN  Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2016 Financial Results on Wednesday, March 1, 2017",," 3/08/2011 063J3K-E PRN  Cellectis and the Etablissement Francais du Sang Launch StemRed, a Program to Produce Red Blood Cells From Stem Cells", 9/26/2017 14075510 PRN  Legal and Medical Cannabis Market Expected to Show Strong Growth,,," 7/23/2014 00847X10 PRN  Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx"," 4/11/2017 46226010 PRN  LION NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Lion Biotechnologies, Inc. To Contact The Firm", 4/06/2015 008H33-E PRN  AnaptysBio Recruits Dr. Gerrit Los to Lead Translational Biology,,,"11/11/2015 G4618810 PRN  INVESTOR ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Horizon Pharma plc and Certain Officers and Directors-- HZNP",," 3/24/2015 45845P10 PRN  Critical Alerts For Canadian Solar, Intrexon, Intercept Pharmaceuticals, Amazon.com, Caesars Entertainment, AutoZone, Qlogic, Darden Restaurants, AbbVie and NTELOS Released By InvestorsObserver", 5/08/2012 0844XQ-E PRN  Karyopharm Therapeutics Announces Appointment of Co-founder Dr. Ronald DePinho to the National Academy of Sciences,, 5/07/2018 98401F10 PRN  Xencor Reports First Quarter 2018 Financial Results," 3/03/2014 46116X10 PRN  Intra-Cellular Therapies Announces Initiation of Phase I/II Clinical Trial for ITI-007 in Healthy Geriatric Subjects and Patients with Dementia, Including Alzheimer's Disease", 7/25/2019 G8807B10 PRN  Theravance Biopharma to Report Second Quarter 2019 Financial Results on July 31,11/21/2013 079TK4-E PRN  Novocure Announces Launch of the inovitro™ Lab Research System," 3/14/2019 03969710 PRN  Ardelyx Appoints Renowned Nephrologist, Geoffrey A. Block, M.D., to Its Board of Directors",,,,, 5/01/2017 M4613510 PRN  Foamix Pharmaceuticals Announces Plans for Additional Phase 3 Trial for FMX101 in Moderate to Severe Acne, 8/19/2011 001THX-E PRN  PRA Strengthens Psychiatry Capabilities,,," 9/21/2016 74587V10 PRN  Gilead Sciences, Puma Biotechnology, Yum! Brands, Vmware, and McDonald's and more offer option-trading opportunities that offer returns of more than 20%",, 5/16/2017 21833P10 PRN  Legal Cannabis and CBD Markets Grow in the United States, 4/01/2019 05070R10 PRN  Audentes Therapeutics Appoints Legal and Corporate Communications Executives; Promotes Thomas P. Soloway to Executive Vice President and Chief Financial Officer,,," 9/22/2014 06S6MV-E PRN  Seres Health Named a ""Fierce 15"" Biotech Company for 2014",,, 7/24/2019 75901B10 PRN  REGENXBIO Expands Pipeline Using NAV Vectors to Deliver Therapeutic Antibodies for the Treatment of Hereditary Angioedema and Neurodegenerative Diseases,,,,,,,,10/13/2015 07DMQP-E PRN  Savolitinib Completes Enrolment for Phase II Clinical Trial in Papillary Renal Cell Carcinoma,,,,,10/25/2012 07N3G8-E PRN  arGEN-X Appoints Dr. David L. Lacey to its Supervisory Board,,12/14/2015 00695P-E  PRN  Athenex Announces Recent Business Developments Including the Acquisition of Comprehensive Drug Enterprises,,"12/11/2014 00FMDK-E PRN  Rhythm Appoints Fred T. Fiedorek, M.D., Chief Medical Officer",,,, 5/23/2010 009FRV-E PRN  Groundbreaking Study Published in Nature Biotechnology Demonstrates Sensitivity of Single Molecule Test for Detection of Prostate Cancer,,," 5/15/2017 0FZZYY-E PRN  Homology Medicines Presents Data Demonstrating Highly Efficient, On-Target In Vivo Gene Editing Capabilities of its Novel Human-Derived Adeno-Associated Virus Vectors",,,,,,,,,,,,,,,,, 9/12/2019 50015M10 PRN  Kodiak Sciences to Release Durability Data from Clinical Development Program of KSI-301 for wet AMD at The Retina Society Annual Meeting,, 6/27/2017 00FYYJ-E PRN  New Studies Demonstrate the Need for and Utility of Comprehensive Liquid Biopsies,,, 1/19/2016 00FLML-E PRN  Twist Bioscience Completes $61 Million Series D Financing And $20 Million Debt Facility,,,,,,,"12/12/2018 0JNJRY-E PRN  Akero Therapeutics Announces $70 Million in New Financing to Advance Therapeutic Pipeline for NASH, Serious Metabolic Diseases",,,,," 9/17/2014 0DMSKV-E PRN  Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer",
 7/17/2014 53220K50 PRN  Lemelson Capital Management Announces TTM and Second Quarter 2014 Performance Results for The Amvona Fund, 5/08/2019 74318710 PRN  Velan Calls for Increased Transparency at Progenics Pharmaceuticals During Q1 Earnings Call,"12/23/2016 45232710    PRN  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Illumina, Inc. To Contact The Firm Before Lead Plaintiff Deadline"," 7/14/2014 84763A10 PRN  Upcoming Conference Calls, FDA Approvals, NDA Updates, and Donations - Analyst Notes on The Medicines Company, Bio-Rad, Spectrum Pharmaceuticals, Insys Therapeutics and Hanger"," 9/05/2019 05MP83-E PRN  Endo Announces Execution of Final Settlement Agreement and Release Resolving ""Track 1"" Opioid Cases"," 4/29/2015 04280A10 PRN  Technical Data on Biotech Stocks - ZIOPHARM Oncology, Arrowhead Research, Alkermes, CytRx, and OvaScience", 6/23/2017 09060J10 PRN  BioDelivery Sciences Announces Health Canada Approval of BELBUCA®,10/29/2019 09073M10    PRN  Bio-Techne Releases First Quarter Fiscal 2020 Results,12/20/2019 75886F10    PRN  Regeneron Announces Presentation at the 38th Annual J.P. Morgan Healthcare Conference,, 7/31/2018 68375N10 PRN  Specialty Oncology Drugs One of the Top Markets Generating Most Growth,10/22/2019 46222210 PRN  Ionis Pharmaceuticals to hold third quarter 2019 financial results webcast,11/06/2019 09061G10   PRN  BioMarin to Highlight Innovative Development Pipeline at R&D Day on November 14th," 6/07/2016 01535110 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alexion Pharmaceuticals, Inc. - ALXN", 8/05/2019 64125C10 PRN  AbbVie Submits New Drug Application to US FDA for Investigational Elagolix for Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Women,10/10/2017 81257810 PRN  Astellas and Seattle Genetics Initiate Pivotal Trial of Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer," 5/25/2016 45290710 PRN  Why These Biotech Stocks Have Been on Investors' Radar? - Juno Therapeutics, Immunomedics, Ultragenyx Pharma, and Intercept Pharma", 6/05/2018 00167Y-E  PRN  Phase II Clinical Study Of Elenbecestat Demonstrates Safety And Tolerability In MCI And Mild To Moderate Alzheimer's Disease At 18-Months," 9/25/2014 45253H10 PRN  Critical Alerts For Best Buy, Green Dot, Schlumberger, ImmunoGen and Intuitive Surgical Released By InvestorsObserver","10/02/2014 09058V10 PRN  Critical Alerts For Alibaba, BioCryst Pharmaceuticals, Trina Solar Limited, Vipshop Holdings and Visa Released By InvestorsObserver",10/02/2018 37555810   PRN  Personalized Immunotherapy Could be the Future for Advanced Breast Cancer Treatment,10/22/2019 04004760   PRN  Arena Pharmaceuticals Presented New Data Analyses Demonstrating the Long-Term Safety and Efficacy of Once-Daily Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis at UEG Week,10/21/2019 N5946510  PRN  Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting,11/05/2019 M2572210 PRN  Compugen Presents Initial Clinical Data from Ongoing Phase 1 Trial of COM701 in Patients with Advanced Solid Tumors at SITC 2019," 7/07/2017 00972810 PRN  Johnson & Weaver, Announces Investigations of Omega Protein Corporation, Monogram Residential Trust, Inc. and Akorn, Inc.; Investors Encouraged to Contact Firm",12/10/2019 03116210 PRN  Amgen Data From Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) To Be Presented During Late-Breaking Session At American Society Of Hematology Annual Meeting," 3/15/2018 001D3K-E PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myriad Genetics, Inc. - MYGN", 7/31/2017 52887230 PRN  Lexicon Pharmaceuticals Announces Opt-In Decision For U.S. Co-Promotion Of Sotagliflozin With Sanofi In Type 1 Diabetes,,"10/23/2019 45766930 PRN  Insmed to Host Third Quarter 2019 Financial Results Conference Call on Wednesday, October 30, 2019",," 2/10/2020 45773H20 PRN  Inovio Receives Authorization from the U.S. FDA To Begin Phase 1/2 Clinical Trial for INO-3107, a DNA Medicine To Treat a Rare Disease -- Recurrent Respiratory Papillomatosis (RRP)",10/02/2019 64026810 PRN  Nektar Therapeutics Announces Five Abstracts Accepted for Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting, 5/16/2019 76655960 PRN  Rigel Enrolls First Patient in Phase 3 Clinical Trial of Fostamatinib Disodium Hexahydrate in Warm Autoimmune Hemolytic Anemia," 4/24/2015 37416310 PRN  Biotech Equity Movers and Shakers -- Orexigen Therapeutics, Geron, Exelixis, XOMA Corp., and BioLine RX",,"12/17/2014 02311120 PRN  Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris", 8/30/2017 45337C10 PRN  Lilly to File Baricitinib Resubmission to U.S. FDA before end of January 2018, 5/07/2019 91307C10 PRN  United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin®,"12/16/2015 80360710 PRN  Covered Call Alerts For Frontier Communications Corp, GW Pharmaceuticals, Lumber Liquidators, Sarepta Therapeutics and Relypsa Released By InvestorsObserver", 9/26/2019 G0176710 PRN  Alkermes to Present at the Cantor Fitzgerald Global Healthcare Conference,," 3/06/2014 AMAG-US  PRN  Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare",," 7/11/2019 55027E10 PRN  Luminex Corporation Second Quarter Earnings Release Scheduled for July 31, 2019", 2/07/2019 80067710 PRN  Sangamo Announces Interim Results Of Phase 1/2 EMPOWERS Study Evaluating SB-318 Zinc Finger Nuclease (ZFN) In Vivo Genome Editing Demonstrating Increased Leukocyte IDUA Activity In Patients With MPS I,"12/28/2015 30161Q10 PRN  Covered Call Alerts For Fitbit, Keryx Biopharmaceuticals, SolarEdge Technologies, Chipotle Mexican Grill and Exelixis Released By InvestorsObserver", 9/30/2019 80105N10  PRN  New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer," 7/31/2015 92532F10  PRN  Critical Alerts For Linn Energy, Bank of America, Netflix, General Electric and Vertex Pharmaceuticals Released By InvestorsObserver",, 8/19/2016 04351P10 PRN  Ascendis Pharma A/S to Report Second Quarter 2016 Financial Results and Host Conference Call on August 31," 5/20/2015 09609G10 PRN  Critical Alerts For BlackBerry, Noble Corporation, bluebird bio Inc., Twitter and Take-Two Interactive Released By InvestorsObserver"," 8/02/2016 00422510 PRN  InvestorsObserver releases covered-call reports for OPKO Health, ACADIA Pharmaceuticals, Whiting Petroleum, VMware and Jabil Circuit",, 6/17/2019 74366E10 PRN  Protagonist Therapeutics to Present at the BMO 2019 Prescription for Success Healthcare Conference,," 4/02/2015 88338N10 PRN  Technical Commentary on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Depomed, TherapeuticsMD, and Aoxing Pharma"," 7/22/2014 98978L20    PRN  Technical Coverage on Pharma Stocks -- GlaxoSmithKline, TherapeuticsMD, AstraZeneca, Zogenix, and Novartis",, 8/17/2015 OMER-US  PRN  Omeros Announces Plan to File Infringement Suit Against ANDA Filer,,," 7/01/2014 46333X10 PRN  Pre-Market Review on Health Care Sector Equities -- Research on Dyax, Repligen, Vanda Pharma, and Ironwood Pharma",," 4/18/2012 00D326-E PRN  Ultragenyx Appoints Shalini Sharp as Chief Financial Officer and Senior Vice President, Finance",,, 8/05/2019 69329Y10 PRN  Evofem Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update,,,," 9/11/2019 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL",11/21/2014 29251M10 PRN  CHMP Grants Positive Opinions of AbbVie's VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe," 9/24/2015 AGEN-US  PRN  Health Care Stocks Technical Review -- Agenus, Esperion Therapeutics, BioScrip, Affymetrix and Alnylam Pharmaceuticals",, 1/19/2016 ISIS-US  PRN  Akcea Therapeutics Appoints Louis St. L. O'Dea as Chief Medical Officer, 4/29/2019 60468T10 PRN  Mirati Therapeutics Reports First Quarter 2019 Financial Results,"12/30/2013 69512710 PRN  Healthcare Companies Report Board Changes, FDA Approvals, and Conference Call Schedules - Research Report on Quest Diagnostics, Supernus Pharma, Puma Biotechnology, Pacira, and ResMed",,,, 6/26/2012 007MPF-E PRN  Data on Investigational Oral Octreolin™ for Acromegaly Demonstrate Growth Hormone Suppression,12/20/2011 05LJZC-E PRN  MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim, 8/28/2019 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences in September,, 5/09/2019 28249U10 PRN  Eiger BioPharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update,"10/23/2013 60877T10 PRN  Healthcare Sector Announced Clinical Data Presentation, Upcoming Financial Release Schedules and Updates on New Drug Applications - Research Report on Alexion, Pacira, pSivida, Momenta and Impax",,,,,, 7/31/2019 92165910 PRN  Vanda Pharmaceuticals Reports Second Quarter 2019 Financial Results,,, 3/29/2017 45781M10   PRN  Sarissa Capital Responds To Innoviva's Many Misstatements," 9/21/2010 005XF5-E PRN  ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD)", 7/19/2019 HALO-US  PRN  Halozyme Announces Janssen Submits Extension Application To European Medicines Agency For Subcutaneous Formulation Of DARZALEX® Utilizing ENHANZE® Technology, 8/13/2018 G2151510 PRN  China Biologic Names Bing Li as New CEO," 9/30/2015 56400P70 PRN  Scanning the Pulse of the Healthcare Stocks - ZIOPHARM Oncology, VIVUS, Keryx Biopharmaceuticals, MannKind and Ovascience",,," 5/28/2015 29664W10 PRN  Critical Alerts For Juno Therapeutics Inc, Broadcom, Eli Lilly, Esperion Therapeutics and World Wrestling Entertainment Released By InvestorsObserver","12/12/2019 03236M20 PRN  SHAREHOLDER NOTICE: Scott+Scott Attorneys at Law LLP Continues Investigating Amyris, Inc.'s Directors and Officers for Breach of Fiduciary Duty - AMRS",11/18/2019 69366J20 PRN  PTC Therapeutics Launches A No-Cost Testing Program to Drive AADC Deficiency Patient Identification," 4/17/2015 00448Q20 PRN  Critical Alerts For Tesla Motors, Alcoa, Halliburton, Achillion Pharmaceuticals and Amazon.com Released By InvestorsObserver"," 4/27/2017 87166B10 PRN  Technical Roundup on Research Services Stocks -- Myriad Genetics, QIAGEN, INC Research, and Bioanalytical Systems"," 8/13/2014 03152W10 PRN  Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics",,,, 6/13/2018 36197T10 PRN  International Cannabis Legalization to Spur Global Medical and Recreational Sales," 2/27/2014 29428V10 PRN  Epizyme Achieves Lead Candidate Selection Milestone in GSK Collaboration, Earning $2 Million Milestone", 8/27/2019 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences,," 1/23/2019 RIGL-US  PRN  Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe",,11/15/2019 73701010 PRN  Andexxa Highlighted as a First-Line Factor Xa Reversal Option by the American College of Emergency Physicians, 2/08/2017 92337F10 PRN  Veracyte to Expand Patient Access to the Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement with Quest Diagnostics,, 2/28/2011 063J3K-E PRN  Cellectis bioresearch Makes Genome Engineering Affordable for All Users, 9/19/2017 14075510 PRN  Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects,,," 7/02/2014 00847X10 PRN  Orphan Drug Designations, Financial Results, Board Elections, and Raised Financial Guidance - Analyst Notes on Agios, Alder, Healthways, NeoGenomics and Sequenom"," 7/21/2016 46226010 PRN  Biotechnology Stocks Technical Data -- EPIRUS Biopharma, Ampio Pharma, Spark Therapeutics, and Lion Biotechnologies",10/20/2014 008H33-E PRN  AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement,,,"11/06/2015 G4618810 PRN  Covered Call Alerts For Frontier Communications Corp, SolarEdge Technologies, Horizon Pharma, ABIOMED and Second Sight Medical Products Inc. Released By InvestorsObserver",," 3/03/2015 45845P10 PRN  Critical Alerts For Celgene, Aeropostale, NXP Semiconductors, Deutsche Bank and Intercept Pharmaceuticals Released By InvestorsObserver", 3/07/2012 0844XQ-E PRN  Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting,, 5/02/2018 98401F10 PRN  Xencor to Present at Deutsche Bank 43rd Annual Health Care Conference, 2/26/2014 46116X10 PRN  Intra-Cellular Therapies to Present at the Cowen and Company 34th Annual Healthcare Conference, 7/22/2019 G8807B10 PRN  Theravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Oral Presentation at 32nd European Neurology Congress,11/19/2013 079TK4-E PRN  Novocure Enrolls First Patients in a Randomized Trial of NovoTTF™ Therapy for Patients with Brain Metastases from Non-Small Cell Lung Cancer, 3/07/2019 03969710 PRN  Ardelyx Announces Peer-Reviewed Publication of Positive Phase 3 Results of Tenapanor for the Treatment of Hyperphosphatemia in the Journal of the American Society of Nephrology,,,,, 4/27/2017 M4613510 PRN  Foamix Pharmaceuticals to Present at the 42nd Annual Deutsche Bank Health Care Conference, 7/12/2011 001THX-E PRN  PRA Expands Operations in the Balkan Region,,," 8/22/2016 74587V10 PRN  Research Report Initiation on Biotech Stocks -- PTC Therapeutics, Grifols, Puma Biotech, and 22nd Century",," 5/03/2017 21833P10 PRN  Lifshitz & Miller LLP Announces Investigation of Bingo Nation Inc., BofI Holding, Inc., Corbus Pharmaceuticals Holdings, Inc., Lion Biotechnologies, Inc., NewLink Genetics Corporation, Power Solutions International, Inc., Walter Investment Management Corp. and XBIOTECH INC.", 3/08/2019 05070R10 PRN  Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,, 9/08/2014 0CT325-E PRN  Seres Health Presents Final Data for Study of SER-109 in Recurrent Clostridium difficile Infection at ICAAC 2014 Conference,,, 7/24/2019 75901B10 PRN  REGENXBIO and Neurimmune Announce Collaboration to Develop Vectorized Antibodies for the Treatment of Neurodegenerative Diseases,,,,,,,,"10/08/2015 44842L10 PRN  Perrigo, Hain Celestial And Hutchison China MediTech Bring Earth's Best Organic® Infant Formula To $16.5 Billion China Formula Market",,,,,"10/04/2012 07N3G8-E PRN  RuiYi (formerly Anaphore) and arGEN-X Announce Exclusive Worldwide License Agreement for ARGX-109, a Novel anti-IL-6 Antibody",,"10/16/2015 00695P-E  PRN  Athenex Completes Public/Private Partnership Agreement With Chongqing, China To Construct Two New Pharmaceutical Manufacturing Plants",,"10/22/2014 091B1B-E PRN  Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin",,,,,,, 4/24/2017 0FZZYY-E PRN  Homology Medicines Announces Four Presentations on its Gene Editing and Gene Therapy Platform at the American Society of Gene & Cell Therapy Meeting,,,,,,,,,,,,,,,,, 9/06/2019 50015M10 PRN  Kodiak Sciences to Present at the Morgan Stanley Global Healthcare Conference,," 6/03/2017 00FYYJ-E PRN  Guardant Health announces broad, long-term alliance with Pfizer Oncology supporting multiple clinical programs with the Guardant360 assay",,,12/01/2015 00FLML-E PRN  Emily Leproust Of Twist Bioscience Named 2015 Global Thinker By Foreign Policy Magazine,,,,,,,12/06/2018 0JNJRY-E PRN  Akero Therapeutics Appoints Mark Iwicki to its Board of Directors,,,,," 9/16/2014 0DMSKV-E PRN  Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer",
" 7/08/2014 53220K50 PRN  Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne", 5/06/2019 74318710 PRN  Velan Delivers Letter to the Board of Progenics Pharmaceuticals,"10/28/2016 45232710    PRN  Lifshitz & Miller Law Firm Announces Investigation of Alnylam Pharmaceuticals, Inc., Chesapeake Energy Corporation, Cognizant Technology Solutions Corporation, Fenix Parts, Inc., Genworth Financial, Inc., Illumina Inc., ProNAi Therapeutics, Inc., and Supreme Industries Inc."," 5/14/2014 84763A10 PRN  Biotech Companies Report Quarterly Financial Results - Analyst Notes on Intrexon, Acorda, Anika, Sangamo and Spectrum", 9/05/2019 G3040110 PRN  Endo to Present New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 American Society for Surgery of the Hand's (ASSH) Annual Meeting," 4/17/2015 04280A10 PRN  Where Are The Investors Headed: Complementary Research on Clovis Oncology, DBV Technologies, Cleveland BioLabs, Arrowhead Research and Athenahealth", 6/21/2017 CVS-US   PRN  BioDelivery Sciences Announces Agreement with CVS/Caremark for BELBUCA® and BUNAVAIL® Through 2020,10/29/2019 09073M10    PRN  Bio-Techne Declares Dividend,12/12/2019 75886F10    PRN  Society for Science & the Public Announces Regeneron as New Title Sponsor of the International Science and Engineering Fair,," 6/05/2018 68375N10 PRN  Lifshitz & Miller LLP Announces Investigation of Cadus Corporation, CYS Investments, Inc., Gener8 Maritime, Inc. KLX Inc., OPKO Health, Inc., Recro Pharma, Inc., Vectren Corporation and Xcerra Corporation",10/10/2019 46222210 PRN  Ionis' leadership in RNA-targeted therapeutics recognized at the Oligonucleotide Therapeutics Society annual meeting,10/23/2019 09061G10   PRN  BioMarin Announces Third Quarter 2019 Financial Results," 9/02/2015 01535110 PRN  Critical Alerts For Apple, United Continental Holdings, Windstream, Horizon Pharma and Alexion Pharmaceuticals Released By InvestorsObserver", 7/29/2019 64125C10 PRN  Neurocrine Biosciences Reports Second Quarter 2019 Financial Results, 6/05/2017 81257810 PRN  Astellas and Seattle Genetics Announce Updated Enfortumab Vedotin Phase 1 Data in Metastatic Urothelial Cancer at 2017 ASCO Annual Meeting," 3/19/2015 45290710 PRN  Technical Coverage on Biotech Stocks -- Cytori Therapeutics, Oncolytics Biotech, BioMarin Pharma, Aeterna Zentaris, and Immunomedics", 3/14/2018 0FYJ7K-E  PRN  Flagship Pioneering Launches Foghorn Therapeutics With Initial Capital Commitment of $50 Million," 8/21/2014 45253H10 PRN  Market Movers - Biotech Stocks -- Progenics Pharma, Rexahn Pharma, ImmunoGen, Hemispherx Biopharma, and Incyte"," 8/25/2014 09058V10 PRN  Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma"," 9/14/2018 003VXV-E   PRN  Fish & Richardson Principals Chad Shear and Jonathan Singer Named ""2018 Winning Litigators"" by The National Law Journal",10/18/2019 04004760   PRN  Arena Pharmaceuticals' Presence at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community, 9/27/2019 N5946510  PRN  Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission,11/04/2019 M2572210 PRN  Compugen Announces FDA Clearance of IND Application for COM902," 7/06/2017 00972810 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: August 21, 2017",12/09/2019 03116210 PRN  Beyond Cholesterol: Landmark deCODE Study Elucidates Role of Lipoprotein(a) as Major Risk Factor for Heart Disease," 3/15/2018 001D3K-E PRN  Scott+Scott Attorneys at Law LLP Announces Investigation into Myriad Genetics, Inc. (MYGN)"," 7/24/2017 52887230 PRN  Lexicon Pharmaceuticals To Host Second Quarter 2017 Financial Results Conference Call And Webcast On August 1, 2017",,10/07/2019 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),," 2/03/2020 45773H20 PRN  Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections",10/01/2019 64026810 PRN  Nektar Announces Key Executive Promotions, 5/07/2019 76655960 PRN  Rigel Announces First Quarter 2019 Financial Results and Provides Company Update," 3/23/2015 37416310 PRN  Technical Pulse on Biotech Stocks -- Geron, Lexicon Pharma, XOMA Corp., Spectrum Pharma, and BioLine RX",,"10/29/2014 02311120 PRN  Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin", 7/25/2017 45337C10 PRN  Lilly and Incyte Provide Update on Baricitinib, 5/01/2019 91307C10 PRN  United Therapeutics Corporation Reports First Quarter 2019 Financial Results,"10/02/2015 80360710 PRN  Critical Alerts For Micron, Sarepta Therapeutics, Transocean, Express and Intrexon Released By InvestorsObserver"," 9/13/2019 G0176710 PRN  Alkermes Announces the Appointment of Richard Gaynor, M.D. and Andy Wilson to its Board of Directors and the Retirement of Director Floyd Bloom, M.D.",," 1/10/2014 00163U10 PRN  Annual J.P. Morgan Healthcare Conference Presentations, Results of Self-Tender Offer, and Executive Appointment - Research Report on ICU Medical, Integra, Taro, AMAG, and Array BioPharma",, 7/01/2019 55027E10 PRN  Luminex Submits ARIES MRSA Assay for FDA Clearance, 2/01/2019 80067710 PRN  Sangamo Therapeutics To Host Conference Call To Review Interim Results From Phase 1/2 CHAMPIONS And EMPOWERS Studies For MPS II And MPS I,"12/11/2015 30161Q10 PRN  Covered Call Alerts For Exelixis, Alleghany Technologies, NVIDIA, Qorvo and Palo Alto Networks Released By InvestorsObserver", 9/20/2019 000VC1-E  PRN  The Lancet Publishes Results from Two Positive Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)," 7/16/2015 92532F10  PRN  Critical Alerts For Seadrill, Vertex Pharmaceuticals, Chipotle Mexican Grill, UnitedHealth and Tableau Software Released By InvestorsObserver",, 8/15/2016 04351P10 PRN  Ascendis Pharma A/S Announces R&D Update to Review Expanded Pipeline and Long-term Strategic Outlook," 5/14/2015 09609G10 PRN  Biotech Stocks Technical Analysis - Achillion Pharma, CTI BioPharma, StemCells, Progenics Pharma, and Bluebird Bio"," 7/25/2016 00422510 PRN  Learn how to target a 20% return on Tesla Motors, or get option-trade ideas on Opko Health, Activision Blizzard, Smith & Wesson and ACADIA Pharmaceuticals or any stock you choose",, 6/04/2019 74366E10 PRN  Protagonist Therapeutics Reports Granting of Inducement Award,," 9/29/2014 88338N10 PRN  Pharma Equities Technical Momentum - Provectus Biopharma, Shire, Impax Labs, Zogenix, and TherapeuticsMD"," 7/07/2014 98978L20    PRN  Kosher Certifications, Biologic License Applications, Positive Study Results, Development Programs, and Product Acquisitions - Analyst Notes on Pfizer, Novartis, Sanofi, Zogenix and Impax",, 8/10/2015 68214310 PRN  Omeros Corporation Reports Second Quarter 2015 Financial Results,,," 1/09/2014 46333X10 PRN  Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood",," 3/28/2012 00D326-E PRN  Ultragenyx Granted Orphan Designations in Europe for Two Lead Product Candidates, UX001 for HIBM and UX003 for MPS 7",,," 7/31/2019 69329Y10 PRN  PDL BioPharma to Announce Second Quarter 2019 Financial Results on August 7, 2019",,,, 8/07/2019 00182C10 PRN  ANI Pharmaceuticals Reports Second Quarter Results,11/11/2014 29251M10 PRN  AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting® 2014," 4/06/2015 BMR-US   PRN  BioMed Realty Signs Alnylam Pharmaceuticals To 295,000 Square Foot Lease For Class A Laboratory And Office Space In Cambridge",,, 4/01/2019 60468T10 PRN  Mirati Therapeutics To Present At The H.C. Wainwright & Co. Global Life Sciences Conference,"12/18/2013 69512710 PRN  Updated Estimates, Stock Movements, and Regulatory Approvals - Research Report on Quest Diagnostics, Zimmer Holdings, Pacira Pharmaceuticals, Geron, and Oculus Innovative Sciences",,,, 9/14/2011 007MPF-E PRN  Chiasma to Present at the UBS Global Life Sciences Conference,12/01/2011 05LJZC-E PRN  MacroGenics and Servier Enter Development and Commercialization Agreement for Novel Anti-Cancer Drug, 8/26/2019 0GCTXG-E PRN  CStone announces first patient dosed in China for Phase I/II registrational bridging trial of avapritinib in advanced GIST,, 4/30/2019 28249U10 PRN  Eiger to Present at ChinaBio® Partnering Forum 2019," 7/13/2012 MYL-US   PRN  The Zacks Analyst Blog Highlights: Teva Pharmaceutical, Mylan, Momenta Pharmaceuticals, General Electric and A123 Systems",,,,,," 7/22/2019 92165910 PRN  Vanda Pharmaceuticals to Announce Second Quarter 2019 Financial Results on July 31, 2019",,, 3/27/2017 45781M10   PRN  Sarissa Capital Files Presentation In Proxy Contest With Innoviva Highlighting Innoviva's Lack Of Shareholder Focus And Poor Corporate Governance, 6/17/2010 005XF5-E PRN  ChemoCentryx Reports Positive Phase I Study Results for CCX354 at the Annual European Congress of Rheumatology (EULAR), 7/17/2019 40637H10 PRN  Halozyme Announces First Clinical Dosing In argenx's Phase 1 Trial Of Efgartigimod (ARGX-113) With ENHANZE® Drug Delivery Technology, 8/03/2018 G2151510 PRN  China Biologic Reports Financial Results for the Second Quarter of 2018," 9/23/2015 SGMO-US  PRN  Technical Briefing on Biotechnology Equities -- MannKind, Novavax, Incyte, BioMarin Pharma, and Sangamo Biosciences",,," 5/15/2015 29664W10 PRN  Critical Alerts For Under Armour, Cal-Maine Foods, Opko Health, Microsoft and Esperion Therapeutics Released By InvestorsObserver",12/12/2019 03236M20 PRN  Amyris Launches Purecane™ Brand Sweetener Direct to Consumers,11/11/2019 69366J20 PRN  Risdiplam (RG7916) Pivotal SUNFISH Study Demonstrates Statistically Significant Improvement for Patients with Type 2/3 Spinal Muscular Atrophy," 3/25/2015 00448Q20 PRN  Critical Alerts For Sonic, Ross Stores, Potbelly, Achillion Pharmaceuticals and Keryx Biopharmaceuticals Released By InvestorsObserver"," 3/29/2017 87166B10 PRN  Gartner Set to Join S&P 500; Dun & Bradstreet, Wintrust Financial and INC Research to Join S&P MidCap 400; Heska to Join S&P SmallCap 600"," 7/30/2014 03152W10 PRN  Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis",,,, 5/30/2018 36197T10 PRN  5 Companies Using Tech to Transform the Cannabis Industry, 2/21/2014 29428V10 PRN  Epizyme Announces Publication of Preclinical Data Demonstrating Clinical Candidate EPZ-6438 as Potent and Selective Inhibitor of EZH2 in Genetically Defined Non-Hodgkin Lymphoma," 8/12/2019 G5087110 PRN  Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.",," 1/08/2019 00394S-E PRN  Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions",,11/06/2019 73701010 PRN  Portola Pharmaceuticals to Present Multiple Abstracts at the 61st American Society of Hematology (ASH) Annual Meeting, 2/06/2017 92337F10 PRN  Veracyte Announces Final Medicare Coverage Policies for Percepta® Bronchial Genomic Classifier,, 1/25/2011 063J3K-E PRN  Cellectis bioresearch First to Launch Revolutionary Custom TAL Nuclease Service, 9/07/2017 14075510 PRN  Legal and Medical Cannabis Market Investments on the Rise,,," 5/19/2014 06W57R-E PRN  Business Highlights, Financial Results, and Leadership Appointments - Analyst Notes on PDL BioPharma, bluebird, Osiris, Agios and Ophthotech", 6/15/2016 09N40F-E PRN  TroyGould Closes $100 Million Lion Biotech Deal, 9/08/2014 008H33-E PRN  Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibody Program from AnaptysBio,,,11/03/2015 HZNP-IE  PRN  ISS and Glass Lewis Recommend Horizon Pharma Shareholders Vote AGAINST the Issuance of Horizon Shares in Connection with Horizon's Attempted Takeover of Depomed,," 2/02/2015 45845P10 PRN  Critical Alerts For Zynga, Intercept Pharmaceuticals, Biogen, Nabors Industries and CyberArk Software Released By InvestorsObserver",11/08/2011 06QBQ2-E PRN  Karyopharm Therapeutics Announces Presentations by Seven Collaborators Showing Major Progress in Advancing Selective Inhibitors of Nuclear Export (SINE) for Hematologic Malignancies at American Society of Hematology (ASH) Meeting,," 4/30/2018 98401F10 PRN  Xencor to Host First Quarter 2018 Financial Results Webcast and Conference Call on May 7, 2018", 2/07/2014 46116X10 PRN  Intra-Cellular Therapies to Present at Two Upcoming Healthcare Conferences, 6/18/2019 G8807B10 PRN  Theravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Presentation at 2019 International Association of Parkinsonism and Related Disorders (IAPRD) World Congress,11/18/2013 079TK4-E PRN  Novocure to Present Fifteen Abstracts Describing Latest Aspects of NovoTTF™ Therapy at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO), 3/06/2019 03969710 PRN  Ardelyx Reports Fourth Quarter 2018 Financial Results and Recent Highlights,,,,," 4/26/2017 M4613510 PRN  Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled for Tuesday, May 10", 6/15/2011 001THX-E PRN  PRA International Expands Scandinavian Operations,,," 6/08/2016 GRF-ES   PRN  Biotechnology Equities Technical Notes -- Grifols, Achillion Pharma, Jazz Pharma, and Puma Biotechnology",, 4/05/2017 21833P10 PRN  The Legal Cannabis Market Growth in North America," 2/28/2019 05070R10 PRN  Audentes Therapeutics Recognizes Rare Disease Day by Launching ""Be Bold for Courageous Patients"" Program to Support Patients Living with Rare Diseases",,, 8/28/2014 0CT325-E PRN  Seres Health to Present Clinical Findings at ICAAC 2014 Conference,,, 6/11/2019 75901B10 PRN  REGENXBIO to Present at the Raymond James 2019 Life Sciences and MedTech Conference,,,,,,,, 9/14/2015 HCM-HK   PRN  Fruquintinib Phase II Clinical Results in Colorectal Cancer to be Presented at the 2015 European Cancer Congress,,,,, 3/19/2012 07N3G8-E PRN  arGEN-X Appoints Alain Thibault as Chief Medical Officer and Koos Rasser as IP Counsel,, 5/18/2015 00695P-E  PRN  Kinex Completes Largest Private Placement Equity Raise in its History to Support the Company's Global Manufacturing Strategy,,,,,,,,, 4/20/2017 0FZZYY-E PRN  Homology Medicines to Present at the Alliance for Regenerative Medicine's Cell & Gene Therapy Investor Day,,,,,,,,,,,,,,,,, 9/04/2019 50015M10 PRN  Kodiak Sciences Announces Upcoming Presentations at EURETINA Meeting,, 5/24/2017 00FYYJ-E PRN  New York State Issues Approval for the Guardant360 Assay,,,11/24/2015 00FLML-E PRN  Twist Bioscience To Present At The 2015 Piper Jaffray Healthcare Conference,,,,,,,10/17/2018 0JNJRY-E PRN  Akero Therapeutics Expands Leadership Team,,,,," 7/08/2014 0DMSKV-E PRN  Veteran Microsoft Executive and Distinguished Engineer, Sean Nolan, joins Adaptive Biotechnologies as Chief Technology Officer",
" 7/07/2014 53220K50 PRN  Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Appends its LGND Research Report", 4/26/2018 74318710 PRN  Developments in the Medical Imaging Market, 9/19/2016 NLS-US      PRN  Simplexity Opens Bay Area Office,"12/25/2013 84763A10 PRN  Stock Price Movements, New Drug Applications, and Public Offerings - Research Report on Impax, Volcano, Spectrum, XOMA, and Insulet", 9/04/2019 0650LH-E PRN  Endo Announces Approval of First Generic Orfadin® in U.S.," 4/02/2015 04280A10 PRN  Critical Alerts For Inovio Pharmaceuticals, Arrowhead Research, 3D Systems, Stratasys and Pixelworks Released By InvestorsObserver", 6/01/2017 09060J10 PRN  BioDelivery Sciences to Present at the Jefferies 2017 Healthcare Conference and the William Blair 2017 Growth Stock Conference,10/28/2019 09073M10    PRN  Bio-Techne Announces Investment For New GMP Manufacturing Facility,12/12/2019 75886F10    PRN  Regeneron and Cold Spring Harbor Laboratory Unveil New Dedicated Laboratories for Student Science Education,," 5/21/2018 68375N10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OPKO Health, Inc.  - OPK",10/09/2019 IONS-US  PRN  Ionis' Factor XI anti-thrombotic medicine advances with Bayer following positive clinical results,"10/09/2019 09061G10   PRN  BioMarin to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, October 23 at 4:30pm ET"," 7/27/2015 GERN-US  PRN  Pre-market Equity Watch on Biotechnology -- Geron, Alexion Pharma, Cytori Therapeutics, TG Therapeutics, and Rexahn Pharma", 7/10/2019 64125C10 PRN  Neurocrine Biosciences Announces FDA Acceptance of New Drug Application for Opicapone as an Adjunctive Treatment for Patients with Parkinson's Disease," 5/15/2017 81257810 PRN  How These Biotech Stocks are Faring? -- Seattle Genetics, Sangamo Therapeutics, Vertex Pharma, and VIVUS"," 3/05/2015 45290710 PRN  Recent Developments at Biotechnology Companies: Special Research on Immunomedics, Nymox, Meridian, Myriad, and Neogen", 9/12/2017 09062X10  PRN  Alzheimer's Disease: Cannabis Formulation Shows Promise," 8/04/2014 45253H10 PRN  Critical Alerts For Disney, ImmunoGen, Vodafone Group, Toyota Motor, and NASDAQ Released By InvestorsObserver"," 7/21/2014 09058V10 PRN  Biotech Stocks Scanner -- Regeneron Pharma, BioCryst Pharma, Spectrum Pharma, Exact Sciences, and Vical Inc.", 5/22/2018 37555810   PRN  Recent Developments in the Stem Cell Market, 9/26/2019 04004760   PRN  Arena Pharmaceuticals Presented New Data from the Phase 2 OASIS trial for Etrasimod at the World Congress of Gastroenterology Meeting," 9/17/2019 N5946510  PRN  Mylan Expands Oncology Portfolio with Launch of Generic Faslodex® Injection, a Treatment for Advanced Breast Cancer","10/28/2019 M2572210 PRN  Compugen to Release Third Quarter 2019 Results on Monday, November 11, 2019"," 6/29/2017 FRE-DE   PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc. (AKRX)",12/09/2019 000C35-E PRN  Amgen Selects Location For R&D Facility In The South San Francisco Biotechnology Hub,10/02/2017 62855J10 PRN  Myriad Genetics Highlights Strong Commitment to Preventing and Fighting Breast Cancer as Part of Breast Cancer Awareness Month, 7/21/2017 52887230 PRN  Lexicon Collaborator Ipsen Receives Positive CHMP Opinion For Xermelo® (Telotristat Ethyl),, 9/05/2019 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 1/30/2020 003J92-E PRN  Agencies Expect Possible Treatments and Hope for a Coronavirus Vaccine as Soon as Three Months, 9/26/2019 64026810 PRN  Las Vegas Sands Set to Join S&P 500; Nektar Therapeutics to Join S&P MidCap 400; The Pennant Group to Join S&P SmallCap 600, 4/30/2019 76655960 PRN  Rigel Announces Conference Call and Webcast to Report First Quarter 2019 Financial Results and Company Update," 2/09/2015 37416310 PRN  Momentum Indicators for Biotech Equities - PDL BioPharma, Geron, Celldex Therapeutics, XOMA Corp., and Juno Therapeutics",," 9/22/2014 02311120 PRN  Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma"," 7/03/2017 45337C10 PRN  Japan Ministry of Health, Labor and Welfare (MHLW) Grants Marketing Approval For Olumiant® (baricitinib) for the Treatment of Rheumatoid Arthritis", 4/29/2019 91307C10 PRN  United Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion Services," 9/30/2015 0B0WJD-E PRN  Parent Project Muscular Dystrophy Launches Next Phase of Genetic Testing Program, Decode Duchenne in collaboration with BioMarin Pharmaceutical Inc., PTC Therapeutics, and Sarepta Therapeutics", 7/30/2019 G0176710 PRN  Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis,, 6/10/2013 00163U10 PRN  Access Pharmaceuticals Signs US License Agreement With AMAG Pharmaceuticals For MuGard,, 5/28/2019 LMNX-US  PRN  EDP Biotech to Develop and Market Colorectal Cancer Early Detection Blood Test Using Luminex xMAP® Technology," 1/22/2019 80067710 PRN  Sangamo Therapeutics Appoints Adrian Woolfson, BM., B.Ch., Ph.D., As Executive Vice President Of Research And Development","11/30/2015 30161Q10 PRN  Covered Call Alerts For Disney, Exelixis, BlackBerry, NVIDIA and JetBlue Released By InvestorsObserver", 9/20/2019 000VC1-E  PRN  CHMP Recommends Approval of Dupixent® (dupilumab) for Severe Chronic Rhinosinusitis with Nasal Polyposis," 7/06/2015 92532F10  PRN  Critical Alerts For Alcoa, Vertex Pharmaceuticals, Vale, Stratasys and Intrexon Released By InvestorsObserver",, 8/11/2016 06CR5C-E PRN  Ascendis Pharma A/S Initiates Phase 3 Registration Trial for TransCon Growth Hormone in Children with Growth Hormone Deficiency," 3/30/2015 09609G10 PRN  Today's Review on Biotech Equities -- Biocept, Biogen Idec, Kite Pharma, Organovo Holdings, and Bluebird Bio"," 7/18/2016 00422510 PRN  Facebook trade offers a 30% return in 32 days, or find similar option trades on ACADIA Pharmaceuticals, Perrigo Co., Jabil Circuit, and SolarCity",, 5/29/2019 74366E10 PRN  Protagonist Therapeutics Appoints Don Kalkofen as Chief Financial Officer,," 7/22/2014 88338N10 PRN  Technical Coverage on Pharma Stocks -- GlaxoSmithKline, TherapeuticsMD, AstraZeneca, Zogenix, and Novartis"," 6/23/2014 98978L20    PRN  Technical Roundup on Health Care Sector Stocks -- Research on HCA Holdings, Community Health Systems, GlaxoSmithKline, and Zogenix",, 8/07/2015 OMER-US  PRN  Omeros to Present at the 2015 Wedbush PacGrow Healthcare Conference,,,"12/25/2013 46333X10 PRN  FDA Drug Approvals, Newly Elected Board of Directors, and Stock Price Updates on Healthcare Companies - Research Report on Theravance, Quintiles, Ironwood, Progenics, and Immunomedics",," 3/08/2012 00D326-E PRN  Ultragenyx Announces the Completion of the Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease",,, 6/25/2019 69329Y10 PRN  PDL BioPharma Announces Departure of CFO,,,, 7/31/2019 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2019 Financial Results,11/11/2014 29251M10 PRN  AbbVie to Present Results from Phase 2 PEARL-I Study in Genotype 4 Chronic Hepatitis C Patients at The Liver Meeting® 2014," 2/12/2015 02043Q10 PRN  A Look at the Latest Happenings in Health Care Sector: New Research on Alliqua, Almost Family, Alnylam Pharmaceuticals, Alphatec Holdings, and AMAG Pharmaceuticals",,, 3/05/2019 60468T10 PRN  Mirati Therapeutics To Present At Upcoming Healthcare Conferences,"12/10/2013 69512710 PRN  Stock Price Movements, Share Repurchase Programs, and Regulatory Submissions - Research Report on Viropharma, Santarus, Cyberonics, Pacira Pharmaceuticals, and Dyax",,,, 6/06/2011 007MPF-E PRN  Chiasma's Octreolin™ (Oral Octreotide) Shown to Inhibit Growth Hormone in Healthy Subjects," 6/28/2011 05LJZC-E PRN  The Lancet Publishes Data from Protege, MacroGenics' Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients", 8/07/2019 09627Y10 PRN  Blueprint Medicines Announces FDA Acceptance of New Drug Application for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST,, 4/17/2019 28249U10 PRN  Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock, 1/27/2012 60877T10 PRN  S&P Indices Announces Change to U.S. Index,,,,,, 7/22/2019 92165910 PRN  Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag Disorder,,, 3/13/2017 45781M10   PRN  Sarissa Capital Responds To Innoviva's Preemptive Launch Of Proxy Contest," 5/19/2010 002PSJ-E PRN  ChemoCentryx President and CEO, Thomas J. Schall, Ph.D., Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist in Northern California", 7/12/2019 HALO-US  PRN  Halozyme Announces Janssen Submits BLA To FDA For Subcutaneous Formulation Of DARZALEX® Utilizing ENHANZE® Technology, 7/27/2018 G2151510 PRN  China Biologic Products to Report Second Quarter 2018 Financial Results," 9/22/2015 56400P70 PRN  Critical Alerts For Tesla Motors, Denbury Resources, MannKind, SolarCity and Under Armour Released By InvestorsObserver",,, 5/07/2015 002VD4-E PRN  Myrtle Potter & Company Announces Engagement with Esperion Therapeutics for Development of ETC-1002 Commercialization Strategy,"12/04/2019 03236M20 PRN  Biossance Leading the Clean Beauty Revolution with Biossance.com Cyber Monday Sales up over 3X from Last Year, Marking Highest One-Day Sales in Brand History",10/31/2019 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 3/04/2015 00448Q20 PRN  Critical Alerts For Box, Achillion Pharmaceuticals, Kinder Morgan, Mondelez International and Broadcom Released By InvestorsObserver", 3/28/2017 87166B10 PRN  INC Research Accelerates Clinical Trial Start-up with goBalto Activate," 7/10/2014 03152W10 PRN  Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma",,,," 4/24/2018 36197T10 PRN  Innovative Cannabis Delivery Technology Boosts Discovery, Momentum in Biotech Sectors"," 2/19/2014 29428V10 PRN  Epizyme, Inc. to Report Fourth Quarter and Year-End 2013 Financial Results on February 27, 2014", 8/06/2019 G5087110 PRN  Jazz Pharmaceuticals Announces Second Quarter 2019 Financial Results,,11/01/2018 00394S-E PRN  Grifols affirms commitment to patients during Alpha-1 Awareness Month,,11/05/2019 73701010 PRN  Portola Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update, 2/02/2017 92337F10 PRN  Veracyte to Present at LEERINK Partners 6th Annual Global Healthcare Conference,, 1/19/2011 063J3K-E PRN  Cellectis' Meganuclease Technology Used to Efficiently Prevent Viral Infection, 8/25/2017 14075510 PRN  Data on Legal Cannabis Products Show Strong Sales,,," 3/25/2014 00BBFF-E PRN  Candidate Selection for Clinical Trials, Financial Results, and Patient Enrollments for Phase I Study - Analyst Notes on Synta, Ziopharm, Aastrom, Agios, and OncoMed"," 5/23/2016 46226010 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Lion Biotechnologies, Inc. - LBIO", 4/03/2014 008H33-E PRN  AnaptysBio Announces Issuance Of United States Patent Covering Proprietary Antibody Humanization Technology,,,"10/22/2015 G4618810 PRN  Covered Call Alerts For Chipotle Mexican Grill, Horizon Pharma, Abbott Laboratories, Bank of America and Amgen Released By InvestorsObserver",," 2/02/2015 45845P10 PRN  Quarterly Results Review & Outlook: Complementary Reports on Costco, Chevron, ImmunoGen, MasterCard, and Intercept",11/02/2011 0844XQ-E PRN  Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors of Nuclear Export (SINE) for Cancer,," 4/18/2018 98401F10 PRN  Xencor Presents Preclinical Data on XmAb®24306, Introduces XmAb® IL15 Bispecific Platform at American Association for Cancer Research (AACR) 2018 Annual Meeting", 2/05/2014 46116X10 PRN  Intra-Cellular Therapies Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares, 6/14/2019 G8807B10 PRN  Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories,11/05/2013 079TK4-E PRN  Novocure Announces FDA Approval of the NovoTAL™ (Transducer Array Layout) System, 2/21/2019 03969710 PRN  Ardelyx to Participate in Leerink Partners 8th Annual Global Healthcare Conference,,,,, 3/27/2017 M4613510 PRN  Foamix Reports Topline Results from Phase 3 Trials for FMX101 in Patients with Acne, 5/20/2011 001THX-E PRN  PRA International Acquires Key Software Developer,,," 7/24/2015 74587V10 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Puma Biotechnology, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 3, 2015 - PBYI",, 4/03/2017 21833P10 PRN  The CBD Submarket Plays a Major Role in the Legal Cannabis Industry, 2/27/2019 05070R10 PRN  Audentes Therapeutics Reports Fourth Quarter 2018 and Full Year Financial Results and Provides Corporate Update,,, 7/16/2014 0CT325-E PRN  Seres Health Completes Enrollment in a Clinical Study for SER-109 in Recurrent Clostridium difficile Infection and Announces Positive Preliminary Data,,, 5/30/2019 75901B10 PRN  REGENXBIO Announces Completion of Dosing for Phase I/IIa Clinical Trial of RGX-314 in Wet AMD,,,,,,,, 9/04/2015 44842L10 PRN  Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint,,,,, 3/19/2012 07N3G8-E PRN  Argen-X Launches NHance™ Technology to Generate Better Human Antibody Therapies,, 3/09/2015 00695P-E  PRN  Hanmi Pharmaceuticals to Assign the Rights of the Indian Territory to Kinex as Part of the Orascovery Program Strategic Plan,,,,,,,,, 4/04/2017 0FZZYY-E PRN  Homology Medicines Appoints Brad Smith as Chief Financial Officer,,,,,,,,,,,,,,,,, 8/14/2019 50015M10 PRN  Kodiak Sciences Announces Second Quarter 2019 Financial Results and Recent Business Highlights,, 5/18/2017 00FYYJ-E PRN  Guardant Health Announces Draft Medicare Local Coverage Determination for the Guardant360 Assay,,,11/05/2015 00FLML-E PRN  Twist Bioscience Congratulates Winners Of Blue Sky Bio Competition,,,,,,," 9/11/2018 0JNJRY-E PRN  Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer",,,,, 6/27/2014 0DMSKV-E PRN  Study Reports clonoSEQ™ Detects Residual Disease in 33% More Childhood Leukemia Patients Compared to Current Standard of Care Laboratory Test,
" 6/30/2014 53220K50 PRN  Patent Issuance, Positive Trial Data, Recognitions, and Priority Review - Analyst Notes on Keryx, Puma, Ligand, Sagent and Enanta", 9/01/2017 74318710 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenics Pharmaceuticals Inc. - PGNX, 8/08/2016 00DFXS-E    PRN  Personal Genome Diagnostics To Collaborate With Illumina On Development Of Cancer In Vitro Diagnostic Test Kits,"11/22/2013 84763A10 PRN  Early Briefing and Review: Arena Pharma Inc., Geron Corp., Incyte Corp., and Spectrum Pharma Inc.", 9/03/2019 0650LH-E PRN  Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Delayed-release Tablets in the United States," 3/25/2015 04280A10 PRN  Biotech Equities Technical Coverage - ZIOPHARM Oncology, Arrowhead Research, Merrimack Pharma, Vertex Pharma, and Advaxis"," 5/15/2017 09060J10 PRN  /C O R R E C T I O N -- BioDelivery Sciences International, Inc./",10/10/2019 000XKX-E    PRN  Medicare Issues Final Local Coverage Decision For Bio-Techne's ExoDx™ Prostate(IntelliScore) Test,12/10/2019 000VC1-E    PRN  Regeneron and Sanofi Announce Intent to Restructure Antibody Collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab),," 1/26/2018 68375N10 PRN  What's Happening With These Biotech Stocks? -- Novavax, Opko Health, Otonomy, and Puma Biotech", 9/25/2019 46222210 PRN  Ionis to receive the CLSA's 2019 Pantheon DiNA™ Award for Company of the Year,"10/07/2019 09061G10   PRN  BioMarin Promotes Lon Cardon, Ph.D. to Chief Scientific Strategy Officer"," 5/15/2015 01535110 PRN  Technical Notes Covering Biotech Stocks -- Aeterna Zentaris, Oncolytics Biotech, Alexion Pharma, Synergy Pharma, and MEI Pharma", 7/08/2019 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2019 Financial Results, 3/02/2017 81257810 PRN  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Seattle Genetics Inc. -- SGEN," 2/05/2015 45290710 PRN  Coverage of Biotech Equities -- Amarin, Cytori Therapeutics, Medivation, Sangamo BioSciences, and Immunomedics", 8/30/2017 00167Y-E  PRN  Ionis Earns $40 Million SPINRAZA Regulatory Milestone Payment from Biogen," 7/18/2014 45253H10 PRN  Review on Biotech Stocks -- Incyte, ACADIA Pharma, Cel-Sci, Aegerion Pharma, and ImmunoGen"," 5/30/2014 09058V10 PRN  Pre-clinical Trial Results, Expanded Studies, Preliminary Data Release, and Leadership Appointments - Analyst Notes on Alnylam, BioCryst, Puma Biotechnology, Intrexon and NW Bio"," 4/18/2018 37555810   PRN  Astellas Announces Sale of Certain Agensys Research Facilities to Kite, a Gilead Company", 9/25/2019 04004760   PRN  Arena Pharmaceuticals to Present at the Cantor Global Healthcare Conference on October 2," 7/29/2019 00GDWJ-E  PRN  Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine",10/02/2019 M2572210 PRN  Compugen to Present Data from Ongoing COM701 Phase 1 Clinical Trial at SITC 2019," 5/23/2017 FRE-DE   PRN  Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Akorn, Inc. - AKRX","12/06/2019 03116210 PRN  FDA Approves Amgen's AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab)", 9/07/2017 62855J10 PRN  Hereditary Cancer Risk Assessment Is an Important Option for Prostate Cancer Patients during Prostate Cancer Awareness Month, 6/19/2017 52887230 PRN  NCCN Guidelines For Neuroendocrine Tumors Include XERMELO In Combination With Somatostatin Analog Therapy As A Recommended Treatment Option For Patients With Carcinoid Syndrome Diarrhea,, 9/03/2019 45766930 PRN  Insmed to Present at Two September Conferences,, 1/30/2020 062S3Y-E PRN  Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China, 9/26/2019 64026810 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR, 3/26/2019 76655960 PRN  Rigel Welcomes Jane Wasman to Board of Directors,"12/18/2014 37416310 PRN  Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma",," 9/09/2014 02311120 PRN  Notice to Investors in Amarin Corp. plc's (AMRN) July 10, 2013 Public Offering: Wolf Popper LLP Announces Anticipated Filing of Amended Complaint Against Amarin Corp. plc (NASDAQ: AMRN)", 6/16/2017 45337C10 PRN  New Safety and Long-Term Efficacy Data from Baricitinib Clinical Trials in Patients with Moderate-to-Severe Rheumatoid Arthritis Presented at EULAR 2017," 4/24/2019 91307C10 PRN  United Therapeutics Corporation To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019", 8/26/2015 80360710 PRN  New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market, 7/29/2019 G0176710 PRN  Alkermes Announces Settlement With Amneal Over VIVITROL® Patent Dispute,," 5/28/2013 00163U10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in AMAG Pharmaceuticals, Inc. of Class Action Lawsuit Investigation - AMAG",, 5/21/2019 55027E10 PRN  Luminex Corporation Declares Second Quarter Cash Dividend, 1/04/2019 80067710 PRN  Sangamo Therapeutics To Present at the 37th Annual J.P. Morgan Healthcare Conference,"11/17/2015 30161Q10 PRN  Covered Call Alerts For Disney, Celgene, Petrobras, Shake Shack and Exelixis Released By InvestorsObserver", 9/17/2019 80105N10  PRN  Happify Health and Sanofi Sign Global Agreement to Bring Prescription Digital Mental Health Therapeutics to Individuals with Multiple Sclerosis," 5/07/2015 92532F10  PRN  Biotech Stocks in Motion -- Vertex Pharma, Advaxis, Merrimack Pharma, Tekmira Pharma, and United Therapeutics",, 8/08/2016 04351P10 PRN  Ascendis Pharma A/S Appoints Scott T. Smith as Chief Financial Officer," 2/18/2015 09609G10 PRN  Critical Alerts For JC Penney, Tile Shop, Sarepta Therapeutics, Goodrich Petroleum Corp. and bluebird bio Inc. Released By InvestorsObserver"," 7/07/2016 00422510 PRN  InvestorsObserver releases covered-call reports for Valeant Pharmaceuticals, Amazon.com, Progressive Corporation, ACADIA Pharmaceuticals and Pure Storage Inc.",, 5/14/2019 74366E10 PRN  Oral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates Superior Dose-Related Target Engagement Activity to PTG-100 in Single Ascending Dose Phase 1 Study,," 1/08/2014 88338N10 PRN  Technical Dossier: Theravance, Alkermes, Cubist Pharma, and TherapeuticsMD"," 5/30/2014 98978L20    PRN  Equities Updates on Top Gainers -- Research on Comstock Resources, Zogenix, Mercadolibre, and Clovis Oncology",, 8/03/2015 68214310 PRN  Omidria® Approved for Commercialization Throughout the European Union and Additional Countries,,,"12/23/2013 46333X10 PRN  Pre-Market Commentary: Perrigo, Allscripts Healthcare Solutions, Catalyst Pharma Partners, and Ironwood Pharma",, 2/28/2012 00D326-E PRN  Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7),,, 6/24/2019 69329Y10 PRN  Natasha A. Hernday Elected to PDL BioPharma's Board of Directors,,,, 6/25/2019 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Ranitidine Capsules,10/01/2014 29251M10 PRN  AbbVie Demonstrates Commitment to Continued Research in Hepatitis C with Investigational Data from Clinical Program Being Presented at The Liver Meeting®,"12/09/2014 02043Q10 PRN  Critical Alerts For MannKind, Merck, Alnylam Pharmaceuticals, Nu Skin Enterprises and Organovo Released By InvestorsObserver",,, 2/28/2019 60468T10 PRN  Mirati Therapeutics Reports Fourth Quarter Financial Results,"11/22/2013 69512710 PRN  Grants and Stock Movements of Major Drug Manufacturers - Research Report on AbbVie, Keryx Biopharmaceuticals, Pacira Pharmaceuticals, Rockwell Medical, and Impax Laboratories",,,, 9/21/2010 007MPF-E PRN  Chiasma to Present at the UBS Global Life Sciences Conference, 6/23/2011 05LJZC-E PRN  MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28, 8/06/2019 09627Y10 PRN  Blueprint Medicines to Present at 2019 Wedbush PacGrow Healthcare Conference,, 4/17/2019 28249U10 PRN  Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock," 1/27/2012 SIRI-US  PRN  Research Reports on Top Traded Stocks: Boston Scientific, Sirius, Momenta Pharmaceuticals, Gran Tierra Energy, Taseko Mines and TiVo",,,,,, 7/16/2019 92165910 PRN  Tradipitant Effective in Preventing Motion Sickness,,," 1/10/2017 45781M10   PRN  Ehave, Inc. Appoints New Members to its Board of Directors", 5/04/2010 005XF5-E PRN  ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohn's Disease at the Digestive Disease Week (DDW) 2010 Conference, 6/25/2019 40637H10 PRN  Halozyme Announces CRADA With National Institute of Allergy and Infectious Diseases For Use Of ENHANZE® Drug Delivery Technology, 7/02/2018 G2151510 PRN  China Biologic Announces Results of Its 2018 Annual General Meeting of Shareholders," 9/10/2015 56400P70 PRN  Critical Alerts For Netflix, MannKind, Arrowhead Research, Google Inc. and CyberArk Software Released By InvestorsObserver",,," 4/21/2015 29664W10 PRN  Critical Alerts For BlackBerry, Hasbro, Esperion Therapeutics, Chesapeake Energy and OmniVision Released By InvestorsObserver",11/25/2019 03236M20 PRN  Amyris Engages 30-Year Wall Street Veteran to Support Capital Markets Activities & Further Balance Sheet Transformation,10/29/2019 69366J20 PRN  PTC Therapeutics Reports Third Quarter 2019 Financial Results and Provides a Corporate Update," 3/04/2015 00448Q20 PRN  Stocks Coverage on the Biotech Industry - Achillion Pharma, CTI BioPharma, MiMedx, Momenta Pharma, and Anthera Pharma"," 8/02/2016 87166B10 PRN  Technical Roundup on Services Stocks -- Booz Allen Hamilton, Qiagen, Myriad Genetics, and INC Research"," 7/07/2014 03152W10 PRN  Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc.",,,, 3/21/2018 36197T10 PRN  Ontario Moves Ahead With Plan to License Cannabis Lounges, 2/11/2014 29428V10 PRN  Epizyme Announces Exercise of Underwriters' Option to Purchase Additional Shares of Common Stock, 8/06/2019 G5087110 PRN  Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program,,10/27/2018 39843840 PRN  Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's disease using its AMBAR treatment protocol,,11/01/2019 73701010 PRN  Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),12/13/2016 001482-E PRN  Veracyte Announces Appointment of Kevin K. Gordon and Other Changes to Its Board of Directors,,12/07/2010 063J3K-E PRN  Cellectis bioresearch Signs Non-Exclusive License With Evrogen for Access to Fluorescent Proteins, 7/20/2017 14075510 PRN  The Next Gold Rush is Green,,,"12/25/2013 00847X10 PRN  Additional Shares Purchased, Extended Collaboration, Credit Facility, Publication of Data, and Interim Results - Research Report on Karyopharm, Agios, Lannett, MacroGenics, and ZIOPHARM",10/08/2015 JUNO-US  PRN  Multi-Billion Dollar Tissue Engineered Skin Substitutes Market Expected Robust Growth with Latest Biotech Advancements for Treating & Restoring Damaged Tissues, 3/13/2014 TSRO-US  PRN  AnaptysBio And TESARO Announce Strategic Immuno-Oncology Antibody Collaboration,,,10/22/2015 G4618810 PRN  Depomed Comments on Recent Reports Regarding Horizon Pharma's Business Model,," 1/14/2015 45845P10 PRN  Critical Alerts For Alibaba, El Pollo Loco, Bank of America, Pharmacyclics and Intercept Pharmaceuticals Released By InvestorsObserver",10/11/2011 0844XQ-E PRN  Karyopharm Therapeutics Inc. and Katholieke Universiteit Leuven Sign Exclusive Collaboration for the Discovery of Novel CRM1/Exportin 1 Inhibitors,, 3/21/2018 98401F10 PRN  Xencor to Present at 17th Annual Needham Healthcare Conference," 1/30/2014 46116X10 PRN  Intra-Cellular Therapies Announces Pricing of Public Offering of Common Stock; To Begin Trading on NASDAQ Global Select Market under ""ITCI""", 6/14/2019 G8807B10 PRN  Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories, 7/31/2013 079TK4-E PRN  Novocure Treats First Recurrent Glioblastoma Patient in Japan with NovoTTF™ Therapy," 2/07/2019 07F754-E PRN  Ardelyx Collaboration Partner, Kyowa Hakko Kirin, Announces Initiation of a Phase 2 Clinical Study of Tenapanor for Hyperphosphatemia Patients on Dialysis in Japan",,,,, 3/08/2017 008XK0-E PRN  Foamix Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference, 5/16/2011 001THX-E PRN  PRA International Expert to Speak at Early Phase Conference,,," 6/23/2015 74587V10 PRN  Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Puma Biotechnology, Inc.",, 3/28/2017 21833P10 PRN  The Growth of Legal Cannabis in Approved States," 2/21/2019 05070R10 PRN  Audentes Therapeutics to Release Fourth Quarter and Full Year 2018 Financial Results and Provide Corporate Update on Wednesday, February 27, 2019",,, 7/07/2014 0CT325-E PRN  Seres Health Announces Allowance for Key Patent on the Use of Synergistic Bacterial Compositions,,, 5/24/2019 75901B10 PRN  REGENXBIO Announces First FDA Approval of a Gene Therapy Based on Its Proprietary NAV® Technology Platform,,,,,,,, 7/23/2015 HCM-HK   PRN  Mitsui Exchanges its Shares in Hutchison MediPharma for Shares in Chi-Med,,,,, 2/29/2012 07N3G8-E PRN  arGEN-X Enters Into a Therapeutic Antibody Alliance With Shire,, 1/20/2015 00695P-E  PRN  Kinex Pharmaceuticals Announces First Patient Dosed with KX2-391 Ointment for Actinic Keratosis in a Phase 1 Clinical Study,,,,,,,,, 9/15/2016 0619FF-E PRN  Homology Medicines Acquires License to Novel AAV Technology to Develop Treatments for Central Nervous System Disorders,,,,,,,,,,,,,,,,, 8/08/2019 50015M10 PRN  Kodiak Sciences to Present at Wedbush PacGrow Healthcare Conference,, 1/31/2017 00FYYJ-E PRN  MD Anderson and Guardant Health announce partnership to make comprehensive liquid biopsy part of oncology standard of care,,,11/04/2015 00FLML-E PRN  Ginkgo Bioworks To Purchase 100 Million Base Pairs Of Synthetic DNA From Twist Bioscience To Meet Growing Customer Demand For Biological Manufacturing,,,,,,,,,,,," 6/19/2014 0DMSKV-E PRN  Veteran Genomic Health Executive, Dean Schorno, CPA, joins Adaptive Biotechnologies as Chief Financial Officer",
 6/24/2014 53220K50 PRN  Lemelson Capital Reaffirms Research Report and Price Target for Ligand Pharmaceuticals (NASDAQ: LGND)," 5/12/2017 74318710 PRN  Biotech Stocks on Investors' Radar -- Progenics Pharma, Dynavax Technologies, Intrexon, and Heat Biologics"," 8/05/2016 45232710    PRN  Learn how to target a 20% return on GoPro, or get option-trade ideas on Barrick Gold Corporation, Illumina, Ball Corporation and Intel or any stock you choose","11/18/2013 84763A10 PRN  Financial Results, Conference Calls Schedules, and Outlook- Research Report on Spectrum, Magellan, Insmed, GenMark, and Envision"," 8/22/2019 G3040110 PRN  Football Legend John Elway Reveals He has Dupuytren's Contracture and Wants Others to Get the ""Facts on Hand"""," 3/10/2015 04280A10 PRN  Critical Alerts For Goodrich Petroleum Corp., General Electric, Arrowhead Research Released By InvestorsObserver"," 5/09/2017 09060J10 PRN  BioDelivery Sciences to Host Conference Call and Webcast Reporting First Quarter 2017 Financial Results on Monday, May 15","10/08/2019 09073M10    PRN  Bio-Techne To Host Conference Call On October 29, 2019, To Announce First Quarter 2020 Financial Results",12/08/2019 75886F10    PRN  First Clinical Data for REGN5458 (BCMAxCD3) Show Positive Preliminary Results in Multiple Myeloma,,"11/01/2017 68375N10 PRN  Stocks Under Scanner in the Biotech Space -- Axovant Sciences, Gilead Sciences, Novavax, and Opko Health", 9/17/2019 46222210 PRN  Positive preliminary results from ATL1102 for DMD Phase II trial,"10/01/2019 09061G10   PRN  BioMarin to Participate in Jefferies Gene Therapy/Editing Summit on October 8, 2019 in New York"," 5/12/2015 01535110 PRN  Healthcare Sector in Focus: Complementary Research on Alexion, OraSure, Lannett, BioTelemetry and Versartis", 6/11/2019 64125C10 PRN  Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2019 World Congress on Parkinson's Disease and Related Disorders, 2/10/2017 81257810 PRN  Immunomedics Announces Postponement of 2016 Annual Meeting,"12/17/2014 45290710 PRN  Scanning Biotech Equities -- Celgene, Novavax, Amarin, Immunomedics, and Aeterna Zentaris"," 8/25/2017 09062X10  PRN  Technical Snapshots for these Biotech Stocks -- Gilead Sciences, Biogen, bluebird bio, and BioMarin Pharma"," 7/08/2014 45253H10 PRN  Critical Alerts For Royal Gold, Bed Bath & Beyond, ImmunoGen, ResMed, and Whirlpool Released By InvestorsObserver"," 5/16/2014 09058V10 PRN  Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst", 4/03/2018 MRK-US     PRN  Fish & Richardson Litigation Team Named California Lawyer Attorneys of the Year, 9/17/2019 04004760   PRN  Arena Pharmaceuticals to Present New Preclinical Atopic Dermatitis Data for Etrasimod at the European Society for Dermatologic Research Annual Meeting," 7/29/2019 N5946510  PRN  Statement from Mylan's Board of Directors Regarding Retirement of CEO and Board Member Heather Bresch in Conjunction with the Combination of Mylan and Upjohn, a Division of Pfizer", 9/19/2019 M2572210 PRN  Compugen Presents Update on COM701 Phase 1 Study at 2019 IGCS," 5/15/2017 00972810 PRN  How These Generic Drugs Stocks are Faring? -- Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharmacy",12/04/2019 000C35-E PRN  First Industry Datasets Submitted to ASH Research Collaborative Data Hub, 6/20/2017 001D3K-E PRN  Agena Bioscience Announces Expanded Partnership with Assurex Health, 6/10/2017 52887230 PRN  Sotagliflozin Data from Pivotal inTandem1 and inTandem2 Studies in Patients with Type 1 Diabetes Presented at ADA 2017,, 8/05/2019 0GMZGZ-E PRN  Thor Equities Launches New Life Sciences Platform - Thor Sciences,, 1/29/2020 062S3Y-E PRN  VGXI to Manufacture Vaccine Against Novel Coronavirus Under CEPI Funded Collaboration, 9/26/2019 64026810 PRN  Clinical Data Presented from PIVOT-02 Study of Bempegaldesleukin (NKTR-214) with Nivolumab in Triple-Negative Breast Cancer Patients at the 2019 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, 2/28/2019 76655960 PRN  Rigel Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update,"11/18/2014 37416310 PRN  Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA",," 8/18/2014 02311120 PRN  Technical Summary on Biotech Equities -- Alkermes, Amarin, Array BioPharma, Navidea Biopharma, and Pharmacyclics Inc.", 6/13/2017 45337C10 PRN  Lilly to Present New Data on Olumiant® (baricitinib) in Rheumatoid Arthritis and Taltz® (ixekizumab) in Psoriatic Arthritis at the Annual European Congress of Rheumatology (EULAR 2017), 4/17/2019 91307C10 PRN  United Therapeutics Issues Statement In Response To Meritless Lawsuit," 8/17/2015 80360710 PRN  Critical Alerts For PayPal Holdings Inc., MannKind, Sysco Corporation, Transocean and Sarepta Therapeutics Released By InvestorsObserver", 7/25/2019 G0176710 PRN  Alkermes Plc Reports Second Quarter 2019 Financial Results,," 5/22/2013 00163U10 PRN  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.",, 5/14/2019 55027E10 PRN  Luminex Corporation to Present at Upcoming Healthcare Investor Conferences, 1/04/2019 80067710 PRN  Sangamo Announces Upcoming Clinical Data Presentations At WORLDSymposium 2019,"11/04/2015 30161Q10 PRN  Covered Call Alerts For Ambarella, Exelixis, Electronic Arts, Nabors Industries and Whole Foods Market Released By InvestorsObserver", 8/06/2019 000VC1-E  PRN  Dupixent® (dupilumab) Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years with Severe Atopic Dermatitis," 4/24/2015 92532F10  PRN  Health of Health Care Stocks: Complementary Research on Enzon Pharmaceuticals, Durect Corporation, Vertex Pharmaceuticals, Advaxis, and Omnicare",, 5/19/2016 04351P10 PRN  Ascendis Pharma A/S Reports First Quarter 2016 Financial Results," 2/16/2015 09609G10 PRN  Latest Updates on Health Care Sector: Special Research on bluebird bio, Brainstorm, CASI Pharmaceuticals, Celladon, and Cellular Dynamics"," 7/05/2016 00422510 PRN  Biotechnology Stocks Technical Review - Medivation, ACADIA Pharma, Regulus Therapeutics, and Vascular Biogenics",, 5/08/2019 74366E10 PRN  Protagonist Therapeutics Reports First Quarter 2019 Financial Results,,, 4/24/2014 00FV7G-E    PRN  Endo Acquires Rights to Sumavel® DosePro®,," 7/31/2015 68214310 PRN  Omeros Corporation to Announce Second Quarter 2015 Financial Results on August 10, 2015",,,"12/17/2013 46333X10 PRN  Cooperative Investigations, Clinical Studies, Conference Calls, New Drug Applications, and Strategies- Research Report on Insys, Integra, Bio-Reference, Raptor, and Ironwood",, 1/05/2012 00D326-E PRN  Ultragenyx In-Licenses Therapeutic Program for Rare Genetic Disease Mucopolysaccharidosis Type 7 from St. Louis University,,, 6/10/2019 69329Y10 PRN  Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors,,,," 6/20/2019 00182C10 PRN  ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml"," 6/30/2014 29251M10 PRN  Patent Issuance, Positive Trial Data, Recognitions, and Priority Review - Analyst Notes on Keryx, Puma, Ligand, Sagent and Enanta","11/04/2014 02043Q10 PRN  Biotech Equities Coverage - Achillion Pharma, Sarepta Therapeutics, Alnylam Pharma, Incyte, and Cytori Therapeutics",,, 2/19/2019 60468T10 PRN  Mirati Therapeutics Announces The Appointment Of Faheem Hasnain As Chairman Of The Board Of Directors,"11/13/2013 69512710 PRN  Extension Study Data, Financial Results, Scheduled Conferences and Presentations - Research Report on Keryx, Raptor, Pacira, Horizon Pharma, and Impax",,,, 6/28/2010 007MPF-E PRN  Chiasma Receives Orphan Drug Designation From the FDA for Octreolin™ for the Oral Treatment of Acromegaly, 4/28/2011 05LJZC-E PRN  Data Published in Blood Demonstrate Potent Activity of MacroGenics' Proprietary DART™ Technology, 8/01/2019 09627Y10 PRN  Blueprint Medicines Reports Second Quarter 2019 Financial Results,," 4/15/2019 28249U10 PRN  Eiger BioPharmaceuticals Appoints Market Access, Public Policy Expert, and Biotech Veteran Amit K. Sachdev to Board of Directors"," 1/25/2012 MNTA-US  PRN  Zacks Releases Four Powerful ''Buy'' Stocks: Momenta Pharmaceuticals, Lowe's Companies, Humana and Energy Partners Limited",,,,,, 6/18/2019 92165910 PRN  Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference,,,12/19/2016 TBPH-KY    PRN  Theravance Biopharma Highlights Initiation of Phase 3 Study of the Closed Triple in Patients with Asthma by GlaxoSmithKline and Innoviva,, 6/04/2019 40637H10 PRN  Halozyme To Participate In Upcoming Investor Conferences, 6/19/2018 G2151510 PRN  China Biologic Announces Receipt of Non-Binding Acquisition Proposal," 8/27/2015 56400P70 PRN  Critical Alerts For Google Inc., Wayfair Inc., MannKind, Avago Technologies and Nike Released By InvestorsObserver",,," 3/18/2015 29664W10 PRN  Critical Alerts For Rite Aid, Esperion Therapeutics, Vivint Solar Inc, Priceline and PepsiCo Released By InvestorsObserver",11/19/2019 03236M20 PRN  American Diabetes Association Announces Amyris CEO John Melo as Executive Committee Chair of 2020 Wine Country Tour de Cure,10/24/2019 69366J20 PRN  PTC Therapeutics Announces Results from Long-Term AADC Deficiency Gene Therapy Treatment Demonstrating Sustained Improvements," 2/11/2015 00448Q20 PRN  Critical Alerts For Transocean, Crane, Achillion Pharmaceuticals, Endocyte and Monster Beverage Released By InvestorsObserver"," 5/12/2015 87166B10 PRN  Recent Updates From Services Providers: Complementary Research on Chegg, Dex Media, INC Research, Career Education and ANN Inc."," 7/03/2014 03152W10 PRN  Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array",,,," 2/28/2018 000BKB-E PRN  Pre-Market Technical Scan on Drug Makers Equities -- GW Pharma, Heron Therapeutics, Immune Pharma, and Johnson & Johnson"," 2/07/2014 29428V10 PRN  Epizyme, Inc. to Present at Upcoming Conferences in February"," 7/23/2019 G5087110 PRN  Jazz Pharmaceuticals to Report 2019 Second Quarter Financial Results on August 6, 2019",,10/12/2018 00394S-E PRN  FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing,,10/28/2019 73701010 PRN  Portola Pharmaceuticals Presents New Analysis from the ANNEXA-4 Study of its Factor Xa Inhibitor Reversal Agent Andexxa® in Patients with Acute Gastrointestinal Bleeding,11/22/2016 92337F10 PRN  Veracyte Announces that CMS Will Maintain Historic Medicare Reimbursement Rate for the Afirma® Gene Expression Classifier in 2017,,12/02/2010 0031H7-E PRN  Cellectis Grants Harvard Bioscience a License to CytoPulse Electroporation Instruments, 6/28/2017 14075510 PRN  Legal Cannabis and CBD-Based Products Projected to Gain Popularity,,,10/22/2013 00847X10 PRN  Flagship VentureLabs™ Launches Pronutria to Prevent and Treat Diseases with Novel Protein Nutrients, 2/24/2015 000T07-E PRN  OXIS Biotech Issues Letter to Shareholders, 1/10/2014 008H33-E PRN  AnaptysBio Announces Development Of Novel anti-IL33 Therapeutic Antibody,,,10/15/2015 ASRT-US  PRN  Depomed Issues Statement,,"12/18/2014 45845P10 PRN  Critical Alerts For GoPro, Aeropostale, Magna International, Cliffs Natural Resources and Intercept Pharmaceuticals Released By InvestorsObserver"," 1/05/2011 0844XQ-E PRN  Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer",, 3/20/2018 98401F10 PRN  Xencor Announces Pricing of Public Offering of Common Stock,12/19/2013 0DCCGR-E PRN  Intra-Cellular Therapies Cleared for Quotation on OTCQB, 6/04/2019 G8807B10 PRN  Theravance Biopharma Appoints Andrew Hindman as Senior Vice President and Chief Financial Officer, 5/31/2013 079TK4-E PRN  Novocure to Present NovoTTF™ Therapy Data at the 2013 Annual Scientific Meeting of the American Society of Clinical Oncology,11/13/2018 03969710 PRN  Ardelyx Announces FDA Acceptance of the Filing of its New Drug Application for Tenapanor for the Treatment of Patients with IBS-C,,,,, 3/07/2017 M4613510 PRN  Foamix Pharmaceuticals to Present at the ROTH Capital Partners 29th Annual Growth Conference, 5/04/2011 06S8J6-E PRN  Beardsworth Continues to Strengthen Oncology Operations,,," 6/22/2015 74587V10 PRN  Harwood Feffer LLP Announces Securities Class Action Lawsuit Against Puma Biotechnology, Inc. And Advises Shareholders To Contact Harwood Feffer LLP Prior To The Lead Plaintiff Deadline",," 3/07/2017 21833P10 PRN  How These Biotech Stocks are Faring? -- Corbus Pharma, Advaxis, Vanda Pharma, and Nivalis Therapeutics", 2/20/2019 05070R10 PRN  Audentes Therapeutics to Participate in Upcoming Investor Conferences,,, 6/09/2014 0CT325-E PRN  Seres Health Closes Series B Financing and Enters into a Research Agreement with Mayo Clinic,,, 5/15/2019 75901B10 PRN  REGENXBIO to Launch New Manufacturing Facility for NAV Technology-based AAV Gene Therapies,,,,,,,, 6/01/2015 0085DK-E PRN  Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting,,,,, 2/08/2012 07N3G8-E PRN  ARGEN-X ADVANCES A THIRD THERAPEUTIC ANTIBODY PROGRAM INTO PRECLINICAL DEVELOPMENT,,12/24/2014 00695P-E  PRN  Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study,,,,,,,,," 6/06/2016 0FZZYY-E PRN  Homology Medicines Appoints James Warren, Ph.D. as Vice President of Manufacturing",,,,,,,,,,,,,,,,," 7/27/2019 50015M10 PRN  Kodiak Sciences Announces Positive Interim Data from Ongoing Phase 1b Clinical Study of KSI-301, a Novel Anti-VEGF Antibody Biopolymer Conjugate for Treatment of Wet AMD, Diabetic Eye Disease, and Retinal Vein Occlusion, at the American Society of Retina Specialists 2019 Annual Meeting",, 1/06/2017 000TBT-E PRN  Guardant Health to create a new 500-plus-gene liquid biopsy panel with several leading pharmaceutical companies to accelerate clinical trials and drug development,,, 8/05/2015 00FLML-E PRN  Twist Bioscience To Present At The 2015 Wedbush PacGrow Healthcare Conference,,,,,,,,,,,, 5/27/2014 0DMSKV-E PRN  Adaptive Biotechnologies and Collaborators to Present Data Advancing the Clinical Utility of Immunosequencing at the 50th Annual Meeting of the American Society of Clinical Oncology,
 6/16/2014 53220K50 PRN  Lemelson Capital Releases Investment Report On Ligand Pharmaceuticals (NASDAQ: LGND), 2/15/2017 74318710 PRN  Progenics Pharmaceuticals and Shutterfly to Join S&P SmallCap 600," 7/27/2016 45232710    PRN  Apple, Illumina, Alleghany Technologies, Las Vegas Sands, and Cirrus Logic and more offer option-trading opportunities that offer returns of more than 20%","11/13/2013 0CJTLG-E PRN  Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc."," 8/20/2019 PRX-US   PRN  Endo Announces Settlement in Principle to Resolve ""Track 1"" Opioid Cases"," 2/20/2015 04280A10 PRN  Latest updates on Biotechnology Companies: Special Research on Arrowhead, Bioanalytical Systems, Cleveland BioLabs, Dyax, and Exact Sciences", 5/02/2017 09060J10 PRN  BioDelivery Sciences Announces the Approval of BUNAVAIL® for Induction of Buprenorphine Treatment for Opioid Dependence,10/07/2019 09073M10    PRN  Bio-Techne Leverages The RNAscope™ Technology To Advance A Multiomic Approach To Antibody Validation,12/05/2019 75886F10    PRN  Regeneron Announces Positive Topline Phase 2 Data with Anti-C5 Antibody Pozelimab in Patients with a Rare Blood Disorder,," 9/25/2017 68375N10 PRN  Technical Reports on Biotech Equities -- Opko Health, Otonomy, Pacific Biosciences of California, and Portola Pharma", 8/28/2019 46222210 PRN  Ionis Pharmaceuticals to present at upcoming investor conferences," 9/26/2019 09061G10   PRN  BioMarin, Pioneer in Phenylketonuria (PKU) Therapies, Submits Clinical Trial Application (CTA) in U.K. for Investigational Gene Therapy for PKU"," 5/08/2015 01535110 PRN  SYNAGEVA BIOPHARMA CORP. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout", 6/04/2019 64125C10 PRN  Neurocrine Biosciences to Present at Goldman Sachs 40th Annual Global Healthcare Conference," 2/10/2017 81257810 PRN  Immunomedics Enters into Exclusive Global Licensing Agreement with Seattle Genetics for Sacituzumab Govitecan (IMMU-132) with Potential Payments of up to Approximately $2 Billion, Plus Royalties"," 9/30/2014 45290710 PRN  Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences", 7/28/2017 09062X10  PRN  Abarca Health Announces Innovative Value-Based Contract With Biogen For Multiple Sclerosis Therapies," 6/25/2014 45253H10 PRN  Collaborations, Clinical Study Results, and Laboratory Inspection Clearance - Analyst Notes on Amgen, Regeneron, Lexicon, WuXi PharmaTech and ImmunoGen"," 5/14/2014 09058V10 PRN  Top Gainers Pre-Market Notes -- Research on Halozyme Therapeutics, Goodrich Petroleum, BioCryst Pharma, and Coronado Biosciences", 2/23/2018 064FG9-E   PRN  Fish & Richardson Wipes Out $2.5 Billion Patent Verdict Against Gilead Sciences on JMOL, 9/09/2019 04004760   PRN  Arena Pharmaceuticals Presented New Patient-Reported Outcomes Data for Olorinab at the European Society of Neurogastroenterology & Motility NeuroGASTRO 2019 Meeting, 7/29/2019 N5946510  PRN  Mylan Reports Second Quarter 2019 Results, 8/05/2019 M2572210 PRN  Compugen Reports Second Quarter 2019 Results," 4/28/2017 00972810 PRN  Lifshitz & Miller LLP Announces Investigation of AdvancePierre Foods Holdings, Inc., Akorn, Inc., AllianceMMA, Inc., Altisource Portfolio Solutions, DelTaco Restaurants, Inc., Express Scripts Holding Company, China Unicom (Hong Kong) Limited, and Global Eagle Entertainment Inc.","12/03/2019 000C35-E PRN  Abarca, Amgen Enter Outcome-Based Agreement For Enbrel"," 4/27/2017 62855J10 PRN  Technical Roundup on Research Services Stocks -- Myriad Genetics, QIAGEN, INC Research, and Bioanalytical Systems", 6/09/2017 52887230 PRN  Lexicon Pharmaceuticals Reports Positive Top-Line Results In Phase 3 inTandem3 Study For Sotagliflozin In Patients With Type 1 Diabetes,, 8/02/2019 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 1/29/2020 000PQQ-E PRN  Point of Care Testing Essential for Preventing Spread Of Coronavirus in U.S., 9/23/2019 64026810 PRN  Nektar Therapeutics Announces Abstract Accepted for Presentation at the 5th CRI-CIMT-EATI-AACR Cancer Immunotherapy Conference, 2/21/2019 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results,"10/15/2014 37416310 PRN  Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics",," 7/17/2014 02311120 PRN  Health Care Sector Stocks Technical Review: Valeant Pharma, Teva Pharma Industries, Novo Nordisk, Curis, and Amarin"," 4/28/2017 45337C10 PRN  Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, Inc., Incyte Corporation, MOCON, Inc., Ocwen Financial Corporation and ThereapeuticsMD, Inc.", 4/08/2019 91307C10 PRN  United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint," 8/04/2015 80360710 PRN  Critical Alerts For MannKind, Sarepta Therapeutics, NXP Semiconductors, Rockwell Medical and Micron Released By InvestorsObserver", 7/18/2019 G0176710 PRN  Alkermes to Host Conference Call to Discuss Second Quarter 2019 Financial Results,, 9/18/2012 00B0RT-E PRN  Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors,, 5/06/2019 55027E10 PRN  Luminex Corporation Reports First Quarter 2019 Financial Results,12/17/2018 80067710 PRN  Sangamo Announces Treatment Of First Patient In Phase 1/2 Clinical Trial Of In Vivo Genome Editing Therapy For Hemophilia B,"10/22/2015 30161Q10 PRN  Covered Call Alerts For FireEye, Exelixis, eBay, Intuitive Surgical and SolarCity Released By InvestorsObserver", 7/29/2019 SAN-FR    PRN  What's New for 13th Digital Pharma East at the Pennsylvania Convention Center," 3/25/2015 92532F10  PRN  Biotech Equities Technical Coverage - ZIOPHARM Oncology, Arrowhead Research, Merrimack Pharma, Vertex Pharma, and Advaxis",," 5/17/2016 04351P10 PRN  Ascendis Pharma A/S to Present at the UBS Global Healthcare Conference on May 23, 2016"," 1/27/2015 09609G10 PRN  Biotech Stocks Technical Analysis - Achillion Pharma, Array BioPharma, Rexahn Pharma, Neurocrine Biosciences, and Bluebird Bio"," 6/07/2016 00422510 PRN  Biotechnology Stocks in Motion -- Celldex Therapeutics, Medivation, Opko Health, and ACADIA Pharma",, 5/08/2019 74366E10 PRN  Protagonist Therapeutics Expands PTG-200 Collaboration Agreement with Janssen to Include Second Generation Oral IL-23 Receptor Antagonists,,," 4/23/2014 98978L20    PRN  Zogenix Responds to Governor's Action Singling Out Zohydro™ ER in Massachusetts, Encourages Officials to Consider Patient Needs and Effective Class-Wide Measures",," 7/23/2015 OMER-US  PRN  FDA Grants ""Fast Track"" to Omeros' Complement Inhibitor OMS721 for aHUS",,,"11/27/2013 46333X10 PRN  Positive Opinion, Program Honorees, Positive Medical Results, and Investor Day - Research Report on Bristol-Myers Squibb, Ariad Pharmaceuticals, Dyax, Ironwood Pharmaceuticals, and Immunomedics",,11/21/2011 00D326-E PRN  Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team,,, 5/28/2019 69329Y10 PRN  PDL BioPharma to Participate in Jefferies 2019 Global Healthcare Conference,,,," 6/18/2019 00182C10 PRN  ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc."," 6/17/2014 29251M10 PRN  European Medicines Agency Validates Marketing Authorization Applications for AbbVie's Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 1 Chronic Hepatitis C","10/14/2014 02043Q10 PRN  Critical Alerts For Alnylam Pharmaceuticals, Burger King, Under Armour, MetLife and F5 Networks Released By InvestorsObserver",,, 2/07/2019 60468T10 PRN  Mirati Therapeutics To Present At The Guggenheim Healthcare Talks Idea Forum & Oncology Day,"11/06/2013 69512710 PRN  Conference Call Schedules, Presentations, Collaborations and FDA Approvals - Research Report on Pharmacyclics, Pacira Pharmaceuticals, Raptor Pharmaceuticals, Impax Laboratories, and AcelRx",,,, 6/14/2010 007MPF-E PRN  Chiasma Reports Successful Oral Delivery Of A Peptide In Clinical Study, 1/06/2011 05LJZC-E PRN  MacroGenics Initiates Phase I Clinical Trial of MGAH22 for Patients With HER2-Expressing Solid Tumors," 7/25/2019 09627Y10 PRN  Blueprint Medicines to Report Second Quarter 2019 Financial Results on Thursday, August 1, 2019",, 4/11/2019 28249U10 PRN  Eiger Announces 36% Durable Virologic Response at 24 Weeks Post-Treatment with Peginterferon Lambda in Phase 2 LIMT HDV Study at The International Liver Congress™ 2019, 1/13/2012 STBZ-US  PRN  Zacks Announces 12 Stocks for 2012,,,,,, 5/31/2019 92165910 PRN  Vanda Pharmaceuticals Announces Participation at the Jefferies 2019 Global Healthcare Conference,,,12/05/2016 TBPH-KY    PRN  Theravance Biopharma Highlights Filing of EU Regulatory Submission for the Closed Triple in COPD by GlaxoSmithKline and Innoviva,, 5/22/2019 40637H10 PRN  Halozyme Announces argenx Has Selected Second Target Under ENHANZE® Technology Collaboration And License Agreement," 6/18/2018 G2151510 PRN  WeissLaw LLP Investigates China Biologic Products Holdings, Inc."," 8/17/2015 56400P70 PRN  Critical Alerts For PayPal Holdings Inc., MannKind, Sysco Corporation, Transocean and Sarepta Therapeutics Released By InvestorsObserver",,,10/28/2014 06XCXX-E PRN  Juventas Therapeutics Strengthens Management Team with New Senior Vice President of Finance and Operations,11/18/2019 03236M20 PRN  Amyris Advances to Regulatory Stage with Another Significant Health & Nutrition Molecule,10/23/2019 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 2/10/2015 00448Q20 PRN  Critical Alerts For Transocean, Crane, Achillion Pharmaceuticals, Endocyte and Monster Beverage Released By InvestorsObserver"," 4/30/2015 87166B10 PRN  Where Opportunity is Found: Complementary Research on E-Commerce China, Potbelly, INC Research, Globus Maritime, EnviroStarm","10/09/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: GlaxoSmithKline, Pfizer, Theravance, Amicus Therapeutics and Parker-Hannifin",,,," 1/25/2018 36197T10 PRN  Fast-Growing Cannabis Industry Drives Biotech Research, Innovative Medical Therapy Development", 2/05/2014 29428V10 PRN  Epizyme Announces Pricing of Public Offering of Common Stock, 7/10/2019 G5087110 PRN  Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma,,10/08/2018 00394S-E PRN  Grifols Delivers Promise of Advancing Plasma-derived Medicines through Innovative Vision and Donor Support,,"10/15/2019 73701010 PRN  Portola Pharmaceuticals to Announce Third Quarter 2019 Financial Results on Tuesday, November 5, 2019",11/21/2016 MCGC-US  PRN  Veracyte Appoints Keith Kennedy as Chief Financial Officer,,11/30/2010 063J3K-E PRN  Cellectis Hosts Inaugural R&D Day, 6/15/2017 14075510 PRN  Consumers Spending on Legal Cannabis Products Projected to Grow,,, 9/04/2013 05Q0XH-E PRN  Flagship VentureLabs Launches Midori Renewables, 5/22/2012 46226010 PRN  Genesis Biopharma Mentioned Favorably in BioMedReports Article,12/17/2013 008H33-E PRN  AnaptysBio Announces Antibody Development Agreement With Momenta,,, 9/28/2015 ASRT-US  PRN  Depomed Issues Statement on ISS Report,,"11/19/2014 45845P10 PRN  Critical Alerts For JA Solar, 2U, AT&T, Mobileye NV and Intercept Pharmaceuticals Released By InvestorsObserver","11/03/2010 0844XQ-E PRN  Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders",," 3/19/2018 98401F10 PRN  Xencor, Inc. Announces Proposed Public Offering of Common Stock",12/09/2013 0DCCGR-E PRN  Intra-Cellular Therapies Announces Positive Topline Phase II Clinical Results of ITI-007 for the Treatment of Schizophrenia, 5/21/2019 G8807B10 PRN  Theravance Biopharma Reports Data from Phase 1b Study of TD-1473 in Oral Presentation at Digestive Disease Week (DDW) 2019, 5/07/2013 079TK4-E PRN  Clinical Trial for Newly Diagnosed Glioblastoma Opened in Korea,11/07/2018 03969710 PRN  Ardelyx Reports Third Quarter 2018 Financial Results and Recent Highlights,,,,, 2/27/2017 M4613510 PRN  Foamix Pharmaceuticals to Present at the Cowen & Company 37th Annual Healthcare Conference, 4/14/2011 001THX-E PRN  PRA International CRA Named US Clinical Researcher of the Year,,," 6/08/2015 74587V10 PRN  Robbins Arroyo LLP: Puma Biotechnology, Inc. (PBYI) Misled Shareholders According to a Recently Filed Class Action",, 3/03/2017 21833P10 PRN  Legal Cannabis Market Might be Beneficial to U.S. Economy, 2/08/2019 05070R10 PRN  Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,," 6/02/2014 0CT325-E PRN  Seres Health Appoints Former Merck Senior Executive, Roger J. Pomerantz, M.D., F.A.C.P., as Chief Executive Officer and Chairman",,, 5/08/2019 75901B10 PRN  REGENXBIO to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference,,,,,,,, 5/13/2015 HCM-HK   PRN  Chi-Med Announces Positive Fruquintinib Proof-of-concept Study Results Trigger Payments From Lilly,,,,,12/19/2011 07N3G8-E PRN  arGEN-X is Awarded €1.3 Million IWT Grant to Advance Proprietary SIMPLE Antibody™ Platform for Addressing Challenging Disease Targets,,12/17/2014 00695P-E  PRN  Kinex Pharmaceuticals Appoints Chief Operating Officer,,,,,,,,, 5/02/2016 0FZZYY-E PRN  Homology Medicines Emerges with Next Generation Gene Editing Technology Driven by Industry-leading Team in Rare Diseases,,,,,,,,,,,,,,,,, 7/24/2019 50015M10 PRN  Kodiak Sciences Announces Upcoming Presentation at American Society of Retina Specialists (ASRS) 2019 Annual Meeting,, 1/06/2017 05FGM6-E PRN  Ian Clark joins Guardant Health Board of Directors,,, 6/17/2015 00FLML-E PRN  Twist Bioscience To Present At The 2015 JMP Securities Life Sciences Conference,,,,,,,,,,,, 4/07/2014 0DMSKV-E PRN  Adaptive Biotechnologies Announces Completion of Series C and Series D Financing Rounds Through a $105 million Private Investment from Viking Global Investors,
" 1/10/2014 53220K50 PRN  Healthcare Companies Report Stock Price Movement, Conference Call Schedules, Study Results, and Presentations - Research Report on Merck, Keryx Biopharma, Pacira, Ligand Pharma, and Dyax"," 2/09/2017 74318710 PRN  Technical Reports on Biotech Stocks -- Progenics Pharma, Intrexon, Synthetics Biologics, and 22nd Century"," 7/07/2016 45232710    PRN  Learn how to target a 10% return on Freeport-McMoRan, or get option-trade ideas on Kohls, Halliburton, Ross Stores and Illumina or any stock you choose","11/07/2013 84763A10 PRN  Upcoming Earnings Schedules, Quarterly Financial Results, Clinical Trial Results and Updates - Research Report on INSYS, Acorda, Spectrum Pharmaceuticals, XOMA, and Cambrex", 8/05/2019 G3040110 PRN  Endo Reports Second-Quarter 2019 Financial Results," 2/17/2015 04280A10 PRN  Critical Alerts For Tesla Motors, CyberArk Software, Regeneron Pharmaceuticals, Microsoft and Arrowhead Research Released By InvestorsObserver", 4/26/2017 09060J10 PRN  BioDelivery Sciences to Present at the Deutsche Bank 42nd Annual Health Care Conference, 9/16/2019 09073M10    PRN  Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility,11/27/2019 75886F10    PRN  New England Journal of Medicine Publishes Results of Ebola Clinical Trial Confirming Superiority of Regeneron's REGN-EB3 to ZMapp in Preventing Ebola Deaths,," 8/02/2017 68375N10 PRN  Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP, Increasing Total Raised in Series C to US$38 million", 8/27/2019 IONS-US  PRN  Ionis licenses hepatitis B program to GSK," 9/09/2019 09061G10   PRN  BioMarin to Participate in Morgan Stanley 17th Annual Global Healthcare Conference on September 10, 2019 in New York"," 3/10/2015 01535110 PRN  Coverage of Biotech Equities -- MannKind, Novavax, Curis, Pharmacyclics, and Alexion Pharma", 5/30/2019 64125C10 PRN  Neurocrine Biosciences to Present at Jefferies 2019 Global Healthcare Conference," 1/21/2017 81257810 PRN  SEATTLE GENETICS (SGEN) ALERT:  Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Seattle Genetics, Inc.; Encourages all Investors to Contact the Firm for Information"," 8/08/2014 45290710 PRN  Technical Recap on Biotech Equities -- CytRx, AVEO Pharma, Mast Therapeutics, Immunomedics, and Dynavax Technologies", 7/27/2017 09062X10  PRN  Abarca Health And Biogen Announces Innovative Value-Based Contract For Multiple Sclerosis Therapies, 3/11/2014 45253H10 PRN  IDEXX Laboratories Elects Daniel Junius to Board of Directors," 1/16/2014 09058V10 PRN  Unaudited Results, Partnerships, and Stock Price Movements - Research Report on Cubist, Novavax, Exelixis, BioCryst, and Foundation Medicine"," 2/22/2018 SGMO-US    PRN  Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer", 8/28/2019 04004760   PRN  Arena Pharmaceuticals to Participate in Upcoming Investor Conferences, 7/08/2019 0B6RP3-E  PRN  Mylan and Atomo Diagnostics Announce WHO Prequalification Approval for Mylan HIV Self Test," 7/22/2019 M2572210 PRN  Compugen Second Quarter 2019 Conference Call Scheduled for Monday, August 5, 2019 at 8:30 AM ET"," 4/25/2017 00972810 PRN  AKORN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akorn, Inc.",12/02/2019 03116210 PRN  Amgen Announces Data Being Presented At ASH 2019, 2/10/2017 62855J10 PRN  Myriad Genetics to Join S&P SmallCap 600, 6/05/2017 52887230 PRN  Lexicon Pharmaceuticals To Present New Clinical Data At 77th American Diabetes Association Scientific Sessions,, 8/01/2019 45766930 PRN  Insmed Reports Second Quarter 2019 Financial Results and Provides Business Update,, 1/23/2020 45773H20 PRN  Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus, 9/12/2019 64026810 PRN  NKTR CLASS ACTION ALERT: Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Lawsuit Against Nektar Therapeutics," 1/23/2019 RIGL-US  PRN  Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe","10/10/2014 0017CF-E PRN  GERON SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors In Geron Corporation's January 2014 Offering To Contact The Firm",," 6/25/2014 02311120 PRN  Rick Harrison of Television's ""Pawn Stars®"" Discusses His Revelations on Seeking Treatment for His Very High Triglycerides in National Awareness Campaign"," 4/20/2017 45337C10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Incyte Corporation (INCY)", 3/12/2019 91307C10 PRN  United Therapeutics Corporation to Present at Oppenheimer 29th Annual Healthcare Conference," 7/10/2015 80360710 PRN  Critical Alerts For MannKind, Pandora, Micron, Sarepta Therapeutics and NXP Semiconductors Released By InvestorsObserver", 7/15/2019 G0176710 PRN  Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder,,11/17/2010 000D61-E PRN  Reportlinker Adds Global Nanomaterials Industry,," 4/18/2019 55027E10 PRN  Luminex Corporation First Quarter Earnings Release Scheduled for May 6, 2019",12/03/2018 80067710 PRN  Sangamo Announces Completion Of TxCell Acquisition,"10/12/2015 30161Q10 PRN  Critical Alerts For Linn Energy, Autodesk, Palo Alto Networks, Exelixis and MannKind Released By InvestorsObserver", 7/29/2019 80105N10  PRN  Sanofi delivered solid growth in Q2 2019, 3/24/2015 000YJB-E  PRN  Pronutria Biosciences™ Appoints Dr. Christopher Wright as Senior Vice President and Chief Medical Officer,," 5/06/2016 ASND-DK  PRN  Ascendis Pharma A/S to Present at the Bank of America Merrill Lynch 2016 Healthcare Conference on May 11, 2016"," 1/07/2015 09609G10 PRN  BLUE INVESTOR ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into bluebird bio, Inc. Regarding Possible Breaches of Fiduciary Duty"," 9/29/2015 00422510 PRN  Covered Call Alerts For Ambarella, Regeneron Pharmaceuticals, ACADIA Pharmaceuticals, Achillion Pharmaceuticals and JC Penney Released By InvestorsObserver",, 5/07/2019 74366E10 PRN  Protagonist Therapeutics to Present Preclinical Data on PN-943 at Digestive Disease Week Conference 2019,,, 4/15/2014 98978L20    PRN  Zogenix Announces Ruling Preventing the Implementation of Massachusetts Governor's Order that Prevented Access to Zohydro™ ER,," 6/17/2015 68214310 PRN  Rajiv Shah, M.D., Appointed to Omeros' Board of Directors",,,"11/25/2013 46333X10 PRN  Morning Research: Allscripts Healthcare Solutions Inc., Perrigo Co., and Ironwood Pharma Inc.",,10/05/2011 00D326-E PRN  Ultragenyx Granted Orphan Drug Designation for UX001 SA-ER for the Treatment of Hereditary Inclusion Body Myopathy (HIBM),,, 5/15/2019 69329Y10 PRN  PDL BioPharma to Participate at UBS Global Healthcare Conference,,,, 6/12/2019 00182C10 PRN  ANI Pharmaceuticals to Present at Raymond James Life Sciences and MedTech Conference," 5/08/2014 29251M10 PRN  AbbVie Submits for EU Marketing Authorization its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Chronic Hepatitis C"," 9/25/2014 02043Q10 PRN  Market Movers - Biotech Stocks - Hemispherx Biopharma, Aegerion Pharma, Cytori Therapeutics, Alnylam Pharma, and Rexahn Pharma",,, 1/22/2019 60468T10 PRN  Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares,"10/23/2013 69512710 PRN  Healthcare Sector Announced Clinical Data Presentation, Upcoming Financial Release Schedules and Updates on New Drug Applications - Research Report on Alexion, Pacira, pSivida, Momenta and Impax",,,,,10/26/2010 000TBT-E PRN  MacroGenics Enters Global Research Collaboration and License Agreement with Pfizer, 7/18/2019 09627Y10 PRN  Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application for Avapritinib for the Treatment of PDGFRα D842V Mutant GIST and Fourth-Line GIST,, 3/26/2019 28249U10 PRN  Eiger BioPharmaceuticals to Participate in Conferences in April,10/28/2011 000YQ7-E PRN  Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®,,,,,, 5/22/2019 92165910 PRN  Tradipitant in the Treatment of Gastroparesis: Vanda Presents Clinical Trial Results at DDW 2019,,,11/21/2016 45781M10   PRN  GSK files regulatory submission in US for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD,, 5/13/2019 40637H10 PRN  Halozyme To Participate In Bank of America Merrill Lynch Health Care Conference 2019, 6/11/2018 G2151510 PRN  China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant," 8/04/2015 56400P70 PRN  Critical Alerts For MannKind, Sarepta Therapeutics, NXP Semiconductors, Rockwell Medical and Micron Released By InvestorsObserver",,, 1/07/2013 002VD4-E PRN  Esperion Announces Positive Topline Results from a Phase 2 Clinical Trial of ETC-1002 in Patients with Type 2 Diabetes,11/15/2019 03236M20 PRN  Amyris Closes on Exchange to Resolve CVI Heights Debt,10/15/2019 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2019 Financial Results," 1/27/2015 00448Q20 PRN  Biotech Stocks Technical Analysis - Achillion Pharma, Array BioPharma, Rexahn Pharma, Neurocrine Biosciences, and Bluebird Bio", 1/13/2015 87166B10 PRN  goBalto Announces Latest Release of goBalto Activate, 4/03/2012 07FFZD-E PRN  Attorneys Share Insights on Licensing Issues in Bio Pharma/Life Sciences,,,, 1/16/2018 36197T10 PRN  Arizona Law May Protect Medical-marijuana Users From Feds' New Stance, 2/03/2014 29428V10 PRN  Epizyme Announces Proposed Public Offering of Common Stock, 6/25/2019 G5087110 PRN  Jazz Pharmaceuticals Announces Webcast for Sunosi Investor Update,," 9/24/2018 00394S-E PRN  Grifols Announces the Opening of Biotest Pharmaceuticals Corporation's Newest Plasma Donor Center in Bowling Green, Ohio",," 9/19/2019 73701010 PRN  Portola Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors",11/15/2016 92337F10 PRN  Veracyte to Participate in Two Upcoming Investor Conferences,,10/25/2010 063J3K-E PRN  Cellectis and the Center for iPS Cells Research and Application Enter Collaboration," 6/02/2017 14075510 PRN  Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Cara Therapeutics, Cerus, and Concert Pharma",,,, 5/21/2012 46226010 PRN  Genesis Biopharma Issues Letter To Shareholders,10/17/2013 008H33-E PRN  AnaptysBio Receives Allowance Of US Patent Covering Proprietary ABELmAb™ Libraries,,, 9/22/2015 DPLO-US  PRN  Diplomat Addresses Unusual Market Activity,,"10/22/2014 45845P10 PRN  Recognition, Product Enhancement, Marketing Approval, Upcoming Events, and Quarterly Earnings - Research Reports on Abbott, Illumina, Thermo Fisher, Intercept and Stryker"," 6/07/2010 0844XQ-E PRN  O2h to Provide Discovery Support to Karyopharm Therapeutics, Inc.",, 2/27/2018 98401F10 PRN  Xencor Reports Fourth Quarter and Full Year 2017 Financial Results,, 5/20/2019 G8807B10 PRN  Theravance Biopharma and Mylan Present Additional YUPELRI® (revefenacin) Phase 3 Data Analysis at the 2019 ATS International Conference, 4/10/2013 079TK4-E PRN  Novocure Presents Preclinical Data at the American Association for Cancer Research (AACR),10/26/2018 03969710 PRN  Ardelyx Presents New Preclinical Data Demonstrating Synergy between Tenapanor and Sevelamer When Dosed in Combination for Elevated Serum Phosphorus,,,,, 2/23/2017 M4613510 PRN  Foamix Pharmaceuticals to Participate in a Panel Discussion at the Dermatology Innovation Forum, 4/12/2011 001THX-E PRN  PRA International Experts to Speak at Drug Safety Conference,,," 6/05/2015 74587V10 PRN  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Puma Biotechnology To Contact The Firm",,10/20/2016 21833P10 PRN  Biotech Stocks Worth A Glance Testing Sector Trends, 1/31/2019 05070R10 PRN  Audentes Therapeutics Announces Next Steps in the Development of AT132 to Treat XLMTM Following Collaborative Initial Meeting with FDA Under RMAT Designation,,, 3/25/2014 0CT325-E PRN  Seres Health to Present at 21st Annual BioCentury Future Leaders in the Biotech Industry Conference,,, 5/07/2019 75901B10 PRN  REGENXBIO Reports First Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD,,,,,,,, 5/24/2011 HCM-HK   PRN  Hain Celestial Announces Official Launch of The Earth's Best® and Zhi Ling Tong® Co-Branded Infant Formula,,,,,12/01/2011 05WM9Q-E PRN  arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round,,10/15/2014 00695P-E  PRN  Hanmi Pharmaceuticals and Collaborative Partner Kinex Pharmaceuticals Announce Preliminary Results from a Phase I Clinical Study (HM-OTE-103) with Oratecan® in Patients with Advanced Cancer,,,,,,,,,,,,,,,,,,,,,,,,,, 5/30/2019 50015M10 PRN  Kodiak Sciences to Present at the Jefferies 2019 Healthcare Conference,,11/16/2016 00FYYJ-E PRN  Guardant Health Announces Milestone Partnership with Robert H. Lurie Comprehensive Cancer Center of Northwestern University,,, 6/16/2015 00FLML-E PRN  Twist Bioscience Names Solange Glaize As Chief Financial Officer,,,,,,,,,,,,,
"12/24/2013 53220K50 PRN  Healthcare Companies Announce Study Results, Acquisitions and Company Updates - Research Report on Sirona Dental Systems, Ligand Pharmaceuticals, Genomic Health, Unilife, and Sykes", 9/06/2016 74318710 PRN  Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets," 6/30/2016 065MX1-E    PRN  Merck KGaA, Darmstadt, Germany Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance","10/31/2013 84763A10 PRN  Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc.", 8/02/2019 G3040110 PRN  Endo Applauds U.S. District Court Decision that Vasopressin Cannot be Used for Compounding by Outsourcing Facilities," 2/10/2015 04280A10 PRN  Today's Review on Biotech Equities - Vertex Pharma, Alexion Pharma, Arrowhead Research, Medivation, and Incyte"," 3/31/2017 09060J10 PRN  BioDelivery Sciences Announces the Granting of Two New Patents to be Listed in FDA's Orange Book Further Extending and Strengthening Patent Protection on BELBUCA®, BUNAVAIL® and ONSOLIS®", 8/20/2019 09073M10    PRN  Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice™ System,11/22/2019 75886F10    PRN  Regeneron's Yancopoulos Receives Columbia College's Alexander Hamilton Award,," 7/27/2017 68375N10 PRN  Technical Reports on Biotech Equities -- Opko Health, Array BioPharma, Immunomedics, and TG Therapeutics"," 8/08/2019 IONS-US  PRN  Dynacure Receives Orphan Drug Designation from the US FDA for DYN101, an Antisense Medicine to Treat Rare Disease 'Centronuclear Myopathies'"," 8/28/2019 09061G10   PRN  BioMarin to Participate in Morgan Stanley 17th Annual Global Healthcare Conference on September 10, 2019 in New York", 3/03/2015 0017F0-E PRN  Blueprint Medicines Announces Strategic Collaboration with Alexion to Advance Kinase Drug Candidates in Rare Genetic Disease," 5/20/2019 64125C10 PRN  Neurocrine Biosciences Presents New Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia, Demonstrating the Effect of Involuntary Movements on Patient Quality of Life", 1/20/2017 81257810 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Announces the Filing of a Class Action against Seattle Genetics Inc. and Certain Officers - SGEN," 3/18/2014 DRRX-US  PRN  Lifshitz & Miller Law Firm Announces Investigation of CytRx Corporation, DURECT Corporation, Hastings Entertainment, Inc., Immunomedics, Inc. and NII Holdings, Inc.", 7/17/2017 00167Y-E  PRN  Ionis Earns $10 Million Milestone Payment from Biogen for Advancing a New Program in its Neurology Collaboration," 1/15/2014 45253H10 PRN  Upcoming Earnings Schedule, Supply and Collaboration Agreements, Financial Results, and Stock Options - Research Report on Natus, Haemonetics, AngioDynamics, Horizon Pharma, and ImmunoGen"," 1/03/2014 09058V10 PRN  Pre-Market Highlight of the Day: Questcor Pharma, PDL BioPharma, Amgen, and BioCryst Pharma","12/08/2017 07PRVB-E   PRN  Seattle Cancer Care Alliance Selected as Authorized Treatment Center for Yescarta™ - A Novel, New Immunotherapy Treatment"," 8/07/2019 04004760   PRN  Arena Reports Second Quarter Financial Results with Strong Liquidity Position, and Initiation of Etrasimod ELEVATE UC 52 and Olorinab CAPTIVATE Trials", 6/14/2019 N5946510  PRN  Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories, 7/16/2019 M2572210 PRN  Compugen Expands Intellectual Property Portfolio for COM701 with New U.S. Patent Covering Combination Use with anti-PD-1 Antibody," 4/25/2017 00972810 PRN  Harwood Feffer LLP Announces Investigation of Akorn, Inc.","11/26/2019 03116210 PRN  Thinking about trading options or stock in Amgen, The Medicines Company, Netflix, NVIDIA, or Charles Schwab?","11/15/2016 62855J10 PRN  Learn how to target a 20% return on Sears Holdings, or get option-trade ideas on Intrexon, Agios Pharmaceuticals, Mattel Inc. and Myriad Genetics or any stock you choose", 5/31/2017 52887230 PRN  Lexicon Pharmaceuticals To Present At Upcoming Investor Conferences,," 7/25/2019 45766930 PRN  Insmed to Host Second Quarter 2019 Financial Results Conference Call on Thursday, August 1, 2019",, 1/15/2020 45773H20 PRN  Inovio Welcomes Biotech Leader to its Board of Directors," 9/03/2019 64026810 PRN  Kessler Topaz Meltzer & Check, LLP:  Securities Fraud Class Action Filed Against Nektar Therapeutics - NKTR", 1/07/2019 76655960 PRN  Rigel Pharmaceuticals Provides Business Update," 9/08/2014 37416310 PRN  Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals",," 3/28/2014 02311120 PRN  Amarin Corporation plc. Analyst Report: Special Situation \ Turnaround Opportunity in Biopharmaceuticals - Targeting large existing cardiovascular health market by BrokerBank Securities, Inc.", 4/19/2017 45337C10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporation - INCY, 3/04/2019 91307C10 PRN  United Therapeutics Corporation To Present At Cowen And Company 39th Annual Health Care Conference," 6/24/2015 80360710 PRN  Critical Alerts For Tesla Motors, ImmunoGen, Celgene, Sarepta Therapeutics and Lululemon Released By InvestorsObserver", 7/01/2019 G0176710 PRN  Alkermes Demonstrates Commitment to Local Community for 11th Consecutive Year With Largest Volunteer Event in Company History,,11/16/2010 000FGW-E PRN  Reportlinker Adds Global Imaging Agents Industry,, 3/05/2019 55027E10 PRN  Luminex Corporation to Present at the Barclays Global Healthcare Conference,11/08/2018 80067710 PRN  Sangamo Therapeutics Reports Third Quarter 2018 Financial Results," 9/30/2015 HCBK-US  PRN  Technical Review on Healthcare and Financial Sectors -- Two Harbors Investments, Hudson City Bancorp, Novavax, Opko Health and Exelixis", 7/03/2019 005M9Z-E  PRN  Easing the Burden for People with Hemophilia," 2/10/2015 92532F10  PRN  Today's Review on Biotech Equities - Vertex Pharma, Alexion Pharma, Arrowhead Research, Medivation, and Incyte",, 4/14/2016 04351P10 PRN  Ascendis Pharma A/S Reports Full Year 2015 Financial Results,"12/12/2014 09609G10 PRN  Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio"," 9/24/2015 00422510 PRN  Market Pulse of Healthcare Sector - Concert Pharmaceuticals, Clovis Oncology, bluebird bio, ACADIA Pharmaceuticals and DENTSPLY International",," 4/01/2019 74366E10 PRN  Protagonist Therapeutics to Present at the H.C. Wainwright & Co. Global Life Sciences Conference on Tuesday, April 9",,, 4/11/2014 98978L20    PRN  Let's Get the Facts Straight About Zohydro™ ER--and the Important Patient Need It Fills,, 6/16/2015 OMER-US  PRN  Omeros Announces Exclusive License Agreement for Omeros' Arthroscopic Product OMS103,,,"11/11/2013 46333X10 PRN  Upcoming Earnings Schedules, Conferences and Quarterly Financial Results - Research Report on Supernus, Ironwood, Neurocrine Biosciences, PhotoMedex, and Kythera",," 8/15/2011 00D326-E PRN  Ultragenyx Initiates Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Muscle Wasting Disease",,, 5/09/2019 69329Y10 PRN  PDL BioPharma Reports 2019 First Quarter Financial Results,,,, 5/09/2019 00182C10 PRN  ANI Pharmaceuticals Reports First Quarter 2019 Results and Reaffirms Guidance," 4/22/2014 29251M10 PRN  AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C"," 7/08/2014 02043Q10 PRN  Patient Enrollments, Board Appointments, Acquisitions, and Technical Updates - Analyst Notes on Questcor, Synta, Clovis, Alnylam and Intrexon",,, 1/16/2019 60468T10 PRN  Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock," 9/30/2013 69512710 PRN  Product Launches, Clinical Study Results, Historical Trials, Joint Lawsuits and Milestone Patient Enrollment - Research Report on Teva, Pacira, Novo Nordisk, Forest, and Amarin",,,,,"10/26/2010 05LJZC-E PRN  Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics"," 6/25/2019 0BP4MZ-E PRN  Frontier Medicines launches with $67 million to develop novel medicines that drug the ""undruggable"" targets driving human disease",, 3/25/2019 28249U10 PRN  Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study Results of Avexitide in Post-Bariatric Hypoglycemia at Endocrine Society Meeting (ENDO) 2019,10/08/2011 000YQ7-E PRN  Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®,,,,,, 5/01/2019 92165910 PRN  Vanda Pharmaceuticals Reports First Quarter 2019 Financial Results,,,11/07/2016 45781M10   PRN  Innoviva Set to Join the S&P SmallCap 600,, 5/07/2019 40637H10 PRN  Halozyme Reports First Quarter 2019 Results, 5/04/2018 G2151510 PRN  China Biologic Reports Financial Results for the First Quarter of 2018," 7/22/2015 56400P70 PRN  Critical Alerts For Fitbit, MannKind, Celgene, Yahoo! and Zulily Released By InvestorsObserver",,, 1/04/2013 002VD4-E PRN  Tim Mayleben Named President And CEO Of Esperion Therapeutics,11/11/2019 03236M20 PRN  Amyris Executes Agreements to Resolve CVI Heights Debt,10/07/2019 69366J20 PRN  PTC Therapeutics Establishes Strategic Collaboration with Aldevron to Support GMP Plasmid Manufacturing," 1/21/2015 00448Q20 PRN  Critical Alerts For General Electric, Achillion Pharmaceuticals, 3D Systems, Apache Corporation and Regeneron Pharmaceuticals Released By InvestorsObserver",, 2/23/2012 0626PS-E PRN  Satori Pharmaceuticals Raises $15M in New Funding,,,,12/20/2017 36197T10 PRN  The Value of Medical Cannabis Products Are Expected to Rise," 1/10/2014 29428V10 PRN  Clinical Study Updates, Milestones Achievements, and Stock Price Movements - Research Report on Johnson & Johnson, Epizyme, Health Management, DENTSPLY, and Charles River", 6/17/2019 G5087110 PRN  Jazz Pharmaceuticals Receives Schedule IV Designation from DEA for Sunosi™ (solriamfetol),, 8/16/2018 39843840 PRN  Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins,, 8/22/2019 73701010 PRN  Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences,11/03/2016 92337F10 PRN  Veracyte Announces Third Quarter 2016 Financial Results,,10/19/2010 063J3K-E PRN  Cellectis Plant Sciences Licenses Plant Transformation Technology From Midwest Oilseeds," 4/13/2017 14075510 PRN  Biotech Stocks on Investors' Radar -- Halozyme Therapeutics, Cara Therapeutics, PDL BioPharma, and Arena Pharma",,,, 5/07/2012 46226010 PRN  Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering," 9/24/2013 008H33-E PRN  AnaptysBio Named a 2013 ""Fierce 15"" Winner",,, 9/14/2015 ASRT-US  PRN  Depomed's Board of Directors Rejects Horizon Pharma plc's Unsolicited Exchange Offer,,"10/08/2014 45845P10 PRN  Critical Alerts For Exxon Mobil, Celgene, Verizon, Intercept Pharmaceuticals and Lockheed Martin Released By InvestorsObserver",,, 2/22/2018 98401F10 PRN  Xencor Doses First Patient in Phase 1 Study of XmAb®18087 Bispecific Tumor Targeting Antibody for the Treatment of Neuroendocrine Tumors and Gastrointestinal Stromal Tumors,, 5/20/2019 G8807B10 PRN  Theravance Biopharma and Mylan Present Additional YUPELRI® (revefenacin) Phase 3 Data Analysis at the 2019 ATS International Conference, 1/22/2013 079TK4-E PRN  NCCN Guidelines® Recommend NovoTTF™ Therapy as a Standard Treatment Option for CNS Cancers,10/08/2018 03969710 PRN  Ardelyx Showcases New Data from T3MPO-3 Long-Term Safety Trial of Tenapanor for IBS-C in Presidential Poster at ACG 2018 Annual Meeting,,,,, 2/22/2017 M4613510 PRN  Foamix Reports Year End 2016 Financial Results and Provides Business Update, 3/29/2011 001THX-E PRN  PRA International Experts to Chair BioPharma Asia Panels,,," 5/14/2015 74587V10 PRN  /C O R R E C T I O N -- Bronstein, Gewirtz & Grossman, LLC/",," 5/18/2015 21833P10 PRN  Tracking the Pulse of the Healthcare Sector: Complementary Research on Corbus, Vascular Biogenics, Alexza, TetraLogic and Cleveland BioLabs", 1/07/2019 05070R10 PRN  Audentes Therapeutics Reports on Recent Progress and Outlines 2019 Key Priorities,,, 1/13/2014 0CT325-E PRN  Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile,,, 4/30/2019 75901B10 PRN  REGENXBIO to Host Conference Call on May 7 to Discuss First Quarter 2019 Financial Results and Recent Operational Highlights,,,,,,,, 9/20/2010 0013W7-E PRN  Hutchison Hain Organic Launches Earth's Best and Zhi Ling Tong Co-Branded Infant Formula in China,,,,, 9/07/2011 07N3G8-E PRN  arGEN-X Presents Significant Progress at BioPharm America 2011,, 9/09/2014 0CVTR5-E  PRN  Kinex Completes Acquisition of QuaDPharma,,,,,,,,,,,,,,,,,,,,,,,,,, 5/15/2019 50015M10 PRN  Kodiak Sciences Announces First Quarter 2019 Financial Results and Recent Business Highlights,,11/03/2016 00FYYJ-E PRN  Guardant Health Announces Enhancements to Guardant360 Designed to Further Improve Clinical Sensitivity and Utility,,, 6/09/2015 00FLML-E PRN  Twist Bioscience Raises $37 Million In Oversubscribed Series C Financing,,,,,,,,,,,,,
"12/16/2013 53220K50 PRN  Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health", 7/19/2016 74318710 PRN  Valeant and Progenics Announce FDA Approves RELISTOR® Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-cancer Pain," 6/23/2016 45232710    PRN  Disney trade offers a 31% return in 58 days, or find similar option trades on BlackBerry, Smith & Wesson, Illumina, and Verizon Communications","10/08/2013 84763A10 PRN  Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp."," 8/01/2019 G3040110 PRN  Endo Appoints Domenico Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics", 1/14/2015 04280A10 PRN  Robbins Arroyo LLP Is Investigating the Officers and Directors of Arrowhead Research Corporation (ARWR) on Behalf of Shareholders," 3/24/2017 09060J10 PRN  Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma", 8/15/2019 09073M10    PRN  Bio-Techne To Present At The Baird 2019 Global Healthcare Conference,11/12/2019 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentations,, 5/22/2017 68375N10 PRN  MabVax Therapeutics Announces the Closing of its $4.1 Million Public Offering, 8/07/2019 46222210 PRN  Ionis Reports Second Quarter 2019 Financial Results, 8/01/2019 09061G10   PRN  BioMarin Announces Second Quarter 2019 Financial Results," 2/10/2015 01535110 PRN  Today's Review on Biotech Equities - Vertex Pharma, Alexion Pharma, Arrowhead Research, Medivation, and Incyte"," 5/16/2019 64125C10 PRN  Neurocrine Biosciences to Present New Quality-of-Life Data Analysis from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia Patients, at the 2019 American Psychiatric Association Annual Meeting"," 1/19/2017 81257810 PRN  Lifshitz & Miller Law Firm Announces Investigation of Ally Financial Inc., Amphastar Pharmaceuticals, Inc., Lannett Company, Inc., Live Ventures Incorporated, MiMedx Group, Inc., Seattle Genetics, Inc., Teligent, Inc., TerraVia Holdings, Inc., and Zimmer Biomet Holdings, Inc."," 3/05/2014 TWC-US   PRN  Investor Alert: Pittsburgh Law Office of Alfred G. Yates, Jr., P.C. Announces Investigations into Carnival Corporation (NYSE: CCL), Emeritus Corp. (ESC), FedEx Corporation (FDX), Forest Laboratories (FRX), Immunomedics (IMMU), JPMorgan Chase & Co. (JPM), LifeLock (LOCK), Time Warner Cable (TWC), and TriQuint Semiconductor (TQNT)", 6/15/2017 09062X10  PRN  Pharmaceutical Leaders Pave the Way to New Alzheimer's Treatments," 1/14/2014 45253H10 PRN  Critical Alerts For AT&T, Gold SPDR, Arrowhead Research, Johnson & Johnson, and ImmunoGen Released By InvestorsObserver","12/23/2013 09058V10 PRN  Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst","11/01/2017 37555810   PRN  Stocks Under Scanner in the Biotech Space -- Axovant Sciences, Gilead Sciences, Novavax, and Opko Health", 7/31/2019 04004760   PRN  Arena Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on August 7, 6/14/2019 N5946510  PRN  Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories, 7/02/2019 M2572210 PRN  Compugen Appoints Eran Perry to Its Board of Directors, 4/25/2017 00972810 PRN  AKORN (AKRX) ALERT: J&W Launches Investigation into the Sale of Akorn; Is $34 a Fair Price?,11/21/2019 03116210 PRN  Amgen Completes Acquisition Of Otezla® (apremilast),"10/28/2016 62855J10 PRN  Covered Call reports for CenturyLink, Francesca's Holdings Company, Myriad Genetics, Stamps.Com Inc. and Ultragenyx Pharmaceuticals include trade ideas that offer returns of 19% or more!", 5/11/2017 52887230 PRN  Lexicon Pharmaceuticals Reports Additional Positive Data From Pivotal InTandem1 Phase 3 Study For Sotagliflozin In Patients With Type 1 Diabetes,, 7/02/2019 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 1/06/2020 45773H20 PRN  Inovio Provides Update on Clinical Program Plans for 2020," 8/30/2019 64026810 PRN  LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm", 1/03/2019 76655960 PRN  Rigel to Present at the 37th Annual J.P. Morgan Healthcare Conference," 8/01/2014 37416310 PRN  Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma",,"12/27/2013 02311120 PRN  Equity Technical Dimensions:Seattle Genetics, Amarin, and PerkinElmer", 4/14/2017 45337C10 PRN  U.S. FDA Issues Complete Response Letter for Baricitinib, 2/27/2019 91307C10 PRN  United Therapeutics Corporation Reports 2018 Fourth Quarter And Annual Financial Results," 6/09/2015 80360710 PRN  Critical Alerts For Gilead Sciences, Sarepta Therapeutics, General Electric, Clean Energy Fuels and Petrobras Released By InvestorsObserver", 6/12/2019 G0176710 PRN  Alkermes Advances ALKS 4230 into Monotherapy Expansion Phase of ARTISTRY-1 in Patients With Renal Cell Carcinoma or Melanoma,,,, 2/08/2019 55027E10 PRN  Luminex Corporation Declares First Quarter Cash Dividend,11/06/2018 80067710 PRN  Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences," 9/24/2015 30161Q10 PRN  Covered Call Alerts For Exelixis, Heron Therapeutics, BP, Micron and Qihoo 360 Technology Released By InvestorsObserver", 6/26/2019 80105N10  PRN  FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis," 1/07/2015 92532F10  PRN  Technical Scrutiny on Biotech Stocks - Galena Biopharma, Synta Pharma, Merrimack Pharma, Vertex Pharma, and Spectrum Pharma",, 4/04/2016 04351P10 PRN  Ascendis Pharma A/S Announces TransCon Growth Hormone Oral and Poster Presentations at ENDO 2016,"12/09/2014 09609G10 PRN  Critical Alerts For Mobileye NV, bluebird bio Inc., Isis Pharmaceuticals, Castlight Health and ConocoPhillips Released By InvestorsObserver"," 9/17/2015 00422510 PRN  Equities Coverage on the Healthcare Sector -- Achillion Pharma, Perrigo, ACADIA Pharma, Kindred Healthcare, and Insulet",, 3/12/2019 74366E10 PRN  Protagonist Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results,,, 4/08/2014 98978L20    PRN  Zogenix Update on Legal Action,, 5/22/2015 OMER-US  PRN  Omidria® Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use,,,"10/28/2013 46333X10 PRN  Partnership, Quarterly Reports, Acquisition, and Publication - Research Report on Alere, Ironwood, Magellan Health Services, Foundation Medicine, and InterMune",,,,," 5/02/2019 69329Y10 PRN  PDL BioPharma to Announce First Quarter 2019 Financial Results on May 9, 2019",,,, 5/02/2019 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2019 Financial Results, 4/12/2014 29251M10 PRN  AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress™," 6/30/2014 02043Q10 PRN  Senior Notes Offerings, Study Findings, Recognitions, Accreditations, and Collaborations - Analyst Notes on Tenet, Hologic, PAREXEL, Centene and Alnylam",,, 1/16/2019 60468T10 PRN  Mirati Therapeutics Announces Proposed Public Offering Of Common Stock," 9/25/2013 69512710 PRN  Drug Recommendations, Presentations, Marketing Authorizations, and Board Appointments - Research Report on Johnson & Johnson, Lilly, Sanofi, GSK, and Pacira",,,,,"10/26/2010 05LJZC-E PRN  Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics", 6/15/2019 09627Y10 PRN  Blueprint Medicines Presents Updated EXPLORER Trial Data for Avapritinib in Patients with Systemic Mastocytosis at 24th EHA Congress,, 3/20/2019 28249U10 PRN  Eiger BioPharmaceuticals Management Team to Present and Participate in China Healthcare Investment Conference 2019,10/07/2011 000YQ7-E PRN  Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R),,,,,, 4/24/2019 92165910 PRN  Vanda Pharmaceuticals Appoints Phaedra Chrousos to Board of Directors,,," 6/09/2016 45781M10   PRN  Technical Snapshot on Application Software Stocks - Fortinet, Workday, Proofpoint, and Innoviva",, 5/06/2019 40637H10 PRN  Halozyme Names Dr. Alison A. Armour As Senior Vice President Of Research And Development, 4/24/2018 G2151510 PRN  China Biologic to Report First Quarter of 2018 Financial Results," 7/10/2015 56400P70 PRN  Critical Alerts For MannKind, Pandora, Micron, Sarepta Therapeutics and NXP Semiconductors Released By InvestorsObserver",,, 1/03/2013 002VD4-E PRN  Esperion To Present At 31st Annual J.P. Morgan Healthcare Conference,11/07/2019 03236M20 PRN  Amyris Continues to Deliver Strong Revenue Growth,10/04/2019 69366J20 PRN  PTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna™ (ataluren) Slows Disease Progression in Patients with Duchenne Muscular Dystrophy,"12/23/2014 00448Q20 PRN  Critical Alerts For Achillion Pharmaceuticals, AT&T, Peabody Energy, Gilead Sciences and Facebook Released By InvestorsObserver",," 7/13/2011 NSPR-IL  PRN  Sol J. Barer, Ph.D. Joins InspireMD Board of Directors",,,,12/19/2017 36197T10 PRN  Biotech Market Banking on Big Cannabis Returns," 1/06/2014 07CMVM-E PRN  Epizyme and Celgene Advance EPZ-5676 DOT1L Inhibitor Clinical Program to Benefit Cancer Patients with Acute Leukemias, Achieving $25 Million Clinical Proof of Concept Milestone"," 6/03/2019 G5087110 PRN  Jazz Pharmaceuticals Appoints Dr. Robert Iannone as Executive Vice President, Research and Development",, 8/14/2018 00394S-E PRN  Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System,, 8/13/2019 73701010 PRN  Portola Pharmaceuticals Announces Pricing of Public Offering of Common Stock,"11/02/2016 92337F10 PRN  Veracyte Announces Pricing of Public Offering of 5,000,000 Shares of Common Stock",,10/18/2010 063J3K-E PRN  Cellectis In-Licenses Induced Pluripotent Stem Cell Technology From iPS Academia Japan, 3/27/2017 14075510 PRN  The Legal Cannabis Market Developments in 2017,,,, 4/09/2012 46226010 PRN  Genesis Biopharma Announces Proposed Public Offering of Common Stock and Warrants, 8/29/2013 008H33-E PRN  AnaptysBio Expands Immunotherapy Portfolio With Anti-PD-1 Antibody Combinations,,, 9/08/2015 G4618810 PRN  Depomed Issues Statement on Horizon Pharma plc's Unsolicited Exchange Offer,," 9/08/2014 45845P10 PRN  Critical Alerts For Apple, Kinder Morgan, Stratasys, Intercept Pharmaceuticals and NPS Pharmaceuticals Released By InvestorsObserver",,," 2/20/2018 98401F10 PRN  Xencor to Host Fourth Quarter and Full Year 2017 Financial Results Webcast and Conference Call on February 27, 2018",, 5/14/2019 G8807B10 PRN  Theravance Biopharma Announces Data from Phase 1b Study of TD-1473 to be Featured in Oral Presentation at Digestive Disease Week (DDW) 2019, 1/08/2013 079TK4-E PRN  Novocure Appoints Four New Independent Members to its Board of Directors,10/04/2018 03969710 PRN  Ardelyx to Host Its First Annual Investor Day Focused on Treatment Landscape of Renal Disorders,,,,," 2/07/2017 M4613510 PRN  Foamix Pharmaceuticals to Release Fiscal Year 2016 Financial Results and Host Conference Call & Webcast on Wednesday, February 22", 3/23/2011 001THX-E PRN  PRA International Experts to Speak at Industry Events,,,"12/04/2014 PBYI-US  PRN  Lifshitz & Miller Law Firm Announces Investigation of Avanir Pharmaceuticals, Inc., Carbonite, Inc., Casey's General Stores, Inc., Nymox Pharmaceutical Corporation, Puma Biotechnology Inc., RealD Inc., and Spansion, Inc.",, 4/16/2015 0DWCVM-E PRN  OTC Markets Group Congratulates Corbus Pharmaceuticals Holdings on Uplisting to NASDAQ from OTCQB Venture Marketplace, 1/04/2019 05070R10 PRN  Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,, 4/17/2019 75901B10 PRN  REGENXBIO Appoints Dr. Steve Pakola as Chief Medical Officer,,,,,,,,,,,,, 7/26/2011 07N3G8-E PRN  arGEN-X Announces Non-exclusive License with Biowa for Potelligent® Technology,, 7/24/2014 00695P-E  PRN  Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA),,,,,,,,,,,,,,,,,,,,,,,,,, 5/09/2019 50015M10 PRN  Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference 2019,,"10/17/2016 00FYYJ-E PRN  Guardant Health makes commitment to share expertise and data to advance Blood Profiling Atlas, part of White House Cancer Moonshot",,, 4/22/2015 00FLML-E PRN  Twist Bioscience Launches Alpha Manufacturing Program For Synthetic Genes,,,,,,,,,,,,,
"12/10/2013 53220K50 PRN  Healthcare Companies Report Stock Price Updates, and Medical System Integration - Research Report on Johnson & Johnson, Geron, Ligand Pharmaceuticals, Masimo, and Capital Senior Living"," 6/14/2016 74318710 PRN  Biotechnology Equities Technical Briefing -- PTC Therapeutics, Biogen, Progenics Pharma, and VIVUS"," 6/09/2016 45232710    PRN  How These Biotech's Stocks are Performing? - Clovis Oncology, Illumina, NewLink Genetics and Zafgen"," 5/07/2013 84763A10 PRN  SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of May 13, 2013 to Seek a Lead Plaintiff Position", 7/31/2019 G3040110 PRN  Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada," 1/14/2015 04280A10 PRN  Critical Alerts For Juno Therapeutics Inc, Arrowhead Research, Bitauto Holdings, Intrexon and Inovio Pharmaceuticals Released By InvestorsObserver", 3/17/2017 09060J10 PRN  BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results, 8/13/2019 000XKX-E    PRN  Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay,11/06/2019 75886F10    PRN  Regeneron to Report Results from CD20xCD3 and BCMAxCD3 Bispecifics and C5 Antibody Programs at ASH Annual meeting,," 2/03/2017 68375N10 PRN  Biotech Stocks Under Scanner -- Mast Therapeutics, MannKind, Celgene, and Opko Health", 7/30/2019 46222210 PRN  Ionis Pharmaceuticals to hold second quarter 2019 financial results webcast," 7/16/2019 09061G10   PRN  BioMarin to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 1 at 4:30pm ET"," 2/03/2015 01535110 PRN  Insights From the Pharmaceutical Space: New Research on Alcobra, Alder, Aldeyra, Alexion, Alexza", 5/07/2019 64125C10 PRN  Neurocrine Biosciences to Present at Bank of America Merrill Lynch Health Care Conference 2019," 1/11/2017 81257810 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Seattle Genetics, Inc. (SGEN) and Lead Plaintiff Deadline - March 13, 2017"," 1/14/2014 45290710 PRN  Conferences, Preliminary Revenues, Board Changes, Shareholders' Meeting Results, and Clinical Trial Initiation - Research Report on Antares, Quidel, bluebird bio, Given Imaging, and Immunomedics"," 5/16/2017 09062X10  PRN  Biotech Stocks Under Scanner -- BioCryst Pharma, Biogen, Celldex Therapeutics, and Concordia"," 1/07/2014 45253H10 PRN  Conference Presentation Schedules, Executive Appointments, and Product Availability - Research Report on Mallinckrodt, Haemonetics, Select Medical, Horizon Pharma, and ImmunoGen","11/08/2013 09058V10 PRN  Before the Bell Scans: PDL BioPharma Inc., Amgen Inc., Questcor Pharma Inc., and BioCryst Pharma Inc."," 9/29/2017 37555810   PRN  Daily Technical Summary Reports on Biotech Stocks -- Gilead Sciences, Kite Pharma, Novavax, and Sangamo Therapeutics", 7/25/2019 04004760   PRN  Arena Pharmaceuticals Announces First Subject Dosed in CAPTIVATE Phase 2 Trial Evaluating Olorinab in Abdominal Pain Associated with Irritable Bowel Syndrome, 5/20/2019 N5946510  PRN  Theravance Biopharma and Mylan Present Additional YUPELRI® (revefenacin) Phase 3 Data Analysis at the 2019 ATS International Conference, 6/03/2019 M2572210 PRN  Compugen Presents Update on COM701 Phase 1 Trial at the 2019 ASCO Annual Meeting," 1/24/2017 00972810 PRN  Technical Reports on Generic Drugs Stocks -- Zoetis, Mallinckrodt, Akorn, and Diplomat Pharmacy",11/18/2019 03116210 PRN  New Results From COSMIC-HF Presented At AHA 2019 Show Treatment Of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral Or Improved Measures Of Diastolic Function," 8/02/2016 62855J10 PRN  Technical Roundup on Services Stocks -- Booz Allen Hamilton, Qiagen, Myriad Genetics, and INC Research", 5/04/2017 52887230 PRN  Lexicon Pharmaceuticals To Present At The Bank Of America Merrill Lynch 2017 Healthcare Conference,, 6/26/2019 45766930 PRN  Insmed Announces Closing of Public Offering of Common Stock,,11/25/2019 45773H20 PRN  Inovio Pharmaceuticals to Present at the 2019 Piper Jaffray 31st Annual Healthcare Conference," 8/20/2019 64026810 PRN  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Nektar Therapeutics, Inc. (NASDAQ: NKTR) and Encourages Nektar Investors to Contact the Firm",12/05/2018 76655960 PRN  Rigel to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference in New York City," 6/26/2014 37416310 PRN  Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics",,"12/25/2013 02311120 PRN  New Drug Application Updates, Appointments, Partnership Programs, and Stock Movements - Research Report on Amarin, Oramed Pharmaceuticals, Synta Pharmaceuticals, Healthways and AMN Healthcare", 2/15/2017 45337C10 PRN  Additional results from pivotal RA-BEAM study published in New England Journal of Medicine show baricitinib-treated patients demonstrated sustained improvement in rheumatoid arthritis compared to adalimumab and placebo," 2/20/2019 91307C10 PRN  United Therapeutics Corporation To Report Fourth Quarter And Annual 2018 Financial Results Before The Market Opens On Wednesday, February 27, 2019"," 5/21/2015 80360710 PRN  Critical Alerts For Sarepta Therapeutics, CableVision Systems, Petrobras, General Electric and JC Penney Released By InvestorsObserver", 5/22/2019 G0176710 PRN  Alkermes to Present New Data From Mental Health Portfolio at the American Society of Clinical Psychopharmacology 2019 Annual Meeting,,,, 2/04/2019 55027E10 PRN  Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results,11/01/2018 80067710 PRN  Sangamo Therapeutics Announces Third Quarter 2018 Conference Call and Webcast," 9/24/2015 30161Q10 PRN  Technical Coverage on Stocks from Diverse Sectors - CME Group, Commerce Bancshares, Conatus Pharmaceuticals, Exelixis and CTI BioPharma", 6/03/2019 SAN-FR    PRN  Enable Injections Enters into Strategic Partnership with Sanofi,"12/30/2014 92532F10  PRN  On Winning Track: Complementary Research on Vertex, Ignyta, Novartis, Boeing and TransCanada",," 2/25/2016 04351P10 PRN  Ascendis Pharma A/S Appoints Jonathan A. Leff, M.D. as Chief Medical Officer"," 9/02/2014 09609G10 PRN  Critical Alerts For bluebird bio Inc., United Therapeutics Corporation, Mattel Inc, Ulta Salon Cosmetics & Fragrance Inc. and Applied Materials Inc. Released By InvestorsObserver"," 9/04/2015 00422510 PRN  Critical Alerts For Linn Energy, ACADIA Pharmaceuticals, Chevron, General Electric and Hewlett-Packard Released By InvestorsObserver",, 3/05/2019 74366E10 PRN  Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results,,, 4/07/2014 98978L20    PRN  Zogenix Takes Legal Action in Federal Court to Block Massachusetts Improper Ban on Zohydro™ ER,, 5/11/2015 68214310 PRN  Omeros Corporation Reports First Quarter 2015 Financial Results,,,"10/02/2013 46333X10 PRN  Dividend Increases, Research Nominations, New Treatment Options, and Clinical Trials - Research Report on Covidien, Ironwood, ICON, Novadaq, and Antares",,,,," 4/16/2019 69329Y10 PRN  PDL BioPharma to Hold Annual Meeting of Stockholders on June 20, 2019",,,, 4/15/2019 00182C10 PRN  ANI Pharmaceuticals Expands Injectable Portfolio with Distribution Agreement for FDA Approved Injectable Product, 4/11/2014 29251M10 PRN  AbbVie to Present Detailed Phase III Results from SAPPHIRE-I and SAPPHIRE-II Studies in Chronic Hepatitis C Patients at the 2014 International Liver Congress™," 5/30/2014 02043Q10 PRN  Pre-clinical Trial Results, Expanded Studies, Preliminary Data Release, and Leadership Appointments - Analyst Notes on Alnylam, BioCryst, Puma Biotechnology, Intrexon and NW Bio",,," 1/15/2019 60468T10 PRN  Mirati Therapeutics Announces Dosing Of First Patient In Phase 1/2 Clinical Trial Of MRTX849, A Novel KRAS G12C Inhibitor"," 8/19/2013 69512710 PRN  Drug Approvals, Clinical Trials, Awards, Offerings, and Earnings - Research Report on J&J, Sanofi, Novartis, BioScrip, and Pacira",,,,,10/20/2010 000P56-E PRN  MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint, 6/14/2019 09627Y10 PRN  Blueprint Medicines Submits New Drug Application to U.S. Food and Drug Administration for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST,, 3/14/2019 28249U10 PRN  Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update, 9/22/2011 000YQ7-E PRN  Watson Confirms Amphastar Patent Lawsuit,,,,,," 4/18/2019 92165910 PRN  Vanda Pharmaceuticals to Announce First Quarter 2019 Financial Results on May 1, 2019",,, 6/02/2016 06CR5C-E   PRN  Regulatory update on US filing plans for closed triple combination therapy FF/UMEC/VI in patients with COPD,, 4/23/2019 40637H10 PRN  Halozyme To Host First Quarter 2019 Financial Results Webcast And Conference Call, 2/28/2018 G2151510 PRN  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017," 6/29/2015 56400P70 PRN  Critical Alerts For MannKind, Nike, JC Penney, Rite Aid and UnitedHealth Released By InvestorsObserver",,," 4/09/2012 002VD4-E PRN  Noah Rosenberg, MD, Joins Esperion Therapeutics as Chief Medical Officer","10/23/2019 03236M20 PRN  Amyris to Announce Third Quarter Financial Results on Thursday, November 7, 2019",10/02/2019 69366J20 PRN  Risdiplam Spinal Muscular Atrophy Data Demonstrating Continued Benefit Presented at World Muscle Society Congress,"12/23/2014 00448Q20 PRN  Traders Look to Upside: Research Reports on Achillion, Civitas, Twitter, Petrobras, and Zynga",, 6/27/2011 03152W10 PRN  Amicus Therapeutics Joins Russell 3000® Index,,,,12/18/2017 36197T10 PRN  Research Predicts Further Growth for the Medical Cannabis Market," 1/06/2014 29428V10 PRN  Epizyme, Inc. to Present at 32nd Annual J.P. Morgan Healthcare Conference", 5/16/2019 G5087110 PRN  Jazz Pharmaceuticals to Present New Data at Upcoming ASCO Annual Meeting and EHA Congress,, 6/19/2018 00394S-E PRN  Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays,, 8/12/2019 73701010 PRN  Portola Pharmaceuticals Announces Proposed Offering of Common Stock,11/01/2016 92337F10 PRN  Veracyte Announces Proposed Public Offering of Common Stock,,10/15/2010 063J3K-E PRN  Cellectis Publishes Its Financial Statement for the First Half of 2010, 3/20/2017 14075510 PRN  Legal Cannabis Market Contributes to Tax Revenues,,,, 3/22/2012 46226010 PRN  Genesis Biopharma Names Biotech Industry Veteran Hans E. Bishop as Executive Chairman of the Board, 5/16/2013 008H33-E PRN  AnaptysBio Awarded U.S. Government Contract To Develop Anti-Ricin Antibodies,,," 9/02/2015 G4618810 PRN  Critical Alerts For Apple, United Continental Holdings, Windstream, Horizon Pharma and Alexion Pharmaceuticals Released By InvestorsObserver",," 8/28/2014 45845P10 PRN  Acquisitions, Appointments, Patent Grant, Technical Updates, and Awareness Campaign - Research Reports on Covidien, Biogen Idec, Achillion, Intercept and Mylan",,, 2/07/2018 98401F10 PRN  Xencor to Present at Upcoming Investor Conferences,," 5/07/2019 G8807B10 PRN  Theravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update", 5/29/2012 079TK4-E PRN  /C O R R E C T I O N -- Novocure/, 9/13/2018 03969710 PRN  Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administration,,,,, 2/06/2017 008XK0-E PRN  Foamix Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference, 2/23/2011 001THX-E PRN  PRA International Project Manager to Chair CDISC Advisory Board,,,"12/03/2014 74587V10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Puma Biotechnology, Inc.",,"12/02/2014 0DWCVM-E PRN  Eight Companies Webcast Live to Investors, December 4th at VirtualInvestorConferences.com", 1/03/2019 05070R10 PRN  Audentes Therapeutics Appoints Eric B. Mosbrooker as Senior Vice President and Chief Commercial Officer,,,,,, 4/15/2019 75901B10 PRN  REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2019 Annual Meeting,,,,,,,,,,,,, 7/26/2011 07N3G8-E PRN  arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology,, 7/01/2014 00695P-E  PRN  Kinex Pharmaceuticals Appoints Mr. Michael Murphy to the Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,, 4/25/2019 50015M10 PRN  Kodiak Sciences Announces Presentations at ARVO 2019 Annual Meeting,," 9/09/2016 00FYYJ-E PRN  Prospective, independent study demonstrates the utility of Guardant360 for guiding therapy selection in advanced Non-Small-Cell Lung Cancer",,," 2/03/2015 00FLML-E PRN  Twist Bioscience Appoints Industry Veteran Patrick J. Finn, Ph.D., As Vice President Of Sales And Marketing",,,,,,,,,,,,,
"11/29/2013 53220K50 PRN  FDA Approvals, Scheduled Presentations, and Stock Price Movements - Research Report on Amgen, St. Jude Medical, Life Technologies, Ligand, and Infinity Pharmaceuticals", 4/04/2016 06CR5C-E PRN  Valeant and Progenics Announce PDUFA Date Extension for Oral RELISTOR," 6/07/2016 45232710    PRN  InvestorsObserver releases covered-call reports for SolarCity, Illumina, Nabors Industries, Amazon.com and Salesforce.com"," 4/17/2013 84763A10 PRN  Arena Pharma, Celgene, Incyte, Spectrum Pharma, and Geron Under StockCall's Microscope", 7/11/2019 G3040110 PRN  Endo to Announce Second-Quarter 2019 Financial Results,"12/22/2014 04280A10 PRN  Biotech Stocks Technical Report -- Achillion Pharma, Arrowhead Research, Sunesis Pharma, Array BioPharma, and Seattle Genetics", 3/16/2017 09060J10 PRN  BioDelivery Sciences Announces Three Data Presentations on BELBUCA® at the American Academy of Pain Medicine 33rd Annual Meeting, 8/06/2019 09073M10    PRN  Bio-Techne Declares Dividend,11/06/2019 75886F10    PRN  Regeneron and Vyriad Announce Strategic Agreement for Discovery and Development of New Oncolytic Virus Treatments for Cancer,,12/21/2016 68375N10 PRN  RXi Pharmaceuticals Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-allotment Option, 6/18/2019 46222210 PRN  Ionis Pharmaceuticals to present at the BMO Prescription for Success Healthcare Conference," 7/09/2019 09061G10   PRN  BioMarin Appoints Pharmaceutical Veteran and Former J & J Executive, Liz McKee Anderson, to Board of Directors", 1/28/2015 0017F0-E PRN  BioXcel Initiates Rare Disease Project with Alexion Utilizing Big Data Innovation Lab, 5/06/2019 64125C10 PRN  Neurocrine Biosciences Honors Mental Health Month and Raises Awareness of Tardive Dyskinesia and its Impact on Patients," 7/28/2016 81257810 PRN  Learn how to target a 13% return on Under Armour, or get option-trade ideas on SPDR Gold Trust, Seattle Genetics, Priceline and Lockheed Martin Corporation or any stock you choose"," 1/06/2014 45290710 PRN  Drug Designation, Conference Participations, Induction of Winners, Software Solution Deployment, and Patent Issuance - Research Report on GSK, Centene, WuXi PharmaTech, Allscripts, and Immunomedics", 3/17/2017 09062X10  PRN  5 Biotech Companies Set for Major Breakouts in 2017,"12/24/2013 45253H10 PRN  Patent Claims, Agreements, Quarterly Reports, Favorable Clinical Trial Results, and Dividends - Research Report on Acorda, Centene, Neogen, ImmunoGen, and West","11/08/2013 09058V10 PRN  Marketing Authorization Applications, Financial Results, Product Up-gradations, and Presentations - Research Report on Baxter, Seattle Genetics, IDEXX, Hill-Rom, and BioCryst", 9/12/2017 37555810   PRN  Companies to Watch as Biotech Makes a Comeback in 2017, 6/17/2019 04004760   PRN  Arena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 52 Global Phase 3 Trial Evaluating Etrasimod in Ulcerative Colitis, 5/20/2019 N5946510  PRN  Theravance Biopharma and Mylan Present Additional YUPELRI® (revefenacin) Phase 3 Data Analysis at the 2019 ATS International Conference, 5/22/2019 M2572210 PRN  Compugen to Present at the Jefferies 2019 Healthcare Conference,"10/20/2016 00180J-E PRN  Research Reports Coverage on Generic Drugs Stocks -- Akorn, Eagle Pharma, Tetraphase Pharma, and Fibrocell Science",11/16/2019 03116210 PRN  Amgen Announces New FOURIER Analysis Showing Benefit Of Repatha® (evolocumab) In High-Risk Patients Who Have Experienced A Recent Heart Attack," 3/31/2015 62855J10 PRN  Critical Alerts For Tesla Motors, GW Pharmaceuticals, Alcoa, Myriad Genetics and Coach Released By InvestorsObserver", 5/02/2017 52887230 PRN  Lexicon Pharmaceuticals Reports First Quarter 2017 Financial Results And Provides A Business Update,, 6/06/2019 45766930 PRN  Insmed to Present at the Goldman Sachs 40th Annual Global Healthcare Conference,,11/15/2019 45773H20 PRN  Inovio Pharmaceuticals to Present at the Stifel 2019 Healthcare Conference," 8/15/2019 64026810 PRN  Bragar Eagel & Squire, P.C. is Investigating Nektar Therapeutics, Inc. (NASDAQ: NKTR) on Behalf of Stockholders and Encourages Nektar Investors to Contact the Firm",11/15/2018 0G4Y44-E PRN  Foresee Pharmaceuticals Announces Sr. VP of Pharmaceutics and Manufacturing Appointment," 5/30/2014 37416310 PRN  Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron",,"12/06/2013 02311120 PRN  Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin", 2/13/2017 45337C10 PRN  European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis, 1/31/2019 91307C10 PRN  Survival Data From FREEDOM-EV Study of Orenitram Presented at the Pulmonary Vascular Research Institute Annual World Congress," 5/18/2015 80360710 PRN  Technical Coverage on Biotech Stocks -- Anthera Pharma, RXi Pharma, MiMedx, Sarepta Therapeutics, and Navidea Biopharma", 5/14/2019 G0176710 PRN  Alkermes to Present at the UBS Global Healthcare Conference,,,, 1/07/2019 55027E10 PRN  Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2018; Company to Present at 37th Annual J.P. Morgan Healthcare Conference,10/01/2018 80067710 PRN  Sangamo and TxCell announce the completion of the acquisition by Sangamo of majority of TxCell ordinary shares," 9/15/2015 30161Q10 PRN  Critical Alerts For Exelixis, Mirati Therapeutics, BP, TASER International and 3D Systems Released By InvestorsObserver", 5/16/2019 000VC1-E  PRN  Updated Libtayo® (cemiplimab-rwlc) Results Reinforce Durable and Substantial Response Rates in Advanced Cutaneous Squamous Cell Carcinoma,"12/02/2014 92532F10  PRN  Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics",, 2/03/2016 04351P10 PRN  Ascendis Pharma A/S to Present at the Leerink Partners Global Healthcare Conference," 7/23/2014 09609G10 PRN  Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx"," 8/12/2015 00422510 PRN  Critical Alerts For Fitbit, Boeing, Inovio Pharmaceuticals, JetBlue and ACADIA Pharmaceuticals Released By InvestorsObserver",," 2/21/2019 74366E10 PRN  Protagonist Therapeutics to Present at the Leerink Partners 8th Annual Global Healthcare Conference on Thursday, Feb. 28",,, 4/02/2014 98978L20    PRN  Zogenix Statement: Let's Get the Facts Straight About Zohydro ER,," 5/05/2015 68214310 PRN  Omeros Corporation to Announce First Quarter 2015 Financial Results on May 11, 2015",,," 8/26/2013 46333X10 PRN  Positive Clinical Trial Results, Regulatory Wins, and New Appointments - Research Report on Incyte, Edwards, ACADIA Pharmaceuticals, Alnylam, and Ironwood",,,,, 4/11/2019 69329Y10 PRN  PDL BioPharma Announces Equity Investment in Evofem Biosciences,,,, 3/27/2019 00182C10 PRN  ANI Pharmaceuticals Announces Two Generic Product Launches, 3/24/2014 29251M10 PRN  AbbVie to Present Detailed Results from Phase III Studies in Patients with Chronic Hepatitis C at the 2014 International Liver Congress™," 5/14/2014 02043Q10 PRN  Clinical Study Results, Upcoming Events, and Financial Updates - Analyst Notes on Amgen, Insys, Alnylam, Seattle Genetics and Emergent BioSolutions",,, 1/07/2019 000D1R-E PRN  Mirati Announces Clinical Collaboration With Bristol-Myers Squibb For The Planned Phase 3 Trial In Non-Small Cell Lung Cancer To Evaluate Sitravatinib In Combination With Nivolumab (OPDIVO®)," 6/17/2013 69512710 PRN  Litigation Settlements, Data Compliance Reviews, and Clinical Trials Pave Way for Solid Footing in Healthcare - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Keryx and Pacira Pharmaceuticals",,,,, 7/15/2010 05LJZC-E PRN  MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio, 6/03/2019 09627Y10 PRN  Blueprint Medicines' Highly Selective RET Inhibitor BLU-667 Shows Durable Anti-Tumor Activity in Patients with RET-Altered Cancers in Updated ARROW Trial Data Presented at ASCO 2019,, 3/13/2019 28249U10 PRN  Eiger Late-Breaker Oral Presentation of Peginterferon Lambda Phase 2 LIMT Study at The International Liver Congress™ 2019," 9/01/2011 60877T10 PRN  The Zacks Analyst Blog Highlights: Gap, Teva Pharmaceutical Industries, Novartis AG, Momenta Pharmaceuticals and Mylan",,,,,," 4/10/2019 92165910 PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm",,," 9/30/2015 45781M10   PRN  Critical Alerts For GoPro, AFLAC, Repros Therapeutics, INSYS Therapeutics and Theravance Released By InvestorsObserver",, 3/04/2019 40637H10 PRN  Halozyme To Participate In Upcoming Investor Conferences, 2/23/2018 G2151510 PRN  China Biologic Products to Report Fourth Quarter and Fiscal Year 2017 Financial Results," 6/16/2015 56400P70 PRN  Critical Alerts For MannKind, Lennar, Aetna, Yelp and Zulily Released By InvestorsObserver",,, 3/26/2012 002VD4-E PRN  Esperion Announces Positive Phase 2 Clinical Trial Results for ETC-1002,"10/18/2019 03236M20 PRN  WeissLaw LLP: Amyris, Inc. is the Subject of a Legal Investigation", 9/27/2019 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conferences,"12/22/2014 00448Q20 PRN  Biotech Stocks Technical Report -- Achillion Pharma, Arrowhead Research, Sunesis Pharma, Array BioPharma, and Seattle Genetics",," 5/31/2011 03152W10 PRN  Amicus Therapeutics to Present at Jefferies 2011 Global Healthcare Conference on Tuesday, June 7, 2011",,,,12/12/2017 36197T10 PRN  The Top 7 Jurisdictions Likely to Legalize Marijuana in 2018,"12/20/2013 29428V10 PRN  Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market", 5/09/2019 G5087110 PRN  Jazz Pharmaceuticals Data to Showcase Ongoing Sleep Medicine Research at SLEEP 2019,, 5/31/2018 39843840 PRN  Grifols Launches a New Testing Service for Patients Treated with Daratumumab,, 8/07/2019 73701010 PRN  Portola Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update,10/26/2016 06NV21-E PRN  New Data Show that Use of Percepta® Bronchial Genomic Classifier Reduces Surgeries and Other Costly Procedures in Lung Cancer Screening and Diagnosis,,10/13/2010 063J3K-E PRN  Cellectis bioresearch Announces Establishment of Subsidiary in the US, 3/17/2017 14075510 PRN  5 Biotech Companies Set for Major Breakouts in 2017,,,,"11/17/2011 46226010 PRN  Genesis Biopharma's Scientific and Medical Advisory Board Welcomes Dr. Steven A. Rosenberg, Chief of the Surgery Branch at the NCI",12/04/2012 008H33-E PRN  AnaptysBio Develops Novel Antibody Scaffold With Extreme Thermostability,,, 8/19/2015 ASRT-US  PRN  Depomed's Board of Directors Unanimously Rejects Revised Proposal from Horizon Pharma plc,," 8/13/2014 45845P10 PRN  Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver",,, 1/05/2018 98401F10 PRN  Xencor Announces 2018 Priorities and Expected Milestones,, 4/30/2019 G8807B10 PRN  Theravance Biopharma to Report First Quarter 2019 Financial Results on May 7, 5/24/2012 079TK4-E PRN  Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy, 8/29/2018 03969710 PRN  Ardelyx Announces Science Translational Medicine Publication Detailing Tenapanor's Unique Mechanism of Action Inhibiting Paracellular Phosphate Absorption,,,,,"11/28/2016 M4613510 PRN  Foamix to Host Key Opinion Leader Luncheon for Investors Focused on Dermatology, With a Focus on Acne and Rosacea", 2/22/2011 001THX-E PRN  PRA International Expert to Present at Late Phase Event,,,"12/03/2014 74587V10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Puma Biotechnology, Inc. - PBYI",,"12/01/2014 21833P10 PRN  Corbus Pharmaceuticals to Present at VirtualInvestorConferences.com Online Event on December 4, 2014", 1/02/2019 05070R10 PRN  Audentes Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,,,,,, 3/06/2019 75901B10 PRN  REGENXBIO to Participate in Upcoming Investor Conferences,,,,,,,,,,,,, 1/05/2011 000P56-E PRN  arGEN-X Signs Discovery and Development Alliance With Lilly,, 6/30/2014 128940-KR PRN  Hanmi Pharmaceuticals and Collaborative Partner Kinex Pharmaceuticals Report Encouraging Results on Oraxol® for Patients with Advanced Gastric Cancer from a Phase I/II Clinical Study,,,,,,,,,,,,,,,,,,,,,,,,,, 3/28/2019 50015M10 PRN  Kodiak Sciences Announces Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights,, 7/14/2016 00FYYJ-E PRN  Guardant Health Collaborates with OncoMed Pharmaceuticals on Anti-RSPO3 Clinical Trial,,, 9/30/2014 00FLML-E PRN  Twist Bioscience Secures $10 Million Loan Facility,,,,,,,,,,,,,
11/25/2013 53220K50 PRN  Ligand Pharmaceuticals Set to Join the S&P SmallCap 600,"10/13/2015 JUNO-US  PRN  Military Researchers to Conduct Clinical Study of a ""Skin Substitute"" Using a Patient's Own Cells to Treat Complex Burns and Soft Tissue Injuries"," 4/20/2016 45232710    PRN  Illumina (ILMN) Shareholder Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Illumina, Inc."," 3/22/2013 SPPI-US  PRN  Lifshitz Law Firm Announces Investigation of Navistar International Corporation, Spectrum Pharmaceuticals, Inc., and Tech Data Corporation"," 6/06/2019 ENDP-US  PRN  Nationally Recognized Urologist and Author, Aaron Spitz, MD, Teams Up with Endo Pharmaceuticals' Ask About the Curve Campaign to Encourage Men to Get ""In Touch"" With Their Anatomy This Men's Health Month",12/17/2014 04280A10 PRN  Earnings Review - Arrowhead Research," 3/09/2017 09060J10 PRN  BioDelivery Sciences to Host Conference Call and Webcast Reporting Fourth Quarter and Full-Year 2016 Financial Results on Friday, March 17", 8/06/2019 09073M10    PRN  Bio-Techne Releases Fourth Quarter Fiscal 2019 Results,11/05/2019 75886F10    PRN  Regeneron Provides Updates on Phase 3 Libtayo® (cemiplimab) Development Program in Advanced Non-small Cell Lung Cancer,,"12/13/2016 68375N10 PRN  Covered Call reports for Alexion Pharmaceuticals, Cornerstone OnDemand, Inc., Northrop Grumman Corporation, Opko Health and Lockheed Martin Corporation include trade ideas that offer returns of 23% or more!", 6/12/2019 46222210 PRN  Ionis announces appointment of Joan E. Herman to its board of directors, 7/08/2019 09061G10   PRN  BioMarin Plans Regulatory Submissions for Marketing Authorization of Valoctocogene Roxaparvovec to Treat Severe Hemophilia A in 4Q 2019 in both U.S. and Europe," 1/15/2015 01535110 PRN  Critical Alerts For Rite Aid, GameStop, Alexion Pharmaceuticals, Universal Display Corporation and Qualcomm Released By InvestorsObserver", 5/05/2019 64125C10 PRN  Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinson's Disease at the American Academy of Neurology Annual Meeting," 6/28/2016 008BK4-E PRN  Technical Analysis on Biotechnology Equities -- Seattle Genetics, CTI BioPharma, Five Prime Therapeutics, and Intercept Pharma","12/25/2013 45290710 PRN  FDA Drug Approvals, Newly Elected Board of Directors, and Stock Price Updates on Healthcare Companies - Research Report on Theravance, Quintiles, Ironwood, Progenics, and Immunomedics", 1/24/2017 09062X10  PRN  LogMeIn and Bioverativ Set to Join the S&P MidCap 400; Others to Join S&P SmallCap 600,"12/13/2013 45253H10 PRN  Investor Meetings, New Clinical Data, Closing of Offering, and New Programs - Research Report on Teleflex, Orexigen, Sangamo, InterMune, and ImmunoGen","10/17/2013 09058V10 PRN  Technical Study: Amgen Inc., Questcor Pharmaceuticals Inc., PDL BioPharma Inc., and BioCryst Pharma Inc."," 8/31/2017 37555810   PRN  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE", 6/13/2019 04004760   PRN  Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19, 5/18/2019 N5946510  PRN  Mylan Presents Equivalence and Device Usability Data on Wixela™ Inhub™ Compared to Advair Diskus® at American Thoracic Society International Conference, 5/20/2019 M2572210 PRN  Compugen Reports First Quarter 2019 Results," 9/29/2015 00972810 PRN  Drugs - Generic Equities at a Glance -- Mylan, Zoetis, Ironwood Pharma, Akorn, and Supernus Pharma",11/15/2019 03116210 PRN  Amgen And The Duke Clinical Research Institute Announce Initiation Of First Large-Scale Registry To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors," 3/05/2015 62855J10 PRN  Recent Developments at Biotechnology Companies: Special Research on Immunomedics, Nymox, Meridian, Myriad, and Neogen"," 4/28/2017 52887230 PRN  Lexicon Pharmaceuticals To Host First Quarter 2017 Financial Results Conference Call And Webcast On May 2, 2017",, 6/04/2019 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,11/12/2019 45773H20 PRN  Inovio Pharmaceuticals Reports 2019 Third Quarter Financial Results, 8/08/2019 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Second Quarter of 2019,11/06/2018 76655960 PRN  Rigel Announces Third Quarter 2018 Financial Results and Provides Company Update, 5/29/2014 0017CF-E PRN  ViaCyte and Asterias Biotherapeutics Settle Patent Dispute,,"12/04/2013 02311120 PRN  Biotech Briefing: Advancing Biotechs Forging Ahead With Breaking News Developments: Alliqua, OncoMed Pharmaceuticals, EnteroMedics, Unilife, Amarin"," 1/13/2017 45337C10 PRN  U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment", 1/24/2019 91307C10 PRN  Arena Pharmaceuticals Announces Closing of Global License Agreement with United Therapeutics for Ralinepag," 5/11/2015 80360710 PRN  What Influences Business Growth: Complementary Research on Synageva BioPharma, Array BioPharma, Sarepta Therapeutics, Fate Therapeutics and Dyax", 5/13/2019 G0176710 PRN  Alkermes to Showcase Leadership in Schizophrenia With New Data Presentations at Upcoming Scientific Conferences,,,, 1/02/2019 LMNX-US  PRN  Luminex Corporation Completes Acquisition of MilliporeSigma's Flow Cytometry Portfolio, 9/24/2018 80067710 PRN  Sangamo Therapeutics Announces Participation At Upcoming Investor and Industry Conferences," 9/01/2015 30161Q10 PRN  Critical Alerts For Opko Health, Exelixis, First Solar, Freeport-McMoRan and Invensense Released By InvestorsObserver", 5/15/2019 80105N10  PRN  Sanofi oncology pipeline targeting various cancers highlighted at ASCO 2019,11/20/2014 000YJB-E  PRN  Prestigious Boston Companies Join Bunker Hill Community College's Learn & Earn,,11/12/2015 04351P10 PRN  Ascendis Pharma A/S Reports Third Quarter 2015 Financial Results," 7/03/2014 09609G10 PRN  Positive Study Results, Patent Grants, Acquisitions, Patient Enrollment, and Earnings Schedule - Analyst Notes on Synageva, OPKO, bluebird bio, BioDelivery Sciences and Haemonetics"," 7/29/2015 00422510 PRN  Critical Alerts For Seadrill, Amgen, Ariad Pharmaceuticals, Johnson Controls and ACADIA Pharmaceuticals Released By InvestorsObserver",, 1/16/2019 74366E10 PRN  Protagonist Therapeutics Reports Granting of Inducement Award,,," 1/16/2014 98978L20    PRN  Updates on Clinical Trial Enrollment, Product Development Updates, Clinical Collaboration, and Preliminary Sales Report - Research Report on Raptor, Synageva, XenoPort, Portola, and Zogenix",, 4/14/2015 68214310 PRN  European Regulatory Authority Approves Clinical Investigator's Request for Compassionate Use with Omeros Corporation's OMS721,,," 6/26/2013 46333X10 PRN  Innovative Technologies that Yield Improved Treatments - Research Report on Mettler-Toledo, Ironwood, Covance, Teleflex and WuXi",,,,," 4/11/2019 69329Y10 PRN  Evofem Biosciences Enters into Financing Agreement for up to $80 Million, Closes First Tranche of Strategic Investment from PDL BioPharma",,,, 2/27/2019 00182C10 PRN  ANI Pharmaceuticals Reports Record Full Year and Fourth Quarter 2018 Results and Provides 2019 Guidance, 3/03/2014 062WH0-E PRN  AbbVie to Present Late-breaker PEARL-III Study in Patients with Chronic Hepatitis C at the 21st Conference on Retroviruses and Opportunistic Infections, 1/13/2014 02043Q10 PRN  Isis Pharmaceuticals to Receive $7.5 Million from Alnylam,,, 1/02/2019 60468T10 PRN  Mirati Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference, 5/10/2012 69512710 PRN  Oxford Finance Provides $27.5 Million Debt Financing Facility to Pacira Pharmaceuticals,,,,,, 6/01/2019 09627Y10 PRN  Blueprint Medicines Presents NAVIGATOR Trial Data in PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST at ASCO 2019 Supporting Planned Marketing Applications for Avapritinib,, 3/11/2019 28249U10 PRN  Eiger BioPharmaceuticals Management Team to Present and Participate in Jefferies HBV Investor Summit," 8/30/2011 000C6X-E PRN  Significant Insider Trading at Acme Packet, Apache, Momenta, United Continental Holdings, Southern & OpenTable",,,,,," 4/03/2019 92165910 PRN  Hagens Berman Reminds Vanda Pharmaceuticals (VNDA) Investors of April 26, 2019 Lead Plaintiff Deadline and Encourages Investors to Contact the Firm",,," 7/22/2015 45781M10   PRN  Biotechnology Sector Stocks Technical Coverage -- Amgen, Exelixis, XOMA Corp., Theravance, and NewLink Genetics",, 2/28/2019 40637H10 PRN  Halozyme Announces FDA Approval Of Herceptin Hylecta™, 2/14/2018 0H0BF2-E PRN  China Biologic to Build New Collection Station in Hainan Province," 6/01/2015 56400P70 PRN  Critical Alerts For MannKind, Horizon Pharma, Altera, Orexigen Therapeutics and Windstream Released By InvestorsObserver",,, 5/02/2011 002VD4-E PRN  Esperion Announces Results From Phase 1 Study and Four Preclinical Studies for ETC-1002,10/10/2019 03236M20 PRN  Amyris Pipette Brand Successfully Launches on Amazon.com, 9/20/2019 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),"12/16/2014 00448Q20 PRN  Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Halliburton, Agios Pharmaceuticals and Urban Outfitters Released By InvestorsObserver",, 5/04/2011 03152W10 PRN  Amicus Therapeutics Announces First Quarter 2011 Financial Results and Continued Progress of Development Programs,,,,11/28/2017 36197T10 PRN  Medical Cannabis Data Shows Strong Sales and Growth,"12/02/2013 29428V10 PRN  Epizyme, Inc. to Present at Upcoming Conferences in December", 5/07/2019 G5087110 PRN  Jazz Pharmaceuticals Announces First Quarter 2019 Financial Results,, 5/14/2018 39843840 PRN  Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents,, 8/06/2019 73701010 PRN  Portola Launches European Sales of Ondexxya® (Andexanet Alfa) with First Orders in Europe,10/25/2016 92337F10 PRN  Veracyte Announces Launch of Envisia™ Genomic Classifier for Improved Diagnosis of Idiopathic Pulmonary Fibrosis at CHEST Annual Meeting 2016,,10/07/2010 063J3K-E PRN  Cellectis to Present at the Annual Congress of the European Society of Gene & Cell Therapy, 3/15/2017 14075510 PRN  Legal Cannabis Sales Projected to Grow,,,,10/11/2011 46226010 PRN  Genesis Biopharma Signs Worldwide License Agreement with the NIH for Adoptive Cell Therapy to Treat a Variety of Cancers,10/18/2012 008H33-E PRN  AnaptysBio Expands Patent Portfolio with Issuance of U.S. Patent to In Vitro Somatic Hypermutation,,, 8/13/2015 ASRT-US  PRN  Depomed Comments on Horizon Pharma plc Letter,," 6/13/2014 45845P10 PRN  Biotech Equities Technical Analysis -- Research on Hemispherx Biopharma, Intercept Pharma, MiMedx, and Raptor Pharma",,,12/19/2017 98401F10 PRN  Xencor Appoints Richard Ranieri to Board of Directors,, 4/02/2019 G8807B10 PRN  Theravance Biopharma to Present at the 18th Annual Needham Healthcare Conference, 5/21/2012 079TK4-E PRN  Study Results of Novocure's NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer, 8/07/2018 03969710 PRN  Ardelyx Reports Second Quarter 2018 Financial Results and Recent Highlights,,,,,11/28/2016 M4613510 PRN  Foamix Announces Completion of Patient Enrollment in Phase 3 Acne Trials for Minocycline Foam FMX101, 2/09/2011 001THX-E PRN  PRA Expands Operations in Europe and Middle East,,,"10/01/2014 74587V10 PRN  Positive Study Results, CSR Activities, and New Aircraft Livery - Research Reports on Puma Biotechnology, HCA Holdings, United Technologies, Boeing and Caterpillar",,"12/01/2014 00F15R-E PRN  Fort Point Angels Scores First Successful ""Exit""",12/07/2018 05070R10 PRN  Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,, 2/27/2019 75901B10 PRN  REGENXBIO Reports Fourth Quarter and Full-Year 2018 Financial Results and Recent Operational Highlights,,,,,,,,,,,,, 7/08/2010 07N3G8-E PRN  arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform,," 5/13/2014 00695P-E  PRN  Kinex Pharmaceuticals Inc. Announces Key Additions to Clinical Leadership Team in Newly Formed Clinical Development Office in Cranford, New Jersey",,,,,,,,,,,,,,,,,,,,,,,,,, 3/07/2019 50015M10 PRN  Kodiak Sciences to Present at the Barclays Global Healthcare Conference,," 7/07/2016 00FYYJ-E PRN  Priority Health becomes first health plan to cover Guardant Health's comprehensive liquid biopsy, Guardant360®",,,,,,,,,,,,,,,,
"11/20/2013 53220K50 PRN  Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals"," 9/08/2015 74318710 PRN  /C O R R E C T I O N -- Valeant Pharmaceuticals International, Inc./"," 4/05/2016 BMR-US      PRN  BioMed Realty Announces Illumina, Inc., As Sole Tenant For San Diego i3 Campus"," 3/21/2013 84763A10 PRN  Spectrum Pharmaceuticals, Inc. Sued by Shareholders", 5/17/2019 G3040110 PRN  Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment of Cellulite to Be Presented at The Aesthetic Meeting 2019,"12/03/2014 04280A10 PRN  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Arrowhead Research Corp. and Lead Plaintiff Deadline of December 9, 2014", 3/08/2017 09060J10 PRN  BioDelivery Sciences to Present at the 29th Annual ROTH Conference, 7/23/2019 09073M10    PRN  Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay,11/05/2019 75886F10    PRN  Regeneron Reports Third Quarter 2019 Financial and Operating Results,,"12/06/2016 68375N10 PRN  Amazon.com trade offers a 6.05% return in 74 days, or find similar option trades on Intercept Pharmaceuticals, Energous Corporation, Opko Health, and 3D Systems", 6/06/2019 46222210 PRN  Ionis Pharmaceuticals to provide corporate update and 30-year retrospective at its 2019 Annual Meeting of Stockholders," 6/26/2019 09061G10   PRN  BioMarin Announces Acceptance of Late Breaking Abstract at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia from July 6-10, 2019"," 1/02/2015 01535110 PRN  Wall St. Deal Watch: New Research on VSE, Alexion, LCNB Corp., Lime Energy and Mast Therapeutics", 5/05/2019 64125C10 PRN  Neurocrine Biosciences Presents Phase III Data Analysis Demonstrating that Opicapone Added to Levodopa Resulted in a Significant and Sustained Increase in ON Time without Troublesome Dyskinesia in Parkinson's Disease Patients with Motor Fluctuations, 6/11/2016 81257810 PRN  Seattle Genetics Highlights Vadastuximab Talirine (SGN-CD33A) Data in Acute Myeloid Leukemia (AML) at the 21st Congress of the European Hematology Association,"12/19/2013 45290710 PRN  Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics","12/12/2016 09062X10  PRN  Cliffs Natural Resources, Tesla Motors, Biogen, Coca-Cola, and Nordstrom and more offer option-trading opportunities that offer returns of more than 19%","12/05/2013 45253H10 PRN  Marketing Approval, Presentation Schedules, Supplier Agreement, and Management Changes - Research Report on ImmunoGen, Endologix, Unilife, Sangamo, and Dynavax"," 9/25/2013 09058V10 PRN  Data Presentations, FDA Approvals, Board Appointments, Updated Clinical Results and New Contracts - Research Report on Vertex, Celgene, NPS Pharmaceuticals, Cyclacel and BioCryst"," 8/25/2017 37555810   PRN  Technical Snapshots for these Biotech Stocks -- Gilead Sciences, Biogen, bluebird bio, and BioMarin Pharma", 5/17/2019 04004760   PRN  Arena Pharmaceuticals' Presence at Digestive Disease Week (DDW) Reinforces Commitment to the Gastrointestinal Disease Community," 5/17/2019 N5946510  PRN  Mylan to Host Investor Day on July 31, 2019 in New York City", 5/20/2019 M2572210 PRN  Compugen Doses First Patient in COM701/Opdivo® (Nivolumab) Combination Arm of Phase 1 Study in Patients With Advanced Solid Tumors," 7/21/2015 00972810 PRN  Technical Roundup on Drugs - Generic Equities -- Allergan, Akorn, Ironwood Pharma, Pacira Pharma, and Catalent",11/11/2019 03116210 PRN  Amgen Highlights Data To Be Presented At AHA 2019 Across Cardiovascular Portfolio, 2/09/2015 DGX-US   PRN  Quest Diagnostics and Myriad Genetics End BRCA Patent Litigation, 4/03/2017 52887230 PRN  Lexicon To Present At The 16th Annual Needham Healthcare Conference,, 5/24/2019 45766930 PRN  Insmed Announces Closing of Public Offering of Common Stock,,11/06/2019 002LDJ-E PRN  Patients Turn to Advanced Technology in Order to Combat Cancer, 8/01/2019 64026810 PRN  Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo® (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma,11/01/2018 76655960 PRN  Rigel to Present Data on Fostamatinib in Three Presentations at the 60th American Society of Hematology Annual Meeting & Exposition," 4/07/2014 37416310 PRN  Geron Corporation (GERN) Analyst Report: High Potential High Risk Biopharmaceutical Firm Seeking to Advance Novel Innovative Cancer Treatment for myeloid malignancies by BrokerBank Securities, Inc.",,"11/27/2013 02311120 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Amarin Corporation, plc and Certain Officers - AMRN","12/29/2016 45337C10 PRN  Research Reports Initiation on Biotech Stocks -- Incyte, Anavex Life Sciences, Portola Pharma, and Spectrum Pharma", 1/24/2019 91307C10 PRN  United Therapeutics Announces Closing Of License Agreement With Arena Pharmaceuticals For Ralinepag," 4/17/2015 80360710 PRN  Technical Coverage on Biotech Stocks -- Agenus, Raptor Pharma, KaloBios Pharma, Amicus Therapeutics, and Sarepta Therapeutics", 4/25/2019 G0176710 PRN  Alkermes Plc Reports First Quarter 2019 Financial Results,,,,12/11/2018 55027E10 PRN  Luminex Corporation Declares Fourth Quarter Cash Dividend," 9/05/2018 80067710 PRN  Sangamo Announces 16 Week Clinical Results Including Reductions In Glycosaminoglycans In Phase 1/2 Trial Evaluating SB-913, A Zinc Finger Nuclease Genome Editing Treatment For MPS II (Hunter Syndrome)"," 8/18/2015 30161Q10 PRN  Critical Alerts For Exelixis, Opko Health, Chipotle Mexican Grill, NewLink Genetics and Cliffs Natural Resources Released By InvestorsObserver", 5/08/2019 SAN-FR    PRN  Sanofi Recognized by DiversityInc as a Top 50 Company,11/19/2014 000YJB-E  PRN  Cystic Fibrosis Foundation Royalty Sale Will Be Transformational for People with CF,,11/11/2015 ASND-DK  PRN  Ascendis Pharma A/S to Present at the Stifel 2015 Healthcare Conference," 6/17/2014 09609G10 PRN  Critical Alerts For Coca-Cola, bluebird bio, International Business Machines, SPDR Gold Trust, and American Express Released By InvestorsObserver"," 7/15/2015 00422510 PRN  Critical Alerts For FireEye, Ariad Pharmaceuticals, ACADIA Pharmaceuticals, Esperion Therapeutics and Humana Released By InvestorsObserver",, 1/09/2019 74366E10 PRN  Protagonist Therapeutics Initiates Phase 2 Trial of Novel Hepcidin Mimetic PTG-300 for the Treatment of Patients with Beta Thalassemia,,," 1/08/2014 98978L20    PRN  Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix",, 4/09/2015 68214310 PRN  Omeros to Present at the 14th Annual Needham Healthcare Conference,,," 5/31/2013 46333X10 PRN  Further Expansions and Positive Study Results Drive Healthcare Companies - Research Report on Agilent, Thermo Fisher, BG Medicine, Quest Diagnostics, and Ironwood Pharmaceuticals",,,,, 3/26/2019 69329Y10 PRN  PDL BioPharma to Participate at H.C. Wainwright & Co. Global Life Sciences Conference,,,, 2/20/2019 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-to-Date 2018 Financial Results,"12/13/2013 29251M10 PRN  Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine"," 1/09/2014 02043Q10 PRN  Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood",,,12/20/2018 60468T10 PRN  Mirati Therapeutics Added To NASDAQ Biotechnology Index, 4/18/2012 69512710 PRN  Research Alert -- Empire Asset Management Co. Initiates Coverage on Pacira Pharmaceuticals Inc. (NASDAQ: PCRX),,,,,, 5/29/2019 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences in June,," 2/27/2019 28249U10 PRN  Eiger BioPharmaceuticals Announces the Appointment of Stephana Patton as General Counsel, Corporate Secretary, and Chief Compliance Officer"," 8/24/2011 000YVZ-E PRN  Insider Hot Stock Picks: Automatic Data Processing, Allscripts, Momenta, Royal Caribbean Cruises, Whirlpool & Transocean",,,,,, 3/07/2019 92165910 PRN  VNDA LAWSUIT ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. - VNDA,,, 4/30/2015 45781M10   PRN  FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the US,, 2/21/2019 40637H10 PRN  Halozyme Reports Fourth Quarter And Full-Year 2018 Results, 1/08/2018 G2151510 PRN  China Biologic to Attend the 36th Annual J.P. Morgan Healthcare Conference, 5/19/2015 56400P70 PRN  Preclinical Studies Data Used to Pinpoint Potential Disease-Modifying Therapies & Drug Delivery Candidates for Patients with Rare Diseases,,, 5/02/2011 06YWVY-E PRN  Michigan Growth Capital Symposium Unveils Robust Line Up of Presenting Companies for 30th Anniversary Event,10/07/2019 03236M20 PRN  Amyris Files Form 10-Qs to Achieve Compliance - Notes Receipt of Nasdaq Deficiency Notification, 9/18/2019 69366J20 PRN  PTC Therapeutics Announces Pricing of Private Offering of Convertible Senior Notes,"12/01/2014 00448Q20 PRN  Critical Alerts For Achillion Pharmaceuticals, Linn Energy, Sears Holdings, Baidu and Qualcomm Released By InvestorsObserver",, 4/18/2011 03152W10 PRN  Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman,,,,11/08/2017 36197T10 PRN  Successful Cannabis Legalization Campaigns Influence Market,"11/19/2013 29428V10 PRN  Biotech Companies Announce Upcoming Conferences, Appointments - Research Report on Illumina, Epizyme, Questcor Pharmaceuticals, Infinity, and Endocyte", 5/06/2019 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences,, 4/16/2018 39843840 PRN  Grifols donates over 25 million international units of blood clotting factor in 2017,, 8/05/2019 73701010 PRN  U.S. Centers for Medicare and Medicaid Services (CMS) Increases New Technology Add-On Payment (NTAP) Reimbursement for Portola Pharmaceuticals' Andexxa,10/17/2016 92337F10 PRN  Veracyte Releases Preliminary Third Quarter 2016 Financial Results,, 9/27/2010 063J3K-E PRN  Cellectis Bioresearch Announces Availability of Research Kits Through New Online E-Store, 3/13/2017 14075510 PRN  FinancialBuzz.com: The Growth of Legal Cannabis Products,,,," 9/19/2011 46226010 PRN  Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise", 8/08/2012 008H33-E PRN  Anaptysbio Expands Leadership Team With Addition Of Dr. Andrew J. Mcknight,,, 8/07/2015 ASRT-US  PRN  Depomed Sends Letter to Horizon Pharma,," 5/15/2014 45845P10 PRN  Technical Coverage of Health Care Sector Equities -- Research on Intercept Pharma, ACADIA Pharma, DENTSPLY Intl., and OraSure Technologies",,,12/05/2017 98401F10 PRN  Xencor Receives Milestone Payment from Amgen,, 3/25/2019 G8807B10 PRN  Theravance Biopharma Announces Ampreloxetine (TD-9855) Phase 2 Study Results Selected for Oral Presentation at 32nd European Neurology Congress, 5/14/2012 079TK4-E PRN  Novocure Announces Launch of Recurrent Glioblastoma Product Website, 8/01/2018 03969710 PRN  Ardelyx Announces Date of Second Quarter 2018 Financial Results and Conference Call,,,,,11/15/2016 M4613510 PRN  Foamix Reports Third Quarter 2016 Financial Results and Provides Business Update,12/15/2010 001THX-E PRN  PRA International Opens Phase I Unit in Prague,,," 8/22/2014 74587V10 PRN  Termination of Waiting Period, Appointment, Extension Expiration Date, Technical Update, and Financial Results - Research Reports on Salix, Allergan, Valeant, HCA Holdings and Puma Biotechnology",,"12/01/2014 21833P10 PRN  Corbus Pharmaceuticals to Present at VirtualInvestorConferences.com Online Event on December 4, 2014",11/07/2018 05070R10 PRN  Audentes Therapeutics to Participate in Upcoming Investor Conferences,,,,,, 2/20/2019 75901B10 PRN  REGENXBIO to Host Conference Call on February 27 to Discuss Fourth Quarter and Full-Year 2018 Financial Results and Recent Operational Highlights,,,,,,,,,,,,,,," 5/05/2014 00695P-E  PRN  Kinex Receives US FDA Allowance for Oratecan, an Oral Form of Irinotecan with Enhanced Gastrointestinal Absorption, the Second U.S. IND Based on the Orascovery Technology Platform",,,,,,,,,,,,,,,,,,,,,,,,,," 2/08/2019 50015M10 PRN  Kodiak Sciences Announces Upcoming Presentation of KSI-301 12-Week Phase 1a Study Data at Angiogenesis, Exudation, and Degeneration 2019 Meeting",, 6/06/2016 00FYYJ-E PRN  First prospective clinical utility trial using comprehensive liquid biopsy to guide metastatic cancer patients to molecularly matched therapies demonstrates comparable results to tissue-based testing,,,,,,,,,,,,,,,,
"11/12/2013 53220K50 PRN  Upcoming Conferences, Financial Results, Dividends, and Public Offerings - Research Report on Medicines Company, Isis, Ligand, Teleflex, and Tetraphase", 6/23/2015 BHC-CA   PRN  Valeant and Progenics Announce the Submission of U.S. New Drug Application for Oral RELISTOR®," 1/15/2016 45232710    PRN  Covered Call Alerts For Twitter, US Steel, Intel, Amgen and Illumina Released By InvestorsObserver"," 3/19/2013 84763A10 PRN  Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.", 5/15/2019 G3040110 PRN  Endo to Participate at RBC Healthcare Conference,"12/01/2014 04280A10 PRN  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR", 2/23/2017 09060J10 PRN  BioDelivery Sciences Secures Debt Financing with CRG," 7/18/2019 09073M10    PRN  Bio-Techne To Host Conference Call On August 6, 2019, To Announce Fourth Quarter 2019 Financial Results",10/29/2019 75886F10    PRN  Dupixent® (dupilumab) Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal Polyposis,,"11/15/2016 68375N10 PRN  InvestorsObserver releases covered-call reports for GoPro, Opko Health, MINDBODY Inc., Yamana Gold Inc. and The Home Depot Inc.", 5/09/2019 46222210 PRN  Ionis reports first quarter 2019 financial results, 6/21/2019 BMRN-US    PRN  BioMarin Earns Milestone Payments from Pfizer for TALZENNA® (talazoparib) for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation,"12/23/2014 01535110 PRN  Pre-Market Scans on Biotech Stocks - Sarepta Therapeutics, Medivation, Alexion Pharma, Alkermes, and Cepheid", 4/30/2019 64125C10 PRN  Neurocrine Biosciences to Present Data Analyses on INGREZZA® (valbenazine) and Opicapone at the 2019 American Academy of Neurology Annual Meeting, 6/06/2016 81257810 PRN  Astellas and Seattle Genetics Present ASG-15ME and ASG-22ME Phase I Clinical Data in Metastatic Urothelial Cancer at ASCO Annual Meeting,"12/17/2013 45290710 PRN  New Leaders, Quarterly Dividends, Positive Clinical Results, and Data Presentations - Research Report on Quintiles, CR Bard, Theravance, Immunomedics and Progenics Pharmaceuticals",11/30/2016 00167Y-E  PRN  Sangamo's Genome Editing Program for Hemoglobinopathies to Transfer to Biogen's Spin-Off Bioverativ,"11/21/2013 45253H10 PRN  Stock Price Update, Recognitions, and Grant of Stock Options - Research Report on Cyberonics, Hill-Rom Holdings, Bio-Reference Laboratories, Avanir Pharmaceuticals, and ImmunoGen"," 9/20/2013 09058V10 PRN  Today's Research: Amgen Inc., BioCryst Pharmaceuticals Inc., PDL BioPharma Inc., and Questcor Pharmaceuticals Inc.", 8/08/2017 000L1R-E   PRN  Survey of Payers and Gastroenterologists Finds Excitement Over the Prospect of JAK Inhibitors to Treat Inflammatory Bowel Disease, 5/13/2019 04004760   PRN  Arena Pharmaceuticals to Participate in Upcoming Investor Conferences," 5/15/2019 N5946510  PRN  Mylan and Biocon to Present Final Overall Survival Data for Ogivri™ (trastuzumab-dkst), a biosimilar to Herceptin®, at the American Society of Clinical Oncology (ASCO) Annual Meeting"," 5/06/2019 M2572210 PRN  Compugen First Quarter 2019 Conference Call Scheduled for Monday, May 20, 2019 at 8:30 AM ET"," 5/01/2015 00972810 PRN  Pharma Stocks Technical Data -- Akorn, VIVUS, Mallinckrodt, Novo Nordisk, and Cempra",11/07/2019 03116210 PRN  Amgen To Present At The 28th Annual Credit Suisse Healthcare Conference,"11/12/2014 62855J10 PRN  Critical Alerts For Twitter, Isis Pharmaceuticals, TrueCar and Myriad Genetics Released By InvestorsObserver", 3/09/2017 BARC-GB  PRN  Lexicon To Present At The Barclays Global Healthcare Conference,, 5/21/2019 45766930 PRN  Insmed Announces Pricing of Public Offering of Common Stock,,11/05/2019 45773H20 PRN  Inovio Demonstrates 80% 6-Month Progression-Free Survival In Phase 2 Glioblastoma Multiforme (GBM) Study with INO-5401 In Combination with PD-1 Inhibitor Libtayo® (cemiplimab)," 7/30/2019 64026810 PRN  Nektar to Announce Financial Results for the Second Quarter 2019 on Thursday, August 8, 2019, After Close of U.S.-Based Financial Markets",10/30/2018 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Third Quarter 2018 Financial Results," 1/13/2014 37416310 PRN  Executive Appointment, J.P. Morgan Healthcare Conference Presentation Schedules, and Q4 2013 Results Schedule - Research Report on McKesson, Omnicare, HealthSouth, Kindred Healthcare, and Geron",,"11/27/2013 02311120 PRN  AAAResearchReports.com Pre-Market Technical Analysis: Elan Corp., Amarin Corp., Cubist Pharmaceuticals, and Seattle Genetics",12/16/2016 000P56-E PRN  CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis (RA),12/31/2018 91307C10 PRN  United Therapeutics Corporation To Present At 37th Annual J.P. Morgan Healthcare Conference," 2/18/2015 80360710 PRN  Critical Alerts For JC Penney, Tile Shop, Sarepta Therapeutics, Goodrich Petroleum Corp. and bluebird bio Inc. Released By InvestorsObserver", 4/24/2019 G0176710 PRN  Alkermes Appoints Industry Veteran C. Todd Nichols as Senior Vice President of Sales and Marketing,,,,11/05/2018 55027E10 PRN  Luminex Corporation Reports Third Quarter 2018 Financial Results, 8/30/2018 80067710 PRN  Sangamo Therapeutics Announces Conference Call To Review SB-913 CHAMPIONS Study Data And Participation At Upcoming Investor Conferences," 8/04/2015 30161Q10 PRN  Critical Alerts For PayPal Holdings Inc., Exelixis, Glu Mobile, Clorox and AbbVie Released By InvestorsObserver", 5/01/2019 80105N10  PRN  FDA approves Dengvaxia® for the prevention of dengue in individuals ages 9 through 16 living in U.S. endemic areas,11/19/2014 VRTX-US   PRN  Royalty Pharma Announces $3.3 Billion Royalty Transaction with Cystic Fibrosis Foundation Therapeutics,, 9/03/2015 04351P10 PRN  Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences," 5/19/2014 06W57R-E PRN  Business Highlights, Financial Results, and Leadership Appointments - Analyst Notes on PDL BioPharma, bluebird, Osiris, Agios and Ophthotech", 6/30/2015 00422510 PRN  Clinical Studies of Disease-Modifying Therapies & Drug Delivery Candidates Lead to New Drug Therapies & Patents for Treating Patients with Parkinson's Disease & Other Neurodegenerative Disorders,," 1/07/2019 74366E10 PRN  Protagonist Therapeutics Appoints Suneel K. Gupta, Ph.D., as Executive Vice President of Clinical Operations and Pharmacology",,,"12/10/2013 98978L20    PRN  Pharma Industry Morning Assessment: Pfizer, Merck & Co., AbbVie, and Zogenix",, 4/02/2015 68214310 PRN  Omeros Corporation Announces the U.S. Commercial Launch of Omidria™,,," 3/19/2013 46333X10 PRN  Prescription for Success: Commercialization Efforts, Acquisitions and Enhanced Patent Protection - Research Report on PAREXEL International, Ironwood Pharmaceuticals, Opko Health, Amarin Corporation, Progenics Pharmaceuticals",,,,, 3/19/2019 00DWZM-E PRN  Why the FDA Commissioner Pushed to Shorten Medical Device Approval Process,,,,12/27/2018 00182C10 PRN  ANI Pharmaceuticals Secures Refinancing for Convertible Debt Due December 2019 and Enters Amended Five-Year $265 Million Senior Secured Credit Facility,"11/29/2013 29251M10 PRN  Events, Positive Results, Collaborations, and Appointments - Research Report on NPS, Echo Therapeutics, Merrimack, Cyberonics, and Enanta","12/30/2013 02043Q10 PRN  Regulatory Filings, Upcoming Healthcare Conferences, Trial Updates, and Innovative Collaborations - Research Report on Novo Nordisk, Hospira, Tesaro, Alnylam, and Sanofi",,,12/10/2018 60468T10 PRN  Mirati Therapeutics Announces The Appointment Of Maya Martinez-Davis To The Board Of Directors,"12/19/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces Results from EXPAREL™ Pivotal Trial Published in Diseases of the Colon & Rectum",,,,,, 5/16/2019 09627Y10 PRN  Blueprint Medicines Announces Data Presentations at ASCO and EHA Meetings from Registration-Enabling Clinical Trials of Avapritinib and BLU-667 Across Multiple Patient Populations,, 2/06/2019 28249U10 PRN  Eiger BioPharmaceuticals Announces Patent Protection for Lonafarnib Boosted with Ritonavir for Treatment of Hepatitis Delta Virus Infection in Europe and Japan," 8/23/2011 000D69-E PRN  Insider Trading Alerts for Momenta, MEMC, Public Storage, Central European Distribution, OpenTable & Cadence Design Systems",,,,,, 3/07/2019 92165910 PRN  Vanda Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference,,," 3/27/2015 45781M10   PRN  Pharma Stocks Technical Review -- Novo Nordisk, Mallinckrodt, Theravance, Cempra, and Ampio Pharma",, 2/07/2019 40637H10 PRN  Halozyme To Host Fourth Quarter And Full-Year 2018 Financial Results Webcast And Conference Call, 1/08/2018 G2151510 PRN  China Biologic Announces Corporate Update," 5/18/2015 56400P70 PRN  Critical Alerts For Disney, Build-A-Bear Workshop, China Lodging Group, MannKind and Sotheby's Released By InvestorsObserver",,, 1/06/2011 002VD4-E PRN  Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC-1002,10/03/2019 03236M20 PRN  Biossance Introduces The Clean Academy, 9/18/2019 69366J20 PRN  PTC Therapeutics Announces Pricing of Public Offering of Common Stock,"11/11/2014 00448Q20 PRN  Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver",, 3/08/2011 03152W10 PRN  Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease,,,,10/26/2017 36197T10 PRN  Innovative Biotechnology Companies are Transforming Cannabis-based Medical Products,11/14/2013 29428V10 PRN  Epizyme's EPZ-5676 DOT1L Inhibitor Demonstrates Encouraging Initial Findings in an Ongoing Phase 1 Dose Escalation Study," 4/23/2019 G5087110 PRN  Jazz Pharmaceuticals to Report 2019 First Quarter Financial Results on May 7, 2019",," 4/06/2018 39843840 PRN  Grifols 2017 Annual Report on Form 20-F filed with the SEC on April 6, 2018",," 7/17/2019 73701010 PRN  Portola Pharmaceuticals to Announce Second Quarter 2019 Financial Results on Wednesday, August 7, 2019",10/13/2016 92337F10 PRN  Data Demonstrating Clinical Value of Veracyte Genomic Tests for Use in Lung Cancer and IPF to Be Presented at CHEST Annual Meeting 2016,, 9/22/2010 063J3K-E PRN  Cellectis Unveils Its New Corporate Website, 3/06/2017 14075510 PRN  Cannabinoid (CBD) Research and Development Remains Incredibly Strong in Spite of Federal Hesitation on Recreational Marijuana use,,,, 8/30/2011 46226010 PRN  Genesis Biopharma Announces Letter to Shareholders Posted to Website, 5/01/2012 000L1R-E PRN  AnaptysBio Announces Antibody Discovery Partnership With Gilead Sciences,,, 8/03/2015 G4618810 PRN  Depomed Comments on Horizon Pharma Announcement,,"12/18/2013 45845P10 PRN  Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept",,,11/08/2017 98401F10 PRN  Xencor to Present Preclinical Data on Tumor Microenvironment Targeting Bispecifics XmAb®20717 and XmAb®23104 at Society for Immunotherapy of Cancer (SITC) 2017 Annual Meeting,, 3/12/2019 G8807B10 PRN  Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis, 1/05/2012 079TK4-E PRN  Novocure Announces Appointment of Wilco Groenhuysen as Chief Financial Officer, 5/29/2018 03969710 PRN  Ardelyx to Present at the Jefferies 2018 Global Healthcare Conference,,,,,11/10/2016 008XK0-E PRN  Foamix Pharmaceuticals to Present at Jefferies London Healthcare Conference on November 17,12/03/2010 001THX-E PRN  PRA International to Exhibit at Hematology Conference,,," 6/30/2014 74587V10 PRN  Patent Issuance, Positive Trial Data, Recognitions, and Priority Review - Analyst Notes on Keryx, Puma, Ligand, Sagent and Enanta",,,11/06/2018 05070R10 PRN  Audentes Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update,,,,,, 2/14/2019 75901B10 PRN  REGENXBIO to Host RGX-314 Program Analyst and Investor Event with Leading Retina Specialists,,,,,,,,,,,,,,, 3/19/2014 00695P-E  PRN  Kinex and Zenith Technology to Initiate Clinical Studies of an Oral Form of Paclitaxel (Oraxol) in New Zealand,,,,,,,,,,,,,,,,,,,,,,,,,,"12/24/2018 0DK6LR-E PRN  Kodiak Sciences Added to Russell 2000®, 3000® and Microcap® Indexes",," 5/26/2016 00FYYJ-E PRN  Guardant Health Announces Project LUNAR, An Ambitious Multi-arm, Multi-site Umbrella Trial to Study Blood Test for Early Cancer Detection",,,,,,,,,,,,,,,,
"11/04/2013 53220K50 PRN  Healthcare Sector Announced Financial Results - Research Report on Ligand, Auxilium, STERIS, USANA, and Cardiovascular Systems"," 5/14/2015 74318710 PRN  Biotech Stocks Technical Analysis - Achillion Pharma, CTI BioPharma, StemCells, Progenics Pharma, and Bluebird Bio","12/30/2015 45232710    PRN  Covered Call Alerts For GoPro, Chesapeake Energy, Alcoa, Illumina and American Airlines Released By InvestorsObserver"," 3/18/2013 GSK-GB   PRN  Amarin, Celgene, GlaxoSmithKline, Spectrum Pharma, and Geron Briefing and Review", 5/09/2019 G3040110 PRN  Endo Reports First-Quarter 2019 Financial Results,11/07/2014 04280A10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Arrowhead Research Corporation and Certain Officers - ARWR, 1/26/2017 09060J10 PRN  BioDelivery Sciences to Hold Analyst and Investor Day to Discuss BELBUCA® Commercialization Plans on February 1st in New York City, 7/17/2019 09073M10    PRN  Bio-Techne Releases 32x8 Cartridge For The Ella Platform,10/25/2019 75886F10    PRN  Regeneron Ranked #2 in Science Magazine's Top Biopharma Companies to Work For,,"10/13/2016 68375N10 PRN  InvestorsObserver releases covered-call reports for Freeport-McMoRan, Opko Health, NextEra Energy, Best Buy Inc. and Canadian Solar"," 5/06/2019 46222210 PRN  Ionis launches new corporate brand that reflects company's industry-leading innovation and unique culture of saying ""yes"" to patients", 6/18/2019 09061G10   PRN  BioMarin Announces New England Journal of Medicine Publishes Vosoritide Phase 2 Study Showing Sustained Annualized Growth Up to 42 Months in Children with Achondroplasia,"10/30/2014 01535110 PRN  Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna", 4/29/2019 64125C10 PRN  Neurocrine Biosciences Reports First Quarter 2019 Financial Results,12/10/2015 OPY-US   PRN  Oppenheimer's 26th Annual Healthcare Conference Provides Investors With Access To More Than 140 Public And Private Healthcare Companies,"12/09/2013 45290710 PRN  Stock Price Updates, Conferences Participations - Research Report on Quest Diagnostics, Pharmacyclics, Health Management Associates, Theravance, and Immunomedics",11/21/2016 07Z934-E  PRN  Biogen Inc. Renews License with Absorption Systems for Testing Platform,"11/13/2013 45253H10 PRN  Public Offerings, Clinical Tests, and Financial Results- Research Report on InterMune, Emergent BioSolutions, ImmunoGen, Sequenom, and Intrexon"," 8/27/2013 09058V10 PRN  New Programs, Product Launches, Corporate Announcements and Financial Results - Research Report on Aetna, Illumina, Pharmacyclics, WellCare, and BioCryst", 7/26/2017 MYL-US     PRN  Mylan Receives WHO Prequalification for Generic Sovaldi®, 5/08/2019 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2019 Financial Results, 5/10/2019 N5946510  PRN  Mylan Expands Oncology Portfolio with Launch of Generic Tarceva® Tablets, 4/03/2019 M2572210 PRN  Compugen Presents Update on COM701 Phase 1 Trial at the 2019 AACR Annual Meeting," 4/27/2015 00972810 PRN  Updated: Harwood Feffer LLP Announces Investigation of Akorn, Inc.",11/04/2019 0FB9CW-E PRN  Revolution Medicines and Amgen Partner on Phase 1b Study to Evaluate Combination of RMC-4630 and AMG 510,"10/13/2014 62855J10 PRN  Critical Alerts For Apple, Darden Restaurants, Myriad Genetics, Clorox and Ballard Power Systems Released By InvestorsObserver", 3/06/2017 52887230 PRN  Lexicon To Present At The Cowen And Company 37th Annual Healthcare Conference,, 5/20/2019 45766930 PRN  Insmed Announces Proposed Public Offering of Common Stock,,"10/29/2019 45773H20 PRN  Inovio Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 12, 2019"," 6/13/2019 64026810 PRN  First-in-Human Data Presented from Phase 1a Study of NKTR-358, a Novel T Regulatory Cell Stimulator, at Annual European Congress of Rheumatology","10/29/2018 76655960 PRN  Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd. to Develop and Commercialize TAVALISSE™ (fostamatinib disodium hexahydrate) in Japan and other Asian Countries","12/18/2013 37416310 PRN  Updated Estimates, Stock Movements, and Regulatory Approvals - Research Report on Quest Diagnostics, Zimmer Holdings, Pacira Pharmaceuticals, Geron, and Oculus Innovative Sciences",,"11/13/2013 02311120 PRN  Appointments, Financial Results, Divestitures, and Staff Reductions- Research Report on AstraZeneca, VIVUS, Cooper, ARIAD, and Amarin",11/30/2016 AGEN-US  PRN  Agenus Announces Commencement of Phase 1/2 Clinical Trial of anti-OX40 Checkpoint Antibody INCAGN1949 in Patients with Solid Tumors,12/03/2018 91307C10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of United Therapeutics Corporation - UTHR," 1/14/2015 80360710 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Sarepta Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 6, 2015 -- SRPT", 4/18/2019 G0176710 PRN  Alkermes to Host Conference Call to Discuss First Quarter 2019 Financial Results,,,,10/18/2018 55027E10 PRN  Luminex Corporation to Acquire MilliporeSigma's Flow Cytometry Portfolio, 8/10/2018 80067710 PRN  Sangamo Therapeutics Announces Presentation At The 2018 Wedbush PacGrow Healthcare Conference, 7/24/2015 30161Q10 PRN  Positive Results From Phase 3 Clinical Trial of Cabozantinib - Report on Exelixis, 4/26/2019 000VC1-E  PRN  CHMP Issues Positive Opinion for Libtayo® (cemiplimab) in Advanced Cutaneous Squamous Cell Carcinoma,"10/27/2014 92532F10  PRN  Assistance Programs, Dividends, Campaigns, Drug Recommendations, and Research Collaborations - Research Reports on Duke Energy, Exelon, Marriott, Vertex and AstraZeneca",, 8/24/2015 04351P10 PRN  Ascendis Pharma A/S Reports Second Quarter 2015 Financial Results," 3/05/2014 09609G10 PRN  New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara"," 5/18/2015 00422510 PRN  Biotech Equities Technical Study -- Gilead Sciences, Celgene, Novavax, Arena Pharma, and ACADIA Pharma",,"12/13/2018 74366E10 PRN  Protagonist Therapeutics Initiates Phase 1 Trial of Oral, Gut-Restricted, Alpha-4-Beta-7 Integrin Antagonist PN-10943",,,"11/19/2013 98978L20    PRN  Healthcare Sector Announced Reforms, Financial Results, Public Offerings, Top Rankings and Positive Data - Research Report on Kindred, Zogenix, Sangamo, PhotoMedex and Supernus Pharmaceuticals",, 4/02/2015 68214310 PRN  Omeros Corporation Announces the U.S. Commercial Launch of Omidria™,,," 3/07/2013 INVA-US  PRN  Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood",,,,, 3/14/2019 69329Y10 PRN  PDL BioPharma Reports 2018 Fourth Quarter and Full Year Financial Results,,,,12/07/2018 00182C10 PRN  ANI Pharmaceuticals Enters into Separate Privately Negotiated Agreements with Certain Holders of its Convertible Notes,"11/18/2013 29251M10 PRN  AbbVie Releases First of Six Phase III Results from Investigational All-Oral, Interferon-Free, 12-week Regimen, Showing 96 Percent SVR12 in Genotype 1 Hepatitis C Patients New to Therapy","12/18/2013 02043Q10 PRN  Public Offerings, Merger Agreements, New Preclinical Data, New Treatments and Dividend Payments - Research Report on XOMA, MAKO, Alnylam, Avanir, and PDL BioPharma",,,"11/29/2018 60468T10 PRN  Mirati Therapeutics Announces FDA Clearance Of Investigational New Drug (IND) Application To Initiate Phase 1/2 Trial Of KRAS G12C Inhibitor, MRTX849",12/05/2011 69512710 PRN  New Data Demonstrating the Impact of Opioid-Related Adverse Events on Total Hospital Cost Presented at American Society of Health-System Pharmacists Meeting,,,,,, 5/09/2019 09627Y10 PRN  Blueprint Medicines Reports First Quarter 2019 Financial Results,, 2/04/2019 28249U10 PRN  Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study of Avexitide in Post-Bariatric Hypoglycemia (PBH) at Upcoming Endocrine Society (ENDO) Meeting 2019 in New Orleans," 8/18/2011 000DXS-E PRN  Insider Trading Found at Entergy, Momenta, Colgate-Palmolive, priceline.com, F5 Networks & Kulicke and Soffa",,,,,, 2/27/2019 92165910 PRN  Vanda (VNDA) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. - VNDA,,," 2/18/2015 45781M10   PRN  Technical Report on Pharma Stocks -- Novo Nordisk, Theravance, XenoPort, Cempra, and Ampio Pharma",, 2/04/2019 40637H10 PRN  argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE® Technology, 1/03/2018 0H7JCH-E PRN  China Biologic Announces Completion of Acquisition of TianXinFu from PWM," 5/13/2015 56400P70 PRN  Factors Influencing Business Growth: Complementary Research on Citigroup, JPMorgan Chase, Itau Unibanco, Pfizer, and MannKind",,, 6/21/2010 002VD4-E PRN  TransGenRx Protein Therapeutics Technology to Support Research Related to Protein-Based HDL Therapies at Esperion Therapeutics,10/01/2019 03236M20 PRN  Amyris Provides Highlights of First Half 2019 Financial Results, 9/17/2019 69366J20 PRN  PTC Therapeutics Announces Proposed Private Offering of Convertible Senior Notes,"11/04/2014 00448Q20 PRN  Biotech Equities Coverage - Achillion Pharma, Sarepta Therapeutics, Alnylam Pharma, Incyte, and Cytori Therapeutics",," 3/03/2011 03152W10 PRN  Amicus Therapeutics to Present at the 31st Annual Cowen and Company Health Care Conference on Tuesday, March 8, 2011",,,,10/25/2017 36197T10 PRN  Medical Cannabis Sales Projected to Rise Thanks to Legalization Efforts,"11/07/2013 29428V10 PRN  Epizyme, Inc. to Present Pre-Clinical Data on DOT1L and EZH2 Inhibitor Programs at the 55th ASH Annual Meeting", 3/26/2019 G5087110 PRN  Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness,, 3/05/2018 39843840 PRN  Grifols Announces New Agreement with Henry Schein to Distribute Normal Saline Solution in the U.S.,, 7/08/2019 73701010 PRN  Portola Pharmaceuticals Presents New In Vitro Data Demonstrating that Four-Factor Prothrombin Complex Concentrates (4F-PCCs) Had No Direct Effect on Inhibition of Thrombin Generation by Factor Xa Inhibitors, 9/30/2016 92337F10 PRN  Veracyte Releases Statement on CMS's Final 2017 Gapfill Rate for the Afirma® Gene Expression Classifier,, 9/20/2010 063J3K-E PRN  Cellectis bioresearch and Helix Biocon Join Forces for the Promotion of cGPS® and cGPS® Custom Kits and Cell Line Engineering Services in India, 3/03/2017 14075510 PRN  Legal Cannabis Market Might be Beneficial to U.S. Economy,,,, 8/10/2011 46226010 PRN  Genesis Biopharma Signs Cooperative Research and Development Agreement With the National Cancer Institute to Develop Cancer Immunotherapies, 4/09/2012 008H33-E PRN  AnaptysBio Announces Strategic Antibody Discovery Partnership With Celgene Corporation,,," 8/03/2015 G4618810 PRN  Critical Alerts For Opko Health, Horizon Pharma, Fortress Biotech, CyberArk Software and Virgin America Released By InvestorsObserver",,"11/20/2013 45845P10 PRN  Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals",,,11/07/2017 98401F10 PRN  Xencor Reports Third Quarter 2017 Financial Results and Provides Clinical Pipeline Update,," 2/26/2019 G8807B10 PRN  Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update",12/16/2011 079TK4-E PRN  Novocure Adds Three Senior Oncology Executives to its Global Management Team, 5/22/2018 03969710 PRN  Ardelyx Announces Pricing of Public Offering of Common Stock,,,,,"11/07/2016 M4613510 PRN  Foamix Pharmaceuticals to Release Third Quarter 2016 Financial Results and Host Conference Call & Webcast on Wednesday, November 16",12/01/2010 001THX-E PRN  PRA International Experts to Speak at Late Phase Conference,,," 6/19/2014 PBYI-US  PRN  INVESTOR ALERT - The Law Offices of Vincent Wong Investigating Medifast Inc. (MED), Molina Healthcare, Inc. (MOH), Puma Biotechnology Inc. (PBYI), Pioneer Energy Services Corp. (PES), and VOXX International Corporation (VOXX)",,,11/05/2018 05070R10 PRN  Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman,,,,,, 1/31/2019 75901B10 PRN  REGENXBIO Receives Rare Pediatric Disease Designation for RGX-181 Gene Therapy for the Treatment of CLN2 Form of Batten Disease,,,,,,,,,,,,,,, 3/04/2014 00695P-E  PRN  Kinex Completes Oversubscribed USD $40 Million Private Placement Equity Raise,,,,,,,,,,,,,,,,,,,,,,,,,,12/21/2018 50015M10 PRN  Kodiak Sciences Announces Completion of 12-Week Phase 1a Study of KSI-301 in Patients with Diabetic Macular Edema Demonstrating Safety and Durability of Responses Following Single Dose of Intravitreal Anti-VEGF Antibody Biopolymer Conjugate,," 5/13/2016 00FYYJ-E PRN  Guardant Health To Present Liquid Biopsy Data From More Than 15,000 Patients At ASCO Annual Meeting",,,,,,,,,,,,,,,,
"10/30/2013 53220K50 PRN  New Appointments, Upcoming Earnings Releases, Regulatory Approvals, Status Updates and Informative Resources for New Treatment Options - Research Report on Mylan, Alkermes, Salix, Ligand and Hospira"," 5/11/2015 74318710 PRN  Recent Highlights from the Healthcare Sector: Complementary Research on BioMarin, Seattle Genetics, Globus Medical, Nymox and Progenics","12/16/2015 45232710    PRN  Covered Call Alerts For Tesla Motors, Qualcomm, Alcoa, Illumina and BP Released By InvestorsObserver"," 3/15/2013 84763A10 PRN  Ryan & Maniskas, LLP Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc."," 5/01/2019 G3040110 PRN  Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection, USP Due to the Presence of a Glass Fragment Observed in One Vial of Reconstituted Product","11/05/2014 04280A10 PRN  Morning Briefing on Biotech Stocks - Arrowhead Research, Array BioPharma, Aegerion Pharma, Hemispherx Biopharma, and Aeterna Zentaris", 1/09/2017 05MBN8-E PRN  BioDelivery Sciences Closes Transaction to Reacquire License to BELBUCA® from Endo Pharmaceuticals, 7/11/2019 09073M10    PRN  Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues,10/25/2019 75886F10    PRN  Regeneron Colleagues Support 150 Community Organizations During Third Annual Day for Doing Good,," 9/28/2016 68375N10 PRN  Under Armour trade offers a 4.6% return in 51 days, or find similar option trades on Opko Health, Amazon.com, Weibo, and Seagate Technology", 5/01/2019 46222210 PRN  Positive clinical data at AAN 2019 reinforces Ionis' commitment to delivering life-changing medicines to patients with neurological diseases," 6/05/2019 09061G10   PRN  BioMarin to Participate in Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11 in Rancho Palos Verdes, CA","10/24/2014 01535110 PRN  Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells", 4/08/2019 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2019 Financial Results," 9/14/2015 81257810 PRN  Critical Alerts For Disney, YY, Ariad Pharmaceuticals, Whiting Petroleum and Seattle Genetics Released By InvestorsObserver","11/27/2013 45290710 PRN  Positive Opinion, Program Honorees, Positive Medical Results, and Investor Day - Research Report on Bristol-Myers Squibb, Ariad Pharmaceuticals, Dyax, Ironwood Pharmaceuticals, and Immunomedics","11/17/2016 06CR5C-E  PRN  FDA Grants Fast Track Designation for Development of E2609, Eisai's BACE Inhibitor for Early Alzheimer's Disease","11/06/2013 45253H10 PRN  Quarterly Dividends, Financial Results, and FDA Guidance - Research Report on Techne, ImmunoGen, Repros, Halozyme, and Synageva"," 7/23/2013 09058V10 PRN  Tuesday's Biotech Watch List - Alliqua, BioCryst Pharmaceuticals, Trovagene, Delcath Systems, Array BioPharma"," 7/26/2017 37555810   PRN  Options trade ideas for ANI Pharmaceuticals, Facebook, Gilead Sciences, Hilton Worldwide and Shutterfly offer returns of 21% or more!", 5/01/2019 04004760   PRN  Arena Pharmaceuticals to Release First Quarter 2019 Financial Results and Provide Corporate Update on May 8, 5/10/2019 N5946510  PRN  Mylan to Present at the 2019 Bank of America Merrill Lynch Healthcare Conference, 3/26/2019 M2572210 PRN  Compugen Announces Purchase of Company Shares by its Board of Directors and Members of Management," 4/24/2015 00972810 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline - AKRX",10/31/2019 03116210 PRN  Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China," 9/18/2014 62855J10 PRN  Critical Alerts For Linn Energy, Infosys, ITT Education, King Digital and Myriad Genetics Released By InvestorsObserver", 3/03/2017 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Fourth Quarter And Full Year Financial Results,, 5/20/2019 45766930 PRN  New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with Refractory MAC Lung Disease,,10/01/2019 0017CF-E PRN  Biotechs Endeavour to Increase Access to Cancer Treatments, 6/11/2019 64026810 PRN  Nektar Therapeutics to Host Webcast Conference Call with Immunology Expert for Analysts & Investors During 2019 European Congress of Rheumatology (EULAR 2019),10/11/2018 76655960 PRN  Rigel Receives EMA Validation of the Marketing Authorization Application for Fostamatinib Disodium Hexahydrate in Chronic Immune Thrombocytopenia (ITP) in Adult Patients,"12/10/2013 37416310 PRN  Healthcare Companies Report Stock Price Updates, and Medical System Integration - Research Report on Johnson & Johnson, Geron, Ligand Pharmaceuticals, Masimo, and Capital Senior Living",,"11/13/2013 02311120 PRN  Healthcare Sector Announces Financial Results and Financial Restatements - Research Report on Merck, Health Management Associates, ZELTIQ, MAKO, and Amarin",11/14/2016 000P56-E PRN  Baricitinib Demonstrates Early Response Compared to Placebo and Significant Improvement Compared to Adalimumab in Patient-Reported Outcomes,11/29/2018 91307C10 PRN  Health Canada Approves Unituxin® For The Treatment Of Pediatric High-Risk Neuroblastoma,"12/23/2014 80360710 PRN  Pre-Market Scans on Biotech Stocks - Sarepta Therapeutics, Medivation, Alexion Pharma, Alkermes, and Cepheid", 4/09/2019 G0176710 PRN  Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA® and INVEGA SUSTENNA® for the Treatment of Schizophrenia,,,,"10/15/2018 55027E10 PRN  Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018", 8/08/2018 80067710 PRN  Sangamo Announces Positive Preliminary Data from the Phase 1/2 Alta Study Evaluating SB-525 Gene Therapy for Hemophilia A," 7/23/2015 30161Q10 PRN  Critical Alerts For Lumber Liquidators, Exelixis, Ford, Intuitive Surgical and Rite Aid Released By InvestorsObserver", 4/26/2019 80105N10  PRN  Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER,"10/24/2014 92532F10  PRN  Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells",, 7/30/2015 04351P10 PRN  Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency," 1/14/2014 09609G10 PRN  Conferences, Preliminary Revenues, Board Changes, Shareholders' Meeting Results, and Clinical Trial Initiation - Research Report on Antares, Quidel, bluebird bio, Given Imaging, and Immunomedics"," 4/29/2015 00422510 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2015 - ACAD",,12/05/2018 74366E10 PRN  Protagonist Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference,,,"11/14/2013 98978L20    PRN  Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc.",, 4/02/2015 68214310 PRN  Omeros Corporation Announces the U.S. Commercial Launch of Omidria™,,," 1/04/2013 06DDVL-E PRN  The Zacks Analyst Blog Highlights: ADP, Ironwood Pharmaceuticals, Forest Laboratories, Valeant Pharmaceuticals International and Novo Nordisk",,,,, 3/12/2019 69329Y10 PRN  PDL BioPharma to Participate at 31st Annual Roth Conference,,,,"11/15/2018 ANIP-US  PRN  ANI Pharmaceuticals, Inc. Ranked Number 366 Fastest Growing Company in North America on Deloitte's 2018 Technology Fast 500™"," 9/25/2013 29251M10 PRN  Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta","12/11/2013 02043Q10 PRN  Dividends, FDA Approved Treatments, Clinical Data Presentations and Completed License Applications - Research Report on Medtronic, Auxilium, Alnylam, Infinity, and Halozyme",,,11/20/2018 60468T10 PRN  Mirati Therapeutics To Present At The 30th Annual Piper Jaffray Healthcare Conference,"11/22/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces Completion of Follow-on Offering of Common Stock and Exercise of Over-Allotment Option",,,,,, 5/08/2019 09627Y10 PRN  Blueprint Medicines to Present at Bank of America Merrill Lynch 2019 Health Care Conference,," 1/07/2019 28249U10 PRN  Eiger BioPharmaceuticals Appoints Regulatory Expert and Industry Veteran Christine Murray, MS, RAC to its Board of Directors", 7/12/2011 LVS-US   PRN  Substantial Insider Trading Found at an MMM Stock Price between US$93.10 - US$97.34,,,,,, 2/26/2019 92165910 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA,,," 2/04/2015 45781M10   PRN  Critical Alerts For BlackBerry, Canadian Solar, Theravance, Petrobras and Halliburton Released By InvestorsObserver",, 1/09/2019 40637H10 PRN  Halozyme Provides 2019 Pipeline Update And Financial Guidance At 37th Annual JP Morgan Healthcare Conference,12/15/2017 07431J-E PRN  China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province," 4/30/2015 56400P70 PRN  Critical Alerts For MannKind, Netflix, Baidu, Zillow and DISH Network Released By InvestorsObserver",,, 6/14/2010 002VD4-E PRN  Esperion Therapeutics and Cleveland Clinic Establish Collaboration for Research Related to HDL Therapies," 9/27/2019 03236M20 PRN  Amyris to Host First-Half 2019 Financial Results Teleconference on Wednesday, October 2, 2019", 9/17/2019 69366J20 PRN  PTC Therapeutics Announces Proposed Public Offering of Common Stock,"10/27/2014 00448Q20 PRN  Critical Alerts For NetSuite, CVS Caremark, Netflix, VeriFone Systems and Achillion Pharmaceuticals Released By InvestorsObserver",, 2/18/2011 0729L6-E PRN  ACMG Foundation Announces Revolutionary New Summer Genetics Scholars Program,,,,10/24/2017 36197T10 PRN  How Biosynthesis is Revolutionizing Cannabinoid Pharmaceuticals,"10/29/2013 29428V10 PRN  Epizyme, Inc. to Present at Upcoming Conferences in November", 3/20/2019 G5087110 PRN  Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea,," 2/28/2018 39843840 PRN  Grifols Shines Light on Rare Disease with Launch of Educational Campaign ""Look Into Genetic COPD""",, 6/19/2019 73701010 PRN  Portola Presents New Interim Data on its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated Patients with Relapsed/Refractory Follicular Lymphoma, 9/23/2016 92337F10 PRN  Veracyte Presents Data Demonstrating Potential to Enhance Afirma® Gene Expression Classifier Using an RNA Sequencing Platform,," 9/14/2010 063J3K-E PRN  Cellectis to Present at the UBS Global Life Sciences Conference in New York on September 20-22, 2010"," 3/02/2017 14075510 PRN  Technical Reports on Biotech Stocks -- Halozyme Therapeutics, CytRx, Cara Therapeutics, and Keryx Biopharma",,,, 7/25/2011 46226010 PRN  Genesis Biopharma and Lonza Partner to Develop Contego™, 3/15/2012 008H33-E PRN  AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board,,," 7/29/2015 ASRT-US  PRN  Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc",,11/14/2013 45845P10 PRN  Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results,,,11/04/2017 98401F10 PRN  Xencor Presents Final Results from Phase 2 Study of XmAb®5871 in IgG4-Related Disease (IgG4-RD) at the American College of Rheumatology 2017 Annual Meeting,, 2/21/2019 G8807B10 PRN  Theravance Biopharma to Present at the 8th Annual SVB Leerink Global Healthcare Conference,12/02/2011 079TK4-E PRN  Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy, 5/21/2018 009TYV-E PRN  Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank,,,,,11/03/2016 M4613510 PRN  Foamix Pharmaceuticals to Present at the 25th Annual Credit Suisse Healthcare Conference on November 7,11/16/2010 001THX-E PRN  PRA International Expert to Speak at China Drug Safety Summit,,," 5/30/2014 74587V10 PRN  Pre-clinical Trial Results, Expanded Studies, Preliminary Data Release, and Leadership Appointments - Analyst Notes on Alnylam, BioCryst, Puma Biotechnology, Intrexon and NW Bio",,,"10/30/2018 05070R10 PRN  Audentes Therapeutics to Release Third Quarter 2018 Financial Results and Provide Corporate Update on Tuesday, November 6, 2018",,,,,, 1/04/2019 75901B10 PRN  REGENXBIO to Present at the 37th Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,, 2/06/2014 09LQS0-E  PRN  Kinex and PharmaEssentia Expand Drug Development Partnership,,,,,,,,,,,,,,,,,,,,,,,,,,11/16/2018 50015M10 PRN  Kodiak Sciences Announces Third Quarter 2018 Financial Results and Recent Business Highlights,," 4/01/2016 00FYYJ-E PRN  Guardant Health To Present Liquid Biopsy Data From More Than 10,000 Patients At The AACR Annual Meeting",,,,,,,,,,,,,,,,
"10/02/2013 53220K50 PRN  Regulatory Approval, New Appointments, Stock Price Movements, and Other Announcements - Research Report on Pfizer, Warner Chilcott, Rockwell Medical, InterMune, and Ligand", 4/24/2015 BHC-CA   PRN  RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain,"11/18/2015 45232710    PRN  Covered Call Alerts For Fitbit, Facebook, Weight Watchers, NVIDIA and Illumina Released By InvestorsObserver", 3/14/2013 84763A10 PRN  BlackBerry Gets Single Biggest Purchase Order in Company History. Senate Panel to Approve Budget Safety Net, 4/10/2019 G3040110 PRN  Endo to Announce First-Quarter 2019 Financial Results,10/27/2014 TSCO-GB  PRN  Law Offices of Marc S. Henzel Announces Securities Class Action Periods,12/14/2016 UTHR-US  PRN  BioDelivery Sciences Announces the Hiring of Peter Ginsberg as Vice President of Business Development, 7/09/2019 09073M10    PRN  Bio-Techne CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The Heartland,10/18/2019 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentations,," 9/15/2016 68375N10 PRN  Verizon Communications, Twilio Inc., Opko Health, Starbucks, and EMC Corporation and more offer option-trading opportunities that offer returns of more than 20%", 4/25/2019 46222210 PRN  Ionis Pharmaceuticals to hold first quarter 2019 financial results webcast, 6/04/2019 09061G10   PRN  BioMarin Announces Approval of Vimizim® (elosulfase alfa) in China for Treatment of Morquio A Syndrome,"10/21/2014 01535110 PRN  Collaborations, Dividends, New Drug Applications, and Technical Updates - Research Reports on Simon, Regions Financial, American Capital, CareFusion and Alexion", 3/12/2019 64125C10 PRN  Neurocrine Biosciences Reports Positive Interim Results from Phase II Study of NBI-74788 in Adults with Classic Congenital Adrenal Hyperplasia," 5/11/2015 81257810 PRN  Recent Highlights from the Healthcare Sector: Complementary Research on BioMarin, Seattle Genetics, Globus Medical, Nymox and Progenics","11/25/2013 45290710 PRN  Under AAAResearchReports.com Microscope: Celldex Therapeutics Inc., XOMA Corp., Illumina Inc., and Immunomedics Inc.",11/03/2016 500302-IN PRN  New MS Therapies & HTA Bodies: What's Driving Such High Rates of Positive Evaluation?,"10/22/2013 45253H10 PRN  Quarterly Reports, Licensing Agreements, and Clinical Data - Research Report on Theravance, Dendreon, ImmunoGen, Compugen, and Acorda"," 7/11/2013 09058V10 PRN  Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma"," 4/06/2017 37555810   PRN  Special Investors Release: Covered call stock options reports for Comcast, Salesforce, Gilead Sciences, Hewlett Packard Enterprise Company, and Snap Inc.", 4/03/2019 04004760   PRN  Arena Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference on April 10, 5/07/2019 N5946510  PRN  Mylan Reports First Quarter 2019 Results and Reaffirms 2019 Guidance," 3/12/2019 M2572210 PRN  Compugen Announces Issuance of Two U.S. Composition of Matter Patents for COM701, Its Lead Immuno-Oncology Product Candidate"," 4/21/2015 00972810 PRN  Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Akorn, Inc.",10/30/2019 03116210 PRN  The Discovery Of Amgen's Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature," 8/27/2014 62855J10 PRN  Critical Alerts For Vodafone Group, Tim Hortons, Transocean, Myriad Genetics and SINA Released By InvestorsObserver"," 3/01/2017 52887230 PRN  Lexicon To Report Fourth Quarter And Year End 2016 Financial Results On March 3, 2017",, 5/07/2019 45766930 PRN  Insmed Reports First Quarter 2019 Financial Results and Provides Business Update,, 9/17/2019 45773H20 PRN  Inovio Receives NIH Funding to Target its dMAb® Technology Against Antimicrobial-Resistant Infection, 6/01/2019 64026810 PRN  Nektar Therapeutics Presents Biomarker and Clinical Data from PIVOT-02 Phase 2 Study of Bempegaldesleukin with Nivolumab at 2019 ASCO Annual Meeting," 9/27/2018 76655960 PRN  Rigel to Host Investor & Analyst Day in New York City on October 4, 2018","12/02/2013 37416310 PRN  Announcements and Sponsorships by Biotechnology Companies and Major Drug Manufacturers - Research Report on Lilly, Geron, MannKind, Techne, and InterMune",,11/06/2013 02311120 PRN  Attention Amarin Corporation plc Investors: Amarin Corporation plc Misled Investors According to a Newly Filed Class Action,11/14/2016 45337C10 PRN  New Analyses of Phase 3 Trials Show Improvements in Rheumatoid Arthritis Symptoms Following Treatment with Baricitinib Across Diverse Population of Patients,11/15/2018 91307C10 PRN  Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag,"11/19/2014 80360710 PRN  Critical Alerts For SunEdison, Invensense, JinkoSolar, Inovio Pharmaceuticals and Sarepta Therapeutics Released By InvestorsObserver", 4/08/2019 G0176710 PRN  Alkermes Announces Departure of Jim Robinson,,,, 9/11/2018 55027E10 PRN  Luminex Corporation Declares Third Quarter Cash Dividend, 8/08/2018 80067710 PRN  Sangamo Therapeutics Reports Second Quarter 2018 Financial Results," 7/22/2015 30161Q10 PRN  Biotechnology Sector Stocks Technical Coverage -- Amgen, Exelixis, XOMA Corp., Theravance, and NewLink Genetics", 4/17/2019 80105N10  PRN  Sanofi Named One of America's Best Employers by Forbes,"10/02/2014 92532F10  PRN  Regulatory Approvals, Lawsuits, Positive Study Results, Welfare Initiatives, and Technical Updates - Research Reports on Celgene, Actavis, Bristol-Myers Squibb, UnitedHealth and Vertex",," 7/29/2015 04351P10 PRN  Ascendis Pharma A/S to Report Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone and Host Conference Call on Thursday, July 30, 2015 at 9:00 a.m. Eastern Time","12/25/2013 09609G10 PRN  Acquisitions, Appointments, FDA Approvals, and Study Milestones - Research Report on Jazz Pharmaceuticals, Boston Scientific, NuVasive, Endologix, and bluebird bio"," 4/14/2015 00422510 PRN  Updates on Biotech Stocks -- Gilead Sciences, Arena Pharma, ACADIA Pharma, Halozyme Therapeutics, and Anthera Pharma",,11/27/2018 74366E10 PRN  Protagonist Therapeutics Announces New Development Candidate PN-10943 for the Treatment of Inflammatory Bowel Disease,,,"11/04/2013 98978L20    PRN  Presentation, Quarterly Reports, and FDA Approval - Research Report on Merck, United Therapeutics, Endo, Isis Pharmaceuticals, and Zogenix",, 3/16/2015 68214310 PRN  Omeros Corporation Reports Fourth Quarter and Year-End 2014 Financial Results,,," 1/02/2013 06DDVL-E PRN  The Zacks Analyst Blog Highlights:DeVry, Synergy Pharmaceuticals, Takeda Pharmaceutical, Forest Laboratories and Ironwood Pharmaceuticals",,,,," 3/07/2019 69329Y10 PRN  PDL BioPharma to Announce 2018 Fourth Quarter and Full Year Financial Results on March 14, 2019",,,,11/06/2018 00182C10 PRN  ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2018 Results and Reaffirms Guidance,11/06/2012 062WH0-E PRN  Enanta Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering,"12/03/2013 02043Q10 PRN  Healthcare Sector Announce Awards, Conference Participation, Partnerships, and Closure of Public Offering - Research Report on Regeneron, Alnylam, Galena Biopharma, Amedisys, and Aeterna Zentaris",,,11/09/2018 60468T10 PRN  Mirati Presents Preliminary Biomarker Data From Ongoing Phase 2 Clinical Trial Of Sitravatinib In Combination With Nivolumab At The SITC 33rd Annual Meeting,"11/16/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces Pricing of Follow-On Offering",,,,,," 5/02/2019 09627Y10 PRN  Blueprint Medicines to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019",,12/19/2018 28249U10 PRN  Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib in Progeria and Progeroid Laminopathies," 6/13/2011 DLB-US   PRN  Critical Stock Alerts: Insider Trade for Pacific Capital, Momenta Pharmaceuticals, Dolby, Terex, Eaton, & Rockwell Collins",,,,,," 2/20/2019 92165910 PRN  Lifshitz & Miller LLP Announces Investigation of Bristow Group Inc., Helius Medical Technologies, Inc., Nordstrom Inc., PriceSmart, Inc., Ryanair Holdings plc, Solid Biosciences Inc., and Vanda Pharmaceuticals Inc.",,," 1/09/2015 45781M10   PRN  Stocks Coverage on the Pharma Industry -- Mylan, Salix Pharma, Zoetis, Theravance, and Cempra",,12/26/2018 40637H10 PRN  Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference,11/01/2017 G2151510 PRN  China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017," 4/16/2015 56400P70 PRN  Biotech Stocks Technical Report -- Novavax, MannKind, Juno Therapeutics, Curis, and Ohr Pharma",,,," 9/20/2019 03236M20 PRN  Amyris to Present at B. Riley FBR Annual Consumer & Media Conference on October 3, 2019", 9/06/2019 69366J20 PRN  PTC Therapeutics Celebrates the Fifth Anniversary of STRIVE Grant Awards by Announcing 2019 Award Winners,"10/17/2014 00448Q20 PRN  Upcoming Earnings, Presentation of Clinical Data, Dividends, and Technical Updates - Research Reports on Achillion, KB Home, Hovnanian, QEP Resources and Fortune Brands",, 2/16/2011 03152W10 PRN  Amicus Therapeutics Provides Positive Data Update from Phase 2 Long-Term Extension Study of Amigal™ for Fabry Disease,,,,10/16/2017 36197T10 PRN  Future Legal Cannabis Sales Projected to Rise,"10/22/2013 29428V10 PRN  Epizyme, Inc. Provides Third Quarter 2013 Financial Results and Corporate Update", 3/05/2019 G5087110 PRN  Jazz Pharmaceuticals to Present at the Cowen and Company 39th Annual Healthcare Conference,, 2/06/2018 39843840 PRN  Grifols HyperRAB® (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection,," 4/27/2018 006RGD-E PRN  Biotech Stocks' Research Reports Released on Pieris Pharma, Portola Pharma, Protalix BioTherapeutics, and Radius Health", 9/15/2016 92337F10 PRN  Veracyte Secures Draft Medicare Local Coverage Determination for Percepta® Bronchial Genomic Classifier from Palmetto GBA,, 9/09/2010 063J3K-E PRN  Cellectis Acquires Assets from Cyto Pulse Sciences Inc., 2/28/2017 14075510 PRN  FinancialBuzz.com: Legal Cannabis Market Projected to Become a Major Job Creation Force,,,, 7/21/2011 46226010 PRN  Genesis Biopharma Names Former Member of the Joint Chiefs of Staff General Merrill McPeak to Board of Directors, 1/06/2012 008H33-E PRN  AnaptysBio Announces New Strategic Antibody Discovery,,," 7/21/2015 G4618810 PRN  Depomed Confirms Receipt of Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc",,"10/23/2013 45845P10 PRN  Trial Results Presentations, Public Offerings, Acquisitions and Extension Study Results - Research Report on Medtronic, Steris, Intercept, Wright, and Synageva",,,11/01/2017 98401F10 PRN  Xencor to Present at Upcoming Investor Conferences,," 2/19/2019 G8807B10 PRN  /C O R R E C T I O N -- Theravance Biopharma, Inc./", 8/04/2011 079TK4-E PRN  Novocure Announces Long-Term Supply Agreement With ITT Corporation for Ceramic Sensor Technology, 5/21/2018 03969710 PRN  Ardelyx Announces Proposed Public Offering of Common Stock,,,,, 9/28/2016 M4613510 PRN  Foamix Pharmaceuticals Ltd. Announces Pricing of its $57 Million Follow-on Offering of Ordinary Shares,11/15/2010 001THX-E PRN  PRA International to Showcase New Bioanalytical Lab at AAPS,,," 5/20/2014 74587V10 PRN  Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology",,,10/10/2018 05070R10 PRN  Audentes Therapeutics Announces Pricing of Public Offering of Common Stock,,,,,, 1/03/2019 75901B10 PRN  REGENXBIO Reports Continued Progress Across Programs in Year-End 2018 Corporate Update,,,,,,,,,,,,,,, 2/05/2014 00695P-E  PRN  Kinex Appoints Executives To Clinical Leadership Team,,,,,,,,,,,,,,,,,,,,,,,,,,10/10/2018 50015M10 PRN  Kodiak Sciences Inc. Announces Closing of Initial Public Offering,, 3/29/2016 00FYYJ-E PRN  Guardant Health Announces Collaboration With Principia Biopharma To Use Guardant360® for Monitoring Patient Response and Tumor Evolution in FGFR Inhibitor Trials,,,,,,,,,,,,,,,,
" 5/17/2013 53220K50 PRN  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated"," 3/31/2015 74318710 PRN  Morning Briefing on Biotech Equities -- OPKO Health, Progenics Pharma, Neuralstem, Nanosphere, and Sunesis Pharma",11/12/2015 0CGZ6D-E    PRN  Illumina Set to Join the S&P 500," 3/13/2013 84763A10 PRN  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.", 4/05/2019 0650LH-E PRN  Endo Begins Shipment of Authorized Generic Version of PROVENTIL® (albuterol sulfate) HFA Inhalation Aerosol in the United States,"10/16/2014 04280A10 PRN  Critical Alerts For NewLink Genetics, Orexigen Therapeutics, JinkoSolar, Randgold Resources and Arrowhead Research Released By InvestorsObserver",12/13/2016 09060J10 PRN  BioDelivery Sciences Announces Clonidine Topical Gel for Painful Diabetic Neuropathy Phase 2b Trial Fails to Meet its Primary Efficacy Endpoint," 6/26/2019 09073M10    PRN  Bio-Techne China Recognized With ""Decade of Contribution Award""","10/10/2019 75886F10    PRN  Regeneron to Report Third Quarter 2019 Financial and Operating Results and Host Conference Call and Webcast on November 5, 2019",," 8/31/2016 68375N10 PRN  InvestorsObserver releases covered-call reports for Freeport-McMoRan, Potash Corporation of Saskatchewan, Smith & Wesson, JetBlue and Opko Health", 4/08/2019 46222210 PRN  Ionis Pharmaceuticals to Provide Corporate Update at 2019 Annual Meeting of Stockholders," 5/28/2019 09061G10   PRN  BioMarin Announces that Phase 3 Cohort of Valoctocogene Roxaparvovec, Gene Therapy Study in Severe Hemophilia A Met Pre-Specified Criteria for Regulatory Submissions in the U.S. and Europe","10/15/2014 01535110 PRN  Critical Alerts For Sears Holdings, JetBlue, Qlogic, Las Vegas Sands and Alexion Pharmaceuticals Released By InvestorsObserver", 3/05/2019 64125C10 PRN  Neurocrine Biosciences to Present at Upcoming Healthcare Conferences," 5/06/2015 81257810 PRN  Technical Briefing on Biotech Equities -- OPKO Health, Organovo Holdings, Seattle Genetics, CorMedix, and Sunesis Pharma","10/28/2013 45290710 PRN  Recognitions, Patent Issuance, Financial Results, Upcoming Investor Conferences and Update on ClinicalTrial - Research Report on Stereotaxis, Immunomedics, Novadaq, Avanir, and Raptor Pharmaceuticals"," 9/07/2016 09062X10  PRN  Research Reports Coverage on Biotech Stocks -- Biogen, ImmunoGen, Jazz Pharma, and Cempra","10/07/2013 45253H10 PRN  Regulatory Approvals, Public Offerings and Clinical Trial Results - Research Report on Theravance, Synageva, Nektar, Clovis Oncology, and ImmunoGen", 4/15/2013 094VTK-E PRN  Major Indexes End Winning Streak and J.C. Penney to Start Selling Martha Stewart Goods, 4/05/2017 NOC-US     PRN  Young Scientists From Around the State Will Compete for Top Honors at the 66th California State Science Fair, 3/08/2019 04004760   PRN  Arena Pharmaceuticals Presented New Phase 2 Data for Etrasimod and Olorinab at the 14th Congress of European Crohn's and Colitis Organisation," 4/26/2019 N5946510  PRN  Mylan to Release First Quarter 2019 Financial Results on May 7, 2019", 3/05/2019 M2572210 PRN  Compugen to Present at the Cowen and Company 39th Annual Health Care Conference," 3/26/2015 00972810 PRN  Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn",10/29/2019 03116210 PRN  Amgen Reports Third Quarter 2019 Financial Results," 8/18/2014 000CV5-E PRN  Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc.", 2/28/2017 52887230 PRN  FDA Approves Lexicon Drug XERMELO™ (telotristat ethyl) 250 mg As First And Only Oral Treatment For Carcinoid Syndrome Diarrhea In Cancer Patients With Metastatic Neuroendocrine Tumors,," 4/30/2019 45766930 PRN  Insmed to Host First Quarter 2019 Financial Results Conference Call on Tuesday, May 7, 2019",, 9/03/2019 45773H20 PRN  Inovio Pharmaceuticals to Present at Upcoming Investor Conferences," 5/23/2019 64026810 PRN  Nektar Announces the Launch of Inheris Biopharma, Inc.", 9/24/2018 76655960 PRN  Rigel to Present at the Cantor Global Healthcare Conference,"11/22/2013 37416310 PRN  Early Briefing and Review: Arena Pharma Inc., Geron Corp., Incyte Corp., and Spectrum Pharma Inc.",,"11/06/2013 02311120 PRN  Advancing Pipelines, Liquidity Growth, Cost-reduction Initiatives and Breakthrough Studies - Research Report on Alkermes, Abiomed, Gentium, Amarin, and VIVUS",11/02/2016 45337C10 PRN  New data from pivotal RA-BEACON study show significant improvement in patient-reported outcomes in rheumatoid arthritis patients treated with baricitinib compared to placebo,11/12/2018 09V54Q-E PRN  CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants,"11/18/2014 80360710 PRN  Robbins Arroyo LLP Is Investigating the Officers and Directors of Sarepta Therapeutics, Inc. (SRPT) on Behalf of Shareholders", 4/03/2019 G0176710 PRN  Alkermes Expands Awards Program With Focus on Advancing Research in Schizophrenia,,,, 9/06/2018 55027E10 PRN  Luminex Corporation to Present at the Morgan Stanley 16th Annual Global Healthcare Conference, 8/02/2018 80067710 PRN  Sangamo Therapeutics Announces Second Quarter 2018 Conference Call and Webcast, 7/21/2015 30161Q10 PRN  Progression Survival Benefit - BrokerBank Securities, 4/17/2019 80105N10  PRN  World Hemophilia Day: Sanofi Genzyme Donation Impacts Patients Across the Globe," 9/11/2014 92532F10  PRN  Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma",, 5/18/2015 04351P10 PRN  Ascendis Pharma A/S Reports First Quarter 2015 Financial Results," 9/06/2013 09609G10 PRN  Mast Therapeutics Hosting 2nd Annual Sickle Cell Disease Therapeutics Conference On September 19, 2013", 3/13/2015 00422510 PRN  Robbins Arroyo LLP Is Investigating the Officers and Directors of ACADIA Pharmaceuticals Inc. (ACAD) on Behalf of Shareholders,,"11/07/2018 74366E10 PRN  Protagonist Therapeutics to Present at the Stifel 2018 Healthcare Conference Wednesday, Nov. 14",,,"10/25/2013 98978L20    PRN  Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc.",," 3/09/2015 68214310 PRN  Omeros Corporation to Announce Fourth Quarter and Full-Year 2014 Financial Results on March 16, 2015",,,11/28/2012 46333X10 PRN  Constella® (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)in Adults,,,,, 3/05/2019 69329Y10 PRN  PDL BioPharma to Participate at Cowen 39th Annual Health Care Conference,,,,10/30/2018 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2018 Financial Results,10/17/2012 000BG2-E PRN  Enanta's Lead Hepatitis C Compound ABT-450 Advances into a Phase 3 Clinical Trial through its Collaboration with Abbott,"11/25/2013 02043Q10 PRN  Upcoming Webinars, FDA Clearances, Preclinical Data Presentations, Completed Acquisitions and Financial Results - Research Report on Teva, Boston Scientific, Alnylam, Wright Medical, and Onconova",,,11/09/2018 60468T10 PRN  Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting,"10/31/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Reports Third Quarter 2011 Financial Results",,,,,, 4/02/2019 09627Y10 PRN  Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock,,12/18/2018 28249U10 PRN  Eiger Announces PRIME Designation Granted by European Medicines Agency for Lonafarnib for Treatment of Hepatitis Delta Virus Infection," 5/27/2011 ATVI-US  PRN  Critical Insider Trade Reports for Teradyne, Terex, Dendreon, Activision, Aruba, & Momenta",,,,,, 2/13/2019 92165910 PRN  Vanda Pharmaceuticals Reports Fourth Quarter 2018 and Full Year 2018 Financial Results,,,"11/26/2014 45781M10   PRN  Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance",,"11/29/2018 40637H10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therapeutics, Inc. - HALO",10/25/2017 G2151510 PRN  China Biologic Products to Report Third Quarter of 2017 Financial Results," 4/15/2015 56400P70 PRN  Critical Alerts For Bank of America, MannKind, Micron, NXP Semiconductors and Cliffs Natural Resources Released By InvestorsObserver",,,, 9/16/2019 03236M20 PRN  Clean Beauty Leader Biossance Enters the Australian and New Zealand Markets, 8/06/2019 69366J20 PRN  PTC Therapeutics Reports Second Quarter 2019 Financial Results and Provides a Corporate Update," 9/30/2014 00448Q20 PRN  Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver",, 2/14/2011 03152W10 PRN  Amicus Therapeutics Announces Fourth Quarter and Full Year 2010 Financial Results,,,,10/11/2017 36197T10 PRN  For Early Success in Cannabis Look Outside the Box,"10/15/2013 29428V10 PRN  Epizyme, Inc. to Webcast Conference Call Discussing Third Quarter 2013 Financial Results on October 22, 2013", 2/26/2019 G5087110 PRN  Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2018 Financial Results,,12/04/2017 39843840 PRN  Grifols Misterium® Cleanroom Solutions Expands to Include Revolutionary Decontamination Air and Surface Disinfection Systems for Pharmaceutical Preparation,," 9/25/2017 73701010 PRN  Technical Reports on Biotech Equities -- Opko Health, Otonomy, Pacific Biosciences of California, and Portola Pharma", 9/15/2016 92337F10 PRN  Veracyte Announces Data from Seven Afirma® Gene Expression Classifier Studies to Be Presented at the 86th Annual Meeting of the American Thyroid Association,, 9/07/2010 063J3K-E PRN  Cellectis Bioresearch and Cedarlane Join Forces for the Distribution of cGPS® and cGPS® Custom Kits in Canada, 2/17/2017 14075510 PRN  Americans' Favorable Outlook on the Cannabis Market,,,, 7/18/2011 46226010 PRN  Genesis Biopharma Names David Voyticky to Board of Directors,12/05/2011 008H33-E PRN  AnaptysBio Describes Technology for the Discovery and Optimization of Fully Human Antibodies in Original Research Publication,,," 7/17/2015 G4618810 PRN  Critical Alerts For Chesapeake Energy, Starbucks, Horizon Pharma, Halozyme Therapeutics and Citigroup Released By InvestorsObserver",,10/08/2013 45845P10 PRN  Intercept Announces Pricing of Public Offering of Common Stock By Selling Stockholders,,,"10/31/2017 98401F10 PRN  Xencor to Host Third Quarter 2017 Financial Results Webcast and Conference Call on November 7, 2017",, 1/28/2019 G8807B10 PRN  Theravance Biopharma Announces First Patient Dosed in Registrational Phase 3 Study of Ampreloxetine (TD-9855) for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension, 4/15/2011 079TK4-E PRN  FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors, 5/08/2018 03969710 PRN  Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights,,,,, 9/27/2016 M4613510 PRN  Foamix Pharmaceuticals Ltd. Announces Proposed Follow-on Offering of Ordinary Shares,11/15/2010 001THX-E PRN  PRA International Expert to Chair Panel at Partnerships Conference,,," 1/01/2014 74587V10 PRN  Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda",,,10/09/2018 05070R10 PRN  Audentes Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,"12/18/2018 RGNX-US  PRN  Cresa Represents Biotech Innovator, REGENXBIO, for New Corporate Headquarters",,,,,,,,,,,,,,,12/04/2013 00695P-E  PRN  Kinex Pharmaceuticals Announced that the U.S. Food and Drug Administration has Granted Orphan Drug Status to KX02 for the Treatment of Gliomas,,,,,,,,,,,,,,,,,,,,,,,,,,10/03/2018 50015M10 PRN  Kodiak Sciences Inc. Announces Pricing of Initial Public Offering,, 1/07/2016 00FYYJ-E PRN  Guardant Health Secures Series D Financing to Expand the Reach of its Digital Sequencing™ Platform in Oncology,,,,,,,,,,,,,,,,
" 5/11/2011 53220K50 PRN  Zacks.com featured expert Kevin Matras highlights: Cost Plus, Inc. Global Geophysical Services, Inc., Ligand Pharmaceuticals Inc., Rex Energy Corp. and Western Alliance Bancorp.","12/02/2014 74318710 PRN  Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics","11/04/2015 45232710    PRN  Covered Call Alerts For FireEye, Chipotle Mexican Grill, American Airlines, Delta Airlines and Illumina Released By InvestorsObserver"," 1/30/2013 84763A10 PRN  Critical Alerts For Oracle, Cemex, Rackspace, PetSmart, and Spectrum Pharmaceuticals Released By InvestorsObserver", 3/27/2019 G3040110 PRN  Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion Aggregate Purchase Price of its Outstanding Senior Notes,"10/15/2014 0D5F3L-E PRN  Lifshitz & Miller Law Firm Announces Investigation of Apco Oil & Gas International Inc., Arrowhead Research Corporation, Auxilium Pharmaceuticals, Inc., EveryWare Global, Inc., and Gentiva Health Services, Inc.",12/08/2016 002RGM-E PRN  Endo Announces Strategic Updates for BELBUCA™ and U.S. Branded Pain Portfolio, 6/25/2019 09073M10    PRN  Bio-Techne Appoints Rupert Vessey to Board of Directors, 9/20/2019 000VC1-E    PRN  The Lancet Publishes Results from Two Positive Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP),," 8/24/2016 68375N10 PRN  Research Report on Biotech Equities -- Celgene, Sarepta Therapeutics, MannKind, and Opko Health", 3/25/2019 46222210 PRN  Ionis announces appointment of Brett P. Monia Ph.D. to its board of directors, 5/28/2019 09061G10   PRN  BioMarin Provides 3 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A," 9/29/2014 01535110 PRN  Acquisitions, Senior Level Promotions, Public Offering, and Drug Approvals - Research Reports on Acorda, Alexion, Envision, Lilly and Avanir", 2/05/2019 64125C10 PRN  Neurocrine Biosciences Reports Fourth Quarter and Year-End 2018 Financial Results," 3/26/2015 81257810 PRN  Technical Scrutiny on Biotech Stocks -- Exact Sciences, Galena Biopharma, Alkermes, Seattle Genetics, and CorMedix","10/23/2013 45290710 PRN  New Drug Application Reviews, Upcoming Financial Results Schedules, Public Offerings, and Notifications - Research Report on Vanda, Chemed, Portola, Immunomedics, and Sangamo"," 8/03/2016 09062X10  PRN  InvestorsObserver releases covered-call reports for SolarCity, 3D Systems, JC Penney, Avon Products and Biogen"," 9/03/2013 45253H10 PRN  Biotech Firms Announce Financial Results, Resignations, Reintroduce Treatments and Receive Reviews on Key Products - Research Report on Insmed, ImmunoGen, VIVUS, Theravance, and XOMA", 4/02/2013 06SHTG-E PRN  U.S. Manufacturing Activity Expanded More Slowly in March and eBay Gets New Price Target, 2/16/2017 000L1R-E   PRN  Amygdala Neurosciences Acquires GS-6637 from Gilead Sciences, 2/26/2019 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results, 4/18/2019 N5946510  PRN  TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens to Treat Tuberculosis (TB), 3/01/2019 M2572210 PRN  Compugen Presents Update on COM701 Phase 1 Trial at ASCO-SITC Clinical Immuno-Oncology Symposium," 2/27/2015 00972810 PRN  Factors Moving Markets: Special Research on Gogo Inc, Babcock & Wilcox, Avago, PGT Inc., and Akorn",10/24/2019 03116210 PRN  Amgen Announces Webcast of 2019 Third Quarter Financial Results," 7/18/2014 62855J10 PRN  Technical Updates, Recognitions and Social Media Expansions - Analyst Notes on Myriad, Avis Budget, Apollo, Qiagen and SYNNEX", 2/13/2017 52887230 PRN  Lexicon To Present At The Leerink Partners 6th Annual Global Healthcare Conference,, 4/10/2019 002T0L-E PRN  Latest Biotechnology Advancements may be Key to Unlock new Autism Treatments,, 8/19/2019 45773H20 PRN  Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia, 5/15/2019 64026810 PRN  Nektar Therapeutics Announces Five Accepted Abstracts at 2019 American Society of Clinical Oncology's (ASCO) Annual Meeting, 8/29/2018 RIGL-US  PRN  Rigel to Present at the 20th Annual Global Investment Conference in New York City,"11/12/2013 37416310 PRN  Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena",,"11/04/2013 02311120 PRN  Morning Research: Amarin Corp. PLC, Elan Corp. PLC, Cubist Pharma Inc., and Seattle Genetics Inc."," 9/01/2016 45337C10 PRN  Covered Call reports for Twitter, Incyte Corp., Chico's FAS Inc., SolarCity and Bristol-Myers Squibb include trade ideas that offer returns of 20% or more!",11/01/2018 91307C10 PRN  Nilda Mesa Joins The United Therapeutics Corporation Board Of Directors,"11/14/2014 80360710 PRN  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Sarepta Therapeutics, Inc. (SRPT) To Contact The Firm", 4/01/2019 G0176710 PRN  Alkermes to Present New ALKS 3831 Data From ENLIGHTEN-2 and Interim Extension Safety Study Results at 2019 Congress of the Schizophrenia International Research Society,,,, 8/06/2018 55027E10 PRN  Luminex Corporation Reports Second Quarter 2018 Financial Results," 7/31/2018 80067710 PRN  Sangamo Announces Preliminary Data From Champions Study Evaluating SB-913, An Investigational Genome Editing Treatment For MPS II, To Be Presented September 5th At SSIEM 2018 Symposium"," 5/13/2015 30161Q10 PRN  What Their Results Say: Complementary Research on Exelixis, General Electric, Cemex SAB de CV, Alibaba Group, Sirius XM", 4/10/2019 80105N10  PRN  Sanofi provides unprecedented access to its insulins for one set monthly price," 9/10/2014 92532F10  PRN  Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK",," 5/11/2015 04351P10 PRN  Ascendis Pharma A/S to Report First Quarter 2015 Financial Results and Host Conference Call on May 18, 2015",," 3/13/2015 ACAD-US  PRN  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Acadia Pharmaceuticals, Inc. (ACAD) To Contact The Firm",,11/06/2018 74366E10 PRN  Protagonist Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update,,,"10/07/2013 98978L20    PRN  Changes in Senior Management, Grants of Orphan Drug Designations, and Updates on Pipeline Development and NDA - Research Report on Vivus, Omeros, Delcath Systems, Achillion, and Zogenix",," 3/03/2015 68214310 PRN  Critical Alerts For Transocean, Omeros, Freescale Semiconductor, Eli Lilly and SolarCity Released By InvestorsObserver",,,"10/31/2012 46333X10 PRN  BioMed Realty Announces 93,000 Square Foot Lease Expansion And Extension With Ironwood Pharmaceuticals At 301 Binney Street",,,,, 3/04/2019 69329Y10 PRN  PDL BioPharma Announces Launch of an Authorized Generic of Tekturna® (aliskiren) in Partnership with Prasco Laboratories,,,,10/16/2018 00182C10 PRN  ANI Announces Launch of Authorized Generic of Brethine®," 9/19/2012 062WH0-E PRN  FierceBiotech Names Enanta Pharmaceuticals, Inc. a Fierce 15 Winner","11/15/2013 02043Q10 PRN  Healthcare Sector Announced Financial Results and Recognition - Research Report on Alnylam Pharmaceuticals, Opko, Enzymotec, Cambrex, and XOMA",,,11/08/2018 60468T10 PRN  Mirati Therapeutics Announces First Patient Dosed In Phase 1b Clinical Trial Of Sitravatinib In Combination With Anti-PD1 Antibody Tislelizumab In Patients With Advanced Solid Tumors,"10/31/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of EXPAREL™ For Postsurgical Pain Management",,,,,, 3/28/2019 09627Y10 PRN  Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock,,12/17/2018 28249U10 PRN  Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib for Treatment of Hepatitis Delta Virus (HDV) Infection," 4/29/2011 005L7T-E PRN  Critical Stock Alerts: Insider Trade for Illinois Tool Works, PPG, Human Genome Sciences, VistaPrint, Momenta Pharmaceuticals, & Thermo Fisher Scientific",,,,,, 2/05/2019 92165910 PRN  Vanda Pharmaceuticals Takes a Stand Against Unnecessary Animal Research,,," 8/07/2014 45781M10   PRN  Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed",,11/26/2018 40637H10 PRN  Halozyme Announces Change In Primary Endpoint For HALO-301 To Overall Survival,10/13/2017 G2151510 PRN  China Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition," 3/30/2015 56400P70 PRN  Critical Alerts For MannKind, Yahoo!, Sohu.com, Cray and ExOne Released By InvestorsObserver",,,," 9/04/2019 03236M20 PRN  Amyris Launches Pipette, a Clean Baby Care Brand Delivering a Critical Need for a Growing Market", 8/05/2019 69366J20 PRN  PTC Therapeutics Expands Presence in New Jersey by Securing State-of-the-Art Biologics Facility," 9/16/2014 00448Q20 PRN  Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma",," 2/10/2011 03152W10 PRN  Amicus Therapeutics to Present at the 13th Annual BIO CEO and Investor Conference on Tuesday, February 15, 2011",,,,10/10/2017 36197T10 PRN  Data Shows Positive Projections for the Legal Cannabis Industry," 9/30/2013 29428V10 PRN  Epizyme, Inc. to Present at Upcoming Conferences in October", 2/14/2019 G5087110 PRN  Jazz Pharmaceuticals Announces Appointment of Anne O'Riordan to its Board of Directors,,"11/27/2017 39843840 PRN  Quotidian Technical Highlights on Selected Biotech Stocks -- Advaxis, Grifols, Juno Therapeutics, and Lexicon Pharma",," 9/06/2017 73701010 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Portola Pharmaceuticals Inc. (PTLA)", 9/08/2016 92337F10 PRN  Veracyte Achieves Major Medicare Coverage Milestone for the Percepta® Classifier to Improve Lung Cancer Diagnosis,, 7/19/2010 063J3K-E PRN  New Study Shows Meganuclease-Driven Targeted Integration Using Cellectis bioresearch's cGPS® CHO-K1 Kit to be Highly Efficient for Drug Discovery, 2/03/2017 14075510 PRN  Spending on Legal Cannabis Accelerates,,,," 7/15/2011 46226010 PRN  Genesis Biopharma Director William H. Andrews, Ph.D., Profiled in Popular Science Feature Story",,,, 7/09/2015 G4618810 PRN  New Studies & Research Evaluating Stem Cell Therapy Treatments for Bone Marrow Diseases & Conditions Look to Identify Next-Generation Therapies For New Pre-Clinical and Phase I/II Clinical Trials,,"10/04/2013 45845P10 PRN  Business Strategy, Partnerships, Presentation, and Appointment - Research Report on Merck, GSK, Sanofi, Intercept, and KYTHERA",,,10/20/2017 98401F10 PRN  Xencor to Present Final Results from Phase 2 Study of XmAb®5871 in IgG4-Related Disease at American College of Rheumatology (ACR) 2017 Annual Meeting,, 1/07/2019 G8807B10 PRN  Theravance Biopharma Announces Alignment of Workforce with Focus on Key Strategic Priorities,, 3/19/2018 GUD-CA   PRN  Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada,,,,, 9/12/2016 M4613510 PRN  Foamix Announces Positive Topline Results from Phase 2 Trial Evaluating FMX-103 Topical Minocycline Foam for Moderate-to-Severe Papulopustular Rosacea,11/10/2010 001THX-E PRN  PRA International Safety Expert to Present at DIA,,,"12/30/2013 74587V10 PRN  Healthcare Companies Report Board Changes, FDA Approvals, and Conference Call Schedules - Research Report on Quest Diagnostics, Supernus Pharma, Puma Biotechnology, Pacira, and ResMed",,,"10/05/2018 05070R10 PRN  Audentes Therapeutics to Provide Update on New Positive Interim Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-linked Myotubular Myopathy, from the 23rd International Annual Congress of the World Muscle Society",,,,,,11/26/2018 RGNX-US  PRN  REGENXBIO and Rocket Pharmaceuticals Announce New License Agreement for the Treatment of Danon Disease Using NAV AAV9 Vector,,,,,,,,,,,,,,,"10/28/2013 00695P-E  PRN  Kinex Announces First Patient Dosed in Phase Ib Study of Oraxol, an Orally Dosed Paclitaxel",,,,,,,,,,,,,,,,,,,,,,,,,, 9/24/2018 0JJRNG-E PRN  Kodiak Sciences Inc. Announces Launch of Initial Public Offering,,12/21/2015 MRTX-US  PRN  Guardant Health And Mirati Therapeutics Enter Into Collaboration On Glesatinib (MGCD265) In Non Small Cell Lung Cancer (NSCLC) Trial,,,,,,,,,,,,,,,,
 2/25/2011 53220K50 PRN  FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder,"10/22/2014 74318710 PRN  Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma","10/15/2015 45232710    PRN  Covered Call Alerts For Mobileye NV, TripAdvisor Inc., ConocoPhillips, Illumina and Skyworks Solutions Released By InvestorsObserver"," 1/23/2013 84763A10 PRN  Where Opportunity is Found - Research Report on Jazz Pharmaceuticals plc and Spectrum Pharmaceuticals, Inc.", 3/19/2019 G3040110 PRN  Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery,"10/15/2014 04280A10 PRN  Arrowhead Research Corp. Stockholders Who Suffered Losses in Excess of $100,000 Encouraged to Contact Securities Law Firm about Investigation",12/08/2016 05MBN8-E PRN  BioDelivery Sciences Reacquires License to BELBUCA™ from Endo Pharmaceuticals, 6/17/2019 09073M10    PRN  FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx™ Prostate IntelliScore™ (EPI) Test, 9/20/2019 000VC1-E    PRN  CHMP Recommends Approval of Dupixent® (dupilumab) for Severe Chronic Rhinosinusitis with Nasal Polyposis,," 8/23/2016 68375N10 PRN  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating OPKO Health, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors", 3/07/2019 46222210 PRN  Ionis Pharmaceuticals to Present at Upcoming Investor Conferences," 5/27/2019 09061G10   PRN  BioMarin to Host Conference Call Tuesday, May 28, 2019 to Provide a Valoctocogene Roxaparvovec Phase 2 and Phase 3 Update"," 9/11/2014 01535110 PRN  Trial Results, Notes Exchange Offer, Consortium Formation, Market Activity Updates, and Orphan Drug Designation Grant - Research Reports on Lilly, Perrigo, Illumina, HCA and Alexion", 1/16/2019 64125C10 PRN  New INGREZZA® (valbenazine) Analysis Published in the Journal of Affective Disorders Demonstrates Sustained Improvement in Tardive Dyskinesia Symptoms in Patients with Primary Mood Disorders," 2/19/2015 81257810 PRN  A Look at the Latest Occurrences in the Healthcare Sector: Special Research on Sangamo BioSciences,Seattle Genetics, StemCells, Synageva and VBI Vaccines","10/04/2013 45290710 PRN  Positive Results, Close of Public Offerings, Grants, Data Presentations and Partnerships - Research Report on Lexicon, Sangamo Biosciences, Immunomedics, NewLink Genetics, and Pacific Biosciences"," 8/01/2016 0FSTN1-E  PRN  Neurologists Report Increasing Payer Pressure For Disease-Modifying Therapies, Resulting In Suboptimal Treatment For Some Patients With Multiple Sclerosis"," 6/14/2013 45253H10 PRN  Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen",10/14/2010 000CVC-E PRN  Southern Research Expands Capabilities with Acquisition of BioCryst Pharmaceuticals Bioanalytical Lab Unit," 1/31/2017 37555810   PRN  InvestorsObserver releases covered-call reports for General Electric, Gilead Sciences, Marathon Oil Corporation, Tempur Sealy and Tesla Motors", 2/21/2019 04004760   PRN  Arena Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference on February 27, 4/03/2019 N5946510  PRN  Striving to Create Better Health for a Better World: Mylan's Global Social Responsibility 2018 Progress Report Now Available, 2/26/2019 M2572210 PRN  Compugen Reports Fourth Quarter and Full Year 2018 Results and Announces Corporate Restructuring to Streamline Operations," 2/23/2015 00972810 PRN  Pharma Stocks under Review - Zoetis, Actavis, Mylan, Akorn, and VIVUS",10/24/2019 03116210 PRN  Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020," 6/20/2014 62855J10 PRN  Critical Alerts For Blackberry, Ballard Power Systems, Priceline, LinkedIn, and Myriad Genetics Released By InvestorsObserver"," 2/02/2017 52887230 PRN  Research Reports Coverage on Biotech Stocks -- Anavex Life Sciences, Omeros, Spectrum Pharma, and Lexicon Pharma",," 4/09/2019 45766930 PRN  Insmed Granted Additional U.S. Patent For ARIKAYCE® (amikacin liposome inhalation suspension), Strengthening Brand's Global Patent Portfolio",, 8/08/2019 45773H20 PRN  Inovio Pharmaceuticals Reports 2019 Second Quarter Financial Results, 5/08/2019 64026810 PRN  Nektar Therapeutics Reports Financial Results for the First Quarter of 2019, 8/08/2018 76655960 PRN  Rigel Announces Second Quarter 2018 Financial Results and Provides Company Update,"10/31/2013 37416310 PRN  Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc.",,"10/23/2013 02311120 PRN  Publications, Clinical Trial Results, Pending Approvals, and Milestone Payments - Research Report on Merck, Johnson & Johnson, Allergan, Amarin, and Isis", 6/09/2016 45337C10 PRN  Patient-reported outcomes across phase 3 studies of baricitinib demonstrate statistically significant improvements in physical function and quality of life symptoms in patients with rheumatoid arthritis (RA),10/31/2018 91307C10 PRN  United Therapeutics Corporation Reports Third Quarter 2018 Financial Results,"11/04/2014 80360710 PRN  Biotech Equities Coverage - Achillion Pharma, Sarepta Therapeutics, Alnylam Pharma, Incyte, and Cytori Therapeutics", 3/05/2019 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at the Cowen and Company 39th Annual Health Care Conference,,,," 7/13/2018 55027E10 PRN  Luminex Corporation Second Quarter Earnings Release Scheduled for August 6, 2018"," 7/27/2018 80067710 PRN  Sangamo To Host Educational Webcast With Hunter Syndrome (MPS II) Expert, Joseph Muenzer, M.D., Ph.D."," 4/24/2015 30161Q10 PRN  Biotech Equity Movers and Shakers -- Orexigen Therapeutics, Geron, Exelixis, XOMA Corp., and BioLine RX", 4/02/2019 SGMO-US   PRN  Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data," 8/29/2014 92532F10  PRN  Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead",, 5/08/2015 04351P10 PRN  Ascendis Pharma A/S to Present at Upcoming Investor Conferences,," 3/11/2015 00422510 PRN  Critical Alerts For Linn Energy, ACADIA Pharmaceuticals, Arena Pharmaceuticals, Sears Holdings and YY Released By InvestorsObserver",,11/06/2018 74366E10 PRN  Protagonist Therapeutics Announces Completion of Phase 1 Clinical Trial of Oral IL-23 Receptor Antagonist PTG-200,,,"10/04/2013 98978L20    PRN  Under AAAResearchReports.com Microscope: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc.",, 2/19/2015 68214310 PRN  Omeros Corporation's Phase 2 OMS721 Trial Resulting in Extended Access for Compassionate Use,,,"10/29/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Agilent Technologies, STMicroelectronics, Forest Laboratories, Ironwood Pharmaceuticals and ITT Educational Services",,,,,11/19/2018 69329Y10 PRN  PDL BioPharma to Present at the 30th Annual Piper Jaffray Healthcare Conference,,,,10/04/2018 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Authorized Generic of Atacand HCT® Tablets, 4/04/2012 062WH0-E PRN  Enanta Announces Positive Phase 2 Results From Interferon-Free Combination Studies with ABT-450 for Hepatitis C Treatment to be Presented at EASL,"11/08/2013 02043Q10 PRN  Clinical Trial Initiations, Conferences Participations, Strategic Collaborations, and Presentation of New Pre-Clinical Data - Research Report on Biogen Idec, BioMarin, Medivation, Cytori, and Alnylam",,,11/07/2018 60468T10 PRN  Mirati Therapeutics To Present At The 27th Annual Credit Suisse Healthcare Conference,"10/24/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces Timing for Third Quarter 2011 Financial Results Webcast and Conference Call",,,,,, 3/27/2019 09627Y10 PRN  Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock,,12/11/2018 28249U10 PRN  Eiger BioPharmaceuticals Reports on 2018 R&D Day,,,,,,," 1/25/2019 92165910 PRN  Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results on February 13, 2019",,," 7/07/2014 45781M10   PRN  Critical Alerts For 3D Systems, Theravance, Cree, Lululemon, and PACCAR Released By InvestorsObserver",,11/06/2018 40637H10 PRN  Halozyme Reports Third Quarter 2018 Financial Results,10/12/2017 0H7JCH-E PRN  China Biologic Agrees to Acquire TianXinFu from PWM," 3/16/2015 56400P70 PRN  Critical Alerts For El Pollo Loco, Qihoo 360 Technology, MannKind Released By InvestorsObserver",,,," 8/30/2019 03236M20 PRN  Amyris to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019", 7/31/2019 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 9/15/2014 00448Q20 PRN  Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver",, 2/09/2011 GSK-GB   PRN  Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal™ Co-administered with Enzyme Replacement Therapy,,,,10/06/2017 36197T10 PRN  Sales of Hemp and CBD Products Show Strong Growth," 9/03/2013 29428V10 PRN  Epizyme, Inc. Granted Notice of Allowance of Patent for EPZ-5676"," 2/12/2019 G5087110 PRN  Jazz Pharmaceuticals to Report 2018 Fourth Quarter and Full Year Financial Results on February 26, 2019",,"10/19/2017 39843840 PRN  Breakfast Technical Briefing on Biotech Stocks -- Coherus Biosciences, Exelixis, Geron, and Grifols",, 9/06/2017 006RGD-E PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA, 8/30/2016 92337F10 PRN  Veracyte to Present at Morgan Stanley Global Healthcare Conference,, 7/06/2010 05XF6F-E PRN  Taconic's Litigation Contesting License Termination By Cellectis Is Dismissed, 1/11/2017 INSYQ-US PRN  2017 Legal Cannabis Market Developments,,,," 7/05/2011 IOVA-US  PRN  Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board",,,, 7/07/2015 G4618810 PRN  Depomed Confirms Receipt of Unsolicited Proposal from Horizon Pharma plc,,10/01/2013 45845P10 PRN  Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting,,, 9/20/2017 98401F10 PRN  Xencor to Present at Upcoming Investor Conferences,,12/04/2018 G8807B10 PRN  Theravance Biopharma to Highlight Innovative Early Research and Clinical Development at R&D Day on December 12 in New York,," 3/14/2018 03969710 PRN  Ardelyx Reports 2017 Financial Results and Appoints Industry Veteran, Jan Lundberg, Ph.D., to Board of Directors",,,,, 9/09/2016 M4613510 PRN  Foamix to Announce Topline Results in Phase 2 Clinical Trial of FMX-103 Minocycline Topical Foam for Moderate-to-Severe Papulopustular Rosacea,10/28/2010 001THX-E PRN  PRA International to Exhibit at Liver Diseases Conference,,,"12/10/2013 74587V10 PRN  New Clinical Data Access Policy, Portfolio Expansions, Positive Top Line Results and Stock Price Movements - Research Report on Pfizer, Amgen, Puma Biotechnology, Abbott Laboratories, and Agilent",,,"10/05/2018 05070R10 PRN  Audentes Therapeutics Presents New Positive Interim Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-linked Myotubular Myopathy, at 23rd International Annual Congress of the World Muscle Society",,,,,,11/14/2018 75901B10 PRN  FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease,,,,,,,,,,,,,,,10/22/2013 00695P-E  PRN  Hanmi Pharmaceuticals to Assign the Rights to Five New Territories to Kinex as Part of the Orascovery Program Strategic Plan,,,,,,,,,,,,,,,,,,,,,,,,,, 8/31/2018 0JJRNG-E PRN  Kodiak Sciences Announces Completion of Enrollment in the Company's Phase 1 Safety and Tolerability Study in Patients with Retinal Disease,,12/02/2015 00FYYJ-E PRN  Guardant Health and Labco Quality Diagnostics (synlab Group) Announce Joint International Expansion,,,,,,,,,,,,,,,,
 2/23/2011 006BZ5-E PRN  Oxford Finance Corporation Provides $20 Million Senior Credit Facility to Ligand Pharmaceuticals," 8/21/2014 74318710 PRN  Market Movers - Biotech Stocks -- Progenics Pharma, Rexahn Pharma, ImmunoGen, Hemispherx Biopharma, and Incyte","10/02/2015 45232710    PRN  Covered Call Alerts For Mobileye NV, Pandora, The Medicines Co, Illumina and Yahoo! Released By InvestorsObserver",12/17/2012 BDSI-US  PRN  BioDelivery Sciences Announces Hiring of George Ng as General Counsel, 3/14/2019 G3040110 PRN  Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes,"10/15/2014 04280A10 PRN  Technical Scrutiny on Health Care Sector Stocks - ImmunoGen, Arrowhead Research, Chimerix, Tekmira Pharma, and Celgene",11/23/2016 004MR2-E PRN  BioDelivery Sciences to Present at the 28th Annual Piper Jaffray Healthcare Conference, 6/13/2019 09073M10    PRN  Bio-Techne Receives Approval To Offer The ExoDx™ Prostate Intelliscore™ (EPI) Test In New York State, 9/18/2019 75886F10    PRN  Educational Campaign Helps Teens and Their Caregivers Tackle Everyday Challenges of Living with Moderate-to-severe Atopic Dermatitis,, 8/22/2016 68375N10 PRN  MabVax Therapeutics Announces the Closing of its Public Offering, 2/27/2019 46222210 PRN  Ionis Exceeds 2018 Financial Guidance, 5/16/2019 09061G10   PRN  BioMarin to Participate in 2019 RBC Capital Markets Global Healthcare Conference on May 21 in New York City," 9/10/2014 01535110 PRN  Technical Coverage of Biotech Stocks - Dyax, Alexion Pharma, Peregrine Pharma, Merrimack Pharma, and BioMarin Pharma", 1/15/2019 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2018 Financial Results," 2/17/2015 81257810 PRN  Technical Briefing on Biotech Stocks -- Exelixis, Exact Sciences, Idera Pharma, Seattle Genetics, and Ironwood Pharma"," 9/10/2013 45290710 PRN  Acquisitions, Study Results, Product Enhancements, and New Appointments - Research Report on Astex, Boston Scientific, WellCare, ResMed, and Immunomedics"," 7/12/2016 06NMSQ-E  PRN  American Institute of Chemical Engineers' 2016 Gala to Showcase Excellence in Innovation, Honor Exemplary Leaders"," 4/29/2013 BG-US    PRN  Critical Alerts For American International Group, Bunge, Cliffs Natural Resources, Amarin, and ImmunoGen Released By InvestorsObserver",,"12/28/2016 37555810   PRN  Gilead Sciences, Kinder Morgan, Netflix, Merck & Company Incorporated, and Tesla Motors and more offer option-trading opportunities that offer returns of more than 21%", 2/20/2019 04004760   PRN  Arena Pharmaceuticals to Announce Fourth Quarter and Full-Year 2018 Financial Results and Provide Corporate Update on February 26, 3/18/2019 07L72K-E  PRN  Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter," 2/14/2019 M2572210 PRN  Compugen Fourth Quarter and Full Year 2018 Conference Call Scheduled for Tuesday, February 26, 2019 at 8:30 AM ET"," 2/03/2015 00972810 PRN  Latest Updates in Healthcare: Special Research on Agios, Akebia, Akers, Akorn, and Albany",10/23/2019 03116210 PRN  Amgen Recommends Rejection Of 'Mini-Tender' Offer From TRC Capital Corporation," 5/29/2014 62855J10 PRN  Critical Alerts For Tesla, IBM, Myriad Genetics, Broadsoft, and RF Micro Devices Released By InvestorsObserver"," 1/09/2017 52887230 PRN  Lexicon Begins Phase 1 Clinical Trial Of Locally-acting SGLT1 Inhibitor, LX2761, For Potential Treatment Of Diabetes",, 4/08/2019 45766930 PRN  Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch,, 8/06/2019 45773H20 PRN  Inovio Closes $15 Million Private Placement of Convertible Bonds to Institutional Investors in Korea," 5/01/2019 64026810 PRN  Nektar to Announce Financial Results for the First Quarter 2019 on Wednesday, May 8, 2019, After Close of U.S.-Based Financial Markets", 8/01/2018 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Second Quarter 2018 Financial Results,"10/21/2013 37416310 PRN  Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences",,"10/15/2013 02311120 PRN  Under AAAResearchReports.com Microscope: Amarin Corp. PLC, Elan Corp. PLC, Seattle Genetics Inc., and Cubist Pharma Inc.", 6/09/2016 45337C10 PRN  Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs,"10/24/2018 91307C10 PRN  United Therapeutics Corporation To Report Third Quarter 2018 Financial Results Before The Market Opens On Wednesday, October 31, 2018","10/03/2014 80360710 PRN  Critical Alerts For MannKind, Sarepta Therapeutics, Noodles & Company, VoxelJet and Lululemon Released By InvestorsObserver", 2/26/2019 G0176710 PRN  Alkermes Initiates Clinical Study of ALKS 4230 Administered Subcutaneously in Patients With Advanced Solid Tumors,,,, 6/13/2018 55027E10 PRN  Luminex Initiates Clinical Trials for VERIGENE® II Gastrointestinal Assay, 7/23/2018 80067710 PRN  Sangamo Announces Treatment Of First Patient In Phase 1/2 Clinical Trial Evaluating SB-318 Investigational In Vivo Genome Editing Therapy For MPS I," 4/22/2015 0070KW-E PRN  Exelixis on Path to Beat Estimates; Analyst Brief Issued by BrokerBank Securities, Inc.", 4/01/2019 062S3Y-E  PRN  Inovio Completes Enrollment Ahead of Schedule In Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron's PD-1 Inhibitor," 8/13/2014 92532F10  PRN  Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver",, 4/28/2015 04351P10 PRN  Ascendis Pharma A/S Announces Results of Phase 1 Study of TransCon Treprostinil,," 3/11/2015 00422510 PRN  Biotech Equities Technical Updates -- Gilead Sciences, Arena Pharma, ACADIA Pharma, Halozyme Therapeutics, and Juno Therapeutics",,10/22/2018 74366E10 PRN  Protagonist Therapeutics Presents Clinical Data from the PROPEL Study of PTG-100 in Ulcerative Colitis at United European Gastroenterology Week,,," 8/29/2013 98978L20    PRN  Early Briefing and Review: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc.",, 2/03/2015 68214310 PRN  Omeros Closes $84 Million Public Offering of Common Stock and Pre-Funded Warrants,,,"12/13/2011 46333X10 PRN  Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie",,,,,11/06/2018 69329Y10 PRN  PDL BioPharma Reports Third Quarter 2018 Financial Results,,,, 9/27/2018 00182C10 PRN  ANI Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference, 2/21/2012 062WH0-E PRN  Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV,"11/01/2013 02043Q10 PRN  Acquisitions, Financial Results, Clinical Trial Applications, and Upcoming Earnings Schedules - Research Report on Illumina, DENTSPLY, Alnylam, Sirona, and Santarus",,,11/06/2018 60468T10 PRN  Mirati Therapeutics Reports Third Quarter Financial Results,"10/19/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces New Data Demonstrating Longer Time to First Opioid Use and Reduction in Opioid-Related Adverse Events With EXPAREL™ Compared to Bupivacaine HCl",,,,,, 3/27/2019 09627Y10 PRN  Blueprint Medicines Announces Accelerated Regulatory Submission Plans and Recent Clinical Progress,,12/04/2018 28249U10 PRN  Eiger BioPharmaceuticals to Host R&D Day in New York City,,,,,,,12/20/2018 92165910 PRN  FDA Accepts HETLIOZ® (tasimelteon) Supplemental New Drug Application for Review in the Treatment of Jet Lag Disorder,,, 6/20/2014 45781M10   PRN  A New Breed of Targeted Cancer Therapeutics & Stem Cell Advancements; Effective ProDrug Therapeutics Approach for GenSpera,,11/06/2018 40637H10 PRN  Halozyme Names Albert Kildani As Vice President Investor Relations And Corporate Communications,10/09/2017 07431J-E PRN  China Biologic Receives Approval for Commercial Manufacturing of Human Fibrinogen," 3/10/2015 56400P70 PRN  Coverage of Biotech Equities -- MannKind, Novavax, Curis, Pharmacyclics, and Alexion Pharma",,,, 8/22/2019 03236M20 PRN  Amyris Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q, 7/23/2019 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2019 Financial Results," 9/09/2014 00448Q20 PRN  Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications",," 2/08/2011 03152W10 PRN  Amicus Therapeutics to Announce Fourth Quarter and Year End 2010 Financial Results on February 14, 2011",,,,10/04/2017 36197T10 PRN  CBD and Hemp Sales Projected to Remain Strong," 8/28/2013 29428V10 PRN  Epizyme, Inc. to Present at Upcoming Conferences in September"," 1/03/2019 JAZZ-US  PRN  Jazz Pharmaceuticals and Codiak BioSciences Announce Strategic Collaboration to Research, Develop and Commercialize Engineered Exosomes to Create Therapies for Hard-to-Treat Cancers",, 8/22/2017 39843840 PRN  Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces,,"12/29/2016 73701010 PRN  Research Reports Initiation on Biotech Stocks -- Incyte, Anavex Life Sciences, Portola Pharma, and Spectrum Pharma", 8/03/2016 92337F10 PRN  Veracyte Announces Second Quarter 2016 Financial Results,, 6/16/2010 063J3K-E PRN  Cellectis bioresearch Establishes The Genome Customization Award (TGCA),12/23/2016 14075510 PRN  The Mainstream Growth of the Cannabidiol Market,,,, 6/28/2011 46226010 PRN  Genesis Biopharma Conference Call and Webcast Reminder,,,," 7/06/2015 G4618810 PRN  Critical Alerts For Seadrill, Health Net Inc., American Airlines, Horizon Pharma and bluebird bio Inc. Released By InvestorsObserver",, 8/13/2013 45845P10 PRN  Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results,,, 8/07/2017 98401F10 PRN  Xencor Reports Second Quarter 2017 Financial Results,,12/03/2018 G8807B10 PRN  Theravance Biopharma Announces Closing of Private Placement of $250 Million of 9% Non-Recourse Notes,, 2/12/2018 03969710 PRN  Ardelyx Announces Departure of Chief Scientific Officer,,,,," 1/05/2015 M4613510 PRN  Time in the Market, Not Timing the Market: Featured Research on Rite Aid, American Homes 4 Rent, Perfect World, Foamix, and Cesca",10/08/2010 001THX-E PRN  PRA International to Exhibit at European Oncology Congress,,,"11/29/2013 74587V10 PRN  Stock Price Movements, Presentation Schedules, and Quarterly Dividends - Research Report on Biogen Idec, Santarus, Hill-Rom, Puma Biotechnology and Cynosure",,,10/03/2018 05070R10 PRN  Audentes Therapeutics Announces Co-Founder and Chief Executive Officer Matthew R. Patterson Appointed Chairman of the Alliance for Regenerative Medicine,,,,,,11/07/2018 75901B10 PRN  REGENXBIO Reports Third Quarter 2018 Financial and Operating Results and Announces Initiation of Phase I/II Clinical Trial for RGX-121 for the Treatment of MPS II,,,,,,,,,,,,,,,"10/15/2013 00695P-E  PRN  Dr. Daniel Von Hoff, MD, F.A.C.P. Joins Kinex team as the Chair of the Clinical Advisory Committee",,,,,,,,,,,,,,,,,,,,,,,,,," 7/18/2018 0JJRNG-E PRN  Kodiak Sciences Appoints Bassil I. Dahiyat, Ph.D. Robert A. Profusek, J.D. and Richard S. Levy, M.D. to its Board of Directors",,11/09/2015 00FYYJ-E PRN  Guardant Health® and Collaborators Present Further Clinical Utility Data for Guardant360® at the AACR-NCI-EORTC International Conference On Molecular Targets and Cancer Therapeutics,,,,,,,,,,,,,,,,
," 7/18/2014 74318710 PRN  SEC Filings, Positive Trial Results, Technical Updates, and sNDA Updates - Analyst Notes on Questcor, Exelixis, InterMune, Progenics and Arrowhead"," 9/30/2015 45232710    PRN  Biotechnology Equity Picks -- Arena Pharma, Biogen, Omeros, Illumina, and Merrimack Pharma"," 6/26/2012 84763A10 PRN  Critical Alerts For Goldman Sachs, F5 Networks, National Oilwell Varco, PPG Industries, and Spectrum Pharmaceuticals Released By InvestorsObserver", 3/14/2019 G3040110 PRN  Endo International plc Announces an Upsizing of its Cash Tender Offers and Consent Solicitations,10/14/2014 04280A10 PRN  Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Arrowhead Research Corporation,11/09/2016 09060J10 PRN  BioDelivery Sciences Provides Corporate Update and Reports Third Quarter 2016 Financial Results, 6/04/2019 09073M10    PRN  Bio-Techne To Acquire B-MoGen Biotechnologies Inc., 9/17/2019 75886F10    PRN  Regeneron Debuts on Prestigious Dow Jones Sustainability World Index of Most Sustainable Companies,," 8/19/2016 68375N10 PRN  Covered Call reports for Apple, Canadian Solar, Opko Health, Pan American Silver Corp and National Oilwell Varco include trade ideas that offer returns of 20% or more!", 2/13/2019 46222210 PRN  Ionis Pharmaceuticals to Hold 2018 Financial Results Webcast, 5/08/2019 09061G10   PRN  BioMarin to Participate in Bank of America Merrill Lynch Health Care Conference on May 15 in Las Vegas," 9/03/2014 01535110 PRN  Technical Updates, Upcoming Conferences, Drug Trials, and Acquisition Updates - Research Reports on SL Green, Allstate, HCA Holdings, Alexion and Salix", 1/06/2019 64125C10 PRN  Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2018 Net Product Sales Results and 2019 Program Milestones,"12/22/2014 81257810 PRN  Biotech Stocks Technical Report -- Achillion Pharma, Arrowhead Research, Sunesis Pharma, Array BioPharma, and Seattle Genetics"," 8/29/2013 45290710 PRN  Clinical Trials, Pipeline Developments, Financial Results, and New Appointments - Research Report on Amarin, Immunomedics, Seattle Genetics, Repros Therapeutics, and LifePoint", 6/28/2016 09062X10  PRN  Biogen Selects Cognizant's SmartTrials Platform," 2/25/2013 45253H10 PRN  Critical Alerts For General Motors, Best Buy, AutoZone, Crocs, and ImmunoGen Released By InvestorsObserver",,"12/01/2016 37555810   PRN  Twilio Inc. trade offers a 13.03% return in 141 days, or find similar option trades on Gilead Sciences, Energy Select Sector, Halliburton, and NVIDIA", 2/07/2019 04004760   PRN  Arena Pharmaceuticals Presents Preclinical and Early Clinical Development Data for Olorinab at Crohn's & Colitis Congress," 3/07/2019 N5946510  PRN  SBP, Mylan Present Keys to Hurricane Maria Survivor in Welcome Home Party -- Courtesy of $1M Pledge from the Mylan Charitable Foundation", 1/22/2019 M2572210 PRN  Compugen Announces Publication of Two Peer-Reviewed Papers Demonstrating the Role of PVRIG as a Novel Immune Checkpoint for Cancer Immunotherapy," 1/27/2015 00972810 PRN  Akorn Set to Join the S&P MidCap 400; United Insurance Holdings, ANI Pharmaceuticals to Join the S&P SmallCap 600","10/22/2019 03116210 PRN  David Meline, Amgen's Chief Financial Officer, To Retire", 2/05/2014 62855J10 PRN  Advancing Stocks with Increasing Volume This Week & Consumer Goods Spotlight - Industry Innovator Moves Forward With Expansions And 50% Increase in Sales, 1/05/2017 52887230 PRN  Lexicon To Present At The 35th Annual J.P. Morgan Healthcare Conference,, 4/02/2019 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),," 7/30/2019 45773H20 PRN  Inovio Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 8, 2019", 4/02/2019 64026810 PRN  Nektar Therapeutics Presents Preclinical Data on its Immuno-Oncology Pipeline Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2019," 6/26/2018 76655960 PRN  Rigel Initiates Phase 1 Clinical Trial of R835, an IRAK1/4 Inhibitor for Autoimmune and Inflammatory Diseases","10/08/2013 37416310 PRN  Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp.",,"10/14/2013 02311120 PRN  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amarin Corporation plc", 3/31/2016 000P56-E PRN  Phase 3 Study Findings Demonstrate Treatment with Baricitinib Results in Significant Improvements for Patients with Rheumatoid Arthritis Who Had Inadequate Response to Biologics,10/22/2018 91307C10 PRN  CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants," 8/20/2014 80360710 PRN  Critical Alerts For Lowes, FuelCell Energy, Sarepta Therapeutics, Nuance Communications and Herbalife Released By InvestorsObserver", 2/25/2019 G0176710 PRN  Alkermes and Biogen Announce U.S. Food and Drug Administration Acceptance of Diroximel Fumarate New Drug Application for Multiple Sclerosis,,,, 5/18/2018 55027E10 PRN  Luminex Corporation to Present at Upcoming Healthcare Investor Conferences, 7/23/2018 80067710 PRN  Sangamo Therapeutics to Acquire TxCell," 3/20/2015 30161Q10 PRN  Technical Briefing on Biotech Equities - Amgen, Exelixis, Sangamo BioSciences, Medivation, and Tekmira Pharma", 3/13/2019 000VC1-E  PRN  Regeneron and Sanofi to Present New Praluent® (alirocumab) Data at ACC.19," 8/06/2014 92532F10  PRN  New Joint Ventures, Course Launches, Study Results, Earnings Performance, and Approvals - Research Reports on Johnson Controls, Intuitive Surgical, GlaxoSmithKline, Community Health and Vertex",, 3/25/2015 071865-E PRN  Ascendis Pharma A/S Reports Full Year 2014 Financial Results,," 1/28/2015 00422510 PRN  Biotech Stocks Technical Report - Halozyme Therapeutics, Agenus, Biogen Idec, ACADIA Pharma, and Peregrine Pharma",,10/08/2018 74366E10 PRN  Protagonist Therapeutics Announces Acceptance of Late Breaking Abstract for PTG-100 at the United European Gastroenterology Week Meeting,,," 4/10/2013 98978L20    PRN  Today's Research on Celsion, Zogenix, Actavis, and Avanir Pharma",, 2/03/2015 68214310 PRN  Omeros Closes $84 Million Public Offering of Common Stock and Pre-Funded Warrants,,, 9/29/2011 ALM-ES   PRN  Almirall Announces Regulatory Filing of linaclotide for the Treatment of Irritable Bowel Syndrome With Constipation in Europe,,,,,"10/31/2018 69329Y10 PRN  PDL BioPharma to Announce Third Quarter Financial Results on November 6, 2018",,,, 8/08/2018 00182C10 PRN  ANI Pharmaceuticals to Present at New Time at the Canaccord Genuity 38th Annual Growth Conference,10/13/2011 062WH0-E PRN  Enanta Awarded up to $42.7 Million NIAID Contract to Develop a Novel Broad Spectrum Bicyclolide Antibiotic,"10/23/2013 02043Q10 PRN  Financial Results Schedules, Discontinuation of Phase 3 Trial, Data Presentations, Strategic Alliances, and Premarket Filings - Research Report on Biogen, Ariad, BioMarin, Alnylam, and Sequenom",,,11/05/2018 60468T10 PRN  Mirati To Present New Data In Ongoing Phase 2 Clinical Trials At The SITC 33rd Annual Meeting,"10/18/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces Key EXPAREL™ Data to be Presented at American College of Surgeons 97th Annual Clinical Congress",,,,,, 3/05/2019 09627Y10 PRN  Blueprint Medicines to Present at 39th Annual Cowen & Co. Health Care Conference,,12/03/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces the Appointment of Sri Ryali as Chief Financial Officer,,,,,,,12/10/2018 92165910 PRN  Vanda Announces Positive Pivotal Study Results for HETLIOZ® (tasimelteon) in Patients with Smith-Magenis Syndrome,,," 5/20/2014 45781M10   PRN  Critical Alerts For Google, Schlumberger, Eli Lilly, Theravance, and United Rentals Released By InvestorsObserver",,"10/30/2018 40637H10 PRN  Halozyme Licenses New ENHANZE® Targets For $25 Million Upfront Payment, Future Milestones And Royalties", 8/02/2017 G2151510 PRN  China Biologic Reports Financial Results for the Second Quarter of 2017," 2/25/2015 56400P70 PRN  Critical Alerts For MannKind, Keryx Biopharmaceuticals, Isis Pharmaceuticals, Yahoo! and Tekmira Pharmaceuticals Released By InvestorsObserver",,,," 7/26/2019 03236M20 PRN  Amyris to Host Business Update Teleconference and Webcast on Monday, August 5, 2019", 7/01/2019 69366J20 PRN  PTC Therapeutics Announces Strategic Gene Therapy Licensing Agreement with Odylia Therapeutics," 8/28/2014 00448Q20 PRN  Acquisitions, Appointments, Patent Grant, Technical Updates, and Awareness Campaign - Research Reports on Covidien, Biogen Idec, Achillion, Intercept and Mylan",, 1/11/2011 03152W10 PRN  Amicus Therapeutics Provides 2011 Business Outlook and Expected Key Milestones,,,,10/02/2017 36197T10 PRN  Sales of Legal Cannabis Products are Expected to Grow, 8/16/2013 29428V10 PRN  Epizyme Receives Orphan Drug Designation for EPZ-5676,12/21/2018 G5087110 PRN  Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea,, 8/01/2017 39843840 PRN  Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols' Procleix Babesia Assay Under an Investigational New Drug Protocol,," 8/02/2016 73701010 PRN  Biotechnology Stocks on Investors' Radar -- Minerva Neurosciences, Portola Pharma, Trevena, and Anthera Pharma"," 7/12/2016 92337F10 PRN  Veracyte to Host Conference Call and Webcast to Discuss Second Quarter 2016 Financial Results on Wednesday, August 3, 2016",, 6/08/2010 063J3K-E PRN  Cellectis bioresearch and Lonza Enter Development and Commercial Manufacturing Agreement,12/05/2016 0032Q1-E PRN  Cannabis Sales to Grow Faster in Coming Years,,,, 6/22/2011 46226010 PRN  Genesis Biopharma to Hold Business Update Conference Call on June 29,,,," 6/18/2015 G4618810 PRN  Critical Alerts For Esperion Therapeutics, Ambarella, Horizon Pharma, Universal Display Corporation and Vale Released By InvestorsObserver",, 8/05/2013 45845P10 PRN  Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference,,, 8/02/2017 98401F10 PRN  Xencor to Present at Upcoming Investor Conferences,,"11/27/2018 G8807B10 PRN  Theravance Biopharma Announces First Subject Dosed in Phase 1 Clinical Trial of TD-8236, a Novel Inhaled pan-JAK Inhibitor",, 2/08/2018 03969710 PRN  Ardelyx to Participate in Leerink Partners 7th Annual Global Healthcare Conference,,,,, 6/11/2013 008XK0-E PRN  Superior Results in Foamix's Minocycline Foam Clinical Study: 71% Reduction in Inflammatory Lesions in 6 Weeks, 9/23/2010 001THX-E PRN  PRA International Expert to Speak at Late Phase Conference Breakout Session on Statistical Analysis,,,"10/14/2013 74587V10 PRN  Trial Updates and Public Offering - Research Report on Gilead, Celgene, Ariad, Puma Biotechnology, and Dyax",,, 9/26/2018 05070R10 PRN  Audentes Therapeutics to Participate in Upcoming Investor Conferences,,,,,,"11/07/2018 75901B10 PRN  Alexandria Real Estate Equities, Inc. Announces Development of New Build-to-Suit at the Alexandria Life Science and Translational Research Center at 9800 Medical Center Drive with Signing of 15-Year, 132,000 RSF Lease for REGENXBIO's New HQ and R&D Facility",,,,,,,,,,,,,,," 9/12/2013 00695P-E  PRN  Dr. David Hangauer, Chief Scientific Officer and Co-Founder, commits his career to Kinex Pharmaceuticals",,,,,,,,,,,,,,,,,,,,,,,,,,,,"10/20/2015 00FYYJ-E PRN  New studies show the power of comprehensive, non-invasive solid-tumor genomic testing with Guardant360®",,,,,,,,,,,,,,,,
," 7/11/2014 74318710 PRN  Biotechnology Stocks Technical Review -- Research on Medivation, Idenix Pharma, Nanosphere, and Progenics Pharma"," 8/26/2015 45232710    PRN  Critical Alerts For GoPro, Palo Alto Networks, eBay, Arrowhead Research and Illumina Released By InvestorsObserver", 4/18/2012 84763A10 PRN  S&P Indices Announces Changes to U.S. Index," 3/14/2019 G3040110 PRN  Endo International plc Announces Debt Refinancing Transactions, Including Cash Tender Offers and Consent Solicitations for up to $1.0 billion Aggregate Purchase Price of its Outstanding Senior Notes","10/13/2014 04280A10 PRN  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Arrowhead Research Corp. (ARWR) To Contact The Firm",11/08/2016 05MBN8-E PRN  BioDelivery Sciences to Present at the Stifel 2016 Healthcare Conference, 6/03/2019 09073M10    PRN  Bio-Techne To Present At The Goldman Sachs 40th Annual Global Healthcare Conference, 8/28/2019 75886F10    PRN  U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9,," 8/10/2016 68375N10 PRN  Facebook, Opko Health, ZELTIQ Aesthetics, Palo Alto Networks, and Yelp and more offer option-trading opportunities that offer returns of more than 20%", 1/28/2019 46222210 PRN  First Patient Enrolled in Pivotal Study of RG6042 (IONIS-HTT Rx) for People with Huntington's Disease, 5/06/2019 09061G10   PRN  European Commission Approves Palynziq® (pegvaliase injection) for Treatment of Phenylketonuria (PKU) in Patients Aged 16 Years or Older," 8/26/2014 01535110 PRN  Collaborations, Upcoming Seminar, Clinical Trial Results, Data Presentation Schedule - Research Reports on AstraZeneca, Illumina, Novartis, Lilly and Alexion", 1/02/2019 64125C10 PRN  Neurocrine Biosciences to Present at the 37th Annual J.P. Morgan Healthcare Conference,"11/10/2014 81257810 PRN  Technical Pulse on Biotech Stocks - Dendreon, Alkermes, Exact Sciences, Inovio Pharma, and Seattle Genetics"," 8/26/2013 45290710 PRN  HealthCare, Technology Briefing: Market Movers for the Week - Technologies-Scan Corp, GNC, Galena Biopharma, Immunomedics, Amarin"," 6/14/2016 09062X10  PRN  Biotechnology Equities Technical Briefing -- PTC Therapeutics, Biogen, Progenics Pharma, and VIVUS"," 1/22/2013 45253H10 PRN  Critical Alerts For Wal-Mart, State Street, HollyFrontier, Tyson Foods, and ImmunoGen Released By InvestorsObserver",,"11/17/2016 37555810   PRN  Gilead Sciences trade offers a 4.68% return in 93 days, or find similar option trades on Starbucks, Fossil Group, Electronic Arts, and Noble", 1/24/2019 04004760   PRN  Arena Pharmaceuticals Announces Closing of Global License Agreement with United Therapeutics for Ralinepag, 2/28/2019 N5946510  PRN  Mylan to Present at Raymond James 40th Annual Institutional Investors Conference, 1/14/2019 M2572210 PRN  Compugen's Phase 1 Trial of COM701 Featured as a Trial-in-Progress at The ASCO-SITC Clinical Immuno-Oncology Symposium," 1/16/2015 00972810 PRN  Pre-Market Pulse on Pharma Stocks - Teva Pharma Industries, Allergan, Endo Intl., Akorn, and Depomed",10/22/2019 03116210 PRN  Amgen Announces 2019 Fourth Quarter Dividend,"10/08/2013 62855J10 PRN  Leadership Realignments, Strategic Partnerships, Updated Financial Outlook and Upcoming Investor Conferences - Research Report on Sotheby's, Outerwall, Team Health, Myriad, and ExamWorks",12/21/2016 52887230 PRN  Lexicon Reports Positive Top-line Results In Second Pivotal Phase 3 Study For Sotagliflozin In Patients With Type 1 Diabetes,, 4/01/2019 45766930 PRN  Insmed To Showcase New ARIKAYCE® (amikacin liposome inhalation suspension) And Pipeline Data At American Thoracic Society International Conference,, 7/25/2019 45773H20 PRN  Inovio's Positive First-in-Human MERS Vaccine Results Published in The Lancet Infectious Diseases, 4/01/2019 64026810 PRN  Vaccibody AS and Nektar Therapeutics Present New Preclinical Data from their Immuno-Oncology Collaboration at the American Association for Cancer Research (AACR) Annual Meeting 2019, 6/20/2018 76655960 PRN  Rigel Announces Poster Presentations at FOCIS Annual Meeting," 4/17/2013 37416310 PRN  Arena Pharma, Celgene, Incyte, Spectrum Pharma, and Geron Under StockCall's Microscope",,"10/09/2013 02311120 PRN  Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray", 1/19/2016 LLY-US   PRN  Lilly and Incyte Announce Submission of New Drug Application to FDA for Oral Once-Daily Baricitinib for Treatment of Moderate-to-Severe Rheumatoid Arthritis,10/22/2018 91307C10 PRN  CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants," 8/04/2014 80360710 PRN  Technical Data on Biotech Stocks -- Arrowhead Research, Celldex Therapeutics, Synthetic Biologics, StemCells, and Sarepta Therapeutics", 2/20/2019 G0176710 PRN  Alkermes to Present at the 8th Annual SVB Leerink Global Healthcare Conference,,,, 5/18/2018 55027E10 PRN  Luminex Corporation Declares Second Quarter Cash Dividend, 7/13/2018 80067710 PRN  Sangamo Therapeutics Announces Technology Leadership Changes," 2/20/2015 30161Q10 PRN  Recent Developments at Biotechnology Companies: Special Research on Exelixis,ICON, Incyte, Luna Innovations, and Oncothyreon"," 3/12/2019 SGMO-US   PRN  Sangamo Therapeutics Appoints Jason Fontenot, Ph.D., As Senior Vice President, Cell Therapy"," 8/06/2014 92532F10  PRN  Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma",," 3/18/2015 04351P10 PRN  Ascendis Pharma A/S to Report Full Year 2014 Financial Results and Host Conference Call on March 25, 2015",,"12/12/2014 00422510 PRN  Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio",, 9/27/2018 74366E10 PRN  Protagonist Therapeutics Announces Fast Track Designation Granted by U.S. FDA to Hepcidin Mimetic PTG-300,,, 4/04/2013 00C4C5-E    PRN  North American Injectable Drug Delivery Market worth $16.6 Billion by 2017,, 1/29/2015 68214310 PRN  Omeros Prices $75 Million Public Offering of Common Stock and Pre-Funded Warrants,,," 1/19/2011 IRWD-US  PRN  Zacks Analyst Blog Highlights: Comerica Incorporated, Sterling Bancshares, Citigroup, Forest Laboratories and Ironwood Pharmaceuticals",,,,,10/08/2018 69329Y10 PRN  PDL BioPharma Names Edward Imbrogno Vice President of Finance,,,, 8/07/2018 00182C10 PRN  ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance," 9/26/2011 062WH0-E PRN  Enanta's Lead NS5A Inhibitor Candidate for HCV, EDP-239, Selected as One of Windhover's Top 10 Infectious Disease Projects to Watch","10/15/2013 02043Q10 PRN  Upcoming Financial Results Schedules, Clinical Studies and Trials, and New Appointments - Research Report on BioMarin, Alnylam, Aegerion, Omeros, and Tesaro",,,"10/30/2018 60468T10 PRN  Mirati Therapeutics Announces Submission of IND Application for MRTX849, a KRAS G12C Inhibitor, to Treat Non-Small Cell Lung Cancer and Colorectal Cancer","10/11/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data to Be Presented at Upcoming Medical Meetings",,,,,, 2/26/2019 09627Y10 PRN  Blueprint Medicines Reports Fourth Quarter and Full Year 2018 Financial Results,,12/03/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces FDA Acceptance of IND Application for Lonafarnib for the Treatment of Progeria and Progeroid Laminopathies,,,,,,,12/03/2018 92165910 PRN  Vanda Announces Positive Phase II Study Results for Tradipitant in Patients with Gastroparesis,,, 4/28/2014 45781M10   PRN  Anoro™ Ellipta® now available in the US for treatment of COPD,,10/25/2018 40637H10 PRN  Halozyme Announces First Clinical Dosing In Bristol-Myers Squibb's Phase 1 Trial Of BMS-986179 With Enhanze® Technology, 7/19/2017 G2151510 PRN  China Biologic Products to Report Second Quarter of 2017 Financial Results," 2/12/2015 56400P70 PRN  Technical Roundup on Biotech Equities - Gilead Sciences, MannKind, ImmunoGen, Dyax, and Pharmacyclics",,,, 7/19/2019 008CMY-E PRN  ADL Bionatur Solutions and Amyris Expand Contract to 2020, 6/28/2019 69366J20 PRN  PTC Provides Update on Translarna™ (ataluren) Application for Label Expansion," 8/26/2014 00448Q20 PRN  Critical Alerts For Achillion Pharmaceuticals, Intel, YY, JA Solar and Skullcandy Released By InvestorsObserver",," 1/05/2011 03152W10 PRN  Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011",,,, 9/28/2017 36197T10 PRN  Cannabinoid Biosynthesis Poised as Potential Game-Changer in Drug Development," 8/06/2013 29428V10 PRN  Epizyme, Inc. to Present at Wedbush Securities Life Sciences Management Access Conference in August",12/19/2018 G5087110 PRN  Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 7,, 6/22/2017 39843840 PRN  Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples,," 6/22/2016 73701010 PRN  Biotechnology Stocks in Motion -- Minerva Neurosciences, Portola Pharma, Trevena, and Anthera Pharma", 6/30/2016 0032QC-E PRN  Veracyte to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference,, 6/02/2010 063J3K-E PRN  Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering,11/30/2016 14075510 PRN  Cannabis Industry Expects to Become the Next Biggest Market,,,, 6/13/2011 46226010 PRN  Genesis Biopharma Names Martin Schroeder to Board of Directors,,,," 6/01/2015 G4618810 PRN  Critical Alerts For MannKind, Horizon Pharma, Altera, Orexigen Therapeutics and Windstream Released By InvestorsObserver",, 7/01/2013 45845P10 PRN  Intercept Pharmaceuticals to Present at the JMP Securities Healthcare Conference,,," 7/31/2017 98401F10 PRN  Xencor to Host Second Quarter 2017 Financial Results Webcast and Conference Call on August 7, 2017",,11/20/2018 G8807B10 PRN  Theravance Biopharma Announces First Patient Dosed in Phase 2 Study of TD-1473 in Patients with Crohn's Disease,, 1/03/2018 03969710 PRN  Ardelyx Announces Presentation at J.P. Morgan 36th Annual Healthcare Conference,,,,, 3/14/2012 008XK0-E PRN  Foamix's Minocycline Foam - 100% Effective in Impetigo Phase II Clinical Trial With No Side Effects - 80% Improved Significantly After 3 Days of Treatment, 9/13/2010 001THX-E PRN  PRA International's Drug Safety Experts to Speak at Safety Congress,,,12/09/2011 0C4KPC-E PRN  Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium,,," 9/24/2018 05070R10 PRN  Audentes Therapeutics to Present New Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy, at the 23rd International Congress of the World Muscle Society",,,,,,11/06/2018 75901B10 PRN  REGENXBIO to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,, 8/01/2013 00695P-E  PRN  Kinex Receives Research Support from the Hong Kong Innovation and Technology Commission (ITC),,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/03/2015 00FYYJ-E PRN  Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9,,,,,,,,,,,,,,,,
," 3/21/2014 ACER-US  PRN  Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa", 7/07/2015 45232710    PRN  Neogen signs commercialization agreement with Illumina," 4/09/2012 STX-US   PRN  Critical Alerts For Goldman Sachs, Seagate Technology, Spectrum Pharmaceuticals, Dover, and Ericsson by Seven Summits Research", 3/14/2019 0650LH-E PRN  Endo International plc Announces Proposed Private Offering Of Senior Secured Notes,"10/13/2014 04280A10 PRN  Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire","11/01/2016 09060J10 PRN  BioDelivery Sciences to Host Conference Call and Webcast Reporting Third Quarter 2016 Financial Results on Wednesday, November 9", 5/28/2019 09073M10    PRN  Bio-Techne's New Exosome-Based Liquid Biopsies Helping To Advance Personalized Care In Lung Cancer Diagnostics, 8/15/2019 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentation,," 8/02/2016 68375N10 PRN  InvestorsObserver releases covered-call reports for OPKO Health, ACADIA Pharmaceuticals, Whiting Petroleum, VMware and Jabil Circuit", 1/02/2019 46222210 PRN  Ionis Pharmaceuticals to Present at 37th Annual J.P. Morgan Healthcare Conference, 4/25/2019 09061G10   PRN  BioMarin Announces First Quarter 2019 Financial Results," 8/15/2014 01535110 PRN  Technical Updates, Study Outcomes, Project Approvals, and Quarterly Performance Reviews - Research Reports on Alexion, Novartis, CB&I, L-3 and Emerson",12/12/2018 64125C10 PRN  Neurocrine Biosciences Announces Topline Data from Phase IIb T-Force GOLD Study Demonstrating Valbenazine Did Not Meet Primary Endpoint in Pediatric Patients with Tourette Syndrome," 8/20/2014 81257810 PRN  Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio Pharma, Curis, and Seattle Genetics"," 6/27/2013 45290710 PRN  New Clinical Developments and Advanced Clinical Studies Offer Superior Treatment Options - Research Report on Alnylam, Immunomedics, Tesaro, InterMune and Synta", 5/27/2016 09062X10  PRN  Biogen and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA™ (daclizumab) for Multiple Sclerosis,"10/03/2012 06DDVL-E PRN  Zacks Bull and Bear of the Day Highlights: Discover Financial Services, Scientific Games, Roche Holdings, GlaxoSmithKline and ImmunoGen",,"11/04/2016 37555810   PRN  Gilead Sciences trade offers a 3.82% return in 43 days, or find similar option trades on Energous Corporation, NetSuite Inc., NVIDIA, and JetBlue", 1/24/2019 04004760   PRN  United Therapeutics Announces Closing Of License Agreement With Arena Pharmaceuticals For Ralinepag, 2/26/2019 N5946510  PRN  Mylan Reports Fourth Quarter and Full Year 2018 Results and Provides 2019 Guidance,"11/13/2018 M2572210 PRN  Compugen Announces Issuance of U.S. Patent for COM902, Its TIGIT Antibody Product Candidate for Cancer Immunotherapy","12/12/2014 00972810 PRN  Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines",10/18/2019 03116210 PRN  Nplate® (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia, 8/15/2013 0D8SX2-E PRN  Gene By Gene Rejects BRCA1/2 Patent Infringement Claims by Myriad and Joins Ambry Genetics to Sue Myriad for Violating Federal Antitrust Laws,12/05/2016 52887230 PRN  Lexicon Reports Top-Line Results From Phase 2 Clinical Trial Conducted In Collaboration With JDRF,, 4/01/2019 45766930 PRN  Insmed to Present at the H.C. Wainwright Global Life Sciences Conference,, 7/16/2019 45773H20 PRN  Inovio Sharpens Focus On HPV-Related Diseases And Fast-to-Market Product Candidates, 3/27/2019 000D1R-E PRN  Biotechnology Companies Rush to Develop Treatments for Various Illnesses Found Globally, 6/12/2018 76655960 PRN  Rigel To Present Phase 2 Results for Fostamatinib in Autoimmune Hemolytic Anemia at EHA," 3/18/2013 GSK-GB   PRN  Amarin, Celgene, GlaxoSmithKline, Spectrum Pharma, and Geron Briefing and Review",," 9/30/2013 02311120 PRN  Product Launches, Clinical Study Results, Historical Trials, Joint Lawsuits and Milestone Patient Enrollment - Research Report on Teva, Pacira, Novo Nordisk, Forest, and Amarin",11/07/2015 45337C10 PRN  Lilly and Incyte Announce Patients Treated with Baricitinib Demonstrated Significant Improvement in Signs and Symptoms of Rheumatoid Arthritis Compared with Methotrexate,10/16/2018 91307C10 PRN  United Therapeutics And MannKind Announce Closing Of License And Collaboration Agreement," 7/31/2014 80360710 PRN  Critical Alerts For Johnson Controls, Sarepta Therapeutics, China Life Insurance, Finisar, and Petroleo Brasileiro Released By InvestorsObserver", 2/19/2019 G0176710 PRN  Alkermes and Clovis Oncology Initiate Research Collaboration to Explore Combination Cancer Therapies,,,, 5/07/2018 55027E10 PRN  Luminex Corporation Reports First Quarter 2018 Financial Results, 6/28/2018 80067710 PRN  Sangamo Therapeutics Appoints Karen Smith to its Board of Directors," 2/17/2015 30161Q10 PRN  Technical Briefing on Biotech Stocks -- Exelixis, Exact Sciences, Idera Pharma, Seattle Genetics, and Ironwood Pharma", 3/11/2019 80105N10  PRN  FDA approves Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents," 7/07/2014 92532F10  PRN  Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion",, 3/05/2015 071865-E PRN  Ascendis Pharma to Present at ENDO 2015,,"10/31/2014 00422510 PRN  Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma",," 9/24/2018 74366E10 PRN  Protagonist Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference Monday, Oct. 1",,," 3/04/2013 98978L20    PRN  R&D Investments, Pending Approvals, Acquisitions - Research Report on Optimer, Zogenix, Cubist, Merck and Questcor",, 1/28/2015 68214310 PRN  Omeros Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants,,,,,,,, 9/26/2018 69329Y10 PRN  PDL BioPharma to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference,,,, 8/06/2018 00182C10 PRN  ANI Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference, 4/04/2011 000BG2-E PRN  Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data From Phase 2 Study of ABT-450/r for Treatment of Hepatitis C,"10/07/2013 02043Q10 PRN  Clinical Study Updates, Trial Enrollments, NDA Submissions, Partnerships, and Formation of New Subsidiaries - Research Report on BioMarin, Alnylam, Vertex, Illumina, and Intrexon",,,10/22/2018 60468T10 PRN  Mirati Therapeutics Presents Updated Positive Clinical Data From Sitravatinib Immuno-Oncology Combination Trial At ESMO 2018 Congress And Announces FDA Guidance For Registration Trial," 9/26/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at ""Hot Topics in Plastic Surgery"" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons",,,,,," 2/19/2019 09627Y10 PRN  Blueprint Medicines to Report Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 26, 2019",,11/19/2018 28249U10 PRN  Eiger to Participate in Piper Jaffray Healthcare Conference,,,,,,,11/08/2018 92165910 PRN  Vanda Pharmaceuticals Announces Participation at November 2018 Investor Conferences,,," 1/13/2014 45781M10   PRN  Upcoming Earnings Conference Calls, FDA Approvals, and Share Price Updates - Research Report on Actavis, ResMed, West Pharmaceutical, Sirona Dental Systems, and Theravance",,10/22/2018 40637H10 PRN  Halozyme Provides Summary Results Of Data For PEGPH20 Combination Treatments Presented At ESMO 2018 Congress, 5/19/2017 G2151510 PRN  China Biologic Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for 2017 Annual Meeting of Stockholders," 2/03/2015 56400P70 PRN  Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S.",,,, 7/12/2019 03236M20 PRN  Amyris to Participate in and Provide Business Update at Jefferies 2019 Global Industrials Conference, 6/07/2019 69366J20 PRN  PTC Therapeutics Receives FDA Approval for the Expansion of the EMFLAZA® (deflazacort) Labeling to Include Patients 2-5 Years of Age," 8/20/2014 00448Q20 PRN  New Drug Launches, Technical Updates, New Facility, Clinical Trials Data, and Dividend Declarations - Research Reports on Covidien, Mylan, Baxter, Achillion and Perrigo",,"12/08/2010 03152W10 PRN  Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease",,,, 9/26/2017 36197T10 PRN  Medical Cannabis Companies Leverage Biosynthesis to Boost Drug Development," 7/31/2013 29428V10 PRN  Epizyme, Inc. Reports Second Quarter 2013 Financial Results",12/10/2018 G5087110 PRN  Jazz Pharmaceuticals Announces Share Repurchase Program Authorization Increase of $400 Million,, 6/12/2017 39843840 PRN  Grifols and Beckman Coulter Enter into an Exclusive Distribution Agreement,, 7/02/2014 063HNX-E PRN  CMC Biologics Enters into Commercial Supply Agreement with Portola Pharmaceuticals for Manufacturing of First-In-Class Factor Xa Inhibitor Antidote Andexanet Alfa," 6/27/2016 92337F10 PRN  Veracyte Named a San Francisco Bay Area 2016 ""Top Workplace""",, 5/11/2010 063J3K-E PRN  Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting,11/17/2016 14075510 PRN  Biotech Stocks Press Forward with Drug-Development Advancements,,,, 6/06/2011 46226010 PRN  Genesis Biopharma to Develop Autologous Cell Therapy for Metastatic Melanoma,,,," 4/30/2015 G4618810 PRN  Morning Briefing on Pharma Equities -- Mylan, Actavis, Zoetis, Horizon Pharma, and Medicines",, 6/24/2013 45845P10 PRN  Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares,,," 6/16/2017 98401F10 PRN  Xencor Presents Interim Data from an Ongoing, Open-label, Phase 2 Study of XmAb®5871 in IgG4-Related Disease at EULAR 2017",,11/19/2018 G8807B10 PRN  Theravance Biopharma to Present at Two Upcoming Investor Conferences,, 1/03/2018 03969710 PRN  Ardelyx Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C,,,,,, 9/09/2010 001THX-E PRN  PRA International Infectious Disease Experts at ICAAC Explore the Benefits of PRA's Research Center,,,11/23/2011 0C4KPC-E PRN  Puma Biotechnology Announces Completion of Private Placement,,, 8/29/2018 05070R10 PRN  Audentes Therapeutics to Participate in Upcoming Investor Conferences,,,,,,11/05/2018 75901B10 PRN  REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector,,,,,,,,,,,,,,," 7/22/2013 128940-KR PRN  Kinex Announces that the US FDA Allows their IND for Oraxol, an Oral Form of Paclitaxel that is in Phase II Clinical Trials in Korea, to Begin Clinical Trials in the US",,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/19/2015 00FYYJ-E PRN  Guardant Health and Flatiron Health to Develop Innovative Data Platform to Advance Precision Medicine for Cancer and Enhance Patient Care,,,,,,,,,,,,,,,,
,"12/25/2013 74318710 PRN  FDA Drug Approvals, Newly Elected Board of Directors, and Stock Price Updates on Healthcare Companies - Research Report on Theravance, Quintiles, Ironwood, Progenics, and Immunomedics", 6/25/2015 45232710    PRN  BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster," 4/09/2012 ACIIQ-US PRN  Most Attractive Stocks: D.R. Horton, Hewlett-Packard, Arch Coal, CSX, Spectrum Pharmaceuticals, and Micron", 3/04/2019 G3040110 PRN  Endo to Participate at Cowen & Company 39th Annual Healthcare Conference,10/09/2014 04280A10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arrowhead Research Corp. - ARWR,10/24/2016 09060J10 PRN  BioDelivery Sciences Announces Preferred Formulary Status for BUNAVAIL on Texas Medicaid, 5/21/2019 09073M10    PRN  Bio-Techne To Present At The Jefferies 2019 Global Healthcare Conference," 8/14/2019 75886F10    PRN  Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol",," 7/25/2016 68375N10 PRN  Learn how to target a 20% return on Tesla Motors, or get option-trade ideas on Opko Health, Activision Blizzard, Smith & Wesson and ACADIA Pharmaceuticals or any stock you choose",12/20/2018 46222210 PRN  Ionis Announces Plans for Management Transitions in 2020, 4/17/2019 09061G10   PRN  Forbes Names BioMarin 4th Best Midsize Employer in America," 8/11/2014 01535110 PRN  Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma",11/14/2018 64125C10 PRN  AbbVie Presents Positive Phase 3 Data Demonstrating Investigational Elagolix Reduces Heavy Menstrual Bleeding in Women with Uterine Fibroids at 2018 AAGL Global Congress," 7/16/2014 81257810 PRN  Biotechnology Sector Trends Higher with Breakthrough Clinical Trials, Collaborations & License Agreements"," 1/30/2013 45290710 PRN  Free Research Report on Immunomedics, Inc., AEterna Zentaris Inc., Rediff.com India Limited, Century Aluminum Co. and Silicom Limited", 5/10/2016 00167Y-E  PRN  Steven Holtzman Joins Compugen as Strategic Business Advisor," 8/01/2012 45253H10 PRN  Critical Trade Alerts For Ford, Valero, Humana, Sourcefire, and ImmunoGen Released By InvestorsObserver",,"10/21/2016 37555810   PRN  Covered Call reports for Gilead Sciences, American Express, Petrobras, Merrimack Pharmaceuticals and Intra-Cellular Therapies include trade ideas that offer returns of 20% or more!", 1/07/2019 04004760   PRN  Arena Pharmaceuticals Reports Positive Long-Term Data from the Open-Label Extension of the Phase 2 OASIS Trial Evaluating Etrasimod for Treatment of Ulcerative Colitis, 2/22/2019 N5946510  PRN  Mylan Launches Generic Suboxone® Sublingual Film to Treat Opioid Dependence,11/07/2018 M2572210 PRN  Compugen Reports Third Quarter 2018 Results,"11/03/2014 00972810 PRN  Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings",10/18/2019 03116210 PRN  EVENITY® (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture," 6/20/2013 MYGN-US  PRN  Synthetic DNA Deemed Patentable by US Supreme Court, Gene Synthesis and Codon Optimization Provide Potential Pathway to Patentability",11/21/2016 52887230 PRN  Lexicon Announces The Establishment Of The Commercial Leadership Team For Telotristat Ethyl,, 3/27/2019 45766930 PRN  Insmed Announces Management Changes,," 7/10/2019 45773H20 PRN  Geneos Therapeutics Announces First Patient Dosed with its DNA-based, Neoantigen-Targeting Personalized Vaccine Technology", 3/06/2019 64026810 PRN  Nektar Therapeutics to Webcast Presentation at the Cowen and Company 39th Annual Health Care Conference, 5/31/2018 76655960 PRN  Rigel to Present at Jefferies 2018 Global Healthcare Conference, 1/04/2013 BMR-US   PRN  BioMed Realty Trust Appoints Former Amylin President And Chief Executive Officer To Its Board Of Directors,," 9/27/2013 02311120 PRN  Beginning New Clinical Trials, Innovation Recognitions, Expansion in Patent Portfolios, Product Distributions and Offerings - Research Report on Allscripts, Novavax, Amarin, Acura, and Catalyst",11/07/2015 45337C10 PRN  Detailed Results Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis, 9/18/2018 91307C10 PRN  United Therapeutics Corporation To Host Science Day 2018," 7/16/2014 80360710 PRN  Critical Alerts For General Electric, Sarepta Therapeutics, iRobot, Goldman Sachs, and Baidu Released By InvestorsObserver"," 2/14/2019 G0176710 PRN  Alkermes Plc Reports Financial Results for the Year Ended Dec. 31, 2018 and Provides Financial Expectations for 2019",,,," 4/16/2018 55027E10 PRN  Luminex Corporation First Quarter Earnings Release Scheduled for May 7, 2018", 6/04/2018 80067710 PRN  Sangamo Announces U.K. Authorization Of Clinical Trials Evaluating Zinc Finger Nuclease In Vivo Genome Editing Treatments SB-318 For MPS I And SB-913 For MPS II," 1/05/2015 30161Q10 PRN  Exelixis Analyst Report: Riding the Evolutions Issued by BrokerBank Securities, Inc.", 2/27/2019 80105N10  PRN  FDA expands indication for Soliqua® 100/33," 6/27/2014 92532F10  PRN  Biotech Stocks on the Move -- Research on CTI BioPharma, BioMarin Pharma, Vertex Pharma, and Northwest Biotherapeutics",," 2/02/2015 04351P10 PRN  Ascendis Pharma A/S Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares",," 9/26/2014 00422510 PRN  Critical Alerts For FuelCell Energy, VeriFone Systems, Universal Display Corporation, Synaptics Incorporated and ACADIA Pharmaceuticals Released By InvestorsObserver",, 9/19/2018 74366E10 PRN  Protagonist Therapeutics Reports Granting of Inducement Award,,," 3/01/2013 CASC.XX2-US PRN  Today's Technical View on Unitedhealth Group, Aetna, AstraZeneca, Oncothyreon, and Zogenix",,11/19/2014 68214310 PRN  OMS721 Inhibits Thrombus Formation in Sera from aHUS Patients,,,,,,,, 9/24/2018 69329Y10 PRN  PDL BioPharma Announces New $100 Million Stock Repurchase Program,,,, 8/01/2018 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2018 Financial Results,11/01/2010 000BG2-E PRN  Abbott and Enanta Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C," 9/26/2013 02043Q10 PRN  Application for Regulatory Approvals, Conferences and Presentations, and Enrollment in Clinical Trials - Research Report on Gilead, Alnylam, Omeros, PTC, and Stemline",,,10/21/2018 60468T10 PRN  Mirati Therapeutics Announces Updated Data From Ongoing Clinical Trial Of Single Agent Sitravatinib At The 2018 ESMO Congress," 9/13/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference",,,,,, 2/07/2019 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences in February,,11/09/2018 28249U10 PRN  Eiger Bio Reports Third Quarter 2018 Financial Results,,,,,,,11/07/2018 92165910 PRN  Vanda Pharmaceuticals Reports Third Quarter 2018 Financial Results,,," 1/08/2014 45781M10   PRN  Technical Dossier: Theravance, Alkermes, Cubist Pharma, and TherapeuticsMD",,10/10/2018 40637H10 PRN  Halozyme To Host Third Quarter 2018 Financial Results Conference Call, 5/03/2017 G2151510 PRN  China Biologic Reports Financial Results for the First Quarter of 2017," 1/29/2015 56400P70 PRN  Critical Alerts For Mobileye NV, US Steel, GoPro, Invensense and MannKind Released By InvestorsObserver",,,, 6/27/2019 03236M20 PRN  Jonathan Van Ness Joins BIOSSANCE as First Celebrity Ambassador, 6/03/2019 69366J20 PRN  PTC Therapeutics Promotes Emily Hill to Chief Financial Officer," 8/13/2014 00448Q20 PRN  Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics",,11/08/2010 03152W10 PRN  Amicus Therapeutics Announces Third Quarter 2010 Financial Results,,,, 9/19/2017 36197T10 PRN  Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects," 7/24/2013 29428V10 PRN  Epizyme, Inc. to Webcast Conference Call Discussing Second Quarter 2013 Financial Results on July 31, 2013",11/29/2018 G5087110 PRN  Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia,, 5/09/2017 39843840 PRN  Investigational New Drug Application is Now Effective for Babesia Screening in Blood Donations Using Grifols Procleix Panther System in the US,," 3/05/2014 0CXBJZ-E PRN  Quarterly and Annual Financial Results Release, Executive Appointments, Upcoming Conferences, and Promotion Announcements - Analyst Notes on NuVasive, IPC, Portola, ICU Medical, and Prothena", 6/17/2016 92337F10 PRN  Veracyte Releases Statement on CMS's Final PAMA Rule,,,"11/15/2016 14075510 PRN  Biotech-Cannabis Stocks Move on Election, State Ballots",,,," 5/25/2011 46226010 PRN  Patrick Hwu, M.D., and Mario Sznol, M.D., Join Genesis Biopharma's Scientific and Medical Advisory Board",,,," 4/21/2015 G4618810 PRN  A Look at the Health of the HealthCare Sector: Complementary Research on Horizon Pharma, Enzon Pharmaceuticals, Momenta Pharmaceuticals, Athersys, and Pernix Therapeutics",, 6/18/2013 45845P10 PRN  Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock,,," 6/08/2017 98401F10 PRN  Xencor Appoints Raphael Clynes, M.D., Ph.D., as Vice President of Translational Biology",,11/12/2018 G8807B10 PRN  Theravance Biopharma Highlights Expanded COPD Indication for Trelegy Ellipta in Europe,,12/11/2017 0GFM78-E PRN  Ardelyx Announces License Agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited for Tenapanor in China,,,,,, 8/23/2010 001THX-E PRN  PRA International to Exhibit at ESC's Annual Conference,,,,,, 8/21/2018 05070R10 PRN  Audentes Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by the FDA to AT132 for the Treatment of X-Linked Myotubular Myopathy,,,,,,10/31/2018 75901B10 PRN  REGENXBIO to Host Conference Call on November 7 to Discuss Third Quarter 2018 Financial Results and Recent Operational Highlights,,,,,,,,,,,,,,, 7/09/2013 00695P-E  PRN  Kinex Pharmaceuticals Will Take the Lead in the Orascovery Program Development in China,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/24/2015 00FYYJ-E PRN  Guardant Health Partners With National Cancer Institute On First Ever Prospective Study To Implement cfDNA Genomic Profiling For Non-Small Cell Lung Cancer,,,,,,,,,,,,,,,,
,"12/17/2013 74318710 PRN  New Leaders, Quarterly Dividends, Positive Clinical Results, and Data Presentations - Research Report on Quintiles, CR Bard, Theravance, Immunomedics and Progenics Pharmaceuticals"," 6/11/2015 45232710    PRN  Critical Alerts For Hewlett Packard, Illumina, Bitauto Holdings, GW Pharmaceuticals and Ariad Pharmaceuticals Released By InvestorsObserver"," 4/05/2012 84763A10 PRN  Block & Leviton LLP Investigates Allos Therapeutics, Inc. for Possible Breaches of Fiduciary Duties for Its Proposed Merger with Spectrum Pharmaceuticals", 3/01/2019 G3040110 PRN  Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List,10/09/2014 04280A10 PRN  ARROWHEAD SHAREHOLDER ALERT -- National Securities Law Firm Announces Investigation Of Arrowhead For Potential Violations Of Federal Securities Laws. Encourages Shareholders To Contact Law Firm For More Information.,10/05/2016 09060J10 PRN  BioDelivery Sciences Announces Additions to its Board of Directors, 5/14/2019 09073M10    PRN  Bio-Techne To Present At The UBS Global Healthcare Conference, 8/13/2019 75886F10    PRN  FDA Approves EYLEA® (aflibercept) Injection Prefilled Syringe,," 7/14/2016 68375N10 PRN  Covered Call reports for Bank of America, CSX, Reynolds American Incorporated, Barrick Gold Corporation and Opko Health include trade ideas that offer returns of 20% or more!",11/27/2018 46222210 PRN  First-in-class therapies using advanced antisense chemistries highlighted at 2018 American Society of Hematology Annual Meeting," 4/02/2019 09061G10   PRN  BioMarin to Host First Quarter 2019 Financial Results Conference Call and Webcast on Thursday, April 25 at 4:30pm ET"," 8/07/2014 01535110 PRN  Financial Results, FDA Approvals, Orphan Drug Designations, and Certificates - Research Reports on Idenix, Baxter, Alexion, Alere and Zoetis",11/07/2018 64125C10 PRN  Neurocrine Biosciences to Present at the Jefferies 2018 London Healthcare Conference," 7/02/2014 81257810 PRN  Critical Alerts For Transocean, Seattle Genetics, Genuine Parts, Apollo Group, and Men's Wearhouse Released By InvestorsObserver", 8/01/2011 06Z16L-E PRN  Nycomed US Inc. Names Brian A. Markison as Chief Executive Officer," 4/18/2016 09062X10  PRN  Covered Call Alerts For Chevron, Skechers, Allergan, Biogen and NXP Semiconductors Released By InvestorsObserver"," 4/28/2010 000M1T-E PRN  PharmAthene Appoints Mitchel Sayare, Ph.D. to the Company's Board of Directors",,"10/05/2016 37555810   PRN  Gilead Sciences, Google Inc., Tesoro Corporation, Northern Trust Corporation, and Kinder Morgan and more offer option-trading opportunities that offer returns of more than 20%",12/19/2018 04004760   PRN  Arena Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 10," 2/12/2019 N5946510  PRN  Mylan Launches Wixela™ Inhub™ (fluticasone propionate and salmeterol inhalation powder, USP), the First Generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder), at a List Price 70% Less than the Brand","10/24/2018 M2572210 PRN  Compugen Third Quarter 2018 Conference Call Scheduled for Wednesday, November 7, 2018 at 8:30 AM ET"," 9/08/2014 00972810 PRN  Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma",10/15/2019 03116210 PRN  Sports Anchor And Multiple Myeloma Patient Rod Gilmore Joins Amgen's Myeloma MVP™ Team," 6/18/2013 001D3K-E PRN  The Zacks Analyst Blog Highlights:Myriad Genetics, Anika Therapeutics, Biogen Idec, Alexion Pharmaceuticals and Cabot Oil & Gas",11/14/2016 52887230 PRN  Lexicon To Present At The Stifel 2016 Healthcare Conference And The Jefferies 2016 Global Healthcare Conference,, 3/04/2019 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 7/08/2019 45773H20 PRN  Inovio Completes Enrollment of VGX-3100 Phase 2 Trial for the Treatment of HPV-Related Vulvar Dysplasia (VIN)," 3/01/2019 64026810 PRN  Nektar Therapeutics Presents Preliminary Immune Activation, Safety and Clinical Activity Data from the Ongoing Dose-Escalation Stage of the REVEAL Study at 2019 ASCO-SITC Meeting", 5/30/2018 76655960 PRN  Rigel Appoints Dean Schorno as Chief Financial Officer," 9/11/2012 MLNX-IL  PRN  Daily Stocks Highlight by Insiderslab: Microsoft, Mellanox, Potash, A123, Geron, and Exelon",," 9/17/2013 02311120 PRN  NDA Updates, Signed Agreements, Awarded Patents, and Clinical Study Results - Research Report on Merck, Bristol-Myers Squibb, Amarin, GlaxoSmithKline, and Sanofi",10/27/2015 45337C10 PRN  Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase 3 Data, 9/17/2018 91307C10 PRN  Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate," 6/26/2014 80360710 PRN  Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics", 2/07/2019 G0176710 PRN  Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial Results,,,, 3/08/2018 55027E10 PRN  Luminex Corporation to Present at the Barclays Global Healthcare Conference, 5/30/2018 80067710 PRN  Sangamo Therapeutics Announces Presentation At The 2018 Jefferies Global Healthcare Conference,"12/30/2014 30161Q10 PRN  Biotech Stocks Technical Data -- Gilead Sciences, ImmunoGen, Exelixis, Cubist Pharma, and Vanda Pharma", 2/25/2019 000VC1-E  PRN  Positive Results Presented from Two Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)," 6/26/2014 92532F10  PRN  Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva",, 1/28/2015 071865-E PRN  Ascendis Pharma A/S Announces Pricing of Initial Public Offering,," 9/26/2014 00422510 PRN  Biotech Stocks Technical Insight - Incyte, Regado Biosciences, ACADIA Pharma, Pharmacyclics, and Raptor Pharma",, 9/06/2018 74366E10 PRN  Protagonist Therapeutics Receives $1.45 Million SBIR Funding for the Development of PTG-300,,, 1/03/2013 98978L20    PRN  DURECT Announces Positive Results from Relday™ Phase 1 Clinical Trial,,11/10/2014 68214310 PRN  Omeros Corporation Reports Third Quarter 2014 Financial Results,,,,,,,, 9/20/2018 06C5B2-E PRN  SevenSaoi Capital Delivers Letter to the Board of PDL BioPharma,,,, 6/27/2018 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP,," 9/03/2013 02043Q10 PRN  Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals",,,10/15/2018 60468T10 PRN  Mirati Therapeutics To Provide Updated Sitravatinib Clinical Data At The European Society For Medical Oncology (ESMO) 2018 Congress And Conduct Investor Call," 9/06/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Expands EXPAREL™ Commercial Team Infrastructure",,,,,," 1/04/2019 09627Y10 PRN  Blueprint Medicines Announces ""2020 Blueprint"" Global Business Strategy and Outlines Key Corporate Goals",,10/23/2018 28249U10 PRN  Eiger BioPharmaceuticals Prices Previously Announced Public Offering of Common Stock,,,,,,,11/01/2018 92165910 PRN  Vanda Receives FDA Letter Regarding Corporate Webpage,,,"12/25/2013 45781M10   PRN  FDA Drug Approvals, Newly Elected Board of Directors, and Stock Price Updates on Healthcare Companies - Research Report on Theravance, Quintiles, Ironwood, Progenics, and Immunomedics",,10/04/2018 40637H10 PRN  Halozyme Publication In The Journal Clinical Cancer Research Highlights New Nonclinical Data Supporting Multiple Effects Of PEGPH20 On The Tumor Microenvironment, 4/21/2017 G2151510 PRN  China Biologic Products to Report First Quarter of 2017 Financial Results," 1/26/2015 56400P70 PRN  Critical Alerts For Transocean, MannKind, Twitter, iRobot and Micron Released By InvestorsObserver",,,," 6/10/2019 03236M20 PRN  Berkeley Lights, Inc. And Amyris Announce Collaboration To Speed Testing Of Microbial Strains", 5/31/2019 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 8/05/2014 00448Q20 PRN  Critical Alerts For Achillion Pharmaceuticals, Synergy Resources, Invensense, JinkoSolar, and Harley-Davidson Released By InvestorsObserver",,"11/02/2010 03152W10 PRN  Amicus Therapeutics to Host its Third Quarter 2010 Financial Results Conference Call and Webcast on November 8, 2010",,,, 9/12/2017 36197T10 PRN  Cannabis Biotechs Taking Leading Stance in Global Marijuana Market," 7/03/2013 29428V10 PRN  Epizyme, Inc. Appoints Jason P. Rhodes President",11/28/2018 G5087110 PRN  Jazz Pharmaceuticals to Highlight Hematology Research at ASH 2018 Annual Meeting,, 4/24/2017 OSUR-US  PRN  Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility,," 1/16/2014 73701010 PRN  Updates on Clinical Trial Enrollment, Product Development Updates, Clinical Collaboration, and Preliminary Sales Report - Research Report on Raptor, Synageva, XenoPort, Portola, and Zogenix", 6/13/2016 92337F10 PRN  Veracyte Announces Resignation of Its Chief Financial Officer,,,11/07/2016 14075510 PRN  Cannabis Legalization on the Ballots This Election Year,,,, 5/23/2011 46226010 PRN  Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board,,,," 3/30/2015 00G0R2-E PRN  Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests",, 6/17/2013 45845P10 PRN  Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock,,, 5/30/2017 98401F10 PRN  Xencor to Present at Jefferies 2017 Global Healthcare Conference,,11/09/2018 G8807B10 PRN  Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI™ (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease,,11/28/2017 03969710 PRN  Ardelyx and Kyowa Hakko Kirin Announce License Agreement for Tenapanor for Cardiorenal Diseases in Japan,,,,,, 8/16/2010 001THX-E PRN  PRA International Hosts Audio Conference on CV Drug Development,,,,,, 8/09/2018 05070R10 PRN  Audentes Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference,,,,,,10/26/2018 75901B10 PRN  REGENXBIO Announces Additional Positive Interim Phase I Trial Update for RGX-314 for the Treatment of Wet AMD at the American Academy of Ophthalmology 2018 Annual Meeting,,,,,,,,,,,,,,, 7/08/2013 00695P-E  PRN  Flint D. Besecker Joins Kinex Executive Team As Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/27/2015 00FYYJ-E PRN  Leading Cancer Centers To Present Clinical Utility Data for Guardant360® At ASCO,,,,,,,,,,,,,,,,
,"12/09/2013 74318710 PRN  Strategic Collaborations, Clinical Studies, Regulatory Update, and Other Corporate Announcements - Research Report on OncoMed, Auxilium Pharma, BioTelemetry, Progenics Pharma, and Ambit Biosciences", 6/09/2015 00FLML-E    PRN  Twist Bioscience Raises $37 Million In Oversubscribed Series C Financing," 3/02/2012 000HMR-E PRN  Equity Research on Most Popular Searches: Zynga, Windstream, E*TRADE, R.R. Donnelley & Sons, and Spectrum Pharmaceuticals", 3/01/2019 G3040110 PRN  Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting," 9/16/2014 04280A10 PRN  Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver", 9/30/2016 06GTS4-E PRN  BioDelivery Sciences Cites Impressive Number of Physicians Granted Waiver to Increase Patient Limit for Opioid Dependence Treatment Following Recent HHS Rule, 5/06/2019 TECH-US     PRN  Roche expands partnership with Bio-Techne to offer drug discovery researchers new chromogenic detection options for mRNA ISH tissue analysis, 8/12/2019 75886F10    PRN  PALM Ebola Clinical Trial Stopped Early as Regeneron's REGN-EB3 Therapy Shows Superiority to ZMapp in Preventing Ebola Deaths,," 7/06/2016 68375N10 PRN  Tesla Motors, Verizon Communications, Celgene, Opko Health, and Constellation Brands and more offer option-trading opportunities that offer returns of more than 20%",11/13/2018 46222210 PRN  Ionis Pharmaceuticals to Present at Jefferies 2018 London Healthcare Conference, 3/06/2019 09061G10   PRN  BioMarin to Participate in Cowen and Company 39th Annual Health Care Conference on March 12 in Boston," 7/29/2014 01535110 PRN  Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis",11/05/2018 64125C10 PRN  Neurocrine Biosciences Reports Third Quarter 2018 Financial Results," 6/26/2014 81257810 PRN  Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics",11/09/2010 45290710 PRN  Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus, 3/31/2016 00167Y-E  PRN  Ionis Pharmaceuticals Advances Nusinersen in the Ongoing SHINE Study in Patients with SMA,,," 9/21/2016 37555810   PRN  Gilead Sciences, Puma Biotechnology, Yum! Brands, Vmware, and McDonald's and more offer option-trading opportunities that offer returns of more than 20%",12/17/2018 04004760   PRN  Arena Pharmaceuticals Appoints Experienced Life Sciences Industry Finance Executive Manmeet S. Soni to Board of Directors," 2/11/2019 N5946510  PRN  Mylan to Release 2018 Fourth Quarter and Full Year Results and 2019 Guidance on Feb. 26, 2019",10/11/2018 M2572210 PRN  Bristol-Myers Squibb and Compugen Announce Clinical Collaboration to Evaluate Therapeutic Regimen in Advanced Solid Tumors," 9/05/2014 00972810 PRN  Restaurant Openings, Financial Releases, Completed Projects, Regulatory Updates, and Strategic Acquisitions - Research Reports on El Pollo Loco, SunEdison, Workday, PCG and Akorn",10/09/2019 03116210 PRN  Amgen Foundation Launches Amgen Biotech Experience In Pittsburgh, 6/13/2013 001D3K-E PRN  AAPS Applauds Supreme Court's Respect for Medical Innovation,11/07/2016 LXRX-US  PRN  Lexicon Pharmaceuticals Acquires Exclusive Rights To Development Candidate For Neuropathic Pain From Its Alliance With Bristol-Myers Squibb,, 2/22/2019 45766930 PRN  Insmed Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update,, 6/26/2019 45773H20 PRN  Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer, 2/28/2019 64026810 PRN  Nektar Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results, 5/29/2018 76655960 PRN  Rigel Announces Availability of TAVALISSE™ (fostamatinib disodium hexahydrate) in the U.S., 5/10/2011 37416310 PRN  Nation's Second Participant Enrolls in Human Embryonic Stem Cell Trial,," 9/16/2013 02311120 PRN  Pre-Market Analysis: Amarin Corp. PLC, Elan Corp. PLC, Cubist Pharmaceuticals Inc., and Seattle Genetics Inc.",10/14/2015 45337C10 PRN  Baricitinib Demonstrates Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis in Pivotal Phase 3 Study, 9/04/2018 CORV-CA  PRN  Correvio Highlights Completion of SteadyMed Acquisition by United Therapeutics," 6/20/2014 80360710 PRN  Critical Alerts For RF Micro Devices, Sarepta Therapeutics, Smith & Wesson, SINA, and Canadian Solar Released By InvestorsObserver", 2/01/2019 G0176710 PRN  Alkermes Receives Complete Response Letter From U.S. Food and Drug Administration for ALKS 5461 New Drug Application,,,, 2/12/2018 55027E10 PRN  Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results, 5/08/2018 80067710 PRN  Sangamo Therapeutics Reports First Quarter 2018 Financial Results,"11/18/2014 30161Q10 PRN  Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA", 2/11/2019 80105N10  PRN  Sanofi and Regeneron offer Praluent® (alirocumab) at a new reduced U.S. list price," 6/25/2014 92532F10  PRN  Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver",, 1/14/2015 071865-E PRN  Ascendis Pharma A/S Announces Initiation of a Phase 1 Single Ascending Dose Study of TransCon Treprostinil,," 9/05/2014 00422510 PRN  Breakthrough Therapy Designation, Outlook Affirmation, Conference Presentation, Sales Data, and Submarine Delivery - Research Reports on ACADIA, Boeing, United Tech, Caterpillar and General Dynamics",, 9/06/2018 74366E10 PRN  Protagonist Therapeutics Expands Intellectual Property Portfolio,,, 5/02/2012 98978L20    PRN  Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain,,11/06/2014 68214310 PRN  Omeros Announces Positive Data for MASP-2 Inhibitor in Experimental Model of Stroke,,,,,,,, 8/30/2018 69329Y10 PRN  PDL BioPharma to Present at the H.C. Wainwright 20th Annual Global Investment Conference,,,, 6/05/2018 PRX-US   PRN  ANI Shareholders Elect Three New Members to the Board of Directors,," 8/26/2013 02043Q10 PRN  Positive Clinical Trial Results, Regulatory Wins, and New Appointments - Research Report on Incyte, Edwards, ACADIA Pharmaceuticals, Alnylam, and Ironwood",,, 8/29/2018 60468T10 PRN  Mirati Therapeutics To Participate In Oncology Panels At The 2018 Citi Biotech Conference," 8/12/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. to Present at Wedbush Securities 2011 Life Sciences Management Access Conference",,,,,,12/02/2018 09627Y10 PRN  Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis,,10/22/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock,,,,,,,"10/22/2018 92165910 PRN  Vanda Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 7, 2018",,,"12/17/2013 45781M10   PRN  New Leaders, Quarterly Dividends, Positive Clinical Results, and Data Presentations - Research Report on Quintiles, CR Bard, Theravance, Immunomedics and Progenics Pharmaceuticals",, 9/20/2018 40637H10 PRN  Halozyme Therapeutics To Participate In Upcoming Investor Conference, 2/23/2017 G2151510 PRN  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016," 1/08/2015 56400P70 PRN  Critical Alerts For Kinder Morgan, Halozyme Therapeutics, MannKind, BP and Union Pacific Released By InvestorsObserver",,,, 6/04/2019 03236M20 PRN  Amyris Appoints Kathleen Valiasek Chief Business Officer-Appoints Jonathan Wolter as Interim CFO, 5/30/2019 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conference," 7/15/2014 00448Q20 PRN  Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver",,10/29/2010 03152W10 PRN  Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease,,,, 7/27/2017 36197T10 PRN  Biotech Players Lead the Growth Charge in the Legal Cannabis Market," 7/03/2013 29428V10 PRN  Positive Clinical Data, Marketing Authorizations, and New Appointments Support Growth in Biotech Companies - Research Report on Santarus, VIVUS, Epizyme, Peregrine Pharmaceuticals, and PDL BioPharma",11/09/2018 G5087110 PRN  Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea,, 4/17/2017 39843840 PRN  Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program,,"12/09/2013 73701010 PRN  District Court Ruling, Cash Tender Offers, Celebration Events, Conference Presentations, and Repurchase Programs - Research Report on AstraZeneca, Salix, Health Net, Volcano and Portola", 6/10/2016 92337F10 PRN  Veracyte Statement on CMS's Preliminary Gapfill Rate for the Afirma® Gene Expression Classifier,,,10/25/2016 009FQY-E PRN  Support for the Cannabis Industry at an All Time High,,,, 5/19/2011 46226010 PRN  Genesis Biopharma Retains Leading Strategic Consultancy The Emmes Group,,,," 3/30/2015 00G0R2-E PRN  HYPERION THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout",, 5/23/2013 45845P10 PRN  Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference,,," 5/11/2017 98401F10 PRN  Xencor's Lead Drug Candidate, XmAb5871, Receives Orphan Drug Designation from FDA for Treatment of IgG4-Related Disease",,11/07/2018 G8807B10 PRN  Theravance Biopharma to Present at the Credit Suisse 27th Annual Healthcare Conference,,11/21/2017 03969710 PRN  Ardelyx Announces Updated Development Path for its Cardiorenal Pipeline,,,,,, 7/15/2010 001THX-E PRN  PRA International Hosts Audio Conference on Site and Patient Recruitment,,,,,," 8/07/2018 05070R10 PRN  Audentes Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy",,,,,,10/22/2018 RGNX-US  PRN  REGENXBIO Announces Exclusive Worldwide License with Ultragenyx for the Treatment of CDKL5 Deficiency Disorder Using NAV Vectors,,,,,,,,,,,,,,, 6/04/2013 00695P-E  PRN  Kinex Announces that the US FDA Allows their IND to Begin KX02 Clinical Trials,,,,,,,,,,,,,,,,,,,,,,,,,,,," 5/07/2015 00FYYJ-E PRN  Guardant Health Appoints Mort Minaee, Former Roche Senior Director, as VP of Regulatory Affairs",,,,,,,,,,,,,,,,
, 9/18/2013 PGNX-US  PRN  Acquisition of Exclusive Manufacturing and Marketing Rights for DOTATOC," 5/07/2015 45232710    PRN  Critical Alerts For Intel, Box, Illumina, Stratasys and 58.com Released By InvestorsObserver"," 7/14/2011 84763A10 PRN  Zacks Releases Four Powerful ''Buy'' Stocks: OM Group, Magna International, Spectrum Pharmaceuticals and World Acceptance", 2/28/2019 G3040110 PRN  Endo Reports Fourth-Quarter And Full Year 2018 Financial Results," 9/04/2014 04280A10 PRN  Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen", 9/21/2016 001SS7-E PRN  BioDelivery Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference, 5/02/2019 09073M10    PRN  Bio-Techne To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference, 8/06/2019 75886F10    PRN  Regeneron Reports Second Quarter 2019 Financial and Operating Results,," 6/20/2016 68375N10 PRN  Under Armour trade offers a 20% return in 123 days, or find similar option trades on Seagate Technology, Opko Health, Citigroup, and National Oilwell Varco",11/09/2018 46222210 PRN  Ionis Pharmaceuticals to Host Investor Day, 3/01/2019 09061G10   PRN  BioMarin Receives Positive CHMP Opinion in Europe for Palynziq® (pegvaliase Injection) for Treatment of Patients with Phenylketonuria (PKU) Aged 16 and Older," 7/17/2014 01535110 PRN  Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx",10/23/2018 64125C10 PRN  Neurocrine Biosciences to Present New Data Analyses on the Long-Term Effects of INGREZZA® (valbenazine) in Tardive Dyskinesia Patients with Mood Disorders at the 2018 Annual Psych Congress, 6/25/2014 81257810 PRN  Biotech R&D and Clinical Trials Lead To Potential Revenue Growth - Company's Data of Phase l & Phase ll For HCC Patients Highly Suggestive of Positive Clinical Activity, 6/16/2010 45290710 PRN  New Data Presented from EMBLEM™ Study for Pipeline Drug Epratuzumab for Patients Suffering from Moderate to Severe Systemic Lupus Erythematosus," 3/07/2016 00167Y-E  PRN  During Multiple Sclerosis Awareness Month, MSWorld Celebrates Individuals and Groups Who Empower People with MS",,," 9/08/2016 37555810   PRN  Gilead Sciences, PayPal Holdings Inc., Delta Airlines, Kinder Morgan, and Ferrari N.V. and more offer option-trading opportunities that offer returns of more than 20%",11/26/2018 04004760   PRN  Arena Pharmaceuticals Expands Senior Management Team to Support Commercialization and Medical Affairs," 1/31/2019 N5946510  PRN  Mylan Announces FDA Approval of Wixela™ Inhub™ (fluticasone propionate and salmeterol inhalation powder, USP), First Generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder)", 9/20/2018 0028L7-E PRN  Compugen Announces Clinical Milestone Payment in Cancer Immunotherapy Collaboration With Bayer Following Dosing of First Patient in BAY 1905254 Phase 1 Trial," 8/07/2014 00972810 PRN  Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed", 9/28/2019 03116210 PRN  Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO 2019, 6/13/2013 001D3K-E PRN  AMP Celebrates SCOTUS Decision on AMP v. Myriad Case,11/01/2016 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Third Quarter Financial Results,, 2/20/2019 45766930 PRN  Insmed to Present at the Leerink Partners 8th Annual Global Healthcare Conference,, 6/10/2019 45773H20 PRN  Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device, 2/27/2019 64026810 PRN  Nektar Therapeutics Announces Several Preclinical Data Presentations for its Immuno-oncology Pipeline Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2019, 5/01/2018 76655960 PRN  Rigel Announces First Quarter 2018 Financial Results and Provides Company Update," 3/22/2011 05V9MM-E PRN  Telome Health, Inc. Launches With Exclusive IP Portfolio",," 8/29/2013 02311120 PRN  Clinical Trials, Pipeline Developments, Financial Results, and New Appointments - Research Report on Amarin, Immunomedics, Seattle Genetics, Repros Therapeutics, and LifePoint", 9/29/2015 45337C10 PRN  Baricitinib Superior to Methotrexate in Reducing Signs and Symptoms in Pivotal Phase 3 Study in Patients with Rheumatoid Arthritis, 9/04/2018 005SV0-E PRN  United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products," 5/28/2014 80360710 PRN  Clinical Study Results, Schedule of Upcoming Conferences, Dividend Declaration, and Services Agreement - Analyst Notes on Gilead, Quest Diagnostics, Sarepta Therapeutics, Incyte and Centene", 1/25/2019 G0176710 PRN  ALKS ALERT: Rosen Law Firm Files First Securities Class Action Lawsuit Against Alkermes Public Limited Company; Reminds Investors with $100K in Losses of Important February 25th Deadline - ALKS,,,, 2/06/2018 55027E10 PRN  Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference, 5/03/2018 80067710 PRN  Sangamo Therapeutics Announces Senior Leadership Changes,"10/20/2014 30161Q10 PRN  Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma", 2/07/2019 80105N10  PRN  Sanofi delivers 2018 business EPS growth of 5.1% at CER, 6/25/2014 92532F10  PRN  Biotech R&D and Clinical Trials Lead To Potential Revenue Growth - Company's Data of Phase l & Phase ll For HCC Patients Highly Suggestive of Positive Clinical Activity,,12/15/2014 071865-E PRN  Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency,," 9/03/2014 00422510 PRN  Critical Alerts For Activision Blizzard, ACADIA Pharmaceuticals, Shutterstock, Lockheed Martin and Orexigen Therapeutics Released By InvestorsObserver",, 8/17/2018 74366E10 PRN  Protagonist Therapeutics Reports Granting of Inducement Award,,, 6/06/2011 98978L20    PRN  Fast-Acting Migraine Treatment Highlighted During National Migraine Awareness Month,,"11/04/2014 68214310 PRN  Omeros Corporation to Announce Third Quarter 2014 Financial Results on November 10, 2014",,,,,,,, 8/08/2018 69329Y10 PRN  PDL BioPharma Reports Second Quarter 2018 Financial Results,,,, 5/08/2018 00182C10 PRN  ANI Pharmaceuticals Reports First Quarter 2018 Results and Reaffirms Guidance,," 8/15/2013 02043Q10 PRN  Pharma Companies Announce Investments in R&D, Ongoing Clinical Trials and Financial Results - Research Report on Alnylam, Infinity, Nektar, Sequenom, and Merrimack",,, 8/16/2018 60468T10 PRN  Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition," 8/11/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results",,,,,,11/15/2018 09627Y10 PRN  Blueprint Medicines Announces Updated NAVIGATOR Trial Results in Patients with Advanced Gastrointestinal Stromal Tumors Supporting Development of Avapritinib Across All Lines of Therapy,,10/22/2018 28249U10 PRN  Eiger BioPharmaceuticals Receives FDA Rare Pediatric Disease (RPD) Designation for Lonafarnib for the Treatment of Progeria and Progeroid Laminopathies and Plans NDA Filing in 2019,,,,,,, 9/26/2018 92165910 PRN  Vanda Pharmaceuticals Announces Participation at Oppenheimer and Cantor Fitzgerald Fall 2018 Investor Conferences,,,"12/10/2013 45781M10   PRN  Morning Research Covering Healthcare Sector: Hospira, Alkermes, Theravance, and Celsion",, 9/17/2018 40637H10 PRN  Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin®) In Canada, 2/14/2017 G2151510 PRN  China Biologic Products to Report Fourth Quarter and Fiscal Year 2016 Financial Results,"12/31/2014 56400P70 PRN  Technical Report on Biotech Stocks -- MannKind, Amgen, Celldex Therapeutics, Juno Therapeutics, and Ironwood Pharma",,,," 5/15/2019 03236M20 PRN  AMRS JUNE 3rd DEADLINE ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Amyris, Inc. - AMRS"," 5/20/2019 69366J20 PRN  PTC Therapeutics Announces First-Ever Winners of Its PRIORITY Program To Support Research Projects In Rare, Genetic Disorders"," 7/10/2014 00448Q20 PRN  Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis",,10/29/2010 03152W10 PRN  GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease,,,, 7/19/2017 36197T10 PRN  Opportunity of the Decade for Canada's Cannabis Companies," 7/01/2013 29428V10 PRN  Epizyme, Inc. Added to Russell 2000® Index",11/07/2018 G5087110 PRN  National Institute for Health and Care Excellence (NICE) Recommends Jazz Pharmaceuticals' Vyxeos® (Daunorubicin and Cytarabine) for Adults with Specific Types of Secondary Acute Myeloid Leukaemia (AML),," 4/04/2017 39843840 PRN  Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017",,"11/29/2013 73701010 PRN  Proposed M&A's, Conference Schedules, Health Awareness Programs, Prestigious Recognitions and FDA Designations - Research Report on Health Management, Acadia, Health Net, NuVasive and Portola", 6/01/2016 92337F10 PRN  Veracyte to Present at the William Blair & Company 36th Annual Growth Stock Conference,,,"10/12/2016 14075510 PRN  Biotech Stocks on Investors' Radar -- Alexion Pharma, PDL BioPharma, BioCryst Pharma, and Cara Therapeutics",,,, 5/18/2011 46226010 PRN  Genesis Biopharma Forms Scientific and Medical Advisory Board,,,," 3/25/2015 G4618810 PRN  Technical Analysis on Pharma Equities -- Zoetis, Horizon Pharma, Valeant Pharma Intl., Actavis, and Medicines",, 5/20/2013 45845P10 PRN  Intercept Pharmaceuticals Announces Positive Initial Results from Ongoing Phase 2a Trial in Chronic Bile Acid Diarrhea,,, 5/09/2017 98401F10 PRN  Xencor Reports First Quarter 2017 Financial Results,,"11/06/2018 G8807B10 PRN  Theravance Biopharma, Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update",,"11/16/2017 005K0V-E PRN  Stock Performance Review on Biotech Industry -- Ardelyx, Bellicum Pharma, Iovance Biotherapeutics, and Inotek Pharma",,,,,, 6/16/2010 001THX-E PRN  PRA International Opens Phase I Unit in Budapest,,,,,," 7/31/2018 05070R10 PRN  Audentes to Release Second Quarter 2018 Financial Results and Provide Update on ASPIRO, the Phase 1/2 study of AT132 in Patients with X-Linked Myotubular Myopathy",,,,,,10/04/2018 75901B10 PRN  REGENXBIO Announces Completion of Dosing of Fourth Cohort in Phase I Clinical Trial of RGX-314 Gene Therapy for Wet AMD,,,,,,,,,,,,,,," 4/12/2013 07P37C-E  PRN  Kinex Pharmaceuticals' Chief Scientific Officer, Dr. David Hangauer, named the American Cancer Society's 2013 Honoree for its Cuisine for a Cure event",,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/21/2015 00FYYJ-E PRN  Results Of Decision Impact Study Of Guardant360 In Metastatic Colorectal Cancer To Be Presented At AACR,,,,,,,,,,,,,,,,
," 3/19/2013 74318710 PRN  Prescription for Success: Commercialization Efforts, Acquisitions and Enhanced Patent Protection - Research Report on PAREXEL International, Ironwood Pharmaceuticals, Opko Health, Amarin Corporation, Progenics Pharmaceuticals", 5/06/2015 0DMSKV-E    PRN  Adaptive Biotechnologies Enhances Leading Position in Growing Immunosequencing Market with Completion of $195 Million Investment," 4/20/2011 84763A10 PRN  Zacks.com Featured Expert Kevin Matras Highlights: Avid Technology, Inc., Cepheid, Key Energy Services, Inc., Spectrum Pharmaceuticals, Inc. and Wabash National Corp.", 2/27/2019 G3040110 PRN  Endo Announces Termination of Acquisition Agreements with Somerset Therapeutics and Business of Affiliate Wintac Limited," 8/29/2014 04280A10 PRN  Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead", 9/19/2016 09060J10 PRN  BioDelivery Sciences Announces Three New Managed Care Agreements; Further Enhancing Access to BUNAVAIL, 4/30/2019 09073M10    PRN  Bio-Techne Declares Dividend, 8/06/2019 000VC1-E    PRN  Dupixent® (dupilumab) Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years with Severe Atopic Dermatitis,," 6/08/2016 68375N10 PRN  Covered Call Alerts For Gilead Sciences, Western Digital, Costco, Opko Health and Ulta Salon Cosmetics & Fragrance Inc. Released By InvestorsObserver",11/07/2018 46222210 PRN  Ionis Pharmaceuticals to Present at Upcoming Investor Conferences, 2/26/2019 XENE-US    PRN  Behind the Seizure™ Program Expansion Helps Speed the Diagnosis of Genetic Epilepsy in Younger Children Experiencing Unprovoked Seizures," 7/08/2014 01535110 PRN  Market Activity and Upcoming Quarterly Results - Analyst Notes on Bristol-Myers Squibb, Abbott, Alexion, Mallinckrodt and Baxter",10/15/2018 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2018 Financial Results, 6/20/2014 81257810 PRN  A New Breed of Targeted Cancer Therapeutics & Stem Cell Advancements; Effective ProDrug Therapeutics Approach for GenSpera,," 2/10/2016 09062X10  PRN  Covered Call Alerts For Chesapeake Energy, Microsoft, Gilead Sciences, Biogen and JetBlue Released By InvestorsObserver",,," 8/31/2016 37555810   PRN  Gilead Sciences, Palo Alto Networks, The Mosaic Company, Alibaba, and The Kroger Co and more offer option-trading opportunities that offer returns of more than 20%",11/20/2018 04004760   PRN  Arena Pharmaceuticals to Participate in Upcoming Investor Conferences,12/20/2018 N5946510  PRN  Mylan to Present at the 37th Annual J.P. Morgan Healthcare Conference," 9/07/2018 M2572210 PRN  Compugen Announces First Patient Dosed with COM701, a First-in-Class Cancer Immunotherapy Antibody, in Phase 1 Clinical Trial"," 7/02/2014 00972810 PRN  Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt", 9/26/2019 03116210 PRN  Heart Attack Survivors Are Taking Steps To Reduce Their Cardiovascular Risk. But Are They The Right Ones?, 6/13/2013 MYGN-US  PRN  FRC Praises Supreme Court Decision on DNA,10/31/2016 52887230 PRN  Lexicon Announces Publication Of TELESTAR Study Results For Telotristat Ethyl In The Journal Of Clinical Oncology,," 2/15/2019 45766930 PRN  Insmed to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call on Friday, February 22, 2019",, 5/21/2019 45773H20 PRN  Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial, 2/25/2019 64026810 PRN  Nektar Therapeutics to Webcast Conference Call for Analysts and Investors at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium, 4/30/2018 76655960 PRN  TAVALISSE™ (fostamatinib disodium hexahydrate) Phase 3 Data Published in the American Journal of Hematology Describes Pivotal Data and Overall Response Rate Versus Placebo, 1/13/2011 0017CF-E PRN  New U.S. Patent Covers Breakthrough in Anti-Aging Science,," 8/26/2013 02311120 PRN  HealthCare, Technology Briefing: Market Movers for the Week - Technologies-Scan Corp, GNC, Galena Biopharma, Immunomedics, Amarin"," 9/23/2015 SGMO-US  PRN  Technical Briefing on Biotechnology Equities -- MannKind, Novavax, Incyte, BioMarin Pharma, and Sangamo Biosciences", 8/30/2018 91307C10 PRN  United Therapeutics Corporation Completes Acquisition Of SteadyMed Ltd.," 5/23/2014 80360710 PRN  Critical Alerts For Celldex Therapeutics, Best Buy, Weibo, Sarepta Therapeutics, and Dollar Tree Released By InvestorsObserver", 1/16/2019 G0176710 PRN  Alkermes Announces Recipients of 1st Annual ALKERMES PATHWAYS RESEARCH AWARDS (SM) Program,,,, 1/24/2018 55027E10 PRN  Luminex Corporation Declares First Quarter Cash Dividend, 5/01/2018 80067710 PRN  Sangamo Therapeutics Announces First Quarter 2018 Conference Call and Webcast," 9/12/2014 30161Q10 PRN  Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics"," 2/06/2019 80105N10  PRN  FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)", 6/24/2014 VRTX-US   PRN  Cystic Fibrosis Foundation Applauds Successful Phase 3 Results of Ivacaftor (Kalydeco™) and Lumacaftor (VX-809) Drug Combination for People with Two Copies of F508del Mutation of Cystic Fibrosis,,12/01/2014 071865-E PRN  Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing,," 8/20/2014 00422510 PRN  Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio Pharma, Curis, and Seattle Genetics",, 8/07/2018 74366E10 PRN  Protagonist Therapeutics Reports Second Quarter 2018 Financial Results,,, 9/07/2010 008MD1-E    PRN  Zogenix Files Registration Statement for Proposed Initial Public Offering,,10/30/2014 68214310 PRN  Omidria™ Granted Pass-Through Reimbursement Status from CMS,,,,,,,, 8/02/2018 001NBF-E PRN  PDL BioPharma Acquires Depomed's Remaining 50% Interest in Royalties and Milestones on Type 2 Diabetes Products,,,, 5/07/2018 AMRX-US  PRN  ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax,," 7/05/2013 02043Q10 PRN  Positive Data, Lease Agreements, and Product Launches Strengthen Portfolio - Research Report on Celldex, Teva, Health Management, Perrigo, and Alnylam",,, 8/01/2018 60468T10 PRN  Mirati Therapeutics Reports Second Quarter Financial Results," 8/02/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society",,,,,,10/30/2018 09627Y10 PRN  Blueprint Medicines Reports Third Quarter 2018 Financial Results,,10/18/2018 28249U10 PRN  Eiger BioPharmaceuticals to Participate at BTIG Biotech Conference,,,,,,, 9/25/2018 92165910 PRN  Rollins Set to Join S&P 500; Inogen to Join S&P MidCap 400; Vanda Pharmaceuticals and Garrett Motion to Join S&P SmallCap 600,,,"12/09/2013 45781M10   PRN  Stock Price Updates, Conferences Participations - Research Report on Quest Diagnostics, Pharmacyclics, Health Management Associates, Theravance, and Immunomedics",, 9/10/2018 40637H10 PRN  Halozyme Appoints Bernadette Connaughton To Board Of Directors,11/02/2016 G2151510 PRN  China Biologic Reports Financial Results for the Third Quarter of 2016,"12/09/2014 56400P70 PRN  Critical Alerts For MannKind, Merck, Alnylam Pharmaceuticals, Nu Skin Enterprises and Organovo Released By InvestorsObserver",,,," 4/19/2019 03236M20 PRN  AMYRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Amyris, Inc. - AMRS", 5/09/2019 69366J20 PRN  PTC Therapeutics and MRI Interventions Announce Strategic Investment," 7/07/2014 00448Q20 PRN  Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion",," 9/30/2010 03152W10 PRN  Amicus Therapeutics to Present at the BIO Investor Forum on October 5, 2010",,,, 6/15/2017 36197T10 PRN  Consumers Spending on Legal Cannabis Products Projected to Grow," 6/27/2013 29428V10 PRN  Epizyme, Inc. to Present at Upcoming Conferences in July",11/07/2018 G5087110 PRN  Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences,," 1/31/2017 39843840 PRN  Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million",,"11/21/2013 73701010 PRN  Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma", 5/27/2016 06PCHP-E PRN  Veracyte Announces New Data that Advance Understanding of the Role of Gene Alterations In Thyroid Cancer Diagnosis,,, 9/29/2016 14075510 PRN  Awareness Continues to Grow for Medical Uses of Cannabis,,,, 3/17/2011 46226010 PRN  Genesis Biopharma Appoints William H. Andrews Ph.D. to Board of Directors,,,," 2/13/2015 G4618810 PRN  Technical Notes Covering Pharma Equities -- Valeant Pharma Intl., Salix Pharma, Medicines, Hospira, and Horizon Pharma",, 9/04/2012 008BK4-E PRN  Intercept Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering,,," 5/02/2017 98401F10 PRN  Xencor to Host First Quarter 2017 Financial Results Webcast and Conference Call on May 9, 2017",,11/06/2018 G8807B10 PRN  Theravance Biopharma Announces Sale of VIBATIV® (telavancin) to Cumberland Pharmaceuticals,,11/07/2017 03969710 PRN  Ardelyx Reports Third Quarter 2017 Operating Results and Clinical Progress,,,,,, 6/11/2010 001THX-E PRN  PRA International Exhibits at European Hematology Association Congress,,,,,, 6/05/2018 05070R10 PRN  Audentes Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to AT132 for the treatment of X-Linked Myotubular Myopathy,,,,,,10/02/2018 75901B10 PRN  REGENXBIO to Present at the Chardan 2nd Annual Genetic Medicines Conference,,,,,,,,,,,,,,," 1/04/2013 09WD7K-E  PRN  Kinex Pharmaceuticals, LLC converting from a LLC to a C-Corporation",,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/20/2015 00FYYJ-E PRN  Guardant Health Presents Data on Biopsy-Free Tumor Genomic Profiling Of More Than 2000 Clinical Samples via Guardant360,,,,,,,,,,,,,,,,
, 3/18/2013 ULTA-US  PRN  Apple Inc. Shares Rise After Galaxy Launch - Futures Indicate Lower Open as the Market Takes Back Some of its Gains," 4/20/2015 45232710    PRN  Critical Alerts For FireEye, Seagate Technology, Stratasys, Illumina and Facebook Released By InvestorsObserver",11/18/2010 000BQR-E PRN  Reportlinker Adds Global Bladder Cancer Therapeutics Industry, 2/07/2019 G3040110 PRN  Endo Agrees Not To Oppose Additional Stay of FDA Litigation Following Restoration of Government Appropriations," 8/27/2014 04280A10 PRN  Critical Alerts For Arrowhead Research, Isis Pharmaceuticals, MobileIron, JP Morgan Chase and Viacom Released By InvestorsObserver", 9/06/2016 09060J10 PRN  BioDelivery Sciences to Present at the Rodman & Renshaw 18th Annual Global Investment Conference and the 7th Annual Credit Suisse Small and Mid Cap Conference, 4/30/2019 09073M10    PRN  Bio-Techne Releases Third Quarter Fiscal 2019 Results, 8/06/2019 75886F10    PRN  Dupixent® (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis,," 6/07/2016 68375N10 PRN  Biotechnology Stocks in Motion -- Celldex Therapeutics, Medivation, Opko Health, and ACADIA Pharma",11/06/2018 46222210 PRN  Ionis Reports Third Quarter 2018 Financial Results, 2/21/2019 09061G10   PRN  BioMarin Announces Full Year and Fourth Quarter 2018 Results," 7/07/2014 01535110 PRN  Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec",10/09/2018 64125C10 PRN  Neurocrine Biosciences and Jnana Therapeutics Enter Strategic Collaboration to Discover Novel Medicines to Treat Central Nervous System Disorders," 5/30/2014 81257810 PRN  Technical Coverage on Health Care Sector Equities -- Research on Arena Pharma, Exelixis, Dendreon, and Seattle Genetics",," 1/29/2016 09062X10  PRN  Covered Call Alerts For ConocoPhillips, Pfizer Inc., Biogen, Coach and Las Vegas Sands Released By InvestorsObserver",,," 8/19/2016 37555810   PRN  Research Report on Biotech Equities -- Gilead Sciences, Exelixis, Ariad Pharma, and Novavax",11/15/2018 04004760   PRN  Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag,12/17/2018 SHP-GB    PRN  Launch of Generic Lialda® Delayed-Release Tablets Expands Mylan's Gastroenterology Product Offering, 9/05/2018 CELG-US  PRN  Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors," 6/27/2014 00972810 PRN  Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics", 9/25/2019 03116210 PRN  Amgen To Webcast Investor Call At ESMO 2019, 6/13/2013 001D3K-E PRN  Patients Win in Supreme Court Gene Patent Decision,10/25/2016 52887230 PRN  Lexicon Reports Positive Top-Line Results In Phase 2 Dose-Ranging Study For Sotagliflozin In Patients With Type 1 Diabetes,, 2/04/2019 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),," 5/16/2019 45773H20 PRN  Inovio and QIAGEN Establish Collaboration to Develop Diagnostic Test for VGX-3100, Inovio's Novel Immunotherapy Targeting Advanced Cervical Pre-Cancer"," 2/21/2019 64026810 PRN  Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2018 on Thursday, February 28, 2019, After Close of U.S.-Based Financial Markets", 4/24/2018 76655960 PRN  Rigel Announces Conference Call and Webcast to Report First Quarter 2018 Financial Results,11/18/2010 0011XW-E PRN  Reportlinker Adds Global Regenerative Medicine Industry,," 4/29/2013 BG-US    PRN  Critical Alerts For American International Group, Bunge, Cliffs Natural Resources, Amarin, and ImmunoGen Released By InvestorsObserver"," 9/11/2015 45337C10 PRN  Updates on Biotechnology Industry Stocks - BioCryst Pharma, Incyte, bluebird bio, Cempra, and BioLineRx"," 8/08/2018 05MH2B-E PRN  United Therapeutics Announces Settlement Of Patent Litigation With Watson Laboratories, Inc. Relating To Tyvaso"," 5/23/2014 80360710 PRN  Top Gainers Technical Coverage -- Research on NeuStar, Signet Jewelers, Galena Biopharma, and Sarepta Therapeutics"," 1/10/2019 G0176710 PRN  SHAREHOLDER ALERT: Berger Montague Announces Investigation of Alkermes, plc (NASDAQ: ALKS) (CUSIP: G01767105)",,,, 1/07/2018 55027E10 PRN  Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2017; Company to Present at 36th Annual J.P. Morgan Healthcare Conference, 5/01/2018 80067710 PRN  Sangamo Therapeutics Announces Presentations At 2018 Annual Meeting Of The American Society Of Gene & Cell Therapy," 8/13/2014 30161Q10 PRN  Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics", 1/30/2019 005M9Z-E  PRN  Sanofi Presents Research Advances in Rare Genetic Diseases at 15th Annual WORLDSymposium™ 2019, 6/18/2014 005Y9C-E  PRN  Janssen Announces License Agreement With Vertex to Develop Novel Treatment for Influenza A,, 9/16/2014 071865-E PRN  Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency,," 7/30/2014 00422510 PRN  Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA",, 8/06/2018 74366E10 PRN  Final Results from the Protagonist PROPEL Study Support Further Clinical Development of PTG-100 for the Treatment of Ulcerative Colitis,,, 7/13/2010 008MD1-E    PRN  Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital,,10/21/2014 68214310 PRN  Omeros Provides Update on PDE10 Inhibitor Program,,,,,,,," 8/01/2018 69329Y10 PRN  PDL BioPharma to Announce Second Quarter Financial Results on August 8, 2018",,,, 5/01/2018 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2018 Financial Results,," 6/27/2013 02043Q10 PRN  New Clinical Developments and Advanced Clinical Studies Offer Superior Treatment Options - Research Report on Alnylam, Immunomedics, Tesaro, InterMune and Synta",,, 7/24/2018 60468T10 PRN  Mirati Therapeutics To Present Updated Sitravatinib Clinical Data At The European Society For Medical Oncology (ESMO) 2018 Congress," 7/28/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call",,,,,,"10/29/2018 09627Y10 PRN  Blueprint Medicines Strengthens Leadership with the Appointments of Christina Rossi as Chief Commercial Officer and Paul Beresford as General Manager, International",,10/17/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces Positive Phase 2 LIMT Study End of Treatment Data with Pegylated Interferon Lambda Monotherapy in Hepatitis Delta Virus (HDV) Infection,,,,,,, 9/20/2018 92165910 PRN  Vanda Announces Listing of a New HETLIOZ® Patent in the FDA Orange Book,,,"11/29/2013 45781M10   PRN  Promising Partnerships, Stock Price Updates and Participation in Upcoming Healthcare Conferences - Research Report on Quest Diagnostics, Cigna, Arena, Theravance, and Volcano",, 9/05/2018 40637H10 PRN  Halozyme Names Benjamin Hickey As Chief Commercial Officer,10/24/2016 G2151510 PRN  China Biologic Products to Report Third Quarter 2016 Financial Results,"11/14/2014 56400P70 PRN  Critical Alerts For MannKind, CyberArk Software, Best Buy, Nordstrom and ExOne Released By InvestorsObserver",,,," 4/15/2019 03236M20 PRN  Investor Alert: Kaplan Fox Investigates Amyris, Inc.", 5/08/2019 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conferences," 6/17/2014 00448Q20 PRN  Critical Alerts For Bank of America, Achillion Pharmaceuticals, Walmart, SunEdison, and Advanced Micro Devices Released By InvestorsObserver",, 8/05/2010 03152W10 PRN  Amicus Therapeutics Announces Continued Progress on Global Phase 3 Program for Fabry Disease and Second Quarter 2010 Financial Results,,,, 6/13/2017 36197T10 PRN  CBD Products Market Becoming Hottest Segment of Cannabis Industry as Demand Continues to Explode," 6/26/2013 29428V10 PRN  Epizyme, Inc. Publishes Data Demonstrating EPZ-5676 as Potent, Selective Inhibitor of DOT1L for Genetically Defined Acute Leukemias",11/06/2018 G5087110 PRN  Jazz Pharmaceuticals Announces Third Quarter 2018 Financial Results,, 1/31/2017 39843840 PRN  Hologic Completes Divestiture of Blood Screening Business,,"11/13/2013 73701010 PRN  Solid Growth Derived from Successful Product Launches and Registrations - Research Report on Volcano, Dr. Reddy's, USANA, Repligen, and Portola", 5/23/2016 06PCHP-E PRN  Veracyte Announces Data from Multiple Studies Advancing Scientific Understanding of Thyroid Cancer to Be Presented at AACE Congress,,," 9/19/2016 14075510 PRN  Enteris BioPharma's ""Feasibility to Licensing"" Partner, Cara Therapeutics, Advances Peptelligence™-Engineered CR845 into Phase 2b Clinical Trial in Chronic Pain",,,, 3/16/2011 46226010 PRN  Genesis Biopharma Announces Plans to Develop Active Immunotherapy Platform,,,,"12/29/2014 G4618810 PRN  What's Buzzing on Street: New Research on CorMedix, American Apparel, Horizon, Nike and Amazon",, 8/09/2012 07BG3X-E PRN  Intercept Pharmaceuticals Closes $30 Million Series C Financing,,, 4/26/2017 98401F10 PRN  Xencor to Present at 42nd Annual Deutsche Bank Health Care Conference,,11/06/2018 0D4387-E PRN  Cumberland Pharmaceuticals To Acquire VIBATIV®,,10/16/2017 03969710 PRN  Ardelyx Announces Tenapanor Reduces Pain Caused by IBS-C Through Inhibition of TRPV-1 Signaling,,,,,, 6/11/2010 001THX-E PRN  PRA International's Experts Host Innovative Forums at DIA,,,,,, 5/29/2018 05070R10 PRN  Audentes Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference,,,,,, 9/06/2018 75901B10 PRN  REGENXBIO to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,"12/03/2012 00695P-E  PRN  PharmaEssentia Acquires Certain Asian Rights for Dermatology Preparations of Kinex Pharmaceuticals' Promising Novel Dual Src/Pretubulin Inhibitor, KX01",,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/08/2015 00FYYJ-E PRN  Guardant Health And Academic Collaborators To Present Clinical Utility Of Guardant360 For Solid Tumor Cancers,,,,,,,,,,,,,,,,
, 1/14/2013 74318710 PRN  Which Biotech Companies Are Turning the Tables on Patent Cliffs?," 4/06/2015 45232710    PRN  Critical Alerts For Advanced Micro Devices, Illumina, Coca-Cola, Ariad Pharmaceuticals and Ambarella Released By InvestorsObserver",, 1/25/2019 G3040110 PRN  Endo to Announce Fourth-Quarter and Full-Year 2018 Financial Results," 8/04/2014 04280A10 PRN  Technical Data on Biotech Stocks -- Arrowhead Research, Celldex Therapeutics, Synthetic Biologics, StemCells, and Sarepta Therapeutics", 8/09/2016 09060J10 PRN  BioDelivery Sciences Provides Corporate Update and Reports Second Quarter 2016 Financial Results, 4/22/2019 000XKX-E    PRN  Elpiscience and Bio-Techne Announce Strategic Collaboration, 7/18/2019 75886F10    PRN  Regeneron Announces the 2019 Winners of the Regeneron Prize for Creative Innovation,," 5/25/2016 68375N10 PRN  Under Armour trade offers a 19% return in 52 days, or find similar option trades on Opko Health, Herbalife, Costco, and Microsoft",10/31/2018 46222210 PRN  Advances in Ionis' Novel Antisense Technology to be Presented at 2018 Society for Neuroscience Meeting, 2/07/2019 09061G10   PRN  BioMarin Announces Ongoing Study Demonstrates Durable Treatment Benefit from Brineura® (cerliponase alfa) for 3 Years," 6/27/2014 01535110 PRN  Conference Call Schedules, Disclosures, Partnerships, and Acquisitions - Analyst Notes on Pfizer, Covidien, UnitedHealth Group, Alexion and Abbott",10/01/2018 64125C10 PRN  Neurocrine Biosciences to Present New Long-Term Data Analyses on INGREZZA® (valbenazine) at the 2018 International Congress of Parkinson's Disease and Movement Disorders," 5/22/2014 81257810 PRN  Financial Results, Data Presentations, and Breakthrough Therapy Designation - Analyst Notes on Insys, Seattle Genetics, Cubist, Celldex and Clovis",," 1/28/2016 09062X10  PRN  Covered Call Alerts For ConocoPhillips, Pfizer Inc., Biogen, Coach and Las Vegas Sands Released By InvestorsObserver",,," 8/18/2016 37555810   PRN  Learn how to target a 20% return on Tesla Motors, or get option-trade ideas on Gilead Sciences, Perrigo Co., Palo Alto Networks and Activision Blizzard or any stock you choose",11/13/2018 04004760   PRN  Arena Pharmaceuticals Presented Preclinical Data for APD418 in Development for Treatment of Decompensated Heart Failure at American Heart Association Scientific Sessions,12/17/2018 MYL-US    PRN  Mylan Adds First Generic for Canasa® Rectal Suppository to Growing Gastroenterology Portfolio, 8/01/2018 M2572210 PRN  Compugen Reports Second Quarter 2018 Results," 5/16/2014 00972810 PRN  Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co.", 9/24/2019 03116210 PRN  Amgen Announces Positive Results From Two Phase 3 BLINCYTO® (blinatumomab) Studies In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia, 4/16/2013 0BDK6C-E PRN  MediPoint: Predictive Breast Cancer Gene Testing - APAC Analysis and Market Forecasts,"10/25/2016 52887230 PRN  Lexicon To Report Third Quarter 2016 Financial Results On November 1, 2016",, 1/07/2019 45766930 PRN  Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),, 5/15/2019 45773H20 PRN  Inovio and Plumbline Life Sciences Establish Animal Health Collaboration to Develop A Novel Vaccine Against Deadly African Swine Fever Virus, 2/15/2019 64026810 PRN  Clinical Data Presented from PIVOT-02 Study of Bempegaldesleukin (NKTR-214) with Nivolumab in Metastatic Urothelial Carcinoma Patients at the 2019 ASCO Genitourinary Cancers Symposium, 4/19/2018 76655960 PRN  Rigel Announces Pricing Of Public Offering Of Common Stock,,," 4/16/2013 ANTH-US  PRN  Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCall's Microscope"," 8/18/2015 45337C10 PRN  Critical Alerts For Rite Aid, NXP Semiconductors, Bojangles Inc., Juno Therapeutics Inc and Incyte Corp. Released By InvestorsObserver", 8/08/2018 91307C10 PRN  United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint, 5/22/2014 80360710 PRN  HealthCare Briefing for Advancements in Personalized Medicines and Diagnostic Studies - New Appointment to Company's Scientific Advisory Board, 1/08/2019 G0176710 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc - ALKS,,,,12/13/2017 55027E10 PRN  Luminex Corporation Declares Fourth Quarter Cash Dividend, 4/30/2018 80067710 PRN  Sangamo Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares," 7/31/2014 30161Q10 PRN  Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis", 1/23/2019 80105N10  PRN  FDA approves use of 0.5 mL dose of Fluzone® Quadrivalent (influenza vaccine) in children as young as 6 months of age," 5/20/2014 92532F10  PRN  Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology",," 6/02/2014 071865-E PRN  Ascendis Pharma appoints Martin Auster, M.D., as Chief Business Officer",," 7/18/2014 00422510 PRN  Review on Biotech Stocks -- Incyte, ACADIA Pharma, Cel-Sci, Aegerion Pharma, and ImmunoGen",, 8/06/2018 74366E10 PRN  Protagonist Therapeutics Secures $22 Million Equity Financing,,, 6/07/2010 008MD1-E    PRN  New Survey Reveals Critical Demand for Fast Migraine Relief,, 8/11/2014 68214310 PRN  Omeros Corporation Reports Second Quarter 2014 Financial Results,,,,,,,, 6/22/2018 69329Y10 PRN  Elizabeth O'Farrell Named to PDL BioPharma's Board of Directors,,,, 4/27/2018 00182C10 PRN  Amneal And Impax Receive FTC Clearance For Business Combination,, 1/31/2013 02043Q10 PRN  Empire Asset Management Company Initiates Coverage,,, 6/25/2018 0DK6LR-E PRN  Mirati Therapeutics Added to Russell 2000® Index," 6/27/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces Inclusion in Russell 3000 Index",,,,,,"10/23/2018 09627Y10 PRN  Blueprint Medicines to Report Third Quarter 2018 Financial Results on Tuesday, October 30, 2018",,10/16/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces Positive Results in Phase 2 PREVENT Study of Avexitide Targeting GLP-1 in Post-Bariatric Hypoglycemia (PBH),,,,,,, 9/12/2018 92165910 PRN  HETLIOZ® (Tasimelteon) Driving Study Demonstrates No Impairment in Next Morning Performance,,,"11/21/2013 45781M10   PRN  Investments on New Facilities, Marketing Grants, Commercial Releases, and Trial Results - Research Report on AstraZeneca, Theravance, Accuray, Volcano, and Auxilium",, 8/22/2018 40637H10 PRN  Halozyme Therapeutics To Participate In Upcoming Investor Conferences,10/11/2016 G2151510 PRN  China Biologic Receives CFDA Clinical Trial Approval for Human Antithrombin III,"11/14/2014 56400P70 PRN  Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene",,,," 4/12/2019 03236M20 PRN  Kessler Topaz Meltzer & Check, LLP:  Securities Fraud Class Action Filed Against Amyris, Inc. - AMRS"," 5/07/2019 69366J20 PRN  Data from Pivotal FIREFISH and SUNFISH Studies Demonstrate Clinical Benefit of Risdiplam in Type 1, 2, & 3 Spinal Muscular Atrophy Patients"," 6/13/2014 00448Q20 PRN  If Achillion Pharmaceuticals (NASDAQ: ACHN) Investors Are Hoping for a Buyout, This is Not an Investment Strategy; Analyst Report by BrokerBank Securities, Inc.",," 8/04/2010 03152W10 PRN  Amicus Therapeutics to Present at the Canaccord Genuity 30th Annual Growth Conference on August 12, 2010",,,, 4/05/2017 GWPH-US  PRN  Edison Issues Outlook on GW Pharmaceuticals (GWPH)," 6/13/2013 29428V10 PRN  Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2",10/29/2018 G5087110 PRN  Jazz Pharmaceuticals Announces FDA Approval of Xyrem® (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients,," 1/27/2017 39843840 PRN  Research Reports Coverage on Biotech Stocks -- Idera Pharma, Ocular Therapeutix, Radius Health, and Grifols",,"10/23/2013 73701010 PRN  New Drug Application Reviews, Upcoming Financial Results Schedules, Public Offerings, and Notifications - Research Report on Vanda, Chemed, Portola, Immunomedics, and Sangamo", 5/17/2016 92337F10 PRN  New Data Demonstrating Ability of Veracyte's Genomic Test to Improve Idiopathic Pulmonary Fibrosis Diagnosis Presented at ATS 2016,,, 8/24/2016 14075510 PRN  Diversity of the Legal and Medical Marijuana Markets,,,, 3/09/2011 46226010 PRN  Genesis Biopharma to Present at the Roth Capital Growth Stock Conference on March 16,,,,"12/29/2014 G4618810 PRN  Technical Commentary on Pharma Stocks -- AstraZeneca, Horizon Pharma, Valeant Pharma Intl., Exact Sciences, and Novo Nordisk",, 8/09/2011 05K0PC-E PRN  Intercept Pharmaceuticals and Servier Announce Agreement for Intercept's TGR5 Research Program in Type 2 Diabetes,,," 4/17/2017 NBIX-US  PRN  Xencor Appoints Kevin Gorman, Ph.D., to its Board of Directors",,10/30/2018 G8807B10 PRN  Theravance Biopharma to Report Third Quarter 2018 Financial Results on November 6,,10/11/2017 03969710 PRN  Ardelyx's Pivotal Phase 3 Study of Tenapanor for IBS-C Hits Primary and All Secondary Endpoints to Support NDA Submission in 2018,,,,,, 6/10/2010 001THX-E PRN  PRA International Adds Senior VP of Late Phase Services,,,,,," 5/16/2018 05070R10 PRN  Audentes Announces Continuing Positive Data from First Dose Cohort of ASPIRO, a Phase 1/2 Clinical Trial of AT132 in Patients With X-Linked Myotubular Myopathy",,,,,, 8/30/2018 75901B10 PRN  REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease,,,,,,,,,,,,,,,11/06/2012 00695P-E  PRN  Hanmi and Kinex Announced Korean FDA Allowance of the KX01 IND Application,,,,,,,,,,,,,,,,,,,,,,,,,,,," 2/03/2015 00FYYJ-E PRN  Guardant Health Secures Additional $50 Million Based On Strong Demand For Its Biopsy-Free Cancer Blood Test, Guardant360®",,,,,,,,,,,,,,,,
,12/17/2012 PGNX-US  PRN  MedImmune Announces Agreement with Progenics Pharmaceuticals to Develop Therapies Against Serious Bacterial Infections, 3/18/2015 45232710    PRN  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer,,12/31/2018 074HTM-E PRN  Endo Announces Anticipated Further Stay of Compounding Litigation Due to Lapse of Government Appropriations," 7/18/2014 04280A10 PRN  SEC Filings, Positive Trial Results, Technical Updates, and sNDA Updates - Analyst Notes on Questcor, Exelixis, InterMune, Progenics and Arrowhead", 8/04/2016 09060J10 PRN  BioDelivery Sciences Announces Randomization Target Reached in Clinical Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy," 4/09/2019 09073M10    PRN  Bio-Techne To Host Conference Call On April 30, 2019 To Announce Third Quarter 2019 Financial Results"," 7/08/2019 75886F10    PRN  Regeneron to Report Second Quarter 2019 Financial and Operating Results and Host Conference Call and Webcast on August 6, 2019",," 5/16/2016 68375N10 PRN  Learn how to target a 20% return on Google Inc, or get option-trade ideas on LinkedIn, Opko Health, Seagate Technology, and First Solar or any stock you choose",10/24/2018 46222210 PRN  Ionis Pharmaceuticals to Hold Third Quarter 2018 Financial Results Webcast, 2/04/2019 09061G10   PRN  BioMarin Announces 14 Presentations at 15th Annual WORLDSymposium™ 2019, 6/23/2014 01535110 PRN  Alexion and Cincinnati Children's Launch Rare Disease Innovation Fund, 9/05/2018 64125C10 PRN  Neurocrine Biosciences to Present at the Morgan Stanley 16th Annual Global Healthcare Conference," 5/14/2014 81257810 PRN  Clinical Study Results, Upcoming Events, and Financial Updates - Analyst Notes on Amgen, Insys, Alnylam, Seattle Genetics and Emergent BioSolutions",," 1/12/2016 ISIS-US   PRN  Ionis Pharmaceuticals Completes Target Enrollment for Nusinersen Phase 3 Study, CHERISH, in Children with Spinal Muscular Atrophy",,," 8/11/2016 37555810   PRN  Covered Call reports for Gilead Sciences, Intrexon, Ralph Lauren, Smith & Wesson and Eros International include trade ideas that offer returns of 20% or more!",11/07/2018 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2018 Financial Results,"12/13/2018 N5946510  PRN  Sanofi's Formulation Patents on Multibillion-Dollar Lantus® are Invalidated by U.S. Patent and Trademark Office via IPR, Announces Mylan"," 7/18/2018 M2572210 PRN  Compugen Second Quarter 2018 Conference Call Scheduled for Wednesday, August 1, 2018 at 8:30 AM ET", 4/17/2014 091B1B-E PRN  Actavis to Acquire Four Products from Akorn, 9/17/2019 03116210 PRN  Amgen Showcases New Data From Oncology Pipeline And Portfolio At ESMO 2019," 4/16/2013 WPM-CA   PRN  Critical Trade Alerts For Qualcomm, Silver Wheaton, Cummins, Dreamworks Animation, and Myriad Genetics Released By InvestorsObserver","10/07/2016 52887230 PRN  Biotech Stocks Technical Reports -- Tesaro, CTI BioPharma, Sage Therapeutics, and Lexicon Pharma",, 1/04/2019 45766930 PRN  Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch and Outlines Strategic Priorities for 2019,, 5/09/2019 45773H20 PRN  Inovio Pharmaceuticals Reports 2019 First Quarter Financial Results, 2/11/2019 64026810 PRN  Nektar Therapeutics to Webcast Conference Call with Urothelial Cancer Specialist for Analysts & Investors at the 2019 ASCO Genitourinary Cancers Symposium, 4/18/2018 76655960 PRN  Rigel Announces Proposed Public Offering Of Common Stock,,," 3/19/2013 02311120 PRN  Prescription for Success: Commercialization Efforts, Acquisitions and Enhanced Patent Protection - Research Report on PAREXEL International, Ironwood Pharmaceuticals, Opko Health, Amarin Corporation, Progenics Pharmaceuticals", 6/10/2015 LLY-US   PRN  Lilly and Incyte unveil detailed data on two pivotal studies of baricitinib in rheumatoid arthritis, 8/07/2018 91307C10 PRN  United Therapeutics Corporation To Present At 2018 Wedbush PacGrow Healthcare Conference," 5/20/2014 80360710 PRN  Critical Alerts For GlaxoSmithKline, Fusion-io, Sony, VMware, and Sarepta Therapeutics Released By InvestorsObserver", 1/02/2019 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at the 37th Annual J.P. Morgan Healthcare Conference,,,,11/14/2017 55027E10 PRN  Luminex Corporation To Present At The 29th Annual Piper Jaffray Healthcare Conference, 4/27/2018 80067710 PRN  Sangamo Announces $8 Million CIRM Grant For ST-400 -- A Gene-Edited Cell Therapy Candidate -- To Treat Transfusion-Dependent Beta-Thalassemia," 7/29/2014 30161Q10 PRN  Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis", 1/14/2019 80105N10  PRN  FDA Approves Expanded Use of Adacel® (Tdap) Vaccine for Repeat Vaccination," 1/16/2014 92532F10  PRN  Technical Update on Health Care Sector: Solta Medical, Orexigen Therapeutics, Vertex Pharmaceuticals, and Alere",, 1/09/2014 071865-E PRN  Ascendis Pharma Announces the Appointment of Thomas P. Soloway as Chief Financial Officer,," 7/02/2014 00422510 PRN  Critical Alerts For Zillow, ACADIA Pharmaceuticals, Potbelly, American Tower, and HollyFrontier Released By InvestorsObserver",, 6/18/2018 74366E10 PRN  Protagonist Announces Phase 1 and Pre-clinical Data on Hepcidin Mimetic PTG-300 Presented at European Hematology Association Annual Meeting,,,,, 8/08/2014 68214310 PRN  Omeros to Present at the Wedbush PacGrow 2014 Life Sciences Management Access Conference,,,,,,,, 6/11/2018 69329Y10 PRN  Shlomo Yanai Elected to PDL BioPharma's Board of Directors,,,, 4/27/2018 00182C10 PRN  ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax,, 1/03/2013 078VWR-E PRN  Regulus to Present at 31st Annual J.P. Morgan Healthcare Conference,,, 6/11/2018 60468T10 PRN  Mirati Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares," 6/14/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPAREL™ PDUFA Target Date by Three Months",,,,,,"10/06/2018 09627Y10 PRN  Blueprint Medicines Announces Updated Data from Phase 1 ARROW Clinical Trial Showing Broad, Durable Activity of BLU-667 in Advanced RET-Altered Medullary and Papillary Thyroid Cancers",,10/16/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces Phase 2 ULTRA Results of Ubenimex in Lower Leg Lymphedema: Study Did Not Meet Primary or Secondary Endpoint,,,,,,, 9/04/2018 92165910 PRN  Vanda Pharmaceuticals Announces Participation at September 2018 Investor Conferences,,,"11/14/2013 45781M10   PRN  Before the Bell Scans: Theravance Inc., Alkermes PLC, Celsion Corp., and Hospira Inc.",, 8/07/2018 40637H10 PRN  Halozyme Reports Second Quarter 2018 Results, 8/04/2016 G2151510 PRN  China Biologic Reports Financial Results for the Second Quarter of 2016,"10/23/2014 56400P70 PRN  Critical Alerts For MannKind, Alibaba, Yahoo!, El Pollo Loco and Activision Blizzard Released By InvestorsObserver",,,," 4/11/2019 03236M20 PRN  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Amyris, Inc. To Contact The Firm", 5/03/2019 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)," 1/13/2014 00448Q20 PRN  Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos",," 7/27/2010 03152W10 PRN  Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010",,,, 3/28/2017 36197T10 PRN  The Growth of Legal Cannabis in Approved States," 6/05/2013 29428V10 PRN  Epizyme, Inc. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option","10/23/2018 G5087110 PRN  Jazz Pharmaceuticals to Report 2018 Third Quarter Financial Results on November 6, 2018",,"12/14/2016 39843840 PRN  Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million",,"10/21/2013 73701010 PRN  Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences", 5/17/2016 071TZP-E PRN  New Data Suggesting Veracyte's Percepta® Bronchial Genomic Classifier Can Reduce Unnecessary Invasive Procedures In Lung Cancer Diagnosis Presented at ATS 2016,,, 8/23/2016 14075510 PRN  The Growth of the Legal and Medical Marijuana Markets,,,, 3/07/2011 46226010 PRN  Genesis Biopharma Names Marvin S. Hausman M.D. as Chief Science Officer,,,,"11/26/2014 G4618810 PRN  Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance",, 3/31/2011 008BK4-E PRN  Intercept Pharmaceuticals Announces Positive Phase II Results for Obeticholic Acid (INT-747) as Monotherapy in Primary Biliary Cirrhosis,,, 3/15/2017 98401F10 PRN  Xencor to Present at Oppenheimer 27th Annual Healthcare Conference,,10/22/2018 G8807B10 PRN  Theravance Biopharma Reports Data from TD-1473 Phase 1b Four-Week Study in Oral Late-Breaker Presentation at UEG Week 2018,, 8/09/2017 03969710 PRN  Ardelyx Focuses Resources on Late-Stage Programs and Reports Second Quarter 2017 Operational Results,,,,,, 5/26/2010 001THX-E PRN  PRA International's Oncology Experts Host Innovative Panels at ASCO,,,,,, 5/09/2018 05070R10 PRN  Audentes Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update,,,,,, 8/14/2018 75901B10 PRN  REGENXBIO Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,,,,,,,,,,,,,,,10/22/2012 00695P-E  PRN  Kinex Pharmaceuticals Closes First Tranche of Current Round Financing,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/15/2014 00FYYJ-E PRN  Guardant Health Receives Accreditation from the College of American Pathologists,,,,,,,,,,,,,,,,
,10/03/2011 001CVH-E PRN  The Global Competitive Landscape of Antibody Drug Development in Cancer: The Faster Route to Consider Your Options and Position of Others," 3/05/2015 45232710    PRN  Critical Alerts For Halliburton, Charter Communications, Proto Labs, Yum! Brands and Illumina Released By InvestorsObserver",,12/19/2018 G3040110 PRN  Endo to Participate at J.P. Morgan Healthcare Conference," 7/08/2014 04280A10 PRN  Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne"," 8/01/2016 09060J10 PRN  BioDelivery Sciences to Host Conference Call and Webcast of Second Quarter 2016 Results on Tuesday, August 9", 3/28/2019 09073M10    PRN  Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling, 7/01/2019 75886F10    PRN  Libtayo® (cemiplimab) Approved for Advanced Cutaneous Squamous Cell Carcinoma in the European Union,," 4/28/2016 68375N10 PRN  Learn how to target a 21.49% return on Kinder Morgan, or get option-trade ideas on Opko Health, Boeing, JC Penney and SPDR Gold Trust or any stock you choose",10/23/2018 46222210 PRN  Dr. C. Frank Bennett Receives Leslie Gehry Brenner Prize for Innovation in Science," 1/23/2019 09061G10   PRN  BioMarin to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 21 at 4:30pm ET"," 6/10/2014 01535110 PRN  Critical Alerts For Apple, Orexigen Therapeutics, NextEra Energy, Family Dollar Store, and Alexion Pharmaceuticals Technology Released By InvestorsObserver", 8/22/2018 64125C10 PRN  AbbVie Announces Positive Topline Results from Phase 3 Extension Study Evaluating Investigational Elagolix in Women with Uterine Fibroids," 1/09/2014 81257810 PRN  Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals",,12/11/2015 IONS-US   PRN  Isis Pharmaceuticals Announces Initiation of Phase 1/2 Clinical Study of ISIS-SOD1 Rx in Patients With ALS,,," 8/03/2016 37555810   PRN  Gilead Sciences, Williams Companies, Procter & Gamble, Mallinckrodt Public Limited Company, and Western Digital and more offer option-trading opportunities that offer returns of more than 20%",10/31/2018 04004760   PRN  Arena Pharmaceuticals to Release Third Quarter 2018 Financial Results and Provide Corporate Update on November 7,"12/04/2018 N5946510  PRN  Mylan Expands its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to All Lots Within Expiry Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient", 7/02/2018 0028L7-E PRN  Compugen Welcomes FDA Clearance of Bayer's IND Application for BAY 1905254, 4/15/2014 HITK-US  PRN  Repligen Corporation Set to Join the S&P SmallCap 600, 9/13/2019 03116210 PRN  Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference, 4/11/2013 0BDK6C-E PRN  MediPoint: Predictive Breast Cancer Gene Testing - EU Analysis and Market Forecasts,10/05/2016 52887230 PRN  Lexicon Pharmaceuticals Announces Agreement To Buy Out Remaining Obligations To Symphony Icon,,"11/09/2017 000M1T-E PRN  Technical Reports on Biotech Equities -- ImmunoGen, Incyte, Infinity Pharma, and Insmed",," 5/06/2019 45773H20 PRN  Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100", 1/03/2019 NKTR-US  PRN  ImaginAb Announces Immuno-Oncology License and Clinical Trial Collaboration with Nektar Therapeutics, 4/17/2018 76655960 PRN  Rigel Announces FDA Approval of TAVALISSE™ (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia (ITP) in Adult Patients,,," 3/18/2013 GSK-GB   PRN  Amarin, Celgene, GlaxoSmithKline, Spectrum Pharma, and Geron Briefing and Review", 6/01/2015 45337C10 PRN  Advaxis Announces FDA Clearance of Investigational New Drug Application for Phase 2 Study of ADXS-HPV and Incyte's epacadostat for the Treatment of HPV-Associated Early Stage Cervical Cancer, 8/01/2018 91307C10 PRN  United Therapeutics Corporation Reports Second Quarter 2018 Financial Results, 4/21/2014 AVII-US  PRN  Race to Yes Optimistic About Path Forward for Duchenne Children,12/17/2018 G0176710 PRN  Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis,,,,10/31/2017 55027E10 PRN  Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay, 4/25/2018 80067710 PRN  Sangamo Therapeutics Announces Pricing of Public Offering of Common Stock," 7/18/2014 30161Q10 PRN  SEC Filings, Positive Trial Results, Technical Updates, and sNDA Updates - Analyst Notes on Questcor, Exelixis, InterMune, Progenics and Arrowhead", 1/11/2019 PODD-US   PRN  DiabetesSisters Welcomes 2019 National Strategic Partners,"12/31/2013 92532F10  PRN  Commercialization Agreements, Acquisition Updates, Conference Calls Schedules, Stock Price Updates and Clinical Study Data - Research Report on Biogen Idec, Covidien, Vertex, Endo, and Momenta Pharma",,,," 5/15/2014 00422510 PRN  Technical Coverage of Health Care Sector Equities -- Research on Intercept Pharma, ACADIA Pharma, DENTSPLY Intl., and OraSure Technologies",, 6/06/2018 74366E10 PRN  Protagonist Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference,,,,," 6/27/2014 68214310 PRN  Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics",,,,,,,," 5/21/2018 69329Y10 PRN  PDL BioPharma Names Dr. Jill Jene Vice President, Business Development",,,, 4/18/2018 00182C10 PRN  ANI Pharmaceuticals Announces Approval of Morphine Sulfate Oral Solution,,12/20/2012 078VWR-E PRN  Regulus Announces Addition to Russell 2000 Index,,, 6/07/2018 60468T10 PRN  Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock," 6/02/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Appoints Two Life Sciences Industry Veterans to Its Board of Directors",,,,,,"10/01/2018 09627Y10 PRN  Blueprint Medicines Presents Foundational Preclinical Data Supporting the Development of BLU-782, a Highly Selective ALK2 Inhibitor, for the Treatment of Patients with Fibrodysplasia Ossificans Progressiva",, 9/25/2018 28249U10 PRN  Eiger BioPharmaceuticals to Participate in Investor Conferences,,,,,,, 8/14/2018 92165910 PRN  Vanda Wins Denial of Petition For Rehearing on Fanapt®,,,"11/12/2013 45781M10   PRN  FDA Approval, Quarterly Reports, Event, and Licensing Agreement - Research Report on Novo Nordisk, DexCom, Theravance, PDL, and WuXi PharmaTech",, 7/26/2018 40637H10 PRN  Halozyme Therapeutics To Participate In Upcoming Healthcare Conference, 7/22/2016 G2151510 PRN  China Biologic Products to Report Second Quarter 2016 Financial Results,"10/14/2014 56400P70 PRN  Pre-market Biotech Picks - Gilead Sciences, MannKind, IsoRay, Orexigen Therapeutics, and Sunesis Pharma",,,," 4/04/2019 03236M20 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc.  - AMRS", 5/02/2019 69366J20 PRN  PTC Therapeutics Reports First Quarter 2019 Financial Results and Provides a Corporate Update,"12/04/2013 00448Q20 PRN  Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed",," 7/21/2010 03152W10 PRN  Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing",,,, 3/27/2017 36197T10 PRN  The Legal Cannabis Market Developments in 2017," 5/30/2013 07CMVM-E PRN  Epizyme, Inc. Announces Pricing of Initial Public Offering",10/10/2018 G5087110 PRN  Jazz Pharmaceuticals Survey Highlights Significant Impact of Excessive Daytime Sleepiness Related to Sleep Apnea,,12/14/2016 39843840 PRN  Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion,," 3/08/2013 0CN75T-E PRN  Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs", 5/05/2016 92337F10 PRN  Veracyte Announces First Quarter 2016 Financial Results,,," 7/05/2016 14075510 PRN  Why Investors Love These Biotech's Stocks? - XOMA Corp., Navidea Biopharma, Radius Health, and Cara Therapeutics",,,," 2/23/2011 46226010 PRN  Genesis Biopharma Appoints L. Stephen Coles M.D., Ph.D. to Board of Directors",,,,"10/21/2014 G4618810 PRN  Equities Updates on Pharma Industry - Mylan, Horizon Pharma, Hospira, VIVUS, and Endocyte",, 3/30/2011 000FHB-E PRN  Dainippon Sumitomo Pharma and Intercept Pharmaceuticals Announce Agreement to Develop and Commercialize Obeticholic Acid (INT-747) for Chronic Liver Disease,,," 3/06/2017 98401F10 PRN  Xencor Announces Bruce L.A. Carter, Ph.D., Chairman of the Board of Directors, Will Not Stand for Reelection to Board of Directors at 2017 Annual Meeting of Stockholders",,10/11/2018 G8807B10 PRN  Theravance Biopharma and Mylan Report Positive New Data from Multiple Studies of YUPELRI™ (revefenacin) at the 2018 CHEST Annual Meeting,, 8/02/2017 03969710 PRN  Ardelyx Announces Date of Second Quarter Financial Results and Presentation at Wedbush PacGrow Healthcare Conference,,,,,," 5/20/2010 001THX-E PRN  PRA International Hosts Audio Conference on Small, Efficient Designs in Oncology",,,,,, 5/09/2018 05070R10 PRN  Audentes Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference 2018,,,,,, 8/10/2018 75901B10 PRN  REGENXBIO Announces Pricing Of Public Offering Of Common Stock,,,,,,,,,,,,,,, 9/10/2012 00695P-E  PRN  Kinex Pharmaceuticals Appoints Mr. Patrick Gallagher Vice President of Business Development and Investor Relations,,,,,,,,,,,,,,,,,,,,,,,,,,,," 9/08/2014 00FYYJ-E PRN  Guardant Health Appoints Richard Lanman, M.D. as Chief Medical Officer",,,,,,,,,,,,,,,,
,, 2/05/2015 0C5X3Z-E    PRN  TrialReach Raises $13.5M Series B Led by Smedvig Capital,,11/28/2018 G3040110 PRN  Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference," 6/27/2014 04280A10 PRN  Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma", 7/11/2016 09060J10 PRN  BioDelivery Sciences Announces the Securing of Preferred Formulary Status for BUNAVAIL on a Significant Managed Care Plan, 3/05/2019 09073M10    PRN  Bio-Techne Scores A Trio Of CiteAb 2019 Awards, 6/28/2019 75886F10    PRN  CHMP Recommends Approval of Dupixent® (dupilumab) for Moderate-to-Severe Atopic Dermatitis in Adolescents,," 4/18/2016 68375N10 PRN  Covered Call Alerts For Whole Foods Market, Opko Health, Exxon Mobil, Lumber Liquidators and JC Penney Released By InvestorsObserver",10/22/2018 46222210 PRN  Phase 1b/2 Data of Durvalumab Plus Danvatirsen Presented at European Society for Medical Oncology, 1/07/2019 09061G10   PRN  BioMarin Highlights Key Milestones for 2019 at 37th Annual J.P. Morgan Healthcare Conference in San Francisco," 5/14/2014 01535110 PRN  Earnings Releases, Drug Approvals, Study Results, Dividend Declarations, and Long-term Financing - Analyst Notes on Medivation, Alexion, Boston Scientific, Danaher and Caterpillar", 8/15/2018 64125C10 PRN  Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2018 World Congress on Parkinson's Disease and Related Disorders,"12/27/2013 81257810 PRN  Equity Technical Dimensions:Seattle Genetics, Amarin, and PerkinElmer",,12/04/2015 AL-US     PRN  BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use,,," 7/22/2016 37555810   PRN  Exelixis trade offers a 16.41% return in 183 days, or find similar option trades on Consolidated Edison, NextEra Energy, Gilead Sciences, and Barrick Gold Corporation",10/08/2018 04004760   PRN  Arena Pharmaceuticals Presented Phase 2 Clinical Data for Etrasimod in Ulcerative Colitis at the American College of Gastroenterology Annual Meeting,12/04/2018 MYL-US    PRN  Mylan Expands Gastroenterology Portfolio with Launch of Generic for Prevacid® SoluTab Delayed-Release Orally Disintegrating Tablets," 7/02/2018 M2572210 PRN  Compugen Announces FDA Clearance of IND Application for COM701, a First-in-class Immuno-Oncology Therapeutic Antibody"," 4/10/2014 00972810 PRN  Akorn, Inc. Announces First Quarter 2014 Earnings Release and Conference Call Information", 9/13/2019 03116210 PRN  Amgen Announces Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) Meets Primary Endpoint Of Progression-Free Survival, 3/14/2013 003LN3-E PRN  Doctors File in Court to Defend Patents for Genetic Research,10/03/2016 LXRX-US  PRN  Telecast Data Presented At The 2016 North American Neuroendocrine Tumor Society Annual Symposium,,11/01/2017 45766930 PRN  Biotech Stocks Focus on Newest Drug Developments and Advanced Therapies Heading Into 2018,," 5/01/2019 45773H20 PRN  Inovio Pharmaceuticals to Report First Quarter 2019 Financial Results on May 9, 2019","12/27/2018 64026810 PRN  Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA", 4/12/2018 76655960 PRN  Rigel Makes Statement Regarding Website Error,,, 2/15/2013 02311120 PRN  Amarin and Forest Laboratories Under Review: Drug Makers Face Growing Generic Competition, 5/28/2015 45337C10 PRN  Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data, 7/31/2018 91307C10 PRN  United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®," 1/14/2014 80360710 PRN  Critical Alerts For Ford, Clovis Oncology, Johnson Controls, Juniper Networks, and Sarepta Therapeutics Released By InvestorsObserver",11/29/2018 G0176710 PRN  Alkermes Announces Positive Topline Results From ENLIGHTEN-2 Phase 3 Study of ALKS 3831 in Patients With Schizophrenia,,,,10/30/2017 55027E10 PRN  Luminex Corporation Reports Third Quarter 2017 Financial Results, 4/24/2018 80067710 PRN  Sangamo Therapeutics Announces Proposed Public Offering of Common Stock," 7/17/2014 30161Q10 PRN  Exelixis, Inc., Analyst Report; The Upside Potential is Worth the Risk by BrokerBank Securities, Inc.", 1/09/2019 005M9Z-E  PRN  New England Journal of Medicine publishes positive results of the pivotal trial of Cablivi® (caplacizumab) for rare blood clotting disorder,"12/19/2013 92532F10  PRN  Senior Notes Pricing, Contract Renewal, Updated Financial Outlook, Price Movements, and Clinical Trial Results - Research Report on Endo, HCA, Covidien, Vertex, and Seattle Genetics",,,," 1/10/2014 00422510 PRN  Share Price Movements, Upcoming Conferences, Positive Recommendations, and New Agreements - Research Report on Acadia, Dendreon, Cell Therapeutics, Impax, and Anika",, 6/01/2018 74366E10 PRN  Protagonist Therapeutics Reports Granting of Inducement Award,,,,, 6/02/2014 68214310 PRN  Omeros Receives FDA Approval of Omidria™ for Use in Cataract and Other Intraocular Lens Replacement Procedures,,,,,,,, 5/15/2018 69329Y10 PRN  PDL BioPharma to Present at Two Upcoming Investor Conferences,,,," 4/04/2018 ANIP-US  PRN  ANI Acquires 23 ANDAs from IDT Australia, Ltd.",,"12/03/2012 078VWR-E PRN  Regulus to Host NASDAQ Closing Bell Ceremony on December 5, 2012",,, 6/06/2018 60468T10 PRN  Mirati Therapeutics Announces Proposed Public Offering of Common Stock," 5/24/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. to Present at UBS Global Specialty Pharmaceuticals Conference",,,,,," 9/26/2018 09627Y10 PRN  Blueprint Medicines Announces Proof-of-Concept Data Showing Combination of BLU-667 and Osimertinib Overcame Treatment Resistance in Two Patients with EGFR-Mutant, Non-Small Cell Lung Cancer and an Acquired RET Fusion",, 9/24/2018 28249U10 PRN  Eiger Announces FDA Guidance on HDV Phase 3 Study Design: Primary Endpoint Established; D-LIVR Study Initiating Q4 2018,,,,,,, 8/13/2018 92165910 PRN  Vanda Pharmaceuticals Announces the Appointment of General Counsel,,,"11/04/2013 45781M10   PRN  Quarterly Financial Reports, Clinical Study Results, and R&D Events for the Investment Community - Research Report on Gilead Sciences, Clovis, Theravance, Charles River, and Acorda",, 7/26/2018 003DX0-E PRN  Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE® Technology, 5/04/2016 G2151510 PRN  China Biologic Reports Financial Results for the First Quarter of 2016,"10/03/2014 56400P70 PRN  Critical Alerts For MannKind, Sarepta Therapeutics, Noodles & Company, VoxelJet and Lululemon Released By InvestorsObserver",,,," 4/02/2019 03236M20 PRN  Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., iRhythm Technologies, Inc., Orion Group Holdings, Inc., Osmotica Pharmaceuticals plc, Quantenna Communications, Inc., WABCO Holdings, Inc. and Zafgen, Inc.", 4/29/2019 69366J20 PRN  Translarna™ (ataluren) is the First Therapy Approved in Brazil for Duchenne Muscular Dystrophy,"11/15/2013 00448Q20 PRN  Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE",, 5/06/2010 03152W10 PRN  Alzheimer's Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology,,,, 3/20/2017 36197T10 PRN  Legal Cannabis Market Contributes to Tax Revenues," 4/26/2013 07CMVM-E PRN  Epizyme, Inc. Files Registration Statement for Proposed Initial Public Offering", 9/11/2018 G5087110 PRN  Jazz Pharmaceuticals Announces an Informational Webcast for Investors Related to Vyxeos EU Launch,, 9/05/2016 39843840 PRN  Grifols Opens Diagnostic Training Center in Dubai,, 2/05/2013 005Y9C-E PRN  XARELTO® to be Studied with Factor Xa Inhibitor Antidote, 5/03/2016 92337F10 PRN  Data from Multiple Studies Evaluating Veracyte's Genomic Classifiers for Lung Cancer and Idiopathic Pulmonary Fibrosis to Be Presented at ATS 2016,,, 6/01/2016 14075510 PRN  Cannabis & Legal Marijuana Sector Continues To See Steady Growth As Companies Launch Newest Innovative Products; Company to Develop First Ever MMJ Plant to Paper Product,,,, 2/14/2011 46226010 PRN  Genesis Biopharma to Present at the Lippert/Heilshorn Life Sciences and Medtech Virtual Conference on February 17,,,,,, 3/29/2011 063YF7-E PRN  Initiation of FLINT Announced by NIDDK: Study of Intercept Pharmaceuticals' Obeticholic Acid (INT-747) in NASH,,, 3/01/2017 98401F10 PRN  Xencor Presents Preclinical Data on Emerging Bispecific Antibody Candidates at American Association for Cancer Research (AACR) 2017 Annual Meeting,,10/10/2018 G8807B10 PRN  Theravance Biopharma Announces Data from Phase 1b Study of TD-1473 Selected for Oral Late-Breaker Presentation at UEG Week 2018,, 5/12/2017 03969710 PRN  Ardelyx Reports Successful Phase 3 T3MPO-1 Trial of Tenapanor in Patients with IBS-C,,,,,,,,,,,, 5/08/2018 05070R10 PRN  Audentes Therapeutics Announces the Promotion of Natalie Holles to President and Chief Operating Officer,,,,,, 8/08/2018 75901B10 PRN  REGENXBIO Announces Proposed Public Offering Of Common Stock,,,,,,,,,,,,,,, 7/31/2012 00695P-E  PRN  Kinex Pharmaceuticals Receives Substantial Strategic Investment,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/26/2014 00FYYJ-E PRN  Guardant Health Named a 2015 Technology Pioneer by World Economic Forum,,,,,,,,,,,,,,,,
,," 2/05/2015 45232710    PRN  Analysts View on Health Care Sector Equities -- GlaxoSmithKline, Novartis, Illumina, PerkinElmer, and Albany Molecular Research",,11/26/2018 G3040110 PRN  Endo to Participate at Piper Jaffray Global Healthcare Conference," 6/27/2014 04280A10 PRN  Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics", 7/06/2016 06P5F0-E PRN  BioDelivery Sciences to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference, 3/05/2019 09073M10    PRN  Bio-Techne To Present At The Barclays Global Healthcare Conference, 6/26/2019 75886F10    PRN  FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis,," 3/16/2016 68375N10 PRN  Covered Call Alerts For Apple, Mead Johnson Nutrition Company, Cal-Maine Foods, Opko Health and Bank of America Released By InvestorsObserver",10/10/2018 46222210 PRN  Ionis Enters New Collaboration with Partner to Develop IONIS-FB-L Rx for Complement-Mediated Diseases,12/18/2018 09061G10   PRN  BioMarin to Present at 37th Annual J.P. Morgan Healthcare Conference in San Francisco," 2/13/2014 ALXN-US  PRN  Prothelia and the University of Nevada, Reno Enter Into Exclusive Strategic Agreements with Alexion for Catastrophic, Ultra-Rare Neuromuscular Disorder", 7/31/2018 64125C10 PRN  Neurocrine Biosciences Reports Second Quarter 2018 Financial Results,"12/19/2013 81257810 PRN  Senior Notes Pricing, Contract Renewal, Updated Financial Outlook, Price Movements, and Clinical Trial Results - Research Report on Endo, HCA, Covidien, Vertex, and Seattle Genetics",,11/10/2015 IONS-US   PRN  Isis Pharmaceuticals Earns $2.8M for Advancing ISIS-DMPK-2.5 Rx in Patients with Myotonic Dystrophy Type I,,," 7/14/2016 37555810   PRN  Learn how to target a 20% return on Gilead Sciences, or get option-trade ideas on Aetna, Exelixis, Priceline and Abbott Laboratories or any stock you choose",10/02/2018 04004760   PRN  Arena Pharmaceuticals Reports Positive Long-Term Data from the Ongoing Open-Label Extension of the Phase 2 Trial Evaluating Ralinepag for Treatment of Pulmonary Arterial Hypertension,11/26/2018 N5946510  PRN  Mylan to Present at Nasdaq's 39th London Investor Conference, 6/15/2018 M2572210 PRN  Compugen Announces $21 Million Registered Direct Offering of Ordinary Shares and Warrants," 3/03/2014 00972810 PRN  Akorn, Inc. Announces Fourth Quarter 2013 Earnings Release And Conference Call Information", 9/12/2019 03116210 PRN  Amgen Highlights New Data From KYPROLIS® (carfilzomib) And Oncology Pipeline At IMW 2019,"12/12/2012 09WBJY-E PRN  The Zacks Analyst Blog Highlights: Myriad Genetics, Sanofi, Abbott Laboratories, Johnson & Johnson and AstraZeneca", 9/14/2016 52887230 PRN  FDA Extends PDUFA Date For Telotristat Etiprate For The Treatment Of Carcinoid Syndrome,,"10/05/2017 45766930 PRN  Stocks Under Scanner in the Biotech Space -- ImmunoGen, Incyte, Infinity Pharma, and Insmed",, 4/18/2019 45773H20 PRN  Inovio Publishes Cancer Killing Data of Its Transformative DNA-encoded Bi-specific T Cell Engagers (dBiTEs™) in a Peer-reviewed Journal,12/04/2018 64026810 PRN  NKTR ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Nektar Therapeutics; Important Deadline - NKTR, 4/03/2018 76655960 PRN  Rigel Announces Topline Data from Proof-of-Concept Phase 2 Study of Fostamatinib in IgA Nephropathy,,, 2/14/2013 02311120 PRN  High Profile HealthCare Companies: Leading Pharma Company Secures New Patents," 5/08/2015 45337C10 PRN  Biotech Equities Ahead of Market -- Biocept, Athersys, Biogen, Dyax Corp., and Incyte"," 7/26/2018 91307C10 PRN  United Therapeutics Corporation To Report Second Quarter 2018 Financial Results Before The Market Opens On Wednesday, August 1, 2018"," 1/02/2014 80360710 PRN  Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation",11/06/2018 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at Upcoming Healthcare Conferences,,,,"10/09/2017 55027E10 PRN  Luminex Corporation Third Quarter Earnings Release Scheduled for October 30, 2017", 4/04/2018 SGMO-US  PRN  Sangamo Announces Publication In Molecular Therapy Of Preclinical Study Data From MPS II In Vivo Genome Editing Program," 7/15/2014 30161Q10 PRN  Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver", 1/09/2019 SAN-FR    PRN  AbSci Establishes New Collaboration with Sanofi,"12/16/2013 92532F10  PRN  Health Care Sector Update: Orexigen Therapeutics, Vertex Pharma, MAKO Surgical, and Alere",,,," 1/02/2014 00422510 PRN  Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation",," 5/24/2018 74366E10 PRN  Protagonist Therapeutics Names Samuel Saks, M.D., as Chief Development Officer",,,,, 5/12/2014 68214310 PRN  Omeros Corporation Reports First Quarter 2014 Financial Results,,,,,,,, 5/09/2018 69329Y10 PRN  PDL BioPharma Announces First Quarter 2018 Financial Results,,,, 3/02/2018 00182C10 PRN  ANI Pharmaceuticals to Present at the Raymond James 39th Annual Institutional Investors Conference,,"11/27/2012 02043Q10 PRN  Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development",,, 5/31/2018 60468T10 PRN  Mirati To Present New Data In Renal Cell Carcinoma From Ongoing Phase 1b Clinical Trial Of Single Agent Sitravatinib At The 2018 ASCO Annual Meeting," 5/23/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting",,,,,, 9/24/2018 09627Y10 PRN  Blueprint Medicines Showcases Broad Portfolio of Highly Selective Investigational Kinase Medicines with Presentations at Upcoming Medical Meetings,, 9/04/2018 28249U10 PRN  Eiger Announces Positive Meeting with FDA on Progeria Program,,,,,,, 8/01/2018 92165910 PRN  Vanda Pharmaceuticals Reports Second Quarter 2018 Financial Results,,,10/30/2013 45781M10   PRN  BREO® ELLIPTA™ now available in the U.S. for the treatment of COPD,, 7/11/2018 003DX0-E PRN  FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin, 4/22/2016 G2151510 PRN  China Biologic Products to Report First Quarter 2016 Financial Results," 9/16/2014 56400P70 PRN  Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver",,,, 5/17/2018 03236M20 PRN  Biossance Launches Mobile Interactive Clean Beauty Consumer Experience, 4/18/2019 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss First Quarter 2019 Financial Results,"10/07/2013 00448Q20 PRN  Changes in Senior Management, Grants of Orphan Drug Designations, and Updates on Pipeline Development and NDA - Research Report on Vivus, Omeros, Delcath Systems, Achillion, and Zogenix",, 5/06/2010 03152W10 PRN  Amicus Therapeutics Announces First Quarter 2010 Financial Results and Product Pipeline Advancements,,,, 3/16/2017 36197T10 PRN  Unique Cannabis-Pharma Companies Trailblazing the Medical Cannabis Industry, 4/18/2013 07CMVM-E PRN  Epizyme to Partner to Develop DOT1L Companion Diagnostic, 8/29/2018 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences,," 8/22/2016 39843840 PRN  Research Report Initiation on Biotech Stocks -- PTC Therapeutics, Grifols, Puma Biotech, and 22nd Century",," 3/02/2011 006RGD-E PRN  Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.", 4/19/2016 92337F10 PRN  /C O R R E C T I O N -- Veracyte/,,, 4/20/2016 14075510 PRN  Expansion of Legalized Cannabis Continues at a Torrid Pace in the U.S. and Globally For Leading Markets Worldwide; Company Receives Purchase Order for Medical Marijuana Products,,,, 2/11/2011 IOVA-US  PRN  Genesis Biopharma Announces Management and Board Changes,,,,,, 7/28/2010 008BK4-E PRN  Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic Steatohepatitis (NASH),,, 2/28/2017 98401F10 PRN  Xencor Reports Fourth Quarter and Full Year 2016 Financial Results,,10/08/2018 G8807B10 PRN  Theravance Biopharma and Mylan to Present New Data from Studies of YUPELRI™ (revefenacin) at the 2018 CHEST Annual Meeting,, 5/05/2017 03969710 PRN  Ardelyx Reports First Quarter 2017 Operating Results and Highlights Recent Progress,,,,,,,,,,,," 5/02/2018 05070R10 PRN  Audentes Therapeutics to Release First Quarter 2018 Financial Results and Provide Corporate Update on Wednesday, May 9, 2018",,,,,, 8/08/2018 75901B10 PRN  REGENXBIO Reports Second Quarter 2018 Financial and Operating Results and Interim Data from Ongoing Clinical Trials for Wet Age-Related Macular Degeneration and Homozygous Familial Hypercholesterolemia,,,,,,,,,,,,,,, 6/05/2012 00695P-E  PRN  Kinex Pharmaceuticals Appoints Dr. Jean-Pierre Sommadossi to the Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/08/2014 00FYYJ-E PRN  Guardant Health to Present at the WedBush 2014 Life Sciences Management Access Conference,,,,,,,,,,,,,,,,
,," 1/27/2015 45232710    PRN  Critical Alerts For American Airlines, Illumina, Avis, Time and Activision Blizzard Released By InvestorsObserver",,11/08/2018 G3040110 PRN  Endo Reports Third-Quarter 2018 Financial Results," 6/17/2014 CHTP-US  PRN  Upcoming Conferences, Tentative Meeting Schedules, Analyst Day, Public Offerings, and Data Presentations - Analyst Notes on Incyte, NPS Pharmaceuticals, Arrowhead, Novavax and Chelsea Therapeutics"," 7/01/2016 09060J10 PRN  Watch List for Biotechnology Equities -- Genocea Biosciences, BioDelivery Sciences Intl., Sequenom, and INSYS Therapeutics", 2/26/2019 09073M10    PRN  Bio-Techne Signs Strategic Cooperation Agreement with Lisen Imprinting Diagnostics, 6/26/2019 75886F10    PRN  FDA Approves Dupixent® (dupilumab) for Chronic Rhinosinusitis with Nasal Polyposis,," 3/02/2016 68375N10 PRN  Covered Call Alerts For Chesapeake Energy, Kite Pharma, Opko Health, Las Vegas Sands and 3D Systems Released By InvestorsObserver", 9/24/2018 46222210 PRN  Ionis Announces the Appointment of Two New Board Members,"12/03/2018 09061G10   PRN  BioMarin Promotes Amy Wireman to Group Vice President, Human Resources"," 1/09/2014 01535110 PRN  Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals", 7/24/2018 64125C10 PRN  AbbVie Receives U.S. FDA Approval of ORILISSA™ (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis,"12/04/2013 81257810 PRN  Stock Price Updates, and Charitable Contributions - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics",,"10/28/2015 09062X10  PRN  Covered Call Alerts For PayPal Holdings Inc., SanDisk, Walgreens Boots Alliance, CVS Caremark and Biogen Released By InvestorsObserver",,," 7/06/2016 37555810   PRN  Covered Call reports for Gilead Sciences, BP, Amgen, Dr. Pepper Snapple Group and LinkedIn include trade ideas that offer returns of 20% or more!", 9/24/2018 04004760   PRN  Arena Pharmaceuticals Reports Positive Phase 2a Results for Olorinab in Patients with Abdominal Pain Associated with Crohn's Disease,"11/20/2018 MYL-US    PRN  Mylan Initiates Voluntary Nationwide Recall of 15 Lots of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient", 6/11/2018 0G0PYM-E PRN  Compugen Announces the Appointment of New Board Members," 1/30/2014 00972810 PRN  Akorn, Inc. Announces Fourth Quarter 2013 Earnings Release And Conference Call Information", 9/11/2019 08B106-E PRN  deCODE in Iceland Agrees to Sequence Half of UK Biobanks Participants," 7/10/2012 QGEN-NL  PRN  The Zacks Analyst Blog Highlights: Qiagen, Bristol-Myers Squibb, Eli Lilly, Quest Diagnostics and Myriad Genetics", 9/09/2016 52887230 PRN  Lexicon Reports Positive Top-Line Results In Pivotal Phase 3 Study For Sotagliflozin In Patients With Type 1 Diabetes,," 1/17/2017 45766930 PRN  Lifshitz & Miller Law Firm Announces Investigation of Calamos Asset Management, Inc., CDI Corp., comScore, Inc., Earthstone Energy, Inc., Heritage Oaks Bancorp, Insmed Incorporated, OCI Partners LP and Vascular Solutions, Inc.",," 4/17/2019 45773H20 PRN  Inovio's Phase 3 HPV Immunotherapy Selected As ""Best Therapeutic Vaccine"" at World Vaccine Congress","11/14/2018 64026810 PRN  Nektar Appoints Wei Lin, M.D., as Senior Vice President of Clinical Development and Head of Nektar's Oncology Programs", 3/06/2018 76655960 PRN  Rigel Announces Fourth Quarter and Year End 2017 Financial Results and Provides Company Update,,, 2/05/2013 02311120 PRN  Briefing: Leading Pharma Companies to Watch in Today's Market Session," 3/24/2015 45337C10 PRN  Morning Analysis on Biotech Equities -- Hemispherx Biopharma, Celldex Therapeutics, Intrexon, Incyte, and Idera Pharma", 7/20/2018 91307C10 PRN  HSR Act Waiting Period Terminated for United Therapeutics' Acquisition of SteadyMed Ltd.,"12/06/2013 80360710 PRN  Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation",11/06/2018 G0176710 PRN  Alkermes Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer's (SITC) 33rd Annual Meeting,,,, 9/19/2017 55027E10 PRN  Luminex Corporation To Present At Cantor Fitzgerald's Global Healthcare Conference, 3/05/2018 80067710 PRN  Sangamo Therapeutics Announces Presentations At Upcoming Investor Conferences," 7/10/2014 30161Q10 PRN  Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis", 1/07/2019 000VC1-E  PRN  Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development Programs,"11/28/2013 92532F10  PRN  Healthcare Companies Report Growth through FDA Approvals, Agreements and Announcements - Research Report on Johnson & Johnson, Stryker, Vertex, Fonar, and Nordion",,,,"12/25/2013 00422510 PRN  Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch",, 5/17/2018 74366E10 PRN  Protagonist Therapeutics Announces Two Oral Presentations Accepted for 23rd Congress of the European Hematology Association,,,,, 4/07/2014 68214310 PRN  Omeros to Present at the 13th Annual Needham Healthcare Conference,,,,,,,," 5/02/2018 69329Y10 PRN  PDL BioPharma to Announce First Quarter 2018 Financial Results on May 9, 2018",,,," 2/27/2018 00182C10 PRN  ANI Pharmaceuticals Reports Record Full Year Results, Reports Fourth Quarter 2017 Results, and Provides 2018 Guidance",,11/19/2012 078VWR-E PRN  Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights,,, 5/30/2018 60468T10 PRN  Mirati Therapeutics To Present At Jefferies 2018 Global Healthcare Conference," 5/16/2011 PCRX-US  PRN  Pacira Pharmaceuticals, Inc. Announces Phase 3 EXPAREL™ Data Presentation at the American Society of Colon and Rectal Surgeons 2011 Annual Meeting",,,,,, 9/05/2018 09627Y10 PRN  Blueprint Medicines to Present at 16th Annual Morgan Stanley Global Healthcare Conference,, 8/27/2018 28249U10 PRN  Eiger BioPharmaceuticals to Participate in Investor Conferences,,,,,,," 7/17/2018 92165910 PRN  Vanda Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 1, 2018",,,"10/24/2013 45781M10   PRN  Pre-Market Review: Alkermes PLC, Hospira Inc., Celsion Corp., and Theravance Inc.",, 7/06/2018 40637H10 PRN  Halozyme To Host Second Quarter 2018 Financial Results Conference Call, 3/01/2016 G2151510 PRN  China Biologic Announces Secondary Offering of Common Stock," 9/03/2014 56400P70 PRN  Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay",,,," 4/18/2018 008CMY-E PRN  Stock Review for Specialty Chemicals Investors -- Aemetis, Amyris, Axalta Coating Systems, and Delta Technology", 3/04/2019 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conferences," 6/05/2013 CSII-US  PRN  Drug Findings, Applications and Approvals Strengthen Prospects - Research Report on Health Management Associates, Boston Scientific, Endo Health, Achillion Pharmaceuticals, and Cardiovascular Systems",," 5/05/2010 005W0W-E PRN  John F. Crowley, Chairman & CEO, Amicus Therapeutics, to Keynote CBI's 5th Annual Rare Disease Leadership Summit",,,, 3/15/2017 36197T10 PRN  Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth, 3/22/2013 07CMVM-E PRN  Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438, 8/27/2018 G5087110 PRN  Vyxeos® Receives Marketing Authorisation in the European Union for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia,, 6/20/2016 39843840 PRN  FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol,,12/04/2010 006RGD-E PRN  Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting, 4/02/2016 92337F10 PRN  Clinical Utility of Veracyte's Afirma® Gene Expression Classifier Demonstrated in Multiple Studies Presented at ENDO 2016,,, 8/20/2015 14075510 PRN  Enteris BioPharma's Formulation Technology Enables Oral Delivery of Cara Therapeutics' CR845 Peptide in Phase 2 Trial in Osteoarthritis,,,," 2/04/2011 AVXL-GR  PRN  Anavex strengthens management team with addition of VP, Clinical Development & Medical Affairs",,,,,,,,," 2/22/2017 98401F10 PRN  Xencor to Host Fourth Quarter and Full Year 2016 Financial Results Webcast and Conference Call on February 28, 2017",,10/08/2018 G8807B10 PRN  Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV® (telavancin) at IDWeek™ 2018,, 4/18/2017 03969710 PRN  Ardelyx To Present at Upcoming Spring Medical Meetings,,,,,,,,,,,, 4/30/2018 05070R10 PRN  Audentes Therapeutics Announces Presentation of Data at the 21st Annual Meeting of the American Society of Gene and Cell Therapy,,,,,, 8/07/2018 75901B10 PRN  REGENXBIO to Host Conference Call and Webcast on August 8 to Discuss Second Quarter 2018 Financial and Operating Results and Interim Data from Ongoing Clinical Trials for Wet Age-Related Macular Degeneration and Homozygous Familial Hypercholesterolemia,,,,,,,,,,,,,,, 5/21/2012 300147-CN PRN  Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/30/2014 00FYYJ-E PRN  Guardant Health Announces US Commercial Launch of Guardant360™: A Breakthrough Blood Test for Real-Time Cancer Patient Treatment Management,,,,,,,,,,,,,,,,
,," 1/07/2015 45232710    PRN  Critical Alerts For Twitter, Ebix, AngloGold Ashanti, Illumina and General Motors Released By InvestorsObserver",,11/07/2018 G3040110 PRN  Endo Announces Positive Results from Phase 3 Studies of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite," 5/20/2014 04280A10 PRN  Top Gainers Pre-Market Notes -- Research on Millennial Media, Demandware, Arrowhead Research, and KEYW Holding", 6/08/2016 05KRQ7-E PRN  BioDelivery Sciences to Present at the William Blair Annual Growth Stock Conference, 2/20/2019 09073M10    PRN  Bio-Techne To Present At The 8th Annual SVB Leerink Global Healthcare Conference, 6/21/2019 75886F10    PRN  Regeneron and Sanofi Announce Positive Topline Phase 2 Results for IL-33 Antibody in Asthma,, 2/29/2016 OPK-US   PRN  OPKO's GeneDx Recognizes International Rare Disease Day with Donation of Free Exome Tests to Syndromes Without a Name, 8/29/2018 46222210 PRN  Ionis Pharmaceuticals to Present at Upcoming Investor Conferences,12/03/2018 09061G10   PRN  BioMarin to Participate in Citi's 13th Annual Biotech Conference on December 5 in New York City,"12/20/2013 01535110 PRN  Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana", 7/10/2018 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2018 Financial Results,"11/27/2013 81257810 PRN  AAAResearchReports.com Pre-Market Technical Analysis: Elan Corp., Amarin Corp., Cubist Pharmaceuticals, and Seattle Genetics",,10/28/2015 RGLS-US   PRN  Regulus Achieves All Research Milestones in Collaboration with Biogen to Identify microRNA Biomarkers for Multiple Sclerosis,,," 6/27/2016 37555810   PRN  Learn how to target a 20% return on Gilead Sciences, or get option-trade ideas on SPDR Gold Trust, Duke Energy Corporation, Altria Group Incorporated, and American Airlines or any stock you choose", 9/21/2018 04004760   PRN  Arena Pharmaceuticals to Host R&D Day on October 4 in New York City,11/20/2018 N5946510  PRN  Mylan Statement in Response to FDA Warning Letter Relating to Morgantown Plant, 5/09/2018 M2572210 PRN  Compugen Reports First Quarter 2018 Results," 1/09/2014 00972810 PRN  AAAResearchReports.com Daily Briefing: Teva Pharma Industries, Dynavax Technologies, Covidien, and Akorn", 9/08/2019 03116210 PRN  Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Larger Patient Group At WCLC 2019," 7/09/2012 GHDX-US  PRN  Zacks Bull and Bear of the Day Highlights: The New York Times, AK Steel Holding, Genomic Health, Myriad Genetics and Cepheid", 9/07/2016 LXRX-US  PRN  Lexicon To Present At The Bank Of America Merrill Lynch Global Health Care Conference,," 7/30/2016 45766930 PRN  Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigations of; Oracle Corporation, K12 Inc., Juno Therapeutics, Inc., Albany Molecular Research Inc. and Insmed Incorporated; Encourages Long-Term Investors to Contact the Firm Regarding Their Legal Rights",, 4/08/2019 AZN-GB   PRN  Inovio Achieves Third Cancer Indication Milestone for MEDI0457 Phase 2 Development,11/09/2018 64026810 PRN  Nektar Therapeutics Presents New Clinical and Preclinical Data for its Immuno-Oncology Pipeline at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting, 3/01/2018 76655960 PRN  Rigel Announces Two Fostamatinib Presentations at the 4th Biennial Summit of the Thrombosis & Hemostasis Societies of North America,,, 1/31/2013 02311120 PRN  Pharmaceutical Company Achieves Positive In-Vitro Testing Results Diabetes Drug, 2/23/2015 LLY-US   PRN  Baricitinib Superior to Placebo in Reducing Rheumatoid Arthritis Disease Activity in Second Phase 3 Study, 6/12/2018 91307C10 PRN  United Therapeutics And XVIVO Perfusion Announce Collaboration To Reduce Organ Shortage Through Expansion Of Organ Evaluation Service,"11/11/2013 80360710 PRN  Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc.",11/01/2018 G0176710 PRN  Alkermes Reports on Outcome of FDA Advisory Committee Meeting on ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder,,,, 9/12/2017 55027E10 PRN  Luminex Corporation Declares Third Quarter Cash Dividend," 3/02/2018 80067710 PRN  Sangamo Therapeutics, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)"," 5/30/2014 30161Q10 PRN  Technical Coverage on Health Care Sector Equities -- Research on Arena Pharma, Exelixis, Dendreon, and Seattle Genetics",12/18/2018 80105N10  PRN  Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq,"11/20/2013 92532F10  PRN  Upcoming Presentations, Tax Settlements, Prestigious Recognitions, and Share Price Updates - Research Report on Vertex, Teva, Perrigo, Novartis, and Cubist",,,,"12/06/2013 00422510 PRN  Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation",, 5/16/2018 74366E10 PRN  Protagonist Therapeutics Appoints Bryan Giraudo to Board of Directors,,,,, 4/03/2014 68214310 PRN  Investigational New Drug Application Cleared by FDA for OMS721 in Thrombotic Microangiopathies,,,,,,,," 4/16/2018 69329Y10 PRN  PDL BioPharma to Hold Annual Meeting of Stockholders on June 8, 2018",,,, 2/20/2018 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results and 2018 Guidance,,11/12/2012 02043Q10 PRN  Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call,,, 5/07/2018 60468T10 PRN  Mirati Therapeutics Reports First Quarter Financial Results," 5/11/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results",,,,,, 8/01/2018 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences in August,, 8/13/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces Completion of Enrollment in Phase 2 PREVENT Study of Avexitide (formerly Exendin 9-39) in Patients Suffering from Post-Bariatric Hypoglycemia,,,,,,, 6/01/2018 92165910 PRN  Vanda Pharmaceuticals Announces Participation at June 2018 Investor Conferences,,,"10/22/2013 45781M10   PRN  Quarterly Reports, Licensing Agreements, and Clinical Data - Research Report on Theravance, Dendreon, ImmunoGen, Compugen, and Acorda",," 6/11/2018 40637H10 PRN  Halozyme President And Chief Executive Officer, Dr. Helen Torley Named EY Entrepreneur Of The Year 2018 San Diego", 2/25/2016 G2151510 PRN  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2015," 8/28/2014 56400P70 PRN  Critical Alerts For MannKind, Best Buy, Splunk, Rite Aid and Allscripts Released By InvestorsObserver",,,, 7/25/2017 03236M20 PRN  U.S. Chemical Production Industry is Projected to Grow, 3/04/2019 69366J20 PRN  PTC to Expand Product Portfolio in Latin America with WAYLIVRA™," 3/08/2013 00448Q20 PRN  Drug Approvals, Breakthrough Treatments and Royalties - Research Report on Celgene Corporation, Onyx Pharmaceuticals, Sarepta Therapeutics, VIVUS and Achillion Pharmaceuticals",," 4/28/2010 03152W10 PRN  Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010",,,, 3/13/2017 36197T10 PRN  FinancialBuzz.com: The Growth of Legal Cannabis Products, 2/04/2013 07CMVM-E PRN  Epizyme to Present at Upcoming Conferences in February, 8/07/2018 G5087110 PRN  Jazz Pharmaceuticals Announces Second Quarter 2018 Financial Results,," 6/08/2016 GRF-ES   PRN  Biotechnology Equities Technical Notes -- Grifols, Achillion Pharma, Jazz Pharma, and Puma Biotechnology",,, 3/29/2016 008W47-E PRN  Multiple Studies Showcasing Clinical Utility of Veracyte's Afirma® Gene Expression Classifier to Be Presented at ENDO 2016,,, 7/31/2015 14075510 PRN  An Encouraging Turn in the Study - Report on Cara Therapeutics Inc.,,,, 1/24/2011 46226010 PRN  Genesis Biopharma Expresses Support for FDA Codevelopment Guidelines,,,,,,,,," 2/18/2017 98401F10 PRN  IgG4-Related Disease Biomarker Development Update Presented From an Ongoing, Open-label, Phase 2 Study of XmAb®5871 in IgG4-RD at the 3rd International Symposium on IgG4-Related Diseases & Fibrosis",,10/01/2018 G8807B10 PRN  Theravance Biopharma to Present New Data from Multiple Studies of VIBATIV® (telavancin) at IDWeek™ 2018,, 2/27/2017 03969710 PRN  Ardelyx Announces Presentation at Cowen and Company 37th Annual Healthcare Conference,,,,,,,,,,,, 3/08/2018 05070R10 PRN  Audentes Therapeutics Reports Fourth Quarter 2017 and Full Year Financial Results and Provides Corporate Update,,,,,, 8/01/2018 75901B10 PRN  REGENXBIO to Host Conference Call on August 8 to Discuss Second Quarter 2018 Financial Results and Recent Operational Highlights,,,,,,,,,,,,,,,"12/19/2011 00695P-E  PRN  Kinex Pharmaceuticals Acquires Rights for Technology and Products from Hanmi Pharmaceuticals, in United States and European Union Territories",,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/22/2014 00FYYJ-E PRN  Guardant Health Announces $30 Million Series B Financing Led By Khosla Ventures,,,,,,,,,,,,,,,,
,," 1/05/2015 45232710    PRN  BioMed Realty And Illumina To Create New 360,000 Square Foot World-Class Life Science Campus In Foster City, CA",,10/11/2018 G3040110 PRN  Endo Presents Data on the Perception and Measurement of Cellulite Severity at the American Society for Dermatologic Surgery (ASDS) Annual Meeting," 5/16/2014 04280A10 PRN  Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst", 6/06/2016 09060J10 PRN  BioDelivery Sciences Announces Presentation of Data on the Impact of a State Formulary Conversion to BUNAVAIL® at the International Conference on Opioids, 2/05/2019 09073M10    PRN  Bio-Techne Releases Second Quarter Fiscal 2019 Results," 6/14/2019 75886F10    PRN  Regeneron CD20xCD3 Bispecific REGN1979 Shows Positive Results in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma, including in CAR-T Failures",," 2/17/2016 68375N10 PRN  Covered Call Alerts For Opko Health, AbbVie, Weight Watchers, Keryx Biopharmaceuticals and Delta Airlines Released By InvestorsObserver", 8/07/2018 46222210 PRN  Ionis Reports Second Quarter 2018 Financial Results,11/12/2018 09061G10   PRN  BioMarin and Believe Limited Announce the Debut of 'Hemophilia: The Musical',"12/16/2013 01535110 PRN  Appointments, Employee Option Grants, Clinical Data Presentations, New Launches, and Scheduled Financial Results - Research Report on Intuitive, Alexion, Sequenom, AcelRx, and Arrowhead"," 6/08/2018 64125C10 PRN  Chief Executive Officer of Neurocrine Biosciences, Kevin Gorman, Ph.D., Named EY Entrepreneur Of The Year® 2018 San Diego","11/26/2013 81257810 PRN  Potential Acquisitions and Stock Price Updates - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics",," 9/30/2015 09062X10  PRN  Biotechnology Equity Picks -- Arena Pharma, Biogen, Omeros, Illumina, and Merrimack Pharma",,, 6/21/2016 000L1R-E   PRN  ContraVir Doses First Patients in Head-to-Head Study of CMX157 vs. Viread® for Treating Hepatitis B, 9/20/2018 04004760   PRN  Arena Pharmaceuticals to Present at Upcoming Investor Conferences,11/09/2018 N5946510  PRN  Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI™ (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease," 4/30/2018 M2572210 PRN  Compugen First Quarter 2018 Conference Call Scheduled for Wednesday, May 9, 2018 at 10:00 AM ET","12/11/2013 00972810 PRN  Daily Trends Scanner: BioMarin Pharma Inc., Delcath Systems Inc., Akorn Inc., and Insmed Inc.", 9/05/2019 03116210 PRN  Amgen To Present At The Morgan Stanley Global Healthcare Conference, 5/21/2012 001D3K-E PRN  Intermountain Healthcare and Myriad Genetics Enter Into Research Collaboration Agreement, 8/12/2016 LXRX-US  PRN  Lexicon To Present At The 2016 Wedbush PacGrow Healthcare Conference,, 7/22/2016 45766930 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline - INSM,, 4/03/2019 45773H20 PRN  Inovio's Novel HPV Therapy INO-3106 Demonstrates Clinical Efficacy Against Rare Respiratory Tract Tumors in Pilot Clinical Study,"11/09/2018 64026810 PRN  Kessler Topaz Meltzer & Check, LLP:  Securities Fraud Class Action Filed Against Nektar Therapeutics - NKTR", 2/27/2018 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2017 Financial Results,,,"12/10/2012 GNW-US   PRN  Critical Earnings Forecast Alerts: SandRidge Energy, Amarin, Broadcom, EMC, Verizon, and Genworth"," 2/20/2015 45337C10 PRN  Recent Developments at Biotechnology Companies: Special Research on Exelixis,ICON, Incyte, Luna Innovations, and Oncothyreon", 5/02/2018 91307C10 PRN  United Therapeutics Corporation Reports First Quarter 2018 Financial Results,"10/21/2013 80360710 PRN  Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc.",11/01/2018 G0176710 PRN  Trading in Alkermes Ordinary Shares Halted Today,,,, 8/29/2017 LMNX-US  PRN  Luminex Corporation and Sutter Health Collaborate to Improve Patient Care, 2/28/2018 80067710 PRN  Sangamo Announces U.K. Authorization Of Clinical Trial Evaluating Zinc Finger Nuclease In Vivo Genome Editing Treatment For Hemophilia B," 1/16/2014 30161Q10 PRN  Unaudited Results, Partnerships, and Stock Price Movements - Research Report on Cubist, Novavax, Exelixis, BioCryst, and Foundation Medicine",12/13/2018 000PFH-E  PRN  Calling All Startups: Viva Technology Launches Innovation Challenges,"11/13/2013 92532F10  PRN  Before the Bell Scans: Vertex Pharma Inc., MAKO Surgical Corp., Alere Inc., and Orexigen Therapeutics Inc.",,,,"11/29/2013 00422510 PRN  Proposed M&A's, Conference Schedules, Health Awareness Programs, Prestigious Recognitions and FDA Designations - Research Report on Health Management, Acadia, Health Net, NuVasive and Portola",, 5/09/2018 74366E10 PRN  Protagonist Therapeutics Reports First Quarter 2018 Financial Results,,,,, 4/01/2014 68214310 PRN  Omeros Invited to Present on OMS824 Phase 2 Clinical Program at the Schizophrenia International Research Conference,,,,,,,," 4/09/2018 69329Y10 PRN  PDL BioPharma Shareholder, SevenSaoi Capital, Comments on the Nomination of Shlomo Yanai to the PDL Board of Directors and Delivers Letter to the Board Outlining Significant Concerns",,,,12/29/2017 AZN-GB   PRN  ANI Pharmaceuticals Enters Five-Year $125 Million Senior Secured Credit Facility with Citizens Bank,,11/08/2012 078VWR-E PRN  Regulus to Present at the Lazard Capital Markets Healthcare Conference,,," 5/04/2018 005SV0-E PRN  Free Research Reports on These Biotech Stocks -- MannKind, Marinus Pharma, Mirati Therapeutics, and OncoSec Medical"," 5/05/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations",,,,,, 8/01/2018 09627Y10 PRN  Blueprint Medicines Reports Second Quarter 2018 Financial Results,, 8/10/2018 28249U10 PRN  Eiger BioPharmaceuticals Reports Second Quarter 2018 Financial Results,,,,,,, 5/23/2018 92165910 PRN  HETLIOZ® (tasimelteon) Effective in Treating Jet Lag during Transatlantic Travel,,,"10/07/2013 45781M10   PRN  Regulatory Approvals, Public Offerings and Clinical Trial Results - Research Report on Theravance, Synageva, Nektar, Clovis Oncology, and ImmunoGen",, 6/01/2018 40637H10 PRN  Halozyme Identifies Plasma Biomarkers As Potential Predictors Of Survival In Pancreatic Cancer, 2/17/2016 G2151510 PRN  China Biologic Products to Report Fourth Quarter and Fiscal Year 2015 Financial Results," 8/14/2014 56400P70 PRN  Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna",,,," 6/14/2017 03236M20 PRN  AMRS DEADLINE NOTICE: Rosen Law Firm Reminds Amyris, Inc. Investors of the Important June 19 Deadline in First Filed Class Action - AMRS", 3/01/2019 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), 2/26/2013 00448Q20 PRN  Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies,,,,,," 3/10/2017 0DN951-E PRN  Alternate Health Announces US Listing On The OTC, And The Closing Of An Additional $7.5 Million In Funding"," 1/07/2013 000VJ8-E PRN  Epizyme, Eisai and Roche to Develop EZH2 Companion Diagnostic", 8/06/2018 G5087110 PRN  Jazz Pharmaceuticals and MD Anderson Cancer Center Collaborate to Evaluate Potential Treatment Options for Hematologic Malignancies,, 5/31/2016 00394S-E PRN  Singulex announces a $50 million investment by Grifols for a 20% stake in the company,,, 3/28/2016 0FQ7K5-E PRN  Veracyte Secures Up to $45 Million in Financing from Visium Healthcare Partners,,, 7/14/2015 14075510 PRN  Enteris BioPharma Oral Formulation Progresses Into Phase 2 Study With Cara Therapeutics' CR845,,,, 1/06/2011 46226010 PRN  Genesis Biopharma to Present at 2011 Biotech Showcase Conference,,,,,,,,, 2/09/2017 05LK9B-E PRN  Xencor to Present at Leerink Partners 6th Annual Global Healthcare Conference,, 9/25/2018 G8807B10 PRN  Theravance Biopharma to Present at the 2018 Cantor Global Healthcare Conference,, 2/17/2017 03969710 PRN  Ardelyx Reports Clinical Progress and Fourth Quarter and Full Year 2016 Financial Results,,,,,,,,,,,, 3/06/2018 05070R10 PRN  Audentes Therapeutics to Present at the Cowen 38th Annual Health Care Conference,,,,,, 6/12/2018 75901B10 PRN  REGENXBIO Receives FDA Fast Track Designation for RGX-111 Gene Therapy for the Treatment of Mucopolysaccharidosis Type I,,,,,,,,,,,,,,, 5/17/2011 00695P-E  PRN  The Board of Directors of Kinex Pharmaceuticals Appoints Dr. David Hangauer as Chief Scientific Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,12/12/2014 45232710    PRN  HudsonAlpha announces purchase of Illumina HiSeq X Ten sequencing system,, 9/28/2018 G3040110 PRN  Endo to Announce Third-Quarter 2018 Financial Results," 1/29/2014 04280A10 PRN  Critical Alerts For First Solar, Arrowhead Research, Genuine Parts, Royal Dutch Shell, and Shire Released By InvestorsObserver"," 6/03/2016 09060J10 PRN  New Data Demonstrate Safety Of Long-Term, Around-The-Clock Treatment With BELBUCA™ (Buprenorphine) Buccal Film For Chronic Pain", 2/05/2019 09073M10    PRN  Bio-Techne Declares Dividend, 5/23/2019 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentation,," 2/02/2016 68375N10 PRN  Covered Call Alerts For Opko Health, Fitbit, Box, Inovio Pharmaceuticals and AbbVie Released By InvestorsObserver", 8/02/2018 46222210 PRN  IONIS-HTT Rx (RG6042) Granted PRIME Designation by the European Medicines Agency for the Treatment of People with Huntington's Disease,11/08/2018 09061G10   PRN  BioMarin to Participate in Two Investor Conferences in November,"12/06/2013 01535110 PRN  Upcoming Presentations, Stock Price Movements, and Patent Challenge Settlements - Research Report on Johnson & Johnson, Alexion, Intuitive Surgical, Medivation, and Impax", 5/09/2018 64125C10 PRN  Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference,"11/08/2013 81257810 PRN  Marketing Authorization Applications, Financial Results, Product Up-gradations, and Presentations - Research Report on Baxter, Seattle Genetics, IDEXX, Hill-Rom, and BioCryst",, 9/29/2015 0DR1ZS-E  PRN  Core Informatics Expands Next-Generation Sequencing Customer Base,,," 6/17/2016 37555810   PRN  Covered Call reports for Gilead Sciences, Activision Blizzard, General Electric, Cisco Systems, and Merck & Company Incorporated include trade ideas that offer returns of 20% or more!", 9/17/2018 04004760   PRN  Arena Pharmaceuticals Presents Preclinical Data for Olorinab at International Association for the Study of Pain World Congress,11/05/2018 N5946510  PRN  Mylan Reports Third Quarter 2018 Results and Reaffirms 2018 Guidance," 4/27/2018 M2572210 PRN  Compugen Reports on Status of Investigational New Drug Application for COM701, a First-in-Class Immuno-Oncology Therapeutic Antibody","11/28/2013 00972810 PRN  Approvals, Conferences and Steady Numbers - Research Report on Allergan, Orexigen, ISIS, The Medicines Company, and Akron", 9/04/2019 03116210 PRN  Amgen To Webcast Investor Call At IASLC 2019 World Conference on Lung Cancer, 3/27/2012 0B2HRB-E PRN  AMP Optimistic in Suit to Invalidate Patents on Breast Cancer Genes, 8/04/2016 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Second Quarter Financial Results,," 6/08/2016 45766930 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed, Inc. - INSM",, 4/02/2019 45773H20 PRN  Inovio Presents Cancer Killing Data of Its Transformative DNA-Encoded Bi-specific T Cell Engagers (dBiTEs) at AACR,11/07/2018 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Third Quarter of 2018," 2/16/2018 76655960 PRN  Rigel Pharmaceuticals, Inc. Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)",,,"10/19/2012 05QYPH-E PRN  Critical Alerts For Travelers, MGM Mirage, Textron, Amarin, and Sourcefire Released By InvestorsObserver"," 2/10/2015 45337C10 PRN  Today's Review on Biotech Equities - Vertex Pharma, Alexion Pharma, Arrowhead Research, Medivation, and Incyte", 4/30/2018 0FBHHR-E PRN  SteadyMed (STDY) ALERT: Johnson Fistel Investigates Proposed Sale of SteadyMed Ltd.; Are Shareholders Getting a Fair Deal?," 9/25/2013 80360710 PRN  Technical Study: Cell Therapeutics Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc., and Medivation Inc.",10/29/2018 G0176710 PRN  Alkermes Announces Publication of Phase 3 Data for ALKS 5461 for Adjunctive Treatment of Major Depressive Disorder in Molecular Psychiatry,,,, 8/07/2017 55027E10 PRN  Luminex Corporation Reports Second Quarter 2017 Financial Results, 2/22/2018 80067710 PRN  Sangamo Therapeutics Reports Fourth Quarter And Full Year 2017 Financial Results," 1/07/2014 30161Q10 PRN  Upcoming Conference Participations, Cash Dividends, and Share Price Movements - Research Report on Johnson & Johnson, Boston Scientific, NuVasive, Exelixis, and Healthways",11/13/2018 005M9Z-E  PRN  Sanofi holds China Health Road Symposium at CIIE,"11/04/2013 92532F10  PRN  Leadership Changes, Financial Results, Dividends, Stock Performance Update, and Recognitions - Research Report on Teva, Vertex, Zoetis, Humana, and Community Health Systems",,,,"11/21/2013 00422510 PRN  Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma",, 5/03/2018 74366E10 PRN  Protagonist Therapeutics Announces Oral Presentation Accepted for Digestive Diseases Week Conference,,,,," 3/21/2014 ACER-US  PRN  Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa",,,,,,,, 4/03/2018 69329Y10 PRN  PDL BioPharma to Present at the H.C. Wainwright Global Life Sciences Conference,,,,12/29/2017 AZN-GB   PRN  ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million,,"11/07/2012 078VWR-E PRN  Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors",,, 4/24/2018 60468T10 PRN  Mirati Therapeutics Announces Progress Of Lead Programs And Provides Updated Positive Clinical Trial Results For Immuno-Oncology Combination Trials," 5/04/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call",,,,,," 7/25/2018 09627Y10 PRN  Blueprint Medicines to Report Second Quarter 2018 Financial Results on Wednesday, August 1, 2018",, 8/07/2018 28249U10 PRN  Eiger BioPharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference,,,,,,, 5/07/2018 92165910 PRN  Vanda Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference,,,"10/01/2013 45781M10   PRN  Technical Briefing: Celsion Corp., Theravance Inc., Alkermes PLC, and Hospira Inc.",, 5/29/2018 40637H10 PRN  Halozyme Therapeutics To Participate In Upcoming Healthcare Conferences,11/03/2015 G2151510 PRN  China Biologic Reports Financial Results for the Third Quarter of 2015," 8/12/2014 56400P70 PRN  Critical Alerts For MannKind, Kinder Morgan, Kohls, Maxim Integrated Products and United Technologies. Released By InvestorsObserver",,,," 5/30/2017 03236M20 PRN  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Amyris, Inc. - AMRS", 2/28/2019 69366J20 PRN  PTC Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides a Corporate Update,"11/09/2012 00448Q20 PRN  Achillion Pharmaceuticals, Inc. Hosts the HCV Connection Media Briefing at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)",,,,,, 3/06/2017 36197T10 PRN  Cannabinoid (CBD) Research and Development Remains Incredibly Strong in Spite of Federal Hesitation on Recreational Marijuana use, 1/03/2013 07CMVM-E PRN  Epizyme to Present at 31st Annual J.P. Morgan Healthcare Conference 2013, 8/03/2018 G5087110 PRN  CMS Grants New Technology Add-On Payment to Vyxeos® (daunorubicin and cytarabine) Liposome for Injection,," 4/05/2016 39843840 PRN  Grifols 2015 Annual Report on Form 20-F filed with the SEC on April 5, 2016",,, 3/22/2016 008W47-E PRN  New Study Supports Use of Veracyte's Medullary Thyroid Cancer Classifier as Part of Its Comprehensive Afirma Solution,,," 4/24/2015 14075510 PRN  How it All Plays Out: Complementary Research on China Cord Blood, Biolase, Cara Therapeutics, Tonix, and Enzo Biochem",,,," 1/04/2011 46226010 PRN  Genesis Biopharma Raises $845,000 in Private Financings",,,,,,,,,"12/06/2016 98401F10 PRN  Xencor, Inc. Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock",, 9/24/2018 G8807B10 PRN  Theravance Biopharma Highlights Positive CHMP Opinion Supporting Expanded COPD Indication for Trelegy Ellipta in Europe,, 2/15/2017 03969710 PRN  Ardelyx Announces Successful Phase 3 Trial of Tenapanor for Hyperphosphatemia in Patients with End-Stage Renal Disease,,,,,,,,,,,," 3/01/2018 05070R10 PRN  Audentes Therapeutics to Release Fourth Quarter and Full Year 2017 Financial Results and Provide Corporate Update on Thursday, March 8, 2018",,,,,, 6/11/2018 RGNX-US  PRN  REGENXBIO Receives $100 Million Accelerated License Payment Due to Acquisition of AveXis by Novartis,,,,,,,,,,,,,,, 5/09/2011 00695P-E  PRN  The Board of Directors of Kinex Pharmaceuticals Appoints Dr. Allen Barnett as President Emeritus and Dr. Johnson Lau as Chief Executive Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"11/26/2014 45232710    PRN  Life Sciences Tools and Services Equities Ahead of Market - Sequenom, Illumina, PerkinElmer, Affymetrix, and Waters",, 9/28/2018 ENDP-US  PRN  Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label," 1/14/2014 04280A10 PRN  Critical Alerts For AT&T, Gold SPDR, Arrowhead Research, Johnson & Johnson, and ImmunoGen Released By InvestorsObserver"," 6/02/2016 09060J10 PRN  What Investors Think of These Biotech Stocks? - Genocea Biosciences, BioDelivery Sciences Intl., INSYS Therapeutics, and Agios Pharma", 1/31/2019 09073M10    PRN  ExoDx® Prostate(IntelliScore) (EPI) Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection, 5/16/2019 000VC1-E    PRN  Updated Libtayo® (cemiplimab-rwlc) Results Reinforce Durable and Substantial Response Rates in Advanced Cutaneous Squamous Cell Carcinoma,," 1/19/2016 68375N10 PRN  Covered Call Alerts For Disney, Opko Health, Celldex Therapeutics, Shake Shack and Wynn Resorts Released By InvestorsObserver", 8/02/2018 46222210 PRN  Akcea Therapeutics and PTC Therapeutics Collaborate to Commercialize Two Rare Disease Drugs in Latin America,11/07/2018 09061G10   PRN  BioMarin Highlights Breadth of Innovative Development Pipeline at R&D Day on November 7th in New York,"11/28/2013 01535110 PRN  Stock Price Updates, Growth Prospects, and New Obesity Treatment Guidelines - Research Report on Alexion, HCA, Novartis, LabCorp, and VIVUS"," 5/08/2018 64125C10 PRN  Neurocrine Biosciences Presents New Quality of Life Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia in Patients Treated with Antipsychotics","11/04/2013 81257810 PRN  Morning Research: Amarin Corp. PLC, Elan Corp. PLC, Cubist Pharma Inc., and Seattle Genetics Inc.",, 9/14/2015 PRTC-US   PRN  PureTech Appoints Michael MacLean as Chief Financial Officer,,," 6/08/2016 37555810   PRN  Covered Call Alerts For Gilead Sciences, Western Digital, Costco, Opko Health and Ulta Salon Cosmetics & Fragrance Inc. Released By InvestorsObserver", 8/29/2018 04004760   PRN  Arena Pharmaceuticals to Present at Upcoming Investor Conferences,10/19/2018 00DYYX-E  PRN  Mylan Launches Hulio™ (Biosimilar Adalimumab) in Markets Across Europe," 4/17/2018 0028L7-E PRN  Preclinical Data Presented by Bayer at AACR Highlights BAY 1905254, Formerly the CGEN-15001T Program, Efficacy in Cancer Immunotherapy","11/20/2013 00972810 PRN  Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals", 8/28/2019 03116210 PRN  New Amgen Data To Be Presented At ESC Congress 2019 Highlight Additional Evidence For Repatha® (Evolocumab) Effectiveness In Cardiovascular Disease Across Multiple Patient Groups,"11/02/2011 62855J10 PRN  Myriad Genetics Receives the ""Corporate Spirit of Giving Award"" From the Utah Philanthropy Day Committee"," 8/01/2016 52887230 PRN  Lexicon To Report Second Quarter 2016 Financial Results On August 4, 2016",,"12/03/2014 45766930 PRN  Critical Alerts For Twitter, Insmed, Spansion, Advanced Micro Devices and BlackBerry Released By InvestorsObserver",, 4/01/2019 062S3Y-E PRN  Inovio Completes Enrollment Ahead of Schedule In Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron's PD-1 Inhibitor,"11/06/2018 062SS6-E PRN  New Clinical Oncology Collaboration Between Nektar and Pfizer to Evaluate Combination of NKTR-214, a CD122-Biased Agonist, with Avelumab and Talazoparib or Enzalutamide in Multiple Cancers"," 1/26/2018 76655960 PRN  Rigel Pharmaceuticals, Inc. Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)",,,"10/19/2012 PM-US    PRN  Hot Stocks: Freeport-McMoRan, EnCana, MannKind, Amarin, Philip Morris, and Marathon Oil","12/19/2014 45337C10 PRN  Biotech Equities Technical Analysis -- Incyte, ZIOPHARM Oncology, Hemispherx Biopharma, Infinity Pharma, and Orexigen Therapeutics", 4/30/2018 91307C10 PRN  United Therapeutics To Acquire SteadyMed Ltd.," 8/19/2013 80360710 PRN  Technical Study: ACADIA Pharma Inc., Medivation Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc.",10/26/2018 G0176710 PRN  Alkermes Announces Recipients of 3rd Annual ALKERMES INSPIRATION GRANTS®,,,, 7/24/2017 55027E10 PRN  Luminex Corporation Receives FDA Clearance for ARIES C. difficile Assay," 2/22/2018 SGMO-US  PRN  Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer","12/25/2013 30161Q10 PRN  Clinical Study Results, Pending Applications, Trial Updates, and Discontinued Trials - Research Report on ICU Medical, Exelixis, Cempra, Exact Sciences, and Onconova",11/11/2018 80105N10  PRN  ODYSSEY OUTCOMES investigators highlight at AHA that Praluent® (alirocumab) Injection was associated with fewer deaths from any cause,"10/23/2013 92532F10  PRN  Study Updates, Financial Strategy, Quarterly Report, Acquisition, and Presentation - Research Report on Vertex, Chimerix, Anika Therapeutics, Charles River, and Repros",,,,"11/13/2013 00422510 PRN  Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma",, 3/26/2018 74366E10 PRN  Protagonist Therapeutics Discontinues Phase 2b PROPEL Trial of PTG-100 for the Treatment of Ulcerative Colitis following Interim Analysis,,,,, 3/21/2014 68214310 PRN  Omeros to Present at BioCentury Future Leaders in the Biotech Industry Conference,,,,,,,, 3/08/2018 69329Y10 PRN  PDL BioPharma Announces Fourth Quarter and Year End 2017 Financial Results,,,,11/02/2017 00182C10 PRN  ANI Pharmaceuticals Reports Record Third Quarter and Year-To-Date 2017 Results and Narrows Full Year Guidance,,11/05/2012 078VWR-E PRN  Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions,,, 3/08/2018 60468T10 PRN  Mirati Therapeutics Reports Fourth Quarter And Full-Year 2017 Financial Results, 4/08/2011 69512710 PRN  Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference,,,,,, 6/21/2018 09627Y10 PRN  Blueprint Medicines Initiates VOYAGER Phase 3 Clinical Trial of Avapritinib in Patients with Advanced Gastrointestinal Stromal Tumors,, 8/06/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces First Patient Enrolled in Phase 2 LIFT Study of Pegylated Interferon Lambda in Combination with Ritonavir-Boosted Lonafarnib at National Institutes of Health,,,,,,, 5/02/2018 92165910 PRN  Vanda Pharmaceuticals Reports First Quarter 2018 Financial Results,,," 9/25/2013 45781M10   PRN  Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta",, 5/17/2018 DGX-US   PRN  Quest Diagnostics adds Helen Torley to Board of Directors,10/23/2015 G2151510 PRN  China Biologic Products to Report Third Quarter 2015 Financial Results, 8/11/2014 56400P70 PRN  Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin,,,," 5/10/2017 03236M20 PRN  Technical Reports on Basic Materials Equities -- LyondellBasell Industries, Amyris, Platform Specialty Products, and Ternium", 2/25/2019 69366J20 PRN  PTC Therapeutics Announces Partial Exercise of Underwriter's Option to Purchase Additional Shares," 9/20/2012 RF-US    PRN  Today's Market Focus: Questcor, Regions Financial, Achillion, Deckers Outdoor, Yamana Gold, and NIKE",,,,,, 2/28/2017 36197T10 PRN  FinancialBuzz.com: Legal Cannabis Market Projected to Become a Major Job Creation Force,11/29/2012 07CMVM-E PRN  Epizyme In Vivo Data Shows Promise in Personalized Therapeutics Programs for Acute Leukemia and Lymphoma," 7/24/2018 G5087110 PRN  Jazz Pharmaceuticals to Report 2018 Second Quarter Financial Results on August 7, 2018",," 4/01/2015 39843840 PRN  Grifols 2014 Annual Report on Form 20-F filed with the SEC on April 1, 2015",,, 3/16/2016 92337F10 PRN  New Data Show That Veracyte's Afirma® Gene Expression Classifier Reduces Unnecessary Thyroid Surgeries and Costs During Long-Term Follow-Up,,,12/09/2014 14075510 PRN  Enteris BioPharma's Formulation Technology Enables Oral Delivery of Cara Therapeutics' CR845 Peptide for Acute and Chronic Pain in Phase 1a / 1b Trial,,,,11/10/2010 46226010 PRN  Genesis Biopharma Forms Genesis ADP to Promote Drug Development Collaborations,,,,,,,,,"12/01/2016 98401F10 PRN  Xencor, Inc. Prices Public Offering of Common Stock",, 9/17/2018 G8807B10 PRN  Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of YUPELRI™ (revefenacin) in Oral Presentation at the European Respiratory Society International Congress,, 1/03/2017 03969710 PRN  Ardelyx Announces Initiation of Two Clinical Trials for RDX7675 for Treatment of Hyperkalemia,,,,,,,,,,,, 2/28/2018 05070R10 PRN  Audentes Therapeutics Joins Global Organizations In Recognizing Rare Disease Day® 2018,,,,,, 6/04/2018 RGNX-US  PRN  Netflix Set to Join S&P 100; Twitter to Join S&P 500; REGENXBIO to Join S&P SmallCap 600,,,,,,,,,,,,,,," 4/20/2011 00695P-E  PRN  Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"11/11/2014 45232710    PRN  Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver",, 9/24/2018 G3040110 PRN  Endo Agrees to Additional Stay of FDA Litigation Following FDA's Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination By Year End,"12/25/2013 04280A10 PRN  Upcoming Presentations, Milestone Payments, Quarterly Financial Results, and New Appointments - Research Report on Medivation, Acceleron, Aerie, Arrowhead, and Oxford Immunotec", 6/02/2016 09060J10 PRN  BioDelivery Sciences to Present at the Jefferies 2016 Healthcare Conference, 1/29/2019 09073M10    PRN  Bio-Techne Introduces 48-Digoxigenin Cartridge for the Ella Platform, 5/13/2019 75886F10    PRN  FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy,," 1/05/2016 68375N10 PRN  Covered Call Alerts For Opko Health, Peabody Energy, Lululemon, Sturm Ruger and US Steel Released By InvestorsObserver", 7/24/2018 46222210 PRN  Ionis Pharmaceuticals to Hold Second Quarter 2018 Financial Results Webcast,11/01/2018 09061G10   PRN  BioMarin to Highlight Breadth of Innovative Development Pipeline at R&D Day on November 7th in New York,"11/20/2013 01535110 PRN  Stock Price Movement, Grants for Projects, and Clinical Data Presentations - Research Report on Gilead, Bristol-Myers Squibb, HCA, Allergan, and Alexion"," 5/02/2018 64125C10 PRN  Neurocrine Biosciences to Present New Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia Patients, at the 2018 American Psychiatric Association Annual Meeting","10/29/2013 81257810 PRN  Financial Results & Release Schedules, Stock Performance Update, and New Clinical Trials - Research Report on Amgen, Boston Scientific, ACADIA Pharmaceuticals, Seattle Genetics, and Volcano",," 9/08/2015 09062X10  PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of October 19, 2015 - BIIB",,, 6/07/2016 37555810   PRN  BetterInvesting Top 100 Performance Topped S&P Benchmark for 5 Years Ended May 31, 8/28/2018 04004760   PRN  Arena Pharmaceuticals Presented Phase 1 Clinical Data for Ralinepag in Pulmonary Arterial Hypertension at the European Society of Cardiology,"10/19/2018 N5946510  PRN  Mylan and Biocon Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab", 4/02/2018 M2572210 PRN  Compugen Announces Exclusive License Agreement With MedImmune for the Development of Bi-Specific and Multi-Specific Antibody Products,"11/15/2013 00972810 PRN  Pre-Market Review: Delcath Systems Inc., BioMarin Pharma Inc., Insmed Inc., and Akorn Inc."," 8/26/2019 03116210 PRN  Amgen To Acquire Otezla® For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future Cash Tax Benefits"," 7/01/2011 PETS-US  PRN  Zacks Bull and Bear of the Day Highlights: Myriad Genetics, PetMed Express, McCormick & Co., General Mills and Constellation Brands", 7/18/2016 080RQG-E PRN  Lexicon Announces The Validation By The European Medicine Agency Of The Marketing Authorization Application For Telotristat Etiprate For The Treatment Of Carcinoid Syndrome,,"10/27/2014 45766930 PRN  Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon",," 3/27/2019 45773H20 PRN  Inovio Pharmaceuticals to Present at H.C. Wainwright Global Life Sciences Conference in London, UK",11/06/2018 64026810 PRN  Nektar Therapeutics to Host Webcast Conference Call with Melanoma Specialists for Analysts & Investors During 2018 Society for Immunotherapy of Cancer 33rd Annual Meeting," 1/05/2018 76655960 PRN  Rigel Pharmaceuticals, Inc. Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)",,,"10/11/2012 000YMS-E PRN  Breaking Earnings Forecast News: Yum!, Wal-Mart, AuRico Gold, Peabody Energy, Amarin, and OCZ Technology",12/09/2014 45337C10 PRN  Lilly and Incyte Announce Positive Top-Line Results From Phase 3 Trial of Baricitinib in Moderate to Severe Rheumatoid Arthritis," 4/24/2018 91307C10 PRN  United Therapeutics Corporation To Report First Quarter 2018 Financial Results Before The Market Opens On Wednesday, May 2, 2018"," 8/08/2013 LINEQ-US PRN  Earnings Transcripts of Sarepta Therapeutics, LINN Energy and Royal Gold, Inc. Now Available",10/23/2018 G0176710 PRN  Alkermes Plc Reports Third Quarter 2018 Financial Results,,,," 7/17/2017 55027E10 PRN  Luminex Corporation Second Quarter Earnings Release Scheduled for August 7, 2017", 2/20/2018 80067710 PRN  Sangamo Therapeutics Announces Fourth Quarter and Full Year 2017 Conference Call and Webcast,"12/11/2013 30161Q10 PRN  New Clinical Trials, Pricing of Common Stock and Adjusted Conversion of Convertible Senior Notes - Research Report on Regeneron, Celldex, PDL BioPharma, Amedisys, and Exelixis",11/07/2018 80105N10  PRN  New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) Injection cardiovascular outcomes trial,"10/21/2013 92532F10  PRN  Pre-Market Review: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.",,,,"11/11/2013 00422510 PRN  Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc.",, 3/09/2018 74366E10 PRN  Protagonist Therapeutics to Participate in the 28th Annual Oppenheimer Healthcare Conference,,,,, 3/19/2014 68214310 PRN  Omeros Closes $40.25 Million Public Offering of Common Stock,,,,,,,," 3/01/2018 69329Y10 PRN  PDL BioPharma to Announce Fourth Quarter / Year-End 2017 Financial Results on March 8, 2018",,,,10/26/2017 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2017 Financial Results,,11/03/2012 02043Q10 PRN  Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012,,, 3/07/2018 60468T10 PRN  Mirati Therapeutics To Present At Upcoming Healthcare Conferences, 3/31/2011 69512710 PRN  Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results,,,,,, 6/15/2018 09627Y10 PRN  Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity,, 7/31/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces Notice of Allowance for U.S. Patent Covering a Broad Range of Ritonavir-Boosted Lonafarnib Dosing Regimens for Treatment of Hepatitis Delta Virus Infection,,,,,,," 4/25/2018 006GP9-E PRN  Biotech Stocks' Research Reports Released on TG Therapeutics, Trevena, Vanda Pharma, and Verastem",,," 9/11/2013 45781M10   PRN  Acquisitions, Regulatory Filings, New Community Resource Centers and Successful Clinical Trials- Research Report on Baxter, Endo, HCA, Elan, and Theravance",, 5/10/2018 40637H10 PRN  Halozyme Reports First Quarter 2018 Results, 9/10/2015 G2151510 PRN  China Biologic to Attend Upcoming Investor Conferences," 8/01/2014 56400P70 PRN  Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma",,,, 5/08/2017 00308C-E PRN  Royal DSM to Make Equity Investment in Amyris With the Purpose of Establishing a Long-term Relationship, 2/14/2019 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year End 2018 Financial Results," 1/25/2012 BLRX-IL  PRN  Top Stock Alerts for Day Traders: Atmel, R.R. Donnelley & Sons, BioLineRx, Achillion Pharmaceuticals, Windstream and Rare Element Resources",,,,,," 2/15/2017 36197T10 PRN  Marijuana Industry Acquisitions on the Rise as Companies to Diversify Portfolios, Increase Revenue Streams",11/20/2012 07CMVM-E PRN  Epizyme Publishes Current Review on Targeting Protein Methyltransferases for Personalized Cancer Therapeutics, 7/19/2018 G5087110 PRN  Journal of Clinical Oncology publishes pivotal Phase 3 data for Jazz Pharmaceuticals' Vyxeos® (daunorubicin and cytarabine) Liposome for Injection,, 3/04/2015 39843840 PRN  Grifols to make a major equity investment in Alkahest,,," 3/10/2016 92337F10 PRN  Veracyte Announces Fourth Quarter and Full-Year 2015 Financial Results, Provides 2016 Financial Outlook",,, 6/20/2014 14075510 PRN  Enteris BioPharma Oral Peptide Delivery Technology Enables Key Clinical Milestone for Acute and Chronic Pain Drug,,,,11/04/2010 46226010 PRN  Genesis Biopharma Announces Issuance of European Patent for Anti-CD55 Targeted Cancer Therapy,,,,,,,,,"11/30/2016 98401F10 PRN  Xencor, Inc. Announces Proposed Public Offering of Common Stock",, 9/11/2018 G8807B10 PRN  Theravance Biopharma and Mylan to Report New Data from Phase 3 Studies of YUPELRI™ (revefenacin) in Oral Presentation at European Respiratory Society International Congress 2018,, 1/03/2017 ARDX-US  PRN  Ardelyx Announces Presentation at J.P. Morgan 35th Annual Healthcare Conference,,,,,,,,,,,," 2/12/2018 05070R10 PRN  Audentes Therapeutics Announces Dosing of First Patient in VALENS, a Phase 1/2 Clinical Trial of AT342 for the treatment of Crigler-Najjar Syndrome",,,,,, 5/29/2018 75901B10 PRN  Alexandra Glucksmann Joins REGENXBIO Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,11/04/2014 00FW41-E    PRN  Tute Genomics Now Available in Illumina's BaseSpace Apps,, 9/06/2018 G3040110 PRN  Endo to Participate at Morgan Stanley Global Healthcare Conference,"12/16/2013 04280A10 PRN  Appointments, Employee Option Grants, Clinical Data Presentations, New Launches, and Scheduled Financial Results - Research Report on Intuitive, Alexion, Sequenom, AcelRx, and Arrowhead", 5/11/2016 00772J-E PRN  BioDelivery Sciences and Collegium Pharmaceutical Announce the Signing of a Licensing Agreement for ONSOLIS® in the U.S., 1/28/2019 09073M10    PRN  Bio-Techne Introduces CE-SDS PLUS for Maurice™ System, 5/13/2019 75886F10    PRN  FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy,,"12/22/2015 68375N10 PRN  Covered Call Alerts For Opko Health, Avon Products, NXP Semiconductors, Allergan and ONEOK Released By InvestorsObserver", 7/10/2018 05FF4X-E PRN  SRI International Announces Drug Research Collaboration with Ionis Pharmaceuticals,10/25/2018 09061G10   PRN  BioMarin Announces Third Quarter 2018 Results,"11/12/2013 01535110 PRN  Biotechnology Companies Announce Presentations, Stock Options Update and Financial Results - Research Report on Gilead Sciences, Alexion Pharma, Aegerion Pharma, Vanda Pharma, and Tesaro", 4/30/2018 64125C10 PRN  Neurocrine Biosciences Reports First Quarter 2018 Financial Results,"10/21/2013 81257810 PRN  Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros",, 9/08/2015 0BQRC6-E  PRN  Neurimmune Receives Major Development Milestone Upon Initiation of Global Phase 3 Studies With Aducanumab for Early Alzheimer's Disease,,, 6/03/2016 37555810   PRN  BetterInvesting Magazine Releases August Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use, 8/06/2018 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2018 Financial Results,10/18/2018 N5946510  PRN  Mylan Adds to Women's Healthcare Portfolio With Launch of Generic Depo-Provera® Injection," 3/26/2018 M2572210 PRN  Compugen Announces Appointment of Henry Adewoye, MD, as Chief Medical Officer","11/12/2013 00972810 PRN  Updates on Clinical Studies and Milestone Revenues - Research Report on Cyberonics, West, Nektar, OraSure, and Akorn"," 8/22/2019 03116210 PRN  Amgen And Allergan Announce Positive Top-Line Results From Comparative Clinical Study Of ABP 798, Biosimilar Candidate To Rituxan® (Rituximab)", 5/25/2011 62855J10 PRN  Rules-Based Medicine Reaches a Significant Milestone in Companion Diagnostic Program With Roche, 7/07/2016 52887230 PRN  Lexicon To Present At The Cantor Fitzgerald Healthcare Conference,," 9/11/2014 45766930 PRN  Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma",, 3/25/2019 45773H20 PRN  Inovio Appoints Global Commercial Leader to its Board of Directors,"10/30/2018 64026810 PRN  Nektar to Announce Financial Results for the Third Quarter 2018 on Wednesday, November 7, 2018, After Close of U.S.-Based Financial Markets", 1/04/2018 76655960 PRN  Rigel to Provide Business Review and Updated Phase 2 Results for Fostamatinib in AIHA at the 36th Annual J.P. Morgan Healthcare Conference,,,"10/11/2012 000DP6-E PRN  Today's Market Focus: Chevron, Amarin, FedEx, Johnson & Johnson, Cliffs Natural Resources, and MGM Resorts International","11/05/2014 45337C10 PRN  Quarterly Financial Results and Upcoming Conference - Research Reports on Mylan, Aegerion, Bard, Incyte and Boston Scientific", 3/14/2018 91307C10 PRN  United Therapeutics Corporation To Present At Oppenheimer 28th Annual Healthcare Conference," 4/08/2013 005N6L-E PRN  Over $400 Million Raised by U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings in 2012, Reports Brinson Patrick",10/17/2018 G0176710 PRN  Alkermes Highlights Ongoing Commitment to Research and Innovation in Depression and Schizophrenia at 2018 Psych Congress,,,, 6/28/2017 55027E10 PRN  Luminex Corporation Receives CE-IVD Mark for ARIES® Norovirus Assay, 2/13/2018 80067710 PRN  Sangamo Presents Oncology Genome Editing Capabilities at Keystone Symposium on Emerging Cellular Therapies,"12/03/2013 30161Q10 PRN  Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis",11/06/2018 SAN-FR    PRN  FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis,"10/16/2013 92532F10  PRN  Successful Launches, Upcoming Conference Calls, Signing of Agreements, and Trial Results - Research Report on Vertex, Illumina, Alexion, VIVUS, and Endocyte",,,,"11/06/2013 00422510 PRN  Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind",, 3/07/2018 74366E10 PRN  Protagonist Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results,,,,, 3/14/2014 68214310 PRN  Omeros Prices $35.0 Million Public Offering of Common Stock,,,,,,,, 2/20/2018 69329Y10 PRN  Neos Therapeutics Reiterates Confidence in Strategic Plan and Value Creation Opportunities,,,," 9/01/2017 00182C10 PRN  ANI Pharmaceuticals Announces Approval and Launch of Oxycodone Hydrochloride Oral Solution, 100 mg/5mL",,10/23/2012 02043Q10 PRN  Isis Pharmaceuticals To Receive $1.1 Million From Alnylam,,, 2/08/2018 60468T10 PRN  Mirati Therapeutics To Present At Leerink Partners 7th Annual Global Healthcare Conference," 3/24/2011 69512710 PRN  Pacira Pharmaceuticals Announces Timing for 2010 Financial Results, Webcast and Conference Call",,,,,," 6/04/2018 0GCTXG-E PRN  Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Avapritinib, BLU-554 and BLU-667 in Greater China",, 6/04/2018 28249U10 PRN  Eiger Announces HDV Phase 2 Program Oral Presentation and Investigator / Key Opinion Leader Reception for Planned HDV Phase 3 D-LIVR Study at Global Hepatitis Summit 2018™,,,,,,," 4/18/2018 92165910 PRN  Vanda Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 2, 2018",,," 9/03/2013 45781M10   PRN  Biotech Firms Announce Financial Results, Resignations, Reintroduce Treatments and Receive Reviews on Key Products - Research Report on Insmed, ImmunoGen, VIVUS, Theravance, and XOMA",, 4/10/2018 40637H10 PRN  Halozyme To Host First Quarter 2018 Financial Results Conference Call, 8/05/2015 G2151510 PRN  China Biologic Reports Financial Results for the Second Quarter of 2015," 7/21/2014 56400P70 PRN  Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver",,,," 5/02/2017 03236M20 PRN  IMPORTANT EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm", 2/13/2019 69366J20 PRN  PTC Therapeutics Launches Fifth Annual STRIVE Grant Award Program for Duchenne Muscular Dystrophy," 1/10/2012 ZNGA-US  PRN  Research Reports on Top Traded Stocks: Zynga, JetBlue Airways, Flextronics, Achillion Pharmaceuticals, Hercules Offshore and Minefinders",,,,,, 2/03/2017 36197T10 PRN  Spending on Legal Cannabis Accelerates,10/29/2012 07CMVM-E PRN  Epizyme to Present at Upcoming Scientific and Financial Conferences in November, 6/29/2018 G5087110 PRN  Jazz Pharmaceuticals Enters Into Agreement with TerSera Therapeutics LLC for Prialt,," 6/17/2014 39843840 PRN  Grifols opens state-of-the-art facility in Clayton, NC to help advance treatment of rare and life-threatening diseases",,, 2/29/2016 92337F10 PRN  Veracyte Announces Publication of Data Confirming Analytical Verification of Percepta® Bronchial Genomic Classifier,,," 3/05/2014 14075510 PRN  New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst Notes on Ariad, Novavax, Fonar, bluebird, and Cara",,,,"10/11/2010 46226010 PRN  Genesis Biopharma to Present at the Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 13",,,,,,,,,"11/13/2016 98401F10 PRN  Xencor Presents Preliminary Data from an Ongoing, Open-label, Phase 2 Study of XmAb®5871 in IgG4-Related Disease (IgG4-RD) at the American College of Rheumatology 2016 Annual Meeting",," 8/01/2018 G8807B10 PRN  Theravance Biopharma, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update",,11/07/2016 03969710 PRN  Ardelyx Reports Third Quarter 2016 Financial Results and Recent Progress,,,,,,,,,,,, 2/08/2018 05070R10 PRN  Audentes Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference,,,,,, 5/15/2018 75901B10 PRN  REGENXBIO Joins the Mucopolysaccharidosis Community to Advance Research and Innovation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"11/04/2014 45232710    PRN  Quarterly Financial Results and Product Approval - Research Reports on Pacira, PAREXEL, WellPoint, Illumina and St. Jude Medical",, 8/15/2018 G3040110 PRN  Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing Facility,"12/05/2013 04280A10 PRN  Divestitures, Event Participations, Patents, Clinical Studies and Trials - Research Report on Allergan, Zoetis, XOMA, Isis, and Arrowhead", 5/10/2016 09060J10 PRN  BioDelivery Sciences Provides Corporate Update and Reports First Quarter 2016 Financial Results, 1/24/2019 09073M10    PRN  Bio-Techne Launches Cell and Gene Therapy Portfolio, 5/07/2019 75886F10    PRN  Dupixent® (dupilumab) Approved for Severe Asthma by European Commission,,12/14/2015 0649VC-E PRN  OPKO's GeneDx Subsidiary and North Shore-LIJ Health System Form Strategic Alliance for Genetic Testing, 7/05/2018 46222210 PRN  New England Journal of Medicine Publishes Results from Pivotal Study of TEGSEDI™ (inotersen) for the Treatment of Hereditary ATTR Amyloidosis,10/16/2018 BMRN-US    PRN  BioMarin Receives Milestone Payments from Pfizer for Talzenna® (Talazoparib) for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation,"10/31/2013 01535110 PRN  Biotech Companies Report Quarterly Results - Research Report on Biogen Idec, Alexion, Medivation, BioMarin, and Dyax", 4/27/2018 64125C10 PRN  AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting,"10/15/2013 81257810 PRN  Under AAAResearchReports.com Microscope: Amarin Corp. PLC, Elan Corp. PLC, Seattle Genetics Inc., and Cubist Pharma Inc.",, 9/03/2015 09062X10  PRN  Neurocrine Biosciences Announces the Appointment of Dr. Alfred W. Sandrock to its Board of Directors,,," 5/25/2016 37555810   PRN  Learn how to target an 20% return on Gilead Sciences, or get option-trade ideas on LinkedIn, Bank of Nova Scotia, Adobe Systems, and Valero Energy or any stock you choose"," 7/30/2018 04004760   PRN  Arena Pharmaceuticals to Release Second Quarter 2018 Financial Results and Provide Corporate Update on Monday, August 6","10/18/2018 N5946510  PRN  Mylan to Release Third Quarter 2018 Financial Results on November 5, 2018", 3/08/2018 M2572210 PRN  Compugen to Present at the Cowen and Company 38th Annual Health Care Conference,"11/04/2013 00972810 PRN  Healthcare Quarterly Reports and Event - Research Report on Hologic, Akorn, Synta, PDL, and Exact Sciences", 8/09/2019 03116210 PRN  Amgen Wins Patent Case On Enbrel® (etanercept)," 5/12/2011 62855J10 PRN  Rules-Based Medicine, Inc. (RBM) Partners with Institut Pasteur to Boost Innovation in Translational Research", 6/06/2016 52887230 PRN  Lexicon To Present At The Jefferies 2016 Healthcare Conference,," 8/11/2014 45766930 PRN  Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma",, 3/21/2019 45773H20 PRN  Inovio's Ebola Vaccine Delivered Intradermally Demonstrates 100% Immunogenicity in a Clinical Study Published in The Journal of Infectious Diseases,10/03/2018 64026810 PRN  Nektar Therapeutics (NKTR) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws,12/15/2017 76655960 PRN  Rigel Announces Departure of Chief Financial Officer,,," 9/12/2012 PSX-US   PRN  Today's Market Focus: Tibco Software, Amarin, Coca-Cola, Peabody Energy, Radian Group, and Phillips 66","11/04/2014 45337C10 PRN  Biotech Equities Coverage - Achillion Pharma, Sarepta Therapeutics, Alnylam Pharma, Incyte, and Cytori Therapeutics", 3/07/2018 91307C10 PRN  United Therapeutics Corporation To Present At Cowen And Company 38th Annual Health Care Conference," 4/08/2013 80360710 PRN  Pre-Market Analysis on Sarepta Therapeutics, BioMarin Pharma, Theravance, and Chelsea Therapeutics",10/16/2018 G0176710 PRN  Alkermes to Host Conference Call to Discuss Third Quarter 2018 Financial Results,,,, 6/05/2017 55027E10 PRN  Luminex Corporation's VERIGENE Gram-Positive and Gram-Negative Blood Culture Panels Receive Reimbursement Approval in Japan, 2/12/2018 80067710 PRN  Sangamo Therapeutics Announces Appointment Of Heather D. Turner As Senior Vice President And General Counsel,"11/04/2013 30161Q10 PRN  Stock Price Movement Update, Recognitions, and Financial Results - Research Report on Ariad Pharmaceuticals, Quintiles, Molina Healthcare, Exelixis, and Masimo","11/01/2018 80105N10  PRN  Sanofi expands Insulins VALyou Savings Program, helping more people living with diabetes","10/07/2013 92532F10  PRN  Clinical Study Updates, Trial Enrollments, NDA Submissions, Partnerships, and Formation of New Subsidiaries - Research Report on BioMarin, Alnylam, Vertex, Illumina, and Intrexon",,,,"10/29/2013 00422510 PRN  Financial Results & Release Schedules, Stock Performance Update, and New Clinical Trials - Research Report on Amgen, Boston Scientific, ACADIA Pharmaceuticals, Seattle Genetics, and Volcano",, 3/06/2018 74366E10 PRN  FDA Grants Orphan Drug Designation for Protagonist Therapeutics' PTG-300 for the Treatment of Beta-Thalassemia,,,,, 3/13/2014 68214310 PRN  Omeros Announces Proposed Public Offering of Common Stock,,,,,,,, 2/20/2018 69329Y10 PRN  PDL BioPharma Terminates Interest in Pursuing Acquisition of Neos,,,, 8/08/2017 00182C10 PRN  ANI Pharmaceuticals to Present at the Canaccord Genuity 37th Annual Growth Conference,,10/04/2012 02043Q10 PRN  Regulus Announces Pricing of Initial Public Offering,,,11/20/2017 60468T10 PRN  Mirati Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares, 3/08/2011 69512710 PRN  Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference,,,,,, 5/31/2018 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences in June,, 5/30/2018 28249U10 PRN  Eiger BioPharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference,,,,,,, 4/13/2018 08422V-E PRN  Vanda Wins Appeal Case on Fanapt®,,," 8/27/2013 45781M10   PRN  Today's Technical View: Alkermes plc, Hospira Inc., Celsion Corp., and Theravance Inc.",, 3/22/2018 40637H10 PRN  Halozyme Announces Nomination Of Directors For Reelection At 2018 Stockholder Meeting, 7/24/2015 G2151510 PRN  China Biologic Products to Report Second Quarter 2015 Financial Results," 7/04/2014 56400P70 PRN  NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind",,,," 4/28/2017 03236M20 PRN  Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, Inc., Incyte Corporation, MOCON, Inc., Ocwen Financial Corporation and ThereapeuticsMD, Inc."," 1/31/2019 69366J20 PRN  PTC Therapeutics Launches New Program to Support Research Projects in Rare, Genetic Disorders","12/14/2011 ULTA-US  PRN  Zacks.com featured expert Kevin Matras highlights: Ulta Salon, Cosmetics & Fragrance, Inc., Hexcel Corp., On Assignment, Inc., Advance America, Cash Advance Centers, Inc. and Achillion Pharmaceuticals, Inc.",,,,,, 1/11/2017 INSYQ-US PRN  2017 Legal Cannabis Market Developments,"10/11/2012 00C7QW-E PRN  Zyngenia, Inc. Expands Its Board of Directors with Leading Life Sciences Business Executives Christian Itin and Jason Rhodes", 6/29/2018 G5087110 PRN  Vyxeos™ Receives Positive CHMP Opinion for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia,," 4/04/2014 39843840 PRN  Annual Report for 2013 on Form 20-F filed with the SEC on April 4, 2014",,, 2/25/2016 92337F10 PRN  Veracyte Announces Publication of Data Supporting Clinical Utility of the Percepta® Bronchial Genomic Classifier in Lung Cancer Diagnosis,,,11/11/2013 007V62-E PRN  Cara Therapeutics Files Registration Statement for Proposed Initial Public Offering,,,, 9/23/2010 46226010 PRN  Genesis Biopharma Announces $700K Private Financing,,,,,,,,,11/11/2016 98401F10 PRN  Xencor Presents Preclinical Data on XmAb20717 Dual Checkpoint Blockade and Additional Bispecific Antibody Candidates at Society for Immunotherapy of Cancer (SITC) 2016 Annual Meeting,, 8/01/2018 G8807B10 PRN  Theravance Biopharma Reports Positive Top-Line Four-Week Data from Phase 2 Trial of TD-9855 for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension,,"10/31/2016 03969710 PRN  Ardelyx to Announce Third Quarter 2016 Financial Results on November 7, 2016",,,,,,,,,,,, 2/06/2018 05070R10 PRN  Audentes Therapeutics Announces Selection of Optimized Clinical Development Candidate for Pompe Disease Program,,,,,, 5/09/2018 75901B10 PRN  REGENXBIO to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/22/2014 45232710    PRN  Recognition, Product Enhancement, Marketing Approval, Upcoming Events, and Quarterly Earnings - Research Reports on Abbott, Illumina, Thermo Fisher, Intercept and Stryker",, 8/09/2018 ENDP-US  PRN  PGA Golfer Tim Herron Teams Up with Endo Pharmaceuticals to Encourage Parents to Get Their Own Check-Ups This Back-to-School Season,"10/24/2013 04280A10 PRN  FDA Approval, FDA Application, Positive Safety Results, and Presentations - Research Report on Cubist, GSK, Rockwell Medical, Arrowhead, and Horizon Pharma"," 5/03/2016 09060J10 PRN  BioDelivery Sciences to Host Conference Call and Webcast of First Quarter 2016 Results on Tuesday, May 10"," 1/16/2019 09073M10    PRN  Bio-Techne To Host Conference Call On February 5, 2019, To Announce Second Quarter 2019 Financial Results", 5/07/2019 75886F10    PRN  Regeneron Reports First Quarter 2019 Financial and Operating Results,,12/10/2015 OPY-US   PRN  Oppenheimer's 26th Annual Healthcare Conference Provides Investors With Access To More Than 140 Public And Private Healthcare Companies, 6/18/2018 46222210 PRN  Ionis Pharmaceuticals Appoints Damien McDevitt as Chief Business Officer,10/11/2018 09061G10   PRN  BioMarin and Believe Limited Announce Selection of 25 High School Students to Perform in First-of-its-Kind 'Hemophilia: The Musical',"10/23/2013 01535110 PRN  Healthcare Sector Announced Clinical Data Presentation, Upcoming Financial Release Schedules and Updates on New Drug Applications - Research Report on Alexion, Pacira, pSivida, Momenta and Impax", 4/25/2018 64125C10 PRN  Neurocrine Biosciences Presents New Data Analyses at AAN Annual Meeting Demonstrating INGREZZA® Improved Tardive Dyskinesia Symptoms Across Body Regions,10/09/2013 0032YX-E PRN  Seattle enjoys $2.4 million economic boost from It Works! Global conference,, 8/07/2015 09062X10  PRN  BetterInvesting Magazine Releases October Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use,,," 5/13/2016 37555810   PRN  Covered Call reports for Gilead Sciences, Boeing, Smith & Wesson, NetEase Inc., and Dreamworks Animation SKG Inc include trade ideas that offer returns of 20% or more!", 7/10/2018 04004760   PRN  Arena Pharmaceuticals Appoints Life Sciences Industry Veteran Kieran T. Gallahue to Board of Directors,10/12/2018 N5946510  PRN  Mylan Prevails in Copaxone® 40mg/mL Litigation Against Teva in U.S. Appellate Court, 2/21/2018 M2572210 PRN  Compugen Reports Fourth Quarter and Full Year 2017 Results,"10/25/2013 00972810 PRN  Pre-Market Analysis: BioMarin Pharma Inc., Insmed Inc., Delcath Systems Inc., and Akorn Inc.", 8/02/2019 03116210 PRN  Amgen Announces 2019 Third Quarter Dividend," 4/08/2011 SNY-FR   PRN  Zacks Analyst Blog Highlights: Myriad Genetics, BioMarin Pharmaceuticals, Abbott Laboratories, AstraZeneca and Sanofi-Aventis"," 6/02/2016 52887230 PRN  Lexicon Announces The Launch Of Aboutcarcinoid.com To Provide Carcinoid Syndrome Disease Education To Patients, Caregivers And Physicians",," 6/30/2014 45766930 PRN  Technical Scrutiny on Biotech Stocks -- Research on Insmed, Peregrine Pharma, CytRx, and Celldex Therapeutics",, 3/12/2019 45773H20 PRN  Inovio Pharmaceuticals Reports 2018 Fourth Quarter and Year-End Financial Results,10/02/2018 64026810 PRN  Nektar Therapeutics Announces Ten Abstracts Accepted for Presentation at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting,"12/08/2017 76655960 PRN  Rigel Pharmaceuticals, Inc. Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)",,," 9/05/2012 NE-US    PRN  Top Searched Stocks: Pfizer, Netflix, Yahoo!, Cliffs Natural Resources, Noble, and Amarin"," 9/26/2014 45337C10 PRN  Biotech Stocks Technical Insight - Incyte, Regado Biosciences, ACADIA Pharma, Pharmacyclics, and Raptor Pharma"," 2/26/2018 91307C10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of United Therapeutics Corporation (UTHR)"," 3/27/2013 ERJ-BR   PRN  Critical Alerts For IBM, Lions Gate, Sarepta Therapeutics, Cheniere Energy, and Embraer Released By InvestorsObserver", 9/10/2018 G0176710 PRN  Alkermes Initiates Clinical Evaluation of Novel Immuno-Oncology Drug Candidate ALKS 4230 in Combination With PD-1 Inhibitor Pembrolizumab,,,, 5/25/2017 55027E10 PRN  Luminex Corporation To Present At Jefferies 2017 Global Healthcare Conference, 2/07/2018 SGMO-US  PRN  Case Western Reserve and Sangamo Therapeutics Announce $11 Million NIH Grant for Study of Gene-Edited T Cells for Viral Eradication of HIV,"10/29/2013 30161Q10 PRN  Quarterly Reports and Pricing of Public Offering - Research Report on Zimmer, ResMed, ZIOPHARM, MSA, and Exelixis",10/31/2018 80105N10  PRN  Sanofi Q3 2018 Performance Confirms Return to Growth," 9/25/2013 92532F10  PRN  Data Presentations, FDA Approvals, Board Appointments, Updated Clinical Results and New Contracts - Research Report on Vertex, Celgene, NPS Pharmaceuticals, Cyclacel and BioCryst",,,,"10/21/2013 00422510 PRN  Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc.",, 3/01/2018 74366E10 PRN  Protagonist Therapeutics to Participate in the Barclay's Global Healthcare Conference,,,,, 3/13/2014 68214310 PRN  Omeros Corporation Reports Fourth Quarter and Year-End 2013 Financial Results,,,,,,,, 2/14/2018 69329Y10 PRN  PDL BioPharma to Present at Two Upcoming Investor Conferences,,,, 8/03/2017 00182C10 PRN  ANI Pharmaceuticals Reports Record Second Quarter and Year-To-Date 2017 Results and Reaffirms Guidance,," 8/30/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Alnylam Pharmaceuticals, Monsanto, Novartis, Biogen and Cubist Pharmaceuticals",,,11/16/2017 60468T10 PRN  Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock, 3/02/2011 69512710 PRN  Pacira Pharmaceuticals' EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting,,,,,, 5/17/2018 09627Y10 PRN  Blueprint Medicines Announces Data Presentations at Upcoming ASCO and EHA Meetings Supporting Plans for Rapid Development of Avapritinib in Patients with Gastrointestinal Stromal Tumors and Systemic Mastocytosis,, 5/24/2018 28249U10 PRN  Eiger BioPharmaceuticals Prices Previously Announced Public Offering of Common Stock,,,,,,, 4/09/2018 92165910 PRN  Vanda to Present Tradipitant Scientific Posters at the 10th Georg Rajka International Symposium of Atopic Dermatitis,,," 5/17/2013 45781M10   PRN  Critical Alerts For Google, Qualcomm, Yum Brands, NRG Energy, and Theravance Released By InvestorsObserver",, 3/14/2018 40637H10 PRN  Halozyme To Present Data From Six Nonclinical Studies At American Association Of Cancer Research Annual Conference, 6/10/2015 G2151510 PRN  China Biologic Announces Pricing of Public Offering of Common Stock," 7/03/2014 56400P70 PRN  MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc.",,,," 4/28/2017 03236M20 PRN  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc. and Encourages Investors with Losses to Contact the Firm", 1/25/2019 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,12/23/2016 36197T10 PRN  The Mainstream Growth of the Cannabidiol Market,10/03/2012 07CMVM-E PRN  Epizyme Earns $4 Million in Milestone Payments in GlaxoSmithKline Alliance to Discover and Develop Novel HMT Therapeutics, 6/27/2018 G5087110 PRN  Jazz Pharmaceuticals Announces FDA Acceptance of Supplemental New Drug Application for Xyrem® (sodium oxybate) to Treat Cataplexy and Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients,,12/09/2013 39843840 PRN  Talyst Announces GRIFOLS Reseller Agreement,,, 2/25/2016 92337F10 PRN  Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2015 Financial Results on March 10,,,"10/29/2013 007V62-E PRN  Cara Therapeutics Reports Positive Results from Phase 2 Clinical Trial of Novel Peripherally-Acting Kappa Opioid Receptor Agonist, I.V. CR845, for Post-Operative Pain Following Bunionectomy",,,," 8/10/2010 03279730 PRN  Anavex appoints contract research organizations to initiate Phase I/IIa clinical programs, regulatory strategies in Alzheimer's disease",,,,,,,,,11/02/2016 98401F10 PRN  Xencor Reports Third Quarter 2016 Financial Results,, 7/25/2018 G8807B10 PRN  Theravance Biopharma to Report Second Quarter 2018 Financial Results on August 1,,"10/24/2016 03969710 PRN  Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer",,,,,,,,,,,, 1/29/2018 05070R10 PRN  Audentes Therapeutics Announces the Closing of its Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares,,,,,, 5/08/2018 75901B10 PRN  REGENXBIO Reports First Quarter 2018 Financial Results and Recent Operational Highlights,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/21/2014 45232710    PRN  Critical Alerts For GoPro, NQ Mobile, SunEdison, Illumina and Qihoo 360 Technology Released By InvestorsObserver",, 8/08/2018 G3040110 PRN  Endo Reports Second-Quarter 2018 Financial Results,"10/11/2013 04280A10 PRN  Scheduled Earnings Releases, Survey and Study Results, and Enrollment into Clinical Trial - Research Report on Biogen Idec, Questcor, Medivation, Agenus, and Arrowhead Research", 4/29/2016 09060J10 PRN  BioDelivery Sciences Announces Acceptance of an Abstract to the International Conference on Opioids on the Impact of a State Formulary Conversion to BUNAVAIL,12/20/2018 09073M10    PRN  Bio-Techne To Present At The 37th Annual J.P. Morgan Healthcare Conference, 4/29/2019 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentations,,"12/09/2015 68375N10 PRN  Covered Call Alerts For Opko Health, Intrexon, CyberArk Software, Keryx Biopharmaceuticals and Twitter Released By InvestorsObserver", 6/05/2018 46222210 PRN  Ionis Closes Strategic Collaboration with Biogen to Develop Drugs for a Broad Range of Neurological Diseases,10/11/2018 09061G10   PRN  Forbes Names BioMarin Among World's Best Employers,"10/16/2013 01535110 PRN  Successful Launches, Upcoming Conference Calls, Signing of Agreements, and Trial Results - Research Report on Vertex, Illumina, Alexion, VIVUS, and Endocyte", 4/23/2018 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2018 Financial Results,"10/07/2013 81257810 PRN  Partnerships, Product Recall, New Contracts, Promotions, and Stock Movement - Research Report on Valeant, CareFusion, Envision Healthcare, Seattle Genetics, and Osiris",," 8/04/2015 09062X10  PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB",,," 5/03/2016 37555810   PRN  InvestorsObserver releases covered-call reports for Gilead Sciences, Pfizer Inc., Valeant Pharmaceuticals, AIG and Oracle Corporation", 5/21/2018 04004760   PRN  Arena Pharmaceuticals Announces Data Presentation for Ralinepag in Pulmonary Arterial Hypertension at the American Thoracic Society International Conference,10/11/2018 N5946510  PRN  Theravance Biopharma and Mylan Report Positive New Data from Multiple Studies of YUPELRI™ (revefenacin) at the 2018 CHEST Annual Meeting," 2/08/2018 M2572210 PRN  Compugen Fourth Quarter and Full Year 2017 Conference Call Scheduled for Wednesday, February 21, 2018 at 10:00 AM ET","10/23/2013 00972810 PRN  Clinical Study Results, Full-Year Guidance, Upcoming Earnings Schedules, and Trial Completions - Research Report on Covidien, Mallinckrodt, The Medicines Company, Catalyst, and Akorn", 7/30/2019 03116210 PRN  Amgen Reports Second Quarter 2019 Financial Results,, 5/31/2016 06CR5C-E PRN  Lexicon Announces FDA Priority Review Of New Drug Application For Telotristat Etiprate For The Treatment Of Carcinoid Syndrome,," 5/23/2014 45766930 PRN  Clinical Test Results, Improved Medical Care, and Rejection of Buyout Proposal by Medical Companies - Analyst Notes on AstraZeneca, LifePoint, Insmed, Dendreon and Idenix Pharmaceuticals",, 3/12/2019 45773H20 PRN  Inovio Appoints Chief Operating Officer; Announces Strategic Management Changes,10/01/2018 64026810 PRN  Nektar Therapeutics Strengthens Board of Directors with Appointment of Veteran Biotechnology Executive Karin Eastham,12/08/2017 76655960 PRN  Rigel to Present One-Year Efficacy and Safety Results for Fostamatinib in ITP at the 2017 American Society of Hematology Annual Meeting,,," 8/27/2012 ARUN-US  PRN  Hot Stocks Research for Cisco, Aruba Networks, Adobe, United States Steel, Delta Air Lines, and Amarin"," 9/09/2014 45337C10 PRN  Critical Alerts For Gilead Sciences, Incyte Corp., Infinera Corporation, Ford and Pixelworks Released By InvestorsObserver", 2/21/2018 91307C10 PRN  United Therapeutics Corporation Reports 2017 Fourth Quarter And Annual Financial Results," 3/11/2013 80360710 PRN  Emerging Growth Equities, Ltd. Initiates Coverage of Sarepta Therapeutics, Inc. (SRPT) With a BUY Rating and $38.00 Price Target", 9/05/2018 G0176710 PRN  Alkermes Announces 3rd Annual Competitive Grants Program to Support Those Affected by Mental Health and Substance Use Disorders,,,, 5/24/2017 55027E10 PRN  Luminex Corporation Declares Second Quarter Cash Dividend, 2/06/2018 80067710 PRN  Sangamo Therapeutics Presents Initial Safety Data from CHAMPIONS Genome Editing Study for MPS II at WORLDSymposium," 9/25/2013 30161Q10 PRN  Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta",10/30/2018 80105N10  PRN  FDA grants priority review for Sanofi's dengue vaccine candidate," 9/24/2013 92532F10  PRN  Morning Research: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.",,,," 9/25/2013 00422510 PRN  Technical Study: Cell Therapeutics Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc., and Medivation Inc.",," 3/01/2018 74366E10 PRN  Protagonist to Announce Fourth Quarter and Year-End 2017 Financial Results on March 7, 2018; Year-End Update Call to Follow",,,,, 3/10/2014 68214310 PRN  Omeros Announces Positive OMS721 Data in Serum from Patients with aHUS,,,,,,,,11/15/2017 69329Y10 PRN  Noden Pharma Announces FDA Approval of Tekturna®(aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older,,,, 7/27/2017 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2017 Financial Results,, 8/28/2012 ALNY-US  PRN  Isis Pharmaceuticals to receive $1.4 million from Alnylam,,,11/15/2017 60468T10 PRN  Mirati Therapeutics Announces Proposed Public Offering Of Common Stock, 2/15/2011 69512710 PRN  Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting,,,,,, 5/02/2018 09627Y10 PRN  Blueprint Medicines Reports First Quarter 2018 Financial Results,, 5/23/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock,,,,,,, 3/15/2018 92165910 PRN  Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock,,, 5/13/2013 INVA-US    PRN  Cadwalader Advises Elan Corporation in Billion Dollar Royalty Deal,, 2/27/2018 40637H10 PRN  Halozyme Therapeutics To Present At Upcoming Healthcare Conference, 5/06/2015 G2151510 PRN  China Biologic Reports Financial Results for the First Quarter of 2015," 7/01/2014 56400P70 PRN  Critical Alerts For MannKind, AOL, Plug Power, Ctrip.com, and 58.com Released By InvestorsObserver",,,," 4/27/2017 03236M20 PRN  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Amyris, Inc. To Contact The Firm", 1/23/2019 69366J20 PRN  PTC Therapeutics Announces Pricing of Public Offering of Common Stock,,,,,,,"12/05/2016 36197T10 PRN  Covered Call reports for Exelixis, Alibaba, Procter & Gamble, Whiting Petroleum and GW Pharmaceuticals include trade ideas that offer returns of 20% or more!",10/01/2012 07CMVM-E PRN  Epizyme Publishes Landmark Data on Personalized Therapeutics for Lymphomas, 6/06/2018 G5087110 PRN  Jazz Pharmaceuticals to Present at the Goldman Sachs Global Healthcare Conference,,"11/11/2013 39843840 PRN  Grifols to acquire a Novartis diagnostics business unit for US$1,675 million",,, 2/19/2016 92337F10 PRN  Veracyte Announces Publication of Study Reinforcing the Clinical Utility of the Afirma® Gene Expression Classifier in Thyroid Cancer Diagnosis,,," 4/29/2013 07G79K-E PRN  Cara Therapeutics Enters Into Development and Commercial Alliance with Maruishi for Novel Kappa Opioid Agonist , CR845, in Japan",,,,,,,,,,,,,10/31/2016 98401F10 PRN  Xencor to Present at Upcoming Investor Conferences,, 5/29/2018 G8807B10 PRN  Theravance Biopharma Highlights Submission of Regulatory Application in Japan for Once-Daily Single Inhaler Triple Therapy FF/UMEC/VI for Patients with COPD,,10/19/2016 03969710 PRN  Ardelyx Announces the Presentation of Positive Global Endpoint Findings from Phase 2b Trial of Tenapanor in Patients with IBS-C at ACG Annual Meeting,,,,,,,,,,,, 1/24/2018 05070R10 PRN  Audentes Therapeutics Announces Pricing of Public Offering of Common Stock,,,,,, 5/02/2018 75901B10 PRN  REGENXBIO Receives FDA Fast Track Designation for RGX-121 Gene Therapy for the Treatment of Mucopolysaccharidosis Type II,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/14/2014 45232710    PRN  Affordable Housing Project, Lawsuit Settlement, Drug Review, and Earnings Release Schedules - Research Reports on UnitedHealth, Bristol-Myers, Boston Scientific, Abbott and Illumina",," 8/02/2018 G3040110 PRN  Endo Announces Appointment of Laure Park as Senior Vice President, Investor Relations and Corporate Affairs"," 2/07/2013 04280A10 PRN  Lifshitz Law Firm Announces Investigation of Arrowhead Research Corp., MEI Pharma, Inc., Park City Group, Inc., and The Toro Company", 3/14/2016 09060J10 PRN  BioDelivery Sciences to Present Today at the 28th Annual ROTH Conference,12/04/2018 09073M10    PRN  Bio-Techne Releases GMP ROCK Inhibitor and CHIR 99021 for Stem Cell Therapy," 4/26/2019 75886F10    PRN  FDA Approves Praluent® (alirocumab) to Prevent Heart Attack, Stroke and Unstable Angina Requiring Hospitalization",,"11/27/2015 68375N10 PRN  Covered Call Alerts For Opko Health, Kandi Technologies, Keryx Biopharmaceuticals, Exxon Mobil and El Pollo Loco Released By InvestorsObserver", 5/23/2018 46222210 PRN  Webcast Alert: Ionis Pharmaceuticals Provides Corporate Update at 2018 Annual Meeting of Stockholders,"10/04/2018 09061G10   PRN  BioMarin to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Thursday, October 25 at 4:30pm ET"," 9/24/2013 01535110 PRN  Corporate Restructuring, Recognitions, Drug Approvals, Mergers and Stock Price Movements - Research Report on Agilent, UnitedHealth, Onyx, Alexion, and Opko Health"," 4/19/2018 64125C10 PRN  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Neurocrine Biosciences, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors",10/03/2013 0032YX-E PRN  From Bright Drum Production Company: Single In Seattle Documentary Series,," 8/03/2015 09062X10  PRN  Pre-Market Scans on Biotechnology Stocks -- Sunesis Pharma, Biogen, Array BioPharma, Seres Therapeutics, and Athersys",,," 4/21/2016 37555810   PRN  Microsoft trade offers an 8.79% return in 57 days, or find similar option trades on The Goldman Sachs Group, Vmware, Pfizer Inc., and Gilead Sciences", 5/10/2018 04004760   PRN  Arena Pharmaceuticals to Present at Upcoming Investor Conferences,10/08/2018 N5946510  PRN  Theravance Biopharma and Mylan to Present New Data from Studies of YUPELRI™ (revefenacin) at the 2018 CHEST Annual Meeting, 2/06/2018 0028L7-E PRN  Compugen Announces Publication of the Discovery of ILDR2 as a Novel Immune Checkpoint and Its Use for the Treatment of Autoimmune Diseases in Two Back-to-Back Papers in The Journal of Immunology,"10/14/2013 00972810 PRN  Akorn, Inc. Announces Third Quarter 2013 Earnings Release And Conference Call Information", 7/26/2019 03116210 PRN  Amgen Controls 98% Of The Shares In Nuevolution After The End Of The Extended Acceptance Period,," 5/10/2016 LXRX-US  PRN  Praveen Tyle, Ph.D. Joins Lexicon As Executive Vice President Of Research And Development",," 5/21/2014 45766930 PRN  Morning Analysis on Top Gainers -- Research on E-House China Holdings, Insmed, Qunar Cayman Islands, and Lee Enterprises",," 3/05/2019 45773H20 PRN  Inovio Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on March 12, 2019", 8/08/2018 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Second Quarter of 2018,"11/17/2017 76655960 PRN  Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)",,," 8/20/2012 EQIX-US  PRN  Critical Trade Alerts For Pfizer, Travelers, Equinix, Amarin, and Energizer Released By InvestorsObserver"," 8/21/2014 45337C10 PRN  Market Movers - Biotech Stocks -- Progenics Pharma, Rexahn Pharma, ImmunoGen, Hemispherx Biopharma, and Incyte"," 2/15/2018 91307C10 PRN  United Therapeutics Announces Settlement Of Patent Litigation With Actavis Laboratories FL, Inc. Relating To Orenitram"," 3/08/2013 80360710 PRN  Drug Approvals, Breakthrough Treatments and Royalties - Research Report on Celgene Corporation, Onyx Pharmaceuticals, Sarepta Therapeutics, VIVUS and Achillion Pharmaceuticals", 8/01/2018 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at the 38th Annual Canaccord Genuity Growth Conference,,,, 5/03/2017 55027E10 PRN  Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay, 1/08/2018 80067710 PRN  Sangamo Therapeutics Outlines 2018 Key Priorities And Catalysts At J.P. Morgan Healthcare Conference," 7/25/2013 CHTP-US  PRN  Results Schedules, Management Changes, and Pending NDA Approvals - Research Report on Questcor, VIVUS, Exelixis, Incyte, and Chelsea Therapeutics",10/26/2018 005M9Z-E  PRN  Research in Polycystic Kidney Disease Takes an Important Step Forward," 9/12/2013 92532F10  PRN  FDA Approvals, Study Results, Multi-Year Collaborations, Data Presentations, and Supply Agreements - Research Report on Celgene, Amgen, Biogen Idec, Vertex, and Illumina",,,," 8/26/2013 00422510 PRN  Positive Clinical Trial Results, Regulatory Wins, and New Appointments - Research Report on Incyte, Edwards, ACADIA Pharmaceuticals, Alnylam, and Ironwood",, 1/31/2018 74366E10 PRN  Protagonist Therapeutics to Participate in the Leerink Partners 7th Annual Global Healthcare Conference,,,,, 3/06/2014 68214310 PRN  Omeros Reports Additional Positive Data from its OMS824 Phase 2a Schizophrenia Clinical Trial,,,,,,,,11/08/2017 69329Y10 PRN  PDL BioPharma's Proposal to Acquire Neos Therapeutics Expires Today; PDL Urges Neos to Provide Update on Sale Process,,,," 7/26/2017 00182C10 PRN  Options trade ideas for ANI Pharmaceuticals, Facebook, Gilead Sciences, Hilton Worldwide and Shutterfly offer returns of 21% or more!",, 8/20/2012 078VWR-E PRN  Regulus Files Registration Statement for Proposed Initial Public Offering,,,11/13/2017 60468T10 PRN  Mirati Therapeutics Announces Advancement Of First-In-Class Opportunities With Sitravatinib And KRAS Inhibitor Programs," 2/03/2011 69512710 PRN  Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering",,,,,," 4/25/2018 09627Y10 PRN  Blueprint Medicines to Report First Quarter 2018 Financial Results on Wednesday, May 2, 2018",, 5/16/2018 28249U10 PRN  Progeria Research Foundation Announces Collaboration and Supply Agreement with Eiger BioPharmaceuticals,,,,,,, 3/14/2018 92165910 PRN  Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock,,, 5/10/2013 45781M10   PRN  BREO™ ELLIPTA™ gains US approval for the treatment of COPD,, 2/20/2018 40637H10 PRN  Halozyme Reports Fourth Quarter And Full-Year 2017 Results, 4/28/2015 G2151510 PRN  China Biologic Products to Report First Quarter 2015 Financial Results," 6/26/2014 56400P70 PRN  Health Care Sector Equities Ahead of Market -- Research on MannKind, Merrimack Pharma, AVEO Pharma, and Rexahn Pharma",,,," 4/24/2017 03236M20 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Amyris, Inc. (AMRS) & Lead Plaintiff Deadline: June 19, 2017", 1/22/2019 69366J20 PRN  PTC Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,,11/30/2016 36197T10 PRN  Cannabis Industry Expects to Become the Next Biggest Market, 9/28/2012 07CMVM-E PRN  Epizyme to Present at Upcoming Scientific and Financial Conferences in October, 6/03/2018 G5087110 PRN  Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data for Xyrem® (sodium oxybate) in Pediatric Patients with Narcolepsy with Cataplexy,,10/04/2013 39843840 PRN  Grifols Announces Launch of the SPIRIT Registry at the NHF Annual Meeting,,, 1/28/2016 008W47-E PRN  Veracyte Receives Regulatory Authorization to Offer Percepta™ Bronchial Genomic Classifier for Patients in New York State,,," 6/11/2012 007V62-E PRN  Cara Therapeutics Reports Positive Results from Phase II Trial of Novel Peripheral Kappa Agonist, CR845, in Acute Post-Operative Pain",,,,,,,,,,,,,"10/26/2016 98401F10 PRN  Xencor to Host Third Quarter 2016 Financial Results Webcast and Conference Call on November 2, 2016",, 5/17/2018 G8807B10 PRN  Theravance Biopharma to Host Key Opinion Leader Event Focused on the Unmet Medical Need in the Treatment of Neurogenic Orthostatic Hypotension,, 9/22/2016 ARDX-US  PRN  Ardelyx to Present at Ladenburg Thalmann 2016 Healthcare Conference,,,,,,,,,,,, 1/23/2018 05070R10 PRN  Audentes Therapeutics Announces Proposed Public Offering of Common Stock,,,,,, 5/01/2018 75901B10 PRN  REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2018 Financial Results and Recent Operational Highlights,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/01/2014 45232710    PRN  Critical Alerts For Discovery Communications, GlaxoSmithKline, Illumina, Teekay and Gulfport Energy Released By InvestorsObserver",, 7/27/2018 G3040110 PRN  Endo Begins Shipment of Authorized Generic Version of INVANZ® (ertapenem for injection) in the United States,"11/11/2011 000CYW-E PRN  Critical Alerts for Most Active Penny Stocks: Arrowhead Research, VELATEL, CryptoLogic, Hudson City Bancorp, Books-A-Million & Brocade", 3/10/2016 09060J10 PRN  BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2015 Financial Results,11/20/2018 09073M10    PRN  Bio-Techne To Present At The Citi 2018 Global Healthcare Conference, 4/26/2019 000VC1-E    PRN  CHMP Issues Positive Opinion for Libtayo® (cemiplimab) in Advanced Cutaneous Squamous Cell Carcinoma,,"11/13/2015 68375N10 PRN  Covered Call Alerts For Freeport-McMoRan, Flotek Industries, Opko Health, International Game Technology and Alibaba Released By InvestorsObserver", 5/04/2018 46222210 PRN  Ionis Reports First Quarter 2018 Financial Results, 9/19/2018 09061G10   PRN  BioMarin to Participate in Two Investor Conferences in October," 6/14/2013 01535110 PRN  Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen", 4/18/2018 64125C10 PRN  Neurocrine Biosciences to Present New Data from INGREZZA® at the 2018 American Academy of Neurology Annual Meeting," 9/16/2013 81257810 PRN  Pre-Market Analysis: Amarin Corp. PLC, Elan Corp. PLC, Cubist Pharmaceuticals Inc., and Seattle Genetics Inc.",, 7/16/2015 05NDXX-E  PRN  Eisai Enters Agreement to Transfer Its Research Triangle Park Campus to Biogen,,," 4/13/2016 37555810   PRN  Covered Call Alerts For Kinder Morgan, Pfizer Inc., Caterpillar Inc., Gilead Sciences and Valeant Pharmaceuticals Released By InvestorsObserver", 5/08/2018 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2018 Financial Results, 9/24/2018 0B6RP3-E  PRN  Mylan Extends Commitment to Fight HIV/AIDS by Partnering with Atomo Diagnostics to Expand Access to HIV Self-Testing in Low- and Middle-Income Countries, 1/18/2018 M2572210 PRN  Compugen Presents New Preclinical Data Demonstrating the Distinctive Features of the PVRIG Pathway in Immuno-Oncology and the Potential of COM701 for Treating Multiple Solid Tumors," 9/30/2013 00972810 PRN  Today's Research: Astex Pharma Inc., Delcath Systems Inc., BioMarin Pharma Inc., and Akorn Inc.", 7/25/2019 03116210 PRN  Amgen Announces Webcast Of 2019 Second Quarter Financial Results,, 5/05/2016 LXRX-US  PRN  Lexicon To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference,," 5/15/2014 45766930 PRN  Clinical Trial Updates, Leadership Appointments, and Earnings Results - Analyst Notes on Tesaro, Novavax, Vanda, Insmed and Durata",, 3/04/2019 45773H20 PRN  Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For the Treatment of HPV-Related Cervical Pre-cancer," 8/01/2018 64026810 PRN  Nektar to Announce Financial Results for the Second Quarter 2018 on Wednesday, August 8, 2018, After Close of U.S.-Based Financial Markets",11/07/2017 76655960 PRN  Rigel Announces Third Quarter 2017 Financial Results and Provides Company Update,,," 8/14/2012 000DP2-E PRN  Hot Stocks: Focus Media, Research In Motion, International Paper, Chesapeake Energy, Las Vegas Sands, and Amarin"," 7/18/2014 45337C10 PRN  Review on Biotech Stocks -- Incyte, ACADIA Pharma, Cel-Sci, Aegerion Pharma, and ImmunoGen"," 2/14/2018 91307C10 PRN  United Therapeutics Corporation To Report Fourth Quarter And Annual 2017 Financial Results Before The Market Opens On Wednesday, February 21, 2018"," 3/07/2013 80360710 PRN  BioMarin Pharma, Amgen, Sarepta Therapeutics, Chelsea Therapeutics Intl., and Theravance Early Briefing and Review", 7/26/2018 G0176710 PRN  Alkermes Plc Reports Second Quarter 2018 Financial Results,,,, 5/01/2017 55027E10 PRN  Luminex Corporation Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance, 1/04/2018 80067710 PRN  Sangamo Therapeutics To Present At The 36th Annual J.P. Morgan Healthcare Conference," 8/10/2012 WINMQ-US PRN  Consensus Earnings Forecast Reports: Sprint Nextel, Cisco, News Corporation, Exelixis, Windstream, and Intel",10/23/2018 80105N10  PRN  Breakthroughs in Breast Cancer Research," 8/16/2013 92532F10  PRN  Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.",,,," 8/21/2013 00422510 PRN  Biotech Companies Announce Financial Results and Receive New Patents - Research Report on Regeneron, Medivation, Incyte, Santarus, and ACADIA",, 1/04/2018 74366E10 PRN  Protagonist Therapeutics Granted Two New US Patents for Peptide Drug Candidates PTG-100 and PTG-300,,,,," 3/05/2014 OMER-US  PRN  Omeros Closes $32 Million Debt Financing, Receiving $12.6 Million in New Funds",,,,,,,,11/07/2017 69329Y10 PRN  PDL BioPharma to Present at Two Upcoming Investor Conferences,,,, 6/20/2017 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Diphenoxylate HCl and Atropine Sulfate Tablets,," 8/17/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Biogen, Alnylam Pharmaceuticals, Isis Pharmaceuticals, AstraZeneca and Sanofi",,,11/01/2017 60468T10 PRN  Mirati Therapeutics Reports Third Quarter 2017 Financial Results,,,,,,, 4/15/2018 09627Y10 PRN  Blueprint Medicines Publication in Cancer Discovery Highlights Preclinical and Clinical Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667,, 5/16/2018 28249U10 PRN  Eiger Announces Expanded License Agreement with Merck for Investigational Candidate Lonafarnib and Collaboration with The Progeria Research Foundation (PRF),,,,,,, 3/06/2018 92165910 PRN  Vanda Pharmaceuticals Announces Participation at March 2018 Investor Conferences,,, 4/17/2013 45781M10   PRN  FDA Advisory Committee recommends approval of BREO™ ELLIPTA™ for the treatment of COPD,, 1/22/2018 40637H10 PRN  Halozyme To Host Fourth Quarter And Full-Year 2017 Financial Results Conference Call, 3/04/2015 G2151510 PRN  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014," 6/26/2014 56400P70 PRN  Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva",,,," 3/24/2017 03236M20 PRN  Research Reports Coverage on Specialty Chemicals Stocks -- LyondellBasell, Amyris, Axalta Coating, and Platform Specialty", 1/07/2019 69366J20 PRN  PTC Therapeutics Announces Executive Team Updates Focused on Accelerating Pipeline and Bringing Gene Therapy Manufacturing In-house,,,,,,,"11/09/2016 36197T10 PRN  Cannabis Stocks Forge Ahead with Newest Therapy Discoveries, Company Files Cannabinoid Pharmaceutical Patent"," 4/26/2012 07CMVM-E PRN  Deal Announced Today Between Celgene Corporation and Epizyme, an LLS-partner, Will Help Advance a Therapy for Patients with Mixed Lineage Leukemia", 6/03/2018 G5087110 PRN  Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in Narcolepsy or Obstructive Sleep Apnea,, 8/12/2013 39843840 PRN  California State Legislature recognizes Grifols for its Decennial Anniversary in California,,, 1/27/2016 008W47-E PRN  Veracyte to Participate in Two Upcoming Investor Conferences,,," 5/03/2012 007V62-E PRN  Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market",,,,,,,,,,,,,10/03/2016 98401F10 PRN  Preliminary Data from the Ongoing Open-Label XmAb5871 Phase 2 Pilot Study in IgG4-Related Disease to be presented at American College of Rheumatology (ACR) 2016 Annual Meeting,, 5/10/2018 G8807B10 PRN  Theravance Biopharma to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference,, 8/15/2016 ARDX-US  PRN  Ardelyx to Present at Wedbush PacGrow Healthcare Conference,,,,,,,,,,,," 1/04/2018 05070R10 PRN  Audentes Announces Positive Interim Data from First Dose Cohort of ASPIRO, a Phase 1/2 Clinical Trial of AT132 in Patients With X-Linked Myotubular Myopathy",,,,,,"10/31/2017 APOP-IL  PRN  Cellect Chosen Among Selected Global Leaders Presenting at Bio-Europe 2017 Conference Addressing over 3,800 Industry Specialists from Over 2,000 World Leading Companies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 9/29/2014 45232710    PRN  Project Update, Awards, Appointment, Product Launch, and Sponsorship - Research Reports on D.R. Horton, Mallinckrodt, Illumina, Ventas and Capital One Financial",, 7/25/2018 003Q2Y-E PRN  Bioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Pitolisant in Canada,, 3/04/2016 0024VM-E PRN  BioDelivery Sciences to Present at the Cowen and Company 36th Annual Healthcare Conference and the 28th Annual ROTH Conference,10/30/2018 09073M10    PRN  Bio-Techne Declares Dividend," 4/08/2019 75886F10    PRN  Regeneron to Report First Quarter 2019 Financial and Operating Results and Host Conference Call and Webcast on May 7, 2019",,"11/06/2015 68375N10 PRN  Covered Call Alerts For Tesla Motors, Ralph Lauren, Opko Health, BP and Aimmune Therapeutics Released By InvestorsObserver", 4/24/2018 46222210 PRN  New Data from IONIS-HTT Rx Phase 1/2 Study Demonstrates Correlation Between Reduction of Disease-causing Protein and Improvement in Clinical Measures of Huntington's Disease, 9/05/2018 09061G10   PRN  BioMarin Announces 20 Poster Presentations at Society for the Study of Inborn Errors of Metabolism (SSIEM) Symposium 2018," 5/20/2013 01535110 PRN  Critical Alerts For Wells Fargo, Alexion Pharmaceuticals, Cigna, Deckers Outdoor, and Yelp Released By InvestorsObserver", 4/10/2018 64125C10 PRN  AbbVie and Neurocrine Biosciences Announce PDUFA Target Date of Q3 2018 for Elagolix in Endometriosis-Associated Pain," 8/29/2013 81257810 PRN  Clinical Trials, Pipeline Developments, Financial Results, and New Appointments - Research Report on Amarin, Immunomedics, Seattle Genetics, Repros Therapeutics, and LifePoint",," 7/07/2015 07Q3YR-E  PRN  AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck",,, 3/29/2016 000L1R-E   PRN  AcelRx Pharmaceuticals Names Howard B. Rosen as Chief Executive Officer and Provides Update on Clinical Development Activities and Corporate Priorities for 2016," 5/02/2018 04004760   PRN  Arena Pharmaceuticals to Release First Quarter 2018 Financial Results and Provide Corporate Update on Tuesday, May 8"," 9/21/2018 N5946510  PRN  Mylan and Biocon Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim", 1/02/2018 M2572210 PRN  Compugen Announces Presentations at Three Upcoming Cancer Immunotherapy Conferences," 9/02/2013 00972810 PRN  Approvals, Acquisitions, Note Redemptions and Invitations to Conferences - Research Report on Mylan, Warner Chilcott, Salix Pharmaceuticals, Mallinckrodt, and Akorn", 7/18/2019 03116210 PRN  Amgen And Allergan's MVASI™ (bevacizumab-awwb) And KANJINTI™ (trastuzumab-anns) Now Available In The United States,, 5/03/2016 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 First Quarter Financial Results,," 1/14/2014 45766930 PRN  Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed",, 3/01/2019 45773H20 PRN  Inovio Pharmaceuticals Completes Sale of Additional Convertible Senior Notes, 7/31/2018 64026810 PRN  Specialty Oncology Drugs One of the Top Markets Generating Most Growth,11/02/2017 76655960 PRN  Rigel Welcomes Gregg Lapointe to Board of Directors,,," 8/07/2012 AGNC-US  PRN  Top Searched Stocks: Chesapeake Energy, Annaly Capital Management, Amarin, American Capital Agency, Alcoa, and Halliburton"," 7/17/2014 45337C10 PRN  Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx"," 1/17/2018 91307C10 PRN  Faruqi & Faruqi, LLP is Investigating United Therapeutics Corporation (UTHR) on Behalf of its Shareholders"," 1/28/2013 80360710 PRN  Free Research Report on Oshkosh Corp., OCZ Technology Group Inc., LipoScience, Inc., Netflix, Inc. and Sarepta Therapeutics, Inc."," 7/24/2018 G0176710 PRN  Free Technical Research Reports on Biotech Stocks -- Alkermes, Alnylam Pharma, Altimmune, and Alexion Pharma",,,, 4/26/2017 55027E10 PRN  Luminex Corporation To Present At The Deutsche Bank 42nd Annual Health Care Conference, 1/03/2018 SGMO-US  PRN  Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS," 8/10/2012 EXEL-US  PRN  Today's Hot Stocks: Exelixis, Monster Beverage, Delta Air Lines, Robbins & Myers, NRG Energy, and CONSOL Energy",10/19/2018 80105N10  PRN  FDA approves asthsma indication for Dupixent® (dupilumab)," 6/18/2013 92532F10  PRN  Advanced Treatment Methods, Significant Study Results, Conferences, and Final Study Data Releases - Research Report on Amgen, Celgene, Vertex Pharmaceuticals, MannKind, and Peregrine Pharmaceuticals",,,," 8/19/2013 00422510 PRN  Technical Study: ACADIA Pharma Inc., Medivation Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc.",,"12/14/2017 PRTA-US  PRN  Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors",,,,, 3/04/2014 68214310 PRN  Omeros Submits IND to Advance OMS721 Phase 2 Clinical Program,,,,,,,,11/02/2017 69329Y10 PRN  PDL BioPharma Announces Third Quarter 2017 Financial Results,,,, 5/08/2017 ANIP-US  PRN  ANI Pharmaceuticals Announces Launch of Pindolol Tablets,, 8/15/2012 02043Q10 PRN  Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy,,,10/12/2017 60468T10 PRN  Mirati Therapeutics' Mocetinostat Included In Stand Up To Cancer's Cutting-Edge Clinical Trial Initiative For NSCLC Patients,,,,,,, 4/15/2018 09627Y10 PRN  Blueprint Medicines Announces Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667 from Phase 1 ARROW Clinical Trial in Patients with RET-Altered Solid Tumors,, 5/11/2018 28249U10 PRN  Eiger BioPharmaceuticals Reports First Quarter 2018 Financial Results,,,,,,, 3/05/2018 92165910 PRN  HETLIOZ® (tasimelteon) Demonstrates Efficacy to Treat Jet Lag Disorder in an 8 Hour Phase Advance Clinical Study,,," 4/17/2013 45781M10   PRN  Critical Alerts For Merck, NetApp, CSX, Theravance, and Uni-Pixel Released By InvestorsObserver",," 1/17/2018 40637H10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Halozyme Therapeutics, Inc. (HALO)", 2/17/2015 G2151510 PRN  China Biologic Products to Report Fourth Quarter and Fiscal Year 2014 Financial Results," 6/06/2014 56400P70 PRN  Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver",,,," 1/06/2017 008CMY-E PRN  Specialty Chemicals Stocks Under Review -- Amyris, LyondellBasell Industries, Platform Specialty Products, and Olin", 1/07/2019 69366J20 PRN  PTC Therapeutics Provides Corporate Update and Outlines 5-year Strategic Plan at 2019 J.P. Morgan Healthcare Conference,,,,,,,"11/08/2016 36197T10 PRN  InvestorsObserver releases covered-call reports for Disney, GW Pharmaceuticals, YY, CVS Caremark and Tenet Healthcare", 7/28/2011 BMR-US   PRN  BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property, 5/31/2018 G5087110 PRN  New Survey Highlights Lack of Awareness of Neurologic Effects Related to Excessive Sleepiness in Patients with Obstructive Sleep Apnea,, 7/18/2013 39843840 PRN  Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University,,, 1/22/2016 008W47-E PRN  Veracyte Announces Publication of Long-Term Clinical Utility Study for the Afirma® Gene Expression Classifier,,," 4/03/2012 007V62-E PRN  Cara Therapeutics Successfully Completes Phase I Study With Oral Formulation of its Novel Kappa Opioid Receptor Agonist, CR845",,,,,,,,,,,,, 9/15/2016 98401F10 PRN  Xencor Initiates Phase 1b Trial of Subcutaneous Formulation of XmAb7195,," 5/08/2018 TBPH-US  PRN  Theravance Biopharma, Inc. Reports First Quarter 2018 Financial Results and Provides Business Update",, 8/08/2016 03969710 PRN  Ardelyx Reports Second Quarter 2016 Financial Results,,,,,,,,,,,, 1/03/2018 05070R10 PRN  Audentes Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference,,,,,," 8/31/2017 75901B10 PRN  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Dimension Therapeutics, Inc. - DMTX",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 9/22/2014 45232710    PRN  Life Sciences Tools and Services Equities Technical Data - PerkinElmer, Agilent Technologies, Bruker, Sequenom, and Illumina",, 7/20/2018 G3040110 PRN  Endo to Announce Second-Quarter 2018 Financial Results,," 3/03/2016 09060J10 PRN  BioDelivery Sciences to Host Conference Call and Webcast of Fourth Quarter and Full-Year 2015 Results on Thursday, March 10",10/30/2018 09073M10    PRN  Bio-Techne Releases First Quarter Fiscal 2019 Results," 4/08/2019 75886F10    PRN  Regeneron and Alnylam Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and Central Nervous System (CNS) Diseases",,"10/26/2015 68375N10 PRN  Critical Alerts For MannKind, Amazon.com, Synaptics Incorporated, athenahealth and Opko Health Released By InvestorsObserver", 4/24/2018 46222210 PRN  Ionis Pharmaceuticals to Hold First Quarter 2018 Financial Results Webcast, 8/22/2018 09061G10   PRN  BioMarin to Participate in Three Investor Conferences in September," 4/09/2013 01535110 PRN  Stock Alerts For American Express, Norfolk Southern, Toll Brothers, Alexion Pharmaceuticals, and Pier 1 Imports Released By InvestorsObserver", 3/07/2018 64125C10 PRN  Neurocrine Biosciences to Present at Upcoming Healthcare Conferences, 6/26/2013 SGEN-US  PRN  Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman,," 7/07/2015 00DV6T-E  PRN  Dr. Olivier Danos, Cell and Gene Therapy Pioneer, Joins Alcyone Lifesciences Scientific Advisory Board",,," 3/08/2016 37555810   PRN  Covered Call Alerts For Apple, Exact Sciences, American Express, FireEye and Gilead Sciences Released By InvestorsObserver", 5/01/2018 002XMH-E   PRN  Arena Pharmaceuticals and Outpost Medicine Enter into Licensing Agreement for Undisclosed Novel Compound, 9/21/2018 N5946510  PRN  Mylan Launches Authorized Generic of Ampyra® Tablets,11/07/2017 M2572210 PRN  Compugen Reports Third Quarter 2017 Results," 8/21/2013 00972810 PRN  Pre-Market Review: Delcath Systems Inc., Astex Pharma Inc., BioMarin Pharma Inc., and Akorn Inc."," 7/11/2019 03116210 PRN  Amgen, Novartis And Banner Alzheimer's Institute Discontinue Clinical Research Program With BACE Inhibitor CNP520 For Alzheimer's Prevention",," 4/29/2016 52887230 PRN  Lexicon To Report First Quarter 2016 Financial Results On May 3, 2016",," 1/09/2014 45766930 PRN  Quick Market Round-up before the Bell: Delcath Systems, Valeant Pharma Intl., BioMarin Pharma, and Insmed",, 2/21/2019 0JHFN4-E PRN  Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies, 7/30/2018 64026810 PRN  Nektar Therapeutics Announces New Drug Application for NKTR-181 Accepted for Review by FDA,10/31/2017 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Third Quarter 2017 Financial Results,,," 7/30/2012 ESV-GB   PRN  Today's Hot Stocks: Expedia, Amarin, ENSCO, Amgen, Wal-Mart, and Nokia"," 7/08/2014 45337C10 PRN  Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne"," 1/16/2018 00GLW9-E PRN  Spyryx Biosciences Expands with Election of Roger Jeffs, PhD as Independent Director"," 1/04/2013 RIG-CH   PRN  Critical Alerts For Netflix, Transocean, Crocs, Arch Coal, and Sarepta Therapeutics Released By InvestorsObserver", 7/19/2018 G0176710 PRN  Alkermes to Host Conference Call to Discuss Second Quarter 2018 Financial Results,,,, 4/20/2017 55027E10 PRN  Luminex Corporation To Present At Bank Of America Merrill Lynch 2017 Health Care Conference,12/07/2017 80067710 PRN  Sangamo Announces European Medicines Agency Recommendation Of Orphan Medicinal Product Designation For Investigational Genome Editing Treatments For MPS I And MPS II," 6/29/2012 002SHN-E PRN  3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology",10/16/2018 80105N10  PRN  Dupixent® (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps," 5/29/2013 92532F10  PRN  Critical Alerts For Bank of America, Vertex Pharmaceuticals, Dish Network, American Capital, and Advanced Micro Devices Released By InvestorsObserver",,,," 6/10/2013 00422510 PRN  Collaborations, Clinical Development Programs, FDA Approvals, New Treatments and Attractive Product Portfolios - Research Report on Medivation, Acadia, Santarus, Seattle Genetics, and PDL BioPharma",,"12/14/2017 74366E10 PRN  Protagonist Therapeutics Announces Final Phase 1 Study Results with Novel Hepcidin Mimetic, PTG-300",,,,, 2/26/2014 68214310 PRN  Omeros to Present at Cowen and Company 34th Annual Health Care Conference,,,,,,,,10/30/2017 69329Y10 PRN  PDL BioPharma Issues Statement in Response to Neos Therapeutics Rejection of PDL Acquisition Proposal,,,, 5/04/2017 00182C10 PRN  ANI Pharmaceuticals Reports First Quarter Results and Year-To-Date 2017 Highlights and Reaffirms Guidance,," 8/07/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Alnylam Pharmaceuticals, GlaxoSmithKline, Medtronic, Novartis and Biogen Idec",,, 9/19/2017 60468T10 PRN  Mirati Therapeutics To Present At Upcoming Healthcare Conferences,,,,,,, 3/14/2018 09627Y10 PRN  Blueprint Medicines to Present Proof-of-Concept Data from Ongoing Phase 1 Clinical Trial of BLU-667 in Patients with RET-Altered Solid Tumors in a Clinical Trials Plenary Session at AACR Annual Meeting 2018,," 4/17/2018 28249U10 PRN  Eiger Announces Sub-Analysis of Phase 2 Results Demonstrating High Response Rates to ""All-Oral"" Lonafarnib-Ritonavir Regimen in Low Viral Load HDV-Infected Patients at The International Liver Congress™ 2018",,,,,,, 2/14/2018 92165910 PRN  Vanda Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial Results,,," 4/08/2013 45781M10   PRN  Pre-Market Analysis on Sarepta Therapeutics, BioMarin Pharma, Theravance, and Chelsea Therapeutics",," 1/17/2018 HALO-US  PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therapeutics, Inc. - HALO"," 2/16/2015 G2151510 PRN  A Look at the Latest Occurrences in the Biotechnology Sector: Special Research on China Biologic Products, Compugen, Curis, CytRx, and DBV Technologies"," 5/20/2014 56400P70 PRN  Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding",,,,"11/30/2016 03236M20 PRN  Basic Materials Stocks Under Review -- ArcelorMittal, United States Steel, Amyris, and LyondellBasell Industries", 1/02/2019 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conference,,,,,,,"10/14/2016 36197T10 PRN  InvestorsObserver releases covered-call reports for Netflix, JetBlue, GW Pharmaceuticals, Ulta Salon Cosmetics & Fragrance Inc. and Delta Airlines",, 5/24/2018 G5087110 PRN  Jazz Pharmaceuticals Announces Webcast Discussion of Data to be Presented at APSS,, 5/22/2013 39843840 PRN  Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency,,, 1/07/2016 92337F10 PRN  Veracyte Announces Expansion to New South San Francisco Facility,,,11/22/2011 007V62-E PRN  Cara Therapeutics Initiates Phase I Study with Oral Formulation of Novel Peripherally-Acting Kappa Opioid Agonist,,,,,,,,,,,,, 9/12/2016 98401F10 PRN  Xencor Doses First Patient in Lead Immuno-Oncology Bispecific Program XmAb14045 for the Treatment of Acute Myeloid Leukemia and Other CD123-Expressing Hematologic Malignancies,," 5/01/2018 G8807B10 PRN  Theravance Biopharma to Report First Quarter 2018 Financial Results on May 8, 2018",," 8/01/2016 03969710 PRN  Ardelyx to Report Second Quarter 2016 Financial Results on August 8th, 2016",,,,,,,,,,,,"12/13/2017 05070R10 PRN  Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors",,,,,," 8/29/2017 RGNX-US  PRN  DIMENSION THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dimension Therapeutics, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 9/11/2014 45232710    PRN  Trial Results, Notes Exchange Offer, Consortium Formation, Market Activity Updates, and Orphan Drug Designation Grant - Research Reports on Lilly, Perrigo, Illumina, HCA and Alexion",," 7/02/2018 05HWBL-E PRN  Endo Begins Shipment of Authorized Generic Version of Colcrys® (colchicine, USP) in the United States",, 2/22/2016 09060J10 PRN  BioDelivery Sciences Announces the Launch of BELBUCA™ (Buprenorphine) Buccal Film by Endo Pharmaceuticals for Chronic Pain Management,10/26/2018 09073M10    PRN  Bio-Techne To Present At The 2018 Stephens NY Investment Conference, 4/01/2019 062S3Y-E    PRN  Inovio Completes Enrollment Ahead of Schedule In Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron's PD-1 Inhibitor,,"10/12/2015 68375N10 PRN  Covered Call Alerts For FireEye, Southwestern Energy Company, Baidu, Opko Health and Second Sight Medical Products Inc. Released By InvestorsObserver", 4/17/2018 46222210 PRN  Presentations at the 2018 American Academy of Neurology Highlight the Broad Potential of Antisense Drugs for Neurological Diseases, 8/02/2018 09061G10   PRN  BioMarin Announces Second Quarter 2018 Results," 3/18/2013 01535110 PRN  Innovative Product Portfolios Ride Commercialization & Global Expansion - Research Report on Amgen, Onyx Pharmaceuticals, Alexion Pharmaceuticals, BioMarin Pharmaceutical and Incyte", 2/21/2018 64125C10 PRN  AbbVie Announces Positive Topline Results from Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids," 6/10/2013 81257810 PRN  Collaborations, Clinical Development Programs, FDA Approvals, New Treatments and Attractive Product Portfolios - Research Report on Medivation, Acadia, Santarus, Seattle Genetics, and PDL BioPharma",, 7/01/2015 09062X10  PRN  Biogen Invests in the Greater Zurich Area: Biopharmaceutical Plant in the Canton of Solothurn Planned,,," 2/24/2016 37555810   PRN  Covered Call Alerts For Gilead Sciences, Radian Group Incorporated, FireEye, Goldcorp and Facebook Released By InvestorsObserver", 4/12/2018 04004760   PRN  Arena Pharmaceuticals Announces Phase 2 Data Presentation for Ralinepag in Pulmonary Arterial Hypertension at the International Society for Heart and Lung Transplantation Annual Meeting," 9/20/2018 MYL-US    PRN  Mylan and Fujifilm Kyowa Kirin Biologics Receive European Marketing Authorization for Hulio®, Biosimilar Adalimumab","11/06/2017 M2572210 PRN  Compugen to Initiate Manufacturing of COM902, its Lead Anti-TIGIT Monoclonal Antibody"," 7/11/2013 00972810 PRN  Akorn, Inc. Announces Second Quarter 2013 Earnings Release And Conference Call Information"," 7/08/2019 03116210 PRN  Amgen Announces The Outcome Of The Recommended Public Cash Offer To The Shareholders Of Nuevolution, Declares The Offer Unconditional And Completes The Offer",, 4/07/2016 52887230 PRN  Lexicon To Present At The 15th Annual Needham Healthcare Conference,,"12/11/2013 45766930 PRN  Daily Trends Scanner: BioMarin Pharma Inc., Delcath Systems Inc., Akorn Inc., and Insmed Inc.",, 2/20/2019 45773H20 PRN  Inovio Announces First Subject Dosed with its DNA-Encoded Monoclonal Antibody (dMAb™) In First-Ever Human Trial, 6/26/2018 NKTR-US  PRN  IsoPlexis Announces Research Collaboration with Nektar Therapeutics,10/10/2017 76655960 PRN  Rigel Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Option To Purchase Additional Shares,,," 7/20/2012 T-US     PRN  Hot Stocks Research for eBay, JPMorgan, AT&T, Amarin, Textron, and Riverbed Technology"," 5/28/2014 45337C10 PRN  Clinical Study Results, Schedule of Upcoming Conferences, Dividend Declaration, and Services Agreement - Analyst Notes on Gilead, Quest Diagnostics, Sarepta Therapeutics, Incyte and Centene", 1/03/2018 91307C10 PRN  Corsair Pharma and United Therapeutics Enter into Strategic Collaboration to Advance Novel Treprostinil Prodrugs,"11/27/2012 ESRX-US  PRN  Critical Alerts For Dell, Express Scripts, Whole Foods, Pandora, and Sarepta Therapeutics Released By InvestorsObserver", 7/02/2018 G0176710 PRN  FDA Approves ARISTADA INITIO™ for the Initiation of ARISTADA® for Schizophrenia,,,," 4/10/2017 55027E10 PRN  Luminex Corporation First Quarter Earnings Release Scheduled for May 1, 2017","11/24/2017 80067710 PRN  Sangamo Therapeutics, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)",,10/15/2018 005M9Z-E  PRN  Shining a Light on Diagnosis for Rare Genetic Disease Patients," 4/23/2013 NFLX-US   PRN  Netflix Indicating Big Jump Pre-Market on Earnings Surprise - Top Earnings Stocks Ahead of the Bell: Power-One Inc., Goff Corporation, AMR Corporation, Fannie Mae, Vertex Pharmaceuticals",,,," 5/16/2013 00422510 PRN  Critical Alerts For Chevron, MGM Mirage, Charter Communications, Quanta Services, and Acadia Released By InvestorsObserver",,12/04/2017 74366E10 PRN  Protagonist Therapeutics to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference,,,,, 2/19/2014 68214310 PRN  Omeros Announces Enrollment in Second Phase 2 Clinical Trial with OMS824,,,,,,,,10/30/2017 69329Y10 PRN  Neos Therapeutics Board of Directors Unanimously Rejects Unsolicited Proposal from PDL BioPharma,,,, 4/27/2017 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2017 Financial Results,," 7/17/2012 LCC-US   PRN  Most Attractive Stocks: Bank of America, Apple, Chesapeake Energy, Alnylam, VIVUS, and US Airways Group",,, 9/14/2017 60468T10 PRN  Mirati Therapeutics Presents Positive Preliminary Data From On-Going Clinical Trials Of Sitravatinib In Non-Small Cell Lung Cancer,,,,,,, 3/06/2018 09627Y10 PRN  Blueprint Medicines to Present at Cowen and Company 38th Annual Health Care Conference,, 4/02/2018 28249U10 PRN  Eiger BioPharmaceuticals to Participate in Conferences in April,,,,,,," 1/30/2018 92165910 PRN  Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 14, 2018",,," 3/07/2013 SWI.XX1-US PRN  Critical Alerts For Schlumberger, Metlife, Ameriprise, SolarWinds, and Theravance Released By InvestorsObserver",, 1/09/2018 40637H10 PRN  Halozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In 2018, 1/08/2015 G2151510 PRN  China Biologic Adopts Stockholder Rights Plan," 5/16/2014 56400P70 PRN  Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst",,,,11/10/2016 008CMY-E PRN  Biofuel and the Importance in the Renewable Energy Industry,12/20/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,"10/06/2016 36197T10 PRN  Technical Roundup on Drug Makers Stocks -- Tonix Pharma, Retrophin, Heron Therapeutics, and GW Pharma",, 5/10/2018 G5087110 PRN  Jazz Pharmaceuticals to Highlight Breadth of Research in Narcolepsy and Excessive Sleepiness in Obstructive Sleep Apnea at SLEEP 2018 Annual Meeting,," 4/05/2013 39843840 PRN  Annual Report for 2012 on Form 20-F filed with the SEC on April 5, 2013",,,12/21/2015 008W47-E PRN  Veracyte to Present at the 34th Annual J.P. Morgan Healthcare Conference,,, 8/03/2011 007V62-E PRN  Cara Therapeutics Initiates Phase II Trial of Novel Analgesic in Acute Post-Operative Pain,,,,,,,,,,,,, 8/31/2016 98401F10 PRN  Xencor to Present at Upcoming Investor Conferences,, 4/25/2018 G8807B10 PRN  Theravance Biopharma Highlights Approval of Expanded Indication in the US for Once-Daily Trelegy Ellipta for Treatment of COPD Patients,, 8/01/2016 03969710 PRN  Ardelyx Receives Notice of Allowance of Composition of Matter Patent Covering its Novel Potassium Binder RDX227675,,,,,,,,,,,,"11/21/2017 05070R10 PRN  Audentes Therapeutics Announces Publication of Data from RECENSUS, a Retrospective Medical Record Review of Patients With X-Linked Myotubular Myopathy",,,,,, 3/11/2014 05Q366-E PRN  ESTEVE and U.A.B. Advance in Their Program to Develop a Cure for Sanfilippo A Syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 9/03/2014 45232710    PRN  Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott",, 6/11/2018 AUXL-US  PRN  Endo Announces Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement Therapy Product Liability Claims and Entry of Significant Case Management Order,, 2/22/2016 05MBN8-E PRN  Endo Announces Launch Of BELBUCA™ (Buprenorphine) Buccal Film For Chronic Pain Management,10/12/2018 000XKX-E    PRN  Bio-Techne Signs Strategic Cooperation Agreement with Micropoint Bioscience, 3/15/2019 75886F10    PRN  Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease,," 9/30/2015 HCBK-US  PRN  Technical Review on Healthcare and Financial Sectors -- Two Harbors Investments, Hudson City Bancorp, Novavax, Opko Health and Exelixis", 4/09/2018 46222210 PRN  Ionis and AstraZeneca Advance New Drug for NASH," 7/11/2018 09061G10   PRN  BioMarin to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Thursday, August 2 at 4:30pm ET"," 2/20/2013 01535110 PRN  Critical Alerts For Goldman Sachs, Target, V.F. Corp, Franklin Resources, and Alexion Pharmaceuticals Released By InvestorsObserver", 2/14/2018 64125C10 PRN  Neurocrine Biosciences Will File New Drug Application for Opicapone for Parkinson's Disease Based on Existing Pivotal Clinical Trial Data," 4/25/2013 NE-US    PRN  Critical Alerts For ConocoPhillips, Estee Lauder, D.R. Horton, Noble, and Seattle Genetics Released By InvestorsObserver",, 6/18/2015 09062X10  PRN  Biogen and SELF Help Women Reimagine Daily Life with Relapsing Multiple Sclerosis (RMS),,," 2/10/2016 37555810   PRN  Covered Call Alerts For Chesapeake Energy, Microsoft, Gilead Sciences, Biogen and JetBlue Released By InvestorsObserver", 3/26/2018 04004760   PRN  Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares, 9/17/2018 N5946510  PRN  Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of YUPELRI™ (revefenacin) in Oral Presentation at the European Respiratory Society International Congress,11/02/2017 M2572210 PRN  Compugen to Enter Research Collaboration With Mount Sinai on Novel Myeloid Immuno-Oncology Targets," 4/08/2013 ASTX-US  PRN  Mylan, Akorn, Astex Pharma, and Forest Laboratories Under StockCall's Microscope", 6/28/2019 03116210 PRN  Amgen and UCB Provide Regulatory Update on Status of EVENITY™ (romosozumab) in the EU,, 3/30/2016 52887230 PRN  Lexicon Submits New Drug Application To FDA For Telotristat Etiprate For The Treatment Of Carcinoid Syndrome,,"12/03/2013 45766930 PRN  Healthcare Companies Report Appointments, Phase 1 Studies, and Corporate Growth - Research Report on HCA, Isis Pharmaceuticals, Oxygen Biotherapeutics, Insmed, and Zalicus",, 2/14/2019 45773H20 PRN  Inovio Pharmaceuticals Prices $65.0 Million Convertible Senior Notes Offering," 6/14/2018 64026810 PRN  New Data for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Low Back Pain in Adult Patients New to Opioid Therapy, Presented at College on Problems of Drug Dependence 80th Annual Scientific Meeting",10/04/2017 76655960 PRN  Rigel Announces Pricing Of Public Offering Of Common Stock,,," 7/13/2012 AMTD-US  PRN  Stock Alerts For AT&T, UnitedHealth, TD Ameritrade, Amarin, and Body Central Released By InvestorsObserver"," 5/22/2014 000M2Q-E PRN  Novartis presents key advances in cancer research at ASCO and EHA from four new pivotal studies in lung, blood and skin cancers",12/28/2017 91307C10 PRN  United Therapeutics Corporation To Present At 36th Annual J.P. Morgan Healthcare Conference,"10/04/2012 0CS907-E PRN  Critical Earnings Forecast Alerts: Hewlett-Packard, Sarepta Therapeutics, Mondelez International, Kraft, Sirius, and Netflix", 6/06/2018 G0176710 PRN  Alkermes to Present at Goldman Sachs 39th Annual Global Healthcare Conference,,,, 3/01/2017 55027E10 PRN  Luminex Corporation To Present At The Barclays Global Healthcare Conference,11/15/2017 80067710 PRN  Sangamo Announces Treatment of First Patient in Landmark Phase 1/2 Clinical Trial Evaluating In Vivo Genome Editing for MPS II,,10/11/2018 80105N10  PRN  What to Do When You Can't Afford Your Chronic Disease Medication," 4/22/2013 VRTX-US   PRN  Today's Earnings Forecast for EMC, Intel, Cisco, Dell, Vertex Pharmaceuticals, and International Business Machines",,,, 5/06/2013 093TP1-E PRN  Parkinson's Therapeutics Reviewed by NeuroPerspective,,"11/09/2017 74366E10 PRN  Protagonist Therapeutics Initiates Phase 1 Trial of Oral Peptide IL-23 Receptor Antagonist, PTG-200",,,,, 2/11/2014 68214310 PRN  Omeros Reports Additional Positive Phase 1 Clinical Data for OMS824 for the Treatment of Cognitive Disorders,,,,,,,,10/30/2017 69329Y10 PRN  PDL BioPharma Announces Settlement Agreement with Valeant,,,, 4/19/2017 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Indapamide Tablets,," 6/14/2012 06DDVL-E PRN  Zacks.com featured expert Kevin Matras highlights: Alnylam Pharmaceuticals, Inc., Astoria Financial Corp., International Bancshares Corp., United Stationers Inc. and CVB Financial Corp.",,, 9/06/2017 60468T10 PRN  Sitravatinib Data To Be Highlighted At The IASLC 18th World Conference on Lung Cancer,,,,,,, 2/21/2018 09627Y10 PRN  Blueprint Medicines Reports Fourth Quarter and Full Year 2017 Financial Results,, 3/26/2018 28249U10 PRN  Eiger Announces First Patient Dosed in Phase 2 PREVENT Study of Exendin 9-39 in Patients Suffering from Post-Bariatric Hypoglycemia,,,,,,, 1/07/2018 92165910 PRN  Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2017 Revenue Results and 2018 Guidance,,," 3/07/2013 45781M10   PRN  BioMarin Pharma, Amgen, Sarepta Therapeutics, Chelsea Therapeutics Intl., and Theravance Early Briefing and Review",,12/27/2017 40637H10 PRN  Halozyme Therapeutics To Present At The 36th Annual J.P. Morgan Healthcare Conference,12/23/2014 G2151510 PRN  China Biologic Receives GMP Certification for New Coagulation Factor Facility," 5/15/2014 56400P70 PRN  Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver",,,,"10/18/2016 03236M20 PRN  Specialty Chemicals Stocks Under Scanner -- LyondellBasell Industries, Amyris, International Flavors & Fragrances, and Kronos Worldwide",12/18/2018 69366J20 PRN  PTC Therapeutics Deepens Financial and Commercial Expertise of Board with Two New Appointments,,,,,,," 9/27/2016 36197T10 PRN  NVIDIA trade offers an 8% return in 53 days, or find similar option trades on GW Pharmaceuticals, Consol Energy, Micron, and Spark Therapeutics",, 5/09/2018 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences,, 3/25/2013 07G69B-E PRN  Global Blood Plasma 2013 Market Report,,,12/14/2015 008W47-E PRN  Veracyte Announces Positive Coverage Policy for the Afirma® Gene Expression Classifier from Health Care Service Corporation (HCSC),,," 3/30/2011 007V62-E PRN  Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer",,,,,,,,,,,,, 8/03/2016 98401F10 PRN  Xencor to Present at Upcoming Investor Conferences,, 4/23/2018 G8807B10 PRN  Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV® (telavancin) at 2018 ECCMID™ Conference,, 7/15/2016 03969710 PRN  Ardelyx to Raise $110 Million in a Private Placement,,,,,,,,,,,,11/16/2017 05070R10 PRN  Audentes Therapeutics to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 8/18/2014 45232710    PRN  Life Sciences Tools and Services Stocks in Motion -- Affymetrix, Agilent Technologies, Bruker, Illumina, and Sequenom",," 6/08/2018 G3040110 PRN  HollyFrontier, Broadridge Financial Solutions Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600",, 2/18/2016 09060J10 PRN  BioDelivery Sciences to Webcast Analyst & Investor Day on February 25th,"10/11/2018 09073M10    PRN  Bio-Techne To Host Conference Call On October 30, 2018 To Announce First Quarter 2019 Financial Results", 3/13/2019 000VC1-E    PRN  Regeneron and Sanofi to Present New Praluent® (alirocumab) Data at ACC.19,," 9/28/2015 68375N10 PRN  Critical Alerts For Opko Health, Jabil Circuit, Costco, Invensense and Second Sight Medical Products Inc. Released By InvestorsObserver", 3/26/2018 IONS-US  PRN  Ionis and Akcea Present New Data from ATTR Amyloidosis Program at 16th International Symposium on Amyloidosis, 7/09/2018 09061G10   PRN  BioMarin Partners with Believe Limited for 'Breaking Through!' Musical Theater Intensive, 2/19/2013 01535110 PRN  StockCall Scrutinizes Alexion Pharma and Celgene: Biotech Stocks Offers Healthy Returns, 2/13/2018 64125C10 PRN  Neurocrine Biosciences Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Investor Update for 2018," 3/25/2013 81257810 PRN  Critical Alerts For Home Depot, Dow Chemical, Foot Locker, Seattle Genetics, and Texas Roadhouse Released By InvestorsObserver",," 5/08/2015 09062X10  PRN  Biotech Equities Ahead of Market -- Biocept, Athersys, Biogen, Dyax Corp., and Incyte",,," 2/02/2016 37555810   PRN  Covered Call Alerts For Gilead Sciences, Chipotle Mexican Grill, Michael Kors, Valeant Pharmaceuticals and Sysco Corporation Released By InvestorsObserver", 3/23/2018 04004760   PRN  Arena Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference on March 27, 9/13/2018 N5946510  PRN  Mylan Adds to Cardiovascular Portfolio With Launch of First Generic of Brevibloc® Injection in Single-Dose Bags,10/26/2017 M2572210 PRN  Compugen to Present at the Annual Meeting of the Society for Immunotherapy of Cancer Next Month," 4/03/2013 00972810 PRN  Akorn, Inc. Announces First Quarter 2013 Earnings Release And Conference Call Information", 6/25/2019 03116210 PRN  Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket,, 3/08/2016 52887230 PRN  Lexicon Announces Telotristat Etiprate Data To Be Presented At European Neuroendocrine Tumor Society Conference,,"11/18/2013 45766930 PRN  Financial Results, Conference Calls Schedules, and Outlook- Research Report on Spectrum, Magellan, Insmed, GenMark, and Envision",, 2/13/2019 45773H20 PRN  Inovio Pharmaceuticals Announces Proposed Convertible Senior Notes Offering, 6/05/2018 64026810 PRN  Nektar to Webcast Presentation at the Jefferies 2018 Healthcare Conference in New York,10/03/2017 76655960 PRN  Rigel Announces Proposed Public Offering Of Common Stock,,," 7/06/2012 LVS-US   PRN  Today's Hot Stocks: JPMorgan, Oracle, Las Vegas Sands, TJX, McDonald's, and Amarin"," 5/19/2014 45337C10 PRN  Recognitions, Agreements, Study Results, Data Presentations, and Financial Results - Analyst Notes on Baxter, Incyte, Isis, Celldex Therapeutics, Inc. and Agilent",11/20/2017 000P56-E PRN  United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca®,"10/04/2012 WINMQ-US PRN  Most Active Stocks: Sarepta Therapeutics, Kraft, Netflix, Corning, Starbucks, and Windstream", 6/06/2018 00167Y-E PRN  Alkermes Receives $50 Million Payment From Biogen Following Review of Preliminary Gastrointestinal Tolerability Data From the Ongoing BIIB098 Clinical Development Program,,,, 2/21/2017 55027E10 PRN  Luminex Corporation Announces Initiation of Cash Dividend,11/09/2017 SGMO-US  PRN  Sangamo Announces Strategic Investment In Manufacturing And Appointment Of Andy Ramelmeier As Head Of Technical Operations,,10/09/2018 80105N10  PRN  Keeping Women In STEM Careers: Looking to Data For Answers, 4/22/2013 CMG-US    PRN  The Market Rebounds and Sea World Makes its Debut,,,," 4/12/2013 00422510 PRN  GOFF Corporation Shares Halt The Slide Looking For Follow Through- Top Five Small Cap Stocks Ahead Of The Bell: Lyon Williams, Acadia Pharmaceutical, Fannie Mae, AMR Corporation",,11/06/2017 74366E10 PRN  Protagonist Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update,,,,, 2/05/2014 68214310 PRN  FDA Grants Fast Track Designation to Omeros' OMS824 Huntington's Disease Program,,,,,,,,10/26/2017 69329Y10 PRN  Neos Therapeutics to Review Unsolicited Proposal from PDL BioPharma,,,, 3/02/2017 00182C10 PRN  ANI Pharmaceuticals Reports Full Year 2016 Results and Fourth Quarter Results and Provides 2017 Guidance,, 4/30/2012 02043Q10 PRN  Regulus Therapeutics Appoints Bruce Carter to its Board of Directors,,, 8/30/2017 60468T10 PRN  Mirati Therapeutics To Participate In Immuno-Oncology Panel Discussion At The 2017 Citi Biotech Conference,,,,,,," 2/14/2018 09627Y10 PRN  Blueprint Medicines to Report Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 21, 2018",, 3/21/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces Positive Guidance Following FDA Meeting on Hepatitis Delta Virus Registration Program,,,,,,,11/13/2017 92165910 PRN  Vanda Pharmaceuticals Announces Participation at November 2017 Investor Conferences,,," 3/07/2013 INVA-US    PRN  Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood",,11/15/2017 40637H10 PRN  Halozyme Therapeutics To Participate In Upcoming Healthcare Conferences,11/05/2014 G2151510 PRN  China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2014," 5/14/2014 56400P70 PRN  MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc.",,,," 8/26/2016 008CMY-E PRN  Specialty Chemicals Stocks Technical Reports -- LyondellBasell Industries, Olin, Axalta Coating Systems, and Amyris",12/07/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 9/27/2016 36197T10 PRN  Multi-Billion Dollar Cannabis Operations Boosting High Revenue Gains Through Newest Cultivation Uses of Liquid Fulvic and Humic Acid Extract,, 5/08/2018 G5087110 PRN  Jazz Pharmaceuticals Announces First Quarter 2018 Financial Results,, 3/06/2013 39843840 PRN  Cadence Pharmaceuticals Announces Strategic Plan to Secure Long-Term Manufacture and Supply of OFIRMEV® (acetaminophen) Injection,,,11/18/2015 92337F10 PRN  Veracyte to Present at Piper Jaffray 27th Annual Healthcare Conference,,, 7/21/2010 007V62-E PRN  Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845,,,,,,,,,,,,, 8/02/2016 98401F10 PRN  Xencor Reports Second Quarter 2016 Financial Results,, 4/19/2018 0C9L2Z-E PRN  Theravance Biopharma Highlights Landmark IMPACT Study Published in NEJM Showing Significant Benefits of Trelegy Ellipta for COPD Patients,, 6/22/2016 06CR5C-E PRN  Ardelyx Reports Progress of Development Programs,,,,,,,,,,,,11/14/2017 05070R10 PRN  Audentes Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 8/15/2014 45232710    PRN  Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent",, 5/08/2018 G3040110 PRN  Endo Reports First-Quarter 2018 Financial Results,, 1/25/2016 BDSI-US  PRN  BioDelivery Sciences to Host Analyst and Investor Day on February 25th in New York City,10/02/2018 09073M10    PRN  Bio-Techne Scientist Presented with the CASSS CE Pharm Award," 3/12/2019 75886F10    PRN  Teen Scientists Win $1.8 Million at Regeneron Science Talent Search 2019 with Innovative Ideas on Exoplanets, HIV and a Classic Math Problem",," 9/22/2015 68375N10 PRN  Expert Briefing on Biotechnology Stocks -- Baxalta, Opko Health, Spectrum Pharma, Arrowhead Research, and Oncothyreon", 3/23/2018 46222210 PRN  Ionis Pharmaceuticals Provides Corporate Update at 2018 Annual Meeting of Stockholders, 6/28/2018 09061G10   PRN  BioMarin Announces First Recipients of RARE Scholars Scholarship Program," 1/14/2013 01535110 PRN  Critical Alerts For Philip Morris International, SanDisk, Peabody Energy, US Airways, and Alexion Pharmaceuticals Released By InvestorsObserver", 2/08/2018 64125C10 PRN  Neurocrine Biosciences to Present at the Leerink Partners 7th Annual Global Healthcare Conference," 3/25/2013 HALO-US  PRN  Morning Research on Gilead Sciences, Halozyme Therapeutics, InterMune, and Seattle Genetics",, 4/30/2015 IONS-US   PRN  Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen,,," 1/28/2016 GILD-US    PRN  Stocks Alerts for Significant Trades Made by C-Level Officers in Ebay, Apple, Yahoo, Gilead Sciences, Qualcomm, and Texas Instruments", 3/21/2018 04004760   PRN  Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock, 9/11/2018 N5946510  PRN  Theravance Biopharma and Mylan to Report New Data from Phase 3 Studies of YUPELRI™ (revefenacin) in Oral Presentation at European Respiratory Society International Congress 2018,"10/25/2017 M2572210 PRN  Compugen Third Quarter 2017 Conference Call Scheduled for Tuesday, November 7, 2017 at 10:00 AM ET"," 3/08/2013 MYL-US   PRN  Before the Bell Scans of Mylan, Forest Laboratories, Avanir Pharma, Akorn, and Medicines Co.", 6/19/2019 03116210 PRN  Amgen And The Institute For Protein Design (IPD) At University Of Washington Announce Unique Strategic Research Partnership,, 3/03/2016 52887230 PRN  Lexicon To Present At The 36th Annual Cowen Healthcare Conference,,"11/15/2013 45766930 PRN  Pre-Market Review: Delcath Systems Inc., BioMarin Pharma Inc., Insmed Inc., and Akorn Inc.",, 1/24/2019 45773H20 PRN  Inovio Reports 2nd Patient Achieving Full Remission from HPV-Related Head & Neck Cancer after Treatment with Synthetic DNA Vaccine and a PD-1 Checkpoint Inhibitor," 6/02/2018 64026810 PRN  Preliminary Data for NKTR-214 in Combination with Opdivo (nivolumab) for Patients with Stage IV Metastatic Melanoma, Renal Cell Carcinoma, and Urothelial Cancers Presented at ASCO 2018",10/03/2017 76655960 PRN  Biotech Sector Notches Impressive Year-to-date Returns With Positive Outlook for Development of New Drugs and Therapies,,," 6/28/2012 OREXQ-US PRN  Hot Stocks: Orexigen Therapeutics, Amarin, Research In Motion, Starbucks, Ultra Petroleum, and McDonald's"," 5/16/2014 45337C10 PRN  Upcoming Conferences, Stock Price Movements and Support to Humanitarian Programs - Analyst Notes on Celgene, Biogen Idec, Incyte, Jazz Pharmaceuticals and Medivation",10/25/2017 91307C10 PRN  United Therapeutics Corporation Reports Third Quarter 2017 Financial Results, 9/06/2012 001H2N-E PRN  JPM-TMT Awards New Contract to Study Administration using Marburg Virus Drug, 5/29/2018 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at the Jefferies 2018 Healthcare Conference,,,, 2/06/2017 55027E10 PRN  Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results,"11/09/2017 80067710 PRN  Sangamo Announces Plans For New Headquarters In Brisbane, California",, 9/28/2018 80105N10  PRN  FDA approves Libtayo® (cemiplimab-rwlc) as first and only treatment for advanced cutaneous squamous cell carcinoma," 4/22/2013 GOFF-IE   PRN  Cheaper Gas, Airfare, Profits on Way as Commodities Slump Continues? - Top Small Cap Stock Focus Ahead of the Bell:",,,, 4/12/2013 DVOXQ-US PRN  Retailers Push Stocks Higher and Pfizer Inc. hits a new 52-Week High,,11/01/2017 74366E10 PRN  Protagonist Therapeutics to Present at the Stifel 2017 Healthcare Conference,,,,, 2/03/2014 68214310 PRN  Omeros Announces Positive Data after Completion of Dosing in Phase 1 Clinical Trial with OMS721,,,,,,,,10/26/2017 69329Y10 PRN  PDL BioPharma Proposes to Acquire Neos Therapeutics for $10.25 per Share in Cash,,,, 2/24/2017 00182C10 PRN  ANI Pharmaceuticals Acquires Inderal® XL and InnoPran XL®,," 3/28/2012 000C35-E PRN  The Zacks Analyst Blog Highlights: Amgen, Sanofi, Regeneron, Alnylam and Coach",,, 8/03/2017 60468T10 PRN  Mirati Therapeutics Reports Second Quarter 2017 Financial Results,,,,,,,12/15/2017 09627Y10 PRN  Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock,, 3/12/2018 28249U10 PRN  Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results,,,,,,,11/10/2017 92165910 PRN  Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatment of Schizophrenia,,," 1/11/2013 000PQC-E   PRN  The Zacks Analyst Blog Highlights: GlaxoSmithKline, Theravance, Merck, Sanofi and Novartis",,"11/13/2017 002WRP-E PRN  Biotech Stocks on Investors' Radar -- Endocyte, Editas Medicine, Halozyme Therapeutics, and Illumina",11/03/2014 G2151510 PRN  China Biologic to Build Two New Plasma Collection Stations in Hebei Province,"12/31/2013 56400P70 PRN  Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind",,,," 8/11/2015 03236M20 PRN  Biossance™ Brand Announces The Launch Of The Embodied Project, A Four Week Program To Help Women Nurture Their Beauty Within",11/16/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 8/23/2016 36197T10 PRN  The Growth of the Legal and Medical Marijuana Markets,, 5/01/2018 G5087110 PRN  Jazz Pharmaceuticals Submits Supplemental New Drug Application for Xyrem® (sodium oxybate) to Treat Cataplexy and Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients,, 2/05/2013 39843840 PRN  PROLASTIN® celebrates 25 years as leading augmentation therapy for treatment of alpha(1)-antitrypsin deficiency,,,"11/17/2015 008W47-E PRN  Veracyte Applauds CMS Decision to Use ""Gapfill"" Pricing for the Afirma® Gene Expression Classifier",,,,,,,,,,,,,,,," 7/26/2016 98401F10 PRN  Xencor to Host Second Quarter 2016 Financial Results Webcast and Conference Call on August 2, 2016",, 4/17/2018 G8807B10 PRN  Theravance Biopharma to Present New Data from Multiple Studies of VIBATIV® (telavancin) at 2018 ECCMID™ Conference,, 6/07/2016 03969710 PRN  Ardelyx Appoints Robert Bazemore to Its Board of Directors,,,,,,,,,,,,"11/07/2017 05070R10 PRN  Audentes Therapeutics to Release Third Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, November 14, 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 8/11/2014 45232710    PRN  Dividends, New Leaderships, and Scheduled Conference Calls - Research Reports on St. Jude Medical, Endo, Cooper, Zoetis and Illumina",, 5/07/2018 LCI-US   PRN  Lannett Acquires Portfolio Of Generic Products From Endo International,,12/18/2015 09060J10 PRN  BioDelivery Sciences Provides Pipeline Update, 9/27/2018 09073M10    PRN  Bio-Techne Announces Cell and Gene Therapy Initiative," 3/12/2019 75886F10    PRN  Teen Scientists Win $1.8 Million at Regeneron Science Talent Search 2019 with Innovative Ideas on Exoplanets, HIV and a Classic Math Problem",," 9/16/2015 68375N10 PRN  Covered Call Alerts For Seadrill, ABIOMED, Invensense, Planet Fitness and Opko Health Released By InvestorsObserver", 3/15/2018 46222210 PRN  Ionis and Akcea Partner to Commercialize Inotersen for hATTR, 6/14/2018 09061G10   PRN  BioMarin Doses First Participant in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia,12/14/2012 081Y3R-E PRN  Coach CEO Lew Frankfurt Named Top S&P 500 Wealth Creator in 2012, 2/06/2018 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2017 Financial Results," 3/08/2013 81257810 PRN  Pushing Pipelines Forward for Long-Term Success - Research Report on Vertex, Santarus, Arena Pharmaceuticals, Seattle Genetics and Nektar Therapeutics",," 4/29/2015 09062X10  PRN  Recent Highlights From Healthcare, Energy and Technology Space: Complementary Research on Pentair, Spectranetics Corp., Biogen, Agenus and Natural Resource Partners",,," 1/20/2016 37555810   PRN  Covered Call Alerts For NVIDIA, Keryx Biopharmaceuticals, Fitbit, Gilead Sciences and Chipotle Mexican Grill Released By InvestorsObserver", 3/20/2018 04004760   PRN  Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock, 8/13/2018 N5946510  PRN  Mylan Launches First Generic for Adcirca® Tablets,10/09/2017 0DFZ3G-E PRN  A New Immunomodulatory Target Discovered by Compugen Demonstrates Potential for First-in-Class Cancer Therapy," 3/05/2013 00972810 PRN  The Prescription of Success: Improving Pipelines, Increasing Capabilities - Research Report on Globus, Akorn, Anika, Orthofix and Sangamo Biosciences", 6/16/2019 03116210 PRN  Amgen Announces BLINCYTO® (blinatumomab) Five-Year Overall Survival Data At EHA 2019,, 3/01/2016 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 Fourth Quarter And Full Year Financial Results,,"11/05/2013 45766930 PRN  Closing of Over-Allotment Options, Receiving Orphan Drug Designations, Release of Clinical Data, and Obtaining Important Patents - Research Report on Galena, Zalicus, Infinity, Stemline and Insmed",, 1/15/2019 45773H20 PRN  Inovio's dMAb™ PD-1 Checkpoint Inhibitors Demonstrate Higher and More Prolonged Expression Compared to Native Pembrolizumab and Nivolumab Sequences In Preclinical Studies," 5/31/2018 64026810 PRN  Nektar Therapeutics Announces Submission of a New Drug Application to the U.S. FDA for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Low Back Pain in Adult Patients New to Opioid Therapy",10/03/2017 76655960 PRN  Fostamatinib Meets Pre-Specified Primary Endpoint in Stage 1 of Autoimmune Hemolytic Anemia (AIHA) Phase 2 Study,,," 4/04/2012 HST-US   PRN  Hot Stocks Picked by Insiders: Ivanhoe Mines, Nokia, Amarin, Kinross Gold, Host Hotels and Resorts, and Petroleo Brasileiro SA"," 1/16/2014 45337C10 PRN  Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems",10/23/2017 91307C10 PRN  United Therapeutics Announces FDA Approval Of Third Generation Nebulizer For The Tyvaso® Inhalation System," 7/25/2012 0BQSFG-E PRN  Most Active Stocks: Regions Financial, Oracle, Sarepta Therapeutics, United Parcel Service, DeVry, and J.C. Penney", 5/23/2018 G0176710 PRN  Alkermes to Present Data on Depression and Schizophrenia Portfolios at Upcoming American Society of Clinical Psychopharmacology Annual Meeting,,,, 1/09/2017 LMNX-US  PRN  Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance; To Present at 35th Annual J.P. Morgan Healthcare Conference,11/09/2017 80067710 PRN  Sangamo Therapeutics Reports Third Quarter 2017 Financial Results,," 9/25/2018 80105N10  PRN  Sanofi US Named to Working Mother 2018 ""100 Best Companies"" List", 4/19/2013 000YJB-E  PRN  Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.),,,," 4/08/2013 005N6L-E PRN  Over $400 Million Raised by U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings in 2012, Reports Brinson Patrick",,10/11/2017 74366E10 PRN  Protagonist Therapeutics Prices Public Offering of Common Stock,,,,, 1/29/2014 68214310 PRN  Omeros Reports Positive Results from OMS824 Phase 2a Clinical Trial,,,,,,,,"10/26/2017 69329Y10 PRN  Stock Performance Review on Biotech Industry -- MyoKardia, Nabriva Therapeutics, Puma Biotechnology, and PDL BioPharma",,,, 2/16/2017 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2016 Financial Results and 2017 Guidance,, 2/16/2012 02043Q10 PRN  Regulus Announces New Publication Showing Potential Therapeutic Benefit of Targeting microRNA-21 in Fibrosis,,, 7/05/2017 60468T10 PRN  Mirati Therapeutics To Host Key Opinion Leader Breakfast On Immuno-oncology Combinations On July 11 In New York,,,,,,,12/12/2017 09627Y10 PRN  Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock,, 3/06/2018 28249U10 PRN  Eiger BioPharmaceuticals to Participate in U.S. and International Investor and Partnership Conferences in March,,,,,,,11/07/2017 92165910 PRN  Vanda Pharmaceuticals Reports Third Quarter 2017 Financial Results,,,"10/19/2012 06DDVL-E   PRN  Zacks Bull and Bear of the Day Highlights: Texas Capital Bankshares, Avnet, Theravance, Merck and GlaxoSmithKline",,11/10/2017 40637H10 PRN  Halozyme To Present Nonclinical Data At SITC 2017 Supporting Combination Of PEGPH20 With Checkpoint Inhibitors,10/30/2014 G2151510 PRN  China Biologic to Report Third Quarter 2014 Financial Results,"12/23/2013 56400P70 PRN  Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax",,,, 7/22/2015 03236M20 PRN  Strategic Collaborations Driving Growth - Report on Amyris,11/05/2018 69366J20 PRN  PTC Therapeutics Reports Third Quarter 2018 Financial Results and Provides a Corporate Update,,,,,,, 8/10/2016 36197T10 PRN  Identifying Newest Cannabis Strains for Cancer Treatment and Other Ailments Gain Headway Behind Pharmacological Evaluations,," 4/24/2018 G5087110 PRN  Jazz Pharmaceuticals to Report 2018 First Quarter Financial Results on May 8, 2018",,10/08/2012 39843840 PRN  Grifols Announces First Patient Enrolled and Dosed in Phase II Trial of Alpha-1 HC Aerosol to Treat Cystic Fibrosis,,,"11/16/2015 92337F10 PRN  Veracyte Names Tina S. Nova, Ph.D. to Its Board of Directors",,,,,,,,,,,,,,,, 6/28/2016 98401F10 PRN  Xencor Provides Updates on Lead Programs and Reviews Bispecific Oncology Partnership; Announces Expansion of Bispecific Oncology Pipeline at Analyst Day,, 3/21/2018 G8807B10 PRN  Theravance Biopharma to Present at the 17th Annual Needham Healthcare Conference,, 6/03/2016 008SHY-E PRN  Ardelyx to Present at 2016 BIO International Convention,,,,,,,,,,,, 9/27/2017 05070R10 PRN  Audentes Therapeutics Announces Rare Pediatric Disease and Fast Track Designations for AT132 for the Treatment of X-Linked Myotubular Myopathy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 8/07/2014 45232710    PRN  New Product Launch, New Board Member, Major Contracts, Successful Testing, and Grants - Research Reports on Abbott, Illumina, General Dynamics, Raytheon and Northrop Grumman",, 5/02/2018 G3040110 PRN  Endo to Participate at the UBS Global Healthcare Conference,,12/16/2015 09060J10 PRN  BioDelivery Sciences Announces Organizational Changes, 9/19/2018 09073M10    PRN  Bio-Techne Supports International Antibody Validation Meetings, 3/12/2019 75886F10    PRN  FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents,," 9/01/2015 68375N10 PRN  Critical Alerts For Opko Health, Exelixis, First Solar, Freeport-McMoRan and Invensense Released By InvestorsObserver", 3/06/2018 46222210 PRN  Ionis Pharmaceuticals to Present at Upcoming Investor Conferences, 6/07/2018 BMRN-US    PRN  BioMarin Receives Milestone Payments from Pfizer for Talazoparib, 7/18/2012 05LKDV-E PRN  Industrial Directory Reports Connecticut Manufacturing Employment Declined Slightly Over Year," 1/07/2018 64125C10 PRN  Neurocrine Biosciences Announces Retirement of Christopher O'Brien, M.D., and Appointment of Eiry W. Roberts, M.D., as Chief Medical Officer", 6/21/2012 09Z63Q-E PRN  ASCO Impact Report From Encuity Research Indicates Oncologists Are Likely to Shift Patient Treatment Plans,, 4/29/2015 09062X10  PRN  Orphan Drug Designations Lead to New Therapeutic Breakthroughs for Rare Disorders and Diseases,,," 1/08/2016 37555810   PRN  Covered Call Alerts For Gilead Sciences, Synaptics Incorporated, The Gap Incorporated, Fitbit and Chipotle Mexican Grill Released By InvestorsObserver", 3/19/2018 04004760   PRN  Arena Pharmaceuticals Reports Positive Phase 2 Results from the OASIS Trial for Etrasimod in Patients with Ulcerative Colitis, 8/08/2018 N5946510  PRN  Statement from Mylan's Board of Directors, 8/07/2017 M2572210 PRN  Compugen to Present at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Next Month," 2/05/2013 00972810 PRN  Akorn, Inc. Announces Fourth Quarter 2012 Earnings Release And Conference Call Information"," 6/13/2019 03116210 PRN  FDA Approves Amgen And Allergan's KANJINTI™ (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab)",," 2/25/2016 52887230 PRN  Lexicon To Report Fourth Quarter And Year End 2015 Financial Results On March 1, 2016",,"10/25/2013 45766930 PRN  Pre-Market Analysis: BioMarin Pharma Inc., Insmed Inc., Delcath Systems Inc., and Akorn Inc.",, 1/07/2019 45773H20 PRN  Inovio's DNA-Encoded Monoclonal Antibody (dMAb™) Platform Leaps Forward with First-in-Human Trial, 5/30/2018 64026810 PRN  Syndax and Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration,10/02/2017 76655960 PRN  Rigel Provides Update on FDA Review of Fostamatinib for ITP,,," 3/19/2012 RIG-CH   PRN  Equity Research on Most Popular Searches: Ford, Freeport-McMoRan, Potash, Intel, Amarin, and Transocean"," 1/08/2014 45337C10 PRN  Stock Price Movements, Strategic Acquisitions, and Finalized Sales - Research Report on Incyte, Varian, Cooper, Healthcare Trust of America, and National Health Investors","10/19/2017 91307C10 PRN  United Therapeutics Corporation To Report Third Quarter 2017 Financial Results Before The Market Opens On Wednesday, October 25, 2017", 6/20/2012 001H2N-E PRN  AVI BioPharma and Parent Project Muscular Dystrophy Team Up to Run Seattle Marathon & Raise Money to End Duchenne, 5/14/2018 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at the UBS Global Healthcare Conference,,,, 1/04/2017 55027E10 PRN  Luminex Corporation Receives FDA Clearance for ARIES® GBS Assay,10/31/2017 80067710 PRN  Sangamo Therapeutics Announces Third Quarter 2017 Conference Call And Webcast,, 9/17/2018 SAN-FR    PRN  National Meningitis Association Urges Parents to Get Their Teens The 16 Vaccine to Help Protect Against Meningococcal Meningitis," 4/01/2013 92532F10  PRN  Morning Research on Amgen, Affymax, Vertex Pharma, Questcor Pharma, and Repros Therapeutics",,,," 4/05/2013 00422510 PRN  Pre-Market Analysis on Dendreon, ACADIA Pharma, Medivation, and Cell Therapeutics",,10/11/2017 74366E10 PRN  Protagonist Therapeutics Announces Proposed Public Offering of Common Stock,,,,,"12/23/2013 68214310 PRN  Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst",,,,,,,,"10/25/2017 69329Y10 PRN  PDL BioPharma to Announce Third Quarter 2017 Financial Results on November 2, 2017",,,, 1/17/2017 DD-US    PRN  ANI Announces Appointment of Karen Quinn Ph.D as Vice President Corticotropin Regulatory Affairs,, 1/05/2012 02043Q10 PRN  Regulus Therapeutics to Present microRNA Platform and Pipeline Updates at Two Leading Scientific Conferences,,, 6/27/2017 60468T10 PRN  Mirati Therapeutics Announces Appointment Of Neil Reisman To The Board Of Directors,,,,,,,12/11/2017 09627Y10 PRN  Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock,, 3/05/2018 28249U10 PRN  Eiger Announces Abstracts and Presentations of LOWR HDV Program and Planned Registration Program at The International Liver Congress™ Meeting,,,,,,,"10/24/2017 92165910 PRN  Vanda Pharmaceuticals to Announce Third Quarter 2017 Financial Results on November 7, 2017",,,"10/09/2012 06DDVL-E   PRN  The Zacks Analyst Blog Highlights: GlaxoSmithKline, Pfizer, Theravance, Amicus Therapeutics and Parker-Hannifin",,11/07/2017 40637H10 PRN  Halozyme Reports Third Quarter 2017 Results,10/17/2014 G2151510 PRN  China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility,"12/19/2013 56400P70 PRN  Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium",,,, 7/08/2015 03236M20 PRN  Amyris Announces Partnership With I AM THAT GIRL,10/30/2018 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conference,,,,,,, 7/18/2016 36197T10 PRN  Pharmaceutical Studies & Trials of Individual Cannabinoids Aim to Develop Cannabis Strains That Specifically Target Cancer Pain and Nausea,, 3/06/2018 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March,, 9/28/2012 39843840 PRN  Grifols announces robust inventory of HyperRAB® S/D rabies immune globulin for treatment of rabies exposure,,,11/12/2015 92337F10 PRN  Veracyte Announces New Data Supporting Advancement of Its IPF Program Presented Today at PFF Summit 2015,,,,,,,,,,,,,,,," 6/28/2016 98401F10 PRN  Xencor Announces Strategic Collaboration for Bispecific Programs, including XmAb 14045 and XmAb 13676",," 2/27/2018 G8807B10 PRN  Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update",, 5/09/2016 03969710 PRN  Ardelyx Reports First Quarter 2016 Financial Results,,,,,,,,,,,," 9/21/2017 05070R10 PRN  Audentes Therapeutics Announces Dosing of First Patient in ASPIRO, a Phase 1/2 Clinical Trial of AT132 for the Treatment of X-Linked Myotubular Myopathy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 8/05/2014 45232710    PRN  Critical Alerts For VoxelJet, Google, Orexigen Therapeutics, Illumina, and Activision Blizzard Released By InvestorsObserver",, 4/27/2018 G3040110 PRN  Collagenase Clostridium Histolyticum For The Investigational Treatment Of Cellulite To Be Featured During The Hot Topics Symposium At The Aesthetic Meeting 2018,,12/03/2015 09060J10 PRN  BioDelivery Sciences Hires Joseph M. Lockhart as Vice President of Manufacturing and Supply Chain, 9/18/2018 09073M10    PRN  Bio-Techne Announces Publication of Data Demonstrating Additional Clinical Validation of its EPI Test in European Urology Journal, 3/11/2019 75886F10    PRN  FDA approves Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents,, 8/20/2015 IOSP-US  PRN  Innospec Set to Join the S&P SmallCap 600, 3/01/2018 46222210 PRN  IONIS-HTT Rx (RG6042) Top-Line Data Demonstrate Significant Reductions of Disease-Causing Mutant Huntingtin Protein in People with Huntington's Disease," 5/24/2018 09061G10   PRN  BioMarin Receives Standard Approval for Palynziq™ (pegvaliase-pqpz) Injection for Treatment of Adults with Phenylketonuria (PKU), a Rare Genetic Disease", 5/21/2012 01535110 PRN  S&P Indices Announces Change to U.S. Index, 1/07/2018 64125C10 PRN  Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2017 Sales Results and 2018 Program Milestones,"11/07/2011 000LKT-E PRN  Hot Stock Research for Ciena, Linear, QUALCOMM, SanDisk, Seattle Genetics & HCP",," 3/30/2015 09062X10  PRN  Today's Review on Biotech Equities -- Biocept, Biogen Idec, Kite Pharma, Organovo Holdings, and Bluebird Bio",,,"12/28/2015 37555810   PRN  Covered Call Alerts For Gilead Sciences, Weight Watchers, Applied Materials Inc., JetBlue and CSX Released By InvestorsObserver", 3/14/2018 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results, 8/08/2018 N5946510  PRN  Mylan Reports Second Quarter 2018 Results and Updates 2018 Guidance, 8/02/2017 M2572210 PRN  Compugen Welcomes Paul Sekhri as its New Chairman of the Board," 1/14/2013 00972810 PRN  Akorn, Inc. To Host A Conference Call To Discuss 2013 Financial Guidance", 6/12/2019 NUE-SE   PRN  Amgen Publishes Offer Document With Respect To The Recommended Public Cash Offer To The Shareholders Of Nuevolution,, 1/07/2016 LXRX-US  PRN  Lexicon To Present At The 34th Annual J.P. Morgan Healthcare Conference,,"10/21/2013 45766930 PRN  Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros",, 1/03/2019 45773H20 PRN  Inovio Announces Appointments to its Board of Directors, 5/16/2018 64026810 PRN  Nektar Therapeutics Announces Six Abstracts Accepted for Presentation at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, 9/19/2017 76655960 PRN  Rigel to Present at Cantor Fitzgerald Global Healthcare Conference,,," 3/09/2012 HHC-US   PRN  Research Reports for Penny Stock Top Movers: Sequenom, Genworth Financial, Huntsman, New Gold, Huntington Bancshares, and Amarin","12/30/2013 45337C10 PRN  Conference Schedules, Stock Price Movements, Executive Transitions, and Revenue Outlook - Research Report on Incyte, ViroPharma, Cooper, Varian and PDL BioPharma","10/17/2017 91307C10 PRN  Technical Snapshots for These Drug Makers Stocks -- SciClone Pharma, Synergy Pharma, Novo Nordisk, and United Therapeutics",11/18/2010 000BQR-E PRN  Reportlinker Adds Global Bladder Cancer Therapeutics Industry, 5/10/2018 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at the Bank of America Merrill Lynch Health Care Conference,,,,12/05/2016 55027E10 PRN  Luminex wins R&D 100 Award for ARIES Systems,10/17/2017 80067710 PRN  Sangamo Therapeutics Announces Presentations At 2017 Annual Congress Of The European Society Of Gene And Cell Therapy,, 9/12/2018 80105N10  PRN  FDA to review supplemental Biologics License Application for Praluent® (alirocumab) Injection as potential treatment to reduce major adverse cardiovascular events," 3/08/2013 92532F10  PRN  Pushing Pipelines Forward for Long-Term Success - Research Report on Vertex, Santarus, Arena Pharmaceuticals, Seattle Genetics and Nektar Therapeutics",,,, 3/22/2013 00422510 PRN  Apple Shares Bounce on Rumored iPhone 5S,," 9/20/2017 74366E10 PRN  Protagonist Therapeutics Announces Preliminary Phase 1 Study Results with Novel Hepcidin Mimetic, PTG-300",,,,,12/18/2013 68214310 PRN  FDA Grants Orphan Drug Designation to Omeros' OMS721 for Complement-Mediated Thrombotic Microangiopathies,,,,,,,, 9/25/2017 69329Y10 PRN  PDL BioPharma Announces New $25 Million Share Repurchase Program,,,,12/21/2016 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Authorized Generic of Lithobid® Extended Release Tablets,,12/12/2011 02043Q10 PRN  Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer,,, 5/31/2017 60468T10 PRN  Mirati Therapeutics To Present At The 2017 Jefferies Global Healthcare Conference,,,,,,,12/10/2017 09627Y10 PRN  Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of Avapritinib (BLU-285) in Patients with Advanced Systemic Mastocytosis Showing Evidence of Strong Clinical Activity,, 2/06/2018 28249U10 PRN  Eiger BioPharmaceuticals to Participate in Two Upcoming Investor Conferences in February,,,,,,,10/10/2017 92165910 PRN  Vanda Pharmaceuticals Announces Participation at the Oppenheimer Specialty Pharma Summit Conference,,," 8/28/2012 06DDVL-E   PRN  The Zacks Analyst Blog Highlights: GlaxoSmithKline , Theravance, Pfizer, BP and Talisman Energy",,10/31/2017 HALO-US  PRN  Phase 3 Study Of Subcutanous Daratumumab Initiated Using Halozyme's ENHANZE Technology, 9/05/2014 G2151510 PRN  China Biologic to Participate in Upcoming Investor Conferences,"12/11/2013 56400P70 PRN  Stock Price Updates - Research Report on AbbVie, Covance, MannKind, MAKO Surgical, and Envision",,,," 6/03/2015 03236M20 PRN  Amyris Officially Launches Biossance™, Its Consumer Beauty Brand",10/23/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 7/13/2016 36197T10 PRN  Wall Street Targets Funding Opportunities for Multi-Billion Dollar Cannabis & Legal Marijuana Operations,, 3/02/2018 G5087110 PRN  Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea,, 9/04/2012 39843840 PRN  Grifols Awards Winners of the 9th Annual eALTA Research Fellowship at 2012 ERS Meeting,,,11/12/2015 92337F10 PRN  National Survey Reveals Patients with Potentially Deadly Interstitial Lung Diseases are Enduring Significant Diagnosis Delays and Errors,,,,,,,,,,,,,,,," 6/14/2016 98401F10 PRN  Xencor to Host Analyst Day and Webcast on June 28, 2016",," 2/20/2018 G8807B10 PRN  Theravance Biopharma to Report Fourth Quarter and Full Year 2017 Financial Results on February 27, 2018",," 5/02/2016 03969710 PRN  Ardelyx to Report First Quarter 2016 Financial Results on May 9, 2016",,,,,,,,,,,, 9/19/2017 05070R10 PRN  Audentes Therapeutics to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 7/29/2014 45232710    PRN  Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis",, 4/26/2018 G3040110 PRN  Endo to Acquire Somerset Therapeutics and Business of Affiliate Wintac Limited,,11/24/2015 BDSI-US  PRN  BioDelivery Sciences to Present at the 27th Annual Piper Jaffray Healthcare Conference, 9/06/2018 09073M10    PRN  Bio-Techne Fills a Need for Simple Tools to Study Glycobiology, 3/11/2019 75886F10    PRN  FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents,," 8/18/2015 68375N10 PRN  Critical Alerts For Exelixis, Opko Health, Chipotle Mexican Grill, NewLink Genetics and Cliffs Natural Resources Released By InvestorsObserver", 2/27/2018 46222210 PRN  Ionis Reports Fourth Quarter and Full Year 2017 Financial Results, 5/22/2018 09061G10   PRN  BioMarin Provides 2 Years of Clinical Data in 6e13 vg/kg Dose from Ongoing Phase 1/2 Study in Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A at World Federation of Hemophilia 2018 World Congress," 4/19/2012 0017F0-E PRN  Zacks Bull and Bear of the Day Highlights: Alexion Pharmaceuticals, CSN, CBS, News Corporation and Comcast", 1/02/2018 64125C10 PRN  Neurocrine Biosciences to Present at the 36th Annual J.P. Morgan Healthcare Conference,11/01/2011 81257810 PRN  LifeSci Advisors Publishes ADCETRIS Survey Results,," 3/09/2015 09062X10  PRN  Critical Alerts For Alibaba, JC Penney, ExOne, Charles Schwab, Time Warner Cable, Delta Airlines, athenahealth, Glu Mobile, ConocoPhillips and Biogen Released By InvestorsObserver",,,"12/14/2015 37555810   PRN  Covered Call Alerts For Gilead Sciences, Whole Foods Market, Clovis Oncology, Walmart Stores Inc. and Finisar Corporation Released By InvestorsObserver"," 3/08/2018 04004760   PRN  Arena Pharmaceuticals to Announce Fourth Quarter and Full-Year 2017 Financial Results and Provide Corporate Update on Wednesday, March 14"," 7/31/2018 N5946510  PRN  Mylan to Release Second Quarter 2018 Financial Results on August 8, 2018", 8/02/2017 M2572210 PRN  Compugen Reports Second Quarter 2017 Results,"10/10/2012 00972810 PRN  Akorn, Inc. Announces Third Quarter 2012 Earnings Release and Conference Call Information", 6/07/2019 03116210 PRN  Amgen To Present At The Goldman Sachs 40th Annual Global Healthcare Conference,,12/07/2015 52887230 PRN  Lexicon To Present At The Oppenheimer 26th Annual Healthcare Conference,," 9/03/2013 45766930 PRN  Biotech Firms Announce Financial Results, Resignations, Reintroduce Treatments and Receive Reviews on Key Products - Research Report on Insmed, ImmunoGen, VIVUS, Theravance, and XOMA",,"12/15/2017 0033SF-E PRN  Stock Review for Biotech's Investors -- Bioverativ, ACADIA Pharma, Inovio Pharma, and Biogen", 5/10/2018 64026810 PRN  Nektar Therapeutics Reports Financial Results for the First Quarter of 2018," 8/25/2017 76655960 PRN  Rigel Welcomes Brian Kotzin, M.D. to Board of Directors",,," 3/02/2012 RVBD-US  PRN  Critical Alerts for Coca-Cola, Harley Davidson, GameStop, Riverbed Technology, and Amarin Released by Seven Summits Research","12/18/2013 45337C10 PRN  Trial Results, Stock Splits, Share Repurchases, New Appointments, and Completed Acquisitions - Research Report on Incyte, Novo Nordisk, Thoratec, Alere, and Kindred Healthcare", 9/19/2017 91307C10 PRN  Martine Rothblatt is Featured in Forbes Magazine's Special Centennial Issue as one of The World's 100 Greatest Living Business Minds,," 5/04/2018 002R6W-E PRN  Pre-Market Technical Scan on Drug Delivery Equities -- Adamis Pharma, Alkermes, PetMed Express, and Valeant Pharma",,,,11/17/2016 LMNX-US  PRN  ARIES System and Flu A/B & RSV Assay Evaluated by Erasmus MC in New Publication,10/02/2017 80067710 PRN  Sangamo And Bioverativ Announce FDA Acceptance Of IND Application For ST-400 -- A Gene-Edited Cell Therapy Candidate -- To Treat Beta-Thalassemia,, 9/10/2018 SAN-FR    PRN  MediSpend's Senior Director Analytics to Co-Present with Sanofi at 4th Annual Life Sciences Compliance Congress for Specialty Product Manufacturers," 3/01/2013 OPTR-US   PRN  Before the Bell Scans of Affymax, Questcor Pharma, Gilead Sciences, Vertex Pharma, and Optimer Pharma",,,," 3/22/2013 000CSN-E PRN  Insider Trading Update: AT&T, Ford Motor, Cliffs Natural Resources, ACADIA Pharmaceuticals, Best Buy, and SUPERVALU",," 9/11/2017 74366E10 PRN  /C O R R E C T I O N -- Protagonist Therapeutics, Inc./",,,,,12/05/2013 68214310 PRN  Omeros to Present at Oppenheimer 24th Annual Healthcare Conference,,,,,,,, 9/19/2017 69329Y10 PRN  PDL BioPharma Updates Presentation Time for Cantor Fitzgerald Conference,,,,12/20/2016 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Vancomycin Capsules in 50 Count Bottle,,11/08/2011 02043Q10 PRN  Regulus Therapeutics to Present New In Vivo Data for microRNA-21 in Kidney Fibrosis,,, 5/04/2017 60468T10 PRN  Mirati Therapeutics Reports First Quarter 2017 Financial Results,,,,,,,11/10/2017 09627Y10 PRN  Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors Showing Strengthened Clinical Activity across Spectrum of KIT and PDGFRα Genotypes,, 1/16/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces Phase 2 LIBERTY Study in Pulmonary Arterial Hypertension Did Not Meet Primary Endpoint,,,,,,,10/02/2017 92165910 PRN  Vanda to Present Tradipitant Phase II Atopic Dermatitis Data at World Congress of Itch,,, 5/02/2012 076VGM-E   PRN  WomenCorporateDirectors Launches Global Nominating Commission to Increase Diversity in Director Slates,,10/24/2017 40637H10 PRN  First Gastric Cancer Patient Dosed In Clinical Trial Collaboration Evaluating Halozyme's PEGPH20 In Combination With Anti-PDL1 Immunotherapy, 9/04/2014 G2151510 PRN  China Biologic Completes Transaction to Acquire Additional Equity Stake in Guizhou Taibang,"12/02/2013 56400P70 PRN  Announcements and Sponsorships by Biotechnology Companies and Major Drug Manufacturers - Research Report on Lilly, Geron, MannKind, Techne, and InterMune",,,," 5/12/2015 03236M20 PRN  Earnings Update: Complementary Research on CONE Midstream, Amyris, Keurig Green Mountain, Kate Spade & Company, Nu Skin Enterprises",10/22/2018 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2018 Financial Results,,,,,,, 5/25/2016 36197T10 PRN  By 2020 Marijuana Sales are Expected to Reach Nearly $23 Billion With Predictions 2016 Will Be the Greenest Year in History; Company Executes International License Agreement,, 2/27/2018 G5087110 PRN  Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2017 Financial Results,, 7/17/2012 39843840 PRN  Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis,,,11/05/2015 92337F10 PRN  Veracyte Announces Third Quarter 2015 Financial Results,,,,,,,,,,,,,,,, 5/18/2016 98401F10 PRN  Xencor Reports Complete Data Results from XmAb7195 Phase 1a Trial Showing Rapid Reduction of Serum IgE in High IgE Atopic Subjects at ATS 2016 International Conference,, 2/15/2018 G8807B10 PRN  Theravance Biopharma Highlights Submission of Landmark IMPACT Data to EMA to Support Expanded Label for Trelegy Ellipta,, 3/04/2016 03969710 PRN  Ardelyx Reports Fourth Quarter and Full-Year 2015 Financial Results,,,,,,,,,,,, 8/10/2017 05070R10 PRN  Audentes Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 7/24/2014 002WRP-E    PRN  Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery,, 4/17/2018 G3040110 PRN  Endo Receives Paragraph IV Notification on Vasostrict®,,11/11/2015 BDSI-US  PRN  BioDelivery Sciences to Present at the Jefferies 2015 Global Healthcare Conference, 9/05/2018 09073M10    PRN  Bio-Techne To Present At The Morgan Stanley 16th Annual Global Healthcare Conference," 3/11/2019 75886F10    PRN  New Genetic Data from Regeneron and GSK on 50,000 UK Biobank Participants Made Available to Global Health Research Community",," 8/03/2015 68375N10 PRN  Critical Alerts For Opko Health, Horizon Pharma, Fortress Biotech, CyberArk Software and Virgin America Released By InvestorsObserver", 2/20/2018 46222210 PRN  Ionis Licences New Antisense Drug for Kidney Disease to AstraZeneca, 5/17/2018 09061G10   PRN  BioMarin Announces 1 Platform and 3 Poster Presentations at World Federation of Hemophilia 2018 World Congress," 3/13/2012 01535110 PRN  Critical Alerts for Oracle, CME, Alexion, Regeneron, and Hershey Released by Seven Summits Research",12/07/2017 64125C10 PRN  Neurocrine Biosciences to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference,"10/05/2011 81257810 PRN  Critical Alerts For AT&T, CONSOL Energy, BorgWarner, PPG Industries, and Seattle Genetics Released By Seven Summits Research",, 2/26/2015 09062X10  PRN  Post-Earnings Coverage - Biogen Idec,,,"12/02/2015 37555810   PRN  Covered Call Alerts For Gilead Sciences, Google, Valeant Pharmaceuticals, JD.com and American Airlines Released By InvestorsObserver", 3/01/2018 04004760   PRN  Arena Pharmaceuticals to Present Phase 1 and Preclinical Data on APD371 in Development for Treatment of Pain Associated with Crohn's Disease at American Pain Society Annual Scientific Summit," 7/27/2018 MYL-US    PRN  Mylan and Fujifilm Kyowa Kirin Biologics Announce Positive CHMP Opinion for Hulio™, Biosimilar Adalimumab", 7/26/2017 M2572210 PRN  Compugen Discloses Updates to Collaborative Activities with Bayer in Immuno-Oncology," 9/27/2012 IAG-CA   PRN  Critical Alerts For Oracle, JB Hunt, Iamgold, Cosan, and Akorn Released By InvestorsObserver"," 6/04/2019 4502-JP  PRN  Amgen and Takeda join the Quantum Leap project led by CQDM and Feldan Therapeutics, to improve a novel intracellular delivery technology",,12/01/2015 52887230 PRN  Telotristat Etiprate Achieves Positive Top-Line Results In Second Phase 3 Clinical Trial,," 1/17/2013 45766930 PRN  The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Insmed Incorporated in Connection with Executive Compensation",,10/05/2017 45773H20 PRN  Tracking Pre-Clinical Data in Biotech: Risk Versus Reward," 5/08/2018 64026810 PRN  Nektar Therapeutics Announces Initiation of a Phase 1b Clinical Study of NKTR-358, a First-in-Class Regulatory T Cell Stimulator, in Patients with Systemic Lupus Erythematosus"," 8/18/2017 76655960 PRN  Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)",,," 3/01/2012 SPRD-CN  PRN  Research Reports for Penny Stock Top Movers: Liz Claiborne, Amarin, Spreadtrum Communications, First Niagara Financial, and Vocus","12/10/2013 45337C10 PRN  Updated Financial Standings, Company Announcements, and Upcoming Investors Conferences - Research Report on Zimmer, Boston Scientific, Hospira, Elan, and Incyte", 9/07/2017 91307C10 PRN  United Therapeutics Announces FREEDOM-EV Study Of Orenitram® To Continue As Planned Following Interim Analysis,, 5/04/2018 G0176710 PRN  Alkermes Launches Award Program To Support And Advance Central Nervous System Disorders Research,,,,11/07/2016 55027E10 PRN  Luminex Corporation To Present At The 28th Annual Piper Jaffray Healthcare Conference," 9/29/2017 80067710 PRN  Daily Technical Summary Reports on Biotech Stocks -- Gilead Sciences, Kite Pharma, Novavax, and Sangamo Therapeutics",, 9/03/2018 80105N10  PRN  Cablivi™ (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)," 1/28/2013 000DGZ-E  PRN  The Zacks Analyst Blog Highlights: Amgen, Celgene, Gilead Sciences, Vertex Pharmaceuticals and Nasdaq Biotechnology Index ETF",,,," 3/06/2013 00422510 PRN  Today's Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics",, 8/24/2017 74366E10 PRN  Protagonist Therapeutics Announces Closing of Janssen License and Collaboration Agreement for PTG-200 and Receipt of $50 Million Payment,,,,,11/20/2013 68214310 PRN  Omeros Announces FDA Acceptance of Omidria™ as Proprietary Name for OMS302,,,,,,,, 9/11/2017 69329Y10 PRN  PDL BioPharma Appoints Dominique Monnet as President,,,,11/03/2016 ANIP-US  PRN  Therapix Biosciences' Board of Directors is Joined by Stephen M. Simes,,10/26/2011 02043Q10 PRN  Webinar Advisory: Regulus to Host Discussion About Potential of microRNA-33 as Target for Treatment of Atherosclerosis,,, 3/09/2017 60468T10 PRN  Mirati Therapeutics Reports Financial Results And Provides Business Update For The Fourth Quarter And Full Year 2016,,,,,,,11/08/2017 09627Y10 PRN  Blueprint Medicines to Present at Jefferies Global Healthcare Conference,, 1/08/2018 28249U10 PRN  Eiger BioPharmaceuticals Announces Appointment of Commercial Operations Industry Veteran Eldon Mayer to its Board of Directors,,,,,,, 9/29/2017 0BP2LF-E PRN  Vanda to Present Scientific Posters at World Sleep 2017,,, 1/09/2012 06R2GC-E   PRN  Live Press Briefing on Findings of Biomedical Industry CEO Survey,,10/16/2017 40637H10 PRN  Halozyme Initiates Clinical Trial Of PEGPH20 With Anti-PDL1 Immunotherapy In Cholangiocarcinoma And Gallbladder Cancer Patients, 8/25/2014 G2151510 PRN  China Biologic to Increase Equity Stake in Guizhou Taibang,"11/27/2013 56400P70 PRN  Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp.",,,," 7/10/2013 03236M20 PRN  Law Office of Brodsky & Smith, LLC Notifies Amyris Investors of Upcoming July 15, 2013 Deadline in Putative Class Action Lawsuit - AMRS",10/06/2018 69366J20 PRN  PTC Therapeutics Announces Initial Data from Patient Registry Demonstrating Translarna™ (ataluren) Slows Disease Progression in Children with Duchenne Caused by a Nonsense Mutation,,,,,,, 5/16/2016 36197T10 PRN  Industrial Hemp Producing Solid Revenue Opportunities for Cannabis & Agriculture Industries; Company Announces Product Sales of Raw Kenaf,, 2/23/2018 G5087110 PRN  Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of Acute Graft-versus-Host Disease,," 6/11/2012 39843840 PRN  Grifols Publishes Positive Phase I Safety Results for Plasmin, a Novel, Direct-Acting Thrombolytic, in the Journal of Thrombosis and Haemostasis",,,11/04/2015 92337F10 PRN  Veracyte Announces Data to be Presented at PFF Summit 2015 Highlighting IPF Diagnostic Challenges and Potential of New Genomic-Based Testing Approaches,,,,,,,,,,,,,,,, 5/17/2016 98401F10 PRN  Xencor to Present at Upcoming Investor Conferences,," 2/07/2018 0CPNB1-E PRN  Janssen Enters Into Worldwide Collaboration With Theravance Biopharma For Oral, Pan-JAK Inhibitor Drug Candidate For The Treatment Of Inflammatory Bowel Disease",," 2/25/2016 03969710 PRN  Ardelyx to Report Fourth Quarter and Full Year 2015 Financial Results on March 4th, 2016",,,,,,,,,,,," 7/18/2017 05070R10 PRN  Audentes Therapeutics Announces Appointment of Fulvio Mavilio, Ph.D. to Vice President Scientific Affairs, Europe",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 7/17/2014 45232710    PRN  Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx",, 4/13/2018 G3040110 PRN  Endo to Announce First-Quarter 2018 Financial Results,,11/09/2015 09060J10 PRN  BioDelivery Sciences Provides Corporate Update and Reports Third Quarter 2015 Financial Results, 8/28/2018 09073M10    PRN  Bio-Techne To Present At The Baird 2018 Global Healthcare Conference, 3/08/2019 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Call,," 7/20/2015 68375N10 PRN  Critical Alerts For Linn Energy, Gilead Sciences, BP, Alcoa and Opko Health Released By InvestorsObserver", 2/13/2018 46222210 PRN  Ionis Pharmaceuticals to Hold 2017 Financial Results Conference Call, 5/15/2018 09061G10   PRN  BioMarin Announces First Patient Dosed in Phase 1/2 Study Evaluating Valoctocogene Roxaparvovec Gene Therapy in Severe Hemophilia A Patients with Pre-existing AAV5 Antibodies," 1/23/2012 01535110 PRN  Critical Alerts for Target, Green Mountain Coffee Roasters, BB&T, Alexion Pharmaceuticals, and Dish Network Released by Seven Summits Research",12/04/2017 64125C10 PRN  Neurocrine Biosciences Presents Long-term Data Analyses from Open-label KINECT 4 Phase III Study Demonstrating INGREZZA® Improves Tardive Dyskinesia Symptoms," 9/29/2011 0032YX-E PRN  Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis",," 2/10/2015 09062X10  PRN  Valuable Updates on Pharmaceutical Companies: New Research on Avalanche Biotechnologies, BioCryst, Biogen, Biota Pharmaceuticals, and Bio-Techne",,,"11/18/2015 37555810   PRN  Covered Call Alerts For Palo Alto Networks, Gilead Sciences, Ford, Fossil Group and Rockwell Medical Released By InvestorsObserver", 2/16/2018 04004760   PRN  Arena Pharmaceuticals Announces Changes to Board of Directors, 7/20/2018 N5946510  PRN  Mylan Again Defeats Allergan's Efforts to Deny Patients Access to More Affordable Medicine," 7/25/2017 M2572210 PRN  Compugen Announces Issuance of U.S. Patent for COM701, its Lead Immuno-Oncology Product Candidate"," 7/06/2012 00972810 PRN  Akorn, Inc. Announces Second Quarter 2012 Earnings Release And Conference Call Information", 6/03/2019 03116210 PRN  Amgen Announces First Clinical Data Evaluating Novel Investigational KRASG12C Inhibitor AMG 510 At ASCO 2019,,11/12/2015 LXRX-US  PRN  Lexicon To Present At The Stifel 2015 Healthcare Conference And The Jefferies 2015 Global Healthcare Conference,,12/13/2012 INSM-US  PRN  Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference,," 7/28/2017 45773H20 PRN  How These Biotech Stocks are Performing? -- Inovio Pharma, Intra Cellular Therapies, OncoMed Pharma, and Ophthotech"," 5/03/2018 64026810 PRN  Nektar to Announce Financial Results for the First Quarter 2018 on Thursday, May 10, 2018, After Close of U.S.-Based Financial Markets"," 8/14/2017 76655960 PRN  Breakfast Technical Briefing on Generic Drugs Stocks -- Horizon Pharma, Mylan, Neurocrine Biosciences, and Rigel Pharma",,, 2/07/2012 05Z8NN-E PRN  Prismic Pharmaceuticals Acquires Scarista's Exclusive License to Amarin's Omega-3 Patents for CNS Disorders,"12/02/2013 45337C10 PRN  Healthcare Sector Announces Voluntary Recalls, Scheduled Presentations and Offering Programs - Research Report on Baxter, Incyte, Horizon Pharma, POZEN, and IntelliPharmaCeutics"," 8/21/2017 91307C10 PRN  Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform",, 5/03/2018 G0176710 PRN  Alkermes to Host Webcast and Conference Call to Discuss ALKS 3831 Development Program,,,,10/31/2016 06SCZS-E PRN  Luminex Corporation Reports Third Quarter 2016 Results; Raises Full Year Guidance, 9/28/2017 80067710 PRN  Sangamo Therapeutics Announces Participation At Upcoming Investor And Industry Conferences,, 7/31/2018 80105N10  PRN  Q2 2018 Performance Positions Sanofi for New Growth Phase,11/27/2012 92532F10  PRN  SHAREHOLDER ALERT: Morgan & Morgan announces an investigation of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and whether senior management and the board of directors violated fiduciary duties owed to Vertex shareholders.,,,," 1/30/2013 00422510 PRN  Free Research Report on Opko Health, Inc., ACADIA Pharmaceuticals, Inc., Simcere Pharmaceutical Group, SciClone Pharmaceuticals, Inc. and Sequenom, Inc.",, 8/08/2017 74366E10 PRN  Protagonist Therapeutics Reports Second Quarter 2017 Financial Results and Business Highlights,,,,,11/19/2013 68214310 PRN  Omeros Reports Phase 3 OMS302 Clinical Data Presented at the Annual American Academy of Ophthalmology Meeting,,,,,,,, 9/06/2017 69329Y10 PRN  PDL BioPharma to Present at Two Upcoming Investor Conferences,,,,11/03/2016 00182C10 PRN  ANI Pharmaceuticals Reports Record Third Quarter Results and Year-To-Date 2016 Highlights and Narrows Full-year Guidance,,10/24/2011 02043Q10 PRN  Webinar Advisory: Regulus to Host Discussion About Potential of microRNA-33 as Target for Treatment of Atherosclerosis,,, 2/13/2017 60468T10 PRN  Mirati Therapeutics To Present At Leerink Partners 6th Annual Global Healthcare Conference,,,,,,,11/01/2017 09627Y10 PRN  Blueprint Medicines Announces Publication of BLU-285 Translational Data,, 1/04/2018 28249U10 PRN  Eiger BioPharmaceuticals Completes Enrollment of Phase 2 ULTRA Study of Ubenimex in Primary and Secondary Lymphedema Patients,,,,,,, 9/13/2017 92165910 PRN  Vanda's Tradipitant Improves Itch and Disease Severity in Patients with Atopic Dermatitis,,," 5/10/2011 076VGM-E   PRN  Women Board Members from Around the World Meet to Address ""The Director's Role in an Age of Complexity, Uncertainty, and Accelerating Change""",,10/10/2017 40637H10 PRN  Halozyme to Host Third Quarter 2017 Financial Results Conference Call, 8/05/2014 G2151510 PRN  China Biologic Reports Financial Results for the Second Quarter of 2014,"11/13/2013 56400P70 PRN  Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma",,,," 7/02/2013 03236M20 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors With Losses on Their Investment in Amyris, Inc. of Class Action Lawsuit and the Deadline of July 15, 2013 to Seek a Lead Plaintiff Position","10/03/2018 69366J20 PRN  Risdiplam Demonstrates Preliminary Evidence of Clinical Benefit in Type 1, 2, & 3 Spinal Muscular Atrophy Patients",,,,,,, 4/20/2016 36197T10 PRN  Expansion of Legalized Cannabis Continues at a Torrid Pace in the U.S. and Globally For Leading Markets Worldwide; Company Receives Purchase Order for Medical Marijuana Products,," 2/13/2018 G5087110 PRN  Jazz Pharmaceuticals to Report 2017 Fourth Quarter and Full Year Financial Results on February 27, 2018",," 3/30/2012 39843840 PRN  Grifols Annual Report on Form 20-F for 2011 Filed with SEC on March 29, 2012",,,"10/29/2015 92337F10 PRN  Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2015 Financial Results on Thursday, November 5, 2015",,,,,,,,,,,,,,,, 5/02/2016 98401F10 PRN  Xencor Reports First Quarter 2016 Financial Results,, 2/07/2018 0FMFKF-E PRN  Theravance Biopharma Enters Global Collaboration with Janssen for TD-1473 in Inflammatory Intestinal Diseases,, 2/02/2016 03969710 PRN  Ardelyx to Present at the 2016 Leerink Partners Global Healthcare Conference,,,,,,,,,,,, 6/28/2017 05070R10 PRN  Audentes Therapeutics Announces Participation in Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 7/10/2014 45232710    PRN  Pre-Market Pulse on Health Care Stocks -- Research on Team Health Holdings, Antares Pharma, Illumina, and Questcor Pharma",, 4/02/2018 074HTM-E PRN  Endo Agrees to Extend Temporary Stay of FDA Litigation,,"11/02/2015 09060J10 PRN  BioDelivery Sciences to Host Conference Call and Webcast of Third Quarter 2015 Results on Monday, November 9", 8/08/2018 09073M10    PRN  Bio-Techne Introduces GMP Small Molecules for Stem Cell Therapy Development, 3/08/2019 75886F10    PRN  FDA to Undertake Priority Review of Dupixent® (dupilumab) for Adults with Inadequately Controlled Severe Chronic Rhinosinusitis with Nasal Polyps,," 7/15/2015 IMM-AU   PRN  Active Equities to Watch in the Biotechnology Industry -- Prima Biomed, Oncothyreon, Opko Health, ImmunoCellular Therapeutics, and Adaptimmune Therapeutics", 1/08/2018 46222210 PRN  Ionis' Inotersen NDA Accepted for Priority Review by the FDA, 5/02/2018 09061G10   PRN  BioMarin to Attend Upcoming Investor Conference,12/22/2011 05SVYX-E PRN  Inspiration Biopharmaceuticals Expands Leadership Team with Four New Hires,11/29/2017 64125C10 PRN  Neurocrine Biosciences to Present New Long-Term Data Evaluating INGREZZA® for the Treatment of Tardive Dyskinesia at the American College of Neuropsychopharmacology Annual Meeting," 8/19/2011 0032YX-E PRN  The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics' Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977",, 2/09/2015 09062X10  PRN  Developers #HackMS at the First Ever Hackathon for Multiple Sclerosis,,,"11/05/2015 37555810   PRN  Covered Call Alerts For Disney, Facebook, Google, GW Pharmaceuticals and Gilead Sciences Released By InvestorsObserver", 2/06/2018 04004760   PRN  Arena Pharmaceuticals to Present at Upcoming Investor Conferences, 7/17/2018 00DYYX-E  PRN  AbbVie Announces HUMIRA® (adalimumab) Patent License with Mylan," 7/24/2017 M2572210 PRN  Compugen Second Quarter 2017 Conference Call Scheduled for Wednesday, August 2, 2017 at 10:00 AM ET"," 4/17/2012 00972810 PRN  Akorn, Inc. Announces First Quarter 2012 Earnings Release and Conference Call Information", 6/02/2019 03116210 PRN  Amgen Highlights The Versatility Of The BiTE® Immuno-Oncology Platform In Multiple Tumor Types At ASCO 2019,,"11/06/2015 52887230 PRN  Sanofi and Lexicon Pharmaceuticals To Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes",,11/13/2012 45766930 PRN  Insmed Announces CLEAR-108 Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections Has Completed Target Enrollment,, 5/08/2017 45773H20 PRN  Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy, 4/30/2018 64026810 PRN  Nektar Therapeutics to Host Analyst & Investor Event at 2018 ASCO Annual Meeting, 8/01/2017 76655960 PRN  Rigel Announces Second Quarter 2017 Financial Results and Provides Company Update,,," 1/20/2012 0C93TC-E PRN  Research Reports on Top Traded Stocks: Genworth Financial, Suntech Power Holdings, Human Genome Sciences, Sirius, Amarin and Hercules Offshore","11/26/2013 45337C10 PRN  FDA Clearance, Management Changes, and Clinical Study Updates - Research Report on Illumina, Array, Oncolytics, Intrexon, and STERIS", 8/09/2017 91307C10 PRN  United Therapeutics Corporation To Present At 2017 Wedbush PacGrow Healthcare Conference,, 5/02/2018 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at the Deutsche Bank 43rd Annual Health Care Conference,,,,"10/11/2016 55027E10 PRN  Luminex Corporation Third Quarter Earnings Release Scheduled for October 31, 2016", 9/20/2017 80067710 PRN  Sangamo Therapeutics Announces Presentation At The 2017 Cantor Fitzgerald Global Healthcare Conference,, 7/30/2018 06VY62-E  PRN  Sanofi Ships First Flu Vaccines for 2018-2019 Season,11/19/2012 06TXF2-E  PRN  Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease,,,,"11/06/2012 CIS-CN   PRN  Top Five Stocks - Tuesday Large Cap Watch: Apple, Inc. Cisco Systems, Inc. Bank of America Corp. Facebook, Inc. Acadia Pharmaceuticals, Inc.",," 6/08/2017 74366E10 PRN  Protagonist Therapeutics Appoints Five Prime Therapeutics CEO, Lewis T. ""Rusty"" Williams, to its Board of Directors",,,,,11/12/2013 68214310 PRN  Omeros to Present Data from OMS302 Phase 3 Clinical Program at the American Academy of Ophthalmology Annual Meeting,,,,,,,, 8/03/2017 69329Y10 PRN  PDL BioPharma Announces Second Quarter 2017 Financial Results,,,,10/27/2016 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2016 Financial Results,,10/20/2011 02043Q10 PRN  Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism,,, 1/11/2017 05V1WP-E PRN  Mirati Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares,,,,,,,11/01/2017 09627Y10 PRN  Blueprint Medicines to Present Updated Data from Ongoing Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Systemic Mastocytosis in Plenary Scientific Session at 59th ASH Annual Meeting and Exposition,," 1/03/2018 28249U10 PRN  Eiger BioPharmaceuticals Appoints David Apelian, MD, PhD, MBA Chief Operating Officer and Executive Medical Officer",,,,,,, 9/11/2017 92165910 PRN  Vanda Pharmaceuticals Announces Participation at September 2017 Investor Conferences,,,,, 9/14/2017 40637H10 PRN  Halozyme Increases 2017 Financial Guidance, 7/29/2014 G2151510 PRN  China Biologic to Report Second Quarter 2014 Financial Results,"11/06/2013 56400P70 PRN  Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind",,,," 6/29/2013 03236M20 PRN  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Amyris, Inc. To Contact The Firm", 9/28/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,," 3/15/2016 36197T10 PRN  Covered Call Alerts For Netflix, GW Pharmaceuticals, Sarepta Therapeutics, General Electric and Whole Foods Market Released By InvestorsObserver",, 2/08/2018 G5087110 PRN  National Comprehensive Cancer Network® adds Jazz Pharmaceuticals' Vyxeos™ (daunorubicin and cytarabine) Liposome for Injection to Clinical Practice Guidelines in Oncology,, 3/26/2012 39843840 PRN  LA Laker Pau Gasol Introduces New Technology Donated by Grifols to Pharmacy at Children's Hospital Los Angeles,,,10/21/2015 008W47-E PRN  Veracyte Presents New Data on Gene Variants and Fusions In Thyroid Cancer Diagnosis,,,,,,,,,,,,,,,," 4/25/2016 98401F10 PRN  Xencor to Host First Quarter 2016 Financial Results Webcast and Conference Call on May 2, 2016",, 1/29/2018 MYL-US   PRN  Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease,, 1/13/2016 03969710 PRN  Ardelyx Announces Closing of Public Offering Including Exercise of Underwriters' Right to Purchase Additional Shares,,,,,,,,,,,, 6/13/2017 05070R10 PRN  Audentes Therapeutics Appoints Jennifer Jarrett to Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 7/07/2014 45232710    PRN  Critical Alerts For Illumina, T Rowe Price, Dow Chemical, MGM Resorts, and Du Pont Released By InvestorsObserver",," 3/01/2018 G3040110 PRN  Endo Obtains Preliminary Injunction Against QuVa Pharma, Inc. Preventing Marketing and Release of Vasopressin Product",,10/26/2015 BDSI-US  PRN  FDA Approval of BELBUCA™ (CIII) (Buprenorphine HCl) Buccal Film for Chronic Pain Triggers Milestone Payment of $50 Million to BioDelivery Sciences from Partner Endo Pharmaceuticals, 8/07/2018 09073M10    PRN  Bio-Techne Releases Fourth Quarter Fiscal 2018 Results, 3/01/2019 75886F10    PRN  CHMP Recommends Approval of Dupixent® (dupilumab) for Asthma Indication,," 7/07/2015 68375N10 PRN  Critical Alerts For Apple, Bojangles Inc., Opko Health, Netflix and Macy's Released By InvestorsObserver",12/21/2017 46222210 PRN  Ionis Pharmaceuticals Announces The Initiation Of A Clinical Study Of Its First Orally Delivered Antisense Drug For The Treatment Of Gastrointestinal Disorders, 5/01/2018 BMRN-US    PRN  BioMarin Named To Forbes List Of America's Best Mid-size Employers,"10/27/2011 000CYC-E PRN  Zacks Bull and Bear of the Day Highlights: Alexion Pharma, Hospira, Boeing, General Dynamics and Lockheed Martin",11/21/2017 64125C10 PRN  Neurocrine Biosciences to Present at the 29th Annual Piper Jaffray Healthcare Conference, 7/28/2011 0039ZQ-E PRN  IU Confidential Publishes Biotech Investment Report,," 2/02/2015 09062X10  PRN  Critical Alerts For Zynga, Intercept Pharmaceuticals, Biogen, Nabors Industries and CyberArk Software Released By InvestorsObserver",,,"10/27/2015 37555810   PRN  Covered Call Alerts For Skechers, Kinder Morgan, Relypsa, Gilead Sciences and NVIDIA Released By InvestorsObserver", 1/22/2018 04004760   PRN  Arena Pharmaceuticals to Host Key Opinion Leader Event on S1P Modulation and Etrasimod in Autoimmune Diseases on January 29 in New York City, 7/09/2018 05FGM6-E  PRN  Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon® Patch, 6/05/2017 M2572210 PRN  Compugen Presents at ASCO COM701 Drug Combination Data with TIGIT and PD-1 Inhibitors in Preclinical Models," 3/22/2012 00972810 PRN  Brinson Patrick Securities Initiates Research Coverage of Akorn, Inc.", 5/29/2019 03116210 PRN  Amgen To Webcast Investor Meeting At 55th Annual Meeting Of The American Society Of Clinical Oncology (ASCO),,11/06/2015 52887230 PRN  Lexicon Pharmaceuticals Reports 3rd Quarter Financial Results And Discusses Collaboration With Sanofi For Sotagliflozin,,11/12/2012 45766930 PRN  Insmed To Present At Two Upcoming Investor Conferences,,"11/07/2016 45773H20 PRN  InvestorsObserver releases covered-call reports for ACADIA Pharmaceuticals, Valero Energy, Kite Pharma, Inovio Pharmaceuticals and Fitbit"," 4/24/2018 64026810 PRN  New Oncology Clinical Collaboration between Nektar and Takeda to Evaluate Combination of NKTR-214, a CD122-biased Agonist, and TAK-659, a Dual SYK and FLT-3 Inhibitor, in Liquid and Solid Tumors", 7/25/2017 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Second Quarter 2017 Financial Results,,," 5/24/2011 02311120 PRN  Critical Alerts For Amazon.com, State Street, VMware, VFC, and Amarin Released By Seven Summits Research","11/22/2013 45337C10 PRN  Early Briefing and Review: Arena Pharma Inc., Geron Corp., Incyte Corp., and Spectrum Pharma Inc.", 8/03/2017 002G54-E PRN  University of Maryland Medicine Establishes Nation's First Center for Cardiac Xenotransplantation Research With $24 Million Grant and Addition of Top Transplant Surgeon-Scientists,, 4/30/2018 G0176710 PRN  Alkermes to Present Clinical Data at Upcoming American Psychiatric Association Annual Meeting,,,, 8/08/2016 LMNX-US  PRN  Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay, 8/31/2017 80067710 PRN  Sangamo Presents T Cell Engineering Capabilities at Immuno-Oncology Summit,," 7/02/2018 80105N10  PRN  Sanofi to further accelerate its scientific presence with the opening of a Global R&D Operations Hub in Chengdu, China",11/14/2012 079QF4-E  PRN  Leadspace Joins Marketo LaunchPoint Ecosystem,,,,"12/06/2011 07PDMR-E PRN  New Auction of Lab Equipment from Acadia, Elan, Isis, Illumina and More",, 5/30/2017 000NB6-E PRN  Protagonist Therapeutics Enters into Worldwide Agreement with Janssen to Co-Develop and Commercialize PTG-200 for Inflammatory Bowel Disease,,,,,11/07/2013 68214310 PRN  Omeros Announces Positive Data in Phase 1 Clinical Trial with OMS721,,,,,,,," 7/31/2017 69329Y10 PRN  PDL BioPharma to Announce Second Quarter 2017 Financial Results on August 3, 2017",,,,10/25/2016 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Benztropine Mesylate Tablets USP,, 9/08/2011 02043Q10 PRN  Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer,,, 1/06/2017 00C2F6-E PRN  Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock,,,,,,,10/31/2017 09627Y10 PRN  Blueprint Medicines Reports Third Quarter 2017 Financial Results,, 1/02/2018 28249U10 PRN  Eiger BioPharmaceuticals to Present at Biotech Showcase™ 2018,,,,,,, 9/06/2017 92165910 PRN  Vanda Pharmaceuticals Announces Participation at the Citi 12th Annual Biotech Conference,,,,," 9/14/2017 40637H10 PRN  Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties", 6/27/2014 G2151510 PRN  China Biologic Announces Pricing of Public Offering of Common Stock,"11/01/2013 56400P70 PRN  Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc.",,,," 5/23/2013 03236M20 PRN  Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Amyris, Inc.", 9/25/2018 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conference,,,,,,," 2/23/2016 36197T10 PRN  Covered Call Alerts For Starbucks, Caterpillar Inc., GW Pharmaceuticals, United Technologies and Synaptics Incorporated Released By InvestorsObserver",, 1/02/2018 G5087110 PRN  Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 8,, 3/15/2012 39843840 PRN  Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects,,,10/21/2015 008W47-E PRN  Two New Studies Demonstrate the Long-Term Clinical Utility of Veracyte's Afirma® Gene Expression Classifier in Safely Reducing Unnecessary Thyroid Surgeries,,,,,,,,,,,,,,,, 3/07/2016 98401F10 PRN  Xencor Reports Fourth Quarter and Full Year 2015 Financial Results,, 1/29/2018 G8807B10 PRN  Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease,, 1/07/2016 03969710 PRN  Ardelyx Announces Pricing of Public Offering of Common Stock,,,,,,,,,,,, 5/11/2017 05070R10 PRN  Audentes Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 7/04/2014 45232710    PRN  NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind",, 2/27/2018 G3040110 PRN  Endo Reports Fourth-Quarter And Full-Year 2017 Financial Results,,10/26/2015 09060J10 PRN  U.S. FDA Approves BELBUCA™ (buprenorphine) Buccal Film for Chronic Pain Management, 8/07/2018 09073M10    PRN  Bio-Techne Declares Dividend, 3/01/2019 75886F10    PRN  New Analyses to Be Presented at AAD for Dupixent® (dupilumab) and the Burden of Atopic Dermatitis,, 6/29/2015 68375N10 PRN  Nutritional Supplement Industry Flexes its Muscles as Natural & Pharmaceutical Supplement Products Continue to Hit the Market - Company Prepares for Strong Revenue Growth in 2nd Half of 2015,"12/18/2017 46222210 PRN  Ionis' License Agreement for Huntington's Disease Drug, IONIS-HTT Rx, Receives HSR Clearance", 4/25/2018 09061G10   PRN  BioMarin Announces First Quarter 2018 Financial Results,"10/14/2011 01535110 PRN  Critical Alerts for Chevron, Bank of New York Mellon, Aflac, Alexion Pharmaceuticals, and Rackspace Released by Seven Summits Research",11/20/2017 64125C10 PRN  Neurocrine Biosciences Appoints Matt Abernethy as Chief Financial Officer," 7/18/2011 81257810 PRN  Critical Alerts for eBay, Dow Chemical, EOG Resources, Seattle Genetics, and VeriSign Released by Seven Summits Research",," 1/28/2015 09062X10  PRN  Biotech Stocks Technical Report - Halozyme Therapeutics, Agenus, Biogen Idec, ACADIA Pharma, and Peregrine Pharma",,,"10/15/2015 37555810   PRN  Covered Call Alerts For Gilead Sciences, FMC Corp, Micron, ABIOMED and AbbVie Released By InvestorsObserver",12/26/2017 002XMH-E   PRN  Kaplan Fox & Kilsheimer LLP Announces Proposed Settlement in the Arena Securities Litigation, 6/28/2018 N5946510  PRN  Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar, 5/31/2017 M2572210 PRN  Compugen Provides Update on COM701 and Upcoming Presentations, 2/09/2012 00972810 PRN  S&P Indices Announces Changes to U.S. Indices, 5/29/2019 03116210 PRN  Additional Irrevocable Undertakings To Accept Amgen's Recommended Public Cash Offer To The Shareholders Of Nuevolution,,"11/06/2015 52887230 PRN  Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes",,"11/07/2012 45766930 PRN  Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012",,"10/21/2016 45773H20 PRN  InvestorsObserver releases covered-call reports for Inovio Pharmaceuticals, Varian Medical Systems, Heron Therapeutics, Chipotle Mexican Grill and Wynn Resorts"," 4/18/2018 0011X6-E PRN  Free Research Reports on These Biotech Stocks -- Moleculin Biotech, MyoKardia, Nektar Therapeutics, and Novavax", 6/22/2017 76655960 PRN  Rigel Announces Oral Presentation of TAVALISSE™ (fostamatinib disodium) Phase 3 Clinical Data at the European Hematology Association 22nd Annual Congress,,, 5/10/2011 02311120 PRN  Amarin Reports First Quarter 2011 Results,"11/22/2013 45337C10 PRN  Study Results, Private Placements, Collaborations, Product Launches, and Public Offerings - Research Report on ViroPharma, Incyte, Tenet Healthcare, Sagent Pharmaceuticals and Chelsea Therapeutics"," 8/02/2017 91307C10 PRN  Lifshitz & Miller LLP Announces Investigation of EZCORP, Inc., Flowserve Corporation, Halliburton Company, NCI, Inc., Parkway, Inc., United Therapeutics Corporation and ViewRay, Inc.",, 4/26/2018 G0176710 PRN  Alkermes Completes Patient Enrollment in Pivotal Weight Study of ALKS 3831 for Schizophrenia,,,, 8/03/2016 55027E10 PRN  Luminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus, 8/30/2017 80067710 PRN  Sangamo Therapeutics Announces Presentations At Upcoming Investor Conferences,, 6/25/2018 80105N10  PRN  Sanofi presents results from the first head-to-head study comparing Toujeo® to insulin degludec,"11/05/2012 07HPGN-E  PRN  NYSE Hot Stocks Earnings Forecast: EMC, Pitney Bowes, LyondellBasell, Vertex, Hewlett-Packard, and Morgan Stanley",,,,,," 5/30/2017 PTGX-US  PRN  Janssen Enters Into Worldwide Exclusive License and Collaboration Agreement With Protagonist Therapeutics, Inc. for Oral Interleukin-23 Receptor Antagonist Drug Candidate for the Treatment of Inflammatory Bowel Disease",,,,,11/07/2013 68214310 PRN  Omeros Corporation Reports Third Quarter 2013 Financial Results,,,,,,,, 6/05/2017 69329Y10 PRN  Noden Pharma Notified of ANDA Filing for Tekturna®,,,," 9/27/2016 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Erythromycin Ethylsuccinate for Oral Suspension, 200mg/5mL",, 7/20/2011 02043Q10 PRN  Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment,,, 1/05/2017 60468T10 PRN  Mirati Therapeutics Provides Update On Glesatinib And Sitravatinib Clinical Trials And Pipeline Programs,,,,,,,"10/24/2017 09627Y10 PRN  Blueprint Medicines to Report Third Quarter 2017 Financial Results on Tuesday, October 31, 2017",,11/13/2017 28249U10 PRN  Eiger BioPharmaceuticals to Present at Jefferies 2017 Healthcare Conference,,,,,,, 8/02/2017 92165910 PRN  Vanda Pharmaceuticals Reports Second Quarter 2017 Financial Results,,,,, 8/25/2017 40637H10 PRN  Halozyme Therapeutics To Present At Upcoming Healthcare Conferences, 6/23/2014 G2151510 PRN  China Biologic Announces Favorable Reduction in Value Added Tax Rate,"10/21/2013 56400P70 PRN  Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences",,,," 5/22/2013 03236M20 PRN  Lifshitz Law Firm Announces Investigation of BMC Software, Amyris, Inc., Market Leader, Inc., and True Religion Apparel, Inc.", 9/13/2018 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conference,,,,,,," 2/09/2016 36197T10 PRN  Covered Call Alerts For Starbucks, GW Pharmaceuticals, Supernus Pharmaceuticals, CSX and SunEdison Released By InvestorsObserver",,12/21/2017 G5087110 PRN  Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea,," 3/14/2012 39843840 PRN  Grifols Study Suggests Repeated Plasmapheresis May Reduce ""Bad"" LDL Cholesterol Levels While Increasing ""Good"" HDL Cholesterol Levels in Some Individuals",,,10/20/2015 92337F10 PRN  Veracyte Announces Data Supporting Use of the Percepta™ Bronchial Genomic Classifier to Be Presented at CHEST 2015,,,,,,,,,,,,,,,, 3/07/2016 98401F10 PRN  Xencor Initiates Two Phase 2 Trials of XmAb5871 in IgG4-Related Disease and Systemic Lupus Erythematosus,,11/28/2017 G8807B10 PRN  Theravance Biopharma Highlights Submission of Landmark IMPACT Data to FDA to Support Expanded Label for Trelegy Ellipta,, 1/06/2016 03969710 PRN  Ardelyx Announces Proposed Public Offering of Common Stock,,,,,,,,,,,, 5/10/2017 05070R10 PRN  Audentes Therapeutics to Present At Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 6/06/2014 45232710    PRN  Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver",, 2/06/2018 ENDP-US  PRN  Endo Announces Initiation Of Two Pivotal Phase 3  Clinical Trials Of Collagenase Clostridium Histolyticum For The Treatment Of Cellulite,,10/15/2015 09060J10 PRN  BioDelivery Sciences Announces FDA Approval of Change in BUNAVAIL® Product Specification Allowing for Immediate Release of Product, 8/02/2018 09073M10    PRN  Bio-Techne Announces 2018 Investor Day And Webcast, 2/25/2019 75886F10    PRN  Regeneron and Sanofi Strongly Disagree with Verdict Upholding Three of Five Amgen U.S. Patent Claims Relating to PCSK9 Antibodies,," 6/19/2015 68375N10 PRN  Critical Alerts For FireEye, Occidental Petroleum Corporation, eBay, Google and Opko Health Released By InvestorsObserver",12/15/2017 46222210 PRN  Ionis Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference," 4/24/2018 09061G10   PRN  New England Journal of Medicine Published Open-label Study Showing Brineura® (cerliponase alfa) Reduced the Rate of Clinical Decline of Children with CLN2 Disease, a Form of Batten Disease"," 9/19/2011 01535110 PRN  Zacks' Voice of the People Highlights Opportunities with Advance Auto Parts, Alexion Pharma and Solera Holdings",11/14/2017 64125C10 PRN  Neurocrine Announces Long-Term Results Evaluating INGREZZA® for the Treatment of Adults with Tardive Dyskinesia Published in the Journal of Clinical Psychiatry,,, 1/28/2015 09062X10  PRN  NFL Hall of Famer Earl Campbell And Son Tyler Campbell Pair Up With Biogen Idec To Celebrate The Inspiring Stories Of People With Relapsing Multiple Sclerosis,,,"10/02/2015 37555810   PRN  Covered Call Alerts For Gilead Sciences, United Continental Holdings, First Solar, SouFun and Yelp Released By InvestorsObserver",12/21/2017 04004760   PRN  Arena Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference on January 10, 6/18/2018 N5946510  PRN  Mylan Launches Generic Angiomax® Injection, 5/25/2017 M2572210 PRN  Compugen Announces Appointment of Dr. Michal Preminger to Board of Directors," 2/08/2012 YUM-US   PRN  Zacks Releases Four Powerful ''Buy'' Stocks: BE Aerospace, Yum! Brands, Akorn and H.B. Fuller", 5/28/2019 03116210 PRN  Amgen Joins With Community Oncology Networks For New Research Collaboration,,"11/05/2015 52887230 PRN  Lexicon To Report Third Quarter 2015 Financial Results On November 6, 2015",,11/07/2012 45766930 PRN  Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer,,"10/04/2016 45773H20 PRN  Learn how to target a 20% return on Tesla Motors, or get option-trade ideas on Intra-Cellular Therapies, Inovio Pharmaceuticals, Universal Display Corporation and Southwestern Energy Company or any stock you choose", 4/15/2018 64026810 PRN  Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2018, 6/19/2017 76655960 PRN  FDA Accepts Rigel's New Drug Application for TAVALISSE™ (fostamatinib disodium) for the Treatment of Chronic ITP,,, 4/26/2011 02311120 PRN  Amarin to Present at the Deutsche Bank 26th Annual Healthcare Conference,"11/08/2013 45337C10 PRN  Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte", 7/28/2017 91307C10 PRN  Harwood Feffer LLP Announces Investigation of United Therapeutics Corporation,, 4/26/2018 G0176710 PRN  Alkermes Plc Reports First Quarter 2018 Financial Results,,,, 7/28/2016 55027E10 PRN  Luminex Corporation Reports Second Quarter 2016 Results, 8/25/2017 SGMO-US  PRN  Sangamo And Pfizer Announce First Patient Receives Treatment In Phase 1/2 Clinical Trial Evaluating SB-525 Investigational Gene Therapy For Hemophilia A,, 6/04/2018 80105N10  PRN  New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma,"11/05/2012 HUN-US    PRN  Critical Big Stocks and Penny Stocks Volume Alert: Chesapeake Energy, Dendreon, Skyworks Solutions, Vertex, Huntsman, and Regions Financial",,,,,," 5/25/2017 74366E10 PRN  Protagonist Therapeutics Initiates Phase 1 Study with Novel Hepcidin Mimetic, PTG-300",,,,,11/05/2013 68214310 PRN  Omeros Announces Positive OMS721 Data in Model of Age-Related Macular Degeneration,,,,,,,, 6/01/2017 69329Y10 PRN  PDL BioPharma to Present at the Jefferies 2017 Healthcare Conference,,,, 8/04/2016 00182C10 PRN  ANI Pharmaceuticals Reports Record Second Quarter Results and Increases Full-year 2016 Guidance,," 7/14/2011 02043Q10 PRN  Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board",,, 1/05/2017 60468T10 PRN  Mirati Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,,"10/10/2017 09627Y10 PRN  Blueprint Medicines Announces Appointment of Christopher Murray, Ph.D. as Senior Vice President, Technical Operations",,11/09/2017 28249U10 PRN  Eiger BioPharmaceuticals Reports Third Quarter 2017 Financial Results,,,,,,, 7/21/2017 92165910 PRN  Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatment of Schizophrenia,,,,, 8/08/2017 40637H10 PRN  Halozyme Reports Second Quarter 2017 Results, 6/17/2014 G2151510 PRN  China Biologic Announces Proposed Public Offering of Common Stock,"10/10/2013 56400P70 PRN  Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc.",,,," 5/21/2013 03236M20 PRN  Amyris, Inc. Sued by Investor", 9/07/2018 69366J20 PRN  PTC Therapeutics Announces Winners of Global Duchenne Muscular Dystrophy Patient Group STRIVE Awards in Recognition of World Duchenne Awareness Day,,,,,,," 1/26/2016 36197T10 PRN  Covered Call Alerts For Micron, Alibaba, GW Pharmaceuticals, Peabody Energy and Microsoft Released By InvestorsObserver",,12/19/2017 JAZZ-US  PRN  Pfenex earns $18.5 million in milestones and updates Worldwide License and Option Agreement with Jazz Pharmaceuticals,,"12/06/2011 39843840 PRN  Victor Grifols selected as ""Business Leader of the Year 2011"" by the Spain - U.S. Chamber of Commerce",,,10/19/2015 008W47-E PRN  Veracyte CEO Bonnie Anderson Urges CMS to Reverse Its Proposed 2016 Pricing Methodology for Advanced Molecular Diagnostic Tests,,,,,,,,,,,,,,,, 3/02/2016 0024VM-E PRN  Xencor to Present at Cowen and Company 36th Annual Health Care Conference,,11/21/2017 G8807B10 PRN  Theravance Biopharma to Present at Two Upcoming Investor Conferences,, 1/05/2016 03969710 PRN  Ardelyx Reports Positive Clinical Results of RDX022 for the Treatment of Hyperkalemia,,,,,,,,,,,," 5/08/2017 05070R10 PRN  Audentes Therapeutics Announces Appointment of John T. Gray, Ph.D. to Senior Vice President and Chief Scientific Officer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 5/22/2014 45232710    PRN  Study Results, Extension of Supply Agreements, Drug Designations, Senior Level Appointments, and Upcoming Events - Analyst Notes on InterMune, Actavis, Bristol-Myers, AbbVie and Illumina",, 1/29/2018 G3040110 PRN  Endo to Announce Fourth-Quarter 2017 Financial Results,,10/14/2015 09060J10 PRN  BioDelivery Sciences Announces Short-Term Supply Constraints for BUNAVAIL®," 8/01/2018 000XKX-E    PRN  Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc.", 2/25/2019 000VC1-E    PRN  Positive Results Presented from Two Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP),," 6/16/2015 0061W4-E PRN  Pulmatrix Raises $10 Million Private Placement; To Begin Trading on NASDAQ under ""PULM""",12/11/2017 46222210 PRN  Ionis Pharmaceuticals Licenses IONIS-HTT Rx to Partner Following Successful Phase 1/2a Study in Patients with Huntington's Disease," 4/18/2018 09061G10   PRN  BioMarin to Host First Quarter 2018 Financial Results Conference Call and Webcast on Wednesday, April 25 at 4:30pm ET"," 7/18/2011 CPX-US   PRN  Critical Alerts for Starbucks, Southwestern Energy, Complete Production Services, ARM Holdings, and Alexion Pharmaceuticals Released by Seven Summits Research","11/09/2017 64125C10 PRN  INGREZZA®, First FDA Approved Product for the Treatment of Tardive Dyskinesia, Receives Outstanding Therapeutic Product Award from Prestigious California Life Sciences Association",,,"12/12/2014 09062X10  PRN  Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio",,," 9/28/2015 37555810   PRN  Technical Coverage on Financial and Healthcare Stocks - CBOE Holdings, Boston Private, AEterna Zentaris, Great Basin Scientific and Gilead Sciences",12/05/2017 04004760   PRN  Arena Pharmaceuticals and Everest Medicines Enter into Development and Commercialization Partnership for Ralinepag and Etrasimod in China," 6/15/2018 500124-IN PRN  Indivior Responds to Generic SUBOXONE® Approvals and Dr. Reddy's Launch ""At-Risk""", 5/23/2017 M2572210 PRN  Compugen to Present at Two Upcoming Investor Conferences in June," 2/07/2012 00972810 PRN  Akorn, Inc. Announces Fourth Quarter 2011 Earnings Release and Conference Call Information", 5/28/2019 AMGN-US  PRN  Global Summit on Kidney Disease at George Washington University School of Medicine and Health Sciences Engages Huge Worldwide Audience of Patients and Professionals,,10/19/2015 52887230 PRN  Cancer Patients Treated With Lexicon's Telotristat Etiprate Report Improved Function And Well-Being,,10/24/2012 45766930 PRN  Insmed to Host 2012 Third Quarter Earnings Conference Call,," 7/11/2016 45773H20 PRN  Biotechnology Stocks Under the Scanner -- PTC Therapeutics, Inovio Pharma, VIVUS, and Spectrum Pharma", 4/11/2018 64026810 PRN  Nektar Announces Dosing of First Patient in Phase 1/2 Clinical Study to Evaluate Combination of TLR Agonist NKTR-262 with CD122-Biased Agonist NKTR-214 in Patients with Advanced Solid Tumors, 6/01/2017 76655960 PRN  Rigel to Present at Jefferies 2017 Global Healthcare Conference,,," 4/21/2011 APKT-US  PRN  Critical Insider Trade Alerts for Apple, Symantec, Amarin, Broadcom, SanDisk, & Acme Packet",11/05/2013 0016HW-E PRN  Ventana to partner with Incyte on the development of Companion Diagnostic tests," 7/27/2017 91307C10 PRN  UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In United Therapeutics Corporation To Contact The Firm",, 4/19/2018 G0176710 PRN  Alkermes to Host Conference Call to Discuss First Quarter 2018 Financial Results,,,, 7/20/2016 55027E10 PRN  Luminex Corporation Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time, 8/10/2017 80067710 PRN  Sangamo Therapeutics Announces Presentation At The 2017 Wedbush PacGrow Healthcare Conference,, 5/27/2018 07GCHJ-E  PRN  Beactica Signs Three-Year Extension Agreement With Sanofi,11/01/2012 MVIR.B-SE PRN  Medivir Announces Plans for a Phase II All-oral Study of Simeprevir (TMC435) and VX-135 for the Treatment of Hepatitis C to be Conducted by Janssen and Vertex,,,,,, 5/24/2017 74366E10 PRN  Protagonist Therapeutics Receives $1.34 Million SBIR Funding for Development of Biomarkers of IL-23 Receptor Antagonist Activity,,,,,"10/21/2013 68214310 PRN  Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros",,,,,,,, 5/11/2017 69329Y10 PRN  LENSAR® And PDL BioPharma Complete Strategic Financial Restructuring Of LENSAR,,,, 7/28/2016 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2016 Financial Results,, 6/08/2011 02043Q10 PRN  Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes,,,11/03/2016 60468T10 PRN  Mirati Therapeutics Reports Financial Results And Provides Business Update For The Third Quarter 2016,,,,,,, 9/10/2017 09627Y10 PRN  Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma,,11/06/2017 28249U10 PRN  Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences,,,,,,," 7/17/2017 92165910 PRN  Vanda Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 2, 2017",,,,, 8/04/2017 40637H10 PRN  Halozyme Therapeutics To Present At Upcoming Healthcare Conference, 5/06/2014 G2151510 PRN  China Biologic Reports Financial Results for the First Quarter of 2014," 9/23/2013 56400P70 PRN  Conference Calls, New Appointments, Upcoming Presentations, Prospectus Filings and Acquisition Deal Updates - Research Report on Johnson & Johnson, WellPoint, Regeneron, Onyx, and MannKind",,,," 5/17/2013 03236M20 PRN  Bronstein, Gewirtz & Grossman, LLC Announces That A Class Action Has Been Filed Against Amyris, Inc.", 8/24/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 1/22/2016 36197T10 PRN  Bernstein Liebhard LLP Announces That A Suit Has Been Filed Against GW Pharmaceuticals plc,,12/07/2017 G5087110 PRN  Jazz Pharmaceuticals to Present at the BMO Capital Markets Healthcare Conference,, 9/26/2011 39843840 PRN  Health Robotics Selects Grifols' Genesis I.V Room Inventory Management System Carrousels. Unprecedented Integration.,,,10/16/2015 008W47-E PRN  Veracyte Announces Data from Multiple Afirma® Gene Expression Classifier Studies to Be Presented at the 15th International Thyroid Congress,,,,,,,,,,,,,,,," 2/29/2016 98401F10 PRN  Xencor to Host Fourth Quarter and Full Year 2015 Financial Results Webcast and Conference Call on March 7, 2016",,11/16/2017 G8807B10 PRN  Theravance Biopharma Highlights Marketing Authorization in Europe for Trelegy Ellipta as Once-Daily Single Inhaler Triple Therapy for the Treatment of COPD,," 1/04/2016 03969710 PRN  Ardelyx Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Executive Vice President and Chief Medical Officer",,,,,,,,,,,, 5/03/2017 05070R10 PRN  Audentes Therapeutics Announces Presentation of Data at the American Society of Gene and Cell Therapy Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 4/14/2014 45232710    PRN  Collaborative Agreements, Earnings Release Schedules, Scholarship Programs, and Dividend Declarations - Analyst Notes on Aetna , Illumina , Safeway , Grainger and Fastenal",, 1/24/2018 G3040110 PRN  Endo Agrees to FDA's Request to Seek Temporary Litigation Stay,, 9/18/2015 09060J10 PRN  In a Move by the U.S. Department of Health and Human Services - Patient Limit on Access to Opioid Dependence Treatments to be Expanded," 7/24/2018 09073M10    PRN  Bio-Techne Introduces New Member of the Simple Western™ Family, with IR/NIR Detection Capabilities", 2/15/2019 75886F10    PRN  U.S. and EU Patent Office Decisions Invalidate Amgen Subsidiary Immunex's Patents Claiming Antibodies to the IL-4 Receptor,," 6/05/2015 68375N10 PRN  BIO-REFERENCE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Bio-Reference Laboratories, Inc.",12/07/2017 46222210 PRN  Ionis Pharmaceuticals to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference, 3/28/2018 09061G10   PRN  European Medicines Agency (EMA) Accepts BioMarin's Marketing Application for Pegvaliase MAA for Treatment of Phenylketonuria (PKU)," 6/06/2011 MSK-US   PRN  Seven Summits Research Releases Comments on Morgan Stanley, Ciena, Alexion, Navistar and Men's Wearhouse",11/08/2017 64125C10 PRN  Neurocrine Biosciences to Present at the Jefferies 2017 London Healthcare Conference,,,12/09/2014 000L1R-E  PRN  Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council,,," 9/18/2015 37555810   PRN  Covered Call Alerts For Gilead, CableVision Systems, Starbucks, Celgene Corporation and Eli Lilly Released By InvestorsObserver",11/10/2017 04004760   PRN  Arena Pharmaceuticals Completes Full Enrollment in Etrasimod Phase 2 Clinical Study for Ulcerative Colitis, 6/11/2018 N5946510  PRN  Americares Honors Mylan with Power of Partnership Award, 5/09/2017 M2572210 PRN  Compugen Reports First Quarter 2017 Results," 1/25/2012 000BNP-E PRN  Zacks.com featured expert Kevin Matras highlights: Akorn, Inc., Diana Shipping Inc., Endo Pharmaceuticals Holdings Inc., Southwest Airlines Co. and UnitedHealth Group Inc.", 5/22/2019 NUE-SE   PRN  Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen,,10/09/2015 52887230 PRN  Lexicon Announces Telotristat Etiprate Data To Be Presented At North American Neuroendocrine Tumor Society Annual Symposium,, 9/28/2012 45766930 PRN  Insmed Announces Pricing of Approximately $26 Million Direct Public Offering,," 3/16/2016 45773H20 PRN  Covered Call Alerts For Marathon Oil Corporation, Amazon.com, Chesapeake Energy, ConocoPhillips and Inovio Pharmaceuticals Released By InvestorsObserver", 4/03/2018 64026810 PRN  Nektar Therapeutics Announces Effective Date of Global Development & Commercialization Collaboration with Bristol-Myers Squibb, 5/02/2017 76655960 PRN  Rigel Announces First Quarter 2017 Financial Results and Provides Company Update,,, 4/18/2011 02311120 PRN  Amarin's AMR101 Phase 3 ANCHOR Trial Meets all Primary and Secondary Endpoints with Statistically Significant Reductions in Triglycerides at Both 4 Gram and 2 Gram Doses and Statistically Significant Decrease in LDL-C,"10/31/2013 45337C10 PRN  Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc."," 7/27/2017 91307C10 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of United Therapeutics Corporation (UTHR)",," 4/16/2018 G0176710 PRN  Thinking about buying stock in Alkermes, Bank of America, CVS Health Corp, The Goldman Sachs Group and Tesla Motors",,,," 7/08/2016 LMNX-US  PRN  Luminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2016", 8/09/2017 80067710 PRN  Sangamo Therapeutics Reports Second Quarter 2017 Financial Results,, 5/22/2018 SAN-FR    PRN  FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes,11/01/2012 005Y9C-E  PRN  Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C,,,,,, 5/10/2017 74366E10 PRN  Protagonist Therapeutics Reports First Quarter 2017 Financial Results,,,,,10/17/2013 68214310 PRN  Omeros Corporation Files Universal Shelf Registration Statement to Replace Expiring Universal Shelf Registration Statement,,,,,,,, 5/03/2017 69329Y10 PRN  PDL BioPharma Announces First Quarter 2017 Financial Results,,,," 7/18/2016 06CR5C-E PRN  ANI Pharmaceuticals Announces FDA Approval and Immediate Launch of Nilutamide Tablets, the First Generic Competitor to Nilandron®",, 6/06/2011 02043Q10 PRN  Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33,,,10/04/2016 60468T10 PRN  Mirati Therapeutics Appoints Chris LeMasters To Role Of Executive Vice President And Chief Business Officer,,,,,,, 9/06/2017 09627Y10 PRN  Blueprint Medicines to Present at Morgan Stanley 15th Annual Global Healthcare Conference,,10/31/2017 28249U10 PRN  Eiger BioPharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise In Full of Underwriter's Option to Purchase Additional Shares,,,,,,, 6/05/2017 92165910 PRN  Vanda Pharmaceuticals Announces Participation at June 2017 Investor Conferences,,,,, 7/13/2017 40637H10 PRN  Initiation Of Clinical Trial Collaboration Evaluating Halozyme's PEGPH20 In Combination With Anti-PDL1 Immunotherapy, 4/29/2014 G2151510 PRN  China Biologic Products to Report First Quarter 2014 Financial Results," 9/10/2013 56400P70 PRN  Technical Scrutiny: Novavax Inc., MannKind Corp., Galena Biopharma Inc., and Ariad Pharma Inc.",,,,"11/07/2012 ZAZA-US  PRN  Top Six Stocks - Tuesday NASDAQ Volume Watch: Earthlink, Amyris, NII Holdings, Aeterna Zentaris, Affymetrix, ZaZa Energy", 8/23/2018 0JSTQZ-E PRN  PTC Therapeutics Successfully Completes Acquisition of Agilis Biotherapeutics,,,,,,," 1/13/2016 36197T10 PRN  Covered Call Alerts For Starbucks, GW Pharmaceuticals, Cognizant Technology Solutions, NXP Semiconductors and General Electric Released By InvestorsObserver",,12/04/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Appointment Of Daniel Swisher As President And Chief Operating Officer,, 8/02/2011 39843840 PRN  Grifols Announces New North American Commercial Operations Organization,,,10/15/2015 008W47-E PRN  New American Thyroid Association Guidelines Include Recommendation for Veracyte's Afirma® Gene Expression Classifier to Rule Out Cancer in Indeterminate Thyroid Nodules,,,,,,,,,,,,,,,, 2/03/2016 XNCR-US  PRN  Xencor to Present at Two Upcoming Conferences in February,,11/13/2017 G8807B10 PRN  Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease,,11/12/2015 03969710 PRN  Ardelyx Reports Third Quarter 2015 Financial Results,,,,,,,,,,,, 4/18/2017 05070R10 PRN  Audentes Therapeutics Announces Pricing of Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 3/13/2014 45232710    PRN  Critical Alerts For Exxon, Sears, Mastercard, Anheuser-Busch, and Illumina Released By InvestorsObserver",, 1/11/2018 ENDP-US  PRN  Endo Comments on United States Attorney's Office Grand Jury Subpoena Relating to Products Containing Oxymorphone,, 9/10/2015 BDSI-US  PRN  BioDelivery Sciences to Present at the 6th Annual Credit Suisse Small & Mid Cap Conference and the Ladenburg Thalmann 2015 Healthcare Conference," 7/12/2018 09073M10    PRN  Bio-Techne To Host Conference Call On August 7, 2018 To Announce Fourth Quarter 2018 Financial Results", 2/14/2019 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentation,," 6/05/2015 68375N10 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Bio-Reference Laboratories, Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to Opko Health Inc. -- BRLI",11/16/2017 46222210 PRN  Ionis Pharmaceuticals Licenses Second Orally Delivered Antisense Drug to Janssen, 3/21/2018 BMRN-US    PRN  BioMarin's Gene Therapy Manufacturing Facility Recognized with Industry Award," 4/26/2011 T-US     PRN  The Zacks Analyst Blog Highlights: RadioShack, Sprint Nextel, AT&T, Target Corp. and Alexion Pharmaceuticals",11/07/2017 64125C10 PRN  Neurocrine to Present Data on the Patient Impact of Tardive Dyskinesia from the RE-KINECT Study at the 2017 Neuroscience Education Institute Congress,,,11/24/2014 00167Y-E  PRN  U.S. Claims Data Show That Biogen Idec's Tecfidera Captured Nearly Half of Second-Line Share Among Newly Diagnosed Multiple Sclerosis Patients,,, 9/17/2015 37555810   PRN  Second Quarter Financial Report Card – Report on Gilead Sciences,"11/08/2017 001B9Z-E   PRN  Biotech Stocks on Investors' Radar -- Aralez Pharma, Arena Pharma, Arrowhead Pharma, and AveXis"," 6/04/2018 N5946510  PRN  U.S. FDA Approves Mylan and Biocon's Fulphila™ (pegfilgrastim-jmdb), the First Biosimilar to Neulasta®", 5/04/2017 M2572210 PRN  Compugen to Present COM701 Checkpoint Product Candidate for Immuno-Oncology at ASCO,"10/07/2011 00972810 PRN  Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call Information", 5/22/2019 03116210 PRN  Amgen announces a recommended public cash offer to the shareholders of Nuevolution,, 9/29/2015 52887230 PRN  Lexicon's Telotristat Etiprate Shows Clinical Benefit In Treating Carcinoid Syndrome In Cancer Patients When Added To Standard Of Care,, 9/11/2012 INSM-US  PRN  Insmed Appoints Will Lewis as President and Chief Executive Officer,," 3/03/2016 45773H20 PRN  Covered Call Alerts For Bank of America, Twitter, Inovio Pharmaceuticals, Marathon Oil Corporation and Amicus Therapeutics Released By InvestorsObserver"," 3/09/2018 64026810 PRN  Take-Two Interactive Software, SVB Financial and Nektar Pharmaceuticals Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600", 4/27/2017 76655960 PRN  Rigel Announces Tavalisse™ as Proprietary Name for Fostamatinib in the United States,,, 4/05/2011 02311120 PRN  Phase 3 MARINE Trial Data to be Presented in May at the National Lipid Association 2011 Annual Scientific Sessions,"10/16/2013 45337C10 PRN  Dividend Announcements, Earnings Release Scheduled, and Data Presentations from Clinical Studies - Research Report on Questcor, Regeneron, NPS, Incyte, and Nektar", 7/27/2017 91307C10 PRN  United Therapeutics Corporation Reports Second Quarter 2017 Financial Results,, 4/16/2018 G0176710 PRN  Alkermes Announces FDA Acceptance for Review of New Drug Application for ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder,,,, 7/06/2016 LMNX-US  PRN  Luminex Corporation Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System, 8/02/2017 80067710 PRN  Sangamo Therapeutics Announces Second Quarter 2017 Conference Call And Webcast,, 5/21/2018 SAN-FR    PRN  New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma,10/25/2012 000YJB-E  PRN  Kalydeco™ Wins The Wall Street Journal's 2012 Technology Innovation Award for Medicine and Biotech,,,,,," 5/04/2017 74366E10 PRN  Key Patent Issues Covering Protagonist Therapeutics' Oral Peptide IL-23 Receptor Antagonists, including the Development Candidate PTG-200",,,,,10/17/2013 68214310 PRN  Omeros Reports Additional Positive Clinical Data for its Drug Candidate to Treat Cognitive Disorders,,,,,,,," 4/26/2017 69329Y10 PRN  PDL BioPharma to Announce First Quarter 2017 Financial Results on May 3, 2017",,,," 6/28/2016 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Hydroxyprogesterone Caproate Injection USP, 250mg/mL",, 5/10/2011 078VWR-E PRN  Isis Pharmaceuticals' and GSK's Innovative Collaboration Voted Breakthrough Alliance of 2011,,, 9/29/2016 60468T10 PRN  Mirati Therapeutics Announces Appointment Of Dr. Bruce L.A. Carter To Board Of Directors,,,,,,, 8/21/2017 09627Y10 PRN  Blueprint Medicines to Present Updated Data from Ongoing Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma at ESMO 2017 Congress and 11th ILCA Annual Conference,,10/27/2017 28249U10 PRN  Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock,,,,,,, 5/02/2017 92165910 PRN  Vanda Pharmaceuticals Reports First Quarter 2017 Financial Results,,,,, 7/10/2017 40637H10 PRN  Halozyme To Host Second Quarter 2017 Financial Results Conference Call, 4/02/2014 G2151510 PRN  China Biologic Announces Favorable Resolution to Title Dispute Involving Company Shares," 9/03/2013 56400P70 PRN  Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation",,,, 3/21/2012 089B1B-E PRN  Volkswagen Partners With Amyris and Solazyme to Promote Automotive use of Renewable Fuels, 8/10/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 1/11/2016 36197T10 PRN  GW Pharmaceuticals plc Investigated For Potential Securities Law Violations By Block & Leviton LLP,,11/09/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences,, 8/01/2011 00BKVH-E PRN  Health Robotics Announces Record-Breaking 2Q 2011 Results,,, 9/28/2015 008W47-E PRN  Veracyte Statement on CMS's Preliminary 2016 Clinical Laboratory Fee Schedule and Proposed PAMA Rule,,,,,,,,,,,,,,,, 1/11/2016 98401F10 PRN  Xencor Announces Change to Board of Directors,,11/13/2017 G8807B10 PRN  Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease,,"10/29/2015 03969710 PRN  Ardelyx to Report Third Quarter 2015 Financial Results on November 12, 2015",,,,,,,,,,,, 4/17/2017 05070R10 PRN  Audentes Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 3/10/2014 WX-CN       PRN  WuXi PharmaTech Purchases an Illumina HiSeq X Ten Sequencing System,,12/28/2017 G3040110 PRN  Endo to Participate at the 36th Annual J.P. Morgan Healthcare Conference,, 9/09/2015 ENDP-IE  PRN  Endo Pharmaceuticals and BioDelivery Sciences Present New Data on Investigational Product Buprenorphine HCl Buccal Film for Chronic Pain Management, 7/10/2018 09073M10    PRN  Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets, 2/11/2019 75886F10    PRN  Sanofi and Regeneron offer Praluent® (alirocumab) at a new reduced U.S. list price,," 6/04/2015 68375N10 PRN  Harwood Feffer LLP Announces Investigation of Bio-Reference Laboratories, Inc.",11/09/2017 46222210 PRN  Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure, 3/06/2018 09061G10   PRN  BioMarin to Attend Upcoming Investor Conference,,11/01/2017 64125C10 PRN  Neurocrine Biosciences Reports Third Quarter 2017 Results,,,"11/07/2014 09062X10  PRN  Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna",,," 9/08/2015 37555810   PRN  Critical Alerts For Gilead Sciences, Celgene, Mobileye NV, Valero Energy and American Airlines Released By InvestorsObserver",11/07/2017 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2017 Financial Results," 6/01/2018 N5946510  PRN  Mylan and Biocon to Present New Data at the American Society of Clinical Oncology (ASCO) Annual Meeting Reinforcing the Efficacy, Safety and Immunogenicity of Ogivri™, the first biosimilar for Herceptin® approved by FDA"," 4/26/2017 M2572210 PRN  Compugen First Quarter 2017 Conference Call Scheduled for Tuesday, May 9, 2017 at 10:00 AM ET"," 6/23/2011 00972810 PRN  Akorn, Inc. Announces Second Quarter 2011 Earnings Release and Conference Call Information", 5/21/2019 03116210 PRN  Amgen Announces Voting Results Of Annual Meeting Of Stockholders,, 9/28/2015 52887230 PRN  Media Alert: Lexicon To Discuss Complete Results Of Pivotal Phase 3 TELESTAR Study,, 8/30/2012 45766930 PRN  Insmed to Present at Stifel Nicolaus 2012 Healthcare Conference,," 2/17/2016 45773H20 PRN  Covered Call Alerts For Freeport-McMoRan, Inovio Pharmaceuticals, Chevron, NVIDIA and Groupon Released By InvestorsObserver", 3/07/2018 64026810 PRN  Nektar to Webcast Presentation at the Cowen and Company 38th Annual Health Care Conference in Boston," 4/27/2017 76655960 PRN  Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Rigel Pharma",,, 3/31/2011 02311120 PRN  Amarin to Present at the 10th Annual Needham Healthcare Conference,"10/08/2013 45337C10 PRN  Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp."," 7/21/2017 91307C10 PRN  United Therapeutics Corporation to Report Second Quarter 2017 Financial Results Before The Market Opens on Thursday, July 27, 2017",, 4/02/2018 G0176710 PRN  Alkermes Receives Refusal to File Letter From FDA for ALKS 5461,,,," 6/30/2016 55027E10 PRN  Luminex Corporation Completes Acquisition of Nanosphere, Inc.", 7/13/2017 80067710 PRN  Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II,, 5/17/2018 005M9Z-E  PRN  Sanofi: Accelerating Future Breakthroughs Through Clinical Trials -- Part 2 of 3,"10/22/2012 OCZ-US    PRN  Levi & Korsinsky, LLP Announces Class Action Against OCZ Technology Group, Inc. (OCZ) and Vertex Pharmaceuticals Inc. (VRTX) and Investigation of New Frontier Media, Inc. (NOOF) and Versant Corp. (VSNT)",,,,,, 4/20/2017 74366E10 PRN  Protagonist Therapeutics Announces PTG-200 Data Accepted for Oral Presentation at Digestive Diseases Week,,,,,"10/15/2013 68214310 PRN  Upcoming Financial Results Schedules, Clinical Studies and Trials, and New Appointments - Research Report on BioMarin, Alnylam, Aegerion, Omeros, and Tesaro",,,,,,,, 4/24/2017 MRK-US   PRN  PDL BioPharma Announces Settlement of Keytruda Patent Infringement Lawsuit with Merck,,,, 6/13/2016 06CR5C-E PRN  ANI Pharmaceuticals Announces FDA Approval of Oxcarbazepine Tablets,, 5/03/2011 IONS-US  PRN  Isis Pharmaceuticals to Present at the 14th Annual Bank of America Merrill Lynch Health Care Conference,,, 8/04/2016 60468T10 PRN  Mirati Therapeutics Reports Financial Results And Provides Business Update For The Second Quarter 2016,,,,,,, 8/03/2017 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences in August,,10/26/2017 28249U10 PRN  Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock,,,,,,, 5/01/2017 92165910 PRN  Vanda Pharmaceuticals to Present at the Deutsche Bank 42nd Annual Health Care Conference,,,,, 6/28/2017 40637H10 PRN  Halozyme Phase 2 Data In Advanced Pancreas Cancer Presented At European Society For Medical Oncology Symposium, 3/19/2014 G2151510 PRN  China Biologic Announces Receiving GMP Certification at its Guizhou Taibang Facility," 8/28/2013 56400P70 PRN  Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray",,,," 8/03/2011 09PSNC-E PRN  Lockerz Announces Investors in $36 Million of Series C Funding from Entertainment Leader Live Nation Entertainment, DAG Ventures, Liberty Media, and Kleiner Perkins Caufield & Byers", 8/07/2018 69366J20 PRN  PTC Therapeutics Reports Second Quarter 2018 Financial Results and Provides a Corporate Update,,,,,,,"12/30/2015 36197T10 PRN  Covered Call Alerts For FireEye, Dycom Industries Inc., Skechers, Thermo Fisher Scientific and GW Pharmaceuticals Released By InvestorsObserver",,11/07/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Third Quarter 2017 Financial Results,, 6/08/2011 39843840 PRN  Grifols Announces Combined Operations With Talecris to Begin a New Era as a Global Leader of Life-Saving Plasma Therapeutics,,, 9/14/2015 92337F10 PRN  Veracyte Announces Publication of New Long-Term Outcome Study that Reinforces the Clinical Utility of the Afirma® Gene Expression Classifier,,,,,,,,,,,,,,,, 1/07/2016 XNCR-US  PRN  National Institutes of Health Initiates Phase 1 Trial of VRC01LS Anti-HIV Therapeutic Antibody Using Xencor's Xtend Fc Technology,,"11/07/2017 G8807B10 PRN  Theravance Biopharma, Inc. Reports Third Quarter 2017 Financial Results and Provides Business Update",,10/28/2015 03969710 PRN  Ardelyx Announces Upcoming Presentations for Tenapanor at the American Society of Nephrology's Kidney Week Meeting 2015,,,,,,,,,,,, 4/17/2017 05070R10 PRN  Audentes Therapeutics to Present at the ARM 5th Annual Cell & Gene Therapy Investor Day,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 1/14/2014 45232710    PRN  Upcoming Conferences Presentations, Earnings Schedules, Stock Price Updates, and Licensing Agreements - Research Report on TEVA, Novartis, Illumina, BD, and UHS",,12/16/2017 G3040110 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline - ENDP,, 9/08/2015 09060J10 PRN  BioDelivery Sciences Secures Exclusive Preferred Formulary Status for BUNAVAIL® with Tennessee Medicaid (TennCare), 6/26/2018 000XKX-E    PRN  Bio-Techne Expands RNAscope® Assay Services Portfolio to Shorten Development Times and Save Costs, 2/11/2019 75886F10    PRN  Regeneron and Sanofi Offer Praluent® (alirocumab) at a New Reduced U.S. List Price,," 5/27/2015 68375N10 PRN  Critical Alerts For Westport Innovations, Outerwall, Cal-Maine Foods, Opko Health and Time Warner Cable Released By InvestorsObserver",11/08/2017 46222210 PRN  Ionis Pharmaceuticals to Present at Upcoming Investor Conferences, 2/28/2018 09061G10   PRN  Rare Disease Day 2018:  BioMarin Launches RARE Scholars Scholarship Program,,11/01/2017 64125C10 PRN  AbbVie Announces Positive Phase 3 Extension Study Data for Investigational Oral Treatment Elagolix for Management of Endometriosis with Associated Pain,,,"10/30/2014 09062X10  PRN  Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna",,," 8/25/2015 37555810   PRN  Critical Alerts For Gilead Sciences, Kite Pharma, Valero Energy, Starbucks and Nokia Corporation Released By InvestorsObserver",10/31/2017 04004760   PRN  Arena Pharmaceuticals to Present at the Credit Suisse Healthcare Conference on November 8, 6/01/2018 N5946510  PRN  Mylan to Present at Goldman Sachs 39th Annual Global Healthcare Conference, 3/28/2017 M2572210 PRN  Compugen Announces Lead Therapeutic Candidate COM902 for CGEN-15137/TIGIT Immuno-Oncology Program," 5/03/2011 00972810 PRN  Akorn, Inc. Announces First Quarter 2011 Earnings Release and Conference Call Information", 5/16/2019 03116210 PRN  Amgen To Present At The RBC Healthcare Conference And The UBS Global Healthcare Conference,, 9/08/2015 52887230 PRN  Lexicon Announces Sotagliflozin Data To Be Presented At European Association For The Study Of Diabetes,, 8/14/2012 45766930 PRN  Insmed to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference,," 2/02/2016 45773H20 PRN  Covered Call Alerts For Opko Health, Fitbit, Box, Inovio Pharmaceuticals and AbbVie Released By InvestorsObserver", 3/01/2018 NKTR-US  PRN  Nektar Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results, 4/25/2017 76655960 PRN  Rigel Announces Conference Call and Webcast to Report First Quarter 2017 Financial Results,,, 3/16/2011 02311120 PRN  Amarin Reports Year-End and Q4 2010 Results," 8/29/2013 45337C10 PRN  Acquisitions, Dividends, and Positive Data - Research Report on Onyx, Johnson & Johnson, Medtronic, Lilly, and Incyte", 5/31/2017 91307C10 PRN  United Therapeutics Corporation To Present At Jefferies 2017 Global Healthcare Conference,, 3/05/2018 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at Upcoming Healthcare Conferences,,,, 6/22/2016 55027E10 PRN  Luminex Corporation To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference," 6/29/2017 80067710 PRN  Sangamo Therapeutics Appoints Roger Jeffs, Ph.D. and Joseph S. Zakrzewski to its Board of Directors",, 5/16/2018 80105N10  PRN  Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis,"10/16/2012 0C9WFK-E  PRN  SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Announces Investigation of New Frontier Media, Inc. (NOOF) and Yongye International, Inc. (YONG) and Class Action Against Vertex Pharmaceuticals Inc. (VRTX)",,,,,, 3/09/2017 74366E10 PRN  Protagonist Therapeutics to Present at the Oppenheimer & Co. Healthcare Conference,,,,,10/15/2013 68214310 PRN  FDA Agrees with Omeros' Pediatric Study Plan for OMS302,,,,,,,," 4/13/2017 69329Y10 PRN  Biotech Stocks on Investors' Radar -- Halozyme Therapeutics, Cara Therapeutics, PDL BioPharma, and Arena Pharma",,,," 6/13/2016 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Oxycodone Capsules, 5mg",, 5/05/2010 02043Q10 PRN  South Africa Becomes First Government to Use the Pool for Open Innovation to Stimulate Neglected Disease Drug Research and Development,,, 6/22/2016 60468T10 PRN  Mirati Therapeutics Announces Change In Executive Leadership,,,,,,, 8/02/2017 09627Y10 PRN  Blueprint Medicines Reports Second Quarter 2017 Financial Results,,10/23/2017 28249U10 PRN  Eiger Announces Positive Phase 2 Interim 24-Week Data with Pegylated Interferon Lambda in Hepatitis Delta Virus (HDV) Infection at the American Association for the Study of Liver Diseases (AASLD) Meeting,,,,,,," 4/13/2017 92165910 PRN  Vanda Pharmaceuticals to Announce First Quarter 2017 Financial Results on May 2, 2017",,,,," 6/22/2017 HALO-US  PRN  FDA Approves Genentech's RITUXAN HYCELA, A Subcutaneous Rituximab Coformulated With Halozyme ENHANZE Technology", 3/12/2014 G2151510 PRN  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2013," 8/19/2013 56400P70 PRN  Positive Preliminary Results, R&D Investments, and Financial Results - Research Report on MannKind, Anacor, Sangamo, Stereotaxis, and Columbia Laboratories",,,, 7/15/2011 03236M20 PRN  Amyris Joins Diesel Technology Forum, 8/02/2018 69366J20 PRN  Akcea Therapeutics and PTC Therapeutics Collaborate to Commercialize Two Rare Disease Drugs in Latin America,,,,,,,12/16/2015 36197T10 PRN  Latest Studies and Clinical Trials Lead to Compelling Developments Indicating Cannabinoids May Contain Significant Analgesic Effects in Treating Various Diseases & Conditions,,11/03/2017 G5087110 PRN  Jazz Pharmaceuticals Submits Vyxeos™ Marketing Authorization Application to European Medicines Agency for Treatment of Certain Types of High-Risk Acute Myeloid Leukemia,, 6/06/2011 39843840 PRN  Grifols Announces the Appointment of Thomas Glanzmann as Chairman of its New Board of Directors for U.S. Operations,,, 9/09/2015 92337F10 PRN  Veracyte Announces Presentation of Percepta™ Bronchial Genomic Classifier Clinical Validation Data at the 16th World Conference on Lung Cancer,,,,,,,,,,,,,,,,11/24/2015 98401F10 PRN  Xencor to Present at Two Upcoming Conferences in December,,11/01/2017 G8807B10 PRN  Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting,,"10/26/2015 03969710 PRN  Ardelyx Appoints William Bertrand, Jr. to Its Board of Directors",,,,,,,,,,,, 4/03/2017 05070R10 PRN  Audentes Therapeutics Announces FDA Clearance of Investigational New Drug Application for AT132 to Treat X-Linked Myotubular Myopathy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 1/06/2014 45232710    PRN  Updates on Stock Price Movement, Corporate Announcements, and Marketing Authorizations - Research Report on Teva, Illumina, BD, Novartis, and UHS",,"11/17/2017 G3040110 PRN  ENDO INTERNATIONAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Endo International, Plc To Contact The Firm",, 9/03/2015 BDSI-US  PRN  BioDelivery Sciences to Participate at the Wells Fargo Securities 2015 Healthcare Conference and the FBR Second Annual Healthcare Conference," 6/25/2018 000XKX-E    PRN  Bio-Techne To Acquire Exosome Diagnostics, Inc.", 2/09/2019 75886F10    PRN  One-Year Results from Positive Phase 3 EYLEA Trial in Diabetic Retinopathy Presented at Angiogenesis Symposium,," 5/15/2015 68375N10 PRN  Critical Alerts For Under Armour, Cal-Maine Foods, Opko Health, Microsoft and Esperion Therapeutics Released By InvestorsObserver",11/07/2017 46222210 PRN  Ionis Announces Management Transitions, 2/22/2018 09061G10   PRN  BioMarin Announces Fourth Quarter and Full Year 2017 Financial Results,,10/31/2017 64125C10 PRN  Neurocrine Biosciences to Present at the Credit Suisse 26th Annual Healthcare Conference,,,"10/29/2014 09062X10  PRN  Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin",,," 8/12/2015 37555810   PRN  Critical Alerts For Linn Energy, Google Inc., Gilead Sciences, Skechers and ImmunoGen Released By InvestorsObserver","10/30/2017 04004760   PRN  Arena Pharmaceuticals to Release Third Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, November 7", 5/14/2018 N5946510  PRN  Mylan and West Virginia University Join Forces to Inspire West Virginia Youth Through STEM-CARE, 3/22/2017 M2572210 PRN  Compugen to Present CGEN-15001 Autoimmune Product Candidate at Upcoming Conferences," 4/08/2011 00972810 PRN  Akorn, Inc. Announces First Quarter 2011 Earnings Release and Conference Call Information", 5/15/2019 03116210 PRN  Amgen Showcases Oncology Pipeline At ASCO 2019,, 8/26/2015 52887230 PRN  Lexicon Announces Telotristat Etiprate Data To Be Presented At European Cancer Congress,," 8/07/2012 45766930 PRN  Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012",," 1/21/2016 45773H20 PRN  Covered Call Alerts For Facebook, Synaptics Incorporated, Abercrombie & Fitch, Inovio Pharmaceuticals and Whiting Petroleum Released By InvestorsObserver"," 2/21/2018 64026810 PRN  Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2017 on Thursday, March 1, 2018, After Close of U.S.-Based Financial Markets", 4/17/2017 76655960 PRN  Rigel Submits New Drug Application to FDA for Fostamatinib in Chronic ITP,,, 3/08/2011 02311120 PRN  Amarin to Present at Two Upcoming Investor Conferences," 8/26/2013 45337C10 PRN  Positive Clinical Trial Results, Regulatory Wins, and New Appointments - Research Report on Incyte, Edwards, ACADIA Pharmaceuticals, Alnylam, and Ironwood", 4/27/2017 91307C10 PRN  United Therapeutics Announces $250 Million Share Repurchase Program,, 3/01/2018 G0176710 PRN  Alkermes Appoints James Robinson as President and Chief Operating Officer,,,," 6/02/2016 55027E10 PRN  Luminex Corporation Announces Commencement of Tender Offer for All Outstanding Shares of Nanosphere, Inc. Common Stock", 6/26/2017 80067710 PRN  Sangamo Therapeutics Announces Closing Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock,, 5/14/2018 005M9Z-E  PRN  Sanofi: Accelerating Future Breakthroughs Through Clinical Trials - Part 1 of 3,"10/13/2012 0BVP5S-E  PRN  The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Versant Corp. (VSNT), West Coast Bancorp (WCBO) and Union Drilling, Inc. (UDRL) and Class Action Against Vertex Pharmaceuticals Inc. (VRTX)",,,,,, 3/07/2017 74366E10 PRN  Protagonist Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results,,,,,10/08/2013 68214310 PRN  Omeros Hires Michael K. Inouye to Lead Commercial Operations,,,,,,,," 4/06/2017 69329Y10 PRN  PDL BioPharma to Hold Annual Meeting of Stockholders on June 9, 2017",,,, 5/23/2016 QCOR-US  PRN  ANI Announces Appointment of Mark J. Ginski Ph.D as Vice President Corticotropin Product Development,,,,, 6/05/2016 60468T10 PRN  Mirati Therapeutics Provides Progress Update On Current Clinical Trials,,,,,,, 7/27/2017 09627Y10 PRN  Blueprint Medicines to Evaluate Opportunities to Advance Rare Disease Discovery Program in Fibrodysplasia Ossificans Progressiva Following Discontinuation of Collaboration with Alexion,,10/02/2017 28249U10 PRN  Eiger Announces Abstracts and Presentations at the American Association for the Study of Liver Diseases (AASLD) Meeting,,,,,,, 3/29/2017 92165910 PRN  Vanda and UCSF Announce License Agreement for CFTR Activators and Inhibitors,,,,, 6/04/2017 40637H10 PRN  Halozyme Phase 2 Data In Advanced Pancreas Cancer Featured In An Oral Presentation At ASCO, 3/04/2014 G2151510 PRN  China Biologic Products to Report Fourth Quarter and Fiscal Year 2013 Financial Results," 8/14/2013 56400P70 PRN  Quarterly Results, Collaborations and Product Launches - Research Report on Onyx Pharmaceuticals, Express Scripts, NPS Pharmaceuticals, Salix Pharmaceuticals, and MannKind Corporation",,,,12/08/2010 000BNJ-E PRN  Fourteen New Alternative Energy Stocks Added to Ardour Global Alternative Energy Index in Quarterly Rebalancing, 7/26/2018 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2018 Financial Results,,,,,,,"12/16/2015 36197T10 PRN  Covered Call Alerts For Frontier Communications Corp, GW Pharmaceuticals, Lumber Liquidators, Sarepta Therapeutics and Relypsa Released By InvestorsObserver",,11/01/2017 G5087110 PRN  Jazz Pharmaceuticals to Highlight Hematology Research at ASH 2017 Annual Meeting,, 6/03/2011 39843840 PRN  Grifols Announces the Completion of its Acquisition of Talecris and the Listing of its ADSs on NASDAQ,,, 9/02/2015 VCYT-US  PRN  Veracyte to Present at Morgan Stanley Global Healthcare Conference,,,,,,,,,,,,,,,,11/09/2015 XNCR-US  PRN  Xencor Presents Data on XmAb5871 Program at American College of Rheumatology (ACR) 2015 Annual Meeting,,11/01/2017 G8807B10 PRN  Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting,,10/08/2015 03969710 PRN  Ardelyx to Present Phase 2 Data for Tenapanor in IBS-C Patients at the 2015 American College of Gastroenterology Annual Meeting,,,,,,,,,,,," 3/20/2017 05070R10 PRN  Audentes Therapeutics Announces Presentation Of Data From RECENSUS, A Medical Chart Review Of Patients With X-Linked Myotubular Myopathy (XLMTM)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"12/24/2013 45232710    PRN  New Appointments, and Share Price Movements - Research Report on Humana, Illumina, Edwards Lifesciences, Aegerion Pharmaceuticals, and CytRx",,11/17/2017 G3040110 PRN  Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference,, 8/13/2015 BDSI-US  PRN  BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS® (fentanyl buccal soluble film) CII, 6/07/2018 09073M10    PRN  Bio-Techne To Acquire Quad Technologies, 2/06/2019 75886F10    PRN  Regeneron Reports Fourth Quarter and Full Year 2018 Financial and Operating Results,, 5/14/2015 68375N10 PRN  New Collaborations Lead to Advancements in Human Clinical Trials for Development of Clinical Grade Production for Therapeutic Product Candidates With Proprietary Technologies,11/07/2017 46222210 PRN  Ionis Pharmaceuticals Reports Financial Results and Highlights for Third Quarter 2017, 2/07/2018 09061G10   PRN  BioMarin Presents Interim Data of Phase 1/2 Study of BMN 250 for Treatment of Sanfilippo B Syndrome (MPS IIIB) at WORLDSymposium™ 2018,,10/27/2017 64125C10 PRN  AbbVie Receives U.S. FDA Priority Review for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain,,,"10/21/2014 09062X10  PRN  Regulatory Approval, Customer Safety Alert, Patient Support Program Launch, Earnings Releases, and Rating - Research Reports on Medtronic, Covidien, Biogen Idec, Baxter and Express Scripts",,," 7/31/2015 37555810   PRN  Critical Alerts For Fitbit, Gilead Sciences, American Airlines, Skechers and JetBlue Released By InvestorsObserver","10/19/2017 04004760   PRN  Standout Players Find Varied, Innovative Means of Serving the Marijuana Industry", 5/09/2018 N5946510  PRN  Mylan Reports First Quarter 2018 Results and Reaffirms 2018 Guidance, 3/08/2017 M2572210 PRN  Compugen Announces Addition of Prof. Miriam Merad to Its Scientific Advisory Board," 1/31/2011 00972810 PRN  Akorn, Inc. Announces Fourth Quarter 2010 Earnings Release and Conference Call Information", 5/10/2019 03116210 PRN  Amgen To Present At The Bank of America Merrill Lynch 2019 Health Care Conference,, 8/11/2015 52887230 PRN  An Update on Pivotal Phase 3 Study - Report on Lexicon Pharmaceuticals,, 8/06/2012 45766930 PRN  Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors,," 1/07/2016 45773H20 PRN  Covered Call Alerts For Ambarella, Vuzix Corporation, SolarEdge Technologies, Inovio Pharmaceuticals and Juno Therapeutics Inc Released By InvestorsObserver"," 1/03/2018 64026810 PRN  Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, CA"," 3/17/2017 76655960 PRN  How These Generic Drugs Stocks are Faring? -- Neurocrine Biosciences, Lannett, Rigel Pharma, and Catalent",,, 2/22/2011 02311120 PRN  Amarin to Present at Two Upcoming Investor Conferences," 8/21/2013 45337C10 PRN  Biotech Companies Announce Financial Results and Receive New Patents - Research Report on Regeneron, Medivation, Incyte, Santarus, and ACADIA", 4/26/2017 91307C10 PRN  3D Systems and United Therapeutics Announce Bioprinting Agreement,, 2/14/2018 G0176710 PRN  Alkermes Appoints Shane Cooke to Board of Directors,,,, 6/01/2016 55027E10 PRN  Luminex Corporation Receives CE-IVD Mark for ARIES Flu A/B & RSV Assay, 6/21/2017 80067710 PRN  Sangamo Therapeutics Announces Pricing Of $72.5 Million Public Offering Of Common Stock,," 5/03/2018 05MSNJ-E  PRN  TechCare Launches Its Novokid Lice Treatment Products Line in Super Pharm, Israel's Largest Drugstore Chain","10/13/2012 92532F10  PRN  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Vertex Pharmaceuticals Incorporated To Contact the Firm",,,,,, 3/02/2017 BARC-GB  PRN  Protagonist Therapeutics to Present at the Barclays Global Healthcare Conference,,,,,"10/07/2013 68214310 PRN  Changes in Senior Management, Grants of Orphan Drug Designations, and Updates on Pipeline Development and NDA - Research Report on Vivus, Omeros, Delcath Systems, Achillion, and Zogenix",,,,,,,, 3/14/2017 06C5B2-E PRN  PDL BioPharma to Present at the Oppenheimer 27th Annual Healthcare Conference,,,, 5/18/2016 00G7QL-E PRN  ANI Pharmaceuticals to Present at the UBS Global Healthcare Conference,,,,, 6/01/2016 60468T10 PRN  Mirati Therapeutics To Present At The Jefferies 2016 Healthcare Conference,,,,,,," 7/26/2017 09627Y10 PRN  Blueprint Medicines to Report Second Quarter 2017 Financial Results on Wednesday, August 2, 2017",," 9/18/2017 28249U10 PRN  Eiger Announces Appointment of Biopharmaceutical Industry Veteran Evan Loh, MD to its Board of Directors",,,,,,," 3/07/2017 92165910 PRN  How These Biotech Stocks are Faring? -- Corbus Pharma, Advaxis, Vanda Pharma, and Nivalis Therapeutics",,,,, 5/25/2017 40637H10 PRN  Halozyme Therapeutics To Present At Upcoming Healthcare Conferences, 3/03/2014 G2151510 PRN  China Biologic Completes Stock Repurchase Transaction," 6/18/2013 56400P70 PRN  Advanced Treatment Methods, Significant Study Results, Conferences, and Final Study Data Releases - Research Report on Amgen, Celgene, Vertex Pharmaceuticals, MannKind, and Peregrine Pharmaceuticals",,,,12/07/2010 008CMY-E PRN  The 50 Hottest Companies in Bioenergy for 2010-11, 7/24/2018 69366J20 PRN  PTC Therapeutics Announces Publication of Data Demonstrating the Clinical Differentiated Benefit of Deflazacort,,,,,,,"12/01/2015 36197T10 PRN  Covered Call Alerts For Ambarella, GW Pharmaceuticals, Qorvo, ConocoPhillips and NRG Energy Inc. Released By InvestorsObserver",,"10/24/2017 G5087110 PRN  Jazz Pharmaceuticals to Report 2017 Third Quarter Financial Results on November 7, 2017",, 6/01/2011 00394S-E PRN  Grifols and Talecris Biotherapeutics Announce the FTC Has Accepted the Consent Agreement for Public Comment,,, 8/27/2015 VCYT-US  PRN  Pulmonary Fibrosis Foundation and Veracyte Partner on Survey Exploring Diagnostic Experiences of U.S. Patients with Interstitial Lung Disease,,,,,,,,,,,,,,,,11/05/2015 98401F10 PRN  Preclinical Data of Xencor's XmAb Bispecific Technology to be Presented at Upcoming ASH Annual Meeting,,"11/01/2017 G8807B10 PRN  Theravance Biopharma Announces Opening of Company's New Corporate Office in Dublin, Ireland",, 9/01/2015 03969710 PRN  Ardelyx Regains NaP2b Program from Sanofi,,,,,,,,,,,, 3/09/2017 05070R10 PRN  Audentes Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"12/19/2013 45232710    PRN  Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics",,"11/16/2017 G3040110 PRN  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Endo International plc (ENDP) and Lead Plaintiff Deadline: January 16, 2018",," 8/12/2015 09060J10 PRN  BioDelivery Sciences Strengthens Sales Force Leadership with Hiring of Scott Plesha, Former Salix Head of Sales", 6/04/2018 09073M10    PRN  Bio-Techne To Present At The William Blair 38th Annual Growth Stock Conference, 2/04/2019 75886F10    PRN  CHMP Recommends Approval of Praluent® (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease,," 5/06/2015 68375N10 PRN  Technical Briefing on Biotech Equities -- OPKO Health, Organovo Holdings, Seattle Genetics, CorMedix, and Sunesis Pharma",11/06/2017 46222210 PRN  Ionis Announces Submission of New Drug Application (NDA) for Inotersen to the U.S. FDA, 2/06/2018 09061G10   PRN  WORLDSymposium Recognizes BioMarin's Brineura® (cerliponase alfa) with 2018 New Treatment Award,,"10/27/2017 64125C10 PRN  Daily Technical Summary Reports on Generic Drugs Stocks -- Ironwood Pharma, Mylan, Neurocrine Biosciences, and Versartis",,,"10/13/2014 09062X10  PRN  Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire",,," 7/20/2015 37555810   PRN  Critical Alerts For Linn Energy, Gilead Sciences, BP, Alcoa and Opko Health Released By InvestorsObserver",10/19/2017 04004760   PRN  Arena Pharmaceuticals Announces Late Breaking Presentation of Positive Phase 2 Results with Ralinepag in Patients with Pulmonary Arterial Hypertension at the American College of Chest Physicians 2017 Annual Meeting," 5/02/2018 N5946510  PRN  Mylan to Release First Quarter 2018 Financial Results on May 9, 2018", 3/02/2017 M2572210 PRN  Compugen Announces Presentations of COM701 Immuno-oncology Pipeline Product and Predictive Discovery Methodology for Novel Immune Checkpoints at AACR,11/17/2010 000BNP-E PRN  Reportlinker Adds Global Opthalmic Pharmaceutical Drugs Industry, 5/02/2019 03116210 PRN  Amgen To Highlight Extensive Long-Term Safety And Efficacy Data Of Aimovig® (erenumab-aooe) Across The Spectrum Of Migraine At AAN Annual Meeting,, 8/10/2015 LXRX-US  PRN  Lexicon To Present At The 2015 Wedbush PacGrow Healthcare Conference,, 8/02/2012 45766930 PRN  Insmed Receives Second Composition Of Matter Patent For ARIKACE®,,"12/18/2015 45773H20 PRN  Covered Call Alerts For Micron, Inovio Pharmaceuticals, Arrowhead Research, CyberArk Software and Exact Sciences Released By InvestorsObserver",11/27/2017 64026810 PRN  Nektar to Webcast Presentation at the Piper Jaffray 29th Annual Healthcare Conference in New York City, 3/07/2017 76655960 PRN  Rigel Announces Fourth Quarter 2016 and Year End 2016 Financial Results and Provides Company Update,,, 2/07/2011 02311120 PRN  Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference," 7/25/2013 CHTP-US  PRN  Results Schedules, Management Changes, and Pending NDA Approvals - Research Report on Questcor, VIVUS, Exelixis, Incyte, and Chelsea Therapeutics", 4/26/2017 91307C10 PRN  United Therapeutics Corporation Reports First Quarter 2017 Financial Results,," 2/14/2018 G0176710 PRN  Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2017 and Provides Financial Expectations for 2018",,,, 5/26/2016 55027E10 PRN  Luminex Corporation To Present At Jefferies 2016 Healthcare Conference, 6/20/2017 80067710 PRN  Sangamo Therapeutics Announces Proposed Public Offering of Common Stock,, 5/02/2018 005M9Z-E  PRN  Sanofi Named to DiversityInc's Top 50 Companies for Diversity®,"10/12/2012 GM-US     PRN  Hot Stocks: Clearwire, Vertex Pharmaceuticals, Marvell, General Motors, Alcoa, and Barrick Gold",,,,,, 2/17/2017 07F0YZ-E PRN  Protagonist Therapeutics Presents Data on Oral Peptide Drug Candidates at European Crohn's and Colitis Organization (ECCO) Congress,,,,,10/03/2013 063XRR-E PRN  Omeros Settles Insurance Litigation,,,,,,,, 3/02/2017 69329Y10 PRN  PDL BioPharma to Present at Two Upcoming Investor Conferences,,,, 5/17/2016 00182C10 PRN  ANI Pharmaceuticals Enters Into Exclusive Distribution and Supply Agreement for Hydroxyprogesterone Caproate Injection USP,,,,, 5/19/2016 60468T10 PRN  Mirati Therapeutics To Present Abstracts On Pipeline Programs At 2016 American Society Of Clinical Oncology (ASCO) Annual Meeting,,,,,,, 6/05/2017 09627Y10 PRN  Blueprint Medicines Announces New Phase 1 Clinical Data for BLU-285 in Advanced Gastrointestinal Stromal Tumors and Plans to Pursue Expedited Development in Patients with a PDGFRα D842V Mutation,, 9/05/2017 28249U10 PRN  Eiger Announces FDA Orphan Drug Designation Granted for Pegylated Interferon Lambda in Hepatitis Delta Virus Infection,,,,,,, 3/06/2017 92165910 PRN  Vanda Pharmaceuticals Announces Participation at March 2017 Investor Conferences,,,,, 5/24/2017 40637H10 PRN  Halozyme Therapeutics Announces Completion Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares,11/05/2013 G2151510 PRN  China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2013," 6/06/2013 56400P70 PRN  Positive Findings, Collaborations, and NDA Filings Strengthen Pipelines - Research Report on Clovis Oncology, MannKind, TESARO, Peregrine Pharmaceuticals, and Vanda Pharmaceuticals",,,,, 7/19/2018 00FWNL-E PRN  PTC Therapeutics to Acquire Agilis Biotherapeutics,,,,,,,"11/18/2015 36197T10 PRN  Covered Call Alerts For Chipotle Mexican Grill, GW Pharmaceuticals, American Airlines, Walmart Stores Inc. and Applied Materials Inc. Released By InvestorsObserver",, 9/12/2017 G5087110 PRN  Fortune Magazine Names Jazz Pharmaceuticals 78th Fastest Growing Company for 2017,, 5/02/2011 00394S-E PRN  Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement with FTC Staff,,," 8/17/2015 92337F10 PRN  Veracyte, Inc. Appoints Dr. Neil M. Barth as Chief Medical Officer",,,,,,,,,,,,,,,,11/04/2015 XNCR-US  PRN  Xencor to Present at Credit Suisse 24th Annual Healthcare Conference,,10/31/2017 G8807B10 PRN  Theravance Biopharma Reports Positive New VIBATIV® (telavancin) Data from TOUR™ Observational Patient Registry at 2017 CHEST Annual Meeting,, 8/12/2015 03969710 PRN  Ardelyx Reports Second Quarter 2015 Financial Results,,,,,,,,,,,," 3/01/2017 05070R10 PRN  Audentes Therapeutics Announces Commencement of LUSTRO, a Clinical Assessment and Phase 1/2 Run-in Study of Patients with Crigler-Najjar Syndrome",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"12/16/2013 45232710    PRN  Stock Price Updates, Dividends Declaration, and Appointments in Executive Leadership Team - Research Report on Humana, Illumina, Forest Laboratories, Stryker, and Unilife",,11/09/2017 G3040110 PRN  Endo Reports Third-Quarter 2017 Financial Results,, 8/10/2015 09060J10 PRN  BioDelivery Sciences Provides Corporate Update and Reports Second Quarter 2015 Financial Results, 5/24/2018 09073M10    PRN  Bio-Techne To Present At The Jefferies 2018 Healthcare Conference, 1/23/2019 000VC1-E    PRN  Forty of the Nation's Most Brilliant Young Scientists Named Finalists in Regeneron Science Talent Search 2019,," 4/30/2015 68375N10 PRN  Critical Alerts For GoPro, Workday, Starbucks, Opko Health and CBS Released By InvestorsObserver",11/03/2017 46222210 PRN  Ionis Announces Submission of Marketing Authorization Application for Inotersen to the European Medicines Agency, 2/05/2018 09061G10   PRN  BioMarin Announces 20 Presentations at 14th Annual WORLDSymposium™ 2018,,10/25/2017 64125C10 PRN  Neurocrine Initiates Phase IIb Clinical Study of Once-daily INGREZZA® in Children and Adolescents with Tourette Syndrome,,,"10/01/2014 09062X10  PRN  Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter",,, 7/13/2015 37555810   PRN  Biotech Briefing: FDA Events & Recent Clinical Trials Fuel Therapeutic Advancements That Continue to Drive the Pharma & Biotech Sectors, 9/06/2017 04004760   PRN  Arena Pharmaceuticals to Present Additional Pre-Clinical Data on Ralinepag for Treatment of Pulmonary Arterial Hypertension at International Congress of the European Respiratory Society, 4/25/2018 N5946510  PRN  Mylan Adds to Growing Women's Healthcare Portfolio with Launch of Generic for Oral Contraceptive Yaz®, 2/15/2017 M2572210 PRN  Compugen Reports Fourth Quarter and Calendar Year 2016 Results,"10/13/2010 00972810 PRN  CORRECTED - Akorn, Inc. Announces Date Change for Third Quarter 2010 Earnings Release and Conference Call", 5/02/2019 0CYZWD-E PRN  Amgen And Syapse Enter Precision Medicine Collaboration In Oncology,," 8/07/2015 52887230 PRN  Lexicon Pharmaceuticals Reports 2nd Quarter Financial Results, Provides Clinical Pipeline Update",, 7/30/2012 45766930 PRN  Insmed Announces Planned Departure Of Chief Financial Officer,,"12/07/2015 45773H20 PRN  Covered Call Alerts For Anavex Life Sciences Corp, Skyworks Solutions, Amazon.com, and Inovio Pharmaceuticals Released By InvestorsObserver",11/22/2017 64026810 PRN  Nektar Announces Key Executive Promotions to Drive the Continued Growth of the Company's Immuno-Oncology Pipeline, 2/28/2017 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2016 Financial Results,,, 2/02/2011 02311120 PRN  Amarin Corporation Appoints Industry Veteran Paul E. Huff as Chief Commercial Officer," 6/13/2013 45337C10 PRN  Lilly and Incyte Announce Baricitinib Efficacy and Safety Data from the Open-Label, Long-Term Extension of the Phase 2b JADA Study in Patients with Rheumatoid Arthritis"," 4/19/2017 91307C10 PRN  United Therapeutics Corporation To Report First Quarter 2017 Financial Results Before The Market Opens On Wednesday, April 26, 2017",, 2/07/2018 G0176710 PRN  Alkermes To Host Conference Call To Discuss Fourth Quarter And Year-End 2017 Financial Results,,,," 5/23/2016 55027E10 PRN  Luminex Corporation and Nanosphere, Inc. Provide Update on Acquisition Agreement", 6/07/2017 SGMO-US  PRN  Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency,," 5/01/2018 ESRX-US   PRN  Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients","10/11/2012 0BGL4K-E  PRN  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Alliance Financial Corporation (ALNC), Versant Corp. (VSNT) and Class Action Against Vertex Pharmaceuticals Inc. (VRTX)",,,,,, 2/01/2017 74366E10 PRN  Protagonist Therapeutics to Participate in the Leerink Partners 6th Annual Global Healthcare Conference,,,,,10/03/2013 68214310 PRN  Omeros Unlocks Six Additional Class A Orphan GPCRs and Identifies Small Molecules Targeting Two Commercially Validated Class B GPCRs,,,,,,,, 3/02/2017 06C5B2-E PRN  PDL BioPharma Partnering Deals and Alliances 2010 to 2017,,,, 5/16/2016 00182C10 PRN  ANI Pharmaceuticals Launches Authorized Generic of Rowasa® Enema 4g/60mL,,,,, 5/05/2016 60468T10 PRN  Mirati Therapeutics Reports Financial Results And Business Update For The First Quarter 2016,,,,,,, 6/01/2017 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences in June,, 8/30/2017 28249U10 PRN  Eiger BioPharmaceuticals to Present at Two Upcoming Investor Conferences,,,,,,, 2/15/2017 92165910 PRN  Vanda Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial Results,,,,, 5/18/2017 40637H10 PRN  Halozyme Therapeutics Prices Public Offering Of Common Stock,10/28/2013 G2151510 PRN  China Biologic Products to Report Third Quarter 2013 Financial Results," 4/23/2013 56400P70 PRN  MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCall's Microscope",,,,, 7/09/2018 69366J20 PRN  PTC Therapeutics Announces Positive Data from its Translarna™ Phase II Clinical Trial in Children as Young as Two Years with Nonsense Mutation Duchenne Muscular Dystrophy,,,,,,,"11/05/2015 36197T10 PRN  Covered Call Alerts For Disney, Facebook, Google, GW Pharmaceuticals and Gilead Sciences Released By InvestorsObserver",, 9/01/2017 JAZZ-US  PRN  Jazz Pharmaceuticals Announces Completion of Offering and Exercise in Full of Initial Purchasers' Option to Purchase Additional 1.50% Exchangeable Senior Notes due 2024,, 5/02/2011 TLCR-US  PRN  Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement With FTC Staff,,, 8/13/2015 92337F10 PRN  Veracyte Announces Second Quarter 2015 Financial Results,,,,,,,,,,,,,,,,11/03/2015 98401F10 PRN  Xencor Reports Third Quarter 2015 Financial Results and Pipeline Update,,"10/30/2017 G8807B10 PRN  Theravance Biopharma to Report Third Quarter 2017 Financial Results on November 7, 2017",," 8/05/2015 03969710 PRN  Ardelyx to Report Second Quarter 2015 Financial Results on August 12, 2015",,,,,,,,,,,, 2/07/2017 05070R10 PRN  Audentes Therapeutics to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"11/26/2013 45232710    PRN  FDA Clearance, Management Changes, and Clinical Study Updates - Research Report on Illumina, Array, Oncolytics, Intrexon, and STERIS",,11/08/2017 G3040110 PRN  Endo Announces Appointment of Dr. Sharad S. Mansukani to Board of Directors and Resignation of Mr. Douglas S. Ingram,," 8/03/2015 09060J10 PRN  BioDelivery Sciences to Host Conference Call and Webcast of Second Quarter 2015 Results on Monday, August 10", 5/10/2018 09073M10    PRN  Bio-Techne To Present At The UBS Global Healthcare Conference, 1/23/2019 75886F10    PRN  Forty of the Nation's Most Brilliant Young Scientists Named Finalists in Regeneron Science Talent Search 2019,," 4/22/2015 0070KW-E PRN  Pfizer Partnership Ready to Flourish; Opko Health Brief Report Issued by BrokerBank Securities, Inc.",11/02/2017 46222210 PRN  Ionis Presents New Data from NEURO-TTR Study at European ATTR Amyloidosis Meeting," 1/24/2018 09061G10   PRN  BioMarin to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast on Thursday, February 22 at 4:30pm ET",,10/24/2017 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2017 Results,,," 9/23/2014 09062X10  PRN  Results of Clinical Trials, New Drug Applications, Leadership Appointments, and Scheduled Earnings - Research Reports on Biogen, Salix, Express Scripts, Stryker and Shire",,," 7/07/2015 37555810   PRN  Critical Alerts For Bank of America, Regeneron Pharmaceuticals, Ambarella, Zulily and Gilead Sciences Released By InvestorsObserver", 8/29/2017 04004760   PRN  Arena Pharmaceuticals to Participate in Upcoming Investor Conferences, 4/21/2018 N5946510  PRN  Mylan Presents Equivalence Data on Glatiramer Acetate Compared to Copaxone® at American Academy of Neurology 70th Annual Meeting," 1/30/2017 M2572210 PRN  Compugen Fourth Quarter and Yearend 2016 Conference Call Scheduled for Wednesday, February 15, 2017 at 10:00 AM EST","10/07/2010 00972810 PRN  Akorn, Inc. Announces Third Quarter 2010 Earnings Release and Conference Call Information", 5/01/2019 03116210 PRN  Amgen Ignites A Social Fitness Movement To Support The Fight Against Heart Disease And Cancer,," 8/05/2015 52887230 PRN  Lexicon to Report Second Quarter 2015 Financial Results on August 7, 2015",, 7/24/2012 45766930 PRN  Insmed to Host 2012 Second Quarter Earnings Conference Call,,"11/24/2015 45773H20 PRN  Covered Call Alerts For Alcoa, Amazon.com, Inovio Pharmaceuticals, Isis Pharmaceuticals and Transocean Released By InvestorsObserver","11/11/2017 64026810 PRN  First Data for NKTR-214 in Combination with OPDIVO® (nivolumab) for Patients with Stage IV Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancers, Including Patients with PD-L1 Negative Status, Revealed at SITC 2017", 2/03/2017 76655960 PRN  Rigel Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Option To Purchase Additional Shares,,, 1/31/2011 02311120 PRN  Amarin Provides 2010 Year-End Review to Shareholders," 4/23/2013 45337C10 PRN  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and the May 6, 2013 Lead Plaintiff Deadline", 4/12/2017 002G54-E PRN  Respira Therapeutics Announces Collaboration with United Therapeutics to Treat Pulmonary Hypertension,," 2/01/2018 002R6W-E PRN  Pre-Market Technical Scan on Drug Delivery Equities -- Bio-Path, Alkermes, PetMed Express, and Valeant Pharma",,,, 5/16/2016 55027E10 PRN  Luminex to Highlight Latest Additions to Product Portfolio at the 2016 Clinical Virology Symposium, 6/02/2017 80067710 PRN  Sangamo Therapeutics Announces Presentation At The Jefferies 2017 Global Healthcare Conference,, 4/30/2018 80105N10  PRN  FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma,"10/11/2012 UI-US     PRN  SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Announces Class Action Against ZAGG, Inc. (ZAGG), DGSE Companies Inc. (DGSE), Vertex Pharmaceuticals Inc. (VRTX) and and Ubiquiti Networks, Inc. (UBNT)",,,,,, 1/17/2017 74366E10 PRN  Protagonist Therapeutics Initiates Phase 2b Study of Oral Drug Candidate PTG-100 in Ulcerative Colitis,,,,,10/02/2013 68214310 PRN  US and European Regulators Accept for Review OMS302 Marketing Applications,,,,,,,, 3/01/2017 69329Y10 PRN  PDL BioPharma Announces Fourth Quarter and Year End 2016 Financial Results,,,, 5/13/2016 00182C10 PRN  ANI Pharmaceuticals Enters Three Year $30 Million Asset Based Line of Credit with Citizens Bank,,,,, 4/13/2016 60468T10 PRN  QIAGEN Partners to Develop Novel Companion Diagnostic in Lung Cancer,,,,,,, 5/17/2017 09627Y10 PRN  Blueprint Medicines to Present New Data from Ongoing Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors at 2017 ASCO Annual Meeting,, 8/14/2017 28249U10 PRN  Eiger BioPharmaceuticals Reports Second Quarter 2017 Financial Results,,,,,,," 1/19/2017 92165910 PRN  Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017",,,,, 5/18/2017 40637H10 PRN  Halozyme Therapeutics Announces Public Offering Of Common Stock, 8/29/2013 G2151510 PRN  China Biologic to Participate in Upcoming Investor Conferences," 3/22/2013 ZIOP-US  PRN  Before the Bell Scans of MannKind, Ariad Pharma, ZIOPHARM Oncology, NPS Pharma, and Santarus",,,,, 6/16/2018 69366J20 PRN  Updated Preliminary Data from SMA FIREFISH Program in Type 1 Babies Presented at the CureSMA Conference,,,,,,,"10/27/2015 36197T10 PRN  Covered Call Alerts For GW Pharmaceuticals, Qunar Cayman Islands, Invensense, Mobileye NV and Micron Released By InvestorsObserver",, 8/30/2017 G5087110 PRN  Jazz Pharmaceuticals to Present at the Wells Fargo Securities Healthcare Conference,, 3/07/2011 GRF-ES   PRN  Grifols Establishes Expert Advisory Council in Transfusion Medicine,,," 8/06/2015 92337F10 PRN  Veracyte to Host Conference Call and Webcast to Discuss Second Quarter 2015 Financial Results on Thursday, August 13, 2015",,,,,,,,,,,,,,,,"10/27/2015 98401F10 PRN  Xencor to Host Third Quarter 2015 Financial Results Webcast and Conference Call on November 3, 2015",,10/24/2017 G8807B10 PRN  Theravance Biopharma to Present New Data from Studies of VIBATIV® (telavancin) and Revefenacin (TD-4208) at the 2017 CHEST Annual Meeting,, 8/05/2015 ARDX-US  PRN  Ardelyx to Present at the 2015 Wedbush PacGrow Healthcare Conference,,,,,,,,,,,, 2/01/2017 05070R10 PRN  Audentes Therapeutics Announces FDA Clearance of Investigational New Drug Application for AT342 to Treat Crigler-Najjar Syndrome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"11/25/2013 45232710    PRN  Under AAAResearchReports.com Microscope: Celldex Therapeutics Inc., XOMA Corp., Illumina Inc., and Immunomedics Inc.",,11/01/2017 G3040110 PRN  FDA's Efforts to Accelerate New Drug Development is a Big Bonus for Biotech and Pharma Stocks,," 7/14/2015 09060J10 PRN  BioDelivery Sciences Announces Hiring of Enoch Bortey, Ph.D., as Vice President of Clinical Biostatistics and Data Systems", 5/02/2018 09073M10    PRN  Bio-Techne Declares Dividend," 1/18/2019 75886F10    PRN  Regeneron to Report Fourth Quarter and Full Year 2018 Financial and Operating Results and Host Conference Call and Webcast on February 6, 2019",, 4/06/2015 68375N10 PRN  MabVax Therapeutics Announces Closing of Financing,11/01/2017 46222210 PRN  Ionis to Present Inotersen NEURO-TTR Phase 3 Study Results at 1st European ATTR Amyloidosis Meeting, 1/03/2018 09061G10   PRN  BioMarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco,,10/23/2017 64125C10 PRN  Neurocrine Granted FDA Orphan Drug Designation for Valbenazine for the Treatment of Pediatric Patients With Tourette Syndrome,,," 9/15/2014 09062X10  PRN  Event Schedules, Survey Findings, Regulatory Filings, and Market Activity - Research Reports on Amgen, Biogen Idec, Salix, Covidien and Shire",,," 6/24/2015 37555810   PRN  Critical Alerts For Kinder Morgan, Green Dot, Netflix, Gilead Sciences and Petrobras Released By InvestorsObserver", 8/22/2017 04004760   PRN  Arena Pharmaceuticals to Present Additional Pre-Clinical Data on Ralinepag for Treatment of Pulmonary Arterial Hypertension at European Society of Cardiology Congress, 4/11/2018 N5946510  PRN  Investor Day Highlights Durability of Mylan's Global Platform, 1/04/2017 M2572210 PRN  Compugen's CGEN-15001 Demonstrates Restoration of Immune Tolerance in Autoimmunity," 7/01/2010 00972810 PRN  Akorn, Inc. Announces Second Quarter 2010 Earnings Release and Conference Call Information", 4/30/2019 03116210 PRN  Amgen Reports First Quarter 2019 Financial Results,, 8/03/2015 52887230 PRN  Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome,, 7/10/2012 45766930 PRN  Insmed To Present At JMP Securities 7th Annual Healthcare Conference,,"11/03/2015 45773H20 PRN  Covered Call Alerts For Freeport-McMoRan, Whiting Petroleum, Alibaba, Inovio Pharmaceuticals and Weight Watchers Released By InvestorsObserver",11/10/2017 64026810 PRN  Nektar to Webcast Presentation at Jefferies 2017 London Healthcare Conference, 1/31/2017 76655960 PRN  Rigel Announces Pricing Of Public Offering Of Common Stock,,, 1/11/2011 02311120 PRN  Amarin Announces Successful Completion of Offering of American Depositary Shares," 4/17/2013 45337C10 PRN  Arena Pharma, Celgene, Incyte, Spectrum Pharma, and Geron Under StockCall's Microscope", 4/03/2017 91307C10 PRN  United Therapeutics Announces Regulatory Delays For Remosynch Implantable Pump,, 1/31/2018 G0176710 PRN  Alkermes Submits New Drug Application To U.S. FDA For ALKS 5461 For The Adjunctive Treatment Of Major Depressive Disorder,,,," 5/16/2016 55027E10 PRN  Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.", 5/16/2017 SGMO-US  PRN  Sangamo Receives Fast Track Designation From The FDA For SB-525 Investigational Hemophilia A Gene Therapy,, 4/27/2018 SAN-FR    PRN  Sanofi: First-quarter 2018 Business EPS up 1.4% at CER,"10/10/2012 0BGL4K-E  PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Vertex Pharmaceuticals Inc. (VRTX), DGSE Companies Inc. (DGSE), Ubiquiti Networks, Inc. (UBNT) and Peregrine Pharmaceuticals, Inc. (PPHM)",,,,,, 1/05/2017 74366E10 PRN  Key Patent is Issued Covering Protagonist Therapeutics' Alpha4Beta7 Integrin Peptide Inhibitors including Oral Drug Candidate PTG-100,,,,, 9/30/2013 68214310 PRN  FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease,,,,,,,, 3/01/2017 69329Y10 PRN  PDL BioPharma Announces $30 Million Share Repurchase Program,,,, 5/09/2016 00182C10 PRN  ANI Pharmaceuticals Announces Launch of 50mg and 150mg Fenofibrate Capsules in ANI label,,,,, 3/24/2016 06P9WL-E PRN  Mirati Therapeutics To Present Preclinical Data At 2016 American Association For Cancer Research Annual Meeting,,,,,,, 5/03/2017 09627Y10 PRN  Blueprint Medicines Reports First Quarter 2017 Financial Results,, 8/08/2017 28249U10 PRN  Eiger BioPharmaceuticals to Present at 2017 Wedbush PacGrow Healthcare Conference on August 16th,,,,,,, 1/09/2017 92165910 PRN  Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2016 Revenue Results and 2017 Financial Guidance,,,,, 5/17/2017 40637H10 PRN  Halozyme Phase 2 Data In Advanced Pancreas Cancer To Be Featured In An Oral Presentation At ASCO, 8/06/2013 G2151510 PRN  China Biologic Reports Financial Results for the Second Quarter and First Half of 2013," 3/12/2013 56400P70 PRN  Drug Approvals, Increased R&D and Strong Product Portfolios Driving New Growth - Research Report on Medivation, MannKind, Questcor Pharmaceuticals, Charles River Laboratories and Peregrine Pharmaceuticals",,,,, 6/08/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,"10/14/2015 36197T10 PRN  Covered Call Alerts For GW Pharmaceuticals, Shake Shack, Twitter, Clean Energy Fuels and Caterpillar Inc. Released By InvestorsObserver",," 8/29/2017 G5087110 PRN  Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products",, 3/04/2011 GRF-ES   PRN  FDA Approves Revised Alphanate® Labeling to Include Reduced Infectivity of an Experimental Model Agent for vCJD,,, 6/25/2015 92337F10 PRN  Veracyte Announces National Network Agreement with Aetna,,,,,,,,,,,,,,,, 9/24/2015 XNCR-US  PRN  Xencor to Present at Leerink Partners Inaugural Immuno-Oncology Roundtable,,10/09/2017 G8807B10 PRN  Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV® (telavancin) at IDWeek™ 2017,, 7/14/2015 ARDX-US  PRN  Ardelyx to Provide Updates on Research and Development Programs at Today's Inaugural R&D Day in New York City,,,,,,,,,,,, 1/09/2017 05070R10 PRN  Audentes Therapeutics Provides Full Year 2017 Strategic Outlook and Financial Guidance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"11/19/2013 45232710    PRN  Biotech Companies Announce Upcoming Conferences, Appointments - Research Report on Illumina, Epizyme, Questcor Pharmaceuticals, Infinity, and Endocyte",,10/30/2017 G3040110 PRN  Endo Announces Certain Preliminary Financial Results for Third-Quarter 2017 and Affirms Selected 2017 Financial Guidance,, 6/08/2015 09060J10 PRN  BioDelivery Sciences Announces Hiring of Stephana E. Patton as General Counsel, 5/02/2018 09073M10    PRN  Bio-Techne Releases Third Quarter Fiscal 2018 Results, 1/07/2019 75886F10    PRN  Regeneron Provides Update on Commercial and Pipeline Progress at J.P. Morgan Healthcare Conference,," 3/31/2015 68375N10 PRN  Morning Briefing on Biotech Equities -- OPKO Health, Progenics Pharma, Neuralstem, Nanosphere, and Sunesis Pharma",10/27/2017 46222210 PRN  Ionis and Biogen Win Prestigious Prix Galien Best Biotechnology Product Award for SPINRAZA,"12/22/2017 09061G10   PRN  BioMarin Receives Anticipated Notification of PDUFA Extension for Pegvaliase Biologics License Application (BLA) to May 28, 2018",,10/05/2017 64125C10 PRN  Neurocrine Announces FDA Approval of 80 mg INGREZZA® (valbenazine) Capsules for the Treatment of Adults with Tardive Dyskinesia (TD),,," 9/15/2014 09062X10  PRN  Health Care Sector Stocks Technical Review - Ampio Pharma, InterMune, Biogen Idec, Hologic, and CareFusion Corp.",,, 6/11/2015 0CJZ6H-E   PRN  The Medicines Patent Pool and Gilead Sciences Expand Licence to Allow Generic Manufacture of Medicines in South Africa," 8/16/2017 04004760   PRN  Biotech Stock Performance Review -- Aralez Pharma, Arena Pharma, Arrowhead Pharma, and Aviragen Therapeutics"," 4/11/2018 N5946510  PRN  Mylan to Leverage its World-Class Scientific Platform to Develop a Novel Delivery for Meloxicam, a Non-Opioid Pain Medication",12/07/2016 BAYN-DE  PRN  Compugen Announces Key Highlights from R&D Day,, 4/25/2019 03116210 PRN  Amgen Announces Webcast of 2019 First Quarter Financial Results,, 6/06/2015 52887230 PRN  Lexicon Announces Presentation Of Manuscript At The American Diabetes Association Diabetes Care Symposium,, 7/02/2012 45766930 PRN  Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital,,"10/21/2015 45773H20 PRN  Covered Call Alerts For Monster Beverage, Denbury Resources, Inovio Pharmaceuticals, Lumber Liquidators and 3D Systems Released By InvestorsObserver",11/07/2017 NKTR-US  PRN  Nektar Therapeutics Reports Financial Results for the Third Quarter of 2017, 1/30/2017 76655960 PRN  Rigel Announces Proposed Public Offering Of Common Stock,,, 1/07/2011 02311120 PRN  Amarin Announces Underwriters' Exercise of Over-Allotment Option," 4/12/2013 45337C10 PRN  Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of Shareholders of Tangoe (TNGO) and Announces Investigations of Atlantic Power Corp. (AT), Bazaarvoice (BV), Boeing (BA), Caterpillar (CAT), Diodes (DIOD), Harvest Natural Resources (HNR), Hess Corp. (HES), Impax Laboratories ( IPXL), Incyte Corp. (INCY), ITT Educational Services (ESI),", 3/31/2017 91307C10 PRN  United Therapeutics Announces Decision From Patent Trial And Appeal Board And Issuance Of New Patents,, 1/02/2018 G0176710 PRN  Alkermes' Corporate Presentation to be Webcast at the 36th Annual J.P. Morgan Healthcare Conference,,,, 5/02/2016 55027E10 PRN  Luminex Corporation Reports First Quarter 2016 Results, 5/15/2017 80067710 PRN  Sangamo Therapeutics Recognizes International MPS Awareness Day And Celebrates The MPS I And MPS II Communities With Stories Of Hope,, 4/25/2018 80105N10  PRN  FDA accepts for review Supplemental Biologics License Application for 0.5 mL dose of Fluzone® Quadrivalent (Influenza Vaccine) in children 6-35 months of age," 9/24/2012 0BGL4K-E  PRN  Law Firm of Levi & Korsinsky, LLP Announces Class Action Against DGSE Companies Inc. (DGSE), Body Central Corp. (BODY) and Vertex Pharmaceuticals Inc. (VRTX) and Investigation of Mediware Information Systems, Inc. (MEDW)",,,,,,11/14/2016 74366E10 PRN  Protagonist Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update,,,,," 9/26/2013 68214310 PRN  Application for Regulatory Approvals, Conferences and Presentations, and Enrollment in Clinical Trials - Research Report on Gilead, Alnylam, Omeros, PTC, and Stemline",,,,,,,," 2/22/2017 69329Y10 PRN  PDL BioPharma to Announce Fourth Quarter / Year-End 2016 Financial Results on March 1, 2017",,,, 5/05/2016 00182C10 PRN  ANI Pharmaceuticals Reports First Quarter Results and Year-To-Date 2016 Highlights and Reaffirms Updated Guidance,,,,, 3/23/2016 05V1WP-E PRN  Mirati Therapeutics Announces Promotion Of Jamie A. Donadio To Chief Financial Officer,,,,,,," 4/26/2017 09627Y10 PRN  Blueprint Medicines to Report First Quarter 2017 Financial Results on Wednesday, May 3, 2017",, 7/27/2017 28249U10 PRN  Eiger Announces FDA Fast Track Designation Granted for Pegylated Interferon Lambda in Hepatitis Delta Virus Infection,,,,,,,12/07/2016 92165910 PRN  Vanda Pharmaceuticals Settles Fanapt® Patent Litigation with Apotex,,,,, 5/09/2017 40637H10 PRN  Halozyme Reports First Quarter 2017 Financial Results, 7/30/2013 G2151510 PRN  China Biologic Products to Report Second Quarter 2013 Financial Results, 2/22/2013 56400P70 PRN  MannKind and Ariad Pharma Under Review: Biotech Companies Receive Drug Approvals,,,,, 6/01/2018 69366J20 PRN  CHMP Adopts Positive Opinion for the Expansion of the Translarna™ (ataluren) Label to Include Patients as Young as 2 Years of Age,,,,,,," 9/29/2015 36197T10 PRN  Critical Alerts For Organovo, GW Pharmaceuticals, Skechers, Box and Ford Released By InvestorsObserver",, 8/18/2017 JAZZ-US  PRN  Jazz Pharmaceuticals Announces Offering of $500 Million of 1.50% Exchangeable Senior Notes due 2024,," 3/04/2011 TLCR-US  PRN  Grifols and Talecris Announce the Outside Date of Their Merger Agreement has been Extended to June 30, 2011",,, 6/05/2015 92337F10 PRN  Veracyte to Present at the William Blair 25th Annual Growth Stock Conference,,,,,,,,,,,,,,,, 9/24/2015 XNCR-US  PRN  Xencor's Partner Initiates Phase 2 Clinical Trial of a Biologic Candidate Using XmAb® Cytotoxic Fc Domain,,10/03/2017 G8807B10 PRN  Theravance Biopharma to Present New Data from Multiple Studies of VIBATIV® (telavancin) at IDWeek™ 2017,," 6/30/2015 03969710 PRN  Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015",,,,,,,,,,,, 1/04/2017 0035K2-E PRN  Audentes Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"11/01/2013 45232710    PRN  Acquisitions, Financial Results, Clinical Trial Applications, and Upcoming Earnings Schedules - Research Report on Illumina, DENTSPLY, Alnylam, Sirona, and Santarus",,10/26/2017 G3040110 PRN  Endo Files Federal Lawsuit to Obtain FDA Compliance with Drug Quality and Security Act of 2013,, 6/02/2015 09060J10 PRN  BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change, 5/01/2018 09073M10    PRN  Bio-Techne To Present At The Deutsche Bank 43rd Annual Health Care Conference, 1/07/2019 000VC1-E    PRN  Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development Programs,," 3/10/2015 68375N10 PRN  Critical Alerts For TASER International, Cisco Systems, Netflix, Ubiquiti Networks, Ariad Pharmaceuticals, Zoe's Kitchen, Opko Health, Groupon, Alliance Fiber Optic and Silver Wheaton Released By InvestorsObserver",10/27/2017 46222210 PRN  Ionis Pharmaceuticals Announces Plans to Open Expanded Access Program to Provide Inotersen to Patients with Hereditary TTR Amyloidosis in the U.S.,12/19/2017 09061G10   PRN  BioMarin Doses First Patient in Global GENEr8-1 Phase 3 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A,, 9/15/2017 64125C10 PRN  Neurocrine Announces Data on the Real-World Patient Impact of TD from the RE-KINECT Study to be Presented at the 2017 Annual Psych Congress,,," 9/12/2014 09062X10  PRN  Critical Alerts For U.S. Bancorp, Nuverra Environmental Solutions, Biogen, Deere and Philip Morris International Released By InvestorsObserver",,," 6/09/2015 37555810   PRN  Critical Alerts For Gilead Sciences, Sarepta Therapeutics, General Electric, Clean Energy Fuels and Petrobras Released By InvestorsObserver", 8/07/2017 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2017 Financial Results, 4/11/2018 N5946510  PRN  Mylan Partners with Fujifilm Kyowa Kirin Biologics to Commercialize Biosimilar to Humira® (adalimumab),12/07/2016 M2572210 PRN  Compugen Discloses its Cancer Immunotherapy Program Targeting TIGIT Immune Checkpoint,," 4/17/2019 03116210 PRN  Amgen Foundation Launches Amgen Biotech Experience In Tampa, Florida",, 5/28/2015 52887230 PRN  Lexicon To Present At The Jefferies 2015 Healthcare Conference,, 6/27/2012 45766930 PRN  Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycobacteria (NTM) Lung Disease,,"10/08/2015 45773H20 PRN  Covered Call Alerts For Freeport-McMoRan, BlackBerry, Inovio Pharmaceuticals, Whiting Petroleum and VASCO Data Security Released By InvestorsObserver",11/07/2017 64026810 PRN  New Data Featuring Nektar Therapeutics' Wholly-Owned Immuno-Oncology Pipeline to be Presented at the 2017 Society for Immunotherapy of Cancer 32nd Annual Meeting, 1/30/2017 76655960 PRN  Fostamatinib Study Results Continue to Trend Positive,,, 1/06/2011 02311120 PRN  Amarin Prices Public Offering of American Depositary Shares," 4/09/2013 45337C10 PRN  Lifshitz Law Firm Announces Investigation of Diodes, Inc., Incyte Corporation, and VeriFone Systems, Inc.", 3/09/2017 91307C10 PRN  Northwell Health and United Therapeutics Announce Strategic Partnership to Advance Bioelectronic Medicine and Cell Therapy,,12/16/2017 G0176710 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS,,,, 4/28/2016 LMNX-US  PRN  Luminex Corporation To Present At Investment Conferences In May, 5/15/2017 80067710 PRN  Sangamo Therapeutics Presents Recent Developments from Research and Clinical Programs at Annual Meeting of the American Society of Gene & Cell Therapy,, 4/05/2018 80105N10  PRN  New Sanofi insulin savings program aims to lower out-of-pocket costs for people living with diabetes," 9/14/2012 000YJB-E  PRN  Massive Hiring Event for Life Science Professionals in Edison, NJ on 9/18/12",,,,,,"10/13/2016 74366E10 PRN  Protagonist Therapeutics to Present Phase 1 Clinical and Preclinical Data on PTG-100 at UEG Week, Vienna",,,,, 9/20/2013 68214310 PRN  Omeros Chosen to Present at NewsMakers in the Biotech Industry 2013 Conference,,,,,,,, 2/17/2017 69329Y10 PRN  PDL BioPharma to Present at the 2017 RBC Capital Markets Global Healthcare Conference,,,, 4/27/2016 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2016 Financial Results and Reaffirm Guidance,,,,, 3/09/2016 60468T10 PRN  Mirati Therapeutics Reports Fourth Quarter And Full Year 2015 Financial Results And Provides Business Update,,,,,,, 4/04/2017 09627Y10 PRN  Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock,, 7/24/2017 28249U10 PRN  Eiger Completes Enrollment in Phase 2 LIMT HDV Study of Pegylated Interferon Lambda in Hepatitis Delta Virus Infection,,,,,,,11/14/2016 92165910 PRN  Vanda Pharmaceuticals Announces Participation at November 2016 Investor Conferences,,,,," 4/13/2017 40637H10 PRN  Biotech Stocks on Investors' Radar -- Halozyme Therapeutics, Cara Therapeutics, PDL BioPharma, and Arena Pharma", 6/10/2013 G2151510 PRN  China Biologic Waived Application of Preferred Shares Rights Agreement,"10/19/2012 PM-US    PRN  Hot Stocks: Freeport-McMoRan, EnCana, MannKind, Amarin, Philip Morris, and Marathon Oil",,,,, 5/09/2018 69366J20 PRN  PTC Therapeutics Reports First Quarter 2018 Financial Results and Provides a Corporate Update,,,,,,," 9/09/2015 36197T10 PRN  Critical Alerts For GoPro, Teco Energy Inc., Intel, GW Pharmaceuticals and CSX Released By InvestorsObserver",, 8/17/2017 JAZZ-US  PRN  Jazz Pharmaceuticals Announces Offering of $500 Million of Exchangeable Senior Notes due 2024,, 2/23/2011 TLCR-US  PRN  Talecris Biotherapeutics Announces Fourth Quarter and Full Year 2010 Results,,, 5/20/2015 92337F10 PRN  Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples,,,,,,,,,,,,,,,, 9/16/2015 98401F10 PRN  Amgen And Xencor Announce Strategic Collaboration In Cancer Immunotherapy And Inflammation,, 9/20/2017 G8807B10 PRN  Theravance Biopharma Highlights Positive Headline Results from IMPACT Study of Trelegy Ellipta Announced by GlaxoSmithKline and Innoviva,, 6/16/2015 07ZN4D-E PRN  Ardelyx to Present at the 2015 JMP Securities Life Sciences Conference,,,,,,,,,,,,12/13/2016 05070R10 PRN  Audentes Therapeutics Appoints Julie Anne Smith to Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/24/2013 45232710    PRN  Returning Value to Shareholders through Dividends, Strong Financial Results, and Regulatory Approvals - Research Report on Lilly, Illumina, Regeneron, Teva, and Vanda Pharmaceuticals",,10/25/2017 G3040110 PRN  Endo Completes Divestiture of Grupo Farmacéutico SOMAR,, 6/01/2015 09060J10 PRN  BioDelivery Sciences Adds $20 Million in Debt Financing from MidCap Financial, 4/26/2018 09073M10    PRN  Bio-Techne Leads the Way in Scientific Support for Autophagy Research,12/18/2018 75886F10    PRN  Regeneron Announces Presentation at the 37th Annual J.P. Morgan Healthcare Conference,," 2/20/2015 68375N10 PRN  Pre-Market Pulse on Biotech Stocks -- OPKO Health, Organovo Holdings, Neuralstem, Regeneron Pharma, and Raptor Pharma",10/24/2017 46222210 PRN  Ionis Pharmaceuticals to Hold Third Quarter 2017 Financial Results Webcast,12/11/2017 09061G10   PRN  BioMarin Highlights New Results for Gene Therapy Valoctocogene Roxaparvovec at the 2017 American Society of Hemophilia (ASH) Meeting,, 9/06/2017 64125C10 PRN  Neurocrine Biosciences to Present at the Morgan Stanley 15th Annual Global Healthcare Conference,,," 9/05/2014 09062X10  PRN  Upcoming Conferences, Dividends, Regulatory Disclosures, and Acquisitions - Research Reports on Medtronic, Humana, Shire, Biogen and Covidien",,," 5/21/2015 37555810   PRN  Critical Alerts For Tesla Motors, Gilead Sciences, Kandi Technologies, Linn Energy and Micron Released By InvestorsObserver"," 7/31/2017 04004760   PRN  Arena Pharmaceuticals to Release Second Quarter 2017 Financial Results and Provide Corporate Update on Monday, August 7, 2017", 4/10/2018 MAPI-US   PRN  Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma,12/05/2016 M2572210 PRN  Compugen Appoints Senior Vice President Corporate and Business Development,, 4/15/2019 03116210 PRN  EVENITY™ (romosozumab-aqqg) Now Available In The United States For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture,, 5/12/2015 52887230 PRN  Lexicon Announces Selection Of Manuscript To Be Presented At The American Diabetes Association Diabetes Care Symposium,, 5/30/2012 45766930 PRN  Insmed Provides Corporate Update,," 9/23/2015 45773H20 PRN  Covered Call Alerts For Rite Aid, AutoZone, Baidu Inc., Inovio and Freeport-McMoRan Released By InvestorsObserver","11/07/2017 64026810 PRN  Nektar Therapeutics Presents Preclinical Data on NKTR-358, a First-in-Class Regulatory T Cell Stimulator, at 2017 American College of Rheumatology Annual Meeting"," 1/16/2017 76655960 PRN  Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)",,, 1/05/2011 001H9D-E PRN  Amarin Announces Proposed Public Offering of American Depositary Shares," 3/29/2013 45337C10 PRN  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing In Incyte Corporation To Contact The Firm", 3/07/2017 BARC-GB  PRN  United Therapeutics Corporation To Present At Barclays Global Healthcare Conference,,"12/12/2017 0DGVHF-E PRN  Scott+Scott, Attorneys at Law, LLP Alerts Investors to the Filing of Securities Class Action Against Alkermes plc (ALKS)",,,, 4/14/2016 LMNX-US  PRN  Luminex Corporation Receives FDA Clearance and CE Mark for SYNCT Software," 5/15/2017 80067710 PRN  How These Biotech Stocks are Faring? -- Seattle Genetics, Sangamo Therapeutics, Vertex Pharma, and VIVUS",, 3/27/2018 80105N10  PRN  FDA approves Toujeo® Max SoloStar®, 9/12/2012 0B62TY-E  PRN  OBN's 2012 Annual Awards Dinner Celebrates UK Bioscience Success Stories,,,,,, 8/10/2016 07F0YZ-E PRN  Protagonist Therapeutics Announces Pricing of Initial Public Offering,,,,, 9/19/2013 68214310 PRN  Omeros Reports Initiation of Phase 2 Clinical Trial with OMS824,,,,,,,,11/22/2016 69329Y10 PRN  PDL BioPharma Issues $150.0 Million of 2.75% Convertible Senior Notes Due 2021,,,, 4/27/2016 00182C10 PRN  ANI Announces Appointment of Stephen P. Carey as Vice President and Chief Financial Officer,,,,, 3/08/2016 60468T10 PRN  Mirati Therapeutics To Present At The Barclays Global Healthcare Conference,,,,,,, 3/29/2017 09627Y10 PRN  Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock,, 6/29/2017 28249U10 PRN  Eiger BioPharmaceuticals Announces Sale of Non-Strategic Assets to Theragene Pharmaceuticals,,,,,,,11/02/2016 92165910 PRN  Vanda Pharmaceuticals Reports Third Quarter 2016 Financial Results,,,,, 4/10/2017 40637H10 PRN  Halozyme To Host First Quarter 2017 Financial Results Conference Call," 6/03/2013 G2151510 PRN  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of China Biologic Products, Inc.", 9/24/2012 005SV0-E PRN  The Pomerantz Firm and Glancy Binkow & Goldberg LLP announce Notice of Pendency and Proposed Settlement of MannKind Corp. Securities Litigation.,,,,, 5/01/2018 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss First Quarter 2018 Financial Results,,,,,,," 8/24/2015 BAC-US   PRN  Critical Alerts For Bank of America, Cempra, GW Pharmaceuticals, Groupon and General Electric Released By InvestorsObserver",, 8/08/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Second Quarter 2017 Financial Results,, 2/09/2011 TLCR-US  PRN  Talecris Biotherapeutics Announces Teleconference and Webcast Information for Special Meeting of Shareholders,,, 5/18/2015 92337F10 PRN  New England Journal of Medicine Publishes Study Results Suggesting Veracyte's Percepta™ Bronchial Genomic Classifier Can Reduce Unnecessary Invasive Procedures in Lung Cancer Diagnosis,,,,,,,,,,,,,,,, 8/04/2015 98401F10 PRN  Xencor Reports Second Quarter 2015 Financial and Operating Results,, 9/19/2017 G8807B10 PRN  Theravance Biopharma to Present at the Cantor Fitzgerald Global Healthcare Conference,," 6/03/2015 07ZN4D-E PRN  Ardelyx Regains Worldwide Development and Commercialization Rights for Its Late-Stage Development Candidate, Tenapanor, and Related Portfolio of NHE3 Compounds",,,,,,,,,,,,11/29/2016 05070R10 PRN  Audentes Therapeutics Announces Initiation of Large-scale cGMP Production at its Gene Therapy Manufacturing Facility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,10/21/2013 ARYC-US     PRN  ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.,,10/09/2017 G3040110 PRN  Endo to Announce Third-Quarter 2017 Financial Results,, 5/28/2015 09060J10 PRN  BioDelivery Sciences Strengthens BUNAVAIL Sales and Managed Markets Teams, 4/24/2018 09073M10    PRN  Bio-Techne Announces New Leadership Appointment,12/01/2018 75886F10    PRN  Regeneron Presents Positive Data at ASH for REGN1979 CD20xCD3 Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma,," 1/20/2015 68375N10 PRN  Morning Analysis on Biotech Stocks -- Novavax, Isis Pharma, OPKO Health, Nanosphere, and NewLink Genetics",10/18/2017 46222210 PRN  Positive Developments From Clinical Studies and FDA Approvals Pushing Biotech Stocks to New Highs,12/09/2017 09061G10   PRN  BioMarin Provides 1.5 years of Clinical Data for Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A at 59th American Society of Hematology (ASH) Annual Meeting Concurrent with NEJM Publication,, 9/06/2017 64125C10 PRN  AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain,,, 9/04/2014 06TYBS-E  PRN  Diplomat to distribute Plegridy™ (peginterferon beta-1a) for treatment of multiple sclerosis,,," 5/18/2015 37555810   PRN  Biotech Equities Technical Study -- Gilead Sciences, Celgene, Novavax, Arena Pharma, and ACADIA Pharma", 7/31/2017 04004760   PRN  Arena Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares, 4/06/2018 MYL-US    PRN  Mylan Strengthens Its Capital Structure by Extending Its Debt Maturities with a Successful $1.5 Billion Bond Offering,11/21/2016 M2572210 PRN  Compugen to Present at 28th Annual Piper Jaffray Healthcare Conference in New York,, 4/09/2019 03116210 PRN  FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture,, 5/07/2015 LXRX-US  PRN  Lexicon to Present at the Bank of America Merrill Lynch 2015 Health Care Conference,, 5/23/2012 45766930 PRN  Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease,," 9/10/2015 45773H20 PRN  Critical Alerts For Apple, The Kroger Co, Costco, Inovio Pharmaceuticals and Alibaba Released By InvestorsObserver","10/31/2017 64026810 PRN  Nektar to Announce Financial Results for the Third Quarter of 2017 on Tuesday, November 7, 2017, After Close of U.S.-Based Financial Markets", 1/05/2017 RIGL-US  PRN  Rigel Provides Business Updates and Preliminary Data in IgA Nephropathy,,, 1/05/2011 02311120 PRN  Amarin to Present at the 29th Annual J.P. Morgan Healthcare Conference, 3/19/2013 GLUU-US  PRN  Apple May Boost Dividend by 56% According to Analysts. Fed Agrees To Continue Quantitative Easing., 2/28/2017 91307C10 PRN  United Therapeutics Corporation To Present At Cowen And Company 37th Annual Health Care Conference,,"12/01/2017 G0176710 PRN  ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes plc To Contact The Firm",,,," 4/11/2016 55027E10 PRN  Luminex Corporation First Quarter Earnings Release Scheduled for May 2, 2016", 5/10/2017 80067710 PRN  Sangamo Therapeutics Reports First Quarter 2017 Financial Results,, 3/14/2018 005M9Z-E  PRN  Taking Cancer Research to the Summit," 9/05/2012 063YPZ-E  PRN  New Genes, Potential Treatments and Models for ALS Drug Development to Be Discussed this November 1 in Boston",,,,,, 7/28/2016 07F0YZ-E PRN  Protagonist Therapeutics Receives SBIR Funding for the Development of Injectable Hepcidin Mimetics for Treatment of Iron Overload Disorders,,,,, 9/12/2013 68214310 PRN  Omeros Reports Additional Positive Results from OMS824 Program,,,,,,,,11/22/2016 69329Y10 PRN  PDL BioPharma to Present at the 28th Annual Piper Jaffray Healthcare Conference,,,," 4/05/2016 06CR5C-E PRN  ANI Pharmaceuticals Announces FDA Approval of Oxycodone Capsules, 5mg",,,,," 1/08/2016 60468T10 PRN  Mirati Therapeutics Appoints Marcy Graham Vice President, Investor Relations and Corporate Communications",,,,,,, 3/29/2017 09627Y10 PRN  Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock,," 6/14/2017 28249U10 PRN  Eiger Announces Appointment of Biopharmaceutical Industry Veteran David Apelian, MD, PhD, MBA to its Board of Directors",,,,,,,10/24/2016 92165910 PRN  Vanda Pharmaceuticals Settles Fanapt® Patent Litigation with Taro,,,,, 4/03/2017 40637H10 PRN  Halozyme's PEGPH20 Increases Immune Response and Effectiveness of Immunotherapies in Preclinical Cancer Models, 6/03/2013 G2151510 PRN  China Biologic Updates the Hong Kong Litigation in respect of the Shares Held by Ms. Siu Ling Chan, 6/08/2012 005SV0-E PRN  Cancer Immunotherapy Expert Joins Pacific Meso Center Research Team,,,,, 4/30/2018 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conference,,,,,,," 8/11/2015 36197T10 PRN  Critical Alerts For GW Pharmaceuticals, Peabody Energy, Palo Alto Networks, Stratasys and Johnson Controls Released By InvestorsObserver",, 8/03/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Webcast for Vyxeos Investor Update,,11/22/2010 00394S-E PRN  Grifols Announces US Launch of Flebogamma® 10% DIF IVIG,,, 5/17/2015 92337F10 PRN  New England Journal of Medicine Publishes Study Results Suggesting Veracyte's Percepta™ Bronchial Genomic Classifier Can Reduce Unnecessary Invasive Procedures in Lung Cancer Diagnosis,,,,,,,,,,,,,,,, 8/04/2015 98401F10 PRN  Xencor to Present at 2015 Wedbush PacGrow Healthcare Conference,, 9/19/2017 G8807B10 PRN  Theravance Biopharma Highlights Approval of Trelegy Ellipta (Closed Triple) as the First Once-Daily Single Inhaler Triple Therapy for the Treatment of Appropriate Patients with COPD in the US,, 6/03/2015 07ZN4D-E PRN  Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia to Begin Clinical Development in Mid-2015,,,,,,,,,,,,11/21/2016 004MR2-E PRN  Audentes Therapeutics to Attend Piper Jaffray 28th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/16/2013 45232710    PRN  Successful Launches, Upcoming Conference Calls, Signing of Agreements, and Trial Results - Research Report on Vertex, Illumina, Alexion, VIVUS, and Endocyte",,"10/04/2017 G3040110 PRN  Breakfast Technical Briefing on Drug Makers Stocks -- Amarin, Endo, Ionis Pharma, and Teva Pharma",, 5/27/2015 09060J10 PRN  BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference," 4/11/2018 09073M10    PRN  Bio-Techne To Host Conference Call On May 2, 2018 To Announce Third Quarter 2018 Financial Results",11/20/2018 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentation,,"12/04/2014 68375N10 PRN  Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma",10/18/2017 IONS-US  PRN  Ionis Enters into Collaboration with Seventh Sense Biosystems to Support Development of Improved Blood Collection and Diagnostic Device,12/06/2017 09061G10   PRN  BioMarin Announces Presentations at 59th American Society of Hematology Annual Meeting & Exposition,, 8/30/2017 64125C10 PRN  Neurocrine Biosciences to Present at the Baird 2017 Global Healthcare Conference,,," 8/28/2014 09062X10  PRN  Acquisitions, Appointments, Patent Grant, Technical Updates, and Awareness Campaign - Research Reports on Covidien, Biogen Idec, Achillion, Intercept and Mylan",,," 5/12/2015 37555810   PRN  Critical Alerts For Gilead Sciences, GW Pharmaceuticals, AT&T, Petrobras and General Electric Released By InvestorsObserver", 7/12/2017 04004760   PRN  Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock, 3/28/2018 N5946510  PRN  Mylan Introduces Symfi™ Triple Combo Once-Daily HIV Treatment in the U.S.,11/11/2016 M2572210 PRN  Compugen Immune Checkpoint Program Demonstrates Potential for Development of New Cancer Immunotherapy Treatments,, 4/07/2019 03116210 PRN  Amgen Presents New Data At WCO-IOF-ESCEO 2019 Revealing Osteoporosis Treatment Gap In Europe,," 4/29/2015 52887230 PRN  Lexicon Announces One For Seven Reverse Stock Split Effective May 20, 2015",," 5/16/2012 45766930 PRN  Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman",," 8/24/2015 45773H20 PRN  Critical Alerts For Linn Energy, Salesforce.com, Intrexon, Twitter and Inovio Pharmaceuticals Released By InvestorsObserver", 9/21/2017 64026810 PRN  Nektar Therapeutics Appoints Biotechnology Executive Jeff Ajer as New Board Member,11/10/2016 RIGL-US  PRN  Rigel to Present at Jefferies 2016 London Healthcare Conference,,,12/16/2010 02311120 PRN  Amarin Completes Patient Randomization in Phase 3 ANCHOR Trial," 3/19/2013 45337C10 PRN  Morning Research on Arena Pharma, Incyte, Galena Biopharma, and Novavax", 2/22/2017 91307C10 PRN  United Therapeutics Corporation Reports 2016 Fourth Quarter And Annual Financial Results,,"11/27/2017 G0176710 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alkermes plc (ALKS) & Lead Plaintiff Deadline - January 22, 2018",,,," 4/07/2016 55027E10 PRN  Luminex Corporation to Showcase CE-IVD Marked ARIES System, Revolutionary Software, and Assays at ECCMID Annual Meeting", 5/10/2017 SGMO-US  PRN  Sangamo Therapeutics And Pfizer Announce Collaboration For Hemophilia A Gene Therapy,, 3/10/2018 80105N10  PRN  Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk and unmet need," 7/30/2012 JFT-US    PRN  InvestorsObserver releases comments on JP Morgan, Comcast, Merck, Vertex and Delta",,,,,," 7/08/2016 CALA-US  PRN  William D. Waddill, Calithera CFO, Elected to Protagonist Therapeutics Board",,,,, 9/10/2013 68214310 PRN  Omeros Submits OMS302 Marketing Authorization Application to European Medicines Agency,,,,,,,,11/17/2016 69329Y10 PRN  PDL BioPharma Prices Public Offering of $150.0 Million of 2.75% Convertible Senior Notes Due 2021,,,, 4/05/2016 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Hydrocortisone Rectal Cream 1% and 2.5%,,,,,12/21/2015 MRTX-US  PRN  Guardant Health And Mirati Therapeutics Enter Into Collaboration On Glesatinib (MGCD265) In Non Small Cell Lung Cancer (NSCLC) Trial,,,,,,, 3/27/2017 09627Y10 PRN  Blueprint Medicines to Present on BLU-285 and BLU-554 at Upcoming Scientific Conferences,, 6/12/2017 28249U10 PRN  Eiger Reports Additional Positive Phase 2 Results from Multiple-Ascending Dose Study of Exendin 9-39 in Post-Bariatric Hypoglycemia Patients at American Diabetes Association Meeting in San Diego,,,,,,,"10/12/2016 92165910 PRN  Vanda Pharmaceuticals to Announce Third Quarter 2016 Financial Results on November 2, 2016",,,,, 3/30/2017 40637H10 PRN  Halozyme Provides Update On SWOG Collaborative Group Clinical Study, 5/08/2013 G2151510 PRN  China Biologic Reports Financial Results for the First Quarter of 2013,"10/24/2011 000C7F-E PRN  Research Reports for Top Traded Penny Stocks: Bank of America, First Horizon National & RF Micro Devices, More Reports for Apple, Acme Packet & MannKind",,,,, 4/27/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,," 7/27/2015 36197T10 PRN  Critical Alerts For Organovo, Facebook, BlackBerry, GW Pharmaceuticals and Stratasys Released By InvestorsObserver",, 8/03/2017 G5087110 PRN  Jazz Pharmaceuticals Announces FDA Approval of Vyxeos™ (daunorubicin and cytarabine) Liposome for Injection for the Treatment of Adults with Newly-Diagnosed Therapy-Related Acute Myeloid Leukemia (t-AML) or AML with Myelodysplasia-Related Changes (AML-MRC),, 7/20/2010 00394S-E PRN  Health Robotics' CytoCare Continues European Expansion With Grifols and Vall d'Hebron University Hospital,,, 5/14/2015 92337F10 PRN  Veracyte Announces First Quarter 2015 Financial Results,,,,,,,,,,,,,,,, 7/31/2015 98401F10 PRN  Xencor Appoints Yujiro S. Hata to Board of Directors,, 9/18/2017 G8807B10 PRN  Theravance Biopharma Highlights GlaxoSmithKline and Innoviva's Receipt of Positive Opinion from CHMP in Europe for Trelegy Ellipta (Closed Triple),, 5/19/2015 03969710 PRN  Ardelyx Presents Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients at Digestive Disease Week 2015,,,,,,,,,,,,11/10/2016 05070R10 PRN  Audentes Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/07/2013 45232710    PRN  Clinical Study Updates, Trial Enrollments, NDA Submissions, Partnerships, and Formation of New Subsidiaries - Research Report on BioMarin, Alnylam, Vertex, Illumina, and Intrexon",, 9/26/2017 G3040110 PRN  Four-Time PGA TOUR Winner Tim Herron Teams Up with Endo Pharmaceuticals to Encourage Adults to Get the Facts on Hand,, 5/14/2015 00FV7G-E PRN  Endo Pharmaceuticals and BioDelivery Sciences Present Pivotal Data from Two Phase 3 Trials Demonstrating Safety and Efficacy of Buprenorphine HCl Buccal Film for the Management of Chronic Pain, 3/21/2018 09073M10    PRN  Bio-Techne Expands RNAscope® ISH Automation - Facilitating Drug Discovery and Development,11/11/2018 75886F10    PRN  ODYSSEY OUTCOMES investigators highlight at AHA that Praluent® (alirocumab) Injection was associated with fewer deaths from any cause,,"11/18/2014 68375N10 PRN  Critical Alerts For Apache Corporation, Whole Foods Market, Opko Health, EOG Resources and Globalstar Released By InvestorsObserver",10/15/2017 46222210 PRN  Ionis Presents New Data from NEURO-TTR Study and Highlights Programs from Its Neurological Disease Franchise at ANA Congress,11/27/2017 09061G10   PRN  BioMarin Sells Second Priority Review Voucher for $125 Million,," 8/14/2017 64125C10 PRN  Breakfast Technical Briefing on Generic Drugs Stocks -- Horizon Pharma, Mylan, Neurocrine Biosciences, and Rigel Pharma",,," 8/20/2014 09062X10  PRN  Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck",,," 5/08/2015 37555810   PRN  Healthcare, Services and Industrial Goods Companies: Complementary Research on Gilead Sciences, Boston Scientific, General Electric, Sirius XM and MGM Resorts", 7/11/2017 04004760   PRN  Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock," 3/27/2018 N5946510  PRN  Mylan and Biocon Receive Approvals from the European Commission and TGA Australia for Semglee™, Biosimilar Insulin Glargine",11/07/2016 M2572210 PRN  Compugen Ltd. Reports 3rd Quarter 2016 Financial Results,," 3/20/2019 03116210 PRN  Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis",, 4/29/2015 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 First Quarter Financial Results,, 5/08/2012 45766930 PRN  Insmed Announces First Quarter 2012 Financial Results,," 8/12/2015 45773H20 PRN  Critical Alerts For Fitbit, Boeing, Inovio Pharmaceuticals, JetBlue and ACADIA Pharmaceuticals Released By InvestorsObserver", 9/20/2017 64026810 PRN  Nektar Therapeutics Announces Seven Abstracts Accepted for Presentation at 2017 Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting,11/01/2016 76655960 PRN  Rigel Announces Third Quarter 2016 Financial Results and Provides Company Update,,,"12/03/2010 02311120 PRN  Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference"," 3/18/2013 45337C10 PRN  Innovative Product Portfolios Ride Commercialization & Global Expansion - Research Report on Amgen, Onyx Pharmaceuticals, Alexion Pharmaceuticals, BioMarin Pharmaceutical and Incyte"," 2/15/2017 91307C10 PRN  United Therapeutics Corporation To Report Fourth Quarter And Annual 2016 Financial Results Before The Market Opens On Wednesday, February 22, 2017",,"11/16/2017 G0176710 PRN  Lifshitz & Miller LLP Announces Investigation of Acorda Therapeutics, Inc., Alkermes plc, ASB Financial Corp., CalAtlantic Group, Capella Education Company, INC Research Holdings, Inc. and YuMe, Inc.",,,, 3/21/2016 LMNX-US  PRN  Luminex Corporation Receives CE-IVD Mark for ARIES System and ARIES HSV 1&2 Assay, 5/04/2017 80067710 PRN  Sangamo Therapeutics Announces Special Regulatory Designations from the FDA for Three Clinical Programs,," 3/10/2018 80105N10  PRN  Praluent® (alirocumab) Injection significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate"," 7/16/2012 92532F10  PRN  81,200 Square Foot Lease Extension In San Diego Through 2018 Signed By Vertex Pharmaceuticals And BioMed Realty",,,,,, 5/17/2016 07F0YZ-E PRN  Protagonist Therapeutics to Present New Data for PTG-100 and PTG-200 at Digestive Disease Week 2016,,,,, 9/09/2013 68214310 PRN  Omeros to Present at the Stifel Healthcare Conference 2013,,,,,,,,"11/17/2016 69329Y10 PRN  Biotech Stocks Under Scanner -- PDL BioPharma, Intrexon, 22nd Century, and Marinus Pharma",,,, 4/04/2016 00182C10 PRN  ANI Pharmaceuticals Updates 2016 Financial Guidance,,,,,12/21/2015 60468T10 PRN  Foundation Medicine And Mirati Therapeutics Collaborate To Develop A Companion Diagnostic For Glesatinib (MGCD265) In Non-Small Cell Lung Cancer (NSCLC),,,,,,, 3/20/2017 09627Y10 PRN  Blueprint Medicines Announces Enrollment of First Patient in Phase 1 Clinical Trial for BLU-667,, 6/06/2017 28249U10 PRN  Eiger Completes Enrollment in Phase 2 Multiple-Ascending Dose Study of Exendin 9-39 in Post-Bariatric Hypoglycemia Patients,,,,,,, 8/30/2016 92165910 PRN  USPTO Dismisses Petition for Inter Partes Review of Fanapt® Patent,,,,, 3/29/2017 40637H10 PRN  FDA Advisory Committee Provides Unanimous Recommendation For Subcutaneous Rituximab Coformulated With Halozyme Enhanze Technology, 5/02/2013 G2151510 PRN  China Biologic Products to Report First Quarter 2013 Financial Results,"10/19/2011 000SY8-E PRN  Critical Stock Price Alerts for Oracle, QUALCOMM, MannKind, Nuance, SanDisk & Lululemon",,,,, 4/24/2018 69366J20 PRN  Preliminary Clinical Data from FIREFISH Trial in Type 1 SMA Patients Presented at the American Academy of Neurology Annual Meeting,,,,,,," 7/08/2015 36197T10 PRN  Critical Alerts For Goodrich Petroleum Corp., Electronic Arts, Ford, Keryx Biopharmaceuticals and GW Pharmaceuticals Released By InvestorsObserver",, 7/26/2017 G5087110 PRN  Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation® Technology to Develop Long-Acting Asparaginase Product Candidates,, 6/07/2010 00394S-E PRN  Cerberus Announces Its Support of the Merger of Grifols and Talecris,,, 5/12/2015 92337F10 PRN  Veracyte Announces Publication of Study Showcasing Development of Percepta™ Bronchial Genomic Classifier,,,,,,,,,,,,,,,," 7/28/2015 98401F10 PRN  Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015",, 9/05/2017 G8807B10 PRN  Theravance Biopharma to Present at the Morgan Stanley 15th Annual Global Healthcare Conference,," 5/18/2015 03969710 PRN  How Healthy Does Healthcare Look: Complementary Research on Health Insurance, Ardelyx, Electromed, CAS Medical and Capnia",,,,,,,,,,,, 9/21/2016 05070R10 PRN  Audentes Therapeutics to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 9/26/2013 45232710    PRN  FDA Approvals, New Appointments, Positive Litigation Outcomes and Partnerships - Research Report on Edwards Lifesciences, Illumina, Teva, Alere, and Dr. Reddy's",, 9/20/2017 G3040110 PRN  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Endo International plc and Encourages Investors with Losses to Contact the Firm,, 5/11/2015 09060J10 PRN  BioDelivery Sciences Provides Corporate Update and Reports First Quarter 2015 Financial Results," 3/14/2018 09073M10    PRN  Bio-Techne Launches MimEX™ GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract",11/11/2018 75886F10    PRN  ODYSSEY OUTCOMES Investigators Highlight at AHA that Praluent® (alirocumab) Injection Was Associated with Fewer Deaths from Any Cause,,"11/07/2014 68375N10 PRN  Biotech Equities Scrutiny - Vanda Pharma, PDL BioPharma, Synergy Pharma, OPKO Health, and MiMedx",10/13/2017 46222210 PRN  Ionis Pharmaceuticals Initiates Clinical Study of IONIS-MAPT Rx in Patients with Alzheimer's Disease,10/31/2017 09061G10   PRN  BioMarin to Attend Three Upcoming Investor Conferences,, 8/03/2017 64125C10 PRN  Neurocrine Biosciences Reports Second Quarter 2017 Results,,," 8/11/2014 09062X10  PRN  Drug Approvals, Financial Results, Upcoming Earnings, Technical Updates, and New Products - Research Reports on Amgen, Mylan, Biogen, Perrigo and Zimmer",,, 4/28/2015 0801VZ-E   PRN  ISS Recommends Shareholders Vote For Specialty Drug Pricing Risk Assessment Proposal At Gilead Sciences, 7/10/2017 04004760   PRN  Arena Pharmaceuticals Reports Positive Topline Phase 2 Results for Ralinepag in Patients with Pulmonary Arterial Hypertension," 3/21/2018 N5946510  PRN  Mylan to Host Investor Day on April 11, 2018, in New York City","11/03/2016 M2572210 PRN  Compugen to Host R&D Day on December 7, 2016 in New York",, 3/15/2019 03116210 PRN  Amgen Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke,," 4/27/2015 52887230 PRN  Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015",, 5/07/2012 45766930 PRN  Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections,," 8/05/2015 45773H20 PRN  Critical Alerts For Juno Therapeutics Inc, Inovio Pharmaceuticals, Microsoft, Yahoo! and Vivint Solar Inc Released By InvestorsObserver"," 9/12/2017 64026810 PRN  Nektar Therapeutics Initiates PROPEL Clinical Study to Evaluate Combination of NKTR-214, a CD122-Biased Agonist, with TECENTRIQ® (atezolizumab) or KEYTRUDA® (pembrolizumab)",10/28/2016 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Third Quarter 2016 Financial Results,,,11/29/2010 02311120 PRN  Amarin's AMR101 Meets Pivotal Phase 3 Study Endpoints With Highly Statistically Significant Reductions in Triglycerides at 4 Gram and 2 Gram Doses in MARINE Trial With No Statistically Significant Increase in LDL-C and Safety Profile Similar to Placebo, 2/20/2013 45337C10 PRN  Today's Research on Incyte and Arena Pharma: Biotech Stocks Up on Drug Approvals, 1/05/2017 0035K2-E PRN  United Therapeutics Corporation To Present At 35th Annual J.P. Morgan Healthcare Conference,,11/11/2017 G0176710 PRN  ACT NOW: Monteverde & Associates PC Announces an Investigation of Alkermes plc. - ALKS,,,, 2/25/2016 55027E10 PRN  Luminex Corporation Announces Collaboration with University of Sao Paulo to Validate Zika Virus Detection Panel, 5/03/2017 80067710 PRN  Sangamo Therapeutics Announces First Quarter 2017 Conference Call And Webcast,, 2/07/2018 80105N10  PRN  Sanofi Delivers 2017 Business EPS in line with Guidance," 6/29/2012 GNW-US    PRN  Research for Most Active Stocks: Citigroup, Tenet Healthcare, Vertex Pharmaceuticals, Barclays, NVIDIA, and Genworth Financial",,,,,, 2/17/2016 07F0YZ-E PRN  Protagonist Therapeutics Names Thomas P. O'Neil Chief Financial Officer,,,,," 8/13/2013 68214310 PRN  Michael A. Jacobsen Joining Omeros as Vice President, Finance and Chief Accounting Officer",,,,,,,,11/15/2016 69329Y10 PRN  PDL BioPharma Announces Proposed $150 Million Public Offering of New Convertible Senior Notes Due 2021,,,, 4/04/2016 ANIP-US  PRN  ANI Pharmaceuticals Closes Acquisition of Inderal® LA Assets,,,,,12/21/2015 60468T10 PRN  Mirati Therapeutics Initiates Glesatinib (MGCD265) Phase 2 Trial In Non-Small Cell Lung Cancer (NSCLC),,,,,,, 3/09/2017 09627Y10 PRN  Blueprint Medicines Reports Fourth Quarter and Full Year 2016 Financial Results,, 5/30/2017 28249U10 PRN  Eiger BioPharmaceuticals to Present at Jefferies 2017 Global Healthcare Conference June 7th,,,,,,, 8/25/2016 05L7YP-E PRN  Vanda Patents Found Valid and Infringed in Fanapt® ANDA Litigation,,,,," 3/02/2017 40637H10 PRN  Technical Reports on Biotech Stocks -- Halozyme Therapeutics, CytRx, Cara Therapeutics, and Keryx Biopharma", 4/24/2013 G2151510 PRN  China Biologic's Shandong Taibang Subsidiary Donates Lifesaving Plasma Products for the Injured in the Ya'an Earthquake," 9/26/2011 000XNL-E PRN  Critical Stock Alerts for Finisar, salesforce.com, Terex, MannKind, ON Semiconductor & MetroPCS",,,,, 4/12/2018 69366J20 PRN  PTC Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares,,,,,,," 6/25/2015 36197T10 PRN  Critical Alerts For Hewlett Packard, GoPro, GW Pharmaceuticals, CyberArk Software and Ocwen Financial Released By InvestorsObserver",," 7/24/2017 G5087110 PRN  Jazz Pharmaceuticals to Report 2017 Second Quarter Financial Results on August 8, 2017",, 6/07/2010 00394S-E PRN  Grifols to Acquire Talecris Biotherapeutics Creating a World Leading Provider of Life-Saving Plasma Protein Therapies,,," 5/07/2015 92337F10 PRN  Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2015 Financial Results on Thursday, May 14, 2015",,,,,,,,,,,,,,,, 6/26/2015 98401F10 PRN  Xencor Provides Update on Two Lead XmAb® Product Candidates and Expansion of Bispecific Oncology Pipeline at R&D Day,," 8/08/2017 G8807B10 PRN  Theravance Biopharma, Inc. Reports Second Quarter 2017 Financial Results and Provides Business Update",, 5/12/2015 03969710 PRN  Ardelyx Reports First Quarter 2015 Financial Results,,,,,,,,,,,, 8/31/2016 05070R10 PRN  Audentes Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 9/25/2013 45232710    PRN  Global Genomics Group (G3) and Illumina to Partner on Cardiovascular Genomics,, 9/19/2017 G3040110 PRN  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Endo International plc and Encourages Investors with Losses to Contact the Firm,," 5/04/2015 09060J10 PRN  BioDelivery Sciences to Host Conference Call and Webcast of First Quarter 2015 Results on Monday, May 11"," 2/07/2018 09073M10    PRN  Bio-Techne Named ""Researchers' Choice"" by CiteAb",11/07/2018 75886F10    PRN  New England Journal of Medicine Publishes Positive Detailed Results From Praluent® (alirocumab) Injection Cardiovascular Outcomes Trial,,"10/20/2014 68375N10 PRN  Critical Alerts For Boston Beer, Apollo Group, Opko Health, Vale and Silver Wheaton Released By InvestorsObserver","10/04/2017 46222210 PRN  Breakfast Technical Briefing on Drug Makers Stocks -- Amarin, Endo, Ionis Pharma, and Teva Pharma",10/26/2017 09061G10   PRN  BioMarin Announces Third Quarter 2017 Financial Results,, 7/28/2017 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2017 Results,,," 8/11/2014 09062X10  PRN  Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma",,," 4/24/2015 37555810   PRN  Critical Alerts For Gilead Sciences, YPF, SPDR Gold Trust, SouFun and Nuance Communications Released By InvestorsObserver"," 6/29/2017 04004760   PRN  Arena Pharmaceuticals Completes Trial Comparing Once-Daily, Extended Release Formulation of Ralinepag with Twice-Daily, Immediate Release Formulation in Normal Healthy Volunteers", 3/20/2018 N5946510  PRN  Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin® Injection,"10/10/2016 M2572210 PRN  Compugen Third Quarter Financial Statements to be Released November 7, 2016",, 3/12/2019 03116210 PRN  Amgen and Jay Leno Partner to Sound the Alarm on High Cholesterol and its Link to Heart Attack and Stroke in Patients Most at Risk,," 4/27/2015 52887230 PRN  Market Updates on Biotech Stocks -- Lexicon Pharma, Idera Pharma, Synta Pharma, Spectrum Pharma, and Medivation",, 4/24/2012 45766930 PRN  Insmed to Host 2012 First Quarter Earnings Conference Call,," 6/22/2015 45773H20 PRN  Critical Alerts For Alcoa, VASCO Data Security, Zillow, Inovio Pharmaceuticals and Kite Pharma Released By InvestorsObserver"," 9/06/2017 64026810 PRN  Nektar Therapeutics Presents Clinical Data from Phase 3 SUMMIT-07 Study of NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2017 PAINWeek®","10/28/2016 76655960 PRN  Generic Drugs Stocks on Investors' Radar -- Zoetis, Sophiris Bio, Rigel Pharma, and Mallinckrodt",,,"11/26/2010 02311120 PRN  Amarin to Host Conference Call at 8:30 a.m. EST on November 29, 2010, to Discuss Top-Line Results of Phase 3 MARINE Study of AMR101 in Patients with Very High Triglycerides"," 1/15/2013 45337C10 PRN  Critical Alerts For Halliburton, DirecTV, American Eagle Outfitters, Incyte, and Cablevision Released By InvestorsObserver",12/14/2016 UTHR-US  PRN  BioDelivery Sciences Announces the Hiring of Peter Ginsberg as Vice President of Business Development,,"11/07/2017 G0176710 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alkermes plc (ALKS)",,,, 2/22/2016 55027E10 PRN  Luminex Corporation Receives Medical Device License for ARIES System and ARIES HSV 1&2 Assay in Canada, 4/25/2017 80067710 PRN  Sangamo Announces The Retirement Of Its Founder And Genome Editing Pioneer Edward Lanphier From The Board Of Directors,, 1/24/2018 BIVV-US   PRN  WeissLaw LLP Investigates Bioverativ Inc. Acquisition," 5/30/2012 CIEIQ-US  PRN  Critical Alerts For Las Vegas Sands, Broadcom, Vertex Pharmaceuticals, Focus Media, and Cobalt International Energy Released By InvestorsObserver",,,,,, 1/08/2016 07F0YZ-E PRN  Protagonist Therapeutics Initiates Phase 1 Study with Oral Peptide PTG-100,,,,, 8/09/2013 68214310 PRN  Omeros Corporation Reports Second Quarter 2013 Financial Results,,,,,,,,11/03/2016 69329Y10 PRN  PDL BioPharma Announces Third Quarter 2016 Financial Results,,,, 3/11/2016 ANIP-US  PRN  ANI Pharmaceuticals Agrees to Acquire Inderal® LA Assets from Cranford Pharmaceuticals,,,,,12/17/2015 60468T10 PRN  Mirati Therapeutics Doses First Patient In Expansion Cohorts Of MGCD516 Phase 1b Trial In Genetically Selected Patients,,,,,,," 3/02/2017 09627Y10 PRN  Blueprint Medicines to Report Fourth Quarter and Full Year 2016 Financial Results on Thursday, March 9, 2017",, 5/17/2017 28249U10 PRN  Eiger Announces Results Demonstrating Benefit of Ubenimex and Leukotriene B4 (LTB4) Modulation in Experimental Lymphedema,,,,,,, 8/01/2016 071VWR-E PRN  HETLIOZ® is Now Available for the Treatment of Non-24-Hour Sleep-Wake Disorder in Germany,,,,, 2/28/2017 40637H10 PRN  Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results, 3/13/2013 G2151510 PRN  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2012," 9/19/2011 000DGZ-E PRN  Hot Insider Trading of Celgene, MannKind, MetroPCS, McDonald's, Hudson City Bancorp & Entergy",,,,, 4/09/2018 69366J20 PRN  PTC Therapeutics Announces R&D Day to Review Multiple Orphan Disorder Programs,,,,,,," 6/11/2015 36197T10 PRN  Critical Alerts For Hewlett Packard, Illumina, Bitauto Holdings, GW Pharmaceuticals and Ariad Pharmaceuticals Released By InvestorsObserver",, 6/06/2017 G5087110 PRN  Jazz Pharmaceuticals Presents JZP-110 Data in Patients with Excessive Sleepiness Associated with Obstructive Sleep Apnea,, 6/02/2010 00394S-E PRN  Grifols Initiates Clinical Investigation of New Treatment Protocol for Alzheimer's Disease,,," 4/23/2015 92337F10 PRN  Veracyte, Inc. Announces $40 Million Private Placement",,,,,,,,,,,,,,,," 6/12/2015 98401F10 PRN  Xencor to Host R&D Day and Webcast on June 26, 2015",, 8/08/2017 G8807B10 PRN  Theravance Biopharma Reports Encouraging Data from First Cohort of Patients in Phase 1b Clinical Trial of TD-1473 in Ulcerative Colitis,, 5/05/2015 03969710 PRN  Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria,,,,,,,,,,,, 8/17/2016 05070R10 PRN  Audentes Therapeutics Announces First Patient Enrolled in the INCEPTUS Clinical Assessment Study of XLMTM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 9/12/2013 45232710    PRN  FDA Approvals, Study Results, Multi-Year Collaborations, Data Presentations, and Supply Agreements - Research Report on Celgene, Amgen, Biogen Idec, Vertex, and Illumina",," 9/11/2017 G3040110 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Endo International plc (ENDP) & Lead Plaintiff Deadline: October 17, 2017",, 4/30/2015 BDSI-US  PRN  BioDelivery Sciences to Present at the Deutsche Bank 40th Annual Health Care Conference and the Bank of America Merrill Lynch 2015 Health Care Conference, 2/06/2018 09073M10    PRN  Bio-Techne Declares Dividend,11/07/2018 75886F10    PRN  New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) Injection cardiovascular outcomes trial,," 9/30/2014 68375N10 PRN  Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences", 9/11/2017 46222210 PRN  New Data Presented at European Society for Medical Oncology Meeting Demonstrate Antitumor Activity with IONIS-STAT3-2.5 Rx in Combination with Imfinzi,"10/26/2017 09061G10   PRN  FDA Grants Breakthrough Therapy Designation for BioMarin's Valoctocogene Roxaparvovec (formerly BMN 270), an Investigational Gene Therapy for Hemophilia A",, 7/21/2017 64125C10 PRN  Neurocrine Biosciences Announces the Appointment of Julie Cooke as Chief People Officer,,, 8/05/2014 078VWR-E  PRN  Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis,,," 4/14/2015 37555810   PRN  Updates on Biotech Stocks -- Gilead Sciences, Arena Pharma, ACADIA Pharma, Halozyme Therapeutics, and Anthera Pharma", 6/15/2017 04004760   PRN  Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference, 3/02/2018 N5946510  PRN  Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.,10/07/2016 0C7MF0-E PRN  Compugen to Present at the Annual Meeting of the Society for Immunotherapy of Cancer Next Month,, 3/07/2019 03116210 PRN  Amgen Announces 2019 Second Quarter Dividend,, 4/20/2015 52887230 PRN  Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research,, 4/16/2012 45766930 PRN  Insmed Announces First Patient Dosed in Pivotal European Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections,," 6/05/2015 45773H20 PRN  Critical Alerts For Abercrombie & Fitch, Inovio Pharmaceuticals, Wynn Resorts, Mylan and Netflix Released By InvestorsObserver"," 9/06/2017 64026810 PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2017 Morgan Stanley Global Healthcare Conference in New York City",10/20/2016 76655960 PRN  Rigel Announces Results from the Second FIT Phase 3 Study and the Long-Term Open-Label Extension Study for Fostamatinib in ITP,,,11/18/2010 02311120 PRN  Amarin Corporation Appoints Kristine Peterson to Board of Directors,"12/11/2012 BIDU-CN  PRN  Critical Alerts For Baidu.com, Barrick Gold, American Eagle Outfitters, Tesoro, and Incyte Released By InvestorsObserver",10/27/2016 91307C10 PRN  United Therapeutics Corporation Reports Third Quarter 2016 Financial Results,,11/07/2017 0F98BD-E PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc - ALKS,,,, 2/02/2016 55027E10 PRN  Luminex Corporation To Present At 2016 Leerink Global Healthcare Conference, 4/24/2017 80067710 PRN  Sangamo Therapeutics Announces Presentations at 2017 Annual meeting of the American Society of Gene & Cell Therapy,, 1/22/2018 BIVV-US   PRN  ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Bioverativ Inc.," 5/30/2012 ITUB-BR   PRN  Equity Research on Most Popular Searches: Intel, Vertex Pharmaceuticals, Seagate, Las Vegas Sands, Itau Unibanco, and Research In Motion",,,,,, 9/23/2015 07F0YZ-E PRN  Protagonist Therapeutics Receives SBIR Funding for Oral IL-23 Receptor Antagonists for Treatment of Inflammatory Bowel Diseases,,,,, 8/08/2013 68214310 PRN  Omeros to Present at the Wedbush 2013 Life Sciences Management Access Conference,,,,,,,,"10/27/2016 69329Y10 PRN  PDL BioPharma to Announce Third Quarter 2016 Financial Results on November 3, 2016",,,, 3/09/2016 00182C10 PRN  ANI Pharmaceuticals to Present at 28th Annual ROTH Conference,,,,,12/01/2015 MRTX-US  PRN  Mirati Therapeutics To Present At The Oppenheimer 26th Annual Healthcare Conference,,,,,,, 2/28/2017 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences in March,, 5/15/2017 28249U10 PRN  Eiger BioPharmaceuticals Completes Enrollment of Phase 2 LIBERTY Study of Ubenimex in Pulmonary Arterial Hypertension,,,,,,, 7/27/2016 92165910 PRN  Vanda Pharmaceuticals Reports Second Quarter 2016 Financial Results,,,,, 2/23/2017 40637H10 PRN  Halozyme Therapeutics To Present At Upcoming Healthcare Conferences, 3/08/2013 G2151510 PRN  China Biologic Products to Report Fourth Quarter and Fiscal Year 2012 Financial Results, 6/08/2011 UBM-GB   PRN  Innovative Medical Products Showcased at MD&M East Ceremony,,,,, 4/04/2018 005W47-E PRN  PTC Therapeutics and CHDI Foundation Announce a Collaboration on a Small-Molecule Therapeutic for Huntington's Disease,,,,,,," 5/26/2015 36197T10 PRN  Critical Alerts For FireEye, Bank of America, GW Pharmaceuticals, ConocoPhillips and Canadian Solar Released By InvestorsObserver",, 6/06/2017 G5087110 PRN  Jazz Pharmaceuticals Presents Data for the Phase 3 TONES 2 Study of JZP-110 in Patients with Excessive Sleepiness Associated with Narcolepsy,, 5/20/2010 00394S-E PRN  Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB,,, 4/16/2015 92337F10 PRN  Veracyte Initiates Launch of Percepta™ Bronchial Genomic Classifier to Improve Lung Cancer Diagnosis,,,,,,,,,,,,,,,, 6/10/2015 98401F10 PRN  Xencor Reports Complete Data Results on XmAb5871 Program at European League Against Rheumatism (EULAR) 2015 Annual Meeting,, 8/02/2017 G8807B10 PRN  Theravance Biopharma Announces Positive Top-Line Results from Phase 2b Study of Velusetrag (TD-5108) in Patients with Gastroparesis,, 4/20/2015 03969710 PRN  Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors,,,,,,,,,,,, 8/08/2016 05070R10 PRN  Audentes Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 8/27/2013 45232710    PRN  New Programs, Product Launches, Corporate Announcements and Financial Results - Research Report on Aetna, Illumina, Pharmacyclics, WellCare, and BioCryst",, 8/28/2017 0GVLMW-E PRN  Endo Begins Shipment of Generic Sabril® (vigabatrin) for Oral Solution,, 4/28/2015 09060J10 PRN  BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs, 2/06/2018 09073M10    PRN  Bio-Techne Releases Second Quarter Fiscal 2018 Results,11/06/2018 75886F10    PRN  Regeneron Reports Third Quarter 2018 Financial and Operating Results,," 7/31/2014 68375N10 PRN  Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences", 8/30/2017 00167Y-E PRN  Ionis Earns $40 Million SPINRAZA Regulatory Milestone Payment from Biogen,10/18/2017 09061G10   PRN  BioMarin Highlights Breadth of Innovative Development Pipeline at R&D Day on October 18th in New York,, 6/09/2017 64125C10 PRN  Neurocrine Biosciences to Present at the Goldman Sachs 38th Annual Global Healthcare Conference,,," 8/01/2014 09062X10  PRN  Favorable Court Ruling, Quarterly Performance Reviews, Acquisition Completion, and Contract Renewals - Research Reports on Mylan, Biogen, Medtronic, UnitedHealth and Covidien",,, 4/03/2015 091B1B-E   PRN  Actavis Confirms Generic Letairis® Patent Challenge, 6/14/2017 04004760   PRN  Arena Pharmaceuticals Announces Shareholders and Board of Directors Approve Reverse Stock Split, 2/28/2018 N5946510  PRN  Mylan Reports Full Year and Fourth Quarter 2017 Results and Provides 2018 Guidance, 8/30/2016 M2572210 PRN  Compugen Discloses Development of Enhanced LINKS Platform Utilized for the Discovery of Myeloid Targets for Cancer Immunotherapy,, 3/07/2019 03116210 PRN  Amgen To Present At The Cowen and Company 39th Annual Healthcare Conference,, 4/15/2015 LXRX-US  PRN  Lexicon Pharmaceuticals and Bristol-Myers Squibb Select Development Candidate for Neuropathic Pain in Neuroscience Drug Discovery and Development Alliance,, 3/13/2012 45766930 PRN  Insmed Announces Fourth Quarter and Full-Year 2011 Financial Results,," 5/21/2015 45773H20 PRN  Critical Alerts For Apple, Freeport-McMoRan, Celgene, Inovio Pharmaceuticals and Ambarella Released By InvestorsObserver"," 8/30/2017 64026810 PRN  Nektar Therapeutics to Present Clinical Data from Phase 3 SUMMIT-07 Study of NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at PAINWeek®","10/10/2016 76655960 PRN  Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)",,,11/15/2010 02311120 PRN  Amarin to Present at Lazard Capital Markets Annual Healthcare Conference,"11/21/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Incyte, Eli Lilly, Johnson & Johnson, Abbott Laboratories and Express Scripts Holding","10/20/2016 91307C10 PRN  United Therapeutics Corporation To Report Third Quarter 2016 Financial Results Before The Market Opens On Thursday, October 27, 2016",,"10/05/2017 G0176710 PRN  Stock Performance Review on Drug Delivery Industry -- Adamis Pharma, Alkermes, PetMed Express, and Valeant Pharma",,,, 2/01/2016 55027E10 PRN  Luminex Corporation Reports Fourth Quarter And Full Year 2015 Results, 4/24/2017 80067710 PRN  Sangamo Therapeutics Announces Participation In The ARM 5th Annual Cell & Gene Therapy Investor Day,," 1/22/2018 80105N10  PRN  Johnson Fistel, Announces Investigations of the Proposed Sales of Bioverativ Inc., and Juno Therapeutics, Inc.", 1/31/2012 000YJB-E  PRN  FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis,,,,,," 9/10/2015 07F0YZ-E PRN  Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer",,,,, 8/01/2013 68214310 PRN  Omeros Submits New Drug Application to U.S. FDA for OMS302,,,,,,,,"10/12/2016 69329Y10 PRN  Biotech Stocks on Investors' Radar -- Alexion Pharma, PDL BioPharma, BioCryst Pharma, and Cara Therapeutics",,,, 2/24/2016 00182C10 PRN  ANI Pharmaceuticals and Dexcel Announce FDA Approval of Donepezil Hydrochloride 23mg Tablets,,,,,11/06/2015 60468T10 PRN  Mirati Therapeutics Reports Third Quarter 2015 Financial Results And Provides Business Update,,,,,,, 2/15/2017 0BP4MZ-E PRN  Blueprint Medicines to Present at 2017 RBC Capital Markets Global Healthcare Conference,, 5/12/2017 28249U10 PRN  Eiger BioPharmaceuticals Reports First Quarter 2017 Financial Results,,,,,,," 7/12/2016 92165910 PRN  Vanda Pharmaceuticals to Announce Second Quarter 2016 Financial Results on July 27, 2016",,,,, 2/13/2017 40637H10 PRN  MabVax Therapeutics Studies Lead Investigational Drug MVT-5873 with Halozyme PEGPH20,"11/19/2012 G2151510 PRN  China Biologic Products, Inc. Adopts Stockholder Rights Plan"," 5/17/2011 005SV0-E PRN  Daily Stock Reports: Insider Trade for Novellus, Salesforce.com, MannKind, IBM, Rackspace Hosting, & Apache",,,,, 3/28/2018 69366J20 PRN  PTC Therapeutics Announces Pricing of Public Offering of Common Stock,,,,,,," 5/12/2015 36197T10 PRN  Critical Alerts For Gilead Sciences, GW Pharmaceuticals, AT&T, Petrobras and General Electric Released By InvestorsObserver",," 5/31/2017 G5087110 PRN  Jazz Pharmaceuticals Announces FDA Acceptance of NDA for VYXEOS™ (CPX-351), an Investigational Treatment for Acute Myeloid Leukemia, with Priority Review Status",,,,, 4/14/2015 008W47-E PRN  Veracyte and GE Announce Research Collaboration,,,,,,,,,,,,,,,, 5/26/2015 00780K-E PRN  Xencor to Present at Jefferies 2015 Healthcare Conference,," 8/01/2017 G8807B10 PRN  Theravance Biopharma to Report Second Quarter 2017 Financial Results and Business Update on August 8, 2017",, 3/13/2015 03969710 PRN  Ardelyx to Present at the 22nd Annual Future Leaders in the Biotech Industry Conference,,,,,,,,,,,, 7/19/2016 0D7WM8-E PRN  Audentes Therapeutics Announces Pricing of Initial Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 7/18/2013 09810Q-E    PRN  Complete Genomics and Illumina Settle Patent Litigation,, 8/22/2017 G3040110 PRN  Endo to Participate at Morgan Stanley Global Healthcare Conference,," 4/15/2015 09060J10 PRN  Equities Updates on Pharma Industry -- Eli Lilly, Sanofi, AstraZeneca, Nektar Therapeutics, and BioDelivery Sciences Intl.", 2/05/2018 09073M10    PRN  Bio-Techne To Present At The Leerink Partners 7th Annual Global Healthcare Conference,11/06/2018 75886F10    PRN  FDA Grants Priority Review for Dupixent® (dupilumab) as Potential Treatment for Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis,," 7/14/2014 68375N10 PRN  Breakthrough Technologies, Scheduled Conference Calls, Positive Opinions, and Stock Options Grants - Analyst Notes on IDEXX Laboratories, AmSurg, Aegerion Pharmaceuticals, OPKO and PerkinElmer", 8/24/2017 IONS-US  PRN  Ionis Recommends Shareholders Reject The Below-The-Market Mini-Tender Offer By TRC Capital Corporation,"10/18/2017 002GTF-E   PRN  Popular Science Names BioMarin's Brineura® (cerliponase alfa) One of the Top Health Innovations of 2017 with ""Best of What's New"" Award",, 6/02/2017 64125C10 PRN  Neurocrine Announces Presentations Related to INGREZZA® (valbenazine) Capsules at the 21st International Congress of Parkinson's Disease and Movement Disorders,,, 7/22/2014 060RWY-E  PRN  Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted,,," 3/31/2015 37555810   PRN  Critical Alerts For Invensense, SolarCity, Gilead Sciences, Mylan and Foot Locker Released By InvestorsObserver", 6/14/2017 04004760   PRN  Arena Pharmaceuticals Appoints Jennifer Jarrett to Board of Directors, 2/28/2018 N5946510  PRN  Mylan to Bring a Biosimilar of BOTOX to the Market Through a Collaboration and License agreement with Revance Therapeutics, 8/02/2016 M2572210 PRN  Compugen Ltd. Reports 2nd Quarter 2016 Financial Results,, 3/06/2019 03116210 PRN  New Data From Amgen To Be Presented At ACC.19 Continues To Build Evidence For Repatha® (evolocumab) Across Multiple Patient Populations,, 4/09/2015 52887230 PRN  Lexicon To Present At Needham & Company's 14th Annual Healthcare Conference,, 2/28/2012 45766930 PRN  Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call,," 5/13/2015 45773H20 PRN  Critical Alerts For Inovio Pharmaceuticals, TrueCar, HealthStream, Nuance Communications and Kinder Morgan Released By InvestorsObserver", 8/08/2017 NKTR-US  PRN  Nektar Therapeutics Reports Financial Results for the Second Quarter of 2017,10/07/2016 76655960 PRN  Rigel Expands Leadership Team in Research and Business Development,,,11/10/2010 02311120 PRN  Amarin Reports Third Quarter 2010 Financial Results and Positively Updates Phase 3 Guidance,"11/13/2012 LLY-US   PRN  Lilly and Incyte Announce Additional Phase IIb Baricitinib Data, Including MRI Results, in Patients with Rheumatoid Arthritis", 8/10/2016 0033WN-E PRN  United Therapeutics Corporation To Present At The 2016 Wedbush PacGrow Healthcare Conference,,"10/25/2016 G0176710 PRN  How These Healthcare Stocks are Faring? -- Alkermes, Adamis Pharma, BioScrip, and IntelliPharmaCeutics",,,," 1/11/2016 55027E10 PRN  Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 1, 2016", 3/29/2017 80067710 PRN  Sangamo Therapeutics Announces Presentation of New Data Demonstrating Significant Reduction of Tau Expression Using Proprietary ZFP Gene Regulation Technology,,12/14/2017 005M9Z-E  PRN  Mylan Announces the U.S. Patent and Trademark Appeal Board Institutes Inter Partes Review Proceedings on All Claims Against Sanofi's Lantus® Patents," 1/25/2012 92532F10  PRN  Critical Alerts for Starbucks, UnitedHealth, Harley Davidson, Life Technologies, and Vertex Pharmaceuticals Released by Seven Summits Research",,,,,, 7/16/2015 07F0YZ-E PRN  Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development,,,,, 7/02/2013 68214310 PRN  European Medicines Agency Approves Positive Opinion on Omeros' Pediatric Investigation Plan for OMS302,,,,,,,, 8/29/2016 69329Y10 PRN  PDL BioPharma Announces the Successful Conclusion of its Debt Financing Agreement with Paradigm Spine,,,, 2/23/2016 00182C10 PRN  ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results and Provides 2016 Guidance,,,,, 9/28/2015 60468T10 PRN  Mirati Therapeutics Presents Interim Clinical Data From Ongoing MGCD516 Phase 1 Dose Escalation Study In Patients With Advanced Solid Tumors,,,,,,,12/13/2016 09627Y10 PRN  Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock,, 5/08/2017 28249U10 PRN  Eiger Announces Presentation of Prevalence Data of Hepatitis Delta Virus (HDV) Infection in the U.S. at Digestive Disease Week (DDW) in Chicago,,,,,,," 6/30/2016 92165910 PRN  Why Investors Love These Biotech's Stocks? - ImmunoGen, Immunomedics, Vanda Pharma, and Arrowhead Pharma",,,,, 2/01/2017 40637H10 PRN  Halozyme To Host Fourth Quarter 2016 Financial Results Conference Call,11/08/2012 G2151510 PRN  China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2012, 4/29/2011 005SV0-E PRN  UBM Canon and Medical Design Excellence Awards (MDEA) Announce Winner of Lifetime Achievement Award,,,,, 3/27/2018 69366J20 PRN  PTC Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,, 5/05/2015 36197T10 PRN  GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market,, 5/24/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Webcast Discussion of Data to be Presented at APSS,,,,," 3/19/2015 92337F10 PRN  Veracyte, Inc. Announces Fourth Quarter and Full-Year 2014 Financial Results, Provides 2015 Financial Outlook",,,,,,,,,,,,,,,," 5/13/2015 98401F10 PRN  Xencor, Inc. Appoints Mark Lotz, R.Ph., as Vice President of Regulatory Affairs and Wayne Saville, M.D., as Vice President of Clinical Oncology",," 7/31/2017 G8807B10 PRN  Theravance Biopharma Appoints Shehnaaz Suliman, MD, as Senior Vice President of Corporate Development and Strategy",, 2/25/2015 03969710 PRN  Ardelyx Reports Fourth Quarter and Full Year 2014 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 7/17/2013 002WRP-E    PRN  Pathogenica Signs Agreement with Illumina,, 8/08/2017 G3040110 PRN  Endo Reports Second-Quarter 2017 Financial Results,," 3/30/2015 09060J10 PRN  BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development", 1/30/2018 09073M10    PRN  Bio-Techne's Ella™ Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms,10/26/2018 75886F10    PRN  Regeneron Ranked #1 Biopharma Employer for Sixth Time by Science Magazine,, 7/08/2014 68375N10 PRN  Nobel Laureate Roger Kornberg to Chair New ChromaDex Scientific Advisory Board, 8/17/2017 46222210 PRN  Ionis Pharmaceuticals to Present at Upcoming Investor Conferences,10/11/2017 09061G10   PRN  BioMarin to Highlight Breadth of Innovative Development Pipeline at R&D Day on October 18th in New York,, 6/01/2017 64125C10 PRN  Neurocrine Biosciences to Present at the Jefferies 2017 Global Healthcare Conference,,," 7/17/2014 09062X10  PRN  Technical Update, Leadership Appointments, Therapy Approvals, Notifications, and Clinical Trial Results - Analyst Notes on Biogen, Medivation, BioMarin, Acorda and Targacept",,," 3/12/2015 37555810   PRN  Critical Alerts For Bank of America, Gilead Sciences, Kandi Technologies, Intel and Mylan Released By InvestorsObserver", 6/01/2017 04004760   PRN  Arena Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference June 9th, 2/28/2018 N5946510  PRN  Mylan to Present at Raymond James 39th Annual Institutional Investors Conference," 7/21/2016 M2572210 PRN  Compugen Second Quarter 2016 Conference Call Scheduled for Tuesday, August 2, 2016 at 10:00 AM ET",, 2/28/2019 03116210 PRN  Amgen Highlights Progress Of Innovative Early Oncology Pipeline With New Data At AACR 2019,, 3/25/2015 52887230 PRN  Lexicon Pharmaceuticals Announces First Patient Screened In Pivotal Phase 3 Clinical Trial Of Sotagliflozin,, 2/23/2012 0626PS-E PRN  Satori Pharmaceuticals Raises $15M in New Funding,," 4/27/2015 45773H20 PRN  Critical Alerts For Inovio Pharmaceuticals, Hong Kong Television Network, Juniper Networks, United Rentals and Archer-Daniels-Midland Released By InvestorsObserver"," 8/02/2017 64026810 PRN  Nektar to Announce Financial Results for the Second Quarter of 2017 on Tuesday, August 8, 2017, After Close of U.S.-Based Financial Markets", 9/15/2016 76655960 PRN  Rigel Restructures to Focus on Fostamatinib Commercialization,,,11/10/2010 02311120 PRN  Amarin Corporation Announces Senior Management Changes," 8/06/2012 NTAP-US  PRN  Critical Trade Alerts For Las Vegas Sands, NetApp, Polo Ralph Lauren, Best Buy, and Incyte Released By InvestorsObserver", 7/28/2016 91307C10 PRN  United Therapeutics Corporation Reports Second Quarter 2016 Financial Results,,"10/24/2016 G0176710 PRN  Learn how to target a 20% return on Energous Corporation, or get option-trade ideas on Baidu, Netflix, Qualcomm and US Steel or any stock you choose",,,,12/31/2015 LMNX-US  PRN  Luminex Corporation To Present At J.P. Morgan Healthcare Conference, 3/01/2017 80067710 PRN  Sangamo Therapeutics Announces Presentation At The Cowen And Company 37th Annual Health Care Conference,,12/11/2017 80105N10  PRN  FDA Approves Sanofi's Admelog® (insulin lispro injection)," 1/20/2012 INHX-US   PRN  The Zacks Analyst Blog Highlights: GileadSciences, Bristol-Myers Squibb, Inhibitex, Vertex Pharmaceuticals and Merck",,,,,,"12/18/2014 07F0YZ-E PRN  Protagonist Therapeutics Names William A. Hodder as Senior Vice President, Corporate Development",,,,, 6/13/2013 68214310 PRN  Omeros Obtains Regulatory Approval to Initiate Phase 1 Clinical Trial for Lead Antibody in MASP-2 Program,,,,,,,, 8/04/2016 69329Y10 PRN  PDL BioPharma Announces Second Quarter 2016 Financial Results,,,, 2/16/2016 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2015 Financial Results and 2016 Guidance,,,,," 9/25/2015 60468T10 PRN  Critical Alerts For FireEye, Mirati Therapeutics, Axovant Sciences, Shake Shack and Nabors Industries Released By InvestorsObserver",,,,,,,12/07/2016 09627Y10 PRN  Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock,, 5/04/2017 28249U10 PRN  Eiger BioPharmaceuticals to Host Key Opinion Leader Event Addressing Need for Novel Mechanisms in the Treatment of Pulmonary Arterial Hypertension (PAH) on May 10th in New York City,,,,,,, 6/20/2016 92165910 PRN  Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference,,,,," 1/09/2017 40637H10 PRN  Halozyme Provides Program Updates, 2017 Financial Guidance At 35th Annual JP Morgan Healthcare Conference",11/02/2012 G2151510 PRN  China Biologic Products to Report Third Quarter 2012 Financial Results," 4/18/2011 RAX-US   PRN  Critical Stock Alerts: Insider Trade for Finisar, MannKind, Range Resources, MetroPCS, VeriSign, & Rackspace Hosting",,,,, 3/19/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 4/28/2015 36197T10 PRN  GW Pharmaceuticals plc Announces Pricing of U.S. Public Offering of ADSs Raising $179.2 Million on NASDAQ Global Market,," 5/24/2017 G5087110 PRN  Jazz Pharmaceuticals to Present Phase 3 Data on JZP-110, an Investigational Treatment for Excessive Sleepiness in Patients with Narcolepsy and with Obstructive Sleep Apnea, During 31st Annual SLEEP Meeting",,,,," 3/12/2015 92337F10 PRN  Veracyte, Inc. to Announce Fourth Quarter and Full-Year 2014 Financial Results and Host Conference Call and Webcast on Thursday, March 19, 2015",,,,,,,,,,,,,,,, 5/11/2015 98401F10 PRN  Xencor's XmAb®5871 Program to be Featured in Poster Presentation at European League Against Rheumatism (EULAR) 2015 Annual Meeting,, 7/19/2017 G8807B10 PRN  Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD),," 2/18/2015 03969710 PRN  Ardelyx to Report Fourth Quarter and Full Year 2014 Financial Results on February 25th, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 5/20/2013 063YNM-E    PRN  Elsevier Launches Genomics Data App in Collaboration with Illumina,, 8/07/2017 G3040110 PRN  Endo Announces Agreements to Resolve Virtually All Known U.S. Mesh Product Liability Claims,, 3/16/2015 09060J10 PRN  BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results," 1/18/2018 09073M10    PRN  Bio-Techne To Host Conference Call On February 6, 2018 To Announce Second Quarter 2018 Financial Results",10/25/2018 75886F10    PRN  EYLEA® (aflibercept) Injection Improves Diabetic Retinopathy and Reduces Vision-Threatening Complications in Phase 3 Trial,," 7/03/2014 68375N10 PRN  Positive Study Results, Patent Grants, Acquisitions, Patient Enrollment, and Earnings Schedule - Analyst Notes on Synageva, OPKO, bluebird bio, BioDelivery Sciences and Haemonetics", 8/11/2017 IONS-US  PRN  Ionis to Independently Advance Inotersen and IONIS-FB-L Rx,"10/10/2017 09061G10   PRN  BioMarin to Host Third Quarter 2017 Financial Results Conference Call and Webcast on Thursday, October 26 at 4:30 p.m. ET",," 5/30/2017 64125C10 PRN  Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Neurocrine Biosciences",,," 7/07/2014 09062X10  PRN  Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec",,," 3/11/2015 37555810   PRN  Biotech Equities Technical Updates -- Gilead Sciences, Arena Pharma, ACADIA Pharma, Halozyme Therapeutics, and Juno Therapeutics", 5/18/2017 04004760   PRN  Arena Pharmaceuticals to Host Key Opinion Leader Event on Pulmonary Arterial Hypertension (PAH) on May 25 in New York City, 2/28/2018 N5946510  PRN  Mylan to Present at Barclays Global Healthcare Conference, 6/22/2016 00356F-E PRN  Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program,, 2/25/2019 03116210 PRN  Jury Upholds Amgen's Patents On Repatha® (evolocumab),," 3/23/2015 52887230 PRN  Technical Pulse on Biotech Stocks -- Geron, Lexicon Pharma, XOMA Corp., Spectrum Pharma, and BioLine RX",, 2/10/2012 45766930 PRN  Insmed Incorporated Provides Update on Clinical Program for ARIKACE®,," 4/02/2015 45773H20 PRN  Critical Alerts For Inovio Pharmaceuticals, Arrowhead Research, 3D Systems, Stratasys and Pixelworks Released By InvestorsObserver"," 7/24/2017 64026810 PRN  Lilly and Nektar Therapeutics Announce Alliance to Develop and Commercialize NKTR-358, A Novel Autoimmune Therapy", 8/30/2016 76655960 PRN  Market Movers & Headline Makers On Tuesday,,,"11/09/2010 02311120 PRN  Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010"," 8/03/2012 MS-US    PRN  Most Active Stocks: Bristol Myers Squibb, Sealed Air, Symantec, Morgan Stanley, Dow Chemical, and Incyte"," 7/21/2016 91307C10 PRN  United Therapeutics Corporation To Announce Second Quarter 2016 Financial Results Before The Market Opens On Thursday, July 28, 2016",," 7/26/2016 ALKS-IE  PRN  Healthcare Sector Equities Under Review -- Intrexon, Alkermes, BioScrip, and Heartware Intl.",,,,12/18/2015 LMNX-US  PRN  Luminex Corporation Receives FDA Clearance for NxTAG® Respiratory Pathogen Panel, 3/01/2017 80067710 PRN  Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-913 Genome Editing Treatment for MPS II,,12/05/2017 005M9Z-E  PRN  Sanofi and IBM Watson Health real-world analysis showed that individuals not achieving control on basal insulin within 12 months were unlikely to achieve control during the remainder of the two year study,"12/29/2011 GSK-GB    PRN  Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo",,,,,,12/04/2014 07F0YZ-E PRN  Protagonist Therapeutics Closes 2nd Tranche of $18 Million Series B for Advancing Development Candidate to Clinical Trials in 2015,,,,, 5/31/2013 68214310 PRN  Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial,,,,,,,, 8/04/2016 69329Y10 PRN  PDL BioPharma Announces Elimination of Quarterly Cash Dividend,,,, 2/01/2016 00182C10 PRN  ANI Pharmaceuticals Acquires Exclusive Rights to Distribute Three Generic Drug Products from H2-Pharma for $10 Million,,,,, 9/15/2015 60468T10 PRN  Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock,,,,,,,12/06/2016 09627Y10 PRN  Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock,, 5/03/2017 28249U10 PRN  Eiger Announces U.S. IND Filing of Pegylated Interferon Lambda for Hepatitis Delta Virus Infection,,,,,,, 6/15/2016 92165910 PRN  FDA Grants Fanapt® Three Years of Marketing Exclusivity for Labeling Changes Relating to Maintenance Treatment of Schizophrenia,,,,," 1/06/2017 40637H10 PRN  Stock Reports for Halozyme Therapeutics, Alibaba, Kohls, Macy's Incorporated and Sprint Corp include trade ideas with returns over 18%", 9/10/2012 G2151510 PRN  China Biologic's Guizhou Taibang Subsidiary Donates Lifesaving Plasma Products for the Injured in the Yunnan Earthquake, 3/10/2011 ALBO-US  PRN  A Brighter Decade Ahead for Biotech - In-Depth Research Featuring Biodel Inc. and MannKind Corporation,,,,, 3/15/2018 69366J20 PRN  FIREFISH Transitions into Pivotal Phase,,,,,,," 4/24/2015 36197T10 PRN  Critical Alerts For GW Pharmaceuticals, Johnson Controls, Microsoft, Petrobras and Dunkin' Brands Released By InvestorsObserver",, 5/16/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences,,,,, 3/06/2015 92337F10 PRN  Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment,,,,,,,,,,,,,,,, 5/04/2015 98401F10 PRN  Xencor Reports First Quarter 2015 Financial and Operating Results,, 7/19/2017 G8807B10 PRN  Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD),, 2/09/2015 03969710 PRN  Ardelyx to Present at the 2015 Leerink Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 4/24/2013 GM-US       PRN  Critical Alerts For General Motors, PNC Financial, Illumina, Ryland Group, and Brunswick Released By InvestorsObserver",, 8/07/2017 AMRX-US  PRN  Impax Announces Settlement of Contract Litigation on Opana® ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets,," 3/16/2015 09060J10 PRN  Stocks Coverage on the Health Care Sector - AstraZeneca, Novartis, Raptor Pharma, Synthetic Biologics, and BioDelivery Sciences Intl.", 1/15/2018 09073M10    PRN  Advanced Immunolabeling Reagents and Tools from Vector Laboratories Now from Bio-Techne,10/22/2018 75886F10    PRN  FDA Approves Asthma Indication for Dupixent® (dupilumab),," 6/25/2014 68375N10 PRN  Health Care Sector Equities Scrutiny -- Research on OPKO Health, Orexigen Therapeutics, Perrigo, and Auxilium Pharma", 8/08/2017 46222210 PRN  Ionis Provides Improved 2017 Guidance Following Strong Financial Performance,"10/03/2017 09061G10   PRN  BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors",, 5/23/2017 64125C10 PRN  Neurocrine Announces Phase II Results of VMAT2 Inhibitor INGREZZA® For Treatment of Tourette Syndrome,,," 7/04/2014 09062X10  PRN  NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind",,," 2/24/2015 37555810   PRN  Critical Alerts For Gilead Sciences, Celldex Therapeutics, Walgreens Boots Alliance, LinkedIn and Activision Blizzard Released By InvestorsObserver", 5/16/2017 04004760   PRN  Arena Pharmaceuticals to Present Phase 1 Data on Ralinepag for Treatment of Pulmonary Arterial Hypertension at the American Thoracic Society 2017 International Conference, 2/26/2018 N5946510  PRN  Mylan Defeats Allergan's Maneuver to Rent Tribal Sovereign Immunity to Avoid Restasis® Patent Challenge, 6/15/2016 M2572210 PRN  Compugen to Present at JMP Securities Life Sciences Conference in New York,," 2/21/2019 03116210 PRN  Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure",, 3/18/2015 52887230 PRN  Lexicon and Ipsen Expand Their Licensing and Commercialization Agreement for Telotristat Etiprate to Include Canada,, 1/20/2012 45766930 PRN  Insmed Incorporated Provides Corporate Update,," 3/17/2015 45773H20 PRN  Critical Alerts For Inovio Pharmaceuticals, Kandi Technologies, Skyworks Solutions Released By InvestorsObserver"," 7/18/2017 64026810 PRN  Nektar Announces Topline Data from Human Abuse Potential Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain", 8/30/2016 76655960 PRN  Rigel's Fostamatinib Meets Primary Endpoint in Phase 3 Study in Chronic ITP,,,10/28/2010 02311120 PRN  Amarin to Present at Oppenheimer & Co. Inc. Annual Healthcare Conference," 8/03/2012 45337C10 PRN  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Incyte Corporation", 7/11/2016 002G54-E PRN  Children's Neuroblastoma Parent Medical Conference,," 5/19/2016 G0176710 PRN  Why Investors Still See Value in Alkermes, AMAG Pharmaceuticals, IDEXX Laboratories and Atossa Genetics?",,,,11/10/2015 LMNX-US  PRN  Luminex Corporation To Present At Upcoming Investment Conferences, 2/28/2017 80067710 PRN  Sangamo Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results,,12/04/2017 005M9Z-E  PRN  Sanofi's Toujeo® met main objective in head-to-head study versus insulin degludec,12/16/2011 068NJ7-E  PRN  BioSpace Spotlights Leading Life Science Community,,,,,,"11/05/2014 07F0YZ-E PRN  Protagonist Therapeutics Elects Chaitan Khosla, Ph.D. to Board of Directors",,,,, 5/28/2013 68214310 PRN  Omeros Files Clinical Trial Application for Lead Antibody in MASP-2 Program,,,,,,,, 8/01/2016 69329Y10 PRN  PDL BioPharma Completes Second Tranche Payment Under Royalty Transaction with ARIAD Pharmaceuticals,,,, 1/05/2016 ANIP-US  PRN  ANI Pharmaceuticals Closes Transaction to Acquire Two NDAs from Merck for $75 Million,,,,," 9/15/2015 60468T10 PRN  Critical Alerts For Exelixis, Mirati Therapeutics, BP, TASER International and 3D Systems Released By InvestorsObserver",,,,,,,12/04/2016 09627Y10 PRN  Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Systemic Mastocytosis,, 4/24/2017 28249U10 PRN  Eiger Announces Abstract and Presentation at 2017 Digestive Disease Week in Chicago,,,,,,, 6/03/2016 05F9ZW-E PRN  Vanda Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference,,,,, 1/05/2017 40637H10 PRN  Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints, 8/09/2012 G2151510 PRN  China Biologic Reports Financial Results for the Second Quarter and First Half of 2012," 2/16/2011 56400P70 PRN  Shareholder Class Action Filed Against MannKind Corporation by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP",,,,, 3/06/2018 69366J20 PRN  PTC Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update,,,,,,," 4/15/2015 36197T10 PRN  Critical Alerts For GW Pharmaceuticals, Avon Products, 58.com, Box and Kite Pharma Released By InvestorsObserver",, 5/09/2017 G5087110 PRN  Jazz Pharmaceuticals Announces First Quarter 2017 Financial Results,,,,, 2/23/2015 92337F10 PRN  Veracyte to Present at the Cowen and Company 35th Annual Healthcare Conference,,,,,,,,,,,,,,,, 4/29/2015 98401F10 PRN  Xencor to Webcast Presentations at Two Upcoming Conferences in May,, 6/05/2017 G8807B10 PRN  New Data Highlighting in vitro Potency Advantages for VIBATIV® (telavancin) Against Difficult-to-Treat MRSA and MSSA Pathogens Reported at ASM Microbe 2017,, 2/02/2015 03969710 PRN  Ardelyx Reports Results from Phase 2b Clinical Trial Evaluating Tenapanor in Treating Hyperphosphatemia in Chronic Kidney Disease Patients on Hemodialysis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 3/04/2013 YELP-US     PRN  Critical Alerts For Gilead, Newmont Mining, Illumina, Yelp, and Southern Copper Released By InvestorsObserver",, 7/21/2017 G3040110 PRN  Endo to Restructure Manufacturing Network,, 3/03/2015 09060J10 PRN  BioDelivery Sciences to Present at the 27th Annual ROTH Conference, 1/02/2018 09073M10    PRN  Bio-Techne Acquires Atlanta Biologicals Inc.,10/19/2018 75886F10    PRN  FDA Approves Asthma Indication for Dupixent® (dupilumab),," 5/23/2014 68375N10 PRN  Technical Snapshot on Health Care Stocks -- Research on Opko Health, Hologic, RadNet, and Alere", 7/27/2017 46222210 PRN  Akcea and Ionis Announce Submission of Marketing Authorization Application for Volanesorsen to the European Medicines Agency, 9/14/2017 09061G10   PRN  FDA Not Currently Planning to Hold Advisory Committee Meeting for BioMarin's Pegvaliase Biologics License Application (BLA),, 5/18/2017 64125C10 PRN  Neurocrine Announces INGREZZA® (valbenazine) Capsules Pharmacokinetic Profile and Long-Term Data to be Presented at the 2017 American Psychiatric Association Annual Meeting,,," 6/25/2014 09062X10  PRN  Critical Alerts For Vertex Pharmaceuticals, Dollar Tree, Avis, Ryder, and Biogen Released By InvestorsObserver",,," 2/17/2015 37555810   PRN  Track What Biological Products Companies Are Up To: Special Research on Gilead, Halozyme, Heska, Idera, and Kite Pharma", 5/09/2017 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2017 Financial Results, 2/26/2018 N5946510  PRN  16-Year Veteran Director Wendy Cameron to Retire from Mylan N.V. Board after 2018 AGM, 5/23/2016 002G6W-E PRN  Compugen to Present at the Jefferies Global Healthcare Conference in New York,, 2/13/2019 000C35-E PRN  Abilita Bio and Amgen Enter Into a Multi-Target Collaboration,, 3/17/2015 52887230 PRN  Advances in Biotech Expanded Studies Lead to Cutting-Edge Therapeutic Treatments - Company Announces Positive Final Results in Treatment for Alzheimer's Disease,,11/14/2011 45766930 PRN  Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference,, 3/17/2015 45773H20 PRN  Advances in Biotech Expanded Studies Lead to Cutting-Edge Therapeutic Treatments - Company Announces Positive Final Results in Treatment for Alzheimer's Disease," 7/10/2017 64026810 PRN  Nektar Presents New Preclinical Data for NKTR-358, a First-in-Class Regulatory T Cell Stimulator, at 13th World Congress of Inflammation in London"," 8/29/2016 76655960 PRN  Rigel Announces Press Release and Conference Call Schedule on Tuesday, August 30, 2016",,,10/18/2010 02311120 PRN  Amarin to Present at NewsMakers in the Biotech Industry Conference," 6/08/2012 45337C10 PRN  Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis", 4/28/2016 91307C10 PRN  United Therapeutics Corporation Announces Executive Leadership Changes,," 4/29/2015 G0176710 PRN  Technical Data on Biotech Stocks - ZIOPHARM Oncology, Arrowhead Research, Alkermes, CytRx, and OvaScience",,,,11/02/2015 55027E10 PRN  Luminex Corporation Reports 3rd Quarter 2015 Results, 2/27/2017 80067710 PRN  Sangamo Therapeutics Announces Chief Financial Officer Succession,,11/30/2017 80105N10  PRN  Switching to Toujeo® in a real-world setting produced a similar number of severe low blood sugar events as insulin degludec,"12/13/2011 OMV-AT    PRN  The Zacks Analyst Blog Highlights: ConocoPhillips, Talisman Energy, Vertex Pharmaceuticals, Kimberly-Clark and Procter & Gamble",,,,,, 9/19/2013 07F0YZ-E PRN  Protagonist Therapeutics Expands Series B Financing to $18 Million with Addition of $4 Million from Pharmstandard,,,,, 5/23/2013 68214310 PRN  Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease,,,,,,,," 7/28/2016 69329Y10 PRN  PDL BioPharma to Announce Second Quarter 2016 Financial Results on August 4, 2016",,,,12/29/2015 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Flecainide Tablets,,,,, 9/14/2015 MRTX-US  PRN  Mirati Therapeutics Announces Proposed Public Offering of $80 Million of Common Stock,,,,,,,11/30/2016 09627Y10 PRN  Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors,, 4/21/2017 28249U10 PRN  Eiger Announces Additional Phase 2 Clinical Trial Results for Lonafarnib at The International Liver Congress™ 2017,,,,,,, 5/26/2016 06CR5C-E PRN  Vanda Announces FDA Approval of the Fanapt® Supplemental New Drug Application for Maintenance Treatment of Schizophrenia in Adults,,,,,12/22/2016 HALO-US  PRN  Halozyme Therapeutics To Present At The 35th Annual J.P. Morgan Healthcare Conference, 8/03/2012 G2151510 PRN  China Biologic Products to Report Second Quarter 2012 Financial Results," 2/14/2011 06DDVL-E PRN  Zacks Analyst Blog Highlights: MannKind Corporation, Merck, Pfizer, TOTAL S.A. and Suncor Energy",,,,, 3/01/2018 69366J20 PRN  PTC Therapeutics To Participate At Upcoming Investor Conferences,,,,,,," 3/31/2015 36197T10 PRN  Critical Alerts For Tesla Motors, GW Pharmaceuticals, Alcoa, Myriad Genetics and Coach Released By InvestorsObserver",, 4/26/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 2 Study of JZP-110 in Narcolepsy Patients with Excessive Sleepiness,,,,, 2/05/2015 92337F10 PRN  Veracyte Announces Publication of Data Demonstrating Analytical and Clinical Validity of Its Afirma® BRAF Malignancy Classifier,,,,,,,,,,,,,,,," 4/28/2015 98401F10 PRN  Xencor to Host First Quarter 2015 Financial Results Webcast and Conference Call on May 4, 2015",, 5/23/2017 G8807B10 PRN  Theravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS,,"12/01/2014 03969710 PRN  Ardelyx Appoints Jeremy S. Caldwell, Ph.D., as Executive Vice President and Chief Scientific Officer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 1/17/2013 45232710    PRN  Critical Alerts For Deere, Valero Energy, Pioneer Natural Resources, Dunkin Brands, and Illumina Released By InvestorsObserver",, 7/14/2017 G3040110 PRN  Endo to Announce Second-Quarter 2017 Financial Results,, 2/23/2015 09060J10 PRN  BioDelivery Sciences to Receive $10 Million Milestone Payment from Endo Pharmaceuticals Inc. in Conjunction with Acceptance of NDA for BELBUCA™ (buprenorphine HCl) Buccal Film for Chronic Pain,12/28/2017 09073M10    PRN  Bio-Techne To Present At The 36th Annual J.P. Morgan Healthcare Conference,10/19/2018 75886F10    PRN  FDA approves asthsma indication for Dupixent® (dupilumab),,"12/31/2013 68375N10 PRN  Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera", 7/25/2017 46222210 PRN  Ionis Pharmaceuticals to Hold Second Quarter 2017 Financial Results Webcast, 9/06/2017 09061G10   PRN  BioMarin Presents Interim Data of Phase 1/2 Study of BMN 250 for Treatment of Sanfilippo B Syndrome (MPS IIIB) at 13th International Congress of Inborn Errors of Metabolism (ICIEM) 2017,, 5/18/2017 003MP5-E PRN  Madenco Biosciences Creates New Line of Cosmeceuticals to Complement Bellus Skin™ Serum for Anti-Aging,,, 6/17/2014 IONS-US   PRN  Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec,,," 2/12/2015 37555810   PRN  Technical Roundup on Biotech Equities - Gilead Sciences, MannKind, ImmunoGen, Dyax, and Pharmacyclics"," 5/02/2017 04004760   PRN  Arena Pharmaceuticals to Release First Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, May 9, 2017", 2/20/2018 N5946510  PRN  Mylan Receives Tentative Approval for Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program, 5/16/2016 OPY-US   PRN  Compugen to Present at the Oppenheimer Annual Israeli Conference in Tel Aviv,, 1/29/2019 03116210 PRN  Amgen Reports Fourth Quarter And Full Year 2018 Financial Results,, 3/09/2015 52887230 PRN  Lexicon Pharmaceuticals Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Telotristat Etiprate,,"11/08/2011 45766930 PRN  Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2011",," 3/04/2015 45773H20 PRN  Critical Alerts For Inovio Pharmaceuticals, Dollar Tree, Intrexon, Harley-Davidson and HomeAway Released By InvestorsObserver", 6/06/2017 64026810 PRN  Nektar to Webcast Presentation at Jefferies 2017 Global Healthcare Conference in New York City, 8/02/2016 76655960 PRN  Rigel Announces Second Quarter 2016 Financial Results and Provides Portfolio Update,,, 9/16/2010 02311120 PRN  Amarin to Present at UBS Life Sciences Conference," 6/06/2012 45337C10 PRN  Critical Alerts For LinkedIn, Capital One, Agrium, Incyte, and Weight Watchers Released By InvestorsObserver", 4/28/2016 91307C10 PRN  United Therapeutics Corporation Reports First Quarter 2016 Financial Results,," 3/26/2015 G0176710 PRN  Technical Scrutiny on Biotech Stocks -- Exact Sciences, Galena Biopharma, Alkermes, Seattle Genetics, and CorMedix",,,,10/28/2015 55027E10 PRN  Luminex Corporation to Feature ARIES System and NxTAG Respiratory Pathogen Panel at AMP Annual Meeting, 2/27/2017 80067710 PRN  Sangamo Therapeutics Receives Rare Pediatric Disease Designation From FDA For SB-318 In Vivo Genome Editing Therapeutic For MPS I,,"11/28/2017 80105N10  PRN  Free Research Reports on These Healthcare Stocks -- Sanofi, DURECT, Sucampo Pharma, and Perrigo","11/09/2011 000Q07-E  PRN  Hot Stock Research for Time Warner, Boston Scientific, Polycom, Microsoft, Vertex & Dendreon",,,,,, 5/30/2013 07F0YZ-E PRN  Protagonist Therapeutics Names David Liu Chief Scientific Officer,,,,, 5/22/2013 68214310 PRN  Omeros to Present at Two Upcoming Conferences,,,,,,,, 7/06/2016 NVS-CH   PRN  PDL BioPharma Closes Equity Investment Transaction in Noden Pharma for the Acquisition of Tekturna® (aliskiren) and Tekturna HCT® (aliskiren and hydrochlorothiazide),,,,12/23/2015 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Nimodipine 30mg Capsules,,,,, 9/11/2015 60468T10 PRN  Mirati Therapeutics To Present Clinical Data At The European Society for Medical Oncology (ESMO) 2015 European Cancer Congress,,,,,,,11/28/2016 09627Y10 PRN  Blueprint Medicines Announces Proof-of-Concept Data from Global Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma,," 4/18/2017 28249U10 PRN  Eiger Announces Industry Veteran Lisa Porter, M.D. to Lead Development of Exendin 9-39 for the Treatment of Post-Bariatric Hypoglycemia",,,,,,, 5/04/2016 92165910 PRN  Vanda Pharmaceuticals Reports First Quarter 2016 Financial Results,,,,,11/21/2016 HALO-US  PRN  Halozyme Provides Update On AbbVie Collaboration, 6/08/2012 G2151510 PRN  China Biologic to Postpone Annual General Meeting of Shareholders," 1/13/2011 000X58-E PRN  Critical Stock Alerts: Insider Trade for Symantec, ON Semiconductor, RF Micro Devices, LeapFrog, American Capital Strategies, & MannKind",,,,, 2/28/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,," 3/16/2015 36197T10 PRN  Critical Alerts For GoPro, BlackBerry, GW Pharmaceuticals, Cempra, Anacor Pharmaceuticals, TG Therapeutics, Whiting Petroleum, Travelers, Automatic Data Processing and AOL Released By InvestorsObserver",," 4/25/2017 G5087110 PRN  Jazz Pharmaceuticals to Report 2017 First Quarter Financial Results on May 9, 2017",,,,, 2/04/2015 92337F10 PRN  Veracyte to Present at the Leerink Partners 2015 Global Healthcare Conference,,,,,,,,,,,,,,,," 3/19/2015 98401F10 PRN  Xencor Appoints A. Bruce Montgomery, M.D. to Board of Directors",, 5/23/2017 G8807B10 PRN  Theravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS,,11/17/2014 03969710 PRN  Ardelyx's Tenapanor Reduces Phosphorus Absorption and Protects against Vascular Calcification in Preclinical In Vivo Model of Chronic Kidney Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 1/04/2013 BMR-US      PRN  BioMed Realty Trust Appoints Former Amylin President And Chief Executive Officer To Its Board Of Directors,, 7/06/2017 G3040110 PRN  Endo Provides Update On OPANA® ER,, 2/18/2015 09060J10 PRN  BioDelivery Sciences to Present at the 2015 RBC Capital Markets Healthcare Conference,11/28/2017 09073M10    PRN  Bio-Techne's RNAscope® Technology Enabling Robust Gene Expression and Biomarker Analysis Advances Wide-ranging Research with over 1000 Publications,10/19/2018 75886F10    PRN  Kevzara® (sarilumab) Data at the 2018 ACR/ARHP Annual Meeting Provide Additional Insight on Safety and Efficacy in Rheumatoid Arthritis,,"12/19/2013 68375N10 PRN  Strategic Acquisitions, Commercial Collaborations, and New Appointments - Research Report on Solta Medical, Opko Health, NuPathe, AcelRx Pharmaceuticals, and Momenta Pharmaceuticals", 7/19/2017 46222210 PRN  Akcea Therapeutics Announces Closing of Initial Public Offering, 9/05/2017 09061G10   PRN  BioMarin Announces 3 Platform and 15 Poster Presentations at 13th International Congress of Inborn Errors of Metabolism 2017,, 5/17/2017 64125C10 PRN  AbbVie Presents Pivotal Phase 3 Data on Investigational Treatment Elagolix at the World Congress on Endometriosis,,, 5/28/2014 09062X10  PRN  Array BioPharma Announces Drug Discovery Collaboration Agreement With Biogen Idec,,," 1/30/2015 37555810   PRN  Critical Alerts For Amazon.com, JetBlue, KB Home, Stratasys and Gilead Sciences Released By InvestorsObserver", 4/21/2017 04004760   PRN  Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares," 2/08/2018 N5946510  PRN  Mylan to Release 2017 Fourth Quarter and Full Year Results and 2018 Guidance on Feb. 28, 2018", 5/10/2016 M2572210 PRN  Compugen Ltd. Reports First Quarter 2016 Financial Results,, 1/24/2019 03116210 PRN  Amgen Announces Webcast of 2018 Fourth Quarter and Full Year Financial Results,, 3/04/2015 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Fourth Quarter And Full Year Financial Results,,10/25/2011 45766930 PRN  Insmed to Host 2011 Third Quarter Earnings Conference Call,," 2/09/2015 45773H20 PRN  Critical Alerts For Inovio Pharmaceuticals, Pixelworks, Goldman Sachs, Sears Holdings and Cheniere Energy Released By InvestorsObserver"," 6/05/2017 64026810 PRN  Nektar Presents New Clinical Data from Two Studies of NKTR-214, a CD122-Biased Agonist, at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting", 7/26/2016 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Second Quarter 2016 Financial Results,,, 8/17/2010 02311120 PRN  Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer, 1/24/2012 000M2Q-E PRN  LifeSci Advisors Publishes JAKAFI Survey Results, 4/27/2016 91307C10 PRN  United Therapeutics Corporation To Present At Deutsche Bank 41st Annual Health Care Conference,," 2/11/2015 G0176710 PRN  Biotech Stocks Technical Review -- Merrimack Pharma, Orexigen Therapeutics, Alkermes, Galena Biopharma, and Synta Pharma",,,,10/20/2015 55027E10 PRN  Luminex Corporation and Bio-Techne Corporation Extend and Expand Partnership, 2/21/2017 80067710 PRN  Sangamo Therapeutics Announces Fourth Quarter And Full Year 2016 Conference Call And Webcast,,11/16/2017 063Z5S-E  PRN  Blue Cross and Blue Shield Companies Partner with Onduo on Three State Pilot Programs to Address Diabetes,"10/31/2011 000DP6-E  PRN  The Zacks Analyst Blog Highlights: Chevron, Merck & Co., Johnson & Johnson, Vertex Pharmaceutical and Roche",,,,,,,,,,, 5/14/2013 68214310 PRN  Omeros Announces Closing of $16.2 Million Registered Direct Offering of Common Stock,,,,,,,," 6/16/2016 69329Y10 PRN  Biotechnology Stocks on our Radar -- Array BioPharma, PDL BioPharma, Advaxis, and TetraLogic Pharma",,,,"12/17/2015 ANIP-US  PRN  ANI Pharmaceuticals Announces FDA Approval of Polyethylene Glycol 3350 Powder for Oral Solution, 17mg/Scoopful",,,,, 9/09/2015 60468T10 PRN  MGCD265 DEMONSTRATES CLINICAL EFFICACY WITH CONFIRMED RESPONSES IN NSCLC PATIENTS WITH MET AND AXL GENE AMPLIFICATION,,,,,,,11/15/2016 09627Y10 PRN  Blueprint Medicines to Present Preliminary Data from Ongoing Phase 1 Clinical Trials for BLU-285 and BLU-554 at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics,, 4/06/2017 28249U10 PRN  Eiger Announces Abstracts and Presentations of LOWR HDV Program at the European Association for the Study of the Liver (EASL) Meeting,,,,,,," 4/14/2016 92165910 PRN  Vanda Pharmaceuticals to Announce First Quarter 2016 Financial Results on May 4, 2016",,,,,11/10/2016 HALO-US  PRN  Halozyme Announces Broad Clinical Collaboration Agreement To Evaluate PEGPH20 And Tecentriq In Up To Eight Tumor Types," 6/04/2012 G2151510 PRN  China Biologic to Attend Jefferies Healthcare Conference on June 7, 2012 in New York","12/16/2010 000BG2-E PRN  Critical Insider Trade Alerts for Oracle, MannKind, Abbott Laboratories, Time Warner, Symantec, & CIENA",,,,, 2/21/2018 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year End 2017 Financial Results,,,,,,, 1/20/2015 36197T10 PRN  New Provisional Patents Filed for Pharmaceutical Cannabidiol (CBD) Formulation Consisting of Ibuprofen & CBD Compounds Aimed At Treating Pain,, 4/24/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Positive Results from the Phase 2/3 EXPRESS Study of Xyrem in Pediatric Patients with Narcolepsy with Cataplexy,,,,," 1/12/2015 92337F10 PRN  Veracyte, Inc. Names Dr. Robert S. Epstein to Its Board of Directors",,,,,,,,,,,,,,,, 3/16/2015 98401F10 PRN  Xencor to Present at 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference,, 5/17/2017 G8807B10 PRN  Theravance Biopharma and Mylan to Present Additional Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS,,11/06/2014 03969710 PRN  Ardelyx Reports Third Quarter 2014 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"12/03/2012 SXCI-US     PRN  Critical Alerts For Netflix, Nike, Illumina, Progressive, and Catamaran Released By InvestorsObserver",, 7/05/2017 G3040110 PRN  Endo Announces Divestiture of Grupo Farmacéutico SOMAR,, 1/27/2015 BDSI-US  PRN  BioDelivery Sciences Acquires North American Marketing Authorizations for ONSOLIS from Meda,"11/20/2017 000XKX-E    PRN  Bio-Techne Offers Updated Novus Panel Builder, Facilitating Multicolor Flow Cytometry Panel Design",10/16/2018 75886F10    PRN  Dupixent® (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps,,"12/18/2013 68375N10 PRN  Health Care Sector Technical Data: DaVita HealthCare Partners, Opko Health, Life Technologies, and Medicines", 7/17/2017 00167Y-E PRN  Ionis Earns $10 Million Milestone Payment from Biogen for Advancing a New Program in its Neurology Collaboration, 8/29/2017 09061G10   PRN  FDA Accepts BioMarin's Pegvaliase Biologics License Application (BLA) and Grants Priority Review Designation,, 5/11/2017 64125C10 PRN  Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference,,," 5/23/2014 09062X10  PRN  Secondary Offering, Appointments, and Clinical Developments - Analyst Notes on HCA, Biogen Idec, WellPoint, AbbVie and Mylan",,," 1/20/2015 37555810   PRN  Critical Alerts For Mobileye NV, Kandi Technologies, Gilead Sciences, Petrobras and Noodles & Company Released By InvestorsObserver", 4/17/2017 04004760   PRN  Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock, 2/01/2018 000D1R-E  PRN  Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva® Tablets, 5/10/2016 00167Y-E PRN  Steven Holtzman Joins Compugen as Strategic Business Advisor,, 1/24/2019 03116210 PRN  Amgen Receives NMPA Approval For Repatha® (evolocumab) In China To Reduce The Risk Of Cardiovascular Events,," 3/02/2015 52887230 PRN  Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015",,10/14/2011 45766930 PRN  Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria Indication,, 1/29/2015 45773H20 PRN  Inovio Pharmaceuticals Appoints Dr. Mark Gelder to Lead Clinical Development of Cervical Dysplasia and Cancer Programs," 5/22/2017 64026810 PRN  New Research Collaboration between Nektar and Takeda to Explore Combination Cancer Therapy Approaches with NKTR-214, a CD122-Biased Agonist, and Five Takeda Cancer Therapy Compounds", 6/02/2016 76655960 PRN  Rigel to Present at Jefferies 2016 Healthcare Conference,,, 8/10/2010 02311120 PRN  Amarin Reports Q2 2010 Results, 1/24/2012 000M2Q-E PRN  LifeSci Advisors Publishes JAKAFI Survey Results," 4/20/2016 91307C10 PRN  United Therapeutics Corporation To Announce First Quarter 2016 Financial Results Before Market Open On Thursday, April 28, 2016",," 2/03/2015 G0176710 PRN  How it All Plays Out: Research Reports on Align Technology, Alimera, Alkermes, Alliance HealthCare Services, and Allied Healthcare Products",,,,10/19/2015 55027E10 PRN  Luminex Corporation Receives CE-IVD Mark for NxTAG® Respiratory Pathogen Panel, 2/08/2017 80067710 PRN  Sangamo Therapeutics Announces Upcoming Presentations At The 13th Annual WORLDSymposium™ Meeting,,11/02/2017 SAN-FR    PRN  Sanofi: Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed,"10/14/2011 000PK1-E  PRN  Insider Hot Stock Picks: Vertex, Mattel, Jabil Circuit, Clearwire, CBS & Discover Financial Services",,,,,,,,,,, 5/10/2013 68214310 PRN  Omeros Corporation Reports First Quarter 2013 Financial Results,,,,,,,, 6/13/2016 69329Y10 PRN  PDL BioPharma Completes Quarterly Dividend Payment,,,,12/08/2015 ANIP-US  PRN  ANI Pharmaceuticals Presents At Oppenheimer 26th Annual Healthcare Conference,,,,, 8/21/2015 60468T10 PRN  Mirati Therapeutics To Present Preclinical And Clinical Data At The IASLC 16th World Conference On Lung Cancer,,,,,,,"11/14/2016 09627Y10 PRN  Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph Lengauer, Ph.D., MBA, to a Newly Created Executive Vice President Role",, 3/23/2017 28249U10 PRN  Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results,,,,,,, 2/10/2016 92165910 PRN  Vanda Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial Results,,,,,11/07/2016 40637H10 PRN  Halozyme Reports Third Quarter 2016 Financial Results, 5/11/2012 G2151510 PRN  China Biologic Products Names Chairman David Gao to Additional Post of CEO," 9/30/2010 0016K0-E PRN  Critical Insider Trade Alerts for Green Mountain Coffee, MannKind, Brigham Exploration, Bed Bath & Beyond, Aeropostale, & Chevron; Reported by Insiderslab.com",,,,, 2/20/2018 69366J20 PRN  PTC Therapeutics Receives Formal Dispute Resolution Request Decision from the FDA's Office of New Drugs,,,,,,, 1/13/2015 36197T10 PRN  Indoor Cannabis Cultivation Facilities Seek Advanced Climate Control Technology for Successful Grow Operations - Company Secures New Million Dollar Contract with Nevada Grower,, 4/05/2017 JAZZ-US  PRN  Jazz Pharmaceuticals Reaches Settlement with Hikma Pharmaceuticals Related to Xyrem Patent Litigation,,,,, 1/08/2015 92337F10 PRN  Veracyte to Present at the J.P. Morgan 33rd Annual Healthcare Conference,,,,,,,,,,,,,,,," 3/02/2015 98401F10 PRN  Xencor, Inc. Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock",, 5/17/2017 G8807B10 PRN  Theravance Biopharma and Mylan to Present Additional Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS,,"10/30/2014 03969710 PRN  Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/16/2012 000KYG-E    PRN  Breaking Earnings Forecast News: JPMorgan, Oracle, ARMOUR Residential REIT, Gilead Sciences, General Electric, and Illumina",, 7/03/2017 ENDP-US  PRN  Endo Completes Divestiture of Litha Healthcare Group,,12/23/2014 BDSI-US  PRN  Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain,"11/14/2017 09073M10    PRN  Bio-Techne Awards 40,000 USD Research Grant to Innovative Cancer Researcher",10/16/2018 75886F10    PRN  Dupixent® (dupilumab) Showed Positive Topline Results in Two Phase 3 Trials of Patients with Chronic Rhinosinusitis with Nasal Polyps,,"12/09/2013 68375N10 PRN  Events, Appointments, Joint Ventures, and Acquisitions - Research Report on Merrimack, Opko Health, Hill-Rom, LifePoint, and Kindred Healthcare", 7/13/2017 46222210 PRN  Akcea Therapeutics Announces Pricing of Initial Public Offering," 8/25/2017 09061G10   PRN  Technical Snapshots for these Biotech Stocks -- Gilead Sciences, Biogen, bluebird bio, and BioMarin Pharma",, 5/09/2017 64125C10 PRN  Neurocrine Biosciences Reports First Quarter 2017 Results,,," 5/22/2014 09062X10  PRN  Senior Level Appointments, Collaboration Agreements, Prestigious Awards Nominations, and Company Updates - Analyst Notes on Biogen Idec, Questcor, Zimmer, Cigna and Ctrip.com",,,"12/30/2014 37555810   PRN  Factors Moving Markets: Complementary Reports on United Parcel Service, Gilead, Manitowoc, EMC Corporation, and LiveDeal", 4/17/2017 04004760   PRN  Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock, 1/29/2018 MYL-US    PRN  Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease," 4/27/2016 M2572210 PRN  Compugen First Quarter 2016 Conference Call and Webcast Scheduled for Tuesday, May 10, 2016 at 10:00 AM ET",, 1/24/2019 08B106-E PRN  deCODE Publishes the First Full Resolution Genetic Map of the Human Genome,, 2/26/2015 52887230 PRN  Lexicon To Present At The Cowen 35th Annual Health Care Conference,,10/10/2011 45766930 PRN  Insmed Incorporated Provides Regulatory Update,," 1/14/2015 45773H20 PRN  Critical Alerts For Juno Therapeutics Inc, Arrowhead Research, Bitauto Holdings, Intrexon and Inovio Pharmaceuticals Released By InvestorsObserver", 5/18/2017 64026810 PRN  Nektar Therapeutics Announces Data Presentations at ASCO 2017, 5/05/2016 RIGL-US  PRN  Rigel to Present at Upcoming American Association of Immunologists (AAI) Annual Meeting,,, 8/10/2010 02311120 PRN  Amarin's AMR101 Pivotal Phase 3 MARINE Clinical Trial Completes Patient Enrollment and Randomization,11/22/2011 000M2Q-E PRN  OncologyRx Care Advantage™ Chosen to Fill Prescriptions for Jakafi™ (ruxolitinib), 3/08/2016 BCS-GB   PRN  United Therapeutics Corporation To Present At Barclays Global Healthcare Conference,,"12/23/2014 G0176710 PRN  Pre-Market Scans on Biotech Stocks - Sarepta Therapeutics, Medivation, Alexion Pharma, Alkermes, and Cepheid",,,,"10/12/2015 55027E10 PRN  Luminex Corporation Third Quarter Earnings Release Scheduled for November 2, 2015", 1/11/2017 06CR5C-E PRN  Sangamo Therapeutics Receives Orphan Drug Designation from the FDA for SB-318 Genome Editing Treatment for MPS I,,10/16/2017 80105N10  PRN  Regeneron and Sanofi Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis,"10/12/2011 000YJB-E  PRN  Research Reports for Top Traded Penny Stocks: eMagin, CEL-SCI & Procera, More Reports for Netflix, NVIDIA & Vertex",,,,,,,,,,, 5/09/2013 68214310 PRN  Omeros Announces $16.2 Million Registered Direct Offering of Common Stock,,,,,,,, 6/01/2016 06C5B2-E PRN  PDL BioPharma to Present at the Jefferies 2016 Healthcare Conference,,,,11/03/2015 00182C10 PRN  ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2015 Results and Highlights,,,,, 8/06/2015 60468T10 PRN  Mirati Therapeutics Reports Second Quarter 2015 Financial Results and Provides Business Update,,,,,,,11/10/2016 09627Y10 PRN  Blueprint Medicines Reports Third Quarter 2016 Financial Results,, 3/06/2017 28249U10 PRN  Eiger BioPharmaceuticals to Present at the ROTH and Oppenheimer Investor Conferences in March 2017,,,,,,," 2/01/2016 92165910 PRN  Vanda Pharmaceuticals to Participate in the Canaccord Genuity Rare Disease, Biopharma One-on-One Day",,,,,11/03/2016 06CR5C-E PRN  FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab, 5/08/2012 G2151510 PRN  China Biologic Products Reports Higher Results for the First Quarter 2012, 9/30/2010 002QGG-E PRN  Full Agenda Announced for CBI's Commercialization and Market Access Congress (CMAC 2010),,,,, 2/13/2018 69366J20 PRN  PTC Therapeutics Launches Fourth Annual STRIVE Grant Award Program for Duchenne Muscular Dystrophy,,,,,,, 1/06/2015 36197T10 PRN  Cannabis Industry & Legal Marijuana Opportunities Become Hot Topic for 2015 as Product Commercialization Programs Improve Cultivation Operations,," 4/03/2017 G5087110 PRN  Jazz Pharmaceuticals Completes Rolling Submission of New Drug Application for Vyxeos™ (CPX-351), an Investigational Treatment for Acute Myeloid Leukemia",,,,,12/02/2014 92337F10 PRN  Veracyte Announces Positive Coverage Policy for Afirma® Gene Expression Classifier from Blue Shield of California,,,,,,,,,,,,,,,," 2/25/2015 98401F10 PRN  Xencor, Inc. Prices Public Offering of Common Stock",," 5/09/2017 G8807B10 PRN  Theravance Biopharma, Inc. Reports First Quarter 2017 Financial Results and Provides Business Update",,10/23/2014 03969710 PRN  Ardelyx's Tenapanor Selected for Oral and Poster Presentations at the American Society of Nephrology's Kidney Week 2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/16/2012 000SSF-E    PRN  Top Searched Stocks: JPMorgan, Pfizer, Illumina, CYS Investments, U.S. Bancorp, and Occidental Petroleum",, 6/23/2017 G3040110 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endo International plc - ENDP,,12/10/2014 09060J10 PRN  BioDelivery Sciences Launches InReach Support Program for Those Affected by Opioid Dependence,10/31/2017 09073M10    PRN  Bio-Techne Releases First Quarter Fiscal 2018 Results,10/08/2018 75886F10    PRN  Libtayo® (cemiplimab-rwlc) Data at ESMO 2018 Congress Provide New Insights in Six Tumor Types Under Investigation,,"12/09/2013 68375N10 PRN  Events, Appointments, Joint Ventures, and Acquisitions - Research Report on Merrimack, Opko Health, Hill-Rom, LifePoint, and Kindred Healthcare", 7/10/2017 46222210 PRN  New Data Presented at Peripheral Nerve Society Meeting Further Support Potential Benefit of Inotersen, 8/23/2017 09061G10   PRN  BioMarin Announces Exercise in Full of Underwriters' Option to Purchase Additional 0.599% Senior Subordinated Convertible Notes Due 2024,, 5/03/2017 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2017 Results,,," 5/16/2014 09062X10  PRN  Upcoming Conferences, Stock Price Movements and Support to Humanitarian Programs - Analyst Notes on Celgene, Biogen Idec, Incyte, Jazz Pharmaceuticals and Medivation",,,"12/30/2014 37555810   PRN  Biotech Stocks Technical Data -- Gilead Sciences, ImmunoGen, Exelixis, Cubist Pharma, and Vanda Pharma", 4/17/2017 04004760   PRN  Arena Pharmaceuticals Announces Multiple Presentations at ASPET 2017 at Experimental Biology, 1/29/2018 N5946510  PRN  Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease, 4/18/2016 M2572210 PRN  Compugen Achieves Preclinical Milestone in Cancer Immunotherapy Collaboration With Bayer,," 1/24/2019 03116210 PRN  Amgen And Allergan Announce Positive Top-Line Results From Phase 1/ Phase 3 Study Of ABP 798, Biosimilar Candidate To Rituximab",, 2/23/2015 52887230 PRN  Lexicon Announces Management Change,, 9/26/2011 45766930 PRN  Insmed to Present at Sixth Annual JMP Securities Healthcare Conference,, 1/07/2015 45773H20 PRN  Inovio Pharmaceuticals' CEO to Present at 2015 Biotech Showcase Conference, 5/15/2017 64026810 PRN  Nektar to Webcast Presentation at UBS Global Healthcare Conference 2017 in New York, 5/03/2016 76655960 PRN  Rigel Announces First Quarter 2016 Financial Results,,," 8/03/2010 02311120 PRN  Amarin Corporation to Host Investor Conference Call on Tuesday, August 10, 2010"," 8/02/2011 45337C10 PRN  The Zacks Analyst Blog Highlights: Archer Daniels Midland Company, Incyte Corporation, Eli Lilly and Company, Pfizer and Novartis", 2/25/2016 91307C10 PRN  United Therapeutics Corporation Reports 2015 Fourth Quarter And Annual Financial Results,,"11/10/2014 G0176710 PRN  Technical Pulse on Biotech Stocks - Dendreon, Alkermes, Exact Sciences, Inovio Pharma, and Seattle Genetics",,,,10/07/2015 LMNX-US  PRN  Luminex Corporation Receives FDA Clearance for ARIES® System and ARIES® HSV 1&2 Assay, 1/10/2017 SGMO-US  PRN  Sangamo Therapeutics Presents Latest Advances In Zinc Finger Nuclease Platform Technology At Keystone Symposium On Precision Genome Engineering,,10/11/2017 80105N10  PRN  Internationally Acclaimed Writer and Executive Producer of HBO's The Night Of Reveals His Personal Story Detailing the Harsh Realities of Atopic Dermatitis,"10/11/2011 92532F10  PRN  Critical Alerts For Wells Fargo, J. C. Penney, Nucor, Dollar Tree, and Vertex Pharmaceuticals Released By Seven Summits Research",,,,,,,,,,, 5/01/2013 68214310 PRN  Omeros Requests Fast Track Designation for OMS824 for the Treatment of Huntington's Disease,,,,,,,, 5/24/2016 06C5B2-E PRN  PDL BioPharma Commits to Equity Investment in Noden Pharma for the Acquisition of Tekturna® (aliskiren) and Tekturna HCT® (aliskiren and hydrochlorothiazide),,,,11/02/2015 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Vancomycin Capsules,,,,, 8/05/2015 60468T10 PRN  Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer,,,,,,,"11/03/2016 09627Y10 PRN  Blueprint Medicines to Report Third Quarter 2016 Financial Results on Thursday, November 10, 2016",, 1/30/2017 28249U10 PRN  Eiger BioPharmaceuticals to Present at BIO CEO & Investor Conference February 13th and Participate in SunTrust Robinson Humphrey Orphan Drug Day Conference February 14th,,,,,,," 1/22/2016 92165910 PRN  Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2015 Financial Results on February 10, 2016",,,,,10/13/2016 40637H10 PRN  Halozyme To Host Third Quarter 2016 Financial Results Conference Call," 5/07/2012 G2151510 PRN  China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)", 4/27/2010 000TBT-E PRN  Bioscience Achievement Awards Presented at CURE Annual Meeting,,,,, 2/09/2018 69366J20 PRN  PTC Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference,,,,,,,12/18/2014 36197T10 PRN  U.S. Legalized Cannabis Industry Estimated to be Worth Over $2 Billion in 2014 as Licensed Medical Marijuana Operators Grow Exponentially,, 3/30/2017 G5087110 PRN  Jazz Pharmaceuticals and Nippon Shinyaku Enter Into License Agreements for the Development and Commercialization of Defitelio and Vyxeos in Japan,,,,,11/24/2014 92337F10 PRN  Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference,,,,,,,,,,,,,,,," 2/23/2015 98401F10 PRN  Xencor, Inc. Announces Proposed Public Offering of Common Stock",," 5/02/2017 G8807B10 PRN  Theravance Biopharma to Report First Quarter 2017 Financial Results on May 9, 2017",,10/01/2014 03969710 PRN  Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/10/2012 45232710    PRN  Critical Alerts For Las Vegas Sands, Pioneer Natural Resources, Peabody Energy, GameStop, and Illumina Released By InvestorsObserver",," 6/12/2017 G3040110 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Endo International plc (ENDP)",,12/08/2014 09060J10 PRN  BioDelivery Sciences Announces Completion of Randomization in Phase 3 Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy,10/31/2017 09073M10    PRN  Bio-Techne Declares Dividend,"10/08/2018 75886F10    PRN  Regeneron to Report Third Quarter 2018 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2018",,"11/25/2013 68375N10 PRN  Clinical Studies, Convertible Senior Notes, and Commercial Supply Contracts - Research Report on Gilead, Hologic, Regeneron, OPKO, and Unilife", 6/22/2017 46222210 PRN  Enrollment in Phase 1/2a Study of IONIS-HTT Rx in Patients with Huntington's Disease Completed and Open-Label Extension Study to Open in 2H 2017, 8/21/2017 BMRN-US    PRN  Forbes Ranks BioMarin 12th Most Innovative Company in the World,," 5/02/2017 64125C10 PRN  Neurocrine Biosciences, Inc. Announces Closing of Offering of $517.5 Million of Convertible Senior Notes",,," 5/14/2014 09062X10  PRN  Agreements, Earnings Releases, Senior-Level Retirements and Appointments, and Marketing Authorizations - Analyst Notes on Actavis, Jazz Pharmaceuticals, Bristol-Myers, Biogen Idec and AbbVie",,,"12/23/2014 37555810   PRN  Critical Alerts For Achillion Pharmaceuticals, AT&T, Peabody Energy, Gilead Sciences and Facebook Released By InvestorsObserver"," 4/13/2017 04004760   PRN  Biotech Stocks on Investors' Radar -- Halozyme Therapeutics, Cara Therapeutics, PDL BioPharma, and Arena Pharma"," 1/29/2018 N5946510  PRN  Mylan and Biocon Receive Positive CHMP Opinion for Semglee™, Biosimilar Insulin Glargine"," 4/06/2016 M2572210 PRN  Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc.",, 1/22/2019 03116210 PRN  European Commission Approves BLINCYTO® (blinatumomab) In Patients With Philadelphia Chromosome Negative Minimal Residual Disease-Positive B-cell Precursor Acute Lymphoblastic Leukemia,," 2/19/2015 52887230 PRN  Expert Briefing on Biotech Stocks - Lexicon Pharma, Sunesis Pharma, Navidea Biopharma, Tekmira Pharma, and Intrexon",, 8/11/2011 45766930 PRN  Insmed to Present at 2011 Wedbush Securities Life Sciences Management Access Conference,, 1/06/2015 45773H20 PRN  Inovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV, 5/09/2017 64026810 PRN  Nektar Therapeutics Reports Financial Results for the First Quarter of 2017, 4/26/2016 76655960 PRN  Rigel Announces Conference Call and Webcast to Report First Quarter 2016 Financial Results,,, 7/29/2010 02311120 PRN  Amarin to Present at Canaccord Genuity Global Growth Conference,," 2/18/2016 91307C10 PRN  United Therapeutics Corporation To Announce Fourth Quarter And Annual 2015 Financial Results Before Market Open On Thursday, February 25, 2016",," 9/22/2014 G0176710 PRN  Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma",,,, 9/04/2015 LMNX-US  PRN  Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference," 1/06/2017 80067710 PRN  Sangamo BioSciences Changes Name To Sangamo Therapeutics, Underscoring Focus On Clinical Development Of Genomic Therapies",,10/11/2017 80105N10  PRN  Internationally Acclaimed Writer and Executive Producer of HBO's The Night Of Reveals His Personal Story Detailing the Harsh Realities of Atopic Dermatitis,"10/11/2011 000L1R-E  PRN  Critical Stock Alerts for American Capital, Vertex, Kroger, QUALCOMM, Netflix & Gilead",,,,,,,,,,, 4/30/2013 68214310 PRN  Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review,,,,,,,, 5/04/2016 69329Y10 PRN  PDL BioPharma Announces First Quarter 2016 Financial Results,,,,10/27/2015 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call for Third Quarter and Year-to-Date 2015 Financial Results,,,,, 8/04/2015 60468T10 PRN  Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference,,,,,,,11/03/2016 06QBQ2-E PRN  Blueprint Medicines to Present Preliminary Data from Ongoing Phase 1 Clinical Trial for BLU-285 in Advanced Systemic Mastocytosis at 2016 ASH Annual Meeting,, 1/04/2017 EIGR-US  PRN  Eiger Completes $25 Million Debt Financing with Oxford Finance,,,,,,, 1/11/2016 92165910 PRN  Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2015 Results and 2016 Financial Guidance,,,,,10/04/2016 HALO-US  PRN  PEGPH20 Selected For Inclusion In Groundbreaking Clinical Trial Initiative Designed To Transform Outcomes For Pancreatic Cancer Patients, 4/27/2012 G2151510 PRN  China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO,,,,,, 1/27/2018 69366J20 PRN  Preliminary Data from FIREFISH trial in Type 1 SMA Infants Presented at the International Scientific Congress on Spinal Muscular Atrophy,,,,,,,11/04/2014 36197T10 PRN  Cannabinoid Science Advancements Fuel Latest Clinical Trial Developments for Efficacy of CBD Therapies and Patents - Company Enters Stage 2 Of Trials for Cannabinoid Compounds,, 3/20/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 3 and TONES 4 Studies of JZP-110 in Patients with Obstructive Sleep Apnea,,,,,"11/13/2014 92337F10 PRN  Veracyte, Inc. Announces Third Quarter 2014 Financial Results",,,,,,,,,,,,,,,, 2/19/2015 98401F10 PRN  Xencor Reports Fourth Quarter and Full Year 2014 Financial Results,, 4/27/2017 G8807B10 PRN  Theravance Biopharma to Present at the Deutsche Bank 42nd Annual Health Care Conference,," 9/05/2014 03969710 PRN  Ardelyx Chief Scientific Officer, Dominique Charmot, Announces Retirement from the Company at Year-End",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/03/2012 ANRZQ-US    PRN  Insider Hot Stocks: Sprint Nextel, ArQule, Illumina, Alpha Natural Resources, Coca-Cola, and Host Hotels and Resorts",," 6/08/2017 G3040110 PRN  Endo Response to June 8, 2017 FDA Meeting Related to OPANA® ER",,11/25/2014 09060J10 PRN  BioDelivery Sciences to Present at the 26th Annual Piper Jaffray Healthcare Conference,10/27/2017 09073M10    PRN  Bio-Techne To Present At The Stephens Fall Investment Conference, 9/28/2018 75886F10    PRN  FDA approves Libtayo® (cemiplimab-rwlc) as first and only treatment for advanced cutaneous squamous cell carcinoma,,"11/22/2013 68375N10 PRN  Must Watch News & Earnings: Amgen, Micron Technology, Opko Health, GameStop Corp, Halcon Resources", 6/20/2017 46222210 PRN  Akcea Therapeutics Launches Proposed Initial Public Offering, 8/15/2017 09061G10   PRN  BioMarin to Attend Upcoming Investor Conferences,," 4/26/2017 64125C10 PRN  Neurocrine Biosciences, Inc. Prices $450.0 Million Convertible Senior Notes Offering",,, 4/30/2014 09062X10  PRN  ISIS Pharmaceuticals' and Biogen idec's innovative collaboration voted breakthrough alliance of 2014,,,"12/10/2014 37555810   PRN  Critical Alerts For Abercrombie & Fitch, Whole Foods Market, Gilead Sciences, JC Penney and Activision Blizzard Released By InvestorsObserver", 3/27/2017 04004760   PRN  Arena Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference on April 4th, 1/08/2018 N5946510  PRN  Mylan to Complete $1 Billion Share Repurchase Plan, 3/28/2016 00356F-E PRN  Compugen to Present at the Jefferies Immuno-Oncology Summit in Boston,, 1/16/2019 03116210 PRN  Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For EVENITY™ (romosozumab),, 2/06/2015 52887230 PRN  Lexicon To Present At The BIO CEO & Investor Conference,," 8/08/2011 45766930 PRN  Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011",,"12/18/2014 45773H20 PRN  Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers"," 5/03/2017 64026810 PRN  Nektar Appoints Brian L. Kotzin, M.D. as Head of Clinical Development for Nektar's Immunology Program", 4/12/2016 RIGL-US  PRN  Rigel Announces Presentations at Upcoming American Association of Cancer Research (AACR) Conference,,, 6/04/2010 02311120 PRN  Amarin to Present at Two Upcoming Investor Conferences,, 2/18/2016 91307C10 PRN  United Therapeutics Receives Paragraph IV Notice Letter For Orenitram,," 8/18/2014 G0176710 PRN  Technical Summary on Biotech Equities -- Alkermes, Amarin, Array BioPharma, Navidea Biopharma, and Pharmacyclics Inc.",,,, 8/26/2015 55027E10 PRN  Luminex Corporation Submits 510(k) Application for the NxTAG® Respiratory Pathogen Panel, 1/05/2017 06CR5C-E PRN  Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-525 Gene Therapy Program For Hemophilia A,,10/05/2017 SAN-FR    PRN  Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent® (alirocumab),"10/03/2011 000XNL-E  PRN  Hot Stock Research for salesforce.com, Vertex, AutoZone, Abercrombie & Fitch, Tiffany & Terex",,,,,,,,,,, 4/25/2013 68214310 PRN  Omeros Reports OMS302 Clinical Data Presented at the Annual ASCRS and ASOA Symposium and Congress,,,,,,,, 5/04/2016 69329Y10 PRN  PDL BioPharma Announces 2016 Second Quarter Dividend,,,,10/16/2015 00182C10 PRN  ANI Pharmaceuticals Announces Launch of Oxycodone Hydrochloride Oral Solution,,,,, 5/30/2015 60468T10 PRN  Initial Data from Ongoing Expansion Study of MGCD265 Show Preliminary Evidence of Clinical Efficacy in Heavily Pretreated Non-Small Cell Lung Cancer (NSCLC) Patients with MET Gene Alterations,,,,,,,10/28/2016 06QBQ2-E PRN  Blueprint Medicines to Present Preclinical Data and Provide Enrollment Updates for Phase 1 Clinical Trial for BLU-285 in Advanced Systemic Mastocytosis at ECNM Annual Meeting 2016,, 1/03/2017 28249U10 PRN  Eiger Announces First Patient Dosed in Open-Label Extension of Phase 2 LIBERTY Study of Ubenimex in Pulmonary Arterial Hypertension (PAH),,,,,,,12/22/2015 VNDA-US  PRN  European Medicines Agency Accepts Fanaptum® (iloperidone) Marketing Authorization Application for the Treatment of Schizophrenia in Adults,,,,, 9/08/2016 HALO-US  PRN  Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2016 Global Health Care Conference, 4/25/2012 G2151510 PRN  China Biologic's Board Has Appointed Two New Independent Directors to Boost Corporate Governance,,,,,, 1/23/2018 69366J20 PRN  Data from RG7916 Programs in SMA to be Presented at the International Scientific Congress on Spinal Muscular Atrophy,,,,,,,"10/28/2014 36197T10 PRN  As Elections Near, Legal Marijuana Operations Continue Robust Growth Trend - Company Enters Multi-Million Dollar Online Informational Medical Marijuana Vertical",, 3/15/2017 G5087110 PRN  Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Study Evaluating JZP-258 for the Treatment of Cataplexy and Excessive Daytime Sleepiness in Narcolepsy,,,,,11/12/2014 92337F10 PRN  Veracyte Announces Appointment of John L. Bishop to Its Board of Directors Following the Resignation of Samuel D. Colella,,,,,,,,,,,,,,,," 2/12/2015 98401F10 PRN  Xencor, Inc. to Host Fourth Quarter and Full Year 2014 Financial Results Webcast and Conference Call",, 4/25/2017 G8807B10 PRN  New Data for VIBATIV® (telavancin) Reported in Several Presentations at ECCMID 2017,, 8/07/2014 03969710 PRN  Ardelyx Reports Second Quarter 2014 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 9/10/2012 45232710    PRN  Critical Alerts For Las Vegas Sands, Valero Energy, BB&T, USG, and Illumina Released By InvestorsObserver",, 6/07/2017 G3040110 PRN  Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation,,11/13/2014 09060J10 PRN  BioDelivery Sciences to Present at the Stifel 2014 Healthcare Conference and the Jefferies 2014 Global Healthcare Conference,10/26/2017 09073M10    PRN  Bio-Techne Adds Two New Directors to Its Board, 9/28/2018 75886F10    PRN  FDA Approves Libtayo® (cemiplimab-rwlc) as First and Only Treatment for Advanced Cutaneous Squamous Cell Carcinoma,,"11/21/2013 68375N10 PRN  Pre-Market Review: Opko Health Inc., DaVita HealthCare Partners Inc., The Medicines Co., and Life Technologies Corp.", 6/01/2017 46222210 PRN  SPINRAZA® (nusinersen) Approved in the European Union, 8/07/2017 09061G10   PRN  BioMarin Announces Offering of $450 Million of 0.599% Senior Subordinated Convertible Notes Due 2024,, 4/25/2017 64125C10 PRN  Neurocrine Announces Proposed Convertible Senior Notes Offering,,, 3/19/2014 00167Y-E  PRN  Biogen Idec's Tecfidera Captures the Largest U.S. Neurologist-Reported Patient Share Among Oral Disease-Modifying Multiple Sclerosis Therapies Ten Months Post-Launch,,,12/09/2014 000L1R-E   PRN  Class Action Lawsuit Challenges the Exorbitant Pricing of Gilead's Hepatitis-C Drug Sovaldi," 3/20/2017 04004760   PRN  Arena Pharmaceuticals Appoints Dr. Preston Klassen, M.D., M.H.S. as Executive Vice President, Research and Development and Chief Medical Officer"," 1/03/2018 N5946510  PRN  Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA® (aflibercept)", 2/29/2016 M2572210 PRN  Compugen Presents Results for CGEN-15029 Immuno-Oncology Therapeutic Program,, 1/08/2019 03116210 PRN  EVENITY™ (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture,," 1/08/2015 52887230 PRN  Biotech Industry Equities Under the Scanner - NPS Pharma, Mast Therapeutics, Threshold Pharma, Lexicon Pharma, and Regeneron Pharma",, 8/01/2011 45766930 PRN  Insmed Incorporated Announces Clinical Hold on ARIKACE® Phase 3 Clinical Trials,,"12/17/2014 45773H20 PRN  Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology"," 5/02/2017 64026810 PRN  Nektar to Announce Financial Results for the First Quarter of 2017 on Tuesday, May 9, 2017, After Close of U.S.-Based Financial Markets", 4/01/2016 76655960 PRN  Rigel Completes Enrollment of FIT Phase 3 Program for Fostamatinib in ITP,,, 5/13/2010 02311120 PRN  Amarin to Present at the Rodman & Renshaw Global Investment Conference,," 1/19/2016 ASNA-US  PRN  Critical Stocks Alerts: Significant Insider Trade in Ascena Retail Group, Dyax Corp, United Therapeutics Corp, Bank of America, Citigroup, and Exxon Mobil",," 6/25/2014 G0176710 PRN  Clinical Trial Data, NDA Submissions, and Board Changes - Analyst Notes on Alkermes, Cubist, Repligen, Flamel Technologies and Chimerix",,,, 8/05/2015 55027E10 PRN  Luminex Corporation To Present At The 2015 Wedbush PacGrow Healthcare Conference, 1/04/2017 80067710 PRN  Sangamo BioSciences Announces Presentation At The 35th Annual J.P. Morgan Healthcare Conference,,10/05/2017 80105N10  PRN  Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent® (alirocumab)," 9/30/2011 000BK7-E  PRN  Research Reports for Top Traded Penny Stocks: AMD, Micron & Huntington Bancshares, More Reports for Newmont Mining, Vertex & CenturyLink",,,,,,,,,,, 4/24/2013 68214310 PRN  Omeros to Present at the 12th Annual Needham Healthcare Conference,,,,,,,," 4/28/2016 69329Y10 PRN  PDL BioPharma to Announce First Quarter 2016 Financial Results on May 4, 2016",,,,10/13/2015 00182C10 PRN  ANI Pharmaceuticals Appoints Peter A. Lankau to Its Board of Directors,,,,, 5/27/2015 MYG-CA   PRN  Mirati Therapeutics To Present At The Jefferies 2015 Global Healthcare Conference,,,,,,, 9/09/2016 09627Y10 PRN  Blueprint Medicines Announces New Drug Discovery Program Targeting PRKACA Kinase Fusions for the Treatment of Fibrolamellar Carcinoma at 10th International Liver Cancer Association (ILCA) Annual Conference,,12/12/2016 28249U10 PRN  Eiger Announces Multiple Advances in Exendin 9-39 Program for the Treatment of Post-Bariatric Hypoglycemia (PBH),,,,,,,12/18/2015 92165910 PRN  Kenneth Bate Joins the Board of Directors of Vanda Pharmaceuticals,,,,, 9/01/2016 40637H10 PRN  Halozyme Names Mark J. Gergen As Chief Operating Officer, 4/02/2012 G2151510 PRN  China Biologic's Board Has Elected David (Xiaoying) Gao as the New Chairman and Has Adopted a Series of Measures to Enhance China Biologic's Corporate Governance,,,,,, 1/08/2018 69366J20 PRN  PTC Therapeutics Provides Corporate Update and Outlines 2018 Strategic Priorities,,,,,,,"10/09/2014 36197T10 PRN  Clinical Studies Ongoing Process for Identifying New Breakthroughs in Cannabidiol ""CBD"" Uses in Cancer Cell Treatments",, 3/01/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March,,,,,"11/06/2014 92337F10 PRN  Veracyte, Inc. to Host Conference Call and Webcast to Discuss Third Quarter 2014 Financial Results on November 13, 2014",,,,,,,,,,,,,,,, 2/05/2015 98401F10 PRN  Xencor to Webcast Presentations at Two Upcoming Conferences in February,, 4/24/2017 G8807B10 PRN  Theravance Biopharma Reports Positive Clinical Response Rates for Patients in TOUR™ Observational Patient Registry in Several Presentations at ECCMID 2017,, 8/05/2014 03969710 PRN  Ardelyx to Present at the Wedbush 2014 Life Sciences Management Access Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 9/06/2012 LIFE.XX5-US PRN  Zacks Bull and Bear of the Day Highlights: Brinker International, Nabors Industries, Life Technologies, Illumina and Thermo Fisher Scientific",, 6/06/2017 G3040110 PRN  Veloxis Pharmaceuticals A/S and Endo Ventures Limited Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Envarsus XR® in Canada,,11/07/2014 09060J10 PRN  BioDelivery Sciences to Present at the Credit Suisse 2014 Healthcare Conference,"10/11/2017 09073M10    PRN  Bio-Techne To Host Conference Call On October 31, 2017 To Announce First Quarter 2018 Financial Results", 9/15/2018 75886F10    PRN  Positive Phase 3 Results Presented for Dupixent® (dupilumab) Show Significant Improvement on Multiple Measures of Disease Severity in Adolescents with Moderate-to-Severe Atopic Dermatitis,,"11/15/2013 68375N10 PRN  Healthcare Sector Announced Financial Results and Recognition - Research Report on Alnylam Pharmaceuticals, Opko, Enzymotec, Cambrex, and XOMA", 5/25/2017 46222210 PRN  Akcea Announces Publication in The New England Journal of Medicine of Data with AKCEA-ANGPTL3-L Rx Showing Favorable Cardiometabolic Effects, 8/07/2017 09061G10   PRN  BioMarin Announces Offering of $450 Million of Senior Subordinated Convertible Notes Due 2024,, 4/21/2017 64125C10 PRN  Neurocrine Announces INGREZZA™ Long-Term Safety and Efficacy Data to be Presented at the 2017 American Academy of Neurology Annual Meeting,,, 3/14/2014 09062X10  PRN  Biogen Idec Set to Join the S&P 100; Keurig Green Mountain to Join the S&P 500; Changes to the S&P MidCap 400 and the S&P SmallCap 600,,,12/09/2014 37555810   PRN  BetterInvesting Magazine Releases February Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use, 3/14/2017 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results,12/29/2017 MYL-US    PRN  Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace® Cream, 2/09/2016 M2572210 PRN  Compugen Ltd. Reports Fourth Quarter and Calendar 2015 Results,, 1/07/2019 03116210 PRN  Amgen Makes All Repatha® (evolocumab) Device Options Available In The US At A 60 Percent Reduced List Price,, 1/07/2015 52887230 PRN  Lexicon To Present At The 33rd Annual J.P. Morgan Healthcare Conference,, 7/26/2011 45766930 PRN  Insmed to Host 2011 Second Quarter Earnings Conference Call,,12/15/2014 45773H20 PRN  Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index, 4/20/2017 64026810 PRN  Nektar Therapeutics to Host Analyst & Investor Event at 2017 ASCO Annual Meeting, 3/08/2016 76655960 PRN  Rigel Announces Fourth Quarter and Year End 2015 Financial Results,,, 5/13/2010 02311120 PRN  Amarin Reports Q1 2010 Results,, 1/06/2016 UTHR-US  PRN  United Therapeutics Corporation To Present At 34th Annual J.P. Morgan Healthcare Conference,," 1/08/2014 G0176710 PRN  Technical Dossier: Theravance, Alkermes, Cubist Pharma, and TherapeuticsMD",,,, 8/03/2015 55027E10 PRN  Luminex Corporation Reports Record 2nd Quarter 2015 Results,12/05/2016 80067710 PRN  Sangamo BioSciences Presents Hemophilia A Program Data At The 2016 American Society Of Hematology Meeting,, 9/28/2017 80105N10  PRN  Regeneron and Sanofi Announce Approval of DUPIXENT® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis in the European Union," 9/23/2011 92532F10  PRN  Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals",,,,,,,,,,, 4/19/2013 68214310 PRN  Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress,,,,,,,," 3/31/2016 69329Y10 PRN  PDL BioPharma to Hold Annual Meeting of Stockholders on June 2, 2016",,,,10/05/2015 00182C10 PRN  ANI Pharmaceuticals Announces Board Authorization of Stock Repurchase Program,,,,, 5/13/2015 MYG-CA   PRN  Mirati Therapeutics to Provide Updates on Pipeline Programs at 2015 ASCO Annual Meeting,,,,,,, 9/07/2016 09627Y10 PRN  Blueprint Medicines to Present at Morgan Stanley Global Healthcare Conference,,11/29/2016 28249U10 PRN  Eiger Updates Progress in Clinical Development Program for Exendin 9-39 to Treat Post-Bariatric Hypoglycemia (PBH),,,,,,,12/17/2015 92165910 PRN  Vanda Pharmaceuticals appoints Gian Piero Reverberi as Acting Chief Commercial Officer,,,,, 8/31/2016 40637H10 PRN  Halozyme Therapeutics To Present At Upcoming Healthcare Conferences, 3/12/2012 G2151510 PRN  China Biologic Products Reports Results for the Year 2011,,,,,, 1/05/2018 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,"10/07/2014 36197T10 PRN  Online Medical Marijuana & CBD Dispensary Directory Provides Patients with User-Friendly Cannabis App to Identify Products, Various Strains & Dispensary Locations",, 2/28/2017 G5087110 PRN  Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2016 Financial Results,,,,,"10/29/2014 92337F10 PRN  Veracyte, Inc. Announces New Data Supporting Clinical Validity of Afirma® Gene Expression Classifier",,,,,,,,,,,,,,,, 1/29/2015 98401F10 PRN  Xencor Reports Top-line XmAb®5871 Phase 1b/2a Results Showing Promising Clinical Activity in Rheumatoid Arthritis,," 4/18/2017 G8807B10 PRN  Theravance Biopharma to Present New Data from Multiple Studies of VIBATIV® (telavancin), Including Preliminary Results from TOUR™ Observational Patient Registry, at 2017 ECCMID Conference",, 6/24/2014 03969710 PRN  Ardelyx Announces Full Exercise of Underwriters' Option to Purchase Additional Shares,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 4/13/2012 COP-US      PRN  Equity Research on Most Popular Searches: Caterpillar, U.S. Bancorp, Illumina, Vale, ConocoPhillips, and Rowan",, 5/26/2017 G3040110 PRN  Endo to Present at Goldman Sachs 38th Annual Global Healthcare Conference,,11/05/2014 09060J10 PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Third Quarter 2014 Financials,10/05/2017 09073M10    PRN  Joint Consortia Framework Awards Contract to Bio-Techne as Supplier of Research Antibodies, 9/13/2018 75886F10    PRN  FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy,,"11/07/2013 68375N10 PRN  Legal Settlements, Stock Price Updates, Financial Results, and Commencement of Clinical Studies - Research Report on Johnson & Johnson, Elan, Tenet, Opko and Keryx Biopharmaceuticals", 5/15/2017 46222210 PRN  Ionis Pharmaceuticals Announces Phase 3 NEURO-TTR Study of Inotersen (IONIS-TTR Rx) Meets Both Primary Endpoints, 8/02/2017 09061G10   PRN  BioMarin Announces Second Quarter 2017 Financial Results,," 4/17/2017 NBIX-US  PRN  Xencor Appoints Kevin Gorman, Ph.D., to its Board of Directors",,," 1/24/2014 09062X10  PRN  Critical Alerts For General Electric, SodaStream, Biogen Idec, Linn Energy, and Allscripts Released By InvestorsObserver",,,12/09/2014 000L1R-E   PRN  Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council, 3/08/2017 04004760   PRN  Arena Pharmaceuticals to Present at the 27th Annual Oppenheimer Healthcare Conference,"12/29/2017 532523-IN PRN  Biocon and Mylan's Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through their Partner Libbs"," 1/26/2016 M2572210 PRN  Compugen Fourth Quarter and Yearend 2015 Conference Call Scheduled for Tuesday, February 9, 2016 at 10:00 AM EST",, 1/03/2019 03116210 PRN  Amgen To Present At The 37th Annual J.P. Morgan Healthcare Conference,,12/08/2014 52887230 PRN  Lexicon To Present At The Oppenheimer 25th Annual Healthcare Conference,, 7/18/2011 45766930 PRN  Andrea Drucker Joins Insmed as General Counsel,,"12/10/2014 45773H20 PRN  Critical Alerts For Apple, Zynga, Goodrich Petroleum Corp., Inovio Pharmaceuticals and SolarCity Released By InvestorsObserver", 4/04/2017 64026810 PRN  Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting," 3/08/2016 RIGL-US  PRN  Rigel Names Anne-Marie Duliege, M.D., M.S. As Chief Medical Officer",,," 5/12/2010 02311120 PRN  Amarin Corporation to Host Investor Conference Call on Thursday, May 13, 2010",,"11/02/2015 06D48M-E PRN  Bloomberg's ""The Year Ahead: 2016"" to Feature Apple's Angela Ahrendts, Bank Of America's Brian Moynihan, Credit Suisse's Tidjane Thiam, Fashion Legend Diane von Furstenberg and More",,"12/18/2013 G0176710 PRN  FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira",,,, 7/14/2015 55027E10 PRN  Luminex Corporation Submits FDA 510(k) Submissions for ARIES™ System and ARIES™ HSV 1&2 Assay,12/01/2016 80067710 PRN  Sangamo BioSciences Makes Key Leadership Appointments To Strengthen Clinical And Commercial Capabilities,," 9/20/2017 80105N10  PRN  Sanofi and NIH researchers develop ""three-in-one"" antibodies as a potential breakthrough intervention for HIV/AIDS"," 9/16/2011 000Q07-E  PRN  Insider Hot Stock Picks: Microsoft, Vertex, Clean Energy Fuels, Tiffany, SanDisk & NVIDIA",,,,,,,,,,, 4/17/2013 68214310 PRN  Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721,,,,,,,, 3/14/2016 69329Y10 PRN  PDL BioPharma Completes Quarterly Dividend Payment,,,," 9/28/2015 00182C10 PRN  Market Update on the Healthcare Sector - Amedica, Accuray, Acadia Healthcare, ANI Pharmaceuticals, and Akebia Therapeutics",,,,, 5/06/2015 60468T10 PRN  Mirati Therapeutics Reports First Quarter 2015 Financial Results and Provides Business Update,,,,,,, 9/06/2016 09627Y10 PRN  Blueprint Medicines Announces Appointment of Tracey McCain as Chief Legal Officer and Executive Vice President,,11/21/2016 EIGR-US  PRN  Eiger BioPharmaceuticals to Participate in Two Investor Conferences in November 2016,,,,,,,11/12/2015 92165910 PRN  Vanda Pharmaceuticals Announces Participation at Upcoming Investor Conferences,,,,," 8/23/2016 40637H10 PRN  Research Report Coverage on Biotech Stocks -- Halozyme Therapeutics, Achillion Pharma, Aegerion Pharma and Chimerix"," 3/09/2012 G2151510 PRN  China Biologic to Host Earnings Conference Call on March 13, 2012 at 8:00 a.m. EDT (NY)",,,,,, 1/03/2018 69366J20 PRN  PTC Therapeutics to Present at the 36th Annual JP Morgan Healthcare Conference,,,,,,," 9/24/2014 36197T10 PRN  Cannabidiol ""CBD"" Strain of Medical Marijuana Establishing New CBD-Oil Nutraceutical Marketplace - Company Aims for Sales of CBD Products in all 50 States",," 2/14/2017 G5087110 PRN  Jazz Pharmaceuticals to Report 2016 Fourth Quarter and Full Year Financial Results on February 28, 2017",,,,,"10/02/2014 92337F10 PRN  Veracyte Inc. to Host Investor Day on October 9, 2014",,,,,,,,,,,,,,,, 1/29/2015 98401F10 PRN  Xencor Reports XmAb®7195 Top-line Interim Phase 1a Results Showing Rapid Reduction of Serum IgE in Healthy Volunteers,, 3/28/2017 G8807B10 PRN  Theravance Biopharma to Present at the 16th Annual Needham Healthcare Conference,, 6/18/2014 03969710 PRN  Ardelyx Announces Pricing Of Its Initial Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 4/05/2012 ZUMZ-US     PRN  Zacks Bull and Bear of the Day Highlights: Zumiez, Dril-Quip, Roche Holdings, Illumina and Allstate",, 5/09/2017 G3040110 PRN  Endo Reports First-Quarter 2017 Financial Results,,11/03/2014 09060J10 PRN  BioDelivery Sciences Announces the Availability of BUNAVAIL™ in the U.S.," 9/20/2017 000XKX-E    PRN  Bio-Techne Unveils a New Multi-Analyte Cartridge Format for the Ella™ Immunoassay Platform, Improving Sample Throughput", 9/12/2018 75886F10    PRN  FDA to review supplemental Biologics License Application for Praluent® (alirocumab) Injection as potential treatment to reduce major adverse cardiovascular events,,"10/30/2013 68375N10 PRN  Morning Research: Opko Health Inc., Life Technologies Corp., The Medicines Co., and DaVita HealthCare Partners Inc.", 5/11/2017 46222210 PRN  Ionis Pharmaceuticals Provides Corporate Update at 2017 Annual Meeting of Stockholders," 8/02/2017 09061G10   PRN  BioMarin Announces Plans to Progress Both the 6e13vg/kg and 4e13 vg/kg Doses of BMN 270, its Investigational Gene Therapy for Hemophilia A, into Phase 3 Studies",, 4/11/2017 64125C10 PRN  Neurocrine Announces FDA Approval of INGREZZA™ (valbenazine) Capsules as the First and Only Approved Treatment for Adults with Tardive Dyskinesia (TD) (with multimedia),,, 1/09/2014 09062X10  PRN  Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies,,,"11/24/2014 37555810   PRN  Critical Alerts For SouFun, Petroleo Brasileiro, Gilead Sciences, Transocean and iRobot Released By InvestorsObserver", 2/14/2017 04004760   PRN  Arena Pharmaceuticals Appoints Three New Members to Board of Directors,12/20/2017 N5946510  PRN  Mylan to Present at the 36th Annual J.P. Morgan Healthcare Conference," 2/16/2015 M2572210 PRN  A Look at the Latest Occurrences in the Biotechnology Sector: Special Research on China Biologic Products, Compugen, Curis, CytRx, and DBV Technologies",,12/19/2018 03116210 PRN  Amgen Submits Supplemental Biologics License Application For Nplate® (romiplostim),,11/26/2014 52887230 PRN  Lexicon Announces Completion Of $280 Million In Financing Transactions,, 6/28/2011 45766930 PRN  Insmed Announces its Addition to the Russell 3000® Index,,11/24/2014 45773H20 PRN  Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market," 3/27/2017 64026810 PRN  Nektar Therapeutics Initiates Clinical Study of NKTR-358, a First-in-Class Regulatory T Cell Stimulator, Being Developed for the Treatment of Immune and Inflammatory Disorders", 3/01/2016 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2015 Financial Results,,, 4/27/2010 02311120 PRN  Amarin to Present at the Deutsche Bank Securities Health Care Conference,,10/27/2015 91307C10 PRN  United Therapeutics Corporation Reports Third Quarter 2015 Financial Results,,"12/10/2013 G0176710 PRN  Morning Research Covering Healthcare Sector: Hospira, Alkermes, Theravance, and Celsion",,,," 7/13/2015 55027E10 PRN  Luminex Corporation Second Quarter Earnings Release Scheduled for August 3, 2015",11/30/2016 00167Y-E PRN  Sangamo's Genome Editing Program for Hemoglobinopathies to Transfer to Biogen's Spin-Off Bioverativ,, 9/19/2017 80105N10  PRN  Huge Supply Shortage Looms for Canada's Newest Industry," 9/15/2011 000DXS-E  PRN  Insider Hot Stock Picks: Google, Jabil Circuit, Vertex, Colgate-Palmolive, Scotts Miracle-Gro & U.S. Global Investors",,,,,,,,,,, 4/10/2013 68214310 PRN  Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis,,,,,,,, 3/02/2016 06C5B2-E PRN  PDL BioPharma to Present at the Cowen and Company 36th Annual Health Care Conference,,,, 9/21/2015 00182C10 PRN  ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75 Million,,,,, 3/11/2015 60468T10 PRN  Mirati Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Update,,,,,,, 8/09/2016 09627Y10 PRN  Blueprint Medicines Reports Second Quarter 2016 Financial Results,,"11/14/2016 28249U10 PRN  Eiger Announces Additional LOWR HDV Program Data, Clinical and Regulatory Plans at the American Association for the Study of Liver Diseases (AASLD) Meeting",,,,,,,11/04/2015 92165910 PRN  Vanda Pharmaceuticals to Participate in the Citi 2015 Global Healthcare 1x1 Conference,,,,, 8/09/2016 40637H10 PRN  Halozyme Reports Second Quarter 2016 Financial Results,11/07/2011 G2151510 PRN  China Biologic Reports Third Quarter 2011 Results,,,,,,12/15/2017 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 8/14/2014 36197T10 PRN  Small Business Operations to Large Scale Companies Take Steps to Increase Security Surveillance - Company Selected for Comprehensive Cannabis Security System Installation,, 2/08/2017 G5087110 PRN  Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating JZP-110 for Excessive Sleepiness in Parkinson's Disease,,,,," 9/17/2014 92337F10 PRN  Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer",,,,,,,,,,,,,,,,"12/19/2014 98401F10 PRN  Deals Corner: Complementary Research on Xencor, Alcatel-Lucent, Xerox, Affiliated Managers and Cheniere",," 2/27/2017 G8807B10 PRN  Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update",, 5/15/2014 07ZN4D-E PRN  Ardelyx Receives $25 Million Milestone From AstraZeneca For Commencement Of Phase 2b Clinical Trial Of Tenapanor,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 3/21/2012 45232710    PRN  Critical Alerts For eBay, Alcoa, F5 Networks, Illumina, and Stone Energy By Seven Summits Research",," 5/04/2017 G3040110 PRN  Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin",,10/28/2014 09060J10 PRN  BioDelivery Sciences to Develop a Long-Acting Injectable Depot Formulation of Buprenorphine with Evonik for Use in Opioid Dependence and Pain, 9/13/2017 000XKX-E    PRN  Bio-Techne Introduces a New Luminex Multi-analyte Assay Kit, 9/12/2018 75886F10    PRN  FDA to Review Supplemental Biologics License Application for Praluent® (alirocumab)Injection as Potential Treatment to Reduce Major Adverse Cardiovascular Events,,"10/24/2013 68375N10 PRN  Clinical Study Results, Financial Results, Prestigious Awards, and Regulatory Approvals - Research Report on Abbott, Opko, Varian Medical Systems, ICU Medical and Quintiles", 5/10/2017 46222210 PRN  Ionis Pharmaceuticals to Present at Bank of America Merrill Lynch 2017 Healthcare Conference," 7/31/2017 09061G10   PRN  BioMarin to Host Second Quarter 2017 Financial Results Conference Call and Webcast on Wednesday, August 2 at 4:30pm ET",, 4/11/2017 64125C10 PRN  Neurocrine Announces FDA Approval of INGREZZA TM (valbenazine) Capsules as the First and Only Approved Treatment for Adults with Tardive Dyskinesia (TD),,," 1/07/2014 09062X10  PRN  Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA",,,"11/14/2014 37555810   PRN  Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene", 2/09/2017 04004760   PRN  Arena Pharmaceuticals Announces Three Upcoming Presentations at the 12th Congress of European Crohn's and Colitis Organisation - Inflammatory Bowel Diseases 2017,12/20/2017 N5946510  PRN  Mylan to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top," 2/11/2015 M2572210 PRN  Direction of Market Influences: Special Research on Insperity, Compugen, Aeropostale, Starwood Hotels & Resorts, and Coca-Cola",,12/18/2018 03116210 PRN  Amgen And Molecular Partners Announce Strategic Collaboration In Immuno-Oncology,,11/21/2014 52887230 PRN  Lexicon Announces Pricing Of Convertible Senior Notes Offering,, 6/10/2011 064Q9G-E PRN  Insmed's ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections,,11/20/2014 45773H20 PRN  Inovio Pharmaceuticals Melanoma DNA Immunotherapy Inhibits Tumor Growth and Increases Survival in Preclinical Study, 3/20/2017 64026810 PRN  NKTR-181 Meets Primary and Secondary Endpoints in Phase 3 SUMMIT-07 Study in Chronic Pain, 2/29/2016 RIGL-US  PRN  Rigel to Present at Cowen and Company 36th Annual Health Care Conference,,,,,"10/21/2015 91307C10 PRN  United Therapeutics Corporation To Announce Third Quarter 2015 Financial Results Before Market Open On Tuesday, October 27, 2015",,"12/06/2013 G0176710 PRN  Stock Price Movement and Senior Notes Redemption - Research Report on Valeant, Edwards Lifesciences, Alkermes, Mallinckrodt, and Dr. Reddy's",,,, 6/08/2015 55027E10 PRN  Luminex Corporation Begins Clinical Trials for ARIES™ GBS Assay,11/10/2016 80067710 PRN  Sangamo BioSciences Announces Participation At Upcoming Investor Conferences,, 9/16/2017 80105N10  PRN  Regeneron and Sanofi Announce Positive Study Results for DUPIXENT® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis," 9/12/2011 000D8R-E  PRN  Active Insider Trading in Vertex, AmerisourceBergen, Abercrombie & Fitch, eBay, Microsoft & Campbell Soup",,,,,,,,,,, 4/02/2013 68214310 PRN  Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy,,,,,,,, 2/22/2016 69329Y10 PRN  PDL BioPharma Announces Fourth Quarter and Full Year 2015 Financial Results,,,, 8/12/2015 ANIP-US  PRN  ANI Pharmaceuticals and IDT Australia Enter Partnership to Commercialize US Generic Drug Products,,,,, 2/03/2015 60468T10 PRN  Mirati Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,,,,,,, 8/03/2016 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences in August,,11/14/2016 EIGR-US  PRN  Eiger Announces Positive Phase 2 Data at the American Association for the Study of Liver Diseases (AASLD) Meeting: Multiple Paths Forward Identified with Lonafarnib Therapy in LOWR HDV Program,,,,,,,11/03/2015 92165910 PRN  Vanda Pharmaceuticals Reports Third Quarter 2015 Financial Results,,,,, 7/26/2016 HALO-US  PRN  Eisai And Halozyme Initiate Phase 1b/2 Clinical Trial With First Patient Dosing Of Eribulin In Combination With PEGPH20,"11/04/2011 G2151510 PRN  China Biologic to Host Earnings Conference Call on November 8, 2011 at 8:00 a.m. EST (NY)",,,,,,"12/05/2017 09ZBR3-E PRN  Schubert Firm Launches Investigation Of PTC Therapeutics, Inc. Executives For Potential Breaches Of Fiduciary Duty",,,,,,, 8/11/2014 36197T10 PRN  CBD Hemp Oil Product Potential Continues to Grow with Ongoing Scientific & Clinical Studies - Company Launches High CBD Hemp Oil for Sale in U.S.,, 1/17/2017 G5087110 PRN  Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating Defibrotide for the Potential Prevention of VOD in High Risk Patients,,,,," 9/04/2014 00B110-E PRN  Veracyte, Inc. to Acquire Allegro Diagnostics, Accelerating Entry Into Pulmonology Market",,,,,,,,,,,,,,,,12/18/2014 98401F10 PRN  Xencor and Novo Nordisk Enter Discovery Collaboration Using Xencor's XmAb Bispecific and Immune Inhibitor Technologies,, 2/17/2017 G8807B10 PRN  Theravance Biopharma Presents Positive Clinical Data on TD-1473 at the 12th Congress of the European Crohn's and Colitis Organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 3/16/2012 S.XX1-US    PRN  The Zacks Analyst Blog Highlights: Roche Holdings, Illumina, Leap Wireless International, Clearwire and Sprint Nextel",, 5/01/2017 G3040110 PRN  Endo to Present at UBS Global Healthcare Conference,,10/10/2014 09060J10 PRN  BioDelivery Sciences Announces the Hiring of J. Chris Prue as Vice President of Regulatory Affairs and Quality Assurance, 9/06/2017 09073M10    PRN  Bio-Techne Releases A Highly Sensitive and Specific Serological Assay to Detect Zika Virus Infections, 8/24/2018 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentation,,"10/15/2013 68375N10 PRN  Upcoming Earnings Release Schedules, Board Nominations, Strategic Investments and FDA Responses - Research Report on Zimmer, ResMed, Varian, Opko and EnteroMedics", 5/09/2017 ARIA-US  PRN  Akcea Therapeutics Announces Appointment of Edward Fitzgerald to Board of Directors," 7/18/2017 09061G10   PRN  BioMarin to Host Second Quarter 2017 Financial Results Conference Call and Webcast on Wednesday, August 2 at 4:30pm ET",, 4/07/2017 64125C10 PRN  AbbVie Announces Positive Phase 2b Data Demonstrating Investigational Medicine Elagolix Significantly Reduced Heavy Menstrual Bleeding in Women with Uterine Fibroids,,,"12/31/2013 09062X10  PRN  Commercialization Agreements, Acquisition Updates, Conference Calls Schedules, Stock Price Updates and Clinical Study Data - Research Report on Biogen Idec, Covidien, Vertex, Endo, and Momenta Pharma",,,"11/06/2014 060RWY-E   PRN  Surveyed U.S. Specialists Perceive Gilead's Harvoni, the First Single-Tablet Regimen for Hepatitis C Virus Infections, As Having Key Advantages Over Emerging Treatment Options", 1/04/2017 04004760   PRN  Arena Pharmaceuticals and Eisai Amend Marketing and Supply Agreement for BELVIQ Globally,12/14/2017 005M9Z-E  PRN  Mylan Announces the U.S. Patent and Trademark Appeal Board Institutes Inter Partes Review Proceedings on All Claims Against Sanofi's Lantus® Patents,"10/22/2013 M2572210 PRN  Quarterly Reports, Licensing Agreements, and Clinical Data - Research Report on Theravance, Dendreon, ImmunoGen, Compugen, and Acorda",,12/18/2018 0GJLKW-E PRN  Amgen Engages Cambridge Biotech Community To Select 2018 LabCentral Golden Ticket Winners,,11/21/2014 52887230 PRN  Lexicon Announces Pricing Of Common Stock Offering,, 5/10/2011 45766930 PRN  Insmed Announces First Quarter 2011 Financial Results,,"11/19/2014 45773H20 PRN  Critical Alerts For SunEdison, Invensense, JinkoSolar, Inovio Pharmaceuticals and Sarepta Therapeutics Released By InvestorsObserver", 3/02/2017 64026810 PRN  Nektar to Webcast Presentation at Cowen and Company's 37th Annual Health Care Conference in Boston, 2/25/2016 76655960 PRN  Rigel Initiates Phase 2 Clinical Trial Of Fostamatinib In Autoimmune Hemolytic Anemia,,,,,10/15/2015 91307C10 PRN  United Therapeutics Announces Additional $500 Million Share Repurchase Program,,"11/22/2013 G0176710 PRN  Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes",,,, 5/18/2015 55027E10 PRN  Luminex Corporation To Present At Jefferies 2015 Healthcare Conference,10/26/2016 06CR5C-E PRN  Sangamo BioSciences Reports Third Quarter 2016 Financial Results,, 9/14/2017 80105N10  PRN  Patient-Driven Dose Titration with Sanofi's Toujeo Improved Blood Glucose Control Without Increasing Hypoglycemia Risk in Real-Life Clinical Practice," 9/09/2011 CLNE-US   PRN  Hot Stock Research for Google, Acme Packet, Vertex, Clean Energy Fuels, Pacific Capital & Fastenal",,,,,,,,,,, 3/29/2013 68214310 PRN  Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference,,,,,,,, 2/17/2016 PDLI-US  PRN  PDL BioPharma to Present at the 2016 RBC Capital Markets' Healthcare Conference,,,, 8/04/2015 00182C10 PRN  ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights,,,,, 1/29/2015 60468T10 PRN  Mirati Therapeutics to Present at the Leerink Global Healthcare Conference,,,,,,," 8/02/2016 09627Y10 PRN  Blueprint Medicines to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016",,11/08/2016 28249U10 PRN  Eiger BioPharmaceuticals Reports Third Quarter 2016 Financial Results,,,,,,,"10/15/2015 92165910 PRN  Vanda Pharmaceuticals to Announce Third Quarter 2015 Financial Results on November 3, 2015",,,,, 7/25/2016 40637H10 PRN  Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Trial With KEYTRUDA,10/28/2011 G2151510 PRN  China Biologic Nominated for the 2011 Scrip Award as Best Company in an Emerging Market,,,,,,11/20/2017 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 8/01/2014 36197T10 PRN  Health & Wellness Industry Gets Excited by Recent Federal Medical Marijuana Legalization Efforts - Company Initiates Cannabis Drug Development Plan,, 1/03/2017 0035K2-E PRN  Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 9,,,,, 9/02/2014 92337F10 PRN  Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014,,,,,,,,,,,,,,,,12/06/2014 98401F10 PRN  MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting,," 2/15/2017 G8807B10 PRN  Theravance Biopharma to Report Fourth Quarter and Full Year 2016 Financial Results on February 27, 2017",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 3/13/2012 LIFE.XX5-US PRN  The Zacks Analyst Blog Highlights: Starbucks, Green Mountain Coffee Roasters, Illumina, Roche and Life Technologies",, 4/25/2017 G3040110 PRN  Endo to Announce First-Quarter 2017 Financial Results,,10/06/2014 09060J10 PRN  BioDelivery Sciences to Provide BUNAVAIL Launch Update, 9/05/2017 09073M10    PRN  Bio-Techne Acquires Trevigen Inc., 8/17/2018 75886F10    PRN  FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration,," 9/24/2013 68375N10 PRN  Corporate Restructuring, Recognitions, Drug Approvals, Mergers and Stock Price Movements - Research Report on Agilent, UnitedHealth, Onyx, Alexion, and Opko Health", 5/09/2017 46222210 PRN  Ionis Reports Financial Results and Highlights for First Quarter 2017, 7/11/2017 09061G10   PRN  BioMarin's Investigational Gene Therapy for Hemophilia A at 6e13 vg/kg Dose Maintains Average Factor VIII Levels within Normal Range for over One Year,, 3/21/2017 64125C10 PRN  Neurocrine Announces American Journal of Psychiatry Publication of Positive Results from Kinect 3 Phase III Study of INGREZZA TM (valbenazine) for the Treatment of Tardive Dyskinesia,,,"12/23/2013 09062X10  PRN  Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna",,,"11/06/2014 37555810   PRN  Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver",12/19/2016 002XMH-E   PRN  Eisai and Arena Pharmaceuticals Announce Regulatory Approval of BELVIQ® (lorcaserin HCl) in Brazil,12/11/2017 00115K-E  PRN  Teva Dismisses Litigation After Mylan Wins U.S. Court Ruling Related to Teva's Cold Filtration Patents for Copaxone® 40 mg/mL," 5/07/2013 09LL8W-E PRN  Computational Biology Market Is Expected to Reach USD 2,937.3 Million Globally in 2018: Transparency Market Research",,12/17/2018 03116210 PRN  Amgen Submits Biologics License Application for ABP 710 (Biosimilar Infliximab) To US Food And Drug Administration,,11/19/2014 52887230 PRN  Lexicon Announces Proposed Convertible Senior Notes Offering,, 4/26/2011 45766930 PRN  Insmed to Host 2011 First Quarter Earnings Conference Call,,11/17/2014 45773H20 PRN  Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy, 3/01/2017 64026810 PRN  Nektar Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting, 1/28/2016 76655960 PRN  Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP (FIT),,,,, 9/30/2015 91307C10 PRN  United Therapeutics Announces Settlement of Patent Litigation with Sandoz Inc.,,"11/14/2013 G0176710 PRN  Before the Bell Scans: Theravance Inc., Alkermes PLC, Celsion Corp., and Hospira Inc.",,,, 5/04/2015 55027E10 PRN  Luminex Corporation Reports First Quarter 2015 Results,10/19/2016 80067710 PRN  Sangamo BioSciences Announces Third Quarter 2016 Conference Call and Webcast,, 9/13/2017 80105N10  PRN  Daily Blood Glucose Measures in Phase 3 Clinical Trials Demonstrated Better Stability with Sanofi's Toujeo® vs. Insulin Glargine 100 Units/mL," 9/08/2011 000CXX-E  PRN  Critical Stock Alerts for Bank of New York, CVS, AES, Vertex, BMC & Heinz",,,,,,,,,,, 3/28/2013 68214310 PRN  Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials,,,,,,,," 2/16/2016 69329Y10 PRN  PDL BioPharma to Announce Fourth Quarter and Full Year 2015 Financial Results on February 22, 2016",,,, 7/28/2015 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results,,,,, 1/29/2015 60468T10 PRN  Mirati Therapeutics Prices Public Offering of Common Stock,,,,,,, 6/01/2016 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences in June,,10/24/2016 00C5L1-E PRN  AltheaDx Announces Appointment of Chief Financial Officer,,,,,,,10/14/2015 VNDA-US  PRN  Vanda Announces Listing of a New Fanapt® Patent in the FDA Orange Book,,,,, 7/11/2016 40637H10 PRN  Halozyme To Host Second Quarter 2016 Financial Results Conference Call,"10/24/2011 G2151510 PRN  China Biologic Named to Asia's ""200 Best Under a Billion"" by Forbes Asia",,,,,,"11/14/2017 005W47-E PRN  Daily Technical Summary Reports on Biotech Stocks -- Ophthotech, PTC Therapeutics, Trevena, and Tesaro",,,,,,," 7/23/2014 36197T10 PRN  Pharma Stocks under Review -- Impax Laboratories, Sanofi, GW Pharma, AcelRx Pharma, and Salix Pharma",,11/28/2016 G5087110 PRN  Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Study of JZP-110 Evaluating Excessive Sleepiness in Narcolepsy,,,,," 8/13/2014 92337F10 PRN  Veracyte, Inc. Announces Second Quarter 2014 Financial Results",,,,,,,,,,,,,,,,12/04/2014 98401F10 PRN  Xencor to Present at the 25th Annual Oppenheimer & Co. Healthcare Conference,, 2/13/2017 G8807B10 PRN  Theravance Biopharma to Present Clinical Data on TD-1473 at the 12th Congress of the European Crohn's and Colitis Organization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 2/09/2012 000C35-E    PRN  Zacks Bull and Bear of the Day Highlights: Amgen, Montpelier Re Holdings, Cisco Systems, Illumina and Roche Holdings",, 4/12/2017 G3040110 PRN  Endo International plc Announces Pricing of Private Offering of Senior Secured Notes,," 9/24/2014 09060J10 PRN  Active Equities to Watch in Pharma Industry - Pfizer, BioDelivery Sciences Intl., Repros Therapeutics, Catalent, and Nektar Therapeutics", 8/30/2017 000XKX-E    PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bio-Techne Corporation - TECH, 8/16/2018 75886F10    PRN  Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip,," 9/11/2013 68375N10 PRN  Clinical Study Results, Acquisitions, Joint Ventures and Awards for Contributions to the Technology Industry - Research Report on Medtronic, Edwards Lifesciences, Opko, LifePoint, and Allscripts"," 5/04/2017 46222210 PRN  Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin", 6/30/2017 09061G10   PRN  BioMarin Submits Pegvaliase Biologics License Application (BLA) to the U.S. FDA for Treatment of Phenylketonuria (PKU),," 3/17/2017 64125C10 PRN  How These Generic Drugs Stocks are Faring? -- Neurocrine Biosciences, Lannett, Rigel Pharma, and Catalent",,,"12/13/2013 09062X10  PRN  Increased Dividends, Clinical Trial Results, Survey Results, and Updated Financial Guidance - Research Report on Aetna, Biogen, Eli Lilly, WellPoint, and Laboratory Corp. of America",,,"11/06/2014 37555810   PRN  Quarterly Financial Results, Acquisition Agreement, and Accelerated Drug Approval - Research Reports on Gilead, Covance, Laboratory Corp., Pfizer and AbbVie",12/13/2016 0035K2-E   PRN  Arena Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference,12/04/2017 N5946510  PRN  Mylan and Aspen Announce Launch of Generic Busulfex® Injection,,,12/14/2018 03116210 PRN  FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia,,11/19/2014 52887230 PRN  Lexicon Announces Proposed Common Stock Offering,, 3/21/2011 002T0L-E PRN  Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication,,11/11/2014 45773H20 PRN  Inovio to Present at Upcoming Investor Conferences, 3/01/2017 64026810 PRN  Nektar Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results, 1/07/2016 RIGL-US  PRN  Rigel Reviews Recent Progress and Announces Presentation at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco,,,,," 9/22/2015 007PS9-E PRN  Synthetic Genomics Inc. Expands Collaborative Research and Development Agreement with Lung Biotechnology PBC, a Subsidiary of United Therapeutics Corporation, to Develop Organs for Transplantation",,"11/14/2013 G0176710 PRN  Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed",,,, 4/27/2015 55027E10 PRN  Luminex Corporation Provides Updates on ARIES® Clinical Trials,10/17/2016 80067710 PRN  Sangamo BioSciences Announces Participation In Upcoming Scientific Conferences,, 9/12/2017 80105N10  PRN  Sanofi's Soliqua® 100/33 Provided Earlier Blood Sugar Control than Insulin Glargine 100 Units/mL," 9/07/2011 92532F10  PRN  Critical Alerts For Oracle, Best Buy, AFLAC, Agilent, and Vertex Pharmaceuticals Released By Seven Summits Research",,,,,,,,,,, 3/26/2013 68214310 PRN  Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial,,,,,,,, 2/02/2016 PDLI-US  PRN  PDL BioPharma to Present at the 2016 BIO CEO & Investor Conference,,,, 7/27/2015 ANIP-US  PRN  ANI Pharmaceuticals and Sofgen Announce FDA Approval of Nimodipine 30mg Capsules,,,,, 1/28/2015 60468T10 PRN  Mirati Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,, 5/10/2016 09627Y10 PRN  Blueprint Medicines Reports First Quarter 2016 Financial Results,,10/24/2016 28249U10 PRN  Eiger BioPharmaceuticals Launches Nationwide Hepatitis Delta Virus (HDV) Campaign to Expand Awareness and Testing for HDV Infection,,,,,,," 9/30/2015 92165910 PRN  Covered Call Alerts For Fitbit, AmerisourceBergen, Express Scripts, Vanda Pharmaceuticals and SunPower Released By InvestorsObserver",,,,," 6/08/2016 HALO-US  PRN  Halozyme Announces Agreement To Refinance Debt, Increases 2016 Guidance For Year-End Cash Balance",10/06/2011 G2151510 PRN  China Biologic Announces Changes in Directors,,,,,,11/02/2017 69366J20 PRN  PTC Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update,,,,,,," 6/30/2014 36197T10 PRN  Patent Case Settlements, FDA Rulings, Upcoming Investor Day, Product Launching, and Closing of Offering - Analyst Notes on Teva, AstraZeneca, Salix, Mylan and GW",,11/10/2016 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences,,,,," 8/06/2014 92337F10 PRN  Veracyte, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2014 Financial Results on August 13, 2014",,,,,,,,,,,,,,,,11/25/2014 98401F10 PRN  Xencor to Present at the 2014 Deutsche Bank BioFEST Conference,, 2/02/2017 G8807B10 PRN  Theravance Biopharma to Present at the Leerink Partners 6th Annual Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 1/26/2012 45232710    PRN  Critical Alerts for Freeport McMoran, Corning, Illumina, Textron, and Groupon Released by Seven Summits Research",, 4/10/2017 G3040110 PRN  Endo International plc Announces Proposed Private Offering of Senior Secured Notes,, 9/08/2014 09060J10 PRN  BioDelivery Sciences to Present at the Morgan Stanley Global Healthcare Conference, 8/28/2017 09073M10    PRN  Bio-Techne To Present At The Wells Fargo Healthcare Conference, 8/13/2018 75886F10    PRN  Regeneron Provides Regulatory Update on EYLEA® (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration,," 9/03/2013 68375N10 PRN  Market Expansions, FDA Clearance, Updated Products, Dual Listings, and Legal Actions - Research Report on Zimmer, Varian, Allscripts, ResMed, and OPKO", 4/26/2017 46222210 PRN  Ionis Pharmaceuticals to Hold First Quarter 2017 Financial Results Webcast, 6/16/2017 09061G10   PRN  BioMarin Announces Acceptance of Late Breaking Abstract at the International Society on Thrombosis and Haemostasis 2017 Congress,, 2/14/2017 06CR5C-E PRN  Neurocrine Biosciences Reports Year-End 2016 Results and Provides Investor Update for 2017,,,"12/05/2013 09062X10  PRN  Marketing Rights Acquisitions, PDUFA Date Extensions, Accountable Care Relationship and Stock Price Updates - Research Report on Forest Laboratories, Biogen, Bristol-Myers, Express Scripts, and Aetna",,,"10/29/2014 37555810   PRN  Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly",12/07/2016 04004760   PRN  Arena Pharmaceuticals Completes Enrollment in Ralinepag Phase 2 Clinical Trial for Pulmonary Arterial Hypertension (PAH),"12/01/2017 N5946510  PRN  U.S. FDA Approves Mylan and Biocon's Ogivri™, the First Biosimilar for Trastuzumab, for the Treatment of HER2-Positive Breast and Gastric Cancers",,,12/13/2018 03116210 PRN  Amgen And Direct Relief Partner To Aid Cancer Patients In 18 Developing Countries,,"11/19/2014 52887230 PRN  Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics",, 3/21/2011 002T0L-E PRN  Insmed Regains NASDAQ Compliance,,"11/10/2014 45773H20 PRN  Technical Pulse on Biotech Stocks - Dendreon, Alkermes, Exact Sciences, Inovio Pharma, and Seattle Genetics"," 2/22/2017 64026810 PRN  Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2016 on Wednesday, March 1, 2017, After Close of U.S.-Based Financial Markets",11/03/2015 76655960 PRN  Rigel Announces Third Quarter 2015 Financial Results,,,,, 8/19/2015 91307C10 PRN  United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million,,"11/06/2013 G0176710 PRN  Advancing Pipelines, Liquidity Growth, Cost-reduction Initiatives and Breakthrough Studies - Research Report on Alkermes, Abiomed, Gentium, Amarin, and VIVUS",,,," 4/13/2015 55027E10 PRN  Luminex Corporation First Quarter Earnings Release Scheduled for May 4, 2015", 9/29/2016 80067710 PRN  Sangamo BioSciences Announces Participation At Upcoming Investor Conferences,, 9/11/2017 80105N10  PRN  Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Phase 3 Trial in Uncontrolled Persistent Asthma," 8/31/2011 000YJB-E  PRN  Significant Insider Trading Discovered at Pfizer, Exxon, EMC, Xilinx, Vertex & Zions",,,,,,,,,,, 3/19/2013 68214310 PRN  Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction,,,,,,,, 2/01/2016 69329Y10 PRN  PDL BioPharma Announces 2016 First Quarter Dividend,,,, 7/13/2015 ANIP-US  PRN  ANI Pharmaceuticals Acquires 22 Generic Drug Products from Teva Pharmaceuticals for $25 million,,,,, 1/07/2015 60468T10 PRN  Mirati Therapeutics Doses First Patient in Phase 2 Study of Mocetinostat in Bladder Cancer Patients with Genetic Alterations of CREBBP and EP300,,,,,,," 5/03/2016 09627Y10 PRN  Blueprint Medicines to Report First Quarter 2016 Financial Results on Tuesday, May 10, 2016",,10/19/2016 EIGR-US  PRN  Eiger Announces First Patient Dosed in Phase 2 Study of Pegylated Interferon Lambda in Hepatitis D Virus (HDV) Infection,,,,,,, 9/23/2015 VNDA-US  PRN  Vanda Announces Listing of a New Fanapt® Patent in the FDA Orange Book,,,,, 6/04/2016 40637H10 PRN  Halozyme Presents Stage One Efficacy And Safety Analysis Of Phase 2 Clinical Study In Metastatic Pancreatic Cancer Patients Treated With PEGPH20," 9/26/2011 G2151510 PRN  China Biologic to Attend Jefferies Healthcare Conference on September 27 and 28, 2011 in London",,,,,,10/25/2017 69366J20 PRN  PTC Therapeutics Receives Complete Response Letter for Ataluren's NDA,,,,,,," 6/20/2014 36197T10 PRN  Conference Call Schedules, Acquisitions, and Public Offerings - Analyst Notes on Johnson & Johnson, Merck, GW, Endocyte and AVEO",,11/08/2016 G5087110 PRN  Jazz Pharmaceuticals Announces Third Quarter 2016 Financial Results,,,,, 7/03/2014 05L0RB-E PRN  Veracyte Announces Positive Coverage Policies for Afirma® Gene Expression Classifier from Highmark Inc. and Horizon Blue Cross Blue Shield of New Jersey,,,,,,,,,,,,,,,,11/10/2014 98401F10 PRN  Xencor Reports Third Quarter 2014 Financial Results,, 1/23/2017 TBPH-KY  PRN  Theravance Biopharma Reports New Data from Ongoing TOUR™ Observational Patient Registry in Oral Presentation at SCCM Critical Care Congress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 1/26/2012 LCC-US      PRN  Research Reports for Day Traders: Illumina, Xerox, Freeport-McMoRan, Avalon Rare Metals, Advanced Micro Devices and US Airways Group",, 4/05/2017 G3040110 PRN  Endo International plc Announces Plan to Refinance Existing Credit Agreement,, 9/03/2014 09060J10 PRN  BioDelivery Sciences to Ring The NASDAQ Stock Market Opening Bell, 8/22/2017 09073M10    PRN  Bio-Techne To Present At The Baird 2017 Global Healthcare Conference," 8/06/2018 75886F10    PRN  Regeneron and bluebird bio Announce Collaboration to Discover, Develop and Commercialize New Cell Therapies for Cancer",, 9/03/2013 68375N10 PRN  Tel Aviv Stock Exchange Corporate Fact Sheet of August 2013, 4/18/2017 46222210 PRN  Ionis Enters into Collaboration with Ribo to Advance RNA-Targeted Therapeutics in China," 6/01/2017 09061G10   PRN  European Commission Approves Brineura™ (cerliponase alfa), the First Treatment for CLN2 Disease, a Form of Batten Disease and Ultra-Rare Brain Disorder in Children",, 2/09/2017 64125C10 PRN  Neurocrine and BIAL Announce Exclusive North American Licensing Agreement for Opicapone,,,"11/29/2013 09062X10  PRN  Stock Price Movements, Presentation Schedules, and Quarterly Dividends - Research Report on Biogen Idec, Santarus, Hill-Rom, Puma Biotechnology and Cynosure",,,"10/20/2014 37555810   PRN  Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna",11/30/2016 DIS-US     PRN  Arena Pharmaceuticals Announces Four Upcoming Presentations at the 2016 Advances in Inflammatory Bowel Diseases: Crohn's & Colitis Foundation's Clinical and Research Conference,12/01/2017 N5946510  PRN  FDA Approval of Heparin Sodium Injection Continues to Demonstrate Mylan's Deep Expertise in Developing Complex Products,,,"12/11/2018 03116210 PRN  Amgen And Magellan Rx Management Collaborate To Improve Patient Care For Chronic, Difficult-To-Treat Conditions",,11/04/2014 52887230 PRN  Lexicon Strengthens Clincial Operations And Commercial Readiness,, 3/10/2011 002T0L-E PRN  Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results,,11/10/2014 45773H20 PRN  Inovio Pharmaceuticals Reports 2014 Third Quarter Financial Results, 2/18/2017 64026810 PRN  Clinical Data from Phase 1 Dose-Escalation Study of Single-Agent NKTR-214 in Patients with Renal Cell Carcinoma Presented at the ASCO 2017 Genitourinary Cancers Symposium,10/27/2015 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Third Quarter 2015 Financial Results,,,,, 8/17/2015 91307C10 PRN  European Commission Grants Marketing Authorisation for Unituxin™ (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma,,"10/30/2013 G0176710 PRN  New Appointments, Upcoming Earnings Releases, Regulatory Approvals, Status Updates and Informative Resources for New Treatment Options - Research Report on Mylan, Alkermes, Salix, Ligand and Hospira",,,, 4/06/2015 55027E10 PRN  A New Test to Simultaneously Detect 22 Respiratory Pathogens," 9/06/2016 80067710 PRN  Sangamo BioSciences Receives Orphan Drug Designation From The FDA For SB-FIX, The First Application Of Therapeutic In Vivo Genome Editing",, 9/08/2017 80105N10  PRN  Regeneron and Sanofi Announce Cemiplimab (REGN2810) Has Received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma," 8/26/2011 000YJB-E  PRN  Significant Insider Trading Found at Vertex, United Continental Holdings, Public Storage, salesforce.com, First Solar & Kellogg",,,,,,,,,,, 3/18/2013 68214310 PRN  Omeros Corporation Reports Fourth Quarter and Year-End 2012 Financial Results,,,,,,,,12/17/2015 PDLI-US  PRN  PDL BioPharma Announces Closing of Transaction Related to LENSAR Debt Investment,,,, 6/02/2015 00182C10 PRN  ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL,,,,, 1/06/2015 60468T10 PRN  Mirati Therapeutics Doses First Patient in Investigator-Sponsored Phase 2 Study of Mocetinostat in Non-Hodgkin's Lymphoma,,,,,,," 4/15/2016 09627Y10 PRN  Blueprint Medicines Appoints Lynn Seely, M.D. to Board of Directors",,10/17/2016 080RQG-E PRN  Eiger Announces Orphan Designation of Exendin 9-39 for Treatment of Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS) from European Medicines Agency (EMA),,,,,,, 9/15/2015 VNDA-US  PRN  Vanda Announces FDA Has Accepted for Review the Fanapt® Supplemental New Drug Application for Maintenance Treatment of Schizophrenia in Adults,,,,, 5/17/2016 40637H10 PRN  Halozyme Therapeutics To Present At The UBS 2016 Global Health Care Conference, 9/16/2011 G2151510 PRN  China Biologic Products to Present at UBS Global Life Sciences Conference on September 19,,,,,,10/24/2017 69366J20 PRN  PTC Therapeutics to Present at the Credit Suisse 26th Annual Healthcare Conference,,,,,,, 6/02/2014 36197T10 PRN  Development of Cannabinoid-Based Therapies Becoming More Prevalent by Leaps and Bounds - CBIS Forges Ahead with Cannabis-Based Cancer Treatments,,"11/08/2016 G5087110 PRN  Learn how to target a 20% return on Starbucks, or get option-trade ideas on Potash Corporation of Saskatchewan, Jazz Pharmaceuticals, The Home Depot Inc. and Sysco Corporation or any stock you choose",,,,, 6/23/2014 92337F10 PRN  Veracyte Comments On Preliminary American Thyroid Association Guidelines Regarding Thyroid Nodule Management,,,,,,,,,,,,,,,,11/06/2014 98401F10 PRN  Xencor Provides Data Updates on XmAb Bispecific Antibody Programs and Announces Presentations at Upcoming American Society of Hematology 2014 Annual Meeting,, 1/17/2017 G8807B10 PRN  Theravance Biopharma to Present New Data from Ongoing TOUR™ Observational Patient Registry at SCCM Critical Care Congress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 1/25/2012 45232710    PRN  Illumina, Inc. Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate the Board of Illumina Concerning the Receipt of an Acquisition Proposal from Roche Holding",," 3/27/2017 G3040110 PRN  Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin",," 8/27/2014 09060J10 PRN  BioDelivery Sciences to Host Investor and Analyst Event and Webcast Friday, September 5 on BUNAVAIL™ Launch and Pipeline", 8/10/2017 09073M10    PRN  Bio-Techne Declares Dividend, 8/03/2018 75886F10    PRN  Regeneron Announces the 2018 Winners of the Regeneron Prize for Creative Innovation,," 8/30/2013 68375N10 PRN  Under AAAResearchReports.com Microscope: Life Technologies Corp., Opko Health Inc., Medicines Co., and DaVita Inc.", 3/30/2017 46222210 PRN  Akcea Initiates Phase 2 Study of AKCEA-APO(a)-L Rx in Patients with High Lp(a) and Cardiovascular Disease, 5/31/2017 09061G10   PRN  BioMarin to Attend Upcoming Investor Conference,, 2/07/2017 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End 2016 Results,,,"11/26/2013 09062X10  PRN  Official Statement, Stock Price Movements, and Public Offering of Common Stock - Research Report on Amgen, Biogen Idec, Express Scripts, Endo, and CSI",,,"10/15/2014 37555810   PRN  Critical Alerts For Tesla Motors, Tekmira Pharmaceuticals, Gilead Sciences, 3D Systems and TASER International Released By InvestorsObserver",11/09/2016 04004760   PRN  Arena Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference,11/30/2017 N5946510  PRN  European Medicines Agency Accepts Marketing Authorization Applications for Mylan and Biocon's Proposed Biosimilars Trastuzumab and Pegfilgrastim,,,12/10/2018 03116210 PRN  Amgen And Lazarex Cancer Foundation Team Up To Allow More Diversity In Clinical Trials,,11/04/2014 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Third Quarter Financial Results,, 3/03/2011 002T0L-E PRN  Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication,,"11/04/2014 45773H20 PRN  Inovio Pharmaceuticals to Report Third Quarter 2014 Financial Results on November 10, 2014"," 1/05/2017 NKTR-US  PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, CA", 9/09/2015 RIGL-US  PRN  Rigel and Aclaris Therapeutics International Sign License Agreement for JAK Inhibitors to Treat Skin Disorders,,,,, 8/06/2015 91307C10 PRN  United Therapeutics Corporation To Present At The 2015 Wedbush PacGrow Healthcare Conference,,"10/24/2013 G0176710 PRN  Pre-Market Review: Alkermes PLC, Hospira Inc., Celsion Corp., and Theravance Inc.",,,, 3/30/2015 55027E10 PRN  Luminex Corporation Begins Clinical Trials for ARIES® System and ARIES® HSV 1&2 Assay, 8/31/2016 80067710 PRN  Sangamo BioSciences Announces Participation At Upcoming Investor Conferences,, 9/01/2017 80105N10  PRN  Sanofi Receives Tentative FDA Approval of Admelog® (insulin lispro injection) 100 Units/mL," 8/19/2011 000BNN-E  PRN  Critical Stock Alerts for Jabil, AK Steel, Vertex, Nu Skin, Southern & Colgate-Palmolive",,,,,,,,,,, 3/01/2013 68214310 PRN  Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference,,,,,,,,12/14/2015 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,, 5/15/2015 BPAX-US  PRN  ANI Pharmaceuticals Presents at the UBS Global Healthcare Conference,,,,,12/23/2014 60468T10 PRN  Mirati Therapeutics Doses First Patient in Expansion Cohorts of Phase 1b Trial of MGCD265 in Genetically Selected Patients,,,,,,, 4/05/2016 09627Y10 PRN  Blueprint Medicines to Present at 15th Annual Needham Healthcare Conference,,10/13/2016 28249U10 PRN  Eiger Announces Abstracts and Presentations of LOWR HDV Program at the American Association for the Study of Liver Diseases (AASLD) Meeting,,,,,,, 9/14/2015 92165910 PRN  Vanda Pharmaceuticals Announces the Appointment of General Counsel,,,,, 5/09/2016 40637H10 PRN  Halozyme Reports First Quarter 2016 Financial Results, 8/09/2011 G2151510 PRN  China Biologic Products Reports Second Quarter 2011 Results,,,,,,10/23/2017 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 5/22/2014 36197T10 PRN  Clinical Studies for Cannabis Based Drug Development Targets Multitude of Medical Treatments - CBIS Issues CBN Patent and R&D Guidance,,11/07/2016 G5087110 PRN  Jazz Pharmaceuticals to Present New Data at the Annual ASH Meeting,,,,, 6/18/2014 92337F10 PRN  Veracyte to Present at JMP Securities 2014 Healthcare Conference,,,,,,,,,,,,,,,,11/04/2014 98401F10 PRN  Xencor to Present at the 2014 Credit Suisse Annual Healthcare Conference,,12/19/2016 TBPH-KY  PRN  Theravance Biopharma Highlights Initiation of Phase 3 Study of the Closed Triple in Patients with Asthma by GlaxoSmithKline and Innoviva,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 1/16/2012 BAH-US      PRN  The Iron Lady Movie: You Can Learn to Be Confident, Says Charisma Coach Cynthia Burnham",, 3/14/2017 G3040110 PRN  Endo Statement On FDA Advisory Committees' Vote Related To OPANA® ER,," 8/12/2014 09060J10 PRN  Pharma Equities Coverage -- Pfizer, BioDelivery Sciences Intl., The Medicines, Questcor Pharma, and Nektar Therapeutics", 8/08/2017 09073M10    PRN  Bio-Techne Releases Fourth Quarter Fiscal 2017 Results, 8/02/2018 75886F10    PRN  Regeneron Reports Second Quarter 2018 Financial and Operating Results,, 8/29/2013 68375N10 PRN  OPKO Completes Acquisition Of PROLOR Biotech, 3/29/2017 46222210 PRN  Ionis Pharmaceuticals to Present at Needham Healthcare Conference, 5/04/2017 09061G10   PRN  BioMarin Announces First Quarter 2017 Financial Results,," 2/03/2017 64125C10 PRN  How These Generic Drugs Stocks are Faring? -- Neurocrine Biosciences, Evoke Pharma, SCYNEXIS, and Eagle Pharma",,,11/25/2013 00167Y-E  PRN  Two-Thirds of Surveyed U.S. Neurologists Have Prescribed Genzyme's Aubagio to Their Multiple Sclerosis Patients at One Year Post-Launch,,,"10/14/2014 37555810   PRN  Pre-market Biotech Picks - Gilead Sciences, MannKind, IsoRay, Orexigen Therapeutics, and Sunesis Pharma",11/09/2016 06418D-E   PRN  Arena Pharmaceuticals Announces Poster at the American Heart Association (AHA) Scientific Sessions 2016,11/20/2017 N5946510  PRN  Mylan to Present at Evercore ISI Inaugural Biopharma Catalyst/Deep Dive Conference,,,12/07/2018 03116210 PRN  Amgen Announces 10 Percent Increase In 2019 First Quarter Dividend,,"11/03/2014 52887230 PRN  Lexicon To Report Third Quarter 2014 Financial Results On November 4, 2014",, 3/02/2011 002T0L-E PRN  One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective,,"11/03/2014 45773H20 PRN  Critical Alerts For Mobileye NV, Schlumberger, Ambarella, Walter Energy and Inovio Pharmaceuticals Released By InvestorsObserver",11/14/2016 NKTR-US  PRN  Nektar Therapeutics to Present at Jefferies 2016 Global Healthcare Conference in London, 9/08/2015 RIGL-US  PRN  Rigel Granted Orphan Drug Designation for Fostamatinib in ITP,,,,," 7/30/2015 91307C10 PRN  Market Updates on Drug Manufacturers - Other Equities -- Isis Pharma, Endo Intl., Amarin, United Therapeutics, and POZEN",,"10/04/2013 G0176710 PRN  Events, Appointments, Approvals, Recommendations, and Agreements - Research Report on Elan, Alkermes, Hospira, pSivida, and Kindred",,,, 3/12/2015 55027E10 PRN  Luminex Technology Selected by Assurex Health, 8/09/2016 80067710 PRN  Sangamo BioSciences Announces Presentation At The 2016 Wedbush PacGrow Healthcare Conference,, 8/31/2017 00FFJ0-E  PRN  Icertis Selected by Sanofi to Digitally Transform its Contracting Foundation," 8/05/2011 006FSB-E  PRN  Equity Research for Huntington Bancshares, Synovus, Jabil Circuit, Vertex, Colgate-Palmolive & VistaPrint",,,,,,,,,,, 2/07/2013 68214310 PRN  Omeros Announces Toxicology Study Data from MASP-2 Inhibitor,,,,,,,,12/02/2015 69329Y10 PRN  PDL BioPharma Discloses Recent Notable Payments From Income Generating Assets,,,, 5/13/2015 BPAX-US  PRN  ANI Pharmaceuticals Acquires Rights to Testosterone Gel 1%,,,,,11/19/2014 60468T10 PRN  Mirati Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference,,,,,,, 3/17/2016 06P9WL-E PRN  Blueprint Medicines to Present Preclinical Data on RET Inhibitors in an Oral Presentation at American Association for Cancer Research Annual Meeting,, 9/07/2016 28249U10 PRN  Eiger Announces Completion of Dosing in Phase 2 LOWR HDV - 4 Study at Hannover Medical School,,,,,,, 9/10/2015 VNDA-US  PRN  Vanda Announces Favorable Markman Ruling in Fanapt® Patent Infringement Litigation,,,,, 4/20/2016 40637H10 PRN  Halozyme to Host First Quarter 2016 Financial Results Conference Call," 8/08/2011 G2151510 PRN  China Biologic Products to Host Earnings Conference Call on August 10, 2011 at 7:00 a.m. EDT (NY)",,,,,,10/19/2017 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Third Quarter Financial Results,,,,,,, 5/20/2014 36197T10 PRN  Cannabis Briefing for Marijuana Sector - Company Enters Agreement to Acquire Assets of California Medical Cannabis Dispensary,,"10/25/2016 G5087110 PRN  Jazz Pharmaceuticals to Report 2016 Third Quarter Financial Results on November 8, 2016",,,,, 6/03/2014 92337F10 PRN  Veracyte to Present at 2014 William Blair Growth Stock Conference,,,,,,,,,,,,,,,,11/03/2014 98401F10 PRN  Xencor to Host Third Quarter 2014 Financial Results Webcast and Conference Call,,12/06/2016 06CR5C-E PRN  Theravance Biopharma Receives FDA Fast Track Designation for Velusetrag (TD-5108) for Idiopathic and Diabetic Gastroparesis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 1/11/2012 05N6PZ-E    PRN  Insider Hot Stocks: Bank of America, Oracle, Intel, Health Management, Allied Nevada Gold and Illumina",, 3/03/2017 G3040110 PRN  Endo International plc To Delist Ordinary Shares From The Toronto Stock Exchange,, 8/12/2014 09060J10 PRN  BioDelivery Sciences Announces BEMA Buprenorphine NDA Submission on Track following Pre-NDA Meeting with FDA," 7/12/2017 09073M10    PRN  Bio-Techne To Host Conference Call On August 8, 2017 To Announce Fourth Quarter Financial Results"," 7/09/2018 75886F10    PRN  Regeneron to Report Second Quarter 2018 Financial and Operating Results and Host Conference Call and Webcast on August 2, 2018",, 8/21/2013 OPK-US   PRN  OPKO Management and Israel's Minister of Science Open TASE Trading in Honor of OPKO'S Dual-Listing on TASE, 3/28/2017 46222210 PRN  Akcea Therapeutics Announces Three Additions to Board of Directors, 5/02/2017 09061G10   PRN  BioMarin to Attend Two Upcoming Investor Conferences,, 1/17/2017 64125C10 PRN  Neurocrine Announces Completion of Phase II Clinical Study of VMAT2 Inhibitor INGREZZA™ (valbenazine) in Adults with Tourette Syndrome,,,"11/18/2013 09062X10  PRN  FDA Approvals, Stock Price Movements, Published Studies, and Philanthropic Initiatives - Research Report on Johnson & Johnson, Express Scripts, Endo, Biogen and Covidien",,,"10/10/2014 37555810   PRN  Marketing Application Update, Acquisitions, Collaborations, FDA Approvals, and Structural Changes - Research Reports on Gilead, BD, Pfizer, AbbVie and Novartis",11/07/2016 04004760   PRN  Arena Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update,11/13/2017 N5946510  PRN  Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease,,,12/03/2018 03116210 PRN  Amgen Announces First-In-Human Data Evaluating Investigational Novel BiTE® Immunotherapies AMG 420 And AMG 330 At ASH 2018,,10/22/2014 52887230 PRN  Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate,, 3/01/2011 002T0L-E PRN  Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split,,"10/21/2014 45773H20 PRN  Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria",11/09/2016 64026810 PRN  Nektar Therapeutics Presents New Clinical Data from Ongoing Phase 1 Dose-Escalation Study of NKTR-214 at the Society for Immunotherapy of Cancer (SITC) 2016 Annual Meeting," 8/05/2015 SHS-US   PRN  Drugs - Generic Equities Coverage -- Oculus Innovative Sciences, Medicines, Supernus Pharma, Sophiris Bio, and Rigel Pharma",,,,, 7/28/2015 91307C10 PRN  United Therapeutics Corporation Reports Second Quarter 2015 Financial Results,,"10/01/2013 G0176710 PRN  Technical Briefing: Celsion Corp., Theravance Inc., Alkermes PLC, and Hospira Inc.",,,, 2/17/2015 55027E10 PRN  Luminex Corporation To Present At Cowen And Company 35th Annual Health Care Conference, 8/03/2016 80067710 PRN  Sangamo BioSciences Reports Second Quarter 2016 Financial Results,, 8/25/2017 80105N10  PRN  Regeneron and Sanofi to Present New Analyses from Praluent® (alirocumab) Injection Trials at the ESC Congress 2017, 7/28/2011 0039ZQ-E  PRN  IU Confidential Publishes Biotech Investment Report,,,,,,,,,,, 1/22/2013 68214310 PRN  Omeros Announces Positive OMS302 Safety Data in Phase 3 Clinical Trial,,,,,,,,11/24/2015 PDLI-US  PRN  PDL BioPharma to Present at the 27th Annual Piper Jaffray Healthcare Conference,,,, 5/05/2015 00182C10 PRN  ANI Pharmaceuticals Reports First Quarter 2015 Financial Results,,,,,11/10/2014 60468T10 PRN  Mirati Therapeutics Reports Third Quarter 2014 Financial Results and Provides Business Update,,,,,,, 3/15/2016 0BP4MZ-E PRN  Blueprint Medicines Announces Worldwide Collaboration to Accelerate and Expand its Development of Novel Medicines in the Field of Cancer Immunotherapy,, 9/06/2016 28249U10 PRN  Eiger BioPharmaceuticals to Present at the BioCentury NewsMakers in the Biotech Industry Conference on September 9th,,,,,,, 9/08/2015 92165910 PRN  Vanda Pharmaceuticals Announces the Appointment of European General Manager,,,,, 4/18/2016 40637H10 PRN  Halozyme Expands Oncology Pipeline With Two Compounds Designed For Activity In The Tumor Microenvironment," 8/01/2011 G2151510 PRN  China Biologic's 2 Plasma Collection Stations in Guizhou Province Have Been Inspected and Relicensed, 4 Other Stations in Disallowed Counties Closed on August 1, 2011",,,,,,"10/13/2017 69366J20 PRN  PTC THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of PTC Therapeutics, Inc. - (PTCT)",,,,,,, 5/16/2014 36197T10 PRN  Pharmaceutical Development & Medical Cannabis Expand at an Aggressive Rate - Company Attracts Major Attention at WebCongress Conference in San Francisco,,10/03/2016 06CR5C-E PRN  Jazz Pharmaceuticals Initiates Rolling NDA Submission for Vyxeos (CPX-351) Expects to Complete NDA Submission by Early 2017,,,,, 5/28/2014 92337F10 PRN  Veracyte to Present at Jefferies 2014 Global Healthcare Conference,,,,,,,,,,,,,,,,10/28/2014 98401F10 PRN  Xencor Renegotiates XmAb®5871 Agreement with Amgen; Regains All Rights and Plans Clinical Development in Rare Autoimmune Disease,,12/05/2016 TBPH-KY  PRN  Theravance Biopharma Highlights Filing of EU Regulatory Submission for the Closed Triple in COPD by GlaxoSmithKline and Innoviva,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"12/06/2011 NOV-US      PRN  Critical Alerts for Nokia, Capital One, National Oilwell Varco, Illumina, and BlackRock Released by Seven Summits Research",," 3/01/2017 G3040110 PRN  InvestorsObserver releases covered-call reports for Alcoa, Endo International, Netflix, Charles Schwab and Zayo Group Holdings Inc.",, 8/07/2014 09060J10 PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Second Quarter 2014 Financials, 5/24/2017 09073M10    PRN  Bio-Techne To Present At The Jefferies 2017 Global Healthcare Conference, 6/06/2018 75886F10    PRN  Regeneron and Zoetis Announce Collaboration to Research Antibody Therapies for Use in Animal Health,," 8/21/2013 68375N10 PRN  Health Care Companies Release Financial Results and Announce Earnings Schedules - Research Report on Opko, Sirona Dental, Accuray, Techne, and Steris", 3/27/2017 IONS-US  PRN  Akcea Therapeutics Files Registration Statement for Proposed Initial Public Offering," 4/27/2017 09061G10   PRN  FDA Approves Brineura™ (cerliponase alfa) for the Treatment of CLN2 Disease, a Form of Batten Disease and Ultra-Rare Pediatric Brain Disorder in Children",, 1/06/2017 64125C10 PRN  Neurocrine Biosciences Announces the Appointment of David-Alexandre Gros M.D. President and Chief Operating Officer,,,"11/08/2013 09062X10  PRN  Clinical Trial Initiations, Conferences Participations, Strategic Collaborations, and Presentation of New Pre-Clinical Data - Research Report on Biogen Idec, BioMarin, Medivation, Cytori, and Alnylam",,," 9/30/2014 37555810   PRN  Positive Study Results, Acquisitions, Drug Approval, Regulatory Updates, and Collaborations - Research Reports on Gilead, Pfizer, AbbVie, Pacira and Thermo Fisher",11/03/2016 04004760   PRN  Eisai and Arena Pharmaceuticals Announce Presentation of BELVIQ® (lorcaserin HCl) Data at 2016 Annual Obesity Week Meeting,11/13/2017 N5946510  PRN  Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease,,,12/03/2018 03116210 PRN  Amgen To Present At The Citi Global Healthcare Conference,,"10/20/2014 52887230 PRN  Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma",, 2/24/2011 002T0L-E PRN  Insmed to Participate on Phase III and Beyond Panel at 2011 RBC Capital Markets Healthcare Conference,,"10/06/2014 45773H20 PRN  Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma",11/03/2016 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Third Quarter of 2016, 8/04/2015 76655960 PRN  Rigel Announces Second Quarter 2015 Financial Results,,,,," 7/22/2015 91307C10 PRN  United Therapeutics Corporation To Announce Second Quarter 2015 Financial Results Before Market Open On Tuesday, July 28, 2015",," 8/27/2013 G0176710 PRN  Today's Technical View: Alkermes plc, Hospira Inc., Celsion Corp., and Theravance Inc.",,,, 2/02/2015 55027E10 PRN  Luminex Corporation Reports Fourth Quarter And Full Year 2014 Results, 7/27/2016 80067710 PRN  Sangamo BioSciences Announces Second Quarter 2016 Conference Call and Webcast,, 7/31/2017 80105N10  PRN  Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER, 7/27/2011 PM-US     PRN  Insider Trading Activity Amongst Six Top Stock Picks,,,,,,,,,,, 1/16/2013 68214310 PRN  Omeros Identifies Small Molecules for Class B GPCR,,,,,,,,11/16/2015 PDLI-US  PRN  PDL BioPharma Announces Developments Related to LENSAR Debt Investment,,,, 4/28/2015 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results,,,,,11/06/2014 60468T10 PRN  Michael Grey Joins Mirati Therapeutics Board of Directors,,,,,,, 3/11/2016 09627Y10 PRN  Blueprint Medicines Reports Fourth Quarter and Full Year 2015 Financial Results,, 8/18/2016 28249U10 PRN  Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock,,,,,,, 8/10/2015 92165910 PRN  Vanda Pharmaceuticals to Present at the Canaccord Genuity Annual Growth Conference,,,,, 3/17/2016 HALO-US  PRN  Halozyme To Present Data From Five Preclinical Studies At American Association Of Cancer Research Annual Conference, 7/26/2011 G2151510 PRN  China Biologic's Guizhou Taibang Subsidiary Donates Lifesaving Plasma Products for Injured in Train Disaster near Wenzhou,,,,,,10/12/2017 69366J20 PRN  Spinal Muscular Atrophy Program Advances into Pivotal Study in SMA Patients,,,,,,, 5/15/2014 36197T10 PRN  Cannabis Based Medicines Gain Traction as Research & Development Ramp up - Company Looks to Develop Topical Cannabis Medicine to Treat Skin Cancer,, 9/26/2016 G5087110 PRN  Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Studies of JZP-110 Evaluating Excessive Sleepiness in Obstructive Sleep Apnea,,,,," 5/20/2014 92337F10 PRN  Veracyte Presents Preliminary Data for Molecular Classifier to Improve Early, Non-Surgical Diagnosis of Idiopathic Pulmonary Fibrosis",,,,,,,,,,,,,,,," 9/02/2014 98401F10 PRN  Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel",,11/22/2016 G8807B10 PRN  Theravance Biopharma to Present at the 28th Annual Piper Jaffray Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"12/06/2011 07PDMR-E    PRN  New Auction of Lab Equipment from Acadia, Elan, Isis, Illumina and More",, 2/28/2017 G3040110 PRN  Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results,, 8/06/2014 09060J10 PRN  BioDelivery Sciences Provides Update on Ongoing Phase 3 Pivotal Trial for Clonidine Topical Gel for Painful Diabetic Neuropathy, 5/08/2017 09073M10    PRN  Bio-Techne To Present At The Bank Of America Merrill Lynch Health Care Conference, 6/04/2018 75886F10    PRN  New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma,," 8/20/2013 68375N10 PRN  FDA Approvals, Commercialization, and Ongoing Clinical Trials - Research Report on Medtronic, Hologic, St. Jude, OPKO, and Wright"," 3/27/2017 46222210 PRN  Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin"," 4/21/2017 09061G10   PRN  BioMarin Receives Positive CHMP Opinion in Europe for Brineura™ (cerliponase alfa) for First Treatment of CLN2 Disease, a Form of Batten Disease and Ultra-Rare and Fatal Brain Disorder in Children",, 1/05/2017 64125C10 PRN  Neurocrine Provides Update on FDA Advisory Committee for INGREZZA™ (valbenazine) for the Treatment of Tardive Dyskinesia,,,"10/31/2013 09062X10  PRN  Biotech Companies Report Quarterly Results - Research Report on Biogen Idec, Alexion, Medivation, BioMarin, and Dyax",,," 9/24/2014 37555810   PRN  Critical Alerts For Gilead Sciences, Ambarella, American Capital Agency, NetApp and Ford Released By InvestorsObserver","10/31/2016 04004760   PRN  Arena Pharmaceuticals to Release Third Quarter 2016 Financial Results and Provide Corporate Update on Monday, November 7, 2016",11/10/2017 N5946510  PRN  Mylan Announces Voluntary Delisting from the Tel Aviv Stock Exchange (TASE),,,11/30/2018 03116210 PRN  Amgen And UCB Announce FDA Advisory Committee Meeting To Review EVENITY™ (romosozumab) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture,," 9/11/2014 52887230 PRN  Lexicon Announces A Publication In The American Diabetes Association's Journal, Diabetes Care",, 2/23/2011 002T0L-E PRN  Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call,,"10/03/2014 45773H20 PRN  Critical Alerts For General Electric, Inovio Pharmaceuticals, Mylan, Rite Aid and Delta Airlines Released By InvestorsObserver",10/28/2016 NKTR-US  PRN  Nektar to Hold Investor & Analyst Event at 2016 Society for Immunotherapy of Cancer Annual Meeting, 7/28/2015 76655960 PRN  Rigel Announces Conference Call and Webcast to Report Second Quarter 2015 Financial Results,,,,, 6/29/2015 UTHR-US  PRN  Dean Judy D. Olian Joins the United Therapeutics Corporation Board of Directors,," 4/09/2013 G0176710 PRN  Hospira, Delcath Systems, Valeant Pharma, and Alkermes Under StockCall's Microscope",,,, 1/28/2015 55027E10 PRN  Luminex Corporation To Present At 2015 Leerink Global Healthcare Conference, 7/26/2016 80067710 PRN  Sangamo BioSciences Announces New Gene Therapy Clinical Development Program for Treatment Of Hemophilia A,, 7/21/2017 80105N10  PRN  Regeneron and Sanofi Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis," 7/07/2011 NOV-US    PRN  The Zacks Analyst Blog Highlights: Medco Health Solutions, Merck, Vertex Pharmaceuticals, National Oilwell Varco and Ameron International",,,,,,,,,,,12/27/2012 68214310 PRN  Omeros Reports OMS103HP Phase 3 Clinical Trial Results,,,,,,,,11/11/2015 PDLI-US  PRN  PDL BioPharma to Present at the Jefferies Autumn 2015 Global Healthcare Conference,,,, 4/07/2015 00182C10 PRN  ANI Pharmaceuticals Presents At 14th Annual Needham Healthcare Conference,,,,, 9/10/2014 60468T10 PRN  Mirati Therapeutics to Present at BioCentury's NewsMakers in the Biotech Industry Conference,,,,,,, 3/02/2016 0BP4MZ-E PRN  Blueprint Medicines to Present at Cowen and Company 36th Annual Health Care Conference,, 8/17/2016 28249U10 PRN  Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock,,,,,,, 8/05/2015 92165910 PRN  HETLIOZ® (tasimelteon) Phase III SET and RESET Trial Results Published in The Lancet,,,,, 3/16/2016 40637H10 PRN  Halozyme Doses First Patient In Phase 3 Clinical Trial Of PEGPH20 In Combination With ABRAXANE® And Gemcitabine, 7/15/2011 G2151510 PRN  China Biologic Evaluating Possible Effects from a Revised Provincial Plan on Plasma Collection Stations in Guizhou Province,,,,,,10/03/2017 69366J20 PRN  RG7916 Increased SMN Protein Production in SUNFISH Clinical Trial in Patients with Type 2/3 Spinal Muscular Atrophy,,,,,,," 5/14/2014 36197T10 PRN  Health Care Sector Equities Technical Analysis -- Research on CombiMatrix, Quintiles Transnational Holdings, Pfizer, and GW Pharma",, 9/07/2016 MS-US    PRN  Jazz Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference,,,,," 5/13/2014 92337F10 PRN  Veracyte, Inc. Launches Afirma® Malignancy Classifiers to Further Help Thyroid Nodule Patients Avoid Unnecessary Surgeries and Lower Healthcare Costs",,,,,,,,,,,,,,,, 8/05/2014 98401F10 PRN  Xencor to Present at Wedbush Securities 2014 Life Sciences Management Access Conference,,11/21/2016 G8807B10 PRN  Theravance Biopharma Highlights Filing of U.S. New Drug Application for the Closed Triple in COPD by GlaxoSmithKline and Innoviva,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"11/07/2011 002WRP-E    PRN  Top Stock Alerts for Day Traders: Rackspace Hosting, Acme Packet, Evergreen Energy, Universal Display, Altera & Illumina",, 2/24/2017 G3040110 PRN  Endo Pharmaceuticals Inc. Issues Voluntary Nationwide Recall for One Lot of Edex® (alprostadil for injection) 10 mcg 2 Pack Carton Due to Potential Lack of Sterility Assurance,," 7/23/2014 09060J10 PRN  Equities to Watch in the Health Care Sector -- ImmunoCellular Therapeutics, Aeterna Zentaris, Lexicon Pharma, BioDelivery Sciences Intl., and Jazz Pharma", 5/02/2017 09073M10    PRN  Bio-Techne Declares Dividend, 6/04/2018 75886F10    PRN  New England Journal of Medicine Publishes Pivotal Cemiplimab Trials Showing Positive Results in Advanced Cutaneous Squamous Cell Carcinoma,, 7/03/2013 68375N10 PRN  PROLOR Biotech to Present Positive Results From Preclinical Studies of Long-Acting Clotting Factor VIIa-CTP at ISTH 2013," 3/24/2017 46222210 PRN  Lifshitz & Miller LLP Announces Investigation of Air Methods Corporation, Fortress Investment Group LLC, Galena Biopharma, Inc., Ionis Pharmaceuticals, Inc., LMI Aerospace, Inc., Lumos Networks Corp., Silver Bay Realty Trust Corp. and TerraForm Global, Inc."," 4/20/2017 09061G10   PRN  BioMarin to Host First Quarter 2017 Financial Results Conference Call and Webcast on Thursday, May 4 at 4:30pm ET",, 1/03/2017 0035K2-E PRN  Neurocrine Biosciences to Present at the 35th Annual J.P. Morgan Healthcare Conference,,,"10/23/2013 09062X10  PRN  Financial Results Schedules, Discontinuation of Phase 3 Trial, Data Presentations, Strategic Alliances, and Premarket Filings - Research Report on Biogen, Ariad, BioMarin, Alnylam, and Sequenom",,," 9/24/2014 37555810   PRN  Critical Alerts For Gilead Sciences, Ambarella, American Capital Agency, NetApp and Ford Released By InvestorsObserver","10/18/2016 04004760   PRN  Biotech Review DVAX Vaccine Faces Crucial PDUFA Date, CLDX Seeks Fast-Track Orphan Drug Status",11/09/2017 N5946510  PRN  Mylan Launches Generic Clolar® for Injection,,,11/28/2018 03116210 PRN  Amgen To Webcast Investor Call At ASH 2018,, 9/04/2014 52887230 PRN  Lexicon To Present At The Morgan Stanley 2014 Global Healthcare Conference,,12/16/2010 002T0L-E PRN  NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule,, 9/30/2014 45773H20 PRN  Inovio Pharmaceuticals Appoints Vice President of Commercial Development,10/28/2016 64026810 PRN  Nektar Therapeutics Announces Upcoming Presentations at the 2016 Society for Immunotherapy of Cancer Annual Meeting, 6/30/2015 RIGL-US  PRN  Rigel Welcomes Keith A. Katkin to Board of Directors,,,,, 6/15/2015 UTHR-US  PRN  United Therapeutics Corporation Receives Paragraph IV Notice Letter for Tyvaso,," 4/01/2013 08ZX40-E PRN  Will Safety Concerns Slow Nanotechnology Drug Delivery Market Growth? Forecasts Predict 84.79% Growth in US, 73.97% Globally through 2016",,,, 1/21/2015 55027E10 PRN  Luminex xMAP® Tracks 6 of the Most Dangerous Biotoxins, 7/12/2016 SGMO-US  PRN  Sangamo BioSciences Announces Participation At Upcoming Scientific Conferences in July,, 7/17/2017 80105N10  PRN  Sanofi Pasteur Ships First of its U.S. Influenza Vaccine Doses for 2017-2018 Season," 6/15/2011 BIIB-US   PRN  Zacks Industry Outlook Highlights: Bristol-Myers Squibb, Vertex Pharma, Abbott Labs, Allergan and Biogen Idec",,,,,,,,,,,12/06/2012 68214310 PRN  Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program,,,,,,,,11/06/2015 PDLI-US  PRN  PDL BioPharma Provides Additional Information Regarding Acquired Diabetes Royalty Rights,,,, 3/31/2015 00182C10 PRN  ANI Pharmaceuticals Announces the Launch of Propafenone Tablets,,,,, 9/04/2014 60468T10 PRN  Mirati Therapeutics Initiates Phase 1 Study of MGCD516 for Non-Small Cell Lung Cancer and Other Advanced Solid Tumors,,,,,,, 2/16/2016 09627Y10 PRN  Blueprint Medicines to Present at RBC Capital Markets 2016 Global Healthcare Conference,, 8/10/2016 28249U10 PRN  Eiger BioPharmaceuticals Reports Second Quarter 2016 Financial Results,,,,,,, 8/03/2015 VNDA-US  PRN  Vanda Announces Listing of Four New Fanapt® Patents in the FDA Orange Book,,,,, 3/07/2016 40637H10 PRN  Halozyme Appoints Jim Daly To Board Of Directors, 7/13/2011 G2151510 PRN  China Biologic Notified That Guizhou Provincial Government Suspends Implementation of Plan Affecting Plasma Collection Stations,,,,,," 9/27/2017 69366J20 PRN  Long-Term PTC Investors: Johnson Fistel Initiates Investigation of PTC Therapeutics, Inc.; Encourages Investors to Contact the Firm",,,,,,, 5/09/2014 36197T10 PRN  Research & Development Kick Into High Gear For Cannabis Based Medicine - New Collaboration Agreement For Development of Cannabis Based Skin Cancer Medicine,," 9/07/2016 G5087110 PRN  Research Reports Coverage on Biotech Stocks -- Biogen, ImmunoGen, Jazz Pharma, and Cempra",,,,," 5/08/2014 92337F10 PRN  Veracyte, Inc. Announces First Quarter 2014 Financial Results",,,,,,,,,,,,,,,, 7/31/2014 98401F10 PRN  Xencor Reports Second Quarter 2014 Financial Results,,"11/08/2016 G8807B10 PRN  Theravance Biopharma, Inc. Reports Third Quarter 2016 Financial Results and Provides Business Update",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/09/2011 002WRP-E    PRN  deCODE Genetics, in Collaboration with Academic Colleagues and Illumina, Discovers Two Rare Variants that Affect the Risk of Gout and Serum Uric Acid Levels",, 2/13/2017 G3040110 PRN  Endo to Announce Fourth-Quarter and Full-Year 2016 Financial Results,, 7/22/2014 09060J10 PRN  BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors, 5/02/2017 09073M10    PRN  Bio-Techne Releases Third Quarter Fiscal 2017 Results, 5/31/2018 75886F10    PRN  Regeneron's Investigational Ebola Treatment Shipping to Democratic Republic of the Congo for Use in Current Outbreak,, 6/04/2013 68375N10 PRN  PROLOR Biotech Initiates Pivotal Phase III Trial Of Its Longer-Acting Version Of Human Growth Hormone," 3/06/2017 46222210 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ionis Pharmaceuticals, Inc. (IONS)", 4/13/2017 09061G10   PRN  BioMarin Announces Kuvan® (sapropterin dihydrochloride) Patent Challenge Settlement,,12/21/2016 64125C10 PRN  Neurocrine Biosciences Announces Chief Financial Officer Timothy P. Coughlin to Step Down,,,10/16/2013 IONS-US   PRN  Isis Earns $10 Million Milestone Payment from Biogen Idec for Advancement of ISIS-DMPK Rx to Treat Myotonic Dystrophy,,," 9/22/2014 37555810   PRN  Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo",10/11/2016 04004760   PRN  Arena Pharmaceuticals Announces Acceptance of Late Breaking Etrasimod Abstract at the United European Gastroenterology Week (UEGW) Meeting,11/06/2017 N5946510  PRN  Mylan Reports Third Quarter 2017 Results and Updates 2017 Guidance,,,11/21/2018 03116210 PRN  Amgen To Present At the Piper Jaffray And Evercore ISI Healthcare Conferences,," 8/27/2014 52887230 PRN  Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma",,"12/02/2010 002T0L-E PRN  Insmed Incorporated and Transave, Inc. Announce Business Combination",, 9/24/2014 45773H20 PRN  Inovio Pharmaceuticals Ebola Vaccine Moving into Human Trial with GeneOne Life Science,"10/27/2016 64026810 PRN  Nektar to Announce Financial Results for the Third Quarter 2016 on Thursday, November 3, 2016, After Close of U.S.-Based Financial Markets", 5/28/2015 76655960 PRN  Rigel to Present at Jefferies 2015 Global Healthcare Conference,,,,, 5/29/2015 91307C10 PRN  United Therapeutics Corporation To Present At The Jefferies 2015 Global Healthcare Conference,," 3/27/2013 ALKS-IE  PRN  Critical Alerts For AIG, Western Digital, ResMed, Alkermes, and FleetCor Technologies Released By InvestorsObserver",,,," 1/20/2015 55027E10 PRN  Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 2, 2015", 6/20/2016 06CR5C-E PRN  Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II,, 6/27/2017 80105N10  PRN  American Academy of Family Physicians Foundation Launches Highlight on VACCINATIONS 4 TEENS to Help Address Teen Under-Vaccination, 6/10/2011 000YJB-E  PRN  Vertex Plans to Provide Access to Potential CF Therapy VX-770 for Patients with Critical Medical Need,,,,,,,,,,,"11/29/2012 68214310 PRN  Omeros Appoints Thomas A. Mitro as Vice President, Sales and Marketing",,,,,,,,11/04/2015 69329Y10 PRN  PDL BioPharma Announces Third Quarter 2015 Financial Results,,,, 3/10/2015 00182C10 PRN  ANI Pharmaceuticals Announces the Launch of Etodolac 200mg Capsules,,,,, 8/11/2014 60468T10 PRN  Mirati Therapeutics Receives Orphan Designation from U.S. Food & Drug Administration for Mocetinostat in Diffuse Large B-Cell Lymphoma,,,,,,, 2/04/2016 0BP4MZ-E PRN  Blueprint Medicines Appoints Lonnel Coats to Board of Directors,, 8/08/2016 28249U10 PRN  Eiger BioPharmaceuticals to Present at the 2016 Wedbush PacGrow Healthcare Conference on August 17th,,,,,,, 7/29/2015 92165910 PRN  Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results,,,,, 3/02/2016 0024VM-E PRN  Halozyme Therapeutics To Present At Upcoming Healthcare Conferences, 7/11/2011 G2151510 PRN  China Biologic to Open Plasma Collection Station in Shandong Province,,,,,," 9/26/2017 69366J20 PRN  PTC INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In PTC Therapeutics, Inc. To Contact The Firm",,,,,,, 4/16/2014 36197T10 PRN  Marijuana Index Fights Through Recent Pressure - Company Looks To Reduce Outstanding Shares To Fund Expansion,, 8/09/2016 G5087110 PRN  Jazz Pharmaceuticals Announces Second Quarter 2016 Financial Results,,,,, 5/07/2014 92337F10 PRN  Preliminary Data Supporting Veracyte Molecular Classifier for Idiopathic Pulmonary Fibrosis (IPF) Diagnosis to be Presented at ATS 2014,,,,,,,,,,,,,,,, 7/24/2014 98401F10 PRN  Xencor to Host Second Quarter 2014 Financial Results Webcast and Conference Call,,"11/01/2016 G8807B10 PRN  Theravance Biopharma to Report Third Quarter 2016 Financial Results on November 8, 2016",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/02/2011 002WRP-E    PRN  deCODE Genetics, in Collaboration with Academic Colleagues and Illumina, Discovers Mutations Conferring High Risk of Ovarian Cancer",," 1/30/2017 G3040110 PRN  Endo Announces U.S. FDA Approval of Ephedrine Sulfate Injection, USP",, 7/07/2014 05MBN8-E PRN  Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA® buprenorphine in opioid-experienced patients with chronic pain, 4/24/2017 09073M10    PRN  Bio-Techne To Present At The Deutsche Bank 42nd Annual Health Care Conference, 5/21/2018 000VC1-E    PRN  Koneksa Health to Present Asthma Study at the 2018 American Thoracic Society (ATS) International Conference,," 4/29/2013 0BGL4K-E PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health, Inc.", 3/06/2017 46222210 PRN  Akcea and Ionis Announce Positive Results from Pivotal Study of Volanesorsen in Patients with Familial Chylomicronemia Syndrome (FCS), 2/23/2017 09061G10   PRN  BioMarin Announces Fourth Quarter and Full Year 2016 Financial Results,,12/07/2016 NBIX-US  PRN  Neurocrine Biosciences to Present at the 2016 BMO Capital Markets Prescription for Success Healthcare Conference,,,"10/11/2013 09062X10  PRN  Scheduled Earnings Releases, Survey and Study Results, and Enrollment into Clinical Trial - Research Report on Biogen Idec, Questcor, Medivation, Agenus, and Arrowhead Research",,, 9/19/2014 37555810   PRN  Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent,10/03/2016 04004760   PRN  Eisai Inc. and Arena Pharmaceuticals Announce Availability of Once-Daily BELVIQ XR® (lorcaserin HCl) Extended-Release Tablets,11/01/2017 N5946510  PRN  Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting,,,11/16/2018 03116210 PRN  Amgen Receives CHMP Positive Opinion To Expand Use Of BLINCYTO® (Blinatumomab) In Patients With Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia,, 8/08/2014 52887230 PRN  Lexicon To Present At The 2014 Wedbush Life Sciences Management Access Conference,,"11/03/2010 002T0L-E PRN  Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010",, 9/22/2014 45773H20 PRN  Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers,10/19/2016 64026810 PRN  Nektar Therapeutics Prices Public Offering of Shares of Common Stock, 5/07/2015 76655960 PRN  Rigel Announces First Quarter 2015 Financial Results,,,,," 5/21/2015 91307C10 PRN  Critical Alerts For United Therapeutics Corporation, Yahoo!, Chesapeake Energy, Clean Energy Fuels and CyberArk Software Released By InvestorsObserver",," 3/11/2013 G0176710 PRN  Morning Research on Valeant Pharma Intl., Hospira, Delcath Systems, and Alkermes",,,,12/29/2014 55027E10 PRN  Luminex Corporation To Present At J.P. Morgan Healthcare Conference, 6/01/2016 80067710 PRN  Sangamo BioSciences Announces Presentation at the Jefferies 2016 Healthcare Conference,, 6/27/2017 80105N10  PRN  Regeneron and Sanofi Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the European Union, 6/09/2011 000YJB-E  PRN  Phase 2 Study of Two Potential CF Therapies — VX-770 and VX-809 — Shows Promising Results in Patients with Most Common Mutation,,,,,,,,,,,11/20/2012 68214310 PRN  Omeros to Present at the 24th Annual Piper Jaffray Health Care Conference,,,,,,,,"10/28/2015 69329Y10 PRN  PDL BioPharma to Announce Third Quarter 2015 Financial Results on November 4, 2015",,,, 3/05/2015 00182C10 PRN  ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals,,,,, 8/08/2014 60468T10 PRN  Mirati Therapeutics Reports Second Quarter 2014 Financial Results and Provides Business Update,,,,,,, 1/05/2016 09627Y10 PRN  Blueprint Medicines Strengthens Executive Leadership Team,, 7/25/2016 28249U10 PRN  Eiger BioPharmaceuticals Announces First Patient Dosed in Phase 2 ULTRA Study of Ubenimex in Secondary Lymphedema,,,,,,," 7/09/2015 92165910 PRN  Vanda Pharmaceuticals to Announce Second Quarter 2015 Financial Results on July 29, 2015",,,,, 2/29/2016 40637H10 PRN  Halozyme Reports Fourth Quarter And Full Year 2015 Financial Results, 7/11/2011 G2151510 PRN  China Biologic Evaluating Possible Effects from a New Provincial Plan on Plasma Collection Stations in Guizhou Province,,,,,, 9/21/2017 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,," 4/15/2014 36197T10 PRN  Medical Marijuana Operators and Facility Providers Expand Operations - Company Adds Well Known, Major Marijuana Authority to Board of Directors",, 8/02/2016 G5087110 PRN  CMS Grants New Technology Add-On Payment to Defitelio for the Treatment of Hepatic Veno-Occlusive Disease with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation,,,,, 5/06/2014 92337F10 PRN  New Data Validating Veracyte's Afirma® Malignancy Classifiers to be Presented at AACE Congress,,,,,,,,,,,,,,,, 7/15/2014 98401F10 PRN  Xencor Appoints Kurt Gustafson to Board of Directors; Promotes John Desjarlais to Chief Scientific Officer,,11/01/2016 G8807B10 PRN  New Data for VIBATIV® (telavancin) Reported in Presentations at IDWeek™ 2016,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 9/29/2011 002WRP-E    PRN  Verinata Health Announces a Multi-Year Supply Agreement with Illumina in the Field of Non-Invasive Prenatal Diagnostics,, 1/26/2017 G3040110 PRN  Endo Announces Actions to Drive Greater Efficiency and Business Alignment,," 7/03/2014 09060J10 PRN  Positive Study Results, Patent Grants, Acquisitions, Patient Enrollment, and Earnings Schedule - Analyst Notes on Synageva, OPKO, bluebird bio, BioDelivery Sciences and Haemonetics", 4/19/2017 09073M10    PRN  RNAscope Technology Reveals Replication of Zika Virus in Brains of Infants with Microcephaly and Placentas of Women with Pregnancy Losses, 5/21/2018 75886F10    PRN  New England Journal of Medicine Publishes Two Positive Phase 3 Trials Showing DUPIXENT® (dupilumab) Improved Moderate-to-Severe Asthma,," 4/25/2013 007WL2-E PRN  Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.", 2/28/2017 46222210 PRN  Ionis' 2016 Financial Results Outperform Financial Guidance, 2/15/2017 09061G10   PRN  BioMarin Announces 11 Presentations at 13th Annual WORLDSymposium™ 2017,,12/06/2016 ARIA-US  PRN  New Collaborations and Licensing Activities for Biotech/Pharma Industries Pick Up Pace Heading into 2017,,,"10/04/2013 09062X10  PRN  Conference Calls, Philanthropic Activities, Clinical Trial Data, and Regulatory Approvals - Research Report on Celgene, UnitedHealth, Biogen Idec, WellPoint, and Medtronic",,," 9/12/2014 37555810   PRN  Study Results, New Collaboration, Drug Designation, Technical Update, and Completion of Transaction - Research Reports on Gilead, AbbVie, Pfizer, United Therapeutics and Brookdale", 9/01/2016 04004760   PRN  Arena Pharmaceutics Announces Formation of Beacon Discovery,11/01/2017 N5946510  PRN  Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting,,,11/15/2018 0B9LPC-E PRN  The Netherlands' BioPharma Sector Intensifies Through Innovation,, 8/07/2014 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Second Quarter Financial Results,,10/26/2010 002T0L-E PRN  Insmed to Host Third Quarter 2010 Conference Call,, 9/18/2014 45773H20 PRN  Inovio to Present at Upcoming Investor Conferences,10/17/2016 64026810 PRN  Nektar Therapeutics Announces Public Offering of Shares of Common Stock, 4/30/2015 76655960 PRN  Rigel Announces Conference Call and Webcast to Report First Quarter 2015 Financial Results and Pipeline Update,,,,," 5/07/2015 91307C10 PRN  Biotech Stocks in Motion -- Vertex Pharma, Advaxis, Merrimack Pharma, Tekmira Pharma, and United Therapeutics",," 3/08/2013 G0176710 PRN  New Partnerships & Brand Loyalty - Research Report on Acura Pharmaceuticals, Élan Corp, Hospira, Alkermes and Valeant",,,,10/27/2014 55027E10 PRN  Luminex Corporation Reports Third Quarter 2014 Results, 6/01/2016 80067710 PRN  Sangamo BioSciences Announces Retirement Of Edward Lanphier As President And CEO; Sandy Macrae Named As Successor,, 6/11/2017 80105N10  PRN  Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia," 6/07/2011 RRC-US    PRN  Daily Stock Alerts for Range Resources, Apache, Vertex, MEMC Electronic Materials, AutoZone, & Linear",,,,,,,,,,,11/15/2012 68214310 PRN  GPR17-Targeting Compounds Identified by Omeros Promote Myelination,,,,,,,, 9/23/2015 69329Y10 PRN  PDL BioPharma Announces Successful Conclusion of Agreement with Avinger,,,, 3/04/2015 00182C10 PRN  ANI Pharmaceuticals To Present At 27th Annual ROTH Conference,,,,, 6/30/2014 60468T10 PRN  Mirati Therapeutics Added to Russell 2000 Index,,,,,,,12/17/2015 0BP4MZ-E PRN  Blueprint Medicines Added to NASDAQ Biotechnology Index,, 7/20/2016 EIGR-US  PRN  Eiger BioPharmaceuticals Announces Completion of Dosing in Phase 2 LOWR HDV - 3 Study at National Institutes of Health (NIH),,,,,,, 7/07/2015 92165910 PRN  HETLIOZ® Receives European Commission Approval for the Treatment of Non-24-Hour Sleep-Wake Disorder in the Totally Blind,,,,, 2/01/2016 40637H10 PRN  Halozyme To Host Fourth Quarter And 2015 Year-End Financial Results Conference Call," 6/22/2011 G2151510 PRN  China Biologic Products Will Present at the Brean Murray, Carret Conference in Beijing on June 27, 2011",,,,,, 9/07/2017 69366J20 PRN  PTC Therapeutics Announces Winners of Global Duchenne Muscular Dystrophy Patient Group STRIVE Awards in Recognition of World Duchenne Awareness Day,,,,,,, 4/10/2014 36197T10 PRN  Marijuana Sector Turns Green with High Volume Activity - Company Strengthens Security Platform With Highly Experienced CTO In Cyber Security Industry,," 7/29/2016 G5087110 PRN  Covered Call reports for Marathon Oil Corporation, Amazon.com, Jazz Pharmaceuticals, Kellogg Company and Nike include trade ideas that offer returns of 20% or more!",,,,, 5/02/2014 92337F10 PRN  Veracyte and Fleury Announce Partnership to Make the Afirma® Gene Expression Classifier Available to Patients in Brazil,,,,,,,,,,,,,,,, 5/28/2014 98401F10 PRN  Xencor Initiates Phase 1 Study of XmAb7195 for Asthma,,10/31/2016 G8807B10 PRN  Theravance Biopharma Presents Interim Data from Ongoing Telavancin Observational Use Registry (TOUR™) at IDWeek™ 2016,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 9/25/2011 002WRP-E    PRN  deCODE genetics, Together with Academic Collaborators and Illumina, Discovers Genetic Risk Factor for Skin, Prostate and Brain Cancers",, 1/23/2017 PRX-US   PRN  Endo Announces Agreement to Resolve Federal Trade Commission Investigation and Litigation,, 6/26/2014 09060J10 PRN  BioDelivery Sciences Announces Completion of Patient Enrollment in its Initial Phase 3 Trial of Clonidine Topical Gel for Painful Diabetic Neuropathy," 4/18/2017 09073M10    PRN  Bio-Techne To Host Conference Call On May 2, 2017 To Announce Third Quarter Financial Results", 5/18/2018 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentation,," 4/24/2013 68375N10 PRN  Acquisition of PROLOR Biotech, Inc. by OPKO Health, Inc. May Not Be in the Best Interests of PROLOR Shareholders", 2/16/2017 46222210 PRN  Ionis and Akcea Close on Strategic Collaboration with Global Pharmaceutical Company to Develop and Commercialize AKCEA-APO(a)-LRx and AKCEA-APOCIII-LRx, 2/08/2017 088WCW-E   PRN  BioMarin to Attend Three Investor Conferences in 1Q17,,12/05/2016 64125C10 PRN  Neurocrine Biosciences Announces INGREZZA™ (valbenazine) Long-Term Data to be Presented at the 55th Annual Meeting of the American College of Neuropsychopharmacology,,,"10/02/2013 09062X10  PRN  Presentation on Research Findings, Recognitions, Clinical Trial Results, and Orphan Drug Designations - Research Report on Celgene, Biogen Idec, Amgen, Nektar, and Zalicus",,," 9/09/2014 37555810   PRN  Critical Alerts For Gilead Sciences, Incyte Corp., Infinera Corporation, Ford and Pixelworks Released By InvestorsObserver", 8/15/2016 04004760   PRN  Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer,10/31/2017 N5946510  PRN  Mylan Provides Statement in Response to Announcement of Proposed Amendments to Civil Complaint,,,11/12/2018 03116210 PRN  Amgen Presents Results Highlighting The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In The Longest Duration Study Of A PCSK9 Inhibitor To Date At AHA Scientific Sessions 2018,," 8/05/2014 52887230 PRN  Lexicon To Report Second Quarter 2014 Financial Results On August 7, 2014",," 8/04/2010 002T0L-E PRN  Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2010",, 9/15/2014 45773H20 PRN  Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange, 9/27/2016 64026810 PRN  Nektar Therapeutics to Host Investor & Analyst Conference Call to Discuss New Clinical Collaboration with Bristol-Myers Squibb," 4/29/2015 76655960 PRN  Recent Highlights Across Sectors: Complementary Research on Rigel Pharma, Acacia Research, Legacy Reserves, Ubiquiti Networks, and ResMed",,,,, 5/01/2015 91307C10 PRN  United Therapeutics Corporation To Present At The Deutsche Bank 40th Annual Health Care Conference,," 2/05/2013 000HYN-E PRN  The Zacks Analyst Blog Highlights: Elan, Alkermes, Biogen Idec, Valeant Pharmaceuticals and Duke Energy",,,,"10/15/2014 55027E10 PRN  Luminex Corporation Announces Retirement of Patrick Balthrop, President and CEO", 5/10/2016 004MR2-E PRN  Sangamo BioSciences Announces Participation At Upcoming Investor Conferences,, 6/11/2017 80105N10  PRN  Regeneron and Sanofi Announce Positive Results from First Dedicated Studies Evaluating Praluent® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia," 5/11/2011 COV-IE    PRN  Daily Insider Trade Alerts for International Paper, Accenture, Vertex, Covidien, Bristol-Myers, & Duke Energy",,,,,,,,,,,11/13/2012 68214310 PRN  Omeros is Not Aware of Any Justification for Share Price Movement,,,,,,,, 9/21/2015 ACRX-US  PRN  AcelRx Pharmaceuticals Receives $65 Million from the Partial Sale of Zalviso™ European Royalties and Commercial Milestones to PDL BioPharma,,,, 2/19/2015 00182C10 PRN  ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2014 Financial Results,,,,, 6/17/2014 60468T10 PRN  Mirati Therapeutics Receives Orphan Drug Designation from U.S. Food & Drug Administration for Mocetinostat in Myelodysplastic Syndrome,,,,,,,12/01/2015 09627Y10 PRN  Blueprint Medicines and PatientCrossroads Launch Registry for Mastocytosis Patients to Increase Understanding of Disease and Speed Therapeutic Development,, 7/18/2016 28249U10 PRN  Eiger BioPharmaceuticals Announces First Patient Dosed in Phase 2 LIBERTY Study of Ubenimex in Pulmonary Arterial Hypertension,,,,,,, 7/02/2015 92165910 PRN  Vanda Announces Listing of a New HETLIOZ® Patent in the FDA Orange Book,,,,, 1/26/2016 40637H10 PRN  Halozyme Announces Closing Of $150 Million Royalty-Backed Debt Financing," 6/03/2011 G2151510 PRN  China Biologic Products Will Present at Jefferies Global Healthcare Conference in New York on June 9, 2011",,,,,, 8/10/2017 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 3/21/2014 36197T10 PRN  Cannabis Sector Continues Rapid Expansions - Company Locates Headquarters in California & Announces 506 Capital Raise Initiative,, 7/28/2016 G5087110 PRN  Jazz Pharmaceuticals and Pfenex Enter into a Worldwide License and Option Agreement Related to Product Candidates in Early Development for Hematological Malignancies,,,,," 5/01/2014 92337F10 PRN  Veracyte, Inc. to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 8, 2014",,,,,,,,,,,,,,,, 5/22/2014 98401F10 PRN  Xencor to Present at Jefferies 2014 Global Healthcare Conference,,"10/28/2016 G8807B10 PRN  Theravance Biopharma Announces Pricing of Public Offerings of 3,850,000 Ordinary Shares and $200 Million of 3.25% Convertible Senior Notes due 2023",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 9/20/2011 0616ZW-E    PRN  Dr. Karen Kerr Joins the USC Stevens Institute for Innovation as Senior Director of New Ventures and Alliances,,12/21/2016 G3040110 PRN  Endo Announces Appointments and Updates to Executive Management Team,," 6/11/2014 09060J10 PRN  BioDelivery Sciences Featured on Bloomberg TV, TheStreet.com and Business News Network"," 3/07/2017 09073M10    PRN  Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for Adult ""Ground-state"" Stem Cell Technology", 5/16/2018 75886F10    PRN  Regeneron and Sanofi Share First Positive Clinical Data for Cemiplimab in Advanced Non-small Cell Lung Cancer at ASCO,," 4/24/2013 0CJTL8-E PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of PROLOR Biotech, Inc. - PBTH", 2/15/2017 46222210 PRN  Ionis Pharmaceuticals to Hold 2016 Financial Results Conference Call," 2/07/2017 09061G10   PRN  BioMarin to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast on Thursday, February 23 at 4:30pm ET",,11/29/2016 64125C10 PRN  Neurocrine Announces FDA Advisory Committee Meeting to Review INGREZZA™ (valbenazine) New Drug Application for the Treatment of Tardive Dyskinesia,,," 9/16/2013 09062X10  PRN  Collaborations, New Studies, and New Drug Applications - Research Report on Amgen, Gilead, Abbott, Biogen Idec, and UnitedHealth",,," 9/04/2014 37555810   PRN  Upcoming Event, Drug Approval, Technical Updates, and Research Grant - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Thermo Fisher", 8/08/2016 04004760   PRN  Arena Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update,10/27/2017 N5946510  PRN  Mylan's EpiPen4Schools® Program Surpasses One Million Free Epinephrine Auto-Injector Donations to U.S. Schools,,,"11/12/2018 03116210 PRN  Amgen Foundation Pledges $500,000 In Relief To Victims Of Ventura And Los Angeles County Wildfires",," 7/23/2014 52887230 PRN  Equities to Watch in the Health Care Sector -- ImmunoCellular Therapeutics, Aeterna Zentaris, Lexicon Pharma, BioDelivery Sciences Intl., and Jazz Pharma",, 7/28/2010 002T0L-E PRN  Insmed to Host Second Quarter 2010 Conference Call,, 9/04/2014 45773H20 PRN  Inovio Pharmaceuticals to List on NASDAQ, 8/03/2016 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Second Quarter of 2016, 3/03/2015 76655960 PRN  Rigel Announces Fourth Quarter and Year End 2014 Financial Results,,,,, 4/28/2015 91307C10 PRN  United Therapeutics Corporation Reports First Quarter 2015 Financial Results,," 1/21/2013 005RBG-E PRN  Zacks Bull and Bear of the Day Highlights: Alkermes, China Life Insurance, Chipotle Mexican Grill, Panera Bread and Jack in the Box",,,,"10/13/2014 55027E10 PRN  Luminex Corporation Third Quarter Earnings Release Scheduled for October 27, 2014", 5/09/2016 80067710 PRN  Sangamo BioSciences Presents Recent Developments From Research And ZFP Therapeutic® Programs In Multiple Presentations At Annual Meeting of the American Society of Gene and Cell Therapy,, 6/10/2017 80105N10  PRN  New Analysis Shows Sanofi's Soliqua® 100/33 Lowered HbA1c by More Than 2 Percent in Patients with Screening Levels Greater than 9 Percent," 5/10/2011 WW-US     PRN  Critical Alerts For Alcoa, NVIDIA, Baker Hughes, Vertex Pharmaceuticals, and Weight Watchers Released By Seven Summits Research",,,,,,,,,,,11/09/2012 68214310 PRN  Omeros Corporation Reports Third Quarter 2012 Financial Results,,,,,,,, 9/21/2015 PDLI-US  PRN  PDL BioPharma Acquires a Portion of AcelRx Pharmaceuticals' Expected Royalties and Commercial Milestones from Zalviso™ for $65 Million,,,, 2/12/2015 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2014 Financial Results,,,,, 6/12/2014 60468T10 PRN  Mirati Therapeutics to Present at the 9th Annual JMP Securities Healthcare Conference,,,,,,,11/12/2015 0BP4MZ-E PRN  Blueprint Medicines to Present Preclinical Data at 2015 ASH Annual Meeting Demonstrating Anti-tumor Activity of BLU-285 in a Model of Acute Myeloid Leukemia,, 7/06/2016 0G4L3T-E PRN  Eiger BioPharmaceuticals to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference on July 12th,,,,,,, 6/23/2015 VNDA-US  PRN  Vanda Announces Positive Results from the Relapse Prevention Study in Patients with Schizophrenia (REPRIEVE) Demonstrating the Long-Term Maintenance Effects of Fanapt® (iloperidone),,,,, 1/21/2016 HALO-US  PRN  Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE™ Technology, 5/12/2011 G2151510 PRN  China Biologic Products to Present at Two Upcoming Investor Conferences,,,,,, 8/08/2017 69366J20 PRN  PTC Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update,,,,,,," 3/18/2014 36197T10 PRN  Medical Marijuana Industry Hitting New Highs -Company Closes $4.6 Million Dollar Acquisition of 83,000 S/F Industrial Park",, 7/28/2016 G5087110 PRN  Jazz Pharmaceuticals and Pfenex Enter into a Worldwide License and Option Agreement Related to Product Candidates in Early Development for Hematological Malignancies,,,,," 3/18/2014 92337F10 PRN  Veracyte, Inc. Announces Fourth Quarter and Full-Year 2013 Financial Results, Provides 2014 Financial Outlook",,,,,,,,,,,,,,,, 5/15/2014 98401F10 PRN  Xencor Presents Study Comparing XmAb7195 to Omalizumab at the American Thoracic Society 2014 International Conference,,10/26/2016 G8807B10 PRN  Theravance Biopharma Announces Proposed Public Offerings of $100 Million of Ordinary Shares and $150 Million of Convertible Senior Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 9/19/2011 001BFQ-E    PRN  Critical Stock Price Alerts for Yahoo, Exxon Mobil, CVS, RF Micro Devices, GT Advanced Technologies & Illumina",,12/20/2016 G3040110 PRN  Endo Announces Appointment of Blaise Coleman as Chief Financial Officer,, 6/10/2014 09060J10 PRN  BioDelivery Sciences to Present at the William Blair and Wells Fargo Healthcare Conferences, 3/01/2017 09073M10    PRN  Innovative Veterinary Diagnostic Setting A New Standard, 5/16/2018 75886F10    PRN  Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis,, 4/24/2013 68375N10 PRN  Management Buyout Of PROLOR - Law Firm Seeks Higher Price For Shareholders, 2/14/2017 46222210 PRN  Ionis Earns $75 Million from Bayer for Advancing IONIS-FXI Rx and IONIS-FXI-L Rx, 2/01/2017 09061G10   PRN  BioMarin Receives Access to Priority Medicines (PRIME) Regulatory Support from EMA for BMN 270 Gene Therapy in Hemophilia A,,11/21/2016 64125C10 PRN  Neurocrine Biosciences to Present at the 28th Annual Piper Jaffray Healthcare Conference,,," 9/12/2013 09062X10  PRN  FDA Approvals, Study Results, Multi-Year Collaborations, Data Presentations, and Supply Agreements - Research Report on Celgene, Amgen, Biogen Idec, Vertex, and Illumina",,," 9/03/2014 37555810   PRN  Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay"," 8/03/2016 04004760   PRN  Biotech Stocks Technical Report -- Arena Pharma, BIND Therapeutics, Nektar Therapeutics, and Regeneron Pharma","10/27/2017 N5946510  PRN  Daily Technical Summary Reports on Generic Drugs Stocks -- Ironwood Pharma, Mylan, Neurocrine Biosciences, and Versartis",,,11/05/2018 03116210 PRN  Amgen Announces Presentation Of Research Reinforcing The Long-Term Safety And Efficacy Of Repatha® (Evolocumab) In High-Risk Patients At AHA Scientific Sessions 2018,, 7/09/2014 52887230 PRN  Lexicon And JDRF Collaborate For Phase 2 Clinical Trial Of LX4211 In Type 1 Diabetes,, 6/21/2010 45766930 PRN  Insmed Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price,, 9/03/2014 45773H20 PRN  Inovio to Present at Upcoming Investor Conferences," 8/03/2016 64026810 PRN  Biotech Stocks Technical Report -- Arena Pharma, BIND Therapeutics, Nektar Therapeutics, and Regeneron Pharma"," 2/26/2015 76655960 PRN  Rigel Pharmaceuticals Collaboration Agreement Initiates Analyst Report Issued by BrokerBank Securities, Inc.",,,,," 4/21/2015 91307C10 PRN  United Therapeutics Corporation To Announce First Quarter 2015 Financial Results Before Market Open On Tuesday, April 28, 2015",,"10/26/2012 ALKS-IE  PRN  Zacks Bull and Bear of the Day Highlights: Alkermes, Avnet, Apple, Magellan Midstream Partners and Occidental Petroleum",,,, 9/29/2014 55027E10 PRN  Luminex Receives FDA Clearance To Add New Clinical Targets And Additional Sample Type For Use With xTAG® Gastrointestinal Pathogen Panel, 5/02/2016 80067710 PRN  Sangamo BioSciences Reports First Quarter 2016 Financial Results,," 6/10/2017 80105N10  PRN  In Senior Adults Treated with Basal Insulin, Switching to Sanofi's Toujeo® Halved Hypoglycemia Risk", 5/02/2011 VRTX-US   PRN  Reportlinker Adds R&D Trends: Hepatitis C,,,,,,,,,,,11/09/2012 68214310 PRN  Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer,,,,,,,, 9/16/2015 PDLI-US  PRN  Dr. Samuel Saks Joins PDL BioPharma's Board of Directors,,,, 2/03/2015 00182C10 PRN  ANI Pharmaceuticals Announces Appointment of Dr. David Sullivan to VP of Quality Operations,,,,, 5/22/2014 60468T10 PRN  Mirati Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference,,,,,,,11/09/2015 09627Y10 PRN  Blueprint Medicines Highlights Advances in Preclinical Discovery Efforts,, 6/13/2016 EIGR-US  PRN  Eiger Announces Positive Clinical Results of Single Ascending Dose Study of Subcutaneous Exendin (9-39) in Patients with Post-Bariatric Hypoglycemia,,,,,,, 6/19/2015 VNDA-US  PRN  Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference,,,,," 1/11/2016 HALO-US  PRN  Halozyme Provides Key Program Updates, 2016 Financial Guidance At 34th Annual JP Morgan Healthcare Conference"," 5/10/2011 G2151510 PRN  China Biologic Products Corrects two Administrative Errors in its May 9, 2011 Earnings Release",,,,,, 7/25/2017 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Second Quarter Financial Results,,,,,,," 3/13/2014 091B1B-E PRN  New Drug Applications, Earnings Release Schedules, Drug Designations, New Services, and Clinical Trials - Analyst Notes on Actavis, Intercept, GW Pharmaceuticals, Galena, and Conatus",," 7/25/2016 G5087110 PRN  Jazz Pharmaceuticals to Report 2016 Second Quarter Financial Results on August 9, 2016",,,,," 3/17/2014 92337F10 PRN  Veracyte, Inc. Appoints Julie A. Brooks as Executive Vice President, General Counsel and Secretary; and Andy Thorson as Executive Vice President, Corporate Strategy and Business Development",,,,,,,,,,,,,,,, 5/14/2014 98401F10 PRN  Xencor Reports First Quarter 2014 Financial Results,,"10/25/2016 G8807B10 PRN  Theravance Biopharma Announces Positive Results Including Biomarker Data from Phase 1 Multiple-Ascending Dose Study of TD-0714, an Inhibitor of Neprilysin (NEP)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 8/29/2011 45232710    PRN  Critical Alerts For Disney, Las Vegas Sands, Capital One, Green Mountain Coffee Roasters, and Illumina Released By Seven Summits Research",,12/19/2016 0035K2-E PRN  Endo to Present at the 35th Annual J.P. Morgan Healthcare Conference,, 6/09/2014 09060J10 PRN  BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence, 2/13/2017 09073M10    PRN  Bio-Techne To Present At The Leerink Partners 6th Annual Global Healthcare Conference, 5/16/2018 75886F10    PRN  Positive Phase 3 Trial of DUPIXENT® (dupilumab) in Adolescents with Inadequately Controlled Moderate-to-severe Atopic Dermatitis,, 4/24/2013 68375N10 PRN  OPKO Health To Acquire PROLOR Biotech, 2/02/2017 46222210 PRN  Ionis Earns $5 Million Milestone Payment from Biogen for Advancing a New Program Under Its Broad Neurology Strategic Collaboration, 1/08/2017 09061G10   PRN  BioMarin to Provide Update to Proof-of-Concept Data for BMN 270 Gene Therapy in Hemophilia A at 35th Annual J.P. Morgan Healthcare Conference,,11/10/2016 NBIX-US  PRN  Neurocrine Biosciences to Present at the Jefferies 2016 London Healthcare Conference,,, 9/09/2013 09062X10  PRN  Biogen Idec and Isis Pharmaceuticals Announce Strategic Collaboration to Advance Treatment of Neurological Disorders,,," 8/27/2014 37555810   PRN  Upcoming Conference Schedule, Scholarship, Approved Supplemental New Drug Application, and Technical Updates - Research Reports on Gilead, AbbVie, Pfizer, Express Scripts and Bard"," 8/01/2016 04004760   PRN  Arena Pharmaceuticals to Release Second Quarter 2016 Financial Results and Provide Corporate Update on Monday, August 8, 2016",10/26/2017 N5946510  PRN  Mylan Wins UK Court Ruling Related to Copaxone® 40 mg/mL Patent,,,11/05/2018 03116210 PRN  Amgen And Provention Bio Announce Co-Development Collaboration In Celiac Disease,, 7/07/2014 52887230 PRN  Lexicon Announces Appointment of Lonnel Coats as President and Chief Executive Officer,, 5/06/2010 45766930 PRN  Insmed Announces First Quarter 2010 Financial Results,," 8/20/2014 45773H20 PRN  Technical Data on Biotech Equities -- Aegerion Pharma, ACADIA Pharma, Inovio Pharma, Curis, and Seattle Genetics"," 7/27/2016 64026810 PRN  Nektar to Announce Financial Results for the Second Quarter 2016 on Wednesday, August 3, 2016, After Close of U.S.-Based Financial Markets", 2/23/2015 RIGL-US  PRN  Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in Immuno-Oncology Related Indications,,,,, 3/10/2015 91307C10 PRN  United Therapeutics Receives a Rare Pediatric Disease Priority Review Voucher following the Approval of Unituxin™ for Pediatric High-Risk Neuroblastoma,,"10/18/2012 06DDVL-E PRN  Zacks Bull and Bear of the Day Highlights: Alkermes, Intel, Gap, American Eagle Outfitters and TJX",,,, 8/25/2014 55027E10 PRN  Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference, 4/28/2016 DB-DE    PRN  Sangamo BioSciences Announces Presentation At The Deutsche Bank 41st Annual Health Care Conference,, 6/04/2017 80105N10  PRN  Sanofi and Regeneron Present Positive Study Results for Investigational PD-1 Antibody REGN2810 at American Society of Clinical Oncology (ASCO) Annual Meeting, 2/23/2011 000YJB-E  PRN  Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation,,,,,,,,,,,11/08/2012 68214310 PRN  Omeros to Present Data from Successful OMS302 Phase 3 Clinical Trial at the American Academy of Ophthalmology Annual Meeting,,,,,,,, 9/14/2015 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,, 1/30/2015 00182C10 PRN  ANI Pharmaceuticals Announces the Launch of Etodolac 300mg Capsules,,,,, 5/15/2014 60468T10 PRN  Mirati Therapeutics Reports First Quarter 2014 Financial Results and Provides Business Update,,,,,,,11/09/2015 09627Y10 PRN  Blueprint Medicines Reports Third Quarter 2015 Financial Results,, 6/06/2016 0G4L3T-E PRN  Eiger to Participate in Jefferies 2016 Healthcare Conference,,,,,,, 6/02/2015 92165910 PRN  Vanda Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference,,,,, 1/05/2016 HALO-US  PRN  Halozyme Therapeutics To Present At The 34th Annual J.P. Morgan Healthcare Conference, 5/09/2011 G2151510 PRN  China Biologic Products Reports First Quarter 2011 Results,,,,,, 7/24/2017 69366J20 PRN  PTC Therapeutics Announces Promotion of Dr. Joseph McIntosh to Senior Vice President and Head of Clinical Development,,,,,,, 3/12/2014 36197T10 PRN  Cannabis Market Continues Rapid Growth: Advancer with Recent Acquisitions Moves Forward to Become Full Reporting Company,," 7/22/2016 G5087110 PRN  Learn how to target an 11% return on Bank of America, or get option-trade ideas on Jazz Pharmaceuticals, Humana, Freeport-McMoRan and Celgene or any stock you choose",,,,," 3/11/2014 92337F10 PRN  Veracyte, Inc. to Announce Fourth Quarter and Full-Year 2013 Financial Results and Host Conference Call on Tuesday, March 18, 2014",,,,,,,,,,,,,,,, 5/07/2014 98401F10 PRN  Xencor to Host First Quarter 2014 Financial Results Webcast and Conference Call,,10/20/2016 G8807B10 PRN  Theravance Biopharma and Mylan Announce Positive Results from Two Pivotal Phase 3 Studies of Revefenacin (TD-4208) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 8/23/2011 002WRP-E    PRN  Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)",,12/12/2016 073W4T-E PRN  Endo Begins Shipment of Generic ZETIA®,, 6/06/2014 09060J10 PRN  BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence," 2/09/2017 09073M10    PRN  Bio-Techne Named ""Company of the Year"" by Instrument Business Outlook", 5/03/2018 75886F10    PRN  Regeneron Reports First Quarter 2018 Financial and Operating Results,," 4/15/2013 OPK-US   PRN  Opko Health, Accuray, Medicines, DaVita, and DENTSPLY Intl. Early Briefing and Review", 2/01/2017 46222210 PRN  Ionis Pharmaceuticals to Present at Upcoming Investor Conferences, 1/03/2017 BMRN-US    PRN  BioMarin to Present at 35th Annual J.P. Morgan Healthcare Conference in San Francisco,,11/02/2016 64125C10 PRN  Neurocrine Biosciences Reports Third Quarter 2016 Results,,," 9/03/2013 09062X10  PRN  Pharmaceuticals Report Revolutionary Findings, Approved Treatments, Investor Conferences - Research Report on Celgene, Amgen, Biogen Idec, Regeneron, and Questcor",,," 8/21/2014 37555810   PRN  Critical Alerts For Gilead Sciences, Disney, Starbucks, Rockwell Medical and AT&T Released By InvestorsObserver", 7/19/2016 002XMH-E   PRN  Eisai Inc. and Arena Pharmaceuticals Announce FDA Approval of BELVIQ XR® (lorcaserin HCl) Extended-Release Tablets,"10/17/2017 N5946510  PRN  Mylan to Report Third Quarter 2017 Financial Results on Nov. 6, 2017",,,11/01/2018 03116210 PRN  Amgen To Present New Data Showcasing Extensive Portfolio And Exciting Early Oncology Pipeline At ASH 2018,," 6/25/2014 52887230 PRN  Collaborations, Clinical Study Results, and Laboratory Inspection Clearance - Analyst Notes on Amgen, Regeneron, Lexicon, WuXi PharmaTech and ImmunoGen",, 4/22/2010 45766930 PRN  Insmed to Host First Quarter 2010 Conference Call,, 8/11/2014 45773H20 PRN  Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results, 6/06/2016 NKTR-US  PRN  Preclinical Data Presented at ASCO 2016 Annual Meeting Demonstrate that Single-Agent NKTR-214 Produces a Large Increase in Tumor-Infiltrating Lymphocytes to Provide Durable Anti-Tumor Activity, 1/08/2015 76655960 PRN  Rigel to Present at the 33rd Annual J.P. Morgan Healthcare Conference,,,,, 3/10/2015 91307C10 PRN  FDA Approves Unituxin™ (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma,,"10/04/2012 ALKS-IE  PRN  Zacks.com featured expert Kevin Matras highlights: Alkermes plc, TASER International Inc., Bofl Holdings, Inc., FleetCor Technologies, Inc. and PennyMac Mortgage Investment Trust",,,, 8/04/2014 55027E10 PRN  Luminex Is Supporting U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Research Efforts to Control African Ebola Outbreak, 4/25/2016 80067710 PRN  Sangamo BioSciences Announces First Quarter 2016 Conference Call and Webcast,, 6/04/2017 80105N10  PRN  Regeneron and Sanofi Present Positive Study Results for Investigational PD-1 Antibody REGN2810 at American Society of Clinical Oncology (ASCO) Annual Meeting," 2/22/2011 UAL-US    PRN  Critical Alerts for Wal-Mart, Mosaic, United Continental Holdings, MetroPCS, and Vertex Pharmaceuticals Released by Seven Summits Research",,,,,,,,,,,11/05/2012 68214310 PRN  Omeros' Ophthalmology Product OMS302 Successful in Second Phase 3 Clinical Trial,,,,,,,, 9/10/2015 PDLI-US  PRN  PDL BioPharma to Present at the 6th Annual Credit Suisse US Small & Mid Cap Conference,,,," 1/27/2015 00182C10 PRN  Akorn Set to Join the S&P MidCap 400; United Insurance Holdings, ANI Pharmaceuticals to Join the S&P SmallCap 600",,,,, 3/20/2014 60468T10 PRN  William R. Ringo Joins Mirati Board of Directors,,,,,,, 9/30/2015 09627Y10 PRN  Blueprint Medicines Receives FDA Orphan Drug Designation for Novel Drug Candidate for Treatment of Hepatocellular Carcinoma,, 5/16/2016 28249U10 PRN  Eiger BioPharmaceuticals Provides Corporate Update and Reports First Quarter 2016 Financial Results,,,,,,, 5/11/2015 VNDA-US  PRN  Vanda Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference,,,,, 1/04/2016 40637H10 PRN  Halozyme Enters Into Agreement For $150 Million Non-Dilutive Royalty-Backed Debt Financing," 5/06/2011 G2151510 PRN  China Biologic Products to Host Earnings Conference Call on May 10, 2011 at 7:30 a.m. EDT (NY)",,,,,, 7/18/2017 69366J20 PRN  PTC Therapeutics Announces Publication of Data from ACT DMD in The Lancet,,,,,,, 2/26/2014 36197T10 PRN  Cannabis Sector's High Volume Trading Report - Company Enters Into Agreement with a Colorado Marijuana Facility Developer,," 7/12/2016 G5087110 PRN  Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares of Common Stock of Celator Pharmaceuticals, Inc.",,,,, 3/03/2014 92337F10 PRN  Veracyte Updates Presentation Date and Time at the Cowen and Company 34th Annual Health Care Conference,,,,,,,,,,,,,,,," 4/29/2014 98401F10 PRN  Xencor, Inc. to Present at Deutsche Bank 39th Annual Health Care Conference",,10/20/2016 TBPH-KY  PRN  Theravance Biopharma and Mylan Announce Positive Results from Two Pivotal Phase 3 Studies of Revefenacin (TD-4208) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 7/28/2011 0039ZQ-E    PRN  IU Confidential Publishes Biotech Investment Report,,12/08/2016 002RGM-E PRN  Endo Announces Strategic Updates for BELBUCA™ and U.S. Branded Pain Portfolio,," 5/27/2014 09060J10 PRN  Technical Coverage on Top Gainers -- Research on Noranda Aluminum Holding, Teekay Tankers, BioDelivery Sciences Intl. and Quality Systems", 2/07/2017 09073M10    PRN  Bio-Techne Declares Dividend," 5/01/2018 ESRX-US     PRN  Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients",," 3/19/2013 68375N10 PRN  Prescription for Success: Commercialization Efforts, Acquisitions and Enhanced Patent Protection - Research Report on PAREXEL International, Ironwood Pharmaceuticals, Opko Health, Amarin Corporation, Progenics Pharmaceuticals", 1/06/2017 46222210 PRN  Ionis Pharmaceuticals Significantly Improves Upon 2016 Financial Guidance,"10/14/2016 09061G10   PRN  Biotech Stocks on Investors' Radar -- BioMarin Pharma, Keryx Biopharma, Puma Biotech, and Arrowhead Pharma",,10/31/2016 CS-CH    PRN  Neurocrine Biosciences to Present at the Credit Suisse 25th Annual Healthcare Conference,,, 6/27/2013 BIIB-US   PRN  Adaptive Biotechnologies and Biogen Idec Sign Immunological Services Agreement,,," 8/19/2014 37555810   PRN  Technical Updates, Drug Recommendations, and Upcoming Events - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Humana", 7/14/2016 04004760   PRN  Eisai and Arena Pharmaceuticals Announce Regulatory Approval of VENESPRI® (lorcaserin HCl) in Mexico,10/16/2017 N5946510  PRN  Mylan Invalidates Allergan's Patents on Restasis®,,,11/01/2018 03116210 PRN  Amgen Foundation Deepens Commitment To Aspiring Scientists Worldwide By Expanding Amgen Scholars Program,, 6/14/2014 52887230 PRN  Lexicon Presents LX4211 Data at American Diabetes Association Meeting,,,," 8/06/2014 45773H20 PRN  INOVIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Inovio Pharmaceuticals, Inc."," 6/02/2016 64026810 PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the Jefferies 2016 Global Healthcare Conference in New York City",11/24/2014 76655960 PRN  Rigel Announces Executive Management Changes,,,,, 2/25/2015 91307C10 PRN  United Therapeutics Corporation To Present At The Cowen And Company 35th Annual Healthcare Conference,," 8/16/2012 ALKS-IE  PRN  Zacks.com featured expert Kevin Matras highlights: Agilysys Inc., Alkermes plc., Covenant Transportation Group, Inc., Isle of Capri Casinos, Inc. and Louisiana-Pacific Corp.",,,, 7/28/2014 55027E10 PRN  Luminex Corporation Reports Second Quarter 2014 results, 4/18/2016 SGMO-US  PRN  Sangamo BioSciences Announces Presentations On ZFP Therapeutic® Programs And Applications At 2016 Annual Meeting Of The American Society Of Gene & Cell Therapy,, 5/22/2017 80105N10  PRN  Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients, 2/01/2011 06X6M8-E  PRN  Nation's Birthplace Hosts U.S. Launch of International Year of Chemistry,,,,,,,,,,,11/01/2012 68214310 PRN  Omeros Announces Enrollment in Phase 1 Clinical Trial Evaluating OMS824,,,,,,,, 9/08/2015 PDLI-US  PRN  Paul Edick Joins PDL BioPharma's Board of Directors,,,,12/11/2014 00182C10 PRN  ANI Pharmaceuticals Presents At Oppenheimer 25th Annual Healthcare Conference,,,,, 3/17/2014 60468T10 PRN  Mirati Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results,,,,,,, 9/10/2015 0BP4MZ-E PRN  Blueprint Medicines Receives FDA Authorization to Advance Novel Drug Candidate into Clinical Trial for Systemic Mastocytosis,, 5/10/2016 28249U10 PRN  Eiger Announces First Patient Dosed in Phase 2 Multiple Ascending Dose Study of Subcutaneous Exendin (9-39) in Patients with Hypoglycemia Post-Gastric Bypass Surgery,,,,,,, 5/06/2015 92165910 PRN  Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results,,,,,12/21/2015 40637H10 PRN  Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly, 4/12/2011 G2151510 PRN  China Biologic Operations to Be Awarded for Outstanding Product and Process Quality,,,,,, 7/01/2017 69366J20 PRN  Preliminary Phase 2 Data from Spinal Muscular Atrophy Program Presented at CureSMA Conference,,,,,,, 2/20/2014 36197T10 PRN  Cannabis Sector Briefing: Company Launches Natural Resource Development Program for Marijuana & Hemp Products,," 6/27/2016 G5087110 PRN  Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. Acquisition",,,,, 2/26/2014 92337F10 PRN  Veracyte to Present at Cowen and Company 34th Annual Health Care Conference,,,,,,,,,,,,,,,, 4/10/2014 00780K-E PRN  Xencor Receives Milestone Payment from Merck for Initiation of Phase 1 Clinical Trial of a Biologic Candidate using XmAb® Antibody Engineering Intellectual Property,," 6/08/2016 G8807B10 PRN  Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 7/11/2011 45232710    PRN  Sequenom Announces Multi-Year Supply Agreement With Illumina,,12/06/2016 G3040110 PRN  Endo Begins Shipment of Generic CellCept®,, 5/08/2014 09060J10 PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2014 Financials, 2/07/2017 09073M10    PRN  Bio-Techne Releases Second Quarter Fiscal 2017 Results," 5/01/2018 000VC1-E    PRN  Regeneron and Sanofi to Lower Net Price of Praluent® (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients",," 3/15/2013 68375N10 PRN  Pre-Market Analysis on MGIC Investment, Ultra Petroleum, Opko Health, and Accuray", 1/06/2017 46222210 PRN  Ionis and Akcea Enter into Strategic Collaboration with Global Pharmaceutical Company to Develop and Commercialize AKCEA-APO(a)-L Rx and AKCEA-APOCIII-L Rx," 7/28/2016 09061G10   PRN  Covered Call reports for GoPro, American Airlines, BioMarin Pharmaceutical, Caterpillar Inc. and TASER International include trade ideas that offer returns of 20% or more!",,10/26/2016 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2016 Results,,," 6/14/2013 00167Y-E  PRN  Biogen, Crocs, Krispy Kreme Doughnut, Burger King Worldwide and AFC Enterprises highlighted as Zacks Bull and Bear of the Day",,," 8/08/2014 37555810   PRN  Positive Opinion on the Drug, Acquisition, Orphan Drug Designation, Analysis Results, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Tenet Health", 6/30/2016 04004760   PRN  Arena Pharmaceuticals Announces Shift to Focus on Proprietary Clinical Stage Pipeline,"10/05/2017 00115K-E  PRN  Mylan, in Partnership with Synthon, Receives Marketing Authorization Approval in Europe for First Generic for Copaxone® 40 mg/mL",,,10/30/2018 03116210 PRN  Amgen Reports Third Quarter 2018 Financial Results,, 5/30/2014 52887230 PRN  Lexicon To Present At The Jefferies 2014 Global Healthcare Conference,,,," 8/01/2014 45773H20 PRN  Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014", 6/02/2016 64026810 PRN  Nektar Therapeutics Announces Executive Management Promotions,11/04/2014 76655960 PRN  Rigel Announces Third Quarter 2014 Financial Results,,,,, 2/24/2015 91307C10 PRN  United Therapeutics Corporation Reports 2014 Fourth Quarter And Annual Financial Results,," 8/07/2012 ALKS-IE  PRN  Zacks Bull and Bear of the Day Highlights: Alkermes, GlaxoSmithKline, Limited Brands, Hanesbrands and Gap",,,," 7/07/2014 55027E10 PRN  Luminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2014", 3/15/2016 80067710 PRN  Sangamo BioSciences Announces Participation In The 4th Annual Cell & Gene Therapy Investor Day Meeting In New York,, 5/22/2017 80105N10  PRN  Regeneron and Sanofi Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients,"12/22/2010 000P4S-E  PRN  Pathfinder LLC and SyntheMed, Inc. Announce Merger Agreement",,,,,,,,,,,"10/24/2012 68214310 PRN  Adding Four More, Omeros Has Now Unlocked 46 Orphan GPCRs",,,,,,,, 8/05/2015 69329Y10 PRN  PDL BioPharma Announces Second Quarter 2015 Financial Results,,,,12/10/2014 00182C10 PRN  ANI Pharmaceuticals Announces Closing of 3.00% Convertible Senior Notes and Full Exercise of Over-Allotment Option,,,,, 2/05/2014 60468T10 PRN  Mirati Therapeutics to Present at the 2014 Leerink Global Healthcare Conference,,,,,,, 9/03/2015 09627Y10 PRN  Blueprint Medicines to Present at the 22nd Annual NewsMakers in the Biotech Industry Conference,," 5/03/2016 28249U10 PRN  Eiger Bio Strengthens Senior Management Team with Announcement of Debra Odink, PhD as Senior Vice President of Technical Operations",,,,,,," 5/05/2015 92165910 PRN  Early Briefing on Biotech Stocks -- Galena Biopharma, Isis Pharma, Exact Sciences, Keryx Biopharma, and Vanda Pharma",,,,,12/09/2015 HALO-US  PRN  Halozyme Therapeutics and Eisai to present data evaluating the antitumor effects of PEGPH20 in combination with eribulin mesylate in preclinical breast cancer models, 3/31/2011 G2151510 PRN  China Biologic Products Reports Record Sales and Net Income for 2010,,,,,, 6/30/2017 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,," 2/19/2014 36197T10 PRN  Medical Marijuana Explosion Continues as Company Agrees to Purchase 83,000 S/F Complex in AZ",, 6/21/2016 0CBRZ9-E PRN  Jazz Launches Channel Partner Program to Accelerate Growth and to Expand Distribution of its Recruiting Software,,,,, 2/05/2014 92337F10 PRN  Veracyte To Present At 2014 Leerink Global Healthcare Conference,,,,,,,,,,,,,,,, 3/28/2014 98401F10 PRN  Xencor Showcases Bispecific Antibody Programs at Annual Summit on Practical and Emerging Trends in Multiple Myeloma,, 9/14/2015 MYL-GB   PRN  Theravance Biopharma and Mylan Initiate Phase 3 Program for Revefenacin (TD-4208) for Treatment of Chronic Obstructive Pulmonary Disease (COPD),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 7/08/2011 MT-LU       PRN  Critical Alerts For Cisco, UPS, Schwab, Arcelor Mittal, and Illumina Released By Seven Summits Research",,11/18/2016 G3040110 PRN  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline - ENDP,, 5/08/2014 09060J10 PRN  BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference," 1/25/2017 09073M10    PRN  Bio-Techne To Host Conference Call On February 7, 2017 To Announce Second Quarter Financial Results", 4/30/2018 75886F10    PRN  FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma,," 1/30/2013 68375N10 PRN  Free Research Report on Opko Health, Inc., ACADIA Pharmaceuticals, Inc., Simcere Pharmaceutical Group, SciClone Pharmaceuticals, Inc. and Sequenom, Inc.", 1/04/2017 46222210 PRN  Ionis Pharmaceuticals Reports Positive Data from Phase 2 Study of IONIS-GCGR Rx in Patients with Type 2 Diabetes," 7/19/2016 09061G10   PRN  Micron, JC Penney, Seagate Technology, Amazon.com, and BioMarin Pharmaceutical and more offer option-trading opportunities that offer returns of more than 20%",,10/19/2016 64125C10 PRN  AbbVie Announces Positive Pivotal Phase 3 Data Demonstrating Investigational Medicine Elagolix Reduces Menstrual and Non-Menstrual Pelvic Pain Associated with Endometriosis at the American Society for Reproductive Medicine Scientific Congress,,," 5/31/2013 GSK-GB    PRN  Regulatory Wins, Leadership Changes, and New Partnerships Creating Healthy Prospects - Research Report on Gilead, Biogen Idec, GlaxoSmithKline, Viropharma, and Celsion",,," 8/04/2014 37555810   PRN  Critical Alerts For Groupon, Gilead Sciences, Ballard Power Systems, GlaxoSmithKline, and Eli Lilly Released By InvestorsObserver"," 6/23/2016 04004760   PRN  How These Biotech's Stocks are Performing? - Intrexon, Vertex Pharma, Arena Pharma, and Regeneron Pharma",10/05/2017 N5946510  PRN  Mylan Launches First AP-rated Generic Avelox® Injection,,,10/26/2018 03116210 PRN  Amgen Announces New FOURIER Analysis Showing Benefit With Repatha® (Evolocumab) In High-Risk Patients With Established Cardiovascular Disease And Chronic Kidney Disease,, 5/09/2014 52887230 PRN  Lexicon To Present At The 2014 Bank of America Merrill Lynch Healthcare Conference,,,, 7/23/2014 45773H20 PRN  Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial," 6/01/2016 NKTR-US  PRN  Nektar Therapeutics and Daiichi Sankyo Europe GmbH Sign European Licensing Agreement for ONZEALD™ (etirinotecan pegol), an Investigational Drug Candidate Being Developed to Treat Patients with Advanced Breast Cancer and Brain Metastases", 8/13/2014 76655960 PRN  R348 Did Not Meet Endpoints in Phase 2 Dry Eye Study,,,,," 2/17/2015 91307C10 PRN  United Therapeutics Corporation To Announce Fourth Quarter And Annual 2014 Financial Results Before Market Open On Tuesday, February 24, 2015",," 7/11/2012 ALKS-IE  PRN  Zacks Bull and Bear of the Day Highlights: Alkermes, AGL Resources, Monsanto, Syngenta and The Dow Chemical",,,," 5/12/2014 55027E10 PRN  Luminex Corporation Announces Group B Streptococcus (GBS), as a Launch Menu Assay for its New Sample-to-Answer System, ARIES™", 3/02/2016 80067710 PRN  Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform Programs For MPS I And MPS II At The 12th Annual WORLDSymposium™ Meeting,, 5/17/2017 000VC1-E  PRN  Dupixent Delivers… and Sanofi-Regeneron Ushers in a New Era of Atopic Dermatitis (AD) Treatment,12/06/2010 92532F10  PRN  S&P Equity Research Picks VRTX Focus Stock of the Week,,,,,,,,,,,10/18/2012 68214310 PRN  Omeros Adds Vice Presidents of Regulatory and Clinical to Management Team,,,,,,,, 7/29/2015 PDLI-US  PRN  PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals,,,,12/05/2014 00182C10 PRN  ANI Pharmaceuticals Announces Pricing of Upsized $125 Million Convertible Notes Offering,,,,,12/09/2013 60468T10 PRN  Mirati Presents Clinical Response Results of Mocetinostat in Combination with Azacitidine as a Treatment for MDS,,,,,,, 9/01/2015 09627Y10 PRN  Blueprint Medicines to Present Preclinical Data on BLU-554 and on Novel Drug Target at International Liver Cancer Association 9th Annual Conference,, 4/20/2016 28249U10 PRN  Eiger BioPharmaceuticals Announces License of Worldwide Rights to Pegylated Interferon Lambda-1a from Bristol-Myers Squibb,,,,,,, 4/24/2015 92165910 PRN  Vanda Receives Positive CHMP Opinion for HETLIOZ® (tasimelteon) for the Treatment of Non-24-Hour Sleep-Wake Disorder in the European Union,,,,,11/24/2015 HALO-US  PRN  Halozyme Therapeutics To Present At Upcoming Healthcare Conferences," 3/30/2011 G2151510 PRN  China Biologic Products To Host Earnings Conference Call on April 1, 2011 at 7:00 a.m. EDT",,,,,, 6/22/2017 69366J20 PRN  New Analyses of Translarna™ (ataluren) Data from ACT DMD Presented at the 12th Annual European Pediatric Neurology Society Congress,,,,,,, 2/05/2014 36197T10 PRN  Medical Marijuana Industry Continues Rapid Expansion As Leaders Acquire New Dispensary Sites,, 6/14/2016 G5087110 PRN  Jazz Pharmaceuticals Announces Conference Call and Webcast for JZP-110 Investor Update,,,,,12/16/2013 92337F10 PRN  Veracyte Announces Cigna Coverage for the Afirma® Gene Expression Classifier,,,,,,,,,,,,,,,, 3/24/2014 98401F10 PRN  Xencor to Present at 21st Annual BioCentury Future Leaders in the Biotech Industry Conference,," 7/04/2014 G8807B10 PRN  Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 6/21/2011 002WRP-E    PRN  Insider Trading Alerts for CVS, Tiffany, Illumina, Dolby, Texas Industries, & Helix",,11/17/2016 G3040110 PRN  Endo Announces Positive Data from Phase 2b Study of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite,, 5/06/2014 09060J10 PRN  BioDelivery Sciences Announces Randomization of Over 50% of Subjects in its Initial Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy, 1/24/2017 09073M10    PRN  Bio-Techne Congratulates Astute Medical on Clinical Trial Results, 4/30/2018 75886F10    PRN  FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma,, 1/08/2013 00772M-E PRN  OPKO Health to acquire privately held Cytochroma,12/23/2016 46222210 PRN  SPINRAZA™ (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy," 7/08/2016 09061G10   PRN  Learn how to target a 32% return on Valero Energy, or get option-trade ideas on BioMarin Pharmaceutical, NXP Semiconductors, Western Digital and Coca-Cola Enterprises or any stock you choose",,10/11/2016 64125C10 PRN  Neurocrine Announces INGREZZA™ (valbenazine) New Drug Application for the Treatment of Tardive Dyskinesia has been Accepted for Priority Review by U.S. FDA,,, 5/14/2013 0BDK6C-E  PRN  PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022,,," 7/31/2014 37555810   PRN  Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis", 6/15/2016 04004760   PRN  Arena Pharmaceuticals Announces Appointment of Kevin R. Lind as Chief Financial Officer,10/04/2017 N5946510  PRN  Mylan Confirms U.S. Launch of First Generic for Copaxone® 40 mg/mL 3-Times-a-Week and Generic for Copaxone® 20 mg/mL Once-Daily,,,10/26/2018 03116210 PRN  Amgen Announces Webcast Of 2018 Third Quarter Financial Results,, 5/08/2014 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 First Quarter Financial Results,,,," 7/09/2014 45773H20 PRN  Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma", 5/03/2016 NKTR-US  PRN  Nektar Therapeutics Reports Financial Results for the First Quarter of 2016, 8/05/2014 76655960 PRN  Rigel Announces Second Quarter 2014 Financial Results,,,,," 2/04/2015 91307C10 PRN  Biotech Stocks Scanner - ARIAD Pharma, Celgene, CytRx, Amicus Therapeutics, and United Therapeutics",," 2/16/2012 ALKS-IE  PRN  The Zacks Analyst Blog Highlights: Charles Schwab, E*TRADE Financial, TD Ameritrade Holding, Amylin Pharmaceuticals and Alkermes plc",,,, 5/05/2014 55027E10 PRN  Luminex Corporation Announces European Unveiling of its New Sample-to-Answer System at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 3/01/2016 80067710 PRN  Sangamo BioSciences Announces Presentation At The Cowen And Company 36th Annual Health Care Conference,, 5/11/2017 80105N10  PRN  Allegra® Allergy Gears Up for Bike to Work Day Across the U.S.,,,,,,,,,,,,10/03/2012 68214310 PRN  Omeros Announces Completion of Enrollment in OMS302 Phase 3 Clinical Trial,,,,,,,," 7/28/2015 69329Y10 PRN  PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015",,,,"12/04/2014 00182C10 PRN  ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering of Convertible Notes",,,,,12/02/2013 60468T10 PRN  Updated Presentation Time: Mirati Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference,,,,,,, 8/10/2015 09627Y10 PRN  Blueprint Medicines Reports Second Quarter 2015 Financial Results and Provides Business Update,," 4/04/2016 06R1ZF-E PRN  Eiger BioPharmaceuticals Strengthens Board of Directors with Addition of Industry Veteran Charles J. ""Chuck"" Bramlage",,,,,,, 4/20/2015 92165910 PRN  Vanda Pharmaceuticals Announces the Appointment of Chief Commercial Officer,,,,,11/17/2015 40637H10 PRN  Halozyme To Expand With A Satellite Office In San Francisco, 3/16/2011 G2151510 PRN  China Biologic Products Reports Unaudited Preliminary Highlights for the Year 2010,,,,,, 6/06/2017 69366J20 PRN  PTC Therapeutics Announces FDA Advisory Committee Meeting for Ataluren for the Treatment of Nonsense Mutation Dystrophinopathy,,,,,,," 1/14/2014 36197T10 PRN  Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed",," 6/14/2016 G5087110 PRN  Jazz Pharmaceuticals Presents New Data from a Human Abuse Liability (HAL) Study for JZP-110, an Investigational Treatment for Excessive Sleepiness in Patients with Narcolepsy or with Obstructive Sleep Apnea, at 30th Annual SLEEP Meeting",,,,,"11/25/2013 92337F10 PRN  Veracyte, Inc. Announces Third Quarter 2013 Financial Results",,,,,,,,,,,,,,,, 3/19/2014 98401F10 PRN  Xencor Reports Fourth Quarter and Full Year 2013 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 5/30/2011 APKT-US     PRN  Critical Stock Reports: Insider Trade for IBM, Acme Packet, Biogen Idec, McKesson, Illumina, & C.R. Bard",,11/08/2016 G3040110 PRN  Endo Reports Third Quarter 2016 Financial Results,, 4/07/2014 09060J10 PRN  BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference, 1/11/2017 09073M10    PRN  COPD Biomarker Qualification Consortium Partners with Bio-Techne to Identify COPD Indicator, 4/23/2018 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentations,,12/19/2011 05K81Z-E PRN  Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities,12/22/2016 0017CR-E PRN  Ionis Pharmaceuticals Earns Milestone Payment from Janssen for Advancing a New Program Under GI Collaboration," 5/16/2016 BMRN-US    PRN  AbSci Appoints Daniel Gold, Ph.D. to Board of Directors",,10/06/2016 00DYYX-E PRN  AbbVie Presents Pivotal Phase 3 Data on Investigational Treatment Elagolix and Research on the Economic Burden of Endometriosis at the 72nd American Society for Reproductive Medicine Scientific Congress,,, 5/06/2013 08H44W-E  PRN  Drugs.com Releases Q1 Sales for Top 100 U.S. Drugs: Rough U.S Flu Season Boosts Numbers for Tamiflu,,," 7/31/2014 37555810   PRN  Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences"," 6/13/2016 04004760   PRN  Arena Pharmaceuticals Announces USAN Approval of Nonproprietary Name ""Etrasimod"" for its Drug Candidate APD334",10/04/2017 0FSTN1-E  PRN  FDA Approval of Mylan's Glatiramer Acetate Will Turn the Payer Pressure On for Teva's Copaxone and Sandoz's Glatopa,,,10/24/2018 03116210 PRN  Amgen Makes Repatha® (Evolocumab) Available In The US At A 60 Percent Reduced List Price,," 5/05/2014 52887230 PRN  Lexicon To Report First Quarter 2014 Financial Results On May 8, 2014",,,," 7/01/2014 45773H20 PRN  Inovio Pharmaceuticals Added To Russell Global, Russell 2000® and Russell Microcap® Indexes"," 4/28/2016 64026810 PRN  Nektar to Announce Financial Results for the First Quarter 2016 on Tuesday, May 3, 2016, After Close of U.S.-Based Financial Markets", 7/16/2014 76655960 PRN  Rigel Initiates Phase 3 Studies of Fostamatinib in ITP,,,,, 1/06/2015 91307C10 PRN  United Therapeutics Corporation To Present At 33rd Annual J.P. Morgan Healthcare Conference,," 2/13/2012 G0176710 PRN  BYDUREON™, First and Only Once-Weekly Type 2 Diabetes Treatment, Now Available in U.S. Pharmacies",,,, 5/01/2014 55027E10 PRN  Luminex Corporation To Present At UBS Global Healthcare Conference, 2/24/2016 80067710 PRN  Sangamo BioSciences Presents Phase 2 Immunological Data from SB-728-T ZFP Therapeutic® HIV Program at CROI 2016,, 5/09/2017 SAN-FR    PRN  Exscientia Announces EUR250 Million Collaboration for a Multiple-Product Development and Licence Option Agreement with Sanofi,,,,,,,,,,,,10/02/2012 68214310 PRN  Investigational New Drug Application Cleared for Omeros' Lead Compound in PDE10 Program,,,,,,,," 7/24/2015 69329Y10 PRN  Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics",,,,11/06/2014 00182C10 PRN  ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP,,,,,11/22/2013 60468T10 PRN  Mirati Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference,,,,,,, 8/04/2015 09627Y10 PRN  Blueprint Medicines to Present at 2015 Wedbush PacGrow Healthcare Conference,, 3/30/2016 EIGR-US  PRN  Eiger BioPharmaceuticals Announces Abstracts and Presentations of Lonafarnib Data in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Meeting,,,,,,," 4/16/2015 92165910 PRN  Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015",,,,,11/09/2015 40637H10 PRN  Halozyme Reports Third Quarter 2015 Financial Results, 3/04/2011 G2151510 PRN  China Biologic to Present at the Cowen Healthcare Conference,,,,,, 6/05/2017 69366J20 PRN  PTC Therapeutics Announces Executive Promotions,,,,,,, 1/08/2014 36197T10 PRN  GW Pharmaceuticals plc Announces Pricing of U.S. Follow-On Offering of ADSs Raising $87.9 Million on NASDAQ Global Market,," 6/08/2016 GRF-ES   PRN  Biotechnology Equities Technical Notes -- Grifols, Achillion Pharma, Jazz Pharma, and Puma Biotechnology",,,,,11/13/2013 92337F10 PRN  Veracyte Presents Data Suggesting Ability of Its Afirma® Gene Expression Classifier To Detect Medullary Thyroid Cancer Among Indeterminate Thyroid Nodule Biopsies,,,,,,,,,,,,,,,," 3/13/2014 98401F10 PRN  Xencor, Inc. to Host Fourth Quarter and Full Year 2013 Financial Results Webcast and Conference Call",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 5/11/2011 MHS.XX1-US  PRN  Critical Alerts for Citigroup, MedcoHealth, Sina, Whole Foods, and Illumina Released by Seven Summits Research",,11/07/2016 G3040110 PRN  Endo Strengthens Leadership Team with Appointment of Two Key Executives,, 4/03/2014 09060J10 PRN  BioDelivery Sciences Announces Enrollment of the First Patient in a Phase 3 Clinical Study of Clonidine Topical Gel for Painful Diabetic Neuropathy,12/14/2016 09073M10    PRN  Bio-Techne And Astute Medical Form Strategic Partnership," 4/09/2018 75886F10    PRN  Regeneron to Report First Quarter 2018 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2018",," 9/15/2011 000L4D-E PRN  Equity Research on Top Moving Stocks in AMEX: Golden Star Resources, Vista Gold, & Opko Health Inc.",12/19/2016 46222210 PRN  Ionis and AstraZeneca Advance First Generation 2.5 LICA Drug into Preclinical Development to Treat Cardiovascular Disease," 5/02/2016 BMRN-US    PRN  AbSci Appoints V. Bryan Lawlis, Ph.D. to Board of Directors",, 9/07/2016 MS-US    PRN  Neurocrine Biosciences to Present at the Morgan Stanley Global Healthcare Conference,,," 4/30/2013 ARCO-AR   PRN  Critical Alerts For IBM, Biogen Idec, St. Jude Medical, NII Holdings, and Arcos Dorados Released By InvestorsObserver",,, 7/28/2014 000L1R-E   PRN  Diplomat receives distribution contract for Zydelig® (idelalisib), 5/09/2016 04004760   PRN  Arena Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update,10/04/2017 N5946510  PRN  Mylan Provides Support for U.S. Disaster-Relief Efforts,,,10/24/2018 03116210 PRN  First Head-to-Head Trial of a TNF Inhibitor Versus Methotrexate Monotherapy in Psoriatic Arthritis Shows ENBREL® (Etanercept) Monotherapy and Combination Therapy Both Superior to Methotrexate,, 4/14/2014 52887230 PRN  LX4211 Achieves Positive Results In Type 1 Diabetes Clinical Trial,,,," 6/26/2014 45773H20 PRN  Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma", 4/18/2016 NKTR-US  PRN  Preclinical Data Presented at AACR Demonstrate that Combining NKTR-214 with Checkpoint Blockade is Superior to Dual Checkpoint Inhibition in Increasing Clonality of the T Cell Receptor (TCR) Repertoire and T Cell Tumor Infiltration, 7/16/2014 76655960 PRN  Rigel Initiates Phase 3 Studies of Fostamatinib in ITP,,,,,12/31/2014 91307C10 PRN  United Therapeutics Announces Signing Of Agreement For New Remodulin Delivery System,," 2/06/2012 0C2G14-E PRN  The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals and Eli Lilly & Company",,,, 4/28/2014 55027E10 PRN  Luminex Corporation Reports First Quarter 2014 Results, 2/09/2016 80067710 PRN  Sangamo BioSciences Reports Fourth Quarter And Full Year 2015 Financial Results,," 5/02/2017 80105N10  PRN  Survey Results Show Eighty Percent of Rheumatoid Arthritis Patients Report Life-Altering Pain Daily or Multiple Times a Week, Despite Treatment",,,,,,,,,,,, 9/27/2012 68214310 PRN  Arnold C. Hanish Elected to Board of Directors of Omeros,,,,,,,, 7/21/2015 PDLI-US  PRN  Edison Initiates Coverage on PDL BioPharma,,,,11/03/2014 00182C10 PRN  ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights,,,,,11/12/2013 60468T10 PRN  Mirati Therapeutics Reports Third Quarter 2013 Financial Results,,,,,,, 7/13/2015 BPMC-US  PRN  Blueprint Medicines Receives FDA Authorization to Proceed with Clinical Trials for Two Drug Candidates,, 3/28/2016 080RQG-E PRN  Eiger BioPharmaceuticals Granted Orphan Medicinal Product Designation for Ubenimex in Pulmonary Arterial Hypertension by European Medicines Agency,,,,,,, 4/13/2015 92165910 PRN  Vanda Announces Trial Date for Fanapt® Patent Cases,,,,,11/05/2015 40637H10 PRN  First Patient Dosed in Clinical Trial of Halozyme Investigational Drug PEGPH20 in Combination With Merck Immuno-oncology Drug KEYTRUDA, 1/04/2011 G2151510 PRN  China Biologic Now Included in the NASDAQ Global Select Market,,,,,, 6/02/2017 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,12/20/2013 36197T10 PRN  GW Pharmaceuticals Files Registration Statement for Proposed Follow-On Offering,," 6/03/2016 G5087110 PRN  Celator Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of CPXX Shareholders",,,,,"11/11/2013 92337F10 PRN  Veracyte, Inc. to Announce Third Quarter 2013 Financial Results and Host Conference Call on Monday, November 25, 2013",,,,,,,,,,,,,,,, 2/06/2014 98401F10 PRN  Xencor to Present at 2014 Leerink Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 3/31/2011 002D70-E    PRN  Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing",,11/04/2016 G3040110 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endo International plc - ENDP,, 3/27/2014 093RC9-E PRN  BioDelivery Sciences Announces Commercialization Agreement with Quintiles to Support the Launch of BUNAVAIL in the U.S.,12/01/2016 000XKX-E    PRN  ProteinSimple's Single-Cell Western platform named #1 on The Scientist's Top 10 Innovations of 2016, 4/03/2018 75886F10    PRN  EMA to Review DUPIXENT® (dupilumab) as Potential Treatment for Inadequately Controlled Moderate-to-Severe Asthma,, 1/05/2011 000NB6-E PRN  Dale Pfost Joins Advent Venture Partners,12/19/2016 0017CR-E PRN  Akcea and Ionis Announce Positive Results from Compass Phase 3 Study of Volanesorsen," 3/02/2016 09061G10   PRN  Covered Call Alerts For AbbVie, Micron, Ohr Pharmaceuticals, Merrimack Pharmaceuticals and BioMarin Pharmaceutical Released By InvestorsObserver",, 9/01/2016 64125C10 PRN  Neurocrine Biosciences to Present at the Baird 2016 Healthcare Conference,,," 4/26/2013 06DDVL-E  PRN  Zacks Bull and Bear of the Day Highlights: Overstock.com, Titan Machinery, Acorda Therapeutics, Biogen Idec and Novartis",,," 7/14/2014 37555810   PRN  Critical Alerts For SunEdison, Twitter, Gilead Sciences, Darden Restaurants, and Blackrock Released By InvestorsObserver", 5/09/2016 04004760   PRN  Arena Pharmaceuticals Announces Appointment of Amit D. Munshi as President and Chief Executive Officer,10/03/2017 N5946510  PRN  Mylan Announces U.S. FDA Approval of First Generic for Copaxone® 40 mg/mL 3-Times-a-Week and May Be Eligible for 180-Day Exclusivity,,,10/23/2018 03116210 PRN  Amgen Announces 2018 Fourth Quarter Dividend,, 4/03/2014 52887230 PRN  Lexicon To Present At The 2014 Needham Healthcare Conference,,,, 6/23/2014 45773H20 PRN  Inovio Pharmaceuticals Initiates Cervical Cancer Clinical Trial," 3/03/2016 64026810 PRN  Nektar Therapeutics to Present at Cowen and Company's 36th Annual Health Care Conference in Boston, MA", 5/29/2014 76655960 PRN  Rigel to Present at Jefferies 2014 Global Healthcare Conference,,,,,12/24/2014 UTHR-US  PRN  United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin,, 1/27/2012 G0176710 PRN  FDA Approves BYDUREON™ -- The First and Only Once-Weekly Treatment for Type 2 Diabetes,,,," 4/22/2014 55027E10 PRN  Luminex Corporation Announces Norovirus as a Launch Menu Assay for its New Sample-to-Answer System, ARIES™", 2/08/2016 SGMO-US  PRN  Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I,, 4/28/2017 80105N10  PRN  Sanofi Delivers Robust Q1 2017 Financial Results,,,,,,,,,,,, 9/19/2012 68214310 PRN  Omeros Awarded NIMH Grant for Development of Orphan GPCR Antibodies,,,,,,,, 6/29/2015 69329Y10 PRN  PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications,,,,10/27/2014 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call for Third Quarter 2014 Financial Results,,,,,11/08/2013 60468T10 PRN  Mirati Therapeutics to Present Data on Phase 1/2 Trial of Mocetinostat at the 55th American Society of Hematology Annual Meeting,,,,,,," 6/29/2015 09627Y10 PRN  Blueprint Medicines Added to Russell 2000®, 3000® and Global Indexes",, 2/29/2016 28249U10 PRN  Eiger to Participate in Cowen & Company 2016 Health Care Conference,,,,,,, 4/09/2015 92165910 PRN  Vanda Announces Listing of a New Fanapt® Patent in the FDA Orange Book,,,,,11/04/2015 HALO-US  PRN  Halozyme Announces First Clinical Dosing Of Janssen's Daratumumab Using ENHANZE™ Technology,12/07/2010 G2151510 PRN  China Biologic Starts Plasma Collection at Yishui Station,,,,,, 5/23/2017 69366J20 PRN  New Analysis of ACT DMD Placebo Data on Corticosteroids Presented at International Society for Pharmacoeconomics and Outcomes Research 22nd Annual International Meeting,,,,,,,12/11/2013 36197T10 PRN  GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma,, 5/31/2016 0CBRZ9-E PRN  Celator Pharmaceuticals® Cancels Analyst and Investor Meeting and Postpones Annual Meeting of Stockholders,,,,,"11/04/2013 92337F10 PRN  Veracyte, Inc. Announces Closing of Initial Public Offering",,,,,,,,,,,,,,,,"12/06/2013 98401F10 PRN  Xencor, Inc. Announces Closing of Initial Public Offering",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 3/25/2011 WPM-CA      PRN  Critical Alerts for Qualcomm, SanDisk, Illumina, Silver Wheaton, and Gap Released by Seven Summits Research",,11/01/2016 00FV7G-E PRN  Endo Begins Shipment of Generic SEROQUEL XR®,, 3/14/2014 09060J10 PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2013 Annual Report,10/31/2016 000XKX-E    PRN  Bio-Techne Releases First Quarter Fiscal 2017 Results, 4/03/2018 75886F10    PRN  EMA to Review Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma,,11/17/2010 000BNP-E PRN  Reportlinker Adds Global Opthalmic Pharmaceutical Drugs Industry,12/16/2016 46222210 PRN  Ionis Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer," 9/30/2015 0B0WJD-E   PRN  Parent Project Muscular Dystrophy Launches Next Phase of Genetic Testing Program, Decode Duchenne in collaboration with BioMarin Pharmaceutical Inc., PTC Therapeutics, and Sarepta Therapeutics",, 8/31/2016 64125C10 PRN  Neurocrine Announces FDA Conditional Acceptance of Proprietary Name INGREZZA™ for VMAT2 Inhibitor Valbenazine,,, 4/17/2013 00167Y-E  PRN  American Management Association Teams With Biogen Idec To Create Life Skills Workshops For People Living With Hemophilia,,," 7/04/2014 37555810   PRN  NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind"," 5/02/2016 04004760   PRN  Arena Pharmaceuticals to Host First Quarter 2016 Financial Results and Corporate Update Conference Call and Webcast on Monday, May 9",10/02/2017 N5946510  PRN  Mylan Launches Generic Cancidas® for Injection,,,10/22/2018 03116210 PRN  Data Projects the Global Biotechnology Market Will Continue to Grow,, 2/28/2014 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Fourth Quarter And Full Year Financial Results,,,, 6/17/2014 45773H20 PRN  Inovio Pharmaceuticals Broadens its Intellectual Property Portfolio from the University of Pennsylvania, 3/01/2016 64026810 PRN  Nektar Therapeutics Reports Fourth Quarter and Year-End 2015 Financial Results, 5/07/2014 76655960 PRN  Rigel Announces First Quarter 2014 Financial Results,,,,,12/17/2014 91307C10 PRN  United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change,, 1/04/2012 ALKS-IE  PRN  Halo Therapeutics' HT-100 Receives FDA's Orphan Designation for Duchenne Muscular Dystrophy,,,," 4/07/2014 55027E10 PRN  Luminex Corporation First Quarter Earnings Release Scheduled for April 28, 2014", 2/04/2016 80067710 PRN  Sangamo BioSciences Announces Presentation At The Leerink Partners 5th Annual Global Healthcare Conference,, 4/28/2017 80105N10  PRN  Regeneron and Sanofi Announce Kevzara® (sarilumab) Biologics License Application Resubmission Accepted for Review by U.S. FDA,,,,,,,,,,,, 9/06/2012 68214310 PRN  Omeros Files Investigational New Drug Application for Lead Compound in PDE10 Program,,,,,,,, 6/25/2015 69329Y10 PRN  PDL BioPharma to Present at the Nasdaq 32nd Investor Program,,,, 8/04/2014 00182C10 PRN  ANI Reports Second Quarter 2014 Financial Results and Year-To-Date Highlights,,,,,10/23/2013 60468T10 PRN  Mirati Therapeutics Prices Public Offering Of Common Stock,,,,,,, 6/22/2015 0BP4MZ-E PRN  Blueprint Medicines Debuts Preclinical Data for First-in-Class RET Drug Candidate,," 7/30/2015 28249U10 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Celladon Corporation of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 31, 2015 - CLDN",,,,,,, 3/27/2015 006GP9-E PRN  Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025,,,,,11/03/2015 HALO-US  PRN  Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference,12/06/2010 G2151510 PRN  China Biologic Special Committee Completes Investigation,,,,,, 5/19/2017 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,"12/02/2013 36197T10 PRN  Events, Marketing Recommendation, FDA Meeting, and Marketing Authorization - Research Report on Hospira, Novo Nordisk, Repros Therapeutics, GW Pharmaceuticals, and Envision Healthcare",, 5/31/2016 G5087110 PRN  Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share,,,,,"10/30/2013 92337F10 PRN  Veracyte, Inc. Announces Pricing of Initial Public Offering",,,,,,,,,,,,,,,,12/03/2013 98401F10 PRN  Xencor Prices Initial Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 3/06/2011 002WRP-E    PRN  deCODE Discovers Genetic Risk Factor for Sick Sinus Syndrome,,10/20/2016 G3040110 PRN  Endo Announces Departure of Chief Financial Officer,, 3/05/2014 09060J10 PRN  BioDelivery Sciences to Present at the 26th Annual ROTH Conference,10/31/2016 09073M10    PRN  Bio-Techne Declares Dividend, 3/21/2018 75886F10    PRN  Regeneron and Alnylam Pharmaceuticals Announce Collaboration to Discover New Treatments for Nonalcoholic Steatohepatitis (NASH),," 4/27/2010 68375N10 PRN  UPDATED: ChromaDex Receives Investment from The Frost Group, LLC",12/15/2016 46222210 PRN  Ionis Pharmaceuticals to Host a Pipeline Update Webcast," 9/23/2015 BMRN-US    PRN  Scanning Stocks from the Healthcare Sector - Amicus Therapeutics, Arena Pharmaceuticals, Cerner Corporation, Amarin Corporation and BioMarin Pharmaceutical",, 8/29/2016 64125C10 PRN  Neurocrine Submits New Drug Application for Valbenazine for Treatment of Tardive Dyskinesia,,, 4/09/2013 BIIB-US   PRN  Blockbuster Expectations Don't Always Translate to Market Reality,,," 7/01/2014 37555810   PRN  Dividends, Mergers, and Study Results - Analyst Notes on Pfizer, Gilead, Pacira, QLT and Agenus", 4/12/2016 04004760   PRN  Arena Pharmaceuticals Reports Favorable Results from Phase 1b Multiple-Ascending Dose Clinical Trial of APD371, 9/29/2017 N5946510  PRN  Mylan Launches Generic Gleevec® Tablets,,,10/18/2018 03116210 PRN  Amgen Invests £50 Million ($66 Million) In Oxford Nanopore Technologies,," 2/20/2014 52887230 PRN  Lexicon to Report Fourth Quarter and Year End 2013 Financial Results on February 28, 2014",,,, 6/16/2014 45773H20 PRN  Inovio Pharmaceuticals to Present at Upcoming Healthcare Conferences," 2/26/2016 64026810 PRN  Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2015 on Tuesday, March 1, 2016, After Close of U.S.-Based Financial Markets"," 4/30/2014 76655960 PRN  Rigel Announces Webcast of Investor Day on May 6, 2014",,,,,11/13/2014 91307C10 PRN  Professor Katherine J. Klein Joins The United Therapeutics Corporation Board Of Directors,,"11/16/2011 000CQ8-E PRN  The Zacks Analyst Blog Highlights: Alkermes plc, Elan Corporation, Sprint, AT&T and Verizon",,,, 3/17/2014 55027E10 PRN  Pioneering Human Protein Atlas Project Achieves a Major Milestone, 2/02/2016 80067710 PRN  Sangamo BioSciences Announces Fourth Quarter And Full Year 2015 Conference Call And Webcast,, 4/25/2017 80105N10  PRN  Regeneron and Sanofi Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection,,,,,,,,,,,, 9/04/2012 68214310 PRN  Omeros to Present at the 19th Annual Newsmakers in the Biotech Industry Conference,,,,,,,, 6/24/2015 69329Y10 PRN  PDL BioPharma Appoints Steffen Pietzke as Controller and Chief Accounting Officer,,,, 8/01/2014 00182C10 PRN  ANI Pharmaceuticals Acquires Vancocin® Capsules and Additional Vancomycin Assets from Shire,,,,,10/16/2013 60468T10 PRN  Mirati Therapeutics Announces Public Offering Of Common Stock,,,,,,, 6/11/2015 09627Y10 PRN  Blueprint Medicines Reports First Quarter 2015 Financial Results,," 7/24/2015 28249U10 PRN  Lifshitz & Miller Law Firm Announces Investigation of Celladon Corporation, Edison International, Inc., Louisiana Bancorp, Inc., Navient Corp., On Deck Capital, Inc., Thoratec, and Vivint Solar",,,,,,," 3/12/2015 92165910 PRN  Scanning Biotech Equities -- Agenus, Amicus Therapeutics, Peregrine Pharma, Vanda Pharma, and Acorda Therapeutics",,,,,10/29/2015 HALO-US  PRN  Halozyme Announces First Clinical Dosing Of Pfizer's Rivipansel Using Enhanze™ Technology,11/16/2010 G2151510 PRN  China Biologic Products Announces Record Third Quarter 2010 Results,,,,,, 5/08/2017 69366J20 PRN  PTC Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update,,,,,,,12/02/2013 36197T10 PRN  GW Pharmaceuticals to Present at the Piper Jaffray 25th Annual Health Care Conference,, 5/18/2016 0CBRZ9-E PRN  Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences,,,,,10/18/2013 008W47-E PRN  Veracyte Presents Preliminary Data Suggesting Potential for an RNA-Based Gene Expression Test to Detect the BRAF V600E Mutation in Thyroid Nodule Biopsy Samples,,,,,,,,,,,,,,,,10/11/2013 00780K-E PRN  Xencor Files Registration Statement for Proposed Initial Public Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 2/03/2011 002WRP-E    PRN  Genomic Health Announces Results from Biomarker Discovery Program Utilizing Next-Generation Sequencing to Compare Normal and Tumor Breast Tissue,,"10/18/2016 G3040110 PRN  Endo to Announce Third Quarter 2016 Financial Results on November 8, 2016",, 2/28/2014 09060J10 PRN  BioDelivery Sciences to Present at the Cowen and Company 34th Annual Health Care Conference,"10/17/2016 09073M10    PRN  Bio-Techne To Host Conference Call On October 31, 2016 To Announce First Quarter Financial Results", 3/21/2018 75886F10    PRN  Regeneron Genetics Center® Publication in New England Journal of Medicine Identifies New Genetic Variant Providing Protection from Chronic Liver Disease,,,12/13/2016 46222210 PRN  Ionis Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference," 9/23/2015 SGMO-US    PRN  Technical Briefing on Biotechnology Equities -- MannKind, Novavax, Incyte, BioMarin Pharma, and Sangamo Biosciences",, 8/03/2016 64125C10 PRN  Neurocrine Biosciences Reports Second Quarter 2016 Results,,, 4/08/2013 06680H-E  PRN  Surveyed U.S. Neurologists Would Prescribe Biogen Idec's Tecfidera to 20 Percent of Their Patients with Relapsing-Remitting Multiple Sclerosis (RR-MS),,," 6/26/2014 37555810   PRN  Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma", 2/29/2016 04004760   PRN  Arena Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update, 9/14/2017 N5946510  PRN  Mylan Expands Women's Healthcare Portfolio with Launch of Generic Minastrin® 24 FE Tablets,,,10/16/2018 03116210 PRN  Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across Europe,, 2/03/2014 52887230 PRN  Lexicon To Present At The BIO CEO And Investor Conference,,,, 6/11/2014 45773H20 PRN  Inovio Pharmaceuticals Clarifies Facts of its VGX-3100 Phase II Trial and Immunotherapy Technology, 2/25/2016 NKTR-US  PRN  Baxalta Announces Submission of Supplemental BLAs to Expand Use of ADYNOVATE to Pediatric Patients and Surgical Settings," 3/10/2014 09NWNQ-E PRN  Regulatory Approvals, Pricing of Public Offering, Stock Price Movements, and Financial Reports - Analyst Notes on Arrowhead, ANI, OraSure, Rigel, and Foundation Medicine",,,,,"10/31/2014 91307C10 PRN  Clinical Trial Results, Product Approval Letter, Financial Results, and Upcoming Event - Research Reports on Receptos, Wright, United Therapeutics, Abbott and CareFusion",, 9/12/2011 G0176710 PRN  Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011,,,, 2/03/2014 55027E10 PRN  Luminex Corporation Reports Fourth Quarter And Full Year 2013 Results, 1/11/2016 SGMO-US  PRN  Sangamo BioSciences Highlights 2016 Catalysts at the 34th Annual J.P. Morgan Healthcare Conference,, 4/25/2017 80105N10  PRN  Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection,,,,,,,,,,,, 8/15/2012 68214310 PRN  Omeros Has Now Unlocked Over Half of the Class A Orphan GPCRs,,,,,,,, 6/15/2015 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,, 7/28/2014 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results,,,,,,,,,,,, 6/05/2015 09627Y10 PRN  Blueprint Medicines to Present at Upcoming Investor Conferences in June,," 5/06/2015 28249U10 PRN  Financial Services and Health Care Stocks: Complementary Research on World Acceptance, Celladon Corporation, WuXi PharmaTech, AtriCure and AAC Holdings",,,,,,, 3/04/2015 92165910 PRN  Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis,,,,,"10/19/2015 40637H10 PRN  /C O R R E C T I O N -- Halozyme Therapeutics, Inc./","11/15/2010 G2151510 PRN  China Biologic Products to Present at Brean Murray, Carret 2010 China Growth Conference",,,,,, 4/26/2017 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,11/27/2013 36197T10 PRN  GW Pharmaceuticals plc Announces Sativex® Regulatory Approval in Switzerland,, 5/10/2016 G5087110 PRN  Jazz Pharmaceuticals Announces First Quarter 2016 Financial Results,,,,," 9/20/2013 008W47-E PRN  Veracyte, Inc. Files Registration Statement for Initial Public Offering",,,,,,,,,,,,,,,, 7/02/2013 00780K-E PRN  Xencor Licenses Fc Antibody Engineering IP to Merck,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 1/06/2011 000YMW-E    PRN  Critical Alerts for Baidu, Walgreens, Dollar Tree, Illumina, and Weyerhaeuser Released by Seven Summits Research",, 9/30/2016 074H1G-E PRN  Endo Pharmaceuticals Presents New Phase 2 Data Evaluating the Safety and Effectiveness of XIAFLEX® (Collagenase Clostridium Histolyticum) for Dupuytren's Disease Nodules,, 2/13/2014 09060J10 PRN  BioDelivery Sciences Closes $60 Million Registered Direct Offering, 9/28/2016 000XKX-E    PRN  ACD Launches BaseScope™ Suite of Tissue Analysis Assays Enabling Breakthrough Advances in Molecular Pathology, 3/19/2018 75886F10    PRN  EYLEA® (aflibercept) Injection Demonstrates Positive Topline Results in Phase 3 Non-Proliferative Diabetic Retinopathy Trial,,,12/07/2016 0017CR-E PRN  Ionis Pharmaceuticals to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference, 6/12/2015 09061G10   PRN  PTC Therapeutics and BioMarin Pharmaceutical to Host DMD Industry Symposium,, 7/28/2016 64125C10 PRN  Neurocrine Announces Initiation of a Long-Term Phase II Clinical Study of VMAT2 Inhibitor Valbenazine in Tourette Syndrome,,," 4/05/2013 06DDVL-E  PRN  Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics",,," 6/13/2014 37555810   PRN  Critical Alerts For Ralph Lauren, Rackspace Hosting, Gilead Sciences, Fortinet, and Express Scripts Technology Released By InvestorsObserver"," 2/23/2016 04004760   PRN  Arena Pharmaceuticals to Host Fourth Quarter and Full Year 2015 Financial Results and Corporate Update Conference Call and Webcast on Monday, February 29", 9/13/2017 N5946510  PRN  Mylan Names Dennis Zeleny as Chief Human Relations Officer,,,10/01/2018 03116210 PRN  FDA Approves KYPROLIS® (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone (Kd70) For Patients With Relapsed Or Refractory Multiple Myeloma,, 1/13/2014 52887230 PRN  Lexicon Announces Focus On Late-Stage Development Programs And Preparation For Commercialization,,,, 6/10/2014 45773H20 PRN  Inovio Pharmaceuticals Initiates Immune Therapy Trial for Head & Neck Cancer Caused by HPV," 2/01/2016 64026810 PRN  Nektar Publishes Pre-clinical Results for NKTR-214, an Investigational CD122-Biased Immune-Stimulatory Cytokine for the Treatment of Cancer in Clinical Cancer Research", 3/06/2014 76655960 PRN  Rigel Announces Publication of R118 AMPK Activator Research,,,,,"10/29/2014 91307C10 PRN  Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin",," 8/04/2011 G0176710 PRN  The Zacks Analyst Blog Highlights: Alkermes, Johnson & Johnson, Amylin Pharmaceuticals, Eli Lilly and Company and Elan Corporation",,,, 1/29/2014 55027E10 PRN  Luminex Corporation To Present At 2014 Leerink Global Healthcare Conference, 1/05/2016 SGMO-US  PRN  Sangamo BioSciences Announces Presentation At The 34th Annual J.P. Morgan Healthcare Conference,, 4/24/2017 80105N10  PRN  Sanofi Receives FDA Approval of Thymoglobulin® for the Prevention of Acute Kidney Transplant Rejection,,,,,,,,,,,, 8/08/2012 68214310 PRN  Omeros to Present at Two Upcoming Conferences,,,,,,,, 5/27/2015 PDLI-US  PRN  PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference,,,," 7/04/2014 00182C10 PRN  Acquisitions, Study Results, Merger Agreements, and Completed Trial Recruitments - Analyst Notes on Cooper, Agenus, Transcept, CTI and ANI",,,,,,,,,,,, 5/11/2015 09627Y10 PRN  Blueprint Medicines Publishes Strategy for Advancing Kinase Drug Discovery,," 2/16/2015 28249U10 PRN  Latest Updates on Health Care Sector: Special Research on bluebird bio, Brainstorm, CASI Pharmaceuticals, Celladon, and Cellular Dynamics",,,,,,, 2/19/2015 92165910 PRN  Vanda Pharmaceuticals Reports Fourth Quarter 2014 and Full Year 2014 Financial Results,,,,," 9/23/2015 40637H10 PRN  Stocks Update from Health Care Sector -- Halozyme Therapeutics, Celldex Therapeutics, Galena Biopharma, AMAG Pharmaceuticals and EXACT Sciences",11/09/2010 G2151510 PRN  China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results,,,,,, 4/24/2017 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss First Quarter Financial Results,,,,,,,11/19/2013 36197T10 PRN  GW Pharmaceuticals plc Reports 2013 Q4 and Full Year Financial Results,," 4/26/2016 G5087110 PRN  Jazz Pharmaceuticals to Report 2016 First Quarter Financial Results on May 10, 2016",,,,, 6/28/2013 008W47-E PRN  Veracyte Completes $28 Million Series C Financing Round With GE Ventures as a New Investor,,,,,,,,,,,,,,,, 4/16/2013 003Q91-E PRN  Xencor Licenses Xtend™ Therapeutic Protein Half-life Extension Technology to CSL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"11/23/2010 45232710    PRN  Critical Alerts For Exxon Mobil, Barrick Gold, Illumina, Dover, and Novellus Systems Released By Seven Summits Research",, 9/26/2016 06VZMW-E PRN  Meeting Market Demand Strategies & Potential Acquisition Scenarios Stimulate Opportunities in These Stocks,, 2/10/2014 09060J10 PRN  BioDelivery Sciences to Raise $60 Million in Registered Direct Offering From Institutional Investors, 8/31/2016 09073M10    PRN  Bio-Techne Announces Investor Day And Webcast," 3/13/2018 75886F10    PRN  Teen Scientists Win $1.8 Million at Regeneron Science Talent Search 2018 with Top Awards for Novel Research on Crop Blight, Vaping and Rare Disease",,,11/15/2016 0017CR-E PRN  Ionis Pharmaceuticals Reports Positive Clinical Data from IONIS-ANGPTL3-L Rx," 5/11/2015 09061G10   PRN  Recent Highlights from the Healthcare Sector: Complementary Research on BioMarin, Seattle Genetics, Globus Medical, Nymox and Progenics",, 7/27/2016 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2016 Results,,," 3/28/2013 09062X10  PRN  Critical Alerts For Apache, Hess, Biogen, Beazer Homes, and Deckers Released By InvestorsObserver",,," 5/30/2014 37555810   PRN  Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron", 1/12/2016 04004760   PRN  Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to Advance Research in Schizophrenia, 8/24/2017 N5946510  PRN  Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba™) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries,,, 9/24/2018 03116210 PRN  BLINCYTO® (blinatumomab) Approved In Japan For The Treatment Of Relapsed Or Refractory B-cell Acute Lymphoblastic Leukemia,, 1/08/2014 52887230 PRN  Lexicon To Present At The J.P. Morgan Healthcare Conference,,,, 5/30/2014 45773H20 PRN  Inovio Pharmaceuticals Announces Reverse Stock Split Date," 1/06/2016 NKTR-US  PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, CA", 3/04/2014 76655960 PRN  Rigel Announces Fourth Quarter and Year End 2013 Financial Results,,,,,10/28/2014 91307C10 PRN  United Therapeutics Corporation Reports Third Quarter 2014 Financial Results,," 7/13/2011 G0176710 PRN  The Zacks Analyst Blog Highlights: Alkermes, Amylin Pharmaceuticals, Eli Lilly and Company, Liberty Property Trust and Duke Realty",,,," 1/14/2014 55027E10 PRN  Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014",12/11/2015 80067710 PRN  Sangamo BioSciences Presents Phase 2 Clinical Data From Two SB-728-T HIV Studies,, 4/24/2017 80105N10  PRN  Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis,,,,,,,,,,,, 8/08/2012 68214310 PRN  Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial,,,,,,,, 5/06/2015 69329Y10 PRN  PDL BioPharma Announces First Quarter 2015 Financial Results,,,, 7/01/2014 069GKH-E PRN  ANI Pharmaceuticals Acquires Lithobid® Extended Release Tablets from Noven Therapeutics,,,,,,,,,,,, 5/05/2015 09627Y10 PRN  Blueprint Medicines Announces Closing of Initial Public Offering,," 7/02/2014 28249U10 PRN  Financial Guidance, Appointments, Board Elections, and Technical Updates - Analyst Notes on Amedisys, Dyax, TearLab, Celladon and Alphatec",,,,,,," 2/02/2015 92165910 PRN  Vanda Pharmaceuticals to Announce Fourth Quarter 2014 Financial Results on February 19, 2015",,,,, 8/24/2015 40637H10 PRN  Halozyme Appoints Michael J. Labarre As Chief Scientific Officer, 8/16/2010 G2151510 PRN  China Biologic Products Announces Record Second Quarter 2010 Results,,,,,, 4/20/2017 69366J20 PRN  PTC Therapeutics Completes Acquisition of Emflaza™ for the Treatment of Duchenne Muscular Dystrophy in the U.S.,,,,,,,11/18/2013 36197T10 PRN  GW Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference,, 3/30/2016 06CR5C-E PRN  Jazz Pharmaceuticals Announces Webcast for Defitelio® (defibrotide sodium) Investor Update,,,,, 4/17/2013 008W47-E PRN  Veracyte Announces That New Study Suggests The Number Of Patients At Risk For Unnecessary Thyroid Surgery Is Likely On The Rise,,,,,,,,,,,,,,,, 2/13/2013 00780K-E PRN  Xencor Initiates Phase 1b/2a Trial of XmAb®5871 for Autoimmune Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,10/28/2010 45232710    PRN  Caliper Life Sciences Reports Third Quarter 2010 Results,, 9/23/2016 G3040110 PRN  Endo Names Paul Campanelli President and Chief Executive Officer,, 1/30/2014 09060J10 PRN  BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference, 8/17/2016 09073M10    PRN  Bio-Techne Declares Dividend," 3/13/2018 75886F10    PRN  Teen Scientists Win $1.8 Million at Regeneron Science Talent Search 2018 with Top Awards for Novel Research on Crop Blight, Vaping and Rare Disease",,,11/09/2016 46222210 PRN  Ionis Pharmaceuticals Reports Financial Results and Highlights for Third Quarter 2016," 4/23/2015 09061G10   PRN  Active Equities to Watch in the Health Care Sector -- Cytori Therapeutics, Endo Intl., BioMarin Pharma, Novogen, and Receptos",," 6/28/2016 NBIX-US  PRN  Drugs - Generic Stocks Technical Snapshot - Sophiris Bio, Neurocrine Biosciences, Lannett, and Supernus Pharma",,," 3/20/2013 0BB0Z1-E  PRN  Tracking Over $7 Billion Worth of Pharmaceutical Industry Partnerships, Investments, Mergers and Acquisitions in February",,," 5/28/2014 37555810   PRN  Clinical Study Results, Schedule of Upcoming Conferences, Dividend Declaration, and Services Agreement - Analyst Notes on Gilead, Quest Diagnostics, Sarepta Therapeutics, Incyte and Centene", 1/07/2016 ARNA-US    PRN  Arena Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference, 8/17/2017 MYL-US    PRN  Mylan Finalizes Settlement Agreement on Medicaid Rebate Classification for EpiPen® Auto-Injector,,, 9/20/2018 03116210 PRN  Amgen And Los Angeles County Announce Collaboration To Support Life Science Innovation Hub - BioLA,,"12/20/2013 52887230 PRN  Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical",,,, 5/27/2014 45773H20 PRN  Inovio Pharmaceuticals Subsidiary Sells Animal Health Assets,12/21/2015 NKTR-US  PRN  Baxalta's ADYNOVATE Meets Endpoints in Phase 3 Study of Hemophilia A Patients Under 12 Years of Age, 2/27/2014 76655960 PRN  Rigel Announces Participation at Two Investor Conferences,,,,,"10/21/2014 91307C10 PRN  United Therapeutics Corporation To Announce Third Quarter 2014 Financial Results Before Market Open On Tuesday, October 28, 2014",, 6/24/2011 G0176710 PRN  Studies Show Effect of BYDUREON™ on A1C and Weight for Up to Three Years,,,, 1/02/2014 55027E10 PRN  Luminex Corporation To Present At JP Morgan Healthcare Conference,12/07/2015 SGMO-US  PRN  Sangamo BioSciences Presents Data At The 2015 American Society Of Hematology Meeting Highlighting ZFP Therapeutic® Programs For Hemophilia And Hemoglobinopathies,, 4/18/2017 80105N10  PRN  5 Stocks to Watch as Canada Gets Hooked on Cannabis,,,,,,,,,,,, 8/07/2012 68214310 PRN  Omeros Corporation Reports Second Quarter 2012 Financial Results,,,,,,,," 4/29/2015 69329Y10 PRN  PDL BioPharma to Announce First Quarter 2015 Financial Results on May 6, 2015",,,, 6/18/2014 0BBBSX-E PRN  ANI Pharmaceuticals Signs Exclusive License and Supply Agreement with Dexcel Pharma Technologies Ltd.,,,,,,,,,,,, 4/29/2015 09627Y10 PRN  Blueprint Medicines Announces Pricing of Initial Public Offering,,,,,,,,," 1/29/2015 92165910 PRN  Vanda Pharmaceuticals to Participate in the Canaccord Genuity Rare Disease, Biopharma One-on-One Day",,,,, 8/10/2015 40637H10 PRN  Halozyme Reports Second Quarter 2015 Financial Results, 8/12/2010 G2151510 PRN  China Biologic Products Schedules Conference Call to Discuss Second Quarter 2010 Results,,,,,," 4/10/2017 69366J20 PRN  PTC Therapeutics Announces Departure of Chief Financial Officer, Shane Kovacs",,,,,,,11/15/2013 36197T10 PRN  GW Pharmaceuticals Provides Update on Orphan Program in Childhood Epilepsy for Epidiolex®,, 3/30/2016 06CR5C-E PRN  Jazz Pharmaceuticals Announces FDA Approval of Defitelio® (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease (VOD) with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation (HSCT),,,,, 4/12/2013 008W47-E PRN  Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer,,,,,,,,,,,,,,,, 1/17/2013 00780K-E PRN  Xencor Receives Milestone Payment for Xtend™ Antibody,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,10/21/2010 45232710    PRN  Caliper Life Sciences Signs Co-Marketing Pact with Illumina to Improve Sequencing Workflows,, 8/18/2016 G3040110 PRN  Endo's President and CEO Adopts 10b5-1 Trading Plan,, 1/23/2014 05MBN8-E PRN  Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain, 8/17/2016 09073M10    PRN  Bio-Techne Releases Fourth Quarter Fiscal 2016 Results, 3/10/2018 75886F10    PRN  Regeneron and Sanofi Announce Plans to Make Praluent® (alirocumab) More Accessible and Affordable for Patients with the Greatest Health Risk and Unmet Need,,,11/02/2016 46222210 PRN  Ionis Pharmaceuticals to Present at Upcoming Investor Conferences," 3/30/2015 09061G10   PRN  Critical Alerts For GoPro, BioMarin Pharmaceutical, Altera, CVS Caremark and Halliburton Released By InvestorsObserver",, 6/02/2016 64125C10 PRN  Neurocrine Biosciences to Present at the Jefferies 2016 Healthcare Conference,,," 3/14/2013 06DDVL-E  PRN  Zacks Bull and Bear of the Day Highlights: Cincinnati Financial, ArcelorMittal, Biogen, Sanofi and Osiris Therapeutics",,," 5/20/2014 37555810   PRN  Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology",12/01/2015 ARNA-US    PRN  Eisai and Arena Pharmaceuticals Announce Completion of Enrollment in BELVIQ® (lorcaserin HCI) CAMELLIA-TIMI 61 Study," 8/14/2017 N5946510  PRN  Breakfast Technical Briefing on Generic Drugs Stocks -- Horizon Pharma, Mylan, Neurocrine Biosciences, and Rigel Pharma",,, 9/17/2018 03116210 PRN  World's Largest Alzheimer's Survey Reveals Most Adults Believe a Cure Will be Developed in Their Lifetime,,12/03/2013 52887230 PRN  Lexicon Completes Phase 2 Study Of LX1033 In IBS-d,,,, 5/27/2014 45773H20 PRN  Inovio Pharmaceuticals Breakthrough DNA-Based Monoclonal Antibody Therapy Completely Protects Animals From Lethal Viral Challenge,12/08/2015 NKTR-US  PRN  Nektar Therapeutics to Present at Oppenheimer 26th Annual Healthcare Conference in New York, 2/06/2014 76655960 PRN  Rigel Announces Participation at Two Investor Conferences,,,,,"10/08/2014 91307C10 PRN  Upcoming Events, New Facilities, Technical Updates, and Pilot Programs - Research Reports on Aetna, United Therapeutics, Quest Diagnostics, Cummins and Danaher",, 6/24/2011 G0176710 PRN  Analysis Shows BYDUREON™ Was Not Associated with Clinically Relevant QT Prolongation in Patients with Type 2 Diabetes: Results Presented at ADA 2011,,,,11/04/2013 55027E10 PRN  Luminex Corporation Reports Third Quarter 2013 Results,"12/01/2015 SGMO-US  PRN  Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B",, 4/03/2017 80105N10  PRN  Sanofi Launches First-Ever ACT® Kids Toothpaste in the U.S.,,,,,,,,,,,, 7/31/2012 68214310 PRN  Omeros Announces Discovery in MASP-2 Program,,,,,,,," 4/21/2015 69329Y10 PRN  Stock Updates on Biotech -- Celgene, Amgen, PDL BioPharma, Amarin, and Pharmacyclics",,,," 5/05/2014 00182C10 PRN  ANI Pharmaceuticals Reports Record Net Revenues of $10.9 million, EPS of $0.33, and Adjusted Non-GAAP EBITDA of $4.2 Million for the First Quarter Ended March 31, 2014",,,,,,,,,,,, 4/24/2015 0BP4MZ-E PRN  Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma,,,,,,,,, 1/16/2015 92165910 PRN  Vanda Announces Listing of a New Fanapt® Patent in the FDA Orange Book,,,,, 8/06/2015 HALO-US  PRN  UCSF To Study Halozyme PEGPH20 In Pancreatic Cancer Patients Who Are Candidates For Potentially Curative Surgery, 7/29/2010 G2151510 PRN  China Biologic Products to Attend Canaccord Genuity 30th Annual Growth Conference,,,,,, 3/16/2017 69366J20 PRN  PTC Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update,,,,,,,"11/12/2013 36197T10 PRN  GW Pharmaceuticals to Report 2013 Q4 and Full Year Financial Results and Host Conference Call on 19 November, 2013",," 3/30/2016 0CBRZ9-E PRN  Jazz Announces Expansion Of Executive Leadership Team, to Accelerate Rapid Growth",,,,, 3/12/2013 008W47-E PRN  Veracyte Announces Results of Study Assessing Use of BRAF Mutation Testing With Its Afirma® Gene Expression Classifier,,,,,,,,,,,,,,,, 4/19/2012 00780K-E PRN  Xencor Receives Milestone Payment from CSL Limited Under Antibody Optimization Collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,"10/12/2010 002WRP-E    PRN  WaferGen Names Gary P. Schroth, Ph.D., as New SVP, Genomics Research and Applications",," 8/15/2016 G3040110 PRN  Under Armour trade offers a 5% return in 32 days, or find similar option trades on Endo International, Sears Holdings, Celgene, and Barrick Gold Corporation",, 1/10/2014 09060J10 PRN  BioDelivery Sciences Provides an Update of Anticipated 2014 Milestones," 8/03/2016 09073M10    PRN  Bio-Techne To Host Conference Call On August 17, 2016 To Announce Fourth Quarter Financial Results", 3/10/2018 75886F10    PRN  Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk and unmet need,,,11/01/2016 46222210 PRN  Ionis Pharmaceuticals Reports Positive Phase 2 Data for IONIS-FXI Rx in Patients with End-Stage Renal Disease on Hemodialysis," 3/19/2015 09061G10   PRN  Technical Coverage on Biotech Stocks -- Cytori Therapeutics, Oncolytics Biotech, BioMarin Pharma, Aeterna Zentaris, and Immunomedics",, 5/20/2016 64125C10 PRN  Neurocrine Biosciences Announces the Retirement of W. Thomas Mitchell from the Board of Directors,,," 3/11/2013 06DDVL-E  PRN  Zacks Bull and Bear of the Day Highlights: Winnebago Industries, Gold Fields, Teva Pharmaceutical Industries, Biogen and Novartis",,," 5/19/2014 000L1R-E   PRN  While Gilead's Sovaldi Continues to Dominate the Hepatitis C Space, Janssen's Olysio Has Gained Market Share Driven by Off-label Prescribing",11/30/2015 ARNA-US    PRN  Eisai and Arena Pharmaceuticals Announce FDA Acceptance of New Drug Application for Extended Release Formulation of Lorcaserin, 8/10/2017 N5946510  PRN  Mylan Advances Access in the Fight Against HIV with the Launch of Three Generic Antiretroviral Medicines in Canada,,, 9/11/2018 03116210 PRN  Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference,,12/02/2013 52887230 PRN  Lexicon Pharmaceuticals To Host 2013 Research And Development Day,,,, 5/23/2014 45773H20 PRN  Inovio Pharmaceuticals Announces 1 For 4 Reverse Split,"12/08/2015 64026810 PRN  Nektar Announces First Patient Dosed in Phase 1/2 Clinical Study of NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine", 1/10/2014 76655960 PRN  Rigel Will Present Clinical Product Portfolio Update at J.P. Morgan Healthcare Conference,,,,," 9/25/2014 91307C10 PRN  Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics",, 6/24/2011 G0176710 PRN  Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011,,,,10/29/2013 55027E10 PRN  LUMINEX CORPORATION TO HOST INVESTOR EVENT AT ASSOCIATION FOR MOLECULAR PATHOLOGY ANNUAL MEETING,11/23/2015 SGMO-US  PRN  Sangamo BioSciences Announces Presentation At The 2015 Piper Jaffray Healthcare Conference,, 4/02/2017 80105N10  PRN  Switching to Sanofi's Toujeo® Showed Significant Reductions in Blood Sugar and Significantly Lower Incidence of Hypoglycemia in a Real-World Observational Study,,,,,,,,,,,, 7/18/2012 68214310 PRN  Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway,,,,,,,," 3/18/2015 69329Y10 PRN  Biotech Stocks Technical Study -- Orexigen Therapeutics, Celgene, PDL BioPharma, Amarin, and Synergy Pharma",,,, 5/01/2014 0DDR1Z-E PRN  ANI Pharmaceuticals Expands Product Development Collaboration with Sofgen,,,,,,,,,,,, 4/19/2015 0BP4MZ-E PRN  Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity of BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets,,,,,,,,,"12/30/2014 92165910 PRN  Biotech Stocks Technical Data -- Gilead Sciences, ImmunoGen, Exelixis, Cubist Pharma, and Vanda Pharma",,,,, 8/05/2015 40637H10 PRN  Halozyme Appoints Jeffrey W. Henderson To Board, 6/08/2010 G2151510 PRN  China Biologic Products to Present at Jeffries 2010 Global Life Sciences Conference,,,,,, 3/16/2017 69366J20 PRN  PTC Therapeutics Announces Agreement to Acquire Emflaza™ for the Treatment of Duchenne Muscular Dystrophy in U.S.,,,,,,,11/11/2013 36197T10 PRN  GW Pharmaceuticals Commences Phase 1b/2a Clinical Trial for the Treatment of Glioblastoma Multiforme (GBM),, 3/02/2016 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March,,,,, 3/08/2013 008W47-E PRN  Veracyte Announces UnitedHealthcare Coverage Policy For the Afirma® Gene Expression Classifier,,,,,,,,,,,,,,,, 4/04/2012 00780K-E PRN  Xencor Receives Second Milestone Payment from Boehringer Ingelheim Under Antibody Technology License Agreement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 9/28/2010 45232710    PRN  Covaris Signs Co-Marketing Agreement with Illumina to Combine Next-Gen Sequencing Platforms with Controlled DNA Shearing,, 8/12/2016 06CR5C-E PRN  Endo Announces OPANA® ER Regulatory Update,,12/03/2013 09060J10 PRN  BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets, 8/01/2016 09073M10    PRN  Bio-Techne Corporation Completed its Acquisition of Advanced Cell Diagnostics," 3/10/2018 75886F10    PRN  Praluent® (alirocumab) Injection significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate",,,10/26/2016 46222210 PRN  Webcast Alert: Ionis Pharmaceuticals' Third Quarter 2016 Financial Results Conference Call," 1/09/2015 09061G10   PRN  Today's Review on Biotech Equities - Kite Pharma, Organovo Holdings, BioMarin Pharma, NephroGenex, and Neuralstem",, 5/06/2016 NBIX-US  PRN  Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2016 Health Care Conference,,," 3/06/2013 09062X10  PRN  Potential Buyouts, Stronger Pipelines, FDA Filings - Research Report on Keryx, Lilly, Baxter, Biogen Idec and Shire",,," 5/14/2014 37555810   PRN  Critical Alerts For Goldman Sachs, Noodles & Company, Starbucks, Gilead Sciences, and Time Warner Cable Released By InvestorsObserver",11/24/2015 ARNA-US    PRN  Arena Pharmaceuticals to Present at Piper Jaffray 27th Annual Healthcare Conference, 8/09/2017 N5946510  PRN  Mylan Reports Second Quarter 2017 Results and Updates 2017 Guidance,,, 9/07/2018 03116210 PRN  Amgen To Present At The Morgan Stanley Global Healthcare Conference,,11/15/2013 52887230 PRN  Lexicon To Present At The Jefferies Global Healthcare Conference,,,, 5/21/2014 45773H20 PRN  Inovio Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference,"11/30/2015 00GGZW-E PRN  Baxalta Announces U.S. Availability of ADYNOVATE, A New Treatment for Adult Patients with Hemophilia A With a Simple, Twice-Weekly Dosing Schedule",12/05/2013 76655960 PRN  Rigel to Present at Oppenheimer Healthcare Conference,,,,," 9/12/2014 91307C10 PRN  Study Results, New Collaboration, Drug Designation, Technical Update, and Completion of Transaction - Research Reports on Gilead, AbbVie, Pfizer, United Therapeutics and Brookdale",, 6/21/2011 G0176710 PRN  BYDUREON™ RECEIVES MARKETING AUTHORIZATION IN EUROPE,,,,"10/15/2013 55027E10 PRN  Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2013",11/11/2015 SGMO-US  PRN  Sangamo BioSciences Announces Presentation At The Jefferies Autumn 2015 Global Healthcare Conference,, 3/28/2017 80105N10  PRN  Regeneron and Sanofi to Host Investor Conference Call to Discuss DUPIXENT® (dupilumab) Approval,,,,,,,,,,,, 7/02/2012 68214310 PRN  Omeros Announces Closing of $34.5 Million Public Offering of Common Stock,,,,,,,, 3/12/2015 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,, 4/28/2014 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call for First Quarter 2014 Financial Results,,,,,,,,,,,, 4/08/2015 0BP4MZ-E PRN  Blueprint Medicines to Present New Preclinical Data on BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets at Upcoming AACR Annual Meeting,,,,,,,,,"12/24/2014 92165910 PRN  Critical Alerts For Vanda Pharmaceuticals, Avis, YPF, Chesapeake Energy and Baidu Released By InvestorsObserver",,,,, 8/03/2015 40637H10 PRN  Halozyme to Host Second Quarter 2015 Financial Results Conference Call, 5/17/2010 G2151510 PRN  China Biologic Products Announces First Quarter 2010 Results,,,,,, 3/13/2017 69366J20 PRN  PTC Therapeutics Announces Timing Change for Fourth Quarter and Year End 2016 Financial Results,,,,,,,10/21/2013 36197T10 PRN  GW Pharmaceuticals Announces Successful Closing of Mutual Recognition Procedure for Sativex® in France,, 2/23/2016 G5087110 PRN  Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2015 Financial Results,,,,, 2/15/2013 008W47-E PRN  New Article in PLOS Currents: Evidence on Genomic Tests Supports Use of Veracyte's Afirma® Gene Expression Classifier to Resolve Ambiguous Thyroid Nodule Biopsies,,,,,,,,,,,,,,,," 2/21/2012 00780K-E PRN  Boehringer Ingelheim and Xencor Enter a Collaboration Agreement for the Development, Manufacture, and Supply of Biosuperior Monoclonal Antibodies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 8/25/2010 002WRP-E    PRN  Ambry Genetics Announces the Addition of Illumina HiSeq 2000 and First 510(K) Approved BeadXpress® to Its Sequencing and Genotyping Capabilities,, 8/08/2016 G3040110 PRN  Endo Reports Second Quarter 2016 Financial Results,,12/02/2013 09060J10 PRN  Positive FDA Meeting Confirms BDSI Phase 3 Program for Clonidine Topical Gel for Treatment of Painful Diabetic Neuropathy, 7/06/2016 09073M10    PRN  Bio-Techne Announces Agreement To Acquire Advanced Cell Diagnostics," 3/10/2018 75886F10    PRN  Praluent® (alirocumab) Injection Significantly Reduced Risk of Cardiovascular Events in High-Risk Patients, and was Associated with Lower Death Rate",,," 9/28/2016 0017CR-E PRN  Ionis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Lifetime Achievement Award from the Oligonucleotide Therapeutics Society","12/12/2014 BMRN-US    PRN  PROSENSA HOLDING N.V. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout",, 5/06/2016 64125C10 PRN  Neurocrine Biosciences Announces Additional Valbenazine (NBI-98854) Data to be Presented at the American Psychiatric Association's 2016 Annual Meeting in Atlanta,,," 1/30/2013 09062X10  PRN  Free Research Report on CVR Energy, Inc., Youku Tudou Inc., Biogen Idec, Inc., Republic Services, Inc. and Mobile Mini, Inc.",,, 5/02/2014 37555810   PRN  BetterInvesting Magazine Releases July Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use,11/19/2015 04004760   PRN  Arena Pharmaceuticals to Host Analyst & Investor Day on December 3rd, 8/08/2017 N5946510  PRN  Mylan Launches Avonza™ in India,,, 9/07/2018 03116210 PRN  Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype,,11/12/2013 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Third Quarter Financial Results,,,," 5/20/2014 45773H20 PRN  Pre-Market Pulse on Top Gainers -- Research on Inovio Pharma, Novavax, FreeSeas, and ImmunoCellular Therapeutics",11/17/2015 NKTR-US  PRN  Nektar Therapeutics to Present at Jefferies Autumn 2015 Global Healthcare Conference in London,11/05/2013 76655960 PRN  Rigel Announces Third Quarter 2013 Financial Results,,,,," 9/03/2014 91307C10 PRN  Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott",," 3/14/2011 G0176710 PRN  Zacks Analyst Blog Highlights: Amylin Pharmaceuticals, Eli Lilly and Company, Alkermes, Novo Nordisk and The Dow Chemical",,,," 9/23/2013 55027E10 PRN  Luminex Corporation Receives FDA and European Clearance for a New Personalized Medicine Genotyping Assay, xTAG® CYP2C19 Kit",11/09/2015 80067710 PRN  Sangamo BioSciences Announces Publication Of Improved Method For Efficient Targeted Integration In Hematopoietic Stem Cells And T-cells,," 3/28/2017 80105N10  PRN  Regeneron and Sanofi Announce FDA Approval of DUPIXENT® (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis",,,,,,,,,,,, 6/27/2012 68214310 PRN  Omeros Prices $30 Million Public Offering of Common Stock,,,,,,,, 3/04/2015 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note,,,, 3/10/2014 00182C10 PRN  ANI Pharmaceuticals Presents at 26th Annual ROTH Conference,,,,,,,,,,,, 3/24/2015 0BP4MZ-E PRN  Blueprint Medicines Files Registration Statement for Proposed Initial Public Offering,,,,,,,,,"12/24/2014 92165910 PRN  Factors Driving the Equity Markets: Coverage Initiated on GoPro, Lockheed Martin, Smith & Nephew, NQ Mobile and Vanda",,,,, 7/31/2015 HALO-US  PRN  Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer, 5/13/2010 G2151510 PRN  China Biologic Products Schedules Conference Call to Discuss First Quarter 2010 Results,,,,,," 3/08/2017 69366J20 PRN  How These Biotech Stocks are Faring? -- bluebird bio, Opexa Therapeutics, Agios Pharma, and PTC Therapeutics",,,,,,,"10/10/2013 36197T10 PRN  Global Distribution Agreements, New Clinical Study Results, FDA Announcements, and Earnings Schedules - Research Report on Life Technologies, GW, Novartis, Salix, and Mallinckrodt",, 2/18/2016 G5087110 PRN  Jazz Pharmaceuticals To Present Data From Ongoing Evaluations Of Defibrotide At The 2016 BMT Tandem Meeting,,,,, 1/07/2013 008W47-E PRN  Veracyte Announces That New Guidelines Include Molecular Testing for Indeterminate Thyroid Nodules To Reduce Unnecessary Surgeries,,,,,,,,,,,,,,,, 1/06/2012 00780K-E PRN  Xencor Receives U.S. Patent for Monoclonal Antibody Engineering that Extends Duration of Action,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,," 6/14/2010 45232710    PRN  Critical Alerts for Goldman Sachs, Bristol-Myers Squibb, Continental Airlines, Red Hat, and Illumina Released by Seven Summits Research",," 8/08/2016 G3040110 PRN  Endo Announces Appointment of Joseph J. Ciaffoni as President, U.S. Branded Pharmaceuticals",,11/25/2013 09060J10 PRN  BioDelivery Sciences to Present at the 25th Annual Piper Jaffray Healthcare Conference, 7/01/2016 09073M10    PRN  Bio-Techne Acquires Space Import-Export And Strengthens European Leadership Team, 3/02/2018 75886F10    PRN  FDA to Review DUPIXENT® (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma,,, 9/22/2016 0017CR-E PRN  Akcea Announces Publication in The Lancet of Clinical Results with Lp(a)-Lowering Drugs Designed to Treat Cardiovascular Disease,"12/01/2014 09061G10   PRN  KaloBios Elects Robert A. Baffi, BioMarin Senior Executive, to Board of Directors",, 5/05/2016 64125C10 PRN  Neurocrine Biosciences Reports First Quarter 2016 Results,,, 1/30/2013 09062X10  PRN  Emerging Growth Pharmaceutical Company Creates Gravitational Pull Towards Their Products,,, 4/30/2014 006RT2-E   PRN  Parion Sciences Reacquires Rights to Epithelial Sodium Channel Inhibitors,11/10/2015 04004760   PRN  Arena Pharmaceuticals Reports Third Quarter 2015 Financial Results and Provides Corporate Update," 8/07/2017 N5946510  PRN  Mylan Receives Tentative Approval for ""TLD"" Under PEPFAR",,, 9/05/2018 0H6SK8-E PRN  Amgen And LabCentral Open Nomination Process For Lab Residency,,11/07/2013 52887230 PRN  Lexicon To Present At The Credit Suisse Healthcare Conference,,,, 5/13/2014 45773H20 PRN  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis,11/05/2015 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Third Quarter of 2015,10/24/2013 76655960 PRN  Rigel Provides Pipeline Update,,,,," 9/02/2014 91307C10 PRN  Critical Alerts For bluebird bio Inc., United Therapeutics Corporation, Mattel Inc, Ulta Salon Cosmetics & Fragrance Inc. and Applied Materials Inc. Released By InvestorsObserver",,"10/19/2010 G0176710 PRN  Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™",,,, 8/22/2013 55027E10 PRN  Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference,11/05/2015 80067710 PRN  Sangamo BioSciences To Present Data From ZFP Therapeutic Programs At Annual Meeting Of The American Society Of Hematology,," 3/28/2017 80105N10  PRN  Sanofi and Regeneron Announce FDA Approval of Dupixent® (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis",,,,,,,,,,,, 6/26/2012 68214310 PRN  Omeros Announces Proposed Public Offering of Common Stock,,,,,,,, 3/03/2015 69329Y10 PRN  PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit,,,, 3/10/2014 00182C10 PRN  ANI Pharmaceuticals Announces Closing Of Public Offering Of Common Stock,,,,,,,,,,,," 3/23/2015 0BP4MZ-E PRN  Blueprint Medicines Appoints Charles A. Rowland, Jr. to its Board of Directors",,,,,,,,,12/22/2014 92165910 PRN  Vanda to regain US and Canadian rights to Fanapt®,,,,," 7/17/2015 40637H10 PRN  Critical Alerts For Chesapeake Energy, Starbucks, Horizon Pharma, Halozyme Therapeutics and Citigroup Released By InvestorsObserver", 5/12/2010 G2151510 PRN  China Biologic Products to Build Two New Plasma Stations in Shandong Province,,,,,, 3/06/2017 69366J20 PRN  PTC Therapeutics Announces FDA Acknowledgment of New Drug Application Filing for Translarna™ for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy,,,,,,,10/02/2013 36197T10 PRN  GW Pharmaceuticals Announces New Sativex® Data at ECTRIMS,," 2/09/2016 G5087110 PRN  Jazz Pharmaceuticals to Report 2015 Fourth Quarter and Full Year Financial Results on February 23, 2016",,,,,10/22/2012 008W47-E PRN  Veracyte Announces Publication Of Analytic Validity Study For Its Afirma® Gene Expression Classifier,,,,,,,,,,,,,,,,10/21/2011 00780K-E PRN  Xencor Initiates Phase 1 Study of XmAb®5871 Therapeutic Antibody for the Treatment of Autoimmune Diseases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,, 5/23/2010 45232710    PRN  Groundbreaking Study Published in Nature Biotechnology Demonstrates Sensitivity of Single Molecule Test for Detection of Prostate Cancer,," 7/18/2016 G3040110 PRN  Endo to Announce Second Quarter 2016 Financial Results on August 8, 2016",,11/12/2013 09060J10 PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Third Quarter 2013 Financials, 5/04/2016 09073M10    PRN  Bio-Techne Corporation Acquires Access to B-MoGen Biotechnologies' Gene Editing Technology, 2/12/2018 75886F10    PRN  Regeneron Announces Appointment of Marion McCourt as Senior Vice President and Head of Commercial,,, 9/15/2016 46222210 PRN  Akcea Therapeutics Announces Presentations of New Data Underscoring Burden of Disease in Familial Chylomicronemia Syndrome,"11/24/2014 09061G10   PRN  Biotech Stocks in Motion - Amgen, Merrimack Pharma, NPS Pharma, BioMarin Pharma, and Regeneron Pharma",, 4/29/2016 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2016 Results,,," 1/25/2013 09062X10  PRN  Critical Alerts For Lowe's, Marvell Technology, Biogen Idec, Riverbed Technology, and InvenSense By InvestorsObserver",,, 4/01/2014 000L1R-E   PRN  Janssen Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat as Part of Combination HIV Therapy,"11/04/2015 04004760   PRN  Arena Pharmaceuticals to Host Third Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, November 10", 7/27/2017 00GDWJ-E  PRN  Mylan Launches MyHep All™ in India,,, 8/29/2018 03116210 PRN  European Commission Approves BLINCYTO® (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia,,"11/06/2013 52887230 PRN  Lexicon To Report Third Quarter Financial Results On November 12, 2013",,,, 5/12/2014 45773H20 PRN  Inovio Pharmaceuticals Reports 2014 First Quarter Financial Results,"10/29/2015 64026810 PRN  Nektar to Announce Financial Results for the Third Quarter 2015 on Thursday, November 5, 2015, After Close of U.S.-Based Financial Markets", 9/06/2013 76655960 PRN  Rigel to Present at Stifel Healthcare Conference,,,,, 8/29/2014 91307C10 PRN  District Court Decision Received In Remodulin Patent Case,, 9/14/2010 G0176710 PRN  BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010,,,, 8/07/2013 55027E10 PRN  Luminex Corporation Announces Corporate Restructuring Actions to Drive Operational Excellence and Improve Focus on MDx Market,10/28/2015 80067710 PRN  Sangamo BioSciences Reports Third Quarter 2015 Financial Results,, 3/22/2017 80105N10  PRN  Sanofi Genzyme Extends its Multiple Myeloma Journey Partners Program to Cities Nationwide to Help Improve Patient Outcomes through Peer-to-Peer Education,,,,,,,,,,,, 5/31/2012 68214310 PRN  Omeros Announces Initiation of Planned Pharmacokinetic Substudy in OMS302 Phase 3 Clinical Program,,,,,,,," 2/26/2015 69329Y10 PRN  PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2015",,,, 3/10/2014 07BP6K-E PRN  ANI Pharmaceuticals Expands Generic Drug Development Agreement with Sterling Pharmaceuticals,,,,,,,,,,,, 3/16/2015 0BP4MZ-E PRN  Blueprint Medicines Publishes Preclinical Proof-of-Concept Data on Promising New Therapy for Patients with Genomically Defined Hepatocellular Carcinoma,,,,,,,,,12/01/2014 92165910 PRN  Vanda Pharmaceuticals to Present at the 26th Annual Piper Jaffray Healthcare Conference,,,,, 6/19/2015 40637H10 PRN  Halozyme Therapeutics To Present At The JMP Securities 2015 Life Sciences Conference, 4/27/2010 G2151510 PRN  China Biologic Products to Receive Government Benefits to Continue R&D Innovation,,,,,, 3/02/2017 69366J20 PRN  PTC Therapeutics Announces Results from Pivotal Phase 3 Clinical Trial of Ataluren in Patients Living with Nonsense Mutation Cystic Fibrosis,,,,,,, 9/23/2013 36197T10 PRN  GW Pharmaceuticals Announces Agreement on Sativex® Pricing in Germany,, 2/03/2016 0CBRZ9-E PRN  JAZZ PARTNERS WITH AURICO TO PROVIDE COMPANIES WITH HIGH QUALITY BACKGROUND SCREENING TO IMPROVE THE EFFICIENCY OF THEIR HIRING PROCESS,,,,, 8/29/2012 005M9Z-E PRN  Veracyte Receives New York State License for Afirma® Gene Expression Classifier,,,,,,,,,,,,,,,, 1/06/2011 000C35-E PRN  Amgen and Xencor Enter Option Deal to Co-Develop Xencor's Novel Antibody for Autoimmune Diseases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/08/2016 G3040110 PRN  ENDO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Endo International plc - ENDP",,10/21/2013 09060J10 PRN  BioDelivery Sciences Appoints Ernest De Paolantonio as Chief Financial Officer, 5/03/2016 09073M10    PRN  Bio-Techne Releases Third Quarter Fiscal 2016 Results, 2/08/2018 75886F10    PRN  Regeneron Reports Fourth Quarter and Full Year 2017 Financial and Operating Results,,, 8/31/2016 46222210 PRN  Ionis Pharmaceuticals to Present at Upcoming Investor Conferences,"10/29/2014 09061G10   PRN  Quarterly Earnings Releases and Recognitions - Research Reports on GlaxoSmithKline, IDEXX, BioMarin, GE and Lockheed Martin",, 4/27/2016 DB-DE    PRN  Neurocrine Biosciences to Present at the Deutsche Bank 41st Annual Health Care Conference,,, 1/23/2013 09062X10  PRN  The Big Cure for 2013 - Research Report on Biogen Idec Inc. and Keryx Biopharmaceuticals Inc.,,, 2/19/2014 0DCBQX-E   PRN  CURx Pharmaceuticals Announces License Agreement with Gilead Sciences,11/02/2015 ARNA-US    PRN  Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at 2015 Annual Obesity Week Meeting, 7/26/2017 MYL-US    PRN  Mylan Receives WHO Prequalification for Generic Sovaldi®,,, 8/27/2018 03116210 PRN  Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone,,10/09/2013 52887230 PRN  Lexicon Completes Pilot Study Of Telotristat Etiprate In Ulcerative Colitis,,,," 5/05/2014 45773H20 PRN  Inovio Pharmaceuticals to Report First Quarter 2014 Financial Results on May 12, 2014",10/08/2015 64026810 PRN  Nektar Reports on Advancements with Pain and Oncology Clinical Pipeline at Investor and Analyst R&D Day," 9/05/2013 76655960 PRN  Rigel To Focus On ITP, DLE And Dry Eye",,,,, 7/29/2014 91307C10 PRN  United Therapeutics Corporation Reports Second Quarter 2014 Financial Results,, 6/26/2010 G0176710 PRN  BYDUREON(TM) Safety and Tolerability Pooled Summary Data Presented at ADA 2010,,,, 7/29/2013 55027E10 PRN  Luminex Corporation Reports Second Quarter 2013 Results,10/21/2015 80067710 PRN  Sangamo BioSciences Announces Third Quarter 2015 Conference Call and Webcast,, 3/21/2017 80105N10  PRN  Sanofi Announces Results of First-of-Its-Kind Social Experiment Revealing Real-Life Impact of Symptoms on Allergy Sufferers in the U.S.,,,,,,,,,,,, 5/29/2012 68214310 PRN  Omeros to Present at Jefferies 2012 Global Healthcare Conference,,,,,,,, 2/23/2015 69329Y10 PRN  PDL BioPharma Announces Fourth Quarter and Full Year 2014 Financial Results,,,, 3/06/2014 00182C10 PRN  ANI Pharmaceuticals to Present at 26th Annual ROTH Conference,,,,,,,,,,,," 2/11/2015 0BP4MZ-E PRN  Blueprint Medicines Appoints Anthony Boral, M.D., Ph.D., as Senior Vice President, Clinical Development",,,,,,,,,11/18/2014 92165910 PRN  Vanda Pharmaceuticals to Present at the Stifel Nicolaus 2014 Healthcare Conference,,,,," 6/05/2015 40637H10 PRN  Halozyme Announces Plans For CFO Transition, Names Laurie Stelzer CFO",,,,,,, 2/28/2017 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year End 2016 Financial Results,,,,,,, 9/20/2013 36197T10 PRN  GW Pharmaceuticals to Present at the 2013 Aegis Capital Healthcare Conference,, 2/01/2016 JAZZ-IE  PRN  Results from Phase 3 Trial of Defibrotide for the Treatment of Severe Veno-Occlusive Disease and Multi-Organ Failure Published Online in BLOOD,,,,, 7/17/2012 008W47-E PRN  New Study Suggests That Use of Veracyte's Afirma® Gene Expression Classifier Helps to Significantly Reduce Surgeries in Patients with Ambiguous Thyroid Nodule Cytology Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/28/2016 06CR5C-E PRN  Endo Announces Issuance of Vasostrict® Patent,,10/09/2013 09060J10 PRN  BioDelivery Sciences Announces FDA Acceptance of BUNAVAIL NDA for Filing, 5/03/2016 09073M10    PRN  Bio-Techne Declares Dividend," 1/23/2018 75886F10    PRN  Regeneron to Report Fourth Quarter and Full Year 2017 Financial and Operating Results and Host Conference Call and Webcast on February 8, 2018",,," 8/22/2016 46222210 PRN  Ionis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives E. B. Hershberg Award from the American Chemical Society","10/20/2014 09061G10   PRN  Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma",, 3/09/2016 BCS-GB   PRN  Neurocrine Biosciences to Present at the Barclays Global Healthcare Conference,,," 1/09/2013 00167Y-E  PRN  Oral Formulation Drives Early Trial of Genzyme's Aubagio, Although Safety Concerns are Identified as Obstacles at One Month Post-Launch, According to a Recent BioTrends Report",,," 2/04/2014 37555810   PRN  Critical Alerts For Procter and Gamble, Randgold Resources, Cerner, Gilead Sciences, and Walter Energy Released By InvestorsObserver",10/29/2015 04004760   PRN  Arena Pharmaceuticals Initiates a Phase 1b Clinical Trial of APD371, 7/19/2017 N5946510  PRN  Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD),,, 8/21/2018 03116210 PRN  Amgen To Present Robust Data Exploring The Impact Of Treatment With Repatha® (evolocumab) Across Patient Subgroups And High-Risk Populations At ESC Congress 2018,,"10/04/2013 52887230 PRN  Positive Results, Close of Public Offerings, Grants, Data Presentations and Partnerships - Research Report on Lexicon, Sangamo Biosciences, Immunomedics, NewLink Genetics, and Pacific Biosciences",,,, 4/01/2014 45773H20 PRN  Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality,10/07/2015 64026810 PRN  Nektar Submits Investigational New Drug Application (IND) for NKTR-214 To Treat Solid Tumor Malignancies," 8/29/2013 76655960 PRN  M&A Activities, Pending NDA Approvals, and Clinical Trial Results - Research Report on Sanofi, GSK, AstraZeneca, Keryx, and Rigel",,,,," 7/22/2014 91307C10 PRN  United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014",, 6/15/2010 G0176710 PRN  DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment,,,," 7/22/2013 55027E10 PRN  Luminex Corporation Achieves Milestone, Ships 10,000th Instrument", 9/30/2015 80067710 PRN  Sangamo BioSciences Announces Presentation At The 2015 Stem Cell Meeting On The Mesa,, 3/14/2017 80105N10  PRN  Sanofi and Voluntis Announce a Global Alliance to Deliver Digital Insulin Titration Solutions for People with Type 2 Diabetes,,,,,,,,,,,, 5/10/2012 68214310 PRN  Omeros Corporation Reports First Quarter 2012 Financial Results,,,,,,,," 2/18/2015 69329Y10 PRN  Latest on Pharmaceutical Companies: Special Research on PDL BioPharma,Pluristem, Proteon, QIAGEN, and Repligen",,,, 3/05/2014 00182C10 PRN  ANI Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock,,,,,,,,,,,, 1/08/2015 0BP4MZ-E PRN  Blueprint Medicines to Present at the 33rd Annual J.P. Morgan Healthcare Conference,,,,,,,,,"11/07/2014 92165910 PRN  Biotech Equities Scrutiny - Vanda Pharma, PDL BioPharma, Synergy Pharma, OPKO Health, and MiMedx",,,,," 6/04/2015 40637H10 PRN  Critical Alerts For FireEye, Starbucks, Halozyme Therapeutics, CSX and Regeneron Pharmaceuticals Released By InvestorsObserver",,,,,,, 2/21/2017 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 9/18/2013 36197T10 PRN  GW Pharmaceuticals Commences Phase 1 Clinical Trial of GWP42006 as a Potential Treatment for Epilepsy,, 1/04/2016 JAZZ-IE  PRN  Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 11,,,,, 6/25/2012 008W47-E PRN  Veracyte Announces Study Results Published Online in New England Journal of Medicine Which Suggest that Its Afirma® Gene Expression Classifier Can Reduce Unnecessary Thyroid Surgeries,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 6/27/2016 G3040110 PRN  Analysts View on Drug Manufacturers - Other Equities - Endo Intl., Teva Pharma, Synergy Pharma, and Orexigen Therapeutics",, 9/06/2013 09060J10 PRN  BioDelivery Sciences to Present at the Stifel Nicolaus 2013 Healthcare Conference," 4/11/2016 09073M10    PRN  Bio-Techne To Host Conference Call On May 3, 2016 To Announce Third Quarter Financial Results", 1/23/2018 000VC1-E    PRN  Forty of the Nation's Most Promising Young Scientists Named Finalists in Regeneron Science Talent Search 2018,,, 8/09/2016 46222210 PRN  Ionis Pharmaceuticals Reports Financial Results and Highlights for Second Quarter 2016," 9/26/2014 09061G10   PRN  Critical Alerts For Westport Innovations, Royal Bank of Scotland Group PLC ADS, Magnum Hunter Resources Corp, BioMarin Pharmaceutical and Allergan Released By InvestorsObserver",, 3/02/2016 0024VM-E PRN  Neurocrine Biosciences to Present at the Cowen and Company 36th Annual Health Care Conference,,,12/27/2012 061SK1-E  PRN  National MS Society Reports Sweeping Advances Made in MS Research During 2012,,, 1/31/2014 37555810   PRN  Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India,10/27/2015 04004760   PRN  Arena Pharmaceuticals Announces New Strategic Focus and Cost Reduction Plan, 7/19/2017 N5946510  PRN  Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD),,, 8/13/2018 000C35-E PRN  Cumberland Pharmaceuticals Appoints New Senior Executive,,10/01/2013 52887230 PRN  LX4211 Achieves Positive Results in Type 2 Diabetes Patients with Renal Impairment,,,, 3/17/2014 45773H20 PRN  Inovio Pharmaceuticals Reports 2013 Fourth Quarter and Year End Financial Results,10/06/2015 NKTR-US  PRN  Nektar Closes Direct Private Placement with TPG Special Situations Partners of $250 Million of Senior Secured Notes Due in 2020, 8/26/2013 76655960 PRN  Rigel's R343 Did Not Meet Primary Endpoint in Asthma Study,,,,," 7/02/2014 91307C10 PRN  Clinical Trial Update, Recommendations for Approval, Share Repurchase Programs, and Closing of Public Offering - Analyst Notes on Medtronic, Regeneron, Lilly, United Therapeutics and Receptos",, 6/15/2010 G0176710 PRN  DURATION-4 Study Results Released,,,," 7/15/2013 55027E10 PRN  Luminex Corporation Receives FDA and European Clearance for an Updated Version of Its Comprehensive Genotyping Assay, xTAG® CYP2D6 Kit"," 9/23/2015 SGMO-US  PRN  Technical Briefing on Biotechnology Equities -- MannKind, Novavax, Incyte, BioMarin Pharma, and Sangamo Biosciences",, 3/13/2017 80105N10  PRN  OilPrice.com: The Next Big Biotech Breakthrough Could Just be on the Horizon,,,,,,,,,,,, 5/03/2012 68214310 PRN  Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio,,,,,,,," 2/17/2015 69329Y10 PRN  PDL BioPharma to Announce Fourth Quarter and Full Year 2014 Financial Results on February 23, 2015",,,, 3/04/2014 00182C10 PRN  ANI Pharmaceuticals Announces Proposed Public Offering Of Common Stock,,,,,,,,,,,,12/08/2014 0BP4MZ-E PRN  Blueprint Medicines Debuts Comprehensive Preclinical Data Set on First Selective Drug for Patients with Systemic Mastocytosis at 2014 American Society of Hematology Annual Meeting,,,,,,,,,10/29/2014 92165910 PRN  Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock,,,,, 6/03/2015 40637H10 PRN  Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie,,,,,,, 2/08/2017 69366J20 PRN  PTC Therapeutics Announces Third Annual STRIVE Grant Award Program for Duchenne Muscular Dystrophy,,,,,,, 8/14/2013 36197T10 PRN  GW Pharmaceuticals plc Opens an Investigational New Drug Application (IND) in the United States for a Sativex® Phase 3 Clinical Program as a Treatment for Spasticity Due to Multiple Sclerosis,,11/24/2015 MYL-GB   PRN  Mylan Launches Generic FazaClo® Orally Disintegrating Tablets,,,,," 4/05/2012 008W47-E PRN  Richard T. Kloos, M.D., Joins Veracyte as Senior Medical Director",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/15/2016 06CR5C-E PRN  Endo Announces FDA Advisory Committee Meeting For OPANA® ER,, 9/04/2013 05MBN8-E PRN  Endo and BioDelivery Sciences Provide Update on BEMA Buprenorphine Phase III Development Program," 3/21/2016 000XKX-E    PRN  Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc.", 1/23/2018 000VC1-E    PRN  Forty of the Nation's Most Promising Young Scientists Named Finalists in Regeneron Science Talent Search 2018,,, 7/28/2016 46222210 PRN  Akcea Therapeutics Receives Orphan Designation in Europe for Volanesorsen for the Treatment of Familial Partial Lipodystrophy (FPL)," 9/10/2014 09061G10   PRN  Technical Coverage of Biotech Stocks - Dyax, Alexion Pharma, Peregrine Pharma, Merrimack Pharma, and BioMarin Pharma",, 3/02/2016 NBIX-US  PRN  Neurocrine Biosciences Announces the Acceptance of Three Scientific Abstracts for Valbenazine (NBI-98854) at the 68th Annual Meeting of the American Academy of Neurology in Vancouver April 2016,,,"12/21/2012 07L9K9-E  PRN  The Access Group Grows Staff, Business Accounts",,," 1/16/2014 37555810   PRN  Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems",10/27/2015 ARNA-US    PRN  Arena Pharmaceuticals Issued Additional Patent Covering BELVIQ® (lorcaserin HCl) by United States Patent and Trademark Office," 7/19/2017 N5946510  PRN  Mylan to Report Second Quarter 2017 Financial Results on Aug. 9, 2017",,, 7/31/2018 03116210 PRN  Amgen Breaks Ground On Next-Generation Biomanufacturing Plant In Rhode Island,, 9/06/2013 002SM4-E PRN  Lexicon To Present At The Stifel Nicolaus Healthcare Conference,,,," 3/12/2014 45773H20 PRN  Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2013 Financial Results on March 17, 2014",10/01/2015 64026810 PRN  Nektar to Host Research & Development Day for Analysts and Investors on October 8th, 8/06/2013 76655960 PRN  Rigel Announces Second Quarter 2013 Financial Results,,,,, 6/27/2014 91307C10 PRN  United Therapeutics Announces Additional $500 Million Share Repurchase Program,," 5/06/2010 G0176710 PRN  BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010",,,," 7/08/2013 55027E10 PRN  Luminex Corporation Second Quarter Earnings Release Scheduled for July 29, 2013", 9/21/2015 80067710 PRN  Sangamo BioSciences Reports Updated Clinical Data from ZFP Therapeutic® Program for HIV/AIDS at the 2015 Interscience Conference of Antimicrobial Agents and Chemotherapy,, 3/07/2017 80105N10  PRN  Regeneron and Sanofi to Present New Phase 3 Praluent® (alirocumab) Injection Clinical Trial Analyses at ACC.17 Scientific Sessions,,,,,,,,,,,, 5/02/2012 68214310 PRN  Omeros to Present at Deutsche Bank Securities Health Care Conference,,,,,,,," 2/09/2015 69329Y10 PRN  Momentum Indicators for Biotech Equities - PDL BioPharma, Geron, Celldex Therapeutics, XOMA Corp., and Juno Therapeutics",,,," 2/18/2014 00182C10 PRN  ANI Pharmaceuticals Reports Record Net Revenues of $10.5 million, EPS from continuing operations of $0.35, and Adjusted Non-GAAP EBITDA of $3.9 Million for the Fourth Quarter Ended December 31, 2013",,,,,,,,,,,,11/20/2014 0BP4MZ-E PRN  Blueprint Medicines Unveils New Drug Discovery Program for Patients with RET Fusions at 26th EORTC-NCI-AACR Symposium,,,,,,,,,10/28/2014 92165910 PRN  Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock,,,,, 5/31/2015 40637H10 PRN  Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients,,,,,,, 1/09/2017 69366J20 PRN  European Commission Ratifies Positive CHMP Opinion for the Renewal of Translarna™ Marketing Authorization for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy,,,,,,, 8/13/2013 36197T10 PRN  Edison expands North American healthcare sector coverage with ADR report on GW Pharmaceuticals,,11/09/2015 G5087110 PRN  Jazz Pharmaceuticals Announces Third Quarter 2015 Financial Results,,,,, 1/31/2012 008W47-E PRN  Veracyte Appoints Mark Spring as Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/10/2016 G3040110 PRN  Endo Announces Local Qualitest Scholarship Program Award Recipients,, 8/09/2013 09060J10 PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Second Quarter 2013 Financials, 2/02/2016 09073M10    PRN  Bio-Techne Declares Dividend, 1/22/2018 75886F10    PRN  Regeneron Announces Approval of DUPIXENT® (dupilumab) in Japan for the Treatment of Atopic Dermatitis,,, 7/26/2016 46222210 PRN  Webcast Alert: Ionis Pharmaceuticals' Second Quarter 2016 Financial Results Conference Call," 8/07/2014 09061G10   PRN  Biotech Equities Technical Analysis -- BioMarin Pharma, Merrimack Pharma, Sangamo BioSciences, ZIOPHARM Oncology, and Dyax",, 2/11/2016 64125C10 PRN  Neurocrine Biosciences Reports Year-End 2015 Results and Provides Investor Update for 2016,,,12/20/2012 078VWR-E  PRN  Regulus Announces Addition to Russell 2000 Index,,," 1/09/2014 37555810   PRN  Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood","10/07/2015 04004760   PRN  Harwood Feffer LLP Announces Investigation of Arena Pharmaceuticals, Inc.", 7/13/2017 N5946510  PRN  FDA Oncologic Drugs Advisory Committee Unanimously Recommends Approval of Mylan and Biocon's Proposed Biosimilar Trastuzumab,,, 7/31/2018 03116210 PRN  Amgen Announces 2018 Third Quarter Dividend,, 9/05/2013 002SM4-E PRN  Lexicon To Present At The Morgan Stanley Global Healthcare Conference,,,, 3/04/2014 45773H20 PRN  Inovio Pharmaceuticals Closes $63.3 Million Underwritten Financing," 9/21/2015 64026810 PRN  Nektar Presents Data Demonstrating that NKTR-214, a CD122-Biased Immunostimulatory Cytokine, Induces Durable and Specific Anti-Tumor Immunity As a Single-Agent and When Combined with Checkpoint Inhibitors in Preclinical Models", 6/04/2013 76655960 PRN  Rigel Will Resume Responsibility for Fostamatinib Program,,,,," 6/23/2014 91307C10 PRN  Health Care Sector Stocks Technical Analysis -- Research on United Therapeutics, IsoRay, Bruker, and Affymetrix",," 4/22/2010 G0176710 PRN  Amylin, Lilly and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON(TM)",,,, 6/11/2013 55027E10 PRN  Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporation's xMAP Technology," 9/14/2015 INSYQ-US PRN  Biotechnology Stocks Technical Analysis - INSYS Therapeutics, Curis, Sangamo Biosciences, Alder Biopharma, and Dyax Corp.",, 3/04/2017 80105N10  PRN  Regeneron and Sanofi Announce Presentation of Positive Data from Long-Term Pivotal Phase 3 CHRONOS Study of DUPIXENT® (dupilumab) in Moderate-to-Severe Atopic Dermatitis,,,,,,,,,,,, 4/10/2012 68214310 PRN  Omeros Announces Enrollment in Second Phase 3 Clinical Trial Evaluating OMS302,,,,,,,, 2/04/2015 69329Y10 PRN  PDL BioPharma to Present at Upcoming Investor Conferences,,,, 2/06/2014 00182C10 PRN  ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2013 Financial Results,,,,,,,,,,,,11/13/2014 0BP4MZ-E PRN  Blueprint Medicines to Present Discovery of New Cancer Drug Targets at EORTC-NCI-AACR Symposium,,,,,,,,,10/27/2014 92165910 PRN  Vanda Pharmaceuticals Reports Third Quarter 2014 Financial Results,,,,," 5/27/2015 HALO-US  PRN  Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment",,,,,,, 1/09/2017 69366J20 PRN  PTC Therapeutics Provides Corporate Update and Outlines 2017 Strategic Priorities to Maximize the Global Value of Translarna™ and Advance its Innovative Pipeline,,,,,,, 8/08/2013 36197T10 PRN  GW Pharmaceuticals to Present at the 33rd Annual Canaccord Genuity Growth Conference,,11/04/2015 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences,,,,, 1/09/2012 008W47-E PRN  Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/03/2016 G3040110 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline - ENDP,, 8/01/2013 09060J10 PRN  BioDelivery Sciences Announces Submission of NDA for BUNAVAIL, 2/02/2016 09073M10    PRN  Bio-Techne Releases Second Quarter Fiscal 2016 Results," 1/18/2018 000VC1-E    PRN  Technical Perspectives on Biotech Stocks -- Ultragenyx Pharma, Regeneron Pharma, Seattle Genetics, and Sangamo Therapeutics",,, 7/19/2016 46222210 PRN  Ionis Pharmaceuticals Licenses First Oral Antisense Drug Acting Locally in the GI Tract to Janssen," 7/17/2014 09061G10   PRN  Technical Update, Leadership Appointments, Therapy Approvals, Notifications, and Clinical Trial Results - Analyst Notes on Biogen, Medivation, BioMarin, Acorda and Targacept",, 2/10/2016 00DYYX-E PRN  AbbVie Announces Positive Top-Line Results From Second Phase 3 Study Investigating Elagolix in Patients with Endometriosis,,,12/10/2012 IONS-US   PRN  Biogen Idec and Isis Pharmaceuticals Announce Collaboration For Antisense Programs To Treat Neurological Disorders,,," 1/08/2014 37555810   PRN  Stock Price Movements, Conference Presentation Schedules, and Expanded Sharing of Clinical Data - Research Report on Gilead, Express Scripts, Sanofi, Agilent, and Kythera Biopharma",10/05/2015 04004760   PRN  Arena Pharmaceuticals Announces Retirement of President and CEO, 6/15/2017 05J59X-E  PRN  Immune Pharmaceuticals Signs Agreement to Regain Worldwide Rights for Ceplene,,, 7/26/2018 03116210 PRN  Amgen Announces Succession Plans For Two Executive Officers,, 8/07/2013 52887230 PRN  Lexicon To Present At The Wedbush PacGrow Life Sciences Management Access Conference,,,, 2/27/2014 45773H20 PRN  Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock, 9/01/2015 NKTR-US  PRN  Nektar Announces Receipt of $40 Million Milestone Payment Resulting from First Commercial Sale of MOVENTIG® (naloxegol) Tablets in Major European Market, 5/22/2013 76655960 PRN  Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye,,,,," 5/19/2014 91307C10 PRN  Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics",,,,,, 5/28/2013 55027E10 PRN  Luminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement, 9/10/2015 SGMO-US  PRN  Sangamo Announces Unanimous Recombinant DNA Advisory Committee (RAC) Approval Of ZFP Therapeutic Phase 1 Study Protocol For First In Vivo Genome Editing Application,, 2/27/2017 80105N10  PRN  Regeneron and Sanofi to Present New Data on DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses,,,,,,,,,,,, 3/29/2012 68214310 PRN  Omeros Reports Allowance of Additional Patent for Ophthalmology Product OMS302,,,,,,,, 1/29/2015 69329Y10 PRN  PDL BioPharma Announces 2015 Regular Quarterly Dividends,,,, 1/06/2014 00182C10 PRN  ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services,,,,,,,,,,,,11/12/2014 0BP4MZ-E PRN  Blueprint Medicines Secures $50 Million in Series C Financing,,,,,,,,,"10/14/2014 92165910 PRN  Vanda Pharmaceuticals to Announce Third Quarter 2014 Financial Results on October 27, 2014",,,,, 5/12/2015 40637H10 PRN  Halozyme Therapeutics To Present At The UBS 2015 Global Health Care Conference,,,,,,, 1/06/2017 06CR5C-E PRN  RG7916 Granted Orphan Drug Designation in the U.S. for the Treatment of Spinal Muscular Atrophy,,,,,,, 8/05/2013 36197T10 PRN  GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition,,11/03/2015 CTMX-US  PRN  CytomX Appoints Matthew Young to Board of Directors,,,,, 9/01/2011 008W47-E PRN  New Data Suggest Veracyte's Afirma® Gene Expression Classifier Cost-Effectively Resolves Inconclusive Thyroid Nodule FNA Biopsy Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 6/03/2016 G3040110 PRN  New Data Demonstrate Safety Of Long-Term, Around-The-Clock Treatment With BELBUCA™ (Buprenorphine) Buccal Film For Chronic Pain",, 7/29/2013 09060J10 PRN  BioDelivery Sciences Announces Regulatory Approval of ONSOLIS in Taiwan, 1/29/2016 09073M10    PRN  ProteinSimple Unveils the New Single Analyte Cartridge for Simple Plex™, 1/08/2018 75886F10    PRN  Regeneron and Sanofi To Accelerate and Expand Investment for Cemiplimab and Dupilumab Development Programs,,, 7/12/2016 46222210 PRN  Ionis Pharmaceuticals Announces Publication in Nature Biotechnology of a Novel Mechanism of Action for Antisense Drugs That Significantly Expands Therapeutic Opportunities," 7/08/2014 09061G10   PRN  Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne",, 2/08/2016 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End 2015 Results,,,"12/03/2012 078VWR-E  PRN  Regulus to Host NASDAQ Closing Bell Ceremony on December 5, 2012",,,"12/26/2013 37555810   PRN  Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune"," 9/30/2015 04004760   PRN  Biotechnology Equity Picks -- Arena Pharma, Biogen, Omeros, Illumina, and Merrimack Pharma", 6/10/2017 N5946510  PRN  Mylan and Biocon Present Clinical Data on Insulin Glargine at the American Diabetes Association's 77th Scientific Sessions,,, 7/26/2018 03116210 PRN  Amgen Reports Second Quarter 2018 Financial Results,, 7/30/2013 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Second Quarter Financial Results,,,, 2/26/2014 45773H20 PRN  Inovio Pharmaceuticals Announces Public Offering of Common Stock, 8/05/2015 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Second Quarter of 2015, 5/07/2013 76655960 PRN  Rigel Announces First Quarter 2013 Financial Results,,,,," 5/16/2014 91307C10 PRN  Upcoming Analyst Meetings, New Products, Collaborations, and Awards - Analyst Notes on Thermo Fisher Scientific, Agilent, United Therapeutics, Keryx and Centene",,,,,, 5/07/2013 55027E10 PRN  Luminex Corporation To Present At Upcoming Investment Conferences, 9/09/2015 SGMO-US  PRN  Sangamo BioSciences Announces Presentation At The 2015 Morgan Stanley Global Healthcare Conference,, 2/27/2017 80105N10  PRN  Sanofi and Regeneron to Present New Data on Dupixent® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses,,,,,,,,,,,, 3/28/2012 68214310 PRN  Omeros to Present at Two Upcoming Conferences,,,,,,,,"12/18/2014 69329Y10 PRN  Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma",,,,12/26/2013 BPAX-US  PRN  ANI Pharmaceuticals Acquires 31 Generic Drug Products from Teva Pharmaceuticals,,,,,,,,,,,, 9/19/2014 0BP4MZ-E PRN  First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines,,,,,,,,," 8/14/2014 92165910 PRN  Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma",,,,, 5/11/2015 40637H10 PRN  Halozyme Reports First Quarter 2015 Financial Results,,,,,,, 1/05/2017 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 8/05/2013 36197T10 PRN  GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results,,"10/26/2015 G5087110 PRN  Jazz Pharmaceuticals to Report 2015 Third Quarter Financial Results on November 9, 2015",,,,, 1/26/2011 064QW6-E PRN  KGI Hosts Fourth Annual Conference for Women in Life Science Industry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 5/25/2016 G3040110 PRN  Endo Employees Participate in 3rd Annual ""Endo Gives"" Day of Volunteering, Giving Back to Local Communities Around the World",," 7/23/2013 09060J10 PRN  BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs", 1/26/2016 TECH-US     PRN  ProteinSimple® Recharges iCE, 1/08/2018 75886F10    PRN  Regeneron Forms Consortium of Leading Life Sciences Companies to Accelerate Largest Widely-Available 'Big Data' Human Sequencing Resource with UK Biobank,,, 7/07/2016 46222210 PRN  Ionis Pharmaceuticals Reports Positive Clinical Data on IONIS-TTR Rx at the XV International Symposium on Amyloidosis," 6/27/2014 09061G10   PRN  Critical Alerts For Apple, Weyerhaeuser, Aetna, Endo Health Solutions, and BioMarin Pharmaceutical Released By InvestorsObserver",, 2/03/2016 NBIX-US  PRN  Neurocrine Biosciences to Present at the Leerink Partners 5th Annual Global Healthcare Conference,,,"11/26/2012 VMED-US   PRN  The Zacks Analyst Blog Highlights: Virgin Media, Vodafone Group, Sanofi, Novartis and Biogen Idec",,,"12/23/2013 37555810   PRN  Clinical Trial Results, Stock Movements, Grants & Donations, and Drug Resubmissions - Research Report on Gilead, WellPoint, Zoetis, Teleflex, and Orexigen", 9/24/2015 ARNA-US    PRN  Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings, 6/07/2017 N5946510  PRN  Mylan to Present at Goldman Sachs 38th Annual Global Healthcare Conference,,, 7/24/2018 03116210 PRN  Amgen Announces Webcast of 2018 Second Quarter Financial Results,," 7/23/2013 52887230 PRN  Lexicon to Report Second Quarter Financial Results on July 30, 2013",,,," 2/26/2014 45773H20 PRN  Inovio's Revolutionary DNA Immunotherapy Product Slated for Trials in 2014, by BrokerBank Securities, Inc."," 7/31/2015 64026810 PRN  Biotechnology Stocks on our Scanner -- Agenus, RXi Pharma, Nektar Therapeutics, Genetic Technologies, and Agios Pharma", 4/08/2013 RDWR-IL  PRN  Stocks Fall on Weak Payrolls Report and Hewlett-Packard Chairman Resigns,,,,," 5/06/2014 91307C10 PRN  Synthetic Genomics Inc. Signs Collaborative Research and Development Agreement with Lung Biotechnology Inc., a Subsidiary of United Therapeutics Corporation, to Develop Humanized Pig Organs to Revolutionize Transplantation Field",,,,,, 4/29/2013 55027E10 PRN  Luminex Corporation Reports First Quarter 2013 Results, 9/02/2015 SGMO-US  PRN  Sangamo and Shire Restructure Collaboration to Accelerate Development of ZFP Therapeutics® for the Treatment of Hemophilia and Huntington's Disease,, 2/22/2017 05FGM6-E  PRN  Creative Medical Technology Holdings Announces Initiation of In House Research Program at San Diego BioLabs,,,,,,,,,,,, 3/27/2012 68214310 PRN  Omeros Names Dr. Patrick Gray as Scientific Fellow,,,,,,,,12/15/2014 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,12/10/2013 00182C10 PRN  ANI Pharmaceuticals Presents At Oppenheimer 24th Annual Healthcare Conference,,,,,,,,,,,, 9/10/2014 0BP4MZ-E PRN  Blueprint Medicines Discovers Novel Cancer Drug Targets,,,,,,,,, 8/07/2014 92165910 PRN  Vanda Pharmaceuticals Reports Second Quarter 2014 Results,,,,, 5/07/2015 HALO-US  PRN  Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2015 Health Care Conference,,,,,,, 1/05/2017 RHHBY-CH PRN  PTC Therapeutics Announces Initiation of FIREFISH Study in Infant (Type I) SMA Patients,,,,,,, 7/22/2013 36197T10 PRN  GW Pharmaceuticals Files New Regulatory Application to Expand Sativex® Approval to France,, 9/30/2015 JAZZ-IE  PRN  Jazz Pharmaceuticals Announces U.S. FDA Acceptance for Filing with Priority Review of NDA for Defibrotide for Hepatic Veno-Occlusive Disease,,,,, 9/15/2010 008W47-E PRN  New Data Suggest Veracyte's Molecular Test Improves Accuracy of Thyroid Nodule Diagnosis Using Fine Needle Aspirate (FNA) Samples,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/05/2016 G3040110 PRN  Endo Announces Change to Senior Management Team,, 7/08/2013 09060J10 PRN  BioDelivery Sciences Adds $20 Million with Debt Financing," 1/12/2016 09073M10    PRN  Bio-Techne To Host Conference Call On February 2, 2016 To Announce Second Quarter Financial Results",12/27/2017 75886F10    PRN  Regeneron Announces Presentation at the 36th Annual J.P. Morgan Healthcare Conference,,," 6/29/2016 0017CR-E PRN  Akcea Therapeutics Announces Launch of IN-FOCUS, a Research Study to Assess Impact of Familial Chylomicronemia Syndrome"," 6/27/2014 09061G10   PRN  Biotech Stocks on the Move -- Research on CTI BioPharma, BioMarin Pharma, Vertex Pharma, and Northwest Biotherapeutics",, 2/02/2016 64125C10 PRN  Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor Valbenazine in Children and Adolescents with Tourette Syndrome,,,11/08/2012 078VWR-E  PRN  Regulus to Present at the Lazard Capital Markets Healthcare Conference,,,"12/18/2013 37555810   PRN  FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira"," 9/23/2015 BMRN-US    PRN  Scanning Stocks from the Healthcare Sector - Amicus Therapeutics, Arena Pharmaceuticals, Cerner Corporation, Amarin Corporation and BioMarin Pharmaceutical", 6/02/2017 N5946510  PRN  Mylan Launches Generic Azilect® Tablets,,, 7/19/2018 03116210 PRN  Amgen And Cedars-Sinai Partner For Improved Healthcare Quality,," 6/24/2013 52887230 PRN  Lexicon Presents Preclinical Data On LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract",,,, 2/25/2014 45773H20 PRN  Health & Nutritional Stocks in the News - Company Expands Product Diversity Based on Growing Consumer Demand," 7/29/2015 64026810 PRN  Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets", 4/05/2013 AZN-GB   PRN  AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis,,,,, 4/29/2014 91307C10 PRN  United Therapeutics Corporation Reports First Quarter 2014 Financial Results,,,,,, 4/15/2013 55027E10 PRN  Luminex Corporation Receives U.S. FDA Clearance for MAGPIX® Instrument with Novel xTAG® Gastrointestinal Pathogen Panel, 8/05/2015 80067710 PRN  Sangamo BioSciences Reports Second Quarter 2015 Financial Results,, 2/08/2017 80105N10  PRN  Appeals Court Grants Stay of Permanent Injunction for Praluent® (alirocumab) During Appeals Process,,,,,,,,,,,, 3/15/2012 68214310 PRN  Omeros Corporation Reports Fourth Quarter and Year-End 2011 Financial Results,,,,,,,,12/10/2014 69329Y10 PRN  PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million,,,,"11/15/2013 00182C10 PRN  ANI Pharmaceuticals To Present At Oppenheimer 24th Annual Healthcare Conference On December 10, 2013",,,,,,,,,,,, 9/08/2014 0BP4MZ-E PRN  Blueprint Medicines Presents Positive Data on BLU-554 for Hepatocellular Carcinoma,,,,,,,,," 7/17/2014 92165910 PRN  Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014",,,,, 5/04/2015 40637H10 PRN  Halozyme To Host First Quarter 2015 Financial Results Conference Call,,,,,,, 1/03/2017 0035K2-E PRN  PTC Therapeutics to Present 2017 Corporate Update at the 35th Annual J.P. Morgan Healthcare Conference,,,,,,," 7/15/2013 36197T10 PRN  GW Pharmaceuticals to Report Q3 2013 Results and Host Conference Call on 5 August, 2013",, 9/16/2015 PDLI-US  PRN  Dr. Samuel Saks Joins PDL BioPharma's Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/05/2016 0650LH-E PRN  Endo Reports First Quarter 2016 Financial Results,, 7/03/2013 09060J10 PRN  BioDelivery Sciences to Present at the 8th Annual JMP Securities Healthcare Conference,10/29/2015 09073M10    PRN  Bio-Techne Declares Dividend,12/18/2017 000VC1-E    PRN  Regeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology Collaboration,,, 6/27/2016 0017CR-E PRN  Akcea Announces Publication of Positive Volanesorsen Clinical Data Showing Reduced Triglycerides and Improved Insulin Sensitivity in Patients with High Triglycerides and Type 2 Diabetes," 5/30/2014 09061G10   PRN  Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma",, 1/28/2016 00DYYX-E PRN  AbbVie Initiates Enrollment in Phase 3 Clinical Program for Elagolix in Patients with Uterine Fibroids,,,"11/08/2012 09062X10  PRN  Leaders in Hemophilia Advocacy, Healthcare Delivery and Biotechnology Partner to Offer Free Genetic Testing to People with Hemophilia",,,"12/17/2013 37555810   PRN  FDA Approvals, Dividends, Promoting Diversity, Result Publications and Acquisitions - Research Report on Gilead, St. Jude Medical, Cigna, Pharmacyclics, and LifePoint", 9/03/2015 ARNA-US    PRN  Arena Pharmaceuticals to Present at the Wells Fargo 2015 Healthcare Conference, 6/02/2017 N5946510  PRN  Mylan Launches Generic Reclast® Injection,,, 7/18/2018 WMT-US   PRN  Walmart EVP and Amgen SVP Join rfxcel's Board of Directors,, 6/24/2013 52887230 PRN  Lexicon Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211,,,, 2/19/2014 45773H20 PRN  Inovio Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference, 7/16/2015 NKTR-US  PRN  Baxalta's BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A, 3/05/2013 76655960 PRN  Rigel Announces Fourth Quarter and Year End 2012 Financial Results,,,,," 4/22/2014 91307C10 PRN  United Therapeutics Corporation To Announce First Quarter 2014 Financial Results Before Market Open On Tuesday, April 29, 2014",,,,,," 4/08/2013 55027E10 PRN  Luminex Corporation First Quarter Earnings Release Scheduled for April 29, 2013", 8/04/2015 SGMO-US  PRN  Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference,, 2/08/2017 80105N10  PRN  Sanofi Delivers 2016 Sales and Business EPS Growth at CER,,,,,,,,,,,, 3/13/2012 68214310 PRN  Omeros' Ophthalmology Product OMS302 Achieves Primary and Secondary Endpoints in Phase 3 Clinical Trial,,,,,,,,12/04/2014 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes,,,,"11/07/2013 00182C10 PRN  ANI Pharmaceuticals Reports Net Revenues of $7.8 million, adjusted Non-GAAP EBITDA of $1.7 Million, and EPS of $0.13 for the Third Quarter Ended September 30, 2013",,,,,,,,,,,,,,,,,,,,," 7/01/2014 92165910 PRN  Pre-Market Review on Health Care Sector Equities -- Research on Dyax, Repligen, Vanda Pharma, and Ironwood Pharma",,,,," 4/20/2015 40637H10 PRN  Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO",,,,,,,12/16/2016 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,, 7/08/2013 36197T10 PRN  GW Pharmaceuticals plc Announces Sativex® Launch in Italy,, 8/05/2015 G5087110 PRN  Jazz Pharmaceuticals Announces Second Quarter 2015 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/05/2016 G3040110 PRN  Endo Announces Appointment of Douglas S. Ingram and Todd B. Sisitsky to its Board of Directors,, 6/10/2013 09060J10 PRN  BioDelivery Sciences Announces NDA Submission for BUNAVAIL on Track Following Positive Pre-NDA Meeting with FDA,10/28/2015 09073M10    PRN  Bio-Techne Releases First Quarter Fiscal 2016 Results,12/13/2017 75886F10    PRN  Regeneron Collaboration Programs Highlighted During Sanofi Analyst Day,,, 6/22/2016 46222210 PRN  Ionis Pharmaceuticals to Host R&D Day," 1/10/2014 09061G10   PRN  Companies Scheduled to Present at the Annual J.P. Morgan Healthcare Conference - Research Report on Mettler-Toledo, BioMarin, DexCom, Spectranetics, and Acorda",, 1/04/2016 NBIX-US  PRN  Neurocrine Biosciences to Present at the 34th Annual J.P. Morgan Healthcare Conference,,,"11/07/2012 078VWR-E  PRN  Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors",,,"12/11/2013 37555810   PRN  Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew", 8/05/2015 04004760   PRN  Arena Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update," 5/30/2017 N5946510  PRN  Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Neurocrine Biosciences",,, 7/18/2018 03116210 PRN  Former Major League Baseball (MLB) All-Stars Dave Winfield And Steve Garvey Team Up With Amgen To Launch Myeloma MVP™ And Encourage Patients To Create Their Most Valuable Plan For Managing Multiple Myeloma,," 6/18/2013 52887230 PRN  John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations",,,, 2/18/2014 45773H20 PRN  Inovio Pharmaceuticals Bolsters Research and Clinical Development Leadership as it Advances Cancer & Infectious Disease Immunotherapies," 6/02/2015 64026810 PRN  Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine", 2/28/2013 76655960 PRN  Rigel Announces Participation at Two Investor Conferences,,,,," 3/26/2014 UTHR-US  PRN  Japan's Ministry of Health, Labour and Welfare Grants Approval for United Therapeutics' Remodulin",,,,,, 2/04/2013 55027E10 PRN  Luminex Corporation Reports Fourth Quarter And Full Year 2012 Results, 7/29/2015 80067710 PRN  Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast,, 2/08/2017 80105N10  PRN  Sanofi CEO Interview - FY 2016 Results (video),,,,,,,,,,,, 3/01/2012 68214310 PRN  Omeros to Present at the Cowen and Company 32nd Annual Health Care Conference,,,,,,,,11/18/2014 69329Y10 PRN  PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics,,,,"10/29/2013 00182C10 PRN  ANI Pharmaceuticals, Inc. Announces Date for Third Quarter 2013 Earnings Release",,,,,,,,,,,,,,,,,,,,," 6/26/2014 92165910 PRN  New Patents, Clinical Trial Updates, New Agreements, and FDA Approvals - Analyst Notes on Agile Therapeutics, Vanda, Galena, Nanosphere and Rockwell",,,,," 4/14/2015 40637H10 PRN  Updates on Biotech Stocks -- Gilead Sciences, Arena Pharma, ACADIA Pharma, Halozyme Therapeutics, and Anthera Pharma",,,,,,,12/08/2016 69366J20 PRN  PTC Therapeutics Receives France's 2016 Prix Galien for Translarna™,,,,,,, 6/03/2013 36197T10 PRN  GW Pharmaceuticals plc Reports 2013 Second Quarter Financial Results,," 7/22/2015 G5087110 PRN  Jazz Pharmaceuticals to Report 2015 Second Quarter Financial Results on August 5, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/03/2016 00G7QL-E PRN  Endo Announces Appearances at Upcoming Conferences,, 6/05/2013 09060J10 PRN  BioDelivery Sciences to Present at the William Blair 33rd Annual Growth Stock Conference,"10/26/2015 09073M10    PRN  Bio-Techne Certifies over 1,000 Antibodies for Simple Western",12/13/2017 75886F10    PRN  Regeneron and Sanofi Announce Positive Topline Pivotal Results for PD-1 Antibody Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma,,, 5/26/2016 46222210 PRN  Ionis Pharmaceuticals Provides Update on IONIS-TTR Rx Program," 1/09/2014 09061G10   PRN  Quick Market Round-up before the Bell: Delcath Systems, Valeant Pharma Intl., BioMarin Pharma, and Insmed",,12/16/2015 64125C10 PRN  Neurocrine Announces Successful Completion of Phase Ib T-Force Study of VMAT2 Inhibitor NBI-98854 in Adolescents and Children with Tourette Syndrome,,,"11/05/2012 00167Y-E  PRN  Egenix, Inc. Announces New Director",,,"12/09/2013 37555810   PRN  Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma"," 7/30/2015 04004760   PRN  Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5", 5/23/2017 N5946510  PRN  Theravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS,,, 7/13/2018 03116210 PRN  Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY™ (romosozumab) To The US FDA,, 6/07/2013 52887230 PRN  Lexicon To Present At The Goldman Sachs Global Healthcare Conference,,,, 2/11/2014 45773H20 PRN  Inovio Pharmaceuticals Invited To Ring the Opening Bell® at the New York Stock Exchange on February 12," 5/28/2015 NKTR-US  PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the Jefferies 2015 Global Healthcare Conference in New York City", 2/07/2013 76655960 PRN  Rigel to Present at BIO CEO & Investor Conference,,,,, 2/25/2014 91307C10 PRN  United Therapeutics Corporation Reports 2013 Fourth Quarter And Annual Financial Results,,,,,, 1/31/2013 55027E10 PRN  Luminex Corporation To Present At Leerink Swann Global Healthcare Conference, 6/17/2015 SGMO-US  PRN  Sangamo BioSciences Announces Presentation At The 2015 JMP Securities Life Sciences Conference,, 2/01/2017 80105N10  PRN  Sanofi's Xyzal® Allergy 24HR Approved for Over-the-Counter Use in the United States,,,,,,,,,,,," 2/29/2012 68214310 PRN  Adding Six More, Omeros Now Has a Total of 33 Unlocked Orphan GPCRs in its Portfolio",,,,,,,,11/14/2014 69329Y10 PRN  PDL BioPharma Announces Successful Conclusion of Revenue Interest Agreement with AxoGen,,,, 8/12/2013 00182C10 PRN  ANI Pharmaceuticals Announces an Agreement for the Development and Marketing of an Oral Soft Gel Prescription Product with Sofgen Pharmaceuticals,,,,,,,,,,,,,,,,,,,,, 6/03/2014 92165910 PRN  European Medicines Agency Accepts HETLIOZ™ (tasimelteon) Marketing Authorization Application for Non-24-Hour Sleep-Wake Disorder in the Totally Blind,,,,," 4/13/2015 40637H10 PRN  Halozyme Therapeutics Appoints Harry J. Leonhardt, Esq. As Senior Vice President, General Counsel And Chief Compliance Officer",,,,,,,11/18/2016 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,," 5/14/2013 36197T10 PRN  GW Pharmaceuticals to Report Interim 2013 Results and Host Conference Call on 3 June, 2013",, 7/01/2015 G5087110 PRN  Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/02/2016 091B1B-E PRN  Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property,, 5/28/2013 09060J10 PRN  BioDelivery Sciences to Present at the Jefferies 2013 Global Healthcare Conference,10/20/2015 09073M10    PRN  Luminex Corporation and Bio-Techne Corporation Extend and Expand Partnership,12/11/2017 75886F10    PRN  Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of EYLEA® (aflibercept) Injection for Patients with Wet AMD,,, 5/23/2016 0017CR-E PRN  Ionis Pharmaceuticals and MD Anderson Form Strategic Alliance to Advance Novel Cancer Therapeutics,"12/20/2013 09061G10   PRN  Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana",,11/25/2015 NBIX-US  PRN  Neurocrine Biosciences to Present at the 27th Annual Piper Jaffray Healthcare Conference,,,11/05/2012 078VWR-E  PRN  Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions,,,"12/02/2013 37555810   PRN  Market Expert Opinion: Gilead Sciences, NPS Pharma, InterMune, and Halozyme Therapeutics"," 7/29/2015 04004760   PRN  Arena Pharmaceuticals Initiates a Phase 2 Clinical Trial of APD334, its S1P1 Receptor Modulator for Autoimmune Diseases", 5/23/2017 N5946510  PRN  Theravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS,,," 6/28/2018 03116210 PRN  Amgen And Novartis Present New Data Demonstrating Long-Term Efficacy, Safety And Tolerability Of Aimovig™ (erenumab-aooe) In Patients With Chronic And Episodic Migraine",, 5/31/2013 52887230 PRN  Lexicon To Present At The Jefferies Global Healthcare Conference,,,, 1/30/2014 45773H20 PRN  Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference," 5/07/2015 64026810 PRN  Financial Results Galore: Complementary Research on Accuracy Inc., Teradyne, Nektar, Century Aluminum and Newpark Resources", 1/03/2013 RIGL-US  PRN  Rigel to Focus on Extensive Clinical Pipeline at Upcoming J.P. Morgan Presentation,,,,," 2/18/2014 91307C10 PRN  United Therapeutics Corporation To Announce Fourth Quarter And Annual 2013 Financial Results Before Market Open On Tuesday, February 25, 2014",,,,,," 1/16/2013 55027E10 PRN  Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 4, 2013", 5/26/2015 SGMO-US  PRN  Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference,, 2/01/2017 80105N10  PRN  Regeneron and Sanofi Announce First Approval of Kevzara™ (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients by Health Canada,,,,,,,,,,,, 2/23/2012 68214310 PRN  Omeros Announces It Has Unlocked 35 Percent of Class A Orphan GPCRs,,,,,,,,11/12/2014 69329Y10 PRN  PDL BioPharma to Present at Jefferies 2014 Global Healthcare Conference,,,," 8/09/2013 00182C10 PRN  ANI Pharmaceuticals Reports Net Revenues of $6.2 million and adjusted non-GAAP EBITDA of $1.2 Million for the Second Quarter Ended June 30, 2013",,,,,,,,,,,,,,,,,,,,, 6/02/2014 92165910 PRN  HETLIOZ™ (tasimelteon) Data in Patients with Non-24-Hour Sleep-Wake Disorder to be presented at SLEEP 2014 meeting,,,,, 4/08/2015 40637H10 PRN  Halozyme Provides Update Following Type B FDA Meeting,,,,,,,11/11/2016 080RQG-E PRN  CHMP Recommends Renewal of Translarna's™ Marketing Authorization for Nonsense Mutation Duchenne Muscular Dystrophy Based on Continued Positive Benefit-Risk Assessment,,,,,,, 5/08/2013 36197T10 PRN  GW Pharmaceuticals plc Announces the Closing of its Initial Public Offering on the Nasdaq Global Market,, 6/09/2015 0FGNMF-E PRN  Aytu BioScience Acquires Commercial-Stage Prostate Cancer Biologic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/22/2016 G3040110 PRN  Endo to Announce First Quarter 2016 Financial Results on May 5, 2016",, 5/09/2013 09060J10 PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 Financials,"10/14/2015 09073M10    PRN  Bio-Techne To Host Conference Call On October 28, 2015 To Announce First Quarter Financial Results",11/29/2017 75886F10    PRN  Regeneron and Decibel Therapeutics Announce Strategic Collaboration to Discover and Develop Therapeutics for Hearing Loss and Tinnitus,,, 5/16/2016 0017CR-E PRN  Akcea Therapeutics Announces Completion of Enrollment in Phase 3 COMPASS Trial of Volanesorsen,"12/12/2013 09061G10   PRN  Reports, Positive Results, Updated Clinical Safety and Efficacy Data by Healthcare Companies - Research Report on Johnson & Johnson, Merck, BioMarin, Array BioPharma, and Brookdale Senior Living",,11/11/2015 NBIX-US  PRN  Neurocrine Biosciences to Present at the Jefferies Autumn 2015 Global Healthcare Conference,,,11/01/2012 09062X10  PRN  Isis Pharmaceuticals Initiates Phase 1b/2a Study Of ISIS-SMNRx In Patients With Spinal Muscular Atrophy,,,"11/27/2013 37555810   PRN  Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare"," 7/24/2015 04004760   PRN  Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics", 5/17/2017 N5946510  PRN  Theravance Biopharma and Mylan to Present Additional Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS,,, 6/27/2018 03116210 PRN  Amgen And Health And Benefits Consultant Piper Jordan Partner On First Migraine Project With Employers,, 5/28/2013 52887230 PRN  Lexicon To Present At The Deutsche Bank dbAccess Healthcare Conference,,,, 1/23/2014 45773H20 PRN  Inovio Pharmaceuticals Unveils Potent New Immune Activator," 5/04/2015 64026810 PRN  Critical Alerts For American Airlines, Nektar Therapeutics, Ocwen Financial, Skyworks Solutions and Chevron Released By InvestorsObserver",12/13/2012 AZN-GB   PRN  AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis,,,,," 1/01/2014 91307C10 PRN  Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda",,,,,, 1/15/2013 55027E10 PRN  Luminex Receives FDA Clearance for First Comprehensive Gastrointestinal Pathogen Infectious Disease Diagnostic in the United States, 5/18/2015 SGMO-US  PRN  Sangamo BioSciences Presents New Data from Proprietary ZFP Therapeutic Programs for Lysosomal Storge Disorders at Annual Meeting of the American Society of Gene and Cell Therapy,, 1/31/2017 06CR5C-E  PRN  Sanofi Pasteur Announces the Availability of Quadracel™ DTaP-IPV Vaccine for Children 4 Through 6 Years of Age in the U.S.,,,,,,,,,,,, 2/21/2012 68214310 PRN  Omeros Awarded $1 Million NIDA Grant for NMUR2 Drug Development Program,,,,,,,,11/10/2014 69329Y10 PRN  PDL BioPharma Announces Third Quarter 2014 and Year to Date Financial Results,,,," 7/23/2013 00182C10 PRN  ANI Pharmaceuticals, Inc. Announces Receipt of NASDAQ Listing Approval",,,,,,,,,,,,,,,,,,,,, 5/29/2014 92165910 PRN  Vanda Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference,,,,," 3/23/2015 40637H10 PRN  Halozyme Therapeutics Appoints James Mazzola To Lead Corporate Communications, Investor Relations",,,,,,,11/02/2016 06CR5C-E PRN  PTC Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update,,,,,,, 5/07/2013 36197T10 PRN  GW Pharmaceuticals plc Announces Sativex® Commercialization Approval in Italy,, 6/08/2015 G5087110 PRN  Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Clinical Development Program Evaluating JZP-110 as a Potential Treatment of Excessive Daytime Sleepiness (EDS) Associated with Narcolepsy or with Obstructive Sleep Apnea (OSA),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/21/2016 06CR5C-E PRN  Endo Provides Statement Regarding Expected FDA Approval Of Generic Voltaren® Gel Product,, 5/07/2013 09060J10 PRN  BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference, 8/06/2015 09073M10    PRN  Bio-Techne Declares Dividend,11/27/2017 75886F10    PRN  Regeneron Provides Update on EYLEA® (aflibercept) Injection and Nesvacumab (Ang2 Antibody) Combination Program,,, 5/05/2016 46222210 PRN  Ionis Pharmaceuticals Provides Corporate Update at 2016 Annual Meeting of Stockholders,"12/11/2013 09061G10   PRN  Daily Trends Scanner: BioMarin Pharma Inc., Delcath Systems Inc., Akorn Inc., and Insmed Inc.",,11/04/2015 NBIX-US  PRN  Neurocrine Biosciences to Present at Credit Suisse's 24th Annual Healthcare Conference,,," 9/14/2012 NVS-CH    PRN  The Zacks Analyst Blog Highlights: Sanofi, Pfizer, Merck KGaA, Novartis and Biogen",,,"11/25/2013 37555810   PRN  Clinical Studies, Convertible Senior Notes, and Commercial Supply Contracts - Research Report on Gilead, Hologic, Regeneron, OPKO, and Unilife", 7/16/2015 ARNA-US    PRN  The Challenge of Improving - BrokerBank Securities, 5/17/2017 N5946510  PRN  Theravance Biopharma and Mylan to Present Additional Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS,,," 6/27/2018 NOVN-CH  PRN  Amgen And Novartis Highlight Findings From A Large Global Patient Survey Revealing That Worldwide Approximately 60 Percent Of Employed People With Migraine Missed, On Average, A Week Of Work In A Month",, 5/13/2013 52887230 PRN  Lexicon To Present At The Bank of America Merrill Lynch Healthcare Conference,,,," 1/16/2014 45773H20 PRN  Market Technicals Simplified: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories", 4/30/2015 64026810 PRN  Nektar Therapeutics Reports Financial Results for the First Quarter of 2015,11/08/2012 76655960 PRN  Rigel to Present at Jefferies 2012 Global Healthcare Conference in London,,,,,"12/31/2013 91307C10 PRN  Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals",,,,,, 1/02/2013 LMNX-US  PRN  Luminex Corporation To Present At JP Morgan Healthcare Conference, 5/14/2015 SGMO-US  PRN  Sangamo BioSciences Provides Clinical Update On SB-728-T Program and Developments In Other ZFP Therapeutic Programs at American Society of Gene and Cell Therapy Annual Meeting,, 1/09/2017 80105N10  PRN  Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases,,,,,,,,,,,, 2/08/2012 68214310 PRN  Omeros to Present at the 14th Annual BIO CEO & Investor Conference,,,,,,,,"11/07/2014 69329Y10 PRN  Biotech Equities Scrutiny - Vanda Pharma, PDL BioPharma, Synergy Pharma, OPKO Health, and MiMedx",,,," 7/22/2013 00182C10 PRN  ANI Pharmaceuticals, Inc. Announces Date for Second Quarter 2013 Earnings Release",,,,,,,,,,,,,,,,,,,,," 5/15/2014 92165910 PRN  Clinical Trial Updates, Leadership Appointments, and Earnings Results - Analyst Notes on Tesaro, Novavax, Vanda, Insmed and Durata",,,,, 3/18/2015 40637H10 PRN  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer,,,,,,,10/20/2016 09HS74-E PRN  Spinal Muscular Atrophy Program Advances into Phase 2 Clinical Studies in SMA Patients with RG7916,,,,,,, 5/01/2013 36197T10 PRN  GW Pharmaceuticals Announces Pricing of Initial Public Offering on the NASDAQ Global Market,, 6/04/2015 G5087110 PRN  Jazz Pharmaceuticals to Present Abstracts from Ongoing Evaluations of Xyrem® (sodium oxybate) at SLEEP 2015,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/10/2016 G3040110 PRN  Endo Announces Presentation at Barclays Global Healthcare Conference,, 4/29/2013 09060J10 PRN  BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors, 8/06/2015 09073M10    PRN  Bio-Techne Releases Fourth Quarter Fiscal 2015 Results,11/15/2017 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentation,,, 5/04/2016 46222210 PRN  Ionis Reports Financial Results and Highlights for First Quarter 2016,"12/04/2013 09061G10   PRN  Stock Price Updates, and Charitable Contributions - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics",,11/04/2015 NBIX-US  PRN  Neurocrine Biosciences Announces Expansion of its Clinical Pipeline,,, 9/13/2012 0BDK6C-E  PRN  Therapy Trends: Multiple Sclerosis,,,"11/20/2013 37555810   PRN  Stock Price Movement, Grants for Projects, and Clinical Data Presentations - Research Report on Gilead, Bristol-Myers Squibb, HCA, Allergan, and Alexion", 7/13/2015 008H33-E   PRN  AnaptysBio Appoints Robert E. Hoffman As Chief Financial Officer, 5/16/2017 N5946510  PRN  Mylan to Present at UBS Global Healthcare Conference,,," 6/27/2018 03116210 PRN  Amgen Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Candidate To Infliximab",, 5/10/2013 52887230 PRN  Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial,,,, 1/06/2014 45773H20 PRN  Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference," 4/23/2015 64026810 PRN  Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets",11/06/2012 76655960 PRN  Rigel Announces Third Quarter 2012 Financial Results,,,,,12/20/2013 91307C10 PRN  FDA Approves Orenitram™ (treprostinil) Extended-Release Tablets for the Treatment of Pulmonary Arterial Hypertension,,,,,,"11/27/2012 55027E10 PRN  Luminex Corporation To Host Investor Event December 11, 2012", 5/13/2015 80067710 PRN  Sangamo BioSciences Announces Joint Steering Committee Decision To Consolidate ZFP Therapeutic® Strategy For Hemoglobinopathies,, 1/06/2017 05FGM6-E  PRN  Ian Clark joins Guardant Health Board of Directors,,,,,,,,,,,, 2/07/2012 68214310 PRN  Omeros Provides Update on Ongoing OMS302 Phase 3 Clinical Trial,,,,,,,,11/06/2014 69329Y10 PRN  PDL BioPharma Acquires a Portion of the University of Michigan's Royalty Interest in Genzyme's Cerdelga™ (eliglustat) Capsules for $65.6 Million,,,, 7/18/2013 BPAX-US  PRN  ANI Pharmaceuticals Announces Name Change and Reverse Stock Split,,,,,,,,,,,,,,,,,,,,, 5/08/2014 92165910 PRN  Vanda Pharmaceuticals Reports First Quarter 2014 Results,,,,," 3/11/2015 40637H10 PRN  Biotech Equities Technical Updates -- Gilead Sciences, Arena Pharma, ACADIA Pharma, Halozyme Therapeutics, and Juno Therapeutics",,,,,,,10/19/2016 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Third Quarter Financial Results,,,,,,, 3/19/2013 36197T10 PRN  GW Pharmaceuticals Files Registration Statement for NASDAQ Global Market Listing and U.S. Initial Public Offering,, 5/15/2015 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 3/09/2016 G3040110 PRN  National Sports Commentator, Dr. Jerry Punch, Together with Men's Health Network and Endo Pharmaceuticals, Encourages Men with Peyronie's Disease to Ask About the Curve",, 3/26/2013 09060J10 PRN  BioDelivery Sciences Expands Product Pipeline with Acquisition of Patented Topical Clonidine Gel for the Treatment of Painful Diabetic Neuropathy," 7/14/2015 09073M10    PRN  Bio-Techne To Host Conference Call On August 6, 2015 To Announce Fourth Quarter Financial Results",11/08/2017 75886F10    PRN  Regeneron Reports Third Quarter 2017 Financial and Operating Results,,, 5/03/2016 0017CR-E PRN  Ionis Pharmaceuticals and Kastle Therapeutics Announce Acquisition of KYNAMRO®,"12/03/2013 09061G10   PRN  Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis",,10/29/2015 64125C10 PRN  Neurocrine Biosciences Reports Third Quarter 2015 Results,,, 9/10/2012 085DFB-E  PRN  Fashion Meets Fairway at the Multiple Sclerosis Foundation's Annual Golf Tournament Oct. 11 at Parkland Golf & Country Club,,,"11/12/2013 37555810   PRN  Biotechnology Companies Announce Presentations, Stock Options Update and Financial Results - Research Report on Gilead Sciences, Alexion Pharma, Aegerion Pharma, Vanda Pharma, and Tesaro", 6/16/2015 04004760   PRN  Arena Pharmaceuticals Announces the Departure of Chief Financial Officer, 5/16/2017 N5946510  PRN  Mylan Honors National Women's Health Week to Empower Women to Take Control of Their Health,,, 6/27/2018 05DZG8-E PRN  IAG Magnifies Impact Of Brand Activations,, 5/10/2013 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results,,,,"12/17/2013 45773H20 PRN  AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories"," 4/16/2015 NKTR-US  PRN  Baxter Submits Application To Japan's MHLW For Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For Hemophilia A",10/03/2012 76655960 PRN  Rigel Announces Pricing Of Public Offering Of Common Stock,,,,,"12/20/2013 91307C10 PRN  Updated Financial Standings, Company Announcements, and Customer-Centered Suggestions - Research Report on Perrigo, Thermo Fisher, DaVita, United Therapeutics, and Keryx Biopharmaceuticals",,,,,,10/29/2012 55027E10 PRN  Luminex Corporation Reports Third Quarter 2012 Results, 5/12/2015 SGMO-US  PRN  Sangamo BioSciences Announces Presentation At The UBS 2015 Global Healthcare Conference,, 1/05/2017 80105N10  PRN  Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection,,,,,,,,,,,," 2/01/2012 68214310 PRN  BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle",,,,,,,,"11/03/2014 69329Y10 PRN  PDL BioPharma to Announce Third Quarter 2014 Financial Results on November 10, 2014",,,, 7/16/2013 00182C10 PRN  BioSante Hires VP of New Business Development and Contract Manufacturing and Announces New Appointment to Board of Directors,,,,,,,,,,,,,,,,,,,,," 4/24/2014 92165910 PRN  Vanda Pharmaceuticals to Announce First Quarter 2014 Financial Results on May 8, 2014",,,,, 3/10/2015 40637H10 PRN  Halozyme Therapeutics Reports Selection Of First Product Candidate Under Janssen Collaboration,,,,,,,10/17/2016 06CR5C-E PRN  PTC Therapeutics Provides Regulatory Update on Translarna™ (ataluren) for Nonsense Mutation Duchenne Muscular Dystrophy,,,,,,,,, 5/07/2015 G5087110 PRN  Jazz Pharmaceuticals Announces First Quarter 2015 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/02/2016 G3040110 PRN  Endo Provides Informational Frequently Asked Questions & Answers,, 3/18/2013 09060J10 PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2012 Annual Report, 6/05/2015 TECH-US     PRN  Bio-Techne Corporation Agrees to Acquire Cliniqa Corporation,11/07/2017 75886F10    PRN  Regeneron and Sanofi to Present New Analyses from the Praluent® (alirocumab) Injection ODYSSEY Clinical Trial Program at the AHA Scientific Sessions 2017,,, 4/22/2016 46222210 PRN  Webcast Alert: Ionis Pharmaceuticals' First Quarter 2016 Financial Results Conference Call,"11/26/2013 09061G10   PRN  Potential Acquisitions and Stock Price Updates - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics",,10/22/2015 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2015 Results,,," 8/30/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights: Alnylam Pharmaceuticals, Monsanto, Novartis, Biogen and Cubist Pharmaceuticals",,,"11/06/2013 37555810   PRN  Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind", 6/04/2015 ARNA-US    PRN  Lorcaserin HCl Data to be Presented at American Diabetes Association's 75th Scientific Sessions," 5/11/2017 N5946510  PRN  Citigroup, 21st Century Fox, Mylan, TripAdvisor Inc., and Zayo Group Holdings Inc. and more offer option-trading opportunities that offer returns of more than 18%",,, 6/23/2018 03116210 PRN  New Data Show Amgen's Repatha® (evolocumab) Significantly Reduced LDL-C And Non-HDL-C In High-risk Patients With Type 2 Diabetes,," 5/03/2013 52887230 PRN  Lexicon to Report First Quarter Financial Results on May 10, 2013",,,,12/11/2013 45773H20 PRN  CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel," 4/15/2015 64026810 PRN  Equities Updates on Pharma Industry -- Eli Lilly, Sanofi, AstraZeneca, Nektar Therapeutics, and BioDelivery Sciences Intl.",10/02/2012 76655960 PRN  Rigel Announces Proposed Public Offering Of Common Stock,,,,,12/09/2013 91307C10 PRN  United Therapeutics Receives Subpoena From Office of Inspector General,,,,,,"10/08/2012 55027E10 PRN  Luminex Corporation Third Quarter Earnings Release Scheduled for October 29, 2012", 5/07/2015 80067710 PRN  Sangamo BioSciences Announces Presentation At The Bank Of America Merrill Lynch 2015 Health Care Conference,, 1/04/2017 80105N10  PRN  Sanofi Announces Soliqua™ 100/33 Now Available in the U.S.,,,,,,,,,,,, 1/10/2012 68214310 PRN  Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs,,,,,,,,"10/31/2014 69329Y10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against PDL BioPharma, Inc. and Certain Officers - PDLI",,,, 4/19/2013 00182C10 PRN  Ceregene Reports Data From Parkinson's Disease Phase 2b Study,,,,,,,,,,,,,,,,,,,,, 4/09/2014 92165910 PRN  Vanda Pharmaceuticals Announces Availability of HETLIOZ™ (tasimelteon) for Non-24-Hour Sleep-Wake Disorder (Non-24),,,,, 3/03/2015 40637H10 PRN  Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference,,,,,,,10/06/2016 69366J20 PRN  PTC Therapeutics Announces New Analyses that Support the Potential Benefit of Ataluren in Preserving Lung Function in Non-Ambulatory Nonsense Mutation Duchenne Muscular Dystrophy Patients,,,,,,,,," 4/23/2015 G5087110 PRN  Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/29/2016 G3040110 PRN  Endo Reports Fourth Quarter And Full Year 2015 Financial Results,, 3/13/2013 09060J10 PRN  BioDelivery Sciences to Present at the 25th Annual ROTH Conference, 5/05/2015 09073M10    PRN  Bio-Techne Releases Third Quarter Fiscal 2015 Results,11/01/2017 75886F10    PRN  Regeneron to Share Clinical Progress of REGN1979 and Cemiplimab (REGN2810) in B-Cell Lymphomas at the 2017 ASH Annual Meeting,,, 4/20/2016 0017CR-E PRN  Ionis Pharmaceuticals Reports Data Update from Nusinersen Phase 2 Study in Infants with Spinal Muscular Atrophy and Reviews Neurological Disease Franchise,"11/25/2013 09061G10   PRN  FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics",,10/20/2015 64125C10 PRN  Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor NBI-98854 in Adults with Tourette Syndrome,,," 8/17/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights: Biogen, Alnylam Pharmaceuticals, Isis Pharmaceuticals, AstraZeneca and Sanofi",,,"11/04/2013 37555810   PRN  Under AAAResearchReports.com Microscope: Gilead Sciences Inc., NPS Pharma Inc., Halozyme Therapeutics Inc., and InterMune Inc.", 5/26/2015 04004760   PRN  Arena Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference, 5/10/2017 N5946510  PRN  Mylan Reports First Quarter 2017 Results,,, 6/19/2018 03116210 PRN  Amgen Receives European Commission Approval To Add Overall Survival Data To BLINCYTO® (blinatumomab) Label,, 4/25/2013 52887230 PRN  Lexicon To Present At The Needham Healthcare Conference,,,,11/20/2013 45773H20 PRN  Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial, 4/13/2015 64026810 PRN  Nektar Therapeutics to Present at the 14th Annual Needham Healthcare Conference, 9/17/2012 76655960 PRN  Rigel to Present at UBS Global Life Sciences Conference,,,,,"12/04/2013 91307C10 PRN  Stock Price Updates, and Charitable Contributions - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics",,,,,,10/01/2012 55027E10 PRN  Luminex Corporation Participates in Community Initiatives to Save Lives, 4/29/2015 SGMO-US  PRN  Sangamo BioSciences And Collaborators To Present Data On ZFP Therapeutic Applications At Annual Meeting Of The American Society Of Gene And Cell Therapy,,12/12/2016 005M9Z-E  PRN  Scottish Medicines Consortium Approves Sanofi Prostate Cancer Drug,,,,,,,,,,,,11/30/2011 68214310 PRN  Omeros Announces It Has Unlocked Over 20 Percent of Class A Orphan GPCRs,,,,,,,,"10/10/2014 69329Y10 PRN  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In PDL BioPharma, Inc. (PDLI) To Contact The Firm",,,, 3/13/2013 00182C10 PRN  Ceregene And Alzheimer's Disease Cooperative Study Group Complete Enrollment Of CERE-110 Phase 2 Trial,,,,,,,,,,,,,,,,,,,,," 2/28/2014 92165910 PRN  Blind Adventurer, Erik Weihenmayer, Launches National Campaign to Raise Awareness of Non-24-Hour Sleep-Wake Disorder",,,,, 3/02/2015 40637H10 PRN  Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results,,,,,,,10/04/2016 0DC9S7-E PRN  New Research Validates Translarna's™ (ataluren) Mechanism of Action to Promote Readthrough of Nonsense Mutations and Produce Full-length Functional Protein,,,,,,,,, 3/23/2015 0086SH-E PRN  EUSA Pharma Successfully Launches as an Independent Profitable Pharmaceutical Business with Global Reach and a Portfolio of Specialty Products Acquired from Jazz Pharmaceuticals,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/22/2016 05MBN8-E PRN  Endo Announces Launch Of BELBUCA™ (Buprenorphine) Buccal Film For Chronic Pain Management,, 3/01/2013 09060J10 PRN  BioDelivery Sciences to Present at the Cowen and Company 33rd Annual Health Care Conference, 5/05/2015 09073M10    PRN  Bio-Techne Declares Dividend,"10/31/2017 75886F10    PRN  Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function in Phase 3 Study of People with Severe Steroid-Dependent Asthma",,, 4/15/2016 0017CR-E PRN  Ionis Pharmaceuticals Highlights Antisense Drugs to Treat Neurological Diseases at the AAN Meeting,"11/20/2013 09061G10   PRN  Drug Milestones, Favorable Ruling, Official Statement, and Quarterly Report - Research Report on BioMarin, Vanda, Cadence, Prana, and Biostar",,10/08/2015 64125C10 PRN  Neurocrine Announces Positive Results from Phase III Kinect 3 Study of NBI-98854 in Tardive Dyskinesia,,, 8/15/2012 09062X10  PRN  Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy,,,"11/04/2013 37555810   PRN  Quarterly Financial Reports, Clinical Study Results, and R&D Events for the Investment Community - Research Report on Gilead Sciences, Clovis, Theravance, Charles River, and Acorda"," 5/18/2015 04004760   PRN  Biotech Equities Technical Study -- Gilead Sciences, Celgene, Novavax, Arena Pharma, and ACADIA Pharma", 5/01/2017 N5946510  PRN  Mylan Nominates Sjoerd Vollebregt for Election to Board of Directors,,," 6/12/2018 0FSTN1-E PRN  US Dermatologists Report Significant Growth of Next-Generation Psoriasis Biologics--Novartis' Cosentyx, Eli Lilly's Taltz, and Janssen's Tremfya",, 3/01/2013 52887230 PRN  Lexicon To Present At The Cowen Healthcare Conference,,,,"11/19/2013 45773H20 PRN  Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc.", 4/02/2015 64026810 PRN  Nektar Announces Receipt of $100 Million Milestone Payment from AstraZeneca, 9/05/2012 76655960 PRN  Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus,,,,,"11/26/2013 91307C10 PRN  Potential Acquisitions and Stock Price Updates - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics",,,,,, 9/12/2012 55027E10 PRN  Luminex Corporation To Present At Upcoming Investment Conferences In September, 4/22/2015 80067710 PRN  Sangamo BioSciences Reports First Quarter 2015 Financial Results,,12/08/2016 80105N10  PRN  Regeneron and Sanofi Announce Marketing Authorization Application for Dupixent® (dupilumab) Accepted for Review by the EMA,,,,,,,,,,,,11/29/2011 68214310 PRN  Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302,,,,,,,,10/08/2014 69329Y10 PRN  PDL Announces Appointment of PricewaterhouseCoopers LLP as its New Independent Registered Public Accounting Firm,,,," 4/04/2012 00182C10 PRN  Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in BioSante Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to Seek a Lead Plaintiff Position",,,,,,,,,,,,,,,,,,,,, 2/13/2014 92165910 PRN  Vanda Pharmaceuticals Reports Fourth Quarter 2013 and Full Year 2013 Results,,,,, 2/23/2015 40637H10 PRN  Halozyme to Host Fourth Quarter and 2014 Year-End Financial Results Conference Call,,,,,,, 9/20/2016 001H2N-E PRN  Advancing Preclinical Autoimmune Studies & Accelerated FDA Approvals Producing Rewards in Biotech Sector,,,,,,,,," 2/25/2015 G5087110 PRN  Critical Alerts For Invensense, Jazz Pharmaceuticals, SFX Entertainment, JetBlue and Ambarella Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/17/2016 G3040110 PRN  Endo Announces Initiation of Phase 2B Clinical Trial of Collagenase Clostridium Histolyticum in Cellulite,, 2/27/2013 09060J10 PRN  BioDelivery Sciences to Host Buprenorphine Investor and Analyst Event," 4/23/2015 09073M10    PRN  Bio-Techne To Host Conference Call On May 5, 2015 To Announce Third Quarter Financial Results",10/27/2017 75886F10    PRN  Regeneron's First Global Day of Service Supports Over 100 Non-Profit and Community Organizations,,, 4/07/2016 46222210 PRN  Ionis Pharmaceuticals Provides Update on IONIS-TTRRX Program,"11/15/2013 09061G10   PRN  Pre-Market Review: Delcath Systems Inc., BioMarin Pharma Inc., Insmed Inc., and Akorn Inc.",, 9/30/2015 NBIX-US  PRN  Neurocrine Biosciences Announces the Appointment of George J. Morrow to its Board of Directors,,," 8/13/2012 09062X10  PRN  Critical Trade Alerts For Amgen, Western Digital, Biogen Idec, Big Lots, and Oasis Petroleum Released By InvestorsObserver",,,"10/30/2013 37555810   PRN  Sector Leaders Briefing & Capital Raise News: Muscle Warfare, Baidu, Herblife, Gilead Sciences and ARIAD", 5/14/2015 ARNA-US    PRN  Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings," 4/27/2017 N5946510  PRN  Mylan to Report First Quarter 2017 Financial Results on May 10, 2017",,, 6/11/2018 000C35-E PRN  Leading biotech company partners with Williams Lea Tag,, 2/25/2013 52887230 PRN  Lexicon To Present At The RBC Capital Markets Healthcare Conference,,,,11/19/2013 45773H20 PRN  Inovio Pharmaceuticals CEO Appointed to International Vaccine Institute Board of Trustees, 3/31/2015 64026810 PRN  MOVANTIK™ (Naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain Launched In The US, 8/07/2012 76655960 PRN  Rigel Announces Second Quarter 2012 Financial Results,,,,,"11/21/2013 91307C10 PRN  Pre-Market Review: Star Scientific Inc., Pharmacyclics Inc., United Therapeutics Corp., and Impax Laboratories Inc.",,,,,, 9/10/2012 55027E10 PRN  Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco, 4/15/2015 80067710 PRN  Sangamo BioSciences Announces First Quarter 2015 Conference Call and Webcast,,12/01/2016 06VY62-E  PRN  Mymetics Starts Research Project with Sanofi for Influenza Vaccines,,,,,,,,,,,,11/22/2011 68214310 PRN  Omeros to Present at 23rd Annual Piper Jaffray Health Care Conference,,,,,,,,"10/06/2014 69329Y10 PRN  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against PDL BioPharma Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 17, 2014 -- PDLI",,,," 2/28/2012 ANIP-US  PRN  Research Reports for Penny Stock Top Movers: Advanced Micro Devices, Alcoa, Atmel, KeyCorp, and BioSante",,,,,,,,,,,,,,,,,,,,, 2/04/2014 92165910 PRN  Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market,,,,," 2/17/2015 40637H10 PRN  Track What Biological Products Companies Are Up To: Special Research on Gilead, Halozyme, Heska, Idera, and Kite Pharma",,,,,,, 9/12/2016 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,,, 2/24/2015 G5087110 PRN  Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2014 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 2/16/2016 G3040110 PRN  Endo to Announce Fourth Quarter 2015 Financial Results on February 29, 2016",, 2/05/2013 09060J10 PRN  BioDelivery Sciences to Present at the 15th Annual BIO CEO and Investor Conference," 2/10/2015 09073M10    PRN  Valuable Updates on Pharmaceutical Companies: New Research on Avalanche Biotechnologies, BioCryst, Biogen, Biota Pharmaceuticals, and Bio-Techne",10/19/2017 75886F10    PRN  Science Magazine Ranks Regeneron #1 Biopharma Employer for Fifth Time,,, 4/06/2016 05KDBG-E PRN  Akcea Therapeutics to Present at 15th Annual Needham Healthcare Conference,"11/08/2013 09061G10   PRN  Clinical Trial Initiations, Conferences Participations, Strategic Collaborations, and Presentation of New Pre-Clinical Data - Research Report on Biogen Idec, BioMarin, Medivation, Cytori, and Alnylam",, 9/16/2015 00DYYX-E PRN  AbbVie Announces Plans to Proceed to Phase 3 Evaluation of Elagolix in Patients with Uterine Fibroids,,," 8/07/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights: Alnylam Pharmaceuticals, GlaxoSmithKline, Medtronic, Novartis and Biogen Idec",,,"10/22/2013 37555810   PRN  Stock Price Movements, Clinical Study Results, and New Appointments - Research Report on Pfizer, Gilead Sciences, Amgen, Celgene, and Insys Therapeutics", 5/11/2015 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2015 Financial Results," 4/27/2017 N5946510  PRN  Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Rigel Pharma",,, 6/11/2018 03116210 PRN  FDA Approves Addition Of Positive Overall Survival Data From Phase 3 ASPIRE Trial To KYPROLIS® (carfilzomib) Label,, 2/21/2013 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results,,,,11/18/2013 45773H20 PRN  International Vaccine Institute Announces Appointments of New Members to its Board of Trustees, 3/19/2015 64026810 PRN  AstraZeneca And Daiichi Sankyo To Jointly Commercialise MOVANTIK In The US, 6/19/2012 RIGL-US  PRN  AstraZeneca And Rigel Sign Worldwide License Agreement For A Potential New Treatment For Chronic Asthma,,,,,"11/04/2013 91307C10 PRN  Presentation, Quarterly Reports, and FDA Approval - Research Report on Merck, United Therapeutics, Endo, Isis Pharmaceuticals, and Zogenix",,,,,, 8/31/2012 55027E10 PRN  Luminex Corporation Recognized as Best Technology Company in Austin," 3/20/2015 80067710 PRN  Technical Briefing on Biotech Equities - Amgen, Exelixis, Sangamo BioSciences, Medivation, and Tekmira Pharma",,11/30/2016 MRK-US    PRN  Natrix Separations announces collaboration agreements with Merck and Sanofi for the development of membrane-based Protein A purification platform,,,,,,,,,,,,11/08/2011 68214310 PRN  Omeros Corporation Reports Third Quarter 2011 Financial Results,,,,,,,,10/06/2014 69329Y10 PRN  PDL BioPharma Bolsters Management Team,,,," 2/16/2012 06ZBRX-E PRN  Research Reports for Penny Stock Top Movers: Fifth Third Bancorp, Sprint Nextel, BioSante, American Capital, and ON Semiconductor",,,,,,,,,,,,,,,,,,,,, 1/31/2014 92165910 PRN  FDA Approves HETLIOZ™ (tasimelteon) for the Treatment of Non-24-Hour Sleep-Wake Disorder,,,,, 2/17/2015 40637H10 PRN  Halozyme Announces Preclinical Study Results Of PEGPH20 Published In Molecular Cancer Therapeutics,,,,,,, 9/07/2016 69366J20 PRN  PTC Therapeutics Recognizes World Duchenne Awareness Day by Announcing Winners of Global Duchenne Muscular Dystrophy Patient Group Awards and Expanding Disease State Awareness Website,,,,,,,,, 2/23/2015 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/01/2016 ENDP-IE  PRN  Endo Announces the Qualitest Scholarship Program,, 1/22/2013 09060J10 PRN  BioDelivery Sciences Announces Completion of BNX Safety Study, 2/03/2015 09073M10    PRN  Bio-Techne Releases Second Quarter Fiscal 2015 Results,10/16/2017 75886F10    PRN  Regeneron and Sanofi Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis,,, 4/01/2016 GS-US    PRN  Ionis Pharmaceuticals to Present at Upcoming Investor Conferences,"11/01/2013 09061G10   PRN  Critical Alerts For Citigroup, Community Health, Oracle, Boeing, and BioMarin Pharmaceuticals Released By InvestorsObserver",," 9/10/2015 64125C10 PRN  /C O R R E C T I O N -- Neurocrine Biosciences, Inc./",,," 8/02/2012 06DDVL-E  PRN  Zacks Bull and Bear of the Day Highlights: Biogen Idec, McDonald's, Sunoco , PHH and FreightCarAmerica",,,"10/21/2013 37555810   PRN  Innovative Biotechs Making Strides In Healthcare Sector: Alliqua, MiMedx, Organovo, Anacor Pharmaceuticals, Pfizer"," 5/11/2015 04004760   PRN  Arena Pharmaceuticals and Roivant Sciences Enter into Collaboration for Nelotanserin, a Novel Inverse Agonist of the 5-HT2A Receptor", 4/20/2017 N5946510  PRN  Mylan Launches Generic Trilafon Tablets,,, 6/08/2018 03116210 PRN  European Commission Approves Prolia® (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis,," 2/18/2013 52887230 PRN  Lexicon to Report Fourth Quarter and Year End 2012 Financial Results on February 21, 2013",,,,11/18/2013 45773H20 PRN  Inovio Pharmaceuticals to Present at Upcoming Investor Conferences, 3/18/2015 64026810 PRN  Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Nektar Therapeutics, 6/19/2012 76655960 PRN  AstraZeneca and Rigel Sign Worldwide License Agreement for a Potential New Treatment for Chronic Asthma,,,,,"10/30/2013 91307C10 PRN  Under AAAResearchReports.com Microscope: Star Scientific Inc., Pharmacyclics Inc., Impax Laboratories Inc., and United Therapeutics Corp.",,,,,," 8/13/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Hewlett-Packard, Wipro, Amazon.com, International Business Machines and Luminex", 3/18/2015 80067710 PRN  Sangamo BioSciences Announces Participation In The 3rd Annual Regen Med Investor Day Meeting In New York,,11/21/2016 80105N10  PRN  Sanofi Receives FDA Approval of Soliqua™ 100/33 for the Treatment of Adults with Type 2 Diabetes,,,,,,,,,,,,10/11/2011 68214310 PRN  Omeros Announces First Patients Treated in Phase 3 Clinical Program Evaluating OMS302,,,,,,,,"10/06/2014 PDLI-US  PRN  Pittsburgh Law Office of Alfred G. Yates Jr., PC Reminds Ocwen Financial Corporation (OCN) Investors of Important Class Action Deadline, and Announces Investigations of Athlon Energy (ATHL), Bankrate (RATE), Dresser-Rand Group (DRC), Move (MOVE), PDL BioPharma (PDLI), Pike Corp. (PIKE), Sigma-Aldrich Corp. (SIAL), TIBCO Software (TIBX), and Viasystems Group (VIAS)",,,," 2/09/2012 00182C10 PRN  Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.",,,,,,,,,,,,,,,,,,,,," 1/23/2014 92165910 PRN  Vanda Pharmaceuticals to Announce Fourth Quarter 2013 Financial Results on February 13, 2014",,,,," 1/28/2015 40637H10 PRN  Biotech Stocks Technical Report - Halozyme Therapeutics, Agenus, Biogen Idec, ACADIA Pharma, and Peregrine Pharma",,,,,,," 8/22/2016 69366J20 PRN  Research Report Initiation on Biotech Stocks -- PTC Therapeutics, Grifols, Puma Biotech, and 22nd Century",,,,,,,,," 2/12/2015 JAZZ-IE  PRN  Jazz Pharmaceuticals to Present Data on Defibrotide, an Investigational Treatment, in Patients with Hepatic Veno-Occlusive Disease (VOD) at BMT Tandem Meetings",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/21/2015 ENDP-IE  PRN  Endo Announces Appearances At Upcoming Conferences,,12/17/2012 BDSI-US  PRN  BioDelivery Sciences Announces Hiring of George Ng as General Counsel, 2/03/2015 09073M10    PRN  Bio-Techne Declares Dividend,"10/11/2017 75886F10    PRN  Regeneron to Report Third Quarter 2017 Financial and Operating Results and Host Conference Call and Webcast on November 8, 2017",,, 3/31/2016 00167Y-E PRN  Ionis Pharmaceuticals Advances Nusinersen in the Ongoing SHINE Study in Patients with SMA,"10/31/2013 09061G10   PRN  Biotech Companies Report Quarterly Results - Research Report on Biogen Idec, Alexion, Medivation, BioMarin, and Dyax",, 9/03/2015 64125C10 PRN  Neurocrine Biosciences Announces the Appointment of Dr. Alfred W. Sandrock to its Board of Directors,,, 8/01/2012 09062X10  PRN  Isis And Collaborators Alleviate Disease In Animal Models Of Myotonic Dystrophy,,,"10/14/2013 37555810   PRN  Trial Updates and Public Offering - Research Report on Gilead, Celgene, Ariad, Puma Biotechnology, and Dyax", 5/08/2015 04004760   PRN  Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference," 3/31/2017 N5946510  PRN  Mylan Provides Update on Meridian Medical Technologies', a Pfizer Company, Expanded Voluntary Worldwide Recall of EpiPen® Auto-Injector",,, 6/07/2018 03116210 PRN  /C O R R E C T I O N -- Amgen/,, 2/06/2013 52887230 PRN  Lexicon To Present At The BIO CEO & Investor Conference,,,,11/12/2013 45773H20 PRN  Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results, 3/17/2015 64026810 PRN  Etirinotecan Pegol (NKTR-102) Prolonged Median Overall Survival by 2.1 Months versus Active Control in Patients with Advanced Breast Cancer in Phase 3 Study; Trial Did Not Achieve Statistical Significance (p=0.08), 5/31/2012 76655960 PRN  Rigel Announces Participation at Two Investor Conferences,,,,,10/29/2013 91307C10 PRN  United Therapeutics Corporation Reports Third Quarter 2013 Financial Results,,,,,, 8/09/2012 55027E10 PRN  Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA), 3/09/2015 80067710 PRN  Sangamo BioSciences CEO To Present State Of The Industry Address At Alliance For Regenerative Medicine's Advanced Therapies Summit,,11/17/2016 80105N10  PRN  New Survey Finds Men in the U.S. Want to Take Charge of Their Own Health and Wellness,,,,,,,,,,,, 9/13/2011 68214310 PRN  Omeros Unlocks Four Additional Orphan GPCRs,,,,,,,, 9/30/2014 BAGL-US  PRN  Law Offices of Marc S. Henzel Announces Securities Class Action Periods,,,," 2/08/2012 SIRI-US  PRN  Top Stock Alerts for Day Traders: KeyCorp, Sirius, ON Semiconductor, and BioSante",,,,,,,,,,,,,,,,,,,,,12/03/2013 92165910 PRN  Vanda Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference,,,,," 1/21/2015 40637H10 PRN  Halozyme Appoints Jean-Pierre Bizzari, M.D. To Board Of Directors",,,,,,, 8/04/2016 69366J20 PRN  PTC Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update,,,,,,,,," 2/10/2015 G5087110 PRN  Jazz Pharmaceuticals to Report 2014 Fourth Quarter and Full Year Financial Results on February 24, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/14/2015 ENDP-IE  PRN  Endo Announces Extension Of U.S. Rights For Voltaren® Gel,,11/28/2012 09060J10 PRN  BioDelivery Sciences Announces $40 Million Registered Financing," 1/27/2015 09073M10    PRN  Bio-Techne To Host Conference Call On February 3, 2015 To Announce Second Quarter Financial Results",10/11/2017 75886F10    PRN  Internationally Acclaimed Writer and Executive Producer of HBO's The Night Of Reveals His Personal Story Detailing the Harsh Realities of Atopic Dermatitis,,, 3/31/2016 0017CR-E PRN  Akcea Therapeutics Supports World Lipodystrophy Day,"10/25/2013 09061G10   PRN  Pre-Market Analysis: BioMarin Pharma Inc., Insmed Inc., Delcath Systems Inc., and Akorn Inc.",, 9/02/2015 64125C10 PRN  Neurocrine Biosciences to Present at the Baird 2015 Healthcare Conference,,, 7/12/2012 0075XW-E  PRN  AstraZeneca Acquires Neuroscience Assets From Link Medicine,,,"10/11/2013 37555810   PRN  Technical Study: Gilead Sciences Inc., NPS Pharmaceuticals Inc., Halozyme Therapeutics Inc., and InterMune Inc."," 5/07/2015 04004760   PRN  Arena Pharmaceuticals to Host First Quarter 2015 Financial Results Conference Call and Webcast on Monday, May 11", 3/29/2017 N5946510  PRN  Mylan Completes Acquisition of Cold-EEZE® Brand,,," 6/06/2018 03116210 PRN  Amgen, Oklahoma Health Care Authority And University of Oklahoma's Pharmacy Management Consultants Partner To Improve Medicaid Outcomes",, 1/03/2013 LXRX-US  PRN  Lexicon To Present At The J.P. Morgan Healthcare Conference,,,,"11/04/2013 45773H20 PRN  Inovio Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 12, 2013"," 3/10/2015 64026810 PRN  Technical Snapshot on Pharma Stocks -- Pfizer, Zogenix, Sanofi, Nektar Therapeutics, and IGI Laboratories", 5/16/2012 76655960 PRN  Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease,,,,,"10/25/2013 91307C10 PRN  Exhibition, Quarterly Reports, Lawsuit, and Service Launch - Research Report on Zoetis, United Therapeutics, BioReference, ICON, and Abaxis",,,,,, 8/06/2012 55027E10 PRN  Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games, 2/26/2015 80067710 PRN  Sangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed to Provide Functional Control of HIV,,11/16/2016 REGN-US   PRN  Regeneron and Sanofi Present Results from Phase 3 MONARCH Study of Investigational Sarilumab at American College of Rheumatology Annual Meeting,,,,,,,,,,,, 9/06/2011 68214310 PRN  Omeros to Present at Rodman and Renshaw 13th Annual Healthcare Conference,,,,,,,," 9/29/2014 69329Y10 PRN  PDL BIOPHARMA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against PDL BioPharma, Inc.",,,,"12/16/2011 ANIP-US  PRN  Research Reports for Day Traders: Ariad, Delta Air Lines, BioSante, Bank of America, Boston Scientific and News Corp",,,,,,,,,,,,,,,,,,,,,"11/28/2013 92165910 PRN  Settlement Agreements, Prestigious Recognitions, Proposed M&A's, and Support for New Drug Candidates - Research Report on Teva, Aegerion, Community Health Systems, Air Methods and Vanda",,,,, 1/12/2015 40637H10 PRN  Halozyme Therapeutics Provides An Update On Anticipated Milestones For 2015 At The 33rd Annual J. P. Morgan Healthcare Conference,,,,,,, 7/25/2016 69366J20 PRN  PTC Therapeutics Provides Regulatory Update on Translarna™ (ataluren),,,,,,,,," 1/12/2015 0CBRZ9-E PRN  ""Jazz and Love"" Set to Bring Unique Valentine's Day Concert Experience to South Florida",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/25/2015 ENDP-IE  PRN  Endo Announces Appearance At The 27th Annual Piper Jaffray Healthcare Conference,,11/19/2012 09060J10 PRN  BioDelivery Sciences to Present at the 24th Annual Piper Jaffray Healthcare Conference, 1/22/2015 09073M10    PRN  Bio-Techne Launches Simple Plex Platform,10/05/2017 SAN-FR      PRN  Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent® (alirocumab),,, 3/22/2016 0017CR-E PRN  Ionis Pharmaceuticals and Merck Receive Positive Verdict on Gilead HCV Drug Patent Case,"10/23/2013 09061G10   PRN  Financial Results Schedules, Discontinuation of Phase 3 Trial, Data Presentations, Strategic Alliances, and Premarket Filings - Research Report on Biogen, Ariad, BioMarin, Alnylam, and Sequenom",, 8/13/2015 64125C10 PRN  Neurocrine Announces Completion of Enrollment into Kinect 3 Tardive Dyskinesia Study,,, 7/09/2012 05R189-E  PRN  Pappas Ventures Names Pat Gage to Scientific Advisory Board,,,10/07/2013 GILD-US    PRN  Simeprevir Data from COSMOS Study in Hepatitis C Patients Accepted as Late-Breaking Presentation at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), 4/29/2015 04004760   PRN  Arena Pharmaceuticals Reports Favorable Results from Phase 1 Single-Ascending Dose Clinical Trial of APD371, 3/29/2017 MYL-US    PRN  Mylan Comments on Generic Advair Diskus® Abbreviated New Drug Application,,, 6/01/2018 03116210 PRN  Phase 3 A.R.R.O.W. Interim Analysis Shows Once-Weekly 70 mg/m2 KYPROLIS® (carfilzomib) Regimen Significantly Extended Progression-Free Survival Versus A Twice-Weekly 27 mg/m2 Regimen In Patients With Relapsed And Refractory Multiple Myeloma,,12/17/2012 52887230 PRN  Lexicon's Drug Candidate For Irritable Bowel Syndrome Receives Fast Track Status From The FDA,,,,"10/28/2013 45773H20 PRN  Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc.", 2/25/2015 64026810 PRN  Nektar Announces Start of Phase 3 SUMMIT-07 Study of NKTR-181 in Patients with Chronic Low Back Pain, 5/01/2012 76655960 PRN  Rigel Announces First Quarter 2012 Financial Results,,,,,"10/22/2013 91307C10 PRN  United Therapeutics Corporation to Announce Third Quarter 2013 Financial Results Before Market Open on Tuesday, October 29, 2013",,,,,, 7/30/2012 55027E10 PRN  Luminex Corporation Reports Second Quarter 2012 Results, 2/25/2015 80067710 PRN  Sangamo BioSciences Announces Presentation At The Cowen And Company 35th Annual Health Care Conference,,11/11/2016 000VC1-E  PRN  Regeneron and Sanofi to Present Data from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2016,,,,,,,,,,,, 8/09/2011 68214310 PRN  Omeros Corporation Reports Second Quarter 2011 Financial Results,,,,,,,," 9/24/2014 PDLI-US  PRN  Lifshitz & Miller Law Firm Announces Investigation of CommVault Systems, Inc., Dresser-Rand Group Inc., PDL BioPharma, Inc., Santander Consumer USA Holdings Inc., Sigma-Aldrich Corporation, and Viasystems Group, Inc.",,,,12/01/2011 00182C10 PRN  Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson's Disease,,,,,,,,,,,,,,,,,,,,,"11/20/2013 92165910 PRN  Drug Milestones, Favorable Ruling, Official Statement, and Quarterly Report - Research Report on BioMarin, Vanda, Cadence, Prana, and Biostar",,,,," 1/08/2015 40637H10 PRN  Critical Alerts For Kinder Morgan, Halozyme Therapeutics, MannKind, BP and Union Pacific Released By InvestorsObserver",,,,,,, 7/21/2016 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Second Quarter Financial Results,,,,,,,,, 1/05/2015 G5087110 PRN  Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/20/2015 ENDP-IE  PRN  Endo International plc Announces Conditional Redemption of All $400,000,000 Aggregate Principal Amount Outstanding of the Two Series of 7.00% Senior Notes due 2020",,11/08/2012 09060J10 PRN  BioDelivery Sciences Provides Business Update and Summary of Third Quarter Results of Operations,11/25/2014 09073M10    PRN  Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division,10/05/2017 75886F10    PRN  Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent® (alirocumab),,, 3/04/2016 0017CR-E PRN  Akcea Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference,"10/15/2013 09061G10   PRN  Upcoming Financial Results Schedules, Clinical Studies and Trials, and New Appointments - Research Report on BioMarin, Alnylam, Aegerion, Omeros, and Tesaro",," 8/11/2015 PRGO-IE  PRN  Technical Updates on Healthcare Sector Equities -- Brookdale Senior Living, Envision Healthcare Holdings, BioScrip, Perrigo and Neurocrine Biosciences",,," 5/29/2012 09062X10  PRN  The Zacks Analyst Blog Highlights: Biogen, Teva Pharmaceutical, Pfizer, Novartis and U.S. Bancorp",,,"10/01/2013 37555810   PRN  License Agreements, Strategic Partnerships, Regulatory Approvals, Acquisitions and Sale of Senior Notes - Research Report on Johnson & Johnson, Amgen, Gilead, MAKO, and Edwards Lifesciences", 4/20/2015 04004760   PRN  Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research, 3/28/2017 N5946510  PRN  Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer,,," 5/31/2018 065BPX-E PRN  Amgen And MD Anderson Announce Collaboration To Accelerate Early Stage Treatments For Leukemia, Myelodysplastic Syndromes, Multiple Myeloma, Small-Cell Lung And Other Small-Cell Cancers",,11/20/2012 52887230 PRN  Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference,,,,10/21/2013 INO-US   PRN  Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial, 2/24/2015 64026810 PRN  Nektar Therapeutics Reports Fourth Quarter and Year-End 2014 Financial Results, 3/06/2012 76655960 PRN  Rigel Announces Fourth Quarter and Year End 2011 Financial Results,,,,,"10/08/2013 91307C10 PRN  Today's Research: Pharmacyclics Inc., United Therapeutics Corp., Star Scientific Inc., and Impax Laboratories Inc.",,,,,," 7/11/2012 55027E10 PRN  Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012"," 2/19/2015 80067710 PRN  A Look at the Latest Occurrences in the Healthcare Sector: Special Research on Sangamo BioSciences,Seattle Genetics, StemCells, Synageva and VBI Vaccines",,11/03/2016 500302-IN PRN  New MS Therapies & HTA Bodies: What's Driving Such High Rates of Positive Evaluation?,,,,,,,,,,,, 8/03/2011 68214310 PRN  Omeros to Present at Two Upcoming Conferences,,,,,,,, 9/23/2014 69329Y10 PRN  PDL BioPharma Responds to Class Action Lawsuit,,,,"11/16/2011 002QRN-E PRN  Research Reports on Top Traded Penny Stocks: Hanmi Financial, Geron, Towerstream, BioSante, Syntroleum & Sunwin",,,,,,,,,,,,,,,,,,,,,11/14/2013 92165910 PRN  FDA Advisory Committee Recommends Approval of HETLIOZ™ for the Treatment of Non-24-Hour-Disorder (Non-24) in the Totally Blind,,,,," 1/08/2015 40637H10 PRN  Rallying on Street: Special Research on Dick's Sporting, Monsanto, Halozyme, Janus Capital and Sony",,,,,,," 7/11/2016 69366J20 PRN  Biotechnology Stocks Under the Scanner -- PTC Therapeutics, Inovio Pharma, VIVUS, and Spectrum Pharma",,,,,,,,,12/19/2014 G5087110 PRN  Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze® (asparaginase Erwinia chrysanthemi),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/10/2015 ENDP-IE  PRN  Endo Announces Appearance At The Stifel 2015 Healthcare Conference,,10/18/2012 09060J10 PRN  BioDelivery Sciences Reaffirms its Strengthened Position Following Reexamination of MonoSol Patents,11/04/2014 000XKX-E    PRN  Bio-Techne Announces Agreement To Acquire CyVek,"10/02/2017 75886F10    PRN  Regeneron Announces New Collaborations with HHS to Develop Antibodies Against Ebola, Influenza and Multiple Other Emerging Pathogens",,, 2/29/2016 46222210 PRN  Ionis Pharmaceuticals Supports Rare Disease Day,"10/07/2013 09061G10   PRN  Clinical Study Updates, Trial Enrollments, NDA Submissions, Partnerships, and Formation of New Subsidiaries - Research Report on BioMarin, Alnylam, Vertex, Illumina, and Intrexon",, 7/29/2015 64125C10 PRN  Neurocrine Biosciences Reports Second Quarter 2015 Results,,," 5/21/2012 RDY-IN    PRN  The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan",,," 9/26/2013 37555810   PRN  Application for Regulatory Approvals, Conferences and Presentations, and Enrollment in Clinical Trials - Research Report on Gilead, Alnylam, Omeros, PTC, and Stemline"," 4/14/2015 04004760   PRN  Updates on Biotech Stocks -- Gilead Sciences, Arena Pharma, ACADIA Pharma, Halozyme Therapeutics, and Anthera Pharma"," 3/20/2017 N5946510  PRN  Mylan Receives Tentative Approval for ""TLE400"" Under PEPFAR",,, 5/30/2018 03116210 PRN  Amgen Foundation And Harvard Team Up To Offer Free Online Science Education Platform,,11/12/2012 002SM4-E PRN  Lexicon Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference,,,,"10/04/2013 45773H20 PRN  Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc."," 2/17/2015 64026810 PRN  Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2014 on Tuesday, February 24, 2015, After Close of U.S.-Based Financial Markets", 2/23/2012 76655960 PRN  Rigel Announces Participation at Two Investor Conferences,,,,," 9/17/2013 91307C10 PRN  Clinical Trial Updates, Appointments, FDA Acknowledgments and Qualifications - Research Report on Novartis, Endo, The Medicines Company, United Therapeutics, and Forest",,,,,, 7/09/2012 55027E10 PRN  Luminex Corporation Announces Agreement to Acquire GenturaDx, 2/12/2015 80067710 PRN  Sangamo BioSciences Presents Data At 11th Annual WorldSymposium™ Meeting Supporting In Vivo Protein Replacement Platform Approach For The Treatment Of Lysosomal Storage Disorders,,11/03/2016 0GBP93-E  PRN  Pivotal Phase 2/3 Trial of Olipudase Alfa for Adult Patients With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease Type B) to Begin in the UK,,,,,,,,,,,, 6/29/2011 68214310 PRN  Omeros Announces Publication of Phase 2 Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery,,,,,,,," 9/19/2014 69329Y10 PRN  Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.",,,," 8/31/2011 00182C10 PRN  BioSante Pharmaceuticals, Inc. Selected For ""100 Great Investigational Drugs""",,,,,,,,,,,,,,,,,,,,,11/14/2013 92165910 PRN  Vanda Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review HETLIOZ™ NDA,,,,, 1/07/2015 40637H10 PRN  Halozyme Provides Agenda Highlights For Analyst And Investor Meeting,,,,,,, 7/07/2016 69366J20 PRN  NHS England Enables Access to Translarna™ ▼ (ataluren) For Patients with Nonsense Mutation Duchenne Muscular Dystrophy,,,,,,,,,12/11/2014 G5087110 PRN  Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/09/2015 G3040110 PRN  Endo Provides Informational Frequently Asked Questions & Answers,,10/15/2012 09060J10 PRN  BioDelivery Sciences Announces the Launch of BREAKYL (BEMA Fentanyl) in the E.U.,10/30/2014 000XKX-E    PRN  Bio-Techne Declares Dividend, 9/28/2017 75886F10    PRN  Regeneron and Sanofi Announce Approval of DUPIXENT® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis in the European Union,,, 2/25/2016 46222210 PRN  Ionis' 2015 Financial Results Outperform Projections," 9/30/2013 09061G10   PRN  Today's Research: Astex Pharma Inc., Delcath Systems Inc., BioMarin Pharma Inc., and Akorn Inc.",, 7/22/2015 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2015 Results,,," 5/18/2012 WPM-CA    PRN  Critical Alerts For Qualcomm, Simon Property, Silver Wheaton, Biogen Idec, and Nu Skin Released By InvestorsObserver",,," 9/20/2013 37555810   PRN  Issuer Ratings, Recognitions, Positive Clinical Results, and Quarterly Dividends - Research Report on Pfizer, UnitedHealth, Merck, Gilead, and Bristol-Myers", 4/10/2015 ARNA-US    PRN  Eisai and Arena Pharmaceuticals Complete Registrational Trials of an Extended Release Formulation of Lorcaserin, 3/17/2017 N5946510  PRN  5 Biotech Companies Set for Major Breakouts in 2017,,, 5/23/2018 03116210 PRN  Amgen Enters Groundbreaking Collaboration To Improve Symptom Management During Cancer Treatment,,11/06/2012 002SM4-E PRN  LX4211 Phase 2b Results Presented At American Heart Association Annual Conference,,,,10/01/2013 45773H20 PRN  Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum," 2/11/2015 64026810 PRN  Baxter Presents Additional Data From Pivotal Study Of BAX 855, Extended Half-life Investigational Recombinant FVIII Based On ADVATE For Hemophilia A", 1/05/2012 76655960 PRN  Rigel Announces Initiation of Clinical Trials in Two Immunology Programs,,,,, 9/11/2013 91307C10 PRN  United Therapeutics Announces FDA Acceptance of Second Resubmission of Oral Treprostinil NDA,,,,,, 6/07/2012 06KFSS-E PRN  S&P Indices Announces Changes to U.S. Index, 2/10/2015 80067710 PRN  Sangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results,,11/03/2016 0014HM-E  PRN  Phagelux announces the addition of Dr. Rong Chen as Global CMO,,,,,,,,,,,, 6/27/2011 OMER-US  PRN  Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders,,,,,,,, 9/17/2014 69329Y10 PRN  PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors,,,, 2/15/2011 00182C10 PRN  Ceregene Reports New Findings Regarding How Parkinson's Brains Respond to Neurotrophic Factors,,,,,,,,,,,,,,,,,,,,,"11/12/2013 92165910 PRN  Biotechnology Companies Announce Presentations, Stock Options Update and Financial Results - Research Report on Gilead Sciences, Alexion Pharma, Aegerion Pharma, Vanda Pharma, and Tesaro",,,,, 1/06/2015 40637H10 PRN  Halozyme Therapeutics To Present At The 33rd Annual J.P. Morgan Healthcare Conference,,,,,,," 6/14/2016 69366J20 PRN  Biotechnology Equities Technical Briefing -- PTC Therapeutics, Biogen, Progenics Pharma, and VIVUS",,,,,,,,,12/11/2014 0898YV-E PRN  Casio Gifts Electronic Keyboards to the Jazz and Heritage Festival and Foundation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/06/2015 G3040110 PRN  Endo Announces It Will Enter Into Up To $250 Million Share Repurchase Program,, 9/20/2012 09060J10 PRN  MAS Capital Group Newsletter,10/28/2014 000XKX-E    PRN  Bio-Techne Releases First Quarter Fiscal 2015 Results, 9/16/2017 75886F10    PRN  Regeneron and Sanofi Announce Positive Study Results for DUPIXENT® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis,,, 2/11/2016 46222210 PRN  Ionis Pharmaceuticals to Hold 2015 Financial Results Conference Call," 9/09/2013 09061G10   PRN  Appointments, Successful Clinical Trials, Mergers, and New Contracts Boost Growth - Research Report on BioMarin, ARIAD, Bard, Rockwell Medical, and Health Net",, 6/08/2015 64125C10 PRN  Neurocrine Biosciences Provides Update on NBI-77860 Program for Congenital Adrenal Hyperplasia,,," 5/14/2012 NVS-CH    PRN  Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's, Biogen Idec, Abbott, Novartis",,," 9/17/2013 37555810   PRN  Successful Clinical Trials, Recognitions, Enrollment in Studies, Product Launches, and Strategic Announcements - Research Report on Boston Scientific, Gilead, Abbott, Actavis, and Covidien", 4/09/2015 04004760   PRN  Arena Pharmaceuticals to Present at the Annual Needham Healthcare Conference, 3/13/2017 N5946510  PRN  Mylan Launches Generic Aromasin® Tablets,,, 5/22/2018 03116210 PRN  Amgen Announces Voting Results Of Annual Meeting Of Stockholders,,11/06/2012 002SM4-E PRN  Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results,,,, 9/24/2013 45773H20 PRN  Inovio Pharmaceuticals Targets Transformation of Monoclonal Antibody Therapies," 1/13/2015 64026810 PRN  Technical Coverage on Pharma Stocks - Hospira, Auxilium Pharma, Medicines, SciClone Pharma, and Nektar Therapeutics",12/07/2011 76655960 PRN  Rigel to Present at Oppenheimer Annual Healthcare Conference,,,,, 7/25/2013 91307C10 PRN  United Therapeutics Corporation Reports Second Quarter 2013 Financial Results,,,,,, 5/30/2012 55027E10 PRN  Luminex Corporation to Present at Jefferies 2012 Global Healthcare Conference, 2/05/2015 80067710 PRN  Sangamo BioSciences Announces Presentation At The 2015 Leerink Global Healthcare Conference,,"10/28/2016 06CR5C-E  PRN  Regeneron and Sanofi Receive Complete Response Letter from FDA for Sarilumab, an Investigational Treatment for Rheumatoid Arthritis",,,,,,,,,,,, 6/02/2011 68214310 PRN  Omeros to Present at the Jefferies 2011 Global Healthcare Conference,,,,,,,," 9/17/2014 69329Y10 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI",,,, 2/03/2011 00182C10 PRN  Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease,,,,,,,,,,,,,,,,,,,,,11/07/2013 92165910 PRN  Vanda Pharmaceuticals Reports Third Quarter 2013 Results,,,,," 1/05/2015 40637H10 PRN  Halozyme Therapeutics Appoints Athena Countouriotis, M.D. as Chief Medical Officer",,,,,,, 6/13/2016 69366J20 PRN  PTC Therapeutics Appoints Dawn Svoronos to Board of Directors,,,,,,,,,"12/11/2014 08K0N6-E PRN  ""Tony Bennett & Lady Gaga: Cheek To Cheek LIVE!"" First Full Concert Appearance Available on DVD and Blu-Ray on January 20th Featuring Songs from the #1, Grammy Nominated Album",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/05/2015 G3040110 PRN  Endo Reports Third Quarter 2015 Financial Results,, 9/13/2012 09060J10 PRN  BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone,"10/21/2014 000XKX-E    PRN  Bio-Techne To Host Conference Call On October 28, 2014 To Announce First Quarter Financial Results", 9/13/2017 75886F10    PRN  Smart Medical Device Could Save Millions of Lives,,, 2/04/2016 46222210 PRN  Ionis Pharmaceuticals to Present at Upcoming Investor Conferences," 9/03/2013 09061G10   PRN  Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation",," 6/02/2015 64125C10 PRN  Neurocrine Biosciences, Inc. Announces Appointment of Eric Benevich as Chief Commercial Officer",,," 4/11/2012 09062X10  PRN  FAMPYRA™, the First Oral Treatment for the Improvement of Walking in MS, is Now Available in Canada",,," 9/16/2013 37555810   PRN  Collaborations, New Studies, and New Drug Applications - Research Report on Amgen, Gilead, Abbott, Biogen Idec, and UnitedHealth", 4/07/2015 ARNA-US    PRN  Arena Pharmaceuticals Receives Additional Patent for BELVIQ® (lorcaserin HCl) from United States Patent and Trademark Office, 3/13/2017 N5946510  PRN  Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin®,,, 5/21/2018 03116210 PRN  FDA Approves Prolia® (Denosumab) For Glucocorticoid-Induced Osteoporosis,,10/31/2012 52887230 PRN  Lexicon to Provide Third Quarter 2012 Financial Results,,,, 9/18/2013 45773H20 PRN  Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles," 1/06/2015 64026810 PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA",11/03/2011 76655960 PRN  Rigel to Participate at Two Upcoming Investor Conferences,,,,," 7/18/2013 91307C10 PRN  United Therapeutics Corporation to Announce Second Quarter 2013 Financial Results Before Market Open on Thursday, July 25, 2013",,,,,, 4/30/2012 55027E10 PRN  Luminex Corporation Reports First Quarter 2012 Results," 2/05/2015 80067710 PRN  Coverage of Biotech Equities -- Amarin, Cytori Therapeutics, Medivation, Sangamo BioSciences, and Immunomedics",,10/28/2016 80105N10  PRN  Sanofi Announces Strong Q3 2016 Results,,,,,,,,,,,, 5/31/2011 68214310 PRN  Omeros Unlocks Orphan GPCR Family Linked to Metabolic and Psychotic Disorders,,,,,,,," 9/17/2014 69329Y10 PRN  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI",,,,11/11/2010 0021VT-E PRN  Ceregene Raises $11.5 Million in Series D Financing,,,,,,,,,,,,,,,,,,,,,"10/24/2013 92165910 PRN  Returning Value to Shareholders through Dividends, Strong Financial Results, and Regulatory Approvals - Research Report on Lilly, Illumina, Regeneron, Teva, and Vanda Pharmaceuticals",,,,,12/30/2014 40637H10 PRN  Halozyme Therapeutics To Host Analyst And Investor Meeting,,,,,,, 6/10/2016 69366J20 PRN  New Analyses from Phase 3 Study 009 of Translarna™ (ataluren) in Patients with Cystic Fibrosis Presented at 39th European Cystic Fibrosis Conference,,,,,,,,,12/02/2014 G5087110 PRN  Jazz Pharmaceuticals To Present New Analysis Of Defibrotide Data In Patients With Hepatic Veno-Occlusive Disease (VOD) At ASH Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10/26/2015 BDSI-US  PRN  FDA Approval of BELBUCA™ (CIII) (Buprenorphine HCl) Buccal Film for Chronic Pain Triggers Milestone Payment of $50 Million to BioDelivery Sciences from Partner Endo Pharmaceuticals,, 8/29/2012 09060J10 PRN  BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference, 8/11/2014 000XKX-E    PRN  Bio-Techne Declares Dividend, 9/12/2017 75886F10    PRN  Companies to Watch as Biotech Makes a Comeback in 2017,,, 1/19/2016 ISIS-US  PRN  Akcea Therapeutics Appoints Louis St. L. O'Dea as Chief Medical Officer," 8/21/2013 09061G10   PRN  Pre-Market Review: Delcath Systems Inc., Astex Pharma Inc., BioMarin Pharma Inc., and Akorn Inc.",, 5/27/2015 NBIX-US  PRN  Neurocrine Biosciences to Present at the Jefferies 2015 Healthcare Conference,,," 3/27/2012 VFC-US    PRN  Critical Alerts For Exxon Mobil, Biogen Idec, KLA Tencor, VF Corp, and Eldorado Gold By Seven Summits Research",,," 9/12/2013 37555810   PRN  Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc."," 3/11/2015 04004760   PRN  Critical Alerts For Linn Energy, ACADIA Pharmaceuticals, Arena Pharmaceuticals, Sears Holdings and YY Released By InvestorsObserver", 3/10/2017 N5946510  PRN  Mylan to Present at Barclays Global Healthcare Conference,,," 5/17/2018 03116210 PRN  FDA Approves Aimovig™ (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention",,10/18/2012 52887230 PRN  Lexicon Announces Pricing Of Common Stock Offering,,,, 9/10/2013 INO-US   PRN  Inovio Pharmaceuticals to Hold Investor Conference Call to Discuss Partnership with Roche,"12/15/2014 64026810 PRN  Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis",11/01/2011 76655960 PRN  Rigel Announces Third Quarter 2011 Financial Results,,,,," 5/24/2013 06DDVL-E PRN  Zacks Bull and Bear of the Day Highlights: Mohawk Industries, Aruba Networks, Bayer, United Therapeutics and Actelion",,,,,, 4/26/2012 55027E10 PRN  Luminex Corporation Receives CE Mark for Revolutionary Newborn Screening Platform, 2/04/2015 80067710 PRN  Sangamo BioSciences Announces FDA Acceptance of IND to Initiate Clinical Trial of its Novel ZFP Therapeutic® for Beta-Thalassemia,,10/28/2016 005M9Z-E  PRN  Sanofi CFO Interview - Q3 2016 Results (Video),,,,,,,,,,,, 5/24/2011 68214310 PRN  Omeros Reports Allowance of Additional Patent for Arthroscopic Product,,,,,,,," 9/16/2014 69329Y10 PRN  Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma",,,,10/19/2010 00182C10 PRN  Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinson's Disease,,,,,,,,,,,,,,,,,,,,,"10/23/2013 92165910 PRN  New Drug Application Reviews, Upcoming Financial Results Schedules, Public Offerings, and Notifications - Research Report on Vanda, Chemed, Portola, Immunomedics, and Sangamo",,,,,12/19/2014 40637H10 PRN  Halozyme Receives European Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer,,,,,,, 5/16/2016 69366J20 PRN  PTC Therapeutics Announces Winners of the Global Cystic Fibrosis Patient Group Awards,,,,,,,,,12/02/2014 G5087110 PRN  Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10/26/2015 G3040110 PRN  U.S. FDA Approves BELBUCA™ (buprenorphine) Buccal Film for Chronic Pain Management,," 8/27/2012 RB-GB    PRN  The Zacks Analyst Blog Highlights: BioDelivery Sciences International, Reckitt Benckiser, Endo Health Solutions, HSBC Holdings and Moody's", 8/11/2014 000XKX-E    PRN  Bio-Techne Releases Fourth Quarter And Full Year 2014 Results, 9/11/2017 75886F10    PRN  Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Phase 3 Trial in Uncontrolled Persistent Asthma,,, 1/13/2016 ISIS-US  PRN  Ionis Pharmaceuticals Announces that GSK has Initiated a Phase 1 Study of IONIS-HBV-L Rx," 6/14/2013 09061G10   PRN  Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen",," 5/12/2015 64125C10 PRN  Neurocrine Biosciences to Host Analyst and Investor Day in New York City on May 21, 2015",,, 3/14/2012 09062X10  PRN  Biogen Idec Takes Option to MAKScientific MS Program,,," 6/18/2013 37555810   PRN  Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics"," 3/11/2015 04004760   PRN  Biotech Equities Technical Updates -- Gilead Sciences, Arena Pharma, ACADIA Pharma, Halozyme Therapeutics, and Juno Therapeutics", 3/10/2017 000TBT-E  PRN  Mylan Launches Generic Pristiq® Tablets,,, 5/16/2018 03116210 PRN  Amgen Receives European Commission Approval For Repatha® (Evolocumab) To Prevent Heart Attack And Stroke In Adults With Established Cardiovascular Disease,,10/17/2012 52887230 PRN  Lexicon Announces Proposed Common Stock Offering,,,, 9/10/2013 INO-US   PRN  Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products,12/11/2014 64026810 PRN  Nektar Presents Data on Target-Specific Biomarkers from Circulating Tumor Cell Sub-Study of Phase 3 BEACON Study of Etirinotecan Pegol (NKTR-102) in Patients with Advanced Breast Cancer,"10/06/2011 76655960 PRN  Rigel to Webcast Investor Day on October 13, 2011",,,,," 5/13/2013 91307C10 PRN  Critical Alerts For Ford, Hologic, United Therapeutics, Apollo Group, and Zillow Released By InvestorsObserver",,,,,, 4/24/2012 55027E10 PRN  Luminex Corporation Expands Life Science and Biodefense Groups, 2/03/2015 80067710 PRN  Sangamo BioSciences Announces Fourth Quarter and Full Year 2014 Conference Call and Webcast,,10/18/2016 00FNP8-E  PRN  Common Sensing begins Study with Cloud-Based Insulin Monitoring Solution to Address $5B Treatment Management Challenge,,,,,,,,,,,, 5/19/2011 68214310 PRN  Omeros Announces Clinical Development Programs for OMS103HP and OMS302,,,,,,,, 9/15/2014 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,, 6/22/2010 00182C10 PRN  The Michael J. Fox Foundation Awards $2.5 Million to Support Ceregene's New Phase 2 Neurturin Clinical Study for Parkinson's Disease,,,,,,,,,,,,,,,,,,,,,"10/21/2013 92165910 PRN  Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013",,,,,"12/18/2014 40637H10 PRN  Deal Street: Analyst Coverage on Visteon, Halozyme, Coca-Cola, Groupon and Barrick Gold",,,,,,, 5/05/2016 69366J20 PRN  PTC Therapeutics Reports First Quarter 2016 Financial Results and Provides Corporate Update,,,,,,,,,11/25/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"10/22/2015 G3040110 PRN  Endo to Announce Third Quarter 2015 Financial Results on November 5, 2015",, 8/20/2012 09060J10 PRN  BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone, 8/04/2014 000XKX-E    PRN  Bio-Techne Announces Appointment Of Brenda Furlow As General Counsel, 9/08/2017 75886F10    PRN  Regeneron and Sanofi Announce Cemiplimab (REGN2810) Has Received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma,,," 1/12/2016 ISIS-US  PRN  Ionis Pharmaceuticals Completes Target Enrollment for Nusinersen Phase 3 Study, CHERISH, in Children with Spinal Muscular Atrophy"," 6/05/2013 GM-US      PRN  Critical Alerts For General Motors, SAP, Blackberry, BioMarin Pharmaceutical, and Trimble Navigation Released By InvestorsObserver",, 5/08/2015 64125C10 PRN  Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2015 Health Care Conference,,, 3/14/2012 00735W-E  PRN  Pharmaceutical Consortium Selects BioFortis Software to Manage Collaborative Clinical Data and Biobanking Activities,,," 6/07/2013 37555810   PRN  Companies Taking Strategic Initiatives in Delivering Innovative Solutions to Boost Sales and Meet Customer Demands - Research Report on ResMed, Quest Diagnostics, Mettler-Toledo, Gilead, and TearLab", 3/02/2015 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2014 Financial Results, 3/01/2017 N5946510  PRN  Mylan Reports Fourth Quarter and Full Year 2016 Results and Provides 2017 Guidance,,, 5/16/2018 000SY8-E PRN  Oracle Buys DataScience.com,,10/12/2012 52887230 PRN  Lexicon Initiates Phase 3 Clinical Trial Of Telotristat Etiprate In Patients With Carcinoid Syndrome,,,, 9/03/2013 45773H20 PRN  Inovio Pharmaceuticals to Present at Upcoming Investor Conferences,12/09/2014 64026810 PRN  MOVENTIG® Approved In The European Union For Opioid-Induced Constipation, 8/25/2011 76655960 PRN  Rigel to Present at Two Upcoming Investor Conferences,,,,, 4/25/2013 91307C10 PRN  United Therapeutics Corporation Reports First Quarter 2013 Financial Results,,,,,," 4/09/2012 55027E10 PRN  Luminex Corporation First Quarter Earnings Release Scheduled for April 30, 2012", 1/12/2015 80067710 PRN  Sangamo BioSciences To Highlight 2015 Catalysts And Advancement Of ZFP Therapeutic Programs At The 33rd Annual J.P. Morgan Healthcare Conference,,"10/17/2016 80105N10  PRN  Healthcare Stocks Technical Reports -- Immune Pharma, Sanofi, Shire, and Nobilis Health",,,,,,,,,,,, 5/10/2011 68214310 PRN  Omeros Corporation Reports First Quarter 2011 Financial Results,,,,,,,, 9/09/2014 69329Y10 PRN  PDL BioPharma Provides Third Quarter 2014 Revenue Guidance of $165 Million,,,, 4/28/2010 00182C10 PRN  Ceregene has Initiated a New Phase 1/2 Trial Of CERE-120 for Parkinson's Disease,,,,,,,,,,,,,,,,,,,,,"10/16/2013 92165910 PRN  Vanda Pharmaceuticals Announces FDA Advisory Committee Meeting On November 14, 2013",,,,,12/17/2014 40637H10 PRN  Halozyme Therapeutics Enters A Global Collaboration With Janssen To Develop And Commercialize Subcutaneous Products Using ENHANZE™ Technology,,,,,,," 5/02/2016 69366J20 PRN  DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of PTC Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of May 2, 2016 - PTCT",,,,,,,,,"11/10/2014 G5087110 PRN  Quarterly Financial Performance Reviews, Upcoming Events, and Medicare Plan Launch - Research Reports on Actavis, Celgene, UnitedHealth, Jazz and Endo",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10/21/2015 G3040110 PRN  Endo Provides Update on Use of Specialty Pharmacies,, 8/09/2012 09060J10 PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Second Quarter 2012 Financials," 8/04/2014 000XKX-E    PRN  Bio-Techne To Host Conference Call On August 11, 2014 To Announce Fourth Quarter Financial Results", 8/31/2017 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentations,,, 1/11/2016 46222210 PRN  Ionis Pharmaceuticals Revises 2015 Financial Guidance and Provides Pipeline Update in Conjunction with J.P. Morgan Conference," 4/08/2013 09061G10   PRN  Pre-Market Analysis on Sarepta Therapeutics, BioMarin Pharma, Theravance, and Chelsea Therapeutics",," 5/04/2015 64125C10 PRN  Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs",,, 3/05/2012 061BY8-E  PRN  Healthcare Executive Francesco Granata Joins Warburg Pincus as Executive-in-Residence,,," 5/31/2013 SUNEQ-US   PRN  Insider Trading for Federal National Mortgage Association, MEMC Electronic Materials, Applied Materials, Gilead Sciences, Newmont Mining, and Bristol-Myers Squibb"," 2/23/2015 04004760   PRN  Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Monday, March 2", 2/16/2017 06CR5C-E  PRN  U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review,,, 5/10/2018 03116210 PRN  Amgen To Present At The Bank of America Merrill Lynch 2018 Health Care Conference,,10/12/2012 52887230 PRN  Second Phase 2 Trial Of Telotristat Etiprate Shows Positive Results In Carcinoid Syndrome,,,," 8/29/2013 45773H20 PRN  Today's Research: Inovio Pharmaceuticals Inc., Onyx Pharmaceuticals Inc., Sequenom Inc. and Optimer Pharmaceuticals Inc.","12/01/2014 BAX-US   PRN  Baxter Submits Application For US FDA Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For Hemophilia A", 8/02/2011 76655960 PRN  Rigel Announces Second Quarter 2011 Financial Results,,,,," 4/18/2013 91307C10 PRN  United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013",,,,,, 4/03/2012 55027E10 PRN  Luminex and Bio-Rad Extend Their Global Sales and Distribution Agreement to 2023, 1/08/2015 80067710 PRN  Sangamo BioSciences Announces In-Licensing Of mRNA Delivery Technology And Expansion Of Therapeutic Pipeline Opportunities For Sangamo's In Vivo ZFN Genome-Editing Platform,,10/13/2016 005M9Z-E  PRN  Merial Announces Two New Hires to Cultivate and Strengthen Market Position and Industry Relationships,,,,,,,,,,,, 5/05/2011 68214310 PRN  Omeros Announces Expansion of Potential Indications for PDE7 Inhibitors,,,,,,,, 9/04/2014 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,, 9/10/2013 92165910 PRN  Vanda Pharmaceuticals to Present at the Stifel Nicolaus 2013 Healthcare Conference,,,,,"12/12/2014 40637H10 PRN  Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio",,,,,,, 4/26/2016 69366J20 PRN  PTC Therapeutics Appoints Dr. Tuyen Ong as Chief Medical Officer,,,,,,,,,11/06/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10/01/2015 G3040110 PRN  Endo Completes Acquisition of Broad Portfolio of Branded and Generic Products from Aspen Holdings,, 8/08/2012 09060J10 PRN  BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference, 8/01/2014 000XKX-E    PRN  Bio-Techne Announces ProteinSimple Acquisition Completion, 8/25/2017 75886F10    PRN  Regeneron and Sanofi to Present New Analyses from Praluent® (alirocumab) Injection Trials at the ESC Congress 2017,,, 1/05/2016 ISIS-US  PRN  Ionis Pharmaceuticals Receives Orphan Drug Designation from the US FDA for IONIS-HTT Rx for the Treatment of Patients with Huntington's Disease," 3/18/2013 09061G10   PRN  Innovative Product Portfolios Ride Commercialization & Global Expansion - Research Report on Amgen, Onyx Pharmaceuticals, Alexion Pharmaceuticals, BioMarin Pharmaceutical and Incyte",, 4/30/2015 NBIX-US  PRN  Neurocrine Biosciences to Present at the Deutsche Bank 40th Annual Health Care Conference,,," 2/29/2012 8058-JP   PRN  The Zacks Analyst Blog Highlights: Encana, Enbridge, BankAtlantic Bancorp, BB&T and Biogen Idec",,," 5/31/2013 GSK-GB     PRN  Regulatory Wins, Leadership Changes, and New Partnerships Creating Healthy Prospects - Research Report on Gilead, Biogen Idec, GlaxoSmithKline, Viropharma, and Celsion", 2/18/2015 04004760   PRN  Arena Pharmaceuticals to Present at the 2015 RBC Capital Markets Healthcare Conference, 2/14/2017 06T43N-E  PRN  Mylan Applauds the Generic Pharmaceutical Association's Rebrand to the Association for Accessible Medicines,,, 4/30/2018 03116210 PRN  Amgen Receives Positive CHMP Opinion To Add Overall Survival Results From The Phase 3 ASPIRE Study To KYPROLIS® (carfilzomib) Label,, 9/07/2012 52887230 PRN  Lexicon Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference,,,, 8/15/2013 45773H20 PRN  Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models,11/24/2014 64026810 PRN  FDA Grants QIDP Designation to Bayer's Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation, 6/16/2011 76655960 PRN  Rigel to Present at Wells Fargo Securities Healthcare Conference,,,,," 4/11/2013 WCRX-IE  PRN  StockCall Scrutinizes Warner Chilcott, Dynavax Technologies, Isis Pharma, and United Therapeutics",,,,,, 3/28/2012 55027E10 PRN  Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference, 1/05/2015 80067710 PRN  Sangamo BioSciences Announces Presentation At The 33rd Annual J.P. Morgan Healthcare Conference,,10/05/2016 80105N10  PRN  New Survey Reveals the Widespread and Serious Impact of Moderate-to-Severe Atopic Dermatitis on People Living with the Disease,,,,,,,,,,,, 4/27/2011 68214310 PRN  Omeros to Present at Deutsche Bank Health Care Conference,,,,,,,, 8/18/2014 69329Y10 PRN  PDL BioPharma Announces Second Quarter 2014 and Year to Date Financial Results,,,,,,,,,,,,,,,,,,,,,,,,, 8/07/2013 92165910 PRN  Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock,,,,,12/12/2014 40637H10 PRN  Halozyme Announces Presentations Of Preclinical Data At The San Antonio Breast Cancer Symposium Annual Meeting,,,,,,, 4/22/2016 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,,,11/04/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Third Quarter 2014 Financial Results And Updated Guidance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/29/2015 G3040110 PRN  Technical Coverage on Diverse Sectors - American Capital, ARIAD Pharmaceuticals, Endo International, Amgen and Express Scripts",, 8/02/2012 BDSI-US  PRN  BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain," 7/08/2014 000M2Q-E    PRN  Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne", 8/14/2017 75886F10    PRN  Regeneron to Discontinue Development of Suptavumab for Respiratory Syncytial Virus,,, 1/04/2016 46222210 PRN  Ionis Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference," 3/07/2013 09061G10   PRN  BioMarin Pharma, Amgen, Sarepta Therapeutics, Chelsea Therapeutics Intl., and Theravance Early Briefing and Review",, 4/30/2015 64125C10 PRN  Neurocrine Biosciences Reports First Quarter 2015 Results,,, 2/28/2012 TRI-US    PRN  Thomson Reuters Cortellis Drives Drug Discovery and Development With Powerful New Web Services,,," 5/21/2013 FSLR-US    PRN  News Behind Insider Trading: American International Group, First Solar, Gilead Sciences, J.C. Penney, U.S. Bancorp, and Chesapeake Energy"," 2/06/2015 04004760   PRN  Biotech Stocks Review - Arena Pharma, Amgen, NPS Pharma, ZIOPHARM Oncology, and Advaxis"," 2/07/2017 N5946510  PRN  How These Generic Drugs Stocks are Faring? -- Mylan, Allergan, Horizon Pharma, and Catalent",,, 4/27/2018 03116210 PRN  Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia® (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis,, 8/31/2012 52887230 PRN  Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference,,,, 8/09/2013 45773H20 PRN  Inovio Pharmaceuticals Reports 2013 Second Quarter Financial Results,11/20/2014 64026810 PRN  Nektar Presents Preclinical Study Findings for Etirinotecan Pegol (NKTR-102) in Combination with a PARP Inhibitor in BRCA1-deficient Cancer Model, 6/03/2011 76655960 PRN  Rigel to Present at Jefferies Global Healthcare Conference,,,,, 3/25/2013 91307C10 PRN  United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA,,,,,, 2/09/2012 55027E10 PRN  Luminex Corporation to Present at Upcoming Investment Conferences in February and March,12/08/2014 80067710 PRN  Sangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad Application of ZFN Mediated Genome-Editing Approach to Therapeutics for Hemophilia and Lysosomal Storage Disorders,,10/05/2016 80105N10  PRN  New Survey Reveals the Widespread and Serious Impact of Moderate-to-Severe Atopic Dermatitis on People Living with the Disease,,,,,,,,,,,, 4/19/2011 68214310 PRN  Omeros Announces Publication of MASP-2 Data in Proceedings of the National Academy of Sciences,,,,,,,," 8/18/2014 69329Y10 PRN  PDL BioPharma Announces Plans to Issue Second Quarter Financial Results After Market Today and Reschedules Earnings Call for Tuesday, August 19 at 4:30pm EDT",,,,,,,,,,,,,,,,,,,,,,,,, 8/06/2013 92165910 PRN  Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock,,,,,12/03/2014 40637H10 PRN  Halozyme Therapeutics To Present At The 25th Annual Oppenheimer Healthcare Conference,,,,,,, 4/21/2016 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss First Quarter Financial Results,,,,,,,,,"10/21/2014 G5087110 PRN  Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/28/2015 ENDP-IE  PRN  Endo Completes Acquisition of Par Pharmaceutical and Provides Financial Guidance,, 7/09/2012 09060J10 PRN  BioDelivery Sciences to Present at the JMP Securities Healthcare Conference, 7/02/2014 070MCQ-E    PRN  Bio-Techne Announces Agreement To Acquire Novus Biologicals, 8/03/2017 75886F10    PRN  Accessing the Regeneron Second Quarter 2017 Financial and Operating Results Webcast,,,12/18/2015 46222210 PRN  Isis Pharmaceuticals Changes Name to Ionis Pharmaceuticals,"11/06/2012 GRPN-US    PRN  Best Blue Chips and Penny Stocks Monitor: BioMarin, Wells Fargo, AT&T, Walgreen, Ocwen Financial, and Groupon",, 4/23/2015 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results,,, 2/03/2012 BIIB-US   PRN  How Many Stocks Should You Own?,,," 5/14/2013 ZNGA-US    PRN  Reveal Insider Trading in J.C. Penney, Gilead Sciences, Chesapeake Energy, Annaly Capital Management, Endo Health Solutions, and Zynga"," 2/04/2015 04004760   PRN  Critical Alerts For El Pollo Loco, Office Depot, ITT Education, ConocoPhillips and Arena Pharmaceuticals Released By InvestorsObserver"," 2/03/2017 N5946510  PRN  Mylan to Host Investor Day on March 1, 2017 in New York City",,, 4/24/2018 03116210 PRN  Amgen Reports First Quarter 2018 Financial Results,, 8/16/2012 52887230 PRN  Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies,,,, 8/06/2013 45773H20 PRN  Inovio Pharmaceuticals Responds to Market Activity,11/06/2014 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Third Quarter of 2014, 5/26/2011 76655960 PRN  Rigel Announces Pricing of Public Offering of Common Stock,,,,," 3/13/2013 WCRX-IE  PRN  Warner Chilcott, Dynavax Technologies, Isis Pharma, United Therapeutics, and Pharmacyclics Under StockCall's Microscope",,,,,, 2/06/2012 55027E10 PRN  Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results,11/19/2014 80067710 PRN  Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms,,10/01/2016 80105N10  PRN  Regeneron and Sanofi Announce Positive Dupixent® (dupilumab) Phase 3 Atopic Dermatitis Data Published in the New England Journal of Medicine,,,,,,,,,,,, 4/11/2011 68214310 PRN  Omeros to Present at Future Leaders in the Biotech Industry Conference,,,,,,,," 8/12/2014 69329Y10 PRN  Technical Roundup on Biotech Stocks -- Medivation, Ironwood Pharma, Momenta Pharma, Galectin Therapeutics, and PDL BioPharma",,,,,,,,,,,,,,,,,,,,,,,,, 7/31/2013 92165910 PRN  Vanda Pharmaceuticals Reports Second Quarter 2013 Results,,,,,11/25/2014 40637H10 PRN  Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference,,,,,,, 4/15/2016 69366J20 PRN  NICE Recommends Translarna™ (ataluren) for the Treatment of Patients with Nonsense Mutation Duchenne Muscular Dystrophy in England,,,,,,,,,10/21/2014 0CBRZ9-E PRN  Acclaimed Jazz Trio to Perform at Jazz in the Atrium in Downtown Dallas,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/25/2015 G3040110 PRN  Endo Announces Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Par Pharmaceutical,, 6/28/2012 09060J10 PRN  BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study, 6/17/2014 063YZ2-E    PRN  Bio-Techne Announces Agreement To Acquire ProteinSimple, 8/03/2017 75886F10    PRN  Regeneron Reports Second Quarter 2017 Financial and Operating Results,,,12/17/2015 46222210 PRN  Isis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Phase 2 Study of ISIS-TTR Rx in Patients with TTR Cardiomyopathy Amyloidosis," 8/29/2012 DLPH-GB    PRN  Critical Alerts For Halliburton, Juniper Networks, Ann, Delphi Automotive, and BioMarin Pharmaceutical Released By InvestorsObserver",, 3/31/2015 64125C10 PRN  Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets,,," 2/01/2012 NVS-CH    PRN  The Zacks Analyst Blog Highlights: Pfizer, Biogen Idec, Elan, Novartis and Roche",,," 5/07/2013 000HLG-E   PRN  Trace Insider Trading in Intel, Pfizer, Gilead Sciences, General Electric, Exxon Mobil, and Walt Disney", 2/03/2015 04004760   PRN  Arena Pharmaceuticals Announces Marketing Approval in South Korea of BELVIQ® (lorcaserin HCl) for Weight Management, 1/30/2017 N5946510  PRN  Mylan Wins U.S. District Court Ruling Related to Copaxone® 40 mg/mL Patents,,, 4/19/2018 03116210 PRN  Amgen Announces Webcast Of 2018 First Quarter Financial Results,, 8/10/2012 52887230 PRN  Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference,,,, 7/24/2013 45773H20 PRN  Inovio Pharmaceuticals' Potent hTERT DNA Cancer Vaccine Shows Potential to Reduce Tumors and Prevent Tumor Recurrence,"11/03/2014 64026810 PRN  Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings", 5/25/2011 76655960 PRN  Rigel Announces Proposed Public Offering of Common Stock,,,,, 2/26/2013 91307C10 PRN  United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results,,,,,," 1/16/2012 55027E10 PRN  Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012",11/10/2014 80067710 PRN  Sangamo BioSciences President and CEO Edward Lanphier to Serve as Chairman of the Alliance for Regenerative Medicine,, 9/26/2016 80105N10  PRN  Regeneron and Sanofi Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA,,,,,,,,,,,, 4/07/2011 68214310 PRN  Omeros Announces Publication of Data From its PPAR-gamma Addiction Program,,,,,,,, 8/08/2014 69329Y10 PRN  PDL BioPharma Announces Delay in Filing Quarterly Report on Form 10-Q,,,,,,,,,,,,,,,,,,,,,,,,," 7/29/2013 92165910 PRN  Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013",,,,,11/10/2014 40637H10 PRN  Halozyme Reports Third Quarter 2014 Financial Results,,,,,,, 3/23/2016 06CR5C-E PRN  PTC Therapeutics Announces Workforce Reduction as Part of Operating Expense Management Plan,,,,,,,,,"10/07/2014 G5087110 PRN  Positive Study Results, Dividend, Regulatory Warning, Board Statements, and Technical Updates - Research Reports on Regeneron, CVS Health, Valeant, Allergan and Jazz",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/09/2015 ENDP-IE  PRN  Endo Pharmaceuticals and BioDelivery Sciences Present New Data on Investigational Product Buprenorphine HCl Buccal Film for Chronic Pain Management,, 6/25/2012 09060J10 PRN  BioDelivery Sciences Added to the Russell 3000 and Russell 2000 Indexes, 5/15/2014 000XKX-E    PRN  Bio-Techne Announces The Appointment Of Harold Wiens To The Board Of Directors, 7/21/2017 75886F10    PRN  Regeneron and Sanofi Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis,,,12/11/2015 IONS-US  PRN  Isis Pharmaceuticals Announces Initiation of Phase 1/2 Clinical Study of ISIS-SOD1 Rx in Patients With ALS," 7/10/2012 MT-LU      PRN  Stock Alerts For Exxon Mobil, Cliffs Natural Resources, BioMarin Pharmaceutical, Arcelor Mittal, and Lions Gate Entertainment Released By InvestorsObserver",," 3/03/2015 64125C10 PRN  Neurocrine Biosciences to Present at the Barclays Global Healthcare Conference Live Audio Webcast Will be on March 10, 2015",,, 1/20/2012 DGX-US    PRN  Quest Diagnostics STRATIFY JCV™ First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients,,," 5/06/2013 37555810   PRN  Critical Alerts For Gilead, Schlumberger, Charles Schwab, Trulia, and Staples Released By InvestorsObserver", 2/02/2015 04004760   PRN  Arena Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference, 1/11/2017 N5946510  PRN  U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Trastuzumab,,, 4/17/2018 03116210 PRN  Amgen Presents First-Of-Its-Kind Data At AAN Annual Meeting Reinforcing Robust And Consistent Efficacy Of Aimovig™ (erenumab) For Migraine Patients With Multiple Treatment Failures,, 7/31/2012 52887230 PRN  Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results,,,, 7/18/2013 45773H20 PRN  Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovio's Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model,"10/30/2014 64026810 PRN  Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets", 5/06/2011 76655960 PRN  Rigel Assumes Development Responsibility for Inhaled Asthma Therapy,,,,," 2/19/2013 91307C10 PRN  United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013",,,,,, 1/04/2012 55027E10 PRN  Luminex Corporation to Present at JP Morgan Healthcare Conference,10/22/2014 80067710 PRN  Sangamo BioSciences Reports Third Quarter 2014 Financial Results,," 9/12/2016 80105N10  PRN  Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform",,,,,,,,,,,, 4/04/2011 68214310 PRN  Omeros to Present at Needham Healthcare Conference,,,,,,,, 7/30/2014 69329Y10 PRN  PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit,,,,,,,,,,,,,,,,,,,,,,,,, 7/29/2013 92165910 PRN  FDA Accepts Tasimelteon New Drug Application For Priority Review In The Treatment Of Non-24-Hour Disorder In The Totally Blind,,,,,11/05/2014 40637H10 PRN  Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference,,,,,,," 3/21/2016 69366J20 PRN  Shareholder Class Action Filed Against PTC Therapeutics, Inc. - PTCT",,,,,,,,,10/03/2014 065DL3-E PRN  Jazz St. Louis Opens to the World,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/08/2015 ENDP-IE  PRN  Endo Announces Appointment of Craig Paterson, M.D. as Chief Medical Officer",, 5/31/2012 09060J10 PRN  BioDelivery Sciences to Present at the Jefferies 2012 Global Healthcare Conference, 4/28/2014 000XKX-E    PRN  Bio-Techne Declares Dividend," 7/13/2017 75886F10    PRN  Regeneron to Report Second Quarter 2017 Financial and Operating Results and Host Conference Call and Webcast on August 3, 2017",,,"11/24/2015 46222210 PRN  Covered Call Alerts For Alcoa, Amazon.com, Inovio Pharmaceuticals, Isis Pharmaceuticals and Transocean Released By InvestorsObserver"," 6/01/2012 ESV-GB     PRN  Critical Alerts For Petroleo Brasileiro, Kohl's, ENSCO International, BioMarin Pharmaceutical, and Parker Hannifin Released By InvestorsObserver",," 3/03/2015 64125C10 PRN  Early Briefing on Biotech Industry Stocks -- ARIAD Pharma, Array BioPharma, Rexahn Pharma, Inotek Pharma, and Neurocrine Biosciences",,," 1/13/2012 000KN2-E  PRN  The Zacks Analyst Blog Highlights: General Motors, Toyota Motor, Ford Motor, Biogen Idec and Isis Pharmaceuticals",,," 5/06/2013 AGNC-US    PRN  Earning Sneak Peek for American International Group, American Capital Agency, Cisco, General Electric, Intel, and Gilead Sciences", 1/21/2015 04004760   PRN  Arena Pharmaceuticals Announces Agreement to Sell Common Stock, 1/09/2017 0035K2-E  PRN  Mylan to Present at the 35th Annual J.P. Morgan Healthcare Conference,,, 4/10/2018 03116210 PRN  Amgen Announces Rhode Island Will Be Location Of First US Next-Generation Biomanufacturing Plant,, 7/24/2012 52887230 PRN  Lexicon to Provide Second Quarter 2012 Financial Results,,,," 7/10/2013 45773H20 PRN  Inovio's CELLECTRA® Electroporation Delivery Technology Powers Durable, Best-in-Class T-Cell Responses from HIV Vaccine in Human Study", 9/26/2014 64026810 PRN  Nektar Therapeutics Announces MOVENTIG® (naloxegol) Receives Positive CHMP Opinion In EU For Treatment Of Adults With Opioid-Induced Constipation, 5/05/2011 76655960 PRN  Rigel to Present at Bank of America Merrill Lynch Health Care Conference,,,,, 2/14/2013 91307C10 PRN  United Therapeutics Announces FDA Acceptance of Resubmission of Oral Treprostinil NDA,,,,,,11/14/2011 55027E10 PRN  Luminex Corporation Vice President of Biodefense to Speak at DTRA'S 2011 CBD S&T Conference,"10/21/2014 80067710 PRN  Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum Pharma, Sangamo BioSciences, and Cubist Pharma",," 9/09/2016 80105N10  PRN  Research Reports Coverage on Healthcare Stocks -- Immune Pharma, Sanofi, Shire, and Universal Health Services",,,,,,,,,,,, 3/31/2011 68214310 PRN  Omeros Reports Outcome of Phase 3 Trials of OMS103HP,,,,,,,," 7/28/2014 69329Y10 PRN  PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014",,,,,,,,,,,,,,,,,,,,,,,,, 7/08/2013 92165910 PRN  Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences,,,,,11/03/2014 40637H10 PRN  Halozyme to Host Third Quarter 2014 Financial Results Conference Call,,,,,,, 3/14/2016 69366J20 PRN  PTC Therapeutics Announces Presentation of Results from Phase 3 ACT DMD Clinical Trial of Translarna™ (ataluren) in Patients with Duchenne Muscular Dystrophy at 5th International Congress of Myology,,,,,,,,," 9/18/2014 G5087110 PRN  Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 8/31/2015 G3040110 PRN  Endo Pharmaceuticals Announces XIAFLEX® for Dupuytren's Contracture Formal Pricing in Japan; Commercial Launch Set for September 16, 2015",, 5/21/2012 09060J10 PRN  BioDelivery Sciences Receives $2.5 Million Milestone from Meda for BREAKYL in E.U., 4/28/2014 000XKX-E    PRN  Bio-Techne Releases Unaudited Third Quarter And Nine Month Fiscal Year 2014 Results, 7/13/2017 75886F10    PRN  Regeneron Announces the 2017 Winners of the Regeneron Prize for Creative Innovation,,,"11/10/2015 46222210 PRN  Covered Call Alerts For Skechers, Isis Pharmaceuticals, Alnylam Pharmaceuticals, ConocoPhillips and Apache Corporation Released By InvestorsObserver"," 2/14/2012 PRA-US     PRN  Zacks Bull and Bear of the Day Highlights: ProAssurance, BioMarin Pharmaceutical, Diebold, Vodafone and United Parcel Services",, 2/24/2015 64125C10 PRN  Neurocrine Biosciences to Present at Cowen and Company's 35th Annual Health Care Conference,,,"12/29/2011 GSK-GB    PRN  Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo",,," 4/29/2013 COV-IE     PRN  Track Insider Trading for Covidien, Coca-Cola, Gilead Sciences, Starbucks, National-Oilwell Varco, and Pitney Bowes", 1/20/2015 04004760   PRN  Arena Pharmaceuticals Announces Public Offering of Common Stock, 1/09/2017 N5946510  PRN  Mylan Acquires Cold-EEZE® Brand to Further Expand OTC Business,,, 4/09/2018 03116210 PRN  Amgen To Present New Pre-Clinical Data Showcasing Robust Approach To Evaluating Potential Anti-Cancer Therapies At AACR 2018,, 6/29/2012 52887230 PRN  Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics,,,, 7/08/2013 45773H20 PRN  Inovio Pharmaceuticals' Universal H7N9 DNA Vaccine Protects 100% of Vaccinated Animals in Challenge Study," 9/24/2014 64026810 PRN  Active Equities to Watch in Pharma Industry - Pfizer, BioDelivery Sciences Intl., Repros Therapeutics, Catalent, and Nektar Therapeutics", 5/03/2011 76655960 PRN  Rigel Announces First Quarter Financial Results,,,,, 2/04/2013 91307C10 PRN  United Therapeutics Announces Additional $420 Million Share Repurchase Program,,,,,,11/01/2011 55027E10 PRN  Luminex Corporation Reports Third Quarter 2011 Results,10/16/2014 80067710 PRN  Sangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific Conferences in October 2014,, 8/29/2016 80105N10  PRN  Regeneron and Sanofi Present Positive Phase 3 Investigational Data for Praluent® (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016,,,,,,,,,,,, 3/23/2011 68214310 PRN  Omeros' Ophthalmology Product OMS302 Achieves Co-Primary Endpoints in Phase 2b Clinical Study,,,,,,,," 7/09/2014 69329Y10 PRN  Technical Analysis on Health Care Sector Equities -- Research on Ohr Pharma, Synta Pharma, Agenus, and PDL BioPharma",,,,,,,,,,,,,,,,,,,,,,,,," 7/03/2013 92165910 PRN  Vanda Pharmaceuticals, Inc. Sued by Investor",,,,,"10/31/2014 40637H10 PRN  Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma",,,,,,, 3/14/2016 69366J20 PRN  PTC Therapeutics Provides Update on Health Canada Review of Translarna™ (ataluren) for the Treatment of Duchenne Muscular Dystrophy,,,,,,,,," 9/10/2014 G5087110 PRN  Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/14/2015 G3040110 PRN  Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property,, 5/10/2012 BDSI-US  PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its First Quarter 2012 Financials," 4/21/2014 000XKX-E    PRN  Bio-Techne To Host Conference Call On April 28, 2014 To Announce Third Quarter Financial Results", 6/27/2017 75886F10    PRN  Regeneron and Sanofi Announce Approval of Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis in the European Union,,,11/10/2015 IONS-US  PRN  Isis Pharmaceuticals Earns $2.8M for Advancing ISIS-DMPK-2.5 Rx in Patients with Myotonic Dystrophy Type I," 2/07/2012 MHS.XX1-US PRN  Critical Alerts For AIG, Micron Technology, Medcohealth Solutions, Hasbro, and BioMarin Released By Seven Summits Research",," 2/20/2015 64125C10 PRN  Neurocrine Biosciences, Inc. Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares",,,12/22/2011 05SVYX-E  PRN  Inspiration Biopharmaceuticals Expands Leadership Team with Four New Hires,,, 4/25/2013 07G69B-E   PRN  PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013," 1/13/2015 002XMH-E   PRN  Reveal Insider Trading for Yahoo, PulteGroup, Arena Pharmaceuticals, SolarCity, Alcoa, and Agenus",12/29/2016 06CR5C-E  PRN  Mylan Launches Generic Concerta® Tablets,,, 4/03/2018 03116210 PRN  European Commission Approves Expanded Indication For Amgen's XGEVA® (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma,, 6/25/2012 52887230 PRN  Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes,,,," 6/20/2013 45773H20 PRN  Today's Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma"," 9/19/2014 64026810 PRN  Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting", 3/01/2011 76655960 PRN  Rigel Announces Fourth Quarter and Year End 2010 Financial Results,,,,,11/01/2012 91307C10 PRN  United Therapeutics Corporation Reports Third Quarter 2012 Financial Results,,,,,,10/19/2011 55027E10 PRN  Luminex Corporation Receives Deloitte Technology Fast 500™ Award,10/15/2014 80067710 PRN  Sangamo BioSciences Announces Third Quarter 2014 Conference Call and Webcast,, 8/25/2016 005M9Z-E  PRN  Award-Winning Actress Judith Light Asks Seniors to Pledge to Get an Annual Flu Vaccination,,,,,,,,,,,, 3/15/2011 68214310 PRN  Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results,,,,,,,, 6/24/2014 69329Y10 PRN  PDL BioPharma to Participate in Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,," 6/28/2013 92165910 PRN  Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Vanda Pharmaceuticals, Inc.",,,,,10/20/2014 40637H10 PRN  Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant,,,,,,, 3/02/2016 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,,,," 9/02/2014 G5087110 PRN  Positive Drug Results, Market Activity Updates, Sustainability Report, Acquisitions, and Plant Closure - Research Reports on Repros, Jazz, Ingersoll-Rand, Nokia and Duke Energy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/11/2015 G3040110 PRN  Endo Announces Appearance at Canaccord Genuity 35th Annual Growth Conference,, 5/09/2012 09060J10 PRN  BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference, 4/15/2014 000XKX-E    PRN  Bio-Techne Announces Acquisition Agreement, 6/22/2017 75886F10    PRN  Regeneron Details Royalty Agreement with Novartis for Canakinumab (ACZ885),,,11/09/2015 46222210 PRN  Isis Reports Financial Results and Highlights for Third Quarter 2015, 1/03/2012 09061G10   PRN  BioMarin to Present at the J.P. Morgan Healthcare Conference,," 2/19/2015 64125C10 PRN  Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock",,,12/19/2011 09062X10  PRN  ALS Therapy Development Institute Announces Research Agreement with Biogen Idec and UCB to Investigate the Role of CD40L in ALS,,," 4/25/2013 ABX-CA     PRN  Earnings Update for Microsoft, Apple, Barrick Gold, Procter & Gamble, General Electric, and Gilead Sciences", 1/12/2015 04004760   PRN  Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension,12/29/2016 06CR5C-E  PRN  Mylan Launches Generic Cerebyx® Injection,,, 3/29/2018 03116210 PRN  FDA Approves BLINCYTO® (blinatumomab) To Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia In Adults And Children,, 6/08/2012 52887230 PRN  Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting,,,, 6/20/2013 45773H20 PRN  Inovio Pharmaceuticals to Present at OneMedForumNY 2013 Investor Conference, 9/16/2014 64026810 PRN  FDA Approves MOVANTIK™ (naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain, 2/28/2011 76655960 PRN  Rigel to Present at Three Upcoming Investor Conferences,,,,,"10/25/2012 91307C10 PRN  United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012",,,,,,"10/11/2011 55027E10 PRN  Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011", 9/19/2014 80067710 PRN  Medical Instrumentation Automation Advances for Biological Sample Preparation - Company Expects Q4 Revenue Impact from Newest Instrument Systems,, 8/05/2016 005M9Z-E  PRN  MERIAL Hires Three Veterinary Professionals; Expands Animal Health Technical Support Team,,,,,,,,,,,, 3/02/2011 68214310 PRN  Omeros Unlocks Orphan GPCRs Linked to Pancreatic Cancer and Cognitive Disorders,,,,,,,, 6/12/2014 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,," 6/25/2013 92165910 PRN  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm",,,,,10/09/2014 40637H10 PRN  Halozyme Announces Podium Presentation On PEGPH20 At The New York Academy Of Sciences,,,,,,, 2/29/2016 69366J20 PRN  PTC Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update,,,,,,,,," 8/27/2014 G5087110 PRN  Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/10/2015 G3040110 PRN  Endo Reports Second Quarter 2015 Financial Results,, 4/17/2012 09060J10 PRN  BioDelivery Sciences Awarded Patent Resulting in $15 Million Milestone Payment," 4/04/2014 00CF84-E    PRN  Bio-Techne Announces Investment in Cyvek, Inc."," 6/21/2017 75886F10    PRN  Regeneron Recognized on ""The Civic 50"" List of the Most Community-Minded Companies in the United States",,,11/08/2015 46222210 PRN  Isis Pharmaceuticals Reports Positive Clinical Data From Lp(a) Lowering Drugs, 1/03/2012 09061G10   PRN  BioMarin Announces IND for BMN-111 for Achondroplasia is Active,," 2/18/2015 64125C10 PRN  Recent Developments in the Healthcare Sector: Special Research on Neurocrine Biosciences, Novavax, NPS Pharma, Osiris Therapeutics, and OXiGENE",,,12/16/2011 068NJ7-E  PRN  BioSpace Spotlights Leading Life Science Community,,, 4/24/2013 000L1R-E   PRN  Gilead Sciences Supports HarborPath's HIV/AIDS Medication Assistance Pilot Program, 1/09/2015 04004760   PRN  Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV,12/28/2016 06CR5C-E  PRN  Mylan Launches Generic Zovia® Tablets,,, 3/23/2018 03116210 PRN  Amgen Receives Positive CHMP Opinion Recognizing That Repatha® (evolocumab) Prevents Heart Attacks And Strokes,, 5/30/2012 52887230 PRN  Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference,,,, 6/14/2013 45773H20 PRN  Inovio's Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals," 8/21/2014 64026810 PRN  Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients", 2/09/2011 76655960 PRN  Rigel Announces Participation at Two Investor Conferences,,,,,10/23/2012 91307C10 PRN  United Therapeutics Announces Receipt Of Complete Response Letter For Oral Treprostinil NDA,,,,,,10/05/2011 55027E10 PRN  Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match®, 9/10/2014 80067710 PRN  Sangamo BioSciences Announces Target Date For First IND For Sangamo's In Vivo ZFN Genome-Editing Platform For Monogenic Diseases,, 7/29/2016 005M9Z-E  PRN  Merial Hosts 27th Annual Veterinary Scholars Symposium at The Ohio State University,,,,,,,,,,,, 2/22/2011 68214310 PRN  Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Sankyo,,,,,,,, 6/10/2014 69329Y10 PRN  PDL BioPharma Provides Second Quarter 2014 Revenue Guidance of $140 Million,,,,,,,,,,,,,,,,,,,,,,,,," 6/19/2013 92165910 PRN  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vanda Pharmaceuticals Inc.",,,,,10/07/2014 40637H10 PRN  Halozyme Announces Issuance Of U.S. Patent For Companion Diagnostic For PEGPH20,,,,,,, 2/26/2016 69366J20 PRN  PTC Therapeutics Provides Update on German pricing and Reimbursement Process for Translarna™ (ataluren),,,,,,,,," 8/21/2014 G5087110 PRN  Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 8/05/2015 ENDP-IE  PRN  Endo Divests Non-Core Business Lines from Litha Healthcare Group International Business, Enhancing Focus on Specialty Pharmaceuticals",, 4/16/2012 09060J10 PRN  BioDelivery Sciences to Present at the Future Leaders in the Biotech Industry Conference," 2/10/2014 000XKX-E    PRN  Techne Corporation Announces New Trade Name, Bio-Techne", 6/11/2017 75886F10    PRN  Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia,,,11/06/2015 46222210 PRN  Isis Pharmaceuticals to Present at Upcoming Investor Conferences,12/19/2011 09061G10   PRN  BioMarin Receives Positive Opinion from European Regulatory Authorities for Expanded Biologics Manufacturing Facility,," 2/17/2015 64125C10 PRN  Neurocrine Biosciences, Inc. Announces Proposed Public Offering of $225 Million of Common Stock",,,11/04/2011 BIIB-US   PRN  Biogen-Idec's BG-12 Shines At the Top of the Charts in the Treatment of Relapsing-Remitting Multiple Sclerosis,,," 4/23/2013 NFLX-US    PRN  Netflix Indicating Big Jump Pre-Market on Earnings Surprise - Top Earnings Stocks Ahead of the Bell: Power-One Inc., Goff Corporation, AMR Corporation, Fannie Mae, Vertex Pharmaceuticals"," 1/08/2015 04004760   PRN  Critical Alerts For JC Penney, Arena Pharmaceuticals, Dick's Sporting Goods, International Business Machines and Cisco Systems Released By InvestorsObserver",12/27/2016 532523-IN PRN  Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data,,, 3/23/2018 03116210 PRN  Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin®) For The Treatment Of Three Types Of Cancer,, 5/03/2012 52887230 PRN  Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes,,,, 5/14/2013 45773H20 PRN  Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study," 8/12/2014 64026810 PRN  Pharma Equities Coverage -- Pfizer, BioDelivery Sciences Intl., The Medicines, Questcor Pharma, and Nektar Therapeutics", 1/06/2011 76655960 PRN  Rigel to Present at JP Morgan Healthcare Conference,,,,," 9/28/2012 06DDVL-E PRN  Zacks Bull and Bear of the Day Highlights: United Therapeutics, Superior Industries International, Bank of America, Deutsche Bank and Royal Bank of Scotland Group",,,,,, 9/26/2011 55027E10 PRN  Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna," 9/09/2014 80067710 PRN  Biotech Stocks Under Review -- Keryx Biopharma, Sangamo BioSciences, Regeneron Pharma, Sunesis Pharma, and Idera Pharma",, 7/29/2016 80105N10  PRN  Sanofi Announces Q2 2016 Results,,,,,,,,,,,, 2/10/2011 68214310 PRN  Omeros Announces Publication of Data From Antifibrinolytic Program,,,,,,,, 6/04/2014 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,," 6/19/2013 92165910 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals, Inc. -- VNDA",,,,,10/03/2014 40637H10 PRN  Halozyme Receives Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer,,,,,,, 2/24/2016 69366J20 PRN  Investigation of PTC Therapeutics by Block & Leviton for Possible Violations Of Federal Securities Laws,,,,,,,,," 8/14/2014 G5087110 PRN  Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/04/2015 G3040110 PRN  Boston Scientific Closes Acquisition Of The American Medical Systems Male Urology Portfolio,," 4/05/2012 09060J10 PRN  BioDelivery Sciences to Host Opioid Dependence Investor Event and Webcast on April 11, 2012", 2/06/2014 000XKX-E    PRN  Techne Corporation Announces Appointment Of James T. Hippel As Chief Financial Officer, 6/11/2017 75886F10    PRN  Regeneron and Sanofi Announce Positive Results from First Dedicated Studies Evaluating Praluent® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia,,,11/05/2015 46222210 PRN  Isis Pharmaceuticals and Akcea Therapeutics Announce Start of Phase 3 Study of Volanesorsen in Patients with Familial Partial Lipodystrophy,12/08/2011 09061G10   PRN  Highlights from BioMarin's Research & Development Day,, 2/09/2015 64125C10 PRN  Neurocrine Biosciences Reports Year-End 2014 Results and Provides Investor Update for 2015,,,"10/25/2011 000HN8-E  PRN  The Zacks Analyst Blog Highlights: EI DuPont, Dow Chemicals, Roche Holdings, Biogen and Novartis",,," 4/22/2013 000L1R-E   PRN  Insider Trading Watch for Microsoft, Bank of America, Halliburton, Gilead Sciences, Petroleo Brasileiro Petrobras S.A., and Home Depot", 1/07/2015 04004760   PRN  Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases,12/21/2016 00GDWJ-E  PRN  Information to the Holders of Notes Issued by Meda,,, 3/09/2018 03116210 PRN  New Analyses Show Payer Utilization Management Criteria Deny Access To PCSK9 Inhibitors For Patients At The Highest Risk For Subsequent Cardiovascular Events,, 5/03/2012 52887230 PRN  Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results,,,, 5/10/2013 45773H20 PRN  Inovio Pharmaceuticals Reports 2013 First Quarter Financial Results, 7/31/2014 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014,12/09/2010 76655960 PRN  Rigel and AstraZeneca Awarded 'Licensing Deal of the Year' by Scrip for Fostamatinib Collaboration,,,,, 9/20/2012 91307C10 PRN  United Therapeutics Announces Collaboration With Ascendis Pharma To Develop Self-Injectable Treprostinil For Pulmonary Arterial Hypertension,,,,,," 9/07/2011 55027E10 PRN  Zacks Releases Four Powerful ""Buy"" Stocks: Luminex, Brinker International, Select Comfort and Wyndham Worldwide", 9/08/2014 80067710 PRN  Sangamo BioSciences Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple HIV-Infected Subjects Treated with SB-728-T,, 7/29/2016 80105N10  PRN  VIDEO: Sanofi - Q2 2016 Results Interview with CEO Olivier Brandicourt,,,,,,,,,,,, 2/01/2011 68214310 PRN  Omeros Announces Eligibility of OMS103HP for EMA Centralized Marketing Application,,,,,,,, 5/29/2014 69329Y10 PRN  PDL BioPharma to Present at Jefferies 2014 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,, 6/17/2013 92165910 PRN  Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder,,,,, 9/18/2014 40637H10 PRN  SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer,,,,,,, 2/23/2016 06CR5C-E PRN  PTC Receives Refuse to File Letter from FDA for Translarna™ (ataluren),,,,,,,,," 8/11/2014 G5087110 PRN  Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/04/2015 G3040110 PRN  Endo Completes Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific,, 3/19/2012 09060J10 PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report, 2/04/2014 000XKX-E    PRN  Techne Corporation Releases Unaudited Second Quarter And Six Month Fiscal Year 2014 Results, 6/04/2017 75886F10    PRN  Sanofi and Regeneron Present Positive Study Results for Investigational PD-1 Antibody REGN2810 at American Society of Clinical Oncology (ASCO) Annual Meeting,,,11/04/2015 IONS-US  PRN  Isis Pharmaceuticals to Host Webcast to Review ISIS-APO(a) Rx and ISIS-APO(a)-L Rx Data Presented at American Heart Association Scientific Sessions,11/30/2011 09061G10   PRN  BioMarin Announces Buy Back of Naglazyme Royalties From Adelaide Health Authority,, 2/04/2015 64125C10 PRN  Neurocrine Biosciences to Present at the 2015 Leerink Global Healthcare Conference,,,"10/20/2011 000D1R-E  PRN  The Zacks Analyst Blog Highlights: Abbott Labs, Bristol-Myers Squibb, Biogen, United Technologies and CSX",,," 4/22/2013 GOFF-IE    PRN  Cheaper Gas, Airfare, Profits on Way as Commodities Slump Continues? - Top Small Cap Stock Focus Ahead of the Bell:", 1/06/2015 04004760   PRN  Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference,"12/16/2016 N5946510  PRN  Mylan Launches the First Generic for EpiPen® (epinephrine injection, USP) Auto-Injector as an Authorized Generic",,, 3/08/2018 03116210 PRN  Amgen Announces Final Results Of Tender Offer,, 4/25/2012 52887230 PRN  Lexicon to Provide First Quarter 2012 Financial Results,,,, 4/18/2013 45773H20 PRN  Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study," 7/22/2014 64026810 PRN  Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets",11/23/2010 76655960 PRN  Rigel to Present at Piper Jaffray Health Care Conference,,,,," 8/01/2012 CMCSA-US PRN  Zacks Bull and Bear of the Day Highlights: United Therapeutics, Intel, CBS, News Corp and Comcast",,,,,, 8/30/2011 55027E10 PRN  Luminex Corporation to Present at Upcoming Investment Conferences In September, 9/03/2014 80067710 PRN  Sangamo BioSciences Announces Presentation at the 2014 Morgan Stanley Global Healthcare Conference,, 7/27/2016 80105N10  PRN  Sanofi Receives FDA Approval of AdlyxinTM for Treatment of Adults with Type 2 Diabetes,,,,,,,,,,,, 1/05/2011 68214310 PRN  Omeros Licenses Novel Antifibrinolytic Agents,,,,,,,, 5/12/2014 69329Y10 PRN  PDL BioPharma Announces First Quarter 2014 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,," 6/06/2013 92165910 PRN  Positive Findings, Collaborations, and NDA Filings Strengthen Pipelines - Research Report on Clovis Oncology, MannKind, TESARO, Peregrine Pharmaceuticals, and Vanda Pharmaceuticals",,,,," 9/17/2014 40637H10 PRN  Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma",,,,,,, 2/15/2016 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year End 2015 Financial Results,,,,,,,,, 8/08/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/30/2015 G3040110 PRN  Market Updates on Drug Manufacturers - Other Equities -- Isis Pharma, Endo Intl., Amarin, United Therapeutics, and POZEN",, 3/14/2012 09060J10 PRN  Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation, 2/04/2014 000XKX-E    PRN  Techne Corporation Declares Dividend, 6/04/2017 75886F10    PRN  Regeneron and Sanofi Present Positive Study Results for Investigational PD-1 Antibody REGN2810 at American Society of Clinical Oncology (ASCO) Annual Meeting,,,"11/03/2015 46222210 PRN  Isis Pharmaceuticals Reports an Update on ISIS-TTR Rx, Including Positive Data from Multiple Clinical Studies, Presented Today at the EC-ATTR Meeting",11/29/2011 09061G10   PRN  BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA,, 2/02/2015 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End 2014 Results,,," 9/30/2011 000C6X-E  PRN  Hot Stock Research for FedEx, Apache, NIKE, Biogen Idec, OpenTable & Cognizant",,, 4/15/2013 072LZ4-E   PRN  Royalty Pharma Announces Firm Offer to Acquire Elan," 1/02/2015 04004760   PRN  Technical Coverage on Biotech Stocks - Arena Pharma, XOMA, Dyax, Mast Therapeutics, and Tekmira Pharma",12/05/2016 N5946510  PRN  Rosen Law Firm Reminds Mylan N.V. Investors of Important Dec. 12 Deadline in Class Action Filed by Firm - MYL,,, 3/07/2018 03116210 PRN  Amgen Announces 2018 Second Quarter Dividend,, 3/27/2012 52887230 PRN  Lexicon Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference,,,," 4/18/2013 45773H20 PRN  Inovio Pharmaceuticals Recognized With ""Best Therapeutic Vaccine"" and ""Best Early Stage Biotech"" Awards at World Vaccine Congress 2013"," 7/07/2014 64026810 PRN  Technical Pulse on Pharma Stocks -- Research on Pfizer, Hospira, Endo Intl., and Nektar Therapeutics",11/02/2010 76655960 PRN  Rigel Announces Third Quarter 2010 Financial Results,,,,, 7/26/2012 91307C10 PRN  United Therapeutics Corporation Reports Second Quarter 2012 Financial Results,,,,,, 8/08/2011 55027E10 PRN  Luminex Corporation Reports Second Quarter 2011 Results," 8/07/2014 80067710 PRN  Biotech Equities Technical Analysis -- BioMarin Pharma, Merrimack Pharma, Sangamo BioSciences, ZIOPHARM Oncology, and Dyax",, 7/26/2016 06CR5C-E  PRN  Sanofi Pasteur Ships First of its 2016-2017 Seasonal Influenza Vaccine Doses in United States,,,,,,,,,,,,12/29/2010 68214310 PRN  Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy,,,,,,,, 5/08/2014 69329Y10 PRN  PDL BioPharma to Present at the Bank of America Merrill Lynch 2014 Health Care Conference,,,,,,,,,,,,,,,,,,,,,,,,, 6/05/2013 92165910 PRN  Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder,,,,, 9/03/2014 40637H10 PRN  Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation,,,,,,, 2/12/2016 69366J20 PRN  PTC Therapeutics Announces Second Annual STRIVE Grant Award Program for Duchenne Muscular Dystrophy,,,,,,,,, 8/06/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/27/2015 G3040110 PRN  Endo to Announce Second Quarter 2015 Financial Results on August 10, 2015",, 3/12/2012 09060J10 PRN  ONSOLIS Relaunch Postponed Pending Product Modification, 1/31/2014 TMO-US      PRN  Techne Announces Partnership Agreement With Fisher Scientific, 5/24/2017 75886F10    PRN  Regeneron Announces ANGPTL3/Evinacumab Publication in New England Journal of Medicine and Positive Phase 2 Data in People with HoFH,,,"10/30/2015 46222210 PRN  Covered Call Alerts For JetBlue, Lifelock Inc., Transocean, Isis Pharmaceuticals and Clean Energy Fuels Released By InvestorsObserver",11/28/2011 09061G10   PRN  BioMarin Announces FDA Approval of Expanded Biologics Manufacturing Facility,," 1/27/2015 64125C10 PRN  Biotech Stocks Technical Analysis - Achillion Pharma, Array BioPharma, Rexahn Pharma, Neurocrine Biosciences, and Bluebird Bio",,," 9/20/2011 0BXSF7-E  PRN  BioSurplus Hires Top Service Engineer, Roswell Pund",,," 4/10/2013 06DDVL-E   PRN  Zacks Bull and Bear of the Day Highlights: DR Horton, TripAdvisor, GileadSciences, Johnson & Johnson and Bristol-Myers Squibb",11/25/2014 04004760   PRN  Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds,12/01/2016 N5946510  PRN  Mylan's Commitment to Stemming the Tide of HIV/AIDS as Strong as Ever,,, 3/07/2018 03116210 PRN  Amgen To Present At the Cowen and Company 38th Annual Health Care Conference,, 3/20/2012 52887230 PRN  FDA Grants Lexicon Orphan Drug Designation for Telotristat Etiprate for the Treatment of Carcinoid Syndrome,,,," 4/12/2013 45773H20 PRN  Today's Technical View on Sequenom, Peregrine Pharma, Inovio Pharma, and Onyx Pharma"," 7/04/2014 64026810 PRN  Appointments, Acquisitions, Study Results, and Technical Updates - Analyst Notes on Alere, AMRI, Anika Therapeutics, Nektar and Sangamo",10/28/2010 76655960 PRN  Rigel Announces Presentations at Two Investor Conferences,,,,," 7/19/2012 91307C10 PRN  United Therapeutics Corporation to Announce Second Quarter 2012 Financial Results Before Market Open on Thursday, July 26, 2012",,,,,, 7/21/2011 061GG3-E PRN  2011 Prix Galien USA Final Candidates Announced: Competing for Best Biotechnology Product and Best Pharmaceutical Agent, 8/05/2014 80067710 PRN  Sangamo BioSciences Announces Presentation At The 2014 Wedbush Securities Life Sciences Management Access Conference,, 7/18/2016 005M9Z-E  PRN  Icagen Acquisition of Sanofi Arizona Research Facility Complete,,,,,,,,,,,,11/24/2010 68214310 PRN  Omeros to Present at Piper Jaffray Health Care Conference,,,,,,,," 5/07/2014 69329Y10 PRN  PDL BioPharma to Announce First Quarter 2014 Financial Results on May 12, 2014",,,,,,,,,,,,,,,,,,,,,,,,, 5/31/2013 92165910 PRN  Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference,,,,," 8/14/2014 40637H10 PRN  Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma",,,,,,, 1/28/2016 005W47-E PRN  PTC Therapeutics to Participate at Upcoming Investor Conferences,,,,,,,,, 8/05/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 7/20/2015 BSTC-US  PRN  BioSpecifics Announces Approval of XIAFLEX® in Japan for the Treatment of Dupuytren's Contracture,, 3/06/2012 09060J10 PRN  US Patent Office Rejection of All Claims in Final Asserted MonoSol Patent Further Supports BioDelivery Sciences' Position," 1/28/2014 000XKX-E    PRN  Techne Corporation To Host Conference Call On February 4, 2014 To Announce Second Quarter Financial Results", 5/22/2017 75886F10    PRN  Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients,,,10/30/2015 46222210 PRN  Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-FXI Rx in Patients with End-Stage Renal Disease on Hemodialysis,11/17/2011 09061G10   PRN  BioMarin to Host a Research and Development Day on December 8th,, 1/20/2015 64125C10 PRN  Neurocrine Biosciences Announces Oral Presentation of NBI-77860 Clinical Trial Data in Classic Congenital Adrenal Hyperplasia at ENDO 2015,,," 9/08/2011 09062X10  PRN  The Zacks Analyst Blog Highlights: Diageo Plc., Fortune Brands, Anheuser-Busch InBev, Molson Coors Brewing and Biogen Idec",,," 4/04/2013 GRMN-CH    PRN  Critical Alerts For Gilead, Total SA, Garmin, CIT, and Fortinet Released By InvestorsObserver",11/24/2014 04004760   PRN  Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference,11/28/2016 000D1R-E  PRN  Mylan Signs Sub-license Agreement with the Medicines Patent Pool to Increase Access to Hepatitis C Treatment in Developing Countries,,, 3/06/2018 03116210 PRN  Amgen Announces Preliminary Results Of Tender Offer,, 2/29/2012 52887230 PRN  Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference,,,, 4/10/2013 45773H20 PRN  Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device, 6/19/2014 NKTR-US  PRN  Data Published in the New England Journal of Medicine Demonstrate that Naloxegol Improved Opioid-Induced Constipation in Chronic Pain Patients, 9/29/2010 76655960 PRN  Rigel Earns Milestone Payments From AstraZeneca,,,,, 6/27/2012 91307C10 PRN  United Therapeutics Announces Additional $100 Million Share Repurchase Program,,,,,," 7/19/2011 55027E10 PRN  Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test", 8/05/2014 80067710 PRN  Five Sangamo Scientists Recognized By Thomson Reuters Among Most Highly Cited Researchers Worldwide Of 2014,, 7/12/2016 0GBP93-E  PRN  Award-Winning Chef Elizabeth Falkner Reveals Her Struggle with Atopic Dermatitis to Highlight the Physical and Psychological Impact of the Disease,,,,,,,,,,,,11/23/2010 68214310 PRN  Omeros Announces Completion of Acquisition of Assay for GPCR Program,,,,,,,, 4/07/2014 PDLI-US  PRN  PDL BioPharma Completes $150 Million Financing Transaction with kaleo,,,,,,,,,,,,,,,,,,,,,,,,, 5/31/2013 92165910 PRN  Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind,,,,, 8/11/2014 40637H10 PRN  Halozyme Reports Second Quarter 2014 Financial Results,,,,,,, 1/11/2016 005W47-E PRN  PTC Therapeutics Outlines Business Priorities for the Development and Commercialization of Translarna™ and Progress of the Company Pipeline,,,,,,,,," 8/05/2014 JAZZ-IE  PRN  Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 7/08/2015 IMNPQ-US PRN  Immune Pharmaceuticals (Immune) Amends Pain Licensing Agreement,, 3/05/2012 09060J10 PRN  BioDelivery Sciences to Present at Cowen and ROTH Conferences," 1/07/2014 000KNF-E    PRN  Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA", 5/22/2017 75886F10    PRN  Regeneron and Sanofi Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients,,,10/27/2015 46222210 PRN  Isis Pharmaceuticals to Host Webcast to Review ISIS-TTR Rx Data Presented at 1st European Congress of Hereditary ATTR Amyloidosis and Provide Phase 3 Development Plan Update,11/03/2011 09061G10   PRN  BioMarin to Present at the Credit Suisse Healthcare Conference,, 1/16/2015 64125C10 PRN  Neurocrine Biosciences Announces Granting of Orphan Drug Status for NBI-77860 in Congenital Adrenal Hyperplasia,,," 9/01/2011 00167Y-E  PRN  Hot Stock Research for Rackspace Hosting, Nu Skin, Biogen Idec, priceline.com, CF & C.H. Robinson Worldwide",,, 4/01/2013 SXEEQ-US   PRN  S&P 500 Climbs to New Record and EBay to Handle $110 Billion of Marketplace Volume in 2015,"11/19/2014 04004760   PRN  Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics",11/10/2016 05HX9N-E  PRN  The Medicines Patent Pool Announces First World Health Organization Prequalification Submissions for Generic Dolutegravir,,, 2/27/2018 03116210 PRN  Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta® (pegfilgrastim),, 2/23/2012 52887230 PRN  Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference,,,, 4/02/2013 45773H20 PRN  Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection, 6/12/2014 64026810 PRN  US FDA ADVISORY COMMITTEE RECOMMENDS NO CARDIOVASCULAR OUTCOMES TRIAL FOR PERIPHERALLY-ACTING MU-OPIOID RECEPTOR ANTAGONIST (PAMORA) CLASS INCLUDING MOVANTIK, 9/22/2010 002S8R-E PRN  Data Published Today Reveal That Novel Oral Therapy Fostamatinib Demonstrates Positive Response in Rheumatoid Arthritis Patients,,,,," 4/27/2012 NVS-CH   PRN  Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics",,,,,," 7/18/2011 55027E10 PRN  Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011", 7/23/2014 80067710 PRN  Sangamo BioSciences Reports Second Quarter 2014 Financial Results,, 7/12/2016 0GBP93-E  PRN  Award-Winning Chef Elizabeth Falkner Reveals Her Struggle with Atopic Dermatitis to Highlight the Physical and Psychological Impact of the Disease,,,,,,,,,,,,"11/17/2010 68214310 PRN  Omeros Names Dr. Kenneth Ferguson as Vice President, Development",,,,,,,," 3/13/2014 69329Y10 PRN  PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2014",,,,,,,,,,,,,,,,,,,,,,,,, 5/30/2013 92165910 PRN  Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings,,,,, 8/04/2014 40637H10 PRN  Halozyme to Host second Quarter 2014 Financial Results Conference Call,,,,,,, 1/08/2016 005W47-E PRN  PTC Completes Rolling NDA Submission to FDA and Submits Phase 3 ACT DMD Clinical Trial Results to EMA for Translarna™ (ataluren) for Treatment of Nonsense Mutation Duchenne Muscular Dystrophy,,,,,,,,, 8/04/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 6/24/2015 00FV7G-E PRN  Endo International plc Announces Conditional Redemption of All $499,875,000 Aggregate Principal Amount Outstanding of the Two Series of 7.00% Senior Notes due 2019",, 2/28/2012 09060J10 PRN  BioDelivery Sciences and FDA Reach Agreement on BNX Development Plan, 1/02/2014 000XKX-E    PRN  Techne Announces Resignation Of Chief Financial Officer Gregory Melsen, 5/18/2017 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentations,,,10/26/2015 IONS-US  PRN  ISIS Pharmaceuticals Earns $5 Million from GSK for Initiation of Phase 1 Study of ISIS-GSK4-L Rx,10/27/2011 09061G10   PRN  BioMarin Announces Third Quarter 2011 Financial Results,," 1/12/2015 64125C10 PRN  Critical Alerts For Zynga, Neurocrine Biosciences, Yum! Brands, eBay and TrueCar Released By InvestorsObserver",,, 8/09/2011 0B2P4M-E  PRN  Glass Lewis Recommends Forest Labs Stockholders Vote the GOLD Proxy Card,,, 3/26/2013 T-US       PRN  Cyprus Secures Bailout but Major Exchanges still Decline. Shares of BlackBerry Take a Tumble after Downgrade,11/13/2014 04004760   PRN  Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference,11/09/2016 N5946510  PRN  Mylan Reports Third Quarter 2016 Results,,, 2/26/2018 03116210 PRN  Amgen To Present New Data From Repatha® (evolocumab) Clinical Trials At ACC.18,, 2/22/2012 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2011 Fourth Quarter and Full Year Financial Results,,,," 3/28/2013 45773H20 PRN  Inovio Pharmaceuticals to Present at BioCentury's ""Future Leaders in the Biotech Industry"" Conference", 6/11/2014 64026810 PRN  Nektar Therapeutics Stock Trading Halted Today; FDA Advisory Committee to Discuss Peripherally-Acting Opioid Receptor Antagonists, 9/09/2010 76655960 PRN  Rigel to Present at Stifel Nicolaus Healthcare Conference,,,,, 4/26/2012 91307C10 PRN  United Therapeutics Corporation Reports First Quarter 2012 Financial Results,,,,,," 6/27/2011 55027E10 PRN  Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc."," 7/23/2014 80067710 PRN  Scheduled Conference Calls and Product Launches - Research Reports on Anika Therapeutics, NeoGenomics, HeartWare, Sangamo and Dyax",, 7/05/2016 80105N10  PRN  Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan,,,,,,,,,,,,11/09/2010 68214310 PRN  Omeros Identifies Orphan GPCR-Targeting Compound Potentiating Chemotherapeutic Activity,,,,,,,, 3/12/2014 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,, 5/23/2013 92165910 PRN  Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland,,,,, 7/22/2014 40637H10 PRN  Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer,,,,,,, 1/07/2016 005W47-E PRN  Spinal Muscular Atrophy Program Advances with Additional Product Candidate Entering Clinical Development,,,,,,,,," 7/30/2014 G5087110 PRN  Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/24/2015 00FV7G-E PRN  Endo International plc Announces Pricing of Private Offering Of Senior Notes,, 2/22/2012 09060J10 PRN  US Patent Office Rejects All Claims in Second MonoSol Patent,"12/02/2013 000P56-E    PRN  Announcements and Sponsorships by Biotechnology Companies and Major Drug Manufacturers - Research Report on Lilly, Geron, MannKind, Techne, and InterMune", 5/17/2017 000VC1-E    PRN  Dupixent Delivers… and Sanofi-Regeneron Ushers in a New Era of Atopic Dermatitis (AD) Treatment,,,10/23/2015 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Third Quarter 2015 Financial Results Conference Call," 9/29/2011 09061G10   PRN  BioMarin to Host Third Quarter 2011 Financial Results Conference Call and Webcast on Thursday, October 27 at 5:00 p.m. ET",," 1/09/2015 64125C10 PRN  Critical Alerts For Zynga, Neurocrine Biosciences, Yum! Brands, eBay and TrueCar Released By InvestorsObserver",,," 7/29/2011 09062X10  PRN  Zacks Bull and Bear of the Day Highlights: Fastenal, Morgan Stanley, The Medicines Company, Biogen Idec and Pfizer",,," 3/25/2013 S.XX1-US   PRN  Insider Trading Update: Comcast, QUALCOMM, Gilead Sciences, Sprint Nextel, Annaly Capital Management, and BP",11/06/2014 ARNA-US    PRN  Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases,11/08/2016 532523-IN PRN  Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab,,, 2/23/2018 03116210 PRN  Amgen Receives Positive Opinion Expanding Use Of XGEVA® (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe,," 2/16/2012 52887230 PRN  Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012",,,, 3/18/2013 45773H20 PRN  Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results," 6/01/2014 64026810 PRN  Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, at 50th ASCO Meeting", 8/03/2010 76655960 PRN  Rigel Announces Second Quarter 2010 Financial Results,,,,," 4/19/2012 91307C10 PRN  United Therapeutics Corporation To Announce First Quarter 2012 Financial Results Before Market Open On Thursday, April 26, 2012",,,,,, 6/23/2011 55027E10 PRN  Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System, 7/16/2014 80067710 PRN  Sangamo BioSciences Announces Second Quarter 2014 Conference Call And Webcast,," 6/30/2016 80105N10  PRN  Momentum Indicators for Drug Manufacturers - Major Equities -- Sanofi, TherapeuticsMD, Immune Pharma, and Heron Therapeutics",,,,,,,,,,,,11/04/2010 68214310 PRN  Omeros Corporation Reports Third Quarter 2010 Financial Results,,,,,,,, 3/11/2014 69329Y10 PRN  PDL BioPharma Provides First Quarter 2014 Revenue Guidance of $133 Million,,,,,,,,,,,,,,,,,,,,,,,,, 5/09/2013 92165910 PRN  Vanda Pharmaceuticals Reports First Quarter 2013 Results,,,,," 7/10/2014 40637H10 PRN  Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma",,,,,,, 1/06/2016 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,,,," 7/29/2014 G5087110 PRN  Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/19/2015 G3040110 PRN  Endo International plc Announces Proposed Private Offering Of Senior Notes,, 2/16/2012 09060J10 PRN  BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals,"11/15/2013 000LXY-E    PRN  Marketing Authorizations, Financial Results, Public Offering and Leadership Transitions - Research Report on Regeneron, Dendreon, Dyax, Techne, and ICU Medical", 5/08/2017 75886F10    PRN  Regeneron and SillaJen Announce Immuno-Oncology Clinical Study Agreement for Combination Treatment in Kidney Cancer,,,"10/19/2015 46222210 PRN  Critical Alerts For Apple, The Fresh Market, Under Armour, Isis Pharmaceuticals and Yum! Brands Released By InvestorsObserver", 9/20/2011 09061G10   PRN  BioMarin to Present at the Jefferies Global Healthcare Conference,, 1/08/2015 64125C10 PRN  Neurocrine Biosciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference,,, 7/28/2011 0039ZQ-E  PRN  IU Confidential Publishes Biotech Investment Report,,," 3/25/2013 HALO-US    PRN  Morning Research on Gilead Sciences, Halozyme Therapeutics, InterMune, and Seattle Genetics",11/05/2014 04004760   PRN  Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference,"11/04/2016 N5946510  PRN  MYLAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mylan N.V. - MYL",,, 2/14/2018 03116210 PRN  Amgen Announces FDA Advisory Committee Meeting To Review Potential New Use Of BLINCYTO® (blinatumomab),, 2/07/2012 52887230 PRN  Lexicon Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference,,,," 3/14/2013 INO-US   PRN  Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma", 5/31/2014 64026810 PRN  Positive Data from Phase 2 Trial of NKTR-102 in Patients with Avastin®-Refractory High-Grade Glioma Presented at 50th ASCO Meeting, 7/28/2010 76655960 PRN  Rigel to Present at BMO Capital Markets Healthcare Conference,,,,, 3/15/2012 91307C10 PRN  United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents,,,,,," 6/21/2011 55027E10 PRN  Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc."," 7/04/2014 80067710 PRN  Appointments, Acquisitions, Study Results, and Technical Updates - Analyst Notes on Alere, AMRI, Anika Therapeutics, Nektar and Sangamo",," 6/27/2016 005M9Z-E  PRN  Icagen Acquires Sanofi's Oro Valley, Arizona Research Facility",,,,,,,,,,,,11/03/2010 68214310 PRN  Omeros Corporation Awarded $1.7 Million in Grants Under the Qualifying Therapeutic Discovery Project Program,,,,,,,, 3/10/2014 69329Y10 PRN  PDL BioPharma Appoints David Gryska to its Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,," 4/18/2013 92165910 PRN  Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013",,,,," 7/02/2014 40637H10 PRN  New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health",,,,,,,12/23/2015 005W47-E PRN  PTC Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference,,,,,,,,," 7/23/2014 G5087110 PRN  Equities to Watch in the Health Care Sector -- ImmunoCellular Therapeutics, Aeterna Zentaris, Lexicon Pharma, BioDelivery Sciences Intl., and Jazz Pharma",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 6/10/2015 G3040110 PRN  Endo International plc Closes Offering of 27,627,628 Ordinary Shares",, 1/06/2012 09060J10 PRN  Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine,"11/06/2013 000M1T-E    PRN  Quarterly Dividends, Financial Results, and FDA Guidance - Research Report on Techne, ImmunoGen, Repros, Halozyme, and Synageva", 5/08/2017 75886F10    PRN  Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy,,,10/15/2015 46222210 PRN  Isis Pharmaceuticals Initiates SHINE Study to Provide ISIS-SMN Rx for Patients With SMA Who Have Completed the Phase 3 ENDEAR and CHERISH Studies, 9/13/2011 09061G10   PRN  BioMarin to Present at the UBS Global Life Sciences Conference,, 1/08/2015 00DYYX-E PRN  AbbVie Announces Positive Top-Line Results From Phase 3 Study of Investigational Medicine Elagolix in Patients with Endometriosis,,," 7/25/2011 NOV-US    PRN  Critical Alerts For Broadcom, National Oilwell Varco, Cummins, FMC Technologies and Biogen Released by Seven Summits Research",,," 3/18/2013 37555810   PRN  Upcoming Results from Clinical Trials - Research Report on Gilead Sciences, Celgene Corporation, Sinovac Biotech, NPS Pharmaceuticals and ZIOPHARM Oncology",11/03/2014 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results,11/03/2016 532523-IN PRN  Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European Medicines Agency,,, 2/08/2018 03116210 PRN  Results From Phase 3 XGEVA® (Denosumab) Study In Patients With Multiple Myeloma Published In The Lancet Oncology,, 1/09/2012 52887230 PRN  LX4211 Enhances Effects of DPP-4 Inhibition in Patients with Type 2 Diabetes,,,, 3/12/2013 45773H20 PRN  Inovio Pharmaceuticals Closes $15.1 Million Offering of Common Stock and Warrants," 5/19/2014 64026810 PRN  Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer", 6/03/2010 76655960 PRN  Rigel Announces Presentation at Three Investor Conferences,,,,, 2/21/2012 91307C10 PRN  Oral Treprostinil New Drug Application Accepted by FDA for Review,,,,,, 6/08/2011 55027E10 PRN  Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis," 7/01/2014 80067710 PRN  Biotech Stocks Technical Analysis -- Research on Mast Therapeutics, Sangamo BioSciences, DARA Biosciences, and Idera Pharma",," 6/23/2016 80105N10  PRN  New Four-Strain Influenza Vaccine, VaxigripTetra™, Regulatory Dossier from Sanofi Pasteur Now Approved in Europe",,,,,,,,,,,,10/25/2010 68214310 PRN  Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program,,,,,,,, 3/04/2014 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,, 4/17/2013 92165910 PRN  Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer,,,,, 6/25/2014 HALO-US  PRN  Roche's Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme,,,,,,,12/09/2015 005W47-E PRN  PTC Therapeutics and Massachusetts General Hospital Collaborate on Rare Disease Research,,,,,,,,," 7/22/2014 G5087110 PRN  Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 6/04/2015 G3040110 PRN  Endo International plc Prices Offering of 24,024,025 Ordinary Shares",, 1/06/2012 05MBN8-E PRN  BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine,10/31/2013 000XKX-E    PRN  Techne Corporation Declares Dividend, 5/05/2017 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentations,,," 9/11/2015 IONS-US  PRN  Isis Pharmaceuticals' Collaboration to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases with AstraZeneca Receives HSR Clearance", 9/07/2011 09061G10   PRN  BioMarin to Present at the Morgan Stanley Global Healthcare Conference,,"12/12/2014 64125C10 PRN  Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio",,," 6/23/2011 09062X10  PRN  Zacks' Voice of the People highlights opportunities with Biogen Idec, TNS, CIBER and Viacom",,," 3/13/2013 06DDVL-E   PRN  The Zacks Analyst Blog Highlights:Aetna, Humana, UnitedHealth Group, WellPoint and Gilead Sciences",11/03/2014 04004760   PRN  Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation,"11/02/2016 MNTA-US   PRN  Momenta and Mylan Initiate Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIA® (abatacept)",,, 2/08/2018 03116210 PRN  Amgen To Present At The 7th Annual Leerink Partners Global Healthcare Conference,, 1/04/2012 52887230 PRN  Lexicon Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference,,,, 3/07/2013 45773H20 PRN  Inovio Pharmaceuticals Prices $15.1 Million Offering of Common Stock and Warrants, 5/16/2014 64026810 PRN  Nektar Therapeutics To Present at the UBS 2014 Global Healthcare Conference in New York City, 6/01/2010 76655960 PRN  Rigel Pharmaceuticals Names Raul Rodriguez President,,,,, 2/14/2012 91307C10 PRN  United Therapeutics Corporation Reports 2011 Fourth Quarter and Annual Financial Results,,,,,, 6/01/2011 55027E10 PRN  Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument, 6/19/2014 80067710 PRN  Sangamo BioSciences Appoints H. Stewart Parker to its Board of Directors,, 6/12/2016 005M9Z-E  PRN  Sanofi Announces Positive Phase 3 Results for Investigational Titratable Fixed-Ratio Combination of Insulin Glargine and Lixisenatide,,,,,,,,,,,,"10/22/2010 68214310 PRN  Omeros to Host Conference Call Monday, October 25 at 4:00 p.m. ET To Provide Corporate Update",,,,,,,, 3/03/2014 69329Y10 PRN  PDL BioPharma Announces Fourth Quarter and Full Year 2013 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,, 4/04/2013 92165910 PRN  Vanda Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference,,,,, 6/17/2014 40637H10 PRN  Halozyme Therapeutics To Present At The JMP Securities 2014 Healthcare Conference,,,,,,,12/04/2015 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,,," 7/08/2014 G5087110 PRN  Critical Alerts For GoPro, Canadian Solar, Questcor Pharmaceuticals, Caesars Entertainment, and Jazz Pharmaceuticals Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/02/2015 G3040110 PRN  Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares,,12/29/2011 09060J10 PRN  ONSOLIS to Benefit from Approval of Class-Wide REMS for All Transmucosal Fentanyl Products,10/31/2013 000XKX-E    PRN  Fontanot's Techne - the Ultimate Spiral Staircase, 5/04/2017 75886F10    PRN  Regeneron Reports First Quarter 2017 Financial and Operating Results,,," 9/09/2015 46222210 PRN  Critical Alerts For Fitbit, Palo Alto Networks, Regeneron Pharmaceuticals, Isis Pharmaceuticals and Achillion Pharmaceuticals Released By InvestorsObserver", 8/30/2011 09061G10   PRN  BioMarin to Present at the Baird Health Care Conference,,12/10/2014 64125C10 PRN  Neurocrine Biosciences Announces Expansion of its Clinical Pipeline,,," 6/21/2011 CE-US     PRN  Critical Alerts for Starbucks, Petroleo Brasileiro, Coach, Biogen, and Celanese Released by Seven Summits Research",,," 3/13/2013 ZNGA-US    PRN  Today's Market Focus: Zynga, Facebook, Gilead Sciences, Freeport-McMoRan Copper & Gold, Glu Mobile, and Mondelez International",10/31/2014 04004760   PRN  Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting,10/26/2016 06CR5C-E  PRN  Mylan Launches First Generics of Benicar® and Benicar HCT® Tablets,,, 2/01/2018 03116210 PRN  Amgen Reports Fourth Quarter And Full Year 2017 Financial Results,,12/23/2011 52887230 PRN  Lexicon Announces Completion of Rights Offering to Stockholders,,,, 2/27/2013 45773H20 PRN  Inovio Pharmaceuticals to Present at the Cowen & Company Health Care Conference, 5/07/2014 64026810 PRN  Nektar Therapeutics Reports Financial Results for the First Quarter of 2014, 5/04/2010 76655960 PRN  Rigel Announces First Quarter 2010 Financial Results,,,,," 2/07/2012 91307C10 PRN  United Therapeutics Corporation to Announce Fourth Quarter and Annual 2011 Financial Results Before Market Open on Tuesday, February 14, 2012",,,,,, 5/31/2011 55027E10 PRN  Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference, 6/17/2014 80067710 PRN  Sangamo BioSciences Announces Presentation At The 2014 JMP Securities Healthcare Conference,, 6/11/2016 80105N10  PRN  Successful Switch to Sanofi's Toujeo® Evaluated in a Real-World Setting,,,,,,,,,,,,10/15/2010 68214310 PRN  Omeros to Present at the BioCentury NewsMakers Conference,,,,,,,," 2/24/2014 69329Y10 PRN  PDL BioPharma to Announce Fourth Quarter and Full Year 2013 Financial Results on March 3, 2014",,,,,,,,,,,,,,,,,,,,,,,,, 3/25/2013 92165910 PRN  Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind,,,,, 6/15/2014 40637H10 PRN  Halozyme Announces Presentation Of Clinical Data At The American Diabetes Association 74th Scientific Sessions,,,,,,,11/19/2015 69366J20 PRN  PTC Completes Enrollment of Phase 3 Clinical Trial of Translarna™ for Patients with Cystic Fibrosis,,,,,,,,," 7/07/2014 G5087110 PRN  Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/19/2015 00FV7G-E PRN  First Ever Peyronie's Disease (PD) Treatment Guidelines Support Use of XIAFLEX® in Appropriate Patients,,12/20/2011 09060J10 PRN  BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study,10/31/2013 000XKX-E    PRN  Fontanot's Techne - the Ultimate Spiral Staircase," 5/02/2017 75886F10    PRN  Survey Results Show Eighty Percent of Rheumatoid Arthritis Patients Report Life-Altering Pain Daily or Multiple Times a Week, Despite Treatment",,, 9/03/2015 IONS-US  PRN  Isis Pharmaceuticals to Present at Upcoming Investor Conferences, 8/09/2011 BMRN-US    PRN  BioMarin to Present at the Wedbush Life Sciences Conference,,12/04/2014 64125C10 PRN  Neurocrine Biosciences to Present at the 25th Annual Oppenheimer Healthcare Conference,,," 6/15/2011 BIIB-US   PRN  Zacks Industry Outlook Highlights: Bristol-Myers Squibb, Vertex Pharma, Abbott Labs, Allergan and Biogen Idec",,," 3/13/2013 37555810   PRN  A Forward Look, The Year Ahead - Research Report on Kellogg Company, General Mills, Inc., Gilead Sciences, Inc., Celgene Corporation and The Coca-Cola Company",10/28/2014 ARNA-US    PRN  Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl,10/26/2016 N5946510  PRN  Biotech Stocks Advancement of Aggressive Studies and Treatments Playing a Critical Role in Industry Growth,,, 1/30/2018 03116210 PRN  Amgen Receives CHMP Positive Opinion To Add Updated Overall Survival Data To KYPROLIS® (carfilzomib) Label,,11/22/2011 52887230 PRN  Lexicon Announces Commencement of Rights Offering to Stockholders,,,," 2/11/2013 45773H20 PRN  Inovio Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com"," 5/01/2014 64026810 PRN  Nektar to Announce Financial Results for the First Quarter 2014 on Wednesday, May 7, 2014, After Close of U.S.-Based Financial Markets", 4/30/2010 76655960 PRN  Rigel Receives Innovators Award of Excellence in Life Sciences,,,,, 2/06/2012 91307C10 PRN  United Therapeutics Receives Paragraph IV Notice Letter for Remodulin,,,,,, 5/09/2011 55027E10 PRN  Luminex Corporation Reports First Quarter 2011 Results, 5/30/2014 80067710 PRN  Sangamo BioSciences And City of Hope Granted Strategic Partnership Award From California Institute for Regenerative Medicine To Support Clinical Trial Of Stem-Cell Based ZFP Therapeutic® For HIV/AIDS,, 6/08/2016 005M9Z-E  PRN  Kepler Group Rolls Out Healthcare Marketing Optimization Practice,,,,,,,,,,,,10/14/2010 68214310 PRN  Omeros Announces Additional Support from the National Institute on Drug Abuse for Clinical Studies in Addiction Program,,,,,,,, 2/19/2014 69329Y10 PRN  PDL BioPharma to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,, 3/14/2013 92165910 PRN  Vanda Withdraws Its Marketing Authorization Application For Fanaptum™ In The European Union,,,,, 6/04/2014 40637H10 PRN  Halozyme To Resume PEGPH20 Clinical Program In Pancreatic Cancer,,,,,,,"11/09/2015 69366J20 PRN  PTC Therapeutics Reports Third Quarter 2015 Financial Results, Provides Corporate Update and Reviews Key Findings from ACT DMD",,,,,,,,," 7/02/2014 JAZZ-IE  PRN  Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 5/18/2015 00FV7G-E PRN  Endo to Acquire Par Pharmaceutical, Strategically Expanding Generics Business to a Top 5 Industry Leader",,11/28/2011 09060J10 PRN  US Patent Office Rejects All 191 Claims in Key MonoSol Patent Asserted Against BioDelivery Sciences,10/29/2013 000XKX-E    PRN  Techne Corporation Releases Unaudited First Quarter Fiscal Year 2014 Results, 4/28/2017 75886F10    PRN  Regeneron and Sanofi Announce Kevzara® (sarilumab) Biologics License Application Resubmission Accepted for Review by U.S. FDA,,," 8/28/2015 46222210 PRN  Critical Alerts For Alcoa, Ulta Salon Cosmetics & Fragrance Inc., Micron, Bojangles Inc. and Isis Pharmaceuticals Released By InvestorsObserver", 7/28/2011 09061G10   PRN  BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100),,11/25/2014 64125C10 PRN  Neurocrine to Present at the 2014 Deutsche Bank BioFEST and the 26th Annual Piper Jaffray Healthcare Conference,,," 6/15/2011 NUS-US    PRN  Critical Stock Alerts for Office Depot, Biogen Idec, Celgene, Citrix, Tyco, & Nu Skin",,," 3/04/2013 YELP-US    PRN  Critical Alerts For Gilead, Newmont Mining, Illumina, Yelp, and Southern Copper Released By InvestorsObserver","10/27/2014 04004760   PRN  Arena Pharmaceuticals Announces Third Quarter 2014 Conference Call and Webcast on Monday, November 3",10/21/2016 N5946510  PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mylan N.V. of Class Action Lawsuit and Upcoming Deadline - MYL,,, 1/29/2018 03116210 PRN  Amgen Announces Webcast of 2017 Fourth Quarter and Full Year Financial Results,,11/11/2011 52887230 PRN  Lexicon Announces Plans for Rights Offering to Stockholders,,,, 2/05/2013 45773H20 PRN  Life Sciences and Healthcare Companies Join to Webcast Live on February 7th at RetailInvestorConferences.com, 4/09/2014 64026810 PRN  Nektar Reports Positive Preclinical Data for Two Oncology Programs at 2014 AACR,,,,,,12/27/2011 91307C10 PRN  Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union,,,,,, 5/05/2011 55027E10 PRN  New CE Marked Test Simultaneously Detects Up To 95% of Gastrointestinal Infections in Under Five Hours, 5/29/2014 80067710 PRN  Sangamo BioSciences Announces Presentation At The Jefferies 2014 Global Healthcare Conference,, 6/08/2016 005M9Z-E  PRN  Hero Is A Four-Legged Word: The Maker Of NexGard® (Afoxolaner) Presents Hero Tails Video Series To Help Pair More Assistance Dogs With People In Need,,,,,,,,,,,, 9/08/2010 68214310 PRN  Omeros to Present at the Rodman & Renshaw Global Investment Conference,,,,,,,, 2/18/2014 PDLI-US  PRN  PDL BioPharma and Paradigm Spine Complete a $75 Million Financing Transaction,,,,,,,,,,,,,,,,,,,,,,,,, 2/27/2013 92165910 PRN  Vanda Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference,,,,, 5/29/2014 40637H10 PRN  Halozyme Therapeutics To Present At The Jefferies 2014 Global Health Care Conference,,,,,,,11/03/2015 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conferences,,,,,,,,, 6/02/2014 G5087110 PRN  Jazz Pharmaceuticals Presents JZP-110 Phase 2b Data For The Treatment Of EDS Symptoms In Adults With Narcolepsy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/15/2015 G3040110 PRN  Endo Announces Updated XIAFLEX® Label with Recurrence and Retreatment Data in Patients with Dupuytren's Contracture,,11/21/2011 09060J10 PRN  BioDelivery Sciences to Present at the 23rd Annual Piper Jaffray Healthcare Conference,"10/28/2013 000LPQ-E    PRN  Quarterly Financial Reports and Upcoming Earnings and Conferences Call Schedules - Research Report on St. Jude Medical, Varian, Techne, DexCom, and Hill-Rom", 4/25/2017 75886F10    PRN  Regeneron and Sanofi Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection,,," 8/18/2015 46222210 PRN  Critical Alerts For Disney, Isis Pharmaceuticals, El Pollo Loco, Under Armour and Avis Released By InvestorsObserver", 7/28/2011 09061G10   PRN  BioMarin Announces Second Quarter 2011 Financial Results,,11/12/2014 64125C10 PRN  Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference,,," 5/30/2011 APKT-US   PRN  Critical Stock Reports: Insider Trade for IBM, Acme Packet, Biogen Idec, McKesson, Illumina, & C.R. Bard",,," 3/01/2013 OPTR-US    PRN  Before the Bell Scans of Affymax, Questcor Pharma, Gilead Sciences, Vertex Pharma, and Optimer Pharma","10/17/2014 04004760   PRN  Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners",10/20/2016 TBPH-KY   PRN  Theravance Biopharma and Mylan Announce Positive Results from Two Pivotal Phase 3 Studies of Revefenacin (TD-4208) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD),,, 1/22/2018 03116210 PRN  Amgen Reports Aimovig™ (Erenumab) Met All Primary And Secondary Endpoints In Unique Phase 3b Study In Episodic Migraine Patients Who Have Failed Multiple Prior Preventive Treatments,,11/09/2011 52887230 PRN  LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference,,,," 2/05/2013 45773H20 PRN  Inovio Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th", 2/26/2014 64026810 PRN  Nektar Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results,,,,,,"11/11/2011 000NX1-E PRN  Zacks Bull and Bear of the Day Highlights: United Therapeutics, Plexus, Kohl's, Advanced Auto Parts and Viacom",,,,,," 4/18/2011 55027E10 PRN  Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011", 5/28/2014 80067710 PRN  Sangamo BioSciences Announces Publication of Preclinical Data Demonstrating Gene Correction in SCID-X1 Human Hematopoietic Stem Cells,, 6/06/2016 80105N10  PRN  Regeneron and Sanofi Announce that Dupilumab Used with Topical Corticosteroids (TCS) was Superior to Treatment with TCS Alone in Long-term Phase 3 Trial in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients,,,,,,,,,,,, 8/10/2010 68214310 PRN  Omeros Reports Second Quarter 2010 Financial Results,,,,,,,, 2/13/2014 69329Y10 PRN  PDL BioPharma Retains Dr. Stephen Hoffman as Senior Advisor,,,,,,,,,,,,,,,,,,,,,,,,, 2/12/2013 92165910 PRN  Vanda Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Results,,,,," 5/16/2014 40637H10 PRN  Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst",,,,,,,10/29/2015 69366J20 PRN  PTC Therapeutics Announces Launch of STRIVE Grant Award Program for Cystic Fibrosis,,,,,,,,," 5/28/2014 G5087110 PRN  Appointment, Investor Conferences, and Expanded Healthcare Services - Analyst Notes on Jazz Pharmaceuticals, Zoetis, Community Health Systems, Tenet and Stryker",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/14/2015 00FV7G-E PRN  Endo Pharmaceuticals and BioDelivery Sciences Present Pivotal Data from Two Phase 3 Trials Demonstrating Safety and Efficacy of Buprenorphine HCl Buccal Film for the Management of Chronic Pain,,"11/14/2011 09060J10 PRN  BioDelivery Sciences to Host Business Update Webcast and Conference Call on Tuesday, November 15, 2011 at 8:30 AM Eastern Time","10/23/2013 000XKX-E    PRN  Techne Corporation To Host Conference Call On October 29, 2013 To Announce First Quarter Financial Results", 4/25/2017 75886F10    PRN  Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection,,, 8/04/2015 46222210 PRN  Isis Reports Financial Results And Highlights For Second Quarter 2015, 7/28/2011 0039ZQ-E   PRN  IU Confidential Publishes Biotech Investment Report,,11/12/2014 64125C10 PRN  Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference,,," 5/11/2011 00167Y-E  PRN  PATHEON ANNOUNCES APPOINTMENT OF MICHAEL E. LYTTON AS EXECUTIVE VICE PRESIDENT, CORPORATE DEVELOPMENT AND STRATEGY, AND GENERAL COUNSEL",,," 3/01/2013 37555810   PRN  Factors Moving Markets- Research Report on Actavis, Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Gilead Sciences Inc. and Novo Nordisk",10/13/2014 04004760   PRN  Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at the American College of Clinical Pharmacy Annual Meeting,10/20/2016 N5946510  PRN  Theravance Biopharma and Mylan Announce Positive Results from Two Pivotal Phase 3 Studies of Revefenacin (TD-4208) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD),,, 1/18/2018 03116210 PRN  European Commission Approves Amgen And Allergan's MVASI® (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer,,11/03/2011 52887230 PRN  Lexicon to Present LX4211 Clinical and Preclinical Data at Diabetes Conference,,,, 2/04/2013 45773H20 PRN  Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference," 2/19/2014 64026810 PRN  Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2013 on Wednesday, February 26, 2014, After Close of U.S.-Based Financial Markets",,,,,,10/27/2011 91307C10 PRN  United Therapeutics Corporation Reports Third Quarter 2011 Financial Results,,,,,, 4/07/2011 55027E10 PRN  Luminex Corporation Wins Prestigious Medical Design Excellence Award, 5/27/2014 80067710 PRN  Sangamo BioSciences Provides Clinical Update on SB-728-T Program and Progress in Other ZFP Applications at Annual Meeting of the American Society of Gene and Cell Therapy,, 5/25/2016 06CR5C-E  PRN  FDA Advisory Committee Recommends Approval of Sanofi Treatment for Adults with Type 2 Diabetes,,,,,,,,,,,, 8/05/2010 68214310 PRN  Omeros to Webcast Presentation at Canaccord Genuity 30th Annual Growth Conference,,,,,,,, 2/12/2014 69329Y10 PRN  PDL BioPharma Issues $300 Million of Convertible Senior Notes due 2018,,,,,,,,,,,,,,,,,,,,,,,,, 1/31/2013 92165910 PRN  Vanda Announces Phase IIb/III Clinical Study In Major Depressive Disorder Did Not Meet The Primary Endpoint,,,,, 5/14/2014 40637H10 PRN  Halozyme Therapeutics To Present At The UBS 2014 Global Health Care Conference,,,,,,,10/27/2015 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2015 Financial Results,,,,,,,,, 5/27/2014 G5087110 PRN  Jazz Pharmaceuticals To Present Data On Compound In Sleep Pipeline During APSS Annual SLEEP Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 5/11/2015 G3040110 PRN  Endo Acquires Broad Portfolio of Branded and Generic Products, Expanding International Pharmaceuticals Business",,11/10/2011 09060J10 PRN  BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone," 8/21/2013 000WY2-E    PRN  Health Care Companies Release Financial Results and Announce Earnings Schedules - Research Report on Opko, Sirona Dental, Accuray, Techne, and Steris", 4/24/2017 75886F10    PRN  Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis,,, 8/03/2015 46222210 PRN  Isis Reports Positive Data from KYNAMRO® (mipomersen sodium) FOCUS FH Phase 3 Study in Patients with Severe Heterozygous Familial Hypercholesterolemia, 7/14/2011 09061G10   PRN  BioMarin Initiates Phase 1 Trial for BMN 673 in Patients With Advanced Hematological Malignancies,,"11/04/2014 64125C10 PRN  Neurocrine Biosciences, Inc. Announces Appointment of Darin Lippoldt as Chief Legal Officer",,," 5/11/2011 00167Y-E  PRN  PATHEON ANNOUNCES APPOINTMENT OF MICHAEL E. LYTTON AS EXECUTIVE VICE PRESIDENT, CORPORATE DEVELOPMENT AND STRATEGY, AND GENERAL COUNSEL",,," 2/21/2013 000L1R-E   PRN  The Zacks Analyst Blog Highlights: Toyota Motor, General Motors, Volkswagen, Honda Motor and Gilead Sciences",10/10/2014 ARNA-US    PRN  Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® (lorcaserin HCl) CIV in Postgraduate Medicine,"10/13/2016 N5946510  PRN  Bernstein Liebhard LLP Announces That A Suit Has Been Filed Against Mylan, N.V.",,, 1/17/2018 03116210 PRN  FDA Approves Addition Of Overall Survival Data To KYPROLIS® (carfilzomib) Label,,11/01/2011 52887230 PRN  Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results,,,, 1/09/2013 45773H20 PRN  Inovio Pharmaceuticals to Initiate Clinical Trial for its Hepatitis C Therapeutic Vaccine (INO-8000) Later this Year, 1/22/2014 64026810 PRN  Nektar Therapeutics Prices Public Offering of Common Stock,,,,,,"10/20/2011 91307C10 PRN  United Therapeutics Corporation to Announce Third Quarter 2011 Financial Results Before Market Open on Thursday, October 27, 2011",,,,,, 3/02/2011 55027E10 PRN  Luminex Corporation to Present at Cowen and Company's 31st Annual Health Care Conference, 5/15/2014 80067710 PRN  Sangamo BioSciences Announces Presentation At The UBS Global Healthcare Conference,, 5/11/2016 SNY-FR    PRN  Merus Labs Reports Fiscal Q2 2016 Results,,,,,,,,,,,, 7/29/2010 68214310 PRN  Omeros Secures $40 Million Committed Equity Financing Facility,,,,,,,, 2/07/2014 69329Y10 PRN  PDL BioPharma Prices Offering of $260.87 Million of Convertible Senior Notes Due 2018,,,,,,,,,,,,,,,,,,,,,,,,, 1/23/2013 92165910 PRN  Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder,,,,," 5/14/2014 40637H10 PRN  Top Gainers Pre-Market Notes -- Research on Halozyme Therapeutics, Goodrich Petroleum, BioCryst Pharma, and Coronado Biosciences",,,,,,,10/15/2015 69366J20 PRN  PTC Announces Results from Phase 3 ACT DMD Clinical Trial of Translarna™ (ataluren) in Patients with Duchenne Muscular Dystrophy,,,,,,,,, 5/19/2014 G5087110 PRN  Jazz Pharmaceuticals Names Russell J. Cox To Position Of Chief Operating Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/11/2015 G3040110 PRN  BioDelivery Sciences Provides Corporate Update and Reports First Quarter 2015 Financial Results,,11/07/2011 09060J10 PRN  BEMA Fentanyl Submitted for Marketing Authorization in Taiwan," 8/19/2013 000XKX-E    PRN  TECHNE Corporation to Hold a Conference Call on Thursday, September 19, 2013 to Present its Global Strategic Vision"," 4/14/2017 75886F10    PRN  Regeneron to Report First Quarter 2017 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2017",,," 8/03/2015 46222210 PRN  Critical Alerts For GoPro, Alcoa, Expedia, Bojangles Inc. and Isis Pharmaceuticals Released By InvestorsObserver"," 6/30/2011 09061G10   PRN  BioMarin to Host Second Quarter 2011 Financial Results Conference Call and Webcast on Thursday, July 28 at 5:00 p.m. ET",,11/03/2014 64125C10 PRN  Neurocrine Biosciences to Present at the Nomura Biotechnology Conference,,," 5/10/2011 05NC6R-E  PRN  Daily Stock Reports: Insider Trade for Biogen Idec, AFLAC, Fastenal, Campbell, Parker Hannifin & Red Hat",,," 2/21/2013 37555810   PRN  A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.", 9/22/2014 04004760   PRN  Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference,"10/11/2016 N5946510  PRN  Learn how to target a 20% return on First Majestic Silver, or get option-trade ideas on Alder Biopharmaceuticals, Mylan, Merck & Company Incorporated and Corrections Corporation of America or any stock you choose",,, 1/17/2018 03116210 PRN  Overall Survival Analysis From KYPROLIS® (Carfilzomib) Phase 3 ASPIRE Trial Published in the Journal of Clinical Oncology,,10/27/2011 52887230 PRN  Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2011 Financial Results,,,, 1/07/2013 45773H20 PRN  PATH Malaria Vaccine Initiative and Inovio Pharmaceuticals Partner to Accelerate Development of Malaria Vaccines and Innovative Delivery Technologies," 1/21/2014 64026810 PRN  Nektar Therapeutics Announces Public Offering of 8,500,000 Shares of Common Stock",,,,,,"10/12/2011 91307C10 PRN  Critical Alerts For Potash Corp. of Saskatchewan, Sina, General Mills, Nordstrom, and United Therapeutics Released By Seven Summits Research",,,,,, 2/22/2011 55027E10 PRN  Luminex Corporation Ranked One of the 25 Fastest-Growing Technology Companies in America by Forbes for Third Consecutive Year," 5/14/2014 80067710 PRN  Biotech Companies Report Quarterly Financial Results - Analyst Notes on Intrexon, Acorda, Anika, Sangamo and Spectrum",, 4/29/2016 80105N10  PRN  Solid Performance in the First Quarter of 2016 with Business EPS up 5.3% at Constant Exchange Rates,,,,,,,,,,,, 7/27/2010 68214310 PRN  Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery,,,,,,,, 2/07/2014 69329Y10 PRN  PDL BioPharma Announces Entry into Exchange and Purchase Agreements with Certain Holders of Outstanding 2.875% Convertible Senior Notes due 2015 for Common Stock and Cash,,,,,,,,,,,,,,,,,,,,,,,,," 1/22/2013 92165910 PRN  Vanda Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on February 12, 2013",,,,, 5/12/2014 40637H10 PRN  Halozyme Reports First Quarter 2014 Financial Results,,,,,,,10/04/2015 69366J20 PRN  Phase 2 Data from Spinal Muscular Atrophy Program to be Presented at the 20th International Annual Congress of the World Muscle Society,,,,,,,,," 5/16/2014 G5087110 PRN  Upcoming Conferences, Stock Price Movements and Support to Humanitarian Programs - Analyst Notes on Celgene, Biogen Idec, Incyte, Jazz Pharmaceuticals and Medivation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/11/2015 G3040110 PRN  Endo Reports First Quarter 2015 Financial Results,,"10/25/2011 09060J10 PRN  Samuel J. Sears, Jr. Appointed to BioDelivery Sciences Board of Directors", 8/06/2013 000XKX-E    PRN  Techne Corporation Releases Unaudited Fourth Quarter And Fiscal Year 2013 Results, 4/06/2017 75886F10    PRN  Regeneron Announces Evinacumab has Received FDA Breakthrough Therapy Designation for Homozygous Familial Hypercholesterolemia (HoFH),,," 8/03/2015 IONS-US  PRN  AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases", 6/23/2011 09061G10   PRN  BioMarin Agrees to Acquire Biologics Manufacturing Plant in Ireland from Pfizer,,11/03/2014 64125C10 PRN  Neurocrine Biosciences Reports Third Quarter 2014 Results,,," 4/14/2011 T-US      PRN  Critical Alerts For AT&T, Biogen, Cree, Agilent Technologies, and CIENA Released By Seven Summits Research",,," 2/20/2013 CMCSA-US   PRN  How Insiders Trade Hot Stocks: Facebook, Microsoft, Comcast, Freeport-McMoRan Copper & Gold, Coca-Cola, and Gilead Sciences", 9/19/2014 04004760   PRN  Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent,10/07/2016 N5946510  PRN  Mylan Agrees to Settlement on Medicaid Rebate Classification for EpiPen® Auto-Injector,,, 1/08/2018 03116210 PRN  European Medicines Agency Accepts Filing For EVENITY™ (Romosozumab),,10/21/2011 52887230 PRN  Data From Phase 2 Clinical Studies of Telotristat Etiprate in Patients With Carcinoid Syndrome to be Presented at North American Neuroendocrine Tumor Society Meeting,,,,12/20/2012 INO-US   PRN  Inovio Pharmaceuticals to Present at Biotech Showcase 2013 Investor Conference, 1/18/2014 64026810 PRN  Nektar Presents Positive Clinical Data from a Phase 1 Study of Etirinotecan Pegol (NKTR-102) in Combination with 5-Flourouracil/Leucovorin at the 2014 Gastrointestinal Cancers Symposium,,,,,,10/12/2011 91307C10 PRN  United Therapeutics Prices Private Offering of Convertible Senior Notes and Announces Concurrent Exercise of Overallotment Option,,,,,, 2/15/2011 55027E10 PRN  Luminex and Partners HealthCare Announce Collaboration Agreement, 5/14/2014 80067710 PRN  Sangamo BioSciences and Collaborators to Present Data on ZFP Therapeutic Applications and Developments at Annual Meeting of the American Society of Gene and Cell Therapy,, 4/29/2016 80105N10  PRN  Sanofi Q1 2016 Results,,,,,,,,,,,, 6/29/2010 68214310 PRN  Omeros Successfully Unlocks Orphan GPCRs,,,,,,,, 2/05/2014 69329Y10 PRN  PDL BioPharma Announces Proposed $250 Million Public Offering of New Convertible Senior Notes Due 2018,,,,,,,,,,,,,,,,,,,,,,,,,12/18/2012 92165910 PRN  Vanda Announces Positive Phase III Results For Tasimelteon In The Treatment Of Non-24-Hour Disorder,,,,, 5/07/2014 40637H10 PRN  Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2014 Health Care Conference,,,,,,,10/02/2015 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,,,," 5/14/2014 G5087110 PRN  Agreements, Earnings Releases, Senior-Level Retirements and Appointments, and Marketing Authorizations - Analyst Notes on Actavis, Jazz Pharmaceuticals, Bristol-Myers, Biogen Idec and AbbVie",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/06/2015 00FV7G-E PRN  Endo Announces Appearance at UBS Global Healthcare Conference,, 9/28/2011 09060J10 PRN  BioDelivery Sciences Announces Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain, 8/06/2013 000XKX-E    PRN  Techne Corporation Declares Dividend, 3/28/2017 75886F10    PRN  Regeneron and Sanofi to Host Investor Conference Call to Discuss DUPIXENT® (dupilumab) Approval,,," 7/30/2015 46222210 PRN  Market Updates on Drug Manufacturers - Other Equities -- Isis Pharma, Endo Intl., Amarin, United Therapeutics, and POZEN", 6/08/2011 09061G10   PRN  BioMarin to Present at the William Blair Growth Stock Conference,,10/30/2014 64125C10 PRN  Neurocrine Biosciences Receives Breakthrough Therapy Designation for NBI-98854 in Tardive Dyskinesia,,," 3/04/2011 RIMM-CA   PRN  Critical Alerts for Research In Motion, Disney, Charles Schwab, Sherwin-Williams, and Biogen Released by Seven Summits Research",,," 2/20/2013 37555810   PRN  A Forward Look, the Year Ahead - Research Report on CBS Corporation, Comcast Corporation, Gilead Sciences Inc., Celgene Corporation and Kellogg Company"," 9/12/2014 04004760   PRN  Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics","10/06/2016 N5946510  PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Mylan N.V. (MYL)",,, 1/05/2018 03116210 PRN  FDA Approves XGEVA® (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma,, 9/13/2011 52887230 PRN  LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects,,,,12/10/2012 45773H20 PRN  Inovio's Synthetic Flu Vaccine Doubles Rate of Elderly Subjects Displaying Protective Immune Responses," 1/16/2014 64026810 PRN  Market Technicals Simplified: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories",,,,,,10/11/2011 91307C10 PRN  United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program,,,,,," 2/10/2011 06DDVL-E PRN  Zacks Bull and Bear of the Day Highlights: Johnson Controls, Luminex, The Walt Disney Company, News Corporation and Time Warner", 5/06/2014 80067710 PRN  Sangamo BioSciences Reports First Quarter 2014 Financial Results,, 4/27/2016 05G05S-E  PRN  Sanofi US Collaborates with Duke University and Massachusetts General Hospital on Big Data and Type 2 Diabetes,,,,,,,,,,,, 6/03/2010 68214310 PRN  Omeros To Webcast Presentation at Ninth Annual Needham Healthcare Conference,,,,,,,, 2/04/2014 69329Y10 PRN  PDL BioPharma to Present at BIO CEO and Investor Conference,,,,,,,,,,,,,,,,,,,,,,,,,12/13/2012 92165910 PRN  Vanda Receives Negative Opinion from CHMP on Fanaptum™ for the Treatment of Schizophrenia,,,,, 5/05/2014 40637H10 PRN  Halozyme to Host first Quarter 2014 Financial Results Conference Call,,,,,,," 9/30/2015 0B0WJD-E PRN  Parent Project Muscular Dystrophy Launches Next Phase of Genetic Testing Program, Decode Duchenne in collaboration with BioMarin Pharmaceutical Inc., PTC Therapeutics, and Sarepta Therapeutics",,,,,,,,, 5/13/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 4/28/2015 G3040110 PRN  Endo Announces Appointment of Matthew J. Maletta as Chief Legal Officer,, 9/06/2011 09060J10 PRN  BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence, 7/23/2013 000XKX-E    PRN  Techne Corporation Appoints Dr. J. Fernando Bazan As Chief Technology Officer," 3/28/2017 75886F10    PRN  Regeneron and Sanofi Announce FDA Approval of DUPIXENT® (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis",,, 7/29/2015 IONS-US  PRN  Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine, 6/07/2011 09061G10   PRN  BioMarin Initiates Phase 3 Trial for Amifampridine Phosphate for the Treatment of LEMS,,10/27/2014 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2014 Financial Results,,," 3/03/2011 06DDVL-E  PRN  Zacks Industry Outlook Highlights: Abbott Labs, Allergan, Pfizer and Biogen Idec",,, 2/08/2013 000L1R-E   PRN  Gilead Sciences completes acquisition of YM BioSciences, 9/10/2014 05NDXX-E   PRN  Lorcaserin HCl Data to be Presented at the American Society of Bariatric Physicians' 64th Annual Obesity & Associated Conditions Symposium, 9/30/2016 06CR5C-E  PRN  Mylan Launches Generic Fortamet® Tablets,,, 1/04/2018 03116210 PRN  Amgen To Present At The 36th Annual J.P. Morgan Healthcare Conference,, 9/13/2011 52887230 PRN  Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting,,,,12/06/2012 45773H20 PRN  Inovio Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial, 1/14/2014 64026810 PRN  Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer,,,,,,10/10/2011 UTHR-US  PRN  United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program,,,,,, 2/07/2011 55027E10 PRN  Luminex Corporation Reports Fourth Quarter and Full Year 2010 Results, 5/01/2014 80067710 PRN  Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences,, 4/07/2016 0DFTJS-E  PRN  Sanofi Genzyme Donates Corporate Archives To Harvard Business School,,,,,,,,,,,, 5/13/2010 68214310 PRN  Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders,,,,,,,, 2/03/2014 PDLI-US  PRN  PDL BioPharma Announces Agreement with Genentech and Roche to Settle Litigation and Arbitration,,,,,,,,,,,,,,,,,,,,,,,,,11/07/2012 92165910 PRN  Vanda Pharmaceuticals Reports Third Quarter 2012 Results,,,,, 4/09/2014 40637H10 PRN  Halozyme Announces Clinical Hold of PEGPH20 Pancreatic Cancer Trial Following Voluntary Halt of Trial by Halozyme,,,,,,, 9/30/2015 005W47-E PRN  PTC Therapeutics Submits European Application For Translarna™ for Cystic Fibrosis,,,,,,,,, 5/08/2014 G5087110 PRN  Jazz Pharmaceuticals Announces First Quarter 2014 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/27/2015 G3040110 PRN  Endo to Announce First Quarter 2015 Financial Results on May 11, 2015",, 8/31/2011 09060J10 PRN  BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences, 7/22/2013 070SNC-E    PRN  Techne Corporation Announces Acquisition Completion," 3/28/2017 75886F10    PRN  Sanofi and Regeneron Announce FDA Approval of Dupixent® (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis",,, 7/28/2015 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Second Quarter 2015 Financial Results Conference Call, 5/31/2011 09061G10   PRN  BioMarin to Present at the Jefferies Global Healthcare Conference,,"10/27/2014 64125C10 PRN  Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon",,," 2/22/2011 06DDVL-E  PRN  Zacks Analyst Blog Highlights: The Medicines Company, Biogen Idec, Hospira, Pfizer and Cabela’s",,, 2/05/2013 000L1R-E   PRN  YM BioSciences Announces Receipt of Final Court Order Approving the Plan of Arrangement with Gilead Sciences, 9/02/2014 04004760   PRN  Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension, 9/08/2016 N5946510  PRN  Multi-Billion Dollar Cancer Treatment & Patient Care Industry Boosting Biotech Sector to New Highs,,,12/19/2017 0FLYJ6-E PRN  Launchpad Digital Health Expands Advisors,, 9/06/2011 52887230 PRN  Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference,,,,11/26/2012 45773H20 PRN  Inovio Pharmaceuticals Cytomegalovirus (CMV) Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study," 1/14/2014 64026810 PRN  First Subjects Dosed in Phase 1 Clinical Study of NKTR-171, A New Peripherally-Restricted Sodium Channel Blocker to Treat Neuropathic Pain",,,,,, 8/24/2011 91307C10 PRN  FREEDOM-C(2) Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Does Not Meet Primary Endpoint,,,,,," 1/18/2011 55027E10 PRN  Luminex Corporation Fourth Quarter and Full Year 2010 Earnings Release Scheduled for February 7, 2011", 4/29/2014 80067710 PRN  Sangamo BioSciences Announces First Quarter 2014 Conference Call And Webcast,, 4/01/2016 80105N10  PRN  Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients,,,,,,,,,,,, 5/12/2010 68214310 PRN  Omeros Reports First Quarter 2010 Financial Results,,,,,,,, 1/30/2014 69329Y10 PRN  PDL BioPharma Announces 2014 Regular Quarterly Dividends as well as Strategic Decision to Continue Operations,,,,,,,,,,,,,,,,,,,,,,,,,11/05/2012 92165910 PRN  Vanda Pharmaceuticals to Present at the Lazard Healthcare Conference,,,,, 4/08/2014 40637H10 PRN  Halozyme Announces Preclinical Data Presentations At The Association Of Cancer Research Annual Meeting,,,,,,, 9/04/2015 69366J20 PRN  PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award,,,,,,,,," 4/24/2014 G5087110 PRN  Jazz Pharmaceuticals to Report 2014 First Quarter Financial Results on May 8, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/23/2015 G3040110 PRN  Active Equities to Watch in the Health Care Sector -- Cytori Therapeutics, Endo Intl., BioMarin Pharma, Novogen, and Receptos",, 8/22/2011 09060J10 PRN  BioDelivery Sciences Announces Commercial Launch of ONSOLIS in Canada, 6/18/2013 000XKX-E    PRN  Techne Corporation Announces Acquisition Agreement," 3/22/2017 75886F10    PRN  U.K. Biobank, Regeneron and GSK Announce Largest Gene Sequencing Initiative on World's Most Detailed Health Database to Improve Drug Discovery and Disease Diagnosis",,, 7/27/2015 46222210 PRN  ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy, 5/18/2011 09061G10   PRN  BioMarin to Present at the UBS Global Specialty Pharmaceuticals Conference,,10/20/2014 64125C10 PRN  Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854,,," 2/02/2011 09062X10  PRN  Zacks Analyst Blog Highlights: Biogen Idec, Elan Corp, Novartis, Roche and Teva",,," 2/04/2013 000DP2-E   PRN  Top Stocks and Insiders Trade Secrets: National-Oilwell Varco, Gilead Sciences, Dow Chemical, Chesapeake Energy, Barrick Gold, and ConocoPhillips", 8/11/2014 04004760   PRN  Post-Earnings Review and Highlights - Arena Pharma, 9/01/2016 N5946510  PRN  Mylan Invalidates Third Teva Copaxone® 40 mg/mL Patent Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding,,,12/14/2017 03116210 PRN  Amgen Teams Up With Cambridge Biotech Community To Select Two Startups To Receive Golden Tickets At LabCentral,, 8/30/2011 52887230 PRN  Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference,,,,11/14/2012 45773H20 PRN  Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania," 1/08/2014 64026810 PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA",,,,,, 7/28/2011 91307C10 PRN  United Therapeutics Corporation Reports Second Quarter 2011 Financial Results,,,,,, 1/05/2011 55027E10 PRN  Luminex Corporation to Present at JP Morgan Healthcare Conference, 3/20/2014 80067710 PRN  Sangamo BioSciences Announces Pricing Of Public Offering Of Common Stock,, 3/23/2016 000VC1-E  PRN  Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Praluent® (alirocumab) Study in Patients Undergoing LDL Apheresis Therapy,,,,,,,,,,,, 5/03/2010 68214310 PRN  Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery,,,,,,,," 1/03/2014 69329Y10 PRN  Pre-Market Highlight of the Day: Questcor Pharma, PDL BioPharma, Amgen, and BioCryst Pharma",,,,,,,,,,,,,,,,,,,,,,,,,"10/17/2012 92165910 PRN  Vanda Pharmaceuticals to Announce Third Quarter 2012 Financial Results on November 7, 2012",,,,, 4/04/2014 40637H10 PRN  Halozyme Announces Temporary Halt Of Phase 2 Trial Enrollment And Dosing For PEGPH20,,,,,,, 8/21/2015 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,,, 3/31/2014 JAZZ-IE  PRN  Jazz Pharmaceuticals And Gentium Announce European Commercial Launch Of First Approved Life-Saving Treatment For Severe Hepatic Veno-Occlusive Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/30/2015 G3040110 PRN  Post-Earnings Briefing - Endo International,, 7/25/2011 09060J10 PRN  BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study," 5/10/2013 06DDVL-E    PRN  Zacks Bull and Bear of the Day Highlights: Zillow, Techne, Delta Air Lines, Southwest and United Continental Holdings", 3/14/2017 75886F10    PRN  Teen Scientist Researches New Approach to Neurological Damage; Wins Regeneron Science Talent Search 2017,,, 7/22/2015 46222210 PRN  Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet, 5/03/2011 09061G10   PRN  BioMarin to Present at the Bank of America Merrill Lynch Healthcare Conference,,10/02/2014 64125C10 PRN  Neurocrine Announces Expansion Of VMAT2 Inhibitor Program With Initiation Of Tourette Syndrome Clinical Study,,,12/30/2010 00167Y-E  PRN  Dr. Marianne T. Sweetser Recognized by Strathmore's Who's Who Worldwide Publication,,, 1/31/2013 000L1R-E   PRN  YM BioSciences Shareholders Approve Plan of Arrangement with Gilead Sciences, 8/01/2014 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results," 8/29/2016 N5946510  PRN  Mylan to Launch First Generic to EpiPen® Auto-Injector at a List Price of $300 per Two-Pack Carton, a More than 50% Discount to the Brand Product",,,12/12/2017 03116210 PRN  Amgen Announces 15 Percent Increase In 2018 First Quarter Dividend,, 8/11/2011 52887230 PRN  Lexicon Pharmaceuticals to Present at the Wedbush 2011 Life Sciences Management Access Conference,,,,11/12/2012 45773H20 PRN  Inovio Therapeutic Hepatitis B Vaccine Killer T Cells Demonstrate Potential to Clear HBV in Liver,"12/25/2013 64026810 PRN  Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch",,,,,," 7/21/2011 91307C10 PRN  United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011",,,,,,12/07/2010 55027E10 PRN  Luminex and One Lambda Renew Long-Term Strategic Partnership, 3/19/2014 80067710 PRN  Sangamo BioSciences Announces Public Offering Of Common Stock,, 3/16/2016 80105N10  PRN  Regeneron and Sanofi Strongly Disagree with U.S. Jury Verdict in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection and Will Appeal,,,,,,,,,,,, 4/29/2010 68214310 PRN  Omeros to Webcast Presentation at Deutsche Bank 35th Annual Health Care Conference,,,,,,,,"12/30/2013 69329Y10 PRN  Conference Schedules, Stock Price Movements, Executive Transitions, and Revenue Outlook - Research Report on Incyte, ViroPharma, Cooper, Varian and PDL BioPharma",,,,,,,,,,,,,,,,,,,,,,,,,10/15/2012 92165910 PRN  Tasimelteon Restores Daily Cortisol Rhythms in Blind Patients with Non-24-Hour Disorder,,,,, 4/02/2014 40637H10 PRN  Halozyme Announces Appointment Of Oncology Product Team Leader And Other Executive Transitions,,,,,,, 8/14/2015 69366J20 PRN  PTC Therapeutics Announces Closing of $150 Million of Convertible Senior Notes,,,,,,,,, 2/26/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/16/2015 00FV7G-E PRN  Endo Withdraws Proposal For Salix,, 6/07/2011 09060J10 PRN  BioDelivery Sciences to Present at the Jeffries Global Healthcare Conference, 4/30/2013 000XKX-E    PRN  Techne Corporation Releases Unaudited Third Quarter And Nine Month Fiscal Year 2013 Results, 3/14/2017 75886F10    PRN  Teen Scientist Researches New Approach to Neurological Damage; Wins Regeneron Science Talent Search 2017,,," 7/22/2015 46222210 PRN  Critical Alerts For Isis Pharmaceuticals, NXP Semiconductors, Transocean, Microsoft and Boeing Released By InvestorsObserver", 4/28/2011 09061G10   PRN  BioMarin Announces First Quarter 2011 Financial Results,,"10/01/2014 64125C10 PRN  Neurocrine Biosciences, Inc. Announces Appointment of Malcolm Lloyd-Smith as Chief Regulatory Officer",,,12/08/2010 00167Y-E  PRN  Reportlinker Adds Biogen Idec Inc.: PharmaVitae Profile,,, 1/30/2013 37555810   PRN  Emerging Growth Pharmaceutical Company Creates Gravitational Pull Towards Their Products, 7/30/2014 04004760   PRN  Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity," 8/25/2016 N5946510  PRN  Mylan Taking Immediate Action to Further Enhance Access to EpiPen® (Epinephrine Injection, USP) Auto-Injector",,,12/11/2017 03116210 PRN  KYPROLIS® (carfilzomib) Extended Overall Survival In Patients With Relapsed Or Refractory Multiple Myeloma In Phase 3 ASPIRE Trial,, 8/10/2011 52887230 PRN  Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology,,,,11/07/2012 45773H20 PRN  Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results,"12/17/2013 64026810 PRN  AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories",,,,,, 6/06/2011 91307C10 PRN  FREEDOM-M Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Meets Primary Endpoint,,,,,,11/18/2010 000CPS-E PRN  Reportlinker Adds Global Flow Cytometers Industry, 3/06/2014 80067710 PRN  Sangamo Presents Clinical Data At CROI 2014 Demonstrating Enhancement Of SB-728-T Engraftment - Continued Control Of HIV Viral Load For 31 Weeks Without ART In SB-728-T Treated Subject,, 3/11/2016 80105N10  PRN  Regeneron and Sanofi Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis,,,,,,,,,,,,,,,,,,,,"12/18/2013 69329Y10 PRN  Public Offerings, Merger Agreements, New Preclinical Data, New Treatments and Dividend Payments - Research Report on XOMA, MAKO, Alnylam, Avanir, and PDL BioPharma",,,,,,,,,,,,,,,,,,,,,,,,, 8/23/2012 92165910 PRN  Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences,,,,, 3/31/2014 40637H10 PRN  Halozyme Announces that Consistent 1 Trial Of Hylenex® Recombinant Met Primary Endpoint,,,,,,, 8/11/2015 69366J20 PRN  PTC Therapeutics Announces Pricing of $125 Million of Convertible Senior Notes,,,,,,,,, 2/25/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Management Change,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 3/16/2015 G3040110 PRN  Endo Pharmaceuticals Announces the Launch of NATESTO™ (testosterone nasal gel), the First and Only Nasal Gel for Testosterone Replacement Therapy",, 6/02/2011 09060J10 PRN  BioDelivery Sciences Provides Update on Status of Modified REMS Program for ONSOLIS, 4/30/2013 000XKX-E    PRN  Techne Corporation Declares Dividend, 3/07/2017 75886F10    PRN  Regeneron and Sanofi to Present New Phase 3 Praluent® (alirocumab) Injection Clinical Trial Analyses at ACC.17 Scientific Sessions,,, 7/21/2015 46222210 PRN  Isis Pharmaceuticals Initiates Clinical Study of ISIS-HTT Rx in Patients With Huntington's Disease," 4/27/2011 CCEP-US    PRN  Zacks Bull and Bear of the Day Highlights: Joy Global, BioMarin Pharmaceutical, The Coca Cola Company, Coca Cola Enterprises and Pepsico",, 9/03/2014 64125C10 PRN  Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference,,,11/03/2010 00167Y-E  PRN  Reportlinker Adds Multiple Sclerosis Drug Discoveries: what the future holds,,," 1/28/2013 000DGZ-E   PRN  The Zacks Analyst Blog Highlights: Amgen, Celgene, Gilead Sciences, Vertex Pharmaceuticals and Nasdaq Biotechnology Index ETF", 7/29/2014 04004760   PRN  Eisai and Arena Pharmaceuticals Announce BELVIQ® (lorcaserin HCl) CIV Nominated a Second Time for the Prix Galien Award in the Best Pharmaceutical Agent Category, 8/25/2016 532523-IN PRN  Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Trastuzumab Accepted for Review by European Medicines Agency,,,"12/11/2017 03116210 PRN  Amgen Foundation Pledges Up To $500,000 In Relief To Victims Of The Southern California Wildfires",," 8/09/2011 52887230 PRN  Phase 2 Trial of Lexicon's LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome",,,,"11/06/2012 EMPO-US  PRN  NYSE, Toronto TSX and OTC Markets Companies Webcast Live to Investors on November 8th at RetailInvestorConferences.com","11/28/2013 64026810 PRN  New Research Arrangements, Investor Conference Schedules, Reimbursement Agreements, and NDA Acceptances - Research Report on Quintiles, Insys, HeartWare, Given Imaging, and Nektar",,,,,, 4/28/2011 91307C10 PRN  United Therapeutics Corporation Reports First Quarter 2011 Financial Results,,,,,,11/17/2010 55027E10 PRN  Luminex Corporation Board of Directors Authorizes Share Repurchase Plan Through November 2011, 3/05/2014 80067710 PRN  First-In-Man Study Of Genome Editing Using Sangamo's ZFN Technology Published In New England Journal Of Medicine,," 3/07/2016 SNY-FR    PRN  Merus Completes Acquisition of Surgestone®, Provames®, Tredemine® and Speciafoldine® Rights from Sanofi",,,,,,,,,,,,,,,,,,,,12/12/2013 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,, 8/09/2012 92165910 PRN  Fanapt™ is Granted Market Approval in Israel for the Treatment of Schizophrenia,,,,, 3/28/2014 40637H10 PRN  Halozyme Announces Roche Marketing Authorization For MabThera SC For Patients With Common Forms Of Non-Hodgkin Lymphoma In European Union,,,,,,, 8/10/2015 69366J20 PRN  PTC Therapeutics Announces Intention to Offer Convertible Senior Notes,,,,,,,,, 2/25/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2013 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 3/12/2015 G3040110 PRN  Critical Alerts For Mobileye NV, Endo Health Solutions, CyberArk Software, Rocket Fuel and SPDR S&P 500 ETF Released By InvestorsObserver",, 6/01/2011 09060J10 PRN  BioDelivery Sciences Retains The Trout Group for Investor Relations Services, 3/18/2013 000XKX-E    PRN  Board Of Directors Appoints Charles Kummeth As Chief Executive Officer And Director Of Techne Corporation, 3/04/2017 75886F10    PRN  Regeneron and Sanofi Announce Presentation of Positive Data from Long-Term Pivotal Phase 3 CHRONOS Study of DUPIXENT® (dupilumab) in Moderate-to-Severe Atopic Dermatitis,,, 7/14/2015 46222210 PRN  Isis Pharmaceuticals Earns $2.15M For Advancing ISIS-SMN Rx in Children with Spinal Muscular Atrophy, 4/26/2011 09061G10   PRN  BioMarin to Present at the Deutsche Bank Healthcare Conference,, 8/06/2014 64125C10 PRN  Neurocrine Biosciences Reports Second Quarter 2014 Results,,,11/01/2010 000C35-E  PRN  Food and Drug Law Journal E-Advance Discusses Biosimilar Standards,,," 1/25/2013 37555810   PRN  Critical Alerts For Cisco, Sina, Gilead, PACCAR, and MetroPCS By InvestorsObserver"," 7/25/2014 04004760   PRN  Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1", 8/24/2016 TEVVF-IL  PRN  Mylan Invalidates Two of Teva's Copaxone® 40 mg/mL Patents Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding,,,12/07/2017 03116210 PRN  New Data To Be Presented At ASH 2017 Underscore Amgen's Commitment To Improving Lives And Changing Outcomes For Patients With Difficult-To-Treat Blood Cancers,, 8/08/2011 52887230 PRN  Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Second Quarter Results,,,,10/15/2012 45773H20 PRN  Inovio Pharmaceuticals Animal Health Subsidiary's GHRH Treatment Approved in New Zealand,"11/20/2013 64026810 PRN  Financing, Special Reports, and Clinical Trial Updates - Research Report on PDL, DexCom, Quintiles, KYTHERA, and Nektar",,,,,," 4/21/2011 91307C10 PRN  United Therapeutics Corporation to Announce First Quarter 2011 Financial Results Before Market Open on Thursday, April 28, 2011",,,,,,11/17/2010 55027E10 PRN  Luminex Corporation Launches New FDA Cleared Pharmacogenetic Diagnostic Test, 2/26/2014 80067710 PRN  Sangamo BioSciences Announces Presentation At The 2014 Cowen And Company Health Care Conference,, 2/29/2016 80105N10  PRN  Sanofi Genzyme Recognises 2016 International Rare Disease Day with Premiere of Expression of Hope Film,,,,,,,,,,,,,,,,,,,,"12/11/2013 69329Y10 PRN  New Clinical Trials, Pricing of Common Stock and Adjusted Conversion of Convertible Senior Notes - Research Report on Regeneron, Celldex, PDL BioPharma, Amedisys, and Exelixis",,,,,,,,,,,,,,,,,,,,,,,,, 8/02/2012 92165910 PRN  Vanda Pharmaceuticals Reports Second Quarter 2012 Results,,,,, 3/25/2014 40637H10 PRN  Halozyme Announces Positive Results From Phase 1/2 Clinical Trial In Cellulite With HTI-501,,,,,,, 7/30/2015 69366J20 PRN  PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update,,,,,,,,, 2/21/2014 G5087110 PRN  Jazz Pharmaceuticals plc Completes Tender Offer For Gentium S.p.A. Shares,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/11/2015 G3040110 PRN  Valeant Comments On Endo Offer To Acquire Salix,, 5/05/2011 09060J10 PRN  BioDelivery Sciences to Present at the Bank of America Merrill Lynch Health Care Conference, 3/14/2013 LBTA.XX1-US PRN  TechNet Appoints New Executive Council Members Marissa Mayer of Yahoo! and Safra Catz of Oracle, 2/27/2017 75886F10    PRN  Sanofi and Regeneron to Present New Data on Dupixent® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses,,," 7/09/2015 46222210 PRN  Critical Alerts For Tesla Motors, Hasbro, Isis Pharmaceuticals, Freeport-McMoRan and General Motors Released By InvestorsObserver"," 4/08/2011 SNY-FR     PRN  Zacks Analyst Blog Highlights: Myriad Genetics, BioMarin Pharmaceuticals, Abbott Laboratories, AstraZeneca and Sanofi-Aventis",," 7/31/2014 64125C10 PRN  Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences",,,"10/26/2010 09062X10  PRN  Critical Alerts for Du Pont, National Oilwell Varco, Broadcom, Biogen and Valero Released by Seven Summits Research",,," 1/23/2013 37555810   PRN  The True Effect: Positive Findings - Research Report on Celgene Corporation and Gilead Sciences, Inc.", 7/21/2014 04004760   PRN  Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Israel, 8/17/2016 07VK3Z-E  PRN  Groundbreaking on 'Rebuilding Rainelle',,,12/06/2017 03116210 PRN  Amgen To Webcast Investor Call At ASH 2017,, 8/04/2011 52887230 PRN  Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2011 Financial Results,,,,10/10/2012 45773H20 PRN  Inovio Pharmaceuticals' Cancer Vaccine Demonstrates for 1st Time that a DNA-Based Therapeutic Vaccine Can Produce Immune Responses to Kill Target Cells,"11/19/2013 64026810 PRN  Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc.",,,,,," 4/05/2011 002G54-E PRN  Medicomp, Inc. Announces Company Purchase From United Therapeutics",,,,,,11/10/2010 55027E10 PRN  Luminex Corporation to Present at Stephens Fall Investment Conference, 2/11/2014 80067710 PRN  Sangamo BioSciences Reports Fourth Quarter And Full Year 2013 Financial Results,, 2/25/2016 06HNCK-E  PRN  JDRF and Sanofi Announce Expansion of their Joint Research Collaboration to Include Development of Glucose Responsive Insulin Therapies for Treatment of Insulin-Dependent Diabetes,,,,,,,,,,,,,,,,,,,,12/10/2013 69329Y10 PRN  PDL BioPharma Provides Fourth Quarter 2013 Revenue Guidance of $109 Million,,,,,,,,,,,,,,,,,,,,,,,,," 7/10/2012 92165910 PRN  Vanda Pharmaceuticals to Announce Second Quarter 2012 Financial Results on August 2, 2012",,,,, 3/05/2014 40637H10 PRN  Halozyme Therapeutics To Present At The Barclays 2014 Global Healthcare Conference,,,,,,," 7/22/2015 69366J20 PRN  Insight on Financial & Corporate Actions - Report on PTC Therapeutics, Inc.",,,,,,,,," 2/11/2014 G5087110 PRN  Jazz Pharmaceuticals to Report 2013 Fourth Quarter and Full Year Financial Results on February 25, 2014",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/11/2015 G3040110 PRN  Endo Announces Appearance at Upcoming Conference,, 4/05/2011 09060J10 PRN  BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study, 2/05/2013 000XKX-E    PRN  Techne Corporation Declares Dividend, 2/27/2017 75886F10    PRN  Regeneron and Sanofi to Present New Data on DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses,,, 7/06/2015 IONS-US  PRN  Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome," 3/28/2011 09061G10   PRN  BioMarin to Host First Quarter 2011 Financial Results Conference Call and Webcast on Thursday, April 28 at 5:00 p.m. ET",," 7/30/2014 64125C10 PRN  Critical Alerts For Silicon Motion Technology, Pharmacyclics, 3D Systems, Walgreen, and Neurocrine Biosciences Released By InvestorsObserver",,," 8/13/2010 09062X10  PRN  Critical Alerts for Texas Instruments, Mosaic, Biogen Idec, Textron, and Lam Research Released by Seven Summits Research",,, 1/07/2013 37555810   PRN  MacroGenics and Gilead Sciences Enter Strategic Alliance to Develop and Commercialize Four DART™ Products, 7/16/2014 04004760   PRN  Cannabis Based Healing Products Lead Commercialization For Medical Marijuana Patients - Company Introduces New Edible CBD-Rich Product Line, 8/11/2016 MYL-GB    PRN  Breathing Easier: Pharma Successfully Leveraging Smoother EU Regulatory Specs,,,12/01/2017 03116210 PRN  FDA Approves Amgen's Repatha® (evolocumab) To Prevent Heart Attack And Stroke,," 7/28/2011 52887230 PRN  Lexicon's IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical Trial",,,,10/05/2012 45773H20 PRN  Inovio Pharmaceuticals Named Best Mid-Stage Product Development Company by the Philadelphia Business Journal,11/19/2013 NKTR-US  PRN  New Drug Application For Naloxegol Accepted By United States Food And Drug Administration,,,,,, 3/21/2011 91307C10 PRN  United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial,,,,,,11/04/2010 55027E10 PRN  Luminex Corporation Reports Third Quarter 2010 Results, 2/06/2014 80067710 PRN  Sangamo BioSciences Announces Presentation At The 2014 Leerink Swann Global Healthcare Conference,," 2/23/2016 80105N10  PRN  Sanofi US to Return Auvi-Q® (epinephrine injection, USP) Rights to kaléo",,,,,,,,,,,,,,,,,,,,12/04/2013 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,, 7/05/2012 92165910 PRN  Vanda Pharmaceuticals to Present at the JMP Securities Healthcare Conference,,,,, 2/27/2014 40637H10 PRN  Halozyme Reports Fourth Quarter And Year End 2013 Financial Results,,,,,,, 7/16/2015 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2015 Financial Results,,,,,,,,," 2/11/2014 G5087110 PRN  Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versacloz™ (clozapine, USP) Oral Suspension",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/11/2015 G3040110 PRN  Endo Confirms Proposal To Acquire Salix For $175.00 Per Share In Cash And Stock,, 3/21/2011 09060J10 PRN  BioDelivery Sciences Announces Issuance of Patent in Canada Extending Exclusivity for the BEMA Technology to 2027 Covering ONSOLIS and BEMA Buprenorphine, 2/05/2013 000XKX-E    PRN  Techne Corporation Releases Unaudited Second Quarter And Six Month Fiscal Year 2013 Results, 2/13/2017 75886F10    PRN  Regeneron Announces Upcoming 2017 Investor Conference Presentations,,, 6/30/2015 46222210 PRN  Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting, 3/18/2011 09061G10   PRN  First-of-Its-Kind Study Suggests Importance of Routine Mental Health Screening in the Care of Patients Suffering From Genetic Disease PKU,, 7/29/2014 64125C10 PRN  Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results,,, 6/03/2010 00167Y-E  PRN  Hard To Treat Diseases (HTDS.PK) Scientists report results that are encouraging for the future of Multiple Sclerosis Treatment,,, 1/03/2013 06680H-E   PRN  Continued Uptake Of Oral Nucleoside/Nucleotide Analogues Will Drive Growth In The U.S. And European Hepatitis B Markets, 7/15/2014 04004760   PRN  Arena Pharmaceuticals Issued Patent for APD371 by United States Patent and Trademark Office," 8/10/2016 N5946510  PRN  InvestorsObserver releases covered-call reports for Netflix, Nevro Corporation, Eagle Pharmaceuticals, Mylan and Weibo",,,"11/29/2017 03116210 PRN  Aimovig™ (erenumab) Phase 3 STRIVE Data Published In The New England Journal Of Medicine Demonstrate Significant, Sustained Efficacy In Migraine Prevention",, 6/27/2011 52887230 PRN  Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes,,,,10/04/2012 45773H20 PRN  Inovio Pharmaceuticals' Synthetic Vaccines Delivered with Minimally Invasive Skin Electroporation Technology Generate Potent Immune Responses,"11/13/2013 64026810 PRN  Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A",,,,,, 2/15/2011 91307C10 PRN  United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results,,,,,,"10/20/2010 55027E10 PRN  Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2010", 2/04/2014 80067710 PRN  Sangamo BioSciences Announces Fourth Quarter And Full Year 2013 Conference Call And Webcast,, 2/22/2016 80105N10  PRN  FDA Accepts Sanofi New Drug Application for Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide,,,,,,,,,,,,,,,,,,,,"12/03/2013 69329Y10 PRN  Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis",,,,,,,,,,,,,,,,,,,,,,,,, 6/18/2012 92165910 PRN  Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals,,,,, 2/25/2014 40637H10 PRN  Halozyme Therapeutics To Present At The Cowen And Company 34th Annual Healthcare Conference,,,,,,," 6/23/2015 69366J20 PRN  /C O R R E C T I O N -- PTC Therapeutics, Inc./",,,,,,,,, 2/10/2014 G5087110 PRN  Jazz Pharmaceuticals Breaks Ground On New Manufacturing And Development Facility In Ireland,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/02/2015 G3040110 PRN  Endo Reports Fourth Quarter And Full Year 2014 Financial Results,, 3/11/2011 09060J10 PRN  BioDelivery Sciences Announces Business Update Call Following Pricing of $15 Million Common Stock Financing and Filing of 2010 Form 10-K,11/05/2012 000XKX-E    PRN  Techne Corporation Announces Retirement of Thomas Oland; CFO Gregory Melsen To Assume CEO Duties on an Interim Basis, 2/09/2017 75886F10    PRN  Regeneron Reports Fourth Quarter and Full Year 2016 Financial and Operating Results,,, 6/29/2015 46222210 PRN  ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index, 3/08/2011 09061G10   PRN  BioMarin to Present at the Barclays Global Healthcare Conference,, 6/11/2014 64125C10 PRN  Neurocrine Biosciences Presenting NBI-98854 Scientific Abstracts And Posters At The International Parkinson And Movement Disorder Society's 18th Annual Congress,,," 6/01/2010 09062X10  PRN  Critical Alerts for Morgan Stanley, Dow Chemical, American Eagle Outfitters, Biogen, and Riverbed Technology Released by Seven Summits Research",,,"12/20/2012 37555810   PRN  Critical Alerts For Gilead, United Technologies, Schwab, Riverbed Technology, and Tractor Supply Co. Released By InvestorsObserver", 7/10/2014 04004760   PRN  Arena Pharmaceuticals Reports that Eisai Completes Planned Increase in Sales Force for BELVIQ® (lorcaserin HCl) CIV, 8/09/2016 N5946510  PRN  Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8%,,,11/27/2017 03116210 PRN  Amgen To Present At The Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference,, 5/31/2011 52887230 PRN  Lexicon Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference,,,, 9/18/2012 45773H20 PRN  Inovio Pharmaceuticals to Present at Noble Financial Life Sciences Conference,"11/12/2013 64026810 PRN  Updates on Clinical Studies and Milestone Revenues - Research Report on Cyberonics, West, Nektar, OraSure, and Akorn",,,,,," 2/08/2011 91307C10 PRN  United Therapeutics Corporation to Announce Fourth Quarter and Annual 2010 Financial Results Before Market Open on Tuesday, February 15, 2011",,,,,,10/13/2010 55027E10 PRN  Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna, 1/09/2014 80067710 PRN  Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies,, 2/12/2016 000DN7-E  PRN  ACT® Advanced Care™ Mouthwash Named 2016 Product of the Year,,,,,,,,,,,,,,,,,,,,12/02/2013 69329Y10 PRN  PDL BioPharma to Present at the 25th Annual Piper Jaffray Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,, 6/11/2012 92165910 PRN  Seventy Percent of Totally Blind Individuals With Sleep Complaints Suffer From Chronic Circadian Rhythm Sleep Disorder,,,,, 2/20/2014 40637H10 PRN  Halozyme to Host Fourth Quarter and 2013 Year-End Financial Results Conference Call,,,,,,," 6/15/2015 005W47-E PRN  PTC Therapeutics Appoints Glenn D. Steele Jr., M.D., Ph.D. to Board of Directors",,,,,,,,, 1/23/2014 G5087110 PRN  Jazz Pharmaceuticals plc Announces Minimum Tender Condition Exceeded During Initial Offering Period For Gentium S.p.A. Shares,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/02/2015 G3040110 PRN  Boston Scientific Announces Definitive Agreement To Acquire American Medical Systems' Urology Portfolio For Up To $1.65 Billion,, 3/09/2011 09060J10 PRN  BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference,10/25/2012 000XKX-E    PRN  Techne Corporation Declares Dividend And Announces An Increase In Its Share Repurchase Program, 2/08/2017 75886F10    PRN  Appeals Court Grants Stay of Permanent Injunction for Praluent® (alirocumab) During Appeals Process,,," 6/23/2015 46222210 PRN  Critical Alerts For Apple, Boeing, Isis Pharmaceuticals, SAP and Stanley Black & Decker Released By InvestorsObserver", 3/01/2011 09061G10   PRN  BioMarin to Present at the Cowen Health Care Conference,, 5/29/2014 64125C10 PRN  Neurocrine Biosciences To Present At The Jefferies 2014 Global Healthcare Conference,,,,,,12/12/2012 000L1R-E   PRN  Gilead Sciences to Acquire YM Biosciences," 7/10/2014 04004760   PRN  Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma", 8/05/2016 MDABY-SE  PRN  Mylan Completes Acquisition of Meda,,,11/17/2017 03116210 PRN  Amgen Launches The ENBREL Mini™ Single-Dose Prefilled Cartridge With AutoTouch™ Reusable Autoinjector That Is Ergonomically Designed For Patients,, 5/09/2011 52887230 PRN  Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D Day,,,, 9/06/2012 45773H20 PRN  Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine,11/07/2013 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013,,,,,, 2/02/2011 91307C10 PRN  United Therapeutics Corporation Completes Enrollment of FREEDOM-M Trial,,,,,,10/12/2010 55027E10 PRN  Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution, 1/09/2014 80067710 PRN  Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies,, 2/09/2016 80105N10  PRN  Sanofi Delivered 2015 Business EPS up 8.5% on a Reported Basis and Stable at Constant Exchange Rates Consistent with Guidance,,,,,,,,,,,,,,,,,,,,"11/20/2013 69329Y10 PRN  Financing, Special Reports, and Clinical Trial Updates - Research Report on PDL, DexCom, Quintiles, KYTHERA, and Nektar",,,,,,,,,,,,,,,,,,,,,,,,, 6/04/2012 92165910 PRN  Vanda Pharmaceuticals to Present at SLEEP 2012 26th Annual Meeting of the Associated Professional Sleep Societies,,,,, 2/10/2014 40637H10 PRN  Halozyme Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares,,,,,,, 6/12/2015 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,,, 1/13/2014 G5087110 PRN  Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/02/2015 00FV7G-E PRN  Endo Announces Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific,, 3/02/2011 09060J10 PRN  BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting,10/23/2012 000XKX-E    PRN  Techne Corporation Releases Unaudited First Quarter Fiscal Year 2013 Financial Results," 2/07/2017 75886F10    PRN  Regeneron to Report Fourth Quarter and Full Year 2016 Financial and Operating Results and Host Conference Call and Webcast on February 9, 2017",,, 6/22/2015 46222210 PRN  Isis Pharmaceuticals Reports Data from ISIS-SMN Rx in Children with Spinal Muscular Atrophy, 2/22/2011 09061G10   PRN  BioMarin to Present at the Citi Global Healthcare Conference,, 5/08/2014 64125C10 PRN  Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference,,,,,,"12/12/2012 06DDVL-E   PRN  The Zacks Analyst Blog Highlights: GileadSciences, Brown-Forman, Beam, Constellation Brands and Diageo", 6/13/2014 04004760   PRN  Arena Pharmaceuticals to Present at the 2014 Wells Fargo Securities Healthcare Conference," 8/03/2016 00GDWJ-E  PRN  Homes for West Virginia to Rebuild Homes, Restore Lives and Rejuvenate Communities Lost in Flooding",,,11/13/2017 03116210 PRN  New Analyses Presented At AHA 2017 Show Repatha® (evolocumab) Significantly Reduced Cardiovascular Events In Patients With Peripheral Artery Disease And In Patients With A History Of Heart Attacks,, 5/03/2011 52887230 PRN  Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results,,,," 8/27/2012 45773H20 PRN  Inovio Pharmaceuticals to Present at Liolios, Stifel, and Rodman & Renshaw Investor Conferences","10/30/2013 64026810 PRN  Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets",,,,,,10/28/2010 91307C10 PRN  United Therapeutics Corporation Reports Third Quarter 2010 Financial Results,,,,,," 9/30/2010 002SFF-E PRN  UNITAID, Clinton Health Access Initiative Along With Biopharma Drugs and Technologies Win the Prix Galien 2010", 1/08/2014 80067710 PRN  Sangamo BioSciences to Focus on Advancing ZFP Therapeutic Pipeline at J.P. Morgan Healthcare Conference,, 2/09/2016 80105N10  PRN  Sanofi - Full Year 2015 Results,,,,,,,,,,,,,,,,,,,,"11/12/2013 69329Y10 PRN  FDA Approval, Quarterly Reports, Event, and Licensing Agreement - Research Report on Novo Nordisk, DexCom, Theravance, PDL, and WuXi PharmaTech",,,,,,,,,,,,,,,,,,,,,,,,, 5/31/2012 92165910 PRN  Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders,,,,, 2/04/2014 40637H10 PRN  Halozyme Therapeutics Prices Public Offering Of Common Stock,,,,,,, 6/12/2015 69366J20 PRN  PTC Therapeutics and BioMarin Pharmaceutical to Host DMD Industry Symposium,,,,,,,,," 1/09/2014 G5087110 PRN  Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 2/26/2015 G3040110 PRN  Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed",, 2/17/2011 09060J10 PRN  BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule, 7/31/2012 000XKX-E    PRN  Techne Corporation Declares Dividend, 2/01/2017 75886F10    PRN  Regeneron and Sanofi Announce First Approval of Kevzara™ (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients by Health Canada,,, 6/16/2015 IONS-US  PRN  Isis Pharmaceuticals to Present a General Corporate Update at its 2015 Annual Meeting of Stockholders and Open House, 2/18/2011 0729L6-E   PRN  ACMG Foundation Announces Revolutionary New Summer Genetics Scholars Program,, 5/01/2014 64125C10 PRN  Neurocrine Biosciences to Present at Deutsche Bank's 39th Annual Health Care Conference,,,,,,"11/21/2012 GRPN-US    PRN  SP500 Hot Stocks Earnings Forecast: Intel, Lowe's, Groupon, Chesapeake Energy, Teavana, and Gilead Sciences", 6/09/2014 04004760   PRN  Lorcaserin HCl Data to be Presented at American Diabetes Association's 74th Scientific Sessions, 8/02/2016 N5946510  PRN  Meda Shareholders Representing Approximately 94% of Meda Shares Accept Mylan Offer,,,11/10/2017 03116210 PRN  Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate® (romiplostim) In Pediatric Patients With Chronic Immune Thrombocytopenic Purpura,, 4/26/2011 52887230 PRN  Lexicon to Provide First Quarter 2011 Financial Results,,,, 8/09/2012 45773H20 PRN  Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results,"10/28/2013 64026810 PRN  Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc.",,,,,,"10/21/2010 91307C10 PRN  United Therapeutics Corporation to Announce Third Quarter 2010 Financial Results Before Market Open on Thursday, October 28, 2010",,,,,," 9/30/2010 002SFF-E PRN  UNITAID, Clinton Health Access Initiative Along With Biopharma Drugs and Technologies Win the Prix Galien 2010","12/23/2013 80067710 PRN  Stock Price Movements of Healthcare Companies- Research Report on LabCorp, Isis Pharmaceuticals, Mindray, Clovis Oncology and Sangamo Biosciences",," 2/01/2016 09BYCD-E  PRN  Merial Appoints Susan Sholtis as President, North America",,,,,,,,,,,,,,,,,,,,"11/08/2013 69329Y10 PRN  Before the Bell Scans: PDL BioPharma Inc., Amgen Inc., Questcor Pharma Inc., and BioCryst Pharma Inc.",,,,,,,,,,,,,,,,,,,,,,,,, 5/29/2012 92165910 PRN  Vanda Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference,,,,, 2/03/2014 40637H10 PRN  Halozyme Therapeutics Announces Public Offering Of Common Stock,,,,,,, 5/21/2015 69366J20 PRN  German Federal Joint Committee Issues Positive Medical Benefit Rating for Translarna™ in Patients with Nonsense Mutation Duchenne Muscular Dystrophy,,,,,,,,, 1/06/2014 G5087110 PRN  Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/23/2015 G3040110 PRN  BioDelivery Sciences to Receive $10 Million Milestone Payment from Endo Pharmaceuticals Inc. in Conjunction with Acceptance of NDA for BELBUCA™ (buprenorphine HCl) Buccal Film for Chronic Pain,," 1/18/2011 089Q9Z-E PRN  MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.", 7/31/2012 000XKX-E    PRN  Techne Corporation Releases Unaudited Fourth Quarter And Fiscal Year 2012 Results," 1/31/2017 75886F10    PRN  Tony Coles, M.D., Elected to Regeneron Board of Directors",,, 6/11/2015 46222210 PRN  Isis Pharmaceuticals Reports Data from ISIS-SMN Rx Phase 2 Study in Infants with Spinal Muscular Atrophy, 2/17/2011 09061G10   PRN  BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results,, 4/30/2014 64125C10 PRN  Neurocrine Biosciences Reports First Quarter 2014 Results,,,,,,"11/19/2012 06DDVL-E   PRN  The Zacks Analyst Blog Highlights: McGraw-Hill, Moody's, Gilead Sciences, Abbott Labs and Bristol-Myers Squibb", 6/03/2014 04004760   PRN  Arena Pharmaceuticals Initiates Phase 1b Clinical Trial of APD334 for Autoimmune Diseases, 8/01/2016 06CR5C-E  PRN  Mylan Launches Generic Dexedrine® Capsules,,,11/10/2017 03116210 PRN  Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer,, 3/29/2011 52887230 PRN  Lexicon Pharmaceuticals to Present at the 10th Annual Needham Healthcare Conference,,,, 8/07/2012 45773H20 PRN  Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com,10/24/2013 64026810 PRN  Nektar and Roswell Park Cancer Institute Announce Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) as a Second-Line Treatment in Patients with Relapsed or Refractory Small Cell Lung Cancer (SCLC),,,,,, 7/28/2010 91307C10 PRN  United Therapeutics Corporation Reports Second Quarter 2010 Financial Results,,,,,, 9/29/2010 55027E10 PRN  Luminex Corporation Wins Prestigious 2010 Prix Galien USA Award,"12/13/2013 80067710 PRN  Investor Meetings, New Clinical Data, Closing of Offering, and New Programs - Research Report on Teleflex, Orexigen, Sangamo, InterMune, and ImmunoGen",, 1/28/2016 097XPW-E  PRN  Merial Collaborates with Georgia Institute of Technology to Bring Animal Health Information to Connected Devices,,,,,,,,,,,,,,,,,,,,11/07/2013 69329Y10 PRN  PDL BioPharma to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,, 5/22/2012 92165910 PRN  Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting,,,,, 1/24/2014 40637H10 PRN  Halozyme Announces Positive Opinion From CHMP For European Approval Of Roche's MabThera SC,,,,,,, 5/15/2015 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,,,"12/25/2013 G5087110 PRN  Acquisitions, Appointments, FDA Approvals, and Study Milestones - Research Report on Jazz Pharmaceuticals, Boston Scientific, NuVasive, Endologix, and bluebird bio",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/23/2015 00FV7G-E PRN  Endo Pharmaceuticals and BioDelivery Sciences Announce Acceptance of NDA for BELBUCA™ (buprenorphine HCl) Buccal Film for the Management of Chronic Pain,,, 5/01/2012 000XKX-E    PRN  Techne Corporation Declares Dividend, 1/24/2017 75886F10    PRN  Forty of Nation's Brightest Young Scientists Named Regeneron Science Talent Search 2017 Finalists,,, 6/10/2015 46222210 PRN  Isis Pharmaceuticals to Host Webcast to Discuss Data From ISIS-SMN Rx Phase 2 Study in Infants With Spinal Muscular Atrophy, 2/01/2011 09061G10   PRN  BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA,, 4/25/2014 64125C10 PRN  Neurocrine Biosciences Announces Conference Call And Webcast To Report First Quarter 2014 Financial Results,,,,,,"11/15/2012 WPM-CA     PRN  Hot Stocks Insider Trades Radar: Gilead Sciences, Silver Wheaton, Marvell, Dollar Tree, F5 Networks, and American Capital"," 5/30/2014 04004760   PRN  Technical Coverage on Health Care Sector Equities -- Research on Arena Pharma, Exelixis, Dendreon, and Seattle Genetics", 8/01/2016 06CR5C-E  PRN  Mylan Launches Generic Propecia® Tablets,,,"11/06/2017 07C7ZV-E PRN  Banner Alzheimer's Institute, Novartis, and Amgen Expand Collaboration in Pioneering Alzheimer's Prevention Program",, 3/24/2011 52887230 PRN  Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer,,,," 7/31/2012 45773H20 PRN  Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd","10/16/2013 64026810 PRN  Dividend Announcements, Earnings Release Scheduled, and Data Presentations from Clinical Studies - Research Report on Questcor, Regeneron, NPS, Incyte, and Nektar",,,,,," 7/21/2010 91307C10 PRN  United Therapeutics Corporation to Announce Second Quarter 2010 Financial Results Before Market Open on Wednesday, July 28, 2010",,,,,, 9/28/2010 55027E10 PRN  Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe,12/10/2013 80067710 PRN  Sangamo BioSciences Presents Data From Non-Human Primates Providing Proof Of Concept For Disruptive And Broadly Leverageable Platform For Protein Replacement Therapies,, 1/18/2016 SNY-FR    PRN  MERIAL Supports New Online Rabies Vaccination Information Resource for Veterinarians,,,,,,,,,,,,,,,,,,,,11/06/2013 69329Y10 PRN  PDL BioPharma Announces Third Quarter 2013 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,, 5/08/2012 92165910 PRN  Vanda Pharmaceuticals Reports First Quarter 2012 Results,,,,, 1/13/2014 40637H10 PRN  Halozyme Therapeutics Provides an Update on Anticipated Milestones for 2014 at the 32nd Annual J. P. Morgan Healthcare Conference,,,,,,, 5/04/2015 69366J20 PRN  PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update,,,,,,,,,12/19/2013 JAZZ-IE  PRN  Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 2/19/2015 G3040110 PRN  American Medical Systems Announces 1,000th Patient Enrolled in PROPPER Registry",,, 5/01/2012 000XKX-E    PRN  Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results, 1/24/2017 75886F10    PRN  Forty of Nation's Brightest Young Scientists Named Regeneron Science Talent Search 2017 Finalists,,," 6/08/2015 46222210 PRN  Critical Alerts For Isis Pharmaceuticals, Twitter, Kite Pharma, Freeport-McMoRan and Kinder Morgan Released By InvestorsObserver", 1/24/2011 09061G10   PRN  BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results,, 3/04/2014 64125C10 PRN  Neurocrine Biosciences To Present At The 26th Annual Roth Conference,,,,,,"11/13/2012 NTAP-US    PRN  Critical Alerts For Gap Inc., Gilead, Hertz, NetApp, and Tyco Released By InvestorsObserver", 5/27/2014 04004760   PRN  Arena Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference, 7/27/2016 N5946510  PRN  Mylan Receives U.S. FTC Clearance for Proposed Meda Acquisition,,,11/06/2017 03116210 PRN  Amgen Announces New Analyses Of High-Risk Patient Subgroups From Repatha® (evolocumab) Cardiovascular Outcomes Study At AHA Scientific Sessions 2017,, 3/01/2011 52887230 PRN  Lexicon Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference,,,," 7/30/2012 0C1NCG-E PRN  NYSE, NASDAQ and OTC Companies Webcast Live to Online Investors, August 2nd, at RetailInvestorConferences.com",10/08/2013 64026810 PRN  Nektar Reports on Advancements with Clinical Pipeline and Introduces New Preclinical Candidates at Investor and Analyst R&D Day,,,,,, 7/01/2010 91307C10 PRN  United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China,,,,,, 9/09/2010 55027E10 PRN  Luminex Corporation to Present at UBS Global Life Sciences Conference,12/09/2013 80067710 PRN  Sangamo BioSciences Announces First Presentation Of Data From ZFP Therapeutic Program For Treatment Of Sickle Cell Disease And Beta-Thalassemia At American Society Of Hematology Meeting,, 1/08/2016 REGN-US   PRN  Regeneron and Sanofi Announce Sarilumab Biologics License Application Accepted for Review by US FDA,,,,,,,,,,,,,,,,,,,,11/06/2013 69329Y10 PRN  PDL BioPharma Provides $70 Million in Financing to Durata Therapeutics,,,,,,,,,,,,,,,,,,,,,,,,," 4/18/2012 92165910 PRN  Vanda Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 8, 2012",,,,, 1/09/2014 40637H10 PRN  Halozyme Therapeutics To Present At The 32nd Annual J.P. Morgan Healthcare Conference,,,,,,," 4/28/2015 69366J20 PRN  Technical Coverage of Biotech Equities -- Celldex Therapeutics, ImmunoGen, Hemispherx Biopharma, Intrexon, and PTC Therapeutics",,,,,,,,,"12/19/2013 G5087110 PRN  Regulatory Updates, Clinical Trial Results, and Stock Price Movements - Research Report on Johnson & Johnson, Cubist, Regeneron, Medtronic, and Jazz Pharmaceuticals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 2/13/2015 G3040110 PRN  Endo to Announce Fourth Quarter 2014 Financial Results on March 2, 2015",,," 2/09/2012 ABAX-US     PRN  Zacks Sell List Highlights: Avery Dennison, Molex, Abaxis and Techne"," 1/23/2017 75886F10    PRN  Biotech Stocks Under Scanner -- Kite Pharma, BioPharmX, OvaScience, and Regeneron Pharma",,, 6/05/2015 IONS-US  PRN  Isis Pharmaceuticals' License Agreement with Bayer for ISIS-FXI Rx Receives Hart-Scott-Rodino Approval, 1/19/2011 09061G10   PRN  BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease,, 2/27/2014 64125C10 PRN  Neurocrine Biosciences To Present At The Cowen And Company 34th Annual Health Care Conference,,,,,,"11/13/2012 0B1WG8-E   PRN  Earnings Forecast Stock Alerts: Gilead Sciences, Citigroup, Hewlett-Packard, Celgene, JPMorgan, and Sirius"," 5/15/2014 04004760   PRN  Marketing Authorization Applications, Clinical Trial Results, Awards & Recognitions, and Resources Expansions - Analyst Notes on AbbVie, Medtronic, Abbott, Zimmer and Arena", 7/21/2016 MDABY-SE  PRN  Mylan Publishes Supplement to Meda Offer Document,,,11/02/2017 03116210 PRN  Amgen And Novartis Announce Expanded Collaboration With Banner Alzheimer's Institute In Pioneering Prevention Program,, 2/24/2011 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results,,,," 7/10/2012 45773H20 PRN  Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths","10/07/2013 64026810 PRN  Regulatory Approvals, Public Offerings and Clinical Trial Results - Research Report on Theravance, Synageva, Nektar, Clovis Oncology, and ImmunoGen",,,,,, 6/09/2010 000TBT-E PRN  Tyvaso and Adcirca are Each Prescribed By More Than Half of Surveyed Pulmonologists in the Specialized Pulmonary Arterial Hypertension Center Setting,,,,,, 9/08/2010 55027E10 PRN  Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study,12/06/2013 80067710 PRN  Sangamo BioSciences Presents Clinical Data From Key SB-728-T HIV Studies: Proof Of Concept For Ongoing Sustained Functional Control Of HIV Viral Load; Cytoxan Preconditioning Successfully Enhances Engraftment,, 1/05/2016 0DM0JW-E  PRN  Global Genomics Group (G3) Partners with Sanofi to Identify New Signaling Pathways in Atherosclerotic Cardiovascular Diseases,,,,,,,,,,,,,,,,,,,,11/05/2013 PDLI-US  PRN  PDL BioPharma to Provide up to $50 Million Financing to Direct Flow Medical,,,,,,,,,,,,,,,,,,,,,,,,, 4/16/2012 92165910 PRN  Vanda Pharmaceuticals Acquires Rights to NK-1 Receptor Antagonist from Eli Lilly and Company,,,,," 1/09/2014 40637H10 PRN  Healthcare Conference Schedules and Additional Loans - Research Report on Clovis Oncology, LifePoint, Halozyme, Infinity, and Endologix",,,,,,, 4/28/2015 69366J20 PRN  PTC Therapeutics' Cancer Stem Cell Program Targeting BMI1 Enters Phase 1,,,,,,,,,"12/11/2013 G5087110 PRN  Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/03/2015 00FV7G-E PRN  American Medical Systems (AMS) sponsors Healthy Body Healthy Mind episode to raise awareness of Stress Urinary Incontinence and treatment options,,, 1/31/2012 000XKX-E    PRN  Techne Corporation Declares Dividend, 1/05/2017 75886F10    PRN  Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection,,, 6/04/2015 IONS-US  PRN  Isis Pharmaceuticals to Present at the Goldman Sachs 36th Annual Global Healthcare Conference, 1/11/2011 09061G10   PRN  BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers,," 2/26/2014 64125C10 PRN  Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock",,,,,,"10/26/2012 000L1R-E   PRN  Stanford University Expert to Host Pulmonary Hypertension Webinar for Patients and Caregivers on October 30, 2012", 5/12/2014 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2014 Financial Results, 7/21/2016 532523-IN PRN  Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency,,,10/31/2017 03116210 PRN  Kirin-Amgen Joint Venture To Become Wholly-Owned Subsidiary Of Amgen,," 2/15/2011 52887230 PRN  Lexicon to Report Fourth Quarter and Year End 2010 Financial Results on February 24, 2011",,,, 7/09/2012 45773H20 PRN  Inovio Pharmaceuticals to Present at JMP Investor Conference,10/02/2013 64026810 PRN  Nektar to Host Investor and Analyst R&D Day in New York City,,,,,, 5/11/2010 002G54-E PRN  Medicomp's Decipher Holter Monitor Provides Cardiac Reporting on the International Space Station,,,,,, 8/26/2010 55027E10 PRN  Luminex Announces Commercial Launch of New Cystic Fibrosis Test,"12/05/2013 80067710 PRN  Marketing Approval, Presentation Schedules, Supplier Agreement, and Management Changes - Research Report on ImmunoGen, Endologix, Unilife, Sangamo, and Dynavax",,12/23/2015 80105N10  PRN  Sanofi Submits New Drug Application for the Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide,,,,,,,,,,,,,,,,,,,,"11/04/2013 69329Y10 PRN  Healthcare Quarterly Reports and Event - Research Report on Hologic, Akorn, Synta, PDL, and Exact Sciences",,,,,,,,,,,,,,,,,,,,,,,,, 2/23/2012 92165910 PRN  Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences,,,,, 1/06/2014 40637H10 PRN  Halozyme Secures Additional $20 Million Term Loan,,,,,,, 4/23/2015 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conferences,,,,,,,,,"11/28/2013 G5087110 PRN  Upcoming Investor Conference Presentations, Donations and Acquisitions - Research Report on Jazz Pharmaceuticals, DENTSPLY, Teleflex, DexCom, and Cell Therapeutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/29/2015 00FV7G-E PRN  Endo Completes Acquisition Of Auxilium Pharmaceuticals,,, 1/31/2012 000XKX-E    PRN  Techne Corporation Releases Unaudited Second Quarter and Six Month Fiscal Year 2012 Results," 1/04/2017 75886F10    PRN  Regeneron Hires Jay Markowitz, M.D., as Senior Vice President of Portfolio Management",,, 5/28/2015 46222210 PRN  Webcast Alert: Akcea Therapeutics Conference Call, 1/05/2011 09061G10   PRN  BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference,," 2/25/2014 64125C10 PRN  Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock",,,,,,"10/25/2012 GIL-CA     PRN  Critical Alerts For Gilead, United Technologies, ARM Holdings, CIT, and ResMed Released By InvestorsObserver", 5/09/2014 4523-JP    PRN  Arena Pharmaceuticals Reports that Eisai Plans to Further Increase its Sales Force for BELVIQ® (lorcaserin HCl) CIV by 50%, 7/20/2016 06CR5C-E  PRN  Mylan Launches Generic Crestor® Tablets,,,10/25/2017 03116210 PRN  Amgen Reports Third Quarter 2017 Financial Results,, 2/08/2011 52887230 PRN  Lexicon Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference,,,, 6/18/2012 45773H20 PRN  Inovio Pharmaceuticals Appoints International Management Expert Dr. Angel Cabrera to its Board of Directors,"10/02/2013 64026810 PRN  Presentation on Research Findings, Recognitions, Clinical Trial Results, and Orphan Drug Designations - Research Report on Celgene, Biogen Idec, Amgen, Nektar, and Zalicus",,,,,, 4/29/2010 91307C10 PRN  United Therapeutics Reports First Quarter 2010 Financial Results,,,,,, 8/17/2010 55027E10 PRN  Luminex Donates Company's First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research,11/25/2013 80067710 PRN  Sangamo BioSciences Announces Presentation At The 25th Annual Piper Jaffray Healthcare Conference,,12/22/2015 05WD3P-E  PRN  Prime Therapeutics prefers both cholesterol lowering drugs Praluent® and Repatha® on its national drug list,,,,,,,,,,,,,,,,,,,,"10/28/2013 69329Y10 PRN  PDL BioPharma to Announce Third Quarter 2013 Financial Results on November 6, 2013",,,,,,,,,,,,,,,,,,,,,,,,, 2/14/2012 92165910 PRN  Vanda Pharmaceuticals Reports Fourth Quarter 2011 and Full Year 2011 Results,,,,,"12/26/2013 40637H10 PRN  Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune",,,,,,, 4/20/2015 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss First Quarter 2015 Financial Results,,,,,,,,,11/20/2013 G5087110 PRN  Jazz Pharmaceuticals Announces Participation at the Piper Jaffray Healthcare Conference on December 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/21/2015 MHP-US   PRN  Endo International Set to Join the S&P 500; Boston Beer to Join S&P MidCap 400; Southside Bancshares to Join S&P SmallCap 600,,,10/27/2011 000XKX-E    PRN  Techne Corporation Declares Dividend,12/22/2016 0FF1DP-E    PRN  Science Publication Highlights the Precision Medicine Approach of Geisinger Health System and the Regeneron Genetics Center,,," 5/20/2015 46222210 PRN  Critical Alerts For Mobileye NV, Chevron, Isis Pharmaceuticals, Exxon Mobil and Starbucks Released By InvestorsObserver",12/14/2010 09061G10   PRN  MHRA Issues Notice of Acceptance for Phase 3 Trial of GALNS for the Treatment of MPS IVA,, 2/25/2014 64125C10 PRN  Neurocrine Biosciences Announces NBI-98854 Scientific Presentations at the International Parkinson and Movement Disorder Society's 18th Annual Congress,,,,,,"10/16/2012 000KYG-E   PRN  Breaking Earnings Forecast News: JPMorgan, Oracle, ARMOUR Residential REIT, Gilead Sciences, General Electric, and Illumina"," 5/05/2014 04004760   PRN  Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, May 12"," 7/13/2016 N5946510  PRN  InvestorsObserver releases covered-call reports for Google Inc., The Blackstone Group, Yahoo!, Mylan and Sonic",,,10/24/2017 03116210 PRN  Amgen Announces Appointment Of Wanda M. Austin To Board Of Directors,, 1/06/2011 52887230 PRN  Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients,,,, 6/13/2012 45773H20 PRN  Inovio Pharmaceuticals to Participate in BIO Vaccine Panel and Present at Marcum Investor Conference, 9/30/2013 NKTR-US  PRN  Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol,,,,,," 4/22/2010 91307C10 PRN  United Therapeutics Corporation To Announce First Quarter 2010 Financial Results Before Market Open on Thursday, April 29, 2010",,,,,, 8/05/2010 55027E10 PRN  Luminex Corporation Reports Second Quarter 2010 Results,11/20/2013 80067710 PRN  Sangamo BioSciences Announces Seven Data Presentations At The 2013 American Society of Hematology Annual Meeting,,12/11/2015 REGN-US   PRN  Regeneron and Sanofi Announce UnitedHealth Group Selects Praluent® (alirocumab) Injection for Preferred Access,,,,,,,,,,,,,,,,,,,,"10/24/2013 69329Y10 PRN  Divestiture, Agreement, Acquisition, Home Health Assessment, and Quarterly Report - Research Report on Osiris, Clovis, PDL, Amedisys, and Acadia Healthcare",,,,,,,,,,,,,,,,,,,,,,,,, 1/26/2012 92165910 PRN  Initial Clinical Data Reveal Potential of Tasimelteon to Reset the Body Clock in Non-24-Hour Sleep-Wake Disorder,,,,,"12/23/2013 40637H10 PRN  Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst",,,,,,, 4/20/2015 005W47-E PRN  Phase 1 Data from Spinal Muscular Atrophy Program to be Presented at the 2015 American Academy of Neurology Annual Meeting,,,,,,,,,"11/20/2013 G5087110 PRN  Stock Price Movements, Share Repurchase Programs, and Financial Results - Research Report on Jazz Pharmaceuticals, Novo Nordisk, Teleflex, DENTSPLY International, and Fonar",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/21/2015 G3040110 PRN  Endo International plc Announces Pricing of Private Offering Of Senior Notes,,,10/25/2011 000XKX-E    PRN  Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results,12/22/2016 75886F10    PRN  Science Publication Highlights the Precision Medicine Approach of the Regeneron Genetics Center and Geisinger Health System,,, 5/05/2015 46222210 PRN  Isis Reports Financial Results and Highlights for First Quarter 2015,12/07/2010 09061G10   PRN  BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference,, 2/07/2014 64125C10 PRN  Neurocrine Biosciences To Present At The Leerink Global Healthcare Conference,,,,,,"10/16/2012 000L1R-E   PRN  Hot Stocks: Yahoo!, Gilead Sciences, Arch Coal, SunTrust Banks, and Invesco Mortgage Capital", 4/14/2014 05NDXX-E   PRN  Arena Pharmaceuticals Reports Eisai's Launch of National Television Advertising Campaign for BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management, 7/11/2016 06CR5C-E  PRN  Mylan Launches Generic Temodar® Capsules,,,10/24/2017 03116210 PRN  Amgen Announces 2017 Fourth Quarter Dividend,, 1/04/2011 52887230 PRN  Lexicon Pharmaceuticals to Present at the 29th Annual JPMorgan Healthcare Conference,,,, 6/01/2012 45773H20 PRN  Inovio Implements New ATM Agreement, 9/26/2013 64026810 PRN  Nektar Announces Preliminary Topline Results from Phase 2 Efficacy Study for NKTR-181 in Chronic Pain Patients with Osteoarthritis of the Knee,,,,,,,,,,,, 8/03/2010 55027E10 PRN  Luminex Corporation to Present at Canaccord Adams 30th Annual Global Growth Conference,"11/19/2013 80067710 PRN  Healthcare Sector Announced Reforms, Financial Results, Public Offerings, Top Rankings and Positive Data - Research Report on Kindred, Zogenix, Sangamo, PhotoMedex and Supernus Pharmaceuticals",,12/11/2015 80105N10  PRN  Sanofi and Regeneron Announce UnitedHealth Group Selects Praluent® (alirocumab) Injection for Preferred Access,,,,,,,,,,,,,,,,,,,,10/21/2013 PDLI-US  PRN  Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million,,,,,,,,,,,,,,,,,,,,,,,,," 1/18/2012 92165910 PRN  Vanda Pharmaceuticals to Announce Fourth Quarter 2011 Financial Results on February 14, 2012",,,,,"12/19/2013 40637H10 PRN  Portfolio Expansions, Product Data, and Announcements by Healthcare Companies - Research Report on Life Technologies, OncoMed, Halozyme Therapeutics, Infinity, and PTC Therapeutics",,,,,,, 4/10/2015 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,,,"11/06/2013 G5087110 PRN  Presentations, Executive Appointments, and Quarterly Financial Reports - Research Report on Jazz Pharmaceuticals, Insulet, The Cooper Companies, Anika Therapeutics, and Sangamo Biosciences",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/21/2015 002Y7X-E PRN  Legal-Bay Lawsuit Settlement Funding Anticipates More Settlements by Transvaginal Mesh Manufacturers in 2015,,, 8/02/2011 000XKX-E    PRN  Techne Corporation Declares Dividend,12/22/2016 000VC1-E    PRN  Regeneron Genetics Center and Geisinger Study Finds Life-Threatening Genetic Disorder is Substantially Underdiagnosed,,," 5/05/2015 46222210 PRN  Critical Alerts For Chesapeake Energy, Isis Pharmaceuticals, BroadSoft, Zoe's Kitchen and Halliburton Released By InvestorsObserver",12/02/2010 09061G10   PRN  MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers,, 2/06/2014 64125C10 PRN  Neurocrine Biosciences Reports Fourth Quarter And Year End 2013 Results,,,,,,"10/04/2012 GILD-US    PRN  Accordia Global Health Foundation Honors Gilead Sciences, Inc. with Global Health Leadership Award", 2/27/2014 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2013 Financial Results," 7/07/2016 N5946510  PRN  Mylan to Report Second Quarter 2016 Financial Results on August 9, 2016",,,10/24/2017 03116210 PRN  Award-Winning Journalist And Cancer Survivor Joan Lunden Partners With Amgen To Launch 'At Home With Joan' To Empower Patients Battling Cancer,,12/14/2010 52887230 PRN  Lexicon Announces Top-Line Phase 2a Data for LX2931 in Patients with Rheumatoid Arthritis,,,, 5/16/2012 45773H20 PRN  Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial," 8/15/2013 64026810 PRN  Pharma Companies Announce Investments in R&D, Ongoing Clinical Trials and Financial Results - Research Report on Alnylam, Infinity, Nektar, Sequenom, and Merrimack",,,,,,,,,,,, 7/27/2010 55027E10 PRN  Luminex Launches New MAGPIX Multiplexing Instrument,11/15/2013 80067710 PRN  Sangamo BioSciences Announces Presentation Of Clinical Data From Alzheimer's Disease Program,,12/01/2015 80105N10  PRN  Sanofi Launches New Priftin® (Rifapentine) Packaging,,,,,,,,,,,,,,,,,,,,10/21/2013 69329Y10 PRN  PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed,,,,,,,,,,,,,,,,,,,,,,,,,12/13/2011 92165910 PRN  Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel,,,,,12/17/2013 008349-E PRN  Halozyme Therapeutics Announces Executive Transitions,,,,,,," 4/08/2015 69366J20 PRN  PTC Therapeutics Names Eric Pauwels SVP & General Manager Commercial Operations, Americas",,,,,,,,,11/05/2013 G5087110 PRN  Jazz Pharmaceuticals Announces Third Quarter 2013 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/20/2015 G3040110 PRN  Endo International plc Announces Proposed Private Offering Of Senior Notes,,, 8/02/2011 0BR3VR-E    PRN  Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results,12/22/2016 000VC1-E    PRN  Regeneron Announces Presentation at the 35th Annual J.P. Morgan Healthcare Conference,,," 5/05/2015 46222210 PRN  Early Briefing on Biotech Stocks -- Galena Biopharma, Isis Pharma, Exact Sciences, Keryx Biopharma, and Vanda Pharma",11/29/2010 09061G10   PRN  BioMarin to Present at the Piper Jaffray Healthcare Conference,, 2/04/2014 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End 2013 Financial Results,,,,,,"10/03/2012 GM-US      PRN  Earnings Forecast Reports: Bank of America, General Motors, Research In Motion, Facebook, Green Mountain Coffee Roasters, and Gilead Sciences"," 2/20/2014 04004760   PRN  Arena Pharmaceuticals to Provide Corporate Update and Report Financial Results on Thursday, February 27", 7/06/2016 06CR5C-E  PRN  Mylan Launches Generic Fenoglide® Tablets,,,10/23/2017 03116210 PRN  Phase 3 A.R.R.O.W. Study Of Once-Weekly KYPROLIS® (Carfilzomib) Regimen Meets Primary Endpoint Of Progression-Free Survival In Relapsed And Refractory Multiple Myeloma Patients,,"11/30/2010 52887230 PRN  Lexicon Pharmaceuticals to Present at 5th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference",,,, 5/15/2012 45773H20 PRN  Inovio Pharmaceuticals to Present at SPI 2012, 8/08/2013 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013,,,,,,,,,,,," 7/15/2010 55027E10 PRN  Luminex Corporation Second Quarter 2010 Earnings Release Scheduled for August 5, 2010",11/12/2013 80067710 PRN  Sangamo BioSciences Announces Presentation Of First Demonstration Of In Vivo Efficacy Of Novel ZFP Therapeutic® For Huntington's Disease,,"11/24/2015 REGN-US   PRN  Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled",,,,,,,,,,,,,,,,,,,,"10/17/2013 69329Y10 PRN  Technical Study: Amgen Inc., Questcor Pharmaceuticals Inc., PDL BioPharma Inc., and BioCryst Pharma Inc.",,,,,,,,,,,,,,,,,,,,,,,,,11/04/2011 92165910 PRN  Vanda Pharmaceuticals Reports Third Quarter 2011 Results,,,,,"12/11/2013 40637H10 PRN  Dividends, FDA Approved Treatments, Clinical Data Presentations and Completed License Applications - Research Report on Medtronic, Auxilium, Alnylam, Infinity, and Halozyme",,,,,,, 3/19/2015 69366J20 PRN  PTC Therapeutics and University of Pennsylvania Collaborate on Orphan Disease Research,,,,,,,,,11/01/2013 G5087110 PRN  Jazz Pharmaceuticals to Present at the 2013 Credit Suisse Healthcare Conference on November 12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 1/16/2015 G3040110 PRN  Pre-Market Pulse on Pharma Stocks - Teva Pharma Industries, Allergan, Endo Intl., Akorn, and Depomed",,," 6/22/2011 CPSI-US     PRN  Zacks Releases Four Powerful ''Buy'' Stocks: CNH Global, Computer Programs and Systems, Techne Corp. and Universal Health Services",12/08/2016 75886F10    PRN  Regeneron and Sanofi Announce Marketing Authorization Application for Dupixent® (dupilumab) Accepted for Review by the EMA,,, 5/04/2015 BAYN-DE  PRN  Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis,11/09/2010 09061G10   PRN  BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock,, 1/09/2014 64125C10 PRN  Neurocrine Announces 12-Week Safety Results From Initial Phase IIB Study Of VMAT2 Inhibitor NBI-98854,,,,,,"10/03/2012 EXPR-US    PRN  Today's Market Focus: Msci, Gilead Sciences, Express, Potash, Texas Instruments, and Macy's", 2/12/2014 4523-JP    PRN  Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® (lorcaserin HCl) in Brazil, 6/24/2016 06CR5C-E  PRN  Mylan Launches Generic Avodart® Capsules,,,10/20/2017 03116210 PRN  Amgen Announces Webcast of 2017 Third Quarter Financial Results,,11/05/2010 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results,,,, 5/09/2012 45773H20 PRN  Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results," 8/01/2013 64026810 PRN  Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets",,,,,,,,,,,, 5/27/2010 55027E10 PRN  Luminex to Webcast Upcoming Investor Presentations,"11/06/2013 80067710 PRN  Presentations, Executive Appointments, and Quarterly Financial Reports - Research Report on Jazz Pharmaceuticals, Insulet, The Cooper Companies, Anika Therapeutics, and Sangamo Biosciences",,11/20/2015 80105N10  PRN  Perceptions of Counterfeit Medicines: Only 12% of Americans Feel They Have Enough Information,,,,,,,,,,,,,,,,,,,,"10/10/2013 69329Y10 PRN  Stock Option Grants, FDA Agreements, Financing Transactions, Clinical Trial Updates, and New Appointments - Research Report on Aegerion, CTI, PDL, Halozyme, and Acorda",,,,,,,,,,,,,,,,,,,,,,,,,10/24/2011 92165910 PRN  Vanda Pharmaceuticals Appoints Chief Commercial Officer,,,,,"12/03/2013 40637H10 PRN  Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis",,,,,,, 3/03/2015 69366J20 PRN  PTC Announces Translarna™ Access Program In Duchenne Muscular Dystrophy for Siblings of Patients Participating in PTC Clinical Trials,,,,,,,,,"10/25/2013 G5087110 PRN  Commencement of Clinical Trials, Financial Results, Upcoming Earnings Releases, and Asset Acquisitions - Research Report on Questcor, Jazz Pharmaceuticals, Ariad, and USANA",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/09/2015 G3040110 PRN  Endo Announces Changes to Senior Management Team,,, 5/03/2011 000XKX-E    PRN  Techne Corporation Announces Acquisition,11/29/2016 0FF1DP-E    PRN  Children's National Health System to Collaborate with the Regeneron Genetics Center in a Large-Scale Whole Exome Sequencing Research Study of Undiagnosed Diseases,,, 5/04/2015 46222210 PRN  Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis,10/28/2010 09061G10   PRN  BioMarin Announces Third Quarter 2010 Financial Results,," 1/09/2014 64125C10 PRN  Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine",,,,,," 9/26/2012 SID-BR     PRN  Today's Market Focus: Lowe's, Coca-Cola, Safeway, Companhia Siderurgica Nacional, Gilead Sciences, and Joy Global", 2/10/2014 04004760   PRN  Arena Pharmaceuticals Reports Coverage for BELVIQ® (lorcaserin HCl) CIV Now Greater Than 50% of Insured Commercial Lives, 6/23/2016 N5946510  PRN  Mylan Donates €1 Million to the Princess Máxima Center for Pediatric Oncology,,,10/16/2017 03116210 PRN  Amgen And Boston Children's Hospital Enter A Collaboration To Find New Genes And Drug Targets For Severe Pain Syndromes,,10/26/2010 52887230 PRN  Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results,,,, 5/01/2012 45773H20 PRN  Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer, 7/30/2013 64026810 PRN  Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer,,,,,,,,,,,, 5/19/2010 55027E10 PRN  Luminex Corporation and High Throughput Genomics Launch the qBead Assay,11/04/2013 80067710 PRN  Sangamo BioSciences Presents Clinical Data From SB-728-T HIV Study Demonstrating Long-Term Immune Reconstitution and Reduction in the HIV DNA Reservoir In Subjects with Long-Term Infection,,11/10/2015 SNY-FR    PRN  Sanofi and Regeneron Announce New Praluent® (alirocumab) Injection Analyses Presented at AHA Scientific Sessions 2015,,,,,,,,,,,,,,,,,,,,10/02/2013 PDLI-US  PRN  PDL BioPharma Provides $60 Million in Financing to LENSAR,,,,,,,,,,,,,,,,,,,,,,,,,"10/18/2011 92165910 PRN  Vanda Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 4, 2011",,,,,"12/02/2013 40637H10 PRN  Market Expert Opinion: Gilead Sciences, NPS Pharma, InterMune, and Halozyme Therapeutics",,,,,,, 2/27/2015 69366J20 PRN  PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update,,,,,,,,,"10/22/2013 G5087110 PRN  Jazz Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 5, 2013",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/05/2015 G3040110 PRN  Endo Announces Retirement of Chief Legal Officer,,, 5/03/2011 000XKX-E    PRN  Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2011,11/21/2016 000VC1-E    PRN  Regeneron CEO Leonard Schleifer and CSO George Yancopoulos Named EY 2016 National Life Sciences Entrepreneurs Of The Year,,, 4/30/2015 IONS-US  PRN  Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen,10/19/2010 09061G10   PRN  BioMarin Announces Program for BMN-111 for the Treatment of Achondroplasia,, 1/06/2014 64125C10 PRN  Neurocrine Announces Positive Results of VMAT2 Inhibitor NBI-98854 in Kinect 2 Study,,,,,," 9/18/2012 37555810   PRN  Critical Alerts For Boeing, Gilead Sciences, Life Technologies, Tesla, and Vivus Released By InvestorsObserver", 2/05/2014 04004760   PRN  Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences, 6/20/2016 N5946510  PRN  Attorney General Rejects VEB's Request Regarding Mylan Shareholder Approval of Meda Transaction,,,10/12/2017 03116210 PRN  Amgen Foundation Awards Khan Academy $3 Million To Support Development Of Free Comprehensive Biology Lessons,,10/12/2010 52887230 PRN  Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd,,,, 4/02/2012 45773H20 PRN  Inovio Pharmaceuticals Receives Defense Department Funding for Bioterrorism-Related Synthetic Vaccine Program," 6/19/2013 64026810 PRN  Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence",,,,,,,,,,,, 5/06/2010 55027E10 PRN  Luminex Corporation Reports First Quarter 2010 Results,10/28/2013 80067710 PRN  Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia,,11/10/2015 REGN-US   PRN  Regeneron and Sanofi Announce New Praluent® (alirocumab) Injection Analyses Presented at AHA Scientific Sessions 2015,,,,,,,,,,,,,,,,,,,," 9/20/2013 69329Y10 PRN  Today's Research: Amgen Inc., BioCryst Pharmaceuticals Inc., PDL BioPharma Inc., and Questcor Pharmaceuticals Inc.",,,,,,,,,,,,,,,,,,,,,,,,, 9/14/2011 92165910 PRN  Vanda Pharmaceuticals to Participate in UBS Global Life Sciences Conference,,,,,11/26/2013 40637H10 PRN  Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference,,,,,,, 2/16/2015 69366J20 PRN  PTC Therapeutics to Participate at Upcoming March Investor Conferences,,,,,,,,, 8/06/2013 G5087110 PRN  JAZZ PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/23/2014 BDSI-US  PRN  Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain,,, 5/03/2011 TECH-US     PRN  Techne Corporation Declares Dividend,"11/17/2016 0FF1DP-E    PRN  Curable Initiates the International PSC Genome Project in Partnership with the Mayo Clinic, With Contributions from the Regeneron Genetics Center",,, 4/29/2015 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' First Quarter 2015 Financial Results Conference Call,10/14/2010 09061G10   PRN  BioMarin to Host a Research and Development Day on October 19th,,12/04/2013 64125C10 PRN  Neurocrine Biosciences To Present At Oppenheimer's 24th Annual Healthcare Conference,,,,,," 9/18/2012 000L1R-E   PRN  Daily Stocks Highlight by Insiderslab: Gilead Sciences, Office Depot, Threshold, American Capital Agency, ConocoPhillips, and Potash"," 1/09/2014 04004760   PRN  Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena", 6/16/2016 N5946510  PRN  Mylan to Commence Meda Offer on June 17,,,10/09/2017 03116210 PRN  FDA Accepts Supplemental Biologics License Application For Prolia® (Denosumab) In Glucocorticoid-Induced Osteoporosis,, 9/09/2010 52887230 PRN  Lexicon to Present at Stifel Nicolaus Healthcare Conference,,,, 3/27/2012 45773H20 PRN  Inovio Appoints Retired Merck Vaccines President Dr. Adel Mahmoud to its Board of Directors," 6/03/2013 64026810 PRN  Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting",,,,,,,,,,,,,10/23/2013 80067710 PRN  Sangamo BioSciences Reports Third Quarter 2013 Financial Results,,11/08/2015 80105N10  PRN  Sanofi and Regeneron Present Results from Pivotal Phase 3 Study of Sarilumab at American College of Rheumatology Annual Meeting,,,,,,,,,,,,,,,,,,,," 9/12/2013 69329Y10 PRN  Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL",,,,,,,,,,,,,,,,,,,,,,,,, 8/31/2011 92165910 PRN  Vanda Pharmaceuticals to Participate in Stifel Nicolaus Global Healthcare Conference and Jefferies Fall 2011 Mid-Atlantic Corporate Access Day,,,,,"11/25/2013 40637H10 PRN  FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics",,,,,,, 2/13/2015 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year End 2014 Financial Results,,,,,,,,," 7/23/2013 G5087110 PRN  Jazz Pharmaceuticals To Report Second Quarter 2013 Financial Results on August 6, 2013",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/22/2014 G3040110 PRN  Endo Announces Appearances at Upcoming Conferences,,, 4/04/2011 000XKX-E    PRN  Techne Corporation Announces Acquisition,11/17/2016 75886F10    PRN  Regeneron and Sanofi Announce Praluent® (alirocumab) Cardiovascular Outcomes Trial Will Continue as Planned Following Interim Analysis,,," 4/28/2015 0017CR-E PRN  Saudi Arabia Arrests 93 Terror Suspects, Foils Attack on US Embassy","10/07/2010 09061G10   PRN  BioMarin to Host Third Quarter 2010 Financial Results Conference Call and Webcast on Thursday, October 28 at 5:00 p.m. ET",,11/26/2013 64125C10 PRN  Neurocrine Biosciences To Present At Deutsche Bank 2013 Biofest And The 25th Annual Piper Jaffray Healthcare Conference,,,,,," 8/03/2012 37555810   PRN  Critical Trade Alerts For Time Warner, Prudential Financial, Gilead Sciences, Navistar, and Weight Watchers Released By InvestorsObserver", 1/06/2014 04004760   PRN  Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference," 6/15/2016 0CN818-E  PRN  RoundTable Healthcare Partners Completes Sale of the Topical Pharmaceutical Division of Renaissance Acquisition Holdings, LLC to Mylan N.V.",,,10/06/2017 03116210 PRN  Amgen And LabCentral Open Nomination Process For Lab Residency,, 9/07/2010 52887230 PRN  Lexicon to Present at Morgan Stanley Global Healthcare Conference,,,, 3/26/2012 45773H20 PRN  Inovio Receives U.S. Patent for SynCon® H1N1 Influenza Universal Vaccine, 6/01/2013 64026810 PRN  Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting,,,,,,,,,,,,,"10/23/2013 80067710 PRN  New Drug Application Reviews, Upcoming Financial Results Schedules, Public Offerings, and Notifications - Research Report on Vanda, Chemed, Portola, Immunomedics, and Sangamo",,11/08/2015 REGN-US   PRN  Regeneron and Sanofi Present Results from Pivotal Phase 3 Study of Sarilumab at American College of Rheumatology Annual Meeting,,,,,,,,,,,,,,,,,,,, 9/12/2013 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,, 8/04/2011 92165910 PRN  Vanda Pharmaceuticals Reports Second Quarter 2011 Results,,,,,"11/13/2013 40637H10 PRN  Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma",,,,,,, 2/06/2015 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,,,,, 6/13/2013 G5087110 PRN  New Research Demonstrates People with Narcolepsy Face Significant Health and Economic Burden and High Rates of Misdiagnosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"12/17/2014 G3040110 PRN  Pharma Equities Technical Analysis -- GlaxoSmithKline, Bristol-Myers Squibb, Teva Pharmaceutical Industries, Endo Intl., and Allergan",,, 2/01/2011 000XKX-E    PRN  Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011,"11/16/2016 000VC1-E    PRN  The Bloc, Named Agency Of The Year, Sweeps Modern Healthcare's Impact Awards",,," 4/27/2015 46222210 PRN  Critical Alerts For Isis Pharmaceuticals, Tata Motors, Cliffs Natural Resources, Moodys and Coca-Cola Enterprises Released By InvestorsObserver",10/05/2010 09061G10   PRN  BioMarin to Host a Research and Development Day on October 19th,,"11/11/2013 64125C10 PRN  Upcoming Earnings Schedules, Conferences and Quarterly Financial Results - Research Report on Supernus, Ironwood, Neurocrine Biosciences, PhotoMedex, and Kythera",,,,,," 7/30/2012 APKT-US    PRN  Daily Stocks Highlight by Insiderslab: Citigroup, Exxon Mobil, Gilead Sciences, Green Dot, Research In Motion, and Acme Packet","12/31/2013 04004760   PRN  Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals", 6/15/2016 0CN818-E  PRN  Mylan Completes Acquisition of Renaissance's Leading Topicals-Focused Specialty and Generics Business,,,"10/05/2017 03116210 PRN  First Randomized Study To Evaluate IMLYGIC® (Talimogene Laherparepvec), An Oncolytic Viral Therapy, In Combination With A Checkpoint Inhibitor Published In The Journal Of Clinical Oncology",, 8/09/2010 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Second Quarter Financial Results,,,, 3/15/2012 45773H20 PRN  Inovio Pharmaceuticals Reports 2011 Fourth Quarter and Year-End Financial Results," 5/30/2013 64026810 PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the Jefferies 2013 Global Healthcare Conference in New York City",,,,,,,,,,,,,10/16/2013 80067710 PRN  Sangamo BioSciences Announces Third Quarter 2013 Conference Call and Webcast,,"11/06/2015 80105N10  PRN  Sanofi and Lexicon Pharmaceuticals To Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes",,,,,,,,,,,,,,,,,,,, 9/11/2013 69329Y10 PRN  PDL BioPharma to Present at the 4th Annual Credit Suisse Small/Mid Cap Conference,,,,,,,,,,,,,,,,,,,,,,,,, 8/01/2011 92165910 PRN  Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Biotoscana Farma S.A. for Commercialization of Fanapt ™ in Argentina.,,,,,11/08/2013 40637H10 PRN  Halozyme Reports Third Quarter 2013 Financial Results,,,,,,, 2/05/2015 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conferences,,,,,,,,, 6/05/2013 G5087110 PRN  New Research at SLEEP 2013 Demonstrates People with Narcolepsy Face Significant Health and Economic Burden and High Rates of Misdiagnosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/11/2014 G3040110 PRN  Endo Registration Statement Relating to Pending Auxilium Acquisition Declared Effective by the SEC,,, 2/01/2011 000XKX-E    PRN  Techne Corporation Declares Dividend,11/16/2016 REGN-US     PRN  Regeneron and Sanofi Present Results from Phase 3 MONARCH Study of Investigational Sarilumab at American College of Rheumatology Annual Meeting,,, 4/22/2015 46222210 PRN  Isis Pharmaceuticals Reports Positive Data From ISIS-TTR Rx in Patients With TTR Amyloidosis, 9/23/2010 09061G10   PRN  BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors,,10/29/2013 64125C10 PRN  Neurocrine Biosciences Reports Third Quarter 2013 Results,,,,,," 7/12/2012 05ZL54-E   PRN  Hot Stocks: General Electric, Waste Management, Research In Motion, Gilead Sciences, Prospect Capital, and Talisman Energy","12/09/2013 04004760   PRN  Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma", 6/03/2016 532523-IN PRN  Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting,,,10/05/2017 SAN-FR   PRN  Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent® (alirocumab),, 8/03/2010 52887230 PRN  Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2010 Financial Results,,,, 3/13/2012 45773H20 PRN  Inovio Pharmaceuticals' PENNVAX®-B HIV Vaccine Demonstrates Strong T-Cell Immune Responses in Therapeutic Vaccine Trial," 5/16/2013 64026810 PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City",,,,,,,,,,,,,10/07/2013 80067710 PRN  Sangamo BioSciences Announces Presentation At the 2013 Stem Cell Meeting on the Mesa,,"11/06/2015 80105N10  PRN  Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes",,,,,,,,,,,,,,,,,,,, 9/09/2013 69329Y10 PRN  PDL BioPharma Provides Third Quarter 2013 Revenue Guidance of $97 Million,,,,,,,,,,,,,,,,,,,,,,,,, 7/26/2011 92165910 PRN  European Medicines Agency Accepts Vanda Pharmaceuticals Inc.'s Marketing Authorization Application For Oral Iloperidone Tablets,,,,,11/06/2013 40637H10 PRN  Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference,,,,,,, 1/07/2015 69366J20 PRN  PTC Therapeutics to Present at the 33rd Annual J.P. Morgan Healthcare Conference,,,,,,,,, 5/13/2013 G5087110 PRN  Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/09/2014 G3040110 PRN  Endo Completes Acquisition of Rights to Natesto™ Testosterone Nasal Gel,,,10/28/2010 000XKX-E    PRN  Techne Corporation Declares Dividend,11/11/2016 000VC1-E    PRN  Regeneron and Sanofi to Present Data from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2016,,, 4/10/2015 46222210 PRN  Isis Pharmaceuticals to Present at Upcoming Investor Conferences, 9/14/2010 09061G10   PRN  BioMarin to Present at the UBS Global Life Sciences Conference,,10/22/2013 64125C10 PRN  Neurocrine Biosciences Announces Conference Call And Webcast To Present Third Quarter 2013 Financial Results,,,,,," 6/29/2012 37555810   PRN  Stock Alerts For Apple, United Technologies, Gilead Sciences, Community Health, and Bill Barrett Released By InvestorsObserver","12/06/2013 04004760   PRN  Bearish Stocks Analysis: Morgan Stanley, Microsoft Corporation, Arena Pharmaceuticals, Vale SA, JPMorgan Chase & Co", 6/03/2016 06CR5C-E  PRN  Mylan Launches Generic Cleocin® Solution,,,10/03/2017 03116210 PRN  Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology,, 8/02/2010 52887230 PRN  Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs,,,, 3/07/2012 45773H20 PRN  Inovio Appoints Vaccine Industry Leader to its Scientific Advisory Board, 5/09/2013 64026810 PRN  Nektar Therapeutics Reports Financial Results for the First Quarter of 2013,,,,,,,,,,,,,"10/04/2013 80067710 PRN  Positive Results, Close of Public Offerings, Grants, Data Presentations and Partnerships - Research Report on Lexicon, Sangamo Biosciences, Immunomedics, NewLink Genetics, and Pacific Biosciences",,11/05/2015 SNY-FR    PRN  Sanofi and Hanmi Announce License Agreement To Develop Portfolio of Long-Acting Diabetes Treatments,,,,,,,,,,,,,,,,,,,, 9/04/2013 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,," 7/20/2011 92165910 PRN  Vanda Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 4, 2011",,,,,"11/06/2013 40637H10 PRN  Quarterly Dividends, Financial Results, and FDA Guidance - Research Report on Techne, ImmunoGen, Repros, Halozyme, and Synageva",,,,,,, 1/02/2015 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,,,, 5/07/2013 G5087110 PRN  JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2013 FINANCIAL RESULTS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"12/01/2014 G3040110 PRN  Market Movers - Pharma Industry Stocks - Hospira, Perrigo, Auxilium Pharma, Depomed, and Endo Intl.",,,10/26/2010 000XKX-E    PRN  Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2011,11/04/2016 06CR5C-E    PRN  Regeneron Reports Third Quarter 2016 Financial and Operating Results,,, 3/27/2015 46222210 PRN  Earnings Coverage - Isis Pharma, 9/09/2010 09061G10   PRN  BioMarin to Present at the Stifel Nicolaus Healthcare Conference,," 9/19/2013 64125C10 PRN  Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine",,,,,," 5/17/2012 064Q9G-E   PRN  Cystic Fibrosis Foundation Launches ""Walk Weekend"" - More Than 200 Great Strides Fundraisers Scheduled Nationwide for May 19-20","11/29/2013 04004760   PRN  Promising Partnerships, Stock Price Updates and Participation in Upcoming Healthcare Conferences - Research Report on Quest Diagnostics, Cigna, Arena, Theravance, and Volcano", 6/02/2016 N5946510  PRN  Mylan Launches Generic Vidaza® Injection,,,"10/02/2017 03116210 PRN  Today's Research Report Coverage on Biotech Stocks -- Marinus Pharma, NewLink Genetics, Akcea Therapeutics, and Amgen",, 6/21/2010 52887230 PRN  Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes,,,, 3/05/2012 45773H20 PRN  Inovio Therapeutic Vaccine for Head & Neck and Other HPV-Related Cancers Induces Robust T-Cell Immune Response in Mice," 5/02/2013 64026810 PRN  Nektar to Announce Financial Results for the First Quarter of 2013 on Thursday, May 9, 2013, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,, 9/23/2013 80067710 PRN  Sangamo BioSciences Announces Closing Of $74.2 Million Public Offering Of Common Stock And Exercise Of Over-Allotment Option,,11/05/2015 80105N10  PRN  Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015,,,,,,,,,,,,,,,,,,,, 8/08/2013 69329Y10 PRN  PDL BioPharma Announces Second Quarter 2013 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,, 7/11/2011 09CXM7-E PRN  Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Probiomed S.A. de C.V. for Commercialization of Fanapt™ in Mexico,,,,,"11/04/2013 40637H10 PRN  Under AAAResearchReports.com Microscope: Gilead Sciences Inc., NPS Pharma Inc., Halozyme Therapeutics Inc., and InterMune Inc.",,,,,,,12/23/2014 69366J20 PRN  PTC Therapeutics Begins Rolling NDA Submission to the FDA for Translarna to Treat Duchenne Muscular Dystrophy,,,,,,,,," 4/23/2013 G5087110 PRN  Jazz Pharmaceuticals To Report First Quarter 2013 Financial Results On May 7, 2013",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/24/2014 G3040110 PRN  Endo Acquires Rights to Natesto™ Testosterone Nasal Gel,,, 8/03/2010 000XKX-E    PRN  Techne Corporation Declares Dividend,"10/31/2016 75886F10    PRN  Learn how to target a 17% return on Cardinal Health, or get option-trade ideas on Capital One, Dean Foods, Pfizer Inc. and Regeneron Pharmaceuticals or any stock you choose",,, 3/23/2015 46222210 PRN  Isis Pharmaceuticals Reports Positive Phase 1 Data on Isis-ANGPTL3Rx, 9/08/2010 09061G10   PRN  BioMarin to Present at the Robert W. Baird Healthcare Conference,, 9/09/2013 64125C10 PRN  Neurocrine Announces Phase IIb Results Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia,,,,,," 5/15/2012 NILE-US    PRN  The Zacks Analyst Blog Highlights: Gilead Sciences, Abbott Labs, Alliance Data Systems Corporation, Blue Nile and Bristol-Myers Squibb",11/27/2013 04004760   PRN  Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference, 6/02/2016 N5946510  PRN  Mylan Launches Generic Rythmol® Sustained-Release Capsules,,, 9/28/2017 03116210 PRN  Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA™,," 6/15/2010 52887230 PRN  Lexicon to Present Clinical Data for Diabetes Drug Candidate, LX4211, at Two Major Healthcare Conferences",,,, 2/28/2012 45773H20 PRN  Inovio Pharmaceuticals to Present at Cowen and ROTH Investor Conferences," 4/17/2013 NKTR-US  PRN  Critical Alerts For Intel, Delta, Southern Copper, Lam Research, and Nektar Therapeutics Released By InvestorsObserver",,,,,,,,,,,,, 9/18/2013 80067710 PRN  Sangamo BioSciences Announces Pricing Of Public Offering Of Common Stock,,11/03/2015 80105N10  PRN  Sanofi and BioNTech Announce Cancer Immunotherapy Collaboration and License Agreement,,,,,,,,,,,,,,,,,,,," 8/01/2013 69329Y10 PRN  PDL BioPharma to Announce Second Quarter 2013 Financial Results on August 8, 2013",,,,,,,,,,,,,,,,,,,,,,,,, 7/08/2011 92165910 PRN  New Website Targets Common Sleep Disorder in Blind Individuals,,,,,11/01/2013 40637H10 PRN  Halozyme to Host Third Quarter 2013 Financial Results Conference Call,,,,,,,12/19/2014 69366J20 PRN  Translarna Granted Orphan Drug Designation in the U.S. and Europe for the Treatment of Mucopolysaccharidosis I,,,,,,,,, 3/14/2013 000TC1-E PRN  Par Pharmaceutical Begins Shipment of Generic Luvox CR®,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/20/2014 G3040110 PRN  Endo Announces Launch of Generic Version of Valcyte®,,, 8/03/2010 000XKX-E    PRN  Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2010,"10/28/2016 06CR5C-E    PRN  Regeneron and Sanofi Receive Complete Response Letter from FDA for Sarilumab, an Investigational Treatment for Rheumatoid Arthritis",,," 3/19/2015 46222210 PRN  Critical Alerts For Celgene, Cliffs Natural Resources, Cintas, Workday and Isis Pharmaceuticals Released By InvestorsObserver", 9/07/2010 09061G10   PRN  BioMarin to Present at the Morgan Stanley Global Healthcare Conference,," 9/03/2013 64125C10 PRN  Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals",,,,,," 5/14/2012 NUAN-US    PRN  Research Reports for Chesapeake Energy, Bank of America, Ford, Ciena, Nuance Communications, and Gilead Sciences","11/26/2013 04004760   PRN  Trend Analysis Scan: Synovus Financial, Arena Pharmaceuticals, Facebook Inc, J.C. Penney Company, Citigroup"," 6/01/2016 06CR5C-E  PRN  Mylan Launches First Generic of Doxycycline Hyclate Delayed-Release Tablets, 50 mg",,, 9/26/2017 03116210 PRN  Amgen And Simcere Announce Strategic Collaboration To Co-Develop And Commercialize Biosimilars In China,, 6/03/2010 52887230 PRN  Lexicon to Present at Two Major Healthcare Investor Conferences,,,, 2/22/2012 45773H20 PRN  Inovio Researchers Successfully Demonstrate RNA Drug Delivery via Electroporation, 4/16/2013 64026810 PRN  Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia,,,,,,,,,,,,, 9/17/2013 80067710 PRN  Sangamo BioSciences Proposes Public Offering Of Common Stock,,10/29/2015 80105N10  PRN  Update: Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery,,,,,,,,,,,,,,,,,,,, 7/24/2013 69329Y10 PRN  PDL BioPharma Appoints David Montez as Controller and Chief Accounting Officer,,,,,,,,,,,,,,,,,,,,,,,,, 6/02/2011 92165910 PRN  Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference,,,,,"10/25/2013 40637H10 PRN  Marketing Approvals, Disposal of Interests, Positive Study Results and New Clinical Trials - Research Report on Cardiovascular Systems, Depomed, Halozyme, VIVUS, and Gentium",,,,,,,12/17/2014 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,,,, 3/05/2013 G5087110 PRN  Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/19/2014 00FV7G-E PRN  Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals,,, 5/26/2010 09073M10    PRN  Techne Corporation Announces That Dr. Roeland Nusse Has Accepted a Seat on Its Board of Directors,10/27/2016 75886F10    PRN  Science Magazine Once Again Names Regeneron the Best Company to Work For,,, 3/06/2015 46222210 PRN  Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy, 9/01/2010 09061G10   PRN  Results From Investigator-Sponsored Trials Presented at SSIEM Conference,, 9/03/2013 64125C10 PRN  Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference,,,,,, 5/01/2012 000L1R-E   PRN  AnaptysBio Announces Antibody Discovery Partnership With Gilead Sciences,"11/22/2013 04004760   PRN  Early Briefing and Review: Arena Pharma Inc., Geron Corp., Incyte Corp., and Spectrum Pharma Inc.", 6/01/2016 06CR5C-E  PRN  Mylan Launches First Generic of Nuvigil® Tablets,,, 9/25/2017 03116210 PRN  Amgen Provides Update On Hurricane Maria,, 5/10/2010 52887230 PRN  Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 First Quarter Results,,,, 2/21/2012 45773H20 PRN  Inovio's Scientific Advisory Board Chairman Elected as a Fellow by the American Association for the Advancement of Science," 4/07/2013 64026810 PRN  Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013",,,,,,,,,,,,, 9/12/2013 80067710 PRN  Sangamo BioSciences announces presentation of clinical Data Demonstrating Functional Control of Viremia in HIV-Infected Subjects treated with SB-728-T,,"10/29/2015 MYL-GB    PRN  Mylan Confirms Availability of EpiPen® (epinephrine injection) Auto-Injector for U.S. Patients Affected by Sanofi's Auvi-Q® (epinephrine injection, USP) Recall",,,,,,,,,,,,,,,,,,,," 7/11/2013 69329Y10 PRN  Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma",,,,,,,,,,,,,,,,,,,,,,,,, 5/24/2011 92165910 PRN  Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders,,,,,10/22/2013 40637H10 PRN  SWOG Initiates Randomized Phase 2 Clinical Trial of Halozyme's PEGPH20 in Combination with modified FOLFIRINOX for Advanced Pancreatic Cancer,,,,,,,12/03/2014 69366J20 PRN  PTC Therapeutics Announces Launch of Translarna™ (ataluren) in Germany,,,,,,,,, 3/04/2013 G5087110 PRN  Jazz Pharmaceuticals Announces Public Offering Of Ordinary Shares By Selling Shareholders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/19/2014 G3040110 PRN  Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals,,, 5/04/2010 09073M10    PRN  Techne Corporation Declares Dividend,10/21/2016 75886F10    PRN  Regeneron Announces Presentation at the 25th Annual Credit Suisse Healthcare Conference,,, 3/02/2015 46222210 PRN  Isis Pharmaceuticals Earns $15 Million From GSK for Advancing ISIS-TTR Rx, 8/30/2010 09061G10   PRN  BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease,, 8/29/2013 64125C10 PRN  Neurocrine Biosciences Announces the Start of Second Phase III Study of Elagolix in Endometriosis,,,,,," 4/20/2012 LCC-US     PRN  Research Reports for Human Genome Sciences, Gilead Sciences, Bristol Myers Squibb, CVR Energy, UnitedHealth Group, and US Airways Group","11/21/2013 04004760   PRN  Health Care Initiatives, Clinical Data Presentations, Public Offerings, Contract Extensions and Publication of Pre-Clinical Study - Research Report on Cigna, Arena, Synta, Healthways, and Catalyst", 5/31/2016 MDABY-SE  PRN  Mylan Announces Pricing of Senior Notes,,, 9/22/2017 03116210 PRN  Amgen Foundation Pledges Up To $5 Million To Hurricane Maria Relief Efforts,, 5/05/2010 52887230 PRN  Lexicon Presents Positive Outcome in IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action,,,, 2/06/2012 45773H20 PRN  Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference," 3/08/2013 64026810 PRN  Pushing Pipelines Forward for Long-Term Success - Research Report on Vertex, Santarus, Arena Pharmaceuticals, Seattle Genetics and Nektar Therapeutics",,,,,,,,,,,,," 9/12/2013 80067710 PRN  Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL",,10/29/2015 80105N10  PRN  Sanofi Grew Sales and Business EPS in Q3 2015,,,,,,,,,,,,,,,,,,,," 7/03/2013 69329Y10 PRN  Positive Clinical Data, Marketing Authorizations, and New Appointments Support Growth in Biotech Companies - Research Report on Santarus, VIVUS, Epizyme, Peregrine Pharmaceuticals, and PDL BioPharma",,,,,,,,,,,,,,,,,,,,,,,,, 5/05/2011 92165910 PRN  Vanda Pharmaceuticals Reports First Quarter 2011 Results,,,,,"10/21/2013 40637H10 PRN  Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros",,,,,,,"11/21/2014 69366J20 PRN  PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award",,,,,,,,, 2/27/2013 G5087110 PRN  Jazz Pharmaceuticals Announces Participation At Two Investor Conferences In March,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/12/2014 002Y7X-E PRN  Transvaginal Mesh Lawsuit Settlement News: Legal-Bay Lawsuit Settlement Funding Expects More Mesh Manufacturers to Settle Claims by First Quarter of 2015,,, 5/04/2010 09073M10    PRN  Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2010,10/17/2016 75886F10    PRN  Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs,,, 2/27/2015 46222210 PRN  Isis Reports Financial Results and Highlights for 2014," 8/17/2010 09061G10   PRN  BioMarin Acquires ZyStor Therapeutics, Inc.",, 7/25/2013 64125C10 PRN  Neurocrine Biosciences Reports Second Quarter 2013 Results,,,,,," 4/05/2012 SU-CA      PRN  Daily Stocks Highlight by Insiderslab: SanDisk, Gilead Sciences, Goldcorp, Newmont Mining, EMC, and Suncor Energy",11/18/2013 4523-JP    PRN  BELVIQ® (lorcaserin HCl) CIV Data to be Presented at American Heart Association 2013 Scientific Sessions," 5/27/2016 N5946510  PRN  Learn how to target a 20% return on The Home Depot Inc, or get option-trade ideas on Whole Foods Market, Mylan, FireEye and Sysco Corporation or any stock you choose",,," 9/20/2017 03116210 PRN  AMGEN (AMGN) ALERT: Johnson Fistel Announces Investigation of Amgen Inc.; Investors that Bought Before March 17, 2017, Encouraged to Contact the Firm",, 5/03/2010 52887230 PRN  Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2010 Financial Results,,,," 1/31/2012 45773H20 PRN  Inovio Pharmaceuticals Moves Closer to ""Universal"" Influenza Vaccine by Demonstrating Protective Immune Responses Against Multiple H3N2 and Type B Strains in Animal Studies", 3/01/2013 64026810 PRN  Nektar Therapeutics to Present at the 33rd Annual Cowen and Company Healthcare Conference in Boston,,,,,,,,,,,,, 8/26/2013 80067710 PRN  Sangamo BioSciences to Acquire Ceregene,,10/29/2015 80105N10  PRN  Sanofi - Q3 2015 Results,,,,,,,,,,,,,,,,,,,, 7/02/2013 69329Y10 PRN  PDL BioPharma to Present at the JMP Securities Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,," 4/22/2011 92165910 PRN  Vanda Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 5, 2011",,,,,10/15/2013 40637H10 PRN  Yale Researchers Initiate Clinical Trial Evaluating Halozyme's Recombinant Hyaluronidase in Artificial Pancreas Study,,,,,,,11/19/2014 69366J20 PRN  Spinal Muscular Atrophy Program Enters Phase 1b/2a Trial in Patients with SMA,,,,,,,,, 2/26/2013 G5087110 PRN  Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/10/2014 G3040110 PRN  Quarterly Financial Performance Reviews, Upcoming Events, and Medicare Plan Launch - Research Reports on Actavis, Celgene, UnitedHealth, Jazz and Endo",,,,10/07/2016 LBTA.XX1-US PRN  Several Highest Paid CEOs Have Made the Top 25 List for Years,,," 2/25/2015 46222210 PRN  Critical Alerts For MannKind, Keryx Biopharmaceuticals, Isis Pharmaceuticals, Yahoo! and Tekmira Pharmaceuticals Released By InvestorsObserver", 8/17/2010 09061G10   PRN  BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU,, 7/18/2013 64125C10 PRN  Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2013 Financial Results,,,,,," 4/02/2012 37555810   PRN  Critical Alerts for Home Depot, Gilead Sciences, Green Mountain Coffee Roasters, Toll Brothers, and Foot Locker by Seven Summits Research",11/13/2013 05NDXX-E   PRN  BELVIQ® (lorcaserin HCl) CIV Data Featured in Five Abstracts to be Presented at ObesityWeek(SM) 2013, 5/26/2016 GS-US     PRN  Mylan to Present at Goldman Sachs 37th Annual Global Healthcare Conference,,, 9/20/2017 08B106-E PRN  deCODE Study Reveals an Ancient Achilles Heel in the Human Genome,, 4/28/2010 52887230 PRN  Lexicon to Present at BIO International Convention,,,, 1/11/2012 45773H20 PRN  Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference, 2/28/2013 64026810 PRN  Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results,,,,,,,,,,,,," 8/19/2013 80067710 PRN  Positive Preliminary Results, R&D Investments, and Financial Results - Research Report on MannKind, Anacor, Sangamo, Stereotaxis, and Columbia Laboratories",,10/28/2015 80105N10  PRN  Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery,,,,,,,,,,,,,,,,,,,, 6/25/2013 69329Y10 PRN  PDL BioPharma Appoints Glenn Reicin as Senior Advisor,,,,,,,,,,,,,,,,,,,,,,,,, 4/11/2011 92165910 PRN  Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®,,,,,"10/11/2013 40637H10 PRN  Technical Study: Gilead Sciences Inc., NPS Pharmaceuticals Inc., Halozyme Therapeutics Inc., and InterMune Inc.",,,,,,,11/17/2014 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,,,," 2/11/2013 G5087110 PRN  Jazz Pharmaceuticals To Report 2012 Fourth Quarter And Full Year Financial Results On February 26, 2013",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/10/2014 G3040110 PRN  Endo Receives Final Approval for Generic Version of Valcyte®,,,,"10/07/2016 75886F10    PRN  Regeneron to Report Third Quarter 2016 Financial and Operating Results and Host Conference Call and Webcast on November 4, 2016",,," 2/25/2015 46222210 PRN  Market Updates on Biotech Stocks - Hemispherx Biopharma, Nanosphere, Isis Pharma, Keryx Biopharma, and Spectrum Pharma", 8/02/2010 09061G10   PRN  BioMarin Announces Second Quarter 2010 Financial Results,, 7/01/2013 64125C10 PRN  Neurocrine Announces Completion Of Enrollment Into Kinect Study For Treatment Of Tardive Dyskinesia,,,,,, 3/08/2012 080501-E   PRN  Greenberg Traurig's Mergers and Acquisitions Practice Ranked by Corporate Control Alert,"11/12/2013 04004760   PRN  Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena"," 5/23/2016 06CR5C-E  PRN  Mylan Launches First Generic Doryx® Delayed-Release Tablets, 200 mg",,, 9/15/2017 03116210 PRN  New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes,, 4/27/2010 52887230 PRN  Lexicon to Present Phase 2 Clinical Data for IBS Drug Candidate at Digestive Disease Week,,,, 1/05/2012 45773H20 PRN  Inovio Pharmaceuticals to Present at Biotech Showcase Investor Conference, 2/26/2013 64026810 PRN  AstraZeneca Announces Results From Long-Term Safety Trial Of Naloxegol In Patients With Opioid-Induced Constipation,,,,,,,,,,,,, 8/14/2013 80067710 PRN  Sangamo BioSciences Announces Notice Of Allowance For New Patent Application Covering Genome Modification Technology,,"10/15/2015 SNY-FR    PRN  Sanofi Pasteur and the Infectious Disease Research Institute Partner on a Global-Health, Open-Innovation, Vaccine Research & Development Center",,,,,,,,,,,,,,,,,,,," 6/21/2013 PDLI-US  PRN  Delivering Value for Shareholders through Share Buyback Programs, Royalty Revenues, and Capital Plans - Research Report on Abbott, PAREXEL, PDL BioPharma, Health Net, and Molina Healthcare",,,,,,,,,,,,,,,,,,,,,,,,, 3/31/2011 92165910 PRN  Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression,,,,,"10/10/2013 40637H10 PRN  Stock Option Grants, FDA Agreements, Financing Transactions, Clinical Trial Updates, and New Appointments - Research Report on Aegerion, CTI, PDL, Halozyme, and Acorda",,,,,,,"11/17/2014 69366J20 PRN  PTC Therapeutics Appoints Dr. Tuyen Ong SVP, Head of Clinical Development and Translational Research",,,,,,,,," 1/30/2013 G5087110 PRN  Free Research Report on Jazz Pharmaceuticals, Inc., Furiex Pharmaceuticals, Inc., Sunesis Pharmaceuticals, Inc., Prestige Brands Holdings, Inc. and Synta Pharmaceuticals, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/05/2014 G3040110 PRN  Endo Reports Third Quarter Financial Results,,,,10/05/2016 75886F10    PRN  New Survey Reveals the Widespread and Serious Impact of Moderate-to-Severe Atopic Dermatitis on People Living with the Disease,,, 2/24/2015 46222210 PRN  ISIS Pharmaceuticals Reports Positive Phase 1 Data Demonstrating ISIS-PKK Rx Produces Significant Reductions in Prekallikrein Levels, 8/02/2010 09061G10   PRN  Encouraging Preliminary Safety and Efficacy Trends in Phase 2 Clinical Study of PEG-PAL in PKU,, 5/29/2013 64125C10 PRN  Neurocrine Biosciences to Present at the Jefferies 2013 Global Healthcare Conference,,,,,," 3/07/2012 000BTB-E   PRN  Equity Research on Most Popular Searches: Research In Motion, Gilead Sciences, Express Scripts, Texas Instruments, and Skyworks",11/07/2013 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results, 5/17/2016 N5946510  PRN  Mylan Updates Timetable for Commencement of Acceptance Period for Offer for Meda,,, 9/14/2017 03116210 PRN  FDA Approves Amgen And Allergan's MVASI™ (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer,,,,,, 1/04/2012 45773H20 PRN  Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer," 2/13/2013 64026810 PRN  Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2012 On Thursday, February 28, 2013, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,, 8/07/2013 80067710 PRN  Sangamo BioSciences Announces Presentation At The 2013 Wedbush Life Sciences Management Access Conference,,10/01/2015 80105N10  PRN  Sanofi Announces Launch of Authorized Generic Version of Arava® (Leflunomide) Tablets,,,,,,,,,,,,,,,,,,,, 6/12/2013 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,, 3/08/2011 92165910 PRN  Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon,,,,,"10/01/2013 40637H10 PRN  Merger Updates, Milestone Payments, AGM Results, Review of Strategic Alternatives and Other Corporate Announcements - Research Report on Cubist, Halozyme, Taro, Galena and Sequenom",,,,,,,11/14/2014 69366J20 PRN  PTC Therapeutics Recognized for Outstanding Innovation at the 2014 Rare & Orphan Advocacy and Research (ROAR) Awards,,,,,,,,," 1/23/2013 G5087110 PRN  Where Opportunity is Found - Research Report on Jazz Pharmaceuticals plc and Spectrum Pharmaceuticals, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"10/24/2014 G3040110 PRN  Technical Report on Pharma Stocks - Auxilium Pharma, Perrigo, Endo Intl., Depomed, and Ampio Pharma",,,,10/05/2016 75886F10    PRN  New Survey Reveals the Widespread and Serious Impact of Moderate-to-Severe Atopic Dermatitis on People Living with the Disease,,, 2/20/2015 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' 2014 Financial Results and Highlights Conference Call, 8/02/2010 09061G10   PRN  BioMarin Announces Results for Phase 1 Clinical Study of BMN 195 for Duchenne Muscular Dystrophy,, 5/23/2013 64125C10 PRN  Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference,,,,,, 2/23/2012 000L1R-E   PRN  Galen Acquires DaunoXome® (daunorubicin citrate liposome injection) for Advanced HIV-associated Kaposi's Sarcoma,11/07/2013 05NDXX-E   PRN  Arena Pharmaceuticals and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide," 5/13/2016 0CN818-E  PRN  RoundTable Healthcare Partners Announces Sale of the Topical Pharmaceutical Division of Renaissance Acquisition Holdings, LLC",,, 9/14/2017 03116210 PRN  Biotech Sector Looking to Outperform in 2017,,,,,,12/12/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference, 2/05/2013 64026810 PRN  Nektar Announces Initiation of Investigator-Initiated Trial Evaluating Etirinotecan Pegol (NKTR-102) as a Third-Line Treatment in Patients with Metastatic and Recurrent Non-Small Cell Lung Cancer (NSCLC),,,,,,,,,,,,, 7/24/2013 80067710 PRN  Sangamo BioSciences Reports Second Quarter 2013 Financial Results,, 9/29/2015 SNY-FR    PRN  Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA,,,,,,,,,,,,,,,,,,,, 6/11/2013 69329Y10 PRN  PDL BioPharma Provides Second Quarter 2013 Royalty Revenue Guidance of $143 Million,,,,,,,,,,,,,,,,,,,,,,,,, 2/10/2011 92165910 PRN  Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results,,,,, 9/30/2013 40637H10 PRN  Halozyme Presents PEGPH20 Phase 1b Clinical Trial Data at European Cancer Congress 2013,,,,,,,11/13/2014 69366J20 PRN  PTC Therapeutics to Webcast Upcoming Science Day and Investor Conferences,,,,,,,,," 1/17/2013 0CBRZ9-E PRN  LPGA Golfer Nicole Jeray Raises More Than $35,000 to Benefit Narcolepsy Sufferers",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"10/20/2014 G3040110 PRN  Endo to Announce Third Quarter 2014 Financial Results on November 5, 2014",,,,10/01/2016 75886F10    PRN  Regeneron and Sanofi Announce Positive Dupixent® (dupilumab) Phase 3 Atopic Dermatitis Data Published in the New England Journal of Medicine,,, 2/10/2015 46222210 PRN  Isis Pharmaceuticals Earns $5 Million Milestone Payment From Biogen Idec," 7/06/2010 09061G10   PRN  BioMarin to Host Second Quarter 2010 Financial Results Conference Call and Webcast on Monday, August 2 at 5:00 p.m. ET",, 5/09/2013 64125C10 PRN  Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference,,,,,," 2/21/2012 37555810   PRN  Seven Summits Research Releases Comments on UPS, Hewlett-Packard, Gilead, Express Scripts and Chesapeake Energy","11/07/2013 04004760   PRN  FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech", 5/13/2016 0CN818-E  PRN  Mylan to Acquire Renaissance's Leading Topicals-Focused Specialty and Generics Business,,, 9/11/2017 03116210 PRN  Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference,,,,,,12/07/2011 45773H20 PRN  Inovio Pharmaceuticals Closes $4.0 Million Underwritten Financing," 1/04/2013 NKTR-US  PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, CA",,,,,,,,,,,,, 7/17/2013 80067710 PRN  Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome,, 9/28/2015 LLY-US    PRN  Lilly and Sanofi Reach Settlement Agreement in U.S. Insulin Glargine Litigation,,,,,,,,,,,,,,,,,,,, 6/11/2013 69329Y10 PRN  PDL Files for Arbitration Against Genentech Based on Underpayment of Royalties,,,,,,,,,,,,,,,,,,,,,,,,," 2/01/2011 92165910 PRN  Vanda Pharmaceuticals to Announce Fourth Quarter 2010 Financial Results on February 10, 2011",,,,, 9/26/2013 40637H10 PRN  Commercial Launch of Herceptin SC in EU Triggers Milestone Payment to Halozyme from Roche,,,,,,,11/06/2014 69366J20 PRN  PTC Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update,,,,,,,,, 1/02/2013 JAZZ-IE  PRN  Jazz Pharmaceuticals to Webcast Presentation at J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"10/14/2014 G3040110 PRN  Acquisition, Market Activity, and Upcoming Events - Research Reports on Auxilium, Lakeland, Endo, Actavis and Celgene",,,, 9/30/2016 75886F10    PRN  Regeneron Announces Phase 2 Study of Aflibercept Co-Formulated with Rinucumab (anti-PDGFR-beta) Shows No Benefit Over Aflibercept Alone in Neovascular Age-Related Macular Degeneration,,, 2/05/2015 46222210 PRN  Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancing New Drug Into Development to Treat a Neurodegenerative Disease, 6/17/2010 09061G10   PRN  BioMarin to Present at the Wells Fargo Healthcare Conference,, 5/02/2013 64125C10 PRN  Neurocrine Biosciences Reports First Quarter 2013 Results,,,,,," 2/21/2012 000C7R-E   PRN  Equity Research on Most Popular Searches: Gilead Sciences, Chesapeake Energy, Wells Fargo, Applied Materials, and Pfizer","11/04/2013 04004760   PRN  Must Watch Stock News: Arena Pharmaceuticals, Hewlett-Packard Company, Resorts International, Alpha Natural Resources, Chevron Corporation", 5/12/2016 N5946510  PRN  Mylan Launches Generic Frova® Tablets,,, 9/11/2017 03116210 PRN  EVENITY™ (romosozumab) ARCH Study Results Published In The New England Journal Of Medicine,,,,,,12/01/2011 45773H20 PRN  Inovio Pharmaceuticals Announces $3.5 Million Underwritten Financing,"11/15/2012 05ZL54-E PRN  Research Reports on Top Stocks: Verizon, Nokia, CYS Investments, Prospect Capital, Huntington Bancshares, and Nektar Therapeutics",,,,,,,,,,,,, 7/16/2013 80067710 PRN  Sangamo BioSciences Announces Second Quarter 2013 Conference Call And Webcast,, 9/28/2015 SNY-FR    PRN  Sanofi Reaches Patent Settlement on Lantus® SoloSTAR®,,,,,,,,,,,,,,,,,,,," 6/10/2013 69329Y10 PRN  Collaborations, Clinical Development Programs, FDA Approvals, New Treatments and Attractive Product Portfolios - Research Report on Medivation, Acadia, Santarus, Seattle Genetics, and PDL BioPharma",,,,,,,,,,,,,,,,,,,,,,,,, 1/31/2011 92165910 PRN  Vanda Pharmaceuticals Files Shelf Registration Statement,,,,, 9/20/2013 40637H10 PRN  Halozyme Therapeutics To Present At The BioCentury Newsmakers In The Biotech Industry Conference,,,,,,,11/03/2014 69366J20 PRN  PTC Therapeutics Expands Access For Translarna™ (Ataluren),,,,,,,,,12/10/2012 G5087110 PRN  Jazz Pharmaceuticals Announces Presentation Of Largest Safety Trial To Date Of Patients Treated With Erwinaze®,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"10/13/2014 00FV7G-E PRN  AUXILIUM PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Auxilium Pharmaceuticals, Inc.",,,, 9/26/2016 75886F10    PRN  Regeneron and Sanofi Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA,,, 2/04/2015 46222210 PRN  Isis Pharmaceuticals to Present at Upcoming Investor Conferences, 6/10/2010 09061G10   PRN  BioMarin to Present at the Goldman Sachs Healthcare Conference,, 4/26/2013 64125C10 PRN  Neurocrine Biosciences Announces Conference Call And Webcast To Present First Quarter 2013 Financial Results,,,,,, 2/08/2012 UBM-GB     PRN  Investor Uprising IU25 Index Hits New High: Up 12% in 2012,"10/31/2013 04004760   PRN  Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc."," 5/10/2016 N5946510  PRN  The Kroger Co trade offers a 10% return in 256 days, or find similar option trades on NXP Semiconductors, Sotheby's, HEALTHSOUTH Corp., and Mylan",,, 9/09/2017 03116210 PRN  Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress,,,,,,11/17/2011 45773H20 PRN  Inovio Pharmaceuticals' Synthetic Avian Flu Vaccine Demonstrates Inhibition of Multiple H5N1 Strains in Phase I Trial,11/12/2012 64026810 PRN  AstraZeneca Announces Top-line Phase III Results from Naloxegol Pivotal Trials In Patients With Opioid-Induced Constipation,,,,,,,,,,,,, 7/02/2013 80067710 PRN  Sangamo BioSciences Announces Presentation At The 8th Annual JMP Securities Healthcare Conference,, 9/28/2015 REGN-US   PRN  Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union,,,,,,,,,,,,,,,,,,,, 6/03/2013 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,,11/15/2010 92165910 PRN  Vanda Pharmaceuticals Receives Positive Ruling from the IRS,,,,," 9/12/2013 40637H10 PRN  Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc.",,,,,,,10/29/2014 69366J20 PRN  PTC Therapeutics to Present at the Credit Suisse 23rd Annual Healthcare Conference,,,,,,,,,12/04/2012 G5087110 PRN  Jazz Pharmaceuticals Announces Issuance of Additional Xyrem® Patent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10/09/2014 G3040110 PRN  Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion,,,," 9/20/2016 75886F10    PRN  Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain",,, 2/03/2015 46222210 PRN  Isis Pharmaceuticals Reports Data From Phase 2 Study of ISIS-PTP1B Rx in Patients With Type 2 Diabetes, 6/08/2010 09061G10   PRN  BioMarin to Present at the William Blair Growth Stock Conference,, 4/24/2013 64125C10 PRN  Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference,,,,,," 2/08/2012 DFS-US     PRN  Critical Alerts For Disney, Gilead Sciences, Discover, Sunoco, and LG Display Released By Seven Summits Research","10/30/2013 04004760   PRN  Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7"," 5/10/2016 N5946510  PRN  The Kroger Co trade offers a 10% return in 256 days, or find similar option trades on NXP Semiconductors, Sotheby's, HEALTHSOUTH Corp., and Mylan",,, 9/08/2017 03116210 PRN  Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting,,,,,,11/07/2011 45773H20 PRN  Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results,11/12/2012 64026810 PRN  Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol,,,,,,,,,,,,, 5/24/2013 80067710 PRN  Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic® for Beta-thalassemia,, 9/14/2015 80105N10  PRN  Sanofi Reports Positive Top-Line Results in Second Pivotal LixiLan Phase III Study,,,,,,,,,,,,,,,,,,,, 5/30/2013 69329Y10 PRN  PDL BioPharma to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,11/12/2010 92165910 PRN  Vanda Pharmaceuticals Appoints Chief Financial Officer,,,,, 9/12/2013 40637H10 PRN  Halozyme to Present New Data on PEGPH20 in Pancreatic Cancer at European Cancer Congress,,,,,,,10/27/2014 69366J20 PRN  Translarna™ Phase 2b Data Published in Muscle & Nerve,,,,,,,,,12/03/2012 G5087110 PRN  Jazz Pharmaceuticals Begins Clinical Trial of Intravenously Administered Erwinaze® In Patients with Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10/09/2014 G3040110 PRN  Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion,,,," 9/12/2016 75886F10    PRN  Regeneron Announces Election of Bonnie Bassler, Ph.D., and Huda Zoghbi, M.D., to Board of Directors",,," 2/02/2015 46222210 PRN  Critical Alerts For Isis Pharmaceuticals, ImmunoGen, Pixelworks, ManpowerGroup and SouFun Released By InvestorsObserver", 5/19/2010 09061G10   PRN  BioMarin to Present at the Citi Global Healthcare Conference,, 3/27/2013 64125C10 PRN  Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids,,,,,," 2/07/2012 000KYG-E   PRN  Critical Stock Alerts: Gilead Sciences, Alpha Natural Resources, General Electric, and Medco Health Solutions","10/21/2013 04004760   PRN  Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros", 5/05/2016 N5946510  PRN  Mylan Launches Generic Apresoline® Injection,,, 9/07/2017 03116210 PRN  New Data Demonstrate Aimovig™ (erenumab) Reduced Monthly Migraine Days In Patients Who Failed Previous Preventive Therapies,,,,,,10/31/2011 45773H20 PRN  Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling,11/07/2012 64026810 PRN  Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer,,,,,,,,,,,,, 5/20/2013 80067710 PRN  Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases,, 9/01/2015 REGN-US   PRN  Regeneron and Sanofi Announce New Positive Praluent® (alirocumab) Phase 3 Data Presented at ESC Congress 2015,,,,,,,,,,,,,,,,,,,, 5/09/2013 69329Y10 PRN  PDL BioPharma Announces First Quarter 2013 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,11/03/2010 92165910 PRN  Vanda Pharmaceuticals Reports Third Quarter 2010 Results,,,,, 9/02/2013 40637H10 PRN  Halozyme Announces Roche Receives Marketing Authorization for Herceptin SC in European Union,,,,,,,10/23/2014 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2014 Financial Results,,,,,,,,,11/09/2012 G5087110 PRN  Jazz Pharmaceuticals Announces Participation In Three Investor Conferences In November,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/30/2014 G3040110 PRN  Endo Reaches Master Settlement Agreements to Resolve Substantially All Remaining AMS Mesh Litigation Claims,,,, 9/01/2016 75886F10    PRN  Regeneron Announces Upcoming 2016 Investor Conference Presentations,,," 1/20/2015 46222210 PRN  Morning Analysis on Biotech Stocks -- Novavax, Isis Pharma, OPKO Health, Nanosphere, and NewLink Genetics", 5/12/2010 09061G10   PRN  BioMarin to Present at the Baird Growth Stock Conference,, 3/11/2013 64125C10 PRN  Neurocrine Biosciences To Present At The 25th Annual Roth Conference,,,,,," 1/20/2012 INHX-US    PRN  The Zacks Analyst Blog Highlights: GileadSciences, Bristol-Myers Squibb, Inhibitex, Vertex Pharmaceuticals and Merck",10/15/2013 4523-JP    PRN  Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December, 5/04/2016 N5946510  PRN  Sarah Jessica Parker Shares Her Personal Experience with Potentially Life-Threatening (Severe) Allergies through Mylan's Anaphylaxis: For Reel™ Initiative,,, 9/07/2017 03116210 PRN  Amgen To Present At The Morgan Stanley Global Healthcare Conference,,,,,,10/10/2011 45773H20 PRN  Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies,"11/06/2012 64026810 PRN  Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,," 5/15/2013 80067710 PRN  Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic®, SB-728-T",, 8/31/2015 SNY-FR    PRN  Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes,,,,,,,,,,,,,,,,,,,," 5/02/2013 69329Y10 PRN  PDL BioPharma to Announce First Quarter 2013 Financial Results on May 9, 2013",,,,,,,,,,,,,,,,,,,,,,,,,"10/28/2010 92165910 PRN  Vanda Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 3, 2010",,,,, 8/07/2013 40637H10 PRN  Halozyme Reports Second Quarter 2013 Financial Results,,,,,,,10/09/2014 69366J20 PRN  PTC Therapeutics Announces Pricing of Public Offering of Common Stock,,,,,,,,,11/08/2012 G5087110 PRN  Jazz Pharmaceuticals Announces Third Quarter 2012 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/30/2014 G3040110 PRN  Critical Alerts For Yahoo!, Clovis Oncology, Sears Holdings, PetSmart and Endo Health Solutions Released By InvestorsObserver",,,, 8/29/2016 75886F10    PRN  Regeneron and Sanofi Present Positive Phase 3 Investigational Data for Praluent® (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016,,, 1/14/2015 46222210 PRN  Isis Pharmaceuticals Earns $7M for Advancing ISIS-SMN Rx in Children With Spinal Muscular Atrophy, 5/04/2010 09061G10   PRN  BioMarin to Present at the JMP Securities Research Conference,, 2/27/2013 64125C10 PRN  Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference,,,,,," 1/11/2012 LULU-CA    PRN  Hot Stock Research for General Electric, Goodyear Tire & Rubber, Lululemon, Gilead Sciences, EMC and Golden Star Resources","10/08/2013 04004760   PRN  Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp.", 5/04/2016 BAC-US    PRN  Mylan to Present at the Bank of America Merrill Lynch 19th Annual Health Care Conference,,, 9/06/2017 03116210 PRN  Tezepelumab Significantly Reduced Asthma Exacerbations For A Broad Population Of Patients With Severe Uncontrolled Asthma,,,,,,10/06/2011 45773H20 PRN  Inovio Pharmaceuticals' Leadership for Life Sciences Recognized in the Philadelphia Region,"10/15/2012 64026810 PRN  Nektar Presents Positive Preclinical Data for NKTR-171, A Novel Sodium Channel Blocker to Treat Neuropathic Pain, at 41st Annual Meeting of the Society for Neuroscience",,,,,,,,,,,,, 5/09/2013 80067710 PRN  Sangamo BioSciences Announces Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference,, 8/03/2015 SNY-FR    PRN  New Analysis Reports Lower Rates of Serious Cardio-Respiratory Events Among Study Participants Administered Higher-Dose Influenza Vaccine,,,,,,,,,,,,,,,,,,,, 4/30/2013 69329Y10 PRN  PDL BioPharma Appoints Peter Garcia as Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,,,,, 8/26/2010 92165910 PRN  Vanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock,,,,, 8/01/2013 0BCC9H-E PRN  Halozyme Provides Update on ViroPharma Phase 2 Trial of Subcutaneous Cinryze (C1 Esterase Inhibitor [Human]) Formulation with rHuPH20,,,,,,,10/08/2014 69366J20 PRN  PTC Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,,,,11/05/2012 G5087110 PRN  Jazz Pharmaceuticals Announces Support for National Campaign Designed to Curb Prescription Drug Abuse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/30/2014 G3040110 PRN  Response Statement, Technology Deployment, CSR Program, Project Proposal, and Contract - Research Reports on Endo International, General Electric, Emerson, Dresser-Rand and General Dynamics",,,, 8/22/2016 75886F10    PRN  Regeneron Announces Agreement with BARDA for the Manufacturing and Testing of New Antibodies Against MERS Virus,,, 1/08/2015 46222210 PRN  Isis Pharmaceuticals Significantly Improves Upon 2014 Financial Guidance, 4/29/2010 09061G10   PRN  BioMarin Announces First Quarter 2010 Financial Results,, 2/08/2013 64125C10 PRN  Neurocrine Biosciences Reports Fourth Quarter And Year End 2012 Results,,,,,," 1/10/2012 SAN-FR     PRN  The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, Inhibitex, Gilead Sciences and Pharmasset"," 9/25/2013 04004760   PRN  Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta"," 5/03/2016 N5946510  PRN  InvestorsObserver releases covered-call reports for Ulta Salon Cosmetics & Fragrance Inc., Marathon Oil Corporation, Mylan, Sysco Corporation and Southern Co.",,, 8/31/2017 03116210 PRN  European Commission Approves Expanded Use Of Mimpara® (Cinacalcet) For The Treatment Of Secondary Hyperparathyroidism In Children With End-Stage Renal Disease On Dialysis,,,,,,10/05/2011 45773H20 PRN  Inovio Pharmaceuticals' Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress," 9/18/2012 64026810 PRN  NKTR-192, A New Short-Acting Mu-Opioid Analgesic Molecule, Achieves Desired Pharmacokinetic Profile in First Phase 1a Clinical Study",,,,,,,,,,,,, 5/08/2013 80067710 PRN  Sangamo BioSciences Reports First Quarter 2013 Financial Results,, 7/30/2015 80105N10  PRN  Sanofi Delivers Solid Sales and Business EPS Growth in Q2 2015,,,,,,,,,,,,,,,,,,,, 4/22/2013 69329Y10 PRN  PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger,,,,,,,,,,,,,,,,,,,,,,,,, 8/05/2010 92165910 PRN  Vanda Pharmaceuticals Reports Second Quarter 2010 Results,,,,, 7/31/2013 40637H10 PRN  Halozyme to Host Second Quarter 2013 Financial Results Conference Call,,,,,,, 9/24/2014 69366J20 PRN  PTC Therapeutics to Present at the Leerink Partners Rare Disease Roundtable,,,,,,,,,10/29/2012 G5087110 PRN  Jazz Pharmaceuticals Announces Date to Release Third Quarter 2012 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/22/2014 00FV7G-E PRN  Endo International Comments On Auxilium Pharmaceutical's Rejection Of Its Acquisition Proposal,,,, 8/04/2016 75886F10    PRN  Regeneron Reports Second Quarter 2016 Financial and Operating Results,,," 1/06/2015 46222210 PRN  Critical Alerts For JetBlue, Isis Pharmaceuticals, Gold Fields, 58.com and 51job Released By InvestorsObserver", 4/29/2010 09061G10   PRN  BioMarin Reports Positive Results for Phase I/II Trial for BMN 110 for MPS IVA,, 2/06/2013 64125C10 PRN  Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013,,,,,,"12/30/2011 MJN-US     PRN  Critical Alerts for Chevron, Gilead, Medtronic, Mattel, and Mead Johnson Nutrition Released by Seven Summits Research", 9/23/2013 04004760   PRN  Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference, 5/03/2016 N5946510  PRN  Mylan Names Kenneth Parks Chief Financial Officer,,, 8/30/2017 03116210 PRN  Long-Term Analysis Of Phase 3 Head-To-Head Study Confirms KYPROLIS® (Carfilzomib) Regimen Extends Overall Survival In Patients With Relapsed Multiple Myeloma,,,,,, 9/30/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at Scientific Conferences," 9/13/2012 64026810 PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City",,,,,,,,,,,,, 5/01/2013 80067710 PRN  Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast,, 7/30/2015 80105N10  PRN  Sanofi H1 2015 Results - Interview with CEO Olivier Brandicourt,,,,,,,,,,,,,,,,,,,," 4/01/2013 69329Y10 PRN  Today's Technical View on AstraZeneca, GlaxoSmithKline, PDL BioPharma, and Herbalife",,,,,,,,,,,,,,,,,,,,,,,,," 8/02/2010 92165910 PRN  Vanda Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010",,,,, 6/30/2013 40637H10 PRN  Halozyme Presents New HTI-501 Data,,,,,,, 9/24/2014 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,,,,10/15/2012 G5087110 PRN  Jazz Pharmaceuticals Completes Sale of its Women's Health Business to Meda,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/22/2014 G3040110 PRN  Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo",,,," 8/03/2016 75886F10    PRN  Biotech Stocks Technical Report -- Arena Pharma, BIND Therapeutics, Nektar Therapeutics, and Regeneron Pharma",,," 1/06/2015 46222210 PRN  Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors", 4/28/2010 09061G10   PRN  BioMarin to Present at the Deutsche Bank Healthcare Conference,, 2/01/2013 64125C10 PRN  Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results,,,,,,12/20/2011 05QK53-E   PRN  Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment, 9/18/2013 04004760   PRN  Arena Pharmaceuticals to Present Clinical Data for BELVIQ® (lorcaserin HCl) CIV at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), 5/03/2016 N5946510  PRN  Mylan Reports Strong First Quarter 2016 Earnings Results Including Total Revenues Up 17%,,, 8/30/2017 03116210 PRN  FDA Accepts Amgen's Filing Of A Supplemental New Drug Application To Add Overall Survival Results To KYPROLIS® (Carfilzomib) Label,,,,,, 9/27/2011 45773H20 PRN  Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety, 8/09/2012 64026810 PRN  Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012,,,,,,,,,,,,, 4/24/2013 80067710 PRN  Sangamo BioSciences Announces Presentation At The Needham Healthcare Conference,, 7/29/2015 SNY-FR    PRN  Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint,,,,,,,,,,,,,,,,,,,, 3/12/2013 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,," 7/01/2010 92165910 PRN  Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors",,,,, 6/28/2013 40637H10 PRN  Halozyme Announces Positive Opinion from CHMP On Roche's Herceptin SC for European Approval,,,,,,, 9/17/2014 69366J20 PRN  PTC Therapeutics Expands Global Presence in Support of Translarna™ Launch in Duchenne Muscular Dystrophy,,,,,,,,," 9/19/2012 JAZZ-IE  PRN  Critical Alerts For Yahoo!, Adobe, Pulte Homes, Jazz Pharmaceuticals, and Tyson Foods Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/17/2014 00FV7G-E PRN  Auxilium Responds To Unsolicited Proposal From Endo International,,,, 8/02/2016 000VC1-E    PRN  Regeneron and Adicet Bio Announce Strategic Collaboration to Discover and Develop Next-Generation Engineered Immune Cell Therapeutics,,, 1/06/2015 46222210 PRN  Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics,,, 1/23/2013 64125C10 PRN  Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor,,,,,,"12/19/2011 RRR.XX1-US PRN  Critical Stock Alerts for RSC Holdings, Microsoft, Dollar Tree, Allied Nevada Gold, Wells Fargo and Gilead Sciences", 9/16/2013 05NDXX-E   PRN  Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ® (lorcaserin HCl) CIV Enters Consumer Phase," 4/22/2016 N5946510  PRN  Facebook, Ulta Salon Cosmetics & Fragrance Inc., Marathon Oil Corporation, International Business Machines, and Mylan and more offer option-trading opportunities that offer returns of more than 20%",,, 8/29/2017 03116210 PRN  New Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With History Of Stroke,,,,,," 9/14/2011 45773H20 PRN  Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses", 8/07/2012 64026810 PRN  Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma,,,,,,,,,,,,, 4/10/2013 80067710 PRN  Sangamo BioSciences Announces Presentation At Regen Med Investor Day,," 7/28/2015 GSK-GB    PRN  Drug Manufacturers - Major Stocks on the Move -- GlaxoSmithKline, Sanofi, Aerie Pharma, TherapeuticsMD, and Aoxing Pharma",,,,,,,,,,,,,,,,,,,, 3/11/2013 69329Y10 PRN  PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million,,,,,,,,,,,,,,,,,,,,,,,,, 5/04/2010 92165910 PRN  Vanda Pharmaceuticals Reports First Quarter 2010 Results,,,,, 6/03/2013 40637H10 PRN  Halozyme's Phase 1b Clinical Trial Of PEGPH20 With Gemcitabine Indicates Positive Activity Against Pancreatic Cancer,,,,,,, 9/09/2014 69366J20 PRN  PTC Therapeutics Completes Enrollment of Landmark Trial in Duchenne Muscular Dystrophy,,,,,,,,, 9/11/2012 G5087110 PRN  /C O R R E C T I O N -- Jazz Pharmaceuticals/,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/16/2014 00FV7G-E PRN  Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock,,,, 8/01/2016 75886F10    PRN  Sanofi and Regeneron Announce EMA Acceptance for Review of Marketing Authorisation Application for Sarilumab,,, 1/05/2015 46222210 PRN  Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer,,,12/18/2012 64125C10 PRN  Neurocrine Announces Start Of Second Phase IIb Study Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia,,,,,,12/15/2011 GILD-US    PRN  Global HIV Drugs Market 2010-2014, 9/06/2013 04004760   PRN  Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference," 4/19/2016 N5946510  PRN  Mylan to Report First Quarter 2016 Financial Results on May 3, 2016",,, 8/29/2017 03116210 PRN  New Virtual Histology Sub-Study Evaluates Impact Of Repatha® (Evolocumab) On Coronary Artery Plaque Composition,,,,,, 9/13/2011 45773H20 PRN  Inovio Pharmaceuticals' PENNVAX™-G Global HIV Vaccine Plus MVA Boost Achieves 100% Antigen-Specific T-Cell Immune Responses in Interim Phase I Data," 8/02/2012 64026810 PRN  Nektar to Announce Financial Results for the Second Quarter of 2012 On Thursday, August 9, 2012, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,, 3/06/2013 80067710 PRN  Sangamo Presents New Clinical Data at CROI 2013 Demonstrating Persistent Immune System Improvements After Treatment With ZFN Therapeutic® SB-728-T,, 7/28/2015 REGN-US   PRN  Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration,,,,,,,,,,,,,,,,,,,," 3/06/2013 69329Y10 PRN  PDL BioPharma to Hold Annual Meeting of Stockholders on May 21, 2013",,,,,,,,,,,,,,,,,,,,,,,,," 4/27/2010 92165910 PRN  Vanda Pharmaceuticals to Announce First Quarter 2010 Financial Results on May 4, 2010",,,,, 5/23/2013 40637H10 PRN  Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer,,,,,,, 8/20/2014 69366J20 PRN  PTC Therapeutics to Participate at Upcoming Investor Conferences,,,,,,,,, 9/06/2012 G5087110 PRN  Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In New York On September 11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/10/2014 G3040110 PRN  Pharma Equities Technical Coverage - VIVUS, Auxilium Pharma, Depomed, Endo Intl., and Perrigo",,,, 7/18/2016 000VC1-E    PRN  Regeneron Announces Upcoming 2016 Investor Conference Presentation,,, 1/05/2015 46222210 PRN  Isis Pharmaceuticals Announces Collaboration With Janssen to Discover and Develop RNA-Targeted Therapeutics for Autoimmune Diseases in the GI Tract,,,11/27/2012 64125C10 PRN  Neurocrine Biosciences To Present At Deutsche Bank's 2012 dbAccess BioFEST,,,,,,"12/07/2011 000D1R-E   PRN  The Zacks Analyst Blog Highlights: AutoZone, Johnson & Johnson, Bristol-Myers Squibb, Gilead Sciences and Pharmasset"," 9/03/2013 04004760   PRN  Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation", 4/11/2016 N5946510  PRN  Mylan Launches First and Only Available Intermediate Dosage Strengths of Generic Lopressor® Tablets 37.5 mg and 75 mg,,, 8/28/2017 03116210 PRN  New Repatha® (evolocumab) Analysis Demonstrates Cardiovascular Outcomes Efficacy And Safety Of Achieving Very Low LDL-C Levels,,,,,, 9/07/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at Scientific Conferences," 7/24/2012 64026810 PRN  Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain",,,,,,,,,,,,, 3/05/2013 80067710 PRN  Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference,," 7/24/2015 80105N10  PRN  Sanofi and Regeneron Announce FDA Approval of Praluent® (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients",,,,,,,,,,,,,,,,,,,," 3/06/2013 69329Y10 PRN  Today's Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/15/2013 40637H10 PRN  Halozyme To Present New Data On PEGPH20 In Pancreatic Cancer At American Society of Clinical Oncology Annual Meeting,,,,,,," 8/07/2014 69366J20 PRN  Orally Delivered Compounds, Which Selectively Modify RNA Splicing Prevent Deficits In Mouse Models Of Spinal Muscular Atrophy",,,,,,,,, 9/06/2012 G5087110 PRN  Jazz Pharmaceuticals Enters Definitive Agreement to Sell its Women's Health Business to Meda,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/08/2014 002Y7X-E PRN  Top-Line Data Show the Investigational TOPAS™ System Improves Fecal Incontinence in Women,,,, 7/13/2016 75886F10    PRN  Regeneron Announces 2016 Winners of the Regeneron Prize for Creative Innovation,,, 1/02/2015 46222210 PRN  Isis Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference,,,11/20/2012 64125C10 PRN  Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference,,,,,,"11/28/2011 37555810   PRN  Critical Alerts for Amazon.com, Gilead, Lennar, Big Lots, and Collective Brands Released by Seven Summits Research", 8/28/2013 04004760   PRN  Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension, 4/06/2016 0BS815-E  PRN  Mylan Launches Generic Epivir® Tablets,,," 8/24/2017 03116210 PRN  Amgen Foundation Expands The Amgen Biotech Experience, Bringing Total Program Reach To 900,000 High School Students By 2020",,,,,, 9/06/2011 45773H20 PRN  Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board, 7/10/2012 64026810 PRN  Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017,,,,,,,,,,,,," 3/05/2013 80067710 PRN  The Prescription of Success: Improving Pipelines, Increasing Capabilities - Research Report on Globus, Akorn, Anika, Orthofix and Sangamo Biosciences",," 7/24/2015 SNY-FR    PRN  Regeneron and Sanofi Announce FDA Approval of Praluent® (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients",,,,,,,,,,,,,,,,,,,, 3/04/2013 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/08/2013 40637H10 PRN  Halozyme Reports First Quarter 2013 Financial Results,,,,,,, 8/07/2014 69366J20 PRN  PTC Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update,,,,,,,,, 8/07/2012 G5087110 PRN  Jazz Pharmaceuticals Announces Second Quarter 2012 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/08/2014 G3040110 PRN  Endo to Present at Morgan Stanley Global Healthcare Conference 2014,,,, 7/12/2016 0GBP93-E    PRN  Award-Winning Chef Elizabeth Falkner Reveals Her Struggle with Atopic Dermatitis to Highlight the Physical and Psychological Impact of the Disease,,,12/16/2014 46222210 PRN  Isis Pharmaceuticals Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients With Myotonic Dystrophy Type 1,,,11/06/2012 64125C10 PRN  Neurocrine Biosciences To Present At Lazard Capitalmarket's 9th Annual Healthcare Conference,,,,,,"11/22/2011 000L1R-E   PRN  The Zacks Analyst Blog Highlights: Gilead Sciences, Pharmasset, Nasdaq Biotechnology ETF, InterMune and Dendreon", 8/01/2013 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results, 3/28/2016 00GDWJ-E  PRN  Mylan Launches Generic Ultram® Extended-Release Tablets,,, 8/23/2017 03116210 PRN  Overall Survival Analysis From KYPROLIS® (carfilzomib) Phase 3 Endeavor Trial Published In The Lancet Oncology,,,,,, 8/31/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at Investor Conferences," 6/07/2012 64026810 PRN  Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain",,,,,,,,,,,,, 2/27/2013 80067710 PRN  Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference,, 7/24/2015 REGN-US   PRN  Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia,,,,,,,,,,,,,,,,,,,, 3/01/2013 69329Y10 PRN  PDL BioPharma Announces Fourth Quarter and Full Year 2012 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/07/2013 40637H10 PRN  Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference,,,,,,, 8/04/2014 69366J20 PRN  PTC Therapeutics Receives Conditional Approval in the European Union for Translarna™ For the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy,,,,,,,,," 7/31/2012 G5087110 PRN  Jazz Pharmaceuticals Announces Second Quarter 2012 Financial Results Conference Call On August 7, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/08/2014 G3040110 PRN  Endo announces launch of Authorized Generic of FORTESTA® Gel,,,, 7/12/2016 0GBP93-E    PRN  Award-Winning Chef Elizabeth Falkner Reveals Her Struggle with Atopic Dermatitis to Highlight the Physical and Psychological Impact of the Disease,,,"12/09/2014 46222210 PRN  Critical Alerts For Mobileye NV, bluebird bio Inc., Isis Pharmaceuticals, Castlight Health and ConocoPhillips Released By InvestorsObserver",,,10/31/2012 64125C10 PRN  Neurocrine Biosciences Reports Third Quarter 2012 Results,,,,,,"11/21/2011 000L1R-E   PRN  Pharmasset, Inc. Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate the Board of Pharmasset, Inc. Concerning the Sale of Pharmasset to Gilead Sciences, Inc.", 7/25/2013 04004760   PRN  Arena Pharmaceuticals' BELVIQ® (lorcaserin HCl) CIV Nominated for 2013 Prix Galien USA Award, 3/04/2016 BCS-GB    PRN  Mylan to Present at the Barclays Global Healthcare Conference,,, 8/23/2017 03116210 PRN  New Economic Analysis Based On Repatha® (Evolocumab) Outcomes Data Published In JAMA Cardiology,,,,,, 8/08/2011 45773H20 PRN  Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results, 5/30/2012 64026810 PRN  Nektar Therapeutics' President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York,,,,,,,,,,,,, 2/07/2013 80067710 PRN  Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences,, 7/14/2015 SNY-FR    PRN  Sanofi Pasteur Ships First 2015-2016 Seasonal Influenza Vaccine Doses in United States,,,,,,,,,,,,,,,,,,,," 2/25/2013 69329Y10 PRN  PDL BioPharma to Announce Fourth Quarter and Full Year 2012 Financial Results on March 1, 2013",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/01/2013 40637H10 PRN  Halozyme to Host First Quarter 2013 Financial Results Conference Call,,,,,,, 8/01/2014 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,,,, 7/30/2012 G5087110 PRN  Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 8/25/2014 G3040110 PRN  Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo",,,," 7/08/2016 75886F10    PRN  Regeneron to Report Second Quarter 2016 Financial and Operating Results and Host Conference Call and Webcast on August 4, 2016",,,12/07/2014 46222210 PRN  Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery,,,10/24/2012 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results,,,,,,"11/21/2011 37555810   PRN  The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Pharmasset, Inc. in Connection with the Sale of the Company to Gilead Sciences, Inc.", 7/25/2013 04004760   PRN  Arena Pharmaceuticals and CY Biotech Enter into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Taiwan, 3/04/2016 000V94-E  PRN  Mylan to Present at the Raymond James 37th Annual Institutional Investors Conference,,, 8/21/2017 03116210 PRN  Amgen To Present New Data From The Repatha® (Evolocumab) Cardiovascular Outcomes Study At ESC Congress 2017,,,,,, 7/15/2011 45773H20 PRN  Inovio Pharmaceuticals Demonstrates T Cell Immune Response Durability with Fourth Dose of Therapeutic Cervical Dysplasia and Cancer DNA Vaccine, 5/02/2012 64026810 PRN  Nektar Therapeutics Reports Financial Results for the First Quarter of 2012,,,,,,,,,,,,, 2/06/2013 80067710 PRN  Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results,, 7/10/2015 SNY-FR    PRN  Merial Introduces Oravet® Dental Hygiene Chews for Dogs,,,,,,,,,,,,,,,,,,,, 2/20/2013 69329Y10 PRN  PDL BioPharma to Present at Two Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/23/2013 40637H10 PRN  Halozyme Initiates Randomized Phase 2 Trial of PEGPH20 in Pancreatic Cancer,,,,,,, 7/30/2014 69366J20 PRN  PTC Therapeutics to Present at the Wedbush Life Sciences Management Access Conference,,,,,,,,, 7/19/2012 G5087110 PRN  Patient Advocate Foundation and Jazz Pharmaceuticals Announce Partnership for Narcolepsy CareLine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 8/11/2014 G3040110 PRN  Dividends, New Leaderships, and Scheduled Conference Calls - Research Reports on St. Jude Medical, Endo, Cooper, Zoetis and Illumina",,,, 7/05/2016 75886F10    PRN  Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan,,,"12/05/2014 46222210 PRN  Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award",,,10/01/2012 64125C10 PRN  Neurocrine Announces Start Of Phase IIb Study Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia,,,,,,"11/04/2011 000HLG-E   PRN  Significant Insider Trading in JDS Uniphase, Gilead, Riverbed, Walt Disney, Goldman Sachs & Huntington Bancshares"," 7/24/2013 04004760   PRN  Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1", 2/22/2016 N5946510  PRN  Mylan CEO Heather Bresch Elected Chair of Generic Pharmaceutical Association,,, 8/17/2017 03116210 PRN  Amgen And Humana Partner For Improved Health Outcomes And Efficiency,,,,,, 7/14/2011 45773H20 PRN  Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I," 4/25/2012 64026810 PRN  Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,, 1/30/2013 80067710 PRN  Sangamo BioSciences Announces Fourth Quarter And Full Year 2012 Conference Call And Webcast,, 7/08/2015 80105N10  PRN  Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection,,,,,,,,,,,,,,,,,,,, 1/30/2013 69329Y10 PRN  PDL BioPharma Announces 2013 Regular Quarterly Dividends,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/28/2013 HALO-US  PRN  Halozyme Therapeutics Names Matt Posard to Board of Directors,,,,,,, 7/24/2014 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2014 Financial Results,,,,,,,,, 6/12/2012 G5087110 PRN  Jazz Pharmaceuticals Completes EUSA Pharma Acquisition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 8/07/2014 G3040110 PRN  Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix Therapeutics, and Depomed",,,," 6/23/2016 75886F10    PRN  How These Biotech's Stocks are Performing? - Intrexon, Vertex Pharma, Arena Pharma, and Regeneron Pharma",,,"12/04/2014 46222210 PRN  Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma",,, 9/05/2012 64125C10 PRN  Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference,,,,,,"10/12/2011 000L1R-E   PRN  Research Reports for Top Traded Penny Stocks: KeyCorp, SandRidge & Genworth, More Reports for Google, Gilead & Aruba", 6/26/2013 04004760   PRN  Arena Pharmaceuticals Announces BELVIQ™ (lorcaserin HCl) New Drug Submission in Canada, 2/22/2016 N5946510  PRN  Mylan Appoints Anthony Mauro Chief Commercial Officer,,, 8/16/2017 03116210 PRN  Repatha® (Evolocumab) Phase 3 Cognitive Function Study Results Published In The New England Journal Of Medicine,,,,,, 7/07/2011 45773H20 PRN  Inovio Expands DNA Vaccine Intellectual Property License With the University of Pennsylvania, 4/10/2012 64026810 PRN  Nektar to Host Investor and Analyst R&D Day in New York City,,,,,,,,,,,,, 1/02/2013 80067710 PRN  Sangamo BioSciences Announces Presentation At 31st Annual J.P. Morgan Healthcare Conference,, 6/30/2015 REGN-US   PRN  New Film Documents Heart Felt Stories of People Living with High LDL Cholesterol,,,,,,,,,,,,,,,,,,,, 1/30/2013 69329Y10 PRN  PDL BioPharma Announces Departure of Finance VP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 3/25/2013 HALO-US  PRN  Morning Research on Gilead Sciences, Halozyme Therapeutics, InterMune, and Seattle Genetics",,,,,,, 7/09/2014 69366J20 PRN  PTC Therapeutics Announces Expanded Access Program For Translarna™ (ataluren),,,,,,,,," 6/11/2012 G5087110 PRN  ""AWAKEN"" Survey Finds Only 50 Percent of Americans Understand Significant Health Impact of Narcolepsy, and Many Physicians Not Comfortable Diagnosing the Sleep Disorder",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/06/2014 00FV7G-E PRN  Endo completes acquisition of DAVA Pharmaceuticals,,,, 6/06/2016 75886F10    PRN  Regeneron and Sanofi Announce that Dupilumab Used with Topical Corticosteroids (TCS) was Superior to Treatment with TCS Alone in Long-term Phase 3 Trial in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients,,,12/03/2014 46222210 PRN  ISIS-APOCIII Rx Phase 2 Study in Patients With Familial Chylomicronemia Published in the New England Journal of Medicine,,, 7/31/2012 64125C10 PRN  Neurocrine Biosciences Reports Second Quarter 2012 Results,,,,,,"10/11/2011 000L1R-E   PRN  Critical Stock Alerts for American Capital, Vertex, Kroger, QUALCOMM, Netflix & Gilead", 6/20/2013 04004760   PRN  BELVIQ® (lorcaserin HCl) CIV Data to be Presented at the American Diabetes Association's 73rd Scientific Sessions, 2/19/2016 N5946510  PRN  Mylan's ANDA for Generic Advair Diskus® Accepted for Filing by FDA,,, 7/31/2017 03116210 PRN  Amgen Submits Supplemental Biologics License Application For Prolia® (denosumab) In Glucocorticoid-Induced Osteoporosis,,,,,, 7/05/2011 45773H20 PRN  Inovio Pharmaceuticals Synthetic DNA Vaccine Protects Against HIV in Non-Human Primates," 4/02/2012 64026810 PRN  Nektar Doses First Subjects in Phase 1 Clinical Study Evaluating NKTR-192, a New Short-Acting Opioid Molecule for the Treatment of Acute Pain",,,,,,,,,,,,,12/10/2012 80067710 PRN  Sangamo Biosciences Announces Presentation Of Data Demonstrating A Disruptive And Broadly Leverageable Platform For Protein Replacement Therapies At American Society Of Hematology Meeting,, 6/10/2015 80105N10  PRN  Advanced Immunotherapy Clinical Trials for Cancer Therapies & Breast Cancer Treatments Focus on Developing Innovative Therapeutics & Gene-Silencing Cell Studies,,,,,,,,,,,,,,,,,,,, 1/03/2013 PDLI-US  PRN  PDL BioPharma to Present at the 31st Annual JP Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/22/2013 40637H10 PRN  Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union,,,,,,," 7/04/2014 69366J20 PRN  Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma",,,,,,,,, 6/05/2012 G5087110 PRN  Jazz Pharmaceuticals Announces Presentation At The Jefferies 2012 Global Healthcare Conference In New York On June 7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 7/31/2014 G3040110 PRN  Endo Reports Second Quarter Financial Results,,,, 5/31/2016 07H4Q1-E    PRN  Regeneron Presents Positive Interim Data from Phase 2 Proof-of-Concept Study of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia,,,11/25/2014 46222210 PRN  Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy,,, 7/25/2012 64125C10 PRN  Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results,,,,,," 9/28/2011 000DWY-E   PRN  Research Reports for Top Traded Penny Stocks: Metalico, Neostem & Evolution Petroleum, More Reports for Coca-Cola, Gilead Sciences & Duke Energy", 6/14/2013 04004760   PRN  BELVIQ® (lorcaserin HCl) CIV Data to be Presented at ENDO 2013," 2/16/2016 N5946510  PRN  Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2015",,, 7/31/2017 03116210 PRN  Amgen And Allergan Submit Biosimilar Biologics License Application For ABP 980 To US Food And Drug Administration,,,,,, 7/01/2011 45773H20 PRN  Inovio Pharmaceuticals Announces Transition of Avtar Dhillon to Non-Executive Chairman of the Board, 3/28/2012 64026810 PRN  Nektar Reports that Partner Affymax Has Announced FDA Approval of OMONTYS® (Peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis,,,,,,,,,,,,,12/06/2012 80067710 PRN  Sangamo BioSciences Provides Comprehensive Overview Of Company's ZFP Therapeutic® Development Programs At Its 2012 Analyst Briefing,, 6/09/2015 80105N10  PRN  FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia,,,,,,,,,,,,,,,,,,,,12/17/2012 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/05/2013 40637H10 PRN  Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference,,,,,,, 6/30/2014 69366J20 PRN  PTC Therapeutics Initiates Confirmatory Phase 3 Clinical Trial of Translarna™ (ataluren) in Patients with Nonsense Mutation Cystic Fibrosis (nmCF),,,,,,,,, 5/08/2012 G5087110 PRN  Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 7/30/2014 G3040110 PRN  Endo appoints Shane M. Cooke to Board of Directors,,,, 5/26/2016 000VC1-E    PRN  Regeneron Selected by Society for Science & the Public as New Sponsor of the Science Talent Search,,,11/20/2014 46222210 PRN  ISIS-STAT3 Rx and ISIS-AR Rx Data Presented by AstraZeneca at European Cancer Symposium,,, 6/05/2012 64125C10 PRN  Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis,,,,,," 9/27/2011 37555810   PRN  Critical Alerts for ConocoPhillips, Gilead, F5 Networks, Cognizant Technology, and Barclays Released by Seven Summits Research", 6/14/2013 04004760   PRN  Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference, 2/10/2016 MYL-GB    PRN  Mylan Full Year Adjusted Diluted EPS Up 21% to $4.30,,, 7/28/2017 03116210 PRN  Amgen Announces 2017 Third Quarter Dividend,,,,,, 6/30/2011 45773H20 PRN  Inovio Pharmaceuticals' DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study, 3/20/2012 64026810 PRN  Nektar Consolidates Research at Its State-of-the-Art R&D Center Located in San Francisco at Mission Bay,,,,,,,,,,,,,"11/27/2012 80067710 PRN  Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012",, 6/09/2015 80105N10  PRN  FDA Advisory Committee Recommends Approval of Regeneron and Sanofi's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia,,,,,,,,,,,,,,,,,,,,12/06/2012 69329Y10 PRN  PDL BioPharma Provides Fourth Quarter 2012 Royalty Revenue Guidance of $86 Million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/25/2013 40637H10 PRN  Halozyme Reports Fourth Quarter and Year End 2012 Financial Results,,,,,,," 6/25/2014 69366J20 PRN  Patient Enrollments, Innovation Awards, Appointments, and Promotions - Analyst Notes on Endo, St. Jude, Impax, Novavax and PTC Therapeutics",,,,,,,,," 5/07/2012 G5087110 PRN  Critical Alerts For Macy's, Avis, Rackspace, Stone Energy, and Jazz Pharmaceuticals Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 7/24/2014 G3040110 PRN  Endo completes acquisition of Grupo Farmaceutico Somar®,,,, 5/05/2016 75886F10    PRN  Regeneron Reports First Quarter 2016 Financial and Operating Results,,,11/18/2014 46222210 PRN  Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting,,, 5/29/2012 64125C10 PRN  Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference,,,,,," 9/23/2011 000C7R-E   PRN  Significant Insider Trading at Occidental Petroleum, TiVo, CBS, Applied Materials, Gilead & Amazon.com"," 6/13/2013 LUMO-US    PRN  New Research Grants, Product Launches, and Positive Clinical Study Results - Research Report on Boston Scientific, Cooper, Arena Pharmaceuticals, Apricus Biosciences, and NewLink Genetics", 2/10/2016 N5946510  PRN  Mylan to Acquire Meda,,, 7/27/2017 03116210 PRN  FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For Repatha® (evolocumab) To Include Data On Reducing Risk Of Cardiovascular Events,,,,,, 6/29/2011 45773H20 PRN  Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial, 3/02/2012 64026810 PRN  Nektar Therapeutics Announces Webcast of Presentation at the 32nd Annual Cowen and Company Healthcare Conference in Boston,,,,,,,,,,,,,11/06/2012 80067710 PRN  Sangamo BioSciences Announces Presentation At The Lazard Capital Markets Healthcare Conference,, 6/08/2015 80105N10  PRN  Sanofi's Lyxumia® (lixisenatide) Demonstrated Cardiovascular Safety in People with Type 2 Diabetes and High CV Risk,,,,,,,,,,,,,,,,,,,,12/05/2012 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/19/2013 40637H10 PRN  Halozyme to Host Fourth Quarter and 2012 Year-End Financial Results Conference Call,,,,,,, 6/17/2014 005W47-E PRN  PTC Therapeutics to Present at the 9th Annual JMP Securities Healthcare Conference,,,,,,,,," 4/30/2012 G5087110 PRN  Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/15/2014 G3040110 PRN  Endo to Announce Second Quarter 2014 Financial Results on July 31, 2014",,,, 5/02/2016 75886F10    PRN  Regeneron Announces Positive Topline Results from Phase 2/3 Fasinumab Study in Patients with Osteoarthritis Pain,,,11/17/2014 46222210 PRN  Cure SMA Presents Isis Pharmaceuticals with SMA Breakthrough Award,,, 5/17/2012 64125C10 PRN  Neurocrine Biosciences Announces Urocortin 2 Phase II Study Results in Patients With Acute Decompensated Heart Failure,,,,,," 9/07/2011 000L1R-E   PRN  Critical Stock Alerts for QUALCOMM, CVS, Halliburton, Starbucks, Gilead & People's United Financial", 6/07/2013 04004760   PRN  Arena Pharmaceuticals Reports on Launch of BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese," 1/21/2016 N5946510  PRN  Mylan to Report Fourth Quarter and Full Year 2015 Financial Results on Feb. 10, 2016",,, 7/25/2017 03116210 PRN  Amgen Reports Second Quarter 2017 Financial Results,,,,,, 6/17/2011 45773H20 PRN  VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival," 3/01/2012 NGD-CA   PRN  Top Stock Alerts for Day Traders: JDS Uniphase, Kinross Gold, PulteGroup, Nektar Therapeutics, and New Gold",,,,,,,,,,,,,10/24/2012 80067710 PRN  Sangamo BioSciences Reports Third Quarter 2012 Financial Results,, 6/06/2015 80105N10  PRN  Sanofi's Lyxumia® (lixisenatide) Statistically Superior to Rapid Acting Insulin for Body Weight Change with Similar Blood Sugar Control when Both are Added to Basal Insulin,,,,,,,,,,,,,,,,,,,,12/03/2012 69329Y10 PRN  PDL BioPharma Announces Resignation of Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 1/15/2013 000WH6-E PRN  Oxford Finance and Silicon Valley Bank Provide $30 Million Senior Credit Facility to Halozyme Therapeutics,,,,,,," 6/11/2014 69366J20 PRN  PTC Therapeutics Appoints Ronald C. Renaud, Jr. to Board of Directors",,,,,,,,, 4/26/2012 G5087110 PRN  Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/10/2014 G3040110 PRN  New Board Director, Clinical Trial Results, New Drug Designations and Marketing Authorizations - Analyst Notes on Johnson & Johnson, Merck, Novartis, GSK and Endo",,,, 4/29/2016 75886F10    PRN  Regeneron Announces Upcoming 2016 Investor Conference Presentations,,,11/14/2014 46222210 PRN  Isis Pharmaceuticals to Present at Upcoming Investor Conferences,,, 5/04/2012 64125C10 PRN  Neurocrine Biosciences To Present At The Deutsche Bank 37th Annual Health Care Conference,,,,,," 8/25/2011 37555810   PRN  Critical Alerts for Microsoft, CF Industries, Gilead Sciences, BB&T, and China Mobile Released by Seven Summits Research", 5/24/2013 04004760   PRN  Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences, 1/19/2016 MYL-GB    PRN  Mylan Launches Generic Felbatol® Tablets,,, 7/20/2017 03116210 PRN  FDA Accepts Biologics License Application For Aimovig™ (erenumab),,,,,, 6/15/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at Scientific & Industry Conferences, 2/29/2012 64026810 PRN  Nektar Therapeutics Reports Fourth Quarter and Year-End 2011 Financial Results,,,,,,,,,,,,,10/17/2012 80067710 PRN  Sangamo BioSciences Announces Third Quarter 2012 Conference Call and Webcast,, 6/04/2015 80105N10  PRN  Sanofi Announces Study Program Evaluating Toujeo® in a Real-Life Setting,,,,,,,,,,,,,,,,,,,,11/08/2012 69329Y10 PRN  PDL BioPharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 1/07/2013 40637H10 PRN  Halozyme Therapeutics Issues Financial Guidance For 2013,,,,,,, 6/10/2014 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,,,," 4/17/2012 G5087110 PRN  Critical Alerts for Baidu, Philip Morris International, GlaxoSmithKline, Tata Motors, and Jazz Pharmaceuticals Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/07/2014 G3040110 PRN  Technical Pulse on Pharma Stocks -- Research on Pfizer, Hospira, Endo Intl., and Nektar Therapeutics",,,," 4/15/2016 75886F10    PRN  Regeneron to Report First Quarter 2016 Financial and Operating Results and Host Conference Call and Webcast on May 5, 2016",,,11/13/2014 46222210 PRN  AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods,,, 5/02/2012 64125C10 PRN  Neurocrine Biosciences Reports First Quarter 2012 Results,,,,,, 7/28/2011 0039ZQ-E   PRN  IU Confidential Publishes Biotech Investment Report, 5/10/2013 04004760   PRN  Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference, 1/11/2016 N5946510  PRN  Mylan Confirms FDA Submission of ANDA for Generic Advair Diskus®,,, 7/20/2017 03116210 PRN  Amgen Announces Webcast of 2017 Second Quarter Financial Results,,,,,," 6/09/2011 45773H20 PRN  Inovio Pharmaceuticals Subsidiary, VGX Animal Health, to Present at VetHealth Global 2011, June 14-17, 2011", 2/29/2012 64026810 PRN  Nektar Therapeutics Announces Agreement to Sell CIMZIA® and MIRCERA® Royalties to Royalty Pharma for $124 Million,,,,,,,,,,,,,10/17/2012 80067710 PRN  Sangamo BioSciences Announces First Presentation of Data from ZFP Therapeutic® for Huntington's Disease at 2012 Annual Meeting of Society for Neuroscience,," 5/28/2015 0DK6GT-E  PRN  Rosa & Co. Announces Multi-Year, World-Wide PhysioPD™ Research Agreement with Sanofi",,,,,,,,,,,,,,,,,,,,11/05/2012 69329Y10 PRN  PDL BioPharma Announces Third Quarter 2012 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 1/03/2013 HALO-US  PRN  Halozyme Therapeutics to Present at the 31st Annual J.P. Morgan Healthcare Conference,,,,,,," 5/28/2014 69366J20 PRN  Result of Annual Shareholders Meeting, Agreements, FDA Approval, Scheduled Conferences, and Dividends - Analyst Notes on Valeant Pharmaceuticals, Novartis, Teva, PTC Therapeutics and Agilent",,,,,,,,, 3/22/2012 G5087110 PRN  Wake Up Narcolepsy and Jazz Pharmaceuticals Announce Swinging for Sleep to Raise Funds for Narcolepsy Awareness,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 7/07/2014 05MBN8-E PRN  Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA® buprenorphine in opioid-experienced patients with chronic pain,,,, 4/11/2016 75886F10    PRN  Regeneron and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics,,,"11/12/2014 46222210 PRN  Critical Alerts For Twitter, Isis Pharmaceuticals, TrueCar and Myriad Genetics Released By InvestorsObserver",,, 5/01/2012 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results,,,,,," 7/25/2011 LVS-US     PRN  Seven Summits Research Releases Comments on ConocoPhillips, Amazon, Las Vegas Sands, Gilead and Newmont Mining."," 5/09/2013 002XMH-E   PRN  BIOCOM Applauds Arena Pharmaceuticals' Commitment to Innovation, Contributions to Southern California Life Science Community"," 1/08/2016 N5946510  PRN  Mylan CFO John Sheehan to Retire as of April 1, 2016",,, 7/18/2017 03116210 PRN  Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation,,,,,," 5/17/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011"," 2/27/2012 64026810 PRN  Nektar Presents Positive Proof-of-Concept Clinical Data for Its New Opioid Molecule, NKTR-181, at American Academy of Pain Medicine's 28th Annual Meeting",,,,,,,,,,,,, 9/10/2012 80067710 PRN  Sangamo BioSciences Announces Presentation of Clinical Data from ZFP Therapeutic® for HIV/AIDS at ICAAC 2012,, 5/21/2015 80105N10  PRN  Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with Rheumatoid Arthritis,,,,,,,,,,,,,,,,,,,,11/05/2012 69329Y10 PRN  PDL BioPharma Completes Royalty Transaction with Wellstat Diagnostics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/21/2012 HALO-US  PRN  Halozyme Therapeutics And Pfizer Enter Into A Collaboration To Develop And Commercialize Subcutaneous Biologics Using Recombinant Human Hyaluronidase,,,,,,," 5/27/2014 69366J20 PRN  Stock Updates on Top Gainers -- Research on Groupon, LiveDeal, Ruckus Wireless, and PTC Therapeutics",,,,,,,,, 3/05/2012 G5087110 PRN  Jazz Pharmaceuticals Announces Public Offering of Ordinary Shares by Selling Shareholders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 6/27/2014 G3040110 PRN  Critical Alerts For Apple, Weyerhaeuser, Aetna, Endo Health Solutions, and BioMarin Pharmaceutical Released By InvestorsObserver",,,, 4/01/2016 75886F10    PRN  Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients,,,11/12/2014 46222210 PRN  Isis Pharmaceuticals Prices Offering of $425 Million of 1.00% Convertible Senior Notes,,, 4/25/2012 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results,,,,,, 7/12/2011 05QK53-E   PRN  Mylan Receives Voluntary License Rights to Gilead's HIV/AIDS Pipeline Products in Developing World, 5/07/2013 04004760   PRN  Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management, 1/08/2016 MYL-GB    PRN  Mylan Announces Worldwide Collaboration with Momenta to Jointly Develop and Commercialize Six Biosimilar Products,,, 7/16/2017 03116210 PRN  Amgen And UCB Provide Update On Regulatory Status Of EVENITY™ (romosozumab) In The US,,,,,, 5/12/2011 45773H20 PRN  Inovio Pharmaceuticals' Market-Leading Intellectual Property Recognized by MDB Capital Award," 2/24/2012 64026810 PRN  Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2011 on Wednesday, February 29, 2012, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,, 8/30/2012 80067710 PRN  Sangamo BioSciences Announces Presentation At The Stifel Nicolaus 2012 Healthcare Conference,," 5/12/2015 80105N10  PRN  Market Updates on Pharma Stocks - Zogenix, Valeant Pharma Intl., Sanofi, Novartis, and Ampio Pharma",,,,,,,,,,,,,,,,,,,,"11/01/2012 69329Y10 PRN  PDL BioPharma to Announce Third Quarter 2012 Financial Results on November 5, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/19/2012 40637H10 PRN  ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2b Dose Ranging Combination Study for Subcutaneous Administration of Cinryze® (C1 esterase inhibitor [human]) With Hyaluronidase (rHuPH20),,,,,,, 5/23/2014 69366J20 PRN  PTC Therapeutics Receives Positive Opinion from CHMP for Translarna™ (ataluren),,,,,,,,, 2/27/2012 G5087110 PRN  Jazz Pharmaceuticals Reports 2011 Full Year and Fourth Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/25/2014 0DP5N4-E PRN  Endo International plc Announces Pricing of Private Offering Of Senior Notes,,,, 3/30/2016 000VC1-E    PRN  RXi Pharmaceuticals Reports Fourth Quarter and Year End 2015 Financial Results and Recent Corporate Highlights,,,11/10/2014 46222210 PRN  Isis Pharmaceuticals Announces Proposed Offering of $425 Million of Convertible Senior Notes,,, 3/27/2012 64125C10 PRN  Neurocrine Biosciences to Present at the 11th Annual Needham Healthcare Conference,,,,,," 7/07/2011 SPRD-CN    PRN  Critical Alerts for Pepsico, Gilead Sciences, Urban Outfitters, U.S. Bancorp, and Spreadtrum Communications Released by Seven Summits Research", 5/02/2013 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results, 1/07/2016 N5946510  PRN  Mylan Launches Generic Harvoni® (Ledipasvir/Sofosbuvir) Under the Brand Name MyHep LVIR™ in India,,, 7/14/2017 03116210 PRN  Amgen Submits Regulatory Applications In US And Europe To Include Overall Survival Data In KYPROLIS® (Carfilzomib) Label,,,,,, 5/11/2011 45773H20 PRN  Inovio Pharmaceuticals Reports 2011 First Quarter Financial Results, 1/05/2012 64026810 PRN  Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A,,,,,,,,,,,,, 7/25/2012 80067710 PRN  Sangamo BioSciences Reports Second Quarter 2012 Financial Results,, 4/30/2015 80105N10  PRN  Sanofi Delivers Q1 2015 Business EPS Growth of 2.6% at CER and 12.8% on a Reported Basis,,,,,,,,,,,,,,,,,,,,10/09/2012 69329Y10 PRN  PDL BioPharma Completes Royalty Transaction with AxoGen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/08/2012 HALO-US  PRN  Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera,,,,,,, 5/23/2014 69366J20 PRN  PTC Therapeutics Provides EMA Update,,,,,,,,," 2/14/2012 G5087110 PRN  Jazz Pharmaceuticals to Announce 2011 Full Year and Fourth Quarter Financial Results on February 27, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/25/2014 0DP5N4-E PRN  Endo International plc Announces Proposed Private Offering Of Senior Notes,,,, 3/24/2016 000VC1-E    PRN  Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases,,,11/07/2014 46222210 PRN  Isis Pharmaceuticals Reports Financial Results and Highlights for Third Quarter 2014,,, 3/27/2012 64125C10 PRN  Elagolix Endometriosis Phase III Trials on Track to Commence in Second Quarter 2012,,,,,, 6/28/2011 000L1R-E   PRN  Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed-Dose Combination of PREZISTA® and Cobicistat," 4/26/2013 04004760   PRN  Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2", 1/05/2016 N5946510  PRN  Mylan Launches Generic Ortho Tri-Cyclen Lo® Tablets,,," 7/13/2017 03116210 PRN  Amgen And Allergan To Discuss Data Supporting Biologics License Application For ABP 215, A Biosimilar Candidate To Avastin® (bevacizumab)",,,,,, 5/09/2011 45773H20 PRN  Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine," 1/04/2012 64026810 PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA",,,,,,,,,,,,, 7/18/2012 80067710 PRN  Sangamo BioSciences Announces Second Quarter 2012 Conference Call and Webcast,, 4/30/2015 80105N10  PRN  Sanofi Q1 2015 Results - Interview With CFO Jérôme Contamine,,,,,,,,,,,,,,,,,,,, 9/14/2012 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"11/15/2012 HALO-US  PRN  The Zacks Analyst Blog Highlights:ViroPharma Inc, Halozyme Therapeutics, Lockheed Martin Corporation, The Boeing Company and General Dynamics Corporation",,,,,,, 5/21/2014 69366J20 PRN  PTC Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference,,,,,,,,, 1/24/2012 G5087110 PRN  Jazz Pharmaceuticals plc Announces New Executive Appointments,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 6/25/2014 G3040110 PRN  Patient Enrollments, Innovation Awards, Appointments, and Promotions - Analyst Notes on Endo, St. Jude, Impax, Novavax and PTC Therapeutics",,,, 3/23/2016 000VC1-E    PRN  Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Praluent® (alirocumab) Study in Patients Undergoing LDL Apheresis Therapy,,,11/06/2014 46222210 PRN  Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx,,, 3/26/2012 64125C10 PRN  Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia,,,,,," 6/06/2011 SOLR-US    PRN  Daily Stock Alerts for GT Solar, American Tower, Brocade, JDS Uniphase, Limited Brands, & Gilead Sciences"," 4/19/2013 06DDVL-E   PRN  The Zacks Analyst Blog Highlights: Microsoft, VIVUS, Arena Pharmaceuticals, Orexigen Therapeutics and UCB",12/29/2015 MYL-GB    PRN  Mylan Launches Generic Zyvox® Tablets,,, 7/12/2017 03116210 PRN  Second Phase 3 Study Shows KYPROLIS® (Carfilzomib) Regimen Significantly Improves Overall Survival In Patients With Relapsed Multiple Myeloma,,,,,," 5/05/2011 45773H20 PRN  Article in Current Opinion in Immunology Journal Declares Coming ""Decade of DNA Vaccines""","12/13/2011 NKTR-US  PRN  Nektar Announces Positive Clinical Data from Second Phase 1 Clinical Study of NKTR-181, a Novel Opioid Analgesic Molecule to Treat Chronic Pain",,,,,,,,,,,,, 7/03/2012 80067710 PRN  Sangamo BioSciences Announces Presentation at Seventh Annual JMP Securities Healthcare Conference,," 4/15/2015 80105N10  PRN  Equities Updates on Pharma Industry -- Eli Lilly, Sanofi, AstraZeneca, Nektar Therapeutics, and BioDelivery Sciences Intl.",,,,,,,,,,,,,,,,,,,, 9/06/2012 69329Y10 PRN  PDL BioPharma to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/08/2012 40637H10 PRN  Halozyme Reports Third Quarter 2012 Financial Results,,,,,,, 5/16/2014 69366J20 PRN  Ataluren Phase 3 Trial Results in Nonsense Mutation Cystic Fibrosis Published in The Lancet Respiratory Medicine,,,,,,,,, 1/18/2012 G5087110 PRN  Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz Pharmaceuticals plc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/24/2014 00FV7G-E PRN  Endo to Acquire DAVA Pharmaceuticals,,,, 3/16/2016 75886F10    PRN  Regeneron and Sanofi Strongly Disagree with U.S. Jury Verdict in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection and Will Appeal,,,11/05/2014 46222210 PRN  Isis Pharmaceuticals Earns $7.5 Million Milestone Payment From AstraZeneca,,, 3/07/2012 64125C10 PRN  Neurocrine Biosciences to Present at The 24th Annual Roth Conference,,,,,," 5/18/2011 064Q9G-E   PRN  Cystic Fibrosis Foundation Launches ""Walk Weekend""- More Than 200 Great Strides Fundraisers Scheduled for May 21-22"," 4/17/2013 04004760   PRN  Arena Pharma, Celgene, Incyte, Spectrum Pharma, and Geron Under StockCall's Microscope",12/17/2015 MYL-GB    PRN  Mylan to Present at the Goldman Sachs Healthcare CEOs Unscripted: A View from the Top,,, 7/11/2017 03116210 PRN  FDA Grants Full Approval for BLINCYTO® (blinatumomab) to Treat Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia in Adults and Children,,,,,, 5/04/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at Scientific Conferences,12/12/2011 64026810 PRN  Nektar Therapeutics Initiates Phase 3 BEACON Trial of NKTR-102 in Women with Metastatic Breast Cancer,,,,,,,,,,,,, 6/07/2012 06NVWX-E PRN  Manipulating Chromatin Loops to Regulate Genes May Offer Future Treatments for Blood Diseases,, 4/14/2015 08HVR4-E  PRN  Sanofi Korea Launches Anlit Probiotic Supplement for Kids,,,,,,,,,,,,,,,,,,,, 9/06/2012 69329Y10 PRN  PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/06/2012 40637H10 PRN  Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference,,,,,,, 5/06/2014 69366J20 PRN  PTC Therapeutics Reports First Quarter Financial Results and Provides Corporate Update,,,,,,,,, 1/05/2012 G5087110 PRN  Jazz Pharmaceuticals Provides Financial Outlook for 2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/18/2014 079K16-E PRN  Trendlines Acquires Intellectual Property from Collaboration with Endo,,,, 3/11/2016 75886F10    PRN  Regeneron and Sanofi Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis,,,11/03/2014 46222210 PRN  Regulus Announces Closing of Public Offering of $103.5M of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares,,, 2/29/2012 64125C10 PRN  Neurocrine Biosciences to Present at the 32nd Annual Cowen Health Care Conference,,,,,, 5/04/2011 000L1R-E   PRN  Plato BioPharma Presenting Poster at the American Thoracic Society Conference, 4/05/2013 04004760   PRN  Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases,12/17/2015 N5946510  PRN  Mylan to Present at the J.P. Morgan 34th Annual Healthcare Conference,,, 7/11/2017 03116210 PRN  Amgen And QB3@953 Announce Winners Of The Amgen Golden Ticket,,,,,, 4/29/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at Investor Conferences,12/08/2011 64026810 PRN  Nektar Reports Affymax Announced FDA Advisory Committee Voted in Favor of Benefit/Risk Profile for Peginesatide for Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis,,,,,,,,,,,,, 5/21/2012 80067710 PRN  Sangamo BioSciences And Collaborators Highlight Widening Applications Of ZFP Therapeutics® In Presentations At Major Gene Therapy Meeting,, 3/25/2015 07BBFC-E  PRN  Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years of Age,,,,,,,,,,,,,,,,,,,, 9/05/2012 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/01/2012 40637H10 PRN  Halozyme to Host Third Quarter Financial Results Conference Call,,,,,,, 4/23/2014 69366J20 PRN  PTC Therapeutics to Present at Upcoming Investor Conferences,,,,,,,,, 1/04/2012 G5087110 PRN  Jazz Pharmaceuticals to Hold Investor Conference Call on January 5 to Discuss 2012 Financial Guidance and Azur Pharma Transaction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 6/09/2014 0823JR-E PRN  American Medical Systems Enrolls First Patient in Embrace, a 522 Post Market Surveillance Study for the Elevate™ Anterior and Apical Prolapse System",,,, 3/02/2016 000VC1-E    PRN  Regeneron Genetics Center Publication in New England Journal of Medicine Links ANGPTL4 Inhibition and Risk of Coronary Artery Disease,,,11/03/2014 46222210 PRN  Isis Pharmaceuticals Earns $5 Million in Milestone Payment From GSK for Advancement of ISIS-GSK5 Rx,,, 2/21/2012 64125C10 PRN  Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference,,,,,," 4/19/2011 37555810   PRN  Critical Alerts for Schlumberger, Gilead, Covidien, Tata Motors, and Green Mountain Coffee Roasters Released by Seven Summits Research", 4/01/2013 04004760   PRN  Arena Pharmaceuticals Announces Eisai's Submission of BELVIQ® (lorcaserin HCl) Marketing Authorization Application in Mexico,12/04/2015 N5946510  PRN  Mylan Announces Pricing of Senior Notes,,, 6/29/2017 03116210 PRN  FDA Approves Vectibix® (Panitumumab) For Use In Wild-Type RAS Metastatic Colorectal Cancer,,,,,," 4/18/2011 07DZ1R-E PRN  Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C",11/15/2011 64026810 PRN  NKTR-102 Demonstrates Synergistic Anti-Tumor Activity in Combination with Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer,,,,,,,,,,,,, 5/07/2012 80067710 PRN  Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences,, 3/19/2015 80105N10  PRN  Sanofi Announces Top-Line Results for Cardiovascular Outcomes Study of Lyxumia® (lixisenatide),,,,,,,,,,,,,,,,,,,, 8/02/2012 69329Y10 PRN  PDL BioPharma Announces Second Quarter 2012 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/25/2012 40637H10 PRN  Halozyme Therapeutics to Host Analyst / Investor Meeting on October 2nd in New York,,,,,,, 4/22/2014 69366J20 PRN  PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results,,,,,,,,,12/12/2011 G5087110 PRN  Jazz Pharmaceuticals Announces Stockholder Vote in Favor of Transaction With Azur Pharma Limted,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/02/2014 G3040110 PRN  Endo Completes Sale of Early Stage Drug Discovery Portfolio,,,, 2/29/2016 75886F10    PRN  Regeneron Announces Upcoming 2016 Investor Conference Presentation,,,"10/31/2014 46222210 PRN  Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma",,, 2/08/2012 64125C10 PRN  Neurocrine Biosciences Reports Fourth Quarter and Year End 2011 Results,,,,,, 4/11/2011 ALCLS-FR   PRN  Cellectis Strengthens Management Team to Support Stem Cell Activities," 3/19/2013 04004760   PRN  Morning Research on Arena Pharma, Incyte, Galena Biopharma, and Novavax","12/01/2015 MYL-GB    PRN  On World AIDS Day, Mylan Announces Plans to be the First to Market Newly-Recommended Antiretroviral Treatment for $99 Per Patient, Per Year",,, 6/23/2017 03116210 PRN  Amgen Receives Positive CHMP Opinion To Expand Use Of Mimpara® (cinacalcet) For The Treatment Of Secondary Hyperparathyroidism In Certain Children With End-Stage Renal Disease On Dialysis,,,,,, 4/04/2011 45773H20 PRN  OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals,11/14/2011 64026810 PRN  Positive Data for Nektar's New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011,,,,,,,,,,,,, 5/02/2012 80067710 PRN  Sangamo BioSciences Reports First Quarter 2012 Financial Results,, 3/18/2015 80105N10  PRN  Nasacort® Allergy 24HR Partners with The Book of Awesome Author and Renowned Smell Expert to Celebrate the Happy Smells of Spring,,,,,,,,,,,,,,,,,,,," 7/19/2012 69329Y10 PRN  PDL BioPharma to Announce Second Quarter 2012 Financial Results on August 2, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/21/2012 40637H10 PRN  ViroPharma And Halozyme Provide Update On Clinical Development Of Subcutaneous Cinryze® (C1 Esterase Inhibitor [Human]) With Recombinant Human Hyaluronidase (rHuPH20),,,,,,, 4/21/2014 69366J20 PRN  PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),,,,,,,,,11/09/2011 G5087110 PRN  Jazz Pharmaceuticals Announces Presentations at Investor Conferences in November,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 5/23/2014 G3040110 PRN  Relief Efforts, Rights Acquisitions, Recognition, and Settlements - Analyst Notes on UnitedHealth Group, Endo, Baxter, Edwards Lifesciences and Aetna",,,, 2/09/2016 75886F10    PRN  Regeneron Reports Fourth Quarter and Full Year 2015 Financial and Operating Results,,,10/31/2014 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call,,, 2/06/2012 64125C10 PRN  Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference,,,,,," 3/04/2011 CIEN-US    PRN  Critical Alerts for Wells Fargo, Walgreens, Allstate, Gilead, and CIENA Released by Seven Summits Research"," 3/08/2013 04004760   PRN  Pushing Pipelines Forward for Long-Term Success - Research Report on Vertex, Santarus, Arena Pharmaceuticals, Seattle Genetics and Nektar Therapeutics",11/24/2015 MYL-GB    PRN  Mylan Launches Generic FazaClo® Orally Disintegrating Tablets,,, 6/21/2017 03116210 PRN  Amgen To Present New Data At 22nd Congress of the European Hematology Association,,,,,, 3/29/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at Scientific Conferences,11/02/2011 64026810 PRN  Nektar Therapeutics Reports Third Quarter 2011 Financial Results,,,,,,,,,,,,, 4/30/2012 80067710 PRN  Sangamo BioSciences Nominates Saira Ramasastry To The Company's Board Of Directors,, 3/15/2015 80105N10  PRN  Regeneron and Sanofi Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent™ (alirocumab) Published in The New England Journal of Medicine,,,,,,,,,,,,,,,,,,,," 7/05/2012 06DDVL-E PRN  Zacks.com featured expert Kevin Matras highlights: Sinclair Broadcast Group, Inc., PDL BioPharma, Inc., Hawaiian Holdings, Inc., Innospec Inc. and Discover Financial Services",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/06/2012 40637H10 PRN  Halozyme Reports Second Quarter 2012 Financial Results,,,,,,, 3/06/2014 69366J20 PRN  PTC Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update,,,,,,,,,11/01/2011 G5087110 PRN  Jazz Pharmaceuticals Announces Third Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 5/19/2014 G3040110 PRN  Study Results, Analyst Meetings, Upcoming Events, Financial Results, and Welfare Initiatives - Analyst Notes on Pharmacyclics, Thermo Fisher Scientific, Endo, Humana and Aetna",,,, 2/02/2016 75886F10    PRN  Regeneron Announces Upcoming 2016 Investor Conference Presentation,,,"10/30/2014 46222210 PRN  Critical Alerts For AT&T, SolarWinds, Whole Foods Market, FireEye and Isis Pharmaceuticals Released By InvestorsObserver",,, 2/02/2012 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast To Present Fourth Quarter and Year-End 2011 Financial Results,,,,,," 1/28/2011 37555810   PRN  Critical Alerts for Pepsico, Johnson & Johnson, Gilead, Franklin Resources, and Jabil Circuit Released by Seven Summits Research", 3/04/2013 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results,11/20/2015 MYL-GB    PRN  Mylan Completes Acquisition of Certain Businesses from Famy Care to Create a Leading Women's Healthcare Franchise,,, 6/19/2017 03116210 PRN  FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA® (denosumab) To Include Multiple Myeloma Patients,,,,,, 3/21/2011 45773H20 PRN  Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development,"10/26/2011 64026810 PRN  Nektar to Announce Financial Results for the Third Quarter of 2011 on Wednesday, November 2, 2011, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,, 4/25/2012 80067710 PRN  Sangamo BioSciences Announces First Quarter 2012 Conference Call and Webcast,, 3/15/2015 REGN-US   PRN  Sanofi and Regeneron Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent™ (alirocumab) Published in The New England Journal of Medicine,,,,,,,,,,,,,,,,,,,, 6/19/2012 69329Y10 PRN  PDL to Receive Royalties on Sales of Genentech's Pertuzumab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 8/06/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Google, Yahoo, Microsoft, ViroPharma and Halozyme Therapeutics",,,,,,, 2/28/2014 69366J20 PRN  PTC Therapeutics To Present At The Cowen & Company 34th Annual Health Care Conference,,,,,,,,,10/20/2011 G5087110 PRN  Jazz Pharmaceuticals Announces Third Quarter 2011 Results Conference Call on November 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/19/2014 0DP354-E PRN  Endo Completes Acquisition of Rights to Sumavel® DosePro®,,,," 1/26/2016 75886F10    PRN  Regeneron to Report Fourth Quarter and Full Year 2015 Financial and Operating Results and Host Conference Call and Webcast on February 9, 2016",,,10/30/2014 46222210 PRN  Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference,,," 1/30/2012 64125C10 PRN  Neurocrine Biosciences, Inc. Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares",,,,,,"12/27/2010 37555810   PRN  Critical Alerts For General Motors, Gilead Sciences, Barrick Gold, Arch Coal, and Sina Released By Seven Summits Research", 2/27/2013 04004760   PRN  Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference,11/19/2015 N5946510  PRN  Mylan Confirms First-to-File Patent Challenge Relating to DELZICOL®,,, 6/08/2017 03116210 PRN  Amgen Presents Erenumab Data At The 59th Annual Scientific Meeting of the American Headache Society,,,,,, 3/17/2011 45773H20 PRN  Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results," 9/21/2011 64026810 PRN  Nektar Presents Positive Data for Novel Opioid Analgesic, NKTR-181, at the 2011 American Academy of Pain Management Annual Meeting",,,,,,,,,,,,, 4/12/2012 80067710 PRN  Sangamo BioSciences Announces Presentation at the Future Leaders in the Biotech Industry Conference,," 3/10/2015 80105N10  PRN  Technical Snapshot on Pharma Stocks -- Pfizer, Zogenix, Sanofi, Nektar Therapeutics, and IGI Laboratories",,,,,,,,,,,,,,,,,,,, 6/14/2012 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/02/2012 40637H10 PRN  Halozyme to Host Second Quarter Financial Results Conference Call,,,,,,, 2/27/2014 69366J20 PRN  PTC Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4),,,,,,,,,"10/20/2011 G5087110 PRN  Critical Alerts For Intel, Mosaic, Deckers, Foot Locker, and Jazz Pharmaceuticals Released By Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/09/2014 G3040110 PRN  Endo Announces Appearances at Upcoming Conferences,,,, 1/08/2016 REGN-US     PRN  Regeneron and Sanofi Announce Sarilumab Biologics License Application Accepted for Review by US FDA,,,10/28/2014 46222210 PRN  Regulus Announces Pricing of Public Offering of Common Stock,,, 1/25/2012 64125C10 PRN  Neurocrine Biosciences Announces The FDA Has Granted Fast Track Designation For VMAT2 Inhibitor NBI-98854,,,,,,12/08/2010 000L1R-E   PRN  Reportlinker Adds Gilead Sciences: PharmaVitae Profile," 2/25/2013 04004760   PRN  Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4",11/19/2015 N5946510  PRN  Mylan Launches Generic Adderall® Tablets,,, 6/08/2017 03116210 PRN  Amgen To Present At The Goldman Sachs 38th Annual Global Healthcare Conference,,,,,, 3/15/2011 45773H20 PRN  OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals," 9/14/2011 64026810 PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City",,,,,,,,,,,,, 4/02/2012 80067710 PRN  Sangamo BioSciences Announces Publication in Nature Medicine Demonstrating Use of ZFN Technology to Engineer Safer and More Effective Cancer Treatments,, 2/25/2015 80105N10  PRN  Sanofi Receives FDA Approval of Once-Daily Basal Insulin Toujeo®,,,,,,,,,,,,,,,,,,,, 6/13/2012 69329Y10 PRN  PDL BioPharma Provides Second Quarter 2012 Royalty Revenue Guidance of $125 Million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/01/2012 40637H10 PRN  Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA,,,,,,, 2/27/2014 69366J20 PRN  PTC Therapeutics to Host Fourth Quarter and Year End 2013 Financial Results Conference Call,,,,,,,,, 9/27/2011 G5087110 PRN  Jazz Pharmaceuticals Appoints Head of Research and Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 5/06/2014 G3040110 PRN  Endo Health Solutions Inc. Final Results and Settlement of Exchange Offers and Consent Solicitations Relating to its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022",,,, 1/07/2016 REGN-US     PRN  Regeneron Announces Presentation at the 34th Annual J.P. Morgan Healthcare Conference,,,10/10/2014 46222210 PRN  Isis Pharmaceuticals Reports Data From ISIS-SMN Rx Phase 2 Studies in Infants and Children With Spinal Muscular Atrophy,,," 1/19/2012 64125C10 PRN  Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock",,,,,,"11/24/2010 37555810   PRN  Critical Alerts for Coca-Cola, Gilead Sciences, Ingersoll-Rand, Symantec, and Harbin Electric Released by Seven Summits Research", 2/20/2013 04004760   PRN  Today's Research on Incyte and Arena Pharma: Biotech Stocks Up on Drug Approvals,11/17/2015 MYL-GB    PRN  Mylan Launches Generic AXERT® Tablets,,," 6/07/2017 03116210 PRN  Amgen And Allergan Announce FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab",,,,,, 3/15/2011 45773H20 PRN  Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical, 9/09/2011 64026810 PRN  Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium,,,,,,,,,,,,, 3/28/2012 80067710 PRN  Sangamo BioSciences Announces Presentation at Needham Healthcare Conference,," 2/20/2015 80105N10  PRN  Critical Alerts For Walmart, Sanofi-Aventis, Tableau Software, Rackspace Hosting and Qihoo 360 Technology Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,, 6/05/2012 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/11/2012 40637H10 PRN  Halozyme's Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012,,,,,,, 2/25/2014 69366J20 PRN  PTC Therapeutics Expands International Commercial Team,,,,,,,,," 9/21/2011 G5087110 PRN  Critical Alerts for Intel, Southwestern Energy, Lockheed Martin, Humana, and Jazz Pharmaceuticals Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/01/2014 G3040110 PRN  Endo Reports First Quarter Financial Results,,,,"12/27/2015 75886F10    PRN  Regeneron Mourns Passing of Dr. Alfred G. Gilman, Board Member and Nobel Laureate",,,10/09/2014 46222210 PRN  Isis Pharmaceuticals Earns $18 Million From GSK for Advancing ISIS-TTR Rx,,," 1/18/2012 NBIX-US  PRN  Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock",,,,,,11/18/2010 000KXY-E   PRN  BioSpace Highlights the Northwest's Growing Life Science Region, 2/06/2013 04004760   PRN  Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences,11/16/2015 N5946510  PRN  Mylan Authorizes $1 Billion Share Repurchase Plan,,, 6/05/2017 03116210 PRN  Amgen Submits Regulatory Applications For Repatha® (evolocumab) Cardiovascular Outcomes Data In US And Europe,,,,,, 3/14/2011 45773H20 PRN  Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology," 9/08/2011 64026810 PRN  Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain",,,,,,,,,,,,," 3/08/2012 80067710 PRN  Sangamo Presents New Clinical Data at CROI 2012 Demonstrating Persistent Positive Effects of ZFN Therapeutic® for ""Functional Cure"" of HIV/AIDS",, 2/05/2015 80105N10  PRN  Sanofi Delivers Business EPS Growth of 7.3% at CER in 2014,,,,,,,,,,,,,,,,,,,, 6/04/2012 69329Y10 PRN  PDL BioPharma to Present at the Jefferies 2012 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/09/2012 40637H10 PRN  Halozyme Presents Positive Data from Two Ultrafast Insulin Clinical Trials with Human Hyaluronidase Enzyme - rHuPH20 - at ADA 2012,,,,,,, 2/20/2014 69366J20 PRN  PTC Therapeutics to Present at Upcoming Investor Conferences,,,,,,,,, 9/19/2011 G5087110 PRN  Jazz Pharmaceuticals and Azur Pharma Agree to Combine to Form Jazz Pharmaceuticals plc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/30/2014 G3040110 PRN  Endo Health Solutions Inc. Announces Extension of Expiration Date and Reopening of Withdrawal Rights in Exchange Offers for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022",,,,12/22/2015 05WD3P-E    PRN  Prime Therapeutics prefers both cholesterol lowering drugs Praluent® and Repatha® on its national drug list,,,"10/07/2014 46222210 PRN  Critical Alerts For petroleo brasileiro, Herbalife, Micron, FireEye and Isis Pharmaceuticals Released By InvestorsObserver",,," 1/07/2012 64125C10 PRN  Neurocrine Mourns the Passing of Founder and Board Member Wylie Vale, Ph.D.",,,,,,"10/27/2010 000L1R-E   PRN  Owing Largely to the Generic Erosion of Key Antiretroviral Agents, Growth in the HIV Drug Market Will Decline to 2.2 Percent Annually From 2014 to 2019"," 1/23/2013 000CSN-E   PRN  Top Stock Alerts for Day Traders: Facebook, Microsoft, Arena, Nokia, Synovus, and Best Buy","11/16/2015 N5946510  PRN  Covered Call Alerts For Chesapeake Energy, Mylan, Keryx Biopharmaceuticals, Yelp and Corning Inc. Released By InvestorsObserver",,, 6/04/2017 03116210 PRN  Amgen Presents New Data From Phase 3 XGEVA® (Denosumab) Study In Patients With Multiple Myeloma At ASCO 2017,,,,,, 3/07/2011 062S3Y-E PRN  Inovio Pharmaceuticals Enters Phase II Clinical Trial with SynCon™ DNA Vaccine for Cervical Dysplasia Caused by HPV, 8/04/2011 64026810 PRN  Nektar Therapeutics Reports Second Quarter 2011 Financial Results,,,,,,,,,,,,, 2/09/2012 80067710 PRN  Sangamo BioSciences Announces Presentation at 2012 Leerink Swann Global Healthcare Conference,, 2/05/2015 80105N10  PRN  Sanofi FY 2014 - Interview With Chairman & CEO Serge Weinberg,,,,,,,,,,,,,,,,,,,, 5/08/2012 69329Y10 PRN  PDL BioPharma to Present at Upcoming Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/09/2012 40637H10 PRN  Interim Data From Pre-administration of Hylenex in Analog Insulin Pump Therapy Demonstrate Consistent Insulin Action Profile: Data Presented in Late-Breaker Poster at ADA 2012,,,,,,," 2/19/2014 69366J20 PRN  PTC Therapeutics Announces Closing of Registered Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares",,,,,,,,, 9/16/2011 G5087110 PRN  Jazz Pharmaceuticals Announces Presentation at the UBS Global Life Sciences Conference in New York on September 20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 4/30/2014 G3040110 PRN  Endo Reaches Agreements in Principle to Settle a Substantial Majority of AMS Litigation Cases,,,,12/11/2015 REGN-US     PRN  Regeneron and Sanofi Announce UnitedHealth Group Selects Praluent® (alirocumab) Injection for Preferred Access,,,10/02/2014 46222210 PRN  Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress,,, 1/06/2012 64125C10 PRN  Neurocrine Biosciences to Present at the 30th Annual J.P. Morgan Healthcare Conference,,,,,,"10/21/2010 37555810   PRN  Critical Alerts for Las Vegas Sands, Applied Materials, Gilead Sciences, Banco Bradesco, and Alliance Data Systems Released by Seven Summits Research"," 1/23/2013 04004760   PRN  Pill Economics - Research Report on Arena Pharmaceuticals, Inc. and Amgen, Inc.","11/16/2015 N5946510  PRN  Mylan Launches Generic Viramune XR® Extended-Release Tablets, 100 mg",,, 6/03/2017 03116210 PRN  Amgen Presents New Phase 2 Data On IMLYGIC® (Talimogene Laherparepvec) Investigational Combination At ASCO 2017,,,,,, 3/03/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference," 7/27/2011 64026810 PRN  Nektar to Announce Financial Results for the Second Quarter of 2011 on Thursday, August 4, 2011, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,, 2/08/2012 80067710 PRN  Sangamo BioSciences Reports Fourth Quarter and Full Year 2011 Financial Results,," 2/03/2015 80105N10  PRN  Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S.",,,,,,,,,,,,,,,,,,,, 5/03/2012 69329Y10 PRN  PDL BioPharma Announces First Quarter 2012 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/01/2012 40637H10 PRN  Halozyme Therapeutics to Present New Data on the Company's Ultrafast Insulin Programs at ADA 2012,,,,,,, 2/12/2014 69366J20 PRN  PTC Therapeutics Announces Pricing of Public Offering of Common Stock,,,,,,,,, 7/28/2011 G5087110 PRN  Jazz Pharmaceuticals Announces Second Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/30/2014 G3040110 PRN  Endo Health Solutions Inc. Announces Extension of Expiration Date in Exchange Offers for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022",,,,12/11/2015 75886F10    PRN  Sanofi and Regeneron Announce UnitedHealth Group Selects Praluent® (alirocumab) Injection for Preferred Access,,,10/01/2014 46222210 PRN  Isis Pharmaceuticals Earns $1.5 Million From GSK for the Advancement of ISIS-GSK4 Rx,,,11/23/2011 64125C10 PRN  Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care Conference,,,,,, 9/03/2010 37555810   PRN  BetterInvesting Magazine's October Issue Reminds Investors of the Perils of Popularity," 1/16/2013 000HGZ-E   PRN  Breaking News Hot Stocks Earnings: Dell, Research In Motion, Hewlett-Packard, Arena, Lululemon and AT&T",11/16/2015 MYL-GB    PRN  Mylan Launches Generic GLUCOTROL XL® Tablets,,," 6/02/2017 03116210 PRN  Amgen Showcases A Legacy Of Science, Innovation And Collaboration In Cambridge",,,,,, 3/02/2011 45773H20 PRN  Inovio Pharmaceuticals' Foot-and-Mouth Disease DNA Vaccine Introduces Critical Advantages in Fight Against Most Serious Farm Animal Disease, 7/18/2011 64026810 PRN  NKTR-102 Receives Positive Opinion From EMA COMP for Orphan Medicinal Product Designation in Ovarian Cancer,,,,,,,,,,,,, 2/01/2012 80067710 PRN  Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast,," 2/02/2015 80105N10  PRN  Pharma Equities Under the Scanner - Pfizer, Sanofi, Eli Lilly, AstraZeneca, and Zogenix",,,,,,,,,,,,,,,,,,,," 4/27/2012 69329Y10 PRN  PDL BioPharma to Announce First Quarter 2012 Financial Results on May 3, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/31/2012 40637H10 PRN  Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference,,,,,,, 2/10/2014 69366J20 PRN  PTC Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,,,, 7/12/2011 G5087110 PRN  Jazz Pharmaceuticals Announces Second Quarter 2011 Results Conference Call on July 28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 4/29/2014 8152-JP  PRN  Endo to Acquire Specialty Pharmaceuticals Company Somar,,,,"11/24/2015 REGN-US     PRN  Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled",,, 9/24/2014 46222210 PRN  Isis Pharmaceuticals to Present at the Leerink Partners Rare Disease Roundtable,,,11/03/2011 64125C10 PRN  Neurocrine Biosciences to Present at the 2011 Credit Suisse Annual Health Care Conference,,,,,," 9/01/2010 37555810   PRN  Critical Alerts for Research In Motion, Gilead, Arch Coal, V.F. Corp, and CB Richard Ellis Released by Seven Summits Research", 1/02/2013 04004760   PRN  Arena Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference,"11/13/2015 PRGO-IE   PRN  Perrigo Shareholders Convincingly Reject Mylan's Tender Offer, Expressing Confidence in Perrigo's Long-Term Strategy",,," 5/30/2017 GERN-US  PRN  Sofinnova Announces the Addition of Industry Leader Alan Colowick, MD, MPH to its Partnership",,,,,, 2/24/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference, 6/07/2011 64026810 PRN  Data from Phase 1 Study of NKTR-181 Demonstrate Proof-of-Concept for Nektar's Novel Opioid Analgesic Candidate,,,,,,,,,,,,, 2/01/2012 80067710 PRN  Shire and Sangamo Collaborate to Develop Therapeutics for the Treatment of Hemophilia and Other Monogenic Diseases,, 1/26/2015 80105N10  PRN  Regeneron and Sanofi Announce Praluent™ (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA,,,,,,,,,,,,,,,,,,,, 4/26/2012 69329Y10 PRN  PDL BioPharma Appoints Bruce Tomlinson as Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/09/2012 40637H10 PRN  Halozyme Therapeutics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference,,,,,,, 1/24/2014 69366J20 PRN  PTC Therapeutics Provides Update on CHMP Opinion for Conditional Approval of Ataluren for Nonsense Mutation Duchenne Muscular Dystrophy,,,,,,,,, 6/02/2011 G5087110 PRN  Jazz Pharmaceuticals Announces Presentation at the Jefferies 2011 Global Healthcare Conference in New York on June 8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 4/28/2014 G3040110 PRN  Endo Appoints Dr. Hemanth J. Varghese as Executive Vice President of Corporate Development and Strategy,,,,"11/12/2015 ARE-US      PRN  Joel Marcus, CEO of Alexandria Real Estate Equities, Inc., Receives Lifetime Achievement Award from Biotech Executives",,," 9/17/2014 46222210 PRN  New Manufacturing Facility, Special Meeting Updates, Recognition, Technical Updates, and Clinical Data - Research Reports on Valeant, Allergan, Isis, Regeneron and Teva",,,"11/02/2011 000CR1-E PRN  Zacks Bull and Bear of the Day Highlights: Neurocrine Biosciences, Bemis, Societie Generale, Citigroup and Morgan Stanley",,,,,," 8/03/2010 37555810   PRN  Critical Alerts for AT&T, Gilead, Devon Energy, ICICI Bank, and HCP Released by Seven Summits Research",12/06/2012 04004760   PRN  Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference,11/13/2015 N5946510  PRN  Mylan Announces Results of Offer to Acquire Perrigo and Lapse of Offer,,," 5/23/2017 03116210 PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amgen Inc. (AMGN)",,,,,, 2/22/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences, 6/05/2011 64026810 PRN  NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil®,,,,,,,,,,,,, 2/01/2012 80067710 PRN  Shire and Sangamo Collaborate to Develop Therapeutics for the Treatment of Hemophilia and Other Monogenic Diseases,, 1/12/2015 80105N10  PRN  Regeneron and Sanofi Announce Praluent™ (alirocumab) Marketing Authorization Application has Been Accepted for Review by EMA,,,,,,,,,,,,,,,,,,,," 4/12/2012 69329Y10 PRN  PDL BioPharma to Hold Annual Meeting of Stockholders on June 5, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/07/2012 40637H10 PRN  Halozyme Reports First Quarter 2012 Financial Results,,,,,,, 1/24/2014 69366J20 PRN  PTC Therapeutics Expands Management Team,,,,,,,,, 5/03/2011 G5087110 PRN  Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 4/24/2014 00FV7G-E PRN  Endo Acquires Rights to Sumavel® DosePro®,,,,11/10/2015 SNY-FR      PRN  Sanofi and Regeneron Announce New Praluent® (alirocumab) Injection Analyses Presented at AHA Scientific Sessions 2015,,," 9/17/2014 46222210 PRN  Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma",,,10/31/2011 64125C10 PRN  Neurocrine Biosciences Reports Third Quarter 2011 Results,,,,,, 7/26/2010 37555810   PRN  Tibotec Pharmaceuticals Submits New Drug Application for Investigational Once-Daily HIV Treatment TMC278 to U.S. Food and Drug Administration,"11/28/2012 04004760   PRN  Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development and License Agreement for Temanogrel, a Novel Agent for Thrombotic Diseases","11/11/2015 N5946510  PRN  Natural Health, Pharmaceutical Supplements & Sports Nutrition Industries Maintain Continued Growth Opportunities for 3rd QTR - Company Receives Purchase Order for Entire Line Nutritional Supplements",,, 5/22/2017 03116210 PRN  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amgen Inc. - AMGN,,,,,, 2/08/2011 45773H20 PRN  Inovio Pharmaceuticals to Present at 13th Annual BIO CEO & Investor Conference, 6/04/2011 64026810 PRN  NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting,,,,,,,,,,,,, 1/09/2012 80067710 PRN  Sangamo BioSciences Announces Initiation of Two New Phase 2 HIV Clinical Trials,, 1/09/2015 80105N10  PRN  Regeneron and Sanofi Announce Positive Topline Results from First Phase 3 Trials Evaluating Monthly Dosing of Alirocumab in Patients with Hypercholesterolemia,,,,,,,,,,,,,,,,,,,, 3/14/2012 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/30/2012 40637H10 PRN  Halozyme to Host First Quarter 2012 Financial Results Conference Call,,,,,,, 1/22/2014 005W47-E PRN  Joint Program in Spinal Muscular Atrophy Enters First Stage of Clinical Development,,,,,,,,, 4/21/2011 G5087110 PRN  Jazz Pharmaceuticals Announces First Quarter 2011 Results Conference Call on May 3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/17/2014 G3040110 PRN  Endo Health Solutions Inc. Announces Receipt of Requisite Tenders and Consents in the Exchange Offers and Consent Solicitations Relating to its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7¼% Senior Notes due 2022",,,,11/10/2015 REGN-US     PRN  Regeneron and Sanofi Announce New Praluent® (alirocumab) Injection Analyses Presented at AHA Scientific Sessions 2015,,, 9/17/2014 IONS-US  PRN  Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin,,,10/26/2011 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results,,,,,, 7/22/2010 37555810   PRN  TMC278 Pivotal Phase 3 Clinical Trials Achieve Primary Objective,11/21/2012 04004760   PRN  Arena Pharmaceuticals to Webcast Live Presentation at the Piper Jaffray 24th Annual Healthcare Conference,11/10/2015 MYL-GB    PRN  Mylan to Present at 24th Annual Credit Suisse Healthcare Conference,,, 5/21/2017 03116210 PRN  Amgen And UCB Announce Top-Line Phase 3 Data From Active-Comparator Study Of EVENITY™ (Romosozumab) In Postmenopausal Women With Osteoporosis,,,,,," 2/07/2011 45773H20 PRN  Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery", 6/01/2011 64026810 PRN  Nektar Therapeutics' President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York,,,,,,,,,,,,, 1/05/2012 80067710 PRN  Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference,, 1/02/2015 80105N10  PRN  Shareholder Alert: Pomerantz Law Firm Announces the Filing of a Class Action against Sanofi and Certain Officers - SNY,,,,,,,,,,,,,,,,,,,, 3/08/2012 69329Y10 PRN  PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/16/2012 40637H10 PRN  Baxter and Halozyme Provide Update on HyQ Biologics License Application,,,,,,, 1/06/2014 69366J20 PRN  PTC Therapeutics To Present At The J.P. Morgan Healthcare Conference,,,,,,,,, 3/08/2011 G5087110 PRN  Jazz Pharmaceuticals to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/15/2014 G3040110 PRN  Endo to Announce First Quarter 2014 Financial Results on May 1, 2014",,,,11/08/2015 75886F10    PRN  Sanofi and Regeneron Present Results from Pivotal Phase 3 Study of Sarilumab at American College of Rheumatology Annual Meeting,,," 9/16/2014 46222210 PRN  Critical Alerts For Intel, Zynga, Isis Pharmaceuticals, Arrowhead Research and MannKind Released By InvestorsObserver",,,10/04/2011 64125C10 PRN  Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement,,,,,," 6/28/2010 37555810   PRN  Critical Alerts for Capital One, Peabody Energy, Gilead, Discover, and Hershey Released by Seven Summits Research",11/08/2012 04004760   PRN  Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences,11/10/2015 PRGO-IE   PRN  Perrigo Reaffirms Views on Mylan's Inadequate Offer; Maintains Strong Recommendation Shareholders Not Tender,,, 5/20/2017 03116210 PRN  Repatha® (Evolocumab) Reduced Cardiovascular Events In Patients With Baseline LDL-C Levels Below Current Targets,,,,,, 2/02/2011 45773H20 PRN  Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial, 5/18/2011 64026810 PRN  Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting,,,,,,,,,,,,,12/13/2011 80067710 PRN  Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting,,"12/15/2014 80105N10  PRN  Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis",,,,,,,,,,,,,,,,,,,, 3/05/2012 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/09/2012 40637H10 PRN  Halozyme Reports Fourth Quarter and Year End 2011 Financial Results and Provides Guidance for 2012,,,,,,,12/23/2013 69366J20 PRN  PTC Therapeutics Added to NASDAQ Biotechnology Index,,,,,,,,, 3/07/2011 G5087110 PRN  Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/14/2014 G3040110 PRN  Endo Health Solutions Inc. Amends Exchange Offers and Consent Solicitations for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022",,,,11/08/2015 REGN-US     PRN  Regeneron and Sanofi Present Results from Pivotal Phase 3 Study of Sarilumab at American College of Rheumatology Annual Meeting,,, 9/03/2014 46222210 PRN  Isis Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference,,, 9/27/2011 64125C10 PRN  Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine,,,,,, 6/04/2010 000L1R-E   PRN  AHF Lauds Gilead for AIDS Drug Price Concessions for Nation's ADAPs,11/06/2012 04004760   PRN  Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results,11/10/2015 N5946510  PRN  Mylan Highly Confident in Successful Completion of Tender Offer for Perrigo on Friday,,, 5/19/2017 03116210 PRN  Amgen Announces Voting Results of Annual Meeting of Stockholders,,,,,, 1/31/2011 45773H20 PRN  University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology, 4/27/2011 64026810 PRN  Nektar Therapeutics Reports First Quarter 2011 Financial Results,,,,,,,,,,,,,11/08/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at the Lazard Capital Markets 8th Annual Healthcare Conference,,12/15/2014 STD-ES    PRN  Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol,,,,,,,,,,,,,,,,,,,, 2/23/2012 69329Y10 PRN  PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/07/2012 40637H10 PRN  Halozyme Therapeutics to Present at Two Upcoming Investor Conferences in March,,,,,,,"12/19/2013 69366J20 PRN  Portfolio Expansions, Product Data, and Announcements by Healthcare Companies - Research Report on Life Technologies, OncoMed, Halozyme Therapeutics, Infinity, and PTC Therapeutics",,,,,,,,, 2/28/2011 G5087110 PRN  Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results Conference Call on March 7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/11/2014 G3040110 PRN  Endo Health Solutions Inc. Announces Extension of Consent Date and Expiration Date in Exchange Offers and Consent Solicitations for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7-1/4% Senior Notes due 2022",,,,"11/06/2015 75886F10    PRN  Covered Call Alerts For GoPro, Autodesk, Juno Therapeutics Inc, Regeneron Pharmaceuticals and Synaptics Incorporated Released By InvestorsObserver",,, 9/02/2014 46222210 PRN  ATL1103 Phase II Trial - Successful Efficacy Results,,, 9/19/2011 64125C10 PRN  Neurocrine Biosciences Announces That VMAT 2 Program Begins Enrollment in Second Phase II Clinical Trial,,,,,, 6/04/2010 000L1R-E   PRN  AHF Lauds Gilead for AIDS Drug Price Concessions for Nation's ADAPs,11/06/2012 04004760   PRN  Arena Pharmaceuticals Establishes BELVIQ® (lorcaserin HCl) Marketing and Supply Agreement with Ildong Pharmaceutical for South Korea,11/03/2015 PRGO-IE   PRN  Mylan Receives U.S. FTC Clearance for Proposed Acquisition of Perrigo and Confirms Governance Changes for the Combined Mylan-Perrigo Company,,, 5/18/2017 03116210 PRN  Amgen Submits Biologics License Application To The FDA For Erenumab,,,,,, 1/27/2011 05GSQ9-E PRN  Inovio Pharmaceuticals Closes $24.3 Million Registered Offering," 4/21/2011 64026810 PRN  FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer",,,,,,,,,,,,,10/25/2011 80067710 PRN  Sangamo BioSciences Reports Third Quarter 2011 Financial Results,,12/12/2014 0072XH-E  PRN  Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults,,,,,,,,,,,,,,,,,,,, 2/21/2012 69329Y10 PRN  PDL BioPharma to Present at Upcoming Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/06/2012 40637H10 PRN  ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20),,,,,,,12/12/2013 69366J20 PRN  Ataluren Clinical Data Demonstrate an Increase in Dystrophin Expression in Duchenne Muscular Dystrophy Patients,,,,,,,,, 2/23/2011 G5087110 PRN  Jazz Pharmaceuticals to Present at the Citi 2011 Global Health Care Conference in New York on March 1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 4/10/2014 AMPE-US  PRN  Ampio Pharmaceuticals' Vyrix Enters into an Agreement with Paladin Labs for Exclusive Rights to Zertane™ in Canada and Other Territories to Broaden its International Footprint,,,,11/05/2015 REGN-US     PRN  New Survey Of U.S. Adults With Diabetes Reveals Less Than Half Understand Their Risk For Vision Loss,,, 9/02/2014 46222210 PRN  Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014,,, 9/13/2011 64125C10 PRN  Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference,,,,,," 6/02/2010 000L1R-E   PRN  For the Treatment of HIV, Three Novel Products From Gilead and Tibotec Will Earn Combined Peak Year Sales in Excess of $5 Billion","10/31/2012 04004760   PRN  Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Tuesday, November 6",10/30/2015 N5946510  PRN  Perrigo Comments On Mylan's Presentation,,, 5/17/2017 03116210 PRN  Amgen Highlights Data To Be Presented At ASCO 2017 Across Oncology Portfolio,,,,,,," 4/18/2011 64026810 PRN  Nektar to Announce Financial Results for the First Quarter of 2011 on Wednesday, April 27, 2011, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,,10/18/2011 80067710 PRN  Sangamo BioSciences Announces Third Quarter 2011 Conference Call and Webcast,,12/08/2014 SDRL-BM   PRN  Law Offices of Marc S. Henzel Announces Securities Class Action Periods,,,,,,,,,,,,,,,,,,,," 2/16/2012 69329Y10 PRN  PDL BioPharma to Announce Fourth Quarter and Full Year 2011 Financial Results on February 23, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/01/2012 40637H10 PRN  Halozyme to Host Fourth Quarter and 2011 Year-End Financial Results Conference Call,,,,,,,11/14/2013 69366J20 PRN  PTC Therapeutics Reports Third Quarter 2013 Financial and Corporate Results,,,,,,,,, 1/05/2011 G5087110 PRN  Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference in San Francisco on January 12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/08/2014 G3040110 PRN  Endo Health Solutions Inc. Amends Exchange Offers and Consent Solicitations for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022",,,,11/05/2015 REGN-US     PRN  New Survey of U.S. Adults with Diabetes Reveals Less than Half Understand Their Risk for Vision Loss,,," 8/29/2014 46222210 PRN  Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth",,, 9/13/2011 64125C10 PRN  Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids,,,,,," 5/27/2010 37555810   PRN  Critical Alerts for McDonald's, Gilead, Total, NetApp, and Textron Released by Seven Summits Research","10/18/2012 000C77-E   PRN  Most Active Stocks: Check Point, PulteGroup, Apollo Group, Corning, Arena, and Textron",10/30/2015 N5946510  PRN  Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business,,, 5/12/2017 03116210 PRN  Amgen To Present At The Bank Of America Merrill Lynch 2017 Health Care Conference,,,,,,," 3/21/2011 NKTR-US  PRN  Nektar Initiates Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Pain",,,,,,,,,,,,,10/14/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at the 18th Annual Newsmakers in the Biotech Industry Conference,,"12/04/2014 80105N10  PRN  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Sanofi",,,,,,,,,,,,,,,,,,,, 2/07/2012 69329Y10 PRN  PDL BioPharma to Present at the 14th Annual BIO CEO & Investor Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/22/2012 40637H10 PRN  Halozyme Therapeutics to Present at the CITI 2012 Global Healthcare Conference,,,,,,,"11/13/2013 69366J20 PRN  Emerging Growth Equities, Ltd. Initiates Coverage Of PTC Therapeutics, Inc. (PTCT) With An ACCUMULATE Rating And $26.00 Price Target",,,,,,,,,12/21/2010 G5087110 PRN  Jazz Pharmaceuticals Announces New Patent Issued for Sodium Oxybate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/28/2014 G3040110 PRN  Endo International plc Announces Endo Health Solutions Inc. Will Commence Exchange Offers,,,,11/05/2015 75886F10    PRN  Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015,,, 8/28/2014 46222210 PRN  Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-APOCIII Rx in Patients with FCS,,, 9/01/2011 64125C10 PRN  Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference,,,,,, 5/03/2010 000L1R-E   PRN  Biotech Posts Weak Performance in April,10/12/2012 04004760   PRN  Arena Pharmaceuticals Initiates Phase 1 Multiple Dose Clinical Trial of APD811 for Pulmonary Arterial Hypertension,10/30/2015 N5946510  PRN  Mylan Third Quarter 2015 Constant Currency Adjusted Total Revenues Increase 36% and Adjusted Diluted EPS Increases 23% to $1.43,,, 5/09/2017 000C35-E PRN  Feldan Therapeutics and Elasmogen Announce Research Agreement with Amgen to Develop Intracellular Biologics,,,,,,, 3/15/2011 64026810 PRN  AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation,,,,,,,,,,,,,10/13/2011 80067710 PRN  Sangamo BioSciences Announces Publication in Nature of Gene Correction Strategy for Alpha 1-Antitrypsin Deficiency,,"12/04/2014 80105N10  PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of Sanofi -SNY",,,,,,,,,,,,,,,,,,,," 2/02/2012 69329Y10 PRN  PDL BioPharma Announces Exchange of Its 2.875% Convertible Senior Notes due February 15, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/15/2012 40637H10 PRN  Halozyme Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Stock,,,,,,,11/07/2013 69366J20 PRN  PTC Therapeutics to Host Third Quarter 2013 Financial Results Conference Call and Webcast,,,,,,,,,11/11/2010 G5087110 PRN  Jazz Pharmaceuticals Announces Presentation at the Lazard Capital Markets Healthcare Conference on November 17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 3/21/2014 00FV7G-E PRN  Health Car Sector Equities Technical Insight -- Research on Dynavax Technologies, Forest Laboratories, Orexigen Therapeutics and Endo Inl.",,,,11/04/2015 75886F10    PRN  Regeneron Reports Third Quarter 2015 Financial and Operating Results,,," 8/27/2014 46222210 PRN  Critical Alerts For Arrowhead Research, Isis Pharmaceuticals, MobileIron, JP Morgan Chase and Viacom Released By InvestorsObserver",,, 7/28/2011 64125C10 PRN  Neurocrine Biosciences Reports Second Quarter 2011 Results,,,,,, 4/30/2010 37555810   PRN  BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use,"10/10/2012 GLUU-US    PRN  Critical Stock Alerts: Glu Mobile, American Capital Agency, Arena, Vale SA, Weatherford International, and Skyworks Solutions",10/30/2015 N5946510  PRN  U.S. District Court Denies Perrigo's Motion for Preliminary Injunction Related to Certain Mylan Disclosures,,, 5/02/2017 03116210 PRN  Amgen And Harvard Pilgrim Agree To First Cardiovascular Outcomes-Based Refund Contract For Repatha® (Evolocumab),,,,,,, 3/01/2011 64026810 PRN  Nektar Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results,,,,,,,,,,,,,10/03/2011 80067710 PRN  Sangamo BioSciences Announces Phase 2b Trial of SB-509 in Diabetic Neuropathy Did Not Meet Key Study Endpoints,,12/02/2014 80105N10  PRN  Sanofi Receives FDA Approval of Priftin® (rifapentine) Tablets for the Treatment of Latent Tuberculosis Infection,,,,,,,,,,,,,,,,,,,, 1/24/2012 69329Y10 PRN  PDL BioPharma Announces 2012 Regular Quarterly Dividends,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/10/2012 40637H10 PRN  Halozyme Announces Pricing of Public Offering of Common Stock,,,,,,,11/05/2013 69366J20 PRN  PTC Therapeutics to Present at Credit Suisse Annual Health Care Conference,,,,,,,,,11/04/2010 G5087110 PRN  Jazz Pharmaceuticals Announces Adjusted Net Income for the Third Quarter of $0.41 per Share and GAAP Net Income of $0.32 per Share,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/07/2014 00FV7G-E PRN  Higher Functioning Endogenous Opioid System Predicts Better Treatment Response For Neuropathic Pain Treated With Topical NSAIDs: Study,,,,10/30/2015 REGN-US     PRN  Regeneron Announces EU Approval of EYLEA® (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization,,, 8/15/2014 46222210 PRN  Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy,,, 7/28/2011 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results,,,,,," 4/27/2010 37555810   PRN  Critical Alerts for Apple, PNC Financial, Gilead Sciences, Ingersoll-Rand, and Expedia Released by Seven Summits Research"," 9/19/2012 DTV.XX1-US PRN  Critical Alerts For Intel, DirecTV, Arena Pharmaceuticals, Rock Tenn, and Valspar Released By InvestorsObserver","10/29/2015 MYL-GB    PRN  Mylan Confirms Availability of EpiPen® (epinephrine injection) Auto-Injector for U.S. Patients Affected by Sanofi's Auvi-Q® (epinephrine injection, USP) Recall",,, 4/27/2017 03116210 PRN  Amgen To Participate In The 2017 World Medical Innovation Forum™ Focused On Cardiovascular Disease,,,,,,, 3/01/2011 NKTR-US  PRN  Nektar Therapeutics' President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston,,,,,,,,,,,,, 9/30/2011 80067710 PRN  Sangamo BioSciences to Host Conference Call to Discuss Results From Phase 2b Trial of SB-509 in Diabetic Neuropathy,,12/01/2014 80105N10  PRN  Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million Between 2005 and 2013,,,,,,,,,,,,,,,,,,,, 1/05/2012 69329Y10 PRN  PDL BioPharma Announces Settlement and Final Results of its Exchange Offer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/09/2012 40637H10 PRN  Halozyme Announces Proposed Public Offering of Common Stock,,,,,,,10/18/2013 69366J20 PRN  PTC Therapeutics to Showcase Breadth of Pipeline at Upcoming R&D Day,,,,,,,,,10/28/2010 G5087110 PRN  Jazz Pharmaceuticals Announces November 4 Conference Call to Discuss Third Quarter 2010 Results and Guidance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/07/2014 G3040110 PRN  Endo Announces Appointment of Dr. Susan Hall as New Chief Scientific Officer and Global Head of R&D and Quality,,,,10/23/2015 REGN-US     PRN  Regeneron Announces Presentation at the 24th Annual Credit Suisse Healthcare Conference,,," 8/14/2014 46222210 PRN  Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma",,, 7/21/2011 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results,,,,,,, 9/18/2012 04004760   PRN  Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference,10/28/2015 N5946510  PRN  Tel Aviv District Court Rules in Favor of Mylan Listing on Tel Aviv Stock Exchange,,, 4/26/2017 03116210 PRN  Amgen Reports First Quarter 2017 Financial Results,,,,,,," 2/17/2011 64026810 PRN  Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2010 on Tuesday, March 1, 2011, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,, 9/21/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at the Sixth Annual JMP Securities Healthcare Conference,,11/20/2014 80105N10  PRN  Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis,,,,,,,,,,,,,,,,,,,, 1/05/2012 69329Y10 PRN  PDL BioPharma to Present at the 30th Annual JP Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 1/31/2012 HALO-US  PRN  HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial,,,,,,,10/10/2013 69366J20 PRN  PTC Therapeutics to Present at the North American Cystic Fibrosis Conference,,,,,,,,,10/11/2010 G5087110 PRN  Jazz Pharmaceuticals Receives FDA Complete Response Letter Regarding JZP-6 for Treatment of Fibromyalgia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 3/06/2014 05MBN8-E PRN  U.S. FDA Approves AVEED™ (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T",,,,"10/13/2015 75886F10    PRN  Covered Call Alerts For Organovo, UnitedHealth, American Airlines, Regeneron Pharmaceuticals and Ford Released By InvestorsObserver",,," 8/08/2014 46222210 PRN  Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver",,, 6/23/2011 64125C10 PRN  Neurocrine Biosciences Announces Notice of Allowance for Composition of Matter Patent on VMAT2 Inhibitor,,,,,,," 9/13/2012 RF-US      PRN  Insider Hot Stocks: General Electric, Nokia, Altria Group, Juniper Networks, Regions Financial, and Arena",10/27/2015 MYL-GB    PRN  Mylan Launches Generic Fusilev® for Injection,,, 4/24/2017 03116210 PRN  Amgen Announces Expanded Commercial Collaboration With Novartis For Erenumab In Migraine,,,,,,, 1/24/2011 64026810 PRN  Nektar Therapeutics Completes Public Offering of Common Stock,,,,,,,,,,,,, 9/18/2011 80067710 PRN  Sangamo BioSciences Announces Presentation of Groundbreaking Clinical Data From ZFN Therapeutic for HIV/AIDS at ICAAC 2011,,11/19/2014 80105N10  PRN  Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol,,,,,,,,,,,,,,,,,,,, 1/03/2012 69329Y10 PRN  PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 1/18/2012 000KJ3-E PRN  Zacks.com featured expert Kevin Matras highlights: Brookfield Office Properties Inc., Fiserv, Inc., Halozyme Therapeutics, Inc., Jacobs Engineering Group Inc. and MarketAxess Holdings Inc.",,,,,,,10/01/2013 69366J20 PRN  PTC Therapeutics Expands Management Team,,,,,,,,,10/05/2010 G5087110 PRN  Jazz Pharmaceuticals Announces Paragraph IV ANDA Filing for Xyrem,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/28/2014 G3040110 PRN  Endo Reports Fourth Quarter And Full Year 2013 Financial Results,,,,"10/08/2015 75886F10    PRN  Regeneron to Report Third Quarter 2015 Financial and Operating Results and Host Conference Call and Webcast on November 4, 2015",,, 8/04/2014 46222210 PRN  Isis Reports Financial Results and Highlights for Second Quarter 2014,,, 6/16/2011 64125C10 PRN  Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis,,,,,,," 9/05/2012 BHC-CA     PRN  Today's Market Focus: American International Group, Valeant, ARM Holdings, Lowe's, CSX, and Arena",10/13/2015 N5946510  PRN  Mylan Highlights Clear Value Creation to Perrigo Shareholders Available Through its Offer,,, 4/21/2017 03116210 PRN  Amgen Announces Webcast Of 2017 First Quarter Financial Results,,,,,,, 1/19/2011 64026810 PRN  Nektar Therapeutics Prices Public Offering of Common Stock,,,,,,,,,,,,, 9/14/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at the 2011 UBS Global Life Sciences Conference,,11/19/2014 80105N10  PRN  Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol,,,,,,,,,,,,,,,,,,,,12/19/2011 69329Y10 PRN  PDL BioPharma Provides Fourth Quarter 2011 Revenue Guidance of $72 Million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 1/04/2012 40637H10 PRN  Halozyme Therapeutics to Present at the 30th Annual J.P. Morgan Healthcare Conference,,,,,,, 9/30/2013 69366J20 PRN  PTC Therapeutics To Join Russell 2000® Index,,,,,,,,, 9/14/2010 G5087110 PRN  Jazz Pharmaceuticals to Present at the UBS Global Life Sciences Conference on September 20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/27/2014 G3040110 PRN  Endo Health Solutions Announces Departure Of Chief Scientific Officer,,,,10/01/2015 75886F10    PRN  Regeneron Announces Collaboration with Mitsubishi Tanabe Pharma for Investigational Pain Therapy Fasinumab in Asia,,, 8/01/2014 46222210 PRN  Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy,,, 5/31/2011 64125C10 PRN  Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference,,,,,,, 8/30/2012 04004760   PRN  Arena Pharmaceuticals to Present at Upcoming Investor Conferences,10/08/2015 N5946510  PRN  Mylan to Host Investor Conference Call and Webcast for Perrigo Shareholders,,, 4/18/2017 03116210 PRN  Amgen Launches Neulasta® (pegfilgrastim) Onpro® NARRATIVES,,,,,,, 1/18/2011 64026810 PRN  Nektar Therapeutics Announces Proposed Public Offering of Common Stock,,,,,,,,,,,,, 9/08/2011 80067710 PRN  Sangamo BioSciences Announces New SB-728-T HIV/AIDS Data to be Presented at 51st ICAAC,,11/18/2014 80105N10  PRN  Sanofi Names Chief Scientific Officer Gary Nabel as Sanofi Ebola Response Coordinator,,,,,,,,,,,,,,,,,,,,12/15/2011 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/07/2011 40637H10 PRN  Halozyme Therapeutics to Present at the Oppenheimer Annual Healthcare Conference on December 13,,,,,,, 9/27/2013 69366J20 PRN  PTC Therapeutics to Present at Upcoming Investor Conferences,,,,,,,,, 8/20/2010 G5087110 PRN  Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 2/20/2014 G3040110 PRN  Endo to Announce Fourth Quarter 2013 Financial Results on February 28, 2014",,,," 9/29/2015 75886F10    PRN  Covered Call Alerts For Ambarella, Regeneron Pharmaceuticals, ACADIA Pharmaceuticals, Achillion Pharmaceuticals and JC Penney Released By InvestorsObserver",,, 7/28/2014 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call,,, 5/03/2011 64125C10 PRN  Neurocrine Biosciences Reports First Quarter 2011 Results,,,,,,," 8/23/2012 000C7R-E   PRN  Top Searched Stocks: Facebook, Altria, Arch Coal, Arena, Applied Materials, and Procter & Gamble",10/05/2015 MYL-GB    PRN  Mylan Schedules Third Quarter 2015 Financial Results Conference Call and Live Webcast,,, 4/04/2017 03116210 PRN  Amgen Submits Applications In The US And Europe To Expand Current Indication For XGEVA® (denosumab) To Include Patients With Multiple Myeloma,,,,,,," 1/13/2011 000CPS-E PRN  Zacks Sell List Highlights: FreightCar America, Brookfield Asset Management, Becton, Dickinson and Co. and Nektar Therapeutics",,,,,,,,,,,,, 9/01/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at the Stifel Nicolaus 2011 Healthcare Conference,,11/11/2014 REGN-US   PRN  Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma,,,,,,,,,,,,,,,,,,,,12/12/2011 69329Y10 PRN  PDL BioPharma Announces Departure of Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/06/2011 40637H10 PRN  ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20),,,,,,," 9/26/2013 69366J20 PRN  Application for Regulatory Approvals, Conferences and Presentations, and Enrollment in Clinical Trials - Research Report on Gilead, Alnylam, Omeros, PTC, and Stemline",,,,,,,,, 8/10/2010 G5087110 PRN  Jazz Pharmaceuticals Announces Second Quarter 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/19/2014 G3040110 PRN  Endo Announces 2013 Non-Cash Charges,,,, 9/28/2015 REGN-US     PRN  Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union,,, 7/17/2014 46222210 PRN  Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a),,, 4/29/2011 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2011 Financial Results,,,,,,," 8/16/2012 ARNA-US    PRN  Consensus Earnings Forecast Reports: Staples, Deere & Company, JDS Uniphase, Starbucks, Arena Pharmaceuticals, and Abercrombie & Fitch"," 9/29/2015 N5946510  PRN  Drugs - Generic Equities at a Glance -- Mylan, Zoetis, Ironwood Pharma, Akorn, and Supernus Pharma",,, 4/01/2017 03116210 PRN  Amgen And UCB Report New Data At ENDO 2017 Examining The Option Of A Second Course Of Treatment With EVENITY™ (romosozumab),,,,,,," 1/05/2011 64026810 PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA",,,,,,,,,,,,, 8/10/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at the Wedbush Securities 2011 Life Sciences Management Access Conference,,"11/04/2014 80105N10  PRN  Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix",,,,,,,,,,,,,,,,,,,,12/12/2011 69329Y10 PRN  PDL BioPharma Corrects Its Adjusted Conversion Rates for Its Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/07/2011 40637H10 PRN  Halozyme Therapeutics Reports Third Quarter 2011 Financial Results,,,,,,, 9/25/2013 69366J20 PRN  PTC Therapeutics to Present at World Muscle Society Congress,,,,,,,,, 8/06/2010 G5087110 PRN  Jazz Pharmaceuticals to Present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/29/2014 G3040110 PRN  Endo Confirms Court Upholds FROVA Patent,,,, 9/24/2015 75886F10    PRN  Regeneron and Icahn School of Medicine at Mount Sinai Announce New Antibody Research Agreement,,," 7/16/2014 46222210 PRN  Critical Alerts For Cninsure, Freeport-McMoRan, Level 3 Communications, Electronic Arts, and Isis Pharmaceuticals Released By InvestorsObserver",,, 4/27/2011 64125C10 PRN  Neurocrine Biosciences to Present at the Deutsche Bank 36th Annual Healthcare Conference,,,,,,, 8/09/2012 04004760   PRN  Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments, 9/28/2015 MYL-GB    PRN  Mylan Launches Generic Invega® Tablets,,, 3/31/2017 03116210 PRN  Amgen To Highlight New Preclinical Data At The American Association For Cancer Research (AACR) Annual Meeting,,,,,,,12/12/2010 64026810 PRN  NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients,,,,,,,,,,,,, 7/27/2011 05FM1X-E PRN  Sangamo BioSciences Reports Second Quarter 2011 Financial Results,,11/03/2014 80105N10  PRN  Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older,,,,,,,,,,,,,,,,,,,,12/07/2011 69329Y10 PRN  PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/02/2011 40637H10 PRN  Halozyme Therapeutics to Host Third Quarter 2011 Financial Results Conference Call on November 7,,,,,,, 9/18/2013 69366J20 PRN  PTC Therapeutics to Present at European Pediatric Neurology Society Congress,,,,,,,,, 8/02/2010 G5087110 PRN  Jazz Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/21/2014 G3040110 PRN  Endo Merger Agreement with NuPathe Terminated,,,, 9/21/2015 REGN-US     PRN  Regeneron Announces Agreement with BARDA for the Development of New Antibody Treatment for Ebola,,, 7/16/2014 GSK-GB   PRN  Isis Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx,,, 4/05/2011 64125C10 PRN  Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor,,,,,,," 8/02/2012 04004760   PRN  Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9", 9/24/2015 MYL-GB    PRN  Mylan Comments on Meritless Perrigo Lawsuit Filed Today in Israel,,, 3/29/2017 03116210 PRN  FDA Grants Priority Review For Amgen's BLINCYTO® (blinatumomab) Supplemental Biologics License Application,,,,,,,12/09/2010 64026810 PRN  Phase 2 Clinical Data on NKTR-102 in Metastatic Breast Cancer to Be Presented at 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium,,,,,,,,,,,,, 7/21/2011 80067710 PRN  Sangamo BioSciences Announces Efficient Generation of Transgenic Pigs Using Zinc Finger Nuclease (ZFN) Technology,,"10/31/2014 80105N10  PRN  Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis",,,,,,,,,,,,,,,,,,,,"11/15/2011 69329Y10 PRN  PDL BioPharma Inc. Announces Exchange Offer for Its 2.875% Convertible Senior Notes Due February 15, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/27/2011 40637H10 PRN  Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial,,,,,,, 8/29/2013 69366J20 PRN  PTC Therapeutics to Present at Upcoming Investor Conferences,,,,,,,,, 6/30/2010 G5087110 PRN  Jazz Pharmaceuticals Announces Completion of Refinancing of its 15% Senior Secured Notes Due June 2011 With Closing of $50 Million Term Loan Due June 2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 1/16/2014 G3040110 PRN  Divestiture, Service Deployment, Executive Promotion, Updated Outlook, and Designation Granted-Research Report on Endo, ARIAD, Align Technology, PAREXEL, and The Medicines Company",,,," 9/09/2015 75886F10    PRN  Critical Alerts For Fitbit, Palo Alto Networks, Regeneron Pharmaceuticals, Isis Pharmaceuticals and Achillion Pharmaceuticals Released By InvestorsObserver",,," 7/14/2014 46222210 PRN  Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics",,, 3/30/2011 64125C10 PRN  Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference,,,,,,," 8/01/2012 000L54-E   PRN  Insider Hot Stocks: Coach, Lowe's, Goodyear Tire & Rubber, Arch Coal, Arena Pharmaceuticals, and ConocoPhillips", 9/21/2015 N5946510  PRN  Mylan Foundation Requests Cancellation of Preferred Shares,,, 3/29/2017 03116210 PRN  Journal Of Clinical Oncology Publishes Data On BLINCYTO® (Blinatumomab) In High-Risk Patients With Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukemia,,,,,,,11/13/2010 64026810 PRN  Nektar Announces Two Preclinical Data Presentations at Society for Neuroscience 40th Annual Meeting: Neuroscience 2010,,,,,,,,,,,,, 7/20/2011 80067710 PRN  Sangamo BioSciences Announces Second Quarter 2011 Conference Call and Webcast,,"10/30/2014 80105N10  PRN  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sanofi",,,,,,,,,,,,,,,,,,,,11/09/2011 69329Y10 PRN  PDL BioPharma Announces Third Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/27/2011 40637H10 PRN  Halozyme Therapeutics Announces Data From Two Phase 1 Studies of PEGPH20 Demonstrating Targeting of Hyaluronan in Tumor Stroma,,,,,,, 8/26/2013 69366J20 PRN  New Evidence Published in Muscle and Nerve on Measuring 6-Minute Walk Distance in Duchenne Muscular Dystrophy,,,,,,,,," 6/24/2010 G5087110 PRN  Jazz Pharmaceuticals' JZP-6 to be Reviewed at a Joint Meeting of the FDA's Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee on August 20, 2010",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 1/03/2014 G3040110 PRN  Critical Alerts For Google, Celgene, Salesforce.com, Chesapeake Energy, and Endo Pharmaceuticals Released By InvestorsObserver",,,, 9/01/2015 REGN-US     PRN  Regeneron and Sanofi Announce New Positive Praluent® (alirocumab) Phase 3 Data Presented at ESC Congress 2015,,, 7/02/2014 GSK-GB   PRN  Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program,,, 3/08/2011 64125C10 PRN  Neurocrine Biosciences to Present at the Roth 23rd Annual OC Growth Stock Conference,,,,,,, 7/30/2012 04004760   PRN  Eisai and Arena Pharmaceuticals Complete Transfer of BELVIQ® (lorcaserin HCl) New Drug Application, 9/18/2015 N5946510  PRN  Mylan Launches One of First Generic Lescol XL® Tablets,,, 3/28/2017 03116210 PRN  Amgen Awards Three Golden Tickets for LabCentral Residency,,,,,,,11/04/2010 64026810 PRN  Nektar Therapeutics Reports Third Quarter 2010 Financial Results,,,,,,,,,,,,," 7/11/2011 80067710 PRN  Sangamo BioSciences Appoints Dr. Geoffrey Nichol as Executive Vice President, Research and Development",,10/28/2014 80105N10  PRN  Sanofi: Sanofi Delivers Business EPS Growth of 10.3% at CER,,,,,,,,,,,,,,,,,,,,11/08/2011 69329Y10 PRN  PDL BioPharma to Present at Lazard Capital Markets 8th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/24/2011 40637H10 PRN  Halozyme Therapeutics to Present Data on PEGPH20 at the Upcoming 2011 EORTC-NCI-ASCO Annual Meeting,,,,,,, 8/12/2013 69366J20 PRN  PTC Therapeutics Reports Second Quarter 2013 Financial and Corporate Results,,,,,,,,, 6/07/2010 G5087110 PRN  Paul L. Berns Joins Jazz Pharmaceuticals' Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/03/2014 G3040110 PRN  Endo Health Solutions to Present at the 32nd Annual J.P. Morgan Healthcare Conference,,,, 8/31/2015 75886F10    PRN  Regeneron Announces Upcoming 2015 Investor Conference Presentations,,," 6/27/2014 46222210 PRN  Acquisitions, Payments, Agreements, and Commercial Launches - Analyst Notes on Questcor, Isis, BD, CareFusion and Agilent",,, 3/02/2011 64125C10 PRN  Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference,,,,,,," 7/24/2012 000DFY-E   PRN  Today's Hot Stocks: Nexen, Apple, Arena, Ford, Caterpillar, and Alcoa", 9/17/2015 PRGO-IE   PRN  Perrigo Board Unanimously Rejects Mylan's Unsolicited Exchange Offer As Inadequate,,, 3/23/2017 03116210 PRN  European Commission Approves AMGEVITA™ (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases,,,,,,,"10/28/2010 64026810 PRN  Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,, 6/27/2011 80067710 PRN  Sangamo BioSciences Announces Publication of First Demonstration of In Vivo Correction of Hemophilia Gene via Systemic Delivery of a ZFP Therapeutic®,,10/28/2014 80105N10  PRN  New International GPCR Consortium Formed with Pharma and Academia to Advance Structural Information about G-protein Coupled Receptors,,,,,,,,,,,,,,,,,,,,"11/02/2011 69329Y10 PRN  PDL BioPharma to Announce Third Quarter 2011 Financial Results on November 9, 2011",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/21/2011 40637H10 PRN  Halozyme Announces Positive Results From Phase 2 Ultrafast Insulin Trials in Patients with Type 1 and Type 2 Diabetes,,,,,,, 8/08/2013 005W47-E PRN  PTC Therapeutics Announces Achievement Of Major Milestone In SMA Collaboration,,,,,,,,, 6/01/2010 G5087110 PRN  Jazz Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"12/31/2013 G3040110 PRN  Commercialization Agreements, Acquisition Updates, Conference Calls Schedules, Stock Price Updates and Clinical Study Data - Research Report on Biogen Idec, Covidien, Vertex, Endo, and Momenta Pharma",,,, 8/04/2015 75886F10    PRN  Regeneron Reports Second Quarter 2015 Financial and Operating Results,,," 6/26/2014 46222210 PRN  Critical Alerts For General Electric, Deere, Isis Pharmaceuticals, Expedia, and Sears Holdings Released By InvestorsObserver",,, 2/23/2011 64125C10 PRN  Neurocrine Biosciences to Present at Citi's 2011 Global Health Care Conference,,,,,,," 7/17/2012 ANRZQ-US   PRN  Insider Hot Stocks: Alpha Natural Resources, Sprint Nextel, Arena, Marathon Oil, Seagate, and Target", 9/14/2015 MYL-GB    PRN  Mylan to Present at Morgan Stanley Global Healthcare Conference,,, 3/19/2017 03116210 PRN  Analyses Of PCSK9 Inhibitor Prescription Rejection Rates Demonstrate Significant Access Barriers For Appropriate Patients,,,,,,,10/17/2010 64026810 PRN  Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010,,,,,,,,,,,,," 6/26/2011 06NVWX-E PRN  Genome Editing, a Next Step in Genetic Therapy, Corrects Hemophilia in Animals",,10/28/2014 80105N10  PRN  Sanofi Q3 2014 Results - Interview with Jérôme Contamine,,,,,,,,,,,,,,,,,,,,10/19/2011 69329Y10 PRN  PDL BioPharma Retains Franklin Berger and Dr. Evan Bedil as Advisors to Assist with Implementation of Royalty Acquisition Strategy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/18/2011 40637H10 PRN  Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial,,,,,,, 8/06/2013 69366J20 PRN  PTC Therapeutics to Present at Wedbush Conference,,,,,,,,, 5/11/2010 G5087110 PRN  Jazz Pharmaceuticals Announces Pricing of Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"12/19/2013 G3040110 PRN  Senior Notes Pricing, Contract Renewal, Updated Financial Outlook, Price Movements, and Clinical Trial Results - Research Report on Endo, HCA, Covidien, Vertex, and Seattle Genetics",,,, 7/28/2015 REGN-US     PRN  Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration,,, 6/24/2014 GSK-GB   PRN  Isis Pharmaceuticals Earns $1 Million From GSK for Advancing ISIS-TTR Rx,,, 2/10/2011 64125C10 PRN  Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results,,,,,,, 7/11/2012 04004760   PRN  Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control, 9/14/2015 N5946510  PRN  Perrigo Announcement Regarding Unsolicited Offer From Mylan N.V.,,, 3/18/2017 03116210 PRN  Lowering LDL Levels With Repatha® (Evolocumab) Did Not Adversely Affect Cognitive Function In Landmark Phase 3 Study,,,,,,,"10/15/2010 64026810 PRN  NKTR-181, A Mu-Opioid Analgesic With a Novel Molecular Structure, Demonstrates Slower Entry Rate Into the Brain and Reduced CNS Side Effects",,,,,,,,,,,,, 6/02/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at the Jefferies 2011 Global Healthcare Conference,,10/20/2014 REGN-US   PRN  Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis,,,,,,,,,,,,,,,,,,,, 9/15/2011 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"10/05/2011 40637H10 PRN  Halozyme Begins Randomized, Controlled Clinical Trial with PEGPH20 in Patients with Advanced Pancreatic Cancer",,,,,,, 8/05/2013 69366J20 PRN  PTC Therapeutics To Host Second Quarter 2013 Financial Results Conference Call And Webcast,,,,,,,,, 5/10/2010 G5087110 PRN  Jazz Pharmaceuticals Announces Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"12/18/2013 G3040110 PRN  INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of NUPATHE INC. and Its Board of Directors In Connection with the Sale of the Company to Endo Health Solutions -- PATH",,,," 7/24/2015 75886F10    PRN  Sanofi and Regeneron Announce FDA Approval of Praluent® (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients",,, 6/17/2014 IONS-US  PRN  Isis Pharmaceuticals Earns $10 Million Milestone Payment from Biogen Idec,,, 2/10/2011 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results,,,,,,," 7/10/2012 ANRZQ-US   PRN  Critical Stock Alerts: Arena Pharmaceuticals, Ford, Abbott Laboratories, Alpha Natural Resources, Western Digital, and Central European Distribution", 9/14/2015 N5946510  PRN  Mylan Commences Offer to Acquire Perrigo,,, 3/17/2017 03116210 PRN  Landmark Outcomes Study Shows That Repatha® (Evolocumab) Decreases LDL-C To Unprecedented Low Levels And Reduces Risk Of Cardiovascular Events With No New Safety Issues,,,,,,, 9/18/2010 64026810 PRN  Nektar Therapeutics To Present at the UBS 2010 Global Life Sciences Conference,,,,,,,,,,,,, 5/23/2011 80067710 PRN  Sangamo BioSciences and Collaborators Present Data Showcasing Broad Applications of ZFP Therapeutics®,,10/17/2014 AMGN-US   PRN  Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement,,,,,,,,,,,,,,,,,,,, 9/13/2011 69329Y10 PRN  PDL BioPharma to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/28/2011 40637H10 PRN  Halozyme Begins Clinical Trial with HTI-501 in Women with Edematous Fibrosclerotic Panniculopathy,,,,,,, 6/25/2013 69366J20 PRN  PTC Therapeutics Closes Initial Public Offering,,,,,,,,, 5/05/2010 G5087110 PRN  Jazz Pharmaceuticals Announces First Quarter 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/16/2013 G3040110 PRN  Endo to Acquire Specialty Pharmaceutical Company NuPathe,,,," 7/24/2015 SNY-FR      PRN  Regeneron and Sanofi Announce FDA Approval of Praluent® (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients",,, 6/16/2014 46222210 PRN  Isis Pharmaceuticals Reports Final Phase 2 Data on ISIS-GCGR RX Showing Significant Reduction in HbA1c in Patients with Type 2 Diabetes,,, 2/03/2011 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results,,,,,,, 7/09/2012 04004760   PRN  Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference, 9/14/2015 MYL-GB    PRN  Theravance Biopharma and Mylan Initiate Phase 3 Program for Revefenacin (TD-4208) for Treatment of Chronic Obstructive Pulmonary Disease (COPD),,, 3/16/2017 03116210 PRN  Amgen To Present At The Oppenheimer Global Health Care Conference,,,,,,, 8/31/2010 0011X6-E PRN  BioSpace Highlights Northern California's Growing Life Science Region,,,,,,,,,,,,, 5/03/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences,,10/15/2014 00FZRP-E  PRN  Portal Instruments Completes Landmark $11 Million Series A Financing to Develop Innovative Drug Delivery Platform,,,,,,,,,,,,,,,,,,,, 9/08/2011 69329Y10 PRN  PDL BioPharma Provides Third Quarter 2011 Revenue Guidance of $83 Million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/22/2011 40637H10 PRN  Halozyme Therapeutics to Present at the JMP Securities Healthcare Conference on September 28,,,,,,, 6/20/2013 69366J20 PRN  PTC Therapeutics Prices Initial Public Offering,,,,,,,,, 5/05/2010 G5087110 PRN  Rick E. Winningham Joins Jazz Pharmaceuticals' Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"12/12/2013 G3040110 PRN  Stock Movements, Offered Senior Notes, and Company Announcements - Research Report on Perrigo, Thermo Fisher Scientific, Endo, Waters, and Keryx",,,, 7/24/2015 REGN-US     PRN  Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia,,, 6/12/2014 46222210 PRN  Isis Pharmaceuticals to Present at the 2014 Wells Fargo Healthcare Conference,,,11/23/2010 64125C10 PRN  Neurocrine Biosciences to Present at the 22nd Annual Piper Jaffray Health Care Conference,,,,,,, 7/09/2012 05R189-E   PRN  Pappas Ventures Names Pat Gage to Scientific Advisory Board, 9/14/2015 MYL-GB    PRN  Mylan Launches Generic Unasyn® for Injection,,," 3/16/2017 000C35-E PRN  PCSK9 Inhibitors Improve Patient Outcomes, But Will That Convince Payers to Pay for Them?",,,,,,, 7/28/2010 64026810 PRN  Nektar Therapeutics Reports Second Quarter 2010 Financial Results,,,,,,,,,,,,, 4/26/2011 80067710 PRN  Sangamo BioSciences Reports First Quarter 2011 Financial Results,,10/15/2014 STD-ES    PRN  New Survey Finds Differences In Attitudes About Diabetes Based On Age,,,,,,,,,,,,,,,,,,,, 9/07/2011 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/13/2011 40637H10 PRN  ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20),,,,,,, 6/03/2013 005W47-E PRN  PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer,,,,,,,,," 4/28/2010 G5087110 PRN  Jazz Pharmaceuticals to Announce First Quarter 2010 Financial Results on May 5, 2010",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/11/2013 G3040110 PRN  Endo Health Solutions Announces Proposed Private Offering of Senior Notes,,,, 7/08/2015 75886F10    PRN  Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection,,, 6/11/2014 46222210 PRN  Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-GCGR Rx Phase 2 Data Presented at the 2014 ADA Scientific Sessions,,,11/22/2010 64125C10 PRN  Neurocrine Biosciences Announces Successful Completion of Daisy PETAL Study,,,,,,," 7/05/2012 04004760   PRN  Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs", 9/10/2015 PRGO-IE   PRN  Perrigo Responds to Misleading Letter from Mylan Executive Chairman,,, 3/16/2017 03116210 PRN  The Most Promising Biotech Innovation of 2017,,,,,,," 7/21/2010 64026810 PRN  Nektar to Announce Financial Results for the Second Quarter of 2010 On Wednesday, July 28, 2010, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,, 4/19/2011 80067710 PRN  Sangamo BioSciences Announces First Quarter 2011 Conference Call and Webcast,, 9/30/2014 000C35-E  PRN  Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents,,,,,,,,,,,,,,,,,,,, 7/27/2011 69329Y10 PRN  PDL BioPharma Announces Second Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/01/2011 40637H10 PRN  Halozyme Therapeutics to Present at Upcoming Financial Conferences,,,,,,," 5/16/2013 005W47-E PRN  PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering",,,,,,,,, 4/26/2010 G5087110 PRN  Jazz Pharmaceuticals to Present at Deutsche Bank's 35th Annual Health Care Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/10/2013 G3040110 PRN  Arthur J. Higgins Joins Endo Board of Directors,,,," 7/08/2015 75886F10    PRN  Regeneron to Report Second Quarter 2015 Financial and Operating Results and Host Conference Call and Webcast on August 4, 2015",,, 6/10/2014 IONS-US  PRN  Isis Pharmaceuticals Earns $15 Million from AstraZeneca for Initiation of Phase 1 Study of ISIS-AR Rx,,,10/28/2010 64125C10 PRN  Neurocrine Biosciences Reports Third Quarter 2010 Results,,,,,,," 7/03/2012 SIRI-US    PRN  Daily Stocks Highlight by Pennystocksinsiders.com: Arena Pharmaceuticals, Chesapeake Energy, Sirius, Liquidity Services, J.C. Penney, and Groupon", 9/08/2015 PRGO-IE   PRN  Mylan to Launch Offer for Perrigo Directly to Perrigo Shareholders on Sept. 14,,, 3/14/2017 03116210 PRN  Repatha® (Evolocumab) Four-Year Open-Label Follow-Up Study Published In 'JAMA Cardiology',,,,,,, 7/06/2010 64026810 PRN  NKTR-102 Demonstrates Superior Activity to Irinotecan in Nonclinical Studies Presented at ESMO 12th World Congress on Gastrointestinal Cancer,,,,,,,,,,,,, 4/08/2011 80067710 PRN  Sangamo Announces Pricing of Public Offering of Common Stock,, 9/30/2014 REGN-US   PRN  Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps,,,,,,,,,,,,,,,,,,,," 7/20/2011 69329Y10 PRN  PDL BioPharma Announces Second Quarter 2011 Financial Results on July 27, 2011",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/12/2011 HALO-US  PRN  Halozyme Therapeutics to Present at the Wedbush 2011 Global Healthcare Conference on August 17,,,,,,, 4/23/2013 005W47-E PRN  PTC Therapeutics Appoints Mark Rothera As Chief Commercial Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"12/04/2013 G3040110 PRN  Regulatory Approval, Requisite Consents and Expiration of Consent Solicitations, and Stock Price Movements - Research Report on Thermo Fisher, Endo, Perrigo, Keryx, and Waters",,,," 7/07/2015 75886F10    PRN  Critical Alerts For Bank of America, Regeneron Pharmaceuticals, Ambarella, Zulily and Gilead Sciences Released By InvestorsObserver",,, 6/09/2014 46222210 PRN  Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-DMPK Rx to Treat Myotonic Dystrophy Type 1,,,10/26/2010 64125C10 PRN  Neurocrine Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference,,,,,,," 6/28/2012 04004760   PRN  Stock Alerts For Coca-Cola, Deere, News Corp., Arena Pharmaceuticals, and American Tower Released By InvestorsObserver", 9/08/2015 00GDWJ-E  PRN  Mylan Launches Generic Yasmin® Tablets,,, 3/14/2017 03116210 PRN  Amgen To Webcast Investor Meeting At Upcoming American College Of Cardiology Scientific Sessions,,,,,,, 6/24/2010 64026810 PRN  Nektar Announces Dosing of First Patients in Phase 1 Clinical Study of NKTR-102 in Combination With 5-Fluorouracil/Leucovorin,,,,,,,,,,,,, 4/07/2011 80067710 PRN  Sangamo Announces Public Offering of Common Stock,," 9/26/2014 80105N10  PRN  Scanning Pharma Equities - Novo Nordisk, Teva Pharma Industries, Sanofi, Valeant Pharma Intl., and Eli Lilly",,,,,,,,,,,,,,,,,,,, 7/11/2011 0B31SR-E PRN  Nevada State Judge Denies Roche and Genentech's Motions to Dismiss PDL BioPharma's Complaint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/05/2011 40637H10 PRN  Halozyme Therapeutics Reports Second Quarter 2011 Financial Results,,,,,,, 3/07/2013 09VFCX-E PRN  PTC Therapeutics Closes $60 Million Private Financing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/27/2013 G3040110 PRN  Endo Health Solutions Announces Receipt of Requisite Consents and Expiration of Consent Solicitations Relating to its 7% Senior Notes Due 2019, 7.00% Senior Notes Due 2020 and 7 1/4% Senior Notes Due 2022",,,, 6/30/2015 REGN-US     PRN  New Film Documents Heart Felt Stories of People Living with High LDL Cholesterol,,, 6/04/2014 46222210 PRN  Isis Pharmaceuticals to Present at The Goldman Sachs 35th Annual Global Healthcare Conference,,,10/18/2010 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results,,,,,,, 6/27/2012 04004760   PRN  Arena Pharmaceuticals and Eisai Announce FDA Approval of BELVIQ® (lorcaserin HCl) for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese, 8/28/2015 N5946510  PRN  Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction,,, 3/13/2017 03116210 PRN  Repatha® (Evolocumab) Demonstrates Reduced Need For Apheresis In Patients With High LDL Cholesterol In Phase 3 Study,,,,,,, 6/09/2010 64026810 PRN  Nektar Therapeutics Announces Positive Initial Results from Phase 2 Study of NKTR-102 in Metastatic Breast Cancer,,,,,,,,,,,,, 4/05/2011 80067710 PRN  Sangamo BioSciences and CHDI Foundation Announce Collaboration to Develop ZFP Therapeutic® for Huntington's Disease,, 9/17/2014 80105N10  PRN  Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease,,,,,,,,,,,,,,,,,,,, 7/05/2011 69329Y10 PRN  PDL BioPharma Announces Retirement of $133.5 Million of 2.00% Convertible Senior Notes Due February 2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/01/2011 40637H10 PRN  Halozyme Therapeutics to Host Second Quarter 2011 Financial Results Conference Call on August 5,,,,,,,12/06/2012 005W47-E PRN  PTC Therapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Ataluren in Duchenne Muscular Dystrophy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/27/2013 G3040110 PRN  Early Morning Technical Insight: Bristol-Myers Squibb Co., Eli Lilly & Co., Endo Health Solutions Inc., and Allergan Inc.",,,, 6/29/2015 REGN-US     PRN  Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication,,, 6/03/2014 46222210 PRN  Isis Pharmaceuticals to Present a General Corporate Update at its 2014 Annual Meeting of Stockholders and Open House,,,10/18/2010 64125C10 PRN  Neurocrine Biosciences Announces That VMAT2 Program Will Move Into Phase II Clinical Trials,,,,,,," 6/26/2012 CX-MX      PRN  Hot Stocks: Arena Pharmaceuticals, Teva, Cemex, Occidental Petroleum, Potash, and United States Steel", 8/28/2015 N5946510  PRN  Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo,,, 3/07/2017 03116210 PRN  Amgen Announces 2017 Second Quarter Dividend,,,,,,, 6/06/2010 64026810 PRN  NKTR-102 Has High Response Rate and Sustained Clinical Benefit in 48 Percent of Women with Platinum-Resistant/Refractory Ovarian Cancer,,,,,,,,,,,,, 3/29/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at the 10th Annual Needham Healthcare Conference,, 9/08/2014 80105N10  PRN  FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease,,,,,,,,,,,,,,,,,,,, 6/16/2011 69329Y10 PRN  PDL BioPharma Completes Regular Quarterly Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/24/2011 40637H10 PRN  Halozyme's Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps,,,,,,,"11/06/2012 005W47-E PRN  PTC Therapeutics Appoints Geoffrey McDonough, M.D., To Board of Directors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/26/2013 G3040110 PRN  Official Statement, Stock Price Movements, and Public Offering of Common Stock - Research Report on Amgen, Biogen Idec, Express Scripts, Endo, and CSI",,,, 6/26/2015 REGN-US     PRN  EYLEA® (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion,,," 5/29/2014 46222210 PRN  Milestone Payments, Clinical Trial Results, Technical Updates, and Earnings Results - Analyst Notes on Pharmacyclics, Isis, Novo Nordisk, Dr. Reddy's and Orexigen",,, 9/14/2010 64125C10 PRN  Neurocrine Announces Top-Line Results of Corticotropin Releasing Factor Antagonist GSK561679 for Treatment of Major Depressive Disorder,,,,,,," 6/19/2012 SDOCQ-US   PRN  Today's Hot Stocks: Arena Pharmaceuticals, Chesapeake Energy, Starbucks, Kraft Foods, SandRidge Energy, and TJX", 8/25/2015 MYL-GB    PRN  Mylan Confirms the U.S. Patent and Trademark Office Institutes Inter Partes Review Proceedings against Two Copaxone® 40 mg/mL Dosing Patents,,, 3/06/2017 03116210 PRN  Amgen Highlights Landmark Repatha® (Evolocumab) Cardiovascular Outcomes Study Amongst Data To Be Presented At ACC.17,,,,,,, 6/03/2010 64026810 PRN  Nektar Therapeutics' President and CEO Howard W. Robin to Present at the Jefferies 2010 Global Life Sciences Healthcare Conference in New York,,,,,,,,,,,,, 3/03/2011 80067710 PRN  Sangamo BioSciences Announces Four Data Presentations at CROI 2011 of Novel ZFN Therapeutic Approaches to the Treatment of HIV/AIDS,," 9/02/2014 80105N10  PRN  Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK",,,,,,,,,,,,,,,,,,,, 6/09/2011 69329Y10 PRN  PDL BioPharma Revises Second Quarter 2011 Revenue Guidance to $122 Million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/20/2011 40637H10 PRN  Halozyme Therapeutics to Present Data on its Ultrafast Insulin Programs at the Upcoming American Diabetes Association 71st Scientific Sessions,,,,,,,10/22/2012 005W47-E PRN  PTC Therapeutics Receives $1 Million Grant Award from the National Institutes of Health (NIH) to Support Research for a Treatment for Dengue Fever,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/19/2013 G3040110 PRN  Endo Health Solutions Announces Consent Solicitation To Amend Senior Notes,,,," 6/24/2015 75886F10    PRN  Critical Alerts For Linn Energy, Regeneron Pharmaceuticals, Box, General Electric and Nokia Corporation Released By InvestorsObserver",,, 5/22/2014 46222210 PRN  HealthCare Briefing for Advancements in Personalized Medicines and Diagnostic Studies - New Appointment to Company's Scientific Advisory Board,,, 9/09/2010 64125C10 PRN  Neurocrine Biosciences to Present at Two Upcoming Conferences on September 16 and September 22,,,,,,," 6/12/2012 PSX-US     PRN  Equity Research on Most Popular Searches: Bank of America, Arena Pharmaceuticals, Ford Motor, AK Steel Holding, NetApp, and Phillips 66", 8/25/2015 MYL-GB    PRN  Mylan Launches Generic Zosyn® Injection,,, 3/03/2017 03116210 PRN  Amgen Presents New Data From Phase 3 XGEVA® (denosumab) Study In Multiple Myeloma Patients At The 16th International Myeloma Workshop,,,,,,, 5/20/2010 64026810 PRN  NKTR-102 Phase 2 Clinical Data Accepted for Oral Presentation at 2010 ASCO Annual Meeting,,,,,,,,,,,,, 3/01/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at the Cowen and Company 31st Annual Health Care Conference,, 9/02/2014 008349-E  PRN  Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients,,,,,,,,,,,,,,,,,,,, 6/06/2011 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for its Convertible Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/06/2011 008349-E PRN  Halozyme and Intrexon Announce Collaboration to Develop First Subcutaneous Recombinant Alpha 1-Antitrypsin Replacement Therapy,,,,,,," 9/28/2012 005W47-E PRN  PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/18/2013 G3040110 PRN  FDA Approvals, Stock Price Movements, Published Studies, and Philanthropic Initiatives - Research Report on Johnson & Johnson, Express Scripts, Endo, Biogen and Covidien",,,, 6/09/2015 75886F10    PRN  FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia,,, 5/22/2014 46222210 PRN  Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx in the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery,,, 7/28/2010 64125C10 PRN  Neurocrine Biosciences Reports Second Quarter 2010 Results,,,,,,," 5/31/2012 MON-US     PRN  Equity Research on Most Popular Searches: Microsoft, Monsanto, Toll Brothers, Macy's, Applied Materials, and Arena Pharmaceuticals", 8/25/2015 N5946510  PRN  Mylan Comments on Misleading Statements Made by Perrigo,,, 3/03/2017 03116210 PRN  Amgen Presents Overall Survival Data From KYPROLIS® (carfilzomib) Phase 3 ENDEAVOR Trial At 16th International Myeloma Workshop,,,,,,, 5/05/2010 64026810 PRN  Nektar Therapeutics Reports First Quarter 2010 Financial Results,,,,,,,,,,,,, 2/28/2011 80067710 PRN  Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections,, 8/31/2014 80105N10  PRN  Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014,,,,,,,,,,,,,,,,,,,, 6/01/2011 69329Y10 PRN  PDL BioPharma Provides Second Quarter 2011 Revenue Guidance of $128 Million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/02/2011 40637H10 PRN  Halozyme Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference on June 9,,,,,,, 7/23/2012 005W47-E PRN  PTC Therapeutics Closes $30 Million Financing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/11/2013 G3040110 PRN  Endo Health Solutions to Present at the 2013 Credit Suisse Healthcare Conference,,,, 6/09/2015 75886F10    PRN  FDA Advisory Committee Recommends Approval of Regeneron and Sanofi's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia,,, 5/20/2014 46222210 PRN  Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-PKK Rx,,, 7/22/2010 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results,,,,,,," 5/23/2012 ABX-CA     PRN  Equity Research on Most Popular Searches: Arch Coal, El Paso, Cree, Barrick Gold, Arena Pharmaceuticals, and CSX", 8/21/2015 N5946510  PRN  Mylan Clarifies Certain Inaccuracies by Third Parties Related to Lowered Acceptance Condition to Acquire Perrigo,,, 3/02/2017 03116210 PRN  Amgen To Present At The Cowen And Company 37th Annual Health Care Conference,,,,,,," 4/27/2010 64026810 PRN  Nektar to Announce Financial Results for the First Quarter of 2010 on Wednesday, May 5, 2010, After Close of U.S.-Based Financial Markets",,,,,,,,,,,,, 2/07/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at the 13th Annual BIO CEO & Investor Conference,, 8/31/2014 REGN-US   PRN  Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014,,,,,,,,,,,,,,,,,,,," 5/24/2011 69329Y10 PRN  PDL BioPharma Issues Redemption Notice for Its 2.00% Convertible Senior Notes Due February 15, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/11/2011 40637H10 PRN  ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor,,,,,,, 7/11/2012 005W47-E PRN  PTC Therapeutics Announces Achievement of Major Milestone in Wellcome Trust BMI1 Collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/08/2013 G3040110 PRN  Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte",,,, 6/09/2015 75886F10    PRN  Trading in Regeneron Common Stock Halted,,," 5/19/2014 46222210 PRN  Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics",,, 6/17/2010 64125C10 PRN  -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes,,,,,,, 5/21/2012 04004760   PRN  Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock, 8/18/2015 MYL-GB    PRN  Mylan Statement in Response to FDA Warning Letter Relating to Certain Agila Facilities,,, 3/01/2017 03116210 PRN  BLINCYTO® (blinatumomab) Significantly Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Compared To Chemotherapy,,,,,,,,,,,,,,,,,,,, 2/02/2011 80067710 PRN  Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results,," 8/26/2014 80105N10  PRN  Pharma Equities Technical Analysis -- Sanofi, AstraZeneca, Novartis, Salix Pharma, and AcelRx Pharma",,,,,,,,,,,,,,,,,,,," 5/16/2011 69329Y10 PRN  PDL BioPharma, Inc. Completes Issuance of $155.25 Million of Convertible Senior Notes Due May 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/11/2011 40637H10 PRN  Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human]),,,,,,, 6/27/2012 005W47-E PRN  PTC Therapeutics Initiates Open-Label Study for Ataluren in Patients with Nonsense Mutation Duchenne/Becker Muscular Dystrophy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/05/2013 G3040110 PRN  Endo Reports Third Quarter Financial Results,,,," 6/04/2015 75886F10    PRN  Critical Alerts For FireEye, Starbucks, Halozyme Therapeutics, CSX and Regeneron Pharmaceuticals Released By InvestorsObserver",,," 5/19/2014 46222210 PRN  Recognitions, Agreements, Study Results, Data Presentations, and Financial Results - Analyst Notes on Baxter, Incyte, Isis, Celldex Therapeutics, Inc. and Agilent",,, 6/16/2010 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast on Worldwide Agreement With Abbott on Elagolix,,,,,,," 5/16/2012 TRW-US     PRN  Critical Alerts For Research in Motion, Hess, Lions Gate, TRW Automotive, and Arena Pharmaceuticals Released By InvestorsObserver", 8/18/2015 MYL-GB    PRN  Mylan Confirms First-to-File Patent Challenge Relating to Zytiga®,,, 3/01/2017 03116210 PRN  Amgen To Present New KYPROLIS® (Carfilzomib) And XGEVA® (Denosumab) Data At The 16th International Myeloma Workshop,,,,,,,,,,,,,,,,,,,, 1/26/2011 80067710 PRN  Sangamo BioSciences Announces Fourth Quarter and Full Year 2010 Conference Call and Webcast,, 8/25/2014 80105N10  PRN  Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014,,,,,,,,,,,,,,,,,,,," 5/10/2011 69329Y10 PRN  PDL BioPharma, Inc. Prices Offering of $135.0 Million of Convertible Senior Notes Due 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/06/2011 40637H10 PRN  Halozyme Therapeutics Reports First Quarter 2011 Financial Results,,,,,,, 6/08/2012 005W47-E PRN  Top-line Data From Phase 3 Trial of Ataluren in Patients with Nonsense Mutation Cystic Fibrosis Show Promising Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/04/2013 G3040110 PRN  Morning Research: Eli Lilly & Co., Bristol-Myers Squibb Co., Allergan Inc., and Endo Health Solutions Inc.",,,, 5/21/2015 75886F10    PRN  Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with Rheumatoid Arthritis,,, 5/16/2014 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Announces its R&D Day Presentation,,, 6/16/2010 000BG2-E PRN  Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis,,,,,,, 5/16/2012 04004760   PRN  Arena Pharmaceuticals Prices Public Offering of Common Stock, 8/14/2015 N5946510  PRN  Paulson & Co. Votes in Support of Mylan's Proposed Merger with Perrigo,,, 2/28/2017 000C35-E PRN  ASSOS Joins Amgen Tour of California As Official Jersey Partner And Exclusive Tech Apparel Provider,,,,,,,,,,,,,,,,,,,, 1/10/2011 80067710 PRN  Sangamo BioSciences Announces Completion of Enrollment of Phase 2b Clinical Trial in Diabetic Neuropathy,, 8/13/2014 0072XH-E  PRN  Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine,,,,,,,,,,,,,,,,,,,," 5/09/2011 69329Y10 PRN  PDL BioPharma, Inc. Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/05/2011 40637H10 PRN  Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12,,,,,,, 4/02/2012 005W47-E PRN  PTC Therapeutics Announces Executive Promotions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/04/2013 G3040110 PRN  Presentation, Quarterly Reports, and FDA Approval - Research Report on Merck, United Therapeutics, Endo, Isis Pharmaceuticals, and Zogenix",,,," 5/19/2015 75886F10    PRN  Critical Alerts For Seadrill, Skyworks Solutions, Ann Taylor Stores, Regeneron Pharmaceuticals and Dow Chemical Released By InvestorsObserver",,," 5/15/2014 46222210 PRN  Critical Alerts For General Motors, Zulily, Isis Pharmaceuticals, Altria Group, and Dollar Tree Released By InvestorsObserver",,, 6/02/2010 64125C10 PRN  Neurocrine Biosciences to Present at the Jefferies 2010 Global Life Sciences Conference and the 9th Annual Needham Healthcare Conference,,,,,,," 5/16/2012 ARNA-US    PRN  Research Reports for Dow Chemical, Valero Energy, Hartford Financial Services, Arena Pharmaceuticals, CONSOL Energy, and Schlumberger", 8/14/2015 PRGO-IE   PRN  ISS Affirms Perrigo's Position That Proposed Mylan Transaction Would Be Value Destructive,,, 2/28/2017 03116210 PRN  Phase 3 Head-to-Head Trial Showed KYPROLIS® (Carfilzomib) Significantly Improved Overall Survival Compared To Velcade® (Bortezomib) In Relapsed Or Refractory Multiple Myeloma Patients,,,,,,,,,,,,,,,,,,,, 1/05/2011 80067710 PRN  Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference,, 8/12/2014 80105N10  PRN  Sanofi Launches Authorized Generic Version of Eloxatin® (oxaliplatin injection),,,,,,,,,,,,,,,,,,,, 5/03/2011 69329Y10 PRN  PDL BioPharma to Present at Upcoming Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/29/2011 40637H10 PRN  Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6,,,,,,,12/22/2011 005W47-E PRN  PTC Therapeutics' Antibacterial Program Receives $5 Million Award from the Wellcome Trust,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"10/29/2013 G3040110 PRN  Endo to Announce Third Quarter 2013 Financial Results on November 7, 2013",,,, 5/07/2015 75886F10    PRN  Regeneron Reports First Quarter 2015 Financial and Operating Results,,," 5/15/2014 46222210 PRN  Rejected Proposals, Earnings Results, and Financial Outlook - Analyst Notes on Allergan, Isis, Depomed, Lannett and Orexigen",,, 5/24/2010 64125C10 PRN  Neurocrine Biosciences Announces Positive Results in Daisy PETAL Study,,,,,,, 5/15/2012 04004760   PRN  Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock, 8/14/2015 0D8QKN-E  PRN  Mylan Responds to ISS Recommendation Regarding Perrigo Transaction,,, 2/21/2017 03116210 PRN  Repatha® (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option,,,,,,,,,,,,,,,,,,,,12/13/2010 80067710 PRN  Sangamo BioSciences Announces Publication of Data From Program to Develop a ZFP Therapeutic® for Parkinson's Disease,, 8/12/2014 005M9Z-E  PRN  First antimalarial treatments produced with semisynthetic artemisinin enter market,,,,,,,,,,,,,,,,,,,, 4/27/2011 69329Y10 PRN  PDL BioPharma Announces First Quarter 2011 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/14/2011 40637H10 PRN  Halozyme's Ultrafast Insulin Generates Faster-In and Faster-Out Profile for Type 1 Diabetes Patients Using Insulin Pumps,,,,,,,11/29/2011 000VJ8-E PRN  Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"10/15/2013 G3040110 PRN  Under AAAResearchReports.com Microscope: Eli Lilly & Co., Bristol-Myers Squibb Co., Allergan Inc., and Endo Health Solutions Inc.",,,, 4/29/2015 REGN-US     PRN  Regeneron Announces Upcoming 2015 Investor Conference Presentations,,, 5/15/2014 46222210 PRN  Isis Pharmaceuticals Earns $3.0 Million from GSK,,, 4/28/2010 64125C10 PRN  Neurocrine Biosciences Reports First Quarter 2010 Results,,,,,,, 5/10/2012 04004760   PRN  Arena and Eisai Expand Marketing and Supply Agreement for Lorcaserin, 8/13/2015 0D8QKN-E  PRN  Perrigo Comments On Mylan's Reckless Lowering Of Tender Threshold,,, 2/16/2017 05HNPV-E PRN  Helen Mills Joins Mars Petcare as VP Corporate Affairs,,,,,,,,,,,,,,,,,,,,12/07/2010 80067710 PRN  Sangamo BioSciences Announces Data Presentation of First In Vivo Demonstration of ZFN-mediated Gene Correction Via Systemic Delivery at American Society for Hematology Meeting,, 8/11/2014 80105N10  PRN  Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin,,,,,,,,,,,,,,,,,,,," 4/20/2011 69329Y10 PRN  PDL BioPharma to Announce First Quarter 2011 Financial Results on April 27, 2011",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/11/2011 40637H10 PRN  Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results,,,,,,,11/07/2011 005W47-E PRN  PTC Therapeutics Receives Grand Challenges Explorations Funding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/17/2013 G3040110 PRN  Pre-Market Review: Bristol-Myers Squibb Co., Eli Lilly & Co., Endo Health Solutions Inc., and Allergan Inc.",,,," 4/21/2015 75886F10    PRN  Critical Alerts For Advanced Micro Devices, Nuverra Environmental Solutions, Regeneron Pharmaceuticals, Ford and CableVision Systems Released By InvestorsObserver",,, 5/14/2014 46222210 PRN  Isis Pharmaceuticals Reports Phase 2 Data on ISIS-GCGR Rx Showing Significant Reduction in HbA1c in Patients With Type 2 Diabetes,,, 4/26/2010 64125C10 PRN  Neurocrine Biosciences to Present at the Deutsche Bank 35th Annual Health Care Conference,,,,,,, 5/10/2012 04004760   PRN  Lorcaserin Receives Positive Vote From FDA Advisory Committee, 8/13/2015 N5946510  PRN  Mylan Lowers Acceptance Condition on Perrigo Offer to Greater than 50%,,, 2/14/2017 03116210 PRN  Amgen Submits Supplemental Biologics License Application For BLINCYTO® (Blinatumomab) In Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,11/17/2010 80067710 PRN  Sangamo BioSciences Announces Presentation of Phase 2 Data in Amyotrophic Lateral Sclerosis (ALS) at Society for Neuroscience Meeting,, 7/31/2014 80105N10  PRN  Sanofi: Solid Sales and Business EPS Growth at CER,,,,,,,,,,,,,,,,,,,," 4/18/2011 69329Y10 PRN  PDL BioPharma to Hold Annual Meeting of Stockholders on June 22, 2011",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/04/2011 40637H10 PRN  Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11,,,,,,, 9/02/2011 005W47-E PRN  PTC Therapeutics and Genzyme Announce Restructuring of Collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/17/2013 G3040110 PRN  Clinical Trial Updates, Appointments, FDA Acknowledgments and Qualifications - Research Report on Novartis, Endo, The Medicines Company, United Therapeutics, and Forest",,,," 4/10/2015 75886F10    PRN  Regeneron to Report First Quarter 2015 Financial and Operating Results and Host Conference Call and Webcast on May 7, 2015",,, 5/13/2014 46222210 PRN  Isis Pharmaceuticals to Present at the UBS Global Healthcare Conference,,, 4/22/2010 64125C10 PRN  Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results,,,,,,, 5/01/2012 04004760   PRN  Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments, 8/12/2015 MYL-GB    PRN  Mylan and Disney Team Up to Bring New Resources to Life for Families Managing Potentially Life-Threatening Allergies,,, 2/13/2017 000D1R-E PRN  Fast Company Honors Braeburn Pharmaceuticals as a Top Ten Most Innovative Company in Biotech,,,,,,,,,,,,,,,,,,,,11/09/2010 80067710 PRN  Sangamo BioSciences Announces Presentation at Lazard Capital Markets Healthcare Conference,, 7/31/2014 80105N10  PRN  Sanofi H1 2014 Results - Interview with Chris Viehbacher,,,,,,,,,,,,,,,,,,,," 3/08/2011 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustments for 2.00% Convertible Senior Notes Due February 15, 2012 and 2.875% Convertible Senior Notes Due February 15, 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 3/01/2011 40637H10 PRN  Halozyme Therapeutics to Present at Two Investor Conferences in March,,,,,,, 7/01/2011 005W47-E PRN  Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/11/2013 G3040110 PRN  Acquisitions, Regulatory Filings, New Community Resource Centers and Successful Clinical Trials- Research Report on Baxter, Endo, HCA, Elan, and Theravance",,,, 3/25/2015 75886F10    PRN  EYLEA® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Retinopathy in Patients with Diabetic Macular Edema (DME),,, 5/08/2014 46222210 PRN  Isis Pharmaceuticals to Present at the Bank of America Merrill Lynch 2014 Health Care Conference,,,,,,,,,," 4/30/2012 MDRX-US    PRN  Top Stock Alerts for Day Traders: Allscripts, Chesapeake Energy, Expedia, Western Digital, Arena Pharmaceuticals, and Warner Chilcott", 8/12/2015 N5946510  PRN  Egan-Jones Joins Glass Lewis in Recommending Mylan Shareholders Vote For Perrigo Transaction Proposal,,," 2/07/2017 03116210 PRN  FDA Approves Amgen's Parsabiv™ (Etelcalcetide), First New Treatment In More Than A Decade For Secondary Hyperparathyroidism In Adult Patients On Hemodialysis",,,,,,,,,,,,,,,,,,,,11/03/2010 80067710 PRN  Sangamo BioSciences Awarded Grants for the Development of Four ZFP Therapeutic® Programs,, 7/30/2014 80105N10  PRN  Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission,,,,,,,,,,,,,,,,,,,, 3/07/2011 69329Y10 PRN  PDL BioPharma Provides First Quarter 2011 Revenue Guidance of $83 Million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 2/16/2011 HALO-US  PRN  Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera® (rituximab),,,,,,," 3/30/2011 005W47-E PRN  PTC Therapeutics Appoints Robert Spiegel, M.D. as Chief Medical Officer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/09/2013 G3040110 PRN  Endo Health Solutions Announces Appointment of Suketu Upadhyay as New Chief Financial Officer,,,," 3/17/2015 75886F10    PRN  Critical Alerts For Regeneron Pharmaceuticals, Oracle, Edwards Lifesciences Released By InvestorsObserver",,, 5/06/2014 46222210 PRN  Isis Reports Financial Results and Highlights for First Quarter 2014,,,,,,,,,," 4/19/2012 DUK-US     PRN  Top Stock Alerts for Day Traders: Duke Energy, eBay, Arena Pharmaceuticals, KeyCorp, Textron, and United Rentals", 8/12/2015 0D8QKN-E  PRN  Glass Lewis Recommends Mylan Shareholders Vote For Perrigo Transaction Proposal,,, 2/03/2017 05G25V-E PRN  BetterInvesting Magazine Releases April Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use,,,,,,,,,,,,,,,,,,,,10/27/2010 80067710 PRN  Sangamo BioSciences Reports Third Quarter 2010 Financial Results,, 7/30/2014 80105N10  PRN  Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia,,,,,,,,,,,,,,,,,,,, 2/28/2011 PDLI-US  PRN  PDL BioPharma Announces Fourth Quarter and Full Year 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 1/05/2011 40637H10 PRN  Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12,,,,,,, 3/02/2011 005W47-E PRN  PTC Therapeutics Announces Achievement of Milestone in BMI1 Collaboration With the Wellcome Trust,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/06/2013 G3040110 PRN  Endo Health Solutions to Present at the Stifel Nicolaus 2013 Healthcare Conference,,,, 3/15/2015 REGN-US     PRN  Sanofi and Regeneron Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent™ (alirocumab) Published in The New England Journal of Medicine,,, 5/02/2014 46222210 PRN  Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx in Patients With Familial Chylomicronemia,,,,,,,,,," 4/02/2012 ATVI-US    PRN  Top Stock Alerts for Day Traders: Arena Pharmaceuticals, KeyCorp, Symantec, Dendreon, Activision Blizzard, and Gerdau SA"," 8/11/2015 N5946510  PRN  Critical Alerts For Apple, Hewlett Packard, Twitter, Seadrill and Mylan Released By InvestorsObserver",,, 2/03/2017 03116210 PRN  Amgen Announces Appointment of Charles M. Holley Jr. to Board of Directors,,,,,,,,,,,,,,,,,,,,10/20/2010 80067710 PRN  Sangamo BioSciences Announces Third Quarter 2010 Conference Call and Webcast,, 7/30/2014 80105N10  PRN  Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia,,,,,,,,,,,,,,,,,,,, 2/28/2011 69329Y10 PRN  PDL BioPharma Announces Regular Quarterly Dividend Policy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/07/2010 40637H10 PRN  Halozyme Announces Roche Completes Patient Enrollment in Phase 3 Clinical Trial with Subcutaneous Herceptin®,,,,,,, 2/01/2011 005W47-E PRN  PTC Therapeutics and Parent Project Muscular Dystrophy Advance Drug Discovery Program to Improve Heart Function in Duchenne/Becker Muscular Dystrophy Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/02/2013 G3040110 PRN  Acquisitions, Clinical Trial Results, Date Extensions and Financial Results - Research Report on Endo, Astex, Auxilium, Accuray, and BioScrip",,,, 3/15/2015 75886F10    PRN  Regeneron and Sanofi Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent™ (alirocumab) Published in The New England Journal of Medicine,,, 5/01/2014 46222210 PRN  Isis Pharmaceuticals to Present at the Deutsche Bank 39th Annual Health Care Conference,,,,,,,,,," 3/26/2012 ARNA-US    PRN  Equity Research on Most Popular Searches: Dell, Kroger, KIT digital, Masco, Arena Pharmaceuticals, and EXCO Resources"," 8/10/2015 N5946510  PRN  Mylan Celebrates EpiPen4Schools® Third Anniversary, Program Extension Encourages Anaphylaxis Awareness and Preparedness This Back-to-School Season",,, 2/02/2017 03116210 PRN  Amgen Reports Fourth Quarter And Full Year 2016 Financial Results,,,,,,,,,,,,,,,,,,,, 9/14/2010 80067710 PRN  Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences,," 7/25/2014 80105N10  PRN  Critical Alerts For Organovo, Regeneron Pharmaceuticals, CBS, Wynn Resorts and Sanofi Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,, 2/28/2011 69329Y10 PRN  PDL BioPharma Announces European Patent Office Determination of Validity of PDL's European Patent is Final,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/03/2010 40637H10 PRN  Halozyme Therapeutics Realigns Management,,,,,,, 1/19/2011 005W47-E PRN  PTC Therapeutics' President and CEO Elected AAAS Fellow,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/06/2013 G3040110 PRN  Endo Reports Second Quarter Financial Results,,,, 2/26/2015 75886F10    PRN  EYLEA® (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion,,, 5/01/2014 46222210 PRN  Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx in Patients With High Triglycerides and Type 2 Diabetes,,,,,,,,,, 3/26/2012 04004760   PRN  Arena Pharmaceuticals Announces European Medicines Agency's Acceptance of Lorcaserin Marketing Authorization Application for Weight Control, 8/10/2015 N5946510  PRN  Mylan Launches Generic Version of Lidoderm® Patch,,, 2/02/2017 03116210 PRN  Amgen Announces Repatha® (Evolocumab) Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study,,,,,,,,,,,,,,,,,,,, 7/28/2010 80067710 PRN  Sangamo BioSciences Reports Second Quarter 2010 Financial Results,," 7/23/2014 80105N10  PRN  Pharma Stocks under Review -- Impax Laboratories, Sanofi, GW Pharma, AcelRx Pharma, and Salix Pharma",,,,,,,,,,,,,,,,,,,, 2/28/2011 0B31SR-E PRN  PDL Settles Litigation and Resolves Other Disputes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12/01/2010 40637H10 PRN  Halozyme Therapeutics to Present at Upcoming Investor Conference,,,,,,,12/21/2010 005W47-E PRN  PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/29/2013 G3040110 PRN  Endo to Announce Second Quarter 2013 Financial Results on August 6, 2013",,,," 2/24/2015 75886F10    PRN  Critical Alerts For Mobileye NV, Home Depot, JP Morgan Chase, Regeneron Pharmaceuticals and AT&T Released By InvestorsObserver",,, 4/30/2014 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' First Quarter 2014 Financial Results Conference Call,,,,,,,,,, 3/14/2012 04004760   PRN  Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments, 8/06/2015 N5946510  PRN  Mylan Second Quarter 2015 Constant Currency Revenue Increases 36% and Adjusted Diluted EPS Increases 32% to $0.91,,, 1/30/2017 03116210 PRN  Amgen Announces Webcast of 2016 Fourth Quarter and Full Year Financial Results,,,,,,,,,,,,,,,,,,,, 7/21/2010 80067710 PRN  Sangamo BioSciences Announces Second Quarter 2010 Conference Call and Webcast,, 7/22/2014 0072XH-E  PRN  Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States,,,,,,,,,,,,,,,,,,,, 2/24/2011 69329Y10 PRN  PDL BioPharma to Present at Upcoming Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/18/2010 000BQR-E PRN  Reportlinker Adds Global Bladder Cancer Therapeutics Industry,,,,,,,12/01/2010 005W47-E PRN  Observational Data From One-Year Follow-up Study Validate Six-Minute Walk Distance as an Outcome Measure in Duchenne and Becker Muscular Dystrophy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 7/22/2013 G3040110 PRN  Endo Health Solutions Names Don DeGolyer Chief Operating Officer of Pharmaceuticals,,,," 2/20/2015 75886F10    PRN  Pre-Market Pulse on Biotech Stocks -- OPKO Health, Organovo Holdings, Neuralstem, Regeneron Pharma, and Raptor Pharma",,, 4/30/2014 46222210 PRN  ISIS Pharmaceuticals' and Biogen idec's innovative collaboration voted breakthrough alliance of 2014,,,,,,,,,," 3/08/2012 04004760   PRN  Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14", 8/05/2015 N5946510  PRN  Mylan Launches Generic Nexium® Delayed-Release Capsules,,, 1/27/2017 03116210 PRN  Amgen Receives Positive CHMP Opinion For ABP 501 (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases,,,,,,,,,,,,,,,,,,,, 7/06/2010 80067710 PRN  Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells,, 7/09/2014 80105N10  PRN  Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis,,,,,,,,,,,,,,,,,,,," 2/22/2011 69329Y10 PRN  PDL BioPharma to Announce Fourth Quarter and Year End 2010 Financial Results on February 28, 2011",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/12/2010 40637H10 PRN  Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro,,,,,,,11/15/2010 005W47-E PRN  PTC Publishes Results from Phase 2 Study of Ataluren in Children with Cystic Fibrosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/05/2013 G3040110 PRN  Endo Health Solutions Announces Actions To Streamline Operations And Expand Platform For Sustainable Cash Flow And Earnings Growth,,,, 2/18/2015 75886F10    PRN  NIH-Sponsored Comparative Effectiveness Trial in Diabetic Macular Edema Shows EYLEA® (aflibercept) Injection Demonstrated Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab,,, 4/29/2014 46222210 PRN  Isis Reports Updated Results from ISIS-SMN Rx Clinical Studies in Infants and Children with Spinal Muscular Atrophy,,,,,,,,,, 3/02/2012 04004760   PRN  Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control, 8/05/2015 MYL-GB    PRN  Mylan Provides Update on Conditions to Perrigo Offer,,, 1/19/2017 03116210 PRN  OilPrice.com: This Could Be the Biggest Winner of 2017’s Biotech Boom,,,,,,,,,,,,,,,,,,,, 7/01/2010 80067710 PRN  Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinson's Disease,, 7/08/2014 80105N10  PRN  FDA Accepts Sanofi's New Drug Application for Basal Insulin Toujeo®,,,,,,,,,,,,,,,,,,,, 2/16/2011 69329Y10 PRN  MedImmune and PDL BioPharma Resolve Patent Disputes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/05/2010 40637H10 PRN  Halozyme Therapeutics Reports Third Quarter 2010 Financial Results,,,,,,,10/26/2010 005W47-E PRN  PTC Therapeutics Initiates Phase 2 Clinical Trial of Ataluren in Patients With Methylmalonic Acidemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/30/2013 G3040110 PRN  Endo Pharmaceuticals Provides Regulatory Update On AVEED™ (Testosterone Undecanoate) Injection,,,, 2/18/2015 75886F10    PRN  New Results from Cholesterol Counts Show Most Americans Polled Do Not Know Their Bad Cholesterol (LDL-C) Levels,,, 4/22/2014 46222210 PRN  Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at the 2014 AAN Annual Meeting,,,,,,,,,," 2/24/2012 S.XX1-US   PRN  Equity Research on Most Popular Searches: Sprint Nextel, Ford, Micron, GrafTech International, and Arena Pharmaceuticals"," 7/29/2015 N5946510  PRN  Critical Alerts For Palo Alto Networks, Intrexon, FireEye, Mylan and Kite Pharma Released By InvestorsObserver",,, 1/17/2017 03116210 PRN  deCODE Study Shows that Variants in the Sequence of the Genome that Contribute to Educational Attainment are Under Negative Selection,,,,,,,,,,,,,,,,,,,, 6/29/2010 80067710 PRN  Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data From SB-509 Programs in Diabetic Neuropathy at ADA 2010,," 7/07/2014 80105N10  PRN  Kosher Certifications, Biologic License Applications, Positive Study Results, Development Programs, and Product Acquisitions - Analyst Notes on Pfizer, Novartis, Sanofi, Zogenix and Impax",,,,,,,,,,,,,,,,,,,, 2/08/2011 69329Y10 PRN  PDL BioPharma to Present at the 13th Annual BIO CEO & Investor Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,11/04/2010 40637H10 PRN  Halozyme Therapeutics Awarded Four Qualifying Therapeutic Discovery Project Grants,,,,,,,10/15/2010 005W47-E PRN  Pivotal Data Presented at the World Muscle Society Congress Suggest Ataluren Slows the Loss of Walking Ability in Patients with Nonsense Mutation Duchenne/Becker Muscular Dystrophy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/29/2013 G3040110 PRN  Endo Health Solutions Announces Departure Of Chief Financial Officer,,,," 2/17/2015 75886F10    PRN  Critical Alerts For Tesla Motors, CyberArk Software, Regeneron Pharmaceuticals, Microsoft and Arrowhead Research Released By InvestorsObserver",,, 4/01/2014 46222210 PRN  Isis Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference,,,,,,,,,, 2/23/2012 04004760   PRN  Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference, 7/29/2015 PRGO-IE   PRN  Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo,,, 1/17/2017 03116210 PRN  OilPrice.com: Life-Saving Device Could Transform the Medical Market in 2017,,,,,,,,,,,,,,,,,,,, 6/03/2010 80067710 PRN  Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences,, 7/01/2014 06VY62-E  PRN  CureVac Signs an Exclusive License Agreement with Sanofi Pasteur to Develop and Commercialize an mRNA-based Prophylactic Vaccine,,,,,,,,,,,,,,,,,,,, 2/08/2011 PDLI-US  PRN  UCB and PDL BioPharma Resolve Patent Disputes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/28/2010 40637H10 PRN  Halozyme Therapeutics Announces Hiring of New Leadership for Business Development,,,,,,, 9/21/2010 005W47-E PRN  PTC Therapeutics Awarded $1.6 Million FDA Orphan Drug Grant to Support an Ongoing Phase 3 Study in Cystic Fibrosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/29/2013 G3040110 PRN  Endo Health Solutions Announces Departure of Chief Operating Officer,,,, 2/13/2015 75886F10    PRN  Regeneron Announces Upcoming 2015 Investor Conference Presentations,,, 3/31/2014 46222210 PRN  Isis Reports Final Phase 2 Data On ISIS-APOCIII Rx In Patients With High Triglycerides Taking Fibrates,,,,,,,,,, 2/08/2012 04004760   PRN  Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences, 7/27/2015 MYL-GB    PRN  Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders,,, 1/10/2017 0B17F0-E PRN  Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv™ (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis,,,,,,,,,,,,,,,,,,,, 5/24/2010 80067710 PRN  Sangamo BioSciences and Collaborators Present Data in Fifteen Presentations Highlighting Broad Therapeutic Applications of ZFP Technology,, 6/14/2014 80105N10  PRN  Sanofi's Lyxumia® (lixisenatide) Showed More Pronounced After-Test-Meal Blood Sugar Lowering than Liraglutide when Both were Added to Insulin Glargine,,,,,,,,,,,,,,,,,,,, 1/25/2011 69329Y10 PRN  PDL BioPharma Appoints Caroline Krumel as Vice President of Finance and Thanks Karen Wilson for her Contributions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/26/2010 40637H10 PRN  Halozyme Therapeutics to Host Third Quarter Conference Call on November 5 and Present at Two Upcoming Investor Conferences,,,,,,, 6/07/2010 005W47-E PRN  PTC Therapeutics Awarded $5.4 Million Grant From The Wellcome Trust,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/10/2013 G3040110 PRN  Endo Health Solutions Responds to FDA's Denial of OPANA® ER Citizen Petition and the Potential Approval of Additional Non-Abuse Deterrent Formulations of Generic Oxymorphone,,,, 2/10/2015 75886F10    PRN  Regeneron Reports Fourth Quarter and Full Year 2014 Financial and Operating Results,,, 3/24/2014 46222210 PRN  Isis Announces Antisense Targeting Of HBV Produces Dose-Dependent Reductions In Hepatitis B Virus In An Animal Model Of HBV,,,,,,,,,, 2/01/2012 04004760   PRN  Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin, 7/27/2015 MYL-GB    PRN  Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit,,," 1/09/2017 03116210 PRN  Amgen Statement on January 9, 2017, U.S. District Court Decision",,,,,,,,,,,,,,,,,,,, 5/04/2010 80067710 PRN  Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences,, 6/14/2014 80105N10  PRN  Patients Continuing On Sanofi's Lantus® Had Lower Blood Sugar Levels Than Those who Switched to Insulin Detemir,,,,,,,,,,,,,,,,,,,, 1/10/2011 69329Y10 PRN  PDL BioPharma Announces Decisions on Summary Judgment in its Litigation with MedImmune,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/11/2010 40637H10 PRN  Halozyme Therapeutics Announces Implementation of Development Focused Strategy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/07/2013 G3040110 PRN  Endo Reports First Quarter Financial Results,,,, 1/26/2015 75886F10    PRN  Regeneron and Sanofi Announce Praluent™ (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA,,, 3/19/2014 46222210 PRN  Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-ANGPTL3 Rx to Treat Hyperlipidemia,,,,,,,,,, 1/11/2012 04004760   PRN  Arena Pharmaceuticals Announces $33 Million Financing, 7/24/2015 N5946510  PRN  Mylan Schedules Second Quarter 2015 Financial Results Conference Call and Live Webcast,,, 1/09/2017 0015RG-E PRN  DaVita Enters Into New Sourcing and Supply Agreement with Amgen and Initiates 2017 Kidney Care Guidance,,,,,,,,,,,,,,,,,,,, 5/03/2010 80067710 PRN  Sangamo BioSciences Reports First Quarter 2010 Financial Results,," 6/14/2014 80105N10  PRN  Sanofi Reports Positive Phase 3 Results for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL)",,,,,,,,,,,,,,,,,,,, 1/05/2011 69329Y10 PRN  PDL BioPharma to Present at the 29th Annual JP Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10/07/2010 40637H10 PRN  Halozyme Therapeutics to Host Analyst Meeting on October 14 in New York,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/15/2013 G3040110 PRN  Endo to Announce First Quarter 2013 Financial Results on May 7, 2013",,,, 1/23/2015 75886F10    PRN  EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central or Branch Retinal Vein Occlusion in the European Union,,, 3/06/2014 46222210 PRN  Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference,,,,,,,,,, 1/10/2012 05NDXX-E   PRN  FDA Accepts Resubmission of Lorcaserin New Drug Application, 7/23/2015 N5946510  PRN  Mylan Acknowledges Exercise of Full Call Option by the Independent Foundation,,, 1/09/2017 0CZ7R0-E PRN  Amgen And DaVita Enter Into New Sourcing And Supply Agreement,,,,,,,,,,,,,,,,,,,, 4/26/2010 80067710 PRN  Sangamo BioSciences Announces First Quarter 2010 Conference Call and Webcast,," 6/12/2014 80105N10  PRN  Sanofi and Regeneron Announce New, Detailed Data from Positive Sarilumab Phase 3 Rheumatoid Arthritis Trial at EULAR",,,,,,,,,,,,,,,,,,,, 1/05/2011 69329Y10 PRN  PDL BioPharma to Present at the 29th Annual JP Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/15/2010 40637H10 PRN  Halozyme Therapeutics to Present at Two Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 3/28/2013 G3040110 PRN  Today's Analysis on Bristol-Myers Squibb, Eli Lilly & Co., Endo Pharma, and Allergan",,,," 1/21/2015 75886F10    PRN  Critical Alerts For General Electric, Achillion Pharmaceuticals, 3D Systems, Apache Corporation and Regeneron Pharmaceuticals Released By InvestorsObserver",,, 3/03/2014 GSK-GB   PRN  ISIS Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx,,,,,,,,,, 1/05/2012 04004760   PRN  Arena Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference, 7/14/2015 MYL-GB    PRN  Mylan One of First to Launch Generic Version of Namenda® Tablets,,, 1/09/2017 03116210 PRN  Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies,,,,,,,,,,,,,,,,,,,,,," 5/29/2014 80105N10  PRN  Launch of Ultrasonic Device, Conference Participation, Public Offering, and Employee Stock Options - Analyst Notes on Johnson & Johnson, McKesson, AmerisourceBergen, Horizon Pharma and Sanofi",,,,,,,,,,,,,,,,,,,,"12/20/2010 69329Y10 PRN  U.S. Patent and Trademark Office Terminates Interference Proceeding in Favor of PDL BioPharma, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/09/2010 40637H10 PRN  Halozyme Therapeutics Announces Pricing of Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 3/12/2013 G3040110 PRN  A Forward Look into The Year Ahead - Research Report on Warner Chilcott Plc., Endo Health Solutions Inc., The Western Union Company, Euronet Worldwide, Inc. and The Procter & Gamble Company",,,, 1/12/2015 75886F10    PRN  Regeneron and Sanofi Announce Praluent™ (alirocumab) Marketing Authorization Application has Been Accepted for Review by EMA,,, 2/28/2014 46222210 PRN  Isis Reports Financial Results And Highlights For 2013,,,,,,,,,, 1/03/2012 4523-JP    PRN  Arena Submits Response to FDA Complete Response Letter for Lorcaserin," 7/13/2015 N5946510  PRN  Critical Alerts For ConocoPhillips, Mylan, Rite Aid, SolarCity and Juno Therapeutics Inc Released By InvestorsObserver",,," 1/06/2017 068RK3-E PRN  SiteOne Therapeutics Announces Research and Development Agreement With Amgen to Advance Portfolio of Highly Selective, Potent Inhibitors of NaV1.7 for Acute and Chronic Pain",,,,,,,,,,,,,,,,,,,,,, 5/28/2014 SNY-FR    PRN  Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC,,,,,,,,,,,,,,,,,,,,12/01/2010 000KXY-E PRN  PDL BioPharma Provides Fourth Quarter 2010 Revenue Guidance of $74 Million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/08/2010 40637H10 PRN  Halozyme Therapeutics Announces Public Offering of Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/05/2013 G3040110 PRN  Endo Health Solutions to Present at the Cowen and Company 33rd Annual Health Care Conference,,,," 1/09/2015 75886F10    PRN  Regeneron to Report Fourth Quarter and Full Year 2014 Financial and Operating Results and Host Conference Call and Webcast on February 10, 2015",,, 2/25/2014 46222210 PRN  Isis Pharmaceuticals to Present at the Cowen 34th Annual Health Care Conference,,,,,,,,,,12/08/2011 04004760   PRN  Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference, 7/09/2015 N5946510  PRN  Mylan Launches First Generic Targretin® Capsules,,, 1/05/2017 03116210 PRN  Court Grants Permanent Injunction For Infringement Of Amgen's Repatha Patents,,,,,,,,,,,,,,,,,,,,,," 5/22/2014 80105N10  PRN  Rolaids® ""Eat Your Words"" Spelling Bee Celebrates America's Favorite, Yet Heartburn-Inducing Foods",,,,,,,,,,,,,,,,,,,,11/10/2010 69329Y10 PRN  PDL BioPharma Announces Third Quarter 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 9/02/2010 40637H10 PRN  Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro and Aspart With rHuPH20 in Type 1 and Type 2 Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/28/2013 G3040110 PRN  Endo Reports Fourth Quarter Financial Results And Reaffirms 2013 Financial Guidance,,,, 1/09/2015 75886F10    PRN  Regeneron and Sanofi Announce Positive Topline Results from First Phase 3 Trials Evaluating Monthly Dosing of Alirocumab in Patients with Hypercholesterolemia,,, 2/21/2014 46222210 PRN  Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Phase 2 Study in Infants with Spinal Muscular Atrophy,,,,,,,,,,11/23/2011 04004760   PRN  Arena Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference, 6/18/2015 N5946510  PRN  U.S. Court of Appeals for the Federal Circuit Finds Teva's '808 Copaxone® Patent Invalid,,, 1/04/2017 03116210 PRN  Amgen To Present At The 35th Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 5/19/2014 0072XH-E  PRN  Sanofi Pasteur Announces Favorable Phase II Study Results for Investigational Clostridium difficile Vaccine at the American Society for Microbiology Meeting,,,,,,,,,,,,,,,,,,,,11/05/2010 69329Y10 PRN  PDL BioPharma Completes Exchange to Retire $92.0 Million of 2.00% Convertible Notes Due August 2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/31/2010 40637H10 PRN  Halozyme Provides HYLENEX® Product Reintroduction Update,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 2/28/2013 G3040110 PRN  Science Behind the Numbers, The Business of Health - Research Report on Endo Health Solutions Inc, Actavis Inc, Mylan Inc., Elan Corporation, plc and Amgen, Inc.",,,," 1/08/2015 75886F10    PRN  Biotech Industry Equities Under the Scanner - NPS Pharma, Mast Therapeutics, Threshold Pharma, Lexicon Pharma, and Regeneron Pharma",,, 2/21/2014 46222210 PRN  Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Multiple Dose Study in Children with Spinal Muscular Atrophy,,,,,,,,,,11/09/2011 04004760   PRN  Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results, 6/16/2015 N5946510  PRN  Mylan Issues Statement in Response to Abbott's Support for Perrigo Transaction,,,12/20/2016 03116210 PRN  Amgen Announces 15 Percent Increase In 2017 First Quarter Dividend,,,,,,,,,,,,,,,,,,,,,, 4/29/2014 80105N10  PRN  Sanofi Q1 2014 Business EPS up 5.8% at CER,,,,,,,,,,,,,,,,,,,,"11/02/2010 69329Y10 PRN  PDL BioPharma to Announce Third Quarter 2010 Financial Results on November 10, 2010",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/12/2010 40637H10 PRN  Halozyme Announces Issuance of U.S. Patent for rHuPH20 Enzyme Platform,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/25/2013 G3040110 PRN  Rajiv De Silva Named President and CEO of Endo Health Solutions,,,," 1/02/2015 75886F10    PRN  Critical Alerts For iRobot, Regeneron Pharmaceuticals, Sears Holdings, Starbucks and Goldcorp Released By InvestorsObserver",,, 2/20/2014 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' 2013 Financial Results and Highlights Conference Call,,,,,,,,,,"11/03/2011 04004760   PRN  Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, November 10", 6/16/2015 ABT-US    PRN  Abbott Affirms its Support for Mylan Standalone Strategy and Will Vote its Mylan Shares in Favor of Mylan's Proposed Acquisition of Perrigo,,,12/19/2016 AMGN-US  PRN  Amgen And UCB Announce Submission Of Application For Investigational Osteoporosis Medication Romosozumab In Japan,,,,,,,,,,,,,,,,,,,,,, 4/29/2014 80105N10  PRN  Sanofi Q1 2014 Results - Interview with CFO Jérôme Contamine,,,,,,,,,,,,,,,,,,,,10/28/2010 69329Y10 PRN  PDL BioPharma to Present at Oppenheimer and Lazard Capital Markets Annual Healthcare Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/12/2010 40637H10 PRN  Halozyme Announces Issuance of U.S. Patent for rHuPH20 Enzyme Platform,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/25/2013 G3040110 PRN  Allergan and Endo Pharma Under StockCall's Microscope: Drug Companies Restructure Their Businesses,,,,12/19/2014 75886F10    PRN  Regeneron Announces Presentation and Panel Discussion at the 33rd Annual J.P. Morgan Healthcare Conference,,, 2/19/2014 46222210 PRN  Isis Pharmaceuticals to Present at the 2014 RBC Capital Markets Global Healthcare Conference,,,,,,,,,, 9/26/2011 04004760   PRN  New Data Analyses from Lorcaserin Phase 3 Clinical Trials to be Presented at Obesity 2011, 6/16/2015 N5946510  PRN  Pulmatrix and Mylan Enter Into ex-U.S. Development Agreement for PUR0200,,,12/16/2016 080RQG-E PRN  New Repatha® (evolocumab) Dose Delivery Option Receives Positive CHMP Opinion,,,,,,,,,,,,,,,,,,,,,, 4/15/2014 SNY-FR    PRN  Basketball Hall of Famer Nancy Lieberman Teams Up with New Nasacort® Allergy 24HR to Help Allergy Sufferers Put the Full 'Cort Press on Nasal Allergy Symptoms,,,,,,,,,,,,,,,,,,,,"10/27/2010 69329Y10 PRN  PDL BioPharma Announces Exchange to Retire 2.00% Convertible Senior Notes Due February 15, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 8/06/2010 40637H10 PRN  Halozyme Therapeutics Reports Second Quarter 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 2/20/2013 G3040110 PRN  The Race to the Bottom Line - Research Report on Endo Health Solutions Inc., Warner Chilcott Public Limited Company, The Gap, Inc., Guess?, Inc. and Alto Networks, Inc.",,,,12/15/2014 STD-ES      PRN  Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol,,, 2/14/2014 46222210 PRN  Isis Announces Positive Opinion on European Orphan Drug Designation for ISIS-TTR Rx,,,,,,,,,, 9/21/2011 04004760   PRN  Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference, 6/08/2015 N5946510  PRN  Mylan Launches First Bioequivalent Alternative to Combination Asthma Therapy Seretide® Evohaler® (Salmeterol Xinafoate/Fluticasone Propionate) Under the Brand Name Sirdupla™ in the UK,,,"12/06/2016 03116210 PRN  How These Biotech Stocks are Faring? -- Celgene, Sarepta Therapeutics, MannKind and Amgen",,,,,,,,,,,,,,,,,,,,,, 4/01/2014 06VY62-E  PRN  Sanofi Pasteur Announces FDA Has Expanded Age Indication of Adacel® Tdap Vaccine to Include Persons 10 Years of Age,,,,,,,,,,,,,,,,,,,,10/04/2010 69329Y10 PRN  PDL BioPharma Completes October 1 Special Dividend Payment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," 7/30/2010 40637H10 PRN  Halozyme Announces Second Quarter 2010 Financial Results Conference Call on August 6, 2010",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 2/13/2013 G3040110 PRN  Endo to Announce Fourth Quarter 2012 Financial Results on February 28, 2013",,,,12/01/2014 75886F10    PRN  EYLEA® (aflibercept) Injection Accepted for Priority Review by FDA for Diabetic Retinopathy in Patients with Diabetic Macular Edema,,, 2/13/2014 46222210 PRN  Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy,,,,,,,,,," 8/12/2011 04004760   PRN  Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer"," 6/05/2015 N5946510  PRN  Critical Alerts For Abercrombie & Fitch, Inovio Pharmaceuticals, Wynn Resorts, Mylan and Netflix Released By InvestorsObserver",,,12/02/2016 03116210 PRN  Amgen Announces Launch Of Blood Counts™ And Collaboration With StoryCorps To Record And Share Stories Of Those Impacted By Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,, 4/01/2014 80105N10  PRN  Sanofi and Regeneron Report Positive Results With Alirocumab From Phase 2 Japanese Study,,,,,,,,,,,,,,,,,,,, 9/16/2010 69329Y10 PRN  PDL BioPharma Announces Retirement of $54.3 Million of 2.75% Convertible Notes Due 2023,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/28/2010 40637H10 PRN  Coinjection of Halozyme's rHuPH20 Enzyme Accelerates the Absorption and Action of Mealtime Insulin Analogs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 1/31/2013 G3040110 PRN  Critical Alerts For ConocoPhillips, ADT, Endo Pharmaceuticals, Fossil, and Tenet Healthcare Released By InvestorsObserver",,,,"11/26/2014 75886F10    PRN  Critical Alerts For Qihoo 360 Technology, Regeneron Pharmaceuticals, Autodesk, Akamai Technologies and General Motors Released By InvestorsObserver",,, 2/06/2014 46222210 PRN  Isis Pharmaceuticals to Present at the Leerink Global Healthcare Conference,,,,,,,,,, 8/09/2011 04004760   PRN  Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results, 6/03/2015 00GDWJ-E  PRN  Mylan to Present at Goldman Sachs 36th Annual Global Healthcare Conference,,,"12/02/2016 080RQG-E PRN  Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimilar Candidate To Bevacizumab",,,,,,,,,,,,,,,,,,,,,, 3/27/2014 80105N10  PRN  Sanofi and Regeneron To Present Alirocumab Clinical Data at the American College of Cardiology's 63rd Annual Scientific Session,,,,,,,,,,,,,,,,,,,, 9/15/2010 69329Y10 PRN  PDL BioPharma to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/27/2010 40637H10 PRN  Halozyme's Ultrafast Insulin Accelerates Absorption and Lowers Hyperglycemia and Hypoglycemia Risk in Type 2 Diabetes Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/03/2013 G3040110 PRN  Endo Health Solutions Reaffirms 2012 Adjusted Earnings Per Share Outlook and Provides 2013 Financial Guidance,,,,"11/24/2014 75886F10    PRN  Biotech Stocks in Motion - Amgen, Merrimack Pharma, NPS Pharma, BioMarin Pharma, and Regeneron Pharma",,," 2/03/2014 46222210 PRN  Joseph Loscalzo, M.D., Ph.D., Joins Isis Pharmaceuticals' Board of Directors",,,,,,,,,, 8/09/2011 05NDXX-E   PRN  Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study, 6/02/2015 N5946510  PRN  Mylan Launches Generic Version of Seasonique® Tablets,,,12/01/2016 03116210 PRN  Amgen To Present At The Citi 2016 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 3/18/2014 80105N10  PRN  Multiple Sclerosis Association of America's Nationwide Search Uncovers Inspiring Stories of People Living with MS Who Swim for Better Health,,,,,,,,,,,,,,,,,,,," 9/13/2010 69329Y10 PRN  PDL BioPharma Announces Conversion Rate Adjustment for 2.00% Convertible Senior Notes Due February 15, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 6/01/2010 40637H10 PRN  Halozyme to Present at the Jefferies 2010 Global Life Sciences Conference on June 8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"12/11/2012 G3040110 PRN  Endo Health Solutions Launches 7.5mg and 15mg strengths of Reformulated, Designed to be Crush-Resistant, OPANA® ER",,,,11/20/2014 75886F10    PRN  Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis,,, 1/13/2014 46222210 PRN  Isis Pharmaceuticals to Receive $7.5 Million from Alnylam,,,,,,,,,, 8/02/2011 05NDXX-E   PRN  Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses, 6/02/2015 N5946510  PRN  Mylan Launches Generic INTUNIV® Tablets,,,11/30/2016 03116210 PRN  The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function In Patients With Chronic Heart Failure,,,,,,,,,,,,,,,,,,,,,, 3/03/2014 0072XH-E  PRN  Inactivated Polio Vaccines Broadly Available for the World's Children in the Drive Toward Polio Eradication,,,,,,,,,,,,,,,,,,,, 9/10/2010 69329Y10 PRN  PDL BioPharma Provides Clarification Regarding Redemption of Its 2.75% Convertible Subordinated Notes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/17/2010 40637H10 PRN  Halozyme Announces Voluntary Recall of HYLENEX(R),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"12/06/2012 G3040110 PRN  Qualitest Issues Voluntary, Nationwide Recall of 101 Lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized Tablets",,,,11/19/2014 75886F10    PRN  Sanofi and Regeneron Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol,,," 1/13/2014 46222210 PRN  Critical Alerts For GM, Isis Pharmaceuticals, Boston Beer, MasterCard, and Macy's Released By InvestorsObserver",,,,,,,,,," 8/01/2011 04004760   PRN  Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9"," 5/27/2015 N5946510  PRN  Critical Alerts For Under Armour, Mylan, Tableau Software, Charter Communications and Intel Released By InvestorsObserver",,,"11/30/2016 06QBQ2-E PRN  Amgen Announces Presentation Of New Data In Acute Lymphoblastic Leukemia, Multiple Myeloma And Immune Thrombocytopenia At ASH 2016",,,,,,,,,,,,,,,,,,,,,, 2/06/2014 SNY-FR    PRN  Sanofi Returns to Growth in Q4 2013,,,,,,,,,,,,,,,,,,,, 9/09/2010 69329Y10 PRN  PDL BioPharma Announces Ex-Dividend Date of September 13 for Special Dividend,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/16/2010 40637H10 PRN  Halozyme Delivers Notice of Breach to Baxter Healthcare Due to HYLENEX(R) Manufacturing Failures,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/30/2012 G3040110 PRN  Endo Health Solutions Sues FDA to Protect Consumers from Non-Tamper Resistant Oxymorphone,,,,11/19/2014 75886F10    PRN  Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol,,, 1/13/2014 46222210 PRN  Isis Announces Positive Decision On European Orphan Drug Designation For ISIS-APOCIII Rx,,,,,,,,,, 7/12/2011 04004760   PRN  Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension, 5/26/2015 N5946510  PRN  Mylan to Present at the Bernstein Strategic Decisions Conference,,,11/16/2016 0887T9-E PRN  Amgen Announces Erenumab Significantly Reduces Monthly Migraine Days In Patients With Episodic Migraine In Second Phase 3 Study,,,,,,,,,,,,,,,,,,,,,, 2/05/2014 078VWR-E  PRN  Regulus Renews Strategic Alliance with Sanofi to Focus on Orphan Disease and Oncology Targets and Receives Additional $10 Million Equity Investment,,,,,,,,,,,,,,,,,,,, 9/08/2010 69329Y10 PRN  PDL BioPharma to Present at Upcoming Investor Conferences,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 5/07/2010 40637H10 PRN  Halozyme Therapeutics Reports First Quarter 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/13/2012 G3040110 PRN  Endo Health Solutions Supplements Citizen Petition With Preliminary Data Showing a 59% Drop in Abuse of the Reformulated, Designed to be Crush-Resistant, OPANA® ER",,,,11/18/2014 75886F10    PRN  Regeneron Announces EYLEA® (aflibercept) Injection Approved for the Treatment of Diabetic Macular Edema (DME) in Japan,,," 1/09/2014 46222210 PRN  Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals",,,,,,,,,, 6/20/2011 05NDXX-E   PRN  Lorcaserin Data to be Presented at the American Diabetes Association's 71st Scientific Sessions, 5/25/2015 00GDWJ-E  PRN  Mylan/Perrigo Clarification,,,11/15/2016 03116210 PRN  Amgen And Allergan Submit Biosimilar Biologics License Application For ABP 215 To U.S. Food And Drug Administration,,,,,,,,,,,,,,,,,,,,,, 2/04/2014 80105N10  PRN  Sanofi's Consumer Healthcare Division Chattem Announces Nasacort® Allergy 24HR Nasal Spray Now Available Without a Prescription in the U.S.,,,,,,,,,,,,,,,,,,,, 9/01/2010 69329Y10 PRN  PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 4/30/2010 40637H10 PRN  Halozyme Announces First Quarter 2010 Financial Results Conference Call and Presentation at Upcoming Investor Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/13/2012 G3040110 PRN  The Trendlines Group Announces Co-development Agreement with Endo,,,,11/11/2014 REGN-US     PRN  Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma,,, 1/06/2014 46222210 PRN  Isis Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference,,,,,,,,,, 5/26/2011 04004760   PRN  Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals' Lorcaserin Achieved Statistically Significant Weight Loss, 5/12/2015 00GDWJ-E  PRN  Mylan to Present at the UBS Global Healthcare Conference,,,11/15/2016 03116210 PRN  Repatha® (Evolocumab) Regresses Atherosclerosis In Patients With Coronary Artery Disease,,,,,,,,,,,,,,,,,,,,,, 1/31/2014 SNY-FR    PRN  Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit,,,,,,,,,,,,,,,,,,,, 8/13/2010 69329Y10 PRN  PDL BioPharma Receives Letter from Genentech Relating to European Patents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/08/2012 G3040110 PRN  Endo Health Solutions to Present at 2012 Annual Credit Suisse Healthcare Conference,,,,11/04/2014 75886F10    PRN  Regeneron Reports Third Quarter 2014 Financial and Operating Results,,,"12/26/2013 46222210 PRN  Market Technicals on Thursday: Quest Diagnostics, Santarus, Isis Pharma, and Community Health Systems",,,,,,,,,, 5/20/2011 04004760   PRN  Arena Pharmaceuticals' Lorcaserin to be Featured in Presentations at 18th European Congress on Obesity, 5/12/2015 00GDWJ-E  PRN  Mylan to Present at the Bank of America Merrill Lynch Health Care Conference,,,11/14/2016 00BL16-E PRN  New 'Ten To Watch' List Highlights Top Amgen Scholars Poised To Impact The Future Of Science And Medicine,,,,,,,,,,,,,,,,,,,,,," 1/16/2014 80105N10  PRN  Stock Price Updates, Grants, Appointments, and Completed Transactions - Research Report on Express Scripts, Agilent Technologies, Quest Diagnostics, Covidien, and Sanofi",,,,,,,,,,,,,,,,,,,, 8/12/2010 69329Y10 PRN  PDL BioPharma Completes Retirement of $61.7 Million of 2.75% Convertible Notes Due August 2023 for Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/07/2012 G3040110 PRN  Endo Health Solutions to Present at Jefferies 2012 Global Healthcare Conference,,,,11/03/2014 75886F10    PRN  Regeneron Announces Upcoming 2014 Investor Conference Presentations,,,"12/23/2013 46222210 PRN  Stock Price Movements of Healthcare Companies- Research Report on LabCorp, Isis Pharmaceuticals, Mindray, Clovis Oncology and Sangamo Biosciences",,,,,,,,,, 5/10/2011 04004760   PRN  Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments," 5/07/2015 N5946510  PRN  Fashion Icon, Chef and Actor Join Together to Share Personal Stories of Managing Life-Threatening Allergies in New Campaign",,,11/12/2016 03116210 PRN  Results From Phase 3 BRIDGE Study Show Romosozumab Significantly Increases Bone Mineral Density In Men With Osteoporosis,,,,,,,,,,,,,,,,,,,,,, 1/13/2014 80105N10  PRN  Regeneron Announces Amendment to Investor Agreement with Sanofi,,,,,,,,,,,,,,,,,,,, 8/11/2010 69329Y10 PRN  PDL BioPharma to Present at 2010 Global Hunter Securities Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/05/2012 G3040110 PRN  Endo Reports Third Quarter Financial Results And Updates 2012 Financial Guidance,,,,"11/03/2014 75886F10    PRN  Upcoming Earnings, Financial Results, New Affiliations, and Study Results - Research Reports on Regeneron, Valeant, CVS Health, CIGNA and Baxter",,,"12/13/2013 46222210 PRN  Public Offerings of Common Shares, Upcoming Events and Shareholder Meetings, and Stock Price Updates - Research Report on Zoetis, Allergan, Clovis Oncology, Isis Pharmaceuticals, and Mindray",,,,,,,,,, 5/06/2011 04004760   PRN  Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference, 5/06/2015 N5946510  PRN  Pharma Companies Beginning to Mix Diversification by Expanding into the Multi-Billion Dollar Nutritional & Nutraceutical Supplements Market as Projected Growth Opportunities Continue to Rise,,,11/11/2016 03116210 PRN  European Commission Approves Parsabiv™ (etelcalcetide) For The Treatment Of Secondary Hyperparathyroidism In Adults On Hemodialysis,,,,,,,,,,,,,,,,,,,,,," 1/08/2014 80105N10  PRN  Stock Price Movements, Conference Presentation Schedules, and Expanded Sharing of Clinical Data - Research Report on Gilead, Express Scripts, Sanofi, Agilent, and Kythera Biopharma",,,,,,,,,,,,,,,,,,,, 8/05/2010 69329Y10 PRN  PDL BioPharma Announces Retirement of $61.6 Million of 2.75% Convertible Notes due August 2023 for Common Stock,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/02/2012 G3040110 PRN  HealthTronics Launches New Line Of Slimline Cryoprobes For Use With Its Endocare® Cryocare® Systems,,,,"10/23/2014 75886F10    PRN  New Solution for Patients, Quarterly Financial Results, Clinical Study Initiation, Merger Updates, and Product Launch - Research Reports on CVS, Valeant, Regeneron, Allergan and Agilent",,,"12/11/2013 46222210 PRN  Critical Alerts For Micron, Isis Pharmaceuticals, Barrick Gold, Boston Beer Company, and NPS Pharmaceuticals Released By InvestorsObserver",,,,,,,,,," 5/04/2011 04004760   PRN  Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10", 5/05/2015 00GDWJ-E  PRN  Mylan First Quarter 2015 Constant Currency Revenue Increases 15% and Adjusted Diluted EPS Increases 6% to $0.70,,,11/10/2016 03116210 PRN  Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2016,,,,,,,,,,,,,,,,,,,,,,"12/30/2013 80105N10  PRN  Regulatory Filings, Upcoming Healthcare Conferences, Trial Updates, and Innovative Collaborations - Research Report on Novo Nordisk, Hospira, Tesaro, Alnylam, and Sanofi",,,,,,,,,,,,,,,,,,,, 7/29/2010 69329Y10 PRN  PDL BioPharma to Present at BMO Capital Markets' 10th Annual Focus on Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"10/22/2012 G3040110 PRN  Endo to Announce Third Quarter 2012 Financial Results on Nov. 5, 2012",,,,"10/20/2014 75886F10    PRN  Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma",,,"12/05/2013 46222210 PRN  Divestitures, Event Participations, Patents, Clinical Studies and Trials - Research Report on Allergan, Zoetis, XOMA, Isis, and Arrowhead",,,,,,,,,, 3/29/2011 04004760   PRN  Arena Pharmaceuticals Announces $35.5 Million Financing, 5/05/2015 N5946510  PRN  Mylan Launches Generic Seasonale® Tablets,,,11/10/2016 0016D6-E PRN  Janssen Announces Clinical Trial Collaboration and Supply Agreement with Amgen to Evaluate daratumumab (DARZALEX®) in Combination with carfilzomib (KYPROLIS®),,,,,,,,,,,,,,,,,,,,,,"12/27/2013 80105N10  PRN  Technical Stock Coverage for the Day:VIVUS, Sanofi, Healthways, and DENTSPLY Intl.",,,,,,,,,,,,,,,,,,,, 7/28/2010 69329Y10 PRN  PDL BioPharma Announces Second Quarter 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10/04/2012 G3040110 PRN  Endo Health Solutions Will Detail Long-Term Strategy At 2012 Investor Day,,,,10/20/2014 REGN-US     PRN  Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis,,,"12/03/2013 46222210 PRN  Healthcare Companies Report Appointments, Phase 1 Studies, and Corporate Growth - Research Report on HCA, Isis Pharmaceuticals, Oxygen Biotherapeutics, Insmed, and Zalicus",,,,,,,,,, 3/15/2011 002XMH-E   PRN  Polaris Group Appoints Robert E. Hoffman as Chief Financial Officer, 5/05/2015 00GDWJ-E  PRN  Mylan Confirms First-to-File Patent Challenge Relating to Minivelle®,,,11/10/2016 000C35-E PRN  Amgen Announces Collaboration With Janssen To Co-Fund Studies With KYPROLIS® (Carfilzomib) And DARZALEX® (Daratumumab) In Patients With Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,,12/19/2013 80105N10  PRN  Sanofi and Regeneron Announce Collaboration with American College of Cardiology for PCSK9 Inhibitor Clinical Program,,,,,,,,,,,,,,,,,,,," 7/20/2010 69329Y10 PRN  PDL BioPharma to Announce Second Quarter 2010 Financial Results and Hold Conference Call on July 28, 2010",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/28/2012 G3040110 PRN  Endo Health Solutions Appoints Jill D. Smith To Board of Directors,,,,10/17/2014 75886F10    PRN  EYLEA® (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study,,,12/03/2013 46222210 PRN  Isis Pharmaceuticals to Present at the Oppenheimer 24th Annual Healthcare Conference,,,,,,,,,, 3/11/2011 04004760   PRN  Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments, 5/04/2015 00GDWJ-E  PRN  Mylan Launches Gilead Sciences' Sovaldi® Tablets in India,,,11/07/2016 03116210 PRN  Data To Be Presented At ACR/ARHP 2016 Annual Meeting Show Amgen's Ongoing Commitment To Therapies For Patients With Serious Inflammatory And Bone Diseases,,,,,,,,,,,,,,,,,,,,,,"12/16/2013 80105N10  PRN  FDA Reviews, Trial Initiation, New Innovations, and Multi-year Commercial Agreement - Research Report on Sanofi, Medivation, Align Technology, WuXi PharmaTech, and Insulet",,,,,,,,,,,,,,,,,,,, 6/15/2010 69329Y10 PRN  PDL BioPharma Provides Second Quarter 2010 Revenue Guidance of Approximately $120 Million,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/28/2012 G3040110 PRN  Endo Health Solutions to Host Investor Day on Oct. 4, 2012, in New York City",,,,10/16/2014 75886F10    PRN  Regeneron Ranked Number One Biopharmaceutical Employer by Science Magazine for Third Consecutive Year,,,12/02/2013 46222210 PRN  Isis Pharmaceuticals Earns $2 Million from GSK for the Advancement of ISIS-TTR Rx,,,,,,,,,, 3/10/2011 04004760   PRN  Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes," 4/30/2015 N5946510  PRN  Morning Briefing on Pharma Equities -- Mylan, Actavis, Zoetis, Horizon Pharma, and Medicines",,,11/04/2016 03116210 PRN  FDA Approves Expanded Use Of ENBREL® (etanercept) To Treat Children With Chronic Moderate-To-Severe Plaque Psoriasis,,,,,,,,,,,,,,,,,,,,,,"12/13/2013 80105N10  PRN  Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi",,,,,,,,,,,,,,,,,,,," 5/04/2010 69329Y10 PRN  PDL BioPharma to Present at Ninth Annual JMP Securities Research Conference on May 12, 2010",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/26/2012 G3040110 PRN  Endo Health Solutions Announces Receipt of Paragraph IV Certifications for OPANA® ER,,,,"10/16/2014 75886F10    PRN  Regeneron Genetics Center Fully Operational, Announces New Collaborations and Key Appointments",,,"11/28/2013 46222210 PRN  Approvals, Conferences and Steady Numbers - Research Report on Allergan, Orexigen, ISIS, The Medicines Company, and Akron",,,,,,,,,," 3/08/2011 04004760   PRN  Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 11", 4/29/2015 N5946510  PRN  Perrigo Rejects Latest Mylan Unsolicited Offer,,,11/03/2016 CS-CH    PRN  Amgen To Present At The Credit Suisse 25th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,12/09/2013 0D4C3F-E  PRN  Sanofi US Launches Second Innovation Challenge: Collaborate | Innovate,,,,,,,,,,,,,,,,,,,, 4/29/2010 69329Y10 PRN  PDL BioPharma Announces First Quarter 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 9/10/2012 G3040110 PRN  Qualitest Issues Voluntary, Nationwide Recall for One Lot of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized Tablets",,,,"10/15/2014 75886F10    PRN  Regeneron to Report Third Quarter 2014 Financial and Operating Results and Host Conference Call and Webcast on November 4, 2014",,,"11/26/2013 46222210 PRN  Pre-Market Review: Quest Diagnostics Inc., Santarus Inc., Community Health Systems Inc., and Isis Pharma Inc.",,,,,,,,,, 2/10/2011 04004760   PRN  Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer, 4/29/2015 N5946510  PRN  Mylan Raises Offer to Acquire Perrigo,,,"11/02/2016 03116210 PRN  Amgen Appoints Lori Johnston As Senior Vice President, Human Resources",,,,,,,,,,,,,,,,,,,,,,"12/05/2013 80105N10  PRN  Dividends, Recognitions, Positive Opinions, Share Repurchase Programs, and Award Programs - Research Report on BD, Sanofi, GSK, Agilent Technologies, and Align Technology",,,,,,,,,,,,,,,,,,,," 4/22/2010 69329Y10 PRN  PDL BioPharma to Announce First Quarter 2010 Financial Results and Hold Conference Call on April 29, 2010",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/06/2012 G3040110 PRN  Endo Pharmaceuticals Announces Reformulated Version of OPANA® ER with INTAC® Technology Designed to be Crush-Resistant Accounts for more than 90 Percent of OPANA ER Total Prescription Volume,,,,"10/10/2014 75886F10    PRN  Critical Alerts For ITT Education, EOG Resources, Mobileye NV, CBS and Regeneron Pharmaceuticals Released By InvestorsObserver",,,11/26/2013 46222210 PRN  Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-GSK3 Rx and Earns $3 Million Milestone Payment From GSK,,,,,,,,,, 2/09/2011 04004760   PRN  Arena Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference, 4/27/2015 00GDWJ-E  PRN  Mylan Schedules First Quarter 2015 Financial Results Conference Call and Live Webcast,,,10/31/2016 0GD2R1-E PRN  Amgen Highlights Repatha® (Evolocumab) GLAGOV Imaging Study Amongst Data To Be Presented At AHA Scientific Sessions 2016,,,,,,,,,,,,,,,,,,,,,,12/05/2013 80105N10  PRN  New Data Support Flexibility in Timing of Administration for Sanofi's Lyxumia®,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/05/2012 G3040110 PRN  Endo Health Solutions to Present at UBS 2012 Global Life Sciences Conference,,,,"10/07/2014 75886F10    PRN  Positive Study Results, Dividend, Regulatory Warning, Board Statements, and Technical Updates - Research Reports on Regeneron, CVS Health, Valeant, Allergan and Jazz",,,11/25/2013 46222210 PRN  Isis Pharmaceuticals to Present at the 2013 Deutsche Bank BioFEST,,,,,,,,,, 1/27/2011 04004760   PRN  Arena Pharmaceuticals Announces Workforce Reduction and Provides Lorcaserin Regulatory Update, 4/27/2015 00GDWJ-E  PRN  Mylan Board Unanimously Rejects Unsolicited Expression of Interest from Teva,,,10/27/2016 03116210 PRN  Amgen Reports Third Quarter 2016 Financial Results,,,,,,,,,,,,,,,,,,,,,,"12/03/2013 80105N10  PRN  Market Study: VIVUS, DENTSPLY Intl., Sanofi, and Healthways Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/23/2012 G3040110 PRN  Statement on FDA Decision Regarding Endo Citizen Petition and Approval of a Generic Formulation of LIDODERM®,,,,10/06/2014 75886F10    PRN  EYLEA® (aflibercept) Injection Receives FDA Approval for Macular Edema Following Retinal Vein Occlusion (RVO),,,11/22/2013 46222210 PRN  Isis Pharmaceuticals to Investigate a Higher Dose of ISIS-SMN Rx in Children with Spinal Muscular Atrophy,,,,,,,,,, 1/06/2011 04004760   PRN  Arena Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference," 4/27/2015 N5946510  PRN  Be on Top of the Latest Happenings: Complementary Research on Wells Fargo, Mylan, Great Basin, Pfizer, and AbbVie",,,"10/25/2016 0FSTN1-E PRN  Direct To Consumer Campaigns For Pfizer's Xeljanz, Abbvie's Humira, And Amgen's Enbrel The Most Influential With RA Patients",,,,,,,,,,,,,,,,,,,,,,12/03/2013 80105N10  PRN  Sanofi Announces New Phase 3 Results for Investigational New Insulin U300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/21/2012 G3040110 PRN  Endo Health Solutions to Present at Stifel Nicolaus 2012 Healthcare Conference,,,, 9/30/2014 REGN-US     PRN  Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps,,,"11/20/2013 46222210 PRN  Drug Designation, Patents, Milestone Payment, Quarterly Result, and Medical Study - Research Report on The Medicines Company, VIVUS, Isis, HeartWare, and Masimo",,,,,,,,,,12/22/2010 002XMH-E   PRN  Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application, 4/24/2015 N5946510  PRN  Perrigo Rejects Mylan Unsolicited Offer,,,10/25/2016 03116210 PRN  Amgen To Invest In Israel-Based eHealth Ventures,,,,,,,,,,,,,,,,,,,,,,"11/27/2013 80105N10  PRN  FDA Approvals, New Appointments, and Official Statements - Research Report on Pfizer, Aetna, Lilly, GSK, and Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/21/2012 G3040110 PRN  American Medical Systems' New MoXy® Fiber Delivers Over 50 Percent More Energy,,,," 9/25/2014 75886F10    PRN  Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics",,,11/18/2013 46222210 PRN  Isis Pharmaceuticals Reports Fifth Positive Phase 2 Data Set for ISIS-APOCIII Rx Showing Significant Reductions in Triglyceride and ApoC-III Levels,,,,,,,,,,12/21/2010 04004760   PRN  Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA, 4/24/2015 N5946510  PRN  Mylan To Commence Formal Offer To Acquire Perrigo For US$60 In Cash And 2.2 Mylan Shares Per Perrigo Share,,,10/24/2016 03116210 PRN  Amgen Announces Webcast Of 2016 Third Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,11/22/2013 80105N10  PRN  Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/07/2012 G3040110 PRN  Endo Reports Second Quarter Financial Results and Updates 2012 Financial Guidance,,,, 9/22/2014 75886F10    PRN  Regeneron Announces EYLEA® (aflibercept) Injection Approved for the Treatment of Patients with Myopic Choroidal Neovascularization (CNV) in Japan,,,11/16/2013 46222210 PRN  Isis Pharmaceuticals Reports Positive Phase 1 Data Demonstrating ISIS-APO(a) Rx Produces Significant Reductions in Lp(a) Levels,,,,,,,,,,12/10/2010 04004760   PRN  Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension," 4/23/2015 N5946510  PRN  Mylan Launches Generic Sofosbuvir Tablets, MyHep™, in India",,,10/20/2016 03116210 PRN  Amgen Announces Positive Top-Line Results From XGEVA® (Denosumab) Phase 3 Trial For Delay Of Bone Complications In Multiple Myeloma Patients,,,,,,,,,,,,,,,,,,,,,,"11/19/2013 80105N10  PRN  Clinical Trial Results, New Products, Employee Grants, Pricing of Offering - Research Report on GSK, Intuitive, IDEXX, Sanofi, and Foundation Medicine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/07/2012 G3040110 PRN  Endo Health Solutions Announces Authorization of $450 Million Share Repurchase Program,,,, 9/18/2014 000VC1-E    PRN  Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD,,,11/15/2013 46222210 PRN  Isis Earns $5 Million in Milestone Payment from GSK for Advancement of ISIS-GSK4 Rx,,,,,,,,,,11/24/2010 04004760   PRN  Arena Pharmaceuticals to Present at the Piper Jaffray 22nd Annual Health Care Conference," 4/22/2015 N5946510  PRN  Critical Alerts For Celgene, Rambus, Mylan, Amgen and Zoetis Released By InvestorsObserver",,,10/17/2016 WST-US   PRN  West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices,,,,,,,,,,,,,,,,,,,,,,"11/11/2013 80105N10  PRN  New Products, Partnerships, Product Compatibility, and Financial Results - Research Report on LabCorp, Covance, Sanofi, Align Technology, and Rockwell Medical",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/06/2012 G3040110 PRN  Qualitest Launches Generic Singulair®,,,," 9/17/2014 75886F10    PRN  New Manufacturing Facility, Special Meeting Updates, Recognition, Technical Updates, and Clinical Data - Research Reports on Valeant, Allergan, Isis, Regeneron and Teva",,,"11/12/2013 46222210 PRN  Upcoming Conferences, Financial Results, Dividends, and Public Offerings - Research Report on Medicines Company, Isis, Ligand, Teleflex, and Tetraphase",,,,,,,,,,11/09/2010 04004760   PRN  Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments, 4/22/2015 N5946510  PRN  Key Trends in the Pharmaceutical and Nutritional Supplement Industries Outperforming Other Industries as Increase in Pharma Grade Products & Supplements Grow Globally,,,10/14/2016 03116210 PRN  Amgen Announces 2016 Fourth Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,"11/06/2013 80105N10  PRN  Morning Research: VIVUS Inc., Sanofi, DENTSPLY Intl. Inc., and Acura Pharma Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/30/2012 G3040110 PRN  Endo to Announce Second Quarter 2012 Financial Results on August 7, 2012",,,, 9/16/2014 75886F10    PRN  EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema,,,11/12/2013 46222210 PRN  Isis Pharmaceuticals Earns $1.5M from the Advancement of the Phase 2 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy,,,,,,,,,,11/09/2010 04004760   PRN  Lorcaserin Phase 3 Clinical Trial in Patients with Type 2 Diabetes Shows Statistically Significant Weight Loss," 4/22/2015 N5946510  PRN  Healthcare's Health Scanner: Complementary Research on Pfizer, Mylan, Teva Pharmaceutical, Bristol-Myers Squibb, and Merck & Company",,,10/14/2016 03116210 PRN  Amgen Announces Appointment Of Ellen J. Kullman To Board Of Directors,,,,,,,,,,,,,,,,,,,,,,"11/01/2013 80105N10  PRN  Marketing Approval, Quarterly Reports, and Donation - Research Report on Allergan, Forest, Cubist, Sanofi, and The Medicines Company",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/25/2012 G3040110 PRN  Qualitest Receives FDA Approval for Levetiracetam Extended-Release Tablets, 500mg and 750mg",,,," 9/09/2014 75886F10    PRN  Biotech Stocks Under Review -- Keryx Biopharma, Sangamo BioSciences, Regeneron Pharma, Sunesis Pharma, and Idera Pharma",,,11/05/2013 46222210 PRN  Isis Reports Financial Results and Highlights for Third Quarter 2013,,,,,,,,,,11/04/2010 04004760   PRN  Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes, 4/21/2015 N5946510  PRN  Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan,,,10/10/2016 078V1F-E PRN  New Retrospective Analyses Confirm Vectibix® (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin,,,,,,,,,,,,,,,,,,,,,,10/30/2013 80105N10  PRN  Sanofi Q3 2013 Marks the End of the Patent Cliff Period,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 7/18/2012 G3040110 PRN  Endo Health Solutions Names New President of American Medical Systems,,,," 9/08/2014 75886F10    PRN  Critical Alerts For Rocket Fuel, General Motors, International Business Machines, Google and Regeneron Pharmaceuticals Released By InvestorsObserver",,,"11/04/2013 46222210 PRN  Presentation, Quarterly Reports, and FDA Approval - Research Report on Merck, United Therapeutics, Endo, Isis Pharmaceuticals, and Zogenix",,,,,,,,,,"11/04/2010 04004760   PRN  Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 9", 4/17/2015 N5946510  PRN  Mylan Comments on Recent Media Speculation,,,10/05/2016 078V1F-E PRN  New Amgen Data In Melanoma And Metastatic Colorectal Cancer To Be Presented At The European Society For Medical Oncology 2016 Congress,,,,,,,,,,,,,,,,,,,,,,"10/23/2013 80105N10  PRN  Financial Results, Positive Clinical Trial Data, Medicare Plan Ratings, and Arbitration Awards - Research Report on UnitedHealth Group, Humana, Align, Sanofi, and Anacor",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/14/2012 G3040110 PRN  Endo Completes Transition of OPANA® ER Franchise to New Formulation Designed to be Crush Resistant,,,," 9/08/2014 75886F10    PRN  MAA Filing, Acceptance of ANDA Filing, Earnings Release, Study Results and Recognition - Research Reports on Regeneron, Mylan, Toll Brothers, 3M and Eaton",,,"11/01/2013 46222210 PRN  Technical Study: Quest Diagnostics Inc., Santarus Inc., Isis Pharma Inc., and Community Health Systems Inc.",,,,,,,,,,10/23/2010 04004760   PRN  FDA Issues Complete Response Letter for Lorcaserin New Drug Application, 4/17/2015 00GDWJ-E  PRN  Federal Circuit Upholds Mylan's U.S. Patents on Perforomist® Inhalation Solution; Decision Prevents Approval of Teva ANDA,,,10/04/2016 03116210 PRN  Amgen To Participate In Citi Biotech R&D Conference Call,,,,,,,,,,,,,,,,,,,,,,"10/22/2013 80105N10  PRN  Critical Alerts For Linn Energy, Texas Instruments, Clovis, Sanofi-Aventis, and Cliffs Natural Resources Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 6/08/2012 G3040110 PRN  Critical Alerts For Verizon, Southwestern Energy, Endo Pharmaceuticals, Humana, and Goodyear Released By InvestorsObserver",,,, 9/04/2014 75886F10    PRN  Regeneron Announces Submission of Application for EYLEA® (aflibercept) Injection in Japan for Macular Edema Following Branch Retinal Vein Occlusion,,,"10/30/2013 46222210 PRN  Critical Alerts For GlaxoSmithKline, Deutsche Bank, Cummins, Canadian Solar, and Isis Pharmaceuticals Released By InvestorsObserver",,,,,,,,,,10/20/2010 04004760   PRN  Arena Pharmaceuticals Announces Phase 1 Results for APD916 for Narcolepsy with Cataplexy, 4/13/2015 00GDWJ-E  PRN  Mylan Settles Patent Litigation Related to Viagra®,,,10/03/2016 03116210 PRN  Study Results Published In Journal of Clinical Oncology Show BLINCYTO® (blinatumomab) Induced Complete Remission In Heavily Pretreated Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-cell Precursor Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,,,10/22/2013 002118-E  PRN  Global Healthcare Leader Deploys QUOSA's Literature Management Tools,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/07/2012 G3040110 PRN  American Medical Systems and Allergan Sign Agreement for JetTouch™/BOTOX® Co-Development Program,,,, 8/31/2014 REGN-US     PRN  Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014,,,10/29/2013 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Third Quarter 2013 Financial Results Conference Call,,,,,,,,,,10/06/2010 04004760   PRN  Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010, 4/13/2015 N5946510  PRN  Mylan Notifies Perrigo of HSR Filing Regarding Proposed Acquisition,,, 9/29/2016 03116210 PRN  Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations,,,,,,,,,,,,,,,,,,,,,,"10/16/2013 80105N10  PRN  Pre-Market Review: VIVUS Inc., Sanofi, DENTSPLY Intl. Inc., and Acura Pharmaceuticals Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/29/2012 G3040110 PRN  Endo Announces Resolution of Patent Litigation with Watson Pharmaceuticals Related to Lidoderm®,,,, 8/31/2014 75886F10    PRN  Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014,,,"10/23/2013 46222210 PRN  Publications, Clinical Trial Results, Pending Approvals, and Milestone Payments - Research Report on Merck, Johnson & Johnson, Allergan, Amarin, and Isis",,,,,,,,,, 9/16/2010 04004760   PRN  Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting, 4/08/2015 N5946510  PRN  Announcement Regarding Possible Offer,,, 9/28/2016 03116210 PRN  Amgen Announces Erenumab Significantly Reduces Monthly Migraine Days In Patients With Episodic Migraine In First Phase 3 Study,,,,,,,,,,,,,,,,,,,,,,10/16/2013 80105N10  PRN  Sanofi and Regeneron Report Positive Top-line Results with Alirocumab from First Phase 3 Study of a PCSK9 Inhibitor for LDL Cholesterol Reduction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/25/2012 G3040110 PRN  Endo Health Solutions Inc. to Present at Jefferies 2012 Global Healthcare Conference,,,," 8/29/2014 75886F10    PRN  Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth",,,10/16/2013 IONS-US  PRN  Isis Earns $10 Million Milestone Payment from Biogen Idec for Advancement of ISIS-DMPK Rx to Treat Myotonic Dystrophy,,,,,,,,,, 9/13/2010 04004760   PRN  Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting, 4/08/2015 N5946510  PRN  Mylan Proposes To Acquire Perrigo For $205 Per Share,,, 9/27/2016 03116210 PRN  Amgen Announces Top-Line Results From Phase 3 KYPROLIS® (Carfilzomib) CLARION Study In Newly Diagnosed Multiple Myeloma Patients,,,,,,,,,,,,,,,,,,,,,,10/11/2013 80105N10  PRN  FDA Approves Sanofi's Nasacort® Allergy 24HR for Over-the-Counter Use,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/25/2012 G3040110 PRN  Endo Health Solutions Inc. to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference,,,, 8/25/2014 75886F10    PRN  Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014,,,"10/11/2013 46222210 PRN  Technical Study: Isis Pharma Inc., Santarus Inc., Community Health Systems Inc., and Quest Diagnostics Inc.",,,,,,,,,, 8/06/2010 04004760   PRN  FDA Confirms September 16th Advisory Committee Meeting to Review Lorcaserin for Obesity and Weight Management, 4/07/2015 00GDWJ-E  PRN  Mylan Launches First Generic Version of Generess Fe®,,, 9/26/2016 03116210 PRN  Amgen Opens Nomination Process For LabCentral Residency,,,,,,,,,,,,,,,,,,,,,,"10/04/2013 80105N10  PRN  Business Strategy, Partnerships, Presentation, and Appointment - Research Report on Merck, GSK, Sanofi, Intercept, and KYTHERA",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/23/2012 G3040110 PRN  Endo Health Solutions Inc. Announced as New Name for Endo Pharmaceuticals Holdings Inc.,,,," 8/21/2014 75886F10    PRN  Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz",,,"10/09/2013 46222210 PRN  Drug Approvals, Data Presentations, Clinical Trials, New Appointments, and Corporate Events - Research Report on Johnson & Johnson, Novo Nordisk, Isis, Keryx, and The Medicines Company",,,,,,,,,, 8/06/2010 04004760   PRN  Arena Pharmaceuticals to Receive $60 Million from Deerfield Management, 3/31/2015 00GDWJ-E  PRN  Mylan N.V. Announces Pricing of Secondary Public Offering of a Portion of Abbott's Ordinary Shares,,, 9/26/2016 03116210 PRN  Amgen And UCB Announce U.S. FDA Acceptance Of Biologics License Application For Romosozumab,,,,,,,,,,,,,,,,,,,,,,"10/01/2013 80105N10  PRN  Pharmaceutical Companies Announce Trial Results, and Achieve New Contracts, Regulatory Approvals, and Positive Opinion - Research Report on Eli Lilly, Pfizer, Novartis, Sanofi, and AstraZeneca",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/04/2012 G3040110 PRN  Endo to Present at Bank of America Merrill Lynch 2012 Health Care Conference,,,, 8/19/2014 75886F10    PRN  Regeneron Announces Upcoming 2014 Investor Conference Presentations,,,10/07/2013 GSK-GB   PRN  Isis Earns $7 Million in Milestone Payments from GSK for Advancement of ISIS-GSK3 Rx to Treat Viral Infection,,,,,,,,,, 8/03/2010 04004760   PRN  Arena Pharmaceuticals Announces Second Quarter 2010 Financial Results and Recent Developments, 3/31/2015 N5946510  PRN  Mylan Launches Generic Exforge® Tablets,,, 9/23/2016 03116210 PRN  FDA Approves Amgen's AMJEVITA™ (Adalimumab-Atto) For Treatment Of Seven Inflammatory Diseases,,,,,,,,,,,,,,,,,,,,,," 9/25/2013 80105N10  PRN  Drug Recommendations, Presentations, Marketing Authorizations, and Board Appointments - Research Report on Johnson & Johnson, Lilly, Sanofi, GSK, and Pacira",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/01/2012 G3040110 PRN  Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel,,,," 8/12/2014 75886F10    PRN  Financial Results, Study Results, and Proposed Merger - Research Reports on Mallinckrodt, Thoratec, WellPoint, Questcor and Regeneron",,, 9/25/2013 46222210 PRN  Isis Pharmaceuticals to Present at the Leerink Swann Rare Disease Roundtable,,,,,,,,,, 8/03/2010 04004760   PRN  Arena Pharmaceuticals to Present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference," 3/31/2015 N5946510  PRN  Critical Alerts For Invensense, SolarCity, Gilead Sciences, Mylan and Foot Locker Released By InvestorsObserver",,, 9/20/2016 03116210 PRN  Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab),,,,,,,,,,,,,,,,,,,,,," 9/24/2013 80105N10  PRN  March of Dimes and Sanofi Pasteur Launch Sounds of Pertussis® ""Grandparents' Corner"" to Help Grandparents Better Protect Their Families from Whooping Cough",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/17/2012 G3040110 PRN  Endo Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 1, 2012",,,, 8/11/2014 75886F10    PRN  EYLEA® (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME),,, 9/22/2013 46222210 PRN  Isis Pharmaceuticals to Conduct Webcast and Conference Call to Discuss ISIS-APOCIII Rx Phase 2 Data,,,,,,,,,," 7/27/2010 04004760   PRN  Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 3", 3/30/2015 N5946510  PRN  Mylan N.V. Announces Commencement of Secondary Public Offering of a Portion of Abbott's Ordinary Shares,,, 9/18/2016 03116210 PRN  Results From Phase 3 FRAME Study Of Romosozumab Showed Significant Reductions In Both New Vertebral And Clinical Fractures In Postmenopausal Women With Osteoporosis,,,,,,,,,,,,,,,,,,,,,, 9/24/2013 80105N10  PRN  Data Show Sanofi's Lyxumia® Added to Basal Insulin Lowered Blood Sugar Especially when Fasting Plasma Glucose was Controlled,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/12/2012 G3040110 PRN  Qualitest Pharmaceuticals Receives FDA Approval for Levetiracetam Oral Solution, 100 mg/mL",,,, 8/05/2014 75886F10    PRN  Regeneron Reports Second Quarter 2014 Financial and Operating Results,,, 9/21/2013 46222210 PRN  Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Substantial Reductions of Triglycerides and Apoc-III in Patients with Familial Chylomicronemia,,,,,,,,,, 7/14/2010 04004760   PRN  New England Journal of Medicine Publishes Results of Two-Year BLOOM Trial Showing Lorcaserin Caused Significant Weight Loss and Improved Maintenance of Weight Loss," 3/26/2015 N5946510  PRN  Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn",,," 9/16/2016 03116210 PRN  InvestorsObserver releases covered-call reports for Alder Biopharmaceuticals, bluebird bio Inc., Expedia, Amgen and Computer Sciences Corporation",,,,,,,,,,,,,,,,,,,,,," 9/20/2013 80105N10  PRN  Conference Call, Presentation of Drug Trial Results, Breakthrough Therapy Designation, Positive Results, and Drug Revival - Research Report on Johnson & Johnson, Lilly, GSK, Kythera, and Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/29/2012 G3040110 PRN  Endo Announces Departure of American Medical Systems President,,,," 8/04/2014 75886F10    PRN  Robbins Arroyo LLP Is Investigating the Officers and Directors of Regeneron Pharmaceuticals, Inc. on Behalf of Shareholders",,, 9/19/2013 46222210 PRN  Isis Reports Follow-Up Data From ISIS-SMN Rx Phase 1 Study In Children With Spinal Muscular Atrophy,,,,,,,,,, 7/01/2010 04004760   PRN  Eisai to Market Arena Pharmaceuticals' Lorcaserin for Obesity and Weight Management in U.S. Following FDA Approval, 3/12/2015 N5946510  PRN  Mylan N.V. and Mylan Inc. Announce Successful Completion of Consent Solicitations for Mylan Inc.'s Notes,,, 9/16/2016 080RQG-E PRN  Amgen Receives Positive CHMP Opinion For Parsabiv™ (Etelcalcetide) For The Treatment Of Secondary Hyperparathyroidism In Adult Patients With Chronic Kidney Disease On Hemodialysis,,,,,,,,,,,,,,,,,,,,,," 9/19/2013 80105N10  PRN  Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/22/2012 G3040110 PRN  Endo Acquires Johnson Matthey's Oxymorphone Patent,,,," 8/04/2014 75886F10    PRN  Use of Priority Review Voucher and Financial Result Releases of Healthcare Companies - Research Reports on Regeneron, WellPoint, Edwards, Humana and Celgene",,," 9/12/2013 46222210 PRN  Pre-Market Review: Isis Pharmaceuticals Inc., Community Health Systems Inc., Quest Diagnostics Inc., and Santarus Inc.",,,,,,,,,, 6/26/2010 04004760   PRN  Arena Pharmaceuticals' Lorcaserin Reduces Body Weight and Improves Cardiovascular Risk Factors Across Patient Subgroups," 3/12/2015 N5946510  PRN  Critical Alerts For Bank of America, Gilead Sciences, Kandi Technologies, Intel and Mylan Released By InvestorsObserver",,, 9/15/2016 03116210 PRN  Amgen Presents Positive Data At EHMTIC 2016 Demonstrating Erenumab Significantly Reduces Monthly Migraine Days In Patients With Chronic Migraine,,,,,,,,,,,,,,,,,,,,,," 9/17/2013 80105N10  PRN  Technical Study: VIVUS Inc., Sanofi, DENTSPLY Intl. Inc., and Acura Pharmaceuticals Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/19/2012 G3040110 PRN  BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report,,,, 7/30/2014 75886F10    PRN  Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission,,, 9/09/2013 00167Y-E PRN  Biogen Idec and Isis Pharmaceuticals Announce Strategic Collaboration to Advance Treatment of Neurological Disorders,,,,,,,,,, 6/17/2010 04004760   PRN  Arena Pharmaceuticals' Lorcaserin to Be Featured in Presentations at the American Diabetes Association's 70th Scientific Sessions, 3/11/2015 N5946510  PRN  Mylan Launches Generic Subutex® Sublingual Tablets,,, 9/14/2016 03116210 PRN  Amgen To Webcast Investor Call,,,,,,,,,,,,,,,,,,,,,," 9/17/2013 80105N10  PRN  NDA Updates, Signed Agreements, Awarded Patents, and Clinical Study Results - Research Report on Merck, Bristol-Myers Squibb, Amarin, GlaxoSmithKline, and Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/13/2012 G3040110 PRN  Endo Files Amended Citizen Petition Seeking Public FDA Resolution of Several Safety and Efficacy Issues Prior to Approval of a Generic Formulation of LIDODERM®,,,, 7/30/2014 75886F10    PRN  Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia,,, 9/05/2013 0017CR-E PRN  Isis Pharmaceuticals to Present at the 2013 Stifel Healthcare Conference,,,,,,,,,, 6/04/2010 04004760   PRN  Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences, 3/11/2015 N5946510  PRN  Mylan Launches Generic Antabuse® Tablets,,, 9/13/2016 BAC-US   PRN  Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,," 9/10/2013 80105N10  PRN  FDA and EMA Submissions, Partnerships, Milestones, Participation Withdrawals, and Prequalifications - Research Report on Johnson & Johnson, Novartis, AstraZeneca, Astex Pharmaceuticals, and Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/07/2012 G3040110 PRN  Mersana Therapeutics Enters Collaboration with Endo Pharmaceuticals to Develop Next-generation Antibody-drug Conjugates,,,, 7/30/2014 75886F10    PRN  Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia,,, 9/04/2013 0017CR-E PRN  Isis Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference,,,,,,,,,, 6/03/2010 04004760   PRN  Arena Pharmaceuticals to Receive $35.5 Million from Deerfield Management," 3/11/2015 N5946510  PRN  Mylan Launches First and Only Available Intermediate Dosage Strengths of Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr",,, 9/09/2016 06CR5C-E PRN  Apobiologix Announces Victory Over Amgen in Biosimilar Patent Case,,,,,,,,,,,,,,,,,,,,,, 9/09/2013 UNISQ-US  PRN  Unilife Signs Long-Term Supply Contract with Sanofi for the Use of Unifill® Syringes with Lovenox®,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/01/2012 G3040110 PRN  Endo Pharmaceuticals Announces Proposal to Change Name of Parent Company and Rebrands Enterprise: Revealing an Innovative Corporate Structure Dedicated to Redefining Healthcare Value,,,, 7/29/2014 75886F10    PRN  EYLEA® (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Macular Edema (DME),,, 8/31/2013 0017CR-E PRN  Isis Reports Interim Phase 2 Data on ISIS-APOCIII Rx as a Single Agent in Patients With Very High to Severely High Triglycerides,,,,,,,,,, 6/02/2010 04004760   PRN  Arena Pharmaceuticals Announces Notification of Tentative September 16th FDA Advisory Committee Meeting to Review Lorcaserin for Weight Management, 3/06/2015 N5946510  PRN  Mylan to Present at the Barclays Global Healthcare Conference,,, 9/08/2016 MS-US    PRN  Amgen To Present At The Morgan Stanley Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 9/04/2013 80105N10  PRN  Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/24/2012 G3040110 PRN  Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance,,,," 7/25/2014 75886F10    PRN  Critical Alerts For Organovo, Regeneron Pharmaceuticals, CBS, Wynn Resorts and Sanofi Released By InvestorsObserver",,, 8/07/2013 46222210 PRN  Isis Pharmaceuticals to Present at the Canaccord Genuity 33rd Annual Growth Conference,,,,,,,,,, 5/07/2010 04004760   PRN  Arena Pharmaceuticals Announces First Quarter 2010 Financial Results and Recent Developments, 3/03/2015 N5946510  PRN  Mylan N.V. and Mylan Inc. Announce Commencement of Consent Solicitations for Mylan Inc.'s Notes,,, 9/07/2016 03116210 PRN  Amgen to Highlight 19 Abstracts on Osteoporosis Disease State and Treatment at American Society for Bone and Mineral Research Annual Meeting,,,,,,,,,,,,,,,,,,,,,," 9/02/2013 80105N10  PRN  Acquisitions, Topline Results, New Board Members, Events, and Product Milestones - Research Report on Johnson & Johnson, Sanofi, Lilly, AbbVie, and Novartis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/22/2012 G3040110 PRN  Endo Pharmaceuticals to Present at Cowen & Co. 32nd Annual Health Care Conference,,,," 7/21/2014 75886F10    PRN  Biotech Stocks Scanner -- Regeneron Pharma, BioCryst Pharma, Spectrum Pharma, Exact Sciences, and Vical Inc.",,, 8/06/2013 46222210 PRN  Isis Reports Financial Results and Highlights for Second Quarter 2013,,,,,,,,,, 5/06/2010 04004760   PRN  Arena Pharmaceuticals to Present at the Ninth Annual JMP Securities Research Conference," 3/02/2015 N5946510  PRN  Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2014",,, 9/01/2016 03116210 PRN  FDA Approves BLINCYTO® (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-cell Precursor Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,,," 8/29/2013 80105N10  PRN  M&A Activities, Pending NDA Approvals, and Clinical Trial Results - Research Report on Sanofi, GSK, AstraZeneca, Keryx, and Rigel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/17/2012 G3040110 PRN  Endo Pharmaceuticals to Present at J.P. Morgan Annual Global High Yield & Leveraged Finance Conference,,,," 7/18/2014 75886F10    PRN  Regeneron to Report Second Quarter 2014 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2014",,, 8/05/2013 46222210 PRN  Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis,,,,,,,,,," 4/30/2010 04004760   PRN  Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, May 7, 2010", 3/02/2015 N5946510  PRN  Mylan Fourth Quarter 2014 Adjusted Diluted EPS Increases 35% to $1.05 and Full Year Adjusted Diluted EPS Up 23% to $3.56,,, 9/01/2016 03116210 PRN  Amgen Obtains Global Development And Commercial Rights From Boehringer Ingelheim For Investigational BiTE® Immuno-Oncology Drug For Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,, 8/26/2013 0072XH-E  PRN  Sanofi Pasteur's Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/16/2012 G3040110 PRN  BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals,,,, 7/18/2014 75886F10    PRN  Two-Year Results From Phase 3 VIVID-DME Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision,,, 7/30/2013 46222210 PRN  Isis Pharmaceuticals Earns $2 Million from GSK for the Advancement of ISIS-TTR Rx,,,,,,,,,, 4/28/2010 04004760   PRN  Arena Pharmaceuticals to Present at the Deutsche Bank 35th Annual Health Care Conference, 2/27/2015 N5946510  PRN  Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business,,, 9/01/2016 03116210 PRN  Amgen And Servier Extend Omecamtiv Mecarbil Collaboration In Chronic Heart Failure,,,,,,,,,,,,,,,,,,,,,, 8/20/2013 80105N10  PRN  Sanofi Survey Finds Travel Puts Those with Severe Allergies on High Alert,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/13/2012 G3040110 PRN  Endo Pharmaceuticals to Present at Citi 2012 Global Health Care Conference,,,," 7/11/2014 75886F10    PRN  Critical Alerts For Regeneron Pharmaceuticals, Orexigen Therapeutics, News Corp, BorgWarner, and Michael Kors Released By InvestorsObserver",,, 7/29/2013 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Second Quarter 2013 Financial Results Conference Call,,,,,,,,,,, 2/23/2015 N5946510  PRN  Mylan Specialty to Present Findings from EpiPen4Schools® Program Survey,,, 8/29/2016 03116210 PRN  Amgen Announces Positive Top-Line Results From Phase 3 Study Of Prolia® (Denosumab) In Patients Receiving Glucocorticoid Therapy,,,,,,,,,,,,,,,,,,,,,," 8/19/2013 80105N10  PRN  Drug Approvals, Clinical Trials, Awards, Offerings, and Earnings - Research Report on J&J, Sanofi, Novartis, BioScrip, and Pacira",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 2/03/2012 G3040110 PRN  Endo Pharmaceuticals to Announce Fourth Quarter and Full Year 2011 Financial Results on February 24, 2012",,,, 7/09/2014 75886F10    PRN  Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis,,, 7/22/2013 46222210 PRN  Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions of ApoC-III and Triglycerides in Patients With High Triglycerides Taking Fibrates,,,,,,,,,,," 2/23/2015 N5946510  PRN  Pharma Stocks under Review - Zoetis, Actavis, Mylan, Akorn, and VIVUS",,, 8/29/2016 03116210 PRN  New Repatha® (evolocumab) Analyses Show Efficacy And Safety Across Risk Groups In Results Presented At ESC Congress 2016,,,,,,,,,,,,,,,,,,,,,, 8/05/2013 0072XH-E  PRN  Sanofi Pasteur Initiates Phase III Study of Investigational Clostridium difficile Vaccine in the United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/09/2012 G3040110 PRN  Endo Announces Potential Short-Term Supply Constraints of Certain Analgesic Medications as a Result of Temporary Shut Down of Novartis Facility,,,," 7/02/2014 75886F10    PRN  Clinical Trial Update, Recommendations for Approval, Share Repurchase Programs, and Closing of Public Offering - Analyst Notes on Medtronic, Regeneron, Lilly, United Therapeutics and Receptos",,, 7/02/2013 46222210 PRN  Isis Pharmaceuticals to Present at the 8th Annual JMP Securities Healthcare Conference,,,,,,,,,,, 2/23/2015 N5946510  PRN  Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi® and Harvoni® in India,,, 8/24/2016 03116210 PRN  Amgen Provides Update On Status Of Parsabiv™ (Etelcalcetide) New Drug Application (NDA) Submitted To The U.S. Food And Drug Administration (FDA),,,,,,,,,,,,,,,,,,,,,, 8/01/2013 SNY-FR    PRN  Sanofi Q2 2013: Last Quarter with Significant Negative Impact from the Patent Cliff,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/06/2012 G3040110 PRN  Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine,,,, 6/27/2014 75886F10    PRN  EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union,,," 6/27/2013 46222210 PRN  Positive Clinical Study Results, New Product Launches, and Leadership Changes - Research Report on Allergan, Isis, Covidien, BD, and DaVita HealthCare Partners",,,,,,,,,,, 2/09/2015 N5946510  PRN  Mylan Schedules Fourth Quarter and Year End 2014 Financial Results Conference Call and Live Webcast,,, 8/22/2016 03116210 PRN  New Data Add To Understanding Of Repatha® (Evolocumab) In Multiple Patient Populations,,,,,,,,,,,,,,,,,,,,,, 7/31/2013 80105N10  PRN  FDA Advisory Committee Recommends Approval of Sanofi's Nasacort® AQ Nasal Spray for Over-the-Counter Use,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/27/2011 G3040110 PRN  Endo Pharmaceuticals to Present at J.P. Morgan 30th Annual Healthcare Conference,,,," 6/25/2014 75886F10    PRN  Collaborations, Clinical Study Results, and Laboratory Inspection Clearance - Analyst Notes on Amgen, Regeneron, Lexicon, WuXi PharmaTech and ImmunoGen",,, 6/25/2013 46222210 PRN  Breaux Castleman Joins Isis Pharmaceuticals' Board of Directors,,,,,,,,,,, 2/09/2015 N5946510  PRN  Mylan Confirms First-to-File Patent Challenge Relating to NEXAVAR®,,," 8/08/2016 03116210 PRN  Learn how to target a 20% return on Bank of America, or get option-trade ideas on Avago Technologies, Twitter, Amgen and Qualcomm or any stock you choose",,,,,,,,,,,,,,,,,,,,,, 7/25/2013 0072XH-E  PRN  Sanofi Pasteur Announces Shipment of First Lots of 2013-2014 Seasonal Influenza Vaccine in U.S.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/12/2011 G3040110 PRN  Endo Announces FDA Approval of a New Formulation of Opana® ER Designed To Be Crush-Resistant,,,," 6/16/2014 REGN-US     PRN  Clinical Trial Results, Milestone Payments, New Board Members, and Executive Appointments - Analyst Notes on Cubist, Clovis, Ligand, Bio-Techne and Repligen",,, 6/23/2013 46222210 PRN  Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions in Triglycerides and APOC-III in Patients with High Triglycerides and Type 2 Diabetes,,,,,,,,,,," 2/03/2015 N5946510  PRN  Hogging the Limelight: New Research on Exxon Mobil, You On Demand, Mylan, Verizon, and Intel",,, 8/05/2016 03116210 PRN  BetterInvesting Magazine Releases October Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use,,,,,,,,,,,,,,,,,,,,,, 7/15/2013 07BBFC-E  PRN  Pennsylvania Gov. Corbett Announces $5 Million Job Creation Effort in Monroe County,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/28/2011 G3040110 PRN  Qualitest Pharmaceuticals Receives FDA Approval for Myzilra™ Tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, 0.125 mg/0.03 mg (28 - Day TriPhasic Regimen)",,,," 6/12/2014 75886F10    PRN  Sanofi and Regeneron Announce New, Detailed Data from Positive Sarilumab Phase 3 Rheumatoid Arthritis Trial at EULAR",,," 6/18/2013 46222210 PRN  Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics",,,,,,,,,,, 2/02/2015 N5946510  PRN  Mylan to Acquire Famy Care Businesses to Create a Leading Women's Health Care Franchise,,, 8/02/2016 03116210 PRN  Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration,,,,,,,,,,,,,,,,,,,,,, 6/22/2013 80105N10  PRN  Sanofi US and Joslin Diabetes Center Announce Results from Multicultural Outreach Pilot at American Diabetes Association Scientific Sessions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/23/2011 G3040110 PRN  Endo Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Leveraged Finance Conference,,,, 6/11/2014 BAYN-DE     PRN  EYLEA® (aflibercept) Injection Submitted for EU Marketing Authorization for the Treatment of Patients with Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO),,, 6/18/2013 46222210 PRN  Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House,,,,,,,,,,, 1/29/2015 N5946510  PRN  Mylan Shareholders Overwhelmingly Approve Agreement Implementing Acquisition of Abbott's Non-U.S. Developed Markets Specialty and Branded Generics Business,,, 8/01/2016 000PQC-E PRN  Rheumatoid Arthritis (RA) Drugs Markets 2016-2026,,,,,,,,,,,,,,,,,,,,,, 6/22/2013 80105N10  PRN  Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/22/2011 G3040110 PRN  Endo Pharmaceuticals to Present at the Piper Jaffray Annual Healthcare Conference,,,," 6/10/2014 75886F10    PRN  Critical Alerts For Noodles & Company, Regeneron Pharmaceuticals, Akamai Technologies, Ciena, and Dollar General Technology Released By InvestorsObserver",,, 6/10/2013 46222210 PRN  Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies,,,,,,,,,,, 1/26/2015 N5946510  PRN  Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent,,, 7/27/2016 03116210 PRN  Amgen Reports Second Quarter 2016 Financial Results,,,,,,,,,,,,,,,,,,,,,, 6/22/2013 80105N10  PRN  Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/14/2011 G3040110 PRN  Qualitest Pharmaceuticals Receives FDA Approval for Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL",,,, 5/30/2014 75886F10    PRN  Regeneron Announces Update to Upcoming 2014 Investor Conference Presentations,,, 6/06/2013 46222210 PRN  Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca,,,,,,,,,,, 1/20/2015 N5946510  PRN  U.S. Supreme Court Partially Modifies Standard of Review of Patent Claim Construction and Remands Review of Teva's '808 Patent on Copaxone® to Federal Circuit Court of Appeals,,," 7/27/2016 03116210 PRN  Covered Call reports for Chipotle Mexican Grill, Starwood Hotels & Resorts Worldwide, JetBlue, Amgen and Whole Foods Market include trade ideas that offer returns of 20% or more!",,,,,,,,,,,,,,,,,,,,,," 6/17/2013 07BBFC-E  PRN  Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/09/2011 G3040110 PRN  Occupy Oakland Business Fraud Verdict: Oakland Jury Awards $9 Million Against Multi-National Corporation for Business Fraud and Breach of Contract,,,," 5/16/2014 75886F10    PRN  Regulatory Updates, Senior Level Appointments, Earnings Releases, Facilities Closures and New Plants - Analyst Notes on Teva, Medtronic, Regeneron, NextEra Energy and Duke Energy",,, 6/05/2013 46222210 PRN  Isis Pharmaceuticals to Present at the Goldman Sachs 34th Annual Global Healthcare Conference,,,,,,,,,,, 1/15/2015 N5946510  PRN  Mylan Launches Generic Epivir-HBV® Tablets,,, 7/22/2016 03116210 PRN  Amgen Announces Webcast Of 2016 Second Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,," 6/12/2013 80105N10  PRN  Providing Quality Healthcare Through Long-term Investments, Divestitures, New Research, Clinical Trials Results - Research Report on AmerisourceBergen, Zoetis, AstraZeneca, Cardinal Health and Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/03/2011 G3040110 PRN  Endo Pharmaceuticals to Present at the 2011 Credit Suisse Annual Health Care Conference,,,, 5/08/2014 75886F10    PRN  Regeneron Reports First Quarter 2014 Financial and Operating Results,,, 6/03/2013 46222210 PRN  Isis Pharmaceuticals Reports Encouraging Data on ISIS-STAT3rx in Patients With Cancer,,,,,,,,,,," 1/09/2015 N5946510  PRN  Stocks Coverage on the Pharma Industry -- Mylan, Salix Pharma, Zoetis, Theravance, and Cempra",,, 7/22/2016 03116210 PRN  Amgen Announces 2016 Third Quarter Dividend,,,,,,,,,,,,,,,,,,,,,, 6/11/2013 005M9Z-E  PRN  NextDocs and Sanofi Examine Technology Strategies to Optimize Clinical Trial Processes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/02/2011 G3040110 PRN  Endo Pharmaceuticals Receives FDA Approval for Felodipine Extended-Release Tablets USP, 2.5mg, 5mg and 10mg",,,, 5/05/2014 0D98KG-E    PRN  Regeneron and Avalanche Biotechnologies Announce Collaboration to Develop Next-Generation Gene Therapy Products in Ophthalmology,,, 6/03/2013 000Z35-E PRN  Isis Pharmaceuticals Earns $10 Million Milestone Payment from AstraZeneca for ISIS-AR Rx to Treat Prostate Cancer,,,,,,,,,,, 1/05/2015 N5946510  PRN  Mylan Launches Generic Diovan® Tablets,,, 7/22/2016 03116210 PRN  Amgen And UCB Submit Biologics License Application For Romosozumab To The FDA,,,,,,,,,,,,,,,,,,,,,, 6/10/2013 80105N10  PRN  New Four-Strain Influenza Vaccine from Sanofi Pasteur Now Licensed By FDA for Broad Age Range of Children and Adults,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"10/31/2011 G3040110 PRN  Endo Pharmaceuticals to Relocate From Chadds Ford, Pa., to New Facilities in Malvern",,,, 5/02/2014 75886F10    PRN  Regeneron Announces Upcoming 2014 Investor Conference Presentations,,, 5/31/2013 46222210 PRN  Isis Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares,,,,,,,,,,,12/31/2014 N5946510  PRN  South African National Department of Health Selects Mylan as a Leading Supplier for 2015/2018 Antiretroviral Tender,,, 7/21/2016 03116210 PRN  Amgen And Allergan Announce Top-Line Results From Phase 3 Study Evaluating ABP 980 Compared With Trastuzumab In Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer,,,,,,,,,,,,,,,,,,,,,, 6/05/2013 SNY-FR    PRN  Emmy® Award-Winning Actress Sarah Michelle Gellar Joins March of Dimes and Sanofi Pasteur on the Sounds of Pertussis® Campaign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10/27/2011 G3040110 PRN  Endo Pharmaceuticals Reports Strong Third-Quarter Financial Results and Reaffirms 2011 Financial Guidance,,,," 4/11/2014 75886F10    PRN  Regeneron to Report First Quarter 2014 Financial and Operating Results and Host Conference Call and Webcast on May 8, 2014",,, 5/23/2013 46222210 PRN  Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference,,,,,,,,,,,12/22/2014 N5946510  PRN  Mylan Launches First Generic Version of Vivelle-DOT®,,, 7/20/2016 03116210 PRN  Amgen Announces Settlement Of Securities Litigation,,,,,,,,,,,,,,,,,,,,,, 6/04/2013 SNY-FR    PRN  Sanofi US Announces Winner of 2013 Data Design Diabetes Innovation Challenge -- Prove It!,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"10/12/2011 G3040110 PRN  Endo Pharmaceuticals to Announce Third Quarter 2011 Financial Results on October 27, 2011",,,, 4/04/2014 75886F10    PRN  Robert A. Ingram Elected to Regeneron Board of Directors,,, 5/13/2013 46222210 PRN  Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference,,,,,,,,,,,12/17/2014 N5946510  PRN  Mylan to Present at the J.P. Morgan 33rd Annual Healthcare Conference,,, 7/13/2016 03116210 PRN  Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan,,,,,,,,,,,,,,,,,,,,,," 5/22/2013 HCA-US    PRN  Critical Alerts For Sanofi, Salesforce.com, AFLAC, HCA Holdings, and Silver Wheaton Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/20/2011 G3040110 PRN  New Website Provides Comprehensive Resource to Anyone With Erectile Dysfunction,,,, 4/03/2014 75886F10    PRN  Regeneron Announces Initiative for STEM Education in Hudson Valley,,, 5/09/2013 46222210 PRN  Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec,,,,,,,,,,,12/11/2014 N5946510  PRN  Mylan Launches Generic Robaxin® Injection,,," 7/13/2016 03116210 PRN  Under Armour, Whiting Petroleum, Seagate Technology, Amgen, and Cisco Systems and more offer option-trading opportunities that offer returns of more than 20%",,,,,,,,,,,,,,,,,,,,,, 5/21/2013 80105N10  PRN  Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/15/2011 G3040110 PRN  Qualitest Pharmaceuticals Issues a Nationwide Voluntary Recall of Oral Contraceptives,,,, 4/01/2014 75886F10    PRN  Sanofi and Regeneron Report Positive Results With Alirocumab From Phase 2 Japanese Study,,, 5/09/2013 46222210 PRN  Isis Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference,,,,,,,,,,,12/11/2014 N5946510  PRN  Mylan Launches First Generic Version of Orapred ODT®,,," 7/12/2016 06CR5C-E PRN  Amgen To Discuss Data Supporting Biologics License Application For ABP 501, A Biosimilar Candidate To Adalimumab",,,,,,,,,,,,,,,,,,,,,, 5/17/2013 80105N10  PRN  Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/13/2011 G3040110 PRN  Endo Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference,,,, 3/27/2014 75886F10    PRN  Sanofi and Regeneron To Present Alirocumab Clinical Data at the American College of Cardiology's 63rd Annual Scientific Session,,, 5/08/2013 46222210 PRN  Isis Pharmaceuticals Prices Public Offering Of Common Stock,,,,,,,,,,,12/10/2014 N5946510  PRN  Mylan Launches One of First Available Generic Versions of Celebrex® Capsules,,, 7/11/2016 03116210 PRN  FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor,,,,,,,,,,,,,,,,,,,,,, 5/16/2013 SNY-FR    PRN  Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/07/2011 G3040110 PRN  Endo Pharmaceuticals to Present at the UBS Global Life Sciences Conference,,,, 3/03/2014 05LPXM-E    PRN  Bayer HealthCare and Regeneron Announce Regulatory Submission of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Japan,,, 5/07/2013 46222210 PRN  Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock,,,,,,,,,,,12/08/2014 N5946510  PRN  World TeamTennis and Mylan Announce Title Sponsorship Extension Through 2017,,," 7/06/2016 03116210 PRN  Covered Call reports for Gilead Sciences, BP, Amgen, Dr. Pepper Snapple Group and LinkedIn include trade ideas that offer returns of 20% or more!",,,,,,,,,,,,,,,,,,,,,, 5/15/2013 80105N10  PRN  Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/25/2011 G3040110 PRN  Endo Pharmaceuticals to Present at the Stifel Nicolaus Annual Healthcare Conference,,,, 2/24/2014 75886F10    PRN  Regeneron Announces FDA Acceptance of EYLEA® (aflibercept) Injection Supplemental Biologics License Application for the Treatment of Macular Edema Following Branch Retinal Vein Occlusion,,, 5/07/2013 46222210 PRN  Isis Reports Financial Results and Highlights for First Quarter 2013,,,,,,,,,,,12/04/2014 N5946510  PRN  Mylan receives tentative FDA approval for pediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative,,, 7/04/2016 03116210 PRN  European Commission Approves Extended Indication For Amgen's Kyprolis® (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients,,,,,,,,,,,,,,,,,,,,,, 5/14/2013 0BDK6C-E  PRN  PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 8/22/2011 G3040110 PRN  Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President",,,, 2/14/2014 75886F10    PRN  Regeneron Announces Upcoming 2014 Investor Conference Presentations,,, 5/06/2013 46222210 PRN  Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer,,,,,,,,,,,12/01/2014 N5946510  PRN  Mylan and Canadian AIDS Society Team up in Cross-Country Relay to Accelerate Canada's Fight Against HIV/AIDS,,," 6/23/2016 03116210 PRN  Learn how to target an 20% return on Chipotle Mexican Grill, or get option-trade ideas on Amgen, Celgene, Google Inc., and SolarEdge Technologies or any stock you choose",,,,,,,,,,,,,,,,,,,,,, 5/06/2013 80105N10  PRN  New Gold Bond® No Mess Powder Spray Introduced by Sanofi's Chattem,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/17/2011 G3040110 PRN  Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol,,,, 2/11/2014 75886F10    PRN  Regeneron Reports Fourth Quarter and Full Year 2013 Financial and Operating Results,,, 5/02/2013 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' First Quarter 2013 Financial Results Conference Call,,,,,,,,,,,12/01/2014 N5946510  PRN  Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries,,, 6/22/2016 03116210 PRN  Amgen Sponsors QB3@953 Incubator For Life Science Startups,,,,,,,,,,,,,,,,,,,,,," 5/06/2013 SNY-FR    PRN  Sanofi US and Actress Elizabeth Perkins Premiere Documentary -- Diabetes Co-Stars Presents ""Strength in Numbers""",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 8/15/2011 G3040110 PRN  Tengion Appoints Diane Jorkasky, M.D., to its Board of Directors",,,, 2/10/2014 75886F10    PRN  Two-Year Results From Phase 3 VISTA Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision,,," 4/23/2013 ESV-GB   PRN  Critical Alerts For Citigroup, ENSCO International, Hasbro, Isis Pharmaceuticals, and Cree Released By InvestorsObserver",,,,,,,,,,,11/25/2014 N5946510  PRN  Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC®,,," 6/20/2016 03116210 PRN  Biotechnology Stocks Under Review - Eleven Biotherapeutics, Relypsa, Galena Biopharma, and Amgen",,,,,,,,,,,,,,,,,,,,,, 5/02/2013 80105N10  PRN  Sanofi: Q1 2013 business EPS(1) impacted by exclusivity losses in prior year,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 8/09/2011 G3040110 PRN  Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems",,,," 1/21/2014 75886F10    PRN  Regeneron to Report Fourth Quarter and Full Year 2013 Financial and Operating Results and Host Conference Call and Webcast on February 11, 2014",,, 4/23/2013 46222210 PRN  ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy,,,,,,,,,,,11/21/2014 N5946510  PRN  Earnings Highlights - Mylan,,," 6/17/2016 03116210 PRN  Amgen Appoints Esteban Santos Executive Vice President, Operations",,,,,,,,,,,,,,,,,,,,,, 4/30/2013 80105N10  PRN  NextBio Announces Translational Medicine Partnership with Sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/26/2011 G3040110 PRN  Endo Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 9, 2011",,,, 1/13/2014 75886F10    PRN  Regeneron and Bayer to Develop New Treatment Option for Wet Age-Related Macular Degeneration,,, 4/22/2013 46222210 PRN  Isis Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference,,,,,,,,,,,"11/20/2014 N5946510  PRN  Critical Alerts For DISH Network, Lowes, Nuance Communications, Mylan and Visa Released By InvestorsObserver",,, 6/16/2016 077R90-E PRN  New AKF Research Will Examine Challenges Kidney Patients Face In Adhering To Treatment Regimens,,,,,,,,,,,,,,,,,,,,,," 4/30/2013 0BDK6C-E  PRN  Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/30/2011 G3040110 PRN  Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain,,,, 1/13/2014 75886F10    PRN  Regeneron and Geisinger Health System Announce Major Human Genetics Research Collaboration,,," 4/11/2013 WCRX-IE  PRN  StockCall Scrutinizes Warner Chilcott, Dynavax Technologies, Isis Pharma, and United Therapeutics",,,,,,,,,,,11/07/2014 N5946510  PRN  Mylan Signs Strategic Alliance Agreement with Walt Disney Parks and Resorts to Enhance Access to EpiPen® (epinephrine) Auto-Injectors,,," 6/13/2016 06CR5C-E PRN  Amgen Announces FDA Advisory Committee Meeting To Review ABP 501, A Biosimilar Candidate To Adalimumab",,,,,,,,,,,,,,,,,,,,,, 4/23/2013 80105N10  PRN  U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios' Novel Biologic Candidate for Pseudomonas aeruginosa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 6/24/2011 G3040110 PRN  Endo Pharmaceuticals Issues Voluntary, Nationwide Recall of Two Lots of Endocet® (Oxycodone/Acetaminophen, USP) Tablets, 10 Mg /325 Mg",,,, 1/13/2014 75886F10    PRN  Regeneron Launches New Human Genetics Initiative,,, 4/08/2013 46222210 PRN  Roche and Isis Pharmaceuticals form alliance for Huntington's disease,,,,,,,,,,,"11/05/2014 N5946510  PRN  Quarterly Financial Results and Upcoming Conference - Research Reports on Mylan, Aegerion, Bard, Incyte and Boston Scientific",,, 6/10/2016 03116210 PRN  New Analyses From Pivotal Phase 3 Studies Show Kyprolis® (Carfilzomib) Allows Patients With Relapsed Multiple Myeloma To Live Longer Without Disease Progression,,,,,,,,,,,,,,,,,,,,,, 4/17/2013 008W47-E  PRN  Veracyte Announces That New Study Suggests The Number Of Patients At Risk For Unnecessary Thyroid Surgery Is Likely On The Rise,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/23/2011 G3040110 PRN  FDA Accepts Endo Pharmaceuticals' Complete Response for New Formulation of OPANA® ER,,,, 1/13/2014 75886F10    PRN  Regeneron Announces Amendment to Investor Agreement with Sanofi,,," 4/03/2013 06DDVL-E PRN  Zacks Bull and Bear of the Day Highlights: Apollo Global Management, Agnico-Eagle Mines, IsisPharmaceuticals, GlaxoSmithKline and Sanofi",,,,,,,,,,,11/05/2014 N5946510  PRN  Mylan Launches Generic Loestrin 24 Fe®,,, 6/10/2016 03116210 PRN  Amgen Announces Expiration And Final Results Of Senior Notes Exchange Offers,,,,,,,,,,,,,,,,,,,,,, 4/16/2013 0BDK6C-E  PRN  Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/20/2011 G3040110 PRN  Endo Pharmaceuticals Successfully Completes Acquisition of American Medical Systems for $2.9 Billion,,,," 1/09/2014 75886F10    PRN  Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals",,, 4/03/2013 46222210 PRN  Isis Initiates Phase 1 Study of ISIS-APOA Rx to Treat Atherosclerosis,,,,,,,,,,,10/30/2014 N5946510  PRN  Mylan Third Quarter 2014 Adjusted Diluted EPS Increases 41% to $1.16,,, 6/10/2016 03116210 PRN  BLINCYTO® (Blinatumomab) Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,,," 4/16/2013 SNY-FR    PRN  Critical Trade Alerts For JPMorgan Chase, Sanofi-Aventis, Emerson Electric, ASML, and CarMax Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/03/2011 G3040110 PRN  Endo Pharmaceuticals Holdings Inc. Announces Pricing of Private Offering of Senior Notes,,,,"12/31/2013 75886F10    PRN  Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind",,, 4/01/2013 46222210 PRN  Isis Publishes Data Demonstrating Antisense Targeting of ApoC-III Significantly Reduces ApoC-III and Triglycerides,,,,,,,,,,,10/30/2014 N5946510  PRN  Mylan Launches Generic Viramune XR®,,, 6/08/2016 03116210 PRN  Amgen Announces Erenumab (AMG 334) Significantly Reduces Patients' Monthly Migraine Days In Phase 2 Study For The Prevention Of Chronic Migraine,,,,,,,,,,,,,,,,,,,,,, 4/11/2013 80105N10  PRN  New Allegra® Anti-Itch Cream Introduced by Sanofi's Chattem,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/01/2011 G3040110 PRN  Endo Pharmaceuticals to Present at the Goldman Sachs Global Healthcare Conference,,,,"12/19/2013 75886F10    PRN  Regulatory Updates, Clinical Trial Results, and Stock Price Movements - Research Report on Johnson & Johnson, Cubist, Regeneron, Medtronic, and Jazz Pharmaceuticals",,, 3/22/2013 46222210 PRN  Isis Provides Update on CHMP Opinion on KYNAMRO™ (mipomersen),,,,,,,,,,,10/27/2014 N5946510  PRN  EpiPen4Schools® Program Enhances Support of National Movement to Improve Anaphylaxis Preparedness and Access to Emergency Treatment in Schools,,, 6/07/2016 03116210 PRN  New National Survey Sheds Light On How To Better Engage Students In Science Education,,,,,,,,,,,,,,,,,,,,,," 4/09/2013 06DDVL-E  PRN  Zacks Bull and Bear of the Day Highlights: AMERISAFE, Scholastic, GlaxoSmithKline, Novartis and Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/31/2011 G3040110 PRN  Endo Pharmaceuticals to Present at the Jefferies Global Healthcare Conference,,,,12/19/2013 75886F10    PRN  Sanofi and Regeneron Announce Collaboration with American College of Cardiology for PCSK9 Inhibitor Clinical Program,,, 3/20/2013 46222210 PRN  Data From ISIS-SMN Rx Phase 1 Study in Children With Spinal Muscular Atrophy Presented at the American Academy of Neurology Meeting,,,,,,,,,,,"10/21/2014 N5946510  PRN  Equities Updates on Pharma Industry - Mylan, Horizon Pharma, Hospira, VIVUS, and Endocyte",,, 6/06/2016 03116210 PRN  New Phase 3 Secondary Analysis Shows Progression-Free Survival Benefit In Early Relapsing Multiple Myeloma Patients Treated With Kyprolis® (Carfilzomib)-Based Regimen,,,,,,,,,,,,,,,,,,,,,," 4/03/2013 06DDVL-E  PRN  Zacks Bull and Bear of the Day Highlights: Apollo Global Management, Agnico-Eagle Mines, IsisPharmaceuticals, GlaxoSmithKline and Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/26/2011 G3040110 PRN  Endo Pharmaceuticals Holdings Inc. Announces Proposed Private Offering of Senior Notes,,,,12/18/2013 75886F10    PRN  Regeneron Announces FDA Acceptance of EYLEA® (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication,,, 3/15/2013 46222210 PRN  Isis Pharmaceuticals to Present at the 25th Annual ROTH Conference,,,,,,,,,,,"10/20/2014 N5946510  PRN  Earnings Releases, Conference Call Schedule, Acquisitions, Drug Launches, and Initiation of Study - Research Reports on KeyCorp, Itau Unibanco, BD, Mylan and GlaxoSmithKline",,," 6/03/2016 03116210 PRN  Amgen Announces Launch Of KYPROLIS® (carfilzomib) CENTRAL, An Online News Resource Demonstrating The Impact Of Relapsed Multiple Myeloma On The Lives Of Patients And Caregivers",,,,,,,,,,,,,,,,,,,,,, 3/28/2013 80105N10  PRN  Basketball Legend Lisa Leslie Teams Up with Allegra® to Help Families Enjoy Outdoor Workouts This Allergy Season,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 5/18/2011 G3040110 PRN  Qualitest Receives FDA Approval for Dexamethasone Elixir, USP, 0.5mg/ 5 mL and Orsythia™ Tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.1 mg/0.02 mg)",,,,12/17/2013 75886F10    PRN  Regeneron Announces Presentation at the 32nd Annual J. P. Morgan Healthcare Conference,,, 3/14/2013 46222210 PRN  Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting,,,,,,,,,,,"10/08/2014 N5946510  PRN  Revised Guidance, Development Milestones, Appointment, Program Extension, and Event Schedules - Research Reports on Mylan, Tekmira, GSK, Cigna and WellPoint",,, 6/03/2016 03116210 PRN  Amgen To Present At The Goldman Sachs 37th Annual Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 3/28/2013 06F04Q-E  PRN  Marken Hosts Industry Panel Event In Mexico City,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/09/2011 G3040110 PRN  Endo Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference,,,,"12/11/2013 75886F10    PRN  New Clinical Trials, Pricing of Common Stock and Adjusted Conversion of Convertible Senior Notes - Research Report on Regeneron, Celldex, PDL BioPharma, Amedisys, and Exelixis",,, 3/13/2013 46222210 PRN  Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx,,,,,,,,,,,10/06/2014 N5946510  PRN  Mylan Launches Generic Combivir®,,," 6/01/2016 00DYYX-E PRN  The Newly Launched IL-17 Inhibitor Cosentyx is Gradually Gaining Momentum in the EU5, While Established Subcutaneous TNF-Alpha Inhibitors Humira and Enbrel Continue to Dominate Biologics Patient Share in Psoriasis",,,,,,,,,,,,,,,,,,,,,," 3/27/2013 07G69B-E  PRN  China Insulin Industry Report, 2012-2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 4/28/2011 G3040110 PRN  Endo Pharmaceuticals Reports Strong First Quarter 2011 Financial Results,,,,12/04/2013 75886F10    PRN  Regeneron Announces Upcoming 2013 Investor Conference Presentation,,," 3/13/2013 WCRX-IE  PRN  Warner Chilcott, Dynavax Technologies, Isis Pharma, United Therapeutics, and Pharmacyclics Under StockCall's Microscope",,,,,,,,,,,"10/03/2014 N5946510  PRN  Critical Alerts For General Electric, Inovio Pharmaceuticals, Mylan, Rite Aid and Delta Airlines Released By InvestorsObserver",,, 6/01/2016 03116210 PRN  Bayer Collaborates with U.S. National Surgical Adjuvant Breast and Bowel Project (NSABP) to Investigate Stivarga® (Regorafenib) Tablets as Additional Adjuvant Therapy in Colon Cancer,,,,,,,,,,,,,,,,,,,,,," 3/27/2013 SNY-FR    PRN  Morning Research on Sanofi, Keryx Biopharma, VIVUS, and Array BioPharma",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 4/14/2011 G3040110 PRN  Endo Pharmaceuticals to Announce First Quarter 2011 Financial Results on April 28, 2011",,,,"12/03/2013 75886F10    PRN  Healthcare Sector Announce Awards, Conference Participation, Partnerships, and Closure of Public Offering - Research Report on Regeneron, Alnylam, Galena Biopharma, Amedisys, and Aeterna Zentaris",,," 3/12/2013 46222210 PRN  A forward Look into the Year Ahead - Research Report on Boyd Gaming Corporation, Ameristar Casinos, Inc., Aegerion Pharmaceuticals, Inc., ISIS Pharmaceuticals, Inc. and Avon Products, Inc.",,,,,,,,,,,10/03/2014 N5946510  PRN  Mylan Increases Third Quarter and Full Year 2014 Adjusted Diluted EPS Guidance Range,,, 5/27/2016 080RQG-E PRN  Amgen Receives Positive CHMP Opinion To Extend Indication Of Kyprolis® (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,," 3/21/2013 06DDVL-E  PRN  The Zacks Analyst Blog Highlights: Merrimack Pharmaceuticals, Bristol-Myers Squibb, Sanofi, Novo Nordisk and Hewlett-Packard",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 4/11/2011 G3040110 PRN  Endo Announces Agreement to Acquire American Medical Systems for $2.9 Billion,,,,"11/25/2013 75886F10    PRN  Clinical Studies, Convertible Senior Notes, and Commercial Supply Contracts - Research Report on Gilead, Hologic, Regeneron, OPKO, and Unilife",,," 3/07/2013 INVA-US  PRN  Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood",,,,,,,,,,," 9/16/2014 N5946510  PRN  Agreement to Acquire Rights, Product Launch, Program Expansion, Market Activity, and Recognition - Research Reports on Mylan, Eaton, 3M, Union Pacific and Hilton",,," 5/26/2016 03116210 PRN  Kyprolis® (Carfilzomib) Demonstrates Economic Value In Relapsed Or Refractory Multiple Myeloma Manuscript Published In ""Journal of Medical Economics""",,,,,,,,,,,,,,,,,,,,,," 3/20/2013 06DDVL-E  PRN  The Zacks Analyst Blog Highlights: Novartis, Pfizer, Sanofi, Shire and Halliburton",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 3/24/2011 G3040110 PRN  Qualitest Receives FDA Approval for Toresmide Tablets (Generic Demadex®) 5 mg, 10 mg, 20 mg, 100 mg, for the Treatment of Edema Associated with Congestive Heart Failure, Renal Disease, or Hepatic Disease",,,,11/22/2013 75886F10    PRN  EYLEA® (aflibercept) Injection Approved For The Treatment of Macular Edema Following Central Retinal Vein Occlusion In Japan,,, 3/06/2013 46222210 PRN  Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference,,,,,,,,,,, 9/16/2014 N5946510  PRN  Mylan Commences Phase III Clinical Trials for its Generic Version of Advair Diskus® and Insulin Analog to Lantus®,,, 5/25/2016 03116210 PRN  Amgen Announces Early Tender Results Of Senior Notes Exchange Offers,,,,,,,,,,,,,,,,,,,,,," 3/14/2013 06DDVL-E  PRN  Zacks Bull and Bear of the Day Highlights: Cincinnati Financial, ArcelorMittal, Biogen, Sanofi and Osiris Therapeutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 3/09/2011 G3040110 PRN  Zacks Bull and Bear of the Day Highlights: Trinity Biotech, HDFC Bank, Ltd. - ADS, Endo Pharmaceuticals, Johnson & Johnson and Abbott Laboratories",,,,11/22/2013 75886F10    PRN  Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial,,, 2/28/2013 46222210 PRN  Isis Reports Financial Results and Highlights for 2012,,,,,,,,,,," 9/15/2014 N5946510  PRN  Mylan Signs Agreement with Gilead to Accelerate Access to Hepatitis C Treatments, Sovaldi® (Sofosbuvir) and Single Tablet Regimen of Ledipasvir/Sofosbuvir, in Developing Countries",,, 5/25/2016 03116210 PRN  Amgen Announces Pricing Terms Of Senior Notes Exchange Offers,,,,,,,,,,,,,,,,,,,,,," 3/14/2013 SNY-FR    PRN  Sanofi US Offers a New Way to Say ""Thank You"" and Recognize the Unsung Heroes of Severe Allergy Awareness",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/09/2011 G3040110 PRN  Endo to Present at the Barclays Capital 2011 GlobalHealthcare Conference,,,,"11/15/2013 75886F10    PRN  Marketing Authorizations, Financial Results, Public Offering and Leadership Transitions - Research Report on Regeneron, Dendreon, Dyax, Techne, and ICU Medical",,, 2/27/2013 46222210 PRN  Isis Pharmaceuticals To Present At The Cowen and Company 33rd Annual Health Care Conference,,,,,,,,,,," 9/08/2014 N5946510  PRN  Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma",,, 5/19/2016 03116210 PRN  Amgen Announces Voting Results of Annual Meeting of Stockholders,,,,,,,,,,,,,,,,,,,,,, 3/06/2013 80105N10  PRN  Sanofi Oncology and Colon Cancer Coalition Join Forces to Raise Awareness of Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 3/04/2011 G3040110 PRN  Qualitest Receives FDA Approval for Emoquette™ (.15 mg Desogestrel and .03 mg Ethinyl Estradiol), an Oral Contraceptive for Prevention of Pregnancy",,,,11/12/2013 75886F10    PRN  Regeneron Highlights EYLEA® (aflibercept) Injection Data to Be Presented at American Academy of Ophthalmology Annual Meeting,,, 2/26/2013 46222210 PRN  Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation,,,,,,,,,,," 9/08/2014 N5946510  PRN  MAA Filing, Acceptance of ANDA Filing, Earnings Release, Study Results and Recognition - Research Reports on Regeneron, Mylan, Toll Brothers, 3M and Eaton",,, 5/19/2016 07G766-E PRN  Amgen Highlights Data To Be Presented At 21st Congress Of The European Hematology Association,,,,,,,,,,,,,,,,,,,,,," 3/02/2013 80105N10  PRN  Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 3/03/2011 G3040110 PRN  Endo Pharmaceuticals Launches FORTESTA™ (Testosterone) Gel for Topical Use Class III for Adult Men in the U.S. With Low Testosterone,,,,"11/08/2013 75886F10    PRN  Updates on Financial Results and Stock Price Movements - Research Report on Regeneron, Covidien, Salix Pharmaceuticals, Celldex Therapeutics, and Capital Senior Living",,," 2/21/2013 46222210 PRN  A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.",,,,,,,,,,, 9/08/2014 N5946510  PRN  Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex™,,, 5/18/2016 03116210 PRN  Bayer to Showcase Latest Oncology Research at ASCO 2016,,,,,,,,,,,,,,,,,,,,,, 2/26/2013 80105N10  PRN  Today's Technical View on Sanofi and Keryx: Pharma Companies Yield Strong Returns,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/28/2011 G3040110 PRN  Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results,,,,11/07/2013 75886F10    PRN  EYLEA® (aflibercept) Injection Submitted for EU Marketing Authorization for the Treatment of Diabetic Macular Edema,,, 2/21/2013 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' 2012 Financial Results and Highlights Conference Call,,,,,,,,,,, 9/05/2014 N5946510  PRN  Mylan Launches Generic Boniva® Injection,,, 5/18/2016 000C35-E PRN  Amgen Data To Be Presented At ASCO 2016 Demonstrates More Insights Into Treatment Options For Patients,,,,,,,,,,,,,,,,,,,,,," 2/21/2013 80105N10  PRN  A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/17/2011 G3040110 PRN  Urocidin™ Phase III Clinical Trial Results to be Presented at EAU and AUA Conferences,,,,11/05/2013 75886F10    PRN  Regeneron Reports Third Quarter 2013 Financial and Operating Results,,," 2/20/2013 46222210 PRN  Bernstein Liebhard LLP Announces That Only Six Days Remain To File A Motion For Lead Plaintiff In A Class Action Against Isis Pharmaceuticals, Inc.",,,,,,,,,,, 8/28/2014 N5946510  PRN  Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA,,, 5/18/2016 03116210 PRN  Landmark deCODE genetics Study Points to a New Mechanism that Affects Cholesterol Levels and the Risk of Heart Disease,,,,,,,,,,,,,,,,,,,,,, 2/19/2013 80105N10  PRN  Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/16/2011 G3040110 PRN  First Patient Enrolled in Second Phase III Clinical Trial of Urocidin™,,,,11/01/2013 75886F10    PRN  Regeneron Announces Upcoming 2013 Investor Conference Presentations,,," 2/20/2013 46222210 PRN  New Avenues to Market - Research Report on Isis Pharmaceuticals, Inc., Avon Products, Inc., Elizabeth Arden, Inc., Boyd Gaming Corporation and Ameristar Casinos, Inc.",,,,,,,,,,," 8/28/2014 N5946510  PRN  Acquisitions, Appointments, Patent Grant, Technical Updates, and Awareness Campaign - Research Reports on Covidien, Biogen Idec, Achillion, Intercept and Mylan",,," 5/17/2016 03116210 PRN  Amgen's Breakaway from Cancer® Public Service Announcement Delivers Message That Education, Resources And Hope Are Essential In The Fight Against Cancer",,,,,,,,,,,,,,,,,,,,,, 2/12/2013 005M9Z-E  PRN  Finalists Announced for the End Childhood Obesity Innovation Challenge,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/11/2011 G3040110 PRN  Endo to Present at the 2011 RBC Capital Markets Healthcare Conference,,,,"10/28/2013 75886F10    PRN  Regeneron And BioMed Realty Break Ground On A New 300,000 Square Foot R&D Build-to-Suit Facility In Westchester County, New York",,, 2/19/2013 46222210 PRN  Isis Initates Phase 2/3 Study Of ISIS-TTR Rx And Earns $7.5 Million Milestone Payment From GlaxoSmithKline,,,,,,,,,,, 8/25/2014 N5946510  PRN  Ready2Go™ Draft Winners Join Pro Football MVP Adrian Peterson in Educational Video About Anaphylaxis Preparedness,,, 5/12/2016 03116210 PRN  Amgen Commences Exchange Offers for Certain Series of Outstanding Senior Notes from Exchange Eligible Holders,,,,,,,,,,,,,,,,,,,,,, 2/07/2013 80105N10  PRN  Sanofi delivers solid 2012 results despite patent expirations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 2/10/2011 G3040110 PRN  Endo To Present at the Citi 2011 Global Healthcare Conference,,,,"10/24/2013 75886F10    PRN  Returning Value to Shareholders through Dividends, Strong Financial Results, and Regulatory Approvals - Research Report on Lilly, Illumina, Regeneron, Teva, and Vanda Pharmaceuticals",,, 2/07/2013 46222210 PRN  Isis Pharmaceuticals to Present at the 2013 Leerink Swann Global Healthcare Conference,,,,,,,,,,, 8/22/2014 N5946510  PRN  Mylan Launches First Generic Klor-Con® Extended-Release Tablets,,, 5/11/2016 03116210 PRN  Hall of Fame Quarterback Joe Montana and Amgen Team Up to Launch Breakaway from Heart Disease™ to Make Heart Health a Priority,,,,,,,,,,,,,,,,,,,,,, 2/05/2013 80105N10  PRN  ZALTRAP® (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 2/09/2011 G3040110 PRN  Endo Pharmaceuticals to Announce Fourth Quarter and Full-Year 2010 Financial Results on February 28, 2011",,,,10/21/2013 75886F10    PRN  Regeneron Reports Positive Phase 3 Data for EYLEA® (aflibercept) Injection in Macular Edema Following Branch Retinal Vein Occlusion,,," 1/31/2013 000CYC-E PRN  How Insiders Trade Hot Stocks: Freeport-McMoRan, Weatherford International, JDS Uniphase, Boeing, Las Vegas Sands, and ISIS Pharmaceuticals",,,,,,,,,,," 8/20/2014 N5946510  PRN  New Drug Launches, Technical Updates, New Facility, Clinical Trials Data, and Dividend Declarations - Research Reports on Covidien, Mylan, Baxter, Achillion and Perrigo",,, 5/09/2016 03116210 PRN  Platelet BioGenesis Wins Amgen Golden Ticket For LabCentral,,,,,,,,,,,,,,,,,,,,,, 1/29/2013 80105N10  PRN  Football Legend Jerome Bettis and Cookbook Guru Robin Miller Kick-off Auvi-Q™ Anaphylaxis Awareness Campaign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/28/2011 G3040110 PRN  Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration,,,,"10/16/2013 75886F10    PRN  Dividend Announcements, Earnings Release Scheduled, and Data Presentations from Clinical Studies - Research Report on Questcor, Regeneron, NPS, Incyte, and Nektar",,, 1/29/2013 46222210 PRN  Isis Pharmaceuticals To Provide Update On FDA Approval Of KYNAMRO™ (mipomersen),,,,,,,,,,, 8/19/2014 N5946510  PRN  Mylan Launches Generic Precedex™ Injection - Another Key Product Approval,,, 5/06/2016 03116210 PRN  Amgen To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference,,,,,,,,,,,,,,,,,,,,,, 1/29/2013 80105N10  PRN  Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/07/2011 G3040110 PRN  Endo Pharmaceuticals Provides Regulatory Update on New Formulation of OPANA® ER Designed to be Crush-Resistant,,,,10/16/2013 75886F10    PRN  Sanofi and Regeneron Report Positive Top-line Results with Alirocumab from First Phase 3 Study of a PCSK9 Inhibitor for LDL Cholesterol Reduction,,," 1/23/2013 46222210 PRN  Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of Shareholders of Groupon (GRPN) and Announces Investigations of Diodes (DIOD), Hemispherex Biopharma (HEB), ISIS Pharmaceuticals (ISIS), K-Swiss (KSWS), MAP Pharmaceuticals (MAPP), Neptune Technologies & Bioressources (NEPT), SeaCube Container Leasing (BOX), Spirit AeroSystems Holdings (SPR), Verisign (VRSN), and Yum! Brands (YUM)",,,,,,,,,,," 8/11/2014 N5946510  PRN  Drug Approvals, Financial Results, Upcoming Earnings, Technical Updates, and New Products - Research Reports on Amgen, Mylan, Biogen, Perrigo and Zimmer",,, 5/04/2016 BAYN-DE  PRN  Phase III Trial of Regorafenib in Patients with Unresectable Liver Cancer Meets Primary Endpoint of Improving Overall Survival,,,,,,,,,,,,,,,,,,,,,," 1/28/2013 80105N10  PRN  Sanofi Announces Auvi-Q™, the First and Only Voice-Guided Epinephrine Auto-Injector, is Now Available in the U.S.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 1/04/2011 G3040110 PRN  Endo to Present at the J.P. Morgan 29th Annual Healthcare Conference,,,,"10/10/2013 75886F10    PRN  Regeneron to Report Third Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on November 5, 2013",,," 1/19/2013 46222210 PRN  Faruqi & Faruqi, LLP Encourages Investors Who Suffered $100,000 In Losses Investing In Isis Pharmaceuticals, Inc. To Contact The Firm",,,,,,,,,,, 8/11/2014 N5946510  PRN  Mylan Launches Generic Xeloda® Tablets,,, 5/03/2016 03116210 PRN  FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For BLINCYTO® (Blinatumomab),,,,,,,,,,,,,,,,,,,,,," 1/14/2013 80105N10  PRN  NBA Family, American Diabetes Association, and Sanofi US Tip Off 2013 Dribble To Stop Diabetes Awareness Campaign",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/29/2010 G3040110 PRN  Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone,,,," 9/23/2013 75886F10    PRN  Conference Calls, New Appointments, Upcoming Presentations, Prospectus Filings and Acquisition Deal Updates - Research Report on Johnson & Johnson, WellPoint, Regeneron, Onyx, and MannKind",,," 1/11/2013 46222210 PRN  Faruqi & Faruqi, LLP Encourages Investors Who Suffered $100,000 In Losses Investing In Isis Pharmaceuticals, Inc. To Contact The Firm",,,,,,,,,,," 8/07/2014 N5946510  PRN  Mylan Reports Second Quarter 2014 Adjusted Diluted EPS of $0.69, In Line With Guidance",,, 5/02/2016 06418D-E PRN  Introducing...CycleNation™!,,,,,,,,,,,,,,,,,,,,,," 1/11/2013 000PQC-E  PRN  The Zacks Analyst Blog Highlights: GlaxoSmithKline, Theravance, Merck, Sanofi and Novartis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,12/01/2010 G3040110 PRN  Endo Pharmaceuticals Successfully Completes Acquisition of Qualitest Pharmaceuticals for $1.2 Billion,,,," 9/18/2013 75886F10    PRN  Pipeline Developments, Product Recalls, Clinical Trial Results, Recognitions, and New Appointments - Research Report on Johnson & Johnson, Amgen, Regeneron, UnitedHealth, and Bristol-Myers",,," 1/11/2013 46222210 PRN  Critical Alerts For Intel, LinkedIn, Goldcorp, Hasbro, and Isis Pharmaceuticals Released By InvestorsObserver",,,,,,,,,,," 8/06/2014 N5946510  PRN  Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma",,, 4/28/2016 03116210 PRN  Amgen's First Quarter 2016 Revenues Increased 10 Percent To $5.5 Billion And Adjusted Earnings Per Share (EPS) Increased 17 Percent To $2.90,,,,,,,,,,,,,,,,,,,,,," 1/08/2013 000P56-E  PRN  The Zacks Analyst Blog Highlights: Rogers, AAC Technologies Holdings, Eli Lilly, Sanofi and Novartis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/18/2010 G3040110 PRN  Endo Pharmaceuticals Holdings Inc. Announces Pricing of Private Offering of Senior Notes,,,, 9/17/2013 75886F10    PRN  Regeneron to Present Phase 3 Data for EYLEA® (aflibercept) Injection in Diabetic Macular Edema at Upcoming Retina Society Meeting,,," 1/11/2013 46222210 PRN  Critical Alerts For Intel, LinkedIn, Goldcorp, Hasbro, and Isis Pharmaceuticals Released By InvestorsObserver",,,,,,,,,,," 8/01/2014 N5946510  PRN  Favorable Court Ruling, Quarterly Performance Reviews, Acquisition Completion, and Contract Renewals - Research Reports on Mylan, Biogen, Medtronic, UnitedHealth and Covidien",,, 4/25/2016 03116210 PRN  Amgen Announces Webcast Of 2016 First Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,, 1/07/2013 80105N10  PRN  Sanofi's Chattem Acquires Over-the-Counter Antacid Rolaids®,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/15/2010 G3040110 PRN  Endo Pharmaceuticals Holdings Inc. Announces Proposed Private Offering of Senior Notes,,,," 9/10/2013 75886F10    PRN  Regeneron Announces Appointment of Robert E. Landry as Senior Vice President, Finance and Chief Financial Officer",,," 1/08/2013 46222210 PRN  Ryan & Maniskas, LLP Class Action Lawsuit Against Isis Pharmaceuticals, Inc.",,,,,,,,,,, 7/23/2014 N5946510  PRN  Mylan Wins Motion for Temporary Restraining Order Against Apotex for Authorized Generic of Paxil® CR,,, 4/25/2016 03116210 PRN  Amgen To Participate In The 2016 World Medical Innovation Forum™ On Cancer,,,,,,,,,,,,,,,,,,,,,,"12/27/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights:Bayer, Johnson & Johnson, Regeneron Pharmaceuticals, Sanofi and Onyx Pharmaceuticals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/09/2010 G3040110 PRN  Endo to Present at the Credit Suisse Healthcare Conference,,,," 9/03/2013 75886F10    PRN  Pharmaceuticals Report Revolutionary Findings, Approved Treatments, Investor Conferences - Research Report on Celgene, Amgen, Biogen Idec, Regeneron, and Questcor",,, 1/07/2013 46222210 PRN  Isis Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference,,,,,,,,,,, 7/17/2014 N5946510  PRN  Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Generic Product,,, 4/19/2016 03116210 PRN  Nplate® (Romiplostim) Study In The Lancet Shows Significant Increase In Durable Platelet Response Among Children With Immune Thrombocytopenia,,,,,,,,,,,,,,,,,,,,,,"12/21/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights:Novo Nordisk, Sanofi, Eli Lilly, Merck and Johnson & Johnson",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/08/2010 G3040110 PRN  Endo Pharmaceuticals Announces That FDA Eliminates Need for Advisory Committee Meeting to Discuss New Formulation of Long-Acting Oxymorphone,,,, 8/29/2013 75886F10    PRN  EYLEA® (aflibercept) Injection Approved in Europe for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion,,," 1/03/2013 09ZX1M-E PRN  Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Isis Pharmaceuticals, Inc.",,,,,,,,,,, 7/14/2014 N5946510  PRN  Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction,,," 4/03/2016 003LN3-E PRN  Positive Efficacy And Tolerability Study Of Repatha® (evolocumab) In Statin-Intolerant Patients Published In ""Journal of the American Medical Association""",,,,,,,,,,,,,,,,,,,,,,12/19/2012 80105N10  PRN  Sanofi US Reaches Settlement Agreement on Hyalgan,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/04/2010 G3040110 PRN  Penwest Pharmaceuticals Shareholders Approve Merger With Subsidiary of Endo Pharmaceuticals,,,, 8/27/2013 75886F10    PRN  Regeneron Announces Upcoming 2013 Investor Conference Presentations,,, 1/03/2013 078VWR-E PRN  Regulus to Present at 31st Annual J.P. Morgan Healthcare Conference,,,,,,,,,,," 7/14/2014 N5946510  PRN  Drug Application Submission, Merger Agreement, Launch of Newly Approved Drug, and Acquisition - Analyst Notes on Actavis, Salix, Mylan, Zoetis and Hospira",,, 4/01/2016 03116210 PRN  Amgen And UCB Present Positive Data At ENDO 2016 Comparing Romosozumab With Teriparatide,,,,,,,,,,,,,,,,,,,,,,12/19/2012 0829MR-E  PRN  PharmaVentures Acts as Exclusive Advisor to Sanofi in the Divestment of Zentiva's Hlovovec Production Facility to Wood Pharma Holding,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"11/02/2010 G3040110 PRN  Critical Alerts for Best Buy, PNC, Dominion Resources, PPL, and Endo Pharmaceuticals Released by Seven Summits Research",,,," 8/21/2013 75886F10    PRN  Biotech Companies Announce Financial Results and Receive New Patents - Research Report on Regeneron, Medivation, Incyte, Santarus, and ACADIA",,," 1/03/2013 05WQ9Y-E PRN  ISIS Shareholder Alert: Morgan & Morgan announces an investigation of ISIS Pharmaceuticals, Inc. (ISIS) for violations of federal securities fraud.",,,,,,,,,,, 7/08/2014 N5946510  PRN  Mylan Launches Generic Micardis® Tablets,,, 3/21/2016 000C35-E PRN  Amgen To Present Repatha® (Evolocumab) Data At ACC.16,,,,,,,,,,,,,,,,,,,,,,"12/14/2012 SNY-FR    PRN  The Zacks Analyst Blog Highlights:Verizon Communications, Sanofi, Novo-Nordisk, Johnson & Johnson and Roche",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,11/01/2010 G3040110 PRN  Endo Pharmaceuticals Reports Strong Third Quarter 2010 Financial Results; Reaffirms 2010 Financial Guidance and Provides Financial Guidance for 2011,,,, 8/07/2013 75886F10    PRN  Regeneron Granted Fundamental Patents Covering Mouse Antibody Technology Used in VelocImmune® Mice,,, 1/02/2013 IONS-US  PRN  Isis Pharmaceuticals To Present At The 31st Annual J.P. Morgan Healthcare Conference,,,,,,,,,,," 7/01/2014 N5946510  PRN  Mylan Schedules Second Quarter 2014 Financial Results Conference Call and Live Webcast for Aug. 7, 2014",,, 3/21/2016 UCB-BE   PRN  Amgen And UCB Announce Positive Top-Line Results From Phase 3 Study Evaluating Romosozumab In Men With Osteoporosis,,,,,,,,,,,,,,,,,,,,,,12/12/2012 TRI-US    PRN  Thomson Reuters Study Charts Surge in Middle Eastern Trademarks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10/22/2010 G3040110 PRN  Endo to Present at the Oppenheimer Annual Healthcare Conference,,,, 8/06/2013 BAYN-DE     PRN  Regeneron and Bayer Report Positive One-Year Results from Two Phase 3 Trials of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema,,,12/20/2012 078VWR-E PRN  Regulus Announces Addition to Russell 2000 Index,,,,,,,,,,," 7/01/2014 N5946510  PRN  Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis",,," 3/17/2016 000TBT-E PRN  Health Canada, EMA, Amgen, Pfizer, AGES, MedImmune and more to discuss the challenges in biosimilar drug development at the upcoming IQPC summit",,,,,,,,,,,,,,,,,,,,,,"12/12/2012 09WBJY-E  PRN  The Zacks Analyst Blog Highlights: Myriad Genetics, Sanofi, Abbott Laboratories, Johnson & Johnson and AstraZeneca",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,"10/20/2010 G3040110 PRN  Endo Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 1, 2010",,,, 8/06/2013 75886F10    PRN  Regeneron Reports Second Quarter 2013 Financial and Operating Results,,,12/14/2012 46222210 PRN  Isis Pharmaceuticals To Review CHMP Opinion On KYNAMRO™,,,,,,,,,,," 6/30/2014 N5946510  PRN  Patent Case Settlements, FDA Rulings, Upcoming Investor Day, Product Launching, and Closing of Offering - Analyst Notes on Teva, AstraZeneca, Salix, Mylan and GW",,, 3/16/2016 03116210 PRN  Amgen Wins Patent Case On Repatha® (Evolocumab),,,,,,,,,,,,,,,,,,,,,,12/12/2012 80105N10  PRN  Sanofi US Announces Collaborate Activate Innovation Challenge Winner,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10/15/2010 G3040110 PRN  Penwest Pharmaceuticals Announces Intention to Terminate NASDAQ Listing and Registration,,,, 7/26/2013 75886F10    PRN  EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion in Europe,,,12/13/2012 IONS-US  PRN  Isis Announces That ISIS-TTR Rx Was Granted Fast Track Designation For The Treatment Of Patients With FAP,,,,,,,,,,," 6/11/2014 N5946510  PRN  Mylan Launches Generic Actonel® Tablets, 150 mg",,, 3/10/2016 03116210 PRN  FDA Accepts Amgen's Supplemental Biologics License Application For The Expanded Use Of Enbrel® (Etanercept) To Treat Pediatric Patients With Chronic Severe Plaque Psoriasis,,,,,,,,,,,,,,,,,,,,,,"12/11/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights:Merck, Pfizer, Johnson & Johnson, Sanofi and Bayer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,10/05/2010 G3040110 PRN  Endo to Present at the Jefferies 2010 Global SpecPharma and European Healthcare Conference,,,," 7/02/2013 75886F10    PRN  Regeneron to Report Second Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on August 6, 2013",,,12/11/2012 46222210 PRN  Isis Pharmaceuticals And AstraZeneca Form Strategic Alliance On RNA Therapeutics For Cancer,,,,,,,,,,," 6/11/2014 N5946510  PRN  Critical Alerts For eBay, JA Solar, Mylan Laboratories, Future Fuel, and 51Job Technology Released By InvestorsObserver",,, 3/03/2016 0024VM-E PRN  Amgen To Present At The Cowen And Company 36th Annual Health Care Conference,,,,,,,,,,,,,,,,,,,,,,12/09/2012 80105N10  PRN  Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/30/2010 G3040110 PRN  Penwest Pharmaceuticals Sets Special Shareholders Meeting Date for Approval of Merger With Subsidiary of Endo Pharmaceuticals,,,," 6/27/2013 75886F10    PRN  Regeneron Announces First Recipients of Annual ""Regeneron Prize for Creative Innovation""",,,12/10/2012 IONS-US  PRN  Biogen Idec and Isis Pharmaceuticals Announce Collaboration For Antisense Programs To Treat Neurological Disorders,,,,,,,,,,, 6/09/2014 N5946510  PRN  Mylan Launches Generic Paraplatin® Injection,,, 3/02/2016 03116210 PRN  Amgen Announces 2016 Second Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,"12/03/2012 078VWR-E  PRN  Regulus to Host NASDAQ Closing Bell Ceremony on December 5, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/28/2010 G3040110 PRN  Apax Partners to Sell Qualitest Pharmaceuticals to Endo Pharmaceuticals for $1.2 Billion,,,, 6/06/2013 75886F10    PRN  Regeneron and Bayer Report Positive Phase 3 Results for EYLEA® (aflibercept) Injection in Myopic Choroidal Neovascularization (mCNV),,,12/07/2012 46222210 PRN  Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders,,,,,,,,,,, 6/05/2014 N5946510  PRN  Mylan to Present at the Goldman Sachs 35th Annual Global HealthCare Conference,,, 3/01/2016 03116210 PRN  Amgen Submits Supplemental Biologics License Application For BLINCYTO® (Blinatumomab),,,,,,,,,,,,,,,,,,,,,,"11/30/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights:Humana, Novo Nordisk, Merck, Bristol-Myers and Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/28/2010 G3040110 PRN  Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion,,,, 5/21/2013 75886F10    PRN  Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine,,,"12/03/2012 078VWR-E PRN  Regulus to Host NASDAQ Closing Bell Ceremony on December 5, 2012",,,,,,,,,,, 5/30/2014 N5946510  PRN  Mylan Believes Court Erred in its Ruling Regarding Generic Celebrex®,,, 2/22/2016 UNISQ-US PRN  Unilife and Amgen Enter Strategic Collaboration for Injectable Drug Delivery Systems,,,,,,,,,,,,,,,,,,,,,,"11/26/2012 VMED-US   PRN  The Zacks Analyst Blog Highlights: Virgin Media, Vodafone Group, Sanofi, Novartis and Biogen Idec",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/22/2010 G3040110 PRN  Endo Pharmaceuticals Receives FDA Priority Review for New Formulation of Long-Acting Oxymorphone Designed to be Crush Resistant,,,," 5/15/2013 05L1GD-E    PRN  ELNs, Data Analytics, Knowledge Management: Trends, Challenges & Opportunities",,,12/03/2012 46222210 PRN  Isis Pharmaceuticals To Provide Update On Its Metabolic Franchise,,,,,,,,,,, 5/29/2014 N5946510  PRN  Mylan Launches Generic Malarone® Tablets,,, 2/22/2016 03116210 PRN  Amgen And UCB Announce Positive Top-Line Results From The Phase 3 Study Of Romosozumab In Postmenopausal Women With Osteoporosis,,,,,,,,,,,,,,,,,,,,,,11/20/2012 005M9Z-E  PRN  Rachael Ray and Guy Fieri Return to Coach Eight Celebrity Contestants in New Season of Rachael vs. Guy: Celebrity Cook-Off,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/20/2010 G3040110 PRN  Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Penwest Pharmaceuticals,,,," 5/15/2013 75886F10    PRN  Critical Alerts For SanDisk, Computer Sciences, American Tower Corp, Questcor Pharmaceuticals, and Regeneron Pharmaceuticals Released By InvestorsObserver",,,"11/27/2012 46222210 PRN  Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development",,,,,,,,,,, 5/28/2014 N5946510  PRN  Mylan to Present at the INVEST Pennsylvania Equity Conference,,, 2/15/2016 03116210 PRN  Phase 3 Study Demonstrates Aranesp® (Darbepoetin Alfa) Reduces Red Blood Cell Transfusions In Patients With Myelodysplastic Syndrome (MDS),,,,,,,,,,,,,,,,,,,,,,11/19/2012 078VWR-E  PRN  Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 9/15/2010 G3040110 PRN  Endo to Present at the Stifel Nicolaus Healthcare Conference 2010,,,, 5/15/2013 75886F10    PRN  Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA),,,11/20/2012 46222210 PRN  Isis Pharmaceuticals To Present At The 24th Annual Piper Jaffray Healthcare Conference,,,,,,,,,,," 5/23/2014 N5946510  PRN  Secondary Offering, Appointments, and Clinical Developments - Analyst Notes on HCA, Biogen Idec, WellPoint, AbbVie and Mylan",,, 2/12/2016 WST-US   PRN  West's Daikyo Crystal Zenith® Cyclic Olefin Polymer Selected by Amgen,,,,,,,,,,,,,,,,,,,,,,"11/19/2012 005M9Z-E  PRN  Travel Channel To Premiere ""World's Best Bartender"" Today, November 19",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/09/2010 G3040110 PRN  Endo Pharmaceuticals Agrees to Acquire Penwest Pharmaceuticals and Submits NDA For New Formulation of Long-Acting Oxymorphone Designed to be Crush-Resistant,,,, 5/08/2013 75886F10    PRN  Regeneron Announces Upcoming 2013 Investor Conference Presentations,,,11/19/2012 078VWR-E PRN  Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights,,,,,,,,,,," 5/20/2014 N5946510  PRN  Company Updates, Takeover Offers, Stock Price Movements, and FDA Approvals - Analyst Notes on Chubb, Valeant, AstraZeneca, Mylan and Perrigo",,, 2/05/2016 AMGN-US  PRN  Amgen To Present At The Leerink Partners 5th Annual Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,"11/19/2012 80105N10  PRN  Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 8/06/2010 G3040110 PRN  Endo to Present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference,,,, 5/03/2013 75886F10    PRN  Regeneron Reports First Quarter 2013 Financial and Operating Results,,,11/12/2012 0017CR-E PRN  Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call,,,,,,,,,,, 5/14/2014 N5946510  PRN  Mylan Launches Generic Zyprexa Zydis® Tablets,,, 2/04/2016 03116210 PRN  Phase 3 Study of BLINCYTO® (Blinatumomab) Met Primary Endpoint Of Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,,,11/16/2012 80105N10  PRN  ZALTRAP® (ziv-aflibercept) Receives CHMP Positive Opinion in the European Union for Previously Treated Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 7/30/2010 G3040110 PRN  Endo Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results,,,, 5/03/2013 75886F10    PRN  Regeneron Acquires Full Rights to Two Novel Ophthalmology Development Programs,,,11/08/2012 078VWR-E PRN  Regulus to Present at the Lazard Capital Markets Healthcare Conference,,,,,,,,,,, 5/09/2014 N5946510  PRN  Mylan to Present at the UBS Global Healthcare Conference,,, 2/04/2016 03116210 PRN  Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3 Trial Of Repatha® (Evolocumab) In Statin-Intolerant Patients With High Cholesterol,,,,,,,,,,,,,,,,,,,,,,11/14/2012 80105N10  PRN  Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/20/2010 G3040110 PRN  Endo Pharmaceuticals to Announce Second Quarter 2010 Financial Results on July 30, 2010",,,," 4/24/2013 FRAN-US     PRN  Regeneron Set to Join the S&P 500; Eagle Materials, CST Brands to Join the S&P MidCap 400; Francesca's, Northern Oil & Gas to Join the S&P SmallCap 600",,,11/08/2012 0017CR-E PRN  Isis Pharmaceuticals To Present At The 2012 Credit Suisse Healthcare Conference,,,,,,,,,,, 5/09/2014 N5946510  PRN  Mylan to Present at the BofA Merrill Lynch 2014 Health Care Conference,,, 1/28/2016 03116210 PRN  Amgen's 2015 Revenues Increased 8 Percent To $21.7 Billion And Adjusted Earnings Per Share (EPS) Increased 19 Percent To $10.38,,,,,,,,,,,,,,,,,,,,,,11/14/2012 80105N10  PRN  Actress Elizabeth Perkins and Sanofi US Announce Nationwide Casting Call for Diabetes Co-Stars Documentary,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 7/19/2010 G3040110 PRN  Endo Pharmaceuticals Recognizes 10 Years as a Public Company by Ringing the NASDAQ Opening Bell,,,, 4/18/2013 75886F10    PRN  Regeneron Announces Upcoming 2013 Investor Conference Presentations,,,"11/07/2012 078VWR-E PRN  Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors",,,,,,,,,,, 5/01/2014 N5946510  PRN  Mylan First Quarter 2014 Adjusted Diluted EPS Increases 6% to $0.66,,, 1/25/2016 03116210 PRN  FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501,,,,,,,,,,,,,,,,,,,,,,11/08/2012 078VWR-E  PRN  Regulus to Present at the Lazard Capital Markets Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/15/2010 G3040110 PRN  Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc.",,,," 4/11/2013 75886F10    PRN  Regeneron to Report First Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2013",,,11/07/2012 0017CR-E PRN  Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference,,,,,,,,,,, 4/25/2014 N5946510  PRN  Mylan Challenges FDA Ruling on Exclusivity Relating to Celecoxib,,, 1/25/2016 03116210 PRN  Amgen Announces Webcast of 2015 Fourth Quarter and Full Year Financial Results,,,,,,,,,,,,,,,,,,,,,,11/08/2012 80105N10  PRN  Sanofi Pasteur Announces Publication of Pivotal Safety and Immunogenicity Data of Menactra® Vaccine for Infants and Toddlers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/12/2010 G3040110 PRN  Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc.",,,," 4/04/2013 75886F10    PRN  BioMed Realty To Develop 297,000 Square Feet In New York Fully Leased To Regeneron Pharmaceuticals",,,11/06/2012 0017CR-E PRN  Isis Reports Financial Results and Highlights for Third Quarter 2012,,,,,,,,,,, 4/15/2014 N5946510  PRN  Mylan Launches Generic Lunesta® Tablets,,, 1/25/2016 06R0BX-E PRN  EnGeneIC Ltd. Strengthens Board of Directors to Support U.S. Expansion,,,,,,,,,,,,,,,,,,,,,,"11/07/2012 078VWR-E  PRN  Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,," 7/02/2010 G3040110 PRN  Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of HealthTronics, Inc.",,,, 4/04/2013 75886F10    PRN  Regeneron Pharmaceuticals Announces Expansion in New York's Hudson Valley,,,11/05/2012 0017CR-E PRN  Isis Announces Expedited Development Of ISIS-TTR Rx And Amendment To The Collaboration With GSK To Support Phase 2/3 Study,,,,,,,,,,, 4/08/2014 N5946510  PRN  Mylan Schedules First Quarter 2014 Financial Results Conference Call and Live Webcast,,, 1/23/2016 03116210 PRN  Vectibix® (panitumumab) And Best Supportive Care Improves Overall Survival Compared To Best Supportive Care In Chemorefractory KRAS And RAS Wild-Type Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,,11/05/2012 80105N10  PRN  Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 7/01/2010 G3040110 PRN  Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTA™ for Men With Low Testosterone,,,, 3/04/2013 75886F10    PRN  Regeneron Announces Potential Additional Royalty Stream Related to EU Approval for Ilaris® (canakinumab) in Patients Suffering Acute Gouty Arthritis Attacks Who Cannot Gain Relief From Current Treatments,,,11/05/2012 078VWR-E PRN  Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions,,,,,,,,,,, 4/03/2014 N5946510  PRN  United States PTO Rejects Teva's '808 Patent Reissue Application on Copaxone® for the Second Time,,, 1/22/2016 03116210 PRN  Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol,,,,,,,,,,,,,,,,,,,,,,11/05/2012 078VWR-E  PRN  Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/08/2010 G3040110 PRN  Endo to Present at Jefferies 2010 Global Life Sciences Conference,,,," 3/02/2013 75886F10    PRN  Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis",,,11/02/2012 0017CR-E PRN  Isis To Receive $1.25 Million Payment As Pfizer Continues Development Of EXC 001,,,,,,,,,,, 3/24/2014 N5946510  PRN  District Court Upholds Mylan's U.S. Patents on Perforomist® Inhalation Solution,,, 1/21/2016 03116210 PRN  FDA Approves New Kyprolis® (Carfilzomib) Combination Therapy For The Treatment Of Patients With Relapsed Or Refractory Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,,11/02/2012 80105N10  PRN  Sanofi Pasteur Brings Fluzone® Intradermal Vaccine Coop de Quill VacciNation Tour to Baltimore Rite Aid To Raise Awareness About Importance Of Annual Flu Immunization And Vaccine Options For Adults,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/08/2010 G3040110 PRN  Endo and Penwest Enter Into Agreement with Sandoz to Settle OPANA® ER Patent Litigation,,,, 2/19/2013 75886F10    PRN  Regeneron Announces Upcoming 2013 Investor Conference Presentations,,,11/01/2012 46222210 PRN  Isis Pharmaceuticals Initiates Phase 1b/2a Study Of ISIS-SMNRx In Patients With Spinal Muscular Atrophy,,,,,,,,,,, 3/13/2014 N5946510  PRN  Mylan Comments on Favorable Ruling in Generic Celebrex® Patent Suit,,," 1/15/2016 03116210 PRN  Covered Call Alerts For Twitter, US Steel, Intel, Amgen and Illumina Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,10/31/2012 80105N10  PRN  Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 6/08/2010 G3040110 PRN  Endo and Penwest Enter Into Agreement with Impax Laboratories to Settle OPANA® ER Patent Litigation,,,, 2/19/2013 75886F10    PRN  Regeneron and Bayer Initiate Phase 3 Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia,,,10/31/2012 46222210 PRN  Isis Pharmaceuticals Reports Encouraging Interim Phase 1 Data On ISIS-STAT3Rx In Patients With Cancer,,,,,,,,,,, 3/11/2014 N5946510  PRN  Mylan Launches Naloxone Hydrochloride Injection,,, 1/07/2016 03116210 PRN  Amgen To Present At The 34th Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,10/25/2012 80105N10  PRN  Sanofi: Q3 2012 Business EPS(1) reflects patent expirations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/05/2010 G3040110 PRN  HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals,,,, 2/14/2013 75886F10    PRN  Regeneron Reports Fourth Quarter and Full Year 2012 Financial and Operating Results,,,10/29/2012 46222210 PRN  Isis Initiates Phase 2 Study Of ISIS-FXIRX In Patients Undergoing Knee Replacement Surgery,,,,,,,,,,, 3/11/2014 N5946510  PRN  Mylan Introduces Critical Care Segment in India,,,12/22/2015 05WD3P-E PRN  Prime Therapeutics prefers both cholesterol lowering drugs Praluent® and Repatha® on its national drug list,,,,,,,,,,,,,,,,,,,,,,"10/24/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights: UBS, Celgene, Sanofi, Roche and Eli Lilly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/05/2010 G3040110 PRN  Endo Pharmaceuticals To Acquire HealthTronics To Expand Its Delivery of Diversified Urology Treatment and Diagnostic Solutions,,,," 2/13/2013 75886F10    PRN  Critical Alerts For JPMorgan Chase, Precision Castparts, Spirit Aerosystems, Regeneron Pharmaceuticals, and Steel Dynamics Released By InvestorsObserver",,,10/29/2012 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Third Quarter 2012 Financial Results Conference Call,,,,,,,,,,, 3/11/2014 N5946510  PRN  Mylan Nominates JoEllen Lyons Dillon for Election to Board of Directors,,,12/18/2015 03116210 PRN  European Commission Approves Amgen's IMLYGIC™ (talimogene laherparepvec) As First Oncolytic Immunotherapy In Europe,,,,,,,,,,,,,,,,,,,,,,10/23/2012 80105N10  PRN  Sanofi Oncology and BMT InfoNet Join Forces to Raise Awareness of Stem Cell Transplants for Blood Cancers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 5/04/2010 G3040110 PRN  Endo to Present at Bank of America Merrill Lynch Health Care Conference,,,, 2/11/2013 75886F10    PRN  Regeneron Announces Receipt of Hart-Scott-Rodino Notice,,,10/23/2012 46222210 PRN  Isis Pharmaceuticals To Receive $1.1 Million From Alnylam,,,,,,,,,,, 2/28/2014 N5946510  PRN  Mylan to Present at the Barclays Global Healthcare Conference,,,12/15/2015 03116210 PRN  Amgen Announces 27 Percent Increase In 2016 First Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,10/22/2012 80105N10  PRN  Sanofi Pasteur Presents Phase III Data for Investigational Quadrivalent Influenza Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,, 4/30/2010 G3040110 PRN  Endo Pharmaceuticals Reports Strong Revenue Growth and First Quarter 2010 Financial Results,,,, 2/05/2013 75886F10    PRN  ZALTRAP® (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer,,,"10/22/2012 LULU-CA  PRN  Today's Market Focus: Bank of America, Lennar, AT&T, Baker Hughes, ISIS, and Lululemon",,,,,,,,,,, 2/28/2014 N5946510  PRN  Mylan to Present at the Cowen and Company 34th Annual Health Care Conference,,,"12/14/2015 AMGN-US  PRN  Amgen Reacquires All Product Rights To Prolia® (denosumab), XGEVA® (denosumab) And Vectibix® (panitumumab) From GSK In 48 Countries",,,,,,,,,,,,,,,,,,,,,,10/18/2012 80105N10  PRN  Sanofi Pasteur Announces Application for New Four-Strain Influenza Vaccine Accepted by FDA for Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 1/28/2013 75886F10    PRN  Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating Results and Host Conference Call and Webcast on February 14, 2013",,,10/18/2012 46222210 PRN  ISIS Pharmaceuticals Stock Trading Halted Today,,,,,,,,,,, 2/27/2014 N5946510  PRN  Mylan Fourth Quarter 2013 Adjusted Diluted EPS Increases 20% to $0.78 and Full Year Adjusted Diluted EPS Increases 12% to $2.89,,,12/07/2015 AMGN-US  PRN  Amgen Presents Data From Three Trials Evaluating BLINCYTO® (blinatumomab) In Acute Lymphoblastic Leukemia At ASH 2015,,,,,,,,,,,,,,,,,,,,,,10/18/2012 80105N10  PRN  Sanofi Pasteur Brings Fluzone(R) Intradermal Vaccine Coop de Quill VacciNation Tour To Raleigh CVS/pharmacy To Raise Awareness About Importance Of Annual Flu Immunization And Vaccine Options For Adults,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 1/04/2013 75886F10    PRN  Regeneron Recommends Rejection of Mini-Tender Offer by TRC Capital Corporation,,,"10/17/2012 000DTT-E PRN  Critical Earnings Forecast Alerts: Bank of America, Kroger, ISIS, Cliffs Natural Resources, A123 Systems, and Juniper Networks",,,,,,,,,,, 2/11/2014 N5946510  PRN  Mylan Schedules Fourth Quarter and Year End 2013 Financial Results Conference Call and Live Webcast,,,12/07/2015 RGLS-US  PRN  Regulus Appoints Joseph P. Hagan Chief Operating Officer,,,,,,,,,,,,,,,,,,,,,,"10/10/2012 REGN-US   PRN  Regeneron to Report Third Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on October 24, 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,"12/27/2012 06DDVL-E    PRN  The Zacks Analyst Blog Highlights:Bayer, Johnson & Johnson, Regeneron Pharmaceuticals, Sanofi and Onyx Pharmaceuticals",,,"10/16/2012 ITOT-US  PRN  Critical Alerts For Berkshire Hathaway, Polo Ralph Lauren, Ryland, Cirrus Logic, and Isis Pharmaceuticals Released By InvestorsObserver",,,,,,,,,,," 2/03/2014 N5946510  PRN  Mylan Launches First Trastuzumab Biosimilar, HertrazTM, in India",,,12/05/2015 03116210 PRN  Pivotal Head-To-Head ENDEAVOR Study Results Published in The Lancet Oncology Demonstrate Superiority of Kyprolis® (carfilzomib) Combination Over Velcade® (bortezomib) Combination,,,,,,,,,,,,,,,,,,,,,,10/09/2012 80105N10  PRN  Sanofi and Massachusetts General Hospital Launch Oncology Research Collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,12/20/2012 REGN-US     PRN  Regeneron Announces January 2013 Investor Conference Presentations,,,10/11/2012 46222210 PRN  Isis Investment In Regulus Valued At $28 Million At Completion Of Regulus Initial Public Offering,,,,,,,,,,, 1/31/2014 N5946510  PRN  Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India,,,12/05/2015 03116210 PRN  New Analyses Presented At ASH 2015 Demonstrate The Potential Of Kyprolis® (Carfilzomib) As Backbone Therapy In Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,,10/05/2012 80105N10  PRN  Sanofi Pasteur Brings Fluzone® Intradermal Vaccine Coop de Quill VacciNation Tour to San Francisco Walgreens to Raise Awareness About Importance of Annual Flu Immunization and Vaccine Options for Adults,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,12/06/2012 75886F10    PRN  EYLEA® (aflibercept) Submitted for EU Marketing Authorization for the Treatment of Macular Edema Following Central Retinal Vein Occlusion,,,10/04/2012 46222210 PRN  Regulus Announces Pricing of Initial Public Offering,,,,,,,,,,, 1/23/2014 N5946510  PRN  Mylan Launches Generic Prandin® Tablets,,,12/05/2015 03116210 PRN  Amgen Submits Application In Europe To Expand Indication Of Kyprolis® (carfilzomib) For The Treatment Of Relapsed Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,,"10/02/2012 0691FB-E  PRN  The Zacks Analyst Blog Highlights:Mylan, Sanofi, Novartis, Dr. Reddy's Laboratories and Teva Pharmaceutical",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,"12/03/2012 G-BM        PRN  Critical Alerts For eBay, US Steel, J. C. Penney, Goldcorp, and Regeneron Pharmaceuticals Released By InvestorsObserver",,, 9/13/2012 46222210 PRN  Isis Pharmaceuticals Completes Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027,,,,,,,,,,," 1/22/2014 N5946510  PRN  Critical Alerts For Adobe, Foot Locker, Cablevision, GNC Holdings, and Mylan Labs Released By InvestorsObserver",,,12/04/2015 03116210 PRN  Amgen And Merck Announce Cancer Immunotherapy Collaboration For Patients With Non-Hodgkin Lymphoma,,,,,,,,,,,,,,,,,,,,,, 9/24/2012 80105N10  PRN  Sanofi Pasteur Brings Fluzone® Intradermal Vaccine Coop de Quill VacciNation Tour to Seattle-area Walgreens to Raise Awareness About Importance of Annual Flu Immunization and Vaccine Options for Adults,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/29/2012 75886F10    PRN  Regeneron Named Biotechnology Company of the Year,,, 9/12/2012 46222210 PRN  Isis Pharmaceuticals To Present At The UBS Global Life Sciences Conference,,,,,,,,,,," 1/15/2014 N5946510  PRN  Regulatory Updates, Management Changes, and Conference Calls - Research Report on Bristol-Myers Squibb, Amgen, St. Jude Medical, Boston Scientific, and Mylan",,,12/04/2015 03116210 PRN  Amgen's First Biosimilar Marketing Authorization Application Submitted To European Medicines Agency For ABP 501,,,,,,,,,,,,,,,,,,,,,, 9/20/2012 80105N10  PRN  Sanofi and TB Alliance Announce Collaboration to Accelerate New Treatments Against Tuberculosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/27/2012 75886F10    PRN  Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST,,, 9/05/2012 46222210 PRN  Isis Pharmaceuticals To Present At Two Upcoming Investor Conferences,,,,,,,,,,, 1/09/2014 N5946510  PRN  Mylan Announces CE Mark for MyT4™ Point-of-Care CD4 Diagnostic Test,,,11/25/2015 AMGN-US  PRN  Amgen's First Biosimilar Biologics License Application For ABP 501 Submitted To U.S. Food And Drug Administration,,,,,,,,,,,,,,,,,,,,,," 9/14/2012 NVS-CH    PRN  The Zacks Analyst Blog Highlights: Sanofi, Pfizer, Merck KGaA, Novartis and Biogen",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/27/2012 75886F10    PRN  EYLEA® (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Europe,,, 8/30/2012 46222210 PRN  Isis Pharmaceuticals Demonstrates The Potential Of Single-Stranded RNA-Like Antisense Technology To Activate The RNAi Pathway,,,,,,,,,,, 1/09/2014 N5946510  PRN  Mylan Launches Generic Myfortic® Delayed-Release Tablets,,,11/24/2015 03116210 PRN  European Commission Approves Amgen's BLINCYTO® (blinatumomab) for the Treatment of Adults with Philadelphia Chromosome-Negative Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,,, 9/13/2012 0BDK6C-E  PRN  Therapy Trends: Multiple Sclerosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/16/2012 75886F10    PRN  ZALTRAP® (ziv-aflibercept) Receives CHMP Positive Opinion in the European Union for Previously Treated Metastatic Colorectal Cancer,,, 8/30/2012 46222210 PRN  Isis Pharmaceuticals to Present at the 2012 Stifel Nicolaus Healthcare Conference,,,,,,,,,,," 1/08/2014 N5946510  PRN  Mylan Appoints Adele Gulfo as EVP, Global Collaboration and Strategic Operations",,,11/23/2015 AMGN-US  PRN  Amgen Announces Repatha® Preferred Position On CVS Health Commercial Formularies,,,,,,,,,,,,,,,,,,,,,, 9/12/2012 80105N10  PRN  Sanofi Pasteur and Actor Chris O'Donnell Launch Fluzone® Intradermal (Influenza Virus Vaccine) VacciNation Tour to Raise Awareness About Importance of Annual Flu Shot and Vaccine Options for Adults,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/06/2012 75886F10    PRN  Regeneron Announces November 2012 Investor Conference Presentations,,, 8/28/2012 ALNY-US  PRN  Isis Pharmaceuticals to receive $1.4 million from Alnylam,,,,,,,,,,, 1/07/2014 N5946510  PRN  Mylan Launches Generic Detrol® LA Capsules,,,11/19/2015 03116210 PRN  European Commission Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,, 8/29/2012 80105N10  PRN  Veracyte Receives New York State License for Afirma® Gene Expression Classifier,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/05/2012 75886F10    PRN  Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia,,, 8/27/2012 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Hosts Dr. Klaus Parhofer to Review KYNAMRO™ Data Presented at the European Society of Cardiology Congress 2012,,,,,,,,,,," 1/07/2014 N5946510  PRN  Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan",,,11/16/2015 03116210 PRN  Amgen to Present IMLYGIC™ (Talimogene Laherparepvec) Data at the 2015 International Congress of the Society for Melanoma Research,,,,,,,,,,,,,,,,,,,,,," 8/23/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights: CNOOC, Nexen, Sanofi, Taro Pharmaceutical and Pernix Therapeutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,10/31/2012 75886F10    PRN  Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine,,, 8/20/2012 078VWR-E PRN  Regulus Files Registration Statement for Proposed Initial Public Offering,,,,,,,,,,, 1/02/2014 N5946510  PRN  Mylan to Present at the J.P. Morgan 32nd Annual Healthcare Conference,,,11/16/2015 062PWN-E PRN  Ambrx Announces New Chief Medical Officer,,,,,,,,,,,,,,,,,,,,,," 8/20/2012 80105N10  PRN  Sklice® (ivermectin) Lotion, 0.5% Now Available in the US for Topical Treatment of Head Lice",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,10/24/2012 75886F10    PRN  Regeneron Reports Third Quarter 2012 Financial and Operating Results,,," 8/17/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Biogen, Alnylam Pharmaceuticals, Isis Pharmaceuticals, AstraZeneca and Sanofi",,,,,,,,,,, 1/02/2014 N5946510  PRN  Mylan to Present at the Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference,,,11/09/2015 AMGN-US  PRN  Amgen Presents Detailed Results From Phase 3 Study Demonstrating Clinical Equivalence Of Biosimilar Candidate ABP 501 With Adalimumab,,,,,,,,,,,,,,,,,,,,,," 8/20/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights: Watson Pharmaceuticals, Takeda Pharmaceutical, Pfizer, Sanofi and StanCorp Financial Group",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,10/18/2012 75886F10    PRN  Regeneron Announces Publication of EYLEA® (aflibercept) Injection Phase 3 VIEW 1 and VIEW 2 Studies in Ophthalmology,,, 8/15/2012 46222210 PRN  Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy,,,,,,,,,,," 1/02/2014 N5946510  PRN  Rakesh Bamzai Joins Mylan as President, India Commercial and Emerging Markets",,,11/08/2015 03116210 PRN  Amgen And Cytokinetics Announce Late-Breaking Presentation Of COSMIC-HF Trial At AHA Scientific Sessions 2015,,,,,,,,,,,,,,,,,,,,,," 8/17/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights: Biogen, Alnylam Pharmaceuticals, Isis Pharmaceuticals, AstraZeneca and Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,"10/10/2012 REGN-US     PRN  Regeneron to Report Third Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on October 24, 2012",,, 8/13/2012 46222210 PRN  Isis Pharmaceuticals Announces Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027,,,,,,,,,,,"12/25/2013 N5946510  PRN  Presentation of Clinical Study Data, Prestigious Accolades, and Acquisitions - Research Report on Celgene, UnitedHealth, AstraZeneca, Mylan, and Valeant",,,11/07/2015 AMGN-US  PRN  Amgen Presents Detailed Data Comparing Etelcalcetide With Cinacalcet In Patients With Secondary Hyperparathyroidism Receiving Hemodialysis,,,,,,,,,,,,,,,,,,,,,," 8/13/2012 80105N10  PRN  Sanofi Announces FDA Approval for Auvi-Q™, First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 9/28/2012 75886F10    PRN  EYLEA® (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Japan,,, 8/09/2012 46222210 PRN  Isis Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference,,,,,,,,,,,12/18/2013 N5946510  PRN  Mylan Announces Acquisition of Rights to Novel LAMA Respiratory Compound from Pfizer,,,11/06/2015 AMGN-US  PRN  FDA Accepts Amgen's New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide,,,,,,,,,,,,,,,,,,,,,, 8/08/2012 80105N10  PRN  Oxford BioMedica Announces Positive DSMB Review of Ongoing RetinoStat® and StarGen™ Clinical Studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 9/25/2012 06DDVL-E    PRN  The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Bayer, Boston Scientific, Medtronic and Edwards Lifesciences",,," 8/08/2012 46222210 PRN  Isis Pharmaceuticals Prices Offering of $201.25 Million of 2 3/4% Convertible Senior Notes, Including Exercise in Full of Over-Allotment Option",,,,,,,,,,,12/18/2013 N5946510  PRN  Actress Julie Bowen and Mylan Specialty Announce the Four Winning School Districts of the 'Raise Your Hand for Anaphylaxis Awareness' Competition,,,11/05/2015 AMGN-US  PRN  Amgen To Present At The Credit Suisse 24th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,," 8/06/2012 000D1R-E  PRN  Zacks Bull and Bear of the Day Highlights: Loews, Ford Motor, Bristol-Myers Squibb, Pfizer and Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 9/21/2012 75886F10    PRN  Regeneron Announces FDA Approval of EYLEA® (aflibercept) Injection For Macular Edema Following Central Retinal Vein Occlusion,,, 8/06/2012 46222210 PRN  Isis Pharmaceuticals Announces Proposed Offering of $175 Million of Convertible Senior Notes,,,,,,,,,,,12/17/2013 N5946510  PRN  Mylan Announces Settlement Agreement for First-to-File Generic Version of TARGRETIN®,,,11/05/2015 AMGN-US  PRN  Key Data For Amgen Medicines In Relapsed Multiple Myeloma And Acute Lymphoblastic Leukemia To Be Presented At ASH 2015,,,,,,,,,,,,,,,,,,,,,, 8/03/2012 80105N10  PRN  U.S. FDA Approves ZALTRAP® (ziv-aflibercept) After Priority Review for Previously Treated Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 9/21/2012 75886F10    PRN  Regeneron Named World's #1 Biopharmaceutical Employer in Science Magazine Annual Survey,,, 8/06/2012 46222210 PRN  Isis Reports Financial Results And Highlights For Second Quarter 2012,,,,,,,,,,,"12/17/2013 N5946510  PRN  Early Morning Technical Insight:Johnson & Johnson, Mylan, Brookdale Senior Living, and Array BioPharma",,,11/04/2015 03116210 PRN  Amgen Highlights Data To Be Presented At 2015 American College Of Rheumatology And Association For Rheumatology Health Professionals Annual Meeting,,,,,,,,,,,,,,,,,,,,,," 8/02/2012 07GVF3-E  PRN  Healthcare, Regulatory and Reimbursement Landscape - Australia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 9/21/2012 75886F10    PRN  EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Wet Age-Related Macular Degeneration in Europe,,, 8/03/2012 46222210 PRN  European Regulatory Authorities Approve Isis' Manufacturing Facility,,,,,,,,,,,"12/17/2013 N5946510  PRN  Clinical Study Data Presentation, Product Launches, Technology Deployments, and Stock Price Movements - Research Report on Celgene, Mylan, Valeant, Health Management, and CareFusion",,,11/02/2015 AMGN-US  PRN  Amgen To Highlight Cardiovascular Portfolio At American Heart Association Scientific Sessions 2015,,,,,,,,,,,,,,,,,,,,,, 7/30/2012 80105N10  PRN  Sanofi Pasteur to add 2D barcode to six more vaccines,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 8/29/2012 75886F10    PRN  Regeneron Announces September 2012 Investor Conference Presentations,,, 8/01/2012 46222210 PRN  Isis And Collaborators Alleviate Disease In Animal Models Of Myotonic Dystrophy,,,,,,,,,,,"12/09/2013 N5946510  PRN  Stock Price Movements, Completed Acquisitions, and New Clinical Studies - Research Report on UnitedHealth Group, Mylan, St. Jude Medical, and Cigna",,,10/28/2015 03116210 PRN  Amgen's Third Quarter 2015 Revenues Increased 14 Percent To $5.7 Billion And Adjusted Earnings Per Share (EPS) Increased 18 Percent To $2.72,,,,,,,,,,,,,,,,,,,,,," 7/30/2012 06DDVL-E  PRN  Zacks Bull and Bear of the Day Highlights: Texas Capital Bancshares, Ford Motor, Medivation, Sanofi and Johnson and Johnson",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 8/23/2012 EGO-CA      PRN  Critical Alerts For Citigroup, America Movil, Regeneron Pharmaceuticals, Allergan, and Eldorado Gold Released By InvestorsObserver",,, 7/23/2012 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Second Quarter 2012 Financial Results Conference Call,,,,,,,,,,,12/05/2013 N5946510  PRN  Mylan Launches Cabergoline Tablets,,,10/27/2015 AMGN-US  PRN  FDA Approves IMLYGIC™ (Talimogene Laherparepvec) As First Oncolytic Viral Therapy In The US,,,,,,,,,,,,,,,,,,,,,," 7/26/2012 80105N10  PRN  Sanofi: As expected, Q2 2012 Business EPS(1) impacted by the loss of exclusivity of Plavix® and Avapro® in the U.S.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 8/03/2012 75886F10    PRN  U.S. FDA Approves ZALTRAP® (ziv-aflibercept) After Priority Review for Previously Treated Metastatic Colorectal Cancer,,, 7/05/2012 46222210 PRN  Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference,,,,,,,,,,,12/04/2013 N5946510  PRN  Mylan Completes Acquisition of Agila to Create Leading Global Injectables Platform,,,"10/27/2015 03116210 PRN  Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A  Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure",,,,,,,,,,,,,,,,,,,,,," 7/24/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights:Bristol-Myers Squibb, Sanofi, Amylin Pharmaceuticals, Eli Lilly and Pfizer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 8/01/2012 06DDVL-E    PRN  The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, AFLAC, Morgan Stanley, Unum Group and Employers Holdings",,, 6/05/2012 46222210 PRN  Isis Pharmaceuticals to Present a General Corporate Update at Its 2012 Annual Meeting of Stockholders and Open House,,,,,,,,,,,"12/04/2013 N5946510  PRN  Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed",,,10/23/2015 03116210 PRN  Amgen Announces Webcast of 2015 Third Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,, 7/23/2012 80105N10  PRN  Sanofi US Launches Collaborate Activate Innovation Challenge,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 7/30/2012 75886F10    PRN  Regeneron Receives Complete Response Letter From FDA for ARCALYST® (rilonacept) sBLA for the Prevention of Gout Flares in Patients Initiating Uric Acid-lowering Therapies,,, 6/01/2012 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO™ data Presented at the European Atherosclerosis Society 2012 Meeting,,,,,,,,,,,12/01/2013 N5946510  PRN  Elton John AIDS Foundation and Mylan Give $1 Million to Nigeria for the Elimination of Mother-to-Child Transmission of HIV,,,10/23/2015 03116210 PRN  Amgen Receives CHMP Positive Opinion For IMLYGIC™ (Talimogene Laherparepvec),,,,,,,,,,,,,,,,,,,,,, 7/23/2012 80105N10  PRN  Oxford BioMedica Receives Funding Award from the Foundation Fighting Blindness for ongoing UshStat® Phase I/IIa study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 7/25/2012 75886F10    PRN  Regeneron Reports Second Quarter 2012 Financial and Operating Results,,, 5/30/2012 46222210 PRN  Isis Pharmaceuticals to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference,,,,,,,,,,,"11/27/2013 N5946510  PRN  Clinical Trial Enrollments, Bond Offerings, Innovative Solutions, Leadership Appointments, and Certifications - Research Report on Baxter, Mylan, Becton Dickinson, Align and Allscripts",,,"10/22/2015 03116210 PRN  Covered Call Alerts For Chipotle Mexican Grill, Horizon Pharma, Abbott Laboratories, Bank of America and Amgen Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,, 7/20/2012 80105N10  PRN  Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 7/24/2012 06DDVL-E    PRN  Zacks Bull and Bear of the Day Highlights: Regeneron Pharmaceuticals, Avery Dennison, Plains All American Pipeline, BP and Enterprise Products Partners",,, 5/29/2012 46222210 PRN  Isis Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference,,,,,,,,,,,11/25/2013 N5946510  PRN  Mylan-Biocon Receive First Indian Biosimilar Regulatory Approval for Herceptin®,,,10/21/2015 AMGN-US  PRN  Amgen Foundation Announces New $4 Million Commitment to Bring Hands-On Biotechnology Labs to Secondary School Students,,,,,,,,,,,,,,,,,,,,,," 7/18/2012 06RVC7-E  PRN  The Zacks Analyst Blog Highlights:AstraZeneca, The Medicines Company, Bristol-Myers Squibb, Sanofi and Eli Lily",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 7/20/2012 75886F10    PRN  Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody,,, 5/23/2012 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO™ data Presented at the European Atherosclerosis Society 2012 Meeting,,,,,,,,,,,"11/25/2013 N5946510  PRN  Teva and Mylan Settle Copaxone® Patent Litigation in France, the UK and the Netherlands",,,10/14/2015 03116210 PRN  Amgen Announces 2015 Fourth Quarter Dividend,,,,,,,,,,,,,,,,,,,,,, 7/18/2012 80105N10  PRN  Sanofi Signs Agreement for Type 1 Diabetes Research with Boston Academic Teaching Hospital,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 7/11/2012 75886F10    PRN  Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012",,, 5/14/2012 46222210 PRN  Isis Pharmaceuticals to Present A General Corporate Update at Its 2012 Annual Meeting of Stockholders and Open House,,,,,,,,,,,11/19/2013 N5946510  PRN  Mylan Announces Pricing of $2.0 Billion of Senior Notes,,,10/13/2015 03116210 PRN  Amgen And LabCentral Announce 2015 Golden Ticket Winners,,,,,,,,,,,,,,,,,,,,,, 7/17/2012 008W47-E  PRN  New Study Suggests That Use of Veracyte's Afirma® Gene Expression Classifier Helps to Significantly Reduce Surgeries in Patients with Ambiguous Thyroid Nodule Cytology Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 7/09/2012 080VNJ-E    PRN  The Galien Foundation Announces Roster of Luminary Presenters for Third Galien Forum; Program Highlights Include CEO Panel, Panel on Alzheimer's Disease Innovation, Nobel Laureate Elie Wiesel",,, 5/09/2012 46222210 PRN  Isis Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference,,,,,,,,,,,"11/19/2013 N5946510  PRN  Technical Study: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc.",,,10/12/2015 03116210 PRN  New Data Show Consistent Safety Profile For Up To 10 Years With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis,,,,,,,,,,,,,,,,,,,,,, 7/16/2012 80105N10  PRN  Sanofi Pasteur Begins Shipping Fluzone® Influenza Virus Vaccine in U.S. for 2012-2013 Season,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 6/14/2012 000VC1-E    PRN  Regeneron Pharmaceuticals, Inc.: PharmaVitae Report",,, 5/08/2012 46222210 PRN  Isis Reports Financial Results and Highlights for First Quarter 2012,,,,,,,,,,,"11/19/2013 N5946510  PRN  Federal Legislation Support, Philanthropic Activities, and Patent Challenges - Research Report on Mylan, Abbott, Actavis, AbbVie, and Agilent Technologies",,,10/12/2015 AMGN-US  PRN  New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide,,,,,,,,,,,,,,,,,,,,,, 7/16/2012 SNY-FR    PRN  Sanofi US Announces 2012 Data Design Diabetes Innovation Challenge Winner,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/30/2012 75886F10    PRN  Regeneron Announces June 2012 Investor Conference Presentations,,, 5/04/2012 46222210 PRN  Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia,,,,,,,,,,,"11/18/2013 N5946510  PRN  Mylan Launches First Generic Focalin XR® Capsules, 30 mg",,,10/11/2015 03116210 PRN  New Data Show Greater Bone Mineral Density Gains With Prolia® (Denosumab) Compared With Zoledronic Acid,,,,,,,,,,,,,,,,,,,,,, 7/12/2012 SNY-FR    PRN  Sanofi Biosurgery Product MACI® Demonstrates Statistically Significant Clinical Outcomes Compared to Microfracture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/26/2012 75886F10    PRN  Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet,,, 4/30/2012 46222210 PRN  Regulus Therapeutics Appoints Bruce Carter to its Board of Directors,,,,,,,,,,,11/14/2013 N5946510  PRN  Mylan Applauds New Federal Legislation to Increase Anaphylaxis Preparedness in Schools,,,"10/08/2015 03116210 PRN  Covered Call Alerts For Alibaba, Amgen, Windstream, Lumber Liquidators and BP Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,," 7/02/2012 SNY-FR    PRN  Stock Alerts For Amazon.com, Coventry Healthcare, Sanofi, Agilent Technologies, and Illinois Tool Works Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 5/10/2012 75886F10    PRN  Critical Alerts For NVIDIA, Ingersoll Rand, Sotheby's, Nuance Communications, and Regeneron Pharmaceuticals Released By InvestorsObserver",,, 4/25/2012 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' First Quarter 2012 Financial Results Conference Call,,,,,,,,,,,"11/11/2013 N5946510  PRN  Scheduled Conferences, Product Breakthroughs, and Approvals - Research Report on Mylan, Baxter, Actavis, Thermo Fisher, and BD",,,10/06/2015 03116210 PRN  Amgen Announces Repatha™ Co-Preferred Position on Express Scripts National Formulary,,,,,,,,,,,,,,,,,,,,,, 6/19/2012 80105N10  PRN  Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/10/2012 75886F10    PRN  Regeneron Announces Presentation at the Bank of America Merrill Lynch 2012 Healthcare Conference,,, 4/23/2012 46222210 PRN  Rescheduled Webcast: Isis Pharmaceuticals Holds Webcast to Discuss Clinical Development Plans for ISIS-APOCIIIRx,,,,,,,,,,,11/11/2013 N5946510  PRN  Mylan Launches Generic Version of Aciphex® Tablets,,,10/06/2015 AMGN-US  PRN  Amgen To Give 23 Presentations On Osteoporosis Disease And Treatment At American Society For Bone And Mineral Research Annual Meeting,,,,,,,,,,,,,,,,,,,,,," 6/18/2012 079BB3-E  PRN  KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/09/2012 75886F10    PRN  Regeneron Announces Participation in J. P. Morgan Biotech: CEO/CFO Conference Call Series,,, 4/18/2012 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Holds Webcast to Discuss Clinical Development Plans for ISIS-APOCIIIRx,,,,,,,,,,,11/06/2013 N5946510  PRN  Mylan to Present at the 2013 Credit Suisse Healthcare Conference,,,10/02/2015 03116210 PRN  Amgen To Present At The Barclays Biosimilars Symposium,,,,,,,,,,,,,,,,,,,,,, 6/15/2012 07844T-E  PRN  Sanofi US and the Alliance for a Healthier Generation Announce a New Model For the Private Sector to Combat Childhood Obesity,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/08/2012 75886F10    PRN  Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection,,, 3/30/2012 46222210 PRN  Isis Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference,,,,,,,,,,,11/01/2013 N5946510  PRN  Mylan Confirms First-to-File Patent Challenge Relating to Uloric®,,, 9/30/2015 NBIX-US  PRN  Neurocrine Biosciences Announces the Appointment of George J. Morrow to its Board of Directors,,,,,,,,,,,,,,,,,,,,,," 6/13/2012 80105N10  PRN  As Pertussis Cases Climb, Survey Shows Most Parents With Young Children Overlook Vital Precaution That Helps Protect Babies",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/08/2012 75886F10    PRN  Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan,,, 3/22/2012 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Hosts Dr. Raul Santos to Review KYNAMRO™ Data That Will Have Been Presented at ISA 2012 - XVI International Symposium on Atherosclerosis,,,,,,,,,,,"11/01/2013 N5946510  PRN  Earnings Releases, Research Results, and Stock Price Movements - Research Report on UnitedHealth Group, Mylan, Chemed, C.R. Bard, and Universal Health Services",,," 9/29/2015 03116210 PRN  Technical Coverage on Diverse Sectors - American Capital, ARIAD Pharmaceuticals, Endo International, Amgen and Express Scripts",,,,,,,,,,,,,,,,,,,,,, 6/11/2012 80105N10  PRN  New Epidemiological Data Provide Additional Safety Evidence for Lantus®,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 4/26/2012 75886F10    PRN  Regeneron Reports First Quarter 2012 Financial and Operating Results,,, 3/08/2012 46222210 PRN  Isis Pharmaceuticals to Present at the Barclays Capital 2012 Global Healthcare Conference,,,,,,,,,,,10/31/2013 N5946510  PRN  Mylan Reports Third Quarter 2013 Adjusted Diluted EPS of $0.82,,, 9/25/2015 AMGN-US  PRN  Amgen Receives CHMP Positive Opinions For Two New Treatment Options For Patients With Blood Cancer In Europe,,,,,,,,,,,,,,,,,,,,,," 6/11/2012 80105N10  PRN  Sanofi Announces Results of ORIGIN, the World's Longest and Largest Randomized Clinical Trial in Pre- and Early Diabetes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 4/12/2012 75886F10    PRN  Regeneron to Report First Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on April 26, 2012",,," 3/07/2012 46222210 PRN  Isis Initiates Phase 1 Study in Patients With Cancer With the First Generation 2.5 Antisense Drug, ISIS-STAT3Rx",,,,,,,,,,,"10/30/2013 N5946510  PRN  New Appointments, Upcoming Earnings Releases, Regulatory Approvals, Status Updates and Informative Resources for New Treatment Options - Research Report on Mylan, Alkermes, Salix, Ligand and Hospira",,, 9/23/2015 03116210 PRN  Amgen To Present New Kyprolis® (carfilzomib) Data At 15th International Myeloma Workshop,,,,,,,,,,,,,,,,,,,,,, 6/09/2012 SNY-FR    PRN  Lyxumia® (lixisenatide) in Combination with Basal Insulin plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 4/05/2012 75886F10    PRN  Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP® (aflibercept),,, 3/05/2012 46222210 PRN  Isis Pharmaceuticals to Present at the 24th Annual ROTH Conference,,,,,,,,,,,10/17/2013 N5946510  PRN  Mylan Appoints Jacek Glinka as President of Mylan's European Business,,, 9/23/2015 03116210 PRN  Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215,,,,,,,,,,,,,,,,,,,,,, 6/09/2012 80105N10  PRN  Lantus® Initiation after Metformin Achieved Superior Glycemic Control versus Sitagliptin in Type 2 Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 3/28/2012 000C35-E    PRN  The Zacks Analyst Blog Highlights: Amgen, Sanofi, Regeneron, Alnylam and Coach",,, 2/29/2012 46222210 PRN  Isis Reports Financial Results and Highlights for 2011,,,,,,,,,,,10/07/2013 N5946510  PRN  Mylan Schedules Third Quarter 2013 Financial Results Conference Call and Live Webcast,,, 9/18/2015 AMGN-US  PRN  FDA Grants Priority Review for Amgen's Supplemental New Drug Application for Expanded Labeling of Kyprolis® (Carfilzomib) in Relapsed Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,, 6/06/2012 0B1T2F-E  PRN  Low Awareness of Meningococcal Disease and New Vaccination Recommendations Putting Dallas-Fort Worth Teens at Risk; School Nurses Rally Community in Response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 3/26/2012 75886F10    PRN  Sanofi and Regeneron Report Phase 2 Data for Potential First-in-Class Lipid-Lowering PCSK9 Antibody,,, 2/28/2012 46222210 PRN  Isis Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference,,,,,,,,,,,"10/04/2013 N5946510  PRN  Morning Research: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc.",,, 9/16/2015 AMGN-US  PRN  Amgen To Acquire Privately-Held Dezima Pharma,,,,,,,,,,,,,,,,,,,,,, 6/05/2012 0B1T2F-E  PRN  Low Awareness of Meningococcal Disease and New Vaccination Recommendations Putting Minneapolis-St. Paul Teens at Risk; School Nurses Rally Community in Response,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 3/21/2012 75886F10    PRN  Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody,,, 2/22/2012 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' 2011 Financial Results and Highlights Conference Call,,,,,,,,,,," 9/23/2013 N5946510  PRN  Mylan Supports Generic Drug Industry's Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming",,, 9/16/2015 03116210 PRN  Amgen And Xencor Announce Strategic Collaboration In Cancer Immunotherapy And Inflammation,,,,,,,,,,,,,,,,,,,,,," 6/05/2012 SNY-FR    PRN  Sanofi Transforms Data Center with EMC VPLEX to Migrate 4,000 Applications",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 3/13/2012 75886F10    PRN  Critical Alerts for Oracle, CME, Alexion, Regeneron, and Hershey Released by Seven Summits Research",,, 2/21/2012 46222210 PRN  Isis Pharmaceuticals to Present at the 2012 Citi Global Health Care Conference,,,,,,,,,,," 9/16/2013 N5946510  PRN  New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline",,, 9/15/2015 AMGN-US  PRN  Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 5/26/2012 80105N10  PRN  Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 3/09/2012 75886F10    PRN  Regeneron Announces Change in Date for Presentation at Barclays Capital 2012 Global Healthcare Conference,,, 2/16/2012 46222210 PRN  Regulus Announces New Publication Showing Potential Therapeutic Benefit of Targeting microRNA-21 in Fibrosis,,,,,,,,,,," 9/13/2013 N5946510  PRN  New Products, Philanthropic Initiative, Approved Acquisitions, and Pipeline Developments Boost Growth - Research Report on Mylan, UnitedHealth, GSK, Actavis, and Mallinckrodt",,, 9/14/2015 03116210 PRN  Amgen Highlights Key Clinical Data To Be Presented At European Cancer Congress 2015,,,,,,,,,,,,,,,,,,,,,," 5/22/2012 06DDVL-E  PRN  The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr. Reddy's Laboratories",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 3/08/2012 75886F10    PRN  Regeneron and Bayer Announce Approval of EYLEA® (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia,,, 2/08/2012 46222210 PRN  Isis Pharmaceuticals to Present at Leerink Swann's 2012 Global Healthcare Conference,,,,,,,,,,, 9/05/2013 N5946510  PRN  Mylan to Speak at the Bank of America Merrill Lynch Global Healthcare Conference,,, 9/11/2015 AMGN-US  PRN  Amgen To Present At The Morgan Stanley Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 5/21/2012 SNY-FR    PRN  R&D Trends 2012 - Pharmaceutical Companies use Externalization & Collaboration to Drive Growth,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 2/28/2012 75886F10    PRN  Regeneron Announces March 2012 Investor Conference Presentations,,," 1/13/2012 000KN2-E PRN  The Zacks Analyst Blog Highlights: General Motors, Toyota Motor, Ford Motor, Biogen Idec and Isis Pharmaceuticals",,,,,,,,,,, 9/05/2013 N5946510  PRN  Mylan to Speak at the Morgan Stanley Global Healthcare Unplugged Conference,,, 9/11/2015 AMGN-US  PRN  Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab),,,,,,,,,,,,,,,,,,,,,, 5/02/2012 06QBGB-E  PRN  Sanofi iBGStar® Blood Glucose Monitoring System Now Available in the U.S.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 2/21/2012 75886F10    PRN  Regeneron Announces February 2012 Investor Conference Presentations,,, 1/05/2012 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Announces Its R&D Webcast Presentation,,,,,,,,,,," 9/02/2013 N5946510  PRN  Approvals, Acquisitions, Note Redemptions and Invitations to Conferences - Research Report on Mylan, Warner Chilcott, Salix Pharmaceuticals, Mallinckrodt, and Akorn",,, 9/08/2015 0DV5QV-E PRN  Rheumatologists Report Widespread Adoption And Anticipated Gains For Celgene's Otezla In Psoriatic Arthritis (PsA),,,,,,,,,,,,,,,,,,,,,, 5/02/2012 0BDK6C-E  PRN  Therapy Trends: Multiple Sclerosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 2/13/2012 75886F10    PRN  Regeneron Announces Presentation at the Leerink Swann 2012 Global Healthcare Conference,,, 1/05/2012 46222210 PRN  Regulus Therapeutics to Present microRNA Platform and Pipeline Updates at Two Leading Scientific Conferences,,,,,,,,,,," 8/29/2013 N5946510  PRN  Pre-Market Review: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc.",,, 9/02/2015 AMGN-US  PRN  Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency,,,,,,,,,,,,,,,,,,,,,, 5/01/2012 80105N10  PRN  Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 2/13/2012 75886F10    PRN  Regeneron Reports Fourth Quarter and Full Year 2011 Financial and Operating Results,,, 1/05/2012 46222210 PRN  ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein,,,,,,,,,,," 8/22/2013 N5946510  PRN  Mylan Confirms Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg",,, 9/01/2015 03116210 PRN  Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs,,,,,,,,,,,,,,,,,,,,,, 4/27/2012 80105N10  PRN  Sanofi: Strong performance in Q1 2012 including Genzyme contribution,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 2/10/2012 75886F10    PRN  Regeneron Announces February 13, 2012 as Date of Full Year 2011 Financial and Operating Results Conference Call and Webcast",,,12/20/2011 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Announces Its R&D Webcast Presentation,,,,,,,,,,, 8/14/2013 N5946510  PRN  Mylan Kicks Off Second Year of Providing Free EpiPen® (epinephrine) Auto-Injectors to U.S. Schools,,, 9/01/2015 03116210 PRN  Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide,,,,,,,,,,,,,,,,,,,,,," 4/24/2012 SAN-FR    PRN  Critical Alerts For Wells Fargo, Sanofi Aventis, Delta, InterActiveCorp, and DeVry Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 1/26/2012 75886F10    PRN  Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012",,,12/20/2011 46222210 PRN  Isis Initiates Phase 1 Clinical Trial of ISIS-FGFR4Rx a Peripherally Acting Drug to Treat Obesity,,,,,,,,,,, 8/01/2013 N5946510  PRN  Mylan Reports a 13% Increase in Second Quarter 2013 Adjusted Diluted EPS to $0.68,,, 8/27/2015 03116210 PRN  FDA Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab),,,,,,,,,,,,,,,,,,,,,, 4/19/2012 80105N10  PRN  Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 1/12/2012 BTUUQ-US    PRN  Critical Alerts for Coca-Cola, Apache, Peabody Energy, Regeneron, and Ann Inc. Released by Seven Summits Research",,,12/19/2011 46222210 PRN  Isis Initiates Phase 1 Clinical Study of ISIS-SMNRx in Patients With Spinal Muscular Atrophy,,,,,,,,,,," 7/18/2013 N5946510  PRN  Mylan to Host Investor Day on Aug. 1, 2013 in New York City",,, 8/25/2015 AMGN-US  PRN  Amgen To Present New Long-Term Repatha™ (Evolocumab) Data Analysis At ESC Congress 2015,,,,,,,,,,,,,,,,,,,,,, 4/17/2012 06SD18-E  PRN  Quality Standards Established for Competition to Identify Best Researchers in the US,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 1/03/2012 75886F10    PRN  Regeneron Announces Presentation at the 30th Annual J. P. Morgan Healthcare Conference,,,12/15/2011 46222210 PRN  Isis Updates KYNAMRO Submission Timeline,,,,,,,,,,, 7/18/2013 N5946510  PRN  Teva Found on Summary Judgment to Infringe Mylan Patent for Perforomist® Inhalation Solution,,, 8/25/2015 AMGN-US  PRN  Amgen Submits New Drug Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416),,,,,,,,,,,,,,,,,,,,,," 4/09/2012 002VD4-E  PRN  Noah Rosenberg, MD, Joins Esperion Therapeutics as Chief Medical Officer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 1/03/2012 RO-CH       PRN  Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection,,,12/14/2011 46222210 PRN  Isis Adds Three New Drugs to Its Development Pipeline,,,,,,,,,,, 7/16/2013 N5946510  PRN  Court Finds in Favor of Mylan in Patent Infringement Suit Related to Certain Teva Copaxone® Patents,,," 8/18/2015 03116210 PRN  Amgen And University Of California, Berkeley Announce Multi-Year Partnership To Assist Cancer Patient Advocacy Organizations In Measuring Effectiveness Of Programs",,,,,,,,,,,,,,,,,,,,,, 4/05/2012 80105N10  PRN  Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP® (aflibercept),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 1/02/2012 RO-CH       PRN  Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation,,,12/12/2011 46222210 PRN  Isis Reports Positive Phase 1 Data Demonstrating ISIS-FXIRx Reduces Factor XI Activity Without Bleeding,,,,,,,,,,," 7/16/2013 N5946510  PRN  Mylan Launches Generic Nor-Q.D.® Tablets, 0.35 mg (28-Day Cycle)",,, 7/30/2015 AMGN-US  PRN  Amgen Announces Appointment Of Fred Hassan To Board Of Directors,,,,,,,,,,,,,,,,,,,,,, 3/29/2012 SAN-FR    PRN  Canadians Living with Diabetes Get the STAR Treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,12/08/2011 ENS-US      PRN  S&P Indices Announces Changes to U.S. Indices,,,12/12/2011 46222210 PRN  Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer,,,,,,,,,,, 7/15/2013 N5946510  PRN  Mylan Launches One of the First Generic Versions of Trilipix® Capsules,,, 7/30/2015 03116210 PRN  Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57,,,,,,,,,,,,,,,,,,,,,," 3/28/2012 000C35-E  PRN  The Zacks Analyst Blog Highlights: Amgen, Sanofi, Regeneron, Alnylam and Coach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,"12/08/2011 UAL-US      PRN  Critical Alerts For Home Depot, UPS, Juniper Networks, United Continental Holdings, and Regeneron Released By Seven Summits Research",,,12/08/2011 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Holds Webcast to Discuss Recent Additions to its Development Pipeline,,,,,,,,,,, 7/15/2013 N5946510  PRN  Mylan Confirms First-to-File Patent Challenge Relating to Vimpat(R),,," 7/29/2015 03116210 PRN  Critical Alerts For Seadrill, Amgen, Ariad Pharmaceuticals, Johnson Controls and ACADIA Pharmaceuticals Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,, 3/27/2012 SAN-FR    PRN  Media Advisory: Sanofi Canada celebrates the launch of STARsystem - a revolutionary new diabetes management system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,12/05/2011 75886F10    PRN  Two Year Results of Phase 3 Studies with EYLEA™ (aflibercept) Injection in wet AMD Show Sustained Improvement in Visual Acuity,,,12/06/2011 46222210 PRN  Isis Reports Positive Phase 1 Data Demonstrating ISIS-APOCIIIRx Produces Significant Reductions in apoC-III Protein Levels and Triglycerides,,,,,,,,,,, 7/11/2013 N5946510  PRN  Mylan Confirms First-to-File Patent Challenge Relating to CANASA®,,, 7/28/2015 AMGN-US  PRN  Amgen Announces 2015 Third Quarter Dividend,,,,,,,,,,,,,,,,,,,,,, 3/26/2012 80105N10  PRN  Sanofi and Regeneron Report Phase 2 Data for Potential First-in-Class Lipid-Lowering PCSK9 Antibody,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,12/01/2011 75886F10    PRN  Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST,,,"12/06/2011 07PDMR-E PRN  New Auction of Lab Equipment from Acadia, Elan, Isis, Illumina and More",,,,,,,,,,, 7/08/2013 N5946510  PRN  U.S. District Court Issues Final Judgment in Favor of Mylan in Patent Infringement Litigation Against Sunovion's Brovana® Product,,, 7/27/2015 03116210 PRN  Amgen Announces Webcast of 2015 Second Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,," 3/16/2012 80105N10  PRN  Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/28/2011 75886F10    PRN  Regeneron and Bayer Initiate Phase 3 Clinical Program for the Treatment of Wet Age-Related Macular Degeneration in China,,,11/30/2011 46222210 PRN  United States Patent and Trademark Office Upholds Key Santaris Pharma A/S LNA Patents in Two Re-Examination Cases Brought by Isis Pharmaceuticals,,,,,,,,,,," 6/30/2013 N5946510  PRN  Mylan and Zyomyx Enter into Exclusive Distribution Agreement for Innovative Point-of-Care CD4 Diagnostic Test, Enhancing Mylan's Leadership Position in HIV Care",,, 7/24/2015 AMGN-US  PRN  FDA Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,, 3/14/2012 0865G4-E  PRN  WPEO Recognizes Outstanding Women Business Owners and Corporations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/23/2011 75886F10    PRN  Regeneron Announces Upcoming Investor Conference Presentations,,,11/23/2011 46222210 PRN  Isis Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference,,,,,,,,,,, 6/27/2013 N5946510  PRN  Mylan Expresses Support for National HIV Testing Day,,, 7/23/2015 AMGN-US  PRN  Amgen Submits Supplemental New Drug Application For Kyprolis® (Carfilzomib) In Relapsed Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,, 2/23/2012 80105N10  PRN  Sanofi US Launches 2012 Data Design Diabetes Innovation Challenge,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/22/2011 75886F10    PRN  Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review,,,11/22/2011 46222210 PRN  Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals,,,,,,,,,,, 6/27/2013 N5946510  PRN  Mylan Launches Innovative Portfolio of Women's Care Products in India,,," 7/22/2015 03116210 PRN  Biotechnology Sector Stocks Technical Coverage -- Amgen, Exelixis, XOMA Corp., Theravance, and NewLink Genetics",,,,,,,,,,,,,,,,,,,,,," 2/09/2012 BHC-CA    PRN  The Zacks Analyst Blog Highlights: Western Union, Mylan, Valeant Pharmaceuticals, Sanofi and Pfizer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/21/2011 75886F10    PRN  Rockefeller University President Marc Tessier-Lavigne Elected to Regeneron Board of Directors,,,11/08/2011 46222210 PRN  Regulus Therapeutics to Present New In Vivo Data for microRNA-21 in Kidney Fibrosis,,,,,,,,,,, 6/26/2013 N5946510  PRN  Mylan Launches Generic Version of Viagra® in 11 European Countries,,," 7/21/2015 03116210 PRN  European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol",,,,,,,,,,,,,,,,,,,,,, 2/08/2012 SNY-FR    PRN  Sanofi: 2011 Results Benefit from Genzyme Acquisition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/18/2011 75886F10    PRN  Multimedia: Regeneron Announces FDA Approval of EYLEA™ (Aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration,,,11/07/2011 46222210 PRN  Isis Reports Financial Results and Highlights for Third Quarter 2011,,,,,,,,,,," 6/26/2013 N5946510  PRN  Mylan Launches Generic Micronor® Tablets, 0.35 mg (28-Day Cycle)",,, 7/16/2015 03116210 PRN  Amgen Announces Positive BLINCYTO® (blinatumomab) Phase 2 Study Results In Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,,, 2/07/2012 0072XH-E  PRN  Sanofi Announces FDA Approval of Sklice® Lotion for the Treatment of Head Lice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,"11/18/2011 75886F10    PRN  /C O R R E C T I O N -- Regeneron Pharmaceuticals, Inc./",,,11/02/2011 46222210 PRN  Isis Initiates Phase 1 Studies with Isis-GCGRRx and Isis-GCCRRx to Treat Type 2 Diabetes,,,,,,,,,,, 6/24/2013 N5946510  PRN  Roger Graham Named President of Mylan Specialty,,," 6/30/2015 07LTNR-E PRN  Genisphere Appoints New CEO, Thomas Bliss",,,,,,,,,,,,,,,,,,,,,, 2/06/2012 BHC-CA    PRN  Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/10/2011 75886F10    PRN  Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia,,,10/26/2011 46222210 PRN  Webinar Advisory: Regulus to Host Discussion About Potential of microRNA-33 as Target for Treatment of Atherosclerosis,,,,,,,,,,, 6/18/2013 N5946510  PRN  Mylan Announces Pricing of Senior Notes,,, 6/30/2015 00BZD4-E PRN  HUYA Bioscience International Expands Senior Management Team,,,,,,,,,,,,,,,,,,,,,," 1/30/2012 000JHP-E  PRN  The Zacks Analyst Blog Highlights: J. C. Penney, Kohl's, Macy's, Novartis and Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/07/2011 75886F10    PRN  Regeneron Announces Presentation at the 2011 Credit Suisse Annual Healthcare Conference,,,10/25/2011 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Third Quarter 2011 Financial Results Conference Call,,,,,,,,,,, 6/18/2013 N5946510  PRN  Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign,,, 6/22/2015 03116210 PRN  Celimmune to Present Experimental Anti-IL-15 Antibody AMG 714 at 16th International Coeliac Disease Symposium,,,,,,,,,,,,,,,,,,,,,," 1/26/2012 80105N10  PRN  NBA, American Diabetes Association and Sanofi US Tip Off 2012 Dribble to Stop Diabetes Campaign",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,10/27/2011 75886F10    PRN  Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be Presented as a Late-Breaking Poster at the 2011 American College of Rheumatology Annual Meeting,,,10/24/2011 46222210 PRN  Webinar Advisory: Regulus to Host Discussion About Potential of microRNA-33 as Target for Treatment of Atherosclerosis,,,,,,,,,,, 6/12/2013 N5946510  PRN  Mylan to Speak at the Goldman Sachs 34th Annual Global Healthcare Conference,,, 6/19/2015 03116210 PRN  Amgen Presents Open-Label Extension Data From Ongoing Phase 2 Study Of AMG 334 In The Prevention Of Episodic Migraine,,,,,,,,,,,,,,,,,,,,,, 1/19/2012 80105N10  PRN  Catalina Council Boy Scouts Partner With Sanofi US Tucson Research Center to Host First-Ever Chemistry Merit Badge Program,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,10/27/2011 75886F10    PRN  Regeneron Reports Third Quarter 2011 Financial and Operating Results,,,10/20/2011 46222210 PRN  Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism,,,,,,,,,,," 6/06/2013 N5946510  PRN  New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix",,, 6/18/2015 03116210 PRN  Results From Phase 3 Trial Show Vectibix® (Panitumumab) Improves Overall Survival In Chemorefractory Wild-Type KRAS Metastatic Colorectal Cancer Versus Best Supportive Care,,,,,,,,,,,,,,,,,,,,,, 1/16/2012 0B9W6F-E  PRN  Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,"10/18/2011 75886F10    PRN  Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016",,,"10/11/2011 46222210 PRN  Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease",,,,,,,,,,, 5/29/2013 N5946510  PRN  Mylan Specialty L.P. Announces Partnership with Baseball Teams Across Country to Raise Awareness of Potentially Life-Threatening Allergies,,, 6/10/2015 03116210 PRN  Amgen To Discuss Details Of Repatha™ (Evolocumab) Biologics License Application For The Treatment Of High Cholesterol,,,,,,,,,,,,,,,,,,,,,, 1/12/2012 005M9Z-E  PRN  PharmaVentures' Client Sanofi Wins Scrip 'Outsourcing Deal of the Year Award',,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,10/17/2011 75886F10    PRN  Regeneron Pharmaceuticals Announces Proposed Offering of Convertible Senior Notes due 2016,,, 9/26/2011 0017CR-E PRN  iCo Therapeutics and JDRF Partner to Investigate iCo-007 in Diabetic Macular Edema,,,,,,,,,,," 5/21/2013 N5946510  PRN  ""Modern Family"" Star Julie Bowen Calls on Communities to Raise Their Hand for Anaphylaxis Awareness in Nationwide Competition",,, 6/08/2015 03116210 PRN  Amgen To Present At The Goldman Sachs Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,," 1/10/2012 061XJ9-E  PRN  UCSF, Sanofi Collaborate to Find New Diabetes Cures",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 9/23/2011 75886F10    PRN  Regeneron Announces ZALTRAP® Clinical Presentation at European Multidisciplinary Cancer Congress,,, 9/23/2011 46222210 PRN  Isis Pharmaceuticals Files Patent Infringement Suit Against Santaris Pharma,,,,,,,,,,, 5/21/2013 N5946510  PRN  Federal Appellate Court Rules in Favor of Mylan in Patent Infringement Litigation Relating to Sunovion's Brovana® Product,,, 6/05/2015 03116210 PRN  Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease,,,,,,,,,,,,,,,,,,,,,," 1/10/2012 SAN-FR    PRN  The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, Inhibitex, Gilead Sciences and Pharmasset",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 9/20/2011 000VC1-E    PRN  Equity Research for NASDAQ's Top Price Gainer: Priceline.com, Mako Surgical, & Regeneron Pharmaceuticals",,," 9/20/2011 46222210 PRN  Isis Pharmaceuticals and BioMed Realty Trust Celebrate Grand Opening of New R&D Facility in Carlsbad, California",,,,,,,,,,, 5/17/2013 N5946510  PRN  Mylan Launches Generic Tricor® Tablets,,, 6/02/2015 03116210 PRN  Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab,,,,,,,,,,,,,,,,,,,,,, 1/09/2012 08CP0Z-E  PRN  Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 9/15/2011 75886F10    PRN  Regeneron Ranked by Science Magazine as the #2 Employer in the Global Biopharmaceutical Industry,,, 9/13/2011 46222210 PRN  Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference,,,,,,,,,,, 5/15/2013 N5946510  PRN  Mylan Launches Generic Zomig® Tablets,,, 6/01/2015 03116210 PRN  Amgen Presents Phase 3 Data At ASCO Showing Prolia® (Denosumab) Significantly Reduced Bone Fractures In Breast Cancer Patients Receiving Aromatase Inhibitors,,,,,,,,,,,,,,,,,,,,,, 1/05/2012 80105N10  PRN  Sanofi Announces Court Ruling Granting Preliminary Injunction Against Synvisc-One® Competitor Product,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 9/06/2011 000PP9-E    PRN  Hot Stock Research for eBay, Medtronic, RF Micro Devices, Regeneron Pharmaceuticals, Amazon.com & Crocs",,, 9/08/2011 46222210 PRN  Rescheduled Webcast: Isis Pharmaceuticals Hosts Dr. John Kastelein to Review Mipomersen Long-term Data Recently Presented at ESC Congress 2011,,,,,,,,,,, 5/10/2013 N5946510  PRN  Presenting Sponsor Mylan Specialty L.P. Calls on Communities Nationwide to Join The Food Allergy Research & Education (FARE) Walk for Food Allergy,,, 5/31/2015 03116210 PRN  Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (carfilzomib) in Patients With Relapsed And Refractory Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,, 1/05/2012 80105N10  PRN  American Academy of Pediatrics and Sanofi Pasteur Announce the Launch of Two-Dimensional (2D) Barcoding in Pediatric Offices,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 9/06/2011 75886F10    PRN  Regeneron Announces Appointment of Joseph J. LaRosa as Senior Vice President, General Counsel and Secretary",,, 9/08/2011 46222210 PRN  Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer,,,,,,,,,,, 5/02/2013 N5946510  PRN  Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62,,, 5/29/2015 03116210 PRN  Amgen And Merck Announce Expansion Of Collaboration To Support Studies Of Talimogene Laherparepvec In Combination With KEYTRUDA® (Pembrolizumab) In Patients With Head And Neck Cancer,,,,,,,,,,,,,,,,,,,,,,12/20/2011 07NPC1-E  PRN  Scores of Colleges Upgrade to e2Campus in 2011,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 8/31/2011 75886F10    PRN  Regeneron Announces September 2011 Investor Conference Presentations,,, 9/06/2011 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Hosts Dr. John Kastelein to Review Mipomersen Long-term Data Recently Presented at ESC Congress 2011,,,,,,,,,,," 4/30/2013 N5946510  PRN  Deborah Autor, FDA's Deputy Commissioner for Global Regulatory Operations and Policy, to Join Mylan",,, 5/29/2015 03116210 PRN  Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease,,,,,,,,,,,,,,,,,,,,,,12/19/2011 80105N10  PRN  Valeant Pharmaceuticals Completes Acquisition of Dermik,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 8/18/2011 75886F10    PRN  Critical Alerts for AT&T, Clorox, Expedia, Chico's, and Regeneron Pharmaceuticals Released by Seven Summits Research",,, 9/01/2011 46222210 PRN  Isis Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011,,,,,,,,,,, 4/25/2013 N5946510  PRN  Mylan Specialty L.P. Announces 25th Anniversary Celebration of EpiPen® (epinephrine) Auto-Injector,,, 5/28/2015 03116210 PRN  Amgen Launches Program To Further Advance Basic Biology Research,,,,,,,,,,,,,,,,,,,,,,12/14/2011 GSK-GB    PRN  Global Vaccine Market 2010-2014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 8/17/2011 75886F10    PRN  Regeneron Announces Clinical Presentations at ASRS 2011 Annual Meeting,,, 8/11/2011 46222210 PRN  Isis and CHDI Foundation Renew Drug Development Collaboration for Huntington's Disease,,,,,,,,,,, 4/22/2013 N5946510  PRN  Mylan Announces $1 Million Gift to The Pittsburgh Promise Scholarship Fund,,, 5/27/2015 03116210 PRN  Amgen To Present At The Jefferies 2015 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,12/12/2011 0BYDKH-E  PRN  Valeant Pharmaceuticals Receives Approval From FTC in Connection With Acquisition of Ortho Dermatologics and Dermik,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 8/16/2011 75886F10    PRN  Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA,,, 8/04/2011 46222210 PRN  Isis Reports Financial Results and Highlights for Second Quarter 2011,,,,,,,,,,, 4/09/2013 N5946510  PRN  Mylan Schedules First Quarter 2013 Financial Results Conference Call and Live Webcast,,, 5/27/2015 03116210 PRN  Amgen To Advance Understanding Of The Treatment Of Blood Cancers At 20th Congress of European Hematology Association (EHA),,,,,,,,,,,,,,,,,,,,,,"12/08/2011 005M9Z-E  PRN  During This Holiday Season, Uninsured Patients Face a Huge Challenge With Affordable Medication Access",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 8/03/2011 AMN-US      PRN  Zacks Sell List Highlights: Ameron International, Watsco, Regeneron Pharmaceuticals and Amedisys",,, 7/21/2011 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Second Quarter 2011 Financial Results Conference Call,,,,,,,,,,, 4/03/2013 N5946510  PRN  Mylan Launches First Generic Version of Zovirax® Ointment,,, 5/26/2015 03116210 PRN  Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma,,,,,,,,,,,,,,,,,,,,,,"12/05/2011 0705XZ-E  PRN  The European Institute Honors Christine Lagarde, Managing Director of the International Monetary Fund and Dr. Elias Zerhouni, President of Global R&D, Sanofi with the Prestigious Transatlantic Leadership Award",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 7/28/2011 75886F10    PRN  Regeneron Reports Second Quarter 2011 Financial and Operating Results,,, 7/21/2011 46222210 PRN  Isis Initiates Phase 1 Study of ISIS-PTP1BRx to Treat Type 2 Diabetes,,,,,,,,,,, 3/18/2013 N5946510  PRN  Mylan Launches Generic Version of Xopenex® Inhalation Solution,,, 5/22/2015 03116210 PRN  Amgen to terminate participation in co-development and commercialization of brodalumab,,,,,,,,,,,,,,,,,,,,,,11/17/2011 80105N10  PRN  Hagens Berman: Patients Seek to Force FDA to Release Records Showing US Distribution of Thalidomide,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 7/12/2011 75886F10    PRN  Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis,,, 7/20/2011 46222210 PRN  Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment,,,,,,,,,,, 3/13/2013 N5946510  PRN  Mylan Announces Fortamet® Settlement Agreement,,, 5/22/2015 03116210 PRN  Amgen Receives Positive CHMP Opinion For Use Of Repatha™ (Evolocumab) For The Treatment Of High Cholesterol,,,,,,,,,,,,,,,,,,,,,,11/17/2011 80105N10  PRN  Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 7/07/2011 75886F10    PRN  Phase 3 Trial of ZALTRAP™ (aflibercept) in Advanced Prostate Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee,,," 7/14/2011 46222210 PRN  Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board",,,,,,,,,,," 3/04/2013 N5946510  PRN  Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2012",,," 5/18/2015 03116210 PRN  Amgen Appoints Jonathan P. Graham Senior Vice President, General Counsel And Secretary",,,,,,,,,,,,,,,,,,,,,,"11/11/2011 80105N10  PRN  National Campaign Shows Veterans Why ""It's Worth the Fight"" Against Advanced Prostate Cancer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 6/28/2011 05QZSX-E    PRN  EYLEA™ (aflibercept injection) Submitted in Japan for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration,,, 6/08/2011 46222210 PRN  Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes,,,,,,,,,,," 2/28/2013 N5946510  PRN  Science Behind the Numbers, The Business of Health - Research Report on Endo Health Solutions Inc, Actavis Inc, Mylan Inc., Elan Corporation, plc and Amgen, Inc.",,, 5/15/2015 03116210 PRN  Amgen Presents First Phase 2 Data For AMG 334 In The Prevention Of Episodic Migraine,,,,,,,,,,,,,,,,,,,,,,11/10/2011 80105N10  PRN  Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 6/17/2011 75886F10    PRN  Regeneron Announces EYLEA™ (aflibercept ophthalmic solution) Receives Unanimous Recommendation for Approval for Treatment of Wet AMD from FDA Advisory Committee,,, 6/06/2011 46222210 PRN  Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33,,,,,,,,,,, 2/27/2013 N5946510  PRN  Mylan to Acquire Agila to Create Leading Global Injectables Platform,,, 5/14/2015 03116210 PRN  Amgen Announces Voting Results of Annual Meeting of Stockholders,,,,,,,,,,,,,,,,,,,,,,11/03/2011 80105N10  PRN  Sanofi: Net sales up 10.1% and Business net income(1) up 4.1% at CER(2),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 6/17/2011 75886F10    PRN  Trading in Regeneron Common Stock Halted,,, 6/02/2011 46222210 PRN  Isis Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference,,,,,,,,,,, 2/27/2013 N5946510  PRN  Mylan Reports a 23% Increase in Fourth Quarter 2012 Adjusted Diluted EPS to $0.65,,, 5/13/2015 03116210 PRN  Amgen Data At ASCO 2015 Highlight Oncology Pipeline And Portfolio,,,,,,,,,,,,,,,,,,,,,,11/01/2011 80105N10  PRN  Broadway Star Ben Vereen Shows Diabetes Doesn't Have to Hold You Back in New Public Service Announcement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 6/07/2011 75886F10    PRN  VEGF Trap-Eye Submitted for EU Marketing Authorization for Treatment of Wet Age-Related Macular Degeneration,,, 5/23/2011 46222210 PRN  Isis Pharmaceuticals to Present a General Corporate Update at Its 2011 Annual Meeting of Stockholders and Open House,,,,,,,,,,, 2/25/2013 N5946510  PRN  Mylan Launches Generic Antara® Capsules,,, 5/12/2015 03116210 PRN  Amgen's Breakaway From Cancer® Announces Winners Of Its Nationwide Search For Champions In The Fight Against Cancer,,,,,,,,,,,,,,,,,,,,,,"10/28/2011 000D1R-E  PRN  The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi-Aventis, AstraZeneca, Pfizer and Novartis.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 6/06/2011 75886F10    PRN  ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients,,, 5/19/2011 46222210 PRN  Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone Payment From GlaxoSmithKline,,,,,,,,,,, 2/23/2013 N5946510  PRN  Mylan Launches Innovative Portfolio of Antiretroviral Products for Treatment of HIV/AIDS in South Africa,,, 5/11/2015 03116210 PRN  Amgen To Present AMG 334 Data At 17th Congress of the International Headache Society,,,,,,,,,,,,,,,,,,,,,,10/26/2011 005M9Z-E  PRN  Sanofi Study Examines the Role of Blood Sugar Levels in Preventing Cardiac Events,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/23/2011 75886F10    PRN  FDA Schedules Advisory Committee Meeting to Discuss BLA for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration,,, 5/16/2011 46222210 PRN  Isis Earns $3 Million Payment as Collaboration With GSK Expands,,,,,,,,,,, 2/20/2013 N5946510  PRN  Thousands of Schools Nationwide are Receiving Free EpiPen(R) (epinephrine) Auto-Injectors Through the Mylan Specialty L.P. EpiPen4Schools(TM) Program,,," 5/05/2015 009SQW-E PRN  Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors",,,,,,,,,,,,,,,,,,,,,,10/26/2011 005M9Z-E  PRN  Immune Design Corp. and Sanofi-Aventis Announce Research Collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 5/03/2011 75886F10    PRN  Critical Alerts for Visa, Applied Materials, Regeneron Pharmaceuticals, Focus Media, and Jabil Circuit Released by Seven Summits Research",,, 5/10/2011 078VWR-E PRN  Isis Pharmaceuticals' and GSK's Innovative Collaboration Voted Breakthrough Alliance of 2011,,,,,,,,,,, 2/13/2013 N5946510  PRN  Mylan Enhances Partnership with Biocon through Strategic Collaboration for Insulin Products,,, 5/04/2015 03116210 PRN  Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,10/26/2011 SAN-FR    PRN  Health coaching highlighted as key to management of chronic disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/03/2011 75886F10    PRN  Regeneron Reports First Quarter 2011 Financial and Operating Results,,," 5/10/2011 46222210 PRN  The Zacks Analyst Blog Highlights: Dean Foods, Isis Pharmaceuticals, OncoGenex, GlaxoSmithKline and Sanofi-Aventis",,,,,,,,,,, 2/13/2013 N5946510  PRN  Mylan Schedules Fourth Quarter and Year End 2012 Financial Results Conference Call and Live Webcast,,, 4/29/2015 03116210 PRN  Amgen Announces FDA Advisory Committee Meeting To Review Repatha™ (Evolocumab) As A Treatment For High Cholesterol,,,,,,,,,,,,,,,,,,,,,,10/21/2011 80105N10  PRN  Sanofi Pasteur Presents Additional Data on Investigational Quadrivalent Influenza Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/02/2011 75886F10    PRN  Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference,,, 5/05/2011 46222210 PRN  Isis Reports Financial Results and Highlights for First Quarter 2011,,,,,,,,,,, 2/11/2013 N5946510  PRN  Mylan Appoints Melina Higgins and Rajiv Malik to Board of Directors,,, 4/29/2015 03116210 PRN  Amgen To Discuss Details Of The Biologics License Application For Talimogene Laherparepvec For Patients With Metastatic Melanoma,,,,,,,,,,,,,,,,,,,,,,10/21/2011 80105N10  PRN  Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 4/27/2011 75886F10    PRN  Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion,,, 5/03/2011 IONS-US  PRN  Isis Pharmaceuticals to Present at the 14th Annual Bank of America Merrill Lynch Health Care Conference,,,,,,,,,,, 1/31/2013 N5946510  PRN  Valentine's Day Provides Families with Teachable Moments About Potentially Life-Threatening Allergies,,," 4/22/2015 03116210 PRN  Critical Alerts For Celgene, Rambus, Mylan, Amgen and Zoetis Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,10/20/2011 80105N10  PRN  Oral Therapy Teriflunomide (Aubagio™(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 4/26/2011 75886F10    PRN  Sanofi-aventis and Regeneron Report Positive Phase III Results With ZALTRAP™ (aflibercept) in Second-line Metastatic Colorectal Cancer,,, 4/21/2011 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' First Quarter 2011 Financial Results Conference Call,,,,,,,,,,," 1/23/2013 N5946510  PRN  /C O R R E C T I O N -- Mylan, Inc./",,, 4/21/2015 03116210 PRN  Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48,,,,,,,,,,,,,,,,,,,,,,10/11/2011 80105N10  PRN  Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 4/18/2011 75886F10    PRN  FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration,,, 4/11/2011 46222210 PRN  Webcast and Conference Call Alert: Isis Pharmaceuticals Holds Webcast to Discuss Recent Advances in its Development Pipeline,,,,,,,,,,, 1/18/2013 N5946510  PRN  Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy,,," 4/21/2015 03116210 PRN  Stock Updates on Biotech -- Celgene, Amgen, PDL BioPharma, Amarin, and Pharmacyclics",,,,,,,,,,,,,,,,,,,,,,"10/05/2011 80105N10  PRN  Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio™(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 4/08/2011 75886F10    PRN  /C O R R E C T I O N -- Regeneron Pharmaceuticals, Inc./",,, 3/30/2011 46222210 PRN  Isis Pharmaceuticals to Present at the 10th Annual Needham Healthcare Conference,,,,,,,,,,,12/28/2012 N5946510  PRN  Mylan Launches Generic Dilantin® Chewable Tablets,,, 4/16/2015 03116210 PRN  Amgen Announces Webcast Of 2015 First Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,10/03/2011 06QBGB-E  PRN  Paul and Mira Sorvino Reveal Diabetes Co-Stars: Cook-Off Winner,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 3/30/2011 75886F10    PRN  Regeneron Announces Presentation at the 10th Annual Needham Healthcare Conference,,, 3/29/2011 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at ACC's 60th Annual Scientific Session,,,,,,,,,,,12/28/2012 N5946510  PRN  Mylan Launches Generic Nordette® 28 Tablets,,, 4/15/2015 03116210 PRN  FDA Approves Corlanor® (ivabradine) To Reduce The Risk Of Hospitalization For Worsening Heart Failure In Patients With Chronic Heart Failure,,,,,,,,,,,,,,,,,,,,,, 9/28/2011 80105N10  PRN  Influenza Awareness Initiative for Orlando Seniors Highlights Need for Influenza Vaccination and Options for Adults 65 Years of Age and Older,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 3/10/2011 75886F10    PRN  Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer,,, 3/09/2011 46222210 PRN  Isis Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference,,,,,,,,,,,12/20/2012 N5946510  PRN  Mylan Announces Comtan® Settlement Agreement,,, 4/06/2015 03116210 PRN  European Commission Approves Amgen's Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,, 9/23/2011 80105N10  PRN  Walgreens Take Care Health Systems and Sanofi US Open On-site Medical Center and Pharmacy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 2/28/2011 75886F10    PRN  ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Second Phase 3 Trial for Prevention of Gout Flares in Patients Initiating Uric Acid-Lowering Therapy,,, 3/07/2011 46222210 PRN  Isis Pharmaceuticals to Present at the Roth 23rd Annual OC Growth Stock Conference,,,,,,,,,,,12/18/2012 N5946510  PRN  Mylan Launches Generic Version of Qualaquin® Capsules,,, 3/30/2015 03116210 PRN  Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference,,,,,,,,,,,,,,,,,,,,,, 9/19/2011 80105N10  PRN  Sanofi Pasteur Starts Shipping New Intradermal Influenza Vaccine with 90 Percent Smaller Needle,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 2/23/2011 75886F10    PRN  Regeneron Announces March 2011 Investor Conference Presentations,,, 3/01/2011 46222210 PRN  Isis Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference,,,,,,,,,,,12/12/2012 N5946510  PRN  Mylan Announces Pricing of Senior Notes,,, 3/30/2015 03116210 PRN  FDA Grants Amgen Priority Review for Kyprolis® (Carfilzomib) Supplemental New Drug Application for the Treatment of Relapsed Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,," 9/13/2011 80105N10  PRN  Barry Manilow Urges Americans to ""Get Back in Rhythm™"" and Learn About All the Health Risks of Atrial Fibrillation (AFib)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 2/22/2011 75886F10    PRN  Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration,,, 2/28/2011 46222210 PRN  Isis Reports Financial Results and Highlights for 2010,,,,,,,,,,,12/05/2012 N5946510  PRN  Mylan Launches Generic Version of Atacand HCT®,,, 3/26/2015 03116210 PRN  Cancer Survivor Joan Lunden Named 2015 Honorary Breakaway From Cancer® Champion And Joins Nationwide Search For Ten Champions In The Fight Against Cancer,,,,,,,,,,,,,,,,,,,,,, 9/12/2011 80105N10  PRN  Initiation of Lantus Leads to Better Glycemic Control at Similar Weight Gain Versus Other Comparators in Patients With Type 2 Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 2/17/2011 REGN-US     PRN  Regeneron Reports Full Year and Fourth Quarter 2010 Financial and Operating Results,,, 2/23/2011 46222210 PRN  Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study,,,,,,,,,,,12/01/2012 N5946510  PRN  Mylan Commemorates 24th World AIDS Day,,," 3/20/2015 03116210 PRN  Technical Briefing on Biotech Equities - Amgen, Exelixis, Sangamo BioSciences, Medivation, and Tekmira Pharma",,,,,,,,,,,,,,,,,,,,,, 9/12/2011 80105N10  PRN  Lyxumia® (lixisenatide) One-Step Regimen as Effective as Two-Step Regimen in Improving Glycemic Control in Type 2 Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 2/09/2011 75886F10    PRN  Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET",,, 2/22/2011 46222210 PRN  Isis Pharmaceuticals to Present at the 2011 Citi Global Healthcare Conference,,,,,,,,,,,11/29/2012 N5946510  PRN  Mylan Selected As One of the Leading Suppliers to the South African National Department of Health 2013/2014 Antiretroviral Tender,,, 3/20/2015 03116210 PRN  Amgen Submits Application For Investigational LDL Cholesterol-Lowering Medication Repatha™ (evolocumab) In Japan,,,,,,,,,,,,,,,,,,,,,, 9/05/2011 GSK-GB    PRN  Breast Cancer Drug Discoveries: What the Future Holds,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 2/08/2011 75886F10    PRN  Regeneron Announces Presentation at the ISI Annual Conference,,, 2/14/2011 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' 2010 Financial Results and Highlights Conference Call,,,,,,,,,,,11/29/2012 N5946510  PRN  Mylan Launches Generic Detrol® Tablets,,, 3/17/2015 03116210 PRN  Amgen To Present 10 Abstracts From Its Dermatology Portfolio At The 73rd Annual Meeting Of The American Academy Of Dermatology,,,,,,,,,,,,,,,,,,,,,, 8/26/2011 80105N10  PRN  Indiana Fever Forward Tamika Catchings and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 1/18/2011 75886F10    PRN  Regeneron and Bayer Start Phase 3 Trial to Extend Ophthalmology Research & Development Program for VEGF Trap-Eye in Asia,,, 2/02/2011 46222210 PRN  Isis Initiates Phase 1 Clinical Trial of ISIS-FXIRx to Treat Clotting Disorders,,,,,,,,,,,11/20/2012 N5946510  PRN  Moody's and Standard & Poor's Upgrade Mylan to Investment Grade Credit Ratings,,," 3/17/2015 03116210 PRN  Critical Alerts For Amgen, Invensense, Johnson Controls, Under Armour, World Wrestling Entertainment, NQ Mobile, AT&T, Walgreens Boots Alliance, Lowes and Baidu Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,," 8/11/2011 SAN-FR    PRN  ""Sounds of Pertussis"" Campaign Makes Times Square Pit Stop",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 1/03/2011 75886F10    PRN  Regeneron Announces Presentation at the 29th Annual J.P. Morgan Healthcare Conference,,," 1/10/2011 46222210 PRN  Excaliard Announces Positive Results From Three Phase 2 Clinical Trials for EXC 001, Showing Significant Improvement in Both Hypertrophic and Fine Line Scarring",,,,,,,,,,,11/13/2012 N5946510  PRN  Mylan Launches Generic Version of Revatio® Tablets,,, 3/15/2015 03116210 PRN  Amgen Publishes Safety Analysis Of Investigational Cholesterol-Lowering Medication Repatha™ (evolocumab) In The New England Journal of Medicine,,,,,,,,,,,,,,,,,,,,,," 8/10/2011 079KHF-E  PRN  Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your ""Allergy Adventures""",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,12/20/2010 75886F10    PRN  Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME),,, 1/10/2011 0017CR-E PRN  ISIS PHARMACEUTICALS TO DISCUSS PRODUCTIVE REGULATORY DISCUSSIONS REGARDING THE MIPOMERSEN NDA FILING,,,,,,,,,,,11/08/2012 N5946510  PRN  Mylan Announces Ortho Tri-Cyclen Lo® Settlement Agreement,,," 3/05/2015 03116210 PRN  Critical Alerts For Twitter, Abercrombie & Fitch, Best Buy, NewLink Genetics and Amgen Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,, 8/09/2011 UNISQ-US  PRN  Unilife Announces Chairman's Letter to Shareholders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,"12/20/2010 75886F10    PRN  Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)",,, 1/06/2011 46222210 PRN  Isis Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,10/25/2012 N5946510  PRN  Mylan Reports a 51% Increase in Third Quarter 2012 Adjusted Diluted EPS to $0.83,,, 3/04/2015 03116210 PRN  Amgen Announces 2015 Second Quarter Dividend,,,,,,,,,,,,,,,,,,,,,," 8/09/2011 07G766-E  PRN  The Zacks Analyst Blog Highlights: Micromet Inc., Bayer, AstraZeneca, Sanofi Aventis and Amgen",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,12/06/2010 75886F10    PRN  Regeneron Announces Presentation at the 2010 Deutsche Bank BioFest,,, 1/06/2011 46222210 PRN  Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline,,,,,,,,,,,10/23/2012 N5946510  PRN  Mylan Files Expedited Motion in Relation to Pioglitazone,,, 3/02/2015 03116210 PRN  Amgen Showcases Cardiovascular Pipeline At ACC.15 With New Cholesterol-Lowering And Chronic Heart Failure Data,,,,,,,,,,,,,,,,,,,,,, 8/09/2011 80105N10  PRN  Sanofi Announces Nursing Recognition Program to Help Turn Caring Ideas Into Reality,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/23/2010 75886F10    PRN  Regeneron Announces Presentation at the 22nd Annual Piper Jaffray Healthcare Conference,,, 1/04/2011 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Holds Webcast to Discuss Recent Advances in its Development Pipeline,,,,,,,,,,,10/17/2012 N5946510  PRN  Get Schooled in Anaphylaxis™ Unveils Interactive Digital Resources to Educate School Communities about Potentially Life-Threatening Allergies,,, 3/02/2015 03116210 PRN  Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit,,,,,,,,,,,,,,,,,,,,,, 8/02/2011 0B6GC9-E  PRN  New Conference Offers Solutions for Success in the Growing Biologics Market,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/22/2010 75886F10    PRN  Bayer and Regeneron Report Positive Top-Line Results of Two Phase 3 Studies with VEGF Trap-Eye in Wet Age-related Macular Degeneration,,, 1/04/2011 46222210 PRN  Isis Initiates Broad Phase 2 Program of ISIS-EIF4ERx in Cancer,,,,,,,,,,,10/16/2012 N5946510  PRN  World TeamTennis and Mylan Announce Three-Year Collaboration,,, 3/02/2015 03116210 PRN  Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen,,,,,,,,,,,,,,,,,,,,,, 7/28/2011 SAN-FR    PRN  Sanofi: Sales Growth of 6.9% Thanks to Genzyme Acquisition and Performance of Growth Platforms,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,"11/19/2010 75886F10    PRN  Regeneron Schedules November 22, 2010 Teleconference and Webcast to Discuss Results of Two Phase 3 Studies with VEGF Trap-Eye in Wet Age-related Macular Degeneration",,,12/21/2010 46222210 PRN  Isis Initiates Phase 1 Clinical Trial of ISIS-APOCIIIRx to Treat Hypertriglyceridemia,,,,,,,,,,,10/09/2012 N5946510  PRN  Mylan Announces Settlement Agreement for its First-to-File Generic Version of Orapred ODT®,,, 3/01/2015 03116210 PRN  Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis® (carfilzomib) Over Velcade® (bortezomib) In Patients With Relapsed Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,, 7/22/2011 80105N10  PRN  New Senior Executives Appointed at Sanofi:,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/17/2010 000D1R-E    PRN  The First-Line Pancreatic Cancer Patient Population Will Experience A Dynamic Change in Treatment Practice Due to Increased Uptake of FOLFIRINOX and the Launch of Abraxane,,,"12/01/2010 46222210 PRN  Isis Pharmaceuticals to Present at the 5th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference",,,,,,,,,,,10/04/2012 N5946510  PRN  Mylan Schedules Third Quarter 2012 Financial Results Conference Call and Live Webcast,,, 2/27/2015 03116210 PRN  Amgen Receives Positive CHMP Opinion For Use Of Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Advanced Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,, 7/18/2011 80105N10  PRN  Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/15/2010 75886F10    PRN  Christine A. Poon Elected to Regeneron Board of Directors,,,11/23/2010 46222210 PRN  Isis Pharmaceuticals to Present at the 22nd Annual Piper Jaffray Health Care Conference,,,,,,,,,,, 9/28/2012 N5946510  PRN  Mylan Launches Generic Avapro® Tablets and Generic Avalide® Tablets,,, 2/26/2015 03116210 PRN  Amgen Announces The European Medicines Agency Acceptance Of Kyprolis® (Carfilzomib) Marketing Authorization Application For The Treatment Of Relapsed Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,, 7/13/2011 005M9Z-E  PRN  Unilife Commences Initial Supply of the Unifill® Syringe to Sanofi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,11/02/2010 75886F10    PRN  Regeneron Announces Presentation at the 2010 Credit Suisse Annual Healthcare Conference,,,11/16/2010 46222210 PRN  Isis and Xenon Collaborate to Develop Antisense Drugs Against Hemojuvelin and Hepcidin,,,,,,,,,,," 9/26/2012 N5946510  PRN  ""Modern Family"" Star Julie Bowen Joins Mylan Specialty L.P. to Launch Health Awareness Initiative to Address Growing Rate of Life-Threatening Allergic Reactions",,, 2/25/2015 03116210 PRN  Amgen Announces Positive Results From Head-To-Head Study Comparing The Efficacy And Safety Of AMG 416 With Cinacalcet In Patients With Secondary Hyperparathyroidism Receiving Hemodialysis,,,,,,,,,,,,,,,,,,,,,, 7/12/2011 80105N10  PRN  Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,10/28/2010 75886F10    PRN  Regeneron Reports Third Quarter 2010 Financial Results and Business Highlights,,,11/04/2010 46222210 PRN  Isis Reports Financial Results and Highlights for Third Quarter 2010,,,,,,,,,,, 9/21/2012 N5946510  PRN  Mylan Launches First Generic Version of Diovan HCT® Tablets,,, 2/25/2015 03116210 PRN  Amgen To Present At The Cowen And Company 35th Annual Health Care Conference,,,,,,,,,,,,,,,,,,,,,, 7/12/2011 09Z63Q-E  PRN  Ignite Health Hires Brian Lefkowitz as Chief Creative Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,10/15/2010 75886F10    PRN  Regeneron Announces Presentation at the 17th Annual NewsMakers in the Biotech Industry Conference,,,10/21/2010 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Third Quarter 2010 Financial Results Conference Call,,,,,,,,,,," 9/21/2012 N5946510  PRN  Mylan Launches Generic Version of Antivert® Tablets, 12.5 mg, 25 mg and 50 mg",,," 2/13/2015 03116210 PRN  What's New in the Pharma Sector: New Research on Amgen, Applied Genetic Technologies, Aptose, ARIAD, and Atara Biotherapeutics",,,,,,,,,,,,,,,,,,,,,," 7/11/2011 80105N10  PRN  Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,10/13/2010 75886F10    PRN  Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock,,,10/15/2010 46222210 PRN  Isis Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference,,,,,,,,,,, 9/07/2012 N5946510  PRN  Mylan Announces Settlement Agreement in Litigation Relating to Detrol® LA,,, 2/11/2015 03116210 PRN  Amgen Announces FDA Advisory Committees To Review Talimogene Laherparepvec For The Treatment Of Patients With Metastatic Melanoma,,,,,,,,,,,,,,,,,,,,,, 7/11/2011 80105N10  PRN  Valeant Pharmaceuticals Agrees to Acquire Dermik,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,10/08/2010 75886F10    PRN  Regeneron Increases Size of Public Offering of Common Stock,,, 9/14/2010 46222210 PRN  Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference,,,,,,,,,,, 9/06/2012 N5946510  PRN  Mylan Launches First Ever App of Its Generic Brand Reference® Guide,,," 2/06/2015 03116210 PRN  Biotech Stocks Review - Arena Pharma, Amgen, NPS Pharma, ZIOPHARM Oncology, and Advaxis",,,,,,,,,,,,,,,,,,,,,," 7/06/2011 SNY-FR    PRN  The Zacks Analyst Blog Highlights: United Parcel Services, FedEx Corporation, Bayer, Johnson & Johnson and Sanofi-Aventis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,"10/06/2010 75886F10    PRN  Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock",,, 9/08/2010 46222210 PRN  Isis Pharmaceuticals to Present at the Stifel Nicolaus 2010 Healthcare Conference,,,,,,,,,,, 9/04/2012 N5946510  PRN  Mylan Selected as a Leading ARV Supplier to India's National AIDS Control Organization,,, 2/03/2015 03116210 PRN  Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Rheumatoid Arthritis,,,,,,,,,,,,,,,,,,,,,, 6/29/2011 80105N10  PRN  Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments for Tuberculosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 9/28/2010 75886F10    PRN  Regeneron Announces Panel Discussion at Citi's 5th Annual Biotech Day,,, 8/30/2010 46222210 PRN  Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at the ESC Congress 2010,,,,,,,,,,, 8/22/2012 N5946510  PRN  Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan,,," 1/29/2015 03116210 PRN  Amgen, The Familial Hypercholesterolemia Foundation And Stanford Medicine Launch FIND FH™ Initiative To Improve Diagnosis And Care For People With Familial Hypercholesterolemia",,,,,,,,,,,,,,,,,,,,,, 6/28/2011 80105N10  PRN  Sanofi Pasteur Commends Winners of International BioGENEius Challenge,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 9/13/2010 75886F10    PRN  Regeneron Announces Presentation at the UBS Global Life Sciences Conference,,, 8/09/2010 46222210 PRN  Isis Improves Financial Guidance and Reports Financial Results and Highlights for Second Quarter 2010,,,,,,,,,,, 8/17/2012 N5946510  PRN  Mylan Launches Generic Actoplus Met® Tablets and Generic Actos® Tablets,,," 1/28/2015 03116210 PRN  Swimming Against the Tide: Special Research on AT&T, Amgen, Silicon Image, World Wrestling Entertainment and Electronic Arts",,,,,,,,,,,,,,,,,,,,,, 6/27/2011 80105N10  PRN  Lantus®/Apidra® SoloSTAR® Help to Improve Patient Satisfaction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 9/08/2010 75886F10    PRN  Phase 3 Trial of Aflibercept in Second-Line Metastatic Colorectal Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee,,," 8/03/2010 46222210 PRN  Excaliard Announces Positive Data From Phase 2 Clinical Trial of Its Anti-Scarring Drug, EXC 001",,,,,,,,,,, 8/14/2012 N5946510  PRN  Mylan Specialty Offers Free EpiPen® (epinephrine) Auto-Injectors to Schools Nationwide,,, 1/27/2015 03116210 PRN  Amgen Submits Applications In The US And Europe For Kyprolis® (carfilzomib) For The Treatment Of Relapsed Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,," 6/24/2011 SNY-FR    PRN  Sanofi Announces Positive Results from the ""All to Target"" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 9/03/2010 75886F10    PRN  Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference,,, 7/29/2010 46222210 PRN  Isis Earns $5 Million Milestone Payment From GSK for Designation of a Development Candidate to Treat an Undisclosed Rare and Serious Disease,,,,,,,,,,, 8/10/2012 N5946510  PRN  Mylan Launches Lithium Carbonate Extended-Release Tablets USP,,, 1/27/2015 03116210 PRN  Amgen's 2014 Revenues Increased 7 Percent To $20.1 Billion And Adjusted Earnings Per Share (EPS) Increased 14 Percent To $8.70,,,,,,,,,,,,,,,,,,,,,, 6/24/2011 80105N10  PRN  Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 8/05/2010 75886F10    PRN  Regeneron Announces Presentation at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference,,, 7/26/2010 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' Second Quarter 2010 Financial Results Conference Call,,,,,,,,,,, 8/10/2012 N5946510  PRN  Mylan Launches Generic Version of Provigil® Tablets,,, 1/27/2015 000C35-E PRN  Global Pediatric Drugs and Vaccines Market,,,,,,,,,,,,,,,,,,,,,, 6/22/2011 06WYS8-E  PRN  Sanofi Pasteur opens $100M R&D centre in Canada,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 7/28/2010 75886F10    PRN  Regeneron Reports Second Quarter 2010 Financial and Operating Results,,, 6/29/2010 46222210 PRN  Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions,,,,,,,,,,, 8/07/2012 N5946510  PRN  Mylan Specialty and Pfizer Announce Licensing Agreement for EpiPen® Injection 0.3/0.15mg in Japan,,," 1/26/2015 03116210 PRN  Critical Alerts For Infinera Corporation, Pandora, Trulia, ResMed and Amgen Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,," 6/22/2011 05W9DS-E  PRN  Medco, United BioSource and Sanofi Signed Global Agreement to Improve Quality of Patient Care Through Real-World Evidence",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 7/28/2010 75886F10    PRN  Astellas to Pay $295 Million to Extend License of Regeneron's VelocImmune® Antibody Technology through 2023,,, 6/16/2010 46222210 PRN  Isis Pharmaceuticals to Present at The Wells Fargo 2010 Healthcare Conference,,,,,,,,,,, 8/07/2012 N5946510  PRN  Mylan Launches Generic Version of Singulair® Tablets and Singulair® Chewable Tablets,,, 1/22/2015 03116210 PRN  Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results,,,,,,,,,,,,,,,,,,,,,, 6/22/2011 80105N10  PRN  Oxford BioMedica Announces Ocular Programme Update,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 7/13/2010 75886F10    PRN  Regeneron to Webcast Investor Day on July 15, 2010",,," 6/15/2010 46222210 PRN  Isis Pharmaceuticals to Discuss Its Neurodegenerative Franchise in a Conference Call on Thursday, June 17",,,,,,,,,,, 8/06/2012 N5946510  PRN  Mylan Launches Generic Version of Amidate® Injection,,, 1/15/2015 03116210 PRN  Amgen Presents New Data Supporting First-Line Use Of Vectibix® (Panitumumab) In Combination With FOLFOX In Patients With Wild-Type RAS Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,," 6/20/2011 SNY-FR    PRN  Critical Alerts for Wells Fargo, Archer Daniels Midland, Salesforce.com, Sanofi-Aventis, and Citrix Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 6/11/2010 75886F10    PRN  Regeneron Announces Presentation at the Goldman Sachs 31st Annual Global Healthcare Conference,,, 6/11/2010 46222210 PRN  Isis Pharmaceuticals to Present at The Goldman Sachs 31st Annual Global Healthcare Conference,,,,,,,,,,," 8/06/2012 N5946510  PRN  Mylan Launches Commercial Operations in India, Starting with a Broad, Innovative Portfolio of ARV Products to Treat HIV/AIDS",,, 1/12/2015 03116210 PRN  Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome,,,,,,,,,,,,,,,,,,,,,, 6/20/2011 09C227-E  PRN  Pharma IQ's Pharma Distribution Survey report,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 6/09/2010 75886F10    PRN  ARCALYST® (rilonacept) Meets Primary and All Secondary Endpoints in Phase 3 Trial of Prevention of Gout Flares in Patients Initiating Allopurinol Therapy,,, 6/04/2010 46222210 PRN  Isis Pharmaceuticals to Present Company Overview,,,,,,,,,,, 8/02/2012 N5946510  PRN  Mylan Applauds Study Highlighting $1 Trillion in Savings for U.S. Health Care System Due to Generic Drugs Over Past Decade,,, 1/08/2015 03116210 PRN  Amgen To Present At The 33rd Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,," 6/17/2011 080RQG-E  PRN  The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Pfizer, AstraZeneca, Sanofi-Aventis and NCR",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,," 6/08/2010 75886F10    PRN  Regeneron Schedules June 9, 2010 Teleconference and Webcast to Discuss Phase 3 Trial Results in Gout",,," 6/01/2010 0017CR-E PRN  BioMed Realty Trust Breaks Ground on 176,000 Square Foot R&D Facility for Isis Pharmaceuticals in Carlsbad, California",,,,,,,,,,, 8/02/2012 N5946510  PRN  Mylan Signs Agreement with Gilead to Accelerate Access to Generic Single and Fixed-Dose Combination ARVs Containing Emtricitabine,,, 1/05/2015 03116210 PRN  Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies,,,,,,,,,,,,,,,,,,,,,, 6/16/2011 80105N10  PRN  Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 6/04/2010 75886F10    PRN  Regeneron Announces Presentation at the 9th Annual Needham Healthcare Conference,,, 5/26/2010 46222210 PRN  Isis Pharmaceuticals to Present a General Corporate Update at Its 2010 Annual Meeting of Stockholders and Open House,,,,,,,,,,, 7/31/2012 N5946510  PRN  Mylan Specialty L.P. Partners with the Pittsburgh Pirates to Sponsor PNC Park's First Allergy Awareness Night,,,"12/31/2014 03116210 PRN  Technical Report on Biotech Stocks -- MannKind, Amgen, Celldex Therapeutics, Juno Therapeutics, and Ironwood Pharma",,,,,,,,,,,,,,,,,,,,,, 6/07/2011 80105N10  PRN  Paul and Mira Sorvino Announce Nationwide Recipe Contest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/20/2010 75886F10    PRN  Regeneron Announces Presentation at the 2010 Citi Investment Research Global Healthcare Conference,,, 5/21/2010 46222210 PRN  Isis Pharmaceuticals to Present at the 2010 Citi Investment Research Global Health Care Conference,,,,,,,,,,, 7/27/2012 N5946510  PRN  Mylan Launches Generic Version of Sporanox® Capsules,,,"12/22/2014 03116210 PRN  Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts",,,,,,,,,,,,,,,,,,,,,, 6/06/2011 80105N10  PRN  ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/12/2010 75886F10    PRN  Regeneron Provides Initial Data on Two Antibody Product Candidates,,," 5/17/2010 46222210 PRN  Isis Pharmaceuticals to Discuss Its Cancer Franchise in a Conference Call on Wednesday, May 19",,,,,,,,,,," 7/26/2012 N5946510  PRN  Mylan Reports Second Quarter 2012 Adjusted Diluted EPS of $0.60, a 15% Increase Over Prior Year Quarter",,,12/17/2014 03116210 PRN  Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend,,,,,,,,,,,,,,,,,,,,,, 6/04/2011 80105N10  PRN  Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/11/2010 75886F10    PRN  Regeneron Announces Participation in J. P. Morgan Biotech: CEO/CFO Conference Call Series,,, 5/06/2010 46222210 PRN  Isis Reports Financial Results and Highlights for First Quarter 2010,,,,,,,,,,, 7/17/2012 N5946510  PRN  Mylan Announces Settlement Agreement in Litigation Relating to its Generic Silenor®,,,12/11/2014 03116210 PRN  Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1™ Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis,,,,,,,,,,,,,,,,,,,,,, 6/04/2011 80105N10  PRN  Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Reduction in Life-Threatening Venous Thrombo-Embolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 5/07/2010 75886F10    PRN  Regeneron Announces Presentation at the Bank of America Merrill Lynch 2010 Healthcare Conference,,, 4/29/2010 46222210 PRN  Webcast Alert: Isis Pharmaceuticals' First Quarter 2010 Financial Results Conference Call,,,,,,,,,,, 7/10/2012 N5946510  PRN  Mylan Schedules Second Quarter 2012 Financial Results Conference Call and Live Webcast,,,12/08/2014 03116210 PRN  Amgen Presents Data From Pivotal Phase 2 Study Of BLINCYTO™ (blinatumomab) Immunotherapy In Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,,, 6/04/2011 80105N10  PRN  Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64% Risk Reduction in Life-Threatening Venous Thrombo-Embolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,, 4/29/2010 75886F10    PRN  Regeneron Reports First Quarter 2010 Financial and Operating Results,,," 4/26/2010 46222210 PRN  Isis Pharmaceuticals to Discuss Its Metabolic Franchise in a Conference Call on Wednesday, April 28",,,,,,,,,,," 7/09/2012 N5946510  PRN  Mylan Applauds Signing of Landmark ""Food and Drug Administration Safety and Innovation Act""",,,12/08/2014 03116210 PRN  New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec In Combination With Merck's Anti-PD-1 Therapy KEYTRUDA® (Pembrolizumab) For Advanced Melanoma,,,,,,,,,,,,,,,,,,,,,, 5/25/2011 0B9M5K-E  PRN  Incremental innovation: essential to solving Canada's productivity problem #HNHII,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/03/2012 N5946510  PRN  Mylan Launches Generic Version of Lithobid® Tablets,,,12/08/2014 03116210 PRN  FDA Approves Amgen's XGEVA® (Denosumab) For The Treatment Of Hypercalcemia Of Malignancy Refractory To Bisphosphonate Therapy,,,,,,,,,,,,,,,,,,,,,," 5/23/2011 05MCMQ-E  PRN  Trendspotter Marian Salzman, CEO of Euro RSCG Worldwide PR, Shares New Findings for 2020 at Media Future Week",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/03/2012 N5946510  PRN  Mylan Launches Generic Version of Clarinex® Allergy Medication,,,12/06/2014 03116210 PRN  Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease,,,,,,,,,,,,,,,,,,,,,," 5/19/2011 80105N10  PRN  Critical Alerts for Apple, Philip Morris International, Aflac, National Oilwell Varco, and Sanofi-Aventis Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 6/28/2012 N5946510  PRN  Mylan Confirms First-to-File Patent Challenge Relating to Pristiq® Tablets,,,12/06/2014 03116210 PRN  Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,," 5/16/2011 068WTR-E  PRN  Glenmark Pharmaceuticals Out-Licenses Novel Monoclonal Antibody, GBR 500, to Sanofi",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 6/28/2012 N5946510  PRN  Mylan Launches Thiamine Hydrochloride Injection,,,12/03/2014 03116210 PRN  Amgen To Webcast Investor Meeting At Upcoming American Society of Hematology (ASH) 56th Annual Meeting And Exposition,,,,,,,,,,,,,,,,,,,,,, 5/12/2011 064GPT-E  PRN  RAPP Names Wendy Wahl North American Healthcare Practice Lead,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 6/25/2012 N5946510  PRN  Mylan Comments on Copaxone® Ruling,,,12/03/2014 03116210 PRN  Actress Adamari López And Amgen Launch Spanish-Language Chemotherapy: Myths Or Facts™ Website And Resources,,,,,,,,,,,,,,,,,,,,,," 5/10/2011 80105N10  PRN  The Zacks Analyst Blog Highlights: Dean Foods, Isis Pharmaceuticals, OncoGenex, GlaxoSmithKline and Sanofi-Aventis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 6/08/2012 N5946510  PRN  Mylan Settles Provigil® Litigation With Teva,,,12/03/2014 03116210 PRN  FDA Approves BLINCYTO™ (Blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,,, 5/10/2011 80105N10  PRN  Washington Mystics' Monique Currie and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 6/06/2012 N5946510  PRN  Mylan Launches Generic Version of Epivir® Film Coated Tablets in the UK and Italy, its First Generic ARV Launch in Europe",,,11/25/2014 03116210 PRN  Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis,,,,,,,,,,,,,,,,,,,,,, 5/10/2011 80105N10  PRN  FDA Licenses Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 6/06/2012 N5946510  PRN  Mylan Canada Receives Health Canada Approval for Generic Version of Tracleer®,,,11/24/2014 03116210 PRN  Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies Of Rilotumumab In Advanced Gastric Cancer,,,,,,,,,,,,,,,,,,,,,, 5/04/2011 80105N10  PRN  Tulsa Shock Guard Andrea Riley and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/29/2012 N5946510  PRN  Mylan Launches Generic Version of Lipitor®,,,"11/24/2014 03116210 PRN  Biotech Stocks in Motion - Amgen, Merrimack Pharma, NPS Pharma, BioMarin Pharma, and Regeneron Pharma",,,,,,,,,,,,,,,,,,,,,, 4/28/2011 80105N10  PRN  sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/29/2012 N5946510  PRN  Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®,,,11/18/2014 03116210 PRN  Amgen Presents Long-Term Data Showing Efficacy And Safety Of Investigational Cholesterol-Lowering Medication Evolocumab Across Lipid And LDL-C Levels,,,,,,,,,,,,,,,,,,,,,, 4/26/2011 80105N10  PRN  Sanofi-aventis and Regeneron Report Positive Phase III Results With ZALTRAP™ (aflibercept) in Second-line Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/24/2012 N5946510  PRN  Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovion's Brovana® Product,,,11/14/2014 03116210 PRN  Amgen To Present At The Jefferies Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 4/25/2011 0072XH-E  PRN  Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/24/2012 N5946510  PRN  Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy,,,"11/13/2014 03116210 PRN  Critical Alerts For Caesars Entertainment, Orexigen Therapeutics, Amazon.com, Toyota Motor and Amgen Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,, 4/22/2011 0072XH-E  PRN  Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/23/2012 N5946510  PRN  Moody's Upgrades Mylan,,,11/12/2014 03116210 PRN  Amgen To Webcast Investor Call At Upcoming American Heart Association Scientific Sessions,,,,,,,,,,,,,,,,,,,,,, 4/18/2011 80105N10  PRN  Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/23/2012 N5946510  PRN  Mylan Launches Generic Version of Viramune® Tablets,,,11/12/2014 03116210 PRN  Amgen To Highlight New Data For Investigational Cholesterol-Lowering Medication Evolocumab,,,,,,,,,,,,,,,,,,,,,," 4/14/2011 80105N10  PRN  START YOUR ENGINES: NASCAR CHAMPION JEFF GORDON CHALLENGES YOU TO JOIN THE ""RACE TO BLANKET AMERICA(SM)""",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/17/2012 N5946510  PRN  Mylan Launches Generic Version of Plavix® Tablets,,,11/12/2014 03116210 PRN  The Amgen Foundation Expands Amgen Scholars Program to 17 Top Educational Institutions Worldwide,,,,,,,,,,,,,,,,,,,,,," 4/12/2011 SHP-IE    PRN  Zacks Bull and Bear of the Day Highlights: Tractor Supply, Morgan Stanley, Alcoa, Sanofi-Aventis and Shire",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/14/2012 N5946510  PRN  Mylan Specialty L.P. Commemorates 15th Annual Food Allergy Awareness Week,,,11/11/2014 03116210 PRN  Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis,,,,,,,,,,,,,,,,,,,,,, 4/12/2011 80105N10  PRN  Pieris and Daiichi Sankyo Sign Therapeutic Collaboration to Develop Anticalin(R) Therapeutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/11/2012 N5946510  PRN  Mylan Launches Generic Lipitor® in Five European Countries,,,11/10/2014 03116210 PRN  FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab,,,,,,,,,,,,,,,,,,,,,, 4/11/2011 09TCH5-E  PRN  Time for transformational healthcare change - CEO of sanofi-aventis Canada shares thoughts on healthcare reform,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/10/2012 N5946510  PRN  Mylan Increases 2012 Guidance Range to $2.45 to $2.55 in Adjusted Diluted EPS,,,"11/07/2014 03116210 PRN  Collaboration, Breakthrough Therapy Designation, Clinical Trial Data, Voting Rights, and Financial Results - Research Reports on Johnson & Johnson, Merck, Amgen, Shire and HCA",,,,,,,,,,,,,,,,,,,,,, 4/11/2011 80105N10  PRN  Pieris to Present at BioCentury Future Leaders in the Biotech Industry Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/30/2012 N5946510  PRN  Mylan Launches First Generic Version of Doryx® 150 mg,,,11/06/2014 03116210 PRN  Amgen To Present At The Credit Suisse Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 4/08/2011 80105N10  PRN  Sanofi-Aventis Completes Acquisition of Genzyme Corporation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/30/2012 N5946510  PRN  Mylan Announces Settlement Agreement for its First-to-File Generic Version of Nuvigil®,,,11/06/2014 03116210 PRN  Amgen Highlights New Data In The Treatment Of Blood Cancers At ASH 2014,,,,,,,,,,,,,,,,,,,,,," 4/08/2011 SNY-FR    PRN  Zacks Analyst Blog Highlights: Myriad Genetics, BioMarin Pharmaceuticals, Abbott Laboratories, AstraZeneca and Sanofi-Aventis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/28/2012 N5946510  PRN  Mylan to Partner with United Nations and Clinton Health Access Initiative to Fight Diarrhea Fatalities in Children in India,,,11/04/2014 03116210 PRN  Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3 Trebananib TRINOVA-1 Trial In Patients With Recurrent Ovarian Cancer,,,,,,,,,,,,,,,,,,,,,, 4/04/2011 80105N10  PRN  Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 4/26/2012 N5946510  PRN  Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter",,,"10/30/2014 03116210 PRN  Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire",,,,,,,,,,,,,,,,,,,,,, 3/29/2011 80105N10  PRN  Standard & Poor's Announces Change to U.S. Index,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/26/2012 N5946510  PRN  Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva,,,"10/28/2014 03116210 PRN  Amgen Outlines Strategy, Growth Objectives And Capital Allocation Plans",,,,,,,,,,,,,,,,,,,,,, 3/29/2011 80105N10  PRN  Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/24/2012 N5946510  PRN  Mylan Launches Generic Version of Zyprexa® Tablets,,,10/27/2014 03116210 PRN  Amgen's Third Quarter 2014 Revenues Increased 6 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 19 Percent To $2.30,,,,,,,,,,,,,,,,,,,,,," 3/25/2011 SNY-FR    PRN  Zacks Analyst Blog Highlights: Merck, Sanofi-Aventis, Eli Lilly, Pfizer and Johnson & Johnson",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/18/2012 N5946510  PRN  Mylan Announces Expansion in Ireland,,,10/23/2014 03116210 PRN  Amgen To Webcast 2014 Business Review Meeting On October 28,,,,,,,,,,,,,,,,,,,,,, 3/24/2011 07MYGZ-E  PRN  Sanofi-aventis Enters Into Research Collaboration With Columbia University to Develop New Diabetes Treatments,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/13/2012 N5946510  PRN  Mylan Launches First Generic Version of Lescol® Capsules,,,10/23/2014 03116210 PRN  Amgen Announces Webcast of 2014 Third Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,, 3/22/2011 80105N10  PRN  Shawn Marion and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/10/2012 N5946510  PRN  Mylan Schedules First Quarter 2012 Financial Results Conference Call and Live Webcast,,,10/21/2014 03116210 PRN  Amgen Statement Regarding Third Point Investment,,,,,,,,,,,,,,,,,,,,,," 3/17/2011 SNY-FR    PRN  Critical Alerts for Oracle, Peabody Energy, Kroger, Sanofi-Aventis, and Coeur d'Alene Mines Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/05/2012 N5946510  PRN  Mylan Sues FDA Seeking Ruling That Teva Holds No Exclusivity for Its Generic Version of Provigil®,,,"10/21/2014 03116210 PRN  Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA",,,,,,,,,,,,,,,,,,,,,, 3/10/2011 80105N10  PRN  Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/03/2012 N5946510  PRN  Mylan Launches Generic Version of Mesnex Injection®,,,"10/20/2014 03116210 PRN  Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma",,,,,,,,,,,,,,,,,,,,,, 3/09/2011 05N2SY-E  PRN  Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 3/28/2012 N5946510  PRN  Mylan Launches Generic Version of Seroquel® Tablets, 25 mg",,,10/17/2014 03116210 PRN  Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors,,,,,,,,,,,,,,,,,,,,,, 2/24/2011 80105N10  PRN  Sanofi-Aventis Announces Approval and Closing of BMP Sunstone Acquisition Creating a Strong Consumer Health Care Platform in China,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 3/20/2012 N5946510  PRN  Mylan One of First to Launch Generic Version of Boniva®,,,10/17/2014 03116210 PRN  Amgen Announces 2014 Fourth Quarter Dividend,,,,,,,,,,,,,,,,,,,,,, 2/23/2011 07BBFC-E  PRN  Sanofi Pasteur Supports Polio Eradication at First International Stock Exchange Event,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 3/15/2012 N5946510  PRN  Mylan Canada Receives Health Canada Approval for Generic Version of Crestor®,,,10/17/2014 AMGN-US  PRN  Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement,,,,,,,,,,,,,,,,,,,,,, 2/22/2011 80105N10  PRN  Pieris to Present Interim Data From the Phase I Clinical Trial of PRS-050 at Molecular Medicine Tri-Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 3/09/2012 N5946510  PRN  Mylan to Build New Corporate Headquarters,,,"10/13/2014 03116210 PRN  Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen",,,,,,,,,,,,,,,,,,,,,, 2/21/2011 07BDNJ-E  PRN  Sanofi Pasteur and International Vaccine Institute Partner Against Dengue,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 3/02/2012 N5946510  PRN  Mylan Continues to Pursue Damages and Injunction Against Sunovion's Brovana® in Ongoing Litigation,,,10/09/2014 03116210 PRN  Amgen's BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review Designation In Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,,," 2/17/2011 80105N10  PRN  WNBA Legend Lisa Leslie, NBA Legend Bob Lanier and Clippers Forward Brian Cook Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health as Part of NBA Cares All-Star Community Caravan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/29/2012 N5946510  PRN  Mylan Launches First Equivalent Product to Lexapro® Tablets,,,10/08/2014 03116210 PRN  Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Plaque Psoriasis,,,,,,,,,,,,,,,,,,,,,, 2/16/2011 80105N10  PRN  Video Available: Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/29/2012 N5946510  PRN  Mylan Institutional Wins Pharmacy Generic Supplier of the Year Award from Novation,,,10/01/2014 03116210 PRN  The Lancet Publishes Two Phase 3 Studies Showing Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With Serious Genetic Disorders That Cause High Cholesterol,,,,,,,,,,,,,,,,,,,,,, 2/16/2011 80105N10  PRN  Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/24/2012 N5946510  PRN  Mylan Pharmaceuticals President Tony Mauro Elected Chairman of GPhA,,,10/01/2014 03116210 PRN  Amgen Announces Moderate-To-Severe Plaque Psoriasis Data To Be Presented At The 23rd Congress Of The European Academy Of Dermatology And Venereology,,,,,,,,,,,,,,,,,,,,,, 2/15/2011 80105N10  PRN  Sanofi-aventis and Sunnybrook Health Sciences Centre Agree to Develop Treatment for Diabetic Foot Ulcers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/23/2012 N5946510  PRN  Mylan Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy,,,"10/01/2014 03116210 PRN  Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter",,,,,,,,,,,,,,,,,,,,,," 2/15/2011 80105N10  PRN  The World Heart Federation, sanofi-aventis and Boehringer Ingelheim Announce Collaboration on Worldwide AF Awareness Campaign",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 2/21/2012 N5946510  PRN  Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2011",,, 9/30/2014 000C35-E PRN  Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents,,,,,,,,,,,,,,,,,,,,,, 2/09/2011 80105N10  PRN  sanofi-aventis: Solid Results in 2010,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/21/2012 N5946510  PRN  Mylan Provides Blueprint for 2012 and Beyond,,, 9/24/2014 03116210 PRN  Amgen to Host Summary Webcast of Kyprolis® (carfilzomib) for Injection Data Presented at The European Society for Medical Oncology (ESMO) 2014 Congress,,,,,,,,,,,,,,,,,,,,,, 2/09/2011 80105N10  PRN  Sanofi-aventis Video Q&A: CEO Chris Viehbacher Comments on 2010 Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/21/2012 N5946510  PRN  Mylan Secures an Additional $300 Million of Committed Financing,,, 9/24/2014 06SG07-E PRN  ESMO 2014 to Feature New Oncology Data from Across Bayer Franchise,,,,,,,,,,,,,,,,,,,,,," 2/03/2011 80105N10  PRN  Zacks Analyst Blog Highlights: Hospira, Sanofi-Aventis, Eli Lilly, Genzyme and Durect",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 2/21/2012 N5946510  PRN  Mylan Reports Adjusted Diluted EPS of $0.53 for the Quarter, an 18% Increase Over Prior Year Quarter; and $2.04 for the Year, a 27% Increase Over Prior Year",,," 9/23/2014 03116210 PRN  Regulatory Approval, Presentation of Data, Appointment, Clinical Study Results, and Increase in Quarterly Dividend - Research Reports on Johnson & Johnson, Merck, Medtronic, Amgen and Covidien",,,,,,,,,,,,,,,,,,,,,, 2/03/2011 80105N10  PRN  NBA All-Star Chauncey Billups Teams Up With Vaccines for Teens Educational Campaign to Help Teens Take Their Best Shot at Health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/17/2012 N5946510  PRN  Mylan Resolves Defamation Litigation Against Pittsburgh Post-Gazette and Two of Its Reporters,,, 9/22/2014 03116210 PRN  Amgen Submits Biologics License Application for Investigational BiTE® Immunotherapy Blinatumomab,,,,,,,,,,,,,,,,,,,,,, 1/27/2011 80105N10  PRN  Sanofi-aventis Reports Top-line Results from Phase III Study with Iniparib (BSI-201) in Metastatic Triple-Negative Breast Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/16/2012 N5946510  PRN  Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement,,, 9/15/2014 03116210 PRN  Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis,,,,,,,,,,,,,,,,,,,,,, 1/27/2011 80105N10  PRN  China's Ministry of Commerce Grants Clearance for Merger of BMP Sunstone and Sanofi-aventis Subsidiary,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/15/2012 N5946510  PRN  Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty,,, 9/15/2014 03116210 PRN  New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density,,,,,,,,,,,,,,,,,,,,,, 1/25/2011 80105N10  PRN  U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra® for Over-The-Counter Use,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/14/2012 N5946510  PRN  Mylan Actively Addressing Shortage of Preservative-Free Methotrexate Injection,,," 9/15/2014 03116210 PRN  Event Schedules, Survey Findings, Regulatory Filings, and Market Activity - Research Reports on Amgen, Biogen Idec, Salix, Covidien and Shire",,,,,,,,,,,,,,,,,,,,,, 1/25/2011 80105N10  PRN  U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra® for Over-The-Counter Use,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/10/2012 N5946510  PRN  Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution,,, 9/14/2014 03116210 PRN  Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure,,,,,,,,,,,,,,,,,,,,,," 1/13/2011 80105N10  PRN  Critical Alerts for Goldman Sachs, Total, FedEx, Sanofi-Aventis, and AGCO Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 2/09/2012 N5946510  PRN  Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers",,, 9/10/2014 03116210 PRN  Amgen Announces 23 Abstracts To Be Presented At The American Society for Bone and Mineral Research 2014 Annual Meeting,,,,,,,,,,,,,,,,,,,,,," 1/12/2011 80105N10  PRN  Sanofi-aventis Enters Into Two Research & Development Collaborations With the University of California, San Francisco",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 2/09/2012 N5946510  PRN  Mylan Receives Final FDA Approval for First Generic Version of Doryx® Tablets, 150 mg",,," 9/09/2014 03116210 PRN  Critical Alerts For Alcoa, Twitter, General Mills, SunEdison and Amgen Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,, 1/11/2011 005M9Z-E  PRN  Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/06/2012 N5946510  PRN  Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant,,, 9/05/2014 03116210 PRN  Amgen To Present At The Morgan Stanley Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 1/10/2011 000BQR-E  PRN  Takeda San Francisco and Pieris Sign Anticalin(R) Therapeutic Collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/02/2012 N5946510  PRN  Mylan Receives Tentative FDA Approval for Generic Version of Lipitor®,,," 9/05/2014 03116210 PRN  Upcoming Presentations, Technical Update, Study Results, and Marketing Authorization Application - Research Reports on Novartis, InterMune, Johnson & Johnson, Amgen and Merck",,,,,,,,,,,,,,,,,,,,,, 1/05/2011 80105N10  PRN  Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 1/24/2012 N5946510  PRN  Mylan to Host Investor Day on Feb. 21, 2012, in New York City",,," 9/04/2014 03116210 PRN  Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen",,,,,,,,,,,,,,,,,,,,,,12/17/2010 80105N10  PRN  Sanofi-aventis and Oxford University Collaborate to Conduct Oncology Research in India,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 1/19/2012 N5946510  PRN  Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam,,, 9/04/2014 03116210 PRN  Biotech Advancements in Innovative Cancer Therapy Reveal Developing Systemic Treatment Options - Company Receives Recommendation from World Health Organization for Lead Drug Candidate,,,,,,,,,,,,,,,,,,,,,,12/16/2010 80105N10  PRN  Oklahoma City Thunder Point Guard Russell Westbrook and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,12/02/2011 N5946510  PRN  Mylan Launches Generic Version of Cyklokapron® Injection,,, 9/02/2014 03116210 PRN  Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency,,,,,,,,,,,,,,,,,,,,,,12/09/2010 80105N10  PRN  Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,"12/01/2011 N5946510  PRN  Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS",,, 9/02/2014 03116210 PRN  Amgen Submits Marketing Authorization Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The European Medicines Agency,,,,,,,,,,,,,,,,,,,,,,12/08/2010 000NB6-E  PRN  Johnson & Johnson Launches Recommended Public Offer to Acquire Crucell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,12/01/2011 N5946510  PRN  Mylan Confirms First-to-File Patent Challenge Relating to Generess™ Fe,,," 8/28/2014 03116210 PRN  Acquisitions, Appointment, and Vaccine Recommendations - Research Reports on InterMune, Amgen, Johnson & Johnson, Merck and Medtronic",,,,,,,,,,,,,,,,,,,,,,"12/03/2010 000LNN-E  PRN  Richard Pinder &Contagious Present The Contagious Conversation at Eurobest, Wednesday 8th December, Hamburg",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,12/01/2011 N5946510  PRN  Mylan Launches Generic Version of Caduet® Tablets,,, 8/28/2014 03116210 PRN  Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol,,,,,,,,,,,,,,,,,,,,,,"11/30/2010 000HT4-E  PRN  Critical Alerts for Google, DuPont, Sanofi-Aventis, Superior Energy Services, and Carter's Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,"12/01/2011 N5946510  PRN  Mylan Committed to Expanding Access in Developing Countries to High Quality, Affordable HIV/AIDS Treatment",,, 8/28/2014 03116210 PRN  Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA,,,,,,,,,,,,,,,,,,,,,,11/29/2010 005M9Z-E  PRN  Sanofi Pasteur Starts a Phase II Vaccine Trial for Primary Prevention of Clostridium Difficile,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,11/28/2011 N5946510  PRN  Mylan Receives Approval for Generic Version of Zinecard® for Injection,,, 8/27/2014 03116210 PRN  FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure,,,,,,,,,,,,,,,,,,,,,,"11/22/2010 000D1R-E  PRN  Reportlinker Adds Prostate Cancer - Brazil, China, India and Russia (BRIC) Drug Forecasts and Treatment Analysis to 2020",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,11/21/2011 N5946510  PRN  Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot®,,," 8/20/2014 03116210 PRN  Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck",,,,,,,,,,,,,,,,,,,,,,11/22/2010 000D1R-E  PRN  Reportlinker Adds Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,11/14/2011 N5946510  PRN  Mylan Successfully Upsizes and Completes Refinancing of Credit Facility,,, 8/19/2014 03116210 PRN  Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company,,,,,,,,,,,,,,,,,,,,,,11/18/2010 000BQR-E  PRN  Reportlinker Adds Global Bladder Cancer Therapeutics Industry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,"11/09/2011 N5946510  PRN  Mylan Applauds Obama Administration's Call to Create an ""AIDS-Free Generation"" Through Global Fight Against HIV/AIDS",,, 8/18/2014 03116210 PRN  Amgen Announces Positive Top-Line Results From Second Phase 3 Study Of AMG 416 For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis,,,,,,,,,,,,,,,,,,,,,,11/17/2010 000D1R-E  PRN  The First-Line Pancreatic Cancer Patient Population Will Experience A Dynamic Change in Treatment Practice Due to Increased Uptake of FOLFIRINOX and the Launch of Abraxane,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,11/09/2011 N5946510  PRN  Mylan to Acquire Pfizer Respiratory Delivery Platform,,," 8/14/2014 03116210 PRN  Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy",,,,,,,,,,,,,,,,,,,,,,11/17/2010 000D1R-E  PRN  Reportlinker Adds Global Anticoagulants Industry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,"11/02/2011 N5946510  PRN  Critical Alerts For Netflix, Hess, Cummins, Mylan, and Molson Coors Released By Seven Summits Research",,, 8/13/2014 03116210 PRN  Amgen Issues Voluntary Recall of Aranesp® (darbepoetin alfa) (500 mcg) Prefilled Syringes in Several Countries Outside of the United States Due to the Presence of Visible Particulates,,,,,,,,,,,,,,,,,,,,,,11/16/2010 000TBT-E  PRN  Reportlinker Adds Global Analgesics Industry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/27/2011 N5946510  PRN  Mylan Receives Approval for Generic Version of MS Contin® Tablets,,, 8/13/2014 03116210 PRN  Amgen Announces Top-Line Results From Phase 3 Focus Trial Of Kyprolis® In Patients With Relapsed And Advanced Refractory Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,,11/16/2010 003579-E  PRN  Reportlinker Adds Global Blood Glucose Meters and Strips Industry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,"10/26/2011 N5946510  PRN  Mylan Announces New, Expanded Management Structure to be Effective Jan. 1, 2012",,," 8/11/2014 000C35-E PRN  Investors Applaud Amgen and Novartis for Support of Investor Principles on Biosimilars, Alternatives to Higher Cost Drugs",,,,,,,,,,,,,,,,,,,,,,11/16/2010 000BG2-E  PRN  Reportlinker Adds Global Antibiotics Industry,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/26/2011 N5946510  PRN  Mylan's Third Quarter 2011 Adjusted Diluted EPS Increases 28% to $0.55,,," 8/11/2014 03116210 PRN  Drug Approvals, Financial Results, Upcoming Earnings, Technical Updates, and New Products - Research Reports on Amgen, Mylan, Biogen, Perrigo and Zimmer",,,,,,,,,,,,,,,,,,,,,,11/09/2010 80105N10  PRN  BMP Sunstone Reports Third Quarter 2010 Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/25/2011 N5946510  PRN  Mylan Launches First Generic Version of Exelon® Capsules in the U.K.,,," 8/08/2014 03116210 PRN  Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,11/09/2010 80105N10  PRN  U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur's Investigational Clostridium difficile Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/20/2011 N5946510  PRN  Mylan's Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist® Patents,,, 8/04/2014 03116210 PRN  Earnings Headlines - Amgen,,,,,,,,,,,,,,,,,,,,,,11/08/2010 80105N10  PRN  Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/19/2011 N5946510  PRN  Matrix Laboratories Completes Name Change to Mylan Laboratories,,," 8/04/2014 03116210 PRN  Drug Approvals and Earnings Releases - Research Reports on Bristol-Myers, Johnson & Johnson, Merck, Pharmacyclics and Amgen",,,,,,,,,,,,,,,,,,,,,,11/05/2010 80105N10  PRN  NASCAR Champion Jeff Gordon and Sound Off About Pertussis Song Contest Winner Rev Up Pertussis Awareness Through the Power of Music,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/19/2011 N5946510  PRN  Mylan Announces Femcon® Fe Settlement Agreement,,, 8/04/2014 03116210 PRN  Amgen Announces Phase 3 ASPIRE Trial Of Kyprolis® In Patients With Relapsed Multiple Myeloma Met Primary Endpoint,,,,,,,,,,,,,,,,,,,,,,11/04/2010 80105N10  PRN  Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/12/2011 N5946510  PRN  /C O R R E C T I O N -- Mylan Inc./,,, 7/29/2014 03116210 PRN  Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37,,,,,,,,,,,,,,,,,,,,,,11/01/2010 80105N10  PRN  E. J. McKay Advises BMP Sunstone on Its USD520.6 million Sale to Sanofi- aventis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,"10/08/2011 N5946510  PRN  Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan ""Mike"" Puskar",,, 7/25/2014 03116210 PRN  Amgen Announces 2014 Third Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,10/28/2010 80105N10  PRN  Sanofi-aventis to Acquire BMP Sunstone Creating a Strong Consumer Healthcare Platform in China,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/03/2011 N5946510  PRN  Mylan Schedules Third Quarter 2011 Financial Results Conference Call and Live Webcast,,, 7/25/2014 BAYN-DE  PRN  Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer,,,,,,,,,,,,,,,,,,,,,,10/28/2010 80105N10  PRN  Resilient Sales and Business EPS(1) in Q3 2010,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 9/22/2011 N5946510  PRN  Mylan Applauds Study Highlighting $931 Billion in Savings for U.S. Health Care System Due to Generic Drugs,,, 7/24/2014 03116210 PRN  Amgen Announces Webcast of 2014 Second Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,10/26/2010 80105N10  PRN  Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 9/21/2011 N5946510  PRN  Mylan Announces XELODA® Settlement and License Agreement,,, 7/21/2014 000C35-E PRN  Amgen's Evolocumab is Set to Become the Clinical Gold-Standard Among Statin Add-On Therapies for Dyslipidemia,,,,,,,,,,,,,,,,,,,,,,"10/25/2010 80105N10  PRN  Following Positive Phase II Data, Sanofi Pasteur to Conduct Phase III Trials of Quadrivalent Influenza Virus Vaccine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 9/20/2011 N5946510  PRN  Mylan's Matrix Receives Tentative FDA Approval Through PEPFAR for Novel ""Co-Packaged"" Version of HIV/AIDS Treatment",,, 7/17/2014 03116210 PRN  Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis,,,,,,,,,,,,,,,,,,,,,,10/25/2010 80105N10  PRN  Sanofi Pasteur Presents Phase III Data on Intradermal Microinjection of Influenza Vaccine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 9/01/2011 N5946510  PRN  The Zacks Analyst Blog Highlights: Gap, Teva Pharmaceutical Industries, Novartis AG, Momenta Pharmaceuticals and Mylan",,," 7/15/2014 03116210 PRN  Critical Alerts For Citigroup, BlackBerry, RF Micro Devices, Amgen, and Microsoft Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,10/18/2010 80105N10  PRN  Sanofi-aventis Establishes Research Collaboration With Harvard University,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 8/29/2011 N5946510  PRN  Critical Alerts for Google, Schlumberger, Carnival, Coach, and Mylan Released by Seven Summits Research",,," 7/09/2014 03116210 PRN  Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma",,,,,,,,,,,,,,,,,,,,,,10/15/2010 80105N10  PRN  Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 8/24/2011 N5946510  PRN  Dey Pharma to Offer EpiPen 2-Pak® and EpiPen Jr 2-Pak® Exclusively,,," 7/04/2014 03116210 PRN  NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind",,,,,,,,,,,,,,,,,,,,,,10/08/2010 80105N10  PRN  Sanofi Pasteur and U.S. Department of Health and Human Services Enter Into Agreement for Pandemic Vaccine Preparedness,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/27/2011 N5946510  PRN  Mylan's Second Quarter 2011 Adjusted Diluted EPS Increases 41% to $0.52,,, 7/01/2014 03116210 PRN  Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE® Antibody Blinatumomab In Acute Lymphoblastic Leukemia,,,,,,,,,,,,,,,,,,,,,,10/04/2010 80105N10  PRN  Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/12/2011 N5946510  PRN  /C O R R E C T I O N -- Mylan Inc./,,," 6/25/2014 03116210 PRN  Collaborations, Clinical Study Results, and Laboratory Inspection Clearance - Analyst Notes on Amgen, Regeneron, Lexicon, WuXi PharmaTech and ImmunoGen",,,,,,,,,,,,,,,,,,,,,,10/01/2010 80105N10  PRN  NASCAR Champion Jeff Gordon Urges You to Sound Off About Pertussis and Raise Awareness of the Disease by Casting Online Vote,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 6/17/2011 N5946510  PRN  Mylan Defeats Teva's Motion for Summary Judgment on Copaxone; Court Orders Trial on Inequitable Conduct Defense to Commence July 11, 2011",,," 6/23/2014 03116210 PRN  Critical Alerts For Walt Disney, Amgen, 3D Systems, Microsoft, and Lowe's Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,10/01/2010 80105N10  PRN  Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 5/27/2011 N5946510  PRN  The Zacks Analyst Blog Highlights: Mylan, Abbott Laboratories, Ista Pharmaceuticals, Johnson & Johnson and Teva Pharmaceuticals",,, 6/16/2014 03116210 PRN  Amgen Joins The National Cancer Institute And Research Partners To Help Accelerate Development Of Personalized Treatment Approaches For Squamous Cell Lung Cancer,,,,,,,,,,,,,,,,,,,,,, 9/30/2010 80105N10  PRN  Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/27/2011 N5946510  PRN  Mylan to Rebrand Matrix Laboratories,,, 6/11/2014 03116210 PRN  Brodalumab Treatment Improved Clinical Signs And Symptoms In Phase 2 Psoriatic Arthritis Study Published In The New England Journal Of Medicine,,,,,,,,,,,,,,,,,,,,,, 9/28/2010 005M9Z-E  PRN  Pieris Signs Broad Collaboration With Sanofi-Aventis and Sanofi Pasteur to Develop Anticalin Therapeutics,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/03/2011 N5946510  PRN  Mylan's First Quarter 2011 Adjusted Diluted EPS Increases 22% to $0.44,,, 6/09/2014 03116210 PRN  Amgen Appoints David W. Meline Executive Vice President and Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,," 9/27/2010 80105N10  PRN  Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/20/2011 N5946510  PRN  Mylan Schedules First Quarter 2011 Financial Results Conference Call and Live Webcast,,, 6/06/2014 03116210 PRN  Amgen To Present At The Goldman Sachs Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 9/21/2010 80105N10  PRN  Paul and Mira Sorvino Launch New Diabetes Awareness Program,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/05/2011 N5946510  PRN  Mylan Launches Generic Version of Sandostatin®,,, 6/02/2014 03116210 PRN  Amgen Presents New Data On Talimogene Laherparepvec As Single Agent And Combination Therapy In Metastatic Melanoma At ASCO,,,,,,,,,,,,,,,,,,,,,, 9/20/2010 80105N10  PRN  Adding Lantus® to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients with Type 2 Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 3/23/2011 N5946510  PRN  Mylan Introduces Educational Website About Generic Drugs, www.ChoosingGenerics.com",,, 6/01/2014 03116210 PRN  New Detailed Phase 3 Data Show Amgen's Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With A Rare And Serious Genetic Disorder That Causes High Cholesterol,,,,,,,,,,,,,,,,,,,,,, 9/20/2010 80105N10  PRN  Investigational Compound Once-Daily Lixisenatide Demonstrated Significant Improvement in Glucose Control in Patients with Type 2 Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 3/22/2011 N5946510  PRN  Mylan Announces Exclusive Distribution Partnership with Humeca to Expand Burn and Wound Care Portfolio,,, 5/31/2014 03116210 PRN  Amgen Highlights Phase 2 Results Of Vectibix® (panitumumab) Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,," 9/14/2010 80105N10  PRN  Sanofi Pasteur introduces new option for flu vaccination - tiny needle, same effectiveness as traditional flu shots",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 3/11/2011 N5946510  PRN  Moody's Upgrades Mylan,,, 5/30/2014 03116210 PRN  Amgen To Present At The Jefferies 2014 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 9/13/2010 80105N10  PRN  FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 3/10/2011 N5946510  PRN  Standard & Poor's Upgrades Mylan,,," 5/30/2014 03116210 PRN  Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma",,,,,,,,,,,,,,,,,,,,,, 9/08/2010 80105N10  PRN  Phase 3 Trial of Aflibercept in Second-Line Metastatic Colorectal Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 3/01/2011 N5946510  PRN  Robert J. Cindrich and Heather Bresch Appointed to Mylan's Board of Directors,,, 5/29/2014 03116210 PRN  Amgen To Host Post-American Society of Clinical Oncology (ASCO) Summary Webcast,,,,,,,,,,,,,,,,,,,,,, 8/30/2010 80105N10  PRN  Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 2/24/2011 N5946510  PRN  Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2010",,, 5/27/2014 ONXX-US  PRN  Amgen and Onyx Data at ASCO 2014 Highlight Oncology Pipeline and Portfolio,,,,,,,,,,,,,,,,,,,,,, 8/29/2010 80105N10  PRN  Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 2/24/2011 N5946510  PRN  Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year",,, 5/23/2014 03116210 PRN  FDA Approves First-Line Use of Vectibix® (Panitumumab) Plus FOLFOX for Patients with Wild-Type KRAS Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,, 8/26/2010 80105N10  PRN  FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 2/11/2011 N5946510  PRN  Mylan Schedules Fourth Quarter 2010 Financial Results Conference Call and Live Webcast,,, 5/20/2014 03116210 PRN  The New England Journal Of Medicine Publishes Positive Proof-Of-Concept Data For New Asthma Treatment,,,,,,,,,,,,,,,,,,,,,," 8/19/2010 80105N10  PRN  Ingrid Vandebosch, Wife of NASCAR Champion Jeff Gordon, Models Perfect Stance Against Pertussis Following Son's Birth",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 1/20/2011 N5946510  PRN  Dey Pharma Launches MyEpiPen Apps for iPhone and iPad,,," 5/16/2014 03116210 PRN  Acquisition Proposal Rejections, Court Rulings, Study Results, and Events Schedules - Analyst Notes on Allergan, Lilly, Amgen, Express Scripts and GSK",,,,,,,,,,,,,,,,,,,,,, 8/10/2010 80105N10  PRN  Sanofi-aventis Establishes Research Alliance with Scripps Genomic Medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 1/05/2011 N5946510  PRN  Mylan Announces Voluntary De-listing of 1.25% Senior Convertible Notes Due 2012 from Nasdaq,,, 5/15/2014 03116210 PRN  Amgen Announces Voting Results of Annual Meeting of Stockholders,,,,,,,,,,,,,,,,,,,,,, 8/05/2010 80105N10  PRN  Pertussis Awareness Takes Center Stage in Times Square With the Sound Off About Pertussis™ Song Contest Launch,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 1/04/2011 N5946510  PRN  Critical Alerts for Google, Bank of New York Mellon, Green Mountain Coffee Roasters, Mylan, and Avon Products Released by Seven Summits Research",,, 5/14/2014 06SG07-E PRN  Data from Bayer Oncology Portfolio and Pipeline to be Presented at ASCO 2014,,,,,,,,,,,,,,,,,,,,,, 8/05/2010 80105N10  PRN  FDA Approves New Taxotere® (docetaxel) Injection Concentrate Formulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,12/24/2010 N5946510  PRN  Mylan Finalizes Pricing Case Settlements Previously Disclosed in Principle in 2009 10-K,,," 5/14/2014 03116210 PRN  Clinical Study Results, Upcoming Events, and Financial Updates - Analyst Notes on Amgen, Insys, Alnylam, Seattle Genetics and Emergent BioSolutions",,,,,,,,,,,,,,,,,,,,,, 7/30/2010 80105N10  PRN  Sanofi Pasteur Begins Shipping Influenza Vaccine in U.S. for 2010-2011 Season,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,12/20/2010 N5946510  PRN  Dey Pharma Settles Federal Pricing Case,,, 5/13/2014 03116210 PRN  Journal Of The American Medical Association Publishes Phase 3 LAPLACE-2 Study Showing Evolocumab Significantly Reduced LDL Cholesterol In Patients On Statins Regardless Of Statin Dose,,,,,,,,,,,,,,,,,,,,,, 7/29/2010 80105N10  PRN  EPS growth in Q2 2010,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,"12/07/2010 N5946510  PRN  Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Abacavir Sulfate Tablets, 60 mg",,, 5/12/2014 03116210 PRN  Amgen's Breakaway from Cancer® Honors Four California Cancer Survivors During The Ninth Annual Amgen Tour of California,,,,,,,,,,,,,,,,,,,,,, 7/14/2010 80105N10  PRN  Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,11/24/2010 N5946510  PRN  Mylan Announces Completion of Senior Notes Offering,,," 5/12/2014 03116210 PRN  Amgen Names Steven K. Galson, Senior Vice President, Global Regulatory Affairs And Safety",,,,,,,,,,,,,,,,,,,,,," 7/01/2010 80105N10  PRN  Sanofi-aventis and JDRF Form Partnership to Improve Therapies, Work Toward Cure for Type 1 Diabetes",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,11/15/2010 N5946510  PRN  Mylan Announces the Conversion of its Preferred Stock into Common Stock,,, 5/09/2014 AZN-GB   PRN  Amgen And AstraZeneca Announce Positive Results From Phase 3 Study Of Brodalumab (AMG 827) In Patients With Moderate-to-Severe Plaque Psoriasis,,,,,,,,,,,,,,,,,,,,,," 6/30/2010 80105N10  PRN  Sanofi-aventis to Acquire TargeGen, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,11/10/2010 N5946510  PRN  Mylan Announces Final Conversion Rate for Mandatory Convertible Preferred Stock,,, 5/02/2014 03116210 PRN  Amgen To Present At The Deutsche Bank 39th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,," 6/29/2010 80105N10  PRN  Racing Champion Jeff Gordon and Wife, Ingrid, Rev Up Awareness of Pertussis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,11/09/2010 N5946510  PRN  Mylan Announces Pricing of Senior Notes,,," 4/23/2014 06SG07-E PRN  Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet",,,,,,,,,,,,,,,,,,,,,," 6/26/2010 80105N10  PRN  Less Glycemic Variability, Better Patient Reported Outcomes with Lantus® and Apidra® Regimen vs. Premix Analog Insulin",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,11/09/2010 N5946510  PRN  Mylan Announces Proposed Senior Notes Private Placement,,, 4/22/2014 03116210 PRN  Amgen's First Quarter 2014 Revenues Increased 7 Percent To $4.5 Billion,,,,,,,,,,,,,,,,,,,,,, 6/25/2010 80105N10  PRN  Improved Outcomes for Patients Treated with Lantus® and Apidra® Regimen Compared with Sliding Scale Insulin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,"10/28/2010 N5946510  PRN  The Zacks Analyst Blog Highlights: DeVry Inc., Royal Caribbean Cruises Ltd., Conoco Phillips, Mylan Inc. and JAKKS Pacific Inc.",,, 4/17/2014 03116210 PRN  Amgen Announces Webcast of 2014 First Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,," 6/21/2010 80105N10  PRN  Critical Alerts For Intel, Alcoa, Sanofi-Aventis, CBS, and US Airways Released By Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/27/2010 N5946510  PRN  /C O R R E C T I O N -- Mylan Inc./,,, 4/04/2014 03116210 PRN  Amgen Provides Update On Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma,,,,,,,,,,,,,,,,,,,,,, 6/17/2010 80105N10  PRN  Jevtana® (cabazitaxel) Injection Approved by U.S. FDA After Priority Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/26/2010 N5946510  PRN  Mylan Reports Adjusted Diluted EPS of $0.43; Reaffirms 2010 Adjusted Diluted EPS Guidance of $1.55 - $1.65,,, 3/30/2014 03116210 PRN  Data From Phase 3 Pivotal Studies Show Amgen's Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Statin Intolerant Patients And In Patients On Statins,,,,,,,,,,,,,,,,,,,,,, 6/14/2010 80105N10  PRN  Launch of IMIDIA - An Innovative Medicines Initiative Project for Diabetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/22/2010 N5946510  PRN  Mylan and Mylan Charitable Foundation Award a Collective $1.25 Million to Prominent West Virginia Cultural Institutions,,, 3/29/2014 03116210 PRN  New Detailed Data from Three Phase 3 Pivotal Studies Show Amgen's Novel Investigational Cholesterol-Lowering Medicine Evolocumab Significantly Reduced LDL Cholesterol By 55-66 Percent Compared To Placebo In Patients With High Cholesterol,,,,,,,,,,,,,,,,,,,,,, 6/07/2010 80105N10  PRN  Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/21/2010 N5946510  PRN  Mylan Receives Approval for Generic Version of Mirapex® Tablets,,, 3/26/2014 03116210 PRN  Amgen To Webcast Investor Meeting At Upcoming American College of Cardiology's 63rd Annual Scientific Session,,,,,,,,,,,,,,,,,,,,,, 6/05/2010 80105N10  PRN  Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/19/2010 N5946510  PRN  Mylan Declares Quarterly Preferred Stock Dividend,,, 3/24/2014 03116210 PRN  Phase 3 Pivotal Data On Amgen's Novel Investigational Cholesterol-Lowering Medicine To Be Featured At The American College of Cardiology's 63rd Annual Scientific Session,,,,,,,,,,,,,,,,,,,,,, 6/04/2010 80105N10  PRN  Ascenta Therapeutics Licenses Cancer Drug Candidates to sanofi-aventis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/18/2010 N5946510  PRN  Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case,,, 3/17/2014 03116210 PRN  Amgen Announces Positive Top-Line Results From Phase 3 TESLA Trial Of Evolocumab (AMG 145) In Patients With Homozygous Familial Hypercholesterolemia,,,,,,,,,,,,,,,,,,,,,, 6/02/2010 80105N10  PRN  Minnesota Lynx Guard Candice Wiggins Joins Vaccines for Teens Educational Campaign to Urge Local Teens to Get Vaccinated,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/18/2010 N5946510  PRN  Mylan Schedules Third Quarter 2010 Financial Results Conference Call and Live Webcast,,, 3/14/2014 03116210 PRN  Amgen's Talimogene Laherparepvec Reduced Size Of Melanoma Tumors In New Phase 3 Retrospective Analysis,,,,,,,,,,,,,,,,,,,,,, 5/27/2010 80105N10  PRN  NBA Legend Bob Lanier and San Antonio Silver Stars Guard Helen Darling Join Vaccines for Teens Educational Campaign to Urge Local Teens to Get Vaccinated,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/15/2010 N5946510  PRN  Mylan Receives Approvals for Generic Versions of Hyzaar® and Cozaar®,,," 3/13/2014 03116210 PRN  Critical Alerts For IBM, 3M, Sina, Amgen, and JP Morgan Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,, 5/26/2010 80105N10  PRN  Sanofi-aventis Establishes Strategic Alliance with MIT's Center for Biomedical Innovation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,"10/13/2010 N5946510  PRN  Critical Alerts For Wal-Mart, Time Warner, The Children's Place, Mylan, and Lennar Released By Seven Summits Research",,, 3/11/2014 06SG07-E PRN  Bayer and Onyx Report Phase 3 Study Results of NEXAVAR® (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation,,,,,,,,,,,,,,,,,,,,,, 5/25/2010 80105N10  PRN  NBA Legend Bob Lanier and Atlanta Dream Forward Angel McCoughtry Join Vaccines for Teens Educational Campaign to Urge Local Teens to Get Vaccinated,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/05/2010 N5946510  PRN  Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Generic Version of Reyataz® Capsules HIV Treatment,,, 3/05/2014 03116210 PRN  Amgen Announces 2014 Second Quarter Dividend,,,,,,,,,,,,,,,,,,,,,," 5/12/2010 80105N10  PRN  Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,"10/04/2010 N5946510  PRN  Mylan Receives Approval for Fludarabine Phosphate Injection, USP",,, 3/01/2014 03116210 PRN  Amgen To Present At The Cowen And Company 34th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,," 5/10/2010 80105N10  PRN  Critical Alerts for Chesapeake Energy, Kraft, Juniper Networks, Fluor, and Sanofi-Aventis Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,10/01/2010 N5946510  PRN  Mylan Launches Generic Version of Wellbutrin XL® Tablets,,, 2/21/2014 03116210 PRN  Amgen To Present At The RBC Capital Markets' Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,, 5/05/2010 80105N10  PRN  Sanofi-aventis Joins the Massachusetts Life Sciences Center's Corporate Consortium Program to Support Innovation in Research & Development,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 9/21/2010 N5946510  PRN  Mylan Granted Temporary Restraining Order Against GlaxoSmithKline and Apotex Prohibiting the Supply, Sale and/or Importing of a Generic Version of Paxil CR",,, 2/20/2014 06SG07-E PRN  Bayer Initiates Phase III Trial of Stivarga® (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases,,,,,,,,,,,,,,,,,,,,,, 5/04/2010 80105N10  PRN  NBA Legend Bob Lanier and Milwaukee Bucks' Jerry Stackhouse Join Vaccines for Teens Educational Campaign to Urge Local Teens to Get Vaccinated,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 9/21/2010 N5946510  PRN  Mylan Receives Approval for Generic Version of Prograf® Capsules,,, 2/19/2014 000C35-E PRN  Innovative Targeting Solutions Inc. Extends Research Collaboration with Amgen,,,,,,,,,,,,,,,,,,,,,, 4/29/2010 80105N10  PRN  Q1 2010: A Good First Quarter,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 9/07/2010 N5946510  PRN  Mylan Completes Acquisition of Bioniche Pharma Sooner Than Expected,,, 2/05/2014 MRK-US   PRN  Amgen And Merck Announce Collaboration To Evaluate Investigational Combination Treatment For Advanced Melanoma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 8/13/2010 N5946510  PRN  Mylan Announces Completion of Add-On Offering of Senior Notes,,, 1/30/2014 03116210 PRN  Amgen Announces Positive Top-Line Results From Phase 3 RUTHERFORD-2 Trial Of Evolocumab (AMG 145) In Patients With Heterozygous Familial Hypercholesterolemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/30/2010 N5946510  PRN  Mylan Announces Pricing of Add-On Offering of Senior Notes,,, 1/28/2014 03116210 PRN  Amgen Announces Positive Top-Line Results From Phase 3 LAPLACE-2 Trial Of Evolocumab (AMG 145) In Combination With Statins In Patients With High Cholesterol,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/29/2010 N5946510  PRN  Mylan Announces Proposed Add-On Private Placement of its Senior Notes Due 2020,,, 1/28/2014 03116210 PRN  Amgen's 2013 Revenues Increased 8 Percent To $18.7 Billion And Adjusted Earnings Per Share (EPS) Increased 17 Percent To $7.60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 7/28/2010 N5946510  PRN  Mylan Reports Adjusted Diluted EPS of $0.37 for the Three Months Ended June 30, 2010",,, 1/23/2014 03116210 PRN  Amgen Announces Webcast of 2013 Fourth Quarter and Full Year Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 7/22/2010 N5946510  PRN  Mylan Reschedules Second Quarter Earnings Call for Wednesday July 28, at 5 p.m. ET",,, 1/23/2014 03116210 PRN  Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-2 Trial Of Evolocumab (AMG 145) In Statin Intolerant Patients With High Cholesterol,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 7/22/2010 N5946510  PRN  Mylan Launches the Generic Version of Solodyn®, 45 mg, 90 mg and 135 mg Tablets, Announces Settlement Agreement with Medicis",,," 1/15/2014 05LKPZ-E PRN  Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/22/2010 N5946510  PRN  Mylan Announces Settlement Agreement for Namenda®,,," 1/15/2014 03116210 PRN  Regulatory Updates, Management Changes, and Conference Calls - Research Report on Bristol-Myers Squibb, Amgen, St. Jude Medical, Boston Scientific, and Mylan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/19/2010 N5946510  PRN  Mylan Declares Quarterly Preferred Stock Dividend,,, 1/09/2014 03116210 PRN  Amgen To Present At The 32nd Annual J.P. Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/19/2010 N5946510  PRN  Mylan Receives Approval for Generic Version of Catapres-TTS®,,, 1/09/2014 03116210 PRN  Chief Financial Officer Jonathan M. Peacock to Leave Amgen; Company Appoints Michael A. Kelly Acting Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/14/2010 N5946510  PRN  Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business,,," 1/07/2014 03116210 PRN  Critical Alerts For Amgen, Citigroup, Travelers, GlaxoSmithKline, and Dish Network Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/14/2010 N5946510  PRN  Mylan Receives Approval for Nabumetone Tablets,,," 1/07/2014 03116210 PRN  Clinical Trial Results Published, Conference Calls, Earnings Releases Scheduled, and Royalty Agreements - Research Report on Amgen, Cigna, AstraZeneca, CareFusion, and WellCare",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 7/12/2010 N5946510  PRN  Mylan Schedules Second Quarter 2010 Financial Results Conference Call and Live Webcast,,," 1/03/2014 03116210 PRN  Pre-Market Highlight of the Day: Questcor Pharma, PDL BioPharma, Amgen, and BioCryst Pharma",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 6/29/2010 N5946510  PRN  Mylan Receives Approval for Generic Version of Arimidex® Tablets,,, 1/01/2014 03116210 PRN  Romosozumab Phase 2 Data Published In New England Journal Of Medicine Show Significant Increases In Bone Mineral Density At Both Spine And Hip,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 6/24/2010 N5946510  PRN  Mylan Receives Approval for Generic Version of Procardia XL® Tablets,,,12/19/2013 03116210 PRN  Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 6/18/2010 N5946510  PRN  Critical Alerts for Visa, CSX, Newmont Mining, Joy Global, and Mylan Released by Seven Summits Research",,,12/17/2013 03116210 PRN  Amgen Announces Positive Top-Line Results From Phase 3 MENDEL-2 Trial Of Evolocumab (AMG 145) In Patients With High Cholesterol,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 6/18/2010 N5946510  PRN  Mylan Receives Approval for Generic Version of Zocor® Tablets,,,12/13/2013 03116210 PRN  Amgen Announces 2014 First Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 6/17/2010 N5946510  PRN  Mylan Receives Approval for Hydroxyzine Hydrochloride Tablets,,,12/10/2013 ONXX-US  PRN  Amgen To Host Post American Society of Hematology (ASH) Summary Webcast,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 6/04/2010 N5946510  PRN  Mylan Receives Approval for Generic Version of Neurontin® Tablets,,,"12/10/2013 03116210 PRN  New Clinical Data Access Policy, Portfolio Expansions, Positive Top Line Results and Stock Price Movements - Research Report on Pfizer, Amgen, Puma Biotechnology, Abbott Laboratories, and Agilent",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/26/2010 N5946510  PRN  Mylan Receives Approval for Generic Version of Valtrex®,,,12/05/2013 03116210 PRN  Amgen To Present At The Oppenheimer 24th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 5/25/2010 N5946510  PRN  Mylan Launches Temazepam Capsules USP, 7.5 mg",,,"11/29/2013 03116210 PRN  FDA Approvals, Scheduled Presentations, and Stock Price Movements - Research Report on Amgen, St. Jude Medical, Life Technologies, Ligand, and Infinity Pharmaceuticals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/19/2010 N5946510  PRN  Mylan Announces Completion of Senior Notes Offering,,,"11/26/2013 03116210 PRN  Official Statement, Stock Price Movements, and Public Offering of Common Stock - Research Report on Amgen, Biogen Idec, Express Scripts, Endo, and CSI",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/12/2010 N5946510  PRN  Mylan Announces Upsizing and Pricing of Senior Notes,,,"11/22/2013 07RWL7-E PRN  U.S. FDA Approves NEXAVAR® (sorafenib) for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory to Radioactive Iodine Treatment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/04/2010 N5946510  PRN  Mylan Announces Proposed Senior Notes Private Placement,,,"11/22/2013 03116210 PRN  Must Watch News & Earnings: Amgen, Micron Technology, Opko Health, GameStop Corp, Halcon Resources",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 5/04/2010 N5946510  PRN  Mylan Receives Approval for Generic Version of Zyban(R),,,11/19/2013 03116210 PRN  Amgen Announces Evolocumab (AMG 145) Results From First 52-Week Study Of A PCSK9 Inhibitor To Reduce LDL Cholesterol,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,," 4/29/2010 N5946510  PRN  Mylan Reports Adjusted Diluted EPS of $0.36 for the Quarter Ended March 31, 2010",,,11/18/2013 03116210 PRN  Amgen Presents Interim Overall Survival Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/28/2010 N5946510  PRN  Mylan Receives Approval for Generic Version of Flomax(R),,,11/14/2013 03116210 PRN  Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/26/2010 N5946510  PRN  Mylan Begins Marketing First Generic Version of Desoxyn(R),,,11/12/2013 03116210 PRN  Amgen to Highlight New Evolocumab (AMG 145) Data at Upcoming American Heart Association Scientific Sessions 2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,, 4/22/2010 N5946510  PRN  Mylan Schedules First Quarter 2010 Financial Results Conference Call and Live Webcast,,,"11/12/2013 03116210 PRN  Scholarship Grants, Financial Results, and Stock Price Movements - Research Report on Amgen, HCA, Allergan, Teva, and Novartis",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/08/2013 03116210 PRN  Amgen To Present At The Credit Suisse Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"11/08/2013 03116210 PRN  Before the Bell Scans: PDL BioPharma Inc., Amgen Inc., Questcor Pharma Inc., and BioCryst Pharma Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/07/2013 ONXX-US  PRN  Amgen and Onyx Pharmaceuticals Announce Upcoming Data Presentations at 55th American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"11/07/2013 03116210 PRN  Amgen Foundation Commits $2.5 Million In New Grants To Engage 50,000 Students Each Year In The Thrill Of Scientific Inquiry",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"11/06/2013 03116210 PRN  Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"10/29/2013 03116210 PRN  Financial Results & Release Schedules, Stock Performance Update, and New Clinical Trials - Research Report on Amgen, Boston Scientific, ACADIA Pharmaceuticals, Seattle Genetics, and Volcano",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/22/2013 03116210 PRN  Amgen's Third Quarter 2013 Revenues Increased 10 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 16 Percent To $1.94,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/22/2013 001J1Y-E PRN  Amgen Acquires Filgrastim Franchise Rights From Roche In 100 Markets,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"10/22/2013 03116210 PRN  Stock Price Movements, Clinical Study Results, and New Appointments - Research Report on Pfizer, Gilead Sciences, Amgen, Celgene, and Insys Therapeutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/17/2013 03116210 PRN  Amgen Announces Webcast of 2013 Third Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"10/17/2013 03116210 PRN  Technical Study: Amgen Inc., Questcor Pharmaceuticals Inc., PDL BioPharma Inc., and BioCryst Pharma Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/16/2013 03116210 PRN  Amgen Announces Appointment Of Greg C. Garland To Board Of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/16/2013 03116210 PRN  Amgen Announces 2013 Fourth Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"10/09/2013 03116210 PRN  FDA Approvals, Completed Tender Offers, Hospital Ratings, Trial Study Results, and Stock Price Movements - Research Report on Pfizer, Amgen, Cigna, Hologic, and Insys Therapeutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/03/2013 AZN-GB   PRN  Amgen And AstraZeneca Highlight Data To Be Presented At 22nd Congress Of The European Academy Of Dermatology And Venereology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"10/02/2013 03116210 PRN  Presentation on Research Findings, Recognitions, Clinical Trial Results, and Orphan Drug Designations - Research Report on Celgene, Biogen Idec, Amgen, Nektar, and Zalicus",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"10/01/2013 03116210 PRN  License Agreements, Strategic Partnerships, Regulatory Approvals, Acquisitions and Sale of Senior Notes - Research Report on Johnson & Johnson, Amgen, Gilead, MAKO, and Edwards Lifesciences",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/01/2013 03116210 PRN  Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/28/2013 03116210 PRN  Phase 3 Trial Comparing Vectibix® (Panitumumab) to Erbitux® (Cetuximab) Meets Primary Endpoint Of Non-Inferiority Of Overall Survival,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/27/2013 03116210 PRN  Updates on Pipeline Developments, Facility Expansions, and Conference Calls - Research Report on Merck, UnitedHealth, Amgen, Baxter, and Charles River",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/24/2013 03116210 PRN  Amgen And ShanghaiTech University Announce Plans For Amgen China R&D Center To Open On ShanghaiTech Campus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/20/2013 03116210 PRN  Today's Research: Amgen Inc., BioCryst Pharmaceuticals Inc., PDL BioPharma Inc., and Questcor Pharmaceuticals Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/18/2013 03116210 PRN  Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Onyx,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/18/2013 03116210 PRN  Pipeline Developments, Product Recalls, Clinical Trial Results, Recognitions, and New Appointments - Research Report on Johnson & Johnson, Amgen, Regeneron, UnitedHealth, and Bristol-Myers",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/16/2013 03116210 PRN  Collaborations, New Studies, and New Drug Applications - Research Report on Amgen, Gilead, Abbott, Biogen Idec, and UnitedHealth",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/12/2013 03116210 PRN  Amgen Highlights Data To Be Presented At 2013 European Cancer Congress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/12/2013 03116210 PRN  FDA Approvals, Study Results, Multi-Year Collaborations, Data Presentations, and Supply Agreements - Research Report on Celgene, Amgen, Biogen Idec, Vertex, and Illumina",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/11/2013 03116210 PRN  Analysis Published In New England Journal of Medicine Highlights Discovery Of New Predictive Biomarkers For Vectibix® (Panitumumab),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/10/2013 03116210 PRN  Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/06/2013 03116210 PRN  Amgen To Present At The Morgan Stanley Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/03/2013 03116210 PRN  Pharmaceuticals Report Revolutionary Findings, Approved Treatments, Investor Conferences - Research Report on Celgene, Amgen, Biogen Idec, Regeneron, and Questcor",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/03/2013 03116210 PRN  Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/01/2013 03116210 PRN  Amgen Presents Pooled Analysis Showing AMG 145 Significantly Reduced LDL Cholesterol In Over 1,200 Patients",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/30/2013 03116210 PRN  Amgen To Participate At Citi's 8th Annual Biotech Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 8/29/2013 AMGN-US  PRN  ONYX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Onyx Pharmaceuticals, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 8/28/2013 03116210 PRN  Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/27/2013 CYTK-US  PRN  Amgen to Highlight New Data at Upcoming ESC Congress 2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/25/2013 03116210 PRN  Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 8/21/2013 03116210 PRN  Healthy Outlook for Healthcare Supported by Trial Milestones, Approvals, Partnerships, and Commercialization - Research Report on Lilly, Celgene, Onyx, Amgen, and GSK",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/12/2013 05K0PC-E PRN  Amgen And Servier Complete Product Collaboration Transaction,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/30/2013 03116210 PRN  Amgen's Second Quarter 2013 Revenues Increased 5 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 3 Percent To $1.89,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/26/2013 03116210 PRN  Amgen Announces 2013 Third Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/25/2013 03116210 PRN  Amgen Announces Webcast of 2013 Second Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/15/2013 03116210 PRN  The Lancet Oncology Publishes Results Of XGEVA® (denosumab) In Patients With Giant Cell Tumor Of Bone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 7/11/2013 03116210 PRN  Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/09/2013 03116210 PRN  Amgen And Servier Announce Product Collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/26/2013 SGEN-US  PRN  Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/19/2013 03116210 PRN  Amgen Award For Science Teaching Excellence Honors Outstanding Teachers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 6/19/2013 03116210 PRN  Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 6/18/2013 03116210 PRN  Advanced Treatment Methods, Significant Study Results, Conferences, and Final Study Data Releases - Research Report on Amgen, Celgene, Vertex Pharmaceuticals, MannKind, and Peregrine Pharmaceuticals",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/13/2013 03116210 PRN  FDA Approves Amgen's XGEVA® (denosumab) For The Treatment Of Giant Cell Tumor Of Bone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/12/2013 03116210 PRN  Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/12/2013 03116210 PRN  Amgen And AstraZeneca Highlight Data To Be Presented At European League Against Rheumatism Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/06/2013 03116210 PRN  Amgen To Present At The Goldman Sachs 34th Annual Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/01/2013 03116210 PRN  Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/29/2013 03116210 PRN  Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/29/2013 4503-JP  PRN  Amgen And Astellas Announce Japan Alliance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 5/24/2013 JOBS-CN  PRN  Critical Alerts For Amgen, Lockheed Martin, Genuine Parts, TakeTwo Interactive, and 51Job Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/23/2013 03116210 PRN  Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/22/2013 03116210 PRN  Amgen Announces Voting Results of Annual Meeting of Stockholders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/16/2013 03116210 PRN  Amgen To Present At The UBS Global Life Sciences Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/15/2013 03116210 PRN  New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/15/2013 03116210 PRN  Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/09/2013 03116210 PRN  Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/07/2013 03116210 PRN  Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/01/2013 03116210 PRN  Four Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/30/2013 0BDK6C-E PRN  Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/23/2013 03116210 PRN  Amgen's First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/23/2013 03116210 PRN  Critical Alerts For Amgen, Peabody Energy, CME, MDC Holdings, and Hanesbrands Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/23/2013 000C35-E PRN  The Zacks Analyst Blog Highlights: Amgen, Freeport-McMoRan Copper & Gold, Plains Exploration & Production, McMoRan Exploration and Atlatsa Resources",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/18/2013 03116210 PRN  Amgen Announces Webcast of 2013 First Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/17/2013 000C35-E PRN  Kinaxis Event Alert: LogiPharma Europe 2013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/11/2013 064619-E PRN  Epsen Fuller Group Recruits Operations Leader for Global Biotech Firm SOTIO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/05/2013 06DDVL-E PRN  Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/04/2013 0801VZ-E PRN  Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/01/2013 03116210 PRN  Morning Research on Amgen, Affymax, Vertex Pharma, Questcor Pharma, and Repros Therapeutics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/21/2013 BHC-CA   PRN  Critical Alerts For Las Vegas Sands, Amgen, Edwards Lifesciences, Valeant Pharmaceuticals, and China Mobile Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/19/2013 03116210 PRN  Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/18/2013 03116210 PRN  Innovative Product Portfolios Ride Commercialization & Global Expansion - Research Report on Amgen, Onyx Pharmaceuticals, Alexion Pharmaceuticals, BioMarin Pharmaceutical and Incyte",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/14/2013 03116210 PRN  A Forward Look, the Year Ahead - Research Report on Amgen, Inc., Bristol Myers Squibb Co., Ann Inc., Limited Brands, Inc. and AMETEK, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/07/2013 03116210 PRN  BioMarin Pharma, Amgen, Sarepta Therapeutics, Chelsea Therapeutics Intl., and Theravance Early Briefing and Review",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/06/2013 03116210 PRN  Amgen Announces 2013 Second Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/01/2013 03116210 PRN  Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 2/28/2013 LL-US    PRN  Zacks Bull and Bear of the Day Highlights: Lumber Liquidators Holdings, Weight Watchers International, Apple, Intel and Amgen",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 2/28/2013 03116210 PRN  Science Behind the Numbers, The Business of Health - Research Report on Endo Health Solutions Inc, Actavis Inc, Mylan Inc., Elan Corporation, plc and Amgen, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 2/26/2013 00C99L-E PRN  How Insiders Trade Hot Stocks: Intel, Nokia, Marathon Oil, Amgen, J.C. Penney, and SandRidge Energy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 2/25/2013 03116210 PRN  A New Direction, What's Ahead - Research Report on Newmont Mining Corp, AMETEK, Inc., Honeywell International Inc., Amgen, Inc. and Bristol Myers Squibb Co.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/22/2013 03116210 PRN  Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 2/21/2013 03116210 PRN  A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/20/2013 000C35-E PRN  Selexis Announces Expansion of R&D License Agreement with Amgen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/08/2013 03116210 PRN  Amgen Announces Call For Nominations For 2013 Breakaway From Cancer® Champions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/07/2013 03116210 PRN  Amgen Outlines Long-Term Strategy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/06/2013 03116210 PRN  Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/05/2013 03116210 PRN  Briefing: Leading Pharma Companies to Watch in Today's Market Session,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/31/2013 03116210 PRN  Amgen To Webcast 2013 Business Review Meeting On February 7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 1/30/2013 03116210 PRN  Free Research Report on Marriott Vacations Worldwide Corp, Copart, Inc., Five Below, Inc., City National Corp. and Amgen Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/30/2013 03116210 PRN  Emerging Growth Pharmaceutical Company Creates Gravitational Pull Towards Their Products,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 1/29/2013 03116210 PRN  Critical Alerts For Amgen, FedEx, Hertz, Navistar, and Ship Finance International Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/26/2013 03116210 PRN  Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta® (pegfilgrastim) In Patients With Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/25/2013 03116210 PRN  Amgen Backs States' Efforts To Enact Biosimilar Legislation That Allows For Substitution And Supports Patient Safety,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/23/2013 03116210 PRN  Amgen's Full Year 2012 Revenues Increased 11 Percent To $17.3 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $6.51,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 1/23/2013 03116210 PRN  Pill Economics - Research Report on Arena Pharmaceuticals, Inc. and Amgen, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/18/2013 03116210 PRN  Amgen Announces Webcast of 2012 Fourth Quarter and Full Year Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/16/2013 03116210 PRN  Amgen Announces Top-Line Results Of Phase 3 Aranesp® (darbepoetin alfa) RED-HF® Trial,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/16/2013 03116210 PRN  Amgen To Build State-Of-The-Art Manufacturing Facility In Singapore,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/16/2013 000C35-E PRN  National Pharmaceutical Council Welcomes Amgen as Its Newest Member,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 1/04/2013 NKTR-US  PRN  Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, CA",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/03/2013 AMGN-US  PRN  Amgen To Present At The 31st Annual J.P. Morgan Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"12/28/2012 DLPH-GB  PRN  Critical Alerts For Citigroup, Amgen, Questcor Pharmaceuticals, Delphi Automotive, and Pan American Silver Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"12/19/2012 AMGN-US  PRN  Update: Sanford Heisler Announces $762 million Settlement In Qui Tam Action Against Amgen, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/19/2012 03116210 PRN  Amgen Finalizes Agreement Resolving Previously Announced Federal Investigations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/13/2012 MAT-US   PRN  Amgen Announces Appointment of Robert A. Eckert to Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/13/2012 03116210 PRN  Amgen Names Robert A. Bradway Chairman of the Board Of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/13/2012 03116210 PRN  Amgen Announces 31 Percent Increase In 2013 First Quarter Dividend And Increase In Its Share Repurchase Authorization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"12/12/2012 06DDVL-E PRN  Zacks Bull and Bear of the Day Highlights: Amgen, Align Technology, Texas Instruments, Maxim Integrated Products and Intel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"12/10/2012 03116210 PRN  Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/05/2012 03116210 PRN  Amgen Highlights Data To Be Presented At American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/20/2012 03116210 PRN  Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"11/16/2012 09YJZD-E PRN  The Zacks Analyst Blog Highlights: Starbucks Corporation, Tevana Holdings, Inc., Celgene Corporation, Amgen Inc. and Pfizer Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"11/14/2012 FIO-US   PRN  Critical Alerts For Amgen, Southwestern Energy, AmerisourceBergen, Westport Innovations, and Fusion-io Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/12/2012 03116210 PRN  Amgen and Pfizer Highlight Data to be Presented at American College of Rheumatology Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/06/2012 03116210 PRN  The Lancet Publication Of LAPLACE-TIMI 57 And MENDEL Studies Showed AMG 145 Significantly Reduced LDL Cholesterol,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/05/2012 03116210 PRN  Circulation Publishes Results From RUTHERFORD Study Which Showed AMG 145 Significantly Reduced LDL Cholesterol In Patients With Heterozygous Familial Hypercholesterolemia,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/05/2012 03116210 PRN  Journal of the American Medical Association Publishes AMG 145 Phase 2 GAUSS Study Showing Significant Reductions In LDL Cholesterol In Statin-Intolerant Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/03/2012 03116210 PRN  Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial Published In The New England Journal Of Medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/02/2012 03116210 PRN  Amgen To Present Data From Four Phase 2 Studies At Upcoming American Heart Association Scientific Sessions 2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/01/2012 03116210 PRN  Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/23/2012 03116210 PRN  Amgen's Third Quarter 2012 Revenues Increased 10 Percent To $4.3 Billion And Adjusted Earnings Per Share (EPS) Increased 19 Percent To $1.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/18/2012 03116210 PRN  Amgen Announces Webcast of 2012 Third Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/14/2012 03116210 PRN  Amgen Presents Several Sub-Analyses At ASBMR From The Ongoing Open-Label Extension Study Of The Pivotal Phase 3 Prolia Fracture Trial,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/12/2012 03116210 PRN  Amgen Appoints Cynthia Patton Senior Vice President And Chief Compliance Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/11/2012 03116210 PRN  Amgen Announces 2012 Fourth Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"10/10/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Microsoft, AstraZeneca, Roche Holdings, Amgen and Bristol-Myers Squibb",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/26/2012 SNDK-US  PRN  Critical Alerts For Amgen, Tyco, SanDisk, Lam Research, and Eaton Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/20/2012 03116210 PRN  FDA Approves New Indication For Prolia® (Denosumab) For The Treatment Of Bone Loss In Men With Osteoporosis At High Risk For Fracture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/18/2012 000C35-E PRN  Most Active Stocks: Microsoft, Exxon Mobil, Starbucks, US Airways Group, Amgen, and Boeing",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/17/2012 09VT2C-E PRN  West Health Builds Government Affairs Team with Bipartisan Senate Leadership Staff Hires,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/10/2012 03116210 PRN  Amgen Names Ray Jordan Senior Vice President, Corporate Affairs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/10/2012 03116210 PRN  Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/10/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Celgene, Amgen, Pfizer, Dow Chemical and EI DuPont de Nemours",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/07/2012 03116210 PRN  Amgen To Present At The Morgan Stanley Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/31/2012 03116210 PRN  Amgen To Present At The Baird Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 8/17/2012 06DDVL-E PRN  Zacks Bull and Bear of the Day Highlights: DTE Energy, Penn Virginia Resource Partners, Takeda Pharmaceutical, Amgen and Eli Lilly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 8/14/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Amgen, Eli Lilly, AstraZeneca, Goldman Sachs Group and State Street",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 8/13/2012 03116210 PRN  Critical Trade Alerts For Amgen, Western Digital, Biogen Idec, Big Lots, and Oasis Petroleum Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/08/2012 03116210 PRN  Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/03/2012 GOOGL-US PRN  5 Familiar Stocks to Sell (or Short)!,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 7/30/2012 ESV-GB   PRN  Today's Hot Stocks: Expedia, Amarin, ENSCO, Amgen, Wal-Mart, and Nokia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/26/2012 03116210 PRN  Amgen's Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/23/2012 03116210 PRN  Amgen Announces Webcast of 2012 Second Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/19/2012 03116210 PRN  Amgen Announces 2012 Third Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 7/06/2012 SDRL-BM  PRN  Stock Alerts For Amgen, Polo Ralph Lauren, PulteGroup, Seadrill, and China Unicom Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/05/2012 03116210 PRN  Amgen Completes Acquisition of KAI Pharmaceuticals,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/25/2012 03116210 PRN  Actress Maura Tierney And Amgen Launch The Chemotherapy: Myths or Facts™ Campaign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/12/2012 03116210 PRN  Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/11/2012 03116210 PRN  20th Annual Amgen Award For Science Teaching Excellence Honors Nine Outstanding Teachers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/08/2012 03116210 PRN  Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 6/06/2012 06DDVL-E PRN  The Zacks Analyst Blog Highlights: Roche Holdings, Amgen, Merck KGaA, Eli Lilly and Bristol-Myers Squibb",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/05/2012 0C2TPM-E PRN  Hobart Group Holdings and AnswerLab Team Up To Offer Cutting Edge Digital Experiences to Pharmaceutical Manufacturers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 6/05/2012 UAL-US   PRN  Critical Alerts For Amgen, United Continental, D.R. Horton, Cheesecake Factory, and MDC Holdings Released By InvestorsObserver",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/23/2012 03116210 PRN  Amgen Announces Voting Results of Annual Meeting of Stockholders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/16/2012 03116210 PRN  /C O R R E C T I O N -- Amgen/,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/16/2012 03116210 PRN  Analysis Of Rilotumumab (AMG 102) Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/11/2012 03116210 PRN  Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/10/2012 07G75F-E PRN  Kieran Walsh Joins Rosetta as Partner in High-Growth Healthcare Vertical,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 5/09/2012 03116210 PRN  Cancer Support Community Launches National Program to Assist Patients With Cancer, Make Informed Decisions About Care",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 5/08/2012 AMGN-US  PRN  Roger and Ann Worthington Donate $25,000 to Amgen's Breakaway from Cancer Walk in Dana Point, California",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/07/2012 06573K-E PRN  Scientists discover new type of cell with a key role in treatment-resistant asthma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/04/2012 03116210 PRN  Amgen to Present at the Baird Growth Stock Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/03/2012 03116210 PRN  Amgen to Present at the Deutsche Bank 37th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/01/2012 03116210 PRN  Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/26/2012 03116210 PRN  Amgen Receives Complete Response Letter From FDA for XGEVA® sBLA for Prevention of Bone Metastases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/26/2012 0C4D9Y-E PRN  For The First Time, Local Cyclists Can 'Ride The Route' Just Before The World's Best Compete In The 2012 Amgen Tour Of California",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/26/2012 000C35-E PRN  PRA Announces Strategic Relationship with Amgen,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/25/2012 03116210 PRN  Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/24/2012 03116210 PRN  Amgen's First Quarter 2012 Revenue Increased 9 Percent To $4.0 Billion And Adjusted Earnings Per Share (EPS) Increased 20 Percent To $1.61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/23/2012 03116210 PRN  A Tribute to George Rathmann, Amgen's Founding CEO (1927-2012)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/19/2012 03116210 PRN  Amgen Announces Webcast of 2012 First Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/12/2012 LYG-GB   PRN  The Zacks Analyst Blog Highlights: The Goldman Sachs Group, Lloyd's, Bank of America, JPMorgan Chase and Amgen",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/10/2012 03116210 PRN  Amgen to Acquire Privately Held KAI Pharmaceuticals,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/04/2012 03116210 PRN  UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/02/2012 03116210 PRN  Amgen and AstraZeneca Announce Collaboration to Jointly Develop and Commercialize Clinical-Stage Inflammation Portfolio,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/28/2012 03116210 PRN  Amgen Announces Phase 2 Study Results for Brodalumab in Moderate to Severe Plaque Psoriasis Published in the New England Journal of Medicine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/28/2012 000C35-E PRN  The Zacks Analyst Blog Highlights: Amgen, Sanofi, Regeneron, Alnylam and Coach",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/28/2012 XOM-US   PRN  S&P Indices: S&P 500 Stock Buybacks Decrease for First Time Since Q2 2009,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/25/2012 03116210 PRN  Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/15/2012 03116210 PRN  Amgen Announces 2012 Second Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/07/2012 03116210 PRN  Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/06/2012 03116210 PRN  Schwartz Center Receives $500,000 Grant from the Amgen Foundation",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/02/2012 03116210 PRN  Amgen Announces Initial Results of Tender Offer for Outstanding Shares of Micromet, Inc. and Commencement of Subsequent Offering Period",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/01/2012 064Z7G-E PRN  New Pathogenesis Based Seizure Treatment Patent,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/29/2012 03116210 PRN  Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/23/2012 03116210 PRN  Amgen to Present at the Citi 2012 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/15/2012 03116210 PRN  Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Micromet,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 2/14/2012 03116210 PRN  Amgen Names Michael Severino, M.D., Senior Vice President, Global Development and Corporate Chief Medical Officer",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/13/2012 03116210 PRN  Amgen to Present at the Leerink Swann Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 2/09/2012 000C35-E PRN  Zacks Bull and Bear of the Day Highlights: Amgen, Montpelier Re Holdings, Cisco Systems, Illumina and Roche Holdings",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/08/2012 03116210 PRN  Amgen to Discuss Application for New Use of XGEVA® (denosumab) at FDA Oncologic Drugs Advisory Committee Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 2/06/2012 NVS-CH   PRN  CORRECTION - Transparency Market Research: Global Osteoporosis Market is Expected to Attain a Market Size of USD 11.4 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/03/2012 BIIB-US  PRN  How Many Stocks Should You Own?,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/31/2012 000C35-E PRN  Giustino O'Dowd and Polk to Strengthen Weber Shandwick's Chicago Corporate Affairs Practice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 1/30/2012 ITUB-BR  PRN  Research Reports for Day Traders: Newell Rubbermaid, Apple, Amgen, Lowe's, Itau Unibanco Holding and Chevron",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/26/2012 03116210 PRN  Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/26/2012 03116210 PRN  Amgen to Acquire Micromet,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/26/2012 0CBQ1G-E PRN  Kreos Capital Announces the First Close of Kreos Capital IV With €120m ($160m) of Commitments,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/24/2012 03116210 PRN  Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 1/24/2012 06FNL7-E PRN  Bridgeway Aligns Strategy with Industry Shift Towards Legal Operations: Increases Transparency, Collaboration & Productivity",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 1/24/2012 SU-CA    PRN  Critical Alerts for Amgen, Procter and Gamble, Suncor Energy, Under Armour, and Polycom Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/19/2012 000C35-E PRN  Innovative Targeting Solutions Initiates Research Collaboration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/11/2012 000C35-E PRN  Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/04/2012 03116210 PRN  Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/04/2012 07HG7X-E PRN  RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/29/2011 03116210 PRN  FDA to Review Potential New Use of XGEVA® (Denosumab) at Oncologic Drugs Advisory Committee Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/22/2011 NLOK-US  PRN  Alliance Celebrates Passage of SBIR/STTR Reauthorization,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/19/2011 03116210 PRN  Amgen and Watson Announce Collaboration to Develop and Commercialize Oncology Biosimilars,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/19/2011 03116210 PRN  Amgen and Watson Announce Collaboration to Develop and Commercialize Oncology Biosimilars,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"12/19/2011 03116210 PRN  Critical Alerts for Goldman Sachs, Amgen, VeriSign, Coach, and Yamana Gold Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"12/15/2011 03116210 PRN  Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/15/2011 03116210 PRN  Amgen Announces 2012 First Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/14/2011 03116210 PRN  Amgen Announces Final Results of Its Tender Offer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/13/2011 03116210 PRN  Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"12/13/2011 NKTR-US  PRN  Nektar Announces Positive Clinical Data from Second Phase 1 Clinical Study of NKTR-181, a Novel Opioid Analgesic Molecule to Treat Chronic Pain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/09/2011 03116210 PRN  Amgen to Present at the 22nd Annual Oppenheimer Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"12/09/2011 ANRZQ-US PRN  Hot Stock Research for Bank of America, Amgen, Clearwire, Halliburton, Alpha Natural Resources and Petroleo Brasileiro",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/08/2011 03116210 PRN  Amgen Announces Preliminary Results of Its Tender Offer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/06/2011 03116210 PRN  Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/22/2011 03116210 PRN  Enbrel® (etanercept) Patent Issued,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"11/22/2011 TSN-US   PRN  The Zacks Analyst Blog Highlights: Alleghany, TransAtlantic, Tyson Foods, Tech Data and Amgen",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/15/2011 03116210 PRN  The Lancet Publishes Results Demonstrating XGEVA® Significantly Prolonged Bone Metastasis-free Survival in Men With Prostate Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/15/2011 03116210 PRN  Vectibix® (Panitumumab) Granted Approval for Expanded Indications in the European Union,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/14/2011 03116210 PRN  Amgen Statement on European Investor Visit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"11/11/2011 000C35-E PRN  Critical Stock Alerts for National-Oilwell Varco, Duke Energy, Xilinx, Schlumberger, Amgen & Quanta Services",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/07/2011 03116210 PRN  Amgen Announces Plan to Launch Tender Offer and Launch of Senior Notes Offering,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/05/2011 03116210 PRN  Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/05/2011 03116210 PRN  Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits in Rheumatoid Arthritis (RA) Patients With Moderately Active Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/25/2011 09W1QS-E PRN  CDC Introduces Important New Educational Resources to Prevent Infections in Cancer Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/24/2011 03116210 PRN  Amgen’s Third Quarter 2011 Revenue and Adjusted Earnings Per Share (EPS) Each Increased 3 Percent to $3.9 Billion and $1.40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/19/2011 03116210 PRN  Amgen Announces Webcast of 2011 Third Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/19/2011 03116210 PRN  Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"10/17/2011 000BG2-E PRN  The Zacks Analyst Blog Highlights: Abbott Laboratories, Amgen /Pfizer, Johnson & Johnson and Symantec",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/13/2011 03116210 PRN  Amgen Appoints Robert A. Bradway to the Company's Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/13/2011 03116210 PRN  Amgen Announces 2011 Fourth Quarter Dividend,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"10/07/2011 03116210 PRN  Critical Alerts For Verizon, Amgen, Cardinal Health, ProLogis, and Finisar Released By Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"10/06/2011 000C35-E PRN  S1P1 Program Assets Generated by Epix Pharmaceuticals, Inc. and Amgen Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/23/2011 03116210 PRN  Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/19/2011 03116210 PRN  FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/17/2011 03116210 PRN  Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/15/2011 03116210 PRN  Amgen to Present at the UBS Global Life Sciences Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/15/2011 03116210 PRN  Amgen Staff Volunteer Efforts Result in $5,000 For Each of Their Favorite Nonprofits",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/12/2011 03116210 PRN  Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/09/2011 000C35-E PRN  Critical Stock Alerts for Newmont Mining, OpenTable, Amgen, Automatic Data Processing, Intuitive Surgical & American Capital",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/08/2011 03116210 PRN  Amgen to Present at the Morgan Stanley Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/06/2011 03116210 PRN  Amgen to Present at the Baird Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/02/2011 03116210 PRN  Amgen to Present at the Stifel Nicolaus Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/02/2011 000BK7-E PRN  Critical Stock Alerts for Coca-Cola, Charles Schwab, JDS Uniphase, AMD, Amgen & Riverbed",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/25/2011 03116210 PRN  Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/22/2011 03116210 PRN  Amgen Announces PDUFA Date for XGEVA® Supplemental Biologics License Application,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/18/2011 03116210 PRN  Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 8/09/2011 07G766-E PRN  The Zacks Analyst Blog Highlights: Micromet Inc., Bayer, AstraZeneca, Sanofi Aventis and Amgen",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 8/09/2011 HON-US   PRN  Equity Research for Caterpillar, AIG, Amgen, Huntington Bancshares, Honeywell & Citrix",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 8/02/2011 MPC-US   PRN  Critical Alerts for Verizon, Amgen, Abercrombie & Fitch, Tibco Software, and Marathon Petroleum Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/01/2011 06ZNST-E PRN  SolutionSet Launches Relationship Marketing Group,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 8/01/2011 03116210 PRN  The Zacks Analyst Blog Highlights: Chevron, ExxonMobil, Amgen, Abbott and Merck/Johnson & Johnson",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/29/2011 03116210 PRN  Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/28/2011 0039ZQ-E PRN  IU Confidential Publishes Biotech Investment Report,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/28/2011 03116210 PRN  ITG Healthcare Market Research Study Finds XGEVA on Track to Be Top-Prescribed Drug for Prevention of SREs in Cancer Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/25/2011 03116210 PRN  Amgen Announces Webcast of 2011 Second Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 7/19/2011 GSK-GB   PRN  Zacks Bull and Bear of the Day Highlights: Brightpoint, Medtronic, Amgen, Novartis and GlaxoSmithKline",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/18/2011 007BTF-E PRN  Satori Pharmaceuticals Demonstrates its Approach to Modulating Gamma-Secretase Effective In Reducing Plaque-Forming Amyloid Beta Peptide,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/15/2011 03116210 PRN  Amgen Resolves G-CSF Patent Litigation With Teva,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 7/15/2011 03116210 PRN  The Zacks Analyst Blog Highlights: Google, Abbott Laboratories, Amgen, Pfizer and Johnson & Johnson",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/15/2011 03116210 PRN  XGEVA® (Denosumab) Granted Marketing Authorization in the European Union,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/15/2011 000C35-E PRN  XGEVA® (Denosumab) Granted Marketing Authorization in the European Union,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/05/2011 03116210 PRN  Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/27/2011 03116210 PRN  Amgen Submits Application to Expand Indication for XGEVA® (Denosumab) to Prevent or Delay Spread of Prostate Cancer to the Bone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/24/2011 03116210 PRN  Notice to Investors Regarding 2011 and 2015 Guidance,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/24/2011 03116210 PRN  Amgen Announces Modifications to U.S. Prescribing Information for Use of Erythropoiesis-Stimulating Agents in Chronic Kidney Disease,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/24/2011 03116210 PRN  Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 6/21/2011 03116210 PRN  Teachers and Schools Across North America Receive $10,000 Amgen Award for Science Teaching Excellence",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/15/2011 098QVL-E PRN  Health Technology Assessment Goes Online,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 5/25/2011 SOLR-US  PRN  Critical Alerts For Amgen, Boeing, Goldcorp, American Tower, and GT Solar Released By Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/25/2011 03116210 PRN  Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/20/2011 03116210 PRN  Amgen Announces Voting Results Of Annual Meeting of Stockholders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/20/2011 03116210 PRN  Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/18/2011 03116210 PRN  Amgen Oncology Data to be Presented at ASCO Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/17/2011 03116210 PRN  Phase 3 Data Demonstrate XGEVA™ (Denosumab) is First Bone Targeted Therapy to Prevent Spread of Cancer to the Bone in Men With Advanced Prostate Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/13/2011 03116210 PRN  Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 5/12/2011 000C35-E PRN  Patient Advocate Foundation Partners with Breakaway from Cancer for Third Consecutive Year; Raising Awareness, Providing Resources for Cancer Patients",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/11/2011 03116210 PRN  Patrick Dempsey Teams up With Breakaway from Cancer® to Help Connect Cancer Patients to Free Resources,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 5/11/2011 000C35-E PRN  Amgen's Breakaway from Cancer April 30th Event Raises $50,000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/10/2011 03116210 PRN  Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/28/2011 03116210 PRN  Amgen to Present at the Deutsche Bank 36th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/21/2011 03116210 PRN  Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/21/2011 03116210 PRN  Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/20/2011 03116210 PRN  Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/20/2011 03116210 PRN  Critical Alerts for Qualcomm, Amgen, Textron, E Trade and Edwards Lifesciences Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/18/2011 07D5WT-E PRN  SEP Leads $8m Million Investment in Metaforic,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/14/2011 03116210 PRN  Amgen to Webcast 2011 Business Review Meeting on April 21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/13/2011 03116210 PRN  Amgen Announces Webcast of 2011 First Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/11/2011 000C35-E PRN  2011 Extraordinary Healer Award for Oncology Nursing Finalists Announced,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/08/2011 03116210 PRN  Amgen Establishes Commercial Operations in Brazil,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/30/2011 03116210 PRN  Amgen to Appeal CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/30/2011 03116210 PRN  Top-Line Results Announced of Pivotal Phase 3 Motesanib Trial in Advanced Non-Squamous Non-Small Cell Lung Cancer Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/28/2011 000C35-E PRN  Preceding the Dana Point Grand Prix of Cycling, the Breakaway from Cancer Night at the Dana Point Yacht Club, Saturday, April 30th, Benefits the Pacific Meso Center",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/24/2011 000C35-E PRN  Boehringer Ingelheim Finalizes Acquisition of Amgen's Fremont Facility in the USA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/23/2011 03116210 PRN  Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/23/2011 03116210 PRN  Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/22/2011 03116210 PRN  ITG's Majestic Market Research Prostate Cancer Study Indicates Amgen's Xgeva is Poised to Steal Significant Share From Novartis' Zometa; Physicians Still on the Fence About Dendreon's Provenge,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/21/2011 NTAP-US  PRN  Critical Alerts For ConocoPhillips, Amgen, NYSE Euronext, NetApp, and Foot Locker Released By Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/18/2011 03116210 PRN  Amgen Statement on CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/14/2011 03116210 PRN  Amgen Donates $1 Million to Help Japanese Disaster Victims,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/08/2011 000C35-E PRN  Palmetto Peloton Project Teams Up with Amgen's Breakaway from Cancer® for Upcoming Stars and Stripes Challenge,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/08/2011 000C35-E PRN  Palmetto Peloton Project Teams Up with Amgen's Breakaway from Cancer® for Upcoming Stars and Stripes Challenge,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/04/2011 008D8Y-E PRN  Amgen Completes Acquisition of BioVex,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/03/2011 AMGN-US  PRN  Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 3/03/2011 03116210 PRN  Breakaway From Cancer® Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/02/2011 07TX6J-E PRN  World-Class Professional Golfer Phil Mickelson Launches 'On Course with Phil' for People with Certain Inflammatory Joint and Skin Conditions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 3/01/2011 03116210 PRN  NBPTS and Amgen Foundation Join to Bolster Science Education,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/24/2011 03116210 PRN  Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/24/2011 03116210 PRN  Amgen to Present at the Citi 2011 Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/22/2011 03116210 PRN  The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 2/17/2011 WFT-CH   PRN  Critical Alerts for Amgen, Applied Materials, Weatherford International, Air Products & Chemicals, and Dollar General Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 2/04/2011 PFE-US   PRN  Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 1/24/2011 062394-E PRN  Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/24/2011 03116210 PRN  Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/24/2011 03116210 PRN  Amgen Announces Webcast of 2010 Fourth Quarter and Full Year Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/18/2011 03116210 PRN  Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/07/2011 000C35-E PRN  Sensipar® Patents Upheld By District Court,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/06/2011 03116210 PRN  Amgen to Present at the 29th Annual JP Morgan Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 1/06/2011 000C35-E PRN  Amgen and Xencor Enter Option Deal to Co-Develop Xencor's Novel Antibody for Autoimmune Diseases,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 1/05/2011 000C35-E PRN  Critical Alerts for Coca-Cola, Amgen, Western Digital, Suncor Energy, and ON Semiconductor Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/16/2010 03116210 PRN  Teach For America and the Amgen Foundation Renew Partnership to Improve Math and Science Education in Urban and Rural Schools,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/13/2010 03116210 PRN  XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/10/2010 03116210 PRN  Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/08/2010 03116210 PRN  Amgen to Present at Deutsche Bank's 2010 BioFEST,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"12/08/2010 03116210 PRN  Three Innovative Ideas Receive $10,000 Prizes in Patients | Choices | Empowerment Competition",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/05/2010 03116210 PRN  Amgen's Nplate® Maintains Platelet Counts for More Than Five Years in Adults With Chronic ITP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/02/2010 03116210 PRN  Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,12/02/2010 000C35-E PRN  Amsterdam Molecular Therapeutics Amends Amgen GDNF Gene License Agreement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"12/01/2010 03116210 PRN  Critical Alerts for Chevron, Pfizer, Amgen, Lorillard, and Liberty Global Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"12/01/2010 000C35-E PRN  Although Enbrel Will Remain Surveyed Dermatologists' Most-Prescribed First-Line Biologic for Psoriasis, It Will Lose Market Share in This Line to the Il-12/Il-23 Inhibitors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/18/2010 03116210 PRN  FDA Approves Amgen's XGEVA™ (Denosumab) for the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/18/2010 000C35-E PRN  Optimer Pharmaceuticals Appoints Kurt Hartman to New Position of General Counsel and Access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/17/2010 03116210 PRN  Amgen Foundation and Ashoka's Changemakers Announce Finalists in Patients | Choices | Empowerment Competition,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/16/2010 03116210 PRN  Call for Applications: The Amgen Award for Science Teaching Excellence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"11/11/2010 03116210 PRN  Amgen Foundation Recognizes Outstanding Staff Volunteers and Contributes $55,000 to Their Favorite Local Nonprofits",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/10/2010 03116210 PRN  Study Published in New England Journal of Medicine Shows Nplate® Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/10/2010 03116210 PRN  Amgen Scholars Undergraduate Summer Research Program Begins Phase 2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/09/2010 03116210 PRN  Amgen to Present at 19th Annual Credit Suisse Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/08/2010 03116210 PRN  Published Results Show Denosumab Superior to Zometa® in Delaying or Preventing Bone Complications in Patients With Bone Metastases From Advanced Breast Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"11/06/2010 03116210 PRN  Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/05/2010 03116210 PRN  Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/01/2010 03116210 PRN  Amgen to Provide Testimony at FDA Hearing on Biosimilars,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,11/01/2010 000C35-E PRN  Food and Drug Law Journal E-Advance Discusses Biosimilar Standards,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/25/2010 03116210 PRN  Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,"10/25/2010 03116210 PRN  Critical Alerts for Amgen, Starbucks, Procter & Gamble, Salesforce.com, and Joy Global Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/20/2010 03116210 PRN  Breakaway From Cancer® Launches 'Striking the Balance' Podcast Series to Inspire Action and Change Across the Cancer Continuum,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/20/2010 03116210 PRN  Amgen Announces Webcast of 2010 Third Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/18/2010 03116210 PRN  Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/14/2010 03116210 PRN  Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/10/2010 03116210 PRN  Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa®,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/09/2010 03116210 PRN  Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/05/2010 03116210 PRN  Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/04/2010 03116210 PRN  Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,10/04/2010 000C35-E PRN  The Dempsey Challenge Presented by Amgen Raises Over One Million Dollars,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 9/24/2010 03116210 PRN  Critical Alerts for Amgen, MetLife, Newmont Mining, SL Green Realty, and Forest Oil Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/24/2010 03116210 PRN  Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/23/2010 000C35-E PRN  Reportlinker Adds Amgen Inc.: PharmaVitae Profile,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/22/2010 03116210 PRN  Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/20/2010 03116210 PRN  Amgen to Present at the UBS Global Life Sciences Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/14/2010 03116210 PRN  Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 9/13/2010 03116210 PRN  Amgen to Present at the Baird Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 8/27/2010 03116210 PRN  Critical Alerts For Visa, Amgen, Colgate-Palmolive, Intuitive Surgical, and Cintas Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/24/2010 000C35-E PRN  Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 8/11/2010 03116210 PRN  Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/29/2010 03116210 PRN  Amgen’s Second Quarter 2010 Adjusted Earnings Per Share Increased 7 Percent to $1.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/28/2010 03116210 PRN  2010 Addressing Psoriasis™ Contest Winners Attend a Style Consultation with Tim Gunn in New York City,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/26/2010 03116210 PRN  Amgen Announces Webcast of 2010 Second Quarter Financial Results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/26/2010 03116210 PRN  Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/22/2010 03116210 PRN  Amgen Appoints Ronald D. Sugar to the Company's Board of Directors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 7/22/2010 03116210 PRN  Critical Alerts For Bank of America, Amgen, Walter Energy, Eastman Chemical, and J. Crew Released By Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/19/2010 03116210 PRN  Amgen Scholars' Summer Research Helps Lead to Science Careers,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/16/2010 03116210 PRN  FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal Related Events in Advanced Cancer Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/15/2010 03116210 PRN  Amgen Appoints Jonathan M. Peacock Executive Vice President and Chief Financial Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 7/14/2010 03116210 PRN  Amgen Foundation and Changemakers Launch Global Online Competition to Empower Patients for Better Outcomes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 6/29/2010 03116210 PRN  Critical Alerts For Chevron, Potash Corp. of Saskatchewan, Amgen, Accenture, and Garmin Released By Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 6/22/2010 03116210 PRN  34 Teachers and Schools Across North America Receive $10,000 Amgen Award for Science Teaching Excellence",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/15/2010 03116210 PRN  Amgen to Present at the Goldman Sachs Global Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/07/2010 03116210 PRN  Amgen to Present at the Jeffries Global Life Sciences Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/06/2010 03116210 PRN  New AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/05/2010 000C35-E PRN  Striking the Balance: Community Experts Come Together for High-Level Dialogue on Cancer Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/05/2010 03116210 PRN  Denosumab Demonstrated Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Prostate Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/05/2010 03116210 PRN  New Analyses of Denosumab Pivotal Phase 3 Trials Reinforce Potential Advantages Over Standard of Care,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/04/2010 000C35-E PRN  Veteran International Health Care Executive Appointed CEO of BeneChill(R),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/04/2010 03116210 PRN  New AMG 479 Phase 2 Data Show Antitumor Activity in Patients With Metastatic Pancreatic Cancer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 6/01/2010 03116210 PRN  FDA Approves Amgen's Prolia(TM) (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/28/2010 03116210 PRN  Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 5/21/2010 03116210 PRN  Critical Alerts for Freeport-McMoRan, Amgen, DuPont, Kroger, and Stanley Black & Decker Released by Seven Summits Research",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/20/2010 03116210 PRN  Amgen Highlights Key Clinical Data to Be Presented at American Society of Clinical Oncology Annual Meeting,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/14/2010 03116210 PRN  Amgen Submits Denosumab Biologics License Application to FDA for the Reduction of Skeletal Related Events in Cancer Patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/12/2010 03116210 PRN  Amgen Announces Voting Results of Annual Meeting of Stockholders,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/11/2010 03116210 PRN  Amgen's Breakaway From Cancer(R) to Honor Cancer Survivors at Amgen Tour of California,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 5/06/2010 03116210 PRN  Amgen Scientists Visit Biotechnology Classrooms Across the Country in Support of National Lab Day,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 5/04/2010 000C35-E PRN  Patient Advocate Foundation Partners With Breakaway from Cancer, Raising Awareness and Funds for Cancer Patients",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/29/2010 03116210 PRN  Amgen to Present at the Deutsche Bank 35th Annual Healthcare Conference,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/29/2010 000C35-E PRN  The Phosphate Binder Market is Currently Stable Despite Talks of Major Changes in January 2011 Once the Dialysis Bundled Payment System Takes Effect,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,," 4/27/2010 000C35-E PRN  Changes Brewing in the Renal Anemia Market, According to Two Recent Publications from BioTrends",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,, 4/26/2010 03116210 PRN  Amgen Appoints Robert A. Bradway President and Chief Operating Officer,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
